{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "058c3812",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hello world\n"
     ]
    }
   ],
   "source": [
    "print (\"hello world\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "5538d629",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\research'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "bacd9ce5",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os \n",
    "os.chdir(\"../\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "28bcbbad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "bc8d35a5",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\ASUS\\anaconda3\\envs\\chatbot_env\\lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "from langchain.document_loaders import PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "f788c178",
   "metadata": {},
   "outputs": [],
   "source": [
    "# --- IMPORTS ---\n",
    "# We use PyMuPDFLoader because it reads tables and layout better\n",
    "from langchain_community.document_loaders import PyMuPDFLoader\n",
    "from langchain.document_loaders import DirectoryLoader\n",
    "\n",
    "# --- FUNCTION DEFINITION ---\n",
    "def load_pdf_files(data):\n",
    "    loader = DirectoryLoader(\n",
    "        data,\n",
    "        glob=\"*.pdf\",\n",
    "        loader_cls=PyMuPDFLoader  # This forces it to use the better loader\n",
    "    )\n",
    "    \n",
    "    documents = loader.load()\n",
    "    return documents\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "54f98feb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully loaded 421 pages.\n"
     ]
    }
   ],
   "source": [
    "\n",
    "folder_path = r\"C:\\Users\\ASUS\\Desktop\\chat-bot\\data\" \n",
    "extracted_data = load_pdf_files(folder_path)\n",
    "print(f\"Successfully loaded {len(extracted_data)} pages.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "fd2be41c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 0}, page_content='1 \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nGuidelines for Management of Pregnant Women \\n with HIV Infection  2024 \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health \\nSri Lanka \\n \\n                 \\n \\nNational Programme on Elimination of Mother to Child Transmission \\n of HIV and Syphilis in Sri Lanka'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 1}, page_content='2 \\n \\n \\nGuidelines for Management of Pregnant Women \\nwith HIV Infection  2024 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health  Sri Lanka'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 2}, page_content='3 \\n \\nGuidelines for Management of Pregnant Mothers with HIV Infection \\n \\nCoordinated by : \\nDr Nimali Jayasuriya \\nConsultant Venereologist ,  \\nNational Coordinator, EMTCT of Syphilis & HIV Programme National STD/AIDS Control Programme. \\n \\nContributors : \\nDr. Nimali Jayasuriya, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Lilani Rajapakse, Consultant Venereologist, former deputy Director NSACP  \\nDr. Geethani Samaraweera, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Jayanthi Elwitigala, Consultant Microbiologist, National STD/AIDS Control Programme \\nDr. Umedha Jayasinghe, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Loshan Moonasinghe, Consultant community physician, Family Health Bureau \\nDr. Nalaka Kulathunga , Senior Registrar in Venereology, National STD/AIDS Control Programme \\nDr. Shirmila Rajapakshe, Acting Consultant Venereologist, National STD/AIDS Control Programme  \\nDr Champika Gunewardhana, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Sithmi Koswaththa, Senior Registrar in Venereology, National STD/AIDS Control Programme  \\n \\n \\n \\n \\nContributors for  the 3rd t edition :  \\nDr. K A M Ariyaratne, Consutant Venereologist, NSACP  \\nDr. Jayanthi Elwitigala, Consultant Microbiologist NSACP \\nDr. Darshani Mallikarachchi, Consultant Venereologist,  \\nDr. Chandrika Jayakody, Consultant Venereologist,  \\nDr. J Nadeeka, Consultant Virologist'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 3}, page_content='4 \\n \\n \\nPublished by \\nNational STD/AIDS Control Programme      \\nMinistry of Health \\nColombo, Sri Lanka. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n1st Edition 2008 \\n2nd Edition 2011 \\n3rd Edition 2016 \\n4th Edition  2024'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 4}, page_content='5 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nThe guidelines for management of pregnant women with HIV infection - \\n2024 was prepared to assist policymakers to optimize  PMTCT \\ninterventions and healthcare workers to provide optimal services to \\npregnant women with HIV'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 5}, page_content='6 \\n \\nContents \\n \\n1. \\nValidation of Elimination of mother to child transmission (EMTCT) of HIV and syphilis programme 13 \\n1.1 Maintenance of eliminated status of MTCT of HIV ........................................................................ 13 \\n2. \\nHIV testing in pregnant women ....................................................................................................... 15 \\n3. Fertility desires among women with HIV ............................................................................................. 18 \\n3.1 Fertility options for PLHIV ............................................................................................................. 18 \\n3.1.1 Sero-discordant Couples ........................................................................................................ 19 \\n4. Pre-Exposure Prophylaxis .................................................................................................................. 20 \\n5. Management of  pregnant women with HIV ........................................................................................ 21 \\n5.1 When to start ART in pregnant and breastfeeding women? .......................................................... 21 \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) ............................ 21 \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy ............................... 21 \\n5.2.2 ARV regimens ........................................................................................................................ 21 \\n5.2.3 Preferred regimens ................................................................................................................ 22 \\n5.2.4 Women with HIV conceiving while on ART ............................................................................. 23 \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got pregnant \\nwhile maintaining successful viral suppression, oral two drug regimen may be continued with more \\nfrequent (every 1-2 months)  viral load monitoring. ......................................................................... 23 \\n5.2.5 Late-presenting woman not on treatment ............................................................................... 23 \\n6. Monitoring of pregnant women receiving ART .................................................................................... 24 \\n7. Obstetric management ....................................................................................................................... 25 \\n7.1 Antenatal management ................................................................................................................. 25 \\n7.2. Mode of delivery .......................................................................................................................... 26 \\n7.3. Multiple pregnancies .................................................................................................................... 27 \\n8. Antenatal care at the primary health care ANC clinic .......................................................................... 28 \\n9. Management of HIV positive pregnant women in the STD clinic......................................................... 29 \\n9.1  Counselling .................................................................................................................................. 29 \\n10. Management of delivery of pregnant mother with HIV ...................................................................... 30 \\n10.1 Plan for delivery .......................................................................................................................... 30 \\n10.2 Planned normal vaginal delivery ................................................................................................. 31 \\n10.3. Planned caesarean section........................................................................................................ 31 \\n10.4 Management of pre-labour spontaneous rupture of membranes ................................................. 32 \\n10.5 Management of women who present in labor without documentation of HIV status or women who \\nhave not received antepartum antiretroviral drugs .............................................................................. 32 \\n11. Post-partum Management ................................................................................................................ 34'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 6}, page_content='7 \\n \\n11.1  Immediate management ............................................................................................................ 34 \\n11.2 Additional measures ................................................................................................................... 34 \\n11.3 Antiretroviral therapy................................................................................................................... 35 \\n11.4 Support services ......................................................................................................................... 35 \\n11.5 Mental health assessment and support....................................................................................... 35 \\n12. Neonatal management ..................................................................................................................... 36 \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection ............... 37 \\n13. HIV diagnosis in infants and children................................................................................................ 39 \\n13.1 Timing of assessments ............................................................................................................... 40 \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants ................................................... 40 \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis ..................................................... 43 \\n14.  Antiretroviral drug dosing recommendations for newborns .............................................................. 45 \\n15. Co-trimoxazole prophylaxis .............................................................................................................. 48 \\n16. Infant feeding ................................................................................................................................... 49 \\n17. Contraception for women living with HIV .......................................................................................... 50 \\n19. Immunization .................................................................................................................................... 57 \\n20. References....................................................................................................................................... 59 \\n21. Annexures ........................................................................................................................................ 60'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 7}, page_content='8 \\n \\nAbbreviations and acronyms \\nAbacavir  \\nABC \\nAntenatal clinic \\nANC \\nAntiretroviral  \\nARV \\nAntiretroviral therapy \\nART \\nAcquired Immune deficiency syndrome \\nAIDS \\nAtazanavir \\nATV \\nAtazanavir/cobicistat  \\nATV/c \\nAtazanavir/ritonavir  \\nATV/r  * \\nBictegravir  \\nBIC \\nCabotegravir  \\nCAB \\nCaesarean Section   \\nCS \\nCombined hormonal contraception \\nCHC \\nCopper intrauterine device \\nCu- IUD \\nDarunavir/cobicistat (DRV/c \\nDRV/c \\nDarunavir/ritonavir (DRV/r) \\nDRV/r \\nDepot medroxyprogesterone acetate \\nDMPA \\nDolutegravir  \\nDTG \\nDoravirine  \\nDOR \\nDRV darunavir \\nDRV  \\nEarly infant diagnosis \\nEID \\nEfavirenz  \\nEFV \\nElvitegravir  \\nEVG \\nElvitegravir/ cobicistat  \\nEVG/c   \\nEmtricitabine  \\nFTC \\nEnfuvirtide  \\nENF \\nEnhanced postnatal prophylaxis \\nePNP \\nEnzyme Linked Immunosorbent Assay \\nELISA \\nEtonogestrel implant \\nENG-IMP \\nEtravirine  \\nETR \\nExternal cephalic version (ECV)  \\nECV \\nFixed dose combinations  \\nFDCs \\nGlobal validation advisory committee \\nGVAC \\nGlobal AIDS Monitoring  \\nGAM \\nHealth-care worker \\nHCW \\nHIV drug resistance \\nHIVDR \\nHuman immunodeficiency virus \\nHIV \\nIntegrase strand transfer inhibitors  \\nINSTIs \\nLamivudine  \\n3TC \\nLevonorgestrel-releasing intrauterine system \\nLNG-IUD \\nLong-acting injectable cabotegravir \\nCAB-LA \\nLopinavir/ritonavir \\nLPV \\nLopinavir/ritonavir (LPV/r)  \\nLPV/r \\nLower segment caesarean section  \\nLSCS \\nMaraviroc  \\nMVC \\nMaternal and child health \\nMCH \\nMedical officer \\nMO'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 8}, page_content='9 \\n \\nMinistry of Health \\nMOH \\nMother and child health \\nMCH \\nMother to child transmission \\nMTCT \\nMother-to-child transmission \\nMTCT \\nMultidisciplinary team \\nMDT \\nNational Reference Laboratory  \\nNRL \\nNucleic acid amplification test  \\nNAT \\nNevirapine \\nNVP \\nNon-nucleoside reverse transcriptase inhibitors \\nNNRTIs \\nNucleic acid testing  \\nNAT \\nNucleoside reverse transcriptase inhibitors  \\nNRTI \\nPoint-of-care \\nPOC \\nPolymerase chain reaction \\nPCR \\nPost  Exposure Prophylaxis  \\nPEP \\nPre-Exposure Prophylaxis  \\nPrEP \\nPre-labour Caesarean Section   \\nPLCS \\nPrevention of mother-to-child transmission \\nPMTCT \\nProgestogen-only pill \\nPOP \\nPublic health midwife  \\nPHM \\nRaltegravir  \\nRAL \\nRapid diagnostics test \\nRDT \\nRegional validation committee  \\nRVC \\nRilpivirine  \\nRPV \\nSexually Transmitted Infections \\nSTI \\nSpontaneous Rupture of Membranes \\nSROM \\nTenofovir alafenamide  \\nTAF \\nTenofovir disoproxil fumarate  \\nTDF \\nViral load \\nVL \\nWorld Health Organization \\nWHO \\nZidovudine \\nAZT'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 9}, page_content='10 \\n \\nContents of Tables \\n \\n \\n \\nTable 1 : Indicators and targets for validation of EMTCT of the HIV programme \\n13 \\nTable 2 : First line ART regimens \\n22 \\nTable 3 : Recommendations following SROM \\n32 \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\n33 \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high and low risk: \\n36 \\nTable 6 : Infant post-exposure prophylaxis (PEP) \\n38 \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n40 \\nTable 8 : Infant diagnosis among breastfed infants \\n41 \\nTable 9 : ART dosage for infants \\n45 \\nTable 10: Contraceptive methods \\n51 \\nTable 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n52 \\nTable 12: ART and emergency contraception (EC) \\n55 \\nTable 13:  Immunization Schedule \\n57'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 10}, page_content='11 \\n \\nTable of figures \\n \\nFigure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n16 \\nFigure 2 : HIV Testing algorithm for pregnant women \\n17 \\nFigure 3: Early Infant diagnosis algorithm \\n42 \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n44'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 11}, page_content='12 \\n \\nAnnexures  \\nAnnexure 1 : General circular letter No. 01-51/2016 - English \\n61 \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil \\n64 \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala \\n66 \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\n69 \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n71 \\nAnnexure 6 : Blood Collection request form \\n72 \\nAnnexure 7 : EMTCT HIV Case Investigation form \\n73 \\n Annexure 8 : Pregnancy record \\n74 \\nAnnexure 9 : Poster  for EMTCT of HIV \\n75 \\nAnnexure 10 : Leaflet for pregnant women on service package \\n76'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 12}, page_content='13 \\n \\n1. Validation of Elimination of mother to child transmission \\n(EMTCT) of HIV and syphilis programme \\nSri Lanka has been declared as a country that eliminated MTCT of HIV and syphilis by the WHO, \\nGeneva in 2019. The overall goal for EMTCT of HIV and syphilis is to ensure the prevention of MTCT \\nof HIV and syphilis to a level that it is no longer a public health problem. Sri Lanka had to achieve the \\nfollowing impact and process indicators to achieve the elimination status. \\n           Table 1 : Indicators and targets for validation of EMTCT of the HIV programme \\nImpact indicators \\nA case rate of HIV positive infants  ≤50 per 100 000 live births \\nProcess indicators \\n \\nPopulation-level ANC1 coverage (at least one visit) of ≥95% \\nCoverage of HIV testing of pregnant women of ≥95% \\nTreatment coverage of HIV positive pregnant women of ≥95% \\nTreatment coverage of infants exposed to HIV of ≥95% \\n \\nThe EMTCT programme is closely monitored by WHO and will be revalidated once every three years. \\nIt is important to maintain satisfactory process and impact indicators and to sustain the success of the \\nprogramme throughout.  \\nSero-prevalence of HIV among antenatal population has remained at <0.01% for the last two decades \\nin Sri Lanka. \\nThe probability of mother to child transmission of HIV can be eliminated with appropriate \\nmanagement. If there is no intervention, the risk of transmission of HIV from an untreated mother to \\nchild is between 15-45 % depending on the stage of the infection, HIV RNA level and infant feeding \\npractices. \\n \\n1.1 Maintenance of eliminated status of MTCT of HIV  \\nFollowing validation of the EMTCT programme, it is important to maintain the impact and process \\nindicators each year to certify the country as successfully maintaining the services for EMTCT of HIV.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 13}, page_content='14 \\n \\nCountries that fail to maintain the required EMTCT impact and  process indicators or maintain human, \\nsexual and  reproductive rights for women, can lose validation status.  \\nMaintenance of validation reports are expected to be submitted by countries every 3 years after initial \\nvalidation. These reports will be submitted through the regional validation committee (RVC) and \\nreviewed by the GVAC and the global secretariat to verify maintenance of validation.  \\nTo sustain elimination, a country requires comprehensive surveillance and monitoring systems \\n(including among vulnerable and key populations at risk of acquiring HIV and STIs). Such strong \\nsystems are needed to provide accurate data on intervention coverage, and quickly detect changes in \\ndisease transmission trends. For MTCT of HIV and syphilis, these systems provide ongoing monitoring \\nof the prevalence of disease in pregnant women and the coverage and effectiveness of treatment.  \\nThe global secretariat will maintain a list of countries that have achieved validation and maintain \\nvalidation criteria and standards over time. A country may lose its validation status if coverage of \\nservices falls or if impact indicators such as case rate or MTCT rate exceed the global validation targets.  \\nTo maintain validation status, data should be reported through global reporting mechanisms such as \\nthe UNAIDS Global AIDS Monitoring (GAM) system. Indicators that are not captured in the GAM should \\nbe reported directly to the WHO country office.  \\nAt the time of assessment of maintenance of validation, countries will be required to prepare a report \\nthat should include data tables on validation targets (process and impact indicators for the previous 3 \\nyears). For countries like Sri Lanka, with small populations and small numbers of HIV-positive and/or \\nsyphilis-positive pregnant women per year, 4 years of pooled data can be used to assess maintenance \\nof validation. Human rights, gender equality and civil society engagement must be reassessed and \\nincluded in the report at this time to ensure that there are no violations or changes in laws pertaining to \\nthis component of validation since the last validation review. Maintenance reports should include \\nupdates on any programmatic data, laboratory and human rights recommendations provided by the \\nGVAC at the time of validation. Maintenance reports should be submitted to the RVS, which will review \\nthe report and, if the validation criteria are still being met, will submit the report to the RVC (if applicable) \\nand the GVAC for final revalidation.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 14}, page_content='15 \\n \\n2. HIV testing in pregnant women \\n \\nHIV testing services should be offered to all pregnant women during the first visit with the antenatal \\ncare package before 12 weeks of gestation. \\n \\n\\uf0b7 \\nPregnant women should be informed about these tests, with testing being voluntary after \\nproviding adequate information on MTCT of HIV and prevention methods. \\n\\uf0b7 \\nIf a woman declines testing, her decision should be respected, and she should be assured \\nthat it will not affect her access to ANC services. \\n\\uf0b7 \\nFor pregnant women at high risk for HIV or STIs, a second HIV test should be offered at 28 \\nweeks of gestation either through the nearest STD clinic or via RDT. \\n \\n\\uf0b7 \\nAll pregnant women should receive opt-out HIV testing as early as possible during each pregnancy. \\n\\uf0b7 \\nDual HIV and syphilis rapid diagnostic tests can be offered as the first test in antenatal care to \\nincrease testing and treatment coverage.  \\n\\uf0b7 \\nRepeat HIV testing in the third trimester is recommended for pregnant women with negative initial \\nHIV tests who are at increased risk of acquiring HIV. \\n\\uf0b7 \\nRepeat HIV testing is recommended for pregnant women with a sexually transmitted infection, with \\nsigns and symptoms of acute HIV infection, or with ongoing exposure to HIV.  \\n\\uf0b7 \\nExpedited HIV testing should be performed during labor or after delivery for people with \\nundocumented HIV status and for those who tested negative early in pregnancy but are at increased \\nrisk of HIV infection and were not retested in the third trimester.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 15}, page_content='16 \\n \\n \\n               Figure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from the  \\nANC clinics. \\nDate of blood sampling \\nshould be recorded in \\n512 pregnancy record \\n \\n \\nBlood samples are sent \\nto the STD clinics \\n \\nHIV /Syphilis Duo rapid \\ntest is performed at the \\nSTD clinic laboratory \\n \\nPositive results are conveyed \\nimmediately to the MOH or VOG of \\nthe relevant ANC clinic \\n(over the phone) \\nNegative results are  sent back to the \\nMOH through the same request form \\n \\n \\nPregnant women who receive a \\npositive HIV screening result are \\nimmediately referred to the STD \\nclinic for further evaluation and \\nmanagement'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 16}, page_content='17 \\n \\nFigure 2 : HIV Testing algorithm for pregnant women  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n*Any discrepancy of a test results;  sample should be immediately  sent to the NRL for molecular or viral load \\ntesting\\n+ ELISA or + RDT1 \\nPerform Ag/Ab combo \\nRDT1 \\n(second sample)  \\nPerform ELISA or repeat \\nRDT1 \\nConnect to \\nnational HIV \\ntesting \\nalgorithm* \\n+ RDT1 \\nReport as HIV \\nNegative \\n- ELISA or - RDT1 \\n- RDT1 \\nPerform HIV/Syphilis  \\nDuo RDT \\n+HIV \\n- HIV \\nReport as HIV \\nNegative'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 17}, page_content='3. Fertility desires among women with HIV  \\n \\n\\uf0b7 \\nImprovements in life expectancy and quality of life for women living with HIV, along with \\nenhanced access to EMTCT services, have increasingly led HIV positive women to \\ncontemplate the possibility of pregnancy.  \\n\\uf0b7 \\nPre-conception counselling need to be offered to all HIV positive women planning to have \\nchildren. Counselling should include the importance of treatment adherence and virologic \\nsuppression to eliminate the risk of MTCT of HIV. ARV therapy should be discussed with \\nevery woman taking their concerns and preferences into account and management should \\nbe based on the standard treatment guidelines.  \\n\\uf0b7 \\nAll women planning on pregnancy should start folic acid supplementation before pregnancy \\nand continue up to 12 weeks of gestation. \\n \\n3.1 Fertility options for PLHIV \\nIncreasingly, parenting is regarded as a realistic option for couples where one or both partners \\nare infected with HIV and the demand for reproductive care is rising. HIV-positive men and \\nwomen and their partners planning to have children should receive pre-conception counselling \\non all their conception options, including HIV transmission risks associated with each case, so \\nthat they can make an informed choice. All discussions should be documented clearly in clinical \\nnotes. \\nFor sero-concordant or discordant couples who want to conceive, expert consultation is \\nrecommended so that approaches can be tailored to specific needs, which may vary from \\ncouple to couple. \\nThe physician does need to ensure that the uninfected partner has a full understanding of the \\npossibility of becoming infected through unprotected intercourse. More importantly, the need \\nfor ART adherence and regular attendance for STI screening in the couple and viral load \\nchecks in the infected partner should be stressed.  \\nFor couples in which one or both partners are HIV-infected, optimal health should be attained \\nbefore attempting conception.  \\n\\uf0b7 \\nInfected partner/couple should be receiving combination antiretroviral therapy and \\ndemonstrate sustained viral suppression  (two  undetectable viral load over the'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 18}, page_content='19 \\n \\nperiod of six months) of plasma viral load below the limits of detection (at present \\n<34 copies/ml). \\n\\uf0b7 \\nBoth partners should be screened for genital tract infections. Treatment of such \\ninfections is important because genital tract inflammation is associated with genital \\ntract shedding of HIV. \\n\\uf0b7 \\nShould  undergo fertility screen where necessary. \\n3.1.1 Sero-discordant Couples  \\nBefore conception is attempted, the HIV-infected partner should be receiving ART and \\ndemonstrate sustained suppression of plasma viral load below the limits of detection. The \\npossible fertility options are  as follows.  \\n1. Antiretroviral Therapy (ART) for the HIV-Positive Partner: \\nEnsuring the HIV-positive partner is on effective ART and has an undetectable viral \\nload reduces the risk of sexual transmission to effectively zero. This approach is known \\nas \"U=U\" (Undetectable = Untransmittable). Once the viral load is suppressed, natural \\nconception through timed intercourse becomes safer. \\n2. Pre-Exposure Prophylaxis (PrEP) for the HIV-Negative Partner: \\nThe HIV-negative female partner can take PrEP to further reduce the risk of acquiring \\nHIV during conception attempts. PrEP is most effective when taken consistently as \\nprescribed. \\n3. Timed Intercourse with ART and PrEP: \\nThis involves natural conception through intercourse timed around ovulation, combined \\nwith ART for the HIV-positive partner and PrEP for the HIV-negative partner. \\n4. Sperm Washing: \\nSperm washing is a process where sperm is separated from the seminal fluid, which \\nmay contain HIV. The washed sperm can then be used for intrauterine insemination \\n(IUI) or in vitro fertilization (IVF). This method significantly reduces the risk of HIV \\ntransmission. \\n5. In Vitro Fertilization (IVF): \\nIVF using sperm washing is a common method where the washed sperm is used to \\nfertilize the female partner’s ovum in a laboratory, followed by the transfer of the embryo \\nto the uterus. This option is particularly useful for couples with fertility challenges. \\n6. Donor Sperm: \\nIf the couple prefers to avoid the risk of transmission altogether, donor sperm from an \\nHIV-negative donor can be used for insemination or IVF.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 19}, page_content='20 \\n \\n4. Pre-Exposure Prophylaxis  \\n \\nIn sero-discordant couples where the HIV-positive partner is on antiretroviral therapy and has \\nachieved sustained viral suppression, condomless sexual intercourse enables conception \\nwithout the risk of HIV transmission to the HIV-negative partner. As an added precaution, they \\nhave the option to choose PrEP for HIV prevention, even if the HIV-positive partner has achieved \\nviral suppression.  \\nThe preferred PrEP option for HIV prevention in people who have receptive vaginal sex during \\npregnancy and breastfeeding is tenofovir disoproxil fumarate with emtricitabine or lamivudine \\n(TDF+FTC/3TC). People who become pregnant while using TDF/FTC or TDF/3TC as PrEP, can \\ncontinue PrEP throughout pregnancy and breastfeeding. Risk for HIV acquisition should be \\nreassessed, and couple should be counselled regarding the benefits and risks of PrEP use in \\npregnancy and breast feeding. \\nProviders should counsel patients about the importance of adherence to oral PrEP to prevent \\nHIV acquisition. Event driven or non-daily PrEP is not recommended for protection against \\nvaginal exposure to HIV.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 20}, page_content='21 \\n \\n5. Management of  pregnant women with HIV  \\n \\n5.1 When to start ART in pregnant and breastfeeding women? \\nAll pregnant and breastfeeding women living with HIV should initiate and continue lifelong ART, \\nregardless of WHO clinical stage or CD4 count. Pregnant women newly diagnosed with HIV \\nshould start ART as early as possible, while those already on ART with sustained viral \\nsuppression should maintain their current regimen. \\nProviding ART to all pregnant and breast-feeding women living with HIV serves three synergistic \\npurposes. \\n1. Improving mothers’ health \\n2. Preventing mother to child transmission of HIV \\n3. Preventing transmission of HIV from mother to sexual partner/partners \\nFollowing a confirmed HIV diagnosis and clinical assessment, rapid ART initiation should be \\noffered to all individuals, ideally within seven days. Those with advanced HIV disease should \\nbe prioritized. Same-day ART initiation should be available for individuals ready to start \\ntreatment immediately. \\n \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy \\nWhen selecting an ARV regimen for pregnancy, factors to consider include adverse effects, \\ndrug interactions, pharmacokinetics, regimen convenience, pregnancy safety data, virologic \\nefficacy, and comorbidities. The selection of  ARV regimen for pregnancy, is a shared and \\nindividualized decision taken with consideration of available data for drug use in pregnant \\npeople as well as durability, tolerability and simplicity of medication regimen to ensure \\ntreatment adherence \\n5.2.2 ARV regimens \\nThere are five categories of drug recommendations in pregnancy as Preferred, Alternative, \\nInsufficient data to recommend, not recommended except in special circumstances and not \\nrecommended.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 21}, page_content='22 \\n \\nOut of them the preferred first line regimen for the treatment of pregnant people with HIV who \\nhave never received ARV drugs consist of the integrase strand transfer inhibitor (INSTI) \\ndolutegravir (DTG) plus a dual-nucleoside reverse transcriptase inhibitor (NRTIs) combination.  \\n5.2.3 Preferred regimens  \\nTable 2 : First line ART regimens \\nFirst line ART \\nPreferred first –line \\nregimens \\nAlternative first –line regimens* \\n  \\nPregnant and breast-\\nfeeding women  \\n \\nTDF + FTC/3TC + DTG \\nTAF + FTC + DTG \\n \\n \\n \\nABC1 + 3TC +DTG/DRV/r2/EFV3//ATV/r \\nAZT + 3TC + DTG/DRV/r /EFV/ATV/r \\nTDF + FTC + DRV/r2 / EFV3 / RPV4 \\nTAF + FTC + DRV/r2 / EFV3 /RPV4 \\n \\n1ABC - Presence of HLA-B 5701 gene indicates higher risk for hypersensitivity. Viral load should be <100,000 \\ncopies/ml and without chronic hepatitis B virus (HBV) coinfection \\n2DRV Twice daily dose is recommended in pregnancy. \\n3If the preferred ART regimen is unavailable or contraindicated, alternatives for pregnant and breastfeeding women \\ninclude substituting TAF/ABC for TDF or using EFV or DRV/r instead of INSTI. The efficacy of low-dose EFV (400 \\nmg) in pregnancy has not been studied \\n4RPV can be used if VL< 100 000 c/ml and CD4 >200 cells/mm3. \\nNote: \\n\\uf0b7 \\nTAF or boosted PIs (DRV/r, ATV/r, LPV/r) can be used in special circumstances. \\n\\uf0b7 \\nINSTI Bictegravir (BIC) classified as an alternative ARV drug for use in pregnancy. \\n\\uf0b7 \\nOther INSTI Elvitegravir (EVG) or Cabotegravir (CAB) are not recommended in pregnancy due \\nto limited data during pregnancy. \\n \\nIf an ARV regimen is stopped during pregnancy, all drugs should be discontinued together, and \\na complete regimen restarted promptly. Pregnant women with HIV who have defaulted on ART \\nshould resume treatment immediately, adjusting the regimen later if resistance test results \\nrequire it \\nIn addition to ART, they should receive comprehensive pregnancy care, including nutritional \\nsupport, infant feeding counseling, and family planning guidance. Monitoring for pregnancy-\\ninduced hypertension and pre-eclampsia, particularly in women on ART before conception, is \\nessential.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 22}, page_content='23 \\n \\n5.2.4 Women with HIV conceiving while on ART \\n \\nIt is recommended that women conceiving on an effective ART regimen should be continued. \\nThe ART regimens should not be changed just due to non-inclusion of preferred or alternative \\nregimens or drugs, because the changing could lead to increase in viral load, decline in immune \\nstatus, progression of disease and increased risk of mother to child transmission of HIV \\ninfection. However, ART regimen should be changed if it contains medications which are not \\nrecommended to use in pregnancy. \\nIt is recommended to continue suppressive regimen with frequent viral load monitoring when \\nshe is on an ART regimen with insufficient data about using in pregnancy. \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got \\npregnant while maintaining successful viral suppression, oral two drug regimen may be \\ncontinued with more frequent (every 1-2 months)  viral load monitoring. \\n5.2.5 Late-presenting woman not on treatment \\nINSTIs have an important role to play in late pregnancy as DTG and RAL can suppress viral \\nload rapidly. A decrease of approximately 2 log10 copies/ml occurs by two-week therapy with \\nDTG and RAL. DTG preferred and RAL (Raltegravir) is alternative as RAL requires twice daily \\ndosing and has a lower barrier to development of drug resistance than DTG.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 23}, page_content='24 \\n \\n6. Monitoring of pregnant women receiving ART \\n\\uf0b7 \\nClinical and laboratory evaluation is as for non-pregnant women receiving ART.  \\n\\uf0b7 \\nHaematological and biochemistry parameters should be monitored as appropriate to the \\nART regimen used. \\n\\uf0b7 \\nRegular viral load monitoring is needed in pregnancy.  \\n\\uf0b7 \\nAll pregnant women, regardless of when they start ART, may require more intense \\nmonitoring of viral suppression, including conducting viral load testing at 34–36 weeks \\nof gestation (or at the latest at delivery) to identify women who may be at risk of treatment \\nfailure and/or may deliver infants at higher risk of perinatal transmission.  \\n\\uf0b7 \\nIn addition, a viral load test is recommended for all breastfeeding women three months \\nafter delivery and every six months thereafter to detect viraemic episodes during the \\npostnatal period. \\n\\uf0b7 \\nWhen lack of suppression is identified, a thoughtful evaluation of potential contributing \\nfactors is needed, including barriers to adherence, drug resistance, drug–drug and drug–\\nfood interactions, pharmacokinetics  changes in pregnancy that affect drug levels, and \\ncombinations of these factors. \\n\\uf0b7 \\nIn women who commence ART in pregnancy, HIV viral load should be performed four \\nweeks after commencing ART and at 36 weeks. \\n\\uf0b7 \\nIn women commencing ART in pregnancy, liver function tests should be performed at \\ninitiation of ART and then at each antenatal visit. \\n\\uf0b7 \\nIf a woman who has initiated ART during pregnancy has not achieved a plasma viral \\nload of < 50 HIV RNA copies/ml at 36 weeks, following interventions are recommended: \\n\\uf0d8 Review treatment adherence and concurrent use of other medication \\n\\uf0d8 Perform resistance testing if appropriate \\n\\uf0d8 Optimize to the best regimen \\n\\uf0d8 Consider intensification'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 24}, page_content='25 \\n \\n7. Obstetric management \\n7.1 Antenatal management \\n\\uf0b7 \\nPregnant women with HIV should receive comprehensive care from a multidisciplinary \\nteam, including an obstetrician, venereologist, paediatrician, anaesthetist, theatre nurse, \\nMOH, microbiologist/virologist, and infection control nurse. Effective coordination, \\nconfidentiality, and shared responsibility are crucial in their management.  \\n\\uf0b7 \\nHealthcare providers must ensure that antenatal, labor, delivery, and postpartum care \\nare delivered in a supportive environment, with institution heads and consultants working \\nto prevent stigma and discrimination. Ensure privacy and confidentiality during \\nconsultations and reassure the woman that her HIV status will be kept confidential. \\n\\uf0b7 \\nExplain to the woman who the information will be shared with. \\n\\uf0b7 \\nExplain to the woman that she will have to follow routine antenatal clinic visits and give \\nher confidence by discussing the management plan with her. \\n\\uf0b7 \\nFoetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal diagnostic testing should not be performed until after the HIV status of \\nthe mother is known and should ideally be deferred until HIV viral load has been \\nadequately suppressed. \\n\\uf0b7 \\nPlan and discuss the mode of delivery with the pregnant woman during antenatal care. \\nGive her clear instructions on when to get admitted for delivery and whom should be \\ncontacted.  \\n\\uf0b7 \\nExternal cephalic version (ECV) can be performed in women with HIV who are virally \\nsuppressed. \\n\\uf0b7 \\nHealth care workers should practice universal infection control measures for all \\ndeliveries irrespective of the infection status of pregnant women. \\n\\uf0b7 \\nAmniocentesis may be performed on virally suppressed pregnant women with HIV after \\nthorough counseling on risks, benefits, and alternatives, if they are on ART with an \\nundetectable viral load. \\n\\uf0b7 \\nCoordinated multidisciplinary team management involving MCH staff, infection control, \\nvenereologists, obstetricians, pediatricians, and other relevant services is crucial for \\ndelivering quality care.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 25}, page_content='26 \\n \\n\\uf0b7 \\nDuring pregnancy, pregnant woman needs to be counselled on mode of delivery, family \\nplanning and contraceptive options, infant feeding, infant ARV prophylaxis, and timing \\nof infant diagnostic testing. \\n\\uf0b7 \\nFetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal testing should be delayed until the woman\\'s viral load is suppressed \\nto <50 copies/mL. If invasive testing can\\'t wait for viral suppression, ART with DTG \\nshould be initiated, and a single dose of nevirapine administered 2–4 hours before the \\nprocedure.  \\n \\n   7.2. Mode of delivery \\n\\uf0b7 \\nFor women with a plasma viral load of <50 HIV RNA copies/mL at 36 weeks, and in the \\nabsence of obstetric contraindications, planned vaginal delivery can be  supported. \\n\\uf0b7 \\nFor women with a plasma viral load of ≥ 50 HIV RNA copies/mL at 36 weeks, pre-labour \\nCaesarean Section  (PLCS) is recommended. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been planned and labour has commenced, \\nobstetric management should follow the same guidelines as for the HIV-negative \\npopulation, except for managing the duration of ruptured membranes. \\n\\uf0b7 \\nTraditionally amniotomy, fetal scalp electrodes and blood sampling, instrumental \\ndelivery and episiotomy have been avoided in HIV infection because of theoretical \\ntransmission risks. \\n \\nPoints for consideration \\n• \\nAll known HIV infected pregnant women should have an individualized, regularly \\nupdated, plan of care which summarizes mutually agreed obstetric/HIV management \\nincluding the drug regimen and recommended mode of delivery.  \\n• \\nProperly applied universal infection control measures protect staff from blood borne \\ninfections. Routine use of these precautions is essential to minimize occupational \\nrisk. \\n• \\nWard staff must maintain confidentiality regarding a pregnant woman’s HIV status and \\nprovide nonjudgmental, stigma-free care. Information should be shared only on a \"need \\nto know\" basis'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 26}, page_content='27 \\n \\n7.3. Multiple pregnancies \\nMultiple pregnancies should be managed according to obstetric need of the woman and as \\nper HIV-negative protocols.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 27}, page_content='28 \\n \\n 8. Antenatal care at the primary health care ANC clinic \\n \\n \\n• \\nWhen a pregnant woman is diagnosed as having HIV infection, the venereologist of the \\nSTD clinic will communicate with the MOH regarding the steps need to be taken. \\n• \\nMOH and staff play a key role in caring for pregnant women with HIV. Effective \\ncoordination, confidential communication, and shared responsibility are essential for \\nproper management. \\n• \\nEnsure privacy and confidentiality during consultations and reassure the woman that her \\nHIV status will be kept confidential. \\n• \\nExplain to the pregnant woman who the information will be shared with. \\n• \\nExplain to her that she will have to follow routine antenatal clinic visits.  \\n• \\nThe pregnant woman should be reassured and should be referred immediately to the \\nSTD clinic for further management. \\n• \\nHealth care providers should ensure that pregnant women with HIV are provided \\nantenatal care, labour and delivery care and post-partum services in a user-friendly \\nenvironment.  \\n• \\nThe MOH and the staff should take all measures to maintain confidentiality and prevent \\nstigma and discrimination. \\n• \\nCheck whether she has been seen by a VOG as delivery care needs to be arranged in \\na unit with specialist services.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 28}, page_content='29 \\n \\n9. Management of HIV positive pregnant women \\nin the STD clinic \\n \\nThere are two possibilities. \\n\\uf0b7 \\nA pregnant woman may be identified as having HIV infection during routine antenatal \\nscreening and referred to the STD clinic by the MOH or VOG for further management. \\n\\uf0b7 \\nA woman already diagnosed as living with HIV and under care services from STD clinic \\ncan become pregnant. \\n\\uf0d8 All pregnant women with HIV should have an individualized, regularly updated plan of \\ncare which summarizes mutually agreed obstetric and HIV management plan.  \\n\\uf0d8 Check whether the woman has already attended for antenatal care and encourage \\nregular attendance at antenatal visits. \\n\\uf0d8 Ask about the health of other children and encourage checking HIV status of partner and  \\nchildren. \\n \\n9.1  Counselling \\n  The following areas need to be covered in counseling. \\n\\uf0b7 \\nART and adherence to treatment \\n\\uf0b7 \\nPartner disclosure/screening \\n\\uf0b7 \\nHIV testing of other children \\n\\uf0b7 \\nMode of delivery \\n\\uf0b7 \\nChoice of infant feeding \\n\\uf0b7 \\nCondom use to prevent acquiring other STIs, entry of other strains of HIV and onward \\ntransmission to a negative partner \\n\\uf0b7 \\nPostpartum family planning \\n \\nPregnant women should be counselled on delivery options, lifelong HIV therapy, family planning, \\ncontraceptives, infant feeding, ARV prophylaxis for the infant, and timing of infant diagnostic \\ntesting.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 29}, page_content='30 \\n \\n10. Management of delivery of pregnant mother with \\nHIV \\n \\n10.1 Plan for delivery \\n \\nPlan and discuss the mode of delivery with the pregnant woman (and her partner if possible) \\nduring the  antenatal care. \\nGive her instructions on when to get admitted to the hospital for delivery and whom she should \\ncontact. \\nExplain the possibility of preterm labour and what to do in case of an emergency. \\nWhen admitted for delivery \\n• \\nCheck the expected date of delivery \\n• \\nConfirm normal growth of the foetus \\n• \\nCheck which ART regimen have been prescribed and whether drugs have been taken \\nas prescribed \\n• \\nCheck for recent viral load results \\n• \\nWomen with incomplete viral suppression (>50 copies/mL) at the time of delivery \\npreferably should receive IV zidovudine (if available) while continuing oral ARV \\nregimen. \\n• \\nIn situations where IV administration is not possible/not available, oral \\nadministration of zidovudine using a 600-mg loading dose and 400 mg every 3 \\nhours can be considered. \\n• \\nCheck for availability of antiretroviral treatment for infant prophylaxis. \\n• \\nCheck for infant feeding method and emphasize on adherence and support if she has \\ndecided on breast feeding.  \\n• \\nProvide lactation suppression therapy if mother has decided on formula feeding. \\n• \\nArrange parents to collect formula milk from the NGO. The peripheral STD clinics receive \\nformula milk from the EMTCT unit, which obtains it in bulk from the NGO. \\n• \\nCheck for availability of safe delivery kits and post exposure prophylaxis therapy in the \\nhealth care institution which is identified for delivery.  \\n• \\nConfirm that a post-partum family planning method is arranged before being discharged \\nfrom the hospital.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 30}, page_content='31 \\n \\n10.2 Planned normal vaginal delivery \\n \\n\\uf0b7 \\nIf HIV viral load is < 50 copies/mL at 36 weeks, the risk of MTCT of HIV is less in the \\nabsence of other obstetric contraindications. \\n\\uf0b7 \\nMinimize vaginal examinations to reduce the risks of infection to the mother. Maintain \\naseptic techniques throughout labour. \\n\\uf0b7 \\nART should be continued according to the ART plan. \\n\\uf0b7 \\nAmniotomy, fetal scalp electrodes and fetal blood sampling, instrumental delivery and \\nepisiotomy need to be avoided in pregnant women with HIV infection because of \\ntheoretical transmission risks. \\n\\uf0b7 \\nArtificial rupture of membranes increases the risk of infection of the placental \\nmembranes.  \\n\\uf0b7 \\nAvoid prolonged labor by monitoring labour carefully and intervening appropriately (i.e., \\naugmentation of labour through oxytocin or delivery by caesarean section).  \\n\\uf0b7 \\nThe head should be well engaged. \\n\\uf0b7 \\nCheck whether the cervix is effaced and dilated and await spontaneous onset of labour. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been recommended and labour has \\ncommenced, obstetric management should follow the same principles as for the \\nuninfected population.  \\n \\n10.3. Planned caesarean section \\n \\n\\uf0b7 \\nExplain to the pregnant woman about the reason for the caesarean section and obtain \\ninformed consent. \\n\\uf0b7 \\nNotify the Hospital Director, consultant anesthetist, neonatologist, paediatrician, \\ninfection control unit, head of the intensive care unit, sister in charge of the theatre, \\nantenatal ward, postnatal ward and PBU where necessary, while taking every \\nprecaution to maintain confidentiality. \\n\\uf0b7 \\nInform the consultant venereologist of the STD clinic. \\n\\uf0b7 \\nProvide premedication and prepare as usual for surgery. \\n\\uf0b7 \\nRegional analgesia is not contraindicated in delivery care of pregnant women with \\nHIV. \\n\\uf0b7 \\nContinue ARV regimen as recommended. Oral medications can be continued \\npreoperatively with sips of water.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 31}, page_content='32 \\n \\n10.4 Management of pre-labour spontaneous rupture of membranes \\n \\n In all cases of term pre-labour spontaneous rupture of membranes (SROM), delivery should be     \\n expedited. \\nTable 3 : Recommendations following SROM \\nScenario \\nRecommendations \\n1. \\nIf maternal HIV viral load is < 50 RNA copies/mL immediate induction of labour is \\nrecommended, preferably under antibiotic cover. \\n2. \\nIf maternal HIV viral load is ≥ 50 RNA copies/mL plasma, immediate caesarean \\nsection is recommended. \\n3. \\nIf maternal HIV viral load is not available, immediate caesarean section is \\nrecommended \\n \\n \\n \\nIt has been observed that the risk of HIV transmission was twice as high among women with \\nruptured membranes for more than 4 hours before delivery compared with those with shorter \\nduration of membrane rupture. \\nThere is no evidence that steroids for foetal lung maturation (with associated 24-hour delay in \\ninduction) are of overall benefit at 34–37 weeks’ gestation in women with ruptured membranes, \\nthus delay for the optimization of fetal lung maturity is not recommended. For this reason, and \\nto minimize the risk of developing chorioamnionitis, delivery is recommended from 34 weeks’ \\ngestation in women with ruptured membranes who are not in labour. \\n \\n10.5 Management of women who present in labor without documentation of \\nHIV status or women who have not received antepartum antiretroviral drugs \\nWomen presenting in labour / ROM / requiring delivery without a documented HIV result must \\nbe recommended to have a Rapid HIV Test. A reactive/positive result must be acted upon \\nimmediately with initiation of the interventions to PMTCT without waiting for further/formal \\nserological confirmation. Pregnant women with positive rapid HIV screening should be \\npresumed to be infected until HIV confirmatory testing clarifies their infection status \\nAn untreated woman presenting in labour at term should be given a stat dose of nevirapine \\n200 \\nmg \\nand \\ncommence \\non \\nfixed-dose \\nzidovudine \\n+ \\nlamivudine \\nand \\nraltegravir/dolutegravir as the preferred additional agent (because it also rapidly crosses the \\nplacenta). Intravenous zidovudine can be administered for the duration of labour and delivery.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 32}, page_content='33 \\n \\n \\nA single dose of nevirapine should be given immediately to the pregnant woman as this rapidly \\ncrosses the placenta and within 2 hours achieves and maintains effective concentrations in the \\nneonate for up to 10 days .If delivery is not imminent, a caesarean section should be considered. \\nIf delivery occurs less than 2 hours post maternal nevirapine, the neonate should also be dosed \\nwith nevirapine immediately. After partus, refer mother to the STD Clinic for clinical and \\nimmunological assessment. \\n \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\nIntrapartum intravenous zidovudine infusion is recommended in the following circumstances \\n \\n1.  \\nFor women with a viral load >1000 HIV RNA copies/mL plasma who present in \\nlabour or with SROM or who are admitted for PLCS \\n2.  \\nFor untreated women presenting in labour or SROM \\n3. \\nSROM in whom the current viral load is not known. \\n4. \\nCan be considered for women with viral load >50 HIV RNA copies/mL who present \\nin labour or with SROM or who are admitted for CS'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 33}, page_content='34 \\n \\n11. Post-partum Management  \\n \\n11.1  Immediate management \\n• \\nAvoid suctioning the infant’s mouth and pharynx, which may cause trauma to the \\nmucous membranes thus promoting mother to child transmission of HIV. \\n• \\nClean the eyes of the baby with saline at delivery of the head. \\n• \\nClamp the cord as soon as possible to minimize the risk of maternal-fetal micro-\\ntransfusions. \\n• \\nCover the umbilical cord with a swab when cutting to prevent spurting blood. \\n• \\nTowel dry the baby. \\n• \\nClean the baby’s skin thoroughly before any infusions or injections. \\n \\nMinimize the risk of postpartum haemorrhage by: \\no Actively managing the third stage of labor \\no Using controlled cord traction \\no Performing uterine massage \\no Repair any genital tears \\no Carefully removing all products of conception \\n• \\nPhysical assessment in the postpartum period should follow routine guidelines. Examine \\nwomen within 24 hours following delivery. \\n• \\nBe aware of signs of infection following delivery. HIV positive women are also vulnerable \\nto infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early \\ndetection and effective treatment are important measures to prevent complications. \\n• \\nManage infected tears or episiotomy. \\n11.2 Additional measures \\n• \\nAdvice women to come back to the same institution if LSCS wound infection is observed. \\n• \\nWhen they are discharged from the healthcare facility, women should be advised to \\nreturn to the clinic or inform the PHM if they notice symptoms such as fever, lower \\nabdominal pain, burning with urination, foul smelling discharge, abnormal bleeding, \\ncough, shortness of breath, calf pain (increasing on walking), diarrhoea and \\nunusual/abnormal behaviour.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 34}, page_content='35 \\n \\n• \\nGive information to the mother on care of the perineum and breasts. Women living with \\nHIV require special care to reduce breast engorgement, mitigate pain and avoid mastitis. \\n• \\nWomen who choose to breast feed should be counselled to avoid breast engorgement \\nwhich could lead to mastitis, since inflammation is associated with increased risk of HIV \\ntransmission. She should be advised to seek immediate medical care if breast \\nengorgement is associated with fever and pain. \\n• \\nInstruct her about the safe disposal of lochia and blood-stained sanitary wear or other \\npotential infectious materials. \\n• \\nIf family planning has not been discussed before delivery it should be done during the \\nearly postpartum period. \\n \\n11.3 Antiretroviral therapy \\n        All women are recommended to continue ART postpartum. \\n \\n11.4 Support services \\nDuring the postpartum period pregnant woman may face serious challenges to ART adherence \\nand retention in HIV care due to new responsibilities. Continued supportive services need to be \\noffered during this critical period. \\n11.5 Mental health assessment and support \\nWomen should have their mental health needs assessed postpartum and those identified as \\nhaving mental health issues should be referred to appropriate services.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 35}, page_content='36 \\n \\n12. Neonatal management \\n \\nRisk assessment at delivery is essential for identifying high- and low-risk infants, ensuring \\nproper prophylaxis and accurate diagnosis. \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high \\nand low risk: \\nCriteria for infants at high risk \\n \\nCriteria for infants at low risk \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nDid not receive prenatal care. \\n\\uf0b7 \\nReceived no antepartum ARVs or \\nonly intrapartum ARV drugs. \\n\\uf0b7 \\nInitiated ART late in pregnancy \\n(during the late second or third \\ntrimester). \\n\\uf0b7 \\nDiagnosis of acute HIV infection \\nduring pregnancy or in labor. \\n\\uf0b7 \\nHad detectable HIV viral loads        \\n(> 50 copies/mL) close to the time of \\ndelivery, including those who \\nreceived ART but did not achieve \\nsustained viral suppression. \\n \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nReceiving  ART since first trimester \\nor early second trimester . \\n      and  \\n\\uf0b7 \\nHas achieved and maintained viral \\nsuppression. (Defined as \\n<50 copies/mL) \\n     and \\n\\uf0b7 \\nHas reported good adherence and \\nadherence concerns have not been \\nidentified.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 36}, page_content='37 \\n \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or \\nHIV Infection \\n \\nAll newborns perinatally exposed to HIV should receive appropriate antiretroviral (ARV) drugs \\nas soon as possible, preferably within 6 hours, after delivery to reduce the risk of perinatal \\ntransmission of HIV. A newborn’s ARV regimen should be determined based on maternal and \\ninfant factors that influence the risk of perinatal transmission of HIV.  \\n\\uf0b7 \\nNewborns at low risk of perinatal HIV acquisition, 4 to 6 weeks zidovudine (ZDV) or \\nNevirapine  (NVP)  is recommended. \\n\\uf0b7 \\nNewborns at high risk of perinatal acquisition of HIV should receive presumptive HIV \\ntherapy with 3-drug regimens administered from birth for 2 to 6 weeks \\n\\uf0b7 \\nAll premature infants <37 weeks gestation who are not at high risk of perinatal \\nacquisition of HIV should receive ZDV or NVP for 4 to 6 weeks . \\n\\uf0b7 \\nInfants of women  who have primary or acute HIV infection during breast feeding period \\nshould be managed like infants at high risk of perinatal transmission with presumptive \\nHIV therapy. \\n\\uf0b7 \\nThe use of ARV drugs other than ZDV, lamivudine (3TC), and NVP cannot be \\nrecommended for any indication in premature newborns (<37 weeks gestational age) \\nbecause of the lack of dosing and safety data. \\n\\uf0b7 \\nIf an individual presents with unknown HIV status and has a positive HIV test during \\nlabor or shortly after delivery, the infant should begin presumptive HIV therapy . If \\nsupplemental maternal testing is negative, the infant’s ARV regimen should be \\ndiscontinued .'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 37}, page_content='38 \\n \\n Table 6 : Infant post-exposure prophylaxis (PEP) \\nScenario \\nART \\nDuration \\n \\nLow risk Pregnant women and \\nnon-breast-fed  infants \\n \\n \\nNVP (twice daily )  or AZT (twice \\ndaily )   \\n \\n4 - 6 weeks \\n \\nHigh risk Pregnant women and  \\nnon-breast-fed infants \\n \\n \\nAZT (twice daily ) +3TC (twice daily \\n+  NVP (once daily) \\nor  \\nAZT (twice daily ) +3TC (twice daily \\n+  RAL (twice daily) \\n \\n4 -  6 weeks \\n \\nif the duration of the 3-\\ndrug regimen is shorter \\nthan 6 weeks, ZDV / NVP \\nshould be continued \\nalone, to complete a total \\nof 6 weeks of prophylaxis. \\n \\nBreastfed infants* \\n \\n \\n  \\nAZT (twice daily ) and 3TC( twice \\ndaily and  NVP (once daily) \\n \\n12\\u2009weeks or until the \\nmother’s viral load is        \\n<50 cp/mL. \\n* Mothers with acute or primary HIV infection during breastfeeding ,  breastfeeding should be immediately   \\n   discontinued \\n \\nFactors such as prolonged rupture of membranes, preterm delivery and low birth weight are no \\nlonger associated with increased risk of transmission when mothers are with satisfactory viral \\nsuppression. The critical determinant of transmission is maternal viral load. Three-drug infant \\ntherapy is recommended for all circumstances other than where maternal viral load at 36 weeks’ \\ngestation/delivery is < 50 HIV RNA copies/mL. \\nInitiating ART as treatment  in an infant less than 2 weeks of age, a regimen of AZT + 3TC + \\nNVP should be started and NVP be substituted with LPV/r at the earliest opportunity, preferably \\nat 2 weeks of age. In settings where LPV/r syrup is unavailable, NVP should be continued until \\n3 months of age, with close clinical monitoring for children at high risk of NNRTI resistance due \\nto prolonged NVP-based postnatal prophylaxis or documented NNRTI failure in the mother. \\nWhere it is available, raltegravir could also be considered as an option in special circumstances.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 38}, page_content='39 \\n \\n13. HIV diagnosis in infants and children \\n \\n\\uf0b7 \\nVirologic assays (HIV RNA or HIV DNA nucleic acid tests [NATs]) that directly detect \\nHIV must be used to diagnose HIV in infants and children aged <18 months with \\nperinatal and postnatal HIV exposure. HIV antibody and HIV antigen/antibody tests \\nshould not be used .  \\n\\uf0b7 \\nPlasma HIV RNA or cell-associated HIV DNA NATs are generally equally \\nrecommended.  \\n\\uf0b7 \\nPlasma HIV RNA or DNA NAT results can be influenced by maternal ART or infant \\nARV prophylaxis or presumptive HIV therapy. \\n\\uf0b7 \\nAll HIV exposed infants should undergo nucleic acid testing (NAT) at birth to identify \\nHIV infection ,  then at 8 weeks of age (at least 2 weeks after cessation of PEP) or \\nat the earliest opportunity thereafter and at 4-6 months. \\n\\uf0b7 \\nAge-appropriate HIV testing also is recommended for infants and children with signs \\nand/or symptoms of HIV. \\n\\uf0b7 \\nFor children older than 24 months, and for those aged 18 to ≤ 24 months with \\nnon-perinatal HIV exposure, HIV antibody (or HIV antigen/antibody) tests are \\nrecommended for diagnostic testing. \\n\\uf0b7 \\nIn infants with an initial positive virological test result, Antiretroviral therapy (Not PEP) \\nshould be started without delay and at the same time a second blood sample is \\ncollected to confirm the initial positive virological test result.  \\n\\uf0b7 \\nConfirmation of HIV infection among infants less than 18 months should be based \\non two positive virologic tests from separate blood samples.  \\n\\uf0b7 \\nDo not delay ART for confirmatory test results. Immediate initiation of ART saves \\nlives and should not be delayed while waiting for the results of the confirmatory test. \\n.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 39}, page_content='40 \\n \\n 13.1 Timing of assessments \\n \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n \\nVirological assays (HIV RNA and HIV DNA nucleic acid tests) for HIV infection should \\nbe performed on the following occasions  \\n \\n\\uf0b7 \\nAt Birth (During the first 48 hours)  \\n\\uf0b7 \\nAt  8 weeks (or at least 2 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nAt 4-6 months  (or at least 8 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nInfants who are at high risk of perinatal HIV infection additional virological  test at 2-\\n3  weeks of age.  \\n \\nAntibody testing  \\n \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and 18 months.  \\n\\uf0b7 \\nAlthough an HIV antibody test may be negative before this time, engagement in care \\nwith follow-up of the infant should continue until at least 18 months of age.  \\n \\n \\n\\uf076 HIV antibody testing for sero-reversion should be performed at age 9 and 18 months to \\nexclude HIV infection. (If HIV antibody test is negative, the test should be repeated \\nimmediately with a separate blood sample to confirm HIV negative status).  \\n\\uf076 Children with perinatal HIV exposure aged 18-24 months may have residual \\nmaternal HIV antibodies. In such a case, confirmation should be based on nucleic \\nacid test. \\n \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants \\n\\uf0b7 \\nIs based on 2 or more negative virological tests, with one obtained at age ≥1 month \\nand one at age ≥4 months, or 2 negative HIV antibody tests from separate specimens \\nobtained at age ≥6 months \\n\\uf0b7 \\nSome experts confirm the absence of HIV infection at 12 to 18 months of age in children \\nwith prior negative virological tests by performing an antibody test to document loss of \\nmaternal HIV antibodies.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 40}, page_content='41 \\n \\n\\uf0b7 \\nHealth care providers should routinely inquire about abstinence of breastfeeding and \\nemphasise HIV-infected mothers/caregivers on safer feeding options. \\n \\nTable 8 : Infant diagnosis among breastfed infants \\n \\nVirological assays for HIV infection should be performed on the following occasions  \\n \\n\\uf0b7 \\nAt birth (During the first 48 hours) \\n\\uf0b7 \\nAt 2 weeks of age.  \\n\\uf0b7 \\nVirologic diagnostic testing should be performed every 3 months during breastfeeding  \\n\\uf0b7 \\nAfter cessation of breastfeeding, irrespective of when breastfeeding ends, virologic \\ndiagnostic testing should be performed at 4 to 6 weeks, 3 months, and 6 months after \\ncessation. \\n \\nAntibody testing  \\n \\n.  \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and  18 months, or \\nat a minimum of 8 weeks after cessation of breastfeeding, if this is later. \\n\\uf0b7 \\nEngagement in care should continue until this time.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 41}, page_content='42 \\n \\nFigure 3: Early Infant diagnosis algorithm \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\na Virologic diagnostic testing should be performed every 3 months during breastfeeding \\nb Children with perinatal HIV exposure aged 18-24 months may have residual maternal HIV antibodies.   \\n   In such a case, confirmation should be based on nucleic acid test. \\nHIV-exposed newborn \\n(0-2 days) \\nInfant/child is infected \\nConduct NAT at 8 weeks or at \\nthe earliest opportunity \\nthereafter \\nConsider NAT \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nHIV unlikely unless \\nstill a breastfeeding \\nHIV antibody testing for \\nseroreversion should be checked \\nat age at 9 and  b18 months, or at a \\nminimum of 8 weeks after \\ncessation of breastfeeding \\nNegative \\nPositive  \\nPositive  \\nNegative \\nNegative \\nInfant/child is infected \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nConduct NAT at 4-6 months'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 42}, page_content='43 \\n \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis \\n \\nDeclining mother-to-child transmission rates globally have led to concerns about false-positive \\nand indeterminate tests. People with indeterminate results need immediate repeat testing and \\nshould be managed according to the standard operating procedures. People with repeated \\nindeterminate results need a multidisciplinary team of health  care providers to support \\nretention, tracking and status resolution. ART programmes need to give priority to confirmatory \\ntesting of all positive test results using a new sample. Clinical monitoring and further testing \\nbased on the national infant testing schedule need to be done until a definitive HIV status is \\nestablished.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 43}, page_content='44 \\n \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n \\n \\n \\n \\n \\n                                                                  \\n \\n \\n \\n \\n \\n \\n \\n \\nEID sample no. 1  \\ntest no. 1 \\nEID sample no. 1   \\n test no. 2 \\nRequest a new \\nsample within \\n4 weeks \\n          POSITIVE  \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\n          Positive \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\nFurther review by a \\nclinical and \\nlaboratory team'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 44}, page_content=\"45 \\n \\n14.  Antiretroviral drug dosing recommendations for \\nnewborns \\n \\nAll newborns who were exposed perinatally to HIV should receive postpartum antiretroviral \\n(ARV) drugs to reduce the risk of perinatal transmission of HIV . \\nNewborn ARV regimens should be started as soon as possible after birth, ideally within 6 hours, \\nwith doses appropriate for the infant's gestational age. \\nA newborn’s ARV regimen should be determined based on maternal and infant factors that \\ninfluence the risk of perinatal transmission of HIV  \\n \\nTable 9 : ART dosage for infants \\nDrug \\nDrug Doses by Gestational Age at Birth \\nCommon \\nside effects \\nZDV \\nWeight-Band Dosing for Newborns Aged ≥35 Weeks \\nGestation from Birth to 4 Weeks \\nWeight Band \\nVolume of ZDV 10 mg/mL \\nOral Syrup Twice Daily \\n2 to  < 3kg \\n1 mL \\n3 to <4 kg \\n1.5 mL \\n4 to < 5 kg \\n2 mL \\n \\n \\nAnaemia, \\nneutropenia  \\n \\n \\n \\n≥30 to <35 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 2 Weeks to 6 to 8 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >6 to 8 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; make this \\ndose increase only for infants with confirmed HIV \\ninfection.\"),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 45}, page_content='46 \\n \\n<30 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 4 to 8 to 10 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >8 to 10 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; only make \\nthis dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n3TC \\n≥32 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\n3TC 2 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\n3TC 4 mg/kg per dose orally twice daily \\n \\nAnaemia, \\nneutropenia  \\n(much less \\ncommon than \\nwith AZT) \\nNVP \\n≥37 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\nRash and \\nliver \\ndysfunction – \\nrare in \\nneonates  \\n \\nStop NVP \\nafter 2/52, in \\nview of long \\nhalf-life, \\ncontinue other \\nPEP agents \\nfor full 4/52 \\n≥34 to <37 Weeks’ Gestation at Birth \\nBirth to Age 1 Week \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 46}, page_content='47 \\n \\nAge 1 to 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n≥32 to <34 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nNVP 2 mg/kg per dose orally twice daily \\nAge 2 to 4 Weeks \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily \\nAge 4 to 6 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >6 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmake this dose increase for infants with confirmed HIV \\ninfection.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 47}, page_content='48 \\n \\n15. Co-trimoxazole prophylaxis \\n \\nPneumocystis pneumonia (PCP) prophylaxis ,  cotrimoxazole, should be initiated from age 4 \\nweeks in: \\n\\uf0b7 \\nAll HIV-infected infants.  \\n\\uf0b7 \\nInfants with an initial positive HIV DNA/RNA test result (and continued until HIV infection \\nhas been excluded). \\nAge Category \\nDose (Sulfamethoxazole/ trimethoprim) \\nInfants below 6 months or < 5 kg \\n100 mg /20 mg  \\nChildren 6 months–5 years or 5-15 kg \\n200 mg/40 mg \\nChildren 6–14 years old or 15–30 kg \\n400 mg/80 mg \\nover 14 years or >30 kg \\n800 mg/160 mg \\n \\nNote : Cotrimoxazole suspension contains 200 mg/40 mg per 5 ml of syrup. Single strength \\ntablets contain 400 mg/80 mg, double strength tablet twice that. It is possible to divide the tablets \\nfor children and infants.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 48}, page_content='49 \\n \\n16. Infant feeding \\n \\nInfant feeding intentions need to be discussed  early in pregnancy so that appropriate \\ninformation and support can be provided. \\nFactors that increase the risk of HIV transmission via breast milk when women are not on ART \\ninclude:  \\n\\uf0b7 \\nDetectable HIV viral load.  \\n\\uf0b7 \\nAdvanced maternal HIV disease.  \\n\\uf0b7 \\nLonger duration of breastfeeding.  \\n\\uf0b7 \\nBreast and nipple infection/inflammation.  \\n\\uf0b7 \\nInfant mouth or gut infection/inflammation.  \\n\\uf0b7 \\nMixed feeding, in particular solid food given to infants less than 2 months of age \\n \\nThe safest option for infants born to women with HIV is formula feeding, as it eliminates post-\\nbirth HIV exposure risk Women who choose to breastfeed should be advised of the small on-\\ngoing risk of HIV transmission. They should be supported in their decision, if they maintain the \\nfollowing criteria. \\n\\uf0b7 \\nA fully suppressed HIV viral load (for as long a period as possible, but certainly during \\nthe last trimester of pregnancy).  \\n\\uf0b7 \\nA good adherence history.  \\n\\uf0b7 \\nStrong engagement with the perinatal MDT \\n\\uf0b7 \\nPrepared to attend for monthly clinic review and blood HIV viral load tests for themselves \\nand their infant during and for 2 months after stopping breastfeeding \\nWomen not breastfeeding their infants, should be offered cabergoline to suppress lactation.  \\nFormula milk is provided with the support of the NGO, National AIDS Foundation'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 49}, page_content='50 \\n \\n17. Contraception for women living with HIV \\n \\nFamily planning is a cornerstone of maternal and child health and a vital component of global \\nhealth initiatives. The integration of family planning and HIV services is essential for achieving \\nthe Sustainable Development Goals, particularly in reducing maternal mortality, unplanned \\npregnancies, and new pediatric HIV infections. By ensuring universal access to comprehensive \\nsexual and reproductive health services, including family planning, for all individuals living with \\nor affected by HIV, we can significantly improve health outcomes and promote social and \\neconomic well-being. \\n\\uf0b7 \\nContraceptive needs should be discussed with all women during antenatal period. \\n\\uf0b7 \\nUsing condoms alongside another method of contraception is recommended for dual \\nprotection against both pregnancy and the transmission of HIV.  \\n\\uf0b7 \\nThe choice of contraception will depend on individual health, potential drug interactions, \\nand personal preferences.  \\n\\uf0b7 \\nOvulation usually resumes at 6 weeks of postpartum but may occur earlier in non-\\nbreastfeeding women. A plan for contraception postnatally should have been discussed \\nin advance of delivery and revisited in the early postpartum period and at the 4- to 6-\\nweek follow-up.  \\n\\uf0b7 \\nWomen should be advised that it is possible to conceive before the first postnatal \\nmenses and therefore to use condoms, if necessary, until the postnatal review. \\n\\uf0b7 \\nThey have options for oral contraceptive pills, injectables (e.g., Medroxy Progesterone \\nAcetate), implants (e.g.,  Jadelle), intrauterine devices (IUDs), and female sterilization. \\n\\uf0b7 \\nSome antiretroviral medications may interact with hormonal contraceptives potentially \\nreducing their effectiveness. Drug interactions between ART and hormonal \\ncontraceptives should be checked with the WHO Medical Eligibility Criteria .'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 50}, page_content='51 \\n \\nTable 10: Contraceptive methods  \\nNon-hormonal methods \\n \\n\\uf0b7 \\nMale condom \\n\\uf0b7 \\nFemale condom \\n\\uf0b7 \\nIntrauterine device (IUD) \\n\\uf0b7 \\nFemale sterilization \\nHormonal methods \\n \\n\\uf0b7 \\nIntrauterine system (IUS) \\n\\uf0b7 \\nInjection - Depo  Medroxy Progesterone \\nAcetate  is the most common version, and it \\nshould be taken every twelve weeks. \\n\\uf0b7 \\nCombined pill - Contains the hormones \\noestrogen and progestogen. \\n\\uf0b7 \\nImplant - Small flexible rods that are inserted \\nunder the skin, and releases progestogen for up \\nto three years or five years depending on the \\nbrand.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 51}, page_content='Table 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n(Contraceptive methods: CHC, combined hormonal contraception; Cu-IUD, copper intrauterine device; DMPA, progestogen-only injectable: \\ndepot medroxyprogesterone acetate; ENG-IMP, etonogestrel implant; LNG-IUD, levonorgestrel-releasing intrauterine system; POP, \\nprogestogen-only pill) \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD Cu-IUD \\nNucleoside/nucleotide reverse \\ntranscriptase inhibitors (NRTIs)  \\n \\nAbacavir (ABC) Emtricitabine \\n(FTC) Lamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide (TAF) \\nZidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\n \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\nX \\n✓ \\n✓ \\n✓ \\nContraceptive effectiveness could be reduced. Use not advised. \\nRecommend an No need for extra precautions. alternative effective method \\n \\nEtravirine (ETR) \\nNevirapine (NVP \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential weak interaction but not expected to affect contraceptive effectiveness. To err on the side \\nof caution, recommend an alternative effective method or advise additional condoms use \\nDoravirine (DOR) \\nRilpivirine (RPV \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nRilpivirine (RPV) \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 52}, page_content='53 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nBoosted protease inhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat (ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n? \\n \\n \\n \\n \\n? \\n \\n \\n? \\n \\n              \\n              ✓ \\n \\n         ✓ \\n \\n             ✓ \\n\\uf0b7 Interaction that could \\nincrease progestogen \\nexposure but not expected to \\naffect contraceptive \\neffectiveness. \\n\\uf0b7 In case of PIs boosted with \\ncobicistat, recommend an \\nalternative effective method \\nor use with caution due to \\nincreased ethinylestradiol \\nexposure \\n\\uf0b7 Potential weak interaction that could increase progestogen \\nexposure but not expected to affect contraceptive \\neffectiveness. \\nNo need for extra precautions \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) Dolutegravir \\n(DTG) Bictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nBoosted INSTIs \\nElvitegravir/ cobicistat (EVG/c) \\n \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential interaction causing \\ndecreased ethinylestradiol \\nexposure. Should not be given \\nwith a low dose (ie, 20\\uf06dg \\nethinylestradiol) combined oral \\ncontraceptive \\nNo expected effect on contraceptive effectiveness. No need for \\nextra precautions.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 53}, page_content='54 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 54}, page_content='Table 12: ART and emergency contraception (EC) \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nNucleoside/nucleotide \\nreverse transcriptase \\ninhibitors (NRTIs)  \\n \\nAbacavir (ABC) \\nEmtricitabine (FTC) \\nLamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide \\n(TAF) Zidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n \\nNo effect on EC effectiveness. \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\n \\n \\n? \\n \\n \\n? \\n \\n \\nThe effectiveness \\nof EC could be \\nreduced. Offer a \\nCu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC. \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nEtravirine (ETR) \\nNevirapine (NVP \\n? \\n \\n? \\n? \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nDoravirine (DOR) \\nRilpivirine (RPV \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 55}, page_content='56 \\n \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nBoosted protease \\ninhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat \\n(ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) \\nDolutegravir (DTG) \\nBictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nBoosted INSTIs \\nElvitegravir/ cobicistat \\n(EVG/c) \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\nNo effect on EC effectiveness. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 56}, page_content='57 \\n \\n19. Immunization \\n \\nInfants born to HIV-positive mothers should follow the routine national primary immunization. \\nTable 13:  Immunization Schedule \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n0-4 weeks \\nBCG \\nHIV infected infants \\nshould not receive \\nBCG vaccine. BCG \\nshould be avoided till \\nHIV is excluded in \\nHIV exposed infants \\n \\n \\nOn completion of  \\n \\n \\n \\n2 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(1st dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(1st dose) \\nWhen Inactivated \\nPolio vaccine is not \\navailable giving OPV \\ncan be considered \\nwhen the child is not \\nseverely immune \\nsuppressed \\n \\n4 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(2nd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(2nd dose) \\n \\n \\n6 months \\nOPV & Pentavalent \\n(DPT -Hep B-Hib) \\n(3rd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib) \\n(3rd dose) \\n \\n \\n9th month \\nMMR \\nMMR \\n MMR-   should be \\npostponed in severe \\nimmune deficiency \\n \\n12th month \\nLive JE \\nInactivated JE \\nvaccine,  \\nHep A 1st dose (2nd \\ndose in 6-12 months) \\nIf using live attenuated \\nshould not be given to \\nseverely immune \\ncompromised children \\nHep A- patients with \\nsevere \\nimmunosuppression \\nmay have a \\nsuboptimal response \\n \\n13-15 months \\n \\nVaricella -2 doses 3 \\nmonths apart \\nPatients who are \\nseverely'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 57}, page_content='58 \\n \\nimmunosuppressed \\nshould not receive the  \\nvaccine. \\n \\n18th month \\nOPV & DTP (4th \\ndose) \\nInactivated Polio \\nvaccine +DTP \\n \\n \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n3rd year \\nMMR 2nd dose \\nMMR 2nd dose \\n \\n \\n5 years \\nOPV+DT \\nInactivated polio+DT \\n \\n \\n12 years \\naTd \\naTd \\n \\n \\n12-13 years \\n(females, males) \\n \\nHPV (Gardasil) \\n2 doses \\n(0, 6 months)'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 58}, page_content='59 \\n \\n20. References \\n \\n1. British HIV Association guidelines for the management of HIV in pregnancy and \\npostpartum 2018 (2020 third interim update) \\n2. A Guide to Antiretroviral Treatment; 4th Edition, National; STD/AIDS Control \\nProgramme 2020 \\n3. Guidelines for HIV post-exposure prophylaxis (WHO 2024) \\n4. HIV  diagnosis and ARV  use in HIV -exposed infants: a programmatic update             \\n(WHO) July 2018 \\n5. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually \\ntransmitted infections for the period 2022-2030.(WHO 2022) \\n6. Https://www.who.int/tools/elena/interventions/hiv-infant-feeding \\n7. Https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-\\ntransmission-hiv \\n8. Https://npin.cdc.gov/publication/recommendations-use-antiretroviral-drugs-pregnant-\\nhiv-1-infected-women-maternal-health \\n9. Https://www.cdc.gov/pregnancy-hiv-std-tb-hepatitis/about/index.html \\n10. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and \\nmonitoring: recommendations for a public health approach July 2021. \\n11. Pre-Exposure prophylaxis for the prevention of HIV infection in Sri Lanka: A clinical \\npractice guideline; 2023. \\n12. Https://www.who.int/news/item/29-08-2019-who-revises-recommendations-on-\\nhormonal-contraceptive-use-for-women-at-high-hiv-risk. \\n13. Clinical Guidance:  Drug Interactions Between  HIV Antiretroviral Therapy (ART)  and \\nContraception; February 2023 | FSRH. \\n14. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral \\ntherapy July 2017 \\n15. HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update July \\n2018 \\n16. https://clinicalinfo.hiv.gov/en/guidelines/perinatal/pre-exposure-prophylaxis-prep-\\nprevent-hiv \\n17. Antiviral management new borns with perinatal HIV exposure or HIV infection \\nupdated January 31st, 2023.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 59}, page_content='60 \\n \\n21. Annexures'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 60}, page_content='61 \\n \\n \\nAnnexure 1 : General circular letter No. 01-51/2016 - English'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 61}, page_content='62'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 62}, page_content='63'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 63}, page_content='64 \\n \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 64}, page_content='65'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 65}, page_content='66 \\n \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 66}, page_content='67'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 67}, page_content='68'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 68}, page_content='69 \\n \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\nAnnexure 2: Standard of care - PMTCT of syphilis and HIV \\n \\nStandard of care in prevention of mother to child transmission of \\nSyphilis and HIV \\n \\n \\nStandard \\nAll pregnant women should be screened for syphilis and HIV at the first antenatal visit \\nwithin the first trimester. At delivery, women who do not have test results should be tested. \\nWomen  with  positive  syphilis  or  HIV  test  results  should  be  managed  according  to  the \\nnational guidelines. Their partners should also be screened and managed and plans should be \\nmade to screen and manage their infants at birth. \\n \\nAim \\nTo reduce maternal morbidity and mortality, fetal loss and neonatal mortality and morbidity \\ndue to syphilis and HIV \\n \\nRequirements \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and care in \\npregnant women are available and are correctly implemented. \\n\\uf0b7 \\nAll women have access to appropriate ANC care during pregnancy, childbirth and the \\npostpartum period. \\n\\uf0b7 \\nHealth  care  providers  are  competent  in  syphilis  and  HIV  prevention,  screening during  \\npregnancy,  ,  counseling  on  STI prevention,    how  to  prevent  re-infection during pregnancy \\nand referral for management of seropositive pregnant women and their partners, \\nprophylaxis and management of the newborn \\n\\uf0b7 \\nSuitable Screening methods for syphilis and HIV are available in antenatal clinics and \\nmaternity wards. \\n\\uf0b7 \\nAdequate Laboratory facilities (at least one per district) for testing of syphilis and \\n\\uf0b7 \\nHIV with system to ensure quality of laboratory testing are available. \\n\\uf0b7 \\nNecessary supplies for collection and transport of samples are available at the ANC clinic \\nand Supplies for testing of syphilis and HIV are available at the laboratory level. \\n\\uf0b7 \\nDrugs (penicillin, ART etc) are available in the STD clinics and maternity wards where relevant. \\n\\uf0b7 \\nA functioning referral system is available to ensure the management of pregnant women \\nwho are identified as having syphilis or HIV \\n\\uf0b7 \\nAn effective information system is available to monitor the programme. \\n\\uf0b7 \\nHealth education activities are carried out to raise the awareness of individuals, families and \\ncommunities of the importance of attending ANC clinics early in pregnancy and syphilis and \\nHIV prevention and management. \\n \\nApplying the standard \\nProviders of maternal and neonatal health care, in particular public health staff must: \\n\\uf0b7 \\nScreen all pregnant women for syphilis and HIV at the first antenatal visit. Screening \\nshould be done preferably before 12 weeks of gestation to prevent congenital infection. \\n\\uf0b7 \\nReview  syphilis  and  HIV  test  results  at  subsequent  visits.  All  the  women  with \\npositive screening test need to be referred to STD clinic for further management. \\n\\uf0b7 \\nIf a woman was not tested during pregnancy, syphilis and HIV screening should be \\noffered after delivery.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 69}, page_content='70 \\n \\n\\uf0b7 \\nManage  all  women  who  are  seroreactive  for  syphilis  according  to  the  stage  of \\nsyphilis following national guidelines at the STD clinic. \\n\\uf0b7 \\nManage all women with positive HIV test according to the national guidelines to \\nprevent mother to child transmission of HIV \\n\\uf0b7 \\nDiscuss with the woman the importance of treatment for herself, her partner(s) and the \\nbaby, explain the consequences of not treating the infection, and discuss the necessity \\nof condom use during treatment. \\n\\uf0b7 \\nMake plans to manage the baby at birth. \\n\\uf0b7 \\nAdvise women who test positive that their partner(s) must also be screened and \\nmanaged according to the stage of syphilis. The babies also need to be screened as soon \\nas possible after birth. \\n\\uf0b7 \\nAdvise women and partners who test negative how to remain negative. \\n\\uf0b7 \\nScreen all women with adverse pregnancy outcome (abortion, stillbirth, syphilitic \\ninfant, etc.) for syphilis and HIV, if not screened. \\n\\uf0b7 \\nScreen all women with syphilis or HIV for other STIs, and provide counseling and \\nmanagement accordingly. \\n\\uf0b7 \\nRecord test results and if positive for syphilis or HIV details of management, in the \\nclinic and pregnancy records. \\n\\uf0b7 \\nMaintain the confidentiality of the information regarding the patients. \\n \\nAudit \\n \\nInput indicators \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and \\ncare in pregnant women are available and are correctly implemented. \\n\\uf0b7 \\nThe  proportion  of  health  facilities  providing  ANC  services  that  have  screening \\nfacilities for syphilis and HIV. \\n \\nProcess and output indicators \\n\\uf0b7 \\nCoverage of syphilis screening in pregnant women \\n\\uf0b7 \\nCoverage of HIV screening in pregnant women \\n\\uf0b7 \\nCoverage of correct management of syphilis in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of correct management of HIV in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of partners tested and managed accordingly \\n\\uf0b7 \\nCoverage  of  babies  born  to  syphilis  positive  mothers  who  received  appropriate \\ntreatment. \\n\\uf0b7 \\nCoverage of babies born to HIV positive mothers who received prophylactic ARV \\ntreatment \\nOutcome/ Impact indicators \\n\\uf0b7 \\nIncidence of congenital syphilis \\n\\uf0b7 \\nIncidence of HIV among infants \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to congenital syphilis. \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to paediatric  HIV \\n\\uf0b7 \\nStillbirth rate.'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 70}, page_content='71 \\n \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n \\nN'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 71}, page_content='72 \\n \\nAnnexure 6 : Blood Collection request form \\nNational STD/AIDS Control Programme,  \\nMINISTRY OF HEALTH. \\n \\nREQUEST FORM FOR SYPHILIS/HIV TESTING IN ANTENATAL MOTHERS. \\nInstitution/clinic \\n……………………………………………….. \\nMOH area \\n……………………………………………….. \\n \\nDate of sample collection \\n……………………………………………….. \\n \\n \\n \\n \\nNSACP/ANC/14/V/2 \\n \\nPatient No \\n(ANC) \\nAge \\nParity. \\nPOA \\nHIV \\nResults \\nVDRL \\nResults \\n \\n……………………………………… \\n…………………………………. \\n…………………………….. \\nName of collecting officer \\n…………………………………….. \\nDesignation \\n…………………………………. \\nSignature. \\n…………………….. \\nName of Medical officer \\nDesignation \\nSignature \\nLab use only . \\n \\nDate/Time of receipt of samples:………………………… \\n…………………..am/pm \\nMLT:………………………. \\nMedical officer STD/Lab:……………………….. \\nDate ……………………… \\n Date  ………………………………………………..'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 72}, page_content='Annexure 7 : EMTCT HIV Case Investigation form \\n \\n \\nEMTCT HIV: Case Investigation Form                                                                   \\nNational STD/AIDS Control Programme, Ministry of Health \\n \\nName of the STD clinic:_______________________       Pregnant Woman’s file number & PHN No: ___________________   \\nBaby’s file number & PHN No: _________________       Pregnant Woman’s HIV clinic registration date:_______________  \\nFilled by(name & designation): _________________      Pregnant Woman referred from:________________________ \\nNote: Fill this form for all HIV confirmed pregnant women registered in the clinic \\n                                                     Details of the pregnant woman with HIV \\n  1.   Age in years \\n \\n  2.   District of residence \\n \\n  3.   Nationality \\n1. \\nSri Lankan  2. Foreign (country:________________) \\n  4.   Ethnicity \\n \\n  5.   Risk & vulnerability factors (e.g. FSW, DU, \\n        Psychosocial etc) \\n \\n  6.   KP Status   \\n \\n  7.   Parity \\n \\n8.  Past obstetric history \\n \\n  9.   Date of HIV confirmation \\n \\nDetails of the current pregnancy \\n10.   LRMP \\n \\n11.   EDD \\n \\n12.   POA at ANC registration \\n \\n13.   POA when registering for EMTCT  \\n         services \\n \\n14.   1st CD4 count during this  \\n         pregnancy(Result & date) \\n \\n15.   1st VL during this pregnancy \\n         (Result & date) \\n \\n \\n16.   Other relevant diagnoses  \\n         (*TB/Syphilis/Other) \\n \\n17.   Date of ART initiation \\n \\n18.   ART regimen during this pregnancy \\n19.   Adherence (>95%, 80-95%,  \\n         <80%) \\n \\n20.   CD4 count at third trimester \\n \\n21.   Viral load closest to 36 \\n         Weeks of POA \\n \\n22.   Number of ANC visits \\n \\n23.   Post-partum family planning method \\n \\n                                                                              Details of the sexual partner/s \\n24.   Partner’s HIV status \\n \\n25.   File no.(STD or HIV) & PHN No. \\n \\n26.  Partner’s ART regimen \\n \\n27.  Partner’s KP status \\n \\n                                                                     Details of the baby \\n28.   Date of birth \\n \\n29.   Facility/Place of birth \\n \\n30.   Mode of delivery \\n         If LSCS – Em/El \\n         Indication \\n \\n31.   Gestational age at \\n         delivery \\n \\n32.   Birth weight \\n           \\n \\n33.   Infant feeding (exclusive  \\n         formula/breastfeeding) \\n \\n34.    ARV prophylaxis  \\n(Type/dose/duration) \\n \\n35.   DNA PCR at birth (date & result) \\n \\n36.   DNA PCR at 8 weeks \\n \\nDate \\n \\n37.   DNA PCR at 16 weeks \\n \\nDate \\n \\n38.   HIV ELISA around 18 months \\n \\nDate \\n \\n39.   Final diagnosis \\n \\n40.   If miscarriage – Date & POA of miscarriage \\nRemarks'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 73}, page_content='74 \\n \\n Annexure 8 : Pregnancy record'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 74}, page_content='75 \\n \\nAnnexure 9 : Poster  for EMTCT of HIV'),\n",
       " Document(metadata={'producer': 'www.ilovepdf.com', 'creator': 'Microsoft® Word 2016', 'creationdate': '2024-10-03T04:26:32+00:00', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf', 'total_pages': 76, 'format': 'PDF 1.5', 'title': 'Guidelins for Elimination of Mother to Child Transmission of HIV', 'author': 'Ministry of Health-NSACP', 'subject': '', 'keywords': '', 'moddate': '2024-10-03T04:26:32+00:00', 'trapped': '', 'modDate': 'D:20241003042632Z', 'creationDate': \"D:20241003042632+00'00'\", 'page': 75}, page_content='76 \\n \\nAnnexure 10 : Leaflet for pregnant women on service package'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 0}, page_content='NATIONAL GUIDELINES FOR\\nMATERNAL CARE\\nVOLUME I\\nMINISTRY OF HEALTH\\n2013\\n• Management of Labour\\n• Management of Hypertension, Pre Eclampsia \\nand Eclampsia in Pregnancy\\n• Management of Diabetes During Pregnancy\\n• Management of Post-Partum Haemorrhage\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 1}, page_content=''),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 2}, page_content='NATIONAL GUIDELINE FOR MATERNAL CARE\\nVOLUME I\\n• \\nManagement of Labour\\n \\n \\nNormal Labour \\n \\n \\nInduction of Labour\\n \\n \\nUse of Oxytocins in Induction and Augmentation\\n \\n \\nFoetal Monitoring in Labour\\n \\n \\nPain Relief\\n \\n \\nAcute Inversion of Uterus\\n• \\nManagement of Hypertension, Pre Eclampsia and \\nEclampsia in Pregnancy\\n• \\nManagement of Diabetes in Pregnancy\\n• \\nManagement of Post-Partum Haemorrhage\\nMINISTRY OF HEALTH\\n2013\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 3}, page_content='National Guideline for Maternal Care - Volume I\\nii\\nThese guidelines are published by the Family Health Bureau, Ministry of \\nHealth, 231, De Saram Place, Colombo 10, Sri Lanka.\\nWeb: www.familyhealth.gov.lk\\nPrepared by Sri Lanka College of Obstetrians and Gynaecologists\\nEdited By Dr. Nilmini Hemachnadra, Consultant Community Physician, \\nFamily Health Bureau & Prof. Hemantha Senanayake, President, Sri Lan-\\nka College of Obstetricians & Gynaecologists.\\nCopyright@2013 Ministry of Health\\nISBN 978 - 955 - 1503 - 15 - 4\\nStatement of Intent\\nThe main purpose of these guidelines are to improve the quality of \\nclinical care provided by the health care providers at all levels. These \\nparameters of practice should be considered recommendations \\nonly. The ultimate judgement regarding a particular clinical \\nprocedure or a treatment plan must be made by the clinician in \\nlight of the clinical data gathered from the patient and the diagnosis \\nand treatment options available.\\nPrinted by Lazergraphic (PVT) Ltd.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 4}, page_content='National Guideline for Maternal Care - Volume I\\niii\\nForeword from the Secretary to the Ministry of Health\\nAs a country with a mainly government owned health system, maintenance \\nof the uniformity of practices is essential to avoid incurring unnecessary \\nexpenditure. Incorporation and practice of evidence based cost effective \\ninterventions in maternal care will ensure further improvement of the \\nmaternal care indicators.  \\nThe availability and use of guidelines will ensure the quality of the care \\nprovided at each level and facilitate the care provision of practicing \\nclinicians for better care. The Ministry of Health having achieved a \\nsatisfactory level in the coverage of services and geared to improve it \\nfurther, is currently moving towards improving the quality of services \\nprovided. With this view, most of the institutions are now implementing \\nquality improvement programmes.\\nTherefore, this set of guidelines will assist such programmes and auditing \\nsystems in the maternal care such as maternal mortality reviews, \\nconfidential inquiry into maternal deaths, near-miss inquiries and \\nensure a more objective assessment. These guidelines should be link with \\nthe quality standards and the implementation at each level needs to be \\nensured.\\nSri Lanka College of Obstetricians and Gynaecologists has managed to in \\nco-operate the currently available best scientific evidence and the practical \\nexperience of a large number of experts into these guidelines.\\nI wish all the healthcare providers would make maximum use of these \\nguidelines and contribute to the further improvement of the maternal care \\nin our country.\\nDr. Y.D. Nihal Jayathilake\\nSecretary,\\nMinistry of Health,\\nSri Lanka'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 5}, page_content='National Guideline for Maternal Care - Volume I\\niv'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 6}, page_content='National Guideline for Maternal Care - Volume I\\nv\\nPreface\\nThis national guideline on maternal care is very well-timed, as a greater \\nemphasis is being given for improving the quality of maternal and \\nnewborn care services for further reduction of maternal and newborn \\nmortality and morbidity in Sri Lanka. This set of guidelines includes \\nthe revised versions of some guidelines published in 2007 under HSDP \\nPhase I and newly developed guidelines. This is an attempt to improve the \\nquality and uniformity of clinical care with efficiency, cost effectiveness \\nand accountability.\\nI highly appreciate the contribution made by the Sri Lanka College of \\nObstetricians and Gynaecologists in developing these guidelines. Their \\nexperience and updated scientific knowledge is reflected in the guidelines. \\nFurther, these guidelines have been developed considering the policies, \\nfacilities and resources available in the country. As such this set of \\nguidelines will be considered as national guidelines for the conditions \\ndescribed.  \\nDr. P. G. Mahipala\\nDirector General of Health Services,\\nMinistry of Health,\\nSri Lanka.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 7}, page_content='National Guideline for Maternal Care - Volume I\\nvi\\nMessage from the president of Sri Lanka College of \\nObstetricians\\nIt is with a great sense of achievement that I issue this statement for the \\nSri Lanka National Guidelines in obstetrics. There is evidence that the \\nintroduction of guideline-based practice will reduce maternal mortality. \\nWe hope that this effect will be duplicated in Sri Lanka.\\nI must compliment the Guideline Development Group of our College. \\nThis document is testimony to their hard work and their commitment to \\nimproving the quality of care delivered to our women. The group consisted \\nof obstetricians from varying seniority and from hospitals representing \\nall categories of specialist units in the country. We were therefore able to \\ndevelop our guidelines taking into considerations the ground realities in \\nSri Lanka. I was heartened by the maturity shown by the younger members, \\nwho contributed immensely to the many points that were debated while \\nthese were being developed. We have used the latest available evidence \\nand taken into account what would be feasible in a Sri Lankan Unit. For \\nwhat we have recommended as improvements to the existing practice we \\nhave had agreement from the Ministry of Health to procure these. \\nI wish also to acknowledge our general membership who contributed to \\nthese guidelines via email and at a meeting where their views were sought. \\nIt is always a challenge to produce guidelines that will be put into use in \\neveryday practice and it is probable we have achieved this primary goal by \\nhaving a broad based input. \\nThe World Health Organization and the UNFPA supported this activity. \\nDr. Nilmini Hemachandra of the Family Health Bureau helped get the \\nfinal product into a form that was easily understood by the non-specialist. \\nWe are grateful for the advice given by Obstetric Anaesthetists Drs. Saroja'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 8}, page_content='National Guideline for Maternal Care - Volume I\\nvii\\nJayasinghe and Ramani Pallemulla. The guideline on diabetes mellitus \\ncomplicating pregnancy had major inputs from the Nirogi Matha project \\nand many endocrinologists. \\nTo conclude I wish to restate my wish and fervent hope that these \\nguidelines will help save the lives of many Sri Lankan mothers. \\nProf. Hemantha Senanayake\\nPresident,\\nSri Lanka College of Obstetricians & Gynaecologists'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 9}, page_content='National Guideline for Maternal Care - Volume I\\nviii\\nGuideline Development Committee\\nDr. Asoka Weerakkody (Chairman)\\nProf. Hemantha Senanayake\\nProf. Malik Goonawardena\\nDr. Ananda Ranatunga\\nDr.UDP Ratnasiri\\nDr. Sunil Fernando\\nDr. Harsha Atapattu\\nDr. Mangala Dissanayake\\nDr. Chandina Wedamistri\\nDr. Jeevan Marasinghe\\nDr. Tiran Dias\\nDr. Asanka Jayawardena'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 10}, page_content='National Guideline for Maternal Care - Volume I\\nix\\nContent page \\n \\n \\n \\n \\nPage\\n \\nMessage from the Secretary of Ministry of Health \\niii\\n \\nPreface \\n \\nv\\n \\nMessage from the President of the Sri Lanka College of \\n \\nObstetricians and Gynecologists \\nvi \\n \\nGuideline Development Committee \\nviii\\n \\nList of Abbreviations \\nxiii\\n \\nList of Tables \\nxiv\\n \\nDisclaimer \\nxv\\n \\nIntroduction \\nxvi\\n A\\t\\nManagement of Labour\\t\\n3\\n1. \\nIntroduction \\n3\\n2. \\nDiagnosis of labour \\n3\\n3. \\nManagement of Labour \\n4\\n3.1 \\nGeneral considerations \\n4\\n3.1.1 \\nCommunication between women and healthcare  \\n  \\nprofessionals/workers \\n4\\n3.1.2 \\nPreparation of mothers to transfer to labour room \\n4\\n3.1.3 \\nDocumentation \\n5\\n3.1.4  \\nMobilization and Positioning \\n5\\n3.1.6 \\nHygiene during labour \\n5\\n3.1.7 \\nPain relief in labour \\n6\\n3.2. \\nManagement of the three stages of labour \\n6\\n3.2.1.  \\nManagement of the first stage of labour \\n6\\n3.2.1.1 \\nLatent phase  \\n6\\n3.2.1.2 \\nActive phase \\n7\\n3.2.1.2a.  Admitting women to the Labour room \\n7\\n3.2.1.2b.  Management of active phase of first stage \\n8\\n3.2.1.3.  \\nDelayed progress of first stage of labour \\n9\\n3.2.2.  \\nManagement of second stage of labour \\n10\\n3.2.2.1.  \\nPassive second stage of labour (descent phase) \\n10\\n3.2.2.2.  \\nActive second stage of labour (expulsive phase) \\n11\\n3.2.2.3.  \\nObservations for women and babies in the second stage of labour \\n12\\n3.2.2.4.  \\nWomen’s position and pushing in the second stage of labour \\n12\\n3.2.2.5.  \\nIntrapartum interventions to reduce perineal trauma \\n13\\n3.2.2.6.  \\nDelivery \\n13\\n3.2.3 \\nThird stage of Labour \\n14\\n3.2.3.1 \\nActive management of third stage of labour \\n14\\n3.2.3.2 \\nDelayed third stage \\n15\\n4 \\nCare for the newborn baby \\n15\\n5 \\nPerineal care \\n17'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 11}, page_content='National Guideline for Maternal Care - Volume I\\nx\\n B\\t\\nGuideline on Induction of Labour \\n19\\n1 \\nIntroduction \\n19\\n2 \\nDefinition \\n19\\n3 \\nGeneral Principles \\n19\\n4 \\nIndications \\n19\\n4.1 \\nOtherwise uncomplicated pregnancy continuing \\n  \\nbeyond 40 weeks \\n19\\n4.2 \\nPre labour rupture of membranes at term \\n20\\n4.3 \\nPreterm prelabour rupture of membranes (PPROM) \\n20\\n4.4   \\nIntrauterine death \\n20\\n4.5   \\nHistory of precipitate labour \\n20\\n4.6   \\nSuspected macrosomia \\n20\\n4.7   \\nFetal growth restriction \\n21\\n4.8   \\nOlder mothers \\n21\\n5 \\nInduction under specific circumstances \\n21\\n5.1   \\nBreech presentation \\n21\\n5.2 \\nPrevious CS \\n21\\n6.   \\nMethods of induction \\n21\\n6.1 \\nMechanical \\n21\\n6.2   \\nSurgical \\n22\\n6.3   \\nPharmacological \\n22\\n6.3.1   \\nOxytocin \\n22\\n6.3.2 \\nProstaglandins \\n22\\n6.3.3 \\nMifepristone \\n23\\n7.   \\nComplications \\n24\\n7.1 \\nHyperstimulation \\n24\\n7.2 \\nCord prolapse \\n24\\n7.3 \\nUterine rupture \\n25\\n7.4 \\nFailed induction \\n25\\n C\\t\\nGuideline for Use of Oxytocin for Induction and Augmentation \\n\\t\\nof labour\\t \\t\\n27\\n D\\t\\nGuideline on fetal monitoring in labour\\t\\n30\\n\\t\\n E\\t\\nGuideline on Pain Relief in Labour \\n34\\n1 \\nMethods of pain relief in labour \\n34\\n1.1 \\nNon-pharmacological methods of pain relief \\n35\\n1.2 \\nPharmacological methods of pain relief in labour \\n35\\n1.2.1 \\nOral paracetamol/paracetamol& codeine compound \\n35\\n1.2.2 \\nOpioids \\n35\\n1.2.2.A. \\nPethidine \\n35\\n1.2.2.B. \\nMorphine \\n36\\n1.2.2.C. \\nFentanyl \\n36\\n1.2.3 \\nInhalational analgesia – Entonox \\n36\\n1.2.4 \\nRegional Anaesthesia \\n37'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 12}, page_content='National Guideline for Maternal Care - Volume I\\nxi\\n F\\t\\nGuidelines to maintain the partograph\\t\\n39\\n\\t\\n G\\t\\nGuideline on acute puerperal inversion of the uterus \\n41\\n1 \\nIntroduction \\n41\\n2 \\nDefinition \\n41\\n3 \\nPrevention \\n41\\n4 \\nPathophysiology (and clinical correlation) \\n41\\n5 \\nClassification \\n42\\n6 \\nClinical Presentation and diagnosis \\n42\\n7 \\nManagement \\n43\\n7.1 \\nGeneral measures \\n43\\n7.2 \\nRepositioning the uterus \\n43\\n7.2.1 \\nManual replacement of uterus \\n43\\n7.2.2 \\nHydrostatc reduction \\n44\\n7.2.3 \\nTocolytics \\n45\\n7.2.4 \\nGeneral Anaesthesia \\n45\\n7.2.5 \\nSurgical methods \\n45\\n8 \\nDebriefing \\n46\\n H\\t\\nManagement of Hypertensive Disease in Pregnancy \\n47\\n1 \\nIntroduction \\n49\\n2 \\nDefinitions \\n49\\n3 \\nScreening for Hypertension during pregnancy \\n50\\n4 \\nPrevention of hypertensive disorders in pregnancy \\n50\\n5 \\nManagement of Chronic Hypertension  \\n51\\n6 \\nManagement of severe pre eclampsia \\n52\\n6.1 \\nGeneral Considerations \\n52\\n6.2 \\nSpecific Management \\n52\\n6.2.1 \\nAnti-hypertensive drugs \\n53\\n6.2.1.1 \\nLabetalol orally or intravenously \\n53\\n6.2.1.2 \\nHydralazine intravenously \\n54\\n6.2.1.3 \\nOral Nifedipine \\n55\\n6.2.2 \\nPrevention of convulsions \\n55\\n6.2.3 \\nFluid Balance \\n56\\n6.2.4 \\nIn utero/neonatal transfer \\n56\\n6.2.5 \\nDelivery \\n57\\n6.2.6 \\nPost-delivery \\n57\\n6.2.7 \\nFollow up \\n58\\n \\n I\\t\\nManagement of Eclampsia \\n59\\n1 \\nDefinition \\n59\\n2 \\nDiagnosis \\n59\\n3 \\nTime of onset of eclampsia \\n59\\n4 \\nComorbidities \\n59\\n5 \\nPrevention \\n60\\n6 \\nManagement \\n60\\n6.1 \\nGeneral considerations \\n60\\n6.2. \\nDuring the seizure \\n61'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 13}, page_content='National Guideline for Maternal Care - Volume I\\nxii\\n6.3.  \\nAs soon as possible following a seizure \\n61\\n6.4. \\nManagement of seizures in women receiving \\n  \\nmagnesium sulphate \\n62\\n7. \\nDelivery \\n62\\n8. \\nTransfer of a woman who has had a seizure to another institution \\n63\\n9. \\nPostpartum management \\n63\\n10. \\nCounselling  \\n64\\n J\\t\\nManagement of Diabetes during Pregnancy  \\n67\\n1 \\nPurpose \\n67\\n2 \\nScreening \\n67\\n2.1 \\nTarget groups for screening \\n67\\n2.2 \\nRecommended tests \\n68\\n3 \\nManagement – Women with established Diabetes \\n70\\n3.1 \\nPre Pregnancy care \\n70\\n3.2 \\nAntenatal Care \\n71\\n3.3 \\nMedical nutrition therapy (MNT) \\n72\\n3.4 \\nExercise \\n72\\n4 \\nGlyceamic control and Monitoring  \\n73\\n4.1 \\nGlyceamic Control \\n73\\n4.2 \\nMonitoring of glycaemic control \\n74\\n5 \\nDelivery and intra natal care \\n74\\n5.1 \\nTiming of delivery \\n74\\n5.2 \\nLabour care \\n75\\n6 \\nPost natal care \\n75\\n6.1.a \\nNeonatal care \\n75\\n6.1.b \\nImmediate post partum care \\n76\\n6.2 \\nAt hospital discharge \\n76\\n6.3 \\nLate Postnatal care and follow up \\n77\\n7 \\nFamily Planning \\n77\\n K\\t\\nManagement of Primary Post Partum Haemorrhage \\n81\\n1 \\nIntroduction \\n81\\n2 \\nDefinition \\n81\\n3 \\nPrevention of Post Partum Haemorrhage \\n81\\n4 \\nPrediction of Post Partum Haemorrhage \\n82\\n5 \\nManagement of Primary PPH \\n83\\n5.1 \\nGeneral measures \\n83\\n5.2 \\nSpecific measures \\n84\\n5.2.1 \\nEstablish a cause for the bleeding  \\n84\\n5.2.2. \\nManagement of atonic haemorrhage \\n85\\n5.2.3 \\nManagement of traumatic PPH \\n86\\n5.2.4 \\nRupture of the uterus \\n87\\n5.2.5 \\nCoagulopathy causing PPH \\n87\\n6. \\nResuscitation and Fluid management \\n87\\n7. \\nDebriefing \\n88\\n8. \\nRisk Management \\n89\\n  \\nAppendix 1 \\n90\\n  \\nAppendix 2 \\n92\\n  \\nAppendix 3 \\n94'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 14}, page_content='National Guideline for Maternal Care - Volume I\\nxiii\\nList of Abbreviations\\nWHO \\nWorld Health Organization\\nUNFPA \\nUnited Nations Population Fund\\nUNICEF \\nUnited Nations Children’s Fund\\nSLCOG \\nSri Lanka College of Obstetricians and Gynaecologists\\nNICE \\nNational Institutive of Clinical excellency\\nRCOG \\nRoyal College of Obstetricians and Gynaecologists\\nFHR \\nFetal Heart Rate\\nCPD \\nCephalo Pelvic Disproportion\\nNALS \\nNeonatal Advanced Life Support\\nPPROM \\nPreterm prelabour  rapture of the Membranes\\nCS \\nCaesarean Section\\nCTG \\nCardiotocography\\nIV \\nIntravenous\\nIM \\nIntra muscular\\nIU \\nInternational Units\\nEFM \\nElectronic Fetal Monitoring\\nTENS \\nTranscutaneous electrical nerve stimulation\\nHELLP \\nHaemolysis, elevated liver enzymes and low platelet\\nHDU \\nHigh dependency unit\\nICU \\nIntensive care unit\\nPGDM  \\nPre gestational diabetes mellitus\\nGDM \\nGestational Diabetes Mellitus\\nOGCT \\nOral glucose Challenge Test\\nOGTT \\nOral Glucose Tolerance test\\nPPBS \\nPost Prandial Blood Sugar\\nMNT \\nMedical Nutrition therapy\\nDENO \\nDiabetic Educator Nursing officer\\nSMBG \\nSelf-monitoring of blood glucose\\nAC \\nAbdominal Circumference\\nSHO \\nSenior House Officer\\nCBG \\nCapillary Blood Glucose\\nENC \\nEssential  New-born  Care\\nDM \\nDiabetes Mellitus\\nDMPA \\nDepot Medroxy Progesterone Acetate\\nBMI \\nBody Mass Index\\nPPH \\nPost Partum Haemorrhage'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 15}, page_content='National Guideline for Maternal Care - Volume I\\nxiv\\nList of Tables\\nGuidelines for ruse of oxytocin for induction and augmentation of labour\\nTable 1 \\nmU/minute administered at different rates of administration \\naccording to drop rate\\nTable 2 \\nmU/minute infused per minute when administered via an infusion \\npump\\nGuideline on fetal monitoring in labour\\nTable 1 \\nDefinitions of normal, suspicious and pathological FHR rates\\nTable 2 \\nClassification of fetal heart rate patterns\\nGuideline for screening, diagnosis and management of diabetes in pregnant \\nwomen\\nTable 1 \\nTarget values in glycaemic control'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 16}, page_content='National Guideline for Maternal Care - Volume I\\nxv\\nDisclaimer\\nThese guidelines are based on current best available evidence and \\nconsensus opinion of the Guideline Development committee of \\nthe Sri Lanka College of Obstetricians & Gynaecologists. They are \\nneither intended to replace the process of critical evaluation of \\nevery case and nor it is intended to dictate an exclusive course of \\nmanagement or treatment. It must be interpreted with reference to \\nindividual patient needs, available resources and limitations unique \\nto the institution and variations in local populations.\\nMedicine is a continually evolving science and the users must have \\nregard to relevant information, research or material, which may \\nhave been published or become available subsequently.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 17}, page_content='National Guideline for Maternal Care - Volume I\\nxvi\\nIntroduction\\nClinical Guidelines are systematically developed statements which assist \\nclinicians and patients in making decisions about appropriate treatment \\nfor specific conditions based on the best scientific evidence at the time of \\ndevelopment. Guidelines are not intended to limit the clinical freedom; \\nhowever, clinicians are expected to follow these recommendations as the \\nbasis for their decision making. Availability of resources, the existing \\nsituations, and the expectations of individual client needs to be considered. \\nThe guidelines are intended to guide all health care workers in all levels \\nof institutions where maternity care is being provided. Although these \\nguidelines are mainly targeted for the government sector institutions, use \\nin the private sector institutions where maternity care is being provided, \\nis also encouraged.\\nThese guidelines are developed by the guideline development committee \\nof the Sri Lanka College of Obstetricians and Gynaecologists in \\nconsultation with other relevant specialists such as anaesthesiologists, \\nphysicians, endocrinologists, and haematologists etc. The existing \\nnational guidelines developed in 2007, NICE guidelines on intranatal \\ncare, WHO guidelines and RCOG guidelines were perused and mixed \\nwith the local scenarios and expert opinion. The latest available scientific \\nevidences were considered and included where ever necessary. Then, the \\ndraft guidelines were presented to the wider forum of obstetricians and \\nconsensuses were arrived. After that the guidelines were handed over to \\nthe Ministry of Health and consensus was built with the participation \\nof multi-disciplinary team including medical administrators, provincial \\nhealth authorities, representatives from SLCOG and  other relevant \\nprofessional colleges, and national programme managers.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 18}, page_content='National Guideline for Maternal Care - Volume I\\n1\\nManagement of Labour'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 19}, page_content='National Guideline for Maternal Care - Volume I\\n2'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 20}, page_content='National Guideline for Maternal Care - Volume I\\n3\\nManagement of Normal Labour\\n1.\\t Introduction\\nThe aim of this guideline is to provide recommendations to care providers \\nin the management of a healthy woman with a single fetus in labour at \\nterm (37-42weeks). It does not cover the care of women with complicated \\npregnancies. \\nThe objective of this guideline is to ensure optimal management of \\nwomen in labour, detect any abnormalities, take appropriate action, \\nprevent complications and thus make childbirth safer; and also to make \\nsure that these women are treated with respect and compassion, and kept \\nwell informed and well supported throughout labour. \\n2.\\t Diagnosis of Labour\\nLabour is diagnosed by the presence of regular, painful intermittent \\ncontractions, which are of increasing frequency, duration and intensity, \\nleading to progressive cervical effacement and dilatation. \\nNote:  for the purpose of this guideline, labour is also diagnosed in the \\npresence of painful contractions occurring at a frequency of 2 in 10 \\nminutes or more.\\nDefinitions: \\nLatent phase of the first stage of labour – from the commencement \\nof labour to a cervical dilatation of up to 4 cm. (This is a period \\nof time, not necessarily continuous, when there are painful \\ncontractions and some cervical changes including cervical \\neffacement and dilatation up to 4cm take place)\\nActive phase of the first stage of labour – commences at a cervical \\ndilatation of 4cm and ends with full dilatation. (There are regular \\npainful contractions and progressive cervical dilatation from 4cm \\nup to full dilatation).'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 21}, page_content='National Guideline for Maternal Care - Volume I\\n4\\nIf the diagnosis of labour is uncertain, observation should continue and \\nreassessment made in four hours. \\nAny woman who is diagnosed as not being in labour, but continues to \\ncomplain of pain, would require careful reassessment by an experienced \\nmedical officer. Possible diagnoses of placental abruption and non-\\nobstetric causes should be considered. Fetal compromise should be \\nexcluded. \\n3.\\t\\nManagement of labour\\n3.1. \\nGeneral considerations\\n3.1.1. Communication between women and healthcare professionals/\\nworkers\\n• \\nGreet the mother with a smile and a personal welcome\\n• \\nTreat them with respect and dignity \\n• \\nAssure privacy \\n• \\nEstablish a good rapport with the laboring women asking \\nabout their wants and concerns and address them \\n• \\nMaintain a calm and confident approach which will reassure \\nwomen that the situation is under control\\n• \\nAssess the woman’s knowledge of strategies for coping with \\npain and provide balanced information to find out which \\navailable approaches are acceptable to her\\n• \\nAsk her permission before all  procedures and observations, \\nfocusing on the woman rather than technology or the \\ndocumentation\\n3.1.2. Preparation of mothers to transfer to labour room\\n• \\nShaving or trimming of perineal hair may be necessary to \\nfacilitate unhindered performance and repair of the episiotomy.\\n• \\nEfforts must be made to minimize faecal soiling. Where \\nan enema is deemed necessary, a medicated enema is \\nrecommended. \\n      (These two steps should not be considered mandatory)'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 22}, page_content='National Guideline for Maternal Care - Volume I\\n5\\n• \\nWomen should be encouraged to have a companion of her \\nchoice during labour, depending on the facilities and clinical \\nsituation.\\n3.1. 3. Documentation \\n• \\nAdmit the mother to the labour room and complete the \\n‘handing over’ form \\n• \\nEnter relevant notes on the BHT and start a partogragh (see \\npage 39)\\n• \\nReview clinical notes and reassess risk factors.\\n• \\nAccurate documentation of all observations and interventions \\nmust be made, with timing.\\n• \\nAll obstetric examinations and procedures carried out must \\nbe documented in the clinical notes. Each entry must be \\naccompanied by a plan for management and be signed by the \\nresponsible person.  \\n3.1.4. Mobilization and Positioning\\n• \\nWomen should be encouraged and helped to move about \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nThey need to be encouraged to void urine at regular intervals.\\n3.1.5. Eating and drinking in labour\\n• \\nMothers must be encouraged to consume clear, non-\\nfizzy liquids during labour. Isotonic solutions such as oral \\nrehydration fluid and king coconut water are more beneficial \\nthan water. \\n• \\nIn addition to clear fluids, women in the latent phase may \\nconsume light solids e.g. biscuits and fruits. \\n3.1.6. Hygiene measures during labour\\n• \\nStrict asepsis must be maintained during labour. \\n• \\nInstruments should be available in packets'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 23}, page_content='National Guideline for Maternal Care - Volume I\\n6\\n• \\nUse proper hand washing technique.\\n• \\nUse of double gloves and disposable gloves is encouraged.  \\n3.1.7. Pain relief in labour\\nRelief of pain should be a major consideration (please refer guidelines on \\npain relief during labour in page 34)\\n3.2. \\nManagement of the three stages of labour\\nThe practice of maintaining a labour room ‘notice board’ - a ‘white \\nboard’ on which the status of all women in labour is summarized \\nand updated regularly is encouraged. This would convey at a glance \\nto all care providers women who require additional attention. The \\nage, parity status, risk factors, salient findings at each assessment \\nand any abnormalities noted must be included in this.\\n3.2.1. Management of first stage of labour\\n3.2.1. 1. Latent phase \\nIt is important to recognize the latent phase of labour, since its prolongation \\ncould lead to maternal exhaustion, dehydration and acidosis, leading to \\nfetal compromise and dysfunctional labour. \\n \\nWomen in the latent phase of labour would be best managed in the \\nantenatal ward.\\nWomen in the latent phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse half hourly\\n• \\nCheck  temperature four hourly\\n• \\nConsider vaginal examination four hourly, depending on the \\ncontraction pattern and initial cervical dilatation\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 24}, page_content='National Guideline for Maternal Care - Volume I\\n7\\n• \\nUse of a sanitary pad may indicate early, the presence of \\nmeconium. \\n• \\nConsider the requirement for analgesia.\\nIt is important to inform the mother and reassure her that it is common to \\nhave slow progress in the latent phase.  \\nThe latent phase is considered prolonged when it lasts more than 12 hours \\nin a primigravida and 8 hours in a multigravida. In these situations an \\nexperienced medical officer (with a minimum one year of experience in \\nthe field) must reassess the mother with a view of augmentation of labour. \\n3.2.1.2. Active phase\\n3.2.1.2a. Admitting women to the Labour Room\\nAll pregnant women diagnosed as being in active phase of the first stage of \\nlabour need to be admitted to the labour room.\\nThe initial assessment of a woman in the labour room should include:\\n• \\nListening to her story, considering her emotional and \\npsychological needs and reviewing her clinical records\\n• \\nPhysical observation: temperature, pulse, blood pressure\\n• \\nLength, strength and frequency of contractions\\n• \\nAbdominal palpation: fundal height, lie, presentation, position \\nand station\\n• \\nVaginal loss: show, liquor, blood\\n• \\nAssessment of woman’s pain including her wishes for coping \\nwith labour along with the range of options for pain relief\\n• \\nThe fetal heart rate (FHR)  should be auscultated preferably with \\na hand held Doppler for a minimum of 1 minute immediately \\nafter a contraction\\n• \\nThe maternal pulse should be recorded to differentiate between \\nmaternal pulse and FHR\\n• \\nA vaginal examination should be offered'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 25}, page_content='National Guideline for Maternal Care - Volume I\\n8\\nHealth care Professionals who conduct vaginal examination should:\\n• \\nBe sure that there is a valid indication for vaginal examination \\nthat it will add important information to the decision making \\nprocess\\n• \\nBe aware that for many women who may already in pain, \\nhighly anxious and in an unfamiliar environment, vaginal \\nexamination can be very distressing\\n• \\nEnsure the woman’s consent, privacy, dignity and comfort\\n• \\nExplain the reason for examination and what will be involved, \\nand\\n• \\nExplain the findings and their impact sensitively to the woman\\n3.2.1.2b.  Management of active phase of first stage\\nMonitoring must be conducted as instructed in the partogram and \\nfindings recorded accordingly. \\nUse of a sanitary pad may indicate presence of meconium early. \\nWomen in the active phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse every 15 minutes ;\\n• \\nCheck temperature and blood pressure four hourly;\\n• \\nVaginal examination four hourly or earlier, depending on the \\nclinical situation; \\n• \\nFrequency of contractions should be monitored as follows:\\n \\nThe interval between two contractions should be assessed by \\npalpation of the abdomen\\n \\nDuring active labor usually there are at least three contractions \\nper ten minutes. In other words the interval between two \\ncontractions should be three minutes\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture;\\n• \\nConsider the requirement for analgesia, (which now becomes \\nmore important).'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 26}, page_content='National Guideline for Maternal Care - Volume I\\n9\\nIntermittent auscultation of the fetal heart is best performed using \\nhand-held Doppler devices. The fetal heart rate must be counted \\nfor one minute, beginning immediately after a contraction.\\nThe mother may continue to consume clear fluids in the active phase. \\nShe must be encouraged to assume any position that she is comfortable in \\nand to avoid the dorsal position. \\nWomen who have the following conditions are recommended to be have \\nto continuous electronic fetal monitoring: \\n• \\nSignificant meconium staining of amniotic fluid, \\n• \\nAbnormal Fetal heart rate detected by intermittent \\nauscultation (< 110 beats per minute; > 160 beats per minute; \\nany decelerations after a contraction)\\n• \\nFresh vaginal bleeding and \\n• \\nMaternal pyrexia. \\nIn women with spontaneous labour progressing normally, routine \\nearly amniotomy and use of oxytocin is not recommended.\\n3.2.1.3. Delayed progress of first stage of labour\\nDelayed progress is diagnosed when there is progress of less than \\ntwo cm in four hours. Slowing of progress in a woman who has \\npreviously been progressing satisfactorily must also be considered \\nas a delay.\\nIt is extremely important that delay in progress is assessed by an \\nexperienced medical officer. \\nThis assessment must take into account:\\n• \\nthe uterine contractions, \\n• \\ndescent and position of the fetal head  \\n• \\nfeatures of early obstruction of labor (caput and moulding), and \\n• \\nThe fetal condition'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 27}, page_content='National Guideline for Maternal Care - Volume I\\n10\\nIn women with delay in the active phase of the first stage, every effort must \\nbe made to find a cause for the delay. This may either be due to inadequate \\ncontractions or obstruction due to CPD, mal-presentation or malposition \\n(such as occipito-posterior position), or a combination of these. \\nIn cases of inadequate contractions:\\n• \\nAmniotomy must be performed if membranes are still intact. \\n• \\nFollowing that, the woman must be reassessed in two hours \\n• \\nIn case there is inadequate progress, augmentation with \\noxytocin must be considered. \\n• \\nThe situation must be reassessed after four hours or earlier if \\nrequired.\\nMultiparous women with delayed progress: \\n• \\nMust be viewed with extreme caution. \\n• \\nIt is very important to exclude mechanical causes of delay \\nbefore considering oxytocin. \\n• \\nUse of oxytocin in multipara with obstructed labour could be \\nextremely dangerous. \\nIn all cases where progress is slow in spite of adequate contractions a \\ncareful assessment must be made to exclude obstruction of labour. \\nAttention must be paid to effective pain relief and to correcting dehydration \\nin those situations.\\nAfter paying attention to the above,Cesarean section must be considered \\nwhere the progress continues to be slow after four hours (less than two \\ncm) of commencing oxytocin. \\n3.2.2. Management of second stage of labour\\n3.2.2.1. Passive second stage of labour (descent phase)\\n• \\nIs diagnosed when full cervical dilatation is reached in the \\nabsence of involuntary expulsive efforts by the mother. \\n• \\nBearing down must be discouraged at this stage.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 28}, page_content='National Guideline for Maternal Care - Volume I\\n11\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 10 minutes. The maternal pulse should be palpated if \\nthere is suspected fetal bradycardia or any other FHR anomaly \\nto differentiate the two heart rates. \\n• \\nPresence of meconium must be noted. \\n3.2.2.2. Active second stage of labour (expulsive phase) \\n• \\nIs diagnosed when the mother gets the urge to bear down with \\nfull dilatation.\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 5 minutes. The maternal pulse should be palpated if there \\nis fetal bradycardia or any other FHR anomaly \\n• \\nPresence of meconium must be noted. \\nUse of a hand-held Doppler device is recommended (in preference to a \\nPinnard) for fetal heart rate monitoring in the second stage. \\nWomen must be encouraged to continue consuming clear fluids during \\nthe second stage. \\nSupport by the labour companion must be continued. \\nTotal time durations allowed for the second stage of labour are as follows:\\nPrimigravida: \\n• \\nBirth would be expected to take place within 2 hours of the \\nstart of the active second stage in most women.\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 1 hour and need to seek the advice from a \\nhealth professional trained in the assisted/ Operative vaginal \\nbirth if birth is not imminent.\\nMultigravida:\\n• \\nBirth would be expected to take place within 1 hours of the \\nstart of the active second stage in most women.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 29}, page_content='National Guideline for Maternal Care - Volume I\\n12\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 30 minutes and requires advice from a health \\nprofessional trained in assisted/ operative vaginal birth if birth \\nis not imminent.\\n• \\nDelay in the second stage in a multiparous woman must raise \\nsuspicion of disproportion or malposition.\\nOne further hour is permitted for women in each category with an \\nepidural analgesia.\\n3.2.2.3. Observations for women and babies in the second stage of \\nlabour:\\nAll observations should be documented on the partogragh.\\n• \\nChart blood pressure and pulse hourly\\n• \\nContinue four hourly temperature recording \\n• \\nVaginal examination must be offered after an hour in the active \\nsecond stage after abdominal palpation and assessment of \\nvaginal loss\\n• \\nHalf hourly documentation of frequency of contractions\\n• \\nOngoing consideration of the woman’s  emotional and \\npsychological needs\\nIn addition:\\n• \\nAssessment of progress should include maternal behavior, \\neffectiveness of pushing and fetal wellbeing, taking into \\naccount fetal position and station at the onset of the second \\nstage. These factors will assist in deciding the timing of further \\nvaginal examination and the need for obstetric review.\\n• \\nOngoing consideration should be given to the woman’s position, \\nhydration, coping strategies and pain relief throughout the \\nsecond stage.\\n3.2.2.4. Women’s position and pushing in the second stage of labour:\\nAlthough most deliveries in Sri Lanka are conducted in the dorsal/\\nMcRobert’s position, women may be encouraged to adopt squatting, semi \\nupright or lateral positions to aid the expulsion phase.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 30}, page_content='National Guideline for Maternal Care - Volume I\\n13\\nWomen should be informed that in the second stage, they should be \\nguided by their own urge to push.\\nIf pushing is ineffective, strategies to assist birth such as support and \\nencouragement and change of position can be used.\\nIn primigravida in whom contractions have become weak and there \\nis no evidence of fetal compromise or obstruction, oxytocin may \\nbe administered as an infusion. In this case, the expulsive phase \\nmay be continued under close observation for a further 30 minutes. \\nDelivery must be considered at the end of this period.\\n3.2.2.5. Intrapartum interventions to reduce perineal trauma\\nEither the ‘hands on’ (guarding the perineum and flexing the baby’s head) \\nor the ‘hands poised’ (with hands off the perineum and baby’s head but in \\nreadiness) techniques can be used to facilitate spontaneous birth.\\nA routine episiotomy should not be carried out during spontaneous \\nvaginal birth.\\nEpisiotomy should only be performed selectively, in women in whom there \\nis a clinical need such as instrumental birth or suspected fetal compromise \\nor a high chance of perineal tears.  \\nWhere episiotomy is performed, Mediolateral episiotomy, performed at \\n45 – 60 degrees from the midline directed to the right side, beginning at \\nthe vaginal fourchette is preferred to the median episiotomy.  It should be \\nperformed at the time of crowning of the fetal head.\\nEpisiotomy should be performed after infiltration of the perineum up to \\n20 ml of 1% lignocaine. \\n3.2.2.6. Delivery\\nThe fetal head should not be allowed to extend till occiput is felt below \\nthe symphysis pubis. The perineum should be supported during delivery \\nof the head. Once the head is delivered the woman should be discouraged \\nfrom bearing down. Following restitution and external rotation, shoulders'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 31}, page_content='National Guideline for Maternal Care - Volume I\\n14\\nmust be delivered appropriately with directed traction on the fetal head. \\nThe baby must be delivered onto the mother’s abdomen. Breastfeeding \\nshould be initiated within 30 minutes of birth. \\n3.2.3. \\nThird stage of Labour\\nThe third stage of labour is the period from the complete delivery of the \\nbaby to the complete delivery of the placenta and membranes.\\n3.2.3.1. Active Management of the third stage of labour\\nActive management of the third stage of labour is recommended for all \\nmothers. \\nThis includes;\\n• \\nRoutine use of uterotonic drugs: Oxytocin 5 IU intravenously \\nsoon after the delivery of the baby   or 10 IU intramuscularly, \\n• \\nDelayed cord clamping (2 minutes after the birth) and cutting \\nof the cord\\n• \\nFollowed by controlled cord traction. This must be followed by \\nuterine massage.\\nDelayed clamping of the cord allows for placental transfusion, \\nwhich reduces neonatal and infant iron deficiency and anemia. \\nThis policy should be followed unless the baby is born in a poor \\ncondition or if the mother is bleeding or is Rhesus iso-immunized.\\nClamp and cut the cord close to the perineum.  A hand should be placed \\nabove the symphysis pubis to stabilize the uterus by applying counter \\ntraction during controlled cord traction. Application of cord traction \\nwhen the uterus is relaxed could lead to acute inversion of the uterus.\\nAfter delivery, the placenta must be placed on a flat surface and the maternal \\nsurface examined for completeness. On the fetal surface the blood vessels \\nmust be traced to exclude a succenturiate lobe. Completeness of the fetal \\nmembranes must be ensured.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 32}, page_content='National Guideline for Maternal Care - Volume I\\n15\\nObservations in the immediate postpartum period include:\\n• \\nInspection for continued fresh bleeding, \\n• \\nCheck pulse, blood pressure, uterine contraction,  and the level \\nof the fundus every 15 minutes up to 2 hours\\n• \\nHer general  physical condition, as shown by her colour, \\nrespiration and her own report of how she feels \\nExperienced medical personnel should be informed in any one the \\nfollowing instances: \\n• \\nContinuing fresh bleeding;\\n• \\nElevation of the level of the fundus;\\n• \\nIncrease of pulse rate above 100 or by 30 beats per minute;\\n• \\nDrop in systolic blood pressure below 100 or by 30 mmHg. \\nThe level of the fundus must be marked on the skin using a marker to \\nmake observations more objective. \\n3.2.3.2. Delayed third stage\\nDelayed third stage is diagnosed when the placenta is not delivered within \\n30 minutes of active management. \\nThe first step in managing delayed third stage of labour is:\\n• \\nTo proceed to intraumbilical vein oxytocin, in a dose of 50 IU \\nin 30 ml of 0.9% sodium chloride solution. \\n• \\nA period of 30 minutes is allowed and controlled cord traction \\nis attempted again. \\n• \\nIf the placenta is not delivered by this method, manual removal \\nof placenta is proceeded to. \\n4.\\t\\nCare for the newborn baby\\nEffective care at birth is needed in anticipation of problems with the \\ntransition from in utero dependent life to extra utero independent \\nexistence and to provide support to ensure stabilization.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 33}, page_content='National Guideline for Maternal Care - Volume I\\n16\\n• \\nSkilled birth attendant (Medical Officer, Nursing Officer and \\nMidwive) is responsible for the care. \\n• \\nThe care at birth is same irrespective of birthing place or person \\nattending to birth. \\n• \\nAt least one health care provider trained in neonatal \\nresuscitation must be physically available at the time of birth of \\nall infants irrespective of risk status.\\n• \\nThis person must actually be present in the delivery room \\nbefore the birth of the baby.\\n• \\nThe attending personnel should document the details of the \\nbaby such as time of birth, weight, gender and any other \\nrelevant information in all cases.\\nThe aims of neonatal care following birth include the following:\\n• \\nEstablishment of respiration (as per NRP guidelines) \\n• \\nPrevention of hypothermia (Refer to newborn guideline)\\n• \\nEstablishment of breast feeding (Refer to newborn guideline)\\n• \\nPrevention of infection (Refer to newborn guideline)\\n• \\nDetection of danger signs (Refer to newborn guideline)\\nFollowing basic steps should be followed at the time of birth;\\n1. Call out the time of birth\\n2. Deliver the baby onto the mother’s abdomen or into her arms\\n3. Dry baby with a warm towel or a warm piece of cloth\\n4. Wipe baby’s eye\\n5. Assess baby’s breathing while drying \\n6. Make sure that there is no second baby\\n7. Change gloves or remove the first layer of gloves\\n8. Clamp and cut the umbilical cord\\n9. Put the baby between mother’s breast for skin to skin care\\n10. Place an identity label on baby\\n11. Cover mother and baby with warm clothes\\n12. Put a hat on baby’s head\\nThe Apgar score at 1 and 5 minutes should be recorded for all births.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 34}, page_content='National Guideline for Maternal Care - Volume I\\n17\\nInitiation of breast feeding should be aimed for within 1hour after birth. \\nHead circumference, birth weight, length and other measurements should \\nbe carried out once the first feed is complete. A health care professional \\nshould examine the baby to detect any physical abnormality and to \\nidentify any problems that require referral.\\n5.\\t\\nPerineal Care\\nPerineal  or genital trauma caused by either episotomy or tearing need to \\nbe repaired.\\nBefore assessing for genital trauma:\\n• \\nExplain to the woman what they are going to do and why\\n• \\nOffer some analgesia\\n• \\nEnsure good lighting\\n• \\nPosition the woman so that she is comfortable and the genital \\nstructures can be seen clearly.\\nThe initial assessment should be performed gently and with sensitivity \\nand may be done in the immediate period following birth preferably as \\nsoon as the placenta is delivered.\\nClassification of perineal trauma\\nFirst degree: Injury to skin only\\nSecond Degree: Injury to the perineal muscles but not the anal \\nsphincter\\nThird degree: Injury to the perineum involving the anal sphincter  \\ncomplex\\nFourth degree: Injury to the perineum involving the anal sphincter \\ncomplex and anal epithelium\\nPerineal repair should only be undertaken with tested effective analgesia \\nin place using infiltration with up to 20ml of 1% lignocaine or equivalent, \\nor by topping up the epidural, as soon as possible by a medical officer.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 35}, page_content='National Guideline for Maternal Care - Volume I\\n18\\nThe preferred suture material is rapidly absorbable polyglactin acid.\\nThe following basic principles should be observed when performing \\nperineal repairs:\\n• \\nPerineal trauma should be repaired using aseptic techniques.\\n• \\nEquipment should be checked and swabs and needles counted \\nbefore and after the procedure\\n• \\nGood lighting is essential to see and identify the structures \\ninvolved.\\n• \\nDifficult injuries should be repaired by an experienced medical \\nofficer in the theatre under regional or general anaesthesia. An \\nindwelling catheter should be inserted for 24 hours to prevent \\nurinary retention.\\n• \\nGood anatomical alignment of the wound should be achieved, \\nand consideration  given to the cosmetic result.\\n• \\nRectal examination should be carried out after completing the \\nrepair to ensure that suture material has not accidently been \\ninserted through the rectal mucosa.\\n• \\nFollowing completion of repair, an accurate detailed account \\nshould be documented covering the extent of the trauma, the \\nmethod of repair and the materials used.\\n• \\nInformation should be given to the woman regarding the extent \\nof the trauma, pain relief, diet, hygiene and the importance of \\npelvic floor exercises.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 36}, page_content='National Guideline for Maternal Care - Volume I\\n19\\nGuideline on Induction of Labour\\n1.\\t\\nIntroduction \\nThis guideline aims to provide evidence based guidance on induction of \\nlabour to make the process more logical, effective and safer. It also aims to \\nempower women undergoing induction of labour. \\n2.\\t\\nDefinition\\nInduction of labour is defined as initiation of labour by artificial means.\\n3.\\t\\nGeneral Principles\\n• \\nInduction of labour should be performed only in specialist \\nobstetric units when there is a clear indication that its benefits \\noutweigh risks.\\n• \\nA senior clinician must make the decision.\\n• \\nThe reason/s should be clearly explained to the patient, who \\nshould give her consent.\\n• \\nMaternal and fetal wellbeing should be monitored closely.\\n• \\nAdequate pain relief should be an essential part of the \\nmanagement plan, since it is recognized that labor is more \\npainful when it is induced.\\n• \\nPrior to induction of labour, the cervix should be favourable \\n(Modified Bishop score 7 or more). If it is not, an attempt should \\nbe made to ripen the cervix. \\n• \\nDecisions regarding induction of labour should be made taking \\ninto account not only the clinical scenario but also the woman’s \\nviews, the availability of local facilities and cost effectiveness of \\nthe available methods.\\n4.\\t\\nIndications\\n4.1 Otherwise uncomplicated pregnancy continuing beyond 40 weeks\\nInduction of labour is recommended for low-risk women who are known \\nwith certainty to have reached 41 weeks of gestation.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 37}, page_content='National Guideline for Maternal Care - Volume I\\n20\\nHowever, it is good practice to assess fetal wellbeing around 40 weeks to \\nselect women for conservative management until 41 weeks gestation. \\nThe recommended assessments include fetal biometry (at least abdominal \\ncircumference) and amniotic fluid index (lower cut-off = 7 cm). \\n4.2 Prelabour rupture of membranes at term\\nIn the absence of evidence fetal compromise or maternal infection delayed \\ninduction of labour after 24 hours is acceptable. \\nThis may be carried out using either oxytocin infusion or prostaglandins.\\n4.3 Preterm prelabour rupture of membranes (PPROM)\\nPatients with PPROM without evidence of infection or fetal compromise \\nshould be offered induction after the completion 34 weeks.\\n4.4 Intrauterine death\\nThis is a very traumatic time for the woman. Most women would want \\nto be delivered as early as possible and their wishes need to be respected. \\nAmniotomy and repeated vaginal examinations are best avoided. \\nProstaglandins are preferred for induction of labour in these women. \\nAmniotomy is preferred in the presence of abruption placentae. \\n4.5 History of precipitate labour\\nThere are no studies comparing outcomes in induced versus spontaneous \\nlabour.\\n4.6 Suspected macrosomia\\nIn the presence of good clinical and ultrasound evidence of macrosomia \\nor a history of previous shoulder dystocia, there should be a low threshold \\nfor early induction of labour.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 38}, page_content='National Guideline for Maternal Care - Volume I\\n21\\n4.7 Fetal growth restriction\\nThe decision for induction of labour in a growth restricted fetus should be \\nindividualized based on period of gestation at onset, presence or absence \\nof fetal compromise. \\n4.8 Older mothers\\nThere is growing evidence that the risk of stillbirth is higher in older (>40 \\nyrs) women near term. \\nWomen over 40 years should be offered induction between 39-40 weeks.\\n5.\\t\\nInduction under specific circumstances\\n5.1 Breech presentation\\nPresentation per se, is not a contraindication to induction. \\n5.2 Previous CS\\nThere is no contraindication to induction of labour in a woman with a \\npast caesarean section. \\nUse of either oxytocin or prostaglandins increases the risk of scar \\ndehiscence or rupture. \\nThis risk may be lower with artificial separation of membranes or Foley \\ncatheter. \\n6.\\t\\nMethods of induction\\nThis section does not make a distinction between methods of ripening the \\ncervix and induction of labour. \\n6.1 Mechanical\\nThere is good evidence that artificial separation of membranes reduces the \\nneed for formal induction. This method is recommended to be performed \\nwith due regard to asepsis, at 40 weeks gestation.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 39}, page_content='National Guideline for Maternal Care - Volume I\\n22\\nWhere the cervix will not admit a finger, massaging around the cervix in \\nthe vaginal fornices will have a similar effect.\\nExtra-amniotic balloon catheter is an effective method of ripening of the \\ncervix. A Foley catheter is inserted through the cervix and the balloon \\ninflated with 40 – 60 ml of saline. This may be left in situ for a maximum \\nof 48 hours. Following its removal, induction of labour may be proceeded \\nto using another method. \\nIn the presence of evidence of infection, artificial separation of membranes \\nand extra-amniotic Foley catheter must not be used. \\n6.2 Surgical\\n \\nAmniotomy is a definitive mode of induction of labour. It should be \\nundertaken only if one is committed to deliver within 24 hours. Therefore \\nit should be done only when the cervix is ripe and prior cervical assessment \\nby an experienced clinician is essential.\\nThe risk of cord prolapse should be appreciated and steps taken to \\nminimise or to recognize it early.\\nAmniotomy alone may be capable of initiation of labour and it is \\nrecommended that oxytocin be started after a period of observation of at \\nleast two hours. \\n6.3 Pharmacological\\n6.3.1 Oxytocin\\nUse of oxytocin when membranes are intact is not recommended. \\nFor details of how to use oxytocin please refer to the guideline on oxytocin\\n6.3.2 Prostaglandins\\nProstaglandin E2 (PGE2)\\nThese are very effective in inducing labour and are available as vaginal gel, \\ntablet or controlled release pessary.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 40}, page_content='National Guideline for Maternal Care - Volume I\\n23\\nAll preparations carry a risk of hyperstimulation.\\nIntracervical route does not offer any increase in efficacy.\\nCombined use with oxytocin is particularly dangerous. A minimum of six \\nhours from the last vaginal tablet/gel should be allowed before oxytocin \\nis started.\\nPrior to use of prostaglandins the Bishop score should be assessed and \\nthe woman should be monitored electronically to determine the fetal \\ncondition and frequency of contractions.\\nAfter administration the fetal heart should be monitored electronically \\nwhen contractions begin. After confirmation of normal heart rate pattern \\nmonitoring should be done by intermittent auscultation.\\nA second dose may be considered after a minimum interval of 6 hours \\nafter the first, depending on the change of Bishop score, the condition of \\nthe fetus and frequency of contractions.\\nThe dosages are 3 mg for vaginal tablets and 0.5 mg for vaginal gel.\\nMisoprostol\\nThis drug is widely used worldwide for a variety of indications in \\npregnancy. (In Sri Lanka, it is not licensed at present).\\nNevertheless, it is very effective in inducing labour (more than PGE2), \\nespecially in mid trimester fetal death. \\nSensitivity of the uterus increases markedly with advancing pregnancy.\\nThis guideline recommends that it should not be used for induction of \\nlabour with a mature live fetus.\\n6.3.3 Mifepristone\\nIt is a powerful anti-progesterone and is very useful as an adjunct to \\nmisoprostol in cases of intrauterine death. (It is not licenced in Sri Lanka \\nat present)'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 41}, page_content='National Guideline for Maternal Care - Volume I\\n24\\n8.\\t\\nComplications\\n8.1 Hyperstimulation\\nThis is a well-recognized complication of induction of labour with \\npharmacological methods. It could have serious consequences including \\nrupture of the uterus, aminiotic fluid embolism, precipitate labor and fetal \\ncompromise. \\nIt is defined either as a contraction free interval of less than sixty seconds \\nand/or contractions lasting more than ninety seconds.\\nIf diagnosed, the prostaglandin tablet must be retrieved from the vagina \\nor oxytocin infusion stopped immediately and a rapid infusion of 0.9% \\nsodium chloride via a fresh giving set administered.    \\nIf still not resolved, tocolytics should be given if available e.g. terbutaline \\n250 µg IV or SC.  Since this is not available in Sri Lanka, salbutamol \\ninhaler may be tried.\\n8.2  Cord prolapse\\nThis is more likely with amniotomy when the head is high and poorly \\napplied to the cervix. \\nPrecautions to avoid and to detect this early include palpation for cord \\npresentation, palpation for the cord immediately after amniotomy and the \\nfetal heart sounds auscultated immediately afterwards.\\n \\nIf cord prolapse is diagnosed help must be called immediately. Assess \\ncervical dilatation and effect delivery if fully dilated. If not fully dilated \\nand cord pulsations are present, insert a Foley catheter into the bladder \\nand fill it with 500 ml saline. Place the mother in the knee-elbow position \\nand displace the presenting part away from the pelvis by keeping pressure \\ninserting a hand in the vagina. Transport for immediate caesarean section \\nin this position.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 42}, page_content='National Guideline for Maternal Care - Volume I\\n25\\n8.3 Uterine rupture\\nPlease also refer to section 5.2 in this guideline\\nExtra care must be exercised in grandmultipara and in women with \\nscarred uteri.\\n8.4 Failed induction\\nFailed induction is defined as labour failing to start after one cycle of \\ntreatment with medical methods or for 12 hours of amniotomy. \\nIt does not necessarily indicate caesarean section in case medical or \\nmechanical methods.\\nThe clinical situation (maternal and fetal condition) must be reassessed \\nand discussed with the woman. \\nIn case of failure to induce labor using one cycle of prostaglandins another \\ncycle may be administered as described  above. Depending on the clinical \\nsituation it is best that the second cycle is delayed for 24 hours. In case of \\namniotomy, failed induction of labour indicates caesarean section.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 43}, page_content='National Guideline for Maternal Care - Volume I\\n26'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 44}, page_content='National Guideline for Maternal Care - Volume I\\n27\\nGuideline for Use of Oxytocin for Induction and \\nAugmentation of labour\\nOxytocin is an invaluable drug when used carefully. However, it has \\nthe potential to cause uterine hyperstimulation, which could result in \\namniotic fluid embolism, uterine rupture and fetal distress, all of which \\nare life threatening. \\nMultigravidae are particularly susceptible to the above consequences \\nand extra care must be taken to exclude obstruction before a decision is \\nmade to use oxytocin in a multigravid woman during labour. Experienced \\npersonnel must be involved in this decision. \\nUse of oxytocin for induction and/or augmentation of labour results in \\na higher risk of rupture of a scarred uterus. Therefore, in such women \\noxytocin should be used only with the concurrence of a Consultant. \\nIts effects will depend on the concentration of the infusion and the volume \\ninfused per minute. \\nTo achieve this predictably, use of infusion pumps is recommended. \\nWhere a gravity-assisted drip system is used, a burette may be used to \\nimprove accuracy. Such systems however, may deliver variable volumes \\ndepending on many factors including the position of the arm into which \\nit is infused.  \\nIrrespective of the method of administration, oxytocin must be \\nadministered in incremental doses at intervals of 30 minutes, to achieve \\na contraction free interval of two minutes. Once this level is reached, the \\ninfusion rate may be continued at the same level, while closely monitoring \\nthe contractions. \\nHyperstimulation is defined either as a contraction free interval of less \\nthan sixty seconds and/or contractions lasting more than ninety seconds. \\nIn this situation the infusion must be stopped immediately. \\nOxytocin is administered with 5 units in 500 ml of 0.9% sodium chloride \\nsolution. In situations where infusion pumps are not available, oxytocin'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 45}, page_content='National Guideline for Maternal Care - Volume I\\n28\\nmay be administered starting at a drop rate of 15 per minute and increased \\nat rates of 15 drops per minute every 30 minutes, up to a maximum of 60 \\ndrops per minute.  An approximate conversion to mU/minute is given in \\ntable 1.\\nTable 1: mU/minute administered at different rates of administration \\naccording to drop rate\\n \\nDrop rate/min \\nEquivalent  mU/min.\\n \\n15 \\n7.5\\n \\n30 \\n15 \\n \\n45 \\n22.5 \\n \\n60 \\n30 \\n \\n            (based on 5U of oxytocin in 500 ml saline)\\nTable 2 gives mU infused per minute when administered via an infusion \\npump. \\nTable 2: mU infused per minute when administered via an infusion \\npump.\\n TIME AFTER STARTING \\nOXYTOCIN DOSE \\nVOLUME INFUSED\\n \\n(MINS) \\n(MU/MIN) DOSE \\n(10U IN 500MLS MLS/HR)\\n \\n \\n \\nRATE\\n \\n0 \\n1 \\n3\\n \\n30 \\n2 \\n6\\n \\n60 \\n4 \\n12\\n \\n90 \\n8 \\n24\\n \\n120 \\n12 \\n36\\n \\n150 \\n16 \\n48\\n \\n180 \\n20 \\n60\\n \\n210 \\n24 \\n72\\n \\n240 \\n28 \\n84\\n \\n270 \\n32 \\n96\\nOxytocin must not be administered to women with intact membranes. It is \\nrecommended that women on oxytocin infusions should have continuous \\nelectronic fetal monitoring.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 46}, page_content='National Guideline for Maternal Care - Volume I\\n29\\nContinuous EFM during administration of oxytocin:\\n• \\nIf the CTG is normal, oxytocin may be continued in incremental \\ndoses until the woman is experiencing 4 or 5 contractions every \\n10 minutes.\\n• \\nIf the FHR trace is suspicious, this should be reviewed by an \\nexperienced medical officer \\n• \\nIf the FHR trace is classified as abnormal/pathological oxytocin \\ninfusion should be stopped and a full assessment of the fetal \\ncondition undertaken by an experienced medical officer.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 47}, page_content='National Guideline for Maternal Care - Volume I\\n30\\nGuideline on fetal monitoring in labour\\nFetal monitoring in labour could be done by :\\n• \\nIntermittent auscultation (preferably by a hand held Doppler \\ndevice) \\n• \\nIntermittent or continuous electronic monitoring  \\nIntermittent auscultation is recommended for low-risk women in \\nspontaneous labour. \\nElectronic monitoring is recommended when:\\n• \\nThe baby’s  growth is restricted  \\n• \\nThere is significant meconium staining of amniotic fluid \\n• \\nAbnormal fetal heart rate detected by intermittent auscultation \\n• \\nFresh vaginal bleeding \\n• \\nMaternal pyrexia \\n• \\nUse of oxytocin for augmentation or induction of labour \\n• \\nWomen with a scarred uterus \\n• \\nWomen on epidural analgesia \\nIntermittent auscultation \\nThis could be done by using either a Pinnard’s stethoscope or preferably a \\nhand-held Doppler device. \\nAuscultation should be carried out immediately after a contraction for \\none full minute. \\nThe maternal pulse should be palpated if there is suspected fetal \\nbradycardia or any other FHR anomaly to differentiate the two heart rates.\\nThe normal rate is between 110 – 160 beats per minute in a term fetus. \\nThe frequency of auscultation should be as specified in the partogram.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 48}, page_content='National Guideline for Maternal Care - Volume I\\n31\\nElectronic fetal monitoring (EFM)\\nEFM is carried out by external cardiotocography (CTG). \\nThe following are recommended at the commencement of a CTG.\\n1. The paper speed must be set at 1 cm per minute.\\n2. The date and time settings on the machine must be validated.\\n3. The CTG must be labeled with the mother’s name, BHT number \\nand date and time. \\n4. Maternal heart rate should be noted on the CTG.\\n5. The presence and the point at which the fetal heart rate is best \\nheard must be delineated by auscultation and the probe placed \\nat that point.\\n6. Ensure that the contraction probe is functioning properly and \\nused for the recording.\\n7. The woman should be positioned in such a way that aortocaval \\ncompression is avoided.\\n8. It should be interpreted without delay and the categorization \\nrecorded as either normal or suspicious or pathological, as per \\ntable 1, and signed by the responsible officer. The entry on the \\nBHT must include a plan for management. \\n9. If the CTG is categorized as suspicious or abnormal, the \\nConsultant must be informed. \\n10. For the management plan the overall clinical picture must be \\ntaken into account. e.g. the rate of progress of labour, presence \\nor absence of fetal growth restriction, meconium staining of \\namniotic fluid and the evolution of the CTG abnormalities. \\nTable 1: Definitions of normal, suspicious and pathological FHR traces\\nCategory  \\nDefinition \\nNormal  \\nAn FHR trace in which all four features are classified as \\nreassuring \\nSuspicious  \\nAn FHR trace with one feature classified as non-reassuring \\nand the remaining features classified as reassuring \\nPathological  \\nAn FHR trace with two or more features classified as non-\\nreassuring or one or more classified as abnormal'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 49}, page_content='National Guideline for Maternal Care - Volume I\\n32\\nTable 2: Classification of fetal heart rate patterns\\nFurther useful information on FHR patterns\\n• \\nIf repeated accelerations are present with reduced variability, \\nthe FHR trace should be regarded as reassuring.\\n• \\nTrue early uniform decelerations are rare and benign, and \\ntherefore they are not significant.\\n• \\nMost decelerations that occur during labor are variable.\\n• \\nIf a bradycardia occurs in the baby for more than 3 minutes, \\nurgent medical aid should be sought and preparations \\nshould be made to urgently expedite the birth of the baby, i.e. \\nimmediate commencement of cesarean section.  This could \\ninclude moving the woman to theatre if the fetal heart has \\nnot recovered by 9 minutes. If the fetal heart recovers within \\n9 minutes the decision to deliver should be reconsidered in \\nconjunction with the woman if the post-recovery tracing is \\nreassuring.\\n• \\nA tachycardia in the baby of 160–180 bpm, where accelerations \\nare present and no other adverse features appear, should not be \\nregarded as suspicious. However, an increase in the baseline \\nFeature  \\nBaseline \\n(bpm)  \\nVariability \\n(bpm)  \\nDecelerations  \\nAccelerations  \\nReassuring  \\n110–160  \\n≥ 5  \\nNone  \\nPresent  \\nNon-reassuring  \\n100–109  \\n161–180  \\n< 5 for 40 –90 \\nminutes  \\nTypical variable \\ndecelerations with \\nover 50% of \\ncontractions, \\noccurring for over \\n90 minutes  \\nTe absence of \\naccelerations \\nwith otherwise \\nnormal trace is \\nof uncertain \\nsigniﬁcance  \\nAbnormal \\n< 100  \\n> 180  \\nSinusoidal \\npattern ≥ _10 \\nminutes \\n< 5 for 90 \\nminutes \\nEither atypical \\nvariable \\ndecelerations with \\nover 50% of \\ncontractions or late \\ndecelerations, both \\nfor over 30 \\nminutes'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 50}, page_content='National Guideline for Maternal Care - Volume I\\n33\\nheart rate, even within the normal range, with other non-\\nreassuring or abnormal features should increase concern. In \\nsuch cases inquiry must be made to ascertain if the fetus was \\nactive during the recording.  \\nWhen women are having continuous EFM, systematic assessment of above \\ndefinitions and classification should be undertaken with every review.\\nDuring episodes of abnormal FHR patterns, if woman is lying supine, \\nadvise her to adopt the left lateral position'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 51}, page_content='National Guideline for Maternal Care - Volume I\\n34\\nGuideline on Pain Relief in Labour\\nAdequate relief of pain is a basic right of every mother in labour. It is the \\nduty of every member of the obstetric team to endeavor to achieve this. \\nPoor management of pain during labour will result in maternal exhaustion \\nleading to:\\n• \\nacidosis, \\n• \\ndysfunctional labour and \\n• \\nfetal distress. \\n• \\nLoss of morale and a negative birth experience could have \\nsignificant long-term effects. \\nA well-informed, well supported mother will be more in control of events \\nand in a better position to deal with pain than one who is not. Therefore, \\nit is important to keep the mother informed of the progress of labour and \\nthe condition of the fetus throughout the process. \\nReassurance plays a major adjunctive role in pain relief.\\nPrenatal education should include information regarding the available \\nmethods of pain relief and their accessibility.\\nNon pharmacological methods of pain relief such as breathing and \\nrelaxation techniques should be introduced during the antenatal period.\\nIt is well recognized that women who have a birth companion will tolerate \\npain better and require less analgesia. The policy of allowing a birth \\ncompanion must therefore be encouraged.\\n1.\\t\\nMethods of pain relief in labour\\nThe selection of the method of pain relief should be based on the patient \\npreference, availability of resources and the institutional protocols. \\nFollowing methods can be used.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 52}, page_content='National Guideline for Maternal Care - Volume I\\n35\\n1.1 \\n Non-pharmacological methods of pain relief\\n• \\nBreathing techniques, \\n• \\nTranscutaneous electrical nerve stimulation (TENS), \\n• \\nMassaging, \\n• \\nRelaxation techniques, \\n• \\nPositioning and movement\\nAny of these methods can be used to relieve pain during labour\\n1.2. \\nPharmacological methods of pain relief in labour\\n1.2.1. \\nOral paracetamol/paracetamol & codeine compound: \\nThese oral preparations can be used safely in the latent phase of labour.\\n1.2.2. \\nOpioids\\n1.2.2.A. Pethidine\\nPethidine is safe and effective in the latent and early active phase. The dose \\nis 1-1.5 mg/kg IM, repeated after 4 – 6 hours. Administration of a third \\ndose should be done only with the concurrence of senior personnel. \\nIt is generally avoided where delivery is anticipated within 4 hours. \\nMaternal side effects include nausea, vomiting and a reduction in gastric \\nmotility with a subsequent increase in gastric acidity. Therefore, it should \\nbe administered coupled with metoclopramide 5 mg IV or 10 mg  IM.\\nNeonatal respiratory depression is a recognized consequence of \\nadministration of opioids to the mother. Naloxone, a pure opioid \\nantagonist should be available for treatment in all facilities administering \\nopioids for analgesia. Naloxone is given to the baby in a dose of 100μg /kg \\nIV. It has a short duration of action and additional doses may be required. \\nIf no improvement is seen with the first dose of naloxone, the cause of \\nneonatal respiratory depression is more likely to be a factor other than \\nopioids.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 53}, page_content='National Guideline for Maternal Care - Volume I\\n36\\n1.2.2.B. Morphine \\nThis has a longer duration of action than pethidine and may be particularly \\nuseful in women who require analgesia in early labour. \\nThe dose is 0.15 mg/kg IM should be administered with metoclopramide. \\nThe side effects and neonatal effects are similar to those of pethidine.\\n1.2.2.C. Fentanyl \\nIntravenous fentanyl/ramifentanyl may be administered in either a High \\nDependency or Intensive Care Unit settings under the supervision of an \\nanaesthesiologist. \\nThe dose is 50-100μg per hour as an intravenous infusion.\\nPain relief occurs in 3-5 minutes after commencement.\\n \\n1.2.3. \\nInhalational analgesia – Entonox\\nEntonox is a 50:50 mixture of nitrous oxide and oxygen and it has a very \\nshort half-life. The onset of action is 30sec to one minute. \\n \\nThe mother should receive clear and definite instructions about its correct \\nuse. It should only be self-administered.\\nShe should start using entonox through the controlled valve at the very \\nbeginning of the contraction. The mother should be advised to stop using \\nEntonox inhalation in the contraction free interval.\\nLonger and deeper breaths give better result. There is no limit on the \\nduration of its use.  \\nWomen should be informed that Entonox will make them feel nauseous \\nand light-headed.\\nEntonox is contraindicated in women with intestinal obstruction, \\npneumothorax, middle ear and sinus disease, and following cerebral air-\\ncontrast studies.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 54}, page_content='National Guideline for Maternal Care - Volume I\\n37\\n1.2.4. Regional Anaesthesia\\n \\nA.   Epidural analgesia \\nEpidural analgesia is the most effective form of pain relief in labour. \\nTherefore, Its greater use should be encouraged. \\nIt can be given either as a bolus with top-ups or as a continuous infusion. \\nContinuous administration via a syringe pump is preferred to ‘top-ups’, \\nsince it is safer. \\nThe continuous availability of an anesthesiologist is a prerequisite to \\noffering epidural analgesia. It is also essential that staff on site is trained for \\nits setting up, monitoring and to recognize complications early.  Facilities \\nshould be available for emergency resuscitation.\\nBefore offering epidural  analgesia, women should be informed its risks \\nand benefits and its implications on labour:\\n• \\nIt provides more effective pain relief than other methods\\n• \\nIt will not increase the length of the first and the passive second \\nstages of labour. \\n• \\nIt may however increase the length of the expulsive phase \\nand increase the likelihood of an instrumental delivery. An \\nadditional hour is allowed in the expulsive phase therefore.\\n• \\nIt does not increase the chance of cesarean section \\n• \\nIt does not cause long-term backache. \\n• \\nIt needs to be accompanied by a more intensive level of \\nmonitoring.\\nCare and observations for women with regional analgesia in labour\\n• \\nIntravenous access should be secured prior to commencing \\nregional analgesia.\\n• \\nFollowing additional observations should be carried out for \\nwomen with regional analgesia\\n➢ \\nDuring establishment of regional analgesia or after top up \\nbolus blood pressure should be measured every 5 minutes \\nfor 15 minutes.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 55}, page_content='National Guideline for Maternal Care - Volume I\\n38\\n➢ \\nIf the woman is not pain free within after each \\nadministration, the anaesthetist should be called.\\n➢ \\nHourly assessment of the level of sensory block should be \\nundertaken.\\n• \\nWomen with regional analgesia should be encouraged to move \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nOnce established, regional analgesia should be continued \\nuntil after completion of the third stage of labour and when \\nnecessary until perineal repair is done.\\n• \\nWomen should be allowed one additional hour in the second \\nstage of labor, depending on maternal and foetal condition. \\nThereafter pushing during contractions should be actively \\nencouraged.\\n• \\nContinuous EFM is recommended for at least 30 minutes during \\nestablishment of regional analgesia and after administration of \\neach bolus.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 56}, page_content='National Guideline for Maternal Care - Volume I\\n39\\nGuidelines to maintain the partograph'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 57}, page_content='National Guideline for Maternal Care - Volume I\\n40'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 58}, page_content='National Guideline for Maternal Care - Volume I\\n41\\nGuideline on Acute Puerperal Inversion of the Uterus\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide recommendations for the \\nmanagement of acute puerperal inversion of the uterus, which is a rare \\nand life threatening condition. The main reason for its high mortality rate \\nis delay in instituting appropriate treatment, which leads to postpartum \\nhemorrhage and rapid development of shock out of proportion to \\nhaemorrhage. \\n2.\\t\\nDefinition\\nIt is defined as ‘the turning inside out of the fundus into the uterine cavity’.\\n3.\\t\\nPrevention\\nMismanagement of the third stage of labor is recognized as the main \\ncause, although 50% have no identifiable cause. The common initiating \\nfactor seems to be a traction force on the fundus of a relaxed uterus. \\nProper retraction of the uterus in the third stage is the primary factor in \\npreventing an inversion. There is no reliable data to suggest that it recurs \\nin a future pregnancy.\\nThe importance of the active management of the third stage could not be \\nover-emphasized. (Please refer Section 3 of the PPH Guideline and the \\nsection on management of delayed third stage (section 3.2.3 in the Normal \\nLabor Guideline for details) \\n4.\\t\\nPathophysiology (and clinical correlation)\\nAs the inversion progresses, the adnexae with their ligaments get drawn \\ninto the inverting uterine fundus and become increasingly stretched. This \\nproduces significant pain and vagal stimulation, leading to neurogenic \\nshock. \\nAn inverted uterus becomes trapped within the cervix creating \\nprogressive oedema and congestion due to interruption of venous and \\nlymphatic drainage. Oedema and congestion will increase the firmness \\nof the inverted segment, making reduction more difficult. Interruption'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 59}, page_content='National Guideline for Maternal Care - Volume I\\n42\\nof the venous drainage will lead to significant haemorrhage. A partially \\nseparated placenta would add to this.\\n5.\\t\\nClassification\\nAlthough acute, subacute and chronic varieties have been described, this \\nguideline would address only the acute variety as it is life threatening. \\nThis occurs soon after birth, just before or after the delivery of the placenta.\\nThree degrees of inversion have been described, depending on the \\nlevel of the inverted fundus. In practice, second-degree inversion is the \\ncommonest. The fundus has come past the cervical os, but is still within \\nthe vagina.\\n6.\\t\\nClinical Presentation and Diagnosis\\nPrompt diagnosis is vital.\\nThe key to diagnosis is awareness and a high degree of suspicion.\\nThe following are early warnings:\\n• \\nA degree of shock that is out of proportion to overt blood loss\\n• \\nA retained placenta\\n• \\nPlacenta delivered but ‘with some difficulty’\\n• \\nSevere, sustained unexplained pain in the third stage.\\nIn this situation:\\n• \\nFeel for the fundus. If absent or ‘cupped’, acute inversion is \\nprobable diagnosis;\\n• \\nConfirm by a vaginal examination:\\n• \\nLook for a hard mass which looks and feels like a huge \\nulcerated fibroid polyp (sometimes described as a foetal \\nhead); \\n• \\nThe cervix is not to be seen or felt in the normal position, \\ninstead it could be felt as a ring around the base of the \\n‘mass’;\\n• \\nIn incomplete cases, the inverted fundus may be felt \\nthrough the cervical canal in the lower uterine cavity.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 60}, page_content='National Guideline for Maternal Care - Volume I\\n43\\n7.\\t\\nManagement\\n7.1 General measures:\\nEarly diagnosis is vital. Treat it as a life-threatening emergency.\\nFirst attempts at reduction should be made at the place where it is \\ndiagnosed, without moving to theatre.\\nIf these attempts fail, move to theatre and give a general anesthetic without \\ndelay (see section 7.2.4). \\nEarly involvement of experienced personnel and teamwork are absolutely \\nessential.\\nTreat shock aggressively, not forgetting the neurogenic element.\\nProvide adequate pain relief\\nReplace the blood loss, which could be considerable, especially if the \\nplacenta has partially or completely separated.\\nDo not attempt to remove the placenta, if still attached.\\n7.2 Repositioning the uterus\\nReposition the uterus as soon as possible; the sooner it is done the easier \\nand better. It reverses the shock and reduces PPH.\\nNon-surgical methods\\n7.2.1  Manual replacement of uterus.\\n(Johnson’s maneuver)\\nThe operator introduces two thirds of his forearm in to the vagina and \\nextends the hand at the wrist to place the palm on the inverted fundus and \\nfingertips at the utero-cervical junction. Lifting the uterus above the level \\nof the umbilicus creates adequate tension for the cervical ring to dilate and \\nfor the fundus to revert to its normal position.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 61}, page_content='National Guideline for Maternal Care - Volume I\\n44\\nThis could be helped by ‘working the fingers up’ gradually from the cervical \\nring towards the fundus, with gentle but persistent pressure applied.\\nWhere the uterus is too hard to respond, consider tocolytics (see below).\\nOnce reduced, hold the fundus in place for a few minutes (making a fist \\ninside the uterus with upward pressure on the fundus helps).\\nAdminister uterotonics (Ergometrine 0.25 mg i.v. or oxytocin 5-10 IU i.v \\nfollowed by oxytocin infusion at the rate of 10 IU per hour), whilst the \\nhand is still inside. When the uterus begins to contract, slowly remove the \\nhand. \\nThis manouvre is possible only soon after the event, and would need \\nadequate analgesia. Unless it is possible to administer either a general \\nanesthetic immediately, administer pethidine 50 mg iv slow and proceed \\nwith the maneuvres. \\nGive antibiotics (e.g. cephradine 1g and metronidazole 500 mg IV).\\n7.2.2   Hydrostatc reduction (O’Sullivan 1945)\\nSeveral novel and useful modifications have been made to this procedure \\nlately, principally to circumvent the problem of inadequate water seal, \\nwhich has been the major cause of failure in the past. \\nInsert 6 cm silastic ventouse cup into vagina, making sure that it is directed \\nat the posterior vaginal fornix and not at, or cupping the fundus. Place \\nhand at introitus to maintain seal between cup and vagina.\\n(Alternatively 500ml balloon catheter can be placed in vagina. If neither is \\navailable, use a wide tube; a standard giving set will not do).\\nConnect via IV giving set to a bag of warmed normal saline placed 1- 1.5 \\nmetres above the patient.\\nInfuse normal saline (typically 2 litres) into vagina to reduce the uterus by \\nhydrostatic pressure.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 62}, page_content='National Guideline for Maternal Care - Volume I\\n45\\nOnce reduced, remove the placenta if still attached and proceed as in the \\nprevious section.\\nWhere a balloon is used, it would be advisable to leave it for 12-24 hours \\nto prevent re-inversion and reduce haemorrhage. \\nSaline embolisation and fluid overload leading to pulmonary oedema are \\nonly theoretical risks as long as one sticks to hydrostatic pressure only.\\n7.2.3  Tocolytics\\nWhere repositioning is difficult due to retraction of the uterine muscle \\nand the constriction of the cervical ring, tocolytics could be helpful. But \\ngiven this could cause PPH, it would have to be a considered and a senior \\ndecision. They are safest given in the theatre setting. \\nVarious preparations have been used; ideally it should be readily available, \\nwith quick onset and short duration of action. E.g.\\nTurbutaline 0 .25mg i.v. slowly (not available in Sri Lanka at present);\\nSalbutamol 0.25mg in 10 ml saline i.v. slowly;\\nNitroglycerine 0.1mg i.v. slowly or sublingually (acts within 90 seconds)\\n7.2.4  General Anaesthesia\\nIf the initial attempt at manual replacement fails, it is safest to move the \\npatient to the theatre and to administer general anaesthesia. This allows \\nfor muscle relaxation, pain relief and elimination of the neurogenic \\ncontribution to the shock. \\n7.2.5  Surgical methods\\nIf managed properly in the early stages, resort to surgery should be a rare \\noccurrence.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 63}, page_content='National Guideline for Maternal Care - Volume I\\n46\\nHuntingdon’s operation\\nAfter a laparotomy, the indrawn uterine cup is identified near the region \\nof the cervix with the tubes and round ligaments pulled into the cup.  By \\nthe use of two Allis forceps the uterus is pulled out of the constriction ring \\nin a progressive fashion and restored to its normal position. The serosa of \\nthe uterus will invariably sustain lacerations and these are repaired with \\nabsorbable sutures. \\nUse of a silastic vacuum cup from above instead of Allis forceps has been \\nshown to circumvent this problem.\\nHaultain’s operation\\nIn this procedure the constriction in the region of cervix is incised \\nposteriorly using a longitudinal incision. As in the Huntingdon’s method \\ntwo Allis forceps are used to pull the uterus to its normal position. The \\nincision is repaired with interrupted sutures. Uterotonics are given to \\nmaintain contraction of the uterus.\\nHysterectomy\\nWhen all the above methods fail, a hysterectomy will become the only \\nviable option. However, it must be remembered that given the distorted \\nanatomy, this must be undertaken by a surgeon of considerable experience. \\n8.\\t\\nDebriefing\\nAlthough there is no evidence of a recurrence risk, it is sensible to advise \\nthe woman to deliver in a specialized Unit next time, and the third stage \\nto be managed actively by experienced personnel.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 64}, page_content='National Guideline for Maternal Care - Volume I\\n47\\nManagement of \\nHypertensive disease \\nduring pregnancy'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 65}, page_content='National Guideline for Maternal Care - Volume I\\n48'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 66}, page_content='National Guideline for Maternal Care - Volume I\\n49\\nManagement of Hypertensive Disease in  Pregnancy\\n1.\\t\\nIntroduction\\nHypertension in pregnancy is an important cause of direct maternal deaths \\nin Sri Lanka. Early identification, aggressive and intensive treatment of \\nits complications is important in reducing the resulting morbidity and \\nmortality.\\n2.\\t\\nDefinitions\\nChronic Hypertension:\\nWomen with pre-existing hypertension or hypertension detected before \\n20th week of gestation in the absence of trophoblastic disease and \\npersisting more than 42 days post partum. \\nGestational Hypertension\\nA)   Pregnancy Induced Hypertension:\\nHypertension unaccompanied by proteinuria developing after 20 weeks of \\ngestation and resolving within 42 days of delivery.\\nB)   Pre Eclampsia:\\nPregnancy induced hypertension associated with significant proteinuria \\n(300mg/l or 500mg/ 24 hours or dipstick 2+ or more).\\nSevere Preeclampsia:\\nDefined as Pre-eclampsia with severe hypertension and/or with symptoms, \\nand/or biochemical and/or haematological impairment. \\nThe clinical features of severe pre-eclampsia (in addition to hypertension \\nand proteinuria) are:'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 67}, page_content='National Guideline for Maternal Care - Volume I\\n50\\n• \\nSevere headache\\n• \\nVisual disturbance such as blurring or flashing before eyes, \\nscotomas\\n•  Epigastric or hypochondrial pain and/or nausea & vomiting\\n•  Clonus (3 beats or more)\\n•  Papilloedema\\n•  Liver tenderness\\n• \\nOliguria (less than 400 ml per day or 0.5 mg/Kg/hour over a 4 \\nhour period)\\n•  Platelet count falling to below 100 x 106/l \\n•  Abnormal liver enzymes (ALT or AST rising to above 70IU/l)\\n•  HELLP syndrome\\nSevere Hypertension:\\nDefined as systolic blood pressure ≥ 160 mmHg and/or diastolic blood \\npressure ≥110 mmHg. \\nEclampsia: \\nDefined as the development of convulsions and/or unexplained coma \\nduring pregnancy or postpartum in patients with features of preeclampsia.\\n3.\\t\\nScreening for Hypertension during pregnancy\\nBlood pressure must be measured in every clinic visit by a Medical Officer \\nand results recorded and plotted in the pregnancy record. \\nProteinuria must be tested for at every clinic visit.\\nIf blood pressure is more than 140/90 mmHg on two occasions at least 2 \\nhours apart, refer for specialist care.\\n4.\\t\\nPrevention of hypertensive disorders in pregnancy\\nAdvise women at high risk of pre-eclampsia to take 75 mg of aspirin daily \\nfrom 12 weeks until delivery of the baby. Women at high risk are:'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 68}, page_content='National Guideline for Maternal Care - Volume I\\n51\\n Those with any one of the following risk factors:\\n• \\nHypertensive disease during a previous pregnancy\\n• \\nChronic kidney disease\\n• \\nAutoimmune disease such as systemic lupus erythematosis or \\nantiphospholipid syndrome\\n• \\nType 1 or type 2 diabetes\\n• \\nChronic hypertension\\n• \\nMultiple pregnancy\\nOr, any TWO or more of the following \\n• \\n First pregnancy\\n• \\nAge 40 years or older\\n• \\nPregnancy interval of more than 10 years\\n• \\nBody mass index (BMI) of 35 kg/m² or more at first visit\\n• \\nFamily history of preeclampsia\\nContraindications such as allergy, gastritis, peptic ulcer disease must be \\ntaken into account.\\nAdvice women who have the above risk factors to ensure a higher intake of \\ncalcium to achieve a daily intake of at least 1000 mg taking into account the \\naverage intake by Sri Lankan women the recommended supplementation \\nlevel is 600 mg. \\n5.\\t\\nManagement of Chronic Hypertension \\nWomen with chronic hypertension must be managed in specialist units. \\nAnticipate the development of superimposed pre eclampsia in these \\nwomen. This combination adds risks to both mother and baby. ACE \\ninhibitors should be discontinued in women who are planning pregnancy \\nand its use avoided during pregnancy. \\nTreatment of mild to moderate hypertension\\nSince there is no consensus on the value of treating mild to moderate \\nhypertension, this guideline will not address this issue.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 69}, page_content='National Guideline for Maternal Care - Volume I\\n52\\n6.\\t\\nManagement of Severe Pre-Eclampsia\\nThe basic outline of management\\n• Admit to hospital and inform Consultant\\n• Observe and monitor\\n• Control blood pressure\\n• Prevent seizures\\n• Look for complications – such as HELLP / pulmonary oedema/\\ncerebral haemorrhage\\n• Strict fluid balance\\n• In utero transfer where necessary and safe\\n• Timing of Delivery\\n• Continue vigilance post delivery\\n• Follow up\\n6.1. General Considerations\\n• \\nSevere preeclampsia is a life threatening condition.\\n• \\nThe only known cure is delivery of the baby.\\n• \\nThe immediate task is to determine the urgency to effect \\ndelivery.\\n• \\nStabilization of the mother’s condition within an acceptable \\ntime frame prevents maternal complications and may improve \\nfetal condition.  \\n• \\nThe management has to be individualized depending on the \\nclinical condition and available resources.\\n• \\nThe dangers will continue into the immediate postpartum \\nperiod.\\n6.2. Specific Management\\nAdmit women who have severe preeclampsia and inform the Consultant.\\nTreat hypertension if:\\n• \\nSystolic blood pressure ≥ 160 mmHg, or if\\n• \\nDiastolic blood pressure ≥ 110 mmHg, or if\\n• \\nMean arterial pressure ≥ 125 mmHg,'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 70}, page_content='National Guideline for Maternal Care - Volume I\\n53\\nAim to maintain blood pressure at around 130-140/90-100 mmHg.\\nThe main cause of maternal death in severe preeclampsia is poorly \\ncontrolled systolic hypertension causing cerebral haemorrhage. \\nA rapid fall in maternal blood pressure as a result of antihypertensive \\ntreatment may cause fetal heart rate abnormalities & compromise, \\nespecially in growth restricted/compromised fetuses.\\nWhere resources allow, it is recommended to monitor fetal heart with \\ncontinuous CTG during and for 60 minutes after commencing anti-\\nhypertensive therapy.\\nAim to stabilize blood pressure before delivery.\\n6.2.1. \\nAnti-hypertensive drugs\\nOral anti hypertensives may be used when the blood pressure is <180/110 \\nmmHg. Blood pressure must be monitored at 15-minute intervals and \\nintravenous anti hypertensives resorted to in case of an adequate response \\nis not obtained within 30 minutes.\\nThe commonly used antihypertensive drugs for acute control are given \\nbelow. One or the other may be used depending on availability and \\nfamiliarity. \\n6.2.1.1 Labetalol orally or intravenously\\nThis should be avoided in women with a history of bronchial asthma.\\n- 200mg orally stat (only if blood pressure is <180/110 mm Hg)\\n- repeated hourly for up to 4 hours\\n \\nor\\n- 20 mg IV over two minutes\\n• \\nRecord blood pressure after 10 minutes.\\n• \\nIf either value is still above 160 mm Hg systolic and/or 110 \\nmmHg diastolic, give 40 mg iv over 2 minutes.\\n• \\nRecord blood pressure after 10 minutes.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 71}, page_content='National Guideline for Maternal Care - Volume I\\n54\\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/or \\n110 mmHg diastolic, give hydralazine 10 mg iv. For instructions \\nregarding giving a fluid bolus with i.v. hydralazine, see the next \\nsection of this guideline. \\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/\\nor 110 mmHg diastolic, start an IV infusion of labetolol, \\nstarting at 40 mg/hour, doubling dose at half hourly intervals \\nas required to a maximum of 160 mg/hour. \\n• \\nWhere these measures fail, the mother must be moved to a \\nhigh-dependency area or an intensive care unit.\\nIf blood pressure is controlled by the above, continue monitoring the \\nblood pressure at 15 minute intervals for 1 hour and at 30 minute intervals \\nthereafter. \\nAdditional bolus doses as described above may be administered if the \\nblood pressure increases above 160 mmHg systolic and/or 110 mmHg \\ndiastolic.\\n6.2.1.2. Hydralazine intravenously:\\n• \\n5 - 10 mg IV bolus over 2 minutes.\\n• \\nThis must be accompanied by a fluid bolus of 5ml/kg of 0.9% \\nsodium chloride or ringer lactate solution over 30 min, started \\nat the same time as iv hydralazine (this helps vasodilatation & \\nprevents drastic hypotension). This should not be used in the \\npresence of pulmonary oedema. \\n• \\nRecord blood pressure at 15 minute intervals.\\n• \\nRepeat boluses of 5 - 10 mg IV after a 15 minute interval may \\nbe given if necessary up to a maximum of 20 mg (the effect of \\na single dose can last up to 6 hours).\\n• \\nIf the response to above doses is inadequate, give labetolol \\nbolus doses as described above.\\n• \\nIf no lasting effect with above boluses, consider an infusion of \\nhydralazine 2.0 mg/hour increasing by 0.5 mg/hour as required \\n(2-20 mg/hour usually required).'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 72}, page_content='National Guideline for Maternal Care - Volume I\\n55\\n6.2.1.3. Oral Nifedipine\\n• \\nOral nifedipine may be used where the blood pressure is < \\n180/110 mm Hg, in asymptomatic patients.\\n• \\nGive 10 mg orally.\\n• \\nRepeat at 20 minute intervals up to a maximum of 40 mg.\\n• \\nIf there is no response proceed to intravenous labetalol or \\nhydralazine.\\n6.2.2. \\nPrevention of convulsions\\n \\nMagnesium sulphate\\n• \\nMagnesium sulphate is the anticonvulsant of choice.\\n• \\nIt should be given to any woman with features of impending/\\nimminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, and dizziness). \\n• \\nThe loading dose may be given even when the status of renal \\nfunction is uncertain, since it is unlikely that toxic levels of \\nmagnesium could be reached with this dose alone.\\n• \\nGive loading dose of 4 G IV over 10 minutes. There are two \\nmethods of giving magnesium sulphate intravenously. \\no \\nDiluted to a total volume of 20 ml with 0.9% sodium \\nchloride solution, given via an infusion pump or ‘manually’. \\no \\nDiluted to a total volume of 80 ml with 0.9% sodium \\nchloride solution via a burette\\n• \\nImmediately after the loading dose, start infusion of 1 G IV per \\nhour.  Continue this infusion for at least 24 hours after delivery.\\n• \\nWhere there are difficulties with intravenous access, magnesium \\nsulphate may be administered intramuscularly. Give 5 G deep \\nintramuscularly into each buttock with 1 ml of 2% lignocaine \\nin the same syringe.  \\n• \\nIf intramuscular magnesium sulphate is continued as \\nmaintenance therapy, give 5G to alternate buttocks 4 hourly, \\nwith 1ml of 2% lignocaine in the same syringe.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 73}, page_content='National Guideline for Maternal Care - Volume I\\n56\\n• \\nMonitor the mother to ensure hourly urine output of 30 ml per \\nhour, respiratory rate >16/ minute, oxygen saturation >90% \\nand presence of patellar reflexes. \\n• \\nThese should be recorded every 30 minutes.\\n• \\nShould signs of toxicity appear, the antidote is calcium \\ngluconate, 1 G intravenously (10 ml of 10% solution), given \\nover 10 minutes. \\n• \\nMagnesium sulphate may be used safely in women who have \\npreviously received nifedipine\\n6.2.3. \\nFluid Balance\\n• \\nRestrict total fluid intake to 80 ml per hour.\\n• \\nAccurate recording of fluid balance is essential.\\n• \\nSelective colloid expansion may be necessary prior to \\npharmacological \\nvasodilatation \\nto \\nprevent \\nmaternal \\nhypotension and fetal compromise or in oliguria with a low \\ncentral venous pressure.\\n• \\nThe volumes of all drugs administered must be taken into \\naccount and appropriate reduction of the volume of crystalloids \\nmust be made.\\n• \\nColloid (e.g. Hetastarch) should be administered only after \\ndiscussion with the anaesthetist.\\n• \\nDiuretics must be restricted to specific instances only e.g. for \\nwomen with pulmonary oedema.\\n• \\nAvoid non-steroidal analgesia until fluid recovery.\\n6.2.4. \\nIn utero/neonatal transfer:\\n• \\nIf a Unit does not have access to HDU/ICU or is unable to \\ncope with maternal complications, or with maturity of the \\nbaby, it may be appropriate to consider antenatal transfer of \\nthe mother. \\n• \\nHowever, maternal safety must not be jeopardised and each \\ncase should be considered on its clinical merits.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 74}, page_content='National Guideline for Maternal Care - Volume I\\n57\\n• \\nSteps must be taken to bring down blood pressure from very \\nhigh levels (e.g. using nifedipine). \\n• \\nWomen with imminent/impending eclampsia must be \\nadministered a loading dose of magnesium (IM or IV) before \\ntransfer (see 6.2.2) \\n• \\nIt is recommended that where possible telephone advice is \\nobtained from the relevant specialist unit before transfer.\\n• \\nThe patient must be accompanied by a member of staff who is \\ncapable of dealing with a seizure while the patient in transit. \\nThe required drugs and equipment must be made available.  \\n• \\nFull details of the case, including treatment given should \\naccompany the patient.\\n \\n6.2.5. \\nDelivery\\n• \\nUrgency of delivery depends on the maternal and fetal \\nconditions.\\n• \\nEither caesarean section or induction of labour is appropriate \\ndepending on the urgency and favourability of the cervix.\\n• \\nInstitute adequate pain relief. Severe preeclampsia is not a \\ncontraindication for opioid or epidural anaesthesia (see below). \\nIt is accepted that epidural anaesthesia helps to bring down the \\nblood pressure.\\n• \\nSpinal or epidural anaesthesia is safe in the presence of a \\nplatelet count >80,000/dl.\\n• \\nMaternal condition should be optimised before delivery. \\n• \\nIt is inappropriate to deliver an unstable mother for foetal \\nreasons.\\n• \\nErgometrine should not be used during the third stage.\\n6.2.6. \\nPost-delivery\\n• \\nMaintain vigilance as a high proportion of eclamptic seizures \\noccur after delivery. \\n• \\nHigh dependency care should be provided as clinically \\nindicated.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 75}, page_content='National Guideline for Maternal Care - Volume I\\n58\\n• \\nContinue close monitoring, including fluid balance, platelets, \\nliver enzymes and creatinine until they have returned to \\nnormal values. \\n• \\nMagnesium sulphate if started should be continued for 24 \\nhours after the delivery or after the last fit, whichever is later.\\n• \\nReview anti-hypertensive medication as indicated. Some may \\nneed to continue oral medication for a few weeks. Methyldopa \\nis best avoided following delivery because of its tendency to \\ncause depression. \\n• \\nReview magnesium sulphate medication as indicated.\\n6.2.7. \\nFollow up\\n• \\nInform Public Health Midwife and/or Medical Officer of \\nHealth.\\n• \\nReview in 2 weeks (instead of 4 weeks) if discharged on \\nantihypertensives.\\n• \\nDepending on the clinical picture, some patients may need:\\no \\nLong term follow up for blood pressure\\no \\nHematological investigations for conditions such as anti-\\nphospholipid syndrome, thrombophilia \\n• \\nDebrief the patient. \\n• \\nAdvice preconceptual counseling & check prior to the next \\npregnancy.\\n• \\nWomen may be advised regarding the risk of developing \\nhypertensive disease in a future pregnancy as follows:\\no \\nRisk of gestational hypertension - 53% (1 in 2)\\no \\nRisk of preeclampsia – 16% (1 in 6)\\no \\nRisk of preeclampsia if she had severe hypertension or \\nHELLP syndrome or eclampsia or the birth occurred \\nbefore 34 weeks – 25% (1 in 4); & 55% (1 in 2) if the birth \\noccurred before 28 weeks gestation.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 76}, page_content='National Guideline for Maternal Care - Volume I\\n59\\nManagement of Eclampsia\\n1.\\t\\nDefinition:\\nEclampsia is defined as the development of convulsions and/or \\nunexplained coma during pregnancy or postpartum in patients with \\nfeatures of preeclampsia.\\n2.\\t\\nDiagnosis:\\n• \\nHypertension is considered the hallmark for the diagnosis of \\neclampsia. However, in 16% of the cases hypertension may be \\nabsent.\\n• \\nEclampsia is usually associated with proteinuria, but this may \\nbe absent in 14% of cases.\\n• \\nClinical features of imminent eclampsia include:\\n \\nSevere frontal headache, \\n \\nVisual symptoms (halos, scotomas etc.) \\n \\nEpigastric or right hypochondrial pain,\\n \\nLiver tenderness,\\n \\t\\nClonus (3 beats or more) \\n3.\\t\\nTime of onset of eclampsia\\nThe onset of eclamptic convulsions can be antepartum, intrapartum, or \\npostpartum. \\nAntepartum eclampsia \\nAlmost all cases (91%) develop eclampsia at or beyond 28 weeks \\nPostpartum eclampsia \\nAlthough most cases of postpartum eclampsia occur within the first 48 \\nhours, some cases develop beyond 48 hours, up to 4 weeks postpartum \\n(late postpartum eclampsia). In these cases, an extensive neurological \\nevaluation is needed to rule out the presence of other cerebral pathology.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 77}, page_content='National Guideline for Maternal Care - Volume I\\n60\\n4.\\t\\nComorbidities \\n• \\nEclampsia is often complicated by comorbidities (Box 1). \\n• \\nThese are more common among women who develop eclampsia \\nat earlier periods of gestation.\\nBox 1.\\n• Abruptio placentae \\n• Disseminated intravascular coagulopathy  \\n• Pulmonary oedema \\n• Acute renal failure \\n• Aspiration pneumonia \\n• HELLP syndrome (Haemolysis, elevated liver enzymes, low \\nplatelets)\\n5.\\t\\nPrevention\\nAdministration of magnesium sulphate to women with features of \\nimpending/imminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, dizziness) is the only known preventive measure.\\n6.\\t\\nManagement\\n6.1 General considerations\\n6.1.1 The priorities in management are to support respiratory and \\ncardiovascular function, prevent injury and further seizures \\nand to control hypertension. \\n6.1.2 Magnesium sulphate is the anticonvulsant of choice. It must \\nbe administered as soon as possible. See section 6.2.2 of the \\nsevere preeclampsia guideline for details.\\n6.1.3 The bolus dose of magnesium sulphate must be given even \\nto women with unknown renal function or oliguria/anuria \\nsince this dose is unlikely to elevate magnesium levels to toxic \\nranges.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 78}, page_content='National Guideline for Maternal Care - Volume I\\n61\\n6.1.4 Eclampsia dictates delivery (or induction) once the maternal \\ncondition is stabilized, irrespective of the foetal condition or \\nmaturity. A decision regarding the mode and time of delivery \\nwill require to be made early. \\n6.1.5 There is no place for prolongation of the pregnancy in these \\nwomen, unless under rare, exceptional circumstances.\\n6.1.6 For details on administration of medications and intravenous \\nfluids and care of women receiving magnesium sulphate and \\nintravenous antihypertensives, refer the guideline on severe \\npreeclampsia.\\n6.2.  During the seizure – \\no \\nTurn the patient to a side and support her in that position.\\no \\nSuck out secretions from the mouth.\\no \\nAdminister oxygen via a face mask.\\no \\nMost eclamptic seizures resolve spontaneously.\\no \\nIt is imprudent to diagnose fetal hypoxia based on fetal \\nbradycardia during a seizure. This usually recovers \\nspontaneously following the seizure\\no \\nFetal bradycardia persisting beyond 10 minutes following \\nthe seizure should raise suspicion of abruptio placentae.\\n6.3. As soon as possible following a seizure\\no \\nAttempt to establish intravenous access. \\no \\nObtain blood for full blood count, liver transaminases, \\nblood urea, electrolytes and blood for cross-match.\\no \\nStart magnesium sulphate (intravenous bolus and \\ninfusion or intramuscular – details in guideline on severe \\npreeclampsia section 6.2.2.). \\no \\nTreat blood pressure as appropriate. \\no \\nInsert an indwelling catheter.\\no \\nMonitor respiratory rate, urine output, reflexes, SpO2. \\n(Please refer the guideline on severe preeclampsia for \\nfurther details).'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 79}, page_content='National Guideline for Maternal Care - Volume I\\n62\\no \\nCheck for comorbidities (Box 1). \\no \\nInform the Consultant and establish a plan of management\\n6.4. Management of seizures in women receiving magnesium sulphate\\n6.4.1 Women developing a seizure while on magnesium sulphate\\no \\n10% of women receiving magnesium sulphate will develop \\na second seizure.\\no \\nAdminister magnesium sulphate 2 grams diluted to 10 ml \\nwith 0.9% sodium chloride solution over 5 minutes. \\no \\nIncrease the magnesium sulphate infusion to 2 grams per \\nhour with monitoring as above.\\n6.4.2 Women developing more than one seizure while on magnesium \\nsulphate \\no \\nCall a Neurology team for advice. If one is not available, \\nobtain advice from a medical team.\\no \\nConsultant must be informed.\\no \\nInform the anaesthetic team if still not in an intensive care \\nsetting. \\no \\nSecond line anticonvulsants must be considered after \\ndiscussing with anaesthetist.\\no \\nIf the woman develops further seizures, consider moving to \\nintensive care for neuromuscular paralysis and ventilation.\\no \\nThese women will require a full neurological evaluation, \\nincluding imaging.\\n7.\\t\\nDelivery\\no \\nEclampsia is not an indication for caesarean section.\\no \\nConsider caesarean section in women who are not in \\nlabour with a Bishop score below 7.\\no \\nWomen who are in labour may be allowed to continue to \\ndelivery, in the absence of obstetric complications.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 80}, page_content='National Guideline for Maternal Care - Volume I\\n63\\no \\nLabour may be induced where necessary using either \\nprostaglandins or amniotomy and oxytocin infusion. \\no \\nEpidural or spinal anaesthesia may be administered in \\nwomen with platelet counts above 80,000/cu mm. \\no \\nGeneral anaesthesia is best avoided where possible since it \\nincreases the risk of aspiration and failed intubation due to \\nairway oedema. It is also associated with marked increases \\nin systemic and cerebral pressures during intubation and \\nextubation. Women with airway or laryngeal oedema may \\nrequire ‘awake intubation’ under fibre optic observation \\nwith  facilities available  for immediate tracheostomy. The \\nlevel of increase in systemic or cerebral pressures may be \\nreduced by pretreatment with labetalol or nitroglycerine \\ninjections.\\n8.\\t\\nTransfer of a woman who has had a seizure to another institution\\no \\nIn case it is required to transfer a woman who has \\nhad an eclamptic seizure, this must be done only after \\nadministering a bolus of magnesium sulphate. (See section \\n6.2.2 of the severe preeclampsia guideline for details). The \\npatient should ideally be accompanied by a doctor and \\nemergency drugs/equipment (e.g. Ambu bag) must be \\navailable.\\n9.\\t\\nPostpartum management\\no \\nContinue administration of magnesium sulphate and \\nmonitoring as described in the guideline on severe \\npreeclampsia. \\no \\nWomen with abnormal renal function, preexisting \\nhypertension and abruption placentae (due to use of larger \\nthan normal volumes of fluids) are at particularly high \\nrisk of pulmonary oedema. They will require appropriate \\nmonitoring\\no \\nAntihypertensive therapy may be changed to oral and \\ncontinued .'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 81}, page_content='National Guideline for Maternal Care - Volume I\\n64\\n10.\\t Counselling \\n10.1.  Women should be advised that in a subsequent pregnancy:\\no \\nThe rate of preeclampsia is approximately 25%.\\no \\nRate of eclampsia is 2%.\\no \\nThese rates are substantially higher in women who develop \\neclampsia in the second trimester.\\no \\nTaking high-dose calcium from early pregnancy (600 mg \\ndaily) and aspirin (75 mg daily) may reduce this risk.\\n10.2. Regarding long term risk of hypertension\\no \\nThere is no increase of risk in women who were \\nnormotensive before the pregnancy.\\no \\nMultigravidae who develop eclampsia may be at high risk.\\nAcknowledgement: \\nThe following article was used as a resource in developing this guideline: \\nBaha M Sibai, Diagnosis, Prevention and Management of Eclampsia. \\nObstetrics & Gynecology, 2005; 105 (2): 402 - 410.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 82}, page_content='National Guideline for Maternal Care - Volume I\\n65\\nManagement of Diabetes \\nduring Pregnancy'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 83}, page_content='National Guideline for Maternal Care - Volume I\\n66'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 84}, page_content='National Guideline for Maternal Care - Volume I\\n67\\nGuideline for screening, diagnosis and management of \\ndiabetes in pregnant women\\n1.\\t\\nPurpose\\nThe purpose of this guideline is to provide guidance on screening for \\ngestational diabetes mellitus (GDM) and the management of pregnancies \\ncomplicated pre-gestational (PGDM) and GDM in the Sri Lankan setting. \\n2.\\t\\nScreening\\n2.1 Target groups for screening\\nBeing South Asian and pregnant places a woman in Sri Lanka at a higher \\nrisk for diabetes during pregnancy. Therefore, universal screening, using a \\ndiagnostic test is recommended for all Sri Lankan women. \\nA. All pregnant women should be screened for diabetes at the \\nfirst visit unless they are already known to have Diabetes*. This \\nshould be performed as early as possible, preferably before 12 \\nweeks, in order to diagnose previously undetected diabetes.\\nB. Screening using fasting blood glucose, random blood glucose, \\n50g glucose challenge test, HBAIC or urinalysis for reducing \\nsubstances is not recommended.\\nC. Those who are negative for diabetes at the first visit should be \\nscreened for GDM again at 24-28 weeks.\\nD. Women who are known diabetics should not undergo further \\nscreening or diagnostic tests. They should be commenced \\non glycaemic control measures immediately under the \\nsupervision of obstetrician or physician.\\n*Diagnostic criteria for pre pregnancy diabetes are \\nany one of the following\\n \\nFBS \\n \\n≥126mg/dl\\n \\nRBS \\n \\n>200mg/dl\\n \\nHbA1c \\n \\n>6.1%'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 85}, page_content='National Guideline for Maternal Care - Volume I\\n68\\n2.2 Recommended tests\\nA. One stage, non- fasting 75g OGCT as described by the \\nDiabetes in Pregnancy Study Group of India (DIPSI) is \\nrecommended for screening at the first visit and at 28 weeks. \\nA 2- hour blood glucose of more than 140mg/dl confirms \\ngestational diabetes. This is the recommended test for both \\nfield and institutional levels.\\nOne stage Non- fasting 75 g OGCT\\n \\nIn this method 75g oral glucose load is given to the woman \\nirrespective of the fasting status. Therefore a woman could be \\nsubjected to a GTT at any time, without the woman having to \\nfast. \\n \\nA load of 75g of glucose dissolved in 300 ml water is given over \\n3-5 minutes. The water may be flavoured with lime juice. \\n \\n \\nThe plasma glucose level is measured after a period of two \\nhours. \\n(The main advantage of this test is that it would be the best way to \\nensure universal screening. The advantages include reduced cost, the \\nability to make a diagnosis in one test and the woman not requiring \\nto fast for the test. The test has been validated against the WHO and \\nHAPO criteria and been found to correlate well with them (3),(4). \\nData also shows that glucose levels are not significantly affected by \\nthe fasting status and that the non-fasting glucose level effectively \\npredicts adverse effects for the mother and baby (5),(6).)\\nB. Three-point oral GTT - In the event of an equivocal screening \\nresult or when resources permit, the three point OGTT is \\nrecommended. For those who undergo three point OGTT the \\nfollowing cut off should be used for diagnosis.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 86}, page_content='National Guideline for Maternal Care - Volume I\\n69\\nThree-point oral GTT\\nThis is probably the most accepted diagnostic test in the world \\ntoday. \\nThe woman should attend for the test having fasted for eight hours \\nor more, having had a diet unrestricted in carbohydrates. \\nBlood is first drawn for estimation of fasting plasma glucose. \\nThe woman is then given a solution of 75 G glucose dissolved in \\n300 ml of water to be taken within 10 minutes. Squeezing a lime \\ninto this water will make the solution more palatable without \\ninterfering with the result. \\nBlood is then drawn at 60 and 120 minutes for estimation of \\nplasma glucose.\\nC. In situations where neither of the above tests is possible, \\n(Inability to tolerate glucose or non availability of facilities) \\ntwo-stage screening using a 2 hour PPBS is an alternative.  The \\ncut off blood glucose value to refer for a OGTT is ≥120mg/dl.\\n2 hour Post Prandial Blood Glucose Testing (PPBS)\\nAdvice the woman to have normal diet\\nThe time of starting the meal needs to be noted. The meal should \\nbe completed within 15 minutes.\\nThe two-hour cut off is calculated from the time of starting the \\nmeal.\\nAt the end of two hours blood sample should be tested for blood \\nsugar levels using glucometer or other laboratory method.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 87}, page_content='National Guideline for Maternal Care - Volume I\\n70\\n3.\\t\\nManagement – Women with established Diabetes\\n3.1. Pre Pregnancy care\\nThe importance of avoiding unplanned pregnancy is an essential \\ncomponent of diabetes education for women with diabetes.\\nWomen with diabetes who are planning to become pregnant and their \\nfamilies should be offered information on how diabetes affects pregnancy \\nand how pregnancy affects diabetes.\\nDiscuss their plans for pregnancy and reinforce an appropriate \\ncontraceptive method. Any type of contraception can be used except for \\nwomen BMI > 25kg/m2 where DMPA should not be used. Pregnancy is \\ncontraindicated if the woman has proliferative retinopathy, stage 2 or \\nabove Chronic kidney Disease or major cardiac disease. \\nAll women with diabetes wishing to conceive MUST be encouraged to \\nseek specialist advice to ensure satisfactory glycaemic control (HbA1C < \\n6.1%) before conception. \\nIdeally the decision to embark on pregnancy in known diabetics should be \\ndecided on based on her HbA1C .  A value of 6.1 or below would be ideal \\nif safely achievable. Women whose levels are above 10% should be strongly \\nadvised against conception until good glycaemic control is achieved,  in \\nview of higher risk of congenital anomalies. \\nStress that good planning and control will help to achieve pregnancy \\noutcome to be equivalent to that of a non-diabetic women. They should \\nbe informed that establishing good glycaemic control before conception \\nand maintaining this  throughout pregnancy will reduce the risk of \\nmiscarriage, congenital malformation, still births and neonatal deaths.\\nWomen who are using either metformin or insulin for glycaemic control \\nshould be advised that these are safe for use during the peri-conception \\nperiod and into their pregnancy.\\nSelf-testing of blood sugar should be encouraged where ever economically \\nfeasible.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 88}, page_content='National Guideline for Maternal Care - Volume I\\n71\\nWomen must be encouraged to achieve a normal weight before becoming \\npregnant, especially those with a body mass index above 25 kg/m2. They \\nmust receive advice about reducing weight using lifestyle modification. \\nKnown diabetics should be assessed for diabetic nephropathy and \\nretinopathy before and during pregnancy. (see below)\\nStart Folic acid 5 mg daily when trying to conceive.\\n3.2.\\t Antenatal Care\\nAt the first visit \\n• \\nRefer for specialist care immediately once identified. These \\nwomen are best managed with combined inputs from a \\nphysician and an obstetrician. \\n• \\nStart/ continue Folic acid 5 mg daily up-to 12 weeks of \\ngestation. Change to 1mg daily from 12 weeks onwards.\\n• \\nLow dose Aspirin 75mg should be commenced, if there is no \\ncontraindication.\\n• \\nCheck HbA1c (ideally 6.1% or less).\\n• \\nDating ultrasound scan using either crown rump length or \\nhead circumference is recommended.\\n• \\nWomen with pre-existing diabetes mellitus must be screened \\nfor diabetic end-organ damage (retinopathy, nephropathy and \\ncardiovascular disease)\\n• \\nRetinopathy screening is recommended at least twice during \\npregnancy (at first contact and at 28 weeks). \\n• \\nWomen with serum creatinine >120 µmol/litre or 24 hour \\nurinary protein excretion exceeding 300mg must be referred \\nfor renal specialist’s advice.\\n• \\nWomen with complicated diabetes should be managed at a \\ntertiary care institution by a multidisciplinary team\\nAntenatal Appointments\\n• \\nThese women must be identified as high risk and managed \\nalmost entirely by a specialist Obstetrician led team.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 89}, page_content='National Guideline for Maternal Care - Volume I\\n72\\n• \\nPublic Health Midwife should visit such women once in every \\n2 weeks (refer guideline on domiciliary care for high risk \\npregnancies).\\n• \\nReview by the obstetric/diabetic team once every 2 weeks \\nthroughout the pregnancy \\n• \\nAnomaly scans at 18-20 weeks and Obstetric reviews at 22-24, \\n28, 32 and 36-37 weeks with ultrasound growth assessments. \\n• \\nIf required, antenatal steroids for fetal lung maturity may be \\nused. Women should be admitted to hospital for glycaemic \\ncontrol during therapy since glucose levels rise in response to \\nsteroids. \\n• \\nMore attention should be given to the woman with diabetes \\nduring antenatal preparation for breast feeding as they \\nneed to start and establish breast feeding quickly to prevent \\nhypoglycaemia of newborn. \\n• \\nRefer to dental surgeon for screening and maintenance of oral \\nhygiene.\\n3.3.\\t Medical nutrition therapy (MNT) \\nMNT is the cornerstone of the management of diabetes in pregnancy. \\nWomen must be referred to a dietician/ diabetic educator nurse  where \\none is available. \\nEmphasis the importance of small frequent meals, food with low glycaemic \\nindex and the  dietary advice should be culture sensitive. \\n3.4.\\t Exercise \\nExercise has an insulin-like action and women with GDM and pre-existing \\ndiabetes complicating pregnancy. Therefore,  diabetic women must be \\nencouraged to engage in regular exercise. \\nThe intensity of exercise would depend on the woman’s level of fitness, \\npresence of complications and familiarity with exercise. \\nIdeally this should be at least 30 minutes per day of an activity, which \\nleaves her slightly breathless.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 90}, page_content='National Guideline for Maternal Care - Volume I\\n73\\nWomen on insulin must be aware of the  tendency to hypoglycaemia \\nduring exercise. \\n4.\\t\\nGlyceamic control and Monitoring \\n4.1. Glyceamic Control\\n4.1.1. The aim is to achieve optimum glycaemic control throughout the \\nday for the duration of the pregnancy (avoiding hypoglycaemia).\\nThe target values for glycaemic control are given below:\\nTable 1. Target values in glycemic control\\n \\n  Fasting and pre-meal \\n           2 hour post meal\\nVenous plasma \\n70 - 90 (3.9 – 5.0 mMol/L) \\nBelow 120 mg/dl (6.7 mMol/L)\\nCapillary blood \\n80 – 103 (4.4 – 5.7 mMol/L) \\n118 mg/dl (6.5 mMol/L)\\n(The equivalent capillary blood values were derived  using a conversion \\nformula7)\\nRefer to Diabetic Educator Nursing Officer (DENO) where one is available. \\nAt diagnosis, offer diet/ lifestyle advice with a recorded glycaemic \\nassessment within 1-2 weeks.\\nMajority of these women can achieve optimal glycaemia with modest \\nchanges in diet and exercise.\\nConsider insulin and /or metformin treatment if suboptimal glycaemia \\npersists despite diet and exercise modifications. The choice of these \\ntreatments will depend on physician and patient preferences. \\nIdeally the  insulin regimen should be adjusted to achieve targets: in most \\ncases with moderate to severe hyperglycaemia three doses of short acting \\npre prandial insulin combined with a single dose of basal insulin at bed \\ntime is required. However, twice daily dose of pre mixed 30:70 insulin \\nhas high patient compliance with adequate control of blood sugar in most \\ncases. If blood sugar is not controlled by this twice daily regimen, adding \\nmetformin or soluble insulin to cover lunch is an alternative.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 91}, page_content='National Guideline for Maternal Care - Volume I\\n74\\nACE inhibitors, statins and ARBs are contraindicated during pregnancy\\n4.2.\\t Monitoring of glycaemic control\\nSelf-monitoring of blood glucose (SMBG) with close liaison with the \\ndiabetic team is recommended for those who are able to afford a glucometer \\nand test strips. (However, in view of variable quality of glucometers women \\nmust be advised to crosscheck the values occasionally with estimations \\nmade by a reliable laboratory. \\nFor women who cannot afford the cost of SMBG, monitoring with regular \\n6 point blood glucose monitoring should be offered. \\nThe frequency of such monitoring should be decided by the overall \\nglyceamic control, presence or absence of fetal macrosomia and the period \\nof gestation;: with at least four weekly  reviews  in pregnancy two weekly \\nreviews  in late pregnancy\\nSchedule ultrasound measurement of AC at 28, 32 and 36 weeks. If AC > \\n90 centile at any stage, consider insulin therapy to target 2 hour PPBS to \\nbe less than 100mg/dl but avoiding hypoglycaemia.\\nIf crossing centiles or AC <10 centile, do AFI and request obstetrician \\nreview.\\nInsulin requirements change throughout the pregnancy. If requirements \\nare falling (or maternal hypoglycaemia occurs frequently) request early \\nobstetrician review for fetal assessment.\\nHbA1c is not a reliable indicator of glycaemic control in the second \\nand third trimesters. \\n5.\\t\\nDelivery and intra natal care\\n6.1. Timing of delivery\\nFor women with pre-pregnancy diabetes or who receive insulin therapy, \\nschedule obstetrician review at 36-37 weeks for planning their delivery at \\n38-39 weeks.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 92}, page_content='National Guideline for Maternal Care - Volume I\\n75\\nFor women on diet control and/or women having optimal glycaemic \\ncontrol and, carrying a normally grown baby, there is insufficient evidence \\nto suggest the best time for delivery. \\nDiabetes alone is not an indication for a caesarean section.\\nThe obstetrician should make the decision after discussing with the \\nwoman.\\nDelivery should be arranged in the day time, when all supports are more \\neasily available.\\n5.2. Labour care\\nSecond tier obstetric on-call (SHO/Registrar) should be informed of any \\nwoman with diabetes at  the onset of labour. He/she should be present \\nfor the delivery. It is recommended to involve the medical team in the \\nmanagement of difficult cases.\\nInform on-call neonatal team of any planned/ imminent delivery of a \\ndiabetic mother.\\nDuring labour and birth, capillary blood glucose should be monitored \\n1-2 hourly in women with diabetes and maintained at between 4 and 7 \\nmmol/litre. (72 – 126 mg/dl). These CBG records should be entered in the \\npartogram. \\nHartmann’s/ normal saline or Insulin-dextrose – potassium (GIK) \\ninfusion should be started if the values are lower or higher respectively.\\n6.\\t\\nPost natal care\\n6.1a. Neonatal care\\nHandover care of newborn, to neonatal team.\\nEnsure delivery-to-abdomen and initiate breastfeeding as early as possible \\n(within first ½ to 1 hour) unless specific concerns prevent such action.\\nTake all suitable ENC measures to avoid hypothermia.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 93}, page_content='National Guideline for Maternal Care - Volume I\\n76\\nBlood glucose testing should be carried out routinely in babies of women \\nwith diabetes at 2–4 hours after birth. The mother must be informed about \\nthis antenatally to avoid unnecessary distress.\\nNeonatal blood glucose values below 36 mg/dl (2 mMol/L) should trigger \\naction. \\n \\nBlood tests for polycythaemia, hyperbilirubinaemia, hypocalcaemia and \\nhypomagnesaemia should be carried out for babies with clinical signs.\\n6.1b. Immediate post partum care \\nIt is recommended that the mother be tested for RBS within 4 hours of \\ndelivery. The decision to manage maternal diabetes with insulin or oral \\nmedication should be made within the first 48 hours after delivery and \\nprior to discharge from hospital.\\nIf the mother received insulin in the antenatal period, it is recommended \\nthat the dose needs adjustments to pre pregnant doses in those with type \\n2 diabetes mellitus or be maintained on diet alone in those with GDM. \\nThis decision should be based on her post partum blood glucose value. If \\nFBG exceed 126mg/dl or RBS exceeds 200mg/dl, insulin in a lower dose \\n(usually half of the antenatal dose) or metformin would be required. This \\ndecision is best left to the managing physician who should be responsible \\nfor the woman’s long term care. \\n6.2. At hospital discharge\\nInform MOH and area public health midwife (PHM) through woman’s \\npregnancy record.\\nFor women with pre- gestational diabetes, prescribe suitable hypoglycaemic \\nagent, restart statins, schedule follow up clinic date at the medical clinic.\\nFor women who developed GDM, give a date or make arrangements to \\nscreen for DM at 6 weeks postpartum. \\nDiscuss and help to decide on the suitable contraceptive method.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 94}, page_content='National Guideline for Maternal Care - Volume I\\n77\\n6.3. Late Postnatal care and follow up\\nAt 6 -8 weeks postpartum, all women with GDM are screened for diabetes \\nmellitus. The test of screening is ideally the 75g OGTT.  FBS is an alternative \\nif resources are limited. Women whose fasting venous plasma glucose is \\nabove 100 mg/dl (5.5 mMol/L) must be referred for further evaluation. \\nWomen who have been diagnosed with GDM and are screen-negative at \\nthe 6 week review should receive lifestyle advice and screening for diabetes \\nmellitus annually with at least a FBS. The importance of maintaining a \\nnormal BMI and the contribution of breastfeeding to weight loss must be \\nemphasized.\\n7.\\t\\nFamily Planning\\n8.1 All reliable methods of family planning can be used as \\nappropriate for the needs    of the individual woman with \\ndiabetes.\\n8.2  For women with BMI >25kg/m2, DMPA is best avoided.\\n8.3 Women with type 2 diabetes should be advised to complete \\ntheir family within  5-10 years   of diagnosis of diabetes in view \\nof possible development of complications.\\nReferences (need to add the sections taken from NIROGI guide)\\n1. \\nNICE, clinical guideline 63 Diabetes in pregnancy: management \\nof diabetes and its complications from pre-conception to the \\npostnatal period. 2008, National Institute for Health and \\nClinical Excellence.\\n2. \\nSeshiah V., Das AK.,BalajiV et al., Gestational Diabetes Mellitus \\n- Guidelines. Journal of the Association of Physicians of India. \\n2006. 54: 622- 628\\n3. \\nIADPSGCP, International Association of Diabetes and \\nPregnancy Study Groups Recommendations on the Diagnosis \\nand Classification of Hyperglycemia in Pregnancy. Diabetes \\nCare, 2010. 33(3): p. 676-682.\\n4. \\nKuhl C. Insulin Secretion and insulin resistance inpregnancy \\nand GDM. Implications for diagnosis andmanagement. \\nDiabetes 1991;40(December (Suppl. 2)):18–24.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 95}, page_content='National Guideline for Maternal Care - Volume I\\n78\\n5. \\nGough WW, Shack MJ, Bennett PH, Burch TA, Miller \\nM.Evaluation of glucose in the Pima Indians by longitudinal \\nstudies. Diabetes 1970;19(Suppl. 1):388.\\n6. \\nPettitt DJ, Bennett PH, Hanson RL, Narayan KM, KnowlerWC. \\nComparison of World Health Organization and National \\nDiabetes Data Group procedures to detect abnormalities \\nof glucose tolerance during pregnancy. Diabetes Care \\n1994;17(November (11)):1264–8.\\n7. \\nHaeckel R.,  Brinck U, Colic D. et al.,  Comparability of Blood \\nGlucose Concentrations Measured in Different Sample Systems \\nfor Detecting Glucose Intolerance. Clinical Chemistry 2002. 48: \\n(6); 936-939.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 96}, page_content='National Guideline for Maternal Care - Volume I\\n79\\nManagement of \\nPostparum Haemorrhage'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 97}, page_content='National Guideline for Maternal Care - Volume I\\n80'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 98}, page_content='National Guideline for Maternal Care - Volume I\\n81\\nGuideline on Managementof Primary post Partum \\nHaemorrhage\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide evidence based recommendations \\nin the management of primary post partum haemorrhage (PPH). This is \\nthe commonest direct cause of maternal death globally and in Sri Lanka. \\nThe objective of this guideline is to ensure anticipation, prevention, early \\ndetection and timely and appropriate management of PPH. \\n2. \\t\\nDefinition\\nFor the purpose of this guideline PPH is defined as blood loss of 500 ml or \\nmore from the genital tract within 24 hours of the birth of a baby. Blood \\nloss of over 1000 ml is defined as major PPH. \\nIrrespective of blood loss, the appearance of cardiovascular instability (i.e. \\ntachycardia and hypotension) signifies major obstetric hemorrhage.\\n• Since blood volume differs between persons, blood loss must \\nbe individualized. \\n \\nIn general, blood volume = body weight in Kg÷12 (e.g. in a 60 \\nkg woman 60/12 = 5 litres)\\n• The loss of 40% or more of the blood volume is life threatening \\nand will be defined as a massive obstetric hemorrhage e.g. \\n2400 ml in a 60 Kg woman.\\n3.\\t\\nPrevention of Post Partum Haemorrhage\\nActive management of the third stage of labour is the cornerstone \\nof prevention of primary PPH. For details please refer guideline on \\nmanagement of third stage of labor.\\nAnemia in pregnancy should be corrected during antenatal period.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 99}, page_content='National Guideline for Maternal Care - Volume I\\n82\\n4.\\t\\nPrediction of Post Partum Haemorrhage\\nPPH occurs most often in women without risk factors. Therefore the \\nblood group of every woman who goes into labor must be known.\\nHowever, there are known risk factors associated with PPH, as listed in \\nBox 1. Such women should be advised to deliver in a specialist obstetric \\nunit under extra vigilance. Out of these, abruptio placentae and placenta \\npraevia have a particularly higher risk.\\nBox 1\\nRisk Factors for PPH\\nRisks existing prior to labour\\nGrand multiparity\\nPrevious PPH \\nFibroids complicating pregnancy\\nAnaemia complicating pregnancy\\nPre-existing haemorrhagic conditions \\nTreatment with anticoagulants \\nObesity \\nPre-eclampsia/gestational hypertension\\nUterine over distension e.g. multiple pregnancy, etc.\\nLarge baby (>4 kg)\\nChorio-amnionitis\\nDengue infection\\nAny woman with risk factors should have intravenous access established \\nwith either a 16 or 14-gauge cannula and a sample of blood taken and \\npreserved.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 100}, page_content='National Guideline for Maternal Care - Volume I\\n83\\n5.\\t\\nManagement of Primary Pph\\nIn Sri Lanka, the usual practice has been to commence treatment when \\nthere is continuing bleeding despite uterine massage irrespective of the \\namount of blood lost. It is recommended that this practice be continued. \\nIt is good practice to estimate and record blood loss in all deliveries.\\n5.1 General measures\\n• \\nCall for help.\\n• \\nMaintain a calm atmosphere.\\n• \\nKeep the mother (and labor companion/family) informed and \\nreassure the mother regularly.\\n• \\nAssess, monitor and record: general condition, estimated \\nblood loss, pulse, blood pressure and respiratory rate (every 15 \\nminutes)\\n• \\nInsert a Foley catheter and monitor urine output hourly. \\n• \\nCommence an ongoing chronological record of patient’s \\ncondition and interventions. It is recommended that one \\nmember of staff is delegated specifically for this task and to \\ncoordinate with other relevant disciplines.\\n• \\nEnsure there is intravenous access with two wide (14 – 16 G) \\nbore cannulae. \\n• \\nSend blood for cross matching and baseline full blood count. \\nIn cases of massive haemorrahge, other investigations such as \\nclotting profile will be needed.\\n• \\nStart Ringer’s lactate (Hartmann’s) solution.\\n• \\nIdentify the cause of bleeding. \\n• \\nKeep the woman warm.\\n• \\nPay attention to the temperature of labor room, operating \\ntheatre, intravenous fluids, blood, blood products and \\nfluids used for lavage. Hypothermia is known to promote \\ncoagulopathy.\\n• \\nWhere available, the early involvement of the anesthetic team, \\neven while the patient is still in the labor room is recommended.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 101}, page_content='National Guideline for Maternal Care - Volume I\\n84\\n• \\nGive oxygen via a face mask at a minimum rate of 8L/minute \\n(where suitable masks are available, oxygen must be given at a \\nrate of10-15L/min).\\n• \\nIf deterioration of the patient is greater than expected for the \\nvisible blood loss, internal hemorrhage is the probable cause. \\n• \\nCheck for completeness of the placenta. If incomplete or in \\ndoubt consider exploration of the uterus under anesthesia.\\n• \\nThe Consultant must be informed in the situations listed in \\nBox 2.\\nBox 2. Situations in which the Consultant must be informed\\n1. Blood loss of >1000 ml\\n2. Pulse rate of >100/minute\\n3. Systolic blood pressure <100 mm Hg\\n4. Drop of systolic blood pressure by 30 mmHg\\n5. Increase of pulse rate by >30 beats/minute \\n6. Increasing fundal height  \\n7. Deterioration of the patient out of proportion to the overt \\nblood loss.\\n5.2\\t Specific measures\\n5.2.1 Establish a cause for the bleeding \\nPalpate the uterine fundus.\\nA poorly contracted uterus usually indicates atonic PPH, which is the \\ncommonest cause. However, the possibility of concomitant genital tract \\ntrauma needs to be considered. \\nIf the uterus is well contracted, the genital tract must be inspected for \\ntrauma with adequate exposure, in good light.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 102}, page_content='National Guideline for Maternal Care - Volume I\\n85\\n5.2.2. Management of atonic haemorrhage\\n• \\nStart uterine massage by ‘rubbing up the fundus’.\\n• \\nClear the cervical canal and vagina of blood clots by vaginal \\nexamination.\\n• \\nAdminister either ergometrine maleate 0.5 mg slow IV or \\nmethyl ergometrine 0.2 mg slow IV or oxytocin 5 IU IV and \\nstart an infusion of 40 IU in 500 ml of Hartmann’s solution at \\n125 ml per hour via an infusion pump.\\n• \\nStart bimanual compression of uterus.\\n• \\nIf the bleeding fails to abate completely in 5- 10 minutes \\nadminister/repeat ergometrine 0.5mg IV.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nadminister misoprostol 800µg per rectally or sublingually.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nproceed to uterine balloon tamponade and inform the \\nConsultant. At the same time, administer tranexamic acid 1 \\ng by slow IV over 10 minutes. This dose may be repeated after \\n30 minutes if necessary and later if bleeding recommences. \\nFor details of the method of balloon tamponade please refer \\nappendix 1.  \\n• \\nBalloon tamponade is an important step in managing patients \\nwho continue to bleed despite medical measures. It should \\nalways be considered before resorting to surgical measures. \\n• \\nIf the institution does not have personnel trained in the use \\nof balloon tamponade, the woman must be transferred to a \\nhigher institution, at the point where the administration of \\nergometrine and oxytocin infusion has failed to stop bleeding. \\n• \\nTemporizing measures such as manual aortic compression and \\nsand bags to compress the uterus are recommended while the \\npatient is in transit.\\n• \\n Inform the receiving institution.\\n• \\nAfter the balloon is inserted and the vagina packed (to keep \\nthe balloon in the uterus), the woman’s vital parameters and \\nthe level of the fundus must be monitored carefully. Where \\nthese indicate the woman is continuing to bleed, she should'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 103}, page_content='National Guideline for Maternal Care - Volume I\\n86\\nbe moved to the theatre, since the situation would indicate the \\nneed for a laparotomy. \\n• \\nShe should be shifted to the theatre without delay in this \\nsituation. \\n• \\nPrior to laparotomy the woman must be examined under \\nanesthesia for tears in the genital tract. \\n• \\nIn case laparotomy is needed it is best to keep the patient in \\nthe modified Lloyd Davis position so that observations for \\nbleeding could be done with minimum inconvenience and \\ndelay.\\n• \\nThe surgical measures would depend on the woman’s condition. \\n“Too little too late” is the main contributor to mortality in \\nPPH. Surgical measures include brace (compression) sutures \\n(see appendix 2), uterine de-vascularization (See appendix \\n3), haemostatic mattress sutures to bleeding sinusoids, box \\nsutures to include the bleeding lower segment in placenta \\nprevia, internal iliac ligation and hysterectomy. \\n• \\nThe “sandwich technique” involves inserting a balloon \\ntamponade after the application of brace sutures.\\n• \\nIt is important that hysterectomy is resorted to sooner than \\nlater.\\n• \\nHypothermia is a particular risk in the theatre environment. \\nMeasures must be taken to minimize the loss of heat from the \\nwoman. \\n5.2.3 Management of traumatic PPH\\n• \\nExclude high vaginal and cervical tears before suturing \\nepisiotomy.\\n• \\nWhen the apex of the tear or episiotomy is not visible, apply a \\nsuture at the highest visible point, pull downwards and apply \\ncontinuous sutures at progressively higher points until the \\napex is reached. \\n• \\nExamine for paravaginal and broad ligament haematomata \\nwith a combined per vaginal and per rectal examination. \\n• \\nThe management should be individualized according to the \\nsituation.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 104}, page_content='National Guideline for Maternal Care - Volume I\\n87\\n• \\nParavaginal hematomas of more than 5 cm diameter will \\nusually require surgical evacuation. A bleeding point is usually \\npresent and must be looked for. In cases where it is difficult to \\ncontrol bleeding, a Foley catheter with its balloon inflated may \\nbe left in the cavity. Packing of the vagina may also be useful. \\n• \\nCervical tears must be identified by systematic inspection of \\nthe cervix using Green-Armytage forceps and sutured. \\n• \\nIn case of multiple tears with venous oozing, it may be better to \\ninsert a balloon catheter into the vagina or to pack the vagina \\nwith moistened vaginal packs than to try to suture all the tears. \\n5.2.4 Rupture of the uterus\\n• \\nRupture of the uterus must be suspected when the general \\ncondition is deteriorating out of proportion to the visible \\nblood loss and there is continuing bleeding in the presence of a \\ncontracted uterus.\\n• \\nThis is particularly so in a woman with a scarred uterus.\\n• \\nImmediate involvement of a Consultant and surgical \\nintervention are important in this situation.\\n5.2.5 Coagulopathy causing PPH\\n• \\nThis could be due to coagulopathy following death in utero, \\nabruptio placentae, severe preeclampsia, HELLP syndrome, \\nsepsis, amniotic fluid embolism, acute fatty liver, pulmonary \\nimmune thrombocytopenia, Von Willebrand’s disease etc. \\n• \\nIt could also be due to suboptimal management of the PPH. \\n• \\nEarly involvement of a haematologist or transfusion medicine \\nspecialist will be important in this situation. Where available, \\nthromboelastometry would be useful in this situation. \\n6.\\t\\nResuscitation and Fluid management\\n \\nPPH up to 1000 ml\\n• \\nCommence a crystalloid infusion of 2-3 times the estimated \\nblood loss.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 105}, page_content='National Guideline for Maternal Care - Volume I\\n88\\nPPH of more than 1000 ml\\n• \\nPPH of over 1000 ml should be managed in consultation with \\nother relevant specialists e.g. anesthesiologists, hematologists, \\ntransfusion specialists etc. \\n• \\nAssess airway, breathing and circulation.\\n• \\nGive oxygen via face mask. \\n• \\nKeep the woman warm and flat.\\n• \\nTransfuse warmed blood as soon as possible.\\n• \\nUntil blood is available, warm crystalloids (up to 2 litres) \\nand colloids (up to 1-2 litres) may be transfused as rapidly as \\nrequired, up to a maximum of 3.5 litres in total.\\n• \\nDepending on urgency, group-specific blood may be given \\nuntil cross-matched blood is available.\\n• \\nIf group-specific blood is not available, O Rhesus D negative \\nblood could be given.\\n• \\nBlood transfusion should be individualized according to the \\nsituation. When available, involve blood transfusion specialist/\\nHaematologist. Where three or more units of blood are being \\ntransfused, an equal number of packs of fresh frozen plasma \\nmust also be transfused. If available, thromboelastometry will \\nenable factor-specific replacement. \\n• \\nDue consideration must be given to keeping transport facilities \\navailable to obtain blood and blood products from another \\ninstitution.\\n7.\\t\\nDebriefing\\n• \\nIt is possible that a major PPH could result in significant \\npsychological morbidity.\\n• \\nThis could be minimized by timely debriefing of the patient \\nand her family, preferably by the Consultant.\\n• \\nThis should be done immediately after the event, before \\ndischarge and at the postnatal visit or at any time as requested \\nby her or the family.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 106}, page_content='National Guideline for Maternal Care - Volume I\\n89\\n8.\\t\\nRisk Management\\n• \\nIt is good practice to conduct a case review with the members \\nof the team involved in the management and other staff as soon \\nas possible after the event.\\n \\n \\nThe spirit of such a meeting should be one of lessons learnt rather \\nthan of apportioning blame.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 107}, page_content='National Guideline for Maternal Care - Volume I\\n90\\nAppendix 1\\nInsertion of a ‘condom catheter’\\nThis may be performed as an independent procedure or following \\ninspection of the cervix and upper vagina for trauma.\\nTherefore, whenever it is planned to inspect the cervix, or where there is \\nan indication that medical therapy may fail to bring the bleeding under \\ncontrol, keep the materials needed for insertion of a condom catheter \\nready.\\n1. Explain to the mother the need to insert a condom catheter \\nand explain the procedure briefly. Be reassuring.\\n2. Wear a pair of sterile gloves.\\n3. The required items are:\\n• \\nSize 20 – 22 (or largest available) Foley catheter, \\n• \\nA condom, \\n• \\nSterile  No. 0 or 1 suture, \\n• \\nA bottle of warmed saline,\\n• \\nIntravenous infusion set released from the pack \\n• \\nArrange these items on a sterile towel laid on a side trolley.\\n4. Take the Foley catheter out of the packing.\\n5. Unfold the condom over the end of the Foley catheter to about \\ntwo thirds of its length. Hand tie it to the catheter firmly, using \\nseveral rounds of sterile suture at a point about 2 cm distal to \\nthe open end of the condom. \\n6. Have an assistant connect the infusion set to the bottle of \\nwarmed normal saline suspended 4-6 feet above the patient.\\n7. Connect the other end to the catheter, run saline into the \\ncondom to make sure the system is water tight by holding the \\ncatheter tip upwards.\\n8. Afterwards, empty the balloon of the saline and leave it on the \\nsterile trolley, ready for insertion.\\n9. Wash the condom with either warm saline or 5% povidone \\niodine lotion.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 108}, page_content='National Guideline for Maternal Care - Volume I\\n91\\n10. Place the woman either in the dorsal or lithotomy position and \\nexpose the cervix by using one or two Sim’s speculae.\\n11. Grasp the anterior lip of the cervix with a sponge holder.\\n12. Now insert the entire condom catheter system into the uterus. \\nYou may keep the condom catheter between the index and \\nmiddle fingers and introduce it like exploring the uterus (or \\ndoing a pelvic examination). \\n13. Reconnect the catheter to a giving set and start filling the \\ncondom with warmed saline.\\n14. Keep watching the cervix for the balloon to bulge out of it and \\nstop filling it any further for now. You may notice cessation of \\nbleeding from the uterine cavity. \\n15. At this point pack the vagina with a moist vaginal pack (Two \\ninch ribbon gauze pack or a gauze towel) around the catheter \\nin a circumferential manner. \\n16. Continue filling till the gravity aided filling stops. Usually 400 \\n– 500 ml is needed.\\n17. Proximal end of the catheter is folded and a tight tie placed on \\nit to prevent backflow.\\n18.  Insert a size 12 Foley catheter to the bladder.\\n19. Mark the level of the fundus on the abdomen with a marker \\npen. Start a pulse and blood pressure chart.\\n20. Give tranexamic acid 1 G slow i.v. and repeat after 8 hours.\\n21. Keep pack and the condom catheter for 12 – 18 hours.\\n22. Consider appropriate antibiotic prophylaxis.\\n23. If there is no vaginal bleeding and vital signs are stable, plan to \\nremove the catheter at a convenient time, after 12 hours.\\n24. Release half the instilled volume of saline. Do not remove the \\npack at this stage.\\n25. Observe for bleeding through the pack.\\n26. 30 minutes later remove the vaginal pack, without removing \\nthe condom catheter.\\n27. If there is no further bleeding for another 30 minutes, release \\nthe total volume of instilled saline and remove the condom \\ncatheter gently.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 109}, page_content='National Guideline for Maternal Care - Volume I\\n92\\nAppendix 2\\nBrace sutures, the best known of which is the modified B-Lynch sutures \\nare very useful in the presence of a bleeding atonic uterus.\\nThe uterus is exteriorized.  An absorbable No. 2 suture (or highest gauge \\navailable) on a curved ‘hand-needle’ is passed anteroposteriorly through \\nthe uterus above the reflection of the bladder about 2 cm medial to the \\nlateral edge. \\nThe process is repeated on the contralateral side. The sutures are tied \\ntightly over the fundus, with an assistant manually squeezing the uterus. \\nAdditional sutures may be applied medially.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 110}, page_content='National Guideline for Maternal Care - Volume I\\n93'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 111}, page_content='National Guideline for Maternal Care - Volume I\\n94\\nAppendix 3\\nSteps of uterine de-vascularization technique\\n \\n(Adapted from: Salah A. AbdRabbo.Stepwise uterine devascularization: \\nA novel technique for management of uncontrollable postpartum \\nhemorrhage with preservation of the uterus AJOG 1994 Volume 171 \\nNumber 3)\\nStep 1: Bilateral uterine vessel ligation\\nIn this step the uterine arteries are ligated at the level where they run along \\nthe uterine border beside the upper part of the lower uterine segment (Fig. \\n1 Note: Steps I and II in the diagram constitute step 1 in our description. \\nWe recommend that both sides are done in one step.).\\nFig. 1.Sites of uterine artery ligation in steps 1, 2 (upper arrow), and 3 \\n(lower arrow).U.U.S., Upper uterine segment; L.U.S., Lower uterine \\nsegment.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 112}, page_content='National Guideline for Maternal Care - Volume I\\n95\\nWith the surgeon on the right side of the patient, the uterus is grasped and \\nelevated to the contralateral side. A large needle (48 mm or greater) with \\nnumber 1 absorbable suture is passed through the avascular area of the \\nleft broad ligament from anterior to posterior and then brought forward, \\nguided by the four fingers of the left hand, through the myometrium from \\nposterior to anterior 2 cm medial to the left uterine vessels, and the suture \\nis tied.\\nThis process is repeated on the contralateral side.\\nIn these two steps there is no need for bladder mobilization, because the \\nsutures were not placed low. Also, there is no need for a peritoneal incision \\nin cases having vaginal deliveries; however, in cases having caesarean \\nsection the suture should be placed below the level of the transverse \\nuterine incision, under the reflected peritoneal flap.\\nStep 2: Low bilateral uterine vessel ligation\\nThis step is reserved only for cases having continued lower uterine segment \\nhaemorrhage diagnosed at caesarean section and not controlled by step 1.\\nIn this step the bladder is reflected downwards and lower bilateral uterine \\nvessel ligation is performed at the lower part of the lower uterine segment, \\n3 to 5 cm below the upper ligatures, with the same technique in step 1. At \\nthis level the uterine artery is ligated after its cervicovaginal branch turns \\nabruptly upward to extend along the uterine margin. This ligature would \\nobliterate most of the branches of the uterine artery to the lower uterine \\nsegment and a branch of considerable size that extends to the upper \\nportion of the cervix. It is important to include a significant amount of \\nmyometrium to avoid damage to the uterine vessels and to obliterate some \\nof the intramyometrial ascending arterial branches of the cervicovaginal \\nartery (Fig. 1).'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 113}, page_content='National Guideline for Maternal Care - Volume I\\n96\\nStep 3: Ligation of uterine/ovarian arterial anastomosis\\nThis step is indicated in continued uterine bleeding in spite of performing \\nstep 1.The uterus is grasped and pulled to the contralateral side by the \\nleft hand, and a large needle with a number 1 absorbable suture is passed \\nthrough the avascular area in the broad ligament from anterior to posterior, \\nat the level of the ovarian ligament. The needle is then passed anteriorly 2 \\ncm medial to the edge of the uterine wall, to include the uterine muscle. \\nThe suture is tied anteriorly.'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 114}, page_content='National Guideline for Maternal Care - Volume I\\n97'),\n",
       " Document(metadata={'producer': 'Adobe PDF Library 9.0', 'creator': 'Adobe InDesign CS4 (6.0)', 'creationdate': '2014-01-08T09:35:42+05:30', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf', 'total_pages': 116, 'format': 'PDF 1.5', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '2019-11-14T12:09:29+01:00', 'trapped': '', 'modDate': \"D:20191114120929+01'00'\", 'creationDate': \"D:20140108093542+05'30'\", 'page': 115}, page_content='National Guideline for Maternal Care - Volume I\\n98'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 0}, page_content='i'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 1}, page_content='ii \\n \\n \\n \\n \\n \\n \\nMaternal Care Package  \\nA Guide to  \\nField Healthcare Workers \\n \\n \\n \\n \\n \\n \\nFamily Health Bureau \\nMinistry of Health \\n \\n \\n \\n \\n \\n2011'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 2}, page_content='iii \\n \\n \\n \\n \\n \\n \\n \\n1st Edition \\nOctober 2011 \\n \\n \\n \\n \\nISBN : 978-955-1503-07-9 \\n \\n \\n \\nDraft adaptation and writing by: \\nDr. Nilmini Hemachandra \\nConsultant Community Physician \\nNational Programme Manager Maternal Care \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\nPrinted by:  \\nNew Karunadhara Press, \\n97, Maligakanda Road, \\nColombo 10 \\n \\n \\n \\n \\nPublished by: \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\n \\nSponsored by: \\nWorld Health Organization \\nSri Lanka'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 3}, page_content='iv \\n \\n \\nRESOURCE PERSONS \\nResource  Persons: \\nDr.Deepthi   Perera \\n- \\nDirector /Family Health Bureau \\nDr.C. de Silva \\n- \\nDeputy Director /Family Health Bureau \\nDr.Nilmini Hemachandra \\n- \\nConsultant Community Physician / FHB \\nDr.Dammica Rowel \\n- \\nConsultant Community Physician/ FHB \\nDr.Kapila Jayaratne \\n- \\nConsultant Community physician/ FHB \\nDr.Nethanjalee Mapitigama \\n- \\nConsultant Community physician/ FHB \\nDr.Loshan Moonasinghe \\n- \\nConsultant community Physician/ FHB \\nDr.Nirosha Lansakara \\n- \\nConsultant Community Physician/ FHB \\nDr.Udaya Usgodaarachchi \\n- \\nConsultant Community Dental Surgeon/ FHB \\nDr.Sarath Amarasekara \\n-  Consultant Obstetrician and Gynaecologist / SLCOG \\nDr.Sarath Samarathunga \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Gamini Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Hemantha Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nProf. Hemantha Senanayake \\n-   Prof.of Obstetrics and Gynaecology,Faculty of Medicine, Colombo \\nProf.Harsha Seneviratne \\n-  Prof.of Obstetrics and Gynaecology,Faculty of Medicine,Colombo \\nProf.Chandrika Wijeratne         - \\nProf.of  Reprodutive Health, Faculty  of Medicine, Colombo \\nDr.Lakshman Senanayake     \\n-  Consultant Obstetrician and Gynaecologist \\nDr.Athula Kaluarachchi         \\n-   Consultant Obstetrician and Gynaecologist, Faculty of Medicine-Colombo \\nDr.Sujatha Samarakoon          -   Consulatnt Venereologist, NSACP \\nDr.Renuka Jayatissa               - \\nNutritionist, MRI \\nDr.Anoma Jayathilaka \\n-  National Professional Officer,World Health Organization \\nDr.Deepika Attygalle \\n-  Nutrition Specialist, UNICEF \\nDr.Nishamanie Karawita \\n-  National Health officer, UNICEF \\nDr.Nilani Fernando                  - \\nDeputy RDHS – Kandy \\nDr.Daya Wattearachchi         \\n-  Medical Officer /Maternal and Child Health –Rathnapura \\nDr.Badrika Gunawardena      \\n- \\nMedical Officer of Health- Piliyandala \\nDr.Lalitha Ratnayake           \\n-   Medical Officer of Health   - Piliyandala \\nDr.Sapumal Danapala          \\n- \\nConsultant Community Physician - Central Province \\nDr.Sarath Warusavithana    \\n-  Medical Officer of Maternal and Child health – Matara \\nDr.Priyankara Jayawardena  \\n-  Consultant Physician – Castle Street Hospital for Women \\nDr.Uditha Bulugahapitiya       -  Consultant Endocrinologist \\nDr. Prasad Katulanda                 -   Consultant Physician,NHSL \\nDr.Rabindra Abeysinghe         -  Consultant Community Physician, Anti Malaria Campaign \\nDr.Sudath Pieris                       -  Consultant Epidemiologist, Epidemiology Unit, Ministry of Health \\nDr. S de Alwis                       \\n-  Director, National Respiratory and Chest Disease Control Programme \\nMrs. D. Ubeywarna                  - \\nDirector/Nursing (PHS) \\nDr.Hasitha Aluthge                 - \\nMOH, Deraniyagala \\nDr.Dumithra Kahangamage  \\n- \\nMOH ,Padukka \\nDr. Shanika Senanayake  \\n- \\nMedical Officer – Family Health Bureau \\nMrs.K.A. Sunethra                 \\n- \\nPHNS ,Thihagoda MOH area \\nMrs.Nalika Weeraratne \\n- \\nPHNS, Pelmadulla MOH area           \\nEditing \\nDr. Anoma Jayathilake   \\n- \\nNational Professional Officer, WHO \\nDr. Nilmini Hemachandra  \\n- \\nConsultant Community Physician, FHB \\nDr. Dhammica Rowel \\n- \\nConsultant Community Physician, FHB \\nDr. Shanika Senanayake  \\n- \\nMedical Officer, FHB'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 4}, page_content='v'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 5}, page_content='vi \\n \\n \\nCONTENT \\nPreface \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nvii \\nAcknowledgement \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n ix \\nList of Abbreviations  \\n \\n \\n \\n \\n \\n \\n \\n \\n xi \\n1. \\nIntroduction \\n01 \\n2. \\nBasic principles of maternal and newborn health interventions \\n07 \\n3. \\nMaternal care models in Sri Lanka \\n13 \\n4. \\nAntenatal care at the clinic \\n19 \\n5. \\nManagement of risk conditions at field level \\n41 \\n6. \\nDomiciliary care for low risk pregnancies \\n46 \\n7. \\nDomiciliary care for high risk pregnancies \\n54 \\n8. \\nDeveloping a birth and emergency plan \\n65 \\n9. \\nAntenatal classes \\n68 \\n10. Clinical procedures for antenatal care \\n \\n10.1 Anthropometric assessment of pregnant women \\n71 \\n \\n10.2 Measuring blood pressure at the clinic setting \\n75 \\n \\n10.3 Obstetric examination \\n76 \\n \\n10.4 Fetal movement chart or kick count chart \\n80 \\n \\n10.5 Urine testing at the clinic setting \\n81 \\n \\n10.6 Antenatal screening for syphilis: Guidelines for sample collection,  \\n                storage and transportation \\n83  \\n \\n10.7 Estimating Haemoglobin levels using a colour scale                                              84 \\n11. Nutrition during pregnancy and lactation \\n85 \\n12. Common discomforts during pregnancy \\n91 \\n13. National guidelines for prevention and control of maternal anaemia \\n100 \\n14. Management of high blood pressure during pregnancy at field level \\n106 \\n15. Guidelines on immunization against tetanus \\n107 \\n16. Guideline on screening and management of diabetes mellitus during  \\n \\npregnancy in the field /non specialized institutions \\n110 \\n17. Prevention of mother to child transmission of HIV infection (PMTCT) \\n114 \\n18. Elimination of congenital syphilis (ECS) \\n127 \\n19. Syndromic management of sexually transmitted infections during pregnancy \\n135 \\n20. National guidelines for prevention and management of Malaria in pregnancy \\n145 \\n21. Management of Tuberculosis during pregnancy \\n147 \\n22. Postnatal Care \\n155 \\n23. Postnatal Clinic \\n170 \\n24. Family planning after delivery \\n172 \\n25. Screening for postpartum depression \\n173 \\n26. Management information system of maternal care \\n175 \\n27. Surveillance on maternal morbidity and mortality \\n176 \\n28. Supervision of maternal care services \\n191 \\n29 Planning of domiciliary care for pregnant and partum women \\n213 \\nList of References  \\n215'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 6}, page_content='vii'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 7}, page_content='viii \\n \\n \\n \\nPREFACE \\n \\nPregnancy is the most wonderful physiological phenomenon which is responsible for the existence of \\nmankind within the universe, though it creates a high risk environment for a woman’s life. With \\ndevelopment of the discipline of obstetrics and the health systems, the threat to life has been \\nminimized and the world has achieved a lot in maternal and child health. \\nSri Lanka, although a developing country, has been able to achieve remarkable health indices such as \\nlow maternal mortality rate, infant mortality rate, under five mortality rate, higher level of life \\nexpectancy due to the tireless efforts of many stakeholders over the last few decades. The foundation \\nfor these achievements are the policy of free education and free health services for the entire nation, \\ncommitment by all levels of medical and other related professional personnel and the existence of a \\nstrong preventive and curative health infrastructure. \\nProvision of comprehensive maternal, family planning, and child care services through a  well-\\norganized structure at institutional and community level, implementation of evidence based \\ninterventions integrated as packages, use of professionally trained health personnel at the community \\nlevel from the inception of the national MCH/FP programme are the major contributors for the \\nsuccess.   \\nAlthough our targets  in most aspect of the MCH has been  achieved, still some gaps can be \\nidentified in certain areas such as postnatal care, quality of care and geographical  disparity in some \\nindices. Further, some indices such as IMR, MMR, Low birth weight rate have shown slow decline \\nduring the past decade.  \\nTo overcome these gaps and challenges, we need to focus more on targeted interventions, equitable \\nservice provision and quality of care. Therefore, this guide was developed by a group of experts in \\nthe relevant fields considering existing maternal care model and intervention packages, evidence \\nbased interventions, recommendations given by the external review of the Maternal and Newborn \\ncare programme (2007), National Maternal Mortality Reviews, MCH reviews and the felt need of the \\nrelevant experts for the betterment of the maternal care programme in the country.   \\nWe strongly recommend this book as a guide for the health workers who provide maternal and \\nnewborn care in the country and as a hand book for medical, nursing and midwifery students.   \\n \\n \\n \\nDr. Ajith Mendis                                                                        Dr. Deepthi Perera \\nDirector General of Health Services                                            Director/ Maternal and Child Health \\nMinistry of Health \\nFamily Health Bureau \\n                                        \\nSri Lanka. \\nMinistry of Health \\n \\nSri Lanka.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 8}, page_content='ix'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 9}, page_content='x \\n \\n \\n \\n \\n \\nACKNOWLEDGEMENT \\n \\nThis guide is an outcome of the efforts of many people. Dr. L. Siyambalagoda, Deputy Director \\nGeneral (Public Health Services), Dr. Deepthi Perera, Director/ Maternal and Child Health, Family \\nHealth Bureau and Dr. Chitramalee de Silva, Deputy Director/ Maternal and Child Health, Family \\nHealth Bureau guided us to develop this guide providing their fullest support and guidance.  \\nDr. Sarath Amarasekara (president /2010), Dr.Ananda Ranathunga, (President/2011), and other \\nmembers of the Sri Lanka College of Obstetricians and Gynaecologists provided us with their \\ntechnical expertise and cooperation during the development of this guide and pilot testing of the \\nrevised maternal care model. Our gratitude is conveyed to SLCOG. \\n We would like to appreciate the contribution of Consultant Community Physicians at the Family \\nHealth Bureau with their technical expertise in their fields and constructive criticism. We would \\nacknowledge all the Medical Officers (Maternal and Child  Health),  Medical Officers of Health, \\nPublic Health Nursing Sisters, Supervising Public Health Midwives and Public Health Midwives \\nwho contributed for the development of this guide in various ways.  \\nWe would like to appreciate the contribution of the Public Health teams of Ratnapura and Kandy \\ndistricts for the pilot testing of the maternal care package and their contribution to fine tune this. We \\nwould like to acknowledge and appreciate the contribution of Dr. Anoma Jayathilake as a public \\nhealth specialist in the field of maternal care for the success of this endures.  \\nFinancial support received from UNICEF for consultative meetings during the process of \\ndevelopment of this package is highly appreciated. Our sincere gratitude is conveyed to the World \\nHealth Organization Country Office for the guidance and financial support received, for pilot testing \\nscaling up and printing of this document in all three languages.  \\n \\n \\nDr. Nilmini Hemachandra \\nNational Programme manager – Maternal care \\nFamily Health Bureau, \\nMinistry of Health, \\nSri Lanka.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 10}, page_content='xi'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 11}, page_content='xii \\n \\n \\n \\n \\nLIST OF ABBREVIATIONS \\n \\nAIDS\\nAcquired Immune Deficiency Syndrome\\nMOMCH\\nMedical Officer-Maternal & Child \\nHealth \\nAMC\\nAnti Malaria Campaign\\nMSD\\nMedical Supplies Division\\nANC\\nAntenatal Care\\nMTCT\\nMother To Child Transmission\\nAPH\\nAntepartum Haemorrhage\\nNCD\\nNon Communicable Disease\\nART\\nAnti retro viral treatment\\nNICU\\nNeonatal Intensive Care Unit\\nBF\\nBreast Feeding\\nNMMR\\nNational Maternal Mortality Review\\nBMI\\nBody Mass Index\\nNSACP\\nNational STD/AIDS Control \\nProgram \\nBP\\nBlood Pressure\\nOCP\\nOral contraceptive Pills\\nCEmOC\\nComprehensive Emergency Obstetric \\nCare \\nOGTT\\nOral Glucose Tolerance Test\\nCHDR\\nChild Health Development Record\\nPDHS\\nProvincial Director of Health \\nServices \\nCS\\nCongenital Syphilis\\nPHI\\nPublic Health Inspector\\nCSB\\nCorn Soya Blend\\nPHM\\nPublic Health Midwife\\nDMMR\\nDistrict Maternal Mortality Review\\nPHNS\\nPublic Health Nursing Sister\\nEBF\\nExclusive Breast Feeding\\nPID\\nPelvic Inflammatory Disease\\nECCD\\nEarly Childhood Care & Development\\nPIH\\nPregnancy Induced Hypertension\\nEDD\\nExpected Date of Delivery\\nPLHIV\\nPeople Living with HIV\\nEmOC\\nEmergency Obstetric Care\\nPMTCT\\nPrevention of Mother To Child \\nTransmission of HIV \\nEPI\\nExpanded Programme of Immunization\\nPOA\\nPeriod of Amenorrhoea\\nFHB\\nFamily Health Bureau\\nPPBS\\nPost Prandial Blood Sugar\\nFHS\\nFetal Heart Sounds\\nPPH\\nPostpartum Haemorrhage\\nFM\\nFetal Movements\\nRDHS\\nRegional Director of Health services\\nGBV\\nGender Based Violence\\nSCBU\\nSpecial Baby Care Unit\\nGDM\\nGestational Diabetes Mellitus\\nSFH\\nSymphysio- Fundal height\\nHb\\nHaemoglobin\\nSMI\\nSchool Medical Inspection\\nHEO\\nHealth Education Officer\\nSPHM\\nSupervising Public Health Midwife\\nHIV\\nHuman Immunodeficiency Syndrome\\nSTD\\nSexually Transmitted Diseases\\nIUD\\nIntra Uterine Device\\nTB\\nTuberculosis\\nIUGR\\nIntra Uterine Growth Retardation\\nTT\\nTetanus Toxoid\\nIVF\\nIn Vitro Fertilization\\nUSS\\nUltra Sound Scan\\nJMO\\nJudicial Medical Officer\\nVDRL\\nVenereal Disease Reference \\nLaboratory \\nJVP\\nJugular Venous Pressure\\nKCC\\nKick Count Chart\\nLRM\\nLast Regular Menstruation\\nLRT\\nLigation and Resection of Tubes\\nLSCS\\nLower Segment Cesarean Section\\nMO\\nMedical Officer\\nMO/STD\\nMedical Officer/STD clinic\\nMOH\\nMedical Officer of Health'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 12}, page_content='xiii'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 13}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n1 \\n \\n \\nChapter 01 \\nINTRODUCTION \\n \\nDevelopment of maternal care services in Sri Lanka \\nThe history of health care systems in Sri Lanka is extended to king’s era. The documentary evidence \\nsays that there were several hospitals for indigenous medicine and maternity homes for child birth \\nexisted during the reign of the Sinhalese kings as early as 340-368 AD. The expectant mothers were \\nmade to move into these homes in the ninth month of pregnancy and stay there till child birth. Most \\nmothers delivered in the few maternity homes that were available or in their homes under the care of \\nexperienced birth attendants. \\nAround the 15th century, a systematized network of Ayurvedhic treatment centers and hospitals \\nthroughout the country was established and Ayurvedhic Physicians were trained to work in these \\ntreatment centers. This resulted in gradual diffusion of health care within the country. The \\ndocumentary evidence in the history of ancient Ceylon stated that separate hospitals existed for \\nwomen under the Ayurvedic System of Medicine where deliveries have been conducted. \\nSri Lanka came under the colonial rule in1505 and was successively under the Dutch, Portuguese \\nand the British till achieving independence in 1948. During this period, the Western System of \\nmedicine was introduced and hospitals were built to provide medical care. In 1859, a separate Civil \\nMedical Department was established and public health became a function of this department.  \\nThe first organized effort towards care of the childbearing woman was made in 1879 with the \\nopening of the De Soysa Lying- in- Home now known as the De Soysa Hospital for Women. This \\nwas built by a philanthropist (Sir Charles Henry De Soysa) to provide a home for lying-in-mothers as \\nwell as to provide out-patient care to mothers and children. This was probably the first maternity \\nhospital to be established in Asia and soon afterwards the first training school for midwives was \\nopened at this maternity hospital in 1881. In 1887, Legislation for registration of midwives was \\nintroduced which made it mandatory for all midwives to be registered prior to practicing midwifery. \\nThis was a great step taken towards development of maternal care services since it enhanced the \\nquality of midwifery services provided in Sri Lanka. \\nIn 1902, a maternal and child health department was created with in the Colombo Municipality \\nfollowing an investigation into the high rate of infant mortality within the Municipality. In 1906, a \\nsystem of field maternal services commenced within the Colombo Municipality with the \\nappointment of six midwives. This was followed by the appointment of two health visitors in 1913.  \\nThe MCH services were thereafter gradually expanded.  \\nThe first antenatal clinic was started at the De Soysa Lying-in-home in 1921 following the \\ncommencement of Antenatal Clinics in Boston, USA in 1911, Sydney in 1912 and Edinburgh in \\n1915. \\nThe need for developing the preventive and promotive services was recognized by the government as \\nearly as 1920. In the mid 1920’s steps were taken to introduce a Health Unit System which could \\nprovide a comprehensive health care service (institutional and domiciliary) to mothers and children.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 14}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n2 \\n \\n \\nThis scheme was to provide domiciliary as well as clinic based services to mothers during pregnancy \\nand postpartum period and, trained assistance at delivery by encouraging mothers to deliver in \\nmedical institutions or provide trained assistance in the case of home deliveries. The first Health Unit \\nwas established in 1926 at Kalutara and trained Public Health staff (Public Health Midwives and \\nNurses) were appointed to provide the necessary services. This scheme was thereafter extended to \\nother areas and by 1936, eight Health Units were established within the country. \\nUntil 1926, the midwives functioned only in the hospitals and their training was only hospital based. \\nWith the establishment of the Health Unit System, the Midwives were given one month field training \\nin public health midwifery and appointed to the Health Units as Public Health Midwives. After 1938, \\nthe PHM’s training was more systematized with the use of appropriate circular and the field training \\nwas extended to six months.  \\nTraining of Public Health Nurses (PHNs) commenced in 1928 and consisted of six months training \\nin midwifery and six months in public health. Since 1980, training in the public health for nurses \\nconducted at the National Institute of Health Sciences (NIHS) was extended to one year, after which \\na Diploma in Public Health Nursing was awarded. This category is now designated as Public Health \\nNursing Sisters. \\nFormal training for Medical Officers of Health commenced in 1936 and is of one month’s duration. \\nThis facilitated the effective implementation of the Health Unit System. \\nThe control measures adopted following the Malaria epidemic of 1935, led to further expansion of \\nthe Health Unit System. The maternal and child health infrastructure, which originated with the \\nHealth Unit Systems, was linked to the expanding malaria control programme and the medical \\nofficers recruited for malaria control provided MCH services at the health centres in addition to their \\nnormal malaria control activities. \\nThe Government policy in the early 1930’s enunciated the need for diffusion of health services \\nthroughout the country. After the granting of Universal Franchise in 1931, there was political \\ndemand for expansion of health services in rural areas. A large number of maternity homes, rural \\nhospitals and cottage hospitals were constructed and the staff in these medical institutions was \\ntrained in care of the mother and child. The number of Health Units, which was eight in1936, \\nincreased to ninety-one by 1950. Currently there are more than 300 Health Units in the country. \\nThe government provided health care free of charge making health services accessible to the poorest \\nsegments of the population. The introduction of the free education system in 1941 led to an increase \\nin literacy, which helped in increasing the level of health consciousness and greater utilization of \\nhealth facilities. \\nThe number of medical institutions with facilities for delivery increased from 141 in 1941 to 521 in \\n2000. Also the number of health centres increased from 600 in1948 to about 3200 in 2000. \\nSimilarly availability of trained health man power has shown a marked increase since 1940’s. \\nTrained midwives increased from 347 in 1941 to 8741 in 2009 and the Public Health Nurses (now \\ncalled Public Health Nursing Sisters) increased from 41 in 1948 to 254 in 2009.  \\nSince independence in 1948, a more concerted effort was made to provide a comprehensive service \\nto mothers and children throughout the country. The MCH services were extended to the rural areas \\nin an effort to make the service availability more equitable. The second maternity hospital in \\nColombo (Castle Street Maternity Hospital) with accommodation for 144 patients was opened in'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 15}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n3 \\n \\n \\n1950. Thereafter, an increasing number of maternity beds and specialist services were provided to \\nthe Provincial and Base Hospitals with blood transfusion facilities extended to these hospitals. \\nThe policies of Sri Lanka in the early years after independence reflected little concern over the high \\ngrowth rate (31 per 1000) that prevailed during that period. The first organized effort for introducing \\nfamily planning was made in 1953 with the founding of the Family Planning Association (FPA) of \\nCeylon. The activities of the Association were focused on family welfare with a view to reducing \\nmaternal mortality, infant mortality and malnutrition and were mainly centered within and around \\nColombo. The work done by the Association was recognized when the government provided a \\nfinancial grant in 1954. \\nRealizing the importance of family planning, in 1958 the government entered into a bilateral \\nagreement with the Royal Government of Sweden to study community’s attitude toward family \\nplanning and its acceptance by the people. Under this agreement, training programmes for doctors, \\nnurses and midwives were started and two pilot projects were conducted in community family \\nplanning. The results of this project were encouraging. In the pilot areas, the crude birth rate showed \\na promising decline and an increase in positive attitudes towards family planning was seen within the \\ncommunity. The activities of the Swedish project during 1958 – 1965 period demonstrated that \\nfamily planning can be successfully integrated into the MCH services without any great increase in \\npersonnel or expenditure. \\nBased on the above experiences, the government accepted family planning as national policy in 1965 \\nand decided to integrate family planning services with the already well-established Maternal and \\nChild Health services provided through the Ministry of Health. This procedure was adventurous \\nsince the personnel and the infrastructure of an already well- organized system could be made use of \\nwithout any additional cost and also family planning could be introduced as an integral part of the \\nmaternal health package offered by the system. Considering its national importance, a separate \\ndivision, ‘the Family Planning Bureau’ which was later re-designated as ‘Maternal and Child Health \\nBureau’ was set up in 1968 within the Ministry with an Assistant Director MCH responsible for \\nimplementation of the programme throughout the country. This Bureau was given the task to plan, \\noperate, supervise and evaluate the family planning programme within the country. \\nThe period 1966 to 1968 could be regarded as an introductory phase where establishment of family \\nplanning clinics, training of relevant health personnel and administrative strengthening of the \\nMinistry of Health laid the foundation for the expected expansion and intensification of the \\nprogramme. \\nIn 1970, the government made a positive statement towards family planning. It stated that ‘though \\nfamily planning would not be a solution to the economic ills of the country, nevertheless family \\nplanning facilities should be made available on a more intensified scale.’ In the national five year \\nplan of 1971, family planning received due importance and a statement was made emphasizing that \\n‘family planning should be made available to all groups and not be confined to the privileged section \\nof society.’ This provided the necessary political endorsement and support from the government for \\nfamily planning, though some groups still resisted the idea. \\nIn 1972, 100 pilot projects were started, one in each MOH area to try out a coordinated approach to \\nmaternal care, family planning, child care including nutrition and immunization, health education \\netc. Based on the experience gained, the MCH/FP programme received a new dimension with a more \\ncomprehensive approach towards the family.  The Bureau was re-designated the ‘Family Health'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 16}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n4 \\n \\n \\nBureau’ in 1973 and the programme was named ‘Family Health’ so that this would provide a more \\ncomprehensive service to the mother and child. Thereafter maternal and child health services \\nreceived greater emphasis and were given priority in the overall health development plan. This led to \\nmore concerted effort to strengthen the service infrastructure to provide an efficient family health \\nservice through out the country. The government sought the assistance of International Organization \\nto financially support the implementation of services within the country. \\nThe Family Health Bureau was made the central organization of the Ministry of Health responsible \\nfor planning, promoting, coordinating, monitoring and evaluating family health activities. Following \\na revision of the MCH information system in1985, the Family Health Bureau was entrusted the task \\nof collecting, processing and analyzing MCH data from the Health Units  \\nMaternal death investigations were conducted from the early 1950 s, but were actively implemented \\nin the mid 1980’s when instructions were given to investigate and report all maternal deaths \\noccurring in the medical institutions and in the field (community) including those in the plantation \\nsector. These were thereafter reviewed at the district and national levels by the respective health \\nauthorities. Any corrective measures needed to overcome problems and constraints were taken to \\nprevent such deaths in the future. This system was further strengthened in 1989 when maternal \\ndeaths were made a notifiable event and clear guidelines on the procedure for investigation were \\nissued to all hospitals and health units.  \\nSince the International Conference on Population and Development in Cario in 1994, the concept of \\nreproductive health has been introduced which addresses reproductive health issues of the \\nadolescents, young adults, married couples, and women even after menopause thus providing a life \\ncycle approach to family health care. Some of the reproductive health issues that have received \\nemphasis in the programme are RH problems in the adolescents, early identification of reproductive \\nhealth organ malignancies, prevention of reproductive tract infections including sexually transmitted \\ndiseases / HIV-AIDS, concept of women’s empowerment and male involvement in RH activities. \\nServices in respect of sexually transmitted diseases and HIV/AIDS are provided through the National \\nSTD Control Programme (NSACP). The Family Health Bureau in collaboration with the National \\nCancer Control Programme (NCCP) has introduced in 1995 a screening programme for reproductive \\norgan malignancies and certain other conditions. Under this programme ‘Well Women’s Clinics’ \\nhave been established in all Health Unit areas conducted by trained medical officers. Women over 35 \\nyears of age could be screened for such as hypertension, diabetes, breast malignancies and cervical \\ncancers. If any abnormality is detected clients are referred to the health care system for necessary \\nmanagement. The PHM of the area is responsible for follow up of cases in the field and provides \\nnecessary advice and guidance thereafter. \\nTenth anniversary of Safe motherhood concept which was held in Sri Lanka in 1997 was an appraisal \\nof maternal health program in Sri Lanka. \\n \\nInstitutional Framework for Providing Maternal Care \\nMaternal, child health and family planning services are provided through the well-developed health \\ninfrastructure of the Ministry of Health, which has grown steadily over the past few decades. The \\nservices are provided through a net of work of Medical Institutions comprising major hospitals with \\nspecialist services (Teaching, Provincial and Base hospitals), Divisional Hospitals, and central'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 17}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n5 \\n \\n \\ndispensaries and Maternity homes. The institutional network is closely linked to a system of Health \\nUnits, which are primarily responsible for providing preventive and promotive health care to the \\ncommunity. \\nSince 1989, the country’s administration was decentralized with devolution of administrative powers \\nto the Provincial Councils. Each province has a Provincial Director of Health Services (PDHS) who \\nis responsible for total health care within the province. He is supported by a Regional Director of \\nHealth Services (RDHS) who is in charge of a Health District. RDHS is supported by a team \\ncomprising a Medical Officer MCH (MO.MCH), Regional Epidemiologist (RE), Regional \\nSupervising Public Health Nursing Officer (RSPHNO), 2-3 Health Education Officers, a Statistical \\nSurvey Officer (SSO) and a Programme Planning Officer (PPO). Each Health District is further sub-\\ndivided into Health Divisions (7-15) consisting of Health Units and a network of medical institutions \\nof different categories. \\nThe Health Units have a clearly defined area, which is congruent with the administrative divisions \\nof the country. It is managed by a Medical Officer of Health (MOH). He is supported by a team of \\npublic health personnel comprising of one or two Public Health Nursing Sisters (PHNS), Supervising \\nPublic Health Inspector (SPHI), few Supervising Public Health Midwives (SPHM), 20 – 25 Public \\nHealth Midwives (PHM s) and 5-6 Public Health Inspectors (PHI). \\nPublic Health Midwife area (PHM areas) is the smallest working unit in the government health \\nsystem. The PHM is the ‘front line’ health worker for providing domiciliary MCH/FP services in the \\ncommunity. Each PHM has a well defined area consisting of a population ranging from 2000-4000. \\nThough systematic home visits, the Public Health Midwife provides care to pregnant women, infants \\nand pre-school children and family planning services to couples in the reproductive age within her \\narea. In case of necessity, she provides trained assistance during home deliveries when called by the \\ncommunity. She also provides necessary education and advice to adolescents on RH where needed \\nand educates women on the importance of screening for reproductive organ malignancies thus \\nmotivating them to attend the ‘well women clinics’ for necessary check up. She also assists at the \\narea MCH/FP clinics, which are conducted fortnightly, linking the community with the institutional \\nhealth system. Her activities are supported by a system of record keeping which enables her tot plan \\nand monitor her routine activities. Her work is regularly supervised by the Supervising Public Health \\nMidwife, Public Health Nursing sister and the MOH of the area. \\nHigher Level Health Institutions; Teaching Hospitals, Provincial General Hospitals, District General \\nHospitals and Base Hospitals provide specialized care for obstetric including Comprehensive \\nEmergency Obstetric and Neonatal Care (CEmONC) and other specialties. Currently there are 72 \\nhospitals within the country belonging to this category giving a ratio of 1 per 275,000 population. \\nAlmost 80 percent of institutional deliveries occur in these hospitals. \\nIntermediate Level Health Institutions; Divisional Hospitals manned by qualified medical graduates \\n(MBBS) and provide a wide range of services including  in-patient and out -patient care. These \\ninstitutions are capable of providing basic EmONC services. Currently there are 455 Divisional \\nHospitals and 525 Primary care units within the country where almost 20 percent of institutional \\ndeliveries take place. \\nPrimary Level Institutions manned by qualified medical graduates (MBBS) or Registered/ Assistant \\nMedical Practitioners. These are the central dispensaries and Maternity Homes (CD & MH) where \\nfacilities for only uncomplicated deliveries are available.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 18}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n6 \\n \\n \\nThe private sector, which includes private hospitals/nursing homes and general medical practitioners \\nalso provide maternal care services of a varying degree. Although data is not available, it is known \\nthat a considerable proportion of patients obtain maternal care from the private sector. \\n \\nService delivery and Achievements \\nThe Government of Sri Lanka is committed to providing a comprehensive system of health care to its \\npeople. Maternal and Child health and Family Planning form an important component of the \\nprevailing health care system and are an integral part of the Primary Health Care strategy. \\nMaternal care is provided free of charge to all pregnant women during antenatal, intranatal and \\npostnatal periods through the health care system. The use of skilled attendance during pregnancy and \\nlabour has greatly increased over the past five decades. \\nStudies has shown that more than 99 percent of pregnancy women had received antenatal care during \\npregnancy and almost 99 percent received trained assistance at delivery (DHS-2006/2007). \\nAntenatal care is provided at MCH clinics conducted in health centers both in the field and in \\nmedical institutions. These clinics are usually conducted once a fortnight. In addition, domiciliary \\ncare is provided by Public Health Midwives through routine home visiting. Pregnant women are \\nregistered for antenatal care early and ‘Pregnancy record’ is maintained to facilitate proper follow \\nup. Since the early 1990’s, a home based ‘Pregnancy Record’ was introduced which is kept and \\ncarried by the mother so that vital information regarding the pregnancy is made available to the \\nattending doctors and the health staff at any facility she visits. ‘High risk’ mothers are identified and \\nspecial attention is given throughout pregnancy and delivery. An organized system of referral exists \\nfor cases that need special care and attention. \\nThe number of mothers receiving trained care during delivery has more than doubled since 1948. \\nOnly 48 percent of mothers had received trained assistance at delivery (i.e. delivered either in an \\ninstitution or under supervision of a qualified midwife) during the late 1940’s. Currently almost 99 \\npercent of deliveries receive trained assistance with approximately 99 percent taking place in \\nmedical institutions (95 percent in Government institutions and 4 percent in the private hospitals). \\nOf the total deliveries in the government institutions almost 80% take place in larger hospitals where \\nComprehensive Emergency Obstetric Care is available. This has resulted in overcrowding of \\nmaternity wards in the larger hospitals. One of the main reasons for this overcrowding is the people’s \\npreference to have their confinement in larger hospitals with better facilities rather than going to their \\narea hospital. \\nBirths in government medical institutions have increased steadily during the past four decades. Easy \\naccess to institutional care and regular contact with the PHM appears to have influenced their \\ndecision in favour of institutional deliveries.  \\nAfter delivery the mother and child are followed at home by the area PHM with necessary post \\npartum care (including advice and guidance) being provided during these visits. Routine statistics \\nreveal that approximately 80 percent of women receive post natal care at least once during the first \\nten days after delivery (Annual Family Health Report, 2007-FHB)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 19}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n7 \\n \\n \\nChapter 02 \\nBASIC PRINCIPLES OF   MATERNAL AND NEWBORN HEALTH \\nINTERVENTIONS \\nMaternal and Newborn health interventions are treatments, technologies, and key family practices \\nthat prevent or treat Maternal and Newborn illness and reduce deaths in mothers and children (WHO \\n2010).  \\nThese interventions are not only reducing mortality and morbidity in the mother and newborn but \\nalso ensure quality of life. There are simple low-cost interventions for the prevention and treatment \\nof all the most common causes of maternal and newborn, morbidity and mortality. An effective \\nmaternal and newborn health programme must focus on achieving a high level of coverage with such \\ninterventions that have the greatest potential to reduce maternal and newborn mortality and \\nmorbidity in the country. \\n \\nPrinciples of delivering interventions \\n The continuum of care for the mother and child includes the life stages from adolescent, pre \\npregnancy, pregnancy, through birth, the newborn period, infancy and childhood. Interventions \\nshould be targeted at all of these stages in order to maximize impact.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 20}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n8 \\n \\n \\nThe continuum of care across the health system includes the levels at which interventions are \\ndelivered: home and community, first-level health facilities (field clinics and medical institutions up \\nto Divisional Hospitals) and referral facilities (hospitals with specialist facilities). Interventions \\nshould be delivered at each of these levels where relevant. Facility-based interventions should be \\nbalanced with those in the home and community, since the prevention and management of maternal \\nand newborn illness and deaths begins in the home. Continuums of care throughout the lifecycle and \\nacross the health system are a useful way of delivering an intervention.  \\n \\n \\nProgrammatic Pathway to improve health status  \\n \\n \\n \\nIMPLEMENTATION \\nOF ACTIVITIES \\nAdvocacy for health \\n \\nHuman, material and \\nfinancial resource \\nmobilization \\nHuman resource \\ncapacity development \\nCommunication with \\nfamilies & communities \\nHealth system \\ndevelopment \\nMonitoring and supervision \\nIMPROVED \\nAvailability and \\naccess to health \\ncare \\nQuality of care \\nDemand for care \\nKnowledge of \\nfamilies \\nand communities \\nINCREASED \\nPOPULATION- \\nBASED \\nCOVERAGE \\nof key effective \\ninterventions \\nIMPROVED \\nSURVIVAL \\nAND HEALTH \\nMortality, \\nMorbidity, \\nfertility, and \\nNutritional \\nstatus \\nOther determinants'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 21}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n9 \\nPregnancy care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on self-care at home, nutrition, safer sex, HIV, breast feeding, family \\nplanning, healthy life style including harmful effects of smoking and alcohol use, and use of \\ninsecticide treated bed nets \\n\\uf0b7 \\nBirth planning, advice on labour, danger signs and emergency preparedness \\n\\uf0b7 \\nSupport for compliance with preventive treatments \\n\\uf0b7 \\nSupport for woman living with HIV/AIDS \\n\\uf0b7 \\nAssessment of signs of domestic violence and referral \\n\\uf0b7 \\nEducate and support for compliance with preventive treatment \\n \\nPregnancy care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nConfirmation of pregnancy \\n\\uf0b7 \\nMonitoring of progress of pregnancy and assessment of maternal and fetal well-being including \\nnutritional status \\n\\uf0b7 \\nDetection of problems complicating pregnancy ( eg: anaemia, hypertensive disorders, bleeding, \\nmal-presentations, multiple pregnancy) \\n\\uf0b7 \\nResponds to other reported needs \\n\\uf0b7 \\nTetanus immunization \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation and worm treatment) and \\nnutrition counselling \\n\\uf0b7 \\nSyphilis testing and treatment of syphilis ( woman and her partner) \\n\\uf0b7 \\nTreatment of mild to moderate pregnancy complications (mild to moderate anaemia – urinary \\ntract infection, vaginal infection) \\n\\uf0b7 \\nPost abortion care and family planning \\n\\uf0b7 \\nPre- referral treatment of severe complications (pre-eclampsia, eclampsia, bleeding, infection and \\ncomplicated abortion) \\n\\uf0b7 \\nAntibiotics for premature rupture of the membranes \\n\\uf0b7 \\nSupport for women living with violence and HIV \\nSituational \\nAll of the above plus\\n\\uf0b7 \\n HIV testing and counseling, prevention of mother to child transmission of HIV (PMTCT) by \\nantiretroviral including antiretroviral therapy (ART), infant feeding counseling, mode of delivery \\nadvice \\n\\uf0b7 \\nAntimalarial intermittent preventive treatment (IPT) and promotion of insecticide treated nets \\n(ITN) \\n\\uf0b7 \\nDeworming \\n\\uf0b7 \\nAssessment of female genital mutilation \\n\\uf0b7 \\nTreatment of mild to moderate opportunistic infections \\n\\uf0b7 \\nTreatment of simple malarial cases \\nInterventions at REFERRAL FACILITIES \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe pregnancy complications (anaemia, severe pre – eclampsia, eclampsia, \\nbleeding , infection , other medical complications) \\n\\uf0b7 \\nTreatment of abortion complications \\n\\uf0b7 \\nManagement of mal- presentations, multiple pregnancy \\n\\uf0b7 \\nCorticosteroids for preterm labour'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 22}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n10 \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe HIV infection \\n\\uf0b7 \\nTreatment of complicated malaria \\nChild birth care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nCompanion of choice to support the woman during delivery \\n\\uf0b7 \\nSupport for care for the rest of the family \\n\\uf0b7 \\nSupport for transport \\n\\uf0b7 \\nPromote and support for skilled care at birth and institutional delivery \\nChild birth care at FIRST LEVEL FACILITY \\nAll of the above plus\\nCare during labour and delivery \\n\\uf0b7 \\nDiagnosis of labour \\n\\uf0b7 \\nMonitoring progress of labour , maternal and fetal well- being with partogragh \\n\\uf0b7 \\nCompanion of choice to support the woman \\n\\uf0b7 \\nInfection prevention \\n\\uf0b7 \\nSupportive care and pain relief \\n\\uf0b7 \\nDetection of problems and treatment of complications (e.g. malpresentation, prolonged and/ or \\nobstructed labour, hypertension, bleeding and infection) \\n\\uf0b7 \\nDelivery and immediate care of the new born baby \\n\\uf0b7 \\nActive management of third stage of labour \\nImmediate postpartum care of mother \\n\\uf0b7 \\nMonitoring and assessment of maternal well being  \\n\\uf0b7 \\nPrevention and detection of complications (e.g. hypertension , infections, bleeding, anaemia) \\n\\uf0b7 \\nTreatment of abnormalities and complications ( e.g. prolonged labour, vacuum extraction, breech \\npresentation, episiotomy, repair of genital tears, manual removal of placenta) \\n\\uf0b7 \\nPre- referral management of serious complications( e.g. obstructed labour, fetal distress, preterm \\nlabour, severe peri- and postpartum haemorrhage ) \\n\\uf0b7 \\nCounseling and Support for the family if maternal and perinatal death \\n\\uf0b7 \\nCounselling for family planning including insertion of IUDs, LRTs \\nImmediate newborn care \\n\\uf0b7 \\nSkin to skin care \\n\\uf0b7 \\nThermal care \\n\\uf0b7 \\nHygienic cord care \\n\\uf0b7 \\nNewborn resuscitation if required \\n\\uf0b7 \\nEarly initiation of breast feeding \\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nRecognition of danger signs and prompt treatment \\n\\uf0b7 \\nIdentification and initial management of newborn complications and appropriate referral \\n\\uf0b7 \\nSpecial care for small babies including Kangaroo Mother Care \\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nBCG immunization \\n\\uf0b7 \\nPrevention of mother to child transmission of HIV (guidance and support for chosen infant \\nfeeding option) \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nVitamin A administration for mother \\n\\uf0b7 \\nHIV testing and counseling \\n\\uf0b7 \\nPrevention of mother – to- child transmission of HIV by mode of delivery, guidance and support \\nfor chosen infant feeding option \\n\\uf0b7 \\nCare for HIV positive women/ ART'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 23}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n11 \\nChild birth care at REFFERRAL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe complications in child birth and in the immediate postpartum period, \\nincluding caesarean section, blood transfusion and hysterectomy \\n\\uf0b7 \\nInduction and augmentation of labour \\n\\uf0b7 \\nManagement of other obstetric complications \\n\\uf0b7 \\nManagement of severe newborn complications \\nPostpartum care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on selfcare at home, nutrition, safer sex, breast feeding, family \\nplanning/ birth spacing, healthy lifestyle including harmful effects of smoking and alcohol use \\n\\uf0b7 \\nSupport for rest and less work load \\n\\uf0b7 \\nSupport for exclusive breast feeding \\n\\uf0b7 \\nSafe disposal/ washing of pads \\n\\uf0b7 \\nAssessment of maternal wellbeing including maternal nutrition \\n\\uf0b7 \\nMalaria prevention and management of malaria \\n\\uf0b7 \\nSupport for complications with prevention measures and treatments (infections, bleeding, \\nanaemia, UTI, RTI, wound infections, breast feeding problems) \\n\\uf0b7 \\nFamily planning / birth spacing \\n\\uf0b7 \\nRecognition of danger signs, including blues/ depression \\n\\uf0b7 \\nAwareness of signs of domestic and sexual violence and referral \\n\\uf0b7 \\nSupport  for women living with HIV/ AIDS including ART \\n\\uf0b7 \\nReporting birth and death (vital registration) \\n\\uf0b7 \\nUse of insecticide treated bed nets \\n \\nPostpartum care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nPrevention and detection of complications (e.g. infections, bleeding, anaemia) \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation) \\n\\uf0b7 \\nProvision of contraceptive methods \\n\\uf0b7 \\nTreatment of some problems(e.g. mild to moderate anaemia, mild puerperal depression, mastitis) \\n\\uf0b7 \\nPre – referral treatment of  severe complications  (e.g. severe postpartum bleeding , puerperal \\nsepsis) \\n\\uf0b7 \\nVit. A mega dose suplementation \\n\\uf0b7 \\nRecording and reporting  \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nAntiretroviral treatment (ART) \\n\\uf0b7 \\nTreatment of uncomplicated malaria \\n \\nPostpartum care at REFFERRAL FACILITY \\nAll of the above plus\\nTreatment of all complications \\n\\uf0b7 \\nSevere anaemia \\n\\uf0b7 \\nSevere postpartum bleeding \\n\\uf0b7 \\nSevere postpartum infections \\n\\uf0b7 \\nSevere postpartum depression \\nTubal ligation and vasectomy \\nSituational \\nAll of the above plus\\nTreatment of complicated malaria'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 24}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n12 \\n \\n \\nNew born care \\n \\nInterventions at home/ COMMUNITY level \\nPromotion and support for:\\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nThermal protection \\n\\uf0b7 \\nInfection prevention : general hygiene, hand washing , cord care and safe disposal of baby’s \\nfaeces \\n\\uf0b7 \\nCare of a small baby without breathing and feeding problems: frequent  breast feeding , skin – to \\nskin contact \\n\\uf0b7 \\nPrevention of indoor air pollution \\n\\uf0b7 \\nNew born stimulation and play \\n\\uf0b7 \\nRecognition of danger signals, problems, illness and timely care- seeking \\n\\uf0b7 \\nSupport for routine care and follow up visits \\n\\uf0b7 \\nBirth registration \\n\\uf0b7 \\nPromotion, protection and support for exclusive breast feeding \\n\\uf0b7 \\nMonitoring and assessment of wellbeing and response to maternal concerns \\n\\uf0b7 \\nCare of preterm/ low birth weight without breathing problems: support for breast- milk feeding, \\nKangaroo mother care, skin to skin care \\n \\nSituational \\n\\uf0b7 \\nPromotion and provision of insecticide treated bed nets \\n\\uf0b7 \\nAdherence to ARV for PMTCT \\n \\nInterventions at FIRST LEVEL HEALTH FACILITY \\nAll of the above plus\\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nEye infection prophylaxis \\n\\uf0b7 \\nImmunization \\n\\uf0b7 \\nAdditional follow up for at risk babies \\n\\uf0b7 \\nTreatment of local infections (skin , cord, eye, mouth) \\n\\uf0b7 \\nIdentification , initial management and referral of a new born with any sign of severe illness , \\ninjury or malformation \\n\\uf0b7 \\nRecording and reporting \\nSituational \\nAll of the above plus \\n\\uf0b7 \\nARV regimens for PMTCT including ART \\n\\uf0b7 \\nSupport for safer infant feeding options \\n \\nInterventions at REFFERRAL FACILITY \\nAll of the above plus\\nManagement of a new born with severe problems: general care of a sick newborn and specific care for: \\n\\uf0b7 \\nPreterm babies with breathing problem or unable to feed orally (includes provision of KMC) \\n\\uf0b7 \\nSevere infection \\n\\uf0b7 \\nSevere birth asphyxia \\n\\uf0b7 \\nOther: severe jaundice, malformations \\n\\uf0b7 \\nPresumptive treatment of congenital syphilis'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 25}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n13 \\n \\nChapter 03 \\n \\nMATERNAL CARE MODEL IN SRI LANKA \\n \\nAntenatal care model currently used in Sri Lanka is the traditional multi-visit model; once a \\nmonth up to 28weeks, fortnightly during 28-36weeks and weekly thereafter. The domiciliary \\ncare also follows the same model. Pregnant women are simultaneously receiving maternal \\ncare services at multiple settings eg. Field clinic, hospital clinic, specialized care unit, and \\nsome even visits to obstetricians in the private sector.  Therefore, altogether pregnant woman \\nreceived 12-18 clinic visits and 8-10 home visits during antenatal period as more than 90% of \\nwomen registered for antenatal care before 12 weeks. Postnatal care model consists of two \\nhome visits during 1st 10 days, one visit between 11-28 days, and one visit around 42 days \\n(altogether 4 visits). This model also includes a postnatal clinic visit at 4-6 weeks. However, \\nin contrast to antenatal clinic and domiciliary care coverage which is almost universal, only \\n80% of women receive at least one postnatal home visit. Postnatal clinic care is not well \\nestablished in the country.  \\nThough Sri Lanka has achieved effective service coverage in MCH/FP, the quality of service \\ndelivery needs further improvement in order to attain further reductions of maternal mortality \\nand morbidity. Therefore, an external review of Maternal and New born Health in Sri Lanka \\nwas conducted in 2007 to identify the gaps in existing service delivery system. This review \\nhas identified the need to streamline the provision of maternal care and bring it into line with \\nevidence based interventions with the objective of improving the quality of care and \\npreventing the duplication of the services. Further, recommendations of National Maternal \\nMortality Reviews and District Maternal and Child Health Reviews also pointed out the need \\nfor revision to streamline the services and to address the gaps in service provision. \\nMeanwhile, need of strengthening the integration of elimination of congenital syphilis (ECS) \\nand prevention of mother to child transmission of HIV (PMTCT) programmes into maternal \\ncare programme was highlighted.  \\nTherefore, Family Health Bureau in collaboration with Sri Lanka College of Obstetricians, \\nand Gynecologists, WHO and UNICEF revised the existing service provision model of \\nantenatal and postnatal care. Series of consultative meetings were held with the relevant \\nstakeholders and reviewed available models in the world including WHO Antenatal care \\nrandomized trial and NICE guidelines. After considering the existing health policies and \\nhealth care system in the country, achievements and gaps, ability of packaging evidence \\nbased interventions, client and service providers’ satisfaction, development in transport and \\ncommunication, cost effectiveness and expectation of the public, the following model was \\ndeveloped to deliver evidence based interventions to reduce maternal and child mortality and \\nmortality.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 26}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n14 \\n \\n \\nProposed Maternal Care Model \\nDomiciliary and clinic care \\n \\n \\n \\n \\n \\n \\n \\nClinic Visit- 2           12-14weeks \\nClinic Visit -3           18-20 weeks \\nPre pregnancy care\\nEarly Registration of Pregnant Mother \\n(preferably 6-8weeks) either at clinic/home By \\nPHM \\nBooking visit (clinic visit 1) 6-8 weeks \\nLow Risk Pregnancy \\nRisk assessment\\nRisk uncertain \\nHigh Risk Pregnancy  \\nProvide Basic \\nantenatal care \\nRefer to specialized \\ncare to clarify the risk \\nRefer to  Specialized \\ncare\\nClinic Visit -4           22- 24 weeks \\nk\\nClinic Visit – 5       26-28 weeks \\nClinic Visit – 6     32-34 weeks \\nHome visit 1 (6-\\n12 weeks) \\nAt Field Clinic/ \\nMO /MOH/RMO \\nIf registered at home Refer to field ANC\\nAntenatal class I \\n1st Trimester\\nField Clinic/ MO/ \\nMOH/RMO \\nShared care/ Out \\nreach clinic/ field \\nclinic \\nHome visit 2 \\n22-24 weeks\\nAntenatal class II \\n2nd Trimester\\nAntenatal class III \\n3rd Trimester \\nField Clinic/ \\nMO/MOH/RMO\\nField Clinic/ \\nMO/MOH/RMO \\nField Clinic/ \\nMO/MOH/RMO'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 27}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n15 \\n \\nClinic Visit -7         36 weeks \\nClinic Visit -8       38 weeks \\nDelivery at an Institution \\nPostnatal home visit 1 (0-5 days) \\nKCC chart \\nPostnatal home visit 2 (5-10days) \\nPostnatal home visit 3 (14-21days) \\nPostnatal clinic visit (4-5wks) \\nPostnatal home visit (6-7wks) \\nApply EPDS \\nscreening  tool\\nIf no pains admit for \\ninward review\\nImmediate postnatal care\\nPostnatal screening of mother & baby \\nMother \\nBaby \\nWell women  \\nservices \\nFamily \\nplanning \\nservices \\nInfant care \\nClinic Visit -9       40 weeks \\nHome visit 3 \\n36 -38 weeks\\nField Clinic/ \\nMO/MOH/RM\\nField Clinic/ \\nMO/MOH/RMO\\nPHM \\nPHM \\nPHM \\nMO/MOH \\nPHM \\nField Clinic/ \\nMO/MOH/RM'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 28}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n16'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 29}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n17 \\n \\n \\n \\n \\n \\n \\n \\nAntenatal Care'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 30}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n18'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 31}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n19 \\n \\n \\nChapter 04 \\nANTENATAL CARE \\nAll eligible couples should be registered in the eligible couple register (H 526) by the area \\nPHM. All the women who are getting pregnant are assumed to have pre-pregnancy care \\n(Rubella immunization, preconception folic acid supplementation, screening for medical \\ncondition and nutritional assessment and if required necessary family planning services). \\nDuring pre pregnant care, couples should be educated regarding pregnancy symptoms and \\nimportance of early initiation of antenatal care. They should be educated when to and how to \\ninform PHM once they get pregnant. These services should be provided through women’s \\nhealth program and family planning program. In Sri Lanka, antenatal care provides through \\nclinic care and domiciliary care.  \\nThe main objective of antenatal care is to monitor the health of the pregnant mother as well \\nas the health and development of the fetus. Antenatal care helps to screen for possible adverse \\nconditions during pregnancy and to predict problems with pregnancy, labour or birth. \\nTherefore, they can be either prevented, or manage efficiently. It also helps to initiate a plan \\nfor continuing care during pregnancy and post partum period.  \\n Antenatal care consists of: \\n1. Assessment:  Maternal risk factors, Ongoing assessment of maternal and fetal well-\\nbeing and screening for maternal complications \\n2. Care provision \\n3. Health promotion \\n \\nAntenatal care at the clinic \\nFollowing the registration at the clinic or at home, pregnant mother should receive the clinic \\nantenatal care as early as possible, preferably around 6-8 weeks of gestation. The officers \\nwho provide antenatal care should follow the General Circular No. 01-25/2004 issued by the \\nDirector General of Health Services on 14th September 2004 on antenatal care  Each antenatal \\nclinic visit should be objective. All findings of the clinic antenatal care should be entered on \\nthe Pregnancy Record (H512 A and B) by the officer who performs the examination. \\nDesignation of the officer who performs the obstetric examination should enter in the \\nrelevant cage in both H 512 A & B. The services which should be provided at each clinic \\nvisits are mentioned below. \\n \\nBooking Visit 6-8 weeks \\nObjectives of the visit \\n1. To provisional establishment of pregnancy (either clinically/ with laboratory testing)  \\n2. To assess medical and obstetric risk factors and take necessary actions \\n3. To assess the psychological/nutritional status and take necessary actions \\n4. To provide necessary care and health promotion \\n5. Screening for anaemia, syphilis and testing for blood group and Rh \\n6. Check for dental conditions and appropriate referral \\n7. Examination of heart to identify heart diseases'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 32}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n20 \\n \\nWhen mother is registered at the clinic, PHM should visit her home within 12 weeks of \\nPOA as described in the section on domiciliary care. \\nDuring booking Visit/First visit all pregnant mothers must be seen by a medical officer \\n(MOH/AMOH/MO) \\nIf MOH/MO is not available in the first visit, the closest clinic date should be given to the \\nmother for the next visit. A medical officer should examine all the pregnant women. \\na) Obtain information on: \\nPersonal history  \\n\\uf0d8 Name \\n\\uf0d8 Age (date of birth) \\n\\uf0d8 Address and telephone number \\n\\uf0d8 Marital status and duration \\n\\uf0d8 History of consanguinity \\n\\uf0d8 Educational level: primary, secondary, university \\n\\uf0d8 Economic resources: employed? (Salaried work or short-term?) \\n\\uf0d8 Type of occupation of mother and husband \\n\\uf0d8 Substance abuse: alcohol or drugs ( husband & wife)  \\n\\uf0d8 Domestic Violence \\n\\uf0d8 Availability of a responsible person at home in an emergency \\n\\uf0d8 Mode of transport in an emergency \\n\\uf0d8 Closest EMOC facilities –the distance/ transport facility \\n \\nMedical history (Past and present) \\n\\uf0d8  Specific diseases and conditions:\\x00 tuberculosis, heart disease, chronic renal/hepatic \\ndisease, epilepsy, diabetes mellitus, hypertension, psychiatric illnesses and any \\nchronic diseases \\n\\uf0d8 STIs \\n\\uf0d8 HIV status, if known to be positive please follow the guidelines (page 114) without \\nentering into the pregnancy record. \\n\\uf0d8 Other specific conditions depending on prevalence in area (for example, hepatitis, \\nmalaria, Thalaseamia) \\n\\uf0d8 Other diseases; past or chronic; allergy(-ies) \\n\\uf0d8 Operations other than caesarean sections (heart/ lung surgeries) \\n\\uf0d8 Past blood transfusions, Rhesus (D) antibodies \\n\\uf0d8 Current use of medicines – specify \\n\\uf0d8 Period of infertility: when? duration, cause(s), specialized treatment taken for \\ndifficulties in conceiving eg. Ovulation induction, IVF etc. \\n \\nFamily History \\n\\uf0d8 Diabetes mellitus \\n\\uf0d8 Hypertension/ PIH \\n\\uf0d8 Twins \\n\\uf0d8 Congenital abnormalities'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 33}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n21 \\n \\nHistory of present pregnancy \\n\\uf0d8 Date of last menstrual period (LMP) \\n\\uf0d8 Certainty of dates (by regularity, cycle length, accuracy of recall and other \\nrelevant information) \\n\\uf0d8 Habits: smoking/chewing tobacco, alcohol, drugs (frequency and quantity) \\n\\uf0d8 Any other concerns with regards to pregnancy (pain, vaginal bleeding, and \\nexcessive vomiting other: specify) \\n\\uf0d8 History of malaria attacks- when was the last attack \\n\\uf0d8 Any other discomforts \\nContraceptive history \\n\\uf0d8 Method use \\n\\uf0d8 When it was  started \\n\\uf0d8 When it was stopped \\n\\uf0d8 Method failure or not \\n \\nObstetric history (review all the available records, diagnostic cards, clinic records etc.) \\n\\uf0d8  Number of previous pregnancies. \\n\\uf0d8 Date (month, year) and outcome of each event (live birth, stillbirth, abortion, ectopic, \\nhydatidiform mole). Specify (validate) preterm births and type of abortion, if \\napplicable and possible. \\n\\uf0d8 Birth weight (if known) \\n\\uf0d8 Sex of the child \\n\\uf0d8 Periods of exclusive breast-feeding: For how long? \\n\\uf0d8 Did she have any feeding difficulties in previous pregnancies? \\n\\uf0d8 Special maternal complications and events in previous pregnancies; specify which \\npregnancy (- ies), validate by records (if possible): \\n \\n\\uf0b7 Recurrent early abortion, induced abortion and any associated complications \\n\\uf0b7 Thrombosis, embolus \\n\\uf0b7 Hypertension, pre-eclampsia or eclampsia \\n\\uf0b7 Gestational diabetes \\n\\uf0b7 Placenta praevia/ APH \\n\\uf0b7 Liver disease/fatty liver \\n\\uf0b7 Breech or transverse presentation \\n\\uf0b7 Obstructed labour, including dystocia \\n\\uf0b7 Third-degree tears \\n\\uf0b7 Retained placenta \\n\\uf0b7 Post partum haemorrhage \\n\\uf0b7 Puerperal sepsis \\n\\uf0b7 Anesthetic complications \\n \\nObstetrical interventions  \\n\\uf0b7 Cervical cerclage (Shirodkar Suturing) \\n\\uf0b7 Caesarean section (indication, if known) \\n\\uf0b7 Forceps or vacuum extraction'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 34}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n22 \\n \\n\\uf0b7 Manual/instrumental help in vaginal breech delivery \\n\\uf0b7 Manual removal of the placenta. \\n\\uf0b7 Dilatation and evacuation (D&E) or dilatation and curettage (D&C) \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies \\n specify which pregnancy(- ies), validate by records (if possible): \\n\\uf0b7 Twins or higher order multiples \\n\\uf0b7 Low birth weight: <2500 g/ 2500-2000g / 1999- 1500g/ <1500g \\n\\uf0b7 Intrauterine growth retardation (if validated) \\n\\uf0b7 Rhesus-antibody affection (erythroblastosis, hydrops) \\n\\uf0b7 Malformed or chromosomally abnormal child \\n\\uf0b7 Macrosomic (>3500g) newborn \\n\\uf0b7 resuscitation or other treatment of newborn (SCBU and NICU admissions)/ \\nventilation \\n\\uf0b7 perinatal, intrapartum, neonatal or infant death (also: later death) \\n\\uf0b7 Feeding problems \\n \\nb) Perform clinical examination \\n\\uf0b7 Record weight (Kg) and height (metres) (page 71) \\n\\uf0b7 Calculate BMI using BMI chart/cycle (page 71)and record it in pregnancy \\nrecord \\n\\uf0b7 Check for signs of severe anaemia: pale complexion, fingernails, conjunctiva, \\noral mucosa and shortness of breath  \\n\\uf0b7 Look for edema (ankles, fingers, face and abdoman) \\n\\uf0b7 Do a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities spinal/pelvic, icterus, cyanosis, clubbing  \\n\\uf0b7 Measure blood pressure and record  (Page 75) \\n\\uf0b7 Auscultate heart and  chest: Heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0b7 Perform obstetric examination (page 76) \\n\\uf0b7 Perform breast examination if needs (lumps, nipple problems) \\n \\nc) Perform following tests  \\n\\uf0b7 Urine: Check for glucose (Benedicts test) and protein (coagulation test) or if \\navailable use urine test strips for protein and sugar (page 81) \\n\\uf0b7 VDRL testing as a screening test of Syphilis ( page 83) \\n\\uf0b7 Blood group and Rh (Should be done through government sector) \\n\\uf0b7 Check Haemoglobin at first visit using colour scale/ any other method (page \\n84) \\n \\n(Discuss with the nearest hospital with laboratory facilities to test Hb. This will be more \\naccurate method than colour scale) \\n \\n\\uf0b7 If there are risk factors (BMI above 25kg/m2, previous baby weighing \\n3.5kg or above, previous gestational diabetes, first degree relative with \\ndiabetes) do PPBS, if the value is more than 120mg/dl, refer for OGTT in \\na specialized unit'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 35}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n23 \\n \\n \\n \\nd) Implement the following interventions \\no If any risk is identified, act according to the guidelines (page 41) \\no If woman is on treatment for diabetes, hypertension, epilepsy, psychiatric disease or \\nany other disease refer them to the relevant clinics for continuous treatment \\no Mothers without high risk conditions should be offered basic antenatal care \\no Folic acid (5mg daily) supplementation  \\no Nutritional supplementation (2 packets of Triposha/CSB for all mothers) \\no Ask to seek medical advise if having vaginal bleeding, severe vomiting or abdominal \\npain or any other concerns  \\n \\ne) Discuss and understand: \\nGive the pregnant woman an opportunity to discuss issues and ask questions: time for free \\ncommunication \\n\\uf0b7 On whom to communicate or where to go in case of bleeding, abdominal pain and any \\nother emergency, or when in need of other advice (page 65) \\n\\uf0b7 On issues related to sexual relationship and activities  \\n\\uf0b7 Nutrition during pregnancy (page 85) \\n\\uf0b7 Minor ailments and their management during early pregnancy (page  91) \\n\\uf0b7 Advise the woman to participate with the husband or any other care giver for \\nantenatal   classes where they can learn how to deal with a pregnancy (page) \\n \\nf) \\nSchedule next appointment:  \\n \\nPlan second clinic visit at 12-14 weeks of  POA. State the date and time  \\n \\nConfirm the date for antenatal classes \\n \\nThis should be written in the pregnancy record (512A) and in the clinic’s appointment book if \\navailable. \\n \\ng)  Maintain complete records \\n            Complete clinic records. \\n            Complete the Pregnancy record.  \\nGive the record to mother and advice her to bring it with her to all appointments with \\nany health services.                  .'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 36}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n24 \\n \\nSecond Clinic Visit- 12-14 weeks \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. To see the results of the tests and take necessary actions \\n4. Tetanus toxoid immunization  \\n5. To give Antihelminthic  treatment \\n6. To start micronutrient supplementation (Iron, folic acid, Vit C and calcium lactate) \\n7. To provide necessary care and health promotion \\n8. To discuss the birth  and emergency plan \\n \\na) Obtain information on: \\nPersonal/ social history \\n\\uf0d8 Note any changes since first visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc \\n\\uf0d8 Change of home environment \\n\\uf0d8 Change of duty station or occupation of wife or husband  \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at first visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since first visit. \\n\\uf0d8 Review intake of medicines, other than folic acid \\n\\uf0d8 Folic acid intake: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at first visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since first visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral swelling, \\nshortness of breath with mild exertion) observed by the woman herself, by her \\npartner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken  \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart (page 73), Look for deviations \\nof the expected weight gain'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 37}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n25 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion \\n\\uf0a7 Perform abdominal examination- compare the fundal height with POA , look for \\nabdominal masses (page 76) \\n \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb% if signs and symptoms of  severe anaemia are detected on examination \\n\\uf0a7 Check urine for protein using coagulation test  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare based on evidence since first visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain of  bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Tetanus toxoid immunization (page 107). \\n\\uf0a7 Start iron folate supplementation with Vit C and calcium supplementation (page \\n100) if mother does not have vomiting or loss of appetite. Advice not to take iron \\nand calcium together (iron at night and calcium in the morning before/after meal.) \\n\\uf0a7 Malaria prophylaxis to be decided by MOH  according guidelines issued by AMC \\n(page 145) \\n\\uf0a7 Nutritional supplementation (Triposha/CSB 2 packets ) \\n\\uf0a7 Ask to seek medical advice if having vaginal bleeding or abdominal pain or any \\nother symptom  \\n\\uf0a7 If risk conditions are identified, refer them to the specialized care  \\n \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Create an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the pregnancy record) as at first visit (page 65) \\n\\uf0a7 Discuss and write down the birth plan \\n\\uf0a7 Schedule the third visit at 18-20 weeks either at field clinic or at specialist clinic \\ndepending on the local policy. \\n\\uf0a7 Advice to write down the date of quickening \\n\\uf0a7 Confirm the date for antenatal class II \\n \\ng) Maintain complete records \\nComplete clinic records and pregnancy record. Give the record to mother and advise her to \\nbring it with her to all appointments with any health services.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 38}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n26 \\n \\nVisit 3 (18-20 weeks) \\n \\nThis visit may be either at field clinic or at specialist clinic or at out reach clinic. \\nObjectives of this visit in a field clinic \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. For primies, to give second dose of tetanus Toxoid \\n4. To provide necessary care and health promotion \\n5. To Examine the heart to identity abnormalities \\n \\nObjectives of the visit in a specialist clinic \\n1. To confirm dates and placental position \\n2. To serve as a booking visit for delivery \\n3. To assess the progression of pregnancy \\n4. To assess the risk conditions and take necessary actions \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Fetal movements: whether felt or not. Note the date of first recognition in pregnancy \\nrecord. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 39}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n27 \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart – look for deviations of the \\nexpected rise\\x00\\x00 (page  73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0a7 Measure SFH and record (page 76). \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n\\uf0a7 Check urine for protein using coagulation test \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 \\x00If complain bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 For primies give second dose of Tetanus toxoid immunization (page 107). \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at second visit  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the forth visit at 22-24 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record to mother and advise her to bring it with \\nher to all appointments with any health services.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 40}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n28 \\n \\nClinic Visit 4 (22-24 weeks) \\nObjectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To  screen for  risk factors and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge \\n(amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect, refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76).'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 41}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n29 \\n \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If uterine height (SFH) is above expected: refer for evaluation. \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the fifth visit at 26-28 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 42}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n30 \\n \\nClinic Visit 5 (26-28 weeks) \\nObjectives of the visit  \\n1 To assess the progression of pregnancy \\n2 To  screen for  risk factors and take necessary actions \\n3 To screen for gestational diabetes \\n4 To screen for anaemia \\n5 To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 43}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n31 \\n \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76). \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria all mothers  \\n\\uf0a7 Screen all pregnant women for anaemia \\n\\uf0a7 All pregnant mothers should screen for GDM using PPBS (cut off 120mg/dl). For \\nfurther details see page 110) \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina : Refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the sixth visit at 32 - 34 weeks \\n\\uf0a7 Confirm the date for antenatal class III \\n \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 44}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n32 \\n \\n \\nClinic Visit 6 (32-34 weeks) \\n Objectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n4. To look out for signs of PIH, IUGR, macrosomia, polyhydroamnios  \\n5. To ascertain the lie and presentation  \\n6. To provide necessary care and health promotion \\n7. To reevaluate the birth plan \\n8. To examine the heart to detect any abnormalities \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Any other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 45}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n33 \\n \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal \\nbreathing sounds \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH, record, interpret and take necessary action if any deviation from \\nexpected (page 76) \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Look for Lie and Presentation.    \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria   \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit.\\x00 \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina or vaginal discharge: refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n\\uf0a7 If  transverse lie or breech presentation: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal/ written information supported by antenatal classes  \\n\\uf0a7 Give advice on measures to be taken in case of pain, dribbling and bleeding (page 65)  \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency (page 65).'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 46}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n34 \\n\\uf0a7 Plans to ensure transport is available in case of an emergency (page 65). \\n \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Schedule the  seventh visit at 36 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments any health services. \\n \\n \\nClinic Visit 7 (36 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n3. To assess the risk conditions and take necessary actions \\n4. To ascertain the lie and presentation  \\n5. To introduce kick count chart \\n6. To look out for signs of PIH, IUGR  \\n7. To provide necessary care and health promotion \\n8. To reevaluate the birth plan  \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic  difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review medications other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 47}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n35 \\n \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for reduced fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00  \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema (especially facial) and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record \\n\\uf0a7 \\x00Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis,shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 \\x00Any new symptoms of recent onset: refer as required . \\n\\uf0a7 If complained of bleeding per vagina or vaginal discharge, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected : refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 48}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n36 \\n \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Introduce the kick count charts (KCC) and give clear guidance to maintain the \\nchart (page 80) \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Re-emphasis the signs and symptoms of labour \\n\\uf0a7 Re-confirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Plans to ensure transport is available in case of an emergency. \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n(page 172). \\n\\uf0a7 Schedule the eight visit at 38 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (38 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Re-evaluate presentation/ lie/ PIH/ SFH/ weight chart/ KCC \\n4. To provide necessary care and health promotion \\n5. To reevaluate the birth and emergency plan  \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron, folate , calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 49}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n37 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart,  look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected . \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc) Perform the following tests:  \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH above the expected ; refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 50}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n38 \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Explain the signs and symptoms of labour and advice to get admitted to a hospital if \\nshe experience any \\n\\uf0a7 Give advice on measures to be taken in case of labour. \\n\\uf0a7 If no labour pains by 40 weeks ask her to get admitted to a specialized unit for \\nassessment. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Ensure the plans to ensure transport, to whom accompany with her, money and items \\nto be taken  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n\\uf0a7 Schedule the eighth visit at 40 weeks and explain her delivery may occur before the \\nnext clinic visit \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (40 weeks) \\nObjectives of the visit \\n1. To ensure that the mother reaches the place of delivery in time  \\n2. To assess the risk conditions and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n \\nMedical history \\n \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 51}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n39 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. abdominal or back pain, bleeding, \\nvaginal discharge (amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n \\nb)  Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart. Check the total weight gain. \\n\\uf0a7 Measure blood pressure and record .Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH and record. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc)  Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n \\nd) Assess for referral  \\n Refer to the hospital where delivery is planned to be taken place for assessment.                                              \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Ask her to get admit to the hospital for an indoor assessment \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on danger signals (reduced fetal movements, bleeding PV, headache, \\nshortness of breathing, severe chest pain, rapture of membranes and high fever) \\n\\uf0a7 Give advice on measures to be taken in case of  labour \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency or ant other need. \\n\\uf0a7 Plans to ensure transport is available in case of an emergency.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 52}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n40 \\n \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Ask her to go to the nearest hospital if labour signs and symptoms occurred, or if no \\nlabour pain after 40 weeks, ask her to go to specialized care unit. \\n\\uf0a7 Advice to continue iron, folic acid, Vit C and calcium lactate for 6 months after \\ndelivery. \\n\\uf0a7 Emphasis on following: \\nTo inform the area PHM as soon as the mother came home after delivery \\nTo attend the postpartum clinic after 4 weeks of delivery \\nTo continue micronutrients for 6 months after delivery \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 \\x00Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services.  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during pregnancy\\nAdvise to go to the hospital immediately, day or night, without \\nwaiting if any of the following signs: \\n\\uf0a7 Vaginal bleeding \\n\\uf0a7 Convulsions \\n\\uf0a7 Severe headaches with blurred vision \\n\\uf0a7 Fever and too weak to get out of the bed. \\n\\uf0a7 Severe abdominal pain/ epigastric pain /RHC pain \\n\\uf0a7 Fast or difficult breathing \\n\\uf0a7 Reduced fetal movements \\nShe should go to the hospital as soon as possible if any of the following \\nsigns: \\n\\uf0a7 Fever \\n\\uf0a7 Abdominal pain \\n\\uf0a7 Feels ill \\n\\uf0a7 Swelling of fingers, face, legs \\nDating Scan \\nConfirmation of dates is essential for early identification of IUGR. USS is the \\nmost reliable method of confirmation of dates. However the parameters used \\nare depend on the POA. \\n \\n11- 14 weeks of POA– Crown rump length \\n16- 20 weeks of POA – Head circumference'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 53}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n41 \\n \\nChapter 5 \\n \\nMANAGEMENT OF RISK CONDITIONS AT FIELD LEVEL \\nNote: \\n\\uf0b7 When a high risk pregnant woman receives her antenatal care from a specialized unit \\nin a hospital, she should receive domiciliary care from the PHM. If she wish she can \\nattend to the field clinics also. \\n\\uf0b7 When pregnant women are not receiving micronutrients or food supplementations \\nfrom the hospital clinic, they should be supplied from the field clinic. \\n\\uf0b7 If high risk mothers are not receiving the specialized care, they should receive \\nadequate care from the field clinic. \\n\\uf0b7 If pregnant women have any problem they can attend to the field clinic disregarding \\nthe clinic appointment or risk condition \\n\\uf0b7 All the high risk pregnant women should attend to the antenatal classes with their \\nhusbands \\n \\nRisk Condition \\nAction to be taken \\n Past Obstetric History  \\nPrevious stillbirth (antenatal or intrapartum) \\nor neonatal loss or malformed babies \\nRefer at first visit  \\nAct according to the consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM  \\nPay special attention for kick count chart after 36 \\nweeks. \\n \\nHistory of 2 or more consecutive first \\ntrimester miscarriages \\n \\nRefer at first visit.  \\nDepending on the cause, MOH/ consultant \\nObstetricians can decide whether to continue as a \\nrisk mother or not  \\nNeed to do a proper screening including genetic \\nscreening, thrombophilic screening at the specialized \\ncare unit \\n \\nHistory of preterm delivery before 37weeks, \\nor second trimester miscarriage  \\nRefer at first visit.  \\nAct according to the Consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 54}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n42 \\n \\nHistory of PIH,  eclampsia/ pre-eclampsia \\n \\nRefer at first visit. \\nIf there is a history of PIH only, no need to refer \\nspecial care. Closely monitor the BP \\nIf there is H/O of pre eclampsia/Eclampsia, refer at \\nthe 1st visit for specialized care. \\nNeed close/ regular monitoring of BP \\nIf abnormally detected in BP, refer immediately \\n \\nHistory of APH             \\nIf it is due to placenta previa, refer to specialized \\ncare at 18-20wks for scan to ascertain the position of \\nthe placenta   as there is a risk of recurrence. \\nPlacental abruption: there is a possibility of \\nrecurrence. Refer at 1st visit. \\nCorrect the anaemia if detected. \\nAscertain blood group and Rh. \\n \\nHistory of retained placenta \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility  \\n \\nHistory of postpartum haemorrhage \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility \\n \\nHistory of cesarean section/ Myomectomy \\nAll the women with history of LSCS or \\nmyomectomy should have a scan at 18-20 weeks to \\ndetect placental localization. \\nRefer to specialized unit for this and to get \\nspecialized advice regarding delivery. \\nNeed to be admit to an institution with CEmOC \\nfacilities by 38weeks \\nIf she gets pain need to admit to the hospital in \\nfasting  state  \\n \\nHistory of surgery on reproductive tract  \\n(removal of septum, cone biopsy, large loop \\nexcision of  transformational zones \\n(LLETZ),  \\nRefer for specialist care at first visit for a scan. Act \\naccording to the consultant obstetrician’s instructions\\nHistory of a birth with birth weight < 2500g \\nRefer for specialist care at first visit. \\n  \\nHistory of a birth with weight > 3500g \\nDo a PBBS and if the result is > 120mg/dl refer to \\nspecialist clinic for OGTT.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 55}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n43 \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of  IUGR \\nRefer for specialist care at first visit. They will need \\naccurate dating scan before 14 weeks and regular \\nUSS with growth charts.  \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of Feeding difficulties/ breast \\nsurgery \\nMOH should  identify reasons and plan for  \\nappropriate interventions at last trimester \\nPresent pregnancy \\n Age less than 20yrs \\nIf less than 18 years refer to specialized care. \\n18-20yrs MOH / MO who provide antenatal care \\nshould monitor closely.    \\n \\nAdvanced maternal age (Age  >35yrs) \\nNeed more close monitoring by MOH as more prone \\nto Hypertension, Diabetes Mellitus etc \\nRefer necessary cases such as sub fertile mothers, \\nelderly primies, NCD complicating pregnancies to \\nspecialized care \\n \\nHeight < 145cm \\nRefer to a specialist unit at last trimester for an \\nassessment. To be delivered in a CEmOC  facility \\n \\nBMI  < 18.5kg/m2 \\nMOH should manage according to the given \\nguidelines. \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain \\n \\n BMI  25 -29.9kg/ m2 \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain. \\n \\nBMI ≥30kg/ m2 \\nMOH should thoroughly screen for Hypertension, \\nPIH, Diabetes mellitus. \\nRefer to specialist unit for OGTT. \\nClosely monitor the weight gain and SFH to detect  \\nMacrosomia and polyhydroamnios \\nAscertain the lie after 36weeks \\nManage according to instruction given. \\n \\n Primigravida \\nMOH should manage her at his field clinic if there \\nare no other risk factors.  \\nDuring third trimester look for lie, presentation and \\nhead engagement.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 56}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n44 \\n Parity (5 or more) \\n Refer to specialist care at first visit. \\nCorrect anaeamia if her Hb level is  < 11g/dl. \\nNeed   special counseling for Family Planning. \\nTry to identify social problems if any \\nPlan delivery at CEmOC facility \\n \\nMultiple pregnancy \\nIf suspected, refer as early as possible to specialized \\ncare \\n \\nDiastolic blood pressure more than \\n90mmHg   \\nAdmit to a nearest hospital for monitoring for 24 \\nhours, if BP persists above 90mm Hg, transfer to \\nCEMOC facility (refer management guidelines of \\nPIH in the field).  \\n \\nDiastolic > 110mmHg or systolic 160 \\nmmHg or more \\nadmit urgently to the nearest hospital manage \\naccording to guidelines and transfer  immediately to \\na CEmOC facility \\n \\n Vaginal bleeding (any time) \\nAdmit to the nearest hospital  for assessment and \\nmanagement  \\nIf need, refer to a specialist unit \\n \\nMaternal jaundice \\nAdmit to the nearest hospital to transfer specialized \\nunit immediately. \\n \\nSevere maternal anaemia  (Hb% <7g/dl) \\nNeed to admit to a specialized care unit for \\ninvestigation and correction. \\n \\nMaternal malaria \\nAdmit to nearest hospital  medical unit  (manage \\naccording to AMC guideline) \\n \\n Maternal Syphilis \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\n Maternal HIV \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\nUncertain dates/ irregular periods \\nNeed to refer specialized unit to ascertain the dates \\nbefore 20 weeks. (USS is accurate for dating only   \\nbefore 20 weeks.) \\n \\n Intra Uterine Growth Retardation (IUGR) \\nRefer to specialized care. They will need accurate \\ndating and regular USS with growth charts. Need to \\nplan for delivery at a CEmOC facility. POA  of \\ndelivery also need to decide based on the specialist \\nopinion'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 57}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n45 \\n Mal-presentations and abnormal lie  after \\n34 weeks \\nRefer to a specialized unit. \\nOther risk conditions \\n \\nDiabetes Mellitus/ Liver disease and renal \\ndiseases \\nRefer to a consultant Obstetrician. He/she will \\nmanage the pregnant woman with other relevant \\nspecialists. \\n \\nRheumatic and congenital heart disease \\nIf there is a suspicion of having a murmur, refer to \\ncardiologist for confirmation and diagnosis. After \\nthat refer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists.  \\nDiagnosed cases need to refer to consultant \\nObstetrician for combined care with a cardiologist. \\n \\nEpilepsy \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(neurologist/ physician) \\n \\n Mental disorders \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(psychiatrist/ MO mental health) \\n \\nAsthma \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(general or chest physician) \\n \\nRh Negative mother \\nRefer to a consultant Obstetrician. \\nSend a blood sample to the blood bank with special \\nreferral form for screening antibodies.  \\n \\nSub fertility ( inability to conceive \\nirrespective of regular unprotected \\nintercourse  for 2 or more years) \\nRefer for specialized care  \\nSocial problems \\n \\nUnmarried mothers/ widows (single \\nmothers), geographically marginalized and \\nother social factors \\nEnsure social support (MOH/PHM) Social service \\nofficer, Grama Niladhari, Samurdhi officer etc. \\nTargeted and more frequent home visits by PHM \\nLink with social security programs'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 58}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n46 \\n \\nChapter 06 \\nDOMICILIARY CARE FOR LOW RISK PREGNANCIES \\n \\nDomiciliary care for pregnant women is provided by the area PHM. At the time of \\nregistration as an eligible couple, PHM should give the screening questionnaire for newly \\nmarried couples and help them to fill it. Then she should go through the questionnaire and \\nwith further clarifications try to identify the risk conditions if available. After that she should \\nrefer the couple to MOH clinic for further screening by a medical officer and should give the \\ndates for sensitization classes. PHM should make aware the couple regarding the importance \\nof early commencement of antenatal care and pre pregnancy folic acid supplementation. She \\nalso should inform them how to inform PHM once the wife gets pregnant.  \\nWhen a woman gets pregnant, PHM should register her ideally by 6-8 weeks. PHM should \\nmake aware the community regarding the importance of early registration as a pregnant \\nwoman and the means of communicating with her. PHM can register the pregnant women \\neither at home or in the clinic. It is better to register at home as PHM gets an opportunity to \\nassess the socioeconomic condition, home environment and to meet the other members of the \\nfamily during early pregnancy. This is an opportunity to educate the family members \\nregarding pregnancy and other relevant topics.  \\n \\nHome visit 1 (6 -12 weeks) \\n \\nObjectives: \\n1. To assess the condition of the pregnant woman including socio- economic status  \\n2. To develop a rapport and linkage with the pregnant woman and the family \\n3. To educate the  pregnant woman and the family regarding the maternal care \\n \\nWhen the pregnant woman is registered at the home, that visit can be considered as the first \\nhome visit. When the pregnant woman is registered at the clinic, PHM should visit her before \\n12 weeks of POA. During this visit PHM should: \\na) Assess the condition of the pregnant woman (physical, mental, social and \\nenvironmental) \\n \\nObtain information on: \\n \\nPersonal history : \\n- \\nName \\n- \\nAge /date of birth  \\n- \\nAddress and telephone number  \\n- \\nMarital status- duration and history of subfertility \\n- \\nHistory of consanguinity \\n- \\nPre pregnancy care: Eligible couple registration'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 59}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n47 \\n \\n- \\nRubella Immunization  \\n- \\nIntake of folic acid \\n- \\nAttend to a pre pregnancy care programme/not \\n- \\nThalasseamia test if relevant \\n- \\nPlanned/ unplanned pregnancy \\n \\nSocio- economic status:  \\n- \\nHousing: type, size, number of occupants \\n- \\nSanitary conditions: type of toilet, source of water \\n- \\nLighting: Electricity or other sources of  lighting \\n- \\nCooking facilities- gas, electricity, firewood \\n- \\nTobacco use (smoking or chewing habit) or use of other harmful substances \\n- \\nAlcohol use \\n- \\nGender Based Violence \\n- \\nEnvironment: Prone to dengue and accidents, cleanliness etc \\n- \\nDomestic air pollution: smoke inhalation (tobacco smoking, smoke from the \\nhearth, mosquito coils etc.) \\n- \\nEducational level: primary, secondary, university or higher education  \\n- \\nEconomic resources: employed (salaried work or short-term)  \\n- \\nType of work and position: both pregnant woman and husband \\n- \\nOccupation:  distance to travel, harmful occupational exposures, maternity \\nbenefits, work load \\n- \\nNuclear or extended family \\n- \\nRelationship with in-laws \\n- \\nFamily support and social support \\n- \\nAvailability of a responsible person at home  \\n- \\nMode of transport at an emergency \\n- \\nClosest EMOC facilities: distance / transport facilities \\n- \\nHome gardening, iodized salt, eating habits, Myths, House hold food security  \\n- \\nLeisure activities \\n- \\nReligious activities \\n \\nMedical history  \\n \\n- \\nSpecific diseases and conditions:  tuberculosis, heart disease, chronic renal \\ndisease, epilepsy, diabetes mellitus, hypertension, asthma, psychiatric illness \\n- \\nSTIs/ HIV status:  if known \\n- \\nOther specific conditions depending on prevalence in the area: hepatitis, \\nmalaria, thalaseamia \\n- \\nAllergies:  food or drug \\n- \\nOperations other than caesarean sections: heart surgeries, surgeries for \\ngynaecolgical conditions \\n- \\nBlood transfusions: Rhesus (D) antibodies \\n- \\nCurrent use of medicines: specify \\n- \\nPeriod(s) of infertility: Duration, cause(s) treatments etc'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 60}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n48 \\n \\nHistory of present pregnancy \\n \\n- \\nDate of commencement of last menstrual period (LMP) \\n- \\nCertainty of dates: by regularity, accuracy of recall and other relevant \\ninformation \\n- \\nAny unexpected event: pain, vaginal bleeding, other- specify \\n- \\nHistory of malaria attacks \\n- \\nContraceptive history: method used, when it was started, when it was stopped, \\nmethod failure or not \\n \\nFamily history (blood relatives) \\n \\n- \\nDiabetes Mellitus, Hypertension, Twins, Congenital abnormalities \\n \\nObstetric history \\nPrevious pregnancies (Review all the available records, diagnosis cards, clinic records)  \\n \\n- \\nNumber of previous pregnancies \\n- \\nDate (month, year), place of delivery  and outcome of each event (live birth, \\nstillbirth, abortion, ectopic, hydatidiform mole) - Specify and validate with \\navailable documents  \\n- \\nPreterm births and types of abortion: If applicable and possible \\n- \\nBirth weight (if known)  \\n- \\nSex and age of the living children \\n \\nSpecial maternal complications and events in previous pregnancies (specify which \\npregnancy/ ies validate by records (if possible):  \\n \\n- \\nRecurrent early abortion \\n- \\nInduced abortion and any associated complications \\n- \\nGestational diabetes \\n- \\nHypertension, pre-eclampsia or eclampsia \\n- \\nPlacental abruption \\n- \\nPlacenta praevia \\n- \\nBreech or transverse presentation \\n- \\nObstructed labour, including dystocia \\n- \\nThird-degree tears \\n- \\nExcessive bleeding (antepartum or postpartum) \\n- \\nPuerperal sepsis \\n \\nObstetrical interventions: \\n \\n- \\nCaesarean section (indication, if known) \\n- \\nForceps or vacuum extraction \\n- \\nManual/instrumental help in vaginal breech delivery \\n- \\nManual removal of the placenta'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 61}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n49 \\n \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies  \\nspecify which pregnancy/- ies, validate by records (if possible): \\n \\n- \\nTwins  \\n- \\nHigher order multiples \\n- \\nLow birth weight: <2500 g \\n- \\nMalformed or chromosomally abnormal child \\n- \\nMacrosomic (>3500g) newborn \\n- \\nResuscitation or other treatment of newborn \\n- \\nPerinatal, neonatal or infant death (also: later death) \\n- \\nIUGR \\n- \\nRhesus antibody affection (Erythro blastosis, hydrops fetalis) \\n- \\nSCBU or NICU admissions \\n \\nb) Perform physical examination ) \\n \\n- \\nAssess the personnel hygiene \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, \\nconjunctiva, oral mucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema- ankles, fingers, face, and abdomen \\n- \\nDo a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities (spine, pelvic and limbs),  icterus, clubbing, cyanosis \\n- \\nBreast examination: masses, changes in the skin, nipple  \\n- \\nAbdominal examination – masses, tenderness, palpable uterus (compare with \\nthe POA) \\n \\n \\n \\nc) Investigations \\n \\n- \\nCheck urine for glucose and/or proteins if indicated (PIH, hypertension, renal \\ndisease, diabetes) \\n \\nd) Referral for antenatal care \\n \\n- \\nDetermine the expected date of delivery based on LMP and all other relevant \\ninformation. Use 280-day rule (LRMP + 280 days). Some women will refer to \\nthe date of the first missed period when asked about LMP, which may lead to \\nmiscalculation of term by four weeks. \\nEg. Last LRMP: 23rd March 2010   EDD 30th December 2010 \\n- \\nGive an appointment for antenatal clinic care \\n  \\nf) Advice, questions and answers, and scheduling the next appointment \\n \\n- \\nIf new risk factors identified refer to ANC as early as possible (when 1st home \\nvisit after first clinic visit). \\n- \\nGive advice on safe sex. Emphasize the risk of acquiring or transmitting HIV \\nor STIs.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 62}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n50 \\n \\n- \\nAdvise women to stop the use of tobacco (both smoking and chewing), \\nalcohol and other harmful substances. Advice to avoid passive smoking. \\n- \\nAdvice on management of abdominal pain, urinary tract infections and minor \\ndiscomforts during pregnancy, personal hygiene, physical and mental rest and \\nsleep. \\n- \\nAdvice on how to prevent infectious diseases. (use cool boiled  water, hard \\nwashing etc). \\n- \\nAdvice all the family members on family support needed during pregnancy. \\n- \\nAdvice to increase fluid intake, how to prepare a balanced nutritious diet. \\n- \\nExplain the signs and symptoms and actions to be taken in the case of ectopic \\npregnancy or an abortion. \\n- \\nGive advice on whom to call or where to go in case of bleeding, abdominal \\npain and any other emergency, or when in need of other advice. \\n- \\nEmphasis the need of continuation of treatment for medical conditions. \\n- \\nGive advice on how to contact PHM in an emergency (mobile numbers, place \\nof the office and residence). \\n- \\nRequest the woman to record when she notes the first fetal movement. \\n- \\nDiscuss with the woman and the family regarding the importance of \\nmaintaining the good mental status during pregnancy.  \\n- \\nDiscuss with the woman and the husband (or a family member) on the \\nimportance of attending antenatal clinics and antenatal classes. So that they \\ncan be involved in the activities and can learn how to support the woman \\nthrough her pregnancy. \\n- \\nIntroduce the relevant reading material (guide to pregnant mothers, five \\nbooklets on breast feeding, booklets on ECCD) to the pregnant woman and the \\nfamily. \\n \\nSchedule next appointment:  \\n \\n- \\nGive them a date for first antenatal class \\n- \\nMake arrangements for the second home visit, at (or close to) 22 -24 weeks: \\nstate date and hour. This should be written in the pregnancy record (H512) A \\nand B.  \\n- \\nGive a date for the first antenatal clinic visit if she has not gone yet. \\n- \\nAsk her to come to the clinic or inform PHM if there is any problem.  \\n- \\nInform her the dates of the clinic sessions and the dates and place of weighing \\n(children) in the village where she can meet the PHM. \\n \\nh) Maintain complete records \\n \\n- \\nComplete 512 A, B and the diary \\n- \\nIssue properly filled a H512 (pregnancy record) to the mother and explain her \\nand family importance of it and how to self assess the weight gain using \\nweight gain chart and growth of the fetus using SFH chart \\n- \\nAdvise her to bring pregnancy record with her to all appointments she may \\nhave with any health services'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 63}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n51 \\n \\nHome visit 2 (22 -24 weeks) \\nObjectives: \\n1. To access the progression of the pregnancy \\n2. To help the pregnant woman and the family to deal with the pregnancy \\n3. To advice the family regarding birth plan and emergency plan \\n4. To help the family to prepare for the delivery and newborn \\nAsk: \\n- \\nFor any complains  \\n- \\nWhether she feels fetal movements, if she feels, record first date of quickening and see \\nwhether it is compatible with her POA \\n- \\nAbout her mental wellbeing ( happiness, support from the family members)    \\n- \\nAbout the diet, intake of vitamins, worm treatment and immunization ( Tetanus toxoid)    \\n- \\nAbout the rest, sleep, daily activities done at home \\n- \\nFor any physical discomforts: Headache, dysuria, vaginal discharges, any discharges from \\nthe nipples, breast pain, vomiting and morning sickness \\n- \\nAbout the family support ( from the husband and other family members)  \\n- \\nAbout sexual activities \\n- \\nAbout the plans for delivery and emergency (hospital/ transport/ money/arrangements to \\ncare for the home and other children if any) \\n- \\nWhether  all the investigations are done (Grouping and Rh, Hb, VDRL, PPBS) \\n- \\nWhether she has attended for the referrals \\n \\nExamination: \\n \\n- \\nAssess the personnel hygiene \\n- \\nObserve any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath \\n- \\nLook for thyroid diseases, Dental hygiene, icterus, clubbing, cyanosis \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nAbdominal examination : feel for fundus , fundal height, fetal movements, fetal heart \\nsounds \\n- \\nCheck urine for sugar and protein: If needed (women with renal disease, hypertension, \\ndiabetes) \\n \\nInterventions and actions: \\n \\n- \\nEducate mother and care givers regarding danger signals during pregnancy \\n(antepartum haemorrhage, severe abdominal pain, severe headache), importance of \\nclinic visits, proper nutrition, monitoring of weight gain, working and mental well-\\nbeing during pregnancy, items to be taken to the hospital for the delivery, ECCD, rest \\nand sleeping'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 64}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n52 \\n \\n- \\nReferrals should be done if needed- anaemia, severe headache, difficulty in breathing, \\nother difficulties \\n- \\nEmphasis the need of continuation of treatment for medical conditions \\n- \\nCheck for compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nDiscuss with the family: place of delivery, actions to be taken in an emergency, \\narrangement for transport \\n- \\nGive an opportunity to discuss issues and ask questions \\n- \\nGive a date for third home visit \\n- \\nConfirm the attendance for antenatal class II \\n- \\nGive date and place for third antenatal class \\n- \\nMake records in 512 A, B , and in the diary  \\n \\n \\n \\nHome visit 3 (34- 36 weeks) \\nObjectives \\n1. To ensure the birth plan and preparedness for the hospitalization and delivery  \\n2. To help the family to welcome the new member \\n3. To ensure breast feeding, ECCD activities and family planning \\n \\nAsk: \\n- \\nFor any complains, physical discomforts  \\n- \\nWhether she feels fetal movements, and teach her how to maintain a kick count chart \\n- \\nAbout the support from the family \\n- \\nCheck the compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nAdvice and check to prepare the essential items for both mother and baby during \\nhospitalization including transport \\n- \\nAsk about the present illnesses, changes in the vulva, oedema and headache, varicose \\nveins, dysuria, difficulty in breathing \\n- \\nAsk about the advices given in the clinics and see whether she is complying \\n \\n \\nExamination: \\n- \\nAssess personnel hygiene \\n- \\nObserve for any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nExamine abdomen and assess the fundal height compare with POA, check the lie and \\npresentation \\n- \\nListen to fetal heart sounds \\n- \\nCheck urine for sugar and protein- If needed (women with renal disease, \\nhypertension, diabetes)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 65}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n53 \\n \\nInterventions and actions: \\n- \\nEducate and reconfirm what mother and care givers knew regarding signs of labour \\n \\n- \\nEnsure that all the items need for delivery and hospitalization are ready \\n \\n- \\nAware the mother regarding vaginal examination, lithotomy position, pain \\nmanagement,  delivery on to abdomen (skin to skin contact with the baby), \\nimportance of cooperation at the labour room, breathing exercises \\n \\n- \\nEducate mother and the family members about the labour, breast feeding, family \\nplanning, early childhood care development, obstetric emergencies: reduced fetal \\nmovements, antepartum haemorrhage, dribbling, severe headache, abdominal pain, \\nand actions to be taken if she experience any of those, new born care, post partum \\nmicronutrient supplementation, EDD and signs of labour  \\n \\n- \\nDiscuss with the family: actions to be taken during an emergency, transport \\narrangements in an emergency, care for other children while mother is in hospital, \\nfamily and social support after delivery \\n \\n- \\nDiscuss the breast feeding: including first feed, exclusive breast feeding, attachment, \\npositioning etc. and ensure that she has read the booklets on breast feeding \\n \\n- \\nInfection control: importance of limiting visitors, handling of baby, hand washing \\n \\n- \\nAdvice to prepare the home environment to welcome the newborn \\n \\n- \\nServices from the hospital: start breast feeding within the first hour of delivery and \\nexclusive breast feeding, BCG immunization, Vit. A mega dose, birth registration, \\npregnancy record to be returned, CHDR, neonatal examination by a MO  \\n \\n- \\nMethod to inform the PHM after delivery: telephone, messenger \\n \\n- \\nRefer to an appropriate health facility if needed  \\n \\n- \\nGive an opportunity to discuss issues and ask questions \\n \\n- \\nRecord the findings in the 512 A,B and complete the diary \\n \\n- \\nIf needed, complete LRT consent form \\n \\n- \\nIf they change the residence after delivery, ask them to inform the area PHM in the \\nnew residence  for postnatal care'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 66}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n54 \\n \\nChapter 7 \\n \\nDOMICILIARY CARE FOR HIGH RISK PREGNANCIES \\n \\nPlease note all the high risk pregnant women should receive the routine domiciliary care described in the previous chapter.\\nRisk condition \\nFrequency of \\nhome visits \\nAsk\\nExamine\\nRemarks\\nPast Obstetric History \\nPrevious still birth \\n(antenatal or \\nintrapartum) or \\nneonatal loss or \\ncongenitally \\nmalformed babies \\n \\n \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nevery 4 weeks  \\nAsk about fetal \\nmovement \\nInquire about the \\nother risk conditions \\neg. GDM, PIH \\n \\n \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 20 weeks \\n \\nMake aware on conditions which can cause still births \\nE.g. Gestational DM, Placenta abruption , cord round \\nthe neck etc \\nAscertain that blood sugar levels checked. \\nEducate on danger signals \\nAsk pregnant woman:   \\nto be more vigilant about fetal movements  \\nto pay special attention to KCC after 36 weeks \\nto get admit as early as possible if she experience \\nreduced fetal movements  \\nto get admit to hospital as early as possible if she gets a \\nsevere abdominal pain, bleeding per vagina. \\nReassure that it will not happened in consequent \\npregnancies \\nPlan for delivery and emergency  \\nRefer to post-partum clinic for neonatal examination \\nafter delivery'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 67}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n55 \\nHistory of 2 or more \\nconsecutive first \\ntrimester abortions \\nDuring first \\ntrimester, provide \\ndomiciliary care \\nin every 4 weeks. \\nAfter that if no \\nrisk conditions \\nidentified, routine \\nantenatal \\ndomiciliary care \\nInquire about vaginal \\nbleeding , abdominal \\npain \\nIf the reasons for the \\nabortions are other \\nmedical condition, \\nact according to the \\nadvice given. \\nRoutine examination\\nAsk her to get admit as early as possible if she \\nexperience abdominal pain or bleeding per vagina \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units  \\n \\nHistory of preterm \\ndelivery before 37 \\nweeks, or second \\ntrimester miscarriage \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nonce in 4 weeks \\nInquire about lower \\nabdominal pain or \\nvaginal bleeding \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 28 weeks \\n \\n \\nAsk her to avoid heavy work and get adequate rest\\nEnsure the family support for domestic work \\nAsk her to get admit as early as possible if she gets \\nlower abdominal pain or blood stained vaginal discharge \\nor per vaginal bleeding \\nAsk to prepare all the things need for the delivery  \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units \\n \\nHistory of PHI \\neclampsia/ \\npreeclampsia \\nIf high blood \\npressure is not \\ndetected in this \\npregnancy, \\nRoutine three \\nhome visits are \\nadequate. \\nAsk about headache, \\nvisual disturbances, \\nchest pain , shortness \\nof breath and \\nepigastric pain \\n \\nMeasure BP if possible\\nCheck urine for albumin \\nduring home visits. \\n \\n \\nEducate family members on signs and symptoms pre \\neclampsia \\nAsk her to get admit if she experience any of those \\nsymptoms \\nAsk  her to check blood pressure at least once a month \\nand maintain the records. \\nRefer to a doctor if BP is high or if albumin is present in \\nurine or any sign of pre eclampsia'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 68}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n56 \\nHistory of APH\\nRoutine three \\nhome visits are \\nadequate. \\nAsk about vaginal \\nbleeding and  \\nabdominal pain \\nAsk about shortness \\nof breath while \\nmoderate exercise \\n(features of anaemia) \\nSee whether USS has \\ndone to confirm the \\nplacental site \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are  available \\nExamine for signs of \\naneamia \\nEducate her to take nutritious iron rich diet.\\nAsk her to get admit as early as possible in case of \\nvaginal bleeding or abdominal pain. \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice. \\nHistory of retained \\nplacenta  or  history \\nof postpartum \\nhaemorrhage \\nRoutine three \\nhome visits are \\nadequate. \\nAsk for symptoms of \\nanaemia \\nLook for signs of \\nanaemia \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are available \\nHelp her and the family to decide on place of delivery \\n(place with CEMOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of caesarean \\nsection/ myomectomy\\nAfter 28 weeks, \\ndomiciliary care \\nshould be given \\nevery 4 weeks \\nAsk for abdominal \\npain, vaginal \\nbleeding, pain in the \\nscar \\nExamine for scar \\ntenderness \\nSee whether the USS is \\ndone to confirm the \\nplacental site \\nLook whether the Hb  \\nand blood grouping and \\nRh reports are available \\nAsk her to get admit if she experience abdominal pain, \\nvaginal bleeding and scar tenderness \\nIf so ask her to go to the hospital fasting due to \\npossibility of emergency section \\nHelp her and family to decide on place of delivery \\n(place with CEmOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of surgery on \\nreproductive tract \\n(removal of septum, \\ncone biopsy, large \\nloop excision of \\ntransformational \\nzones) \\nMonthly home \\nvisits from the \\nregistration \\nAsk for abdominal \\npain or  vaginal \\nbleeding  \\nExamine for tenderness \\nin the abdomen \\nSee whether intrauterine \\npregnancy is confirmed \\nAsk mother to get admit as early as possible if she \\nexperience severe abdominal pain during first trimester \\nAdvice to get a scan done to confirm intrauterine \\npregnancy \\nCheck the compliance on medical advice given in the \\nspecialized care unit'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 69}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n57 \\nBirth with birth \\nweight <2500g \\nMonthly home \\nvisits \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nAsk her to take balanced nutritious diet\\nAdvise on adequate rest. \\nEnsure the family support on domestic work \\nRefer to the clinic if SFH is less than POA \\n \\nBirth weight > 3500g\\nRoutine home \\nvisits are \\nadequate, if there \\nis no additional \\ncomplication \\nInquire about the \\nGestational DM \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nCheck urine for glucose \\nduring home visit \\nRefer to the clinic if SFH is  more than POA  for USS\\nCheck whether screening for GDM has done  \\nHelp mother to decide on place of delivery( with \\nCEMOC facilities) \\nKick count chart after 36 weeks \\nHistory of IUGR\\nMonthly home \\nvisits \\nAsk for fetal \\nmovements \\nAsk for other risk \\nconditions (PIH) \\nAsk for chronic \\ndiseases and \\nfrequently occurring \\nconditions \\nMeasure SFH \\nMeasure BP if possible \\nCheck maternal weight \\ngain \\nCheck for FHS \\nReassure mother \\nIdentify nutritional problems and intervene \\nEnsure family support and adequate rest at home \\nInquire about the type of household work engaged in \\nRefer to the clinic if SFH is less than POA \\n \\nFeeding difficulties/ \\nhistory of breast \\nsurgery \\nMonthly visits \\nduring last \\ntrimester \\n \\n \\n \\nAdvice on breast feeding technique , how to express \\nbreast milk and importance of  breast feeding'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 70}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n58 \\nPresent pregnancy \\nAge less than 20 \\nyears \\nIf she is less than \\n18 years monthly \\nhome visits \\nSee whether she has \\ngone to a specialized \\nunit \\nEnsure the antenatal clinic care\\nEnsure the help from the family or neighbours  \\nDiscuss the care during postnatal period  \\nDiscus about postpartum family planning \\nDiscuss about Breast Feeding  \\nAdvanced maternal \\nage (Age> 35 years) \\nIf mother is more \\nthan 40 years and \\na primi need \\nmonthly home \\nvisits. For others \\nroutine three \\nvisits are \\nadequate \\nAsk for risk \\nconditions \\n(hypertension, \\ndiabetes Mellitus) \\nAsk for fetal \\nmovements \\nMeasure BP if possible\\n \\nCheck for SFH, FHS \\n \\nCheck whether \\nscreening for GDM has \\ndone \\n \\nExplain her about the risk of chromosomal \\nabnormalities, first trimester miscarriages associate with \\nthe age \\nAsk her to be more vigilant on fetal movements after 36 \\nweeks \\nAsk her to admit as early as possible if she experience \\nreduced fetal movements \\nHelp her to decide on place of delivery with CEmOC \\nfacilities \\nHeight< 145cm\\n \\n \\nRoutine three \\nvisits are \\nadequate \\nSee whether she has \\ngone for pelvic \\nassessment to a \\nspecialized unit during \\nthe third trimester \\nExplain her and family members about the process of \\nlabour \\nHelp her to decide the place of delivery with CEmOC \\nfacilities. \\nBMI <18.5kg/m2 \\nMonthly home \\nvisits until the \\nweight gain is \\nadequate \\naccording to BMI \\nCheck whether mother \\nis taking balanced \\nnutritious diet \\nAsk her to take a balanced nutritious diet\\nAssess the level of physical activity and if she is \\ncarrying out heavy work, discuss with her how to reduce \\nthat kind of work. \\nEnsure the help of the family and adequate rest'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 71}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n59 \\nBMI > 30kg/m2\\nMonthly home \\nvisits \\nAsk for other risk \\nconditions such as \\nHypertension, PIH, \\nGDM \\nCheck whether \\nscreening for GDM has \\ndone \\nMeasure BP if possible \\nMeasure SFH \\nLook for lie and \\npresentation after 36 \\nweeks \\nRefer to the clinic if SFH>POA\\nAdvice on dietary habits- low fat/ carbohydrates \\nExplain  the risks of obesity/ overweight \\nAsk her to check blood pressure regularly \\n \\nPrimigravida\\nRoutine three \\nvisits are \\nadequate \\nCheck for lie \\npresentation and head \\nengagement after 32 \\nweeks \\nEducate on labour , labour pains, environment of the \\nlabour room \\nEnsure the family support \\nAdvise on the items to be taken to the hospital.  \\nEducate on breast feeding and BF techniques \\nParity (5 or more)\\nMonthly visits\\nAsk about the social \\nproblems (GBV, \\npoverty, low \\neducational level) \\nAsk about the \\nsymptoms of anaemia\\nCheck whether the Hb \\nreport is available \\n \\nAsk her to get admit as soon as possible even with slight \\nlower abdominal pain closer to delivery \\nHelp the her decide the place of delivery with EMOC \\nfacilities \\nDiscuss about the family planning method \\nEnsure the family support and arrangements for other \\nchildren \\nMultiple pregnancy\\nMonthly up to \\nsecond trimester \\nand two weekly \\nduring third \\ntrimester \\nAsk about the \\nvomiting and other \\nsymptoms of \\npregnancy during \\nfirst trimester \\nAsk about the \\nCheck whether the Hb \\nreport is available \\nCheck whether mother \\nhas gone to a specialized \\nunit \\nMeasure BP if possible \\nExplain her about risk of having preterm labour and ask \\nto get admit as early as possible if she experiences any \\nlower abdominal pain close to term. \\nExplain her about risk of PIH associated with multiple \\npregnancies and asked to BP checked regularly \\nAsk her to go to a specialized unit in case of an'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 72}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n60 \\nsymptoms of anaemia\\nAsk about other risk \\nconditions (PIH) \\n \\n \\nemergency\\nAdvice on technique of  breast feeding both babies \\n simultaneously \\nAdvice on family planning methods \\nAdvice on how to care twins \\nEmphasis on family support which is very much needed \\nafter delivery  \\nDiastolic BP more \\nthan 90mmhg \\nEvery two weeks \\nafter detecting \\nhigh blood \\npressure \\nAsk about severe \\nheadache , visual \\ndisturbances, chest \\npain and shortness of \\nbreath \\nAsk about fetal \\nmovements \\nMeasure BP if possible \\nCheck  urine for \\nalbumin  \\nCheck the compliance \\non antihypertensives and \\nthe advice given at the \\nclinic \\nCheck FHS \\nRefer to a medical officer  if BP is high or if urine for \\nalbumin is positive \\nAsk her to be fasting while getting admit to hospital in \\ncase of emergency \\nHelp her to decide on place of delivery with C EmOC \\nfacilities \\nEducate the family members regarding danger signals \\nand the actions to be taken in an emergency \\nUncertain dates / \\nirregular periods \\nOnce the dates \\nare corrected, \\nroutine three \\nhome visits are \\nadequate \\nAsk about previously \\nused family planning \\nmethod  method used, \\nwhen did it stop, how \\nlong she has used it,) \\nCheck whether she has \\ngone for dating scan \\nRefer for a dating scan before 20 weeks of POA\\nAsk mother to be more vigilant on date of quickening \\n \\n \\nIntra uterine growth \\nretardation \\n \\n \\nHome visits \\nshould be done \\nevery two weeks \\nonce IUGR is \\ndetected \\nAsk for fetal \\nmovements \\nCheck whether dating \\nscan is done \\nMeasure SFH \\nCheck FHS  \\nCheck the maternal \\nweight gain \\nRefer to specialized clinic for accurate dating and \\nregular USS with growth charts \\nAsk mother to be more vigilant on fetal movements \\nEnsure the adequate rest \\nEnsure that the advice given by the clinics is followed.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 73}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n61 \\nMal-presentation and \\nabnormal lie after 34 \\nweeks \\nHome visits every \\n2 weeks \\nReassure mother \\nRefer to specialized unit \\nVaginal bleeding (any \\ntime) \\nAsk mother to get admit to hospital as early as possible\\nMaternal jaundice \\nAsk mother to get admit to hospital as early as possible \\nMaternal anaemia \\n(Hb 7- 11g/dl) \\nMonthly home \\nvisits until the Hb \\nlevel is normal \\nAsk about the \\nsymptoms of anaemia \\n \\nCheck whether warm \\ntreatment are taken \\nCheck the compliance of \\niron therapy \\nAsk mother to get Hb checked until the levels normal\\nEducate on taking iron rich diet \\nEducate on side effects of iron therapy  \\nGive advice on micronutrients and diet \\nSevere maternal \\nanaemia (Hb < 7 g/dl)\\nTwo weekly \\nhome visits until \\nthe Hb levels \\nnormal \\nAsk about the \\nsymptoms of anaemia\\nCheck the compliance \\non advice given \\nRefer to a specialized unit for correction\\nGive advice on micronutrients and diet \\nMaternal malaria\\nTwo weekly \\nhome visits until \\nthe condition \\nresolved \\nCheck the use of bed \\nnets/ insecticide \\nimpregnated bed nets \\nCheck the compliance \\non malaria prophylaxis \\ntreatment \\nRefer to nearest hospital medical unit\\nAdvise to use insecticide impregnated bed nets \\nEnsure the malaria prophylaxis treatment \\n \\n \\nMaternal syphilis \\nMonthly home \\nvisits  \\nAsk about symptoms \\nof other STIs (vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance \\non the drugs given \\nRefer to the STD clinic as early as possible\\nCheck the compliance on advice given \\nEducate on safe sex practices \\nAdvice to get her partner screened for syphilis \\nEnsure the confidentiality of the information.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 74}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n62 \\nMaternal HIV\\nMonthly home \\nvisits \\nAsk about symptoms \\nof other STIs(vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance of \\ndrugs given. \\nRefer to the STD clinic \\nAdvice to get her partner screened \\nCheck the compliance on advice and treatment given \\nExplain the mother the risk of transmitting the HIV \\ninfection to the baby is very low when mother is on \\ntreatment for HIV \\nDiscuss on Breast feeding \\nRefer to the MOH for further information   \\nOther risk conditions \\nDiabetes Mellitus\\n \\nHome visits  in \\nevery two weeks \\nAsk for fetal \\nmovements \\nCheck urine for sugar \\nCheck for FHS \\nMonitor maternal \\nweight gain \\nMeasure SFH \\nCheck the compliance \\nwith medical advice \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nAsk mother to mark kick count chart after 36 weeks  \\nAsk mother to get admit as early as possible if she \\nexperience reduced fetal movements \\nEducate mother and family members on co- infections \\neg:UTI, fungal infections \\nHelp to plan the delivery in a CEmOC facility \\nLiver disease and \\nrenal disease \\nHome visits in \\nevery two weeks \\nLook for oedema (facial, \\nfinger, and abdomen) \\nLook for jaundice, \\nitching, clubbing etc. \\nCheck urine for proteins \\nMeasure BP if possible \\nMonitor maternal \\nweight gain \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nDelivery in a CEmOC facility'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 75}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n63 \\nRheumatic and \\ncongenital heart \\ndiseases \\nHome visits in \\nevery two weeks \\nAsk for shortness of \\nbreath with exertion \\neg. Climbing stairs \\nAsk for dyspnoea on \\nlying down  \\nAsk whether she need \\ntwo or more pillows \\nfor sleeping \\nLook for features of \\nheart disease( ankle \\nodema, elevated JVP) \\n \\n \\nAdvice to restrict work as advised by cardiologist/ VOG\\nDiscuss about Family Planning \\nDelivery in a CEmOC facility \\n \\nEpilepsy\\nMonthly home \\nvisits \\nAsk for the details of \\nlast attack \\nLook for drug \\ncompliance and places \\nthat can endanger life in \\nthe home environment \\neg: unprotected wells , \\nfloor level fire places \\nAdvice family members on what to do during an \\nepileptic attack, to take necessary precautions \\nExplain  the family members on importance of \\ncompliance on drugs \\n \\nMental disorders \\nMonthly home \\nvisits \\nCheck compliance of \\ndrugs \\nEducate on family members on the disease and advice \\non family support \\nAsk family members to seek medical advice in case of a \\nbehavioural change of the mother \\nExplain that drugs can be used even during breast \\nfeeding and not harmful for the baby \\nExplain family members that mental disorders can be \\naggravated during post-partum period and to be more \\ncautious \\nEducate family members on postpartum psychological \\ndisorders'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 76}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n64 \\nAsthma\\nMonthly home \\nvisits \\nAsk for shortness of \\nbreath \\nCheck respiratory rate\\nExamine breathing \\nsounds if possible \\nCheck the compliance of \\ndrugs/ inhalers \\n \\nEducate family members on importance of drug \\ncompliance \\n \\nRh negative mother\\nRoutine three \\nhome visits are \\nadequate \\nAsk for fetal \\nmovements \\nCheck whether the \\nscreening for Rh \\nantibodies is done  \\n \\nEducate mother on RhOGUM after delivery\\n \\nSubfertility\\n(Failure of a couple to \\nconceive with one \\nyear of regular \\nintercourse) \\nMonthly home \\nvisits \\nAsk for any \\nabdominal pain , per \\nvaginal bleeding \\nAsk for fetal \\nmovements \\nCheck for SFH, FHS\\n \\nAsk mother to get admit as early as possible to a \\nhospital with EMOC facilities in case of an emergency. \\nAsk mother to be more vigilant on fetal movements \\nSocial problems\\nUnmarried/ widows/ \\nseparated (single \\nmother) \\n \\nMonthly\\nAsk for social  \\nproblems \\nHelp them to face the social stigma\\nEnsure the proper antenatal care \\nIntroduce a postpartum family planning method \\nExtreme poverty/ \\ngeographical \\ndifficulties, gender \\nbased violence, \\nalcoholic partner etc. \\nMonthly\\nAsk whether she is \\ngetting any \\ngovernment \\nallowances \\n(samurdhi) \\nHelp them to get social support and support from special \\nprograms with GramaNiladari and other relevant \\nofficials \\nIntroduce a postpartum family planning method'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 77}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n65 \\n \\nChapter 08 \\nDEVELOPING A BIRTH AND EMERGENCY PLAN \\n \\nExplain why birth in a facility is recommended \\n\\uf0a7 Any complication can develop during delivery and they are not predictable. \\n\\uf0a7 A facility has staff, equipment, supplies and drugs to provide best care if needed, and a \\nreferral system. \\n\\uf0a7 If HIV- positive she will need appropriate ARV treatment, for herself and her baby \\nduring childbirth. Complications are more common in HIV-positive women and her \\nnewborns. HIV-positive women should deliver in s facility. \\n \\nAdvice how to prepare \\nReview the arrangements for delivery: \\n\\uf0a7 Where will she go to get treatment for an emergency or delivery? \\n\\uf0a7 How will she get there?  \\n\\uf0a7 How much will it cost to go to the facility? How will she pay for transport ? \\n\\uf0a7 Can she start saving straight away? \\n\\uf0a7 Who will go with her to the hospital? \\n\\uf0a7 Who will help while she is away to care for her home and other children? \\n\\uf0a7 Who to inform in an emergency? \\n \\nAdvise when to go \\n\\uf0a7 If the mother lives near the facility, she should go at the first signs of labour.or dange \\nsignal \\n\\uf0a7 If living far from the facility, she should go 2-3 weeks before baby due date and stay \\neither at the maternity waiting home or with family or friends near the facility. \\n\\uf0a7 Advise to ask for help from the community, if needed. \\n \\n Advise what to bring \\n\\uf0a7 Pregnancy record. \\n\\uf0a7 Clean clothes for drying and wrapping the baby. \\n\\uf0a7 Adequate amount of sanitary pads after birth. \\n\\uf0a7 Cloths for mother and baby. \\n\\uf0a7 Food and water for mother and support person.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 78}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n66 \\n \\nHome delivery in an emergency or due to unavoidable circumstances \\nReinforce the importance of delivery in a health institution. \\nInstruct mother and family on clean and safer delivery at home \\nIf the mother has to deliver at home due to emergency or unavoidable circumstances, review \\nthese simple instructions with the woman and family members. \\nTell her / them to try their best to get down a skilled birth attendant (institutional midwife/ \\nPHM/midwifery qualified nurse or a medical officer) \\n\\uf0a7 To ensure a clean delivery surface for the birth. \\n\\uf0a7 To ensure that the birth attendant should wash her hands with clean water and soap \\nbefore/after touching mother / baby. She should also keep her nails clean. \\n\\uf0a7 To place the baby on the mother’s chest with skin-to skin contact and wipe the baby’s \\neyes using a clean cloth for each eye, after delivery, \\n\\uf0a7 To cover the mother and the baby with a clean cloth. \\n\\uf0a7 To use boiled new blade and a boiled cord to tie and cut the cord. The cord is cut when it \\nstops pulsating. \\n\\uf0a7 To dry the baby after cutting the cord. To wipe clean but not bathe the baby until after 6 \\nhours. \\n\\uf0a7 To wait for the placenta to deliver on its own. \\n\\uf0a7 To start breastfeeding when the baby shows signs of readiness, within the first hour after \\nbirth. \\n\\uf0a7 To NOT leave the mother alone for the first 24 hours. \\n\\uf0a7 To keep the mother and baby warm. To dress or wrap the baby, including baby’s head. \\n\\uf0a7 To dispose of the placenta in a correct, safe and culturally appropriate manner (burn or \\nburry). \\n \\nAdvise to avoid harmful practices \\nFor example: \\nNOT to use local medications to hasten labour. \\nNOT to wait for waters to stop before going to health facility. \\nNOT to insert any substances into the vagina during labour or after delivery. \\nNOT to push on the abdomen during labour or delivery. \\nNOT to pull on the cord to deliver the placenta. \\nNOT to put ashes, cow dung or other substances on umbilical cord /stump.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 79}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n67 \\n \\nAdvise on danger signs \\nIf the mother or baby has any of these signs, she/they must go to the hospital immediately, day \\nor night, WITHOUT waiting \\n \\nMother \\n\\uf0a7 Waters break and not in labour after 6 hours. \\n\\uf0a7 Labour pains / contractions continue for more than 12 hours. \\n\\uf0a7 Heavy bleeding after delivery (pad/cloth soaked in less than 5 minutes). \\n\\uf0a7 Bleeding increases. \\n\\uf0a7 Placenta not expelled 1 hour after birth of the baby. \\n \\nBaby \\n\\uf0a7 Very small \\n\\uf0a7 Difficulty in breathing \\n\\uf0a7 Fits \\n\\uf0a7 Fever \\n\\uf0a7 Feels cold \\n\\uf0a7 Bleeding \\n\\uf0a7 Not able to feed'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 80}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n68 \\n \\nChapter 09 \\nANTENATAL CLASSES \\nIn this maternal care model, health promotion and education of pregnant women regarding \\npregnancy and related topics is carried out during clinic sessions as group education, \\nopportunistic education during clinic visits and home visits and in the antenatal classes for \\ncouples.  \\nObjectives of the antental classes: \\n1. To educate the pregnant women and their husbands/families on topics related to \\npregnancy, child birth, postnatal care and childcare \\n2. To improve the male participation in maternal care \\n3. To give an opportunity to alleviate the doubts on pregnancy related issues \\n4. To improve the community participation in maternal care \\n5. To change the parenting behavior to fulfill the needs of the child \\n \\nGuideline for conducting antenatal classes \\n1. All pregnant women should be participated in three antenatal classes during pregnancy \\n(one per each trimester) with her husband.  \\n2. All the women participating in a class should be in a same trimester eg. All are in first \\ntrimester or all are in second trimester. \\nAntenatal class 1 – for pregnant women in first trimester \\nAntenatal class 2 – for pregnant women in second trimester \\nAntenatal  class 3 – for pregnant women in third trimester \\n3. The topics/ issues discussed in each class should be related to the trimester of the \\npregnancy of the participants. \\n4. PHM should be kept notes in the relevant cage in the pregnancy record regarding the \\nparticipation. \\n5. Antenatal classes should be conducted once a month at the level of PHI area or 3-4 PHM \\nareas together (depending on the number of pregnant mothers in a PHM area). \\n6. A class for a trimester can be organized once in three months to cover all the mothers. \\nEg.  \\nJanuary – Antenatal class 1 \\n \\nFebruary- Antenatal class 2 \\n \\nMarch - Antenatal class 3 \\nApril - Antenatal class 1 …………so on \\n \\nJanuary\\nFeb\\nMarch\\nApril\\nMay\\nJune\\nJuly\\nAugust\\nClass1 \\nClass 2 \\nClass 3 \\nClass 1 \\nClass 2 \\nClass3 \\nClass1 \\nClass 2'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 81}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n69 \\n \\n7. For couples who are unable to attend to classes, arrangement should be made to attend to \\nthe classes at the nearest area. \\n8. The annual plan for antenatal classes should be display in the clinic centres with the \\nvenue, date and time. \\n9. The annual plan for the MOH should be displayed with the annual clinic plan. \\n10. Relevant area PHMM should be organized the classes with the help of the area PHI. \\n11. The lectures and the other activities should be carried out by the PHI and PHMM \\naccording to the guide given. MOMCH, MOH, PHNS, SPHM, HEO or other relevant \\nofficers can be used as special resource persons.   \\n12. MOH, PHNS and SPHM should be supervised the sessions and should be guided them to \\nimprove the quality of the classes. \\n13. All mothers should get breast feeding booklets, guide for pregnant mothers and ECCD \\nbooklets to read. \\n14. Develop a small questionnaire and give it to the couples at the end of the session to assess \\nthe output. \\n15. The places to conduct the classes should be selected from the area eg. Clninic centres, \\ntemples, community centres etc. The recourses to treat the participants should be \\norganized with the community participation. \\n16. Other than the above mentioned facts, there is an enough room for your innovative ideas \\nto improve the quality of the antenatal classes. \\n \\n \\nProposed topics for antenatal classes \\nAntenatal class I: \\n1. Objectives of the antenatal classes \\n2. Activity to identify the participants \\n3. Development of the feotus \\n4. Antenatal care \\n5. Risk conditions and  danger signals during first and second trimesters and emergency \\npreparedness \\n6. Nutrition of the pregnant woman \\n7. Minor discomforts during  first and second trimesters and management of them at home \\n8. Prevention of mother to child transmission of HIV and other sexually transmitted \\ndiseases \\n9. Importance of good oral hygiene during pregnancy \\n10. General wellbeing during pregnancy \\n11. Introduction to the hand book on maternal care (Nirogimath daruparapurak udesa…..)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 82}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n70 \\n \\nAntenatal class II: \\n1. Nutrition during pregnancy II \\n2. Risk conditions and  danger signals during second and third trimesters and emergency \\npreparedness \\n3. Minor discomforts during  second and third trimesters and management of them at \\nhome \\n4. Introduction to breast feeding (importance) \\n5. Early Childhood Development and Care (ECCD) \\n6. Maintenance of correct posture during pregnancy \\n7. Preparation for delivery and newborn  \\n8. Any other topic relevant to the area eg. Prevention of alcoholism, gender based \\nviolence, money and time management \\n \\nAntenatal class III: \\n1. Nutrition during lactation \\n2. Labour signs and symptoms \\n3. Risk conditions and  danger signals during third trimester and postpartum period and \\nemergency preparedness \\n4. Minor discomforts during  third trimester and postpartum period and management of \\nthem at home \\n5. Breast feeding (technique and support from the family) \\n6. Early Childhood Development and Care (ECCD) \\n7. Maintenance of correct posture during pregnancy and postpartum period \\n8. Postpartum Family Planning \\n9. Care for the newborn baby'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 83}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n71 \\n \\nChapter 10 \\n \\nCLINICAL PROCEDURES FOR ANTENATAL CARE \\n \\n \\n10.1   Anthropometric assessment of pregnant women \\nMeasuring weight at the clinic setting \\nThe weighing scale should be placed on a smooth, leveled surface. \\nBefore weighing, the person should be asked to remove slippers, heavy clothes, handbags and \\nany other heavy item (keys, coins etc.) with them. \\nThe reading of the scale should be checked and it was adjusted to ‘0’. \\nThen the person should be asked to step onto the scale. It should be made sure that: \\n\\uf0b7 Person stands upright, with her arms hanging loosely at sides. \\n\\uf0b7 Person looked straight ahead and not moving \\n \\nReading of the scale display should be noted down to the nearest 0.1kg when it stopped \\nchanging.  \\n \\nMeasuring height at the clinic setting \\nMicrotoise tape should be used to measure the height. \\nMicrotoise should be set up against a wall in full length. \\nAsk the mother to remove slippers and stand against the wall as straight as she can. \\nLook at the person from the front and made sure that she is under the Microtoise meter and \\nkeeping the feet slightly apart. \\nLook at the person from the side and make sure that her back of the head, shoulders, buttocks \\nand her heels are touching the wall. \\nLower the head piece of Microtoise until it hits firmly on the top of the head and made sure that \\nit touched the head and not the hair. \\nThe reading should be taken to the nearest 0.5cm.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 84}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n72 \\n \\n \\nCalculation of the Body Mass Index (BMI) \\nBMI = Weight (Kg) \\n \\n \\nHeight (m2) \\nInstead of calculating BMI, field health care workers can use the BMI chart or BMI wheel, \\nwhich gives BMI comparing weight and height. For pregnant mothers BMI should be calculated \\nbefore 12 weeks, ideally at the booking visit around 6-8 weeks.  \\nInterpretation of BMI \\n<18.5 kg/m2\\nUnder nutrition\\n18.5 – 24.9 kg/m2 \\nNormal \\n25 – 29.9 kg/m2 \\nOver weight \\n≥ 30 kg/m2 \\n \\nObese \\n \\nMonitoring of weight gain during pregnancy \\nMonitoring of the weight gain during pregnancy depend on the BMI during the booking visit/ \\nfirst trimester. Expected weight gains according to the BMI as follows: \\n \\nBMI (kg/m2) \\nExpected Weight Gain in kg \\n<18.5 ( underweight ) \\n12.5-18 \\n18.5-24.9 kg/m2 ( Normal)\\n11.5-16\\n25-29.9 kg/m2 (over weight) \\n7.0-11.5 \\n>/= 30 kg/m2 (Obese) \\n< 6.8 \\n \\nMaternal weight gain should be recorded on the weight gain chart in the pregnancy record.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 85}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n73 \\n \\n \\nInstructions to maintain weight gain chart and graph \\n1. Fill in the following information regarding the mother at the first clinic visit  ( before 12 \\nweeks ) in the box located in the left upper corner of the graph: \\n\\uf0b7 Height \\n\\uf0b7 Weight at the first clinic visit ( before 12 weeks ) \\n\\uf0b7 BMI at the first clinic visit ( before 12 weeks ) \\nDuring the first visit no data to plot on the graph. \\n2. During subsequent clinic visits POA and weight should be recorded on the table and \\nweight gain should be calculated (by deducting the mother’s weight at the first clinic visit \\nfrom weight at the current clinic visit).  Then the weight gain should be plotted on the \\ngraph according to the POA. \\n3. Poor weight gain as well as the excessive weight gain should be identified timely and \\nrelevant interventions should be carried out. \\n4. Recommended weight gain \\n\\uf0b7 It is assumed that woman’s pre pregnancy BMI is more or less equal to the BMI \\nat her first clinic (before 12 weeks ) \\n\\uf0b7 For a woman with BMI less than 18.5kg/m2 during first 12 weeks, recommended \\nweight gain range is 12.5 – 18 kg. Her weight gain should be within the areas \\nshown as A & B in the weight gain chart. \\n\\uf0b7 For a woman with normal BMI (18.5 - 24.9kg/m2), recommended weight gain \\nrange is 11.5 – 16 kg. Her weight gain should be within the areas shown as B&C \\nin the weight gain chart. \\n\\uf0b7 For women who are overweight (BMI 25-29.9 kg/m2), recommended weight gain \\nrange is 7 – 11.5 kg (area C & D) while obese women (BMI ≥30kg/m2) should \\ngain weight less than 6.8 g (below area D).  \\n5. Once the infant is born fill the birth weight in the box shown in the right lower corner of \\nthe weight gain graph.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 86}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n74'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 87}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n75 \\n \\n10.2    Measuring blood pressure at the clinic setting \\nStandard mercury sphygmomanometer should be used with an adult cuff. An extra-large cuff \\nshould be available for obese women. \\nThe following procedure should be followed to measure blood pressure accurately. \\n1. Mothers should be asked to sit at a table quietly with both feet flat on the floor and with \\nthe back supported. The bladder should be empty. The room should be comfortable and \\nwith minimal noise. \\n2.  The bare right arm should be placed on the table (at heart level) slightly flexed, with the \\npalm upward. The examiner should be in a position to see the manometer at eye level. \\n3.  Arm circumference should be assessed. An appropriate cuff should be selected and \\nwrapped around the upper arm. The lower edge of the cuff should be 2.5 cm above the \\nelbow joint. \\n4. Wait 5 minutes. \\n5. Palpate the radial pulse and inflate to 30mm Hg above the level where radial pulse \\ndisappeared (Peak inflation level). Deflate the cuff. \\n6. Wait 30 seconds before re- inflating. \\n7. Inflate to peak inflation level. \\n8. Deflate at 2 mm Hg per second. \\n9. Record the systolic BP (first of at least two regular consecutive sounds). Record to the \\nnearest even number. \\n10. Record diastolic BP (the end of the last sound heard). Record to the nearest even number.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 88}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n76 \\n \\n10.3 Obstetric examination \\nThe abdominal examination \\nAlways make sure that the pregnant woman looks comfortable, is laying semi recumbent and has \\na sheet covering her waist and legs, which may be bare. You must examine from the woman’s \\nright side. Remember this order for examining the abdomen: Inspection, palpation and \\nauscultation. \\nInspection: \\n\\uf0b7 Assess shape and size of the uterus, and any obvious asymmetry of the abdomen; fetal \\nmovements. \\n\\uf0b7 Look for surgical scars: loins (kidney transplants); supra pubically (Caesarean sections, \\nectopic pregnancy); grid-iron (appendix); umbilicus (laparoscopy);midline(bowel or \\novarian operations) \\n\\uf0b7 Striae gravidarum (stretch marks) and linea nigra (pigmented vertical line running from \\numbilicus to symphisis pubis) are always commented. \\n \\nPalpation: \\nMeasuring SFH  \\nFirstly measure the fundal height by placing the ulnar border of the left hand gently at the fundus \\nof the uterus, and measuring with the tape in centimeters to the pubic symphysis (keep to 0 cm \\nend at the pubic sympysis). The measurement in cm should give an estimation of gestational age \\nin weeks, i.e. +/- 2 cm from 20 – 38 weeks. Plot the SFH in cm on the SFH chart in the \\npregnancy record according to the POA. \\nThen palpate fetal poles to determine presentation and lie (Fig.1.3b, c and d). When establishing \\nhead engagement in the third trimester, it is better to gently palpate with two hands pacing down \\nover the abdomen as pictured (Fig.1.3b) than to prod around with Paulik’s grip (Fig. 1.5), which \\nin non-experienced hands is painful. \\nTo establish the lie of the fetus, palpate gently using both hands as shown in figures 1.3c and 1.6.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 89}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n77'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 90}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n78 \\n  \\nIt is important to make eye contact with the woman while you are examining as you may be \\nhurting her by palpating too firmly. \\nAfter you have finished the uterus, gently palpate for kidney tenderness and liver and spleen \\nenlargement. \\nAuscultation: \\nFor a fetus with cephalic presentation, it is relatively easy to palpate the anterior shoulder and \\nlisten for the fetal heart at this point. You will obviously have to modify the position for \\nauscultation if the fetus is in the transverse or breech positions. \\nInternal examination: \\nA pelvic (vaginal examination) is not routinely performed unless specially indicated.  \\nTo perform a digital examination, commonly called vaginal examination (VE), or a speculum \\nexamination, ask your patient to lie comfortably on her back, usually with a slight tilt and the \\nknees drawn up with the ankles together. You should have asked her to remove her underwear, \\nand a sheet may be placed covering her abdomen and genitalia. The procedure should be \\nperformed in the presence of a female third party. Both hands should be gloved. \\nFor a digital examination, the labia are gently parted with the left hand, and index and forefinger \\nof the right hand gently introduced in to the vagina. They may be advanced until the cervix is \\npalpated. In later pregnancy, this will provide information on the length and consistency of the \\ncervix and this allows an assessment of favourability for induction of labour. \\nA digital vaginal examination should not be performed in the following circumstances; \\n\\uf0b7 with suspected placenta previa (risk of precipitated haemorrhage) \\n\\uf0b7 When there is prelabour rapture of membranes (risk of introducing infection) \\n\\uf0b7 When consent is withheld'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 91}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n79 \\n \\nA gentle speculum examination is less likely to introduce ascending infection, and may be used \\nto visualize the cervix in prelabour rupture of membranes, or even if a placenta previa is \\nsuspected. The same steps apply as above with the following adjustments: \\n\\uf0b7 Select an appropriate sized speculum; \\n\\uf0b7 The speculum should be pre-warmed to avoid the discomfort of cold metal; \\n\\uf0b7 Lubricating gel or water should be applied to the mouth of the speculum;  \\n\\uf0b7 The labia are parted with the left hand, and speculum held with the right; \\n\\uf0b7 The speculum is inserted through the introitus with the jaws in the vertical plain; it is \\ngently rotated while being advanced into the horizontal plane; \\n\\uf0b7 The speculum’s jaws are slowly opened once the speculum is advanced fully into the \\nvagina; \\n\\uf0b7 At this point, the ratchet nut can be tightened; \\n\\uf0b7 A light source should be at hand to enable easy visualization of the cervix and vaginal \\nwalls; \\n\\uf0b7 On removing the speculum, close the jaws gently and slowly to avoid catching vaginal \\nepithelium in them \\nSymphysio-Fundal Height Chart \\n \\nPOA'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 92}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n80 \\n \\n10. 4   Fetal Movement Chart or Kick count Chart \\nWhat is a kick count chart? \\nDuring the 1970’s, it was thought that the number of times a baby kicked each day would \\nindicate the baby’s wellness after birth. Thus, many women began to use a ‘kick chart’ or ‘kick \\ncount chart’. This is a simple chart that on which record the number and/ or intensity of kicks or \\nother movement that the baby makes. Kick chart try to provide guideline for how active a baby \\nshould be. \\nA kick count chart may be reassuring to a mother. Others may find kick charts time consuming, \\nbothersome and stressful, particularly if their baby doesn’t move much during the time they are \\ntrying to do the chart. \\nOne of the most common types of kick charts is called The ‘Cardiff count to ten’ method. With \\nthis method, mother should use an 8 to 12 hour period to record at least 10 of her baby’s \\nmovements. Mother should choose a time when she thinks her baby is most active. If baby has at \\nleast 10 movements within this 12 hour period they are thought to be well. If mother use this \\nmethod she should start timing at same time each day. Record the first time and should write it \\ndown on the graph. Count every movement or kick until the baby has moved 10 times. Write \\ndown the time after feeling the tenth movement. If mother feels more kicks at one moment \\nconsider it as a one  kick   \\nStart marking the kick count chart every day morning around 6.00am-8.00am \\n\\uf0b7 Write the time started clearly in the relevant place \\n\\uf0b7 Mark and pierce each box for each movement that baby makes \\n\\uf0b7 Write the time clearly after finishing of marking 10 boxes. \\n\\uf0b7 Contact a Medical Officer, Public Health Mid Wife or Nursing Officer if the baby is not \\nmoved for 10 times during 12 hours. \\n\\uf0b7 10 movements for a day is enough for the day. \\n\\uf0b7 The time period between 2 kicks should less than 3 hours \\n \\nFetal movement chart \\nName:                                                                         Age: \\nNo. of pregnancy:      \\nWeeks\\n 36\\n 37\\n38\\n39\\nDate\\nTime started\\n1 \\n2\\n3\\n4\\n5\\n6\\n7\\n8\\n9\\n10\\nTime \\nfinished'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 93}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n81 \\n         \\n10.5    Urine testing at the clinic setting \\n \\nUrine analysis using two para reagent strip \\nReagent strip is a dip and read test strip and intended for use as an in vitro diagnostic aid using \\nurine specimens. The strip contains solid phase reagent areas affixed to a plastic support and is \\nprovided in a dry reagent format. The strip provides qualitative and semi quantitative test for \\nglucose and protein by the visual comparison with colour charts of each concentration range.  \\nSpecimen collection \\nSpecimens were collected at the clinic. A clean, dry vessel was provided to collect the urine. \\nTests were done as soon as possible after collection.  \\nProcedure \\n1. Confirmed that the product was within the expiration date shown on the label \\n2. The strip was removed from the bottle and the cap was replaced immediately. \\n3. The strip was inspected for dis-colouration or darkening of reagent areas. Changes may \\nindicate deterioration. Such strips did not use. \\n4. The test strip was dipped completely for no more than 1 second in fresh, well mixed and \\nun-centrifuged urine specimen. The excessive urine was removed by touching the plastic \\nfilm on the rim of the vessel. \\n5. The test results were compared carefully with the colour chart on the bottle label in good \\nlight. \\n6. Proper reading time (30-60) seconds is critical for optimal results. \\n7. While comparing, to strip was kept in horizontal position to avoid possible interactions of \\nchemicals by excessive urine. Changes in colour that appeared only along the edges of \\nthe test areas or after more than two minutes were of no diagnostic significance.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 94}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n82 \\n \\nCoagulation test for protein \\nNecessary equipment:  Clean bottle, two test tubs, Spirit Lamp, Test tube holder, Acetic acid, \\nPipette \\nProcedure \\nCollect urine into a clean bottle and fill 2/3 of the test tube with collected urine  \\nHeat the upper part of the tube till urine gets boiled \\nIf the heated part gets cloudy, add 4 – 5 drops of acetic acid \\nHeat again. If the cloudiness disappears it is due to urinary phosphates and it is not significant. \\nIf the cloudiness continues it is due to urinary albumin.  \\nResults should be as follows. \\nNegative \\nTrace \\nPositives + 1 to + 4 \\nNormal result should be negative. \\n \\nBenedict’s test for urine sugar \\nNecessary equipment: as for the heat test and   Benedict’s reagent \\nProcedure: \\nPut 2.5 ml of Benedict’s solution to a test tube. \\nAdd 8 drops of urine. Heat this mixture for 2 minutes. \\nPut the tube in the test tube holder till the tube gets cooled. \\nThe colour of urine will change from green to brick red depending on the amount of sugar in \\nurine. \\nThe results should be as follows. \\nNegative – clear blue \\n If present – Green , Yellow, Orange, Brick red'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 95}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n83 \\n \\n10.6  Antenatal screening for syphilis: Guidelines for sample collection,                     \\nstorage and transportation \\nScreen all pregnant women for syphilis at the first antenatal visit preferably 6-8 weeks to prevent \\ncongenital infection. For high risk mothers, re- testing should be offered in the third trimester.  \\nRecord POA of screening, place of testing, testing results and treatment in the pregnancy record \\n(H512 A&B) \\nLaboratory testing facilities should be arranged in the nearest STD clinic/ government institution \\nwith the help of RDHS/MOMCH. \\nEducate all mothers and their partners of the importance of screening for syphilis during \\npregnancy to avoid adverse pregnancy outcomes. \\nVDRL test is the screening test use to screen for syphilis in the maternal care programme in Sri \\nLanka. It is carrying out as a joint activity with National STD AIDS control programme.  \\n \\nSample collection, storage and transportation \\n1. Blood drawing should be done by MOH, MO, RMO/AMO, PHNS or Nurse. If it is a \\nfield clinic, either MOH or PHNS should draw blood. When STD clinic team visit ANCs \\nfor blood drawing either MO/STD, nurse or MLT may draw blood. \\n \\n2. Disposable syringes should be used to draw blood and 5cc blood should be taken in to a \\ntube or a plane bottle.  Label the sample with reference number date and time of \\ncollection.  It should be kept in room temperature for at least 2 hours. \\n3. If it is sent within 12 hours to the laboratory no need to keep in the refrigerator or no need \\nto use special carriers for transportation. If not, keep the collected samples in the main \\ncompartment of the refrigerator and sent to the laboratory in a vaccine carrier within three \\ndays.  Given specimen forms should be used. There should be prior arrangement before \\nsending samples to STD lab. There should be a separate carrier for sample transportation. \\n4. In the STD laboratory if the test is not done on the same day serum should be separated \\nand can be kept maximally one month in the main compartment of the refrigerator.  (Not \\nin the freezer compartment) \\n5. Transport method will be either MOH vehicle or STD vehicle depending on the \\navailability and feasibility or else through a messenger.   \\n6. Result of the screening test will be conveyed to PHM through the MOH and positive \\ncases will be referred to STD clinic and confirmatory test will be done there.  Results of \\nthe confirmatory test will be conveyed to MOH and Syphillis confirmed mothers will be \\nfollowed up by MO/STD. \\n7. MOMCH and MO/STD should meet quarterly and discuss the matters related to antenatal \\nsyphillis screening.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 96}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n84 \\n \\n8. VDRL test will be the first choice for syphilis screening and in areas where facilities not \\navailable rapid test can be recommended by FHB and NSACP. \\n \\nMothers whose screening test is positive should be contacted and sent to STD clinic with a \\nproperly written referral letter. Confidentiality has to be maintained. When the mother is seen in \\nthe STD clinic a second sample will be collected for re-confirmation after counselling. If the \\nsecond sample is positive, the mother will be counseled and treated appropriately.  \\nIf the woman was not tested during pregnancy, syphilis screening should be offered after \\ndelivery (preferably using a rapid test).  \\n \\n10.7    Estimating Haemoglobin levels using a colour scale \\n1. Use only approved test strips for the colour scale. \\n2. Add a drop of blood to one end of a test strip just enough to cover completely an aperture \\nin the colour scale. \\n3. Wait about 30 seconds; then read immediately by comparing the blood stain with the \\nColour Scale to find the best colour match. \\n\\uf0b7 Keep the test strip close to the back of the Colour Scale \\n\\uf0b7 Avoid direct sunlight \\n\\uf0b7 Avoid marked shade \\n\\uf0b7 Avoid your own shadow or any other shadow \\n4. If the blood stain matches one of the shades of red exactly, record the haemoglobin value. \\nIf the colour lies between two shades, record the mid- value. If in doubt between two \\nshades, record the lower value. \\n5. Discard the test strip after use. Wipe the back surface of the Scale at the end of each \\nsession or if it became soiled during the use.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 97}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n85 \\n \\nChapter 11 \\nNUTRITION DURING PREGNANCY AND LACTATION \\n \\nNutrition during the preconception period as well as throughout the pregnancy has a profound \\ninfluence on the course and outcome of the pregnancy as well as mother’s performance during \\nlactation. The association between pre pregnancy weight and BMI, total weight gain and the rate \\nof weight gain in pregnancy and the pregnancy outcome is significant. Weight gain in the second \\nhalf (after 20 weeks) of pregnancy has more pronounced effect on the growth and the birth \\nweight of the baby. Poor weight gain especially in the third trimester is associated with low birth \\nweight of the baby.  \\n      Low birth weight is associated with a higher incidence of infant mortality and morbidity, poor \\ncognitive development and learning disabilities. They are also at a   higher risk of been \\nsubjected to the non-communicable disease such as heart disease, hypertension and diabetes \\nmellitus in later life. Thus , it appears future health of mankind depends to a greater extent on \\nthe nutritional foundation laid during the prenatal life. Therefore, nutrition of the pre pregnant \\nwomen as well as the pregnant mothers should receive utmost attention in order to have a baby \\nwith a good birth weight.  \\nNutrition and care during Pre pregnancy \\nPre pregnancy weight and BMI are strongly linked with the pregnancy outcome. Therefore, \\nnutrition and care of the pre pregnant woman is an essential component in the strategy for low \\nbirth weight reduction. The existing health care system offers following services to improve the \\nnutritional and health status of the pre pregnant woman. \\no Early identification of couples getting married and provision health services and \\nhealth education  \\no Registration of all eligible couples by PHM and provision of necessary services.  \\no Nutritional assessment and take necessary actions: \\n\\uf0b7 Check  Body Mass Index (BMI) do necessary interventions according to \\nthe BMI \\n\\uf0b7 Do Haemoglobin estimations and if anaemic, take necessary actions \\n \\nThe women who intend to become pregnant should be advised that their nutritional status should \\nbe optimal at the time of conception for a successful pregnancy.  \\nProvide Folic acid 5mg daily, for women who expecting a pregnancy. \\nAscertain that they have protected with Rubella immunization.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 98}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n86 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of pre-pregnant women with a BMI less than 18.5kg/m2\\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and \\nmicronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. \\n-Help to modify diet by increasing amount of starch based foods such as rice, \\nmanioc, other cereals, flour based foods at each meal \\n-Consuming 1-2 extra meals than other days \\n-Using 1-2 table spoonful of oil \\n \\n-Including fish/dried fish/egg, pulses, vegetables and green leaves to  \\n daily diet \\n\\uf0a7 Asses dietary habbits, food taboos, misconceptions and correct if there are any  \\nnegative one   \\n\\uf0a7 Excessive work load may have an influence on the weight gain. Therefore, assess the \\nworkload and act accordingly  \\n\\uf0a7 Screen for  the presence of any illnesses by referring to the MOH \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight gain is inadequate after 6 months refer to MOH for further advice.  \\nManagement of pre- pregnant women with BMI more than 24.9 kg/m2 \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy / excessive consumption of diet \\n(calorie, protein and micronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. ( to reduce starch, fats, & sugar ) \\n\\uf0a7 Emphasize the importance of  regular exercise \\n\\uf0a7 Assess dietary habits, food taboos, myths and misconceptions and correct if there \\nare any negative ones. \\n\\uf0a7 Should be screened for Diabetes Mellitus, Hypertension, Hypercholesteraemia by \\nreferring to the MOH. \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight reduction is inadequate after 6 months refer to MOH for further advice.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 99}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n87 \\n \\nNutritional requirements and advice during pregnancy \\nPregnant women should be advice to consume variety of locally available healthy foods \\ncontaining adequate amounts of cereals, yams, animal foods, pulses, vegetables, green leaves, \\nfruits and milk to meet increasing nutritional demands in pregnancy. Mothers should be \\nencouraged to consume 3 nutritious main meals supplemented by one or two additional small \\nmeals.  They should be advised to consume additional ½ a spoonful (spoon made of coconut \\nshell) of rice at each meal with additional amounts vegetables green leaves, pulses and cereals.  \\nThe amount of food a woman should consume during pregnancy varies according to her level of \\nphysical activity and her BMI at the start of pregnancy. The calorie and other nutritional \\nrequirement during pregnancy is stated in the table. The daily menus should be planned to in-\\ncooperate all the essential nutrients using locally available food items. \\n \\nAge of woman\\nAdditions for\\n16-17yrs\\n18-30yrs\\nPregnancy \\nLactation\\nEnergy, kcals\\n2150\\n1750\\n360\\n700\\nProtein, g\\n44\\n44\\n7+\\n19+\\nVitamin A, µg\\n750\\n750\\n-\\n450\\nVitamin D, µg\\n2.5\\n2.5\\n7.5\\n7.5\\nThiamin, mg\\n0.9\\n0.8\\n0.14\\n0.30\\nRiboflavin, mg\\n1.3\\n1.3\\n0.21\\n0.45\\nNiacin, mg\\n14.2\\n13.2\\n2.31\\n4.95\\nFolic Acid, µg\\n200\\n200\\n200\\n100\\nVitamin B12, µg\\n2.0\\n2.0\\n1.0\\n0.5\\nAscorbic acid, mg\\n30\\n30\\n20\\n20\\nCalcium, mg\\n600\\n500\\n600\\n600\\nIron, mg\\n28\\n28\\n60\\n60\\nZinc, mg\\n22\\n22\\n5\\n22\\n \\n The recommended daily dietary allowances during pregnancy'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 100}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n88 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of a pregnant woman with a BMI less than 18.5kg/m2 at first trimester or \\ninadequate weight gain \\n\\uf0a7 Measurement error has to be eliminated as a cause for inappropriate weight gain \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and micronutrient) \\n\\uf0a7 Assess dietary habits, food taboos, misconceptions and correct if there are any negative ones \\n\\uf0a7 Nutrition counseling on appropriate diet: \\nHelp to modify diet by increasing amount of starch based foods such as rice, manioc, \\nstring hoppers etc at each meal \\nConsuming 1-2 extra meals than other days \\nUsing 1-2 table spoonful of oil \\nIncluding fish/dried fish/egg, pulses, vegetables and green leaves to daily diet \\n \\n\\uf0a7 Thriposha 2 packets monthly (to eat 50grams a day mixed with two teaspoons each of sugar \\nand coconut). Assess the compliance \\n\\uf0a7 Prevent anaemia ( Refer the  Genral circular No. 1945  on prevention of maternal anaemia \\npage 100) \\n\\uf0a7 Micronutrients (Iron folate, vitamin C and Calcium) daily after the 1st trimester.   \\n\\uf0a7 Give worm treatment.  \\n\\uf0a7 Assess the compliance of micronutrients and worm treatment. \\n                Mothers who need close monitoring and evaluation \\no Low pre pregnancy BMI ( < 18.5kg/m2 )  \\no Higher pre pregnancy BMI ( ≥25kg/m2) \\no Multiple pregnancies  \\no Anaemic pregnant women \\no Short interval pregnancies \\no Teenage pregnancies \\no Pregnant while lactation \\no Pregnant women with various social problems such as economically \\ndeprived,   single, unmarried, subject to domestic violence, displaced. \\no Pregnant women with infections such as malaria, TB, intestinal \\ninfections, STD, HIV \\no Pregnant women with medical disorders like Type I & II Diabetes, \\ngestational  diabetes, PIH, Thalassemia. \\no Weight gain  of < 1 kg/ month for women with normal BMI <0.5 Kg \\nfor women who are overweight. \\no Gain of more than 3 Kg per month for any pregnant women'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 101}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n89 \\n \\n\\uf0a7 Assess and educate on factors other than dietary which could affect the maternal weight gain  \\n\\uf0d8 Assess the help to reduce the house hold work load and heavy manual work. \\nEducate the husband and the family. \\n\\uf0d8 Assess the mental support she possess and educate regarding the association \\nbetween maternal mental relaxation and fetal well being \\n\\uf0d8 Assess the exposure to house hold smoke and passive tobacco smoke \\n\\uf0d8 Look for any other illnesses from which the mother suffers: eg; Urinary tract \\ninfections, parasitic infections, medical illnesses (Hypertension, DM ). Refer to \\nMOH where necessary. \\n\\uf0d8 Improve the quality of antenatal care received by the mother. \\n\\uf0a7 Follow up monthly \\n\\uf0a7 If weight gain is inadequate, refer to MOH \\n \\nAssessment and management of the nutritional status of overweight or obese pregnant \\nwomen  \\n1. Assess to modify dietary habit; \\n\\uf0b7 Take 24 hour dietary recall and give necessary advice accordingly (to reduce starch, fats, \\n& sugar). \\n\\uf0b7 Assess dietary habits, myths and misconceptions. Correct if there are any. \\n\\uf0b7 Educate regarding the expected weight gain. \\n\\uf0b7 Follow the different dietary menus provided  \\n\\uf0b7 Attain high coverage of micronutrients \\n \\n2. They should be explained the importance of regular exercise in weight management. \\n \\n3. Following advantages of weight management should be explained to them. \\n\\uf0b7 Reduces the risk of hypertension, preeclampsia, gestational diabetes, \\n\\uf0b7 Reduces the risk of obstetric complications such as prolonged labour, and postpartum \\nhaemorrhage. \\n4. Over nourished mothers should be screened for gestational diabetes, pregnancy induced \\nhypertension and fetal wellbeing.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 102}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n90 \\n \\nNutrition and care of the lactating mother \\nNutrition during postpartum period is extremely important due to following reasons: \\ni. \\nTo replenish the lost nutrients during pregnancy and labour \\nii. \\nMothers should exclusively breast feed the child till 6/12. \\niii. \\nAs the principle care taker of the infant, mother needs additional calories for her day \\nto \\nday activities geared towards survival, growth and psychosocial development of the \\nchild. \\niv. \\nTo ensure health & nutrition throughout the life time. \\nLactating mothers should be: \\n\\uf0b7 Provided with postpartum Vitamin A megadose 200,000 IU supplementation within 4 \\nweeks of delivery \\n\\uf0b7 Educated on diet \\no Extra serving of starch based foods at each meal \\no Consume extra piece of fish/egg/dried fish, extra serving of pulses, vegetables and \\ngreen leaves daily  \\no Fat (oil, butter, margarine) 1 tea spoonful  \\no Fruits : ½ riped bananna /  any fruit like wood apple, Nellie, mangoes that is \\nlocally available \\n\\uf0b7 Give Ironfolate/ iron+ folic acid, Vitamin C and Calcium for a period of six months \\n\\uf0b7 Provide Thriposha 2 packets \\n\\uf0b7 Educate on importance of attending postpartum clinics \\n\\uf0b7 Asses and support breast feeding \\n\\uf0b7 Special follow up of children born with Low Birth Weight  \\n(Refer the section on nutrition in the postpartum guide)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 103}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n91 \\n \\nChapter 12 \\nCOMMON DISCOMFORTS DURING PREGNANCY  \\nNausea and morning sickness \\nNausea is very common in early weeks of pregnancy. Advice women: \\n\\uf0b7 If you feel sick first thing in the morning, give yourself time to get up slowly. If possible, \\neat something like dry toast or a plain biscuit before you get up. Then drink a tea without \\nmilk. \\n\\uf0b7 Get plenty of rest and sleep whenever you can. Feeling tired can make the sickness \\nworse. \\n\\uf0b7 Drink plenty of fluids. Take small amount at a time. Eat sugar less biscuits \\n\\uf0b7 Ask those close to you for extra support. \\n\\uf0b7 Distract yourself as much as you can. Often the nausea gets worse the more you think \\nabout it. \\n\\uf0b7 Avoid the foods and smells that make you feel worse. It helps if someone else can cook. \\n\\uf0b7 Remedies containing ginger may be helpful. \\n\\uf0b7 Wear comfortable clothes. Tight waist bands can make you feel worse \\n \\n \\nBack ache \\n \\nDuring pregnancy ligaments become softer and stretch to prepare for labour. This can put a strain \\non the joints of the lower back and pelvis which can cause backache. As the baby grows, the \\nhollow in the lower back may increase and this may also cause backache. \\nAdvice: \\nTo avoid backache; \\n\\uf0b7 Avoid heavy lifting \\n\\uf0b7 Bend your knees and back straight when lifting or picking up something from the floor. \\n\\uf0b7 If you do have to carry something heavy, hold it close to your body. \\n\\uf0b7 Move your feet when turning round to avoid twisting your spine \\n\\uf0b7 Wear flat shoes as these allow your weight to be evenly distributed \\n\\uf0b7 Work at a surface high enough to prevent you stooping \\n\\uf0b7 Try to balance the weight between two baskets if you are carrying shopping. \\n\\uf0b7 Sit with your back straight and well supported. \\nA firm mattress can help to prevent and relieve back ache. If the mattress is too soft, a piece of \\nhardboard under its length will make it firmer. Massage also can help. If the backache is very \\npainful meet a doctor.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 104}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n92 \\n \\nPelvic pain \\n \\nPelvic pain especially if lateral and referring to the upper thighs are usually due to ligamentous \\nstretch. They require reassurance only. Pain is reproduced by gentle sideways traction on an \\notherwise non-tender and soft womb. Low back pain is common due to altered posture; but also \\nto the effects of the hormone relaxing on ligaments, allowing excessive movement of sacro-illiac \\nand apophyseal joints. A regular exercise program, preferably swimming, with physiotherapy as \\nrequired, complements postural back care. Some women develop symphysis-pubis pain, \\nespecially. If coexistent scoliosis, and may a s-p corset, obtainable through physiotherapy \\ndepartments. \\n \\nUrinary Frequency \\nIt is an early sign of pregnancy. Sometimes it continues right throughout the pregnancy. Urinary \\nfrequency is common but should be investigated as 8% of pregnant women will have otherwise \\nasymptomatic UTIs. In later pregnancy it’s the result of the baby’s head pressing on the bladder. \\n\\uf0b7 Try cutting out drinks in the late night but make sure that plenty drinks during daytime \\n\\uf0b7 Later in pregnancy, rock backwards and forwards while they are on the toilet. This lessen \\nthe pressure of the womb on the bladder \\nDysuria \\nIf a pregnant woman has any pain while passing urine or pass any blood, she may have a urine \\ninfection which will need treatment. Ask her to drink plenty of water to dilute the urine and \\nreduce irritation and refer her to a doctor immediately. \\nIncontinence \\nSometimes pregnant women are unable to prevent a sudden spurt of urine or a small leak when \\nmoving suddenly or just getting up from a sitting position. This may be temporary because the \\npelvic floor muscles relax slightly to prepare for the baby’s delivery. Pelvic floor exercises will \\nimprove the condition. \\nSwollen ankles, feet and fingers \\nAnkles, feet and fingers often swell a little in pregnancy because the body holds more water than \\nusual. Ankle oedema may relate to compression of inferior vena cava and to vasodilatation due \\nto increased hormones. Towards the end of the day, especially if the weather is hot or if standing \\nfor a long time, the extra water tends to gather in the lower parts of the body. If no associated \\nproteinuria or hypertension, it is best treated by  \\n\\uf0b7 Try to avoid standing for long periods \\n\\uf0b7 Wear comfortable shoes \\n\\uf0b7 Put your feet up as much as you can – try to rest for an hour a day with your feet higher \\nthan your heart'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 105}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n93 \\n \\n\\uf0b7 Try to do foot exercise \\n\\uf0b7 Take celery – natural diuretic or vitamin B6 \\n\\uf0b7 Confirm the number of fetuses \\n \\nVaricose veins \\nVaricosities occur due to compression of inferior vena cava and vasodilatation due to increased \\nhormones. The veins in the legs are most commonly affected. Some may get varicose veins in \\nthe vulva. They usually relieve after confinements.  \\n\\uf0b7 The early use of support stockings is wise; wear stockings before getting down from the \\nbed, the short term use of pelvic elevation and ice packs can ease the symptoms of vulvar \\nvaricosities. \\n\\uf0b7 Try to avoid standing for long periods of time \\n\\uf0b7 Try not to sit with legs crossed \\n\\uf0b7 Try not to put on too much weight as this increases the pressure \\n\\uf0b7 Try to sleep with your legs higher than the rest of your body- use pillow under your \\nankles or put bricks or books under the foot of your bed \\n\\uf0b7 Do foot exercise \\nHeartburn and indigestion \\nHeartburn and indigestion is partly due to hormonal changes and later due to gastro-oesophageal \\nreflux combined with increased abdominal pressure. Postural and dietary advice with the use of \\nantacids settles most, but occasionally H2 antagonists are required.  \\nTo avoid indigestion: \\n\\uf0b7 Try eating smaller meals more often \\n\\uf0b7 Sit up straight when you are eating as this takes the pressure off your stomach \\n\\uf0b7 Avoid particular foods which cause trouble, for example fried or highly spiced ones, but \\nmake sure you are still eating well \\nTo avoid heart burn: \\n\\uf0b7 Sleep well propped up – try raising the head of your bed with bricks or have plenty of \\npillows \\n\\uf0b7 Try drinking a glass of milk – have one by your bed in case you wake with heartburn in \\nthe night \\n\\uf0b7 Avoiding eating or drinking for a few hours before you go to bed'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 106}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n94 \\n \\nConstipation \\nConstipation can occur early so at least in part is due to hormones, but is aggravated by enlarging \\npelvic contents. With the vasodilatation and compression of pelvic veins this may result in \\nhaemorrhoids.   \\n\\uf0b7 Make sure you include plenty of fibre in your diet through eating foods like whole meal \\nbreads, whole grain cereals, fruit and vegetables, and pulses such as beans and lentils. \\n\\uf0b7 Exercise regularly to keep your muscles toned up \\n\\uf0b7 Make sure you drink plenty of water \\n\\uf0b7 If laxatives are needed they should be of the fibre based type eg. Fybogel \\n \\n \\nDental decay and periodontal disease \\nDental decay and periodontal disease accelerate in pregnancy and should be reviewed by a \\ndentist as early as possible. To keep your teeth and gums healthy, you should: \\n\\uf0b7 Pay special attention to cleaning your teeth. \\n\\uf0b7 Avoid having sugary drinks and foods too often. Try to keep them only to meal times. \\nSkin changes \\nHormonal changes taking place in pregnancy make the nipples and the areola darker. The skin \\ncolour may also darken a little, either in patches or all over. Birth marks, moles and freckles may \\nalso darken. Some women develop a dark line down the middle of the abdomen (Linea Nigra). \\nThese changes will gradually fade after the delivery. Skin changes such as chloasma and spider \\nnaevi, also disappear after the pregnancy.  \\nStretch Marks \\nThese are pink or purplish lines which usually occur on the abdomen or sometimes on the upper \\nthighs or breasts. Some women get them, some don’t. It depends on the skin type. Women with \\nmore elastic skins don’t get them. Women with more than average weight gain, more prone to \\nget them. It is very doubtful whether oils or creams help to prevent stretch marks. After delivery \\nthe marks should gradually pale and become less noticeable. \\nHair Changes \\nHair growth is also likely to increase in pregnancy. The hair may also ne greasier. After the \\ndelivery it may seem that a woman is losing a lot of hair. In fact she is simply losing the increase \\nthat occurred during pregnancy.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 107}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n95 \\n \\nItching  \\nItching occurs in 17% gravid women. Interestingly, 50% women with atopic dermatitis improve \\nduring pregnancy. If no rash, consider iron deficiency, or the potentially more serious \\ncholestatsis of pregnancy. Antihistamines may be helpful. \\nStretch marks may occur when growth has been rapid. The dryness and irritation may be erased \\nby vegetable oil or Vitamin E cream and soap avoidance. \\nCramps \\nCramp is Sudden, sharp pain, usually in your calf muscles or feet. It is most common at night. It \\nusually helps if you pull your toes hard up towards your ankle or rub the muscle hard. Regular, \\ngentle exercise in pregnancy, particularly ankle and leg movements, will improve your \\ncirculation and may help to prevent cramp occurring. \\nTiredness \\nIn the early months of pregnancy, a woman may feel tired or even desperately exhausted. The \\nonly answer is to try to rest as much as possible. Make time to sit with feet up during the day and \\naccept any offers of help from colleagues and family. Towards the end of pregnancy, she may \\nfeel tired because of the extra weight carrying. Make sure that she gets a plenty of rest. \\nFaintness:  \\nPregnant women often feel faint. This happens when not enough blood is getting to the brain. If \\nthe oxygen level gets too low, she may actually faint. It’s more common in pregnancy because of \\nhormonal changes taking place in her body. She is most likely to feel faint if she stand still for \\ntoo long or get up too quickly from a chair. \\n\\uf0b7 Try to get up slowly after sitting or lying down \\n\\uf0b7 If feel faint when standing still, find a seat quickly and the faintness will pass. If it \\ndoesn’t lie down on side. \\n\\uf0b7 If feel faint while lying on her back, turn on side. It’s better not to lie flat on back in later \\npregnancy or during labour. \\nHeadaches \\nSome pregnant women get lots of headaches. A brisk walks may be all they need as well as a \\nlittle more regular rest and relaxation. Although it is wise to avoid drugs in pregnancy, an \\noccasional paracetamol tablets is generally considered safe. If she often has bad headaches meet \\na doctor. It may be a sign of hypertension.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 108}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n96 \\n \\nFeeling hot in pregnancy: \\nDuring pregnancy you are likely to feel warmer than normal. This is due to hormonal changes \\nand to increase in blood supply to the skin.  \\n\\uf0b7 Wear loose clothing made out of natural fibres, as these are more absorbent and breathe \\nmore than synthetic fibres. \\n \\n\\uf0b7 Keep your room cool \\n\\uf0b7 Wash frequently to stay fresh \\n \\nVaginal discharge  \\nAlmost all women have more vaginal discharge in pregnancy. It should be clear and white and it \\nshould not smell unpleasant. If the discharge is colored, or smells strange, or if feel itchy or sore, \\nit may be a vaginal infection. Refer her to a doctor. Ask her to wear loose cotton underwear. \\nSleeplessness \\nLate in pregnancy it can be very difficult to get a good night’s sleep. She is uncomfortable lying \\ndown or just when she is beginning to comfortable, she may have to get up to go to the toilet. \\nSome women have strange dreams or nightmares about the baby and about the birth. Talking \\nwith them can help to alleviate their fears. The relaxation and breathing exercises which are \\ntaught in parent crafting classes might be helpful. \\nIf you are not sleeping well: \\n\\uf0b7 Try not to let it bother you. Don’t worry that it will harm your baby- it won’t \\n\\uf0b7 It might be more comfortable to lie on one side with a pillow under your tummy and \\nother between your knees. \\n\\uf0b7 Relaxation technique may help. \\n\\uf0b7 A warm milky drink, a warm bath, some gentle exercise or some restful music before \\nbedtime may help \\n\\uf0b7 A rest during the day can help you to feel less tired. \\n\\uf0b7 Talk to your partner or family or midwife.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 109}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n97 \\n \\nRespond to observed signs or volunteered problems \\nIf no fetal movements \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the baby \\nlast move? \\n \\nIf no movement \\nfelt, ask woman to \\nmove around for \\nsome time, \\nreassess fetal \\nmovements \\nFeel for fetal \\nmovements \\n \\nListen for fetal \\nheart after 6 \\nmonths of \\npregnancy \\n \\nIf no heartbeat, \\nrepeat after 1 hour \\nNo fetal movement\\nNo fetal heart beat \\nProbably dead \\nbaby \\nInform the mother \\nand the partner \\nabout the possibility \\nof dead baby. \\nRefer to hospital. \\nNo fetal \\nmovements but \\nfetal heart beat \\npresent \\nWell baby\\nInform the mother \\nthat baby is fine and \\nlikely to be well but \\nto return if problem \\npersists. \\n \\nIf ruptured membranes and no labour \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the \\nmembranes \\nrupture? \\nWhen is your \\nbaby due? \\nLook at pad or \\nunder wear for \\nevidence of: \\namniotic fluid, \\nFoul-smelling \\nvaginal discharge \\nIf no evidence, ask \\nher to wear a pad. \\nCheck again in 1 \\nhour. \\nMeasure \\ntemperature. \\nFever 380 C\\nFoul smelling \\nvaginal discharge \\nUterine and \\nfetal infection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nRupture of \\nmembranes at < 8 \\nmonths of \\npregnancy \\nRisk of uterine \\nand fetal \\ninfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nRupture of \\nmembranes at > 8 \\nmonths of \\npregnancy \\nRupture of \\nmembranes \\nManage as woman in \\nchildbirth.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 110}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n98 \\n \\nIf fever or burning on urination \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nHave you had \\nfever? \\nDo you have \\nburning on \\nurination? \\nIf history of fever or \\nfeels hot: \\n- \\nMeasure \\naxillary \\ntemperature \\n- \\nLook or feel \\nfor stiff neck \\n- \\nLook for \\nlethargy \\nPercuss flanks for \\ntenderness \\nFever >380 C and any \\nof: \\n- \\nvery fast \\nbreathing or \\n- \\nStiff neck \\n- \\nLethargy \\n- \\nVery weak/not \\nable to stand \\nVery severe \\nfebrile \\ndisease \\nInsert IV line and \\ngive fluids slowly \\nGive appropriate \\nIM/IV antibiotics \\nGive quinine IM \\nGive glucose \\nRefer urgently to \\nhospital \\nFever >380 C and any \\nof: \\n- \\nFlank pain \\n- \\nBurning on \\nurination  \\nUpper \\nUrinary \\nTract \\nInfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nBurning on urination\\nLower \\nUrinary \\ntract \\nInfection \\nGive appropriate oral \\nantibiotics \\nEncourage her to \\ndrink more fluids \\nIn no improvement in \\n2 days or condition is \\nworse, refer to \\nhospital'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 111}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n99 \\n \\nIf cough or breathing difficulty \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nHow long have \\nyou been \\ncoughing? \\nHow long have \\nyou had \\ndifficulty in \\nbreathing? \\nDo you have \\nchest pain? \\nDo you have \\nany blood in \\nsputum? \\nDoes your \\nhusband smoke? \\nLook for \\nbreathlessness. \\nListen for \\nwheezing. \\nMeasure \\ntemperature. \\nAt least 2 of the \\nfollowing signs: \\n-Fever >380 C. \\n-Breathlessness. \\n-Chest pain \\nPossible \\nPneumonia \\nGive first dose of \\nappropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nAt least 1 of the \\nfollowing signs: \\n- \\nCough or \\nbreathing \\ndifficulty for > \\n3 weeks \\n- \\nBlood in \\nsputum. \\n- \\nWheezing \\nPossible Chronic \\nLung Disease \\nRefer to hospital \\nfor assessment. \\nIf severe \\nwheezing, refer \\nurgently to \\nhospital. \\nFever >380 C, and\\nCough < 3 weeks \\nUpper \\nRespiratory \\nTract Infection \\nAdvise safe, \\nsoothing remedy. \\nAdvice to avoid \\npassive smoking.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 112}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n100 \\n \\n \\nChapter 13 \\nNATIONAL GUIDELINES FOR PREVENTION AND CONTROL OF \\nMATERNAL ANAEMIA \\n1. Advice pregnant women to add food items abundant with iron for their meals. \\nWomen should be encouraged to consume not only animal foods rich in iron such as meat and \\nfish, but also green leafy vegetables and lentils such as green grams, dhal and chick pea. They \\nshould be encouraged to consume foods which are enhanced the absorption of iron, such as citrus \\nfruits and animal foods with plant foods. They should be discouraged to consume foods such as \\nmilk and tea which inhibit the absorption of iron from plant sources during meals or within one \\nhour of meal. \\n \\n2. Supplementation of iron-folate during pregnancy and lactation  \\nAll pregnant women should receive iron and folic acid with Vitamin C after POA of 12 weeks \\nfor 6 months during pregnancy and 6 months after delivery. A pregnant/lactating woman needs a \\n60mg of elementary iron and 400µg of folic acid per day. This can be given as follows: \\ni. \\nGive one tablet of iron-folate (60mg iron + 400µg of folic acid) per day. (This \\ntablet is distributed by FHB.) \\nii. \\nWhen iron-folate tablets are not available, give 200mg of ferrous sulphate (1 \\ntablet) and 5mg of Folic acid (1 tablet) per day. (These tablets are available in \\nMSD). \\niii. \\nGive 50mg of Vitamin C with iron folate/ ferrous sulphate which enhance the iron \\nabsorption. Calcium tablets, foods containing calcium or tea or milk which \\ninhibits iron absorption should not be taken within 1 hour of taking iron tablets. \\niv. \\nDuring first trimester, all pregnant women should be taken one tablet of folic acid \\n(5mg). Ideally folic acid should be started at the time, the couple decided to have \\na child (pre-conception folic acid supplementation). Mothers, who have a history \\nof having children with neural tube defects, should take folic acid till next \\npregnancy. \\nMother should be informed about possible side effects of iron intake such as vomiting, nausea, \\nloss of appetite before prescribing iron tablets. As these tablets contains very low dose of iron, \\nside effects may be mild. However, mothers should be informed how to reduce side effects, if \\nthey occurred.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 113}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n101 \\n \\n \\n \\nAll mothers should receive required number of micronutrient tablets till next clinic visit at once. \\nNext clinic visit\\nNo. of iron folate / iron/ \\nfolic acid tablets \\nNo.of Vit C.(50mg) tablets\\nAfter 1 month \\n30 \\n30 \\nAfter 2 weeks\\n14\\n14\\nAfter 1 week \\n07 \\n07 \\n \\nIron tablets should be stored in dark colored air tight bottles to prevent oxidation. All the women \\nshould be advised to bring a dry container to carry micronutrients. \\nWomen should be   made aware on enhances and inhibitors of iron absorption. \\nCompliance of taking micronutrients should be assessed during each clinic visit and home visits. \\nIf there is any problem with compliance, act accordingly. \\n \\n3. Detection of anaemia during pregnancy \\n \\nAll pregnant mothers should offer Hb testing at the booking visit and at 28weeks. Classification \\nof anaemia based on Hb levels as follows: \\nHb > 11g/dl \\nNo anaemia \\nHb 7-11g/dl \\nModerate anaemia \\nHb < 7g/dl \\nSevere anaemia \\n \\nActions should be taken according to the table given below.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 114}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n102 \\nAsk, \\ncheck, \\nrecord \\nLook, \\nlisten, \\nfeel \\nSigns\\nClassify\\nTreat and advice\\nDo \\nyou \\ntire \\neasily? \\nAre \\nyou \\nbreathless (short \\nof \\nbreath) \\nduring \\nroutine \\nhousehold \\nwork? \\nOn first visit:\\nMeasure Hb \\nOn subsequent \\nvisits: \\nLook for \\nconjunctival \\npallor \\nLook for palmar \\npallor. \\nIf pallor: \\n- Is it severe \\npallor? \\n- Some pallor \\n- Count No. of \\nbreaths in a \\nminute \\nHaemoglobin \\n<7mg/dl  \\nAnd/or \\nSevere palmar and \\nconjunctival pallor  \\nor \\nAny pallor with any \\nof \\n- >30 breaths per \\nminute \\n- tires easily \\n- breathless at rest \\nSevere \\nAnaemia \\nRefer urgently to hospital.\\nRevise the birth plan so as to \\ndeliver in a facility with blood \\ntransfusion services. \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nFollow up in 2 weeks to check \\nclinical progress, test results, \\nand compliance with treatment.\\nHaemoglobin 7-\\n11mg/dl  \\nOr \\nPalmar or \\nconjunctival pallor \\nModerate \\nAnaemia \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress. I \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nReassess at next antenatal visit. \\nIf anaemia persists without any \\nimprovement in Hb levels, \\nrefer to hospital.  \\nOnce Hb levels become normal \\ncontinue with single dose of \\niron (60mg of elementary iron) \\nHaemoglobin \\n>11mg/dl. \\nNo pallor. \\nNo \\nclinical \\nanaemia \\nGive iron 1 tablet once daily \\nfor 6 months. \\nCounsel on compliance with \\ntreatment.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 115}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n103 \\n \\n4. Control of infections related to anaemia \\n \\ni. \\nControl and treatment for intestinal worm infestations \\nAll pregnant mothers should receive worm treatment with Mebendazole just after completion of \\n12 weeks of POA. \\nDosage: \\n  \\nMebendazole 100mg twice a day for 3days or \\n \\n \\nMebendazole 500mg as a single dose \\nMothers should be informed regarding other preventive methods of worm infestations such as \\nuse of sleepers, proper construction and use of toilets, use of safe water, washing hands before \\nmeals and after toileting. \\nii. \\nControl and prevention of malaria \\n \\nAs malaria is low prevalent disease in Sri Lanka, It is not recommended the routine prophylaxis \\ntreatment for pregnant mothers even in the endemic areas. Prophylaxis should be decided by the \\nMOH/ MO after considering the malaria status in the area. If decided on malaria prophylaxis the \\nregime is: \\n \\n\\uf0b7 Chloroquine 300mg (2 tablets) weekly after meal during second and third trimesters and \\n42 days after delivery \\n \\n\\uf0b7 At the booking visit, all pregnant mothers in endemic areas should be tested for malaria \\nusing a blood smear. \\n \\n\\uf0b7 In a malarial endemic area, if a pregnant mother is suffering from fever, she should be \\ntested for malaria. If she is positive for malaria, she should be given the complete course \\nof Chloroquine as follows: \\n \\nDay 1 – Chloroquine 600mg (4 tablets) \\nDay 2 – Chloroquine 600mg (4 tablets) \\nDay 3 - Chloroquine 300mg (2 tablets) \\nAfter that Chloroquine prophylaxis should be continued the rest of the pregnancy and postpartum \\nperiod. Primaquine should not be given during pregnancy and postpartum period.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 116}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n104 \\n \\n5. Information, education and communication \\nIt is important to understand the knowledge, attitudes and practices on anaemia in the \\ncommunity, as control and prevention of anaemia is closely link with the practices of the people. \\nTherefore, well organized and targeted health education program is essential. \\nThese health education programs should be targeted to important groups such as adolescent girls, \\nworking women, women in urban slums, estate women and displaced women. \\n6. Ordering, receiving and storage of drugs needed for the maternal care program  \\nThe drugs needed for the program of prevention of anaemia are iron, iron folate, folic acid, \\nvitamin C (ascorbic acid), mebendazole (worm treatment) and chloroquine. It is important to \\nprepare the estimation properly to order drugs and it should be done at the level of MOH/ RDHS \\nor medical institution. \\n \\nDrug Estimation                  Estimated No of Pregnant women = Total Population x CBR \\nIron/ ironfolate tablets \\nNo. of Ironfolate/ Iron tablets required for a MOH area =  \\n(Estimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n   (After first 12 weeks during pregnancy and 6 months after delivery) \\nFolic acid \\nWhen iron and folic acid are in combination, folic acid should be estimated only for the first 3 \\nmonths of pregnancy. \\nWhen Iron folate is available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers X 90days X 1 tablets  \\nWhen Iron tablets are available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers for the year × 450 days × 1 tablet) \\n(During pregnancy 270 days during pregnancy + 180 days after delivery)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 117}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n105 \\n \\nCalcium lactate  \\nNo. of calcium lactate tablets required for a MOH area =  \\nEstimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n    \\n(After first 12 weeks during pregnancy and 6 months after delivery) \\nMebendazole \\nRequirement of Mebendazole (100mg)= \\n(Estimated No. of pregnant mothers for the year × 6 tablets) \\nRequirement of Mebendazole  (500mg) =  \\n(Estimated No. of pregnant mothers for the year × 1 tablets) \\nThe estimation for the entire district should be prepared by summarizing the estimates from the \\nMOH areas. It should be included in the yearly drug estimation. Ordering of micronutrients  \\nshould be done in similar way as other drugs in medical institutions. The number of inward \\nmothers taking treatment and number mothers attending the clinic should be taken in to \\nconsideration while preparing the estimation.   \\nThe drugs should be stored in dark dry place to avoid oxidization and destruction.  The regional \\nsuppliers division to MOH office and clinic should follow these instructions. \\nWhen issuing drugs, the calculation of drugs should be done in retail at each level (medical \\nsuppliers division, MOH office, and clinic) and a record should be maintained in each clinic at \\nthe end of the day. \\ne.g. \\nDate   \\nAmount in hand     No of mothers \\nattended       \\n         Amount \\nissued      \\nBalance \\n \\n \\n \\n \\n \\nReceiving of drugs, distribution, storage and issuing should be supervised by MOMCH/ an \\nofficer appointed by RDHS when this post is vacant. \\nThe RDHS, MOH, MOMCH, head of the institution and other supervisory officers such as \\npublic health nursing officer (PHNS) and supervising public health mid wife (SPHM) are \\nresponsible for supervisory work at clinic, field and institutional level. \\nAll the activities in this program should be monitored, supervised and evaluated at regional level \\nas well as district level. It is a responsibility of the supervisory committee of the region and \\nMOMCH at district level.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 118}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n106 \\n \\nChapter 14 \\nMANAGEMENT OF HIGH BLOOD PRESSURE DURING PREGNANCY  \\nAT FIELD LEVEL \\nAsk, check \\n&record \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nBlood \\npressure at \\nthe last \\nvisit? \\nMeasure blood pressure in \\nsitting position. \\nIf diastolic blood pressure \\nis ≥90mmHg, repeat after \\n1 hour rest. \\nIf diastolic blood pressure \\nis still ≥90mmHg, ask the \\nwoman if she has: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\n\\uf0a7 \\nCheck protein in \\nurine \\nDiastolic blood pressure \\n≥110 mmHg and 3+ \\nproteinuria,  \\nor \\nDiastolic blood pressure \\n≥90 mmHg on two \\nreadings and 2+ \\nproteinuria, and any of: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\nSevere pre-\\neclampsia \\nRefer Urgently \\nto hospital \\n \\nDiastolic blood pressure \\n90-110 mmHg on two \\nreadings and 2+ \\nproteinuria. \\nPre-\\neclampsia \\nRefer to hospital\\nimmediately. \\nDiastolic blood pressure \\n≥90 mmHg on 2 \\nreadings \\nHypertension\\nAdvise to reduce \\nworkload and to \\nrest. \\nAdvise on danger \\nsigns. \\nReassess at the \\nnext antenatal \\nvisit or in 1 week \\nif >8 months \\npregnant. \\nIf hypertension \\npersists after 1 \\nweek or at next \\nvisit, refer to \\nhospital. \\nNone of the above.\\nNo \\nHypertension\\nNo treatment \\nrequired.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 119}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n107 \\n \\nChapter 15 \\nGUIDELINES ON IMMUNIZATION AGAINST TETANUS \\nIntroduction \\nTetanus is a fatal infectious disease caused by toxigenic strains of Clostredium Tetani. Tetanus \\nand neonatal tetanus is still a major public health problem in a considerable number of \\ndeveloping countries. However, both tetanus and neonatal tetanus have reached elimination \\nlevels in Sri Lanka as a result of the successful immunization programme. \\n Protection against tetanus toxoid could be achieved either through active immunization (by \\ngiving tetanus toxoid containing vaccine) or by passive immunization (by giving tetanus specific \\nimmunoglobin). Neonatal   tetanus is prevented by immunizing the pregnant mothers with \\ntetanus toxoid vaccine. \\nTetanus vaccines are based on tetanus toxoid which is a chemically inactivated tetanus toxin \\nwhich could induce production of antibodies against tetanus toxin. Tetanus toxoid is available as \\nmonovalent tetanus toxoid (TT), combined diphtheria, pertussis, tetanus, hepatitis B and Hib \\nvaccine (pentavalent vaccine), combined diphtheria and pertussis, tetanus vaccine (DPT), \\ncombined diphtheria, tetanus vaccine (DT) or as adult tetanus diphtheria vaccine (aTd). \\nThe goal of tetanus immunization in the Expanded Programme of Immunization (EPI) \\nprogramme is to eliminate tetanus and neonatal tetanus from Sri Lanka. With the emergence of \\nnew knowledge on immunological response of patients after receiving tetanus toxoid, the \\nfollowing recommendations have been made regarding immunization with tetanus containing \\nvaccines. \\n1.) Pre exposure immunization against tetanus \\n \\n1.1)  Immunization from infancy up to adolescence \\n \\n \\nDose\\nAge (on \\ncompletion of) \\nVaccine\\nDuration to be kept between different doses of \\ntetanus containing vaccine when tetanus toxoid \\ncontaining vaccines have not been received \\naccording to the scheduled age \\n1st \\n2 months\\n   Pentavalent     \\n   or DPT             \\n6-8 weeks between\\n1. 1st and 2nd dose \\n2. 2nd and 3rd dose \\n2nd\\n4 months\\n3rd\\n6 months\\n4th\\n18 months\\nDPT\\n12 months between 3rd and 4th doses\\n5th\\n5 years\\nDT\\n3 years between 4th and 5th doses\\n6th\\n12 years( in grade \\n7, during SMI) \\naTd\\n7 years between 5th and 6th doses'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 120}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n108 \\n \\n1.2) Immunization during pregnancy \\n The number of doses required and timing of boosters during pregnancy will depend on the past \\nimmunization history of the pregnant mother with tetanus containing vaccines. \\n1.2.1) Immunization of pregnant mothers who have not received tetanus containing vaccines \\nin infancy and childhood as per the EPI schedule \\nPregnant mothers who have not received tetanus containing vaccine according to the EPI \\nschedule during infancy and child hood should be immunized according to the following \\nschedule. \\nDose \\nTime of Immunization \\n1st \\nDuring 1st pregnancy after 12 weeks of gestation \\n2nd \\nDuring 1st pregnancy (6 – 8 weeks after the first dose, two weeks before delivery) \\n3rd \\nDuring 2nd pregnancy after 12 weeks of gestation \\n4th \\nDuring 3rd  pregnancy after 12 weeks of gestation \\n5th \\nDuring 4th pregnancy after 12 weeks of gestation \\n \\nPregnant mothers who have received 5 doses of tetanus toxoid during previous pregnancies \\nmentioned above do not need further booster doses of tetanus toxoid during subsequent \\npregnancies. \\n1.2.2) Immunization of pregnant mothers who have documented evidence of receipt of six \\ndoses of tetanus containing vaccines as per the national EPI schedule ( 3 doses of DPT / penta \\nin infancy + DPT at 18 months + DT at 5 years + aTd at 12 years) \\n \\nDose \\nTime of Immunization \\nOne booster dose (TT) \\nIf the gap between the 6th dose or any \\nsubsequent tetanus containing vaccine and the \\ncurrent pregnancy is more than 10 years \\n \\nPregnant mothers who belong to the following categories do not need to be immunized with \\ntetanus toxoid during pregnancy. \\n1. If the gap between the 6th dose of tetanus containing vaccine and the current pregnancy is \\nless than 10 years.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 121}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n109 \\n \\n2. If the gap between the subsequent dose of tetanus containing vaccine received after the \\n6th dose and the current pregnancy is less than 10 years. \\n \\n(2) Post exposure vaccination against tetanus \\nDecision on post exposure vaccination should be taken after considering the nature of the injury \\nand the previous history of immunization with tetanus containing vaccine. \\n2.1) Immunization of persons who have been immunized with tetanus containing vaccine \\nduring infancy and childhood \\nIf a person has documented evidence of receipt of six doses of tetanus containing vaccine (with 4 \\ndoses of DPT/ pentavalent, DT, aTd) he/she does not need to be immunized with tetanus toxoid \\nup to 10 years after the 6th dose of tetanus containing vaccine. If a patient presents 10 years after \\nthe 6th dose of tetanus containing vaccine immunity could be boosted up with a dose of tetanus \\ncontaining vaccine. \\nHowever, if a patient presents within 10 years with a severely contaminated wound a booster \\ndose of tetanus toxoid could be given even though the gap between the 6th dose of tetanus and \\nthe injury is less than 10 years. \\n2.2) Immunization of persons who have not been immunized with tetanus containing \\nvaccine according to the EPI schedule \\nAny person who has not been immunized with tetanus containing vaccine during infancy and \\nadolescence according to the national EPI schedule, he/ she should be given a dose of tetanus \\ntoxoid (1st dose) if there is a risk of developing tetanus. Second dose of tetanus toxoid should be \\ngiven 4 weeks after the 1st dose and the third dose 6 months after the second dose. A booster \\ndose (4th dose of tetanus could be given 5 years after the 3rd dose. Fifth dose given 10 years after \\nthe 4th dose will produce long lasting, probably a lifelong immunity. \\n(3) Development of immunity after immunization with tetanus containing vaccines \\nIf there is documentary evidence to show that any infant, child or an adult has been immunized \\nas per EPI schedule, it is not necessary to immunize them in between the routine doses again \\nwhenever they present with trauma as they are protected against tetanus infection in between \\ndoses. However if an infant, child or an adult presents with a severely contaminated wound, a \\ndose of tetanus could be given to boost up the immunity even in between the recommended \\nroutine doses. \\n(4) Storage and administration of tetanus containing vaccines  \\nTetanus containing vaccines should be stored and transported between +2 centigrade and +8 \\ncentigrade and should not be exposed to freezing as it can reduce the potency of these vaccines. \\nOpened tetanus containing vaccine vials should be stored between +2 centigrade and +8 \\ncentigrade and could be re used in subsequent immunization sessions within 4 weeks of opening. \\nTetanus containing vaccines should be given intra muscularly.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 122}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n110 \\n \\n \\nChapter 16 \\nGUIDELINE ON SCREENING AND MANAGEMENT OF DIABETES MELLITUS DURING \\nPREGNANCY IN THE FIELD/NON SPECIALIZED INSTITUTIONS \\nGestational diabetes Mellitus \\nDefinition \\nGestational Diabetes Mellitus (GDM) is defined as carbohydrate intolerance of variable severity with \\nonset or first recognition during the present pregnancy. \\n\\uf0b7 Detailed, comprehensive history should be obtained from all the pregnant women who attend for \\ntheir first antenatal clinic visit by a medical officer. \\n\\uf0b7 Anthropometric assessment should be done at the first antenatal clinic visit using height and \\nweight and by calculating BMI \\n\\uf0b7 If any of the following risk conditions are identified, offer them a 2hour PBBS testing using \\na glucometer. \\n\\uf0b7 Before testing the 2hr PBBS, check the available test reports, as some of the women may have \\nalready done OGTT, GCT or some other blood sugar values. If those reports are sufficient for \\ndecision making do not repeat the PBBS at the clinic. \\n \\nRisk factors:  \\n\\uf0b7 Body Mass Index above 25kg/m2  \\n\\uf0b7 Maternal weight at booking visit > 65 kg \\n\\uf0b7 Mother’s age >35yrs \\n\\uf0b7 Previous macrosomic babies weighing 3.5 kg or above \\n\\uf0b7 Previous gestational diabetes \\n\\uf0b7 History of IUD, Intrapartum death, Neonatal death \\n\\uf0b7 Recurrent PIH \\n\\uf0b7 Polycystic Ovary Syndrome \\n\\uf0b7 Women on long term steroids, antiepileptic, anti-psychotics \\n\\uf0b7 Previous late miscarriages or three or more consecutive miscarries at first trimester \\n\\uf0b7 Family history of diabetes ( 1st degree relative with diabetes) \\n\\uf0b7 Acanthosis Nigricans  \\n\\uf0b7 Essential Hypertension'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 123}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n111 \\n \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl at first antenatal booking refer them to a \\nspecialized unit for urgent OGTT. \\n \\n\\uf0b7 If 2hr PPBS at 1st antenatal visit is >120 mg/dl and OGTT in early pregnancy is normal, they \\nhave repeat OGTT at 24-28 weeks. Therefore, refer such women for OGTT at 24 -28 weeks. \\n \\n\\uf0b7 At the POA of 24-28 weeks, offer all pregnant women 2hr PBBS testing using glucometer. \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl refer them to a specialized unit for urgent OGTT. \\n \\nPreparation for 2hr PBBS: \\n1. Pregnant woman should have an average Sri Lankan meal 2 hours before the test (rice with \\ncurries) \\n2. The meal should be eaten over a maximum period of 15 minutes time. \\n3. The two hours should be calculated from the starting time of the meal. \\nEg. Meal starts at 7.30am. It should be finished by 7.45am and the time for PPBS is 9.30am \\n \\nWomen with gestational diabetes should be offered information covering: \\n• the role of diet, body weight and exercise \\n• the increased risk of having a baby who is large for gestational age, which increases the \\nlikelihood of birth trauma, induction of labour and caesarean section \\n• the importance of maternal glycaemic control during labour and birth and early feeding of the \\nbaby in order to reduce the risk of neonatal hypoglycaemia \\n• the possibility of transient morbidity in the baby during the neonatal period, which may  require \\nadmission to the neonatal unit \\n• The risk of the baby developing obesity and/or diabetes in later life. \\nWomen with gestational diabetes should be advised to choose, where possible, carbohydrates from low \\nglycaemic index sources, lean proteins including oily fish and a balance of polyunsaturated fats and \\nmonounsaturated fats. \\nWomen with gestational diabetes whose pre-pregnancy body mass index was above 25 kg/m2 should be \\nadvised to restrict calorie intake (to 25 kcal/kg/day or less) and to take moderate exercise (of at least 30 \\nminutes daily). \\nHypoglycaemic therapy should be considered by relevant specialists for  \\n\\uf0b7 Women with gestational diabetes if diet and exercise fail to maintain blood glucose targets \\nduring a period of 1–2 weeks.  \\n\\uf0b7 Women with gestational diabetes if ultrasound investigation suggests incipient fetal macrosomia \\n(abdominal circumference above the 70th percentile) at diagnosis.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 124}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n112 \\n \\n \\nHypoglycaemic therapy for women with gestational diabetes which may include regular insulin, and \\nrapid-acting insulin analogues and/or hypoglycaemic agents should be tailored to the glycaemic profile \\nof, and acceptability to, the individual woman. \\nIndividualized targets for self-monitoring of blood glucose should be agreed with women with diabetes \\nin pregnancy, taking into account the risk of hypoglycaemia eg. targeted glycaemic control pre meal 70-\\n90 mg/dl and 2 hour post meal <120 mg/dl \\nWomen with insulin-treated diabetes should be advised of the risks of hypoglycaemia particularly in the \\nfirst trimester. \\nDuring pregnancy, women with insulin-treated diabetes should be provided with a concentrated glucose \\nsolution and women with type 1 diabetes should also be given glucagon; women and their partners or \\nother family members should be instructed in their use. \\nDuring pregnancy, women who are suspected of having diabetic ketoacidosis should be admitted \\nimmediately for critical care, where they can receive both medical and obstetric care. \\nMonitoring fetal growth and wellbeing \\nPregnant women with diabetes should be offered ultrasound monitoring of fetal growth and amniotic \\nfluid volume every 4 weeks from 28 to 36 weeks. \\nRoutine monitoring of fetal wellbeing before 28 weeks is not recommended in pregnant women with \\ndiabetes, unless there is a risk of intrauterine growth restriction. \\nWomen with diabetes and a risk of intrauterine growth restriction (macrovascular disease and/or \\nnephropathy) will require an individualized approach to monitoring fetal growth and wellbeing. \\nWomen with diabetes who are pregnant should be offered immediate contact with a joint diabetes and \\nantenatal clinic. \\nPreterm labour in women with diabetes \\nDiabetes should not be considered a contraindication to antenatal steroids for fetal lung maturation or to \\ntocolysis. \\nWomen with insulin-treated diabetes who are receiving steroids for fetal lung maturation should have \\nadditional insulin according to an agreed protocol and should be closely monitored. \\nBetamimetic drugs should not be used for tocolysis in women with diabetes.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 125}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n113 \\n \\n \\nPostnatal care \\n \\nStart breast feeding immediately and continue. \\n \\nWomen with insulin-treated pre-existing diabetes should reduce their insulin immediately after birth and \\nmonitor their blood glucose levels carefully to establish the appropriate dose. \\nWomen with insulin-treated pre-existing diabetes should be informed that they are at increased risk of \\nhypoglycaemia in the postnatal period, especially when breastfeeding, and they should be advised to \\nhave a meal or snack available before or during feeds \\nWomen who have been diagnosed with gestational diabetes should discontinue hypoglycaemic \\ntreatment immediately after birth. \\nWomen with pre-existing type 2 diabetes who are breastfeeding can resume or continue to take \\nmetformin and glibenclamide immediately following birth but other oral hypoglycaemic agents should \\nbe avoided while breastfeeding. \\nWomen with diabetes who are breastfeeding should continue to avoid any drugs for the treatment of \\ndiabetes complications that were discontinued for safety reasons in the preconception period. \\nInformation and follow-up after birth \\nWomen with pre-existing diabetes should be referred back to their routine diabetes care arrangements. \\nWomen who were diagnosed with gestational diabetes should have their blood glucose tested to exclude \\npersisting hyperglycaemia before they are transferred to community care. \\nWomen who were diagnosed with gestational diabetes should be reminded of the symptoms of \\nhyperglycaemia. \\nWomen who were diagnosed with gestational diabetes should be offered lifestyle advice (including \\nweight control, diet and exercise) and offered a fasting plasma glucose measurement (but not an OGTT) \\nat the 4-6 week postnatal check and annually thereafter. \\nWomen who were diagnosed with gestational diabetes (including those with ongoing impaired glucose \\nregulation) should be informed about the risks of gestational diabetes in future pregnancies and they \\nshould be offered screening (OGTT or fasting plasma glucose) for diabetes when planning future \\npregnancies. \\nWomen with diabetes should be reminded of the importance of contraception and the need for \\npreconception care when planning future pregnancies.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 126}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n114 \\n \\n \\nChapter 17 \\nPREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV INFECTION \\n \\nThere is convincing evidence from several studies that mother to child transmission of HIV can be \\nreduced successfully by various interventions that are now proven to be highly effective.  \\nAt present Sri Lanka is a country with a low level HIV epidemic. The estimated adult prevalence rate is \\n<0.1%.  As of end 2009, the estimated number of people living with HIV was 3000. The number \\nreported in the country is around 1285. The majority of those living with HIV are unaware of their HIV \\nstatus.  The antenatal care package prepared for the benefit of all antenatal mothers in this country \\nconsists of several interventions and it will now include interventions for prevention of mother to child \\ntransmission of HIV infection.  \\nSri Lanka is adopting a 4 prong strategy to achieve zero incidence of paediatric infection.  \\n1. Primary prevention of HIV among men  and women of childbearing age  \\n2. Prevention of unintended pregnancies among women living with HIV \\n3. Prevention of HIV transmission from a woman living with HIV to her infant   \\n4. Provision of appropriate treatment, care and support to women living with HIV  and their \\nchildren and families  \\n \\nSince the antenatal HIV prevalence rate ranges between 0.02-0.03 % the best method for Sri Lanka is \\nprimary prevention of HIV among men and women of childbearing age. The most effective and humane \\nway to prevent HIV in infants is to help young men and women by promoting safer sexual behaviours to \\nremain free from infection before marriage and before the woman gets pregnant.  Further, voluntary \\ncounselling and testing should be available to any pregnant woman who requests it.  There are several \\nkey entry points within the health service which gives the opportunity for young men and women to \\nknow about HIV/AIDS, PMTCT, counselling and testing opportunities and access the available \\ntreatment, care and support services.  Integration of PMTCT services into the maternal and child health \\nservices will provide women with services to prevent new infections and promote male partner \\ninvolvement to prevent infections among men.  \\nIntegrating screening for HIV infection within the established antenatal investigation package eg \\nscreening for  syphilis, anaemia and blood grouping is being considered strongly as a PMTCT \\nintervention as it has public health benefits to the individual woman, her partner and her baby.  \\nOpportunities should be made available within the existing health services to identify HIV infected \\nantenatal mothers in order for them to utilize ART, safer delivery and feeding practices to reduce \\ntransmission to the offspring.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 127}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n115 \\n \\n \\nPrimary prevention strategies  for PMTCT  \\nRaising awareness of antenatal mothers and their partners on PMTCT \\nAll pregnant women, and those planning pregnancy   should have accessibility to appropriate \\ninformation about HIV infection including PMTCT. Information on sexually transmitted infections \\nincluding HIV and syphilis should be included in the general information given to pregnant women \\nalong with information about other infections and antenatal tests. They should be informed about \\nperinatal transmission of HIV and it adverse pregnancy outcomes. They should be aware of the potential \\nbenefits of knowing their HIV infection status by getting tested, both for their own health and to reduce \\nthe risk of perinatal transmission. As part of routine antenatal care all pregnant women should be made \\naware that mother to child transmission of HIV can be greatly reduced through antenatal and perinatal \\ntreatment with anti-retroviral drugs, safer delivery and safer infant feeding practices.  \\nInformation about facilities for screening should be made available to all pregnant women.  Discuss \\nabout the HIV test and the window period and other related issues about the HIV test. Stress those \\nmeasures to prevent unintended pregnancies among women living with HIV and prevention of \\ntransmission of HIV from mother to child can only be offered if HIV infection is diagnosed before or \\nduring pregnancy. In Sri Lanka unfortunately almost 90% of HIV infection in pregnant women remains \\nundiagnosed during pregnancy and often women only discover they are infected when their children \\ndevelop HIV infection or AIDS. Therefore, screening for HIV, as far as possible should be promoted \\nand normalized and should generally be dealt with other conditions discussed within antenatal care. \\nGive details of the procedures for testing and obtaining results. \\nInformation on safe and responsible sexual behaviour and practices should be discussed in a culturally \\nappropriate manner depending on the audience. It should include as appropriate, the importance of \\navoiding commercial and casual sex, reducing the number of sexual partners and consistent condom use.  \\nInformation on services for STI/HIV prevention should also be discussed. Draw their attention to the \\navailability of services to reduce mother to child transmission of HIV for HIV positive women including \\nanti-retrovirals which are offered free of charge.   \\nDiscussions should not be limited only for women. Men should be included when information is \\nprovided at antenatal classes. \\nCommunication \\nInformation should be presented in a way which reflects the positive outcomes of knowing the HIV \\ninfection status for women and men and for their babies. Method of communication should be in forms \\nthat are linguistically, culturally and educationally appropriate to women.  Groups health education \\nshould be utilized for dissemination of information.  \\nDiscussions should include eliciting and giving information about basic facts of STI and HIV and \\nPMTCT, exploring any concerns expressed by women.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 128}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n116 \\n \\nHealth care workers should be aware of the procedures adopted in the respective institution. In some \\nantenatal settings, HIV testing would be included as a routine test in the standard of care package of \\nservices.  Voluntary counselling & testing should be encouraged if HIV testing is not provided in the \\nantenatal care package.  \\nSignificant efforts should be taken to provide men and women with relevant information and services \\nwhich would help them to assess their own risk to infection. Therefore, the service providers should \\nhave updated, comprehensive knowledge on STI/HIV/AIDS including PMTCT to educate antenatal \\nmothers and their partners. They should have correct communication skills to talk about the following \\nconfidently.  \\nHealthcare workers should have correct technical knowledge and communication skills to talk about the \\nfollowing confidently.  \\n1. Basic facts about STD/HIV/ AIDS  \\n \\no What is HIV and AIDS and the  difference between HIV and AIDS \\no HIV / AIDS /STI overview-Local situation  \\no Natural history and what happens when the virus enters the body \\no Methods of transmission and non transmission  \\no Asymptomatic period an HIV infected person could look healthy \\no An infected person is infectious for life  \\no HIV transmission risk during  pregnancy, delivery and breastfeeding \\no Mother to child transmission of HIV and syphilis. Risk factors and methods of prevention  \\no Adverse pregnancy outcomes of maternal HIV infection and STI \\n \\n\\uf0b7 Make antenatal mothers understand that there will not be paediatric infections  if parents are not \\nHIV infected  \\n\\uf0b7 Discuss Behaviour Change efforts among vulnerable groups with promotion and provision of \\ncondoms. Counsel to change behaviours that place individuals at risk for becoming HIV infected \\nor spreading HIV infection. Promote access to condoms and dual protection  \\n\\uf0b7 How people can continue to stay negative \\n \\n2. Screening for HIV infection  \\n\\uf0b7 How to know the HIV status?  Explain about the screening test.  \\n\\uf0b7 Stress that the only way to know for sure whether a person is infected with HIV or not is by \\ntesting of blood.   \\n\\uf0b7 Discuss the purpose of HIV testing and advantages of knowing the HIV status during \\npregnancy.   \\n\\uf0b7 Discuss what the window period is and its interpretation in relation to the risky sexual \\nexposure  \\n\\uf0b7 If HIV testing is not a routine procedure in the institution, promote voluntary counselling & \\ntesting. Inform the availability of test in STD services.  \\n\\uf0b7 Make her understand that testing is done confidentially. \\n\\uf0b7 Provide information about the test procedures'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 129}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n117 \\n \\n \\n\\uf0b7 Discuss the HIV testing process. Explain the types of tests:  client initiated and provider \\ninitiated: screening and confirmatory tests , what the window period means, importance of \\nobtaining test result , implications of both positive and negative results \\n\\uf0b7  Inform that persons who test positive will receive further counselling and referral for \\ntreatment, care and support.  \\n\\uf0b7 Discuss the importance of male partner involvement  \\n\\uf0b7 Approaches for partner disclosure \\n\\uf0b7 If testing is not available in the health institution, it could be done at the closest STD clinic. If \\nit is not possible for the mother to go to the STD clinic inform her that a blood sample could \\nbe collected and sent to the STD clinic for testing  \\n \\nHIV testing is done with informed consent. Informed consent means that the health care worker has \\nexplained the above during the education session and the mother is aware of the implications of a \\nnegative or positive test. No written consent is required for HIV testing. The main objective is to \\neliminate paediatric HIV infection and improve maternal and child survival. \\n \\n \\n3. Interventions available to prevent mother to child transmission of HIV  \\n\\uf0b7 Explain the available interventions to prevent mother to child transmission of HIV to \\neliminate paediatric HIV. Availability of antiretroviral therapy from the government sector \\nfree of charge  \\n\\uf0b7 Promote seeking STD care services and  confidentiality of STD services  \\n\\uf0b7 Discuss  about confidentiality measures and efforts for prevention of stigma and \\ndiscrimination in the institution  \\n\\uf0b7 Discuss about the importance of continuous antenatal and postpartum care  \\n\\uf0b7 Discuss about the importance newborn care  \\n\\uf0b7 Trained healthcare team will provide optimum care for the mother, her partner and the baby  \\n\\uf0b7 Ask her whether she has any questions and concerns. \\n \\nAt the end of the talk, women and men who attend the talk should be able to understand: \\n\\uf0b7 The main modes of transmission of HIV and the need to avoid unsafe sexual behaviours to be \\nHIV free, which is the best method to avoid HIV infection  in the newborn    \\n\\uf0b7 HIV transmission risk to the infant  \\n\\uf0b7 Adverse pregnancy outcomes of maternal HIV infection  \\n\\uf0b7 Importance of HIV testing  as this is the only method of knowing the HIV status of men and \\nwomen. A diagnosis in the mother allows appropriate treatment and follows up of her child. This \\ngives an opportunity for partner testing. In case the partner is negative the couple could take \\nprecautions to help prevent transmission to the sexual partner.  \\n\\uf0b7 Confidentiality of information  \\n\\uf0b7 Available services in the country \\n\\uf0b7 Availability of pre test information/counselling  \\n\\uf0b7 If tests are negative how to stay negative by adopting risk reduction behaviours.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 130}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n118 \\n \\n\\uf0b7 If  HIV infection is confirmed  the availability of interventions for HIV  positive mothers, partner  \\nand the infant  \\n\\uf0b7 Advantages of ART to the mother and infant  \\n\\uf0b7 Importance of partner testing   \\n\\uf0b7 To change attitudes towards People living with HIV (PLHIV) so that stigma & discrimination \\ncould also be reduced \\n\\uf0b7 Safer sexual behaviours can protect both parents  and the baby  \\n \\nScreening for HIV during pregnancy \\n \\nHIV screening is not included in the basic investigation package during pregnancy. Voluntary \\ncounseling and testing method is used to screen pregnant mothers and their partners. The information on \\nHIV and PMTCT is given at the first antenatal class during first trimester.  Facilities for screening for \\nHIV are available at the central STD clinic and all the district STD clinics in the government sector.  \\n  \\n\\uf0b7 Explain the woman that the first blood test is called a screening test. A negative result can \\nmean either that she is not infected with HIV or that she is infected with HIV but, has not \\nyet made adequate levels of antibodies against the virus (“window period”). All positive  \\n \\n\\uf0b7 screening tests in Sri Lanka are tested with a confirmatory test. If this confirmatory test is \\npositive, it means that the woman is infected with HIV.   \\n\\uf0b7 The result of the screening test would be available depending on the test that is done. The \\nresult will be available immediately if a rapid test is done. If an ELISA test is done, it will \\ntake about a week for the result. \\n\\uf0b7 Assure the woman that her test result is confidential and will be shared only with her. \\n \\nAsk her to come in 2 weeks time to get the test result. Test result should be given only to the relevant \\nperson.Do not convey any test result over the phone. \\n \\nWhen a woman request for HIV testing,  the field health staff could ;  \\n\\uf0b7 Refer the pregnant mother to the nearest STD clinic if she agrees. (provide the address) or  \\n\\uf0b7 If the mother does not want to go to the STD clinic then draw a sample of blood, label it \\ncorrectly and send to the nearest STD clinic with a pathology request form.  It would be \\nuseful if the STD clinic is informed.  \\n \\nWhen screening test result is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n\\uf0b7 Explain that a negative result can mean either that she is not infected with HIV or that she is \\ninfected with HIV but, has not yet made adequate levels of antibodies against the virus (“window \\nperiod”)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 131}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n119 \\n \\n \\nWhen the screening test is positive: \\n\\uf0b7 She should be subjected to a detail one- to- one counseling session prior to the confirmatory test  \\n\\uf0b7 Pre-test counseling will be done by a MOH/MO  if he/she has the capacity to do so   \\n\\uf0b7 Select a suitable place where the counselling session could be carried out  maintaining privacy  \\n\\uf0b7 Discuss the HIV results when the woman is alone or with the person of her choice. \\n\\uf0b7 State test results in a neutral tone. Give the woman adequate time to express her emotions. \\n\\uf0b7 Explain to the woman that this is only a screening test and now  the confirmatory test has to be \\ndone with her consent.  \\n\\uf0b7 For the confirmatory test, a second sample has to be taken and explain this to her. Then with her \\nconsent draw the second sample and label it carefully and send it to NSACP-reference \\nLaboratory with the request form H 1214.  \\n\\uf0b7 Stress and explain to her that only if the confirmatory test is positive, there is evidence that she is \\ninfected with HIV. \\n\\uf0b7 Inform her that if she is positive, there are several interventions including medications, safe \\ndelivery and feeding practices which are able to reduce the risk of transmission of HIV to the \\nbaby.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Depending on the situation, it may be useful to discuss the importance of disclosure and partner \\ntesting (see below). \\n\\uf0b7 Identify what difficulties or problems the woman foresees and how to deal with them  \\n\\uf0b7 Encourage her to ask questions  \\n\\uf0b7 Ask the woman if she has any concerns. \\n \\nWhen the confirmatory test results is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n \\nWhen the confirmatory test result is positive: \\n\\uf0b7 Explain to the woman that a positive test results means that she is carrying the infection. \\n\\uf0b7 Reinforce that there are medications and other interventions to reduce the risk of transmission to \\nthe baby \\n\\uf0b7 Inform that she will be managed by a team of health care workers including obstetricians, \\nvenereologists, paediatricians etc.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Reinforce the importance of disclosure and partner testing (see below). \\n\\uf0b7  Give her an opportunity to discuss her concerns and doubts. \\n\\uf0b7 Be sensitive regarding her special concerns and fears \\n\\uf0b7 She may need more than one post test counseling sessions.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 132}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n120 \\n \\n\\uf0b7 There are several issues to be addressed when counselling a pregnant woman in addition to the \\ngeneral issues related to HIV. There will be concerns about risk of MTCT and the impact of HIV \\non the outcome of pregnancy, future fertility etc. Therefore, it is best that arrangements are made \\nto refer the mother (if she agrees) to the closest STD clinic for further counselling.  \\n \\nDiscuss the confidentiality of HIV infection \\n\\uf0b7 Assure the woman that the test result is confidential and will be shared only with her. \\n\\uf0b7 Ensure all records are confidential and kept locked away and only health care workers taking \\ncare of her have access to the records. \\n\\uf0b7 Do not label records as HIV positive. HIV positivity may be identified using a code. \\n\\uf0b7 Inform the woman that referral to the STD clinic is important as further counselling, assessment \\nand medication will be initiated there  \\n \\nBenefits of disclosure and testing the male partner \\nEncourage the woman to disclose the HIV testing results to her husband or another person she trusts. By \\ndisclosing her HIV status to her partner and family, the woman may be in a better position to: \\n\\uf0b7 Encourage partner to be tested for HIV \\n\\uf0b7 Prevent the transmission of HIV to her partner if he is not infected. \\n\\uf0b7 If he is infected, to access treatment and care \\n\\uf0b7 Receive support from her partner and family when accessing antenatal care and HIV treatment, \\ncare and supportive services \\n\\uf0b7 Help to decrease the risk of suspicion and violence. \\n \\nSupport to the HIV positive woman \\nPregnant women who are HIV positive benefit greatly from the following support after the first impact \\nof the test result has been overcome. Therefore take steps to provide the following  \\n\\uf0b7 Empathize with her concerns and fears \\n\\uf0b7 Help her to assess the situation and decide whether to link up with existing support services such \\nas support groups, income generating activities, religious support groups, orphan care and home \\ncare. \\n\\uf0b7 Help her to find ways to involve her husband and/or extended family members in sharing \\nresponsibility of care and support to her and the baby. If she is willing, help her to identify a \\nperson from the community who will support and care for her and the baby. \\n\\uf0b7 Discuss how to provide care for the other children and help her to identify a person from the \\nextended family or from the community who will support her children. \\n\\uf0b7 Confirm and support information given during HIV testing and counseling eg. appropriate ARV \\ntreatment, safe sex, infant feeding and family planning advice \\n\\uf0b7 Help her to absorb the information and apply it in her own case.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 133}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n121 \\n \\n \\n\\uf0b7 If the woman has signs of AIDS and/or other illnesses, refer her to appropriate services. \\n\\uf0b7 Refer individuals or couples for STD services for further support. \\n\\uf0b7 Advice her to get admitted to the hospital as instructed. \\n\\uf0b7 Tell her to take ART medicine as instructed. \\n\\uf0b7 Discuss the infant feeding options \\n\\uf0b7 Counsel her on post partum family planning. \\n \\n \\nPost partum care  \\n \\n\\uf0b7 Be aware of signs of infection following delivery. Like uninfected women, HIV positive women are \\nalso vulnerable to infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early detection and \\neffective treatment are important measures to prevent complications.  \\n\\uf0b7 Monitor for secondary postpartum haemorrhage \\n\\uf0b7 Manage infected tears or episiotomy \\n\\uf0b7 Advice women to come back to the same institution if LSCS wound infection is observed  \\n\\uf0b7 When they are discharged from the healthcare facility women should be advised to return to the \\nclinic or inform the PHM if they notice symptoms such as fever, lower abdominal pain, burning with \\nurination, foul smelling discharge, abnormal bleeding, cough, shortness of breath, calf pain \\n(increasing on walking), diarrhoea, unusual / abnormal behaviour  \\n\\uf0b7 Give the mother information on care of the perineum and breasts. Women living with HIV require \\nspecial care to reduce breast engorgement, mitigate pain and avoid mastitis \\n\\uf0b7 Women who choose to breast feed should be counselled to avoid breast engorgement which could \\nlead to mastitis, since inflammation is associated with increased risk of HIV transmission. She \\nshould be advised to seek  immediate medical care if breast engorgement is associated with fever \\nand pain   \\n\\uf0b7 Instruct her about the safe disposal of lochia and blood-stained sanitary wear or other potential \\ninfectious materials.  \\n\\uf0b7 If contraception has not been discussed before delivery it should be done during the early postpartum \\nperiod (see below).  \\n \\nCounsel HIV positive woman on family planning \\nAdvice and counsel on family planning during antenatal period and post partum visits. \\nHIV positive women and men should be empowered to take informed choices relating to their \\nreproductive lives, free of coercion. When selecting a family planning method, when only one partner is \\nHIV positive the potential risk of transmitting HIV to the uninfected partner as well as the possibility of \\ninfection with other STI should be taken into account. When both partners are living with HIV, possible \\nre-infection with other HIV strains has to be considered.  \\nThe same contraceptive options which are available to uninfected couples are available to HIV infected \\ncouples. Most methods are considered to be safe and effective for HIV infected women.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 134}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n122 \\n \\n \\nRecent WHO publications indicate that there are no restrictions on the use of hormonal contraception \\nby HIV positive women who are not on ART.  However, use of OCP containing high dose oestrogen is \\nrecommended when women are on ART. Rifampicin used in tuberculosis treatment may decrease the \\neffectiveness of oral contraceptives.  Long-acting injectables (DMPA) can be safely used in all   HIV \\npositive women including those on ART.     \\nIntra uterine contraceptive devices (IUD) can be used in case of HIV infection, except for women \\nwith AIDS and not on antiretroviral therapy.  \\nFemale sterilization or male sterilization is often the most commonly used family planning method in \\ndeveloping countries.  \\nEmergency contraception can help to prevent unintended pregnancies. It should not be used as a \\nsubstitute to regular contraception. Women on ART should be given double the normal dose, ie 2 tablets \\nwithin 72 hours and 2 tablets 24 hours later.  \\nProtection against both unintended pregnancy and STI is referred to as “dual protection”. Condoms are \\nthe mainstay of dual protection, alone or in combination with another method.  \\nDuring counselling for a contraceptive plan; \\n\\uf0b7 Encourage the woman to bring her husband for contraception counselling as it is best that they both \\ndecide on a suitable method. \\n\\uf0b7 Discuss their thoughts about having more children. \\n\\uf0b7 Ensure that they have the information they need about their own future prognosis, availability of \\nHIV treatment, and risk of transmission of HIV to the baby in future pregnancies.   \\n\\uf0b7 Listen carefully to the couples’ views.  Correct any factual misunderstandings. \\n\\uf0b7 If the husband is HIV negative emphasize the importance of using condoms to protect him from HIV \\ninfection. \\n\\uf0b7 If the husband is HIV positive, explain that although they both have HIV they could become infected \\nwith another strain of HIV and so it is sensible to use condoms to prevent pregnancy and infection. \\n\\uf0b7 Discuss where they could obtain condoms.  Demonstrate how to use condoms correctly.  Let both \\nmembers of the couple handle a condom.  Provide them with condoms and an information leaflet. \\n\\uf0b7 If they have decided that they want no more children, discuss vasectomy and female sterilization. \\n\\uf0b7 If they are uncertain about having more children in future, explain that waiting at least 2 years after \\nthe last birth to become pregnant again is healthiest for mother and child. Discuss the need of a \\nplanned pregnancy.  \\n\\uf0b7 Discuss other temporary methods of contraception. \\n\\uf0b7 Ask the woman if she has had infant feeding counselling and how she is planning to feed her baby.  \\nIf she has not yet been counselled, counsel or refer for counselling. \\n\\uf0b7 Explain that if not breastfeeding, she could get pregnant again as soon as even 4 weeks after \\nchildbirth. It is necessary to consider a family planning method early \\n\\uf0b7 If breastfeeding, explain that exclusive breastfeeding is very important during first six months for the \\nhealth of her child and to prevent pregnancy. During exclusive breastfeeding no mixed feeding is \\nallowed as mixed feeding will increase the risk of transmission of HIV to the baby. Breastfeeding'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 135}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n123 \\n \\n \\nwill provide protection against pregnancy for up to 6 months but only if the mother is breastfeeding \\noften, day and night, and giving no other food or liquids. \\n \\n\\uf0b7 Discuss about ARV and contraception use. Generally, anti-retrovirals and contraceptives do not \\nconflict, however: \\n\\uf0a7 Rifampicin (used for TB treatment) lowers effectiveness of contraceptive pills and \\nimplants. Other antibiotics do not have this problem. \\n\\uf0a7 Some antiretrovirals (protease inhibitors and NNRTIs) may lower effectiveness of \\nhormonal methods. Correct use of the method and use of condoms can make up \\nfor any decrease in contraceptive effectiveness. \\n\\uf0a7 Some women may have other medical conditions that affect choice of a method  \\n\\uf0b7 While breastfeeding non-hormonal methods such as condoms or IUD are suitable. The IUD can be \\ninserted after 6 weeks. \\n\\uf0b7 Progestogen-only methods can also be used while breastfeeding, starting 6 weeks after childbirth \\n(long-acting DMPA injectables, subdermal implants).  \\n\\uf0b7 If not breastfeeding, she can use any method. She can start any  progestogen-only methods \\nimmediately (the mini-pill, long-acting injectables, implants), or the oral combined contraception pill \\nafter 3 weeks.  \\n \\nInfant feeding with HIV \\nCounselling and support for safer infant feeding  \\nInfant feeding practices by mothers known to be HIV infected should support the greatest likelihood of \\nHIV free survival of their children and not harm the health of mothers. In order to achieve this, \\nprioritization of prevention of HIV transmission need to be balanced with meeting the nutritional \\nrequirements and protection of infants against non-HIV morbidity and mortality.  \\nInfant feeding in the context of HIV is complex because of the major influence that feeding practices \\nexerts on child survival. The counselor has to balance the risk of infants acquiring HIV through breast \\nmilk with the higher risk of death from causes other than HIV in particular malnutrition and serious \\nillness such as diarrhea among non-breastfed infants.  \\nInfants born to HIV infected mothers may escape HIV during pregnancy and delivery but remain \\nvulnerable to transmission through breastfeeding. The cumulative risk of postnatal transmission is 12%–\\n16% with 18–24 months of breastfeeding. In the absence of interventions, the overall risk of MTCT of \\nHIV in utero, peripartum and via breast milk is 30-45% with transmission through breast milk \\naccounting for a substantial proportion (30-50%) of these infant HIV infections. The only method \\nknown to completely eliminate breastfeeding associated HIV transmission is to avoid breastfeeding. \\nThis is recommended in settings in which infant replacement feeding is affordable and sustainable, clean \\nwater is widely available, hygiene and sanitation conditions are good and death due to diarrheal and \\nother infectious conditions are relatively uncommon.  However, this approach may not be feasible or \\nsafe for a variety of reasons including low acceptability due to cultural norms associated with \\nbreastfeeding.  \\nBreast-feeding by any woman confers known benefits to the infant. Children who do not breast feed are \\nup to six times more likely to die from diarrhea, malnutrition or pneumonia. Breast feeding substantially'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 136}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n124 \\n \\n \\nreduces the risk of infant mortality from other infectious diseases and malnutrition on average by 4–6 \\nfolds in the first six months and close to twofold in the second six months of life. The risks of not breast  \\nfeeding range from higher mortality in settings with unpredictable water supply or unsafe sanitation to \\ncompromising confidentiality regarding HIV status.  The combination of potent ART for the mother \\nduring pregnancy and replacement feeding for the infant prevents almost all transmission to infants in \\ndeveloped countries.  \\nFor the first time there is evidence that giving ART prophylaxis to the mother or child throughout the \\nbreastfeeding period would substantially reduce MTCT. Therefore, mothers known to be HIV infected \\nshould be supported to either: \\n\\uf0b7 Breastfeed and receive ARV interventions or \\n\\uf0b7 Avoid all breastfeeding  \\nAs a strategy that will most likely give infants the greatest chance of HIV free survival and to improve \\nthe health of the HIV infected mother.  \\nThe most appropriate infant feeding option for an HIV positive mother depends on her individual \\ncircumstances, including her health status and the local situation, the health services availability and the \\ncounselling and support she is likely to receive. The expectant mother should be counseled by a \\ncounselor who has adequate knowledge on the safer feeding options that are currently recommended. \\nThis is preferably done by a Venereologist or a Pediatrician who is trained in Lactation Management.  \\nCounsel the mother taking the following into consideration: \\n\\uf0b7 Some babies may escape infection although born to HIV infected mothers. These babies are at \\nrisk of being infected through breastfeeding. At present there are no facilities in Sri Lanka to \\ndiagnose infant HIV infection at birth and 4-6 weeks of age (diagnosis could be confirmed or \\nrefuted only after 18 months of age by the HIV antibody test). \\n\\uf0b7 There is now enough evidence that triple ART given during prenatal period for either as \\nprophylaxis or for mothers own health with safer delivery practices and avoidance of \\nbreastfeeding has substantially lowered MTCT of HIV. ART is available for antenatal mothers \\nthrough government health services \\n\\uf0b7 It should be noted that morbidity due to diarrhoea is 7 times higher, and pneumonia 3 times \\nhigher  in formula fed infants, \\n\\uf0b7 Exclusive breast feeding for 6 months have unlimited benefits to any baby and is the \\nrecommendation in Sri Lanka. The health messages given to achieve EFB should not be \\ncompromised by interventions for HIV infected mothers \\n \\n The counsellor should support the mother to decide on how these very specific conditions are met and \\nsupport the mother to decide on the best feeding option for her own baby which is sustainable and safe \\nin her individual socio economic and cultural circumstances.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 137}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n125 \\n \\n \\nRecommendations for use of replacement feeding  \\nMothers known to be HIV infected should only give commercial infant formula milk as a replacement \\nfeed to their HIV uninfected infants or infants who are of unknown HIV status, when specific conditions \\nare met:  \\n\\uf0b7 Safe water and sanitation are assured at the house hold level and in the community  \\n\\uf0b7 The mother or other caregiver can reliably provide sufficient infant formula milk to support \\nnormal growth and development of the infant  \\n\\uf0b7 The mother or caregiver can prepare it cleanly and frequently enough so that it is safe and carries \\nno risk of diarrhoea and malnutrition  \\n\\uf0b7 The mother or caregiver can in the first six months exclusively give infant formula milk and not \\ngive any kind of mixed feeds   \\n\\uf0b7 The family  is supportive of this practice   \\n\\uf0b7 The mother or caregiver can access health care that offers comprehensive child health services \\nFormula fed infants should receive 4-6 weeks of NVP prophylaxis daily or single dose NVP plus 4-6 \\nweeks of zidovudine \\nIf the above conditions cannot be sufficed; and the mother wishes to breast feed then the following is \\nrecommended:  \\nIf breastfeeding is recommended it should be exclusive breastfeeding for 6 months. Breastfeeding \\nshould be stopped only once a nutritionally adequate and safe diet without breast milk can be provided. \\nNo mixed feeding should be allowed during the first 6 months as mixed feeding increases the risk of \\nHIV transmission. EBF should be followed by continued breastfeeding with addition of complementary \\nfoods through age 12 months with gradual weaning over 1 month.The mother should be covered by \\nART as treatment for her or as prophylaxis. Infant prophylaxis for 4-6 weeks is recommended \\nirrespective of the mode of feeding.   \\nThere are two choices for HIV positive women who breastfeed and are not taking ART for their own \\nhealth.  \\n1) If she receives AZT as prophylaxis,  daily NVP is recommended for the infant from birth until \\none week after  the end of the breastfeeding period ( AZT is not recommended for breast fed \\nbabies)  or  \\n2) If a woman received a three drug regimen during pregnancy, she should continue the same \\nregimen until the end of the breastfeeding period. In this situation the infant needs ART only for \\n4-6 weeks.  \\nIf the mother decides to breastfeed it is very important to support the mother to breastfeed. She should \\nbe well trained on proper positioning and attachment of the baby to the breast in order to avoid \\ndifficulties during breastfeeding. A health care worker who is trained on lactation councelling should \\nsupport such a mother.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 138}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n126 \\n \\n \\nWhatever the feeding decision, health services should follow-up all HIV-exposed infants, and continue \\nto offer infant feeding counselling and support, particularly at key points when feeding decisions may be \\nreconsidered, such as the time of early infant diagnosis and at six months of age. \\nWhere mother and infant are both HIV positive, breastfeeding should be encouraged for at least the first \\ntwo years of life in line with recommendations for the general population. The message to health care \\nworkers is that breastfeeding is the best for every baby, even those born to HIV positive mothers \\nwhen they have access to ART.  \\nA pregnant woman living with HIV needs help to decide how to feed her baby. In a counselling session \\non HIV and infant feeding the counsellor has three main tasks: \\no to convey  information \\no to help a mother to assess the risks for her baby in her own situation \\no to give the mother confidence in her choices \\nDuring counselling the idea of weighing up risks can be difficult for a woman to understand.  Her choice \\nis not a simple one of deciding whether   to breast feed or not. Her decision will be influenced by many \\nfactors. It is therefore important that the woman makes the decision and not the counsellor. It is \\nimportant that the counsellor have adequate up to date evidence based knowledge to convey correct   \\ninformation.  \\nA woman does not need to make all decisions about how she will feed her baby at the first counselling \\nsession. While she is pregnant she needs to decide whether she will breastfeed at all or not. But she does \\nnot need to decide when she will stop breastfeeding until later. She does not need information about safe \\nweaning foods until the baby is older. However these points should be mentioned so that she \\nunderstands that they are important points to ask about later'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 139}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n127 \\n \\n. \\nChapter 18 \\nELIMINATION OF CONGENITAL SYPHILIS \\nSexually transmitted infections (STI) are one of the commonest communicable diseases found in the \\nworld today. Primarily they are transmitted through unprotected sexual intercourse. Transmission can \\nalso occur through contaminated blood and blood products and from an infected untreated mother to \\nchild during pregnancy, child birth or via breast milk. \\nSyphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It is estimated \\nthat globally about 12 million cases of syphilis occur annually and of them about 2 million are among \\npregnant women. If a woman with untreated syphilis becomes pregnant, or a woman acquires syphilis \\nduring pregnancy, depending on the stage of syphilis, the infection can be transmitted to the foetus \\ncausing adverse pregnancy outcomes including congenital syphilis. Although estimated vary, adverse \\npregnancy outcomes occur in up to 80% of women with acute syphilis including still birth (40%), peri \\nnatal death (20%) and serious neonatal infection (20%). Such outcomes are 12 times more likely in \\nwomen with syphilis than in sero-negative women. Early congenital is defined as syphilis from birth and \\nwithin two years of life. Late congenital syphilis is when vertically acquired infection manifests from \\nthird year of life onwards. \\nUnlike many neonatal infections, congenital syphilis (CS) can be effectively prevented, either through \\nprevention of maternal infection or by detection of infection early in pregnancy and provision of \\nadequate treatment. Control of sexually transmitted infections in the community by promoting safer sex, \\nincreasing awareness about syphilis and its adverse effects on mother and infant could also help prevent \\nmaternal infection. Universal screening for syphilis during pregnancy, treatment of infected pregnant \\nwomen, their partners and treatment of infants born to sero-positive woman are shown to be cost \\neffective, inexpensive and feasible in the prevention of congenital syphilis. Preventing even an \\noccasional case is economically worthwhile. Economic analyses have shown that serological screening \\nof pregnant woman is cost effective even at very low prevalence of maternal infection. The cost of \\naverting a case of CS is much lower than for other diseases. Yet in this era of concern about the number \\nof babies who are born with HIV infection, congenital syphilis receives scant attention. \\nMaternal Syphilis \\nThe causative bacterium Treponema pallidumcan be transmitted via blood of an infected mother to her \\ndeveloping foetus through the placenta. Haematogenous spread is dependent upon the occurrence of \\nmaternal spirochaetaemia. The spirochetes can cross the placenta at any time during pregnancy although \\noccurs more commonly in the last two trimesters.  \\nThe risk of congenital infection is directly related to the stage of maternal syphilis during pregnancy and \\nthe stage of pregnancy when infection is acquired. The risk of infection to the foetus is much higher \\nduring early stages of syphilis than during late stages. The more recent the maternal infection, the more'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 140}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n128 \\n \\nlikely the foetus will be affected since the early stage of syphilis is characterized by high levels of \\nspirochaetaemia. The probability of transmission to the foetus is nearly 100% when the mother has early \\nsyphilis. The spirochaetaemia diminishes over time and two years after acquisition of syphilis the \\nprobability of transmission to a fetus can take place up to four years after the acquisition of infection by \\nthe mother. \\nClinical manifestation of syphilis in the mother will depend on the stage of syphilis at the time of \\npregnancy. If the mother becomes infected late in pregnancy she may show no signs of before delivery \\nand the infected newborn may also appear normal at birth. \\nThere are two general scenarios that need to be considered when assessing the risk of congenital \\nsyphilis. \\n1. An untreated woman becoming pregnant \\n2. A woman becoming infected during pregnancy. \\nThe latter tends to be associated with overall severe outcomes for the infant as it always involves the \\nearly spirochetemic stages of the disease in which the likelihood of transmission to the fetus is high. \\n \\nDiagnosis of maternal syphilis \\nTraditionally laboratory diagnosis in adults is based on initial use of a non-treponemal screening test. \\nThese tests detect antibody to regain antigen, which is found in both Treponema pallidum and some \\nhuman tissues. They are thus not specific for Treponema pallidum and could give false positive results. \\nExamples include the venereal disease Research laboratory (VDRL) test. If a non-treponemal test is \\npositive it should be confirmed by a treponemal test using an antigen of Treponema pallidum, examples \\ninclude the Treponema pallidum haemagglutination assay (TPHA) and the Treponema pallidum particle \\nagglutination assay (TPPA). Syphilis is diagnosed when the confirmatory treponemal test is positive. \\nWhen a non treponemal test is positive in the absence of a reactive treponemal test is called a biological \\nfalse positive test. The non treponemal test becomes positive sometimes due to technical errors or due to \\ncertain physiological or pathological conditions. Acute false positive tests are found in persons suffering \\nfrom many viral and bacterial infections or who have had certain vaccinations or immunizations. \\nChronic false positives are found in the presence of autoimmune conditions, tuberculosis, leprosy or \\nmalaria. False positives are also found during pregnancy or even without a specific cause or a pre \\nexisting disease. Therefore a positive non-treponemal test should be confirmed by a specific treponemal \\nserological test to arrive at a diagnosis of syphilis \\nThe non treponemal tests have the advantages of being inexpensive and sensitive (especially in early \\ninfection.).  \\nHowever, these tests cannot be done on whole blood, they require a microscope or rotator for \\nprocessing, and misinterpretation is common by inexperienced laboratory technicians because reading of \\nthe result is subjective.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 141}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n129 \\n \\n \\nTreponemal tests, while theoretically more specific than non-treponemal tests may also give false \\npositive results. Moreover, they cannot differentiate between individuals with active (untreated syphilis) \\nand those who have previously been successfully treated for infection. In both cases, the treponemal test \\nresult will be positive. Non treponemal tests, on other hand, can distinguish current or recent infections \\nfrom old, treated infections to a certain extent based on titre levels. \\nFor the diagnosis of syphilis, a combination of the two tests is recommended. Traditional confirmatory \\nassays require expensive laboratory equipment and technical expertise, and are therefore seldom \\navailable outside reference laboratories. However, these can now be replaced by simple, rapid, point- of- \\ncare treponemal tests which use whole blood, require minimal training, no equipment or special storage \\nconditions. \\nRapid simple treponemal tests using immunochromatographic strips (ICS) which use whole blood, do \\nnot need equipment or special storage conditions and require minimal training are now available and can \\nbe used on the site including peripheral areas. Sensitivity (85- 98%0) and specificity (92-98%) of these \\ntests are high. The new rapid test has been estimated to cost U$ 7 per each case of congenital syphilis \\naverted. The affordability, convenience and practicality of rapid tests make them attractive tools, as on-\\nsite screening tests in primary care settings or in areas where laboratory services are not available. \\nHow ever since treponemal antibodies persist for years irrespective of treatment, a positive test will not \\nhelp in distinguishing active infection from past treated infection. Treponemal tests cannot be used to \\nmonitor effectiveness of treatment. \\nIn the event the ICS becomes positive, a second sample should be drawn from the mother and sent to \\nSTD clinic for re-confirmation or refer the mother to the STD clinic as early as possible \\nCase Definition of a mother with syphilis- \\nA pregnant mother with serologic evidence of syphilis (positive TPPA test) in the current pregnancy \\nwith or without symptoms of syphilis. A woman who has documentary evidence of having been \\nadequately treated in the past and in whom re-infected during the current pregnancy is ruled out is \\nexcluded from this case definition. \\nTreatment of maternal syphilis \\nSyphilis in adults is easily cured. If not treated in its early stages, the disease can become chronic, often \\nwith a long latent period with some clinically recognizable stages. In pregnancy, however, early \\ntreatment with penicillin is required for successful pregnancy outcomes. Treatment should be provided \\nearly in gestation before significant fetal involvement take place. Treating the mother with penicillin \\nduring the first and second trimester will prevent major outcomes, but later treatment or lack of \\ntreatment may result in fetal death, fetal damage or birth of an infected child. Mothers with syphilis \\nshould be preferably treated at STD clinics.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 142}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n130 \\n \\n \\nTreatment of primary, secondary and early latent syphilis \\nA single dose of benzathine benzyl penicillin 2.4 million units IM given after excluding allergy. \\nLate latent syphilis: \\nBenzathine benzyl penicillin 2.4 million units IM once a week for consecutive 3 weeks. \\nAdequate penicillin treatment will end infectively within 24-48 hrs. \\nFollow up \\nPregnant mothers treated for early syphilis should have monthly quantitative serologies throughout \\npregnancy  and  will be followed up in the STD clinic . Those who do not show a fourfold drop in titre at \\nthe end of 3 months or who show a 4 fold rise in titre should be re-treated. \\nIt is not necessary to retreat mothers who have documented evidence of adequate therapy for previous \\nsyphilis so long as there is no evidence of serologic or clinical evidence of re-infection or relapse. \\nBabies born to such mothers do not require prophylactic penicillin therapy. \\nIf doubts exist about the adequacy of previous therapy, re-treatment should be commenced promptly. \\nAllergy to penicillin \\nWhen patient sensitivity to penicillin precludes its use, erythromycin is recommended as an alternative. \\nIn early syphilis (primary, secondary and early latent) give erythromycin 500mg oral 6 hrly for 15 days. \\nIn late latent syphilis give erythromycin 500mg oral 6 hrly for 30 days. \\nHIV infection \\nEvidence suggests that treatment for syphilis in pregnant women who are HIV positive should be similar \\nto that given to other pregnant women and follow up should be the same as for adults with HIV \\ninfection. \\nTreatment of partners \\nSexual partners of mothers with primary, secondary, early latent syphilis \\nEpidemiological treatment of sexual contact is mandatory as these stages of syphilis are infectious. \\nTherefore, take necessary steps to counsel and refer to STD clinic. Those with reactive serology will  be \\ntreated according to the stage of syphilis of the partner.  \\nSexual partners of mothers with late latent syphilis \\nSexual partners should be referred to the STD clinic for assessment. They will be treated according to \\nthe stage of syphilis, if clinical evidence of syphilis is present or if serology is positive.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 143}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n131 \\n \\n \\nDiagnosis of congenital syphilis \\nThe diagnosis of congenital syphilis depends on a combination of physical, radiographic, serologic and \\ndirect microscopic evidence. \\nAt birth babies born to mothers with congenital syphilis should be examined thoroughly for physical \\nsigns of congenital syphilis. Serological tests on both the mother and the baby should be done. A sample \\nof fetal blood (5cc) should be sent to the STD clinic together with 5 cc of blood from the mother. Cord \\nblood is not suitable for testing \\nSigns and symptoms \\nAt birth about 50% of babies with congenital syphilis may be asymptomatic. Usually symptoms appear \\nin the first months but the clinical manifestations may be delayed until the second year of life. The most \\nfrequent clinical signs at birth are hapatomegaly with or without splenomegaly (33-100%), blistering \\nskin rash (40%), and bone changes seen on x-ray (75-100%). Other early signs are pseudoparesis (12-\\n36%), bleeding (100%), fever (16%), low birth weight (10-40%), swelling of joints, oedema, abdominal \\ndistension, pallor and respiratory distress. None of these signs are pathognomonic of syphilis and are \\nseen in other congenital infections. \\nInvestigations \\nDark field microscopy \\nA definitive diagnosis of syphilis is made by demonstrating the presence of Treponema pallidum by \\ndark ground microscopy on any suspicious lesions or body fluid eg: nasal discharge, skin rash. However, \\nthis procedure is cumbersome and not always possible. \\nSerology \\nThe diagnosis of congenital syphilis is complicated by passive transfer of maternal non treponemal and \\ntreponemal IgG antibodies to the foetus. The presence of these maternal antibodies makes the \\ninterpretation of reactive serological tests for syphilis in infants difficult. When a positive test for an \\ninfant is due to passively transmitted maternal antibodies they would be catabolized and undetectable in \\nnon-infected infants by 6 months of age. \\nInfants born to mothers with positive serologic tests for syphilis should be evaluated by a quantitative \\nnon-treponemal serologic test at birth. It is necessary to compare the infant’s titre with maternal \\nserologic titre using the same test. A fourfold higher titre in the infants is accepted as significant. Serum \\nfrom the neonate is the preferred specimen, since cord blood may produce false-positive results. \\nThe detection of Immunoglobulin M (IgM) in infant’s serum also indicates active infection because \\nmaternal IgM antibodies do not cross the placenta. IgM antibodies can be detected in more than 80% of \\nsymptomatic infants but data on its sensitivity for asymptomatic infants are limited. Because IgM \\nresponses take time to develop in infants and may be diminished with early treatment or inadequate \\ntreatment. A negative IgM result should not be used to exclude congenital syphilis. False positives also \\ncould occur.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 144}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n132 \\n \\n \\nSerologic evidence of congenital syphilis \\n\\uf0b7 Serum quantitative non treponemal serologic titre (VDRL titre) that is fourfold higher \\nthan the mother’s titre at the time of delivery   or \\n\\uf0b7 Presence of IgM antibodies in the infant (EIA test) or \\n\\uf0b7 Rising non treponemal antibodies in infant’s serum \\n \\nPresence of non treponemal antibodies due to other causes other than syphilis in the pregnant mother \\nwill also cross the placenta to produce a reactive serologic test which is of a false positive nature in the \\nnewborn. The titre usually reverts to non reactive by 3 months of life. \\nTreatment of infants \\nTreatment decisions must be made on the basis of: \\n1. Identification of syphilis in the mother, \\n2. Adequacy of maternal treatment \\n3. Presence of clinical, laboratory or radiological evidence of syphilis in infants \\n4. Comparison of maternal (at delivery) and infant non-treponemal serologic titres \\nAll asymptomatic babies who have no serological evidence of syphilis and are born to mothers who \\nwere adequately treated for maternal syphilis with penicillin during the current pregnancy before 4 \\nweeks of delivery according to guidelines should be treated with a single dose of prophylactic penicillin. \\nIM prophylactic treatment regimen \\nBenzathine benzyl penicillin G 50,000 units/kg as a single intra muscular injection. \\n \\nIV treatment regimen \\nAqueous crystalline benzyl penicillin G 100,000 – 150,000 million units/kg/day intravenously. It could \\nbe given as 50,000 units/kg/dose IV every 12 hrs during the first 7 days of life and thereafter every 8 hrs \\nfor 3 days to complete a total of 10 days treatment. \\nThis should be given to: \\n1. All symptomatic babies \\n2. All asymptomatic babies \\ni. \\nWhose VDRL titre is a 4 fold higher than that of the mother at delivery \\nii. \\nHaving a rising non-treponemal titre \\niii. \\nWith a reactive syphilis specific IgM antibody test \\niv. \\nBorn to mothers with clinical evidence of syphilis \\nv. \\nBorn to mothers who were treated with penicillin <4 weeks before delivery, \\nvi. \\nBorn to mothers who did not complete the recommended course of penicillin during \\npregnancy \\nvii. \\nBorn to mothers whose non treponemal high titre had not dropped four fold at the \\ntime of delivery \\nviii. \\nBorn to mothers who were treated with non penicillin regimens (erythromycin0 \\nduring pregnancy \\nix. \\nBorn to mothers whose treatment status is unknown or undocumented'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 145}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n133 \\n \\n \\nSteps in syphilis screening and management of pregnant women \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPregnant women present to the \\nantenatal clinic \\nScreen for syphilis with  \\nNon-treponemal test (VDRL) \\nScreen for syphilis with on-site rapid \\nICS test \\n\\uf0b7 \\nNo treatment required \\n\\uf0b7 \\nPromote safer sex practices \\nPositive result\\nNegative result\\nRefer to STD clinic for\\n\\uf0b7 \\nConfirmation of syphilis by treponemal test – TPPA \\n\\uf0b7 \\nTreat mother \\n\\uf0b7 \\nCounsel for partner notification, treat partner \\n\\uf0b7 \\nCounsel for HIV test \\n\\uf0b7 \\nScreen for other STI \\n\\uf0b7 \\nPrepare a plan for management of baby and followup \\nTreatment of baby \\n\\uf0b7 \\nIV penicillin regimen \\n\\uf0b7 \\nIM prophylactic penicillin regimen'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 146}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n134 \\n \\n \\nProtocol for antenatal testing for syphilis in the government health system \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from mother (filed clinic, hospitalclinic)\\nSend blood to NSACP/nearest STD clinic/testing institution\\nVDRL test positive. All positives should be confirmed \\nby the specific test (TPPA) and  the laboratory/Mo-IC \\nof STD clinic should inform the positive test results to \\nthe relevant MOH immediately. When a BFP is \\ndetected the MOH should be informed that it is not \\nsyphilis. Hard copy of the positive test results/ BFP \\nshould be sent there after \\nVDRL/TPPA test reports should be \\ncollected by the relevant MOH from \\nthe testing center \\nAll VDRL negative test results \\nshould be entered in pregnancy \\nrecord (H 512 A& B) with the POA \\nby PHM. Sero negative mothers \\nshould be informed that they are \\nfree of syphilis. BFP results and \\nTPPA positive result should be \\nentered by MOH.  Confidentiality \\nof all information should be \\nmaintained   \\nMOH will inform the PHM to trace the respective \\nmother. The mother should be given a referral letter to \\nvisit the STD clinic. Confidentiality should be \\nmaintained. \\nWhen the mother attends the STD clinic a second \\nsample should be collected for re-confirmation after \\ncounseling. When a 2nd sample is positive the mother \\nwill be informed of the diagnosis and a file should be \\nopened\\n1. Detail history + clinical assessment and \\ndetermine the stage of syphilis, whether the \\nmother was treated in the past or this is a new \\ninfection during the current pregnancy \\n2. Screen for other STI \\n3. Treat according to the stage of syphilis  \\n4. Screen spouse/partner and give epidemiological  \\ntreatment/Rx \\n5. Counsel on safer sex \\n6. Promote HIV testing of mother and partner \\n7. Follow up \\n8. Make arrangements for management of baby \\n(Prophylaxis \\npenicillin \\nor \\nIV \\npenicillin \\nregimen) \\n9. Baby should be followed up in the STD clinic \\nat 3,6 and 12 months'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 147}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n135 \\n \\n \\nChapter 19 \\nSYNDROMIC MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS \\nDURING PREGNANCY \\nIdentifying the syndromes \\nSyndrome \\nSymptoms \\nSigns \\nMost common causes \\nVaginal discharge\\nUnusual vaginal \\ndischarge \\nVaginal itching \\nDysuria (pain on \\nurination) \\nDyspareunia (pain \\nduring sexual \\nintercourse) \\nAbnormal vaginal \\ndischarge (Foul \\nsmelling /grey \\n/yellowish discharge) \\nEvidence of cervicitis  \\n- \\nErythema \\n- \\nOedema \\n- \\nInduced \\nbleeding \\n- \\nHypertrophic \\nectopy \\nVAGINITIS:\\n\\uf0b7 Trichomoniasis \\n\\uf0b7 Candidiasis \\n\\uf0b7 Bacterial vaginosis \\nCERVICITIS: \\n\\uf0b7 Gonorrhoea \\n\\uf0b7 Chlamydia \\nGenital ulcers \\nGenital sore \\nGenital ulcer \\nEnlarged inguinal \\nlymph nodes \\nSyphilis \\nChancroid \\nGenital herpes \\nLower abdominal \\npain \\nLower abdominal \\npain \\nDyspareunia \\nVaginal discharge \\nRebound tenderness  \\nAdenexial tenderness \\nPain on moving cervix  \\nTemperature 38c or \\nhigher \\nGonorrhoea \\nChlamydia \\nMixed anaerobe infections \\nOphthalmia \\nneonatorum \\nSwollen eye lids \\nEye discharge \\nBaby cannot open \\neyes \\nOedema of the eye lids \\nPurulent eye discharge \\nGonorrhoea \\nChlamydia'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 148}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n136 \\n \\n \\nVaginal discharge syndrome \\nVaginal discharge in pregnancy may mask signs of abortion complications, rupture of membranes or \\npostpartum infection. If there is no evidence of blood or amniotic fluid, treatment should be given to \\ncover candidiasis, trichomoniasis and bacterial vaginosis. \\nVaginal discharge is due to pathological cause they have either vaginitis or cervicitis or both. Vaginitis \\nis caused by trichomoniasis, candidiasis and bacterial vaginosis whereas cervicitis is causd by \\nGonorrhoea and Chlamydia.  \\nIt is normal for women to have a vaginal discharge during pregnancy. However if the vaginal discharge \\nwith foul smelling, thick and purulent with yellow discolouration, associated with genital ulcer, it could \\nbe due to a pathological cause and therefore it is useful to exclude the presence of a STI. \\n \\n                        \\nVaginitis \\nCervicitis \\n \\n\\uf0b7 Caused by trichomoniasis, candidiasis or \\nbacterial vaginosis      \\n \\n\\uf0b7 Complications are less   \\n \\n \\n\\uf0b7  Need to treat the sexual partner \\n                                                                       \\n\\uf0b7 Caused by gonorrhoea or chlamidia or \\nboth \\n \\n\\uf0b7 If untreated will result in complications to \\nthe mother and neonatal conjunctivitis of \\nthe baby'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 149}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n137 \\n \\n \\nManagement of vaginal discharge- speculum examination is not available \\n \\n \\n \\n \\n \\n \\n \\n \\nYes \\n \\n                                                                  No \\n \\n \\n \\n \\nHistory and examination\\nLower abdominal pain and \\ntenderness \\n       Patient c/o vaginal discharge\\nProfuse \\ndischarge at \\nintroitus/ \\noffensive\\nNo discharge \\nbut risk \\nassessment+ \\nGyn or STD \\nclinic \\nCurdy \\ndischarge at \\nintroitus \\n- \\nTreat for candidiasis\\n- \\nCounsel \\n- \\nScreen for Diabetes \\n- \\nFollow up \\n- \\nTreat for cervicitis & vaginitis\\n- \\nCounsel \\n- \\nPromote provide condoms \\n- \\nPartner treatment \\nAvoid sex until cured and partner treated \\nImproved by 14 days \\nReassure \\nRefer to STD \\nclinic \\nRisk Assessment\\n1. Symptomatic partner \\n2. Recent new sexual partner \\n3. Multiple sexual partner \\n4. Spouse returning after a long stay away'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 150}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n138 \\n \\n \\nManagement of vaginal discharge- speculum available \\n \\n \\n \\n \\n \\n \\n \\n \\nTreatment for Vaginitis \\nIncludes treatment for trichomoniasis, candidiasis and bacterial vaginosis \\nRecommended therapy for trichomoniasis and bacterial vaginosis: \\n\\uf0b7 Metronidazole 400 mg given orally twice daily for 7 days is effective \\nNote: Do not prescribe Metronidazole in the first trimester of pregnancy. \\n \\nPatient c/o vaginal discharge \\nHistory and speculum \\nexamination \\nLower abdominal pain+\\nGyn or STD clinic\\nCheese like discharge in \\nthe vagina\\nEvidence of cervicitis\\n\\uf0d8 cervical \\nerythematous/ \\ncervical oedema \\n\\uf0d8 mucopurulent \\ndischarge \\n\\uf0d8 hypertrophic ectopy \\nThick adherent \\noffensive vaginal \\ndischarge \\nRisk \\nassessment \\nTreat for candida \\nTreat for bacterial \\nvaginosis & \\ntricomonas vaginalis \\nTreat for cervicitis and vaginitis'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 151}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n139 \\n \\n \\nTreat the patient’s partner for trichomoniasis with Metronidazole 2g as a single oral dose or \\nMetronidazole 400mg twice a day for 7 days \\nTreatment for vaginal candidiasis \\nNystatin 100000 units (one pressary), inserted intravaginally, once a day at night for 14 days, or \\nMiconazole or Clotrimazole 200mg, inserted into the vagina once a day at night for three days or  \\nClotrimazole 500mg, inserted into the vagina once only at night \\n(Advise the patient to take the complete course of tablets) \\nTreatment for cervicitis \\nRecommended therapy for Gonacoccal cervicitis: \\nCefuroxime Axetil 1g + Probenecid 1g orally as a single dose, or Ceftriaxone 250mg by intramuscular \\ninjection in a single dose \\nRecommended therapy for chlamydial cervicitis: \\nErythromycin 500mg orally 4 times a day for 7 days ( Preferred treatment is doxycycline 100mg bd for \\n7 days but doxycycline is contraindicated in pregnancy) \\nSexual partners should be treated for gonorrhoea and chlamydia infection. It is preferable to refer to a \\nSTD clinic.  \\n \\nLower abdominal pain syndrome \\nAll sexually active women presenting with lower abdominal pain should be carefully evaluated for signs \\nof pelvic inflammatory disease. Symptoms suggestive of PID include lower abdominal pain, pain on \\nintercourse (dysparunea), bleeding after sex or between periods, and pain associated with periods (if this \\nis a new symptom). Vaginal discharge, pain on urination (dysuria), fever, nausea and vomiting may also \\nbe present. \\nWhen a woman complaints of lower abdominal pain and has missed a menstrual period or a period is \\noverdue, an ectopic pregnancy has to be excluded since it is an obstetric emergency. \\nManagement of lower abdominal pain during pregnancy \\nTreatment for PID \\nCeftriaxone 250mg intra muscular injection in a single dose \\nTreatment of chlamydia infection \\nErythromycin 500mg orally 4 times a day for 14 days, \\nTreatment for anaerobic bacterial infection \\nMetronidazole 400mg orally twice daily for 14 days \\nNote:  Metronidazole should not be used in the first trimester of pregnancy.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 152}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n140 \\n \\n \\nPartner management \\nThe partner has to be treated for gonorrhoea, Chlamydia and mixed anaerobic infections. It is preferable \\nto refer the patient to STD clinic. \\n \\nYes \\nRefer patient for urgent \\nsurgical or \\ngynaecological opinion \\nManage for PID & \\nReview in 3 days \\nImproved\\nYes \\nNO\\nPatient complaints of lower abdominal pain\\nHistory and examination\\nNO\\nAbdomial  \\ntenderness/ vaginal \\ndischarge/ adenexial \\nswelling/ adenexial \\ntenderness/ cervical \\nexcitation \\nYes \\nAny of the following present?\\n\\uf0d8 Missed /overdue period \\n\\uf0d8 Recent delivery/ abortion/ miscarriage \\n\\uf0d8 Abdominal  guarding and /or rebound \\ntenderness \\n\\uf0d8 Abnormal vaginal bleeding \\n\\uf0d8 Abdominal mass \\n\\uf0d8 Fever > 38c \\nReassure\\nRefer\\nContinue treatment until completed\\n\\uf0d8 Educate and counsel \\n\\uf0d8 Promote condom use and provide \\ncondoms \\n\\uf0d8 Treat partner \\n\\uf0d8 Ask patient to return if necessary \\nNO'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 153}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n141 \\n \\n \\nGenital Ulcer Syndrome \\nGenital Herpes, Chanchroid and syphilis are the most common.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 154}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n142 \\n \\n \\nRecommended therapy for syphilis (Primary Chancre) \\nBenzathine penicillin 2.4 million units by single intramuscular injection (Because of the large volume of \\nthe dose, give it as two injections at separate sites.) \\nFor patients who are allergic to penicillin: \\n Doxycycline 100mg orally twice a day for 15 days, or Tetracycline 500mg Orally 4 times daily for 15 \\ndays \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used during pregnancy or lactation \\nIn pregnancy and lactation use: \\nErythromycin 500mg orally four times a day for 15 days \\n\\uf0b7 All babies born to mothers treated for genital ulcers suggestive of syphilis must be treated with \\nBenzathine penicillin 50,000 IU/KG IM or should be referred to a STD clinic for evaluation \\n\\uf0b7 If a baby has signs and symptoms suggestive of congenital syphilis refer to a STD clinic \\n/Peadiatric unit. \\n\\uf0b7 All babies born to mothers treated for GUD syndrome should also be reviewed for symptoms \\nand signs of Neonatal Herpes or referred to a STD clinc. \\n\\uf0b7 Mothers treated for GUD syndrome should be referred to a STD clinic for further evaluation. \\nRecommended therapy for Chancroid: \\n\\uf0b7 Erythromycin 500mg orally four times  a day for seven days \\nAlternatively the following may be used: \\n\\uf0b7 Ciprofloxacin 500mg single oral dose or \\n\\uf0b7  Cotrimoxazole 960mg (2 tablets) orally twice daily for 7 days \\nNote: Ciprofloxacin should not be used during pregnancy \\nRecommended therapy for genital herpes; \\nAcyclovir 200mg orally 5 times a day for 5 days. Advice the patient to keep the ulcers clean by washing \\nwith a weak solution of salt water \\nAdvice the patient to take all the tablets and inform him or her about mode of transmission of STD and \\npossible complications of infection and recurrences.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 155}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n143 \\n \\n \\nOphthalmia neonatorum syndrome \\nOphthalmia Neonatorum is the term used to describe a condition where a neonate develops purulent \\nconjunctivitis in one or both eyes within four weeks of birth. It is a medical emergency and unless \\ntreatment is initiated within 24 hours, there could be permanent damage to eyes leading to blindness. It \\nrequires systemic therapy as well as local irrigation with saline or other appropriate solutions. Irrigation \\nis particularly important when recommended therapeutic regimens are not available.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 156}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n144 \\n \\n  \\nFor the baby, the treatment for gonococcal ophthalmiais: \\nCeftriaxone 50mg/kg (maximum 125mg) in a single IM dose  \\nWhere Ceftriaxone is not available, use: \\nSpectinomycin 25mg/kg ( maximum 75mg) in a single IM dose \\nTreatment of the baby for Chlamydia Ophthalmia: \\nErythromycin syrup 50mg/kg/day orally four times a day for 14 days \\nClean the baby’s eyes with saline, using a clean swab for each eye. Remember to clean from inside to \\nthe outside edge of each eye. Wash your hands carefully afterwards. \\nTreatment of mother and the father: \\nShould be given treatment for both gonorrhoea and Chlamydia infection. \\nRecommended therapy for Gonorrhoea: \\nCefuroxime axetil 1g orally + Probenecid 1g in a single oral dose or Ceftriaxone 250mg IM in a single \\ndose \\nAlternative therapy \\nCiprofloxacin 500mg orally as a single dose, or  Spectinomycin 2g by intramuscular injection in a single \\ndose PLUS \\nRecommended therapy for Chlamydial infection: \\nDoxycycline 100mg orally twice a day for 7 days or Tetracycline 500mg orally 4 times a day for 7 days \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used by lactating women. \\nWhere tetracyclines are not recommended give:  \\nErythromycin500mg orally, four times daily for seven days \\nAdvice mother to complete the course of tablets and educate her about the mode of transmission of STD, \\nthe nature of the baby’s infection, how to clean the baby’s eyes and possible \\ncomplications of infection. Counsel her and promote the use of condoms. \\n \\nPrevention of Gonococcal ophthalmia \\nOphthalmia neonatorum can be prevented by using timely eye prophylaxis. \\nThe infant’s eye should be carefully cleaned immediately after birth with normal saline. \\nIf available apply 1% tetracycline ointment to the eyes of every infant at the time of delivery. This is \\nstrongly recommended prophylactic measure.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 157}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n145 \\n \\n \\nChapter 20 \\nNATIONAL GUIDELINES FOR PREVENTION AND MANAGEMENT OF  \\nMALARIA IN PREGNANCY \\n \\n1. Screening \\nAll pregnant women residing in malaria endemic areas should be screened for malaria parasitaemia at \\nthe time of registration in the antenatal clinic and at the end of the second trimester. The screening \\nshould be done by examining thick and thin blood smears using a finger prick sample of blood. \\n2. Chemoprophylaxis \\nDue to the low incidence of malaria in the country, chemoprophylaxis is not advocated as a policy. \\nHowever, in circumstances where the pregnant women could be considered at risk of acquiring malaria ( \\nas decided by the relevant Obstetrician or the MOH/MO) chemoprophylaxis  may be initiated after the \\nfirst trimester. \\nChoroquine is the drug recommended for prophylaxis. The dose is Chloroquine 300mg base once a \\nweek. \\nChloroquine can be given after the first trimester of the pregnancy and should be continued throughout \\nthe pregnancy and for upto six weeks after delivery. \\nImportant: Before initiating Chloroquine prophylaxis, please ensure that the pregnant woman is free \\nfrom malaria parasitaemia. \\n3. Treatment of malaria during pregnancy \\n(Please refer General Circular No.01-14/2008 dated 7th May 2008 issued by the DGHS “Guidelines \\nfor malaria chemotherapy and management of patients with malaria in Sri Lanka” for further \\ndetails) \\nIf a blood smear is reported positive, ensure that the parasite species is identified (Plasmodium vivax or \\nPlasmodium falciparum). \\nTreatment of a vivax infection in pregnancy: \\nPlasmodium vivax malaria is treated with Chloroquine. \\nDay 1 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 2 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 3 – Chloroquine base 5mg/kg body weight (approx. 300mg = 2 tablets) \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 158}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n146 \\n \\n \\nRadical cure of vivvax infection in pregnancy is recommended by the administration of primaquine six \\nweeks after delivery. The dose of primaquine is 0.25mg/kg/day for 14 days. \\nTreatment of falciparum infection in pregnancy: \\nArtemedsinin + Lumifantrin (Coartem®) is the recommended drug for patient with uncomplicated \\nfalciparum infections. All falciparum patients should be admitted and managed as inward patients. \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment. \\nImportant: \\nPregnant women should not be treated with Coartem® during the first trimester of pregnancy and during \\nthe period of exclusive breast feeding. \\nQuinine (oral or IV) can be used safely during first trimester of pregnancy and in situations that the \\npatient cannot take drugs orally. Quinine can be used safely during the period of lactation. \\nDosage: \\nQuinine sulphate orally 10mg/kg body weight 8 hourly for 7 days or \\nQuinine injection in a dose of 10mg/kg body weight diluted in 5% dextrose solution \\ninfused slowly at 8 hourly intervals till the patient can take oral drugs or for at least \\n7days. \\nAll falciparum infected pregnant women should be administered a single day dose of primaquine \\n(0.75mg/kg/day) six weeks after delivery. \\nPersonal protection: \\nAll pregnant women irrespective of their being on chemoprophylaxis or not, are advised to adopt \\nmeasures for personal protection from mosquito bites including the use of insecticide treated bed nets, \\nrepellants and other measures. \\nImportant: \\nAny pregnant woman arriving from malaria endemic country and suspected of having malaria infection \\nshould be admitted to a medical institution and managed appropriately (please contact Anti Malaria \\nCampaign directorate for advice). \\nPregnant women who are travelling to malaria endemic countries should contact the Anti Malaria \\nCampaign directorate for appropriate advice. \\nAnti Malaria Campaign directorate Contact details: \\n+94 112 588408, +94 112 368173, +94 112 368174'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 159}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n147 \\n \\n \\nChapter 21  \\n \\n \\n \\nMANAGEMENT OF TUBERCULOSIS DURING PREGNANCY \\n \\nTuberculosis is an infectious disease caused by the bacillus- Mycobacterium tuberculosis and \\noccasionally by Mycobacterium bovis and Mycobacterium africanum. Tuberculosis commonly affects \\nthe lungs, but it can affect any other organ in the body. \\n \\nHow does tuberculosis spread?  \\nThe bacteria that cause tuberculosis usually spread through air. When a patient with infectious \\npulmonary tuberculosis coughs, sneezes or laughs, bacilli are expelled into the air in the form of tiny \\ndroplets. These droplets dry up rapidly to form droplet nuclei and may remain suspended in the air for \\nseveral hours. Adequate through and through ventilation removes and dilutes these droplet nuclei, and \\ndirect sunlight quickly kills the bacilli, but they can survive in the dark for several days. When a healthy \\nperson inhales these droplet nuclei containing the tubercle bacilli, he/she may become infected. \\n \\nRisk of infection  \\nAn individual’s risk of infection depends on the extent of exposure to an infectious source and \\nsusceptibility of the individual to infection. The risk of infection is therefore high in a person who has \\nclose, prolonged exposure to a person with sputum smear positive pulmonary TB. The risk of \\ntransmission of infection from sputum smear-negative pulmonary TB is low and with extrapulmonary \\nTB, still lower. \\n \\nWho is a TB suspect?  \\nA TB suspect is a person who presents with symptoms or signs suggestive of TB, particularly cough of \\nthree weeks or more.  \\nWho is considered a ‘Case’ of tuberculosis?  \\nA case of tuberculosis is a patient in whom TB has been bacteriologically confirmed or diagnosed by a \\nclinician.  \\n \\nDefinite case of TB  \\n \\nA definite case of TB is a patient with positive culture for the Mycobacterium tuberculosis complex. (In \\ncountries where culture is not routinely available, a patient with two sputum smears positive for acid-fast \\nbacilli (AFB) is considered a “definite” case)  \\n \\nCommon symptoms of pulmonary tuberculosis  \\nThe clinical presentation of tuberculosis in pregnant women is similar to that in non-pregnant patients. \\n \\nRespiratory symptoms:  \\nCough – usually more than three weeks  \\nHaemoptysis (blood stained sputum)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 160}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n148 \\n \\n \\nShortness of breath  \\nChest pain \\n \\nConstitutional Symaptoms: \\nFever and night sweats \\nLoss of appetite \\nLoss of weight \\nTiredness (Fatigue) \\n \\nSymptoms of Extrapulmonary TB  \\nThe symptoms depend on the organ involved. Patients may present with constitutional features of the \\ndisease – fever, night sweats, loss of weight, and loss of appetite or local symptoms related to the site of \\nthe disease. \\n \\nInvestigations  \\nSputum Smear microscopy  \\nSputum smear microscopy is the most reliable and cost effective method of diagnosing infectious cases \\nof pulmonary tuberculosis cases. Whenever tuberculosis is suspected in a patient who has had a cough \\nof three weeks or more, three sputum samples should be collected and examined by microscopy for \\nAcid-Fast Bacilli (AFB).  \\n \\nCollection of sputum samples  \\nA PTB suspect should submit three sputum samples for microscopy. Three early morning samples are \\npreferable. Patient should be advised to collect sputum after coughing following a deep inspiration and it \\nshould not be saliva.  \\nOutpatients may provide sputum specimens as follows:  \\n \\nFirst spot specimen - Supervised spot specimen at the first visit  \\nEarly morning specimen - Patient is given a sputum container to collect early morning  \\nspecimen on the following day.  \\nSecond spot specimen - Second supervised spot specimen is collected when the patient  \\nreturns with the early morning specimen, on the following day.  \\n \\nChest X-ray  \\nThe chest X-ray has a limited role in confirming the diagnosis of pulmonary tuberculosis. Diagnosis of \\ntuberculosis by means of X-ray alone is unreliable. Abnormalities seen on a chest X-ray may be \\nmimicked by a variety of other conditions. However chest X-ray is helpful particularly to diagnose PTB \\nin a suspect whose sputum smears are negative for AFB. \\n  \\nThe decision to start on anti-TB treatment on patients should not be based solely on abnormal chest X-\\nray findings and all efforts should be made to perform sputum microscopy. \\n  \\nIn pregnancy, chest X-rays should be avoided as far as possible, especially during the first trimester, \\nbecause of the adverse effects of x-rays on the foetus.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 161}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n149 \\n \\n \\nTherefore, diagnosis will depend more on sputum examination when a pregnant mother presents with \\nsymptoms suggestive of tuberculosis. However, if an X-ray is absolutely necessary, this may be done \\nwith the abdomen covered with a lead apron.  \\n \\nSputum Culture for AFB  \\nCulture examination of sputum for AFB is more sensitive and specific than direct smear microscopy and \\nmay be useful in detecting cases where the number of organisms are fewer than can be detected by direct \\nsmear microscopy. But this is more expensive and takes at least 6-8 weeks to get the results.  \\nUnder ideal circumstances pre-treatment sputum cultures for AFB should be performed on all PTB \\npatients. \\n \\nTB treatment regimens  \\nTreatment regimens consist of two phases:  \\n1. Initial intensive phase  \\n2. Continuation phase  \\n \\nIntensive phase  \\nDuring the initial intensive phase, there is rapid killing of TB bacilli. Infectious patients quickly become \\nnon-infectious (within about two weeks) and symptoms improve. Most patients with sputum smear-\\npositive pulmonary TB becomes smear negative within two months. Directly Observed Therapy (DOT) \\nis essential in the initial phase to ensure that the patient takes every single dose. This prevents \\ndevelopment of drug resistance. The risk of development of drug resistance is higher during the early \\nstages of anti-TB treatment, when there are more bacilli.  \\n \\nContinuation Phase  \\nDuring the continuation phase, fewer drugs are necessary, but for a longer period. The sterilizing effect \\nof the drugs eliminates the remaining bacilli, thus preventing subsequent relapses.  \\nPatients who have taken anti-tuberculosis drugs previously are much more likely to develop drug \\nresistance, which may have been acquired through inadequate prior chemotherapy. Such patients require \\na stronger regimen consisting of more drugs and for a longer period.  \\n \\nTherefore, before starting treatment, it is essential to question all patients closely and carefully to \\ndetermine whether or not they have previously taken treatment for tuberculosis, so that they can \\nbe given the proper treatment regimen.  \\n \\nStandard code for TB treatment regimens  \\nThere is a standard code for TB treatment regimens and each anti-tuberculosis drug has an abbreviation.  \\nH – Isoniazid  \\nR - Rifampicin  \\nZ - Pyrazinamide  \\nE - Ethambutol  \\nS – Streptomycin  \\n \\nA TB treatment regimen consists of two phases, the intensive phase and the continuation phase. The \\nnumber before a phase is the duration of that phase in months. A subscript number (e.g. 3) after a letter'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 162}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n150 \\n \\n \\nindicates the number of doses of that drug per week. No subscript number after a letter indicates that the \\ntreatment is daily.  \\nE.g.: 4 HR means 4 months of Isoniazid and Rifampicin daily.  \\n5 H3 R3 E3 means 5 months of Isoniazid, Rifampicin and Ethambutol three times a week. \\n \\nTable 1 Case definitions, Treatment Categories and Recommended Regimens \\n  \\nCase Definition  \\nTreatment \\nCategory  \\nTreatment Regimen  \\nIntensive \\nPhase  \\nContinuation Phase  \\nNew cases  \\n- PTB smear-positive  \\n- PTB smear-negative  \\n- Extrapulmonary TB  \\nCAT 1 \\n2 HRZE \\n4 HR \\nRe-treatment cases  \\n- Relapses  \\n-Treatment after failure  \\n-Treatment after default  \\n(smear-positive)  \\nCAT 2  \\n2HRZES / 1 HRZE 5 HRE  \\n \\nMonitoring of sputum smear-positive pulmonary TB patients \\nResponse to treatment should be monitored by sputum smear examination \\nFor sputum smear positive PTB patients, sputum smear examinations should be performed at the end of \\nthe intensive phase of treatment (i.e.,second month), during the fifth month and ai the end of treatment. \\nNegative sputum smears indicate good treatment progress. \\nFor sputum smear negative patients sputum smear examination should be performed at the end of two \\nmoths of treatment. \\n \\nTreatment during Pregnancy  \\nAnti-TB treatment should be started as soon as the diagnosis is made, and the full course of treatment \\ngiven.  \\nThe basic principles of treatment are the same in pregnancy. Most anti-TB drugs are safe for use during \\npregnancy except streptomycin.  \\nStreptomycin should not be given because it can cause oto-toxicity in the foetus.  \\nPregnant mothers should be given pyridoxine 10mg daily along with INAH.  \\nVitamin K should be administered at birth to the infant of a mother taking rifampicin because of the risk \\nof post-natal haemorrhage.  \\n \\nTreatment during breast-feeding  \\nA patient who has TB and is breast-feeding should receive the full course of anti-TB treatment. Properly \\ntaken treatment is the best way of preventing transmission of TB to her baby. All anti-TB drugs are \\ncompatible with breast-feeding. A patient taking anti-TB treatment can continue to breastfeed her baby \\nin the normal way.  \\n \\nBreastfeeding should be avoided only in cases where the mother has dual TB/HIV infection.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 163}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n151 \\n \\n \\nManagement of a newborn child of a mother with active TB  \\n• Do not separate the child from the mother unless she is acutely ill.  \\n• If the mother is sputum smear negative, and if the infant has no evidence of congenital TB, BCG is \\ngiven to the infant.  \\nIf the mother is sputum smear-positive at the time of delivery, infant should be carefully examined \\nfor evidence of active disease.  \\n- If the infant is ill at birth and congenital TB is suspected, a full course of anti-TB treatment \\nshould be given.  \\n- If the child is well, give prophylactic treatment with INAH 5mg/ kg body weight, daily for \\nthree months. BCG is withheld.  \\n• The Mantoux skin test is done after three months.  \\n- If the Mantoux test is negative and the child is well, prophylactic treatment with INAH is \\nstopped and child is given BCG.  \\n- If the Mantoux test is positive, careful examination of the child for active TB is done \\nincluding a chest X-ray.  \\n- If active disease is diagnosed, a full course of anti-TB treatment should be commenced.  \\n- If the physical examination and the chest X-ray are normal, INAH chemoprophylaxis is \\ncontinued up to six months and BCG is given.  \\n \\nDirectly Observed Treatment  \\nDirectly Observed Treatment (DOT) is one of the important elements of the internationally \\nrecommended strategy for TB control. Directly Observed Treatment means that an observer watches the \\npatient swallow their tablets. This ensures that a TB patient takes the right anti-tuberculosis drugs, in the \\nright doses at the right intervals without interruption and ensures that the patient completes the full \\ncourse of treatment. \\n \\nDOT Providers –  \\nThe following categories will provide Direct Observation of Treatment.  \\n• Health workers at state health care facilities  \\n• Field health care workers  \\n• General practitioners  \\n• Trained volunteers  \\n• Community leaders  \\nPublic health staff especially Public Health Nursing sisters and Public Health Midwives  can play a \\nsignificant role as DOT providers for antenatal and postnatal mothers in their areas who are on \\ntreatment. \\n \\nProvision of drugs for the DOT Centres -  \\nDrugs for each patient will be delivered to the DOT centres from the District Chest Clinic by the PHI or \\nany other staff assigned by the DTCO. \\n \\nInterruption of treatment (default)  \\nDirectly Observed Treatment adapted to the needs of the patient is the best method of avoiding treatment \\ninterruption. However, even with directly observed treatment and during the continuation phase of \\ntreatment, which may be self-administered, there may be treatment interruption.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 164}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n152 \\n \\nMeasures to minimize treatment interruption  \\nAt the time of registration of a TB patient, the staff must educate the patient and the family regarding the \\nduration of treatment and the importance of adherence to treatment.  \\n \\nIt is vital to record the patient’s address and other relevant addresses e.g. parents or work place etc. in \\norder to help locate the patients who interrupt treatment. As far as possible, the address should be \\nverified at the beginning of treatment.  \\n  \\nPublic Health Midwives in their field visits and at antenatal clinics should inquire about uninterrupted \\ncontinuation of treatment from patients and should encourage them to continue treatment. \\n \\nManagement of patients who interrupt treatment  \\nIt is important to take action on defaulters immediately. Patients should be contacted the day after \\nmissing a dose during the intensive phase and as soon as possible during the continuation phase. It is \\nimportant to find out the reason for the patient’s absence in order to take appropriate action and continue \\ntreatment. \\n \\nNotification \\nAt the point of diagnosis, all tuberculosis patients should be notified using TB notification Form (H \\n816). \\n \\nContact screening  \\nHousehold contacts of infectious TB patients (adults and children >5 years) should be screened for \\nsymptoms of TB. Those who have symptoms suggestive of TB should be investigated with sputum \\nsmears irrespective of the duration of the symptoms.  \\nChildren under the age of 5 years should be screened with chest X-ray and Mantoux test.  \\n \\nPreventive treatment  \\nThe aim of preventive treatment is to prevent progression of M. tuberculosis infection to disease.  \\n \\nPrimary chemoprophylaxis  \\nWhen a person is exposed to TB bacilli, but not yet infected eg. newborn breastfed baby of a sputum \\nsmear-positive mother  \\n \\nSecondary chemoprophylaxis  \\nA person who is infected, but not yet developed clinical disease e.g. tuberculin positive close contacts of \\nsputum smear-positive patients.  \\nIn Sri Lanka, chemoprophylaxis is given for the following groups:  \\n• Breast fed infants of sputum smear-positive mothers.  \\n \\n• Household contacts below 5 years of age of sputum smear-positive patients, who do not have \\nevidence of active disease.  \\nProphylactic treatment in Sri Lanka is – INAH 5mg/ kg body weight for 6 months.  \\n \\nFor further details refer ‘General Manual for Tuberculosis Control’ published by National \\nProgram for Tuberculosis Control and Chest Diseases.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 165}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n153 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPOSTNATAL CARE'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 166}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n154'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 167}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n155 \\n \\n \\nChapter 22 \\nPOST NATAL CARE \\nPostnatal period begins immediately after birth of the baby and extend up to 6 weeks (42 days) after \\nbirth:  \\nImmediate postnatal period - the phase immediately following child birth up to 24 hours \\nEarly postnatal period - Day 2-7 \\nLate postnatal period - Day 8-42 \\n The major objectives of the postnatal care are: \\n\\uf0b7 To provide a supportive environment in which a woman, her newborn baby and the wider family \\ncan begin the transition of their lives \\n\\uf0b7 To recognize danger signs in the mother and the newborn and to help them to take timely actions \\n\\uf0b7 To maintain good physical and mental health in both mother and the newborn  \\n\\uf0b7 To support, promote and protect breast feeding \\n\\uf0b7 Counseling on family planning to help the mother to select a method and provision of services \\nwhere needed. \\n\\uf0b7 Recognize the child as a service utilizer \\n \\n22.1  Immediate postnatal period \\nThis is the period during which infant’s physiology undergoes adaptation and the risk of postpartum \\nhaemorrhage is highest. Close professional supervision is required in this period to identify problems \\nearly and intervene appropriately. According to the discharging policy in Sri Lanka, postnatal care \\nduring immediate postnatal period is given at a hospital. \\nImmediate Maternal Care \\n\\uf0b7 All women should be examined one hour after delivery of placenta, including assessment of \\nanaemia. \\n\\uf0b7 All postnatal mothers should have regular assessment of vaginal bleeding, uterine contraction, \\nfundal height and temperature. \\n\\uf0b7 All women should be encouraged to mobilize appropriately as soon as following the birth \\n\\uf0b7 Measure and document BP once within 6 hours after the last measurement taken soon after birth  \\n\\uf0b7 Document urine output during first 6 hours \\n\\uf0b7 Toilet facilities that are hygienic and ensure privacy should be provided at a distance with easy \\naccessibility \\n\\uf0b7 Ensure adequate rest for the woman and access to food and drink on demand'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 168}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n156 \\n \\n \\nConcerns \\n\\uf0b7 If infection is suspected, a woman’s temperature should be measured and documented. If the \\ntemperature is above 38oC, it should be measured again in 4-6 hours and need to find out the \\ncause. \\n\\uf0b7 If a woman has excessive and offensive vaginal discharge, abdominal tenderness, fever and any \\nabnormalities in the size, tone and position of the uterus, she should be evaluated. These women \\nmay need urgent action. \\n\\uf0b7 If diastolic blood pressure is greater than 90mmHg, and there are no other signs and symptoms \\nof pre-eclampsia, the measurement of blood pressure should be repeated within 4 hours. \\n\\uf0b7 If a woman has not voided by 6 hours postpartum irrespective of measures to encourage \\nmicturition (such as taking a warm bath or shower), bladder volume should be assessed and \\ncatheterization need to be considered (urgent action). If a woman is obese, she will require \\nindividualized care. \\n\\uf0b7 Immediate referral or emergency action is required if there is: \\nSudden or profuse blood loss or loss accompanied by any of the signs and symptoms of \\nshock, including trachycardia, hypotension, hypoperfusion and change in consciousness  \\nDiastolic BP is greater than 90mmHg and accompanied by another sign or symptom of \\npre-eclampsia, or if diastolic BP is greater than 90mmHg and is not reduced below \\n90mmHg within 4 hours. \\nThe temperature remains above 380C on the second reading or there are other observable \\nsymptoms and measurable signs of sepsis \\nA woman complained of unilateral calf pain, redness, swelling, and shortness of breath or \\nchest pain \\nAll women should be given information about the physiological process of recovery after birth, and that \\nsome health problems are common, with advice to report any health concerns to health care workers, in \\nparticular: \\nSigns and symptoms of PPH: sudden and profuse blood loss or persistent increased blood loss: \\nfaintishness; dizziness; palpitations/tachycardia \\nSigns and symptoms of infection: fever, shaking, abdominal pain and/ or offensive vaginal loss \\nSigns and symptoms of thrombo-embolism: unilateral calf pain; redness or swelling of calves; \\nshortness of breath or chest pain \\nSigns and symptoms of pre-eclampsia: Headaches, visual disturbances, nausea, vomiting, feeling \\nfaint. \\nWomen who have had an epidural or spinal anaesthesia should be advised to report any severe \\nheadache, particularly when sitting or standing \\n \\n \\nAdvice on postpartum care and hygiene, especially hand washing and use of clean napkins or pads'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 169}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n157 \\n \\n \\nGive advice on proper nutrition during lactation (page 85). \\nCounsel on birth spacing and family planning with special attention to lactational amenorrhoea and \\nemphasis the need of using a family planning method by 6 weeks. \\nAdvise on routine postpartum care at the field and ask them to inform area PHM as soon as they go \\nhome to get routine care. \\nAdvice on postpartum danger signals and discuss the postpartum emergency plan (page 65 ). \\nGive Vit A mega dose (200,000IU) before discharge. \\nIf she is not immunized with Rubella, make arrangement for rubella immunization before discharge. \\nDo a vaginal examination before discharge and ensure that there are no foreign bodies in the vagina eg. \\nGauze packs etc \\nComplete all the documents eg Diagnosis cards, pregnancy record and hand over the relevant documents \\nto mother. \\nHelp the mother to register the birth. \\nAdvice about maternal benefits, if relevant. \\n \\nImmediate Newborn Care \\n\\uf0b7 Baby should be delivered on to the mother’s abdomen \\n\\uf0b7 Immediately dry the baby with a warm clean towel or piece of cloth. Thoroughly dry the baby to \\nprevent it getting cold. Wipe away any blood or meconium. Do not wipe off the vernix ax it \\nhelps to protect the bay’s skin and gets reabsorbed very quickly. \\n\\uf0b7 Assess the baby’s breathing while drying  \\n\\uf0b7 Make sure that there is no second baby \\n\\uf0b7 Change gloves. If this is not possible wash the gloved hands \\n\\uf0b7 Clamp and cut the umbilical cord \\n\\uf0b7 Leave the baby between the mother’s breasts to start skin to skin care \\n\\uf0b7 Place an identity label on the baby \\n\\uf0b7 Cover the baby’s head with a hat and cover the mother and baby with a warm cloth \\n\\uf0b7 Encourage initiation of breastfeeding. Keeping the newborn skin to skin between the mother’s \\nbreasts encourage this process. \\n \\nDuring the first hour of life: \\n\\uf0b7 Ensure the mother and baby are in a warm room which is not  less than 250c with no draught \\n\\uf0b7 Mother and baby should not be separated. Keep the baby in the same room with the mother in \\nher bed or within easy access.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 170}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n158 \\n \\n\\uf0b7 Skin to skin contact should be encouraged for all the newborns in the first hour of life. For low \\nbirth weight newborns skin to skin contact (Kangaroo Mother Care) can be practiced as long as \\nthe baby requires. \\n\\uf0b7 Brest feeding should be initiated within the first hour of life and continue on demand. Identity \\nhunger cues and start breastfeeding when the baby is ready. Support exclusive breastfeeding on \\ndemand day and night Newborn should be dressed adequately in order to to maintain the body \\ntemperature. Baby’s head should be covered with a cap. Additional layer of clothing should be \\nworn if it is in a cooler climate. \\n\\uf0b7 Resuscitate a baby that is not breathing spontaneously (weight, length, head circumference etc.), \\n\\uf0b7 Assess the gestational age and take measrements. \\n\\uf0b7 Vitamin K should be offered for all infants and administered with a single dose of 1mg IM. \\n \\nMaintaining infant health \\nRound the clock keep the mother and baby together in the same bed or in the same room within easy \\naccess to the mother. Continuing skin to skin contact, whenever possible. \\nIn areas where it is necessary, cover the mother and baby with a bed net \\nEnsure exclusive breastfeeding on demand during day and night for the newborn. In case if the mother \\ndevelop difficulties in breastfeeding make her aware how to seek support from her area PHM or at the \\nclosest hospital Lactation Management Centre \\n \\nMake the mother aware about routine care of the newborn \\n- \\nKeeping the baby warm – Newborn should be dressed adequately and the head should be \\ncovered with a cap during the first few days. Additional layer of clothing should be worn if it is \\nin a cooler climate.  \\n- \\nDress the baby well and keep covered with a soft cloth. If the baby is not kept with the mother, \\ncheck for warmth every 4 hours by touching bay’s feet. Delay bathing until at least the baby is 6 \\nhours old. \\n- \\nCare of the umbilical cord (should be kept dry, should not apply anything on the cord stump, if it \\nis soiled, wash with soap and water and dry well. \\n- \\nDaily clean the baby’s face, neck and the arm pits. Clean the buttocks when soiled. Bath the baby \\nwhen required using warm water. After bathing make sure to keep the baby warm \\nAssessment for emotional attachment should be carried out at each postnatal contact \\nFirst clinical examination should be done around an hour after the birth to assess if baby can stay with \\nthe mother or needs additional care or referral to special care. \\nAssess the malformations and birth injuries \\nInfants who develop jaundice within the first 24 hours should be urgently investigated. \\nTeach the mother how to care for a small baby (pre-term or low birth weight) eg. Kangaroo-mother care  \\nGive special support to breast feeding the small bays or twins.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 171}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n159 \\n \\n \\nTeach the mother to observe for the danger signs in the baby and to call health worker if she has \\nconcerns. \\nExamine before discharge. Discuss with mother postnatal care and emergency plan. \\nOnly discharge small babies if discharge criteria met: Exclusive breast feeding, stable temperature, \\nweight gain, mother feeling competent caring for the baby. \\n \\nSupport for breast feeding: \\nBreast feeding support to a woman should be made available regardless of the location of care. \\nWomen should be offered skilled support including mother to mother or peer support from the \\ncommencement of the breast feeding. \\nAdditional support with positioning and attachment to commence breast feeding should be offered to all \\nwomen who had: \\n\\uf0b7 A caesarean section, particularly to assist with handling and  positioning the baby to protect the \\nceasarean section wound \\n\\uf0b7 Initial contact with their baby delayed \\n\\uf0b7 Twins \\nUnrestricted frequency and duration of breast feeding should be encouraged. \\nA PHM should discuss the woman’s experience with breast feeding daily to assess with her if she is on \\ncourse to breast feed effectively and identify need for additional support. \\nA written breastfeeding education material should be available and health care staff should use them in \\nroutine BF lecture/demonstrations. \\nIf breastfeeding problem is identified, refer mother to lactation management center \\nTeach all mothers how to relieve engorgement and expressing breast milk and feeding the baby with a \\ncup. \\nWomen with flat or inverted nipples should be advised that these are not contraindications to \\nbreastfeeding and support should be offered as needs \\nIf a woman is experiencing breast or nipple pain, healthcare worker should review positioning and \\nattachment. \\nA baby who is not attaching effectively may be encouraged to open his/her mouth using different \\nstimuli. \\nSkin to skin contact or massaging the baby’s feet should be used to wake the baby. \\nOnly discharge the baby if mother feels competent in breast feeding. \\nWomen should be offered information and reassurance on: \\n\\uf0b7 Colostrum which will meet the needs of the baby in the first few days after birth \\n\\uf0b7 Timing of the initial breast feed, including the protective effects of colostrum \\n\\uf0b7 The nurturing benefits of putting the bay to the breast in addition to the nutritional benefits of \\nbreasfeeding. \\n \\nWomen should be reassured that brief discomfort at the start of breast feeds in the first few days is not \\nuncommon, but should not persisits.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 172}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n160 \\n \\n \\n22. 2  Post natal care at the field  \\nOnce the mother is discharged from the hospital, professional postnatal care is provided through home \\nvisits by the PHM and postnatal clinics (a component of a poly clinic).  Other than that woman caring \\nfor herself and newborn with the support of the family. Therefore, health workers need to be ensured \\nthat home practices are in line with evidence based best practices and give some skills to the family and \\ncommunity to support women and babies during this critical period.  \\nPostnatal care model in Sri Lanka consists of domiciliary care and clinic care. The area public health \\nmid wife (PHM) is responsible for the post natal home visits while hospital or field clinic manned by a \\nqualified medical officer responsible for clinic care.  \\n \\n \\n \\n \\n \\n \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\nWomen with postnatal complications need more clinic visits as well as home visits. Women who had \\nstill births and infant deaths should be also visited by the PHM.  \\n \\n \\n \\n \\nFor Normal vaginal delivery:    \\n 02 home visits during first 10 days after delivery (first visit first 5 days) \\n \\n01 home visit during 14-21 days (around 15th day) after delivery \\n \\nPostnatal clinic visit at 4-5 weeks  \\n \\n01 visit around 42 days (6-7 weeks) after delivery \\nFor Home delivery:                    \\n  \\n03 visits during first 10 days after delivery \\n01 visit 14-21 days (around 15th day) after delivery \\nPostnatal clinic visit at 4-5 weeks  \\n01 visit around 42 days of delivery'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 173}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n161 \\n \\n \\nFirst and second home visits (within the first 10 days post partum) \\n \\nA locally adopted system should be implemented to inform the PHM regarding the child birth as soon as \\nthey are discharged from the hospital eg. messenger, telephone call or a specially designed card etc. \\n \\nPHM  \\n\\uf0b7 Should be able to identify all the post partum mothers in her area including those come from \\nother areas. \\n\\uf0b7 should be able to identify and take necessary action to the problems in mother and baby  \\n \\nObserve: \\nGeneral condition of the mother and the home: \\nCleanliness and order in the house and the place where new born and mother live (ventilation, \\nlight, safety, warmth, humidity, smoke exposure) \\nMother and baby are within easy reach. \\nPersonnel hygiene of the mother \\nBehaviour and the mood of the mother (sad, happy) \\nSupport and general attitude of other family members towards mother and baby \\n \\nBaby: \\nPHM should mainly consider the following important points in the care of the newborn (essential \\nnewborn care): \\n\\uf0b7 Ensure that the baby is kept warm \\n\\uf0b7 Keep the mother and the baby together, in the same room, same bed or within easy reach \\n\\uf0b7 Support exclusive breastfeeding on demand day and night \\n\\uf0b7 Teach the mother how to care for the baby \\nLook at the CHDR and neonatal diagnosis cards, if any \\nEnsure that BCG immunization has received \\nIdentify the presence of any high risk condition which needs special attention   \\n \\nWash hands with soap and water before examining the baby. \\n Select a place with good light for examination. \\n \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0a7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0a7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0a7 Sleep \\n\\uf0a7 Crying \\n\\uf0a7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0a7 Vomiting'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 174}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n162 \\n \\n \\nObserve and examine : \\n\\uf0a7 General appearance: weight, colour, any other external abnormalities \\n\\uf0a7 Look at the presenting part : swelling or bruises \\n\\uf0a7 Movements : Normal/abnormal \\n\\uf0a7 Observe the cry \\n\\uf0a7 Hygiene of the baby \\n\\uf0a7 Breathing : Normal/ grunting/ and count breaths (30-60 per minute) \\n\\uf0a7 Feel for warmth. If cold or very warm measure the temperature \\n\\uf0a7 Tone : Normal/ abnormal \\n\\uf0a7 Colour:  tip of the nose, eyes, skin (cyanosis, jaundice) \\n\\uf0a7 Condition of the umbilicus \\n\\uf0a7 Presence of any danger signs – box below \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nIf any danger sign is detected refer the baby immediately for care.  If any other problem is detected refer \\naccordingly \\n \\n \\nDanger signs in the newborn \\n\\uf0b7 \\nFast breathing (more than 60 breaths per minute) \\n\\uf0b7 \\nSlow breathing (less than 30 breaths per minute) \\n\\uf0b7 \\nSevere chest in-drawing \\n\\uf0b7 \\nGrunting \\n\\uf0b7 \\nConvulsions \\n\\uf0b7 \\nFloppy or stiff \\n\\uf0b7 \\nBluish discolouration of the body \\n\\uf0b7 \\nFever (temperature > 380C) \\n\\uf0b7 \\nCold body ((temperature < 350C) or not rising after rewarming \\n\\uf0b7 \\nBleeding from umbilical stum or cut \\n\\uf0b7 \\nYellow discoloration of the body \\n\\uf0b7 \\nPallor \\n\\uf0b7 \\nDiarrhoea \\n\\uf0b7 \\nVomiting after every feed \\n\\uf0b7 \\nIf a baby who was breastfeeding well refuses two consecutive \\nfeeds \\n\\uf0b7 \\nUmbilicus draining pus or umbilical redness extending to skin \\n(periumbilical redness)  \\n\\uf0b7 \\nSwelling in one or more limbs \\n\\uf0b7 \\nWeakness in any one of the limb \\n\\uf0b7 \\nWeak cry \\n\\uf0b7 \\nMore than 10 skin pustules or bullae or swelling, redness, \\nhardness of skin'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 175}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n163 \\n \\n \\nBreast feeding: \\nAsk from the mother: \\n\\uf0b7 Any concerns or difficulties in breastfeeding  \\n\\uf0b7 How many times the baby has fed in 24 hours \\n\\uf0b7 Whether the baby is satisfied after a breastfeed \\n\\uf0b7 Whether the baby is exclusively breastfed \\n\\uf0b7 How her breasts are feeling \\n \\nObserve a breast feed: \\nIf the baby has not breastfed in the previous hour ask the mother to put the baby on her breast and \\nobserve breastfeeding for about 5 minutes and observe the following; \\n\\uf0a7 The position of the mother   \\n\\uf0a7 The position of the baby during breastfeeding \\n\\uf0a7 Attachment of the baby to the breast during breast feeding \\n\\uf0a7 Whether the baby is suckling effectively \\n \\nIf the baby has fed in the last hour ask her to tell you when her baby is willing to feed again.  \\n \\n \\nAsses the mother’s breasts if complaining of nipple or breast pain \\n\\uf0b7 Look at the nipples for fissures \\n\\uf0b7 Look at the breasts for swelling, shininess or redness \\n\\uf0b7 Feel gently for the painful part of the breast \\n\\uf0b7 Measure temperature \\n\\uf0b7 Identify and solve problems during breast feeding  \\n\\uf0b7 Advice  to check adequacy of breast milk ( How many times that baby has passed urine, duration \\nof a feed)  \\nEducate mother on activities that should be done for psycho social development of the baby - kissing the \\nbaby, touching, Nalavili gee \\nEducate the mother on how to keep the baby warm. \\nEducate mother on how to keep the home environment safe and clean (with out dust, cold, smoke) \\nAdvice on methods of infection control- the importance of limiting visitors, limiting the number of \\nhandlers, hand washing \\n \\nInquire about the myths and correct them- ratha kalkaya, gammiris pibima \\nInquire and solve the problems with BCG immunization \\nRegister the baby and maintain records \\nDecide on date of next visit according to the problems identified'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 176}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n164 \\n \\n \\nMother: \\nAsk: \\nEnquiries should be made about general wellbeing and all common health problems:  \\n\\uf0b7 Micturition, dysuria and urinary incontinence  \\n\\uf0b7 Bowel functions : diarrhea /constipation \\n\\uf0b7 Vaginal  bleeding: amount/ colour \\n\\uf0b7 Vaginal discharge :  amount/ smell/ colour  \\n\\uf0b7 Lower abdominal pain \\n \\n\\uf0b7 Vomiting \\n\\uf0b7 Breathing difficulties \\n\\uf0b7 Severe headache \\n\\uf0b7 Calf pain \\n\\uf0b7 Visual disturbances \\n\\uf0b7 Healing of any perineal wounds \\n\\uf0b7 Back pain \\n \\nExamine: \\n\\uf0b7 General appearance of the mother: shortness of breath, cyanosis, icterus \\n\\uf0b7 Temperature \\n\\uf0b7 Respiratory rate \\n\\uf0b7 Pulse rate \\n\\uf0b7 Features of anaemia: pallor in tongue, conjunctiva , nails \\n\\uf0b7 Oedema: ankle, facial, fingers \\n\\uf0b7 Breast (if not done earlier): breast engorgement, cracked nipples, breast abscesses \\n\\uf0b7 Abdomen: size and consistency of the uterus, LSCS scar \\n\\uf0b7 Perinium:  \\no Lochia: amount, colour and smell \\no Vaginal discharge: colour and amount \\no Vaginal bleeding \\no Episiotomy scar: infected or not, gaping, healing \\no Personnel hygiene of the mother in relation to perineal area \\no Mental status: sad/happy, features of psychosis \\no Check urine if indicated (Pre eclampsia, diabetes, renal disease \\no If need carry out a vaginal examination'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 177}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n165 \\n \\n \\nIntervene:  \\nEncourage mother to use self care techniques such as taking gentle exercises, taking time to rest, having \\nhelp to care for her baby, talking to someone about her feelings \\n \\nAsk the mother about her emotional well-being, what family and social support they have and their \\nusual coping strategies for dealing with day to day matters. Post natal mother and her partner and family \\nshould be encouraged to tell their health care workers about any changes in mood, emotional state and \\nbehavior that are outside of the mother’s normal pattern. \\n \\nObserve for any risks, signs and symptoms of domestic abuse and aware who to contact for advice and \\nmanagement. \\n \\nThe PHM should identify, evaluate and manage common health problems as appropriate: \\n1. Carry out assessment of perineum. If perineal pain is present advise on tropical cold therapy or \\nParacetamol for pain relief. \\n2. Signs and symptoms of infection, inadequate repair, wound breakdown or non-healing should be \\nreferred to the nearest hospital or MOH clinic for further evaluation and management. \\n \\n3. Management of mild postnatal headache should be based on differential diagnosis of headache \\ntype. Check the blood pressure if BP apparatus is available. Otherwise refer to nearest hospital or \\nhealthcare centre to check blood pressure and act accordingly. \\n4. If a woman has tension or migraine headaches, the PHM should offer advice on relaxation and \\navoidance of factors associated with the onset of headache eg. coffee, chocolate etc. \\n5. Back pain should be managed with paracetamol and correct postures. \\n6. A woman with some involuntary leakage of a small volume of urine should be taught how to do \\npelvic floor exercises. \\n7. If constipation present, advice increased intake of fibre and fluids. If problem persists advise use \\nof gentle stimulant laxative. \\n8. Women with haemorrhoids should take measures to avoid constipation. If a woman has a \\nhaemorrhoid which is severe and swollen or prolapsed, or any rectal bleeding, refer to the \\nhospital for further evaluation and management. \\n9. If the woman complains of persistent fatigue, refer her for haemoglobin level evaluation. \\n10. Inquire about the antenatal complications and see whether she is complying the advices given  \\nfor the postpartum period. \\n11. Once assesses, women with the following conditions should be referred for treatment: \\nSevere or persistent headache and/ or other symptoms of pre-eclampsia \\nSustained postpartum vaginal bleeding \\nPersistent urinary incontinence \\nFaecal incontinence \\n \\nPostpartum women should be offered information and assurance about: \\n\\uf0b7 Perineal pain and perineal hygiene \\n\\uf0b7 Urinary incontinence and micturition \\n\\uf0b7 Bowel functions \\n\\uf0b7 Rest and sleep'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 178}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n166 \\n \\n\\uf0b7 Support from the husband and other family members \\n\\uf0b7 Bathing  \\n\\uf0b7 Nutrition – advise to eat a greater amount and variety. Reassure that she can eat all normal food. \\nAdvise the women against food taboos, continuing iron folate, whether she has got vitamin A \\nmegadose, (if not give her Vit A mega dose) adequate  fluid intake \\n\\uf0b7 Advice the mother and the family on danger signals during postpartum period (heavy vaginal \\nbleeding, severe abdominal pain, fever, foul smelling vaginal discharge, severe headache, calf \\npain etc.)  and actions to be taken if such signal is identified \\n\\uf0b7 Educate the family on importance of breast feeding, rest and possible psychological changes of \\nthe mother. \\n \\nComplete all the relevant records. \\nMothers with problems may need more visits. Decide on date of next visit according to the problems \\nidentified. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during postnatal period \\nIf a postpartum woman has any of the following signs or symptoms, advise to go to a \\nhospital immediately. \\n\\uf0b7  Features of high blood pressure: \\n \\nSevere headache \\n \\nFaintishness \\n \\nBurning pain or tightness in the chest or upper abdomen \\nBlurring of vision or visual disturbances \\nShortness of breathing \\n\\uf0b7 Increased vaginal bleeding or bleeding with clots \\n\\uf0b7 Pain in the calf muscles which increased with walking \\n\\uf0b7 Difficulty in breathing in a mother with heart disease \\nIf a postpartum woman has any of the following signs or symptoms meet a doctor \\nimmediately. \\n\\uf0b7 Foul smelling/ excessive or purulent  vaginal discharge \\n\\uf0b7 Episiotomy wound – gaping, infected, abscess formation or severe pain \\n\\uf0b7 Fever during first six weeks after delivery \\n\\uf0b7 Difficulty in breathing – gradually increasing or increased rate of respiration \\n\\uf0b7 Pain in the chest \\n\\uf0b7 Mental distress- lack of sleep, less attention to the baby, mental liability, feels \\nfrustrated, suicidal thoughts'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 179}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n167 \\n \\n \\nHome visit  3 (within 11-21 days) \\n \\nObserve the general condition of the mother and the home as described earlier. \\nBaby: \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0b7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0b7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0b7 Sleep \\n\\uf0b7 Crying \\n\\uf0b7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0b7 Vomiting \\nExamine: \\n\\uf0b7 Color: cyanosis, icterus \\n\\uf0b7 Umbilicus: fallen or not, discharge, peri-umbilical redness \\n\\uf0b7 BCG scar \\n\\uf0b7 Excretion (stool/ urine: frequency, colour) \\n\\uf0b7 Infections: pustules discharges \\n\\uf0b7 Feeding – correct positioning of the baby to breast, adequacy of breast milk, solve  problems \\nduring breast feeding \\n \\nIntervene: \\nEducate on family on the duties of mother/ father for psycho social development of baby \\nECCD practices \\nSafety of the baby – animals, physical environment, older children, \\nRefer to post natal clinic for weighing, examination by 4 weeks  \\nMaintain records. \\nRevisit if needed \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described in first \\nvisit. \\nAll post natal women should be asked about resumption of sexual intercourse and possible dyspareunia \\nas part of an assessment of overall well-being. \\nAsses the mental condition of the mother – rest, sleep, unhappiness, loneliness \\nAll women should be asked about resolution of symptoms of maternal blues. If symptoms have not \\nresolved, the woman’s psychological well-being should continue to be assessed for postnatal depression. \\nRefer to MOH clinic. \\nContinue to observe for any indication of domestic abuse.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 180}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n168 \\n \\nExamine: \\n\\uf0b7 Involution of the uterus \\n\\uf0b7 Episiotomy scar and LSCS scar \\n\\uf0b7 Vaginal discharge/ lochia \\n\\uf0b7 Breast examination- engorgement, abscess, nipple cracks \\nIntervene: \\nNutrition of the mother – diet, use of micronutrients, see the compliance of drugs taken for any disease \\nconditions. \\nAny positive response to queries about common health problems should be evaluated, treated or referred \\nappropriately: \\nDyspareunia \\nIf a woman expresses anxiety about resuming intercourse, reasons for this should be explored \\nwith her and help her to resolve those anxieties \\nIf a woman is experiencing dyspareunia and has sustained perineal trauma, examine her \\nperineum and assess the condition and act accordingly \\nA water based lubricant gel to help to ease discomfort during intercourse may be advised. \\nIf a woman continues to express anxiety about sexual health problems refer her to MOH clinic \\nfor further evaluation \\nIf persistent postnatal fatigue is impacting on the woman’s care of herself or baby, underlying physical, \\npsychological and social causes should be evaluated. \\nGive information: \\n\\uf0b7 Family planning methods \\n\\uf0b7 Importance of exclusive BF for 6 months \\n\\uf0b7 Personal hygiene of the mother \\n\\uf0b7 Maternal benefits \\n\\uf0b7 Breast feeding  for working mothers \\n\\uf0b7 Older children’s psychological aspects \\n\\uf0b7 Initiation of sexual activity and possible dyspareunia \\n\\uf0b7 Importance of continuing micronutrient intake \\n \\nAll mothers should be referred to a postnatal clinic during 4-6 weeks of postpartum. Give date for the \\npost natal clinic. \\nComplete all relevant records.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 181}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n169 \\n \\n \\nHome visit around 42 days \\n \\nBaby: \\n\\uf0b7 Support mother to maintain the nutrition, cleanliness, and psychosocial development of the baby \\n\\uf0b7 Check whether mother is maintaining the records of psycho social developmental  activities of \\nthe baby according to the age  \\n\\uf0b7 Refer baby for immunization \\n\\uf0b7 Explain the importance of weighing the baby monthly to assess the growth  \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described. \\nEducate mother on family planning method and refer her to family planning clinic (give a date) \\n \\nConfirm the adequacy of breast milk and encourage mother to breast feed exclusively for 6 months \\nEnquire about family support \\nSolve problems in sexual intercourse \\nInquire about mother’s mental status and support mother to develop her self esteem'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 182}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n170 \\n \\n \\nChapter 23 \\nPost Natal Clinic \\n \\nArea public health mid wife should refer all post natal mothers to the post natal clinics in 4-6 weeks post \\npartum. Post natal clinic should be a component of a poly clinic. There should be two post natal clinics \\nper month. A date for the post natal clinic should be given to all mothers during the home visits and it \\nshould be mentioned in H 512 & CHDR. The attendance of mothers for post natal clinics should be \\nentered in the clinic attendance register as well as the clinic summary. The number of mothers attended, \\nmothers found with post partum complications and mothers referred for specialized care should be \\nentered in the quarterly clinic record (H -527). \\nThe goals of post natal clinic: \\nMother \\n\\uf0b7 Monitoring and evaluation of field post natal care \\n\\uf0b7 Identifying  the problems not identified by PHM \\n\\uf0b7 Give treatment / advices/ referrals if needed. \\n\\uf0b7 Counseling on family planning  and provision of FP services \\n\\uf0b7 Analysis of postpartum mental status using EPDS \\n\\uf0b7 Strengthening  the support from family and the husband \\n\\uf0b7 Assess and support the ECCD practices of the mother  \\n \\nBaby \\n\\uf0b7 Complete examination of the baby \\n\\uf0b7 Assess breast feeding, identify and solve problems \\n\\uf0b7 Assess the growth and development of the child \\nActivities: \\n\\uf0b7 Registration of mother and baby \\n\\uf0b7 Measuring of head circumference and the weight of the baby \\nCare for the mother \\nAsk:  \\n\\uf0b7 Inspection of previous records (512 A, 512 B, diagnosis cards) \\n\\uf0b7 History of the pregnancy \\n\\uf0b7 Post partum complications – breast problems, episiotomy scar, constipation, behavioral changes, \\npost partum hemorrhage, vaginal discharges etc. \\n\\uf0b7 Nutritional status and personal hygiene \\n\\uf0b7 Sexual intercourse \\n\\uf0b7 Intake of vitamins/ drugs'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 183}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n171 \\n \\n \\nExamine:  \\n\\uf0b7 Pallor \\n\\uf0b7 Oedema – facial, finger, ankle \\n\\uf0b7 Icterus \\n\\uf0b7 Sudden onset of breathlessness \\n\\uf0b7 Psychological assessment using EPDS \\n\\uf0b7 Blood pressure  \\n\\uf0b7 Abdomen and perineum(if needed) \\nInvestigations (if needed) : \\n\\uf0b7 Urine albumin/ sugar \\n\\uf0b7 Hb \\nActions: \\n\\uf0b7 Advice , treat and refer  for the identified complications \\n\\uf0b7 Refer for family planning services \\n\\uf0b7 Supply nutritional supplements and vitamins \\n\\uf0b7 Give a date for next visit  for FP /immunization \\n\\uf0b7 Give Rubella vaccine if not given before \\nCare for the baby \\nAks: \\n\\uf0b7 Check the diagnosis card if any \\n\\uf0b7 Breast feeding \\n\\uf0b7 Urine output/ bowel opening \\n\\uf0b7 Sleeping habits \\n\\uf0b7 Eye to eye contact (milestones) \\n\\uf0b7 Any worries for the mother \\nExamine: \\n\\uf0b7 General appearance  \\n\\uf0b7 Fill the neonatal examination form / check list / CHDR \\n\\uf0b7 BCG scar \\n\\uf0b7 Check the neonatal diagnosis card if available \\n\\uf0b7 Check the CHDR \\n\\uf0b7 Supervise breast feeding technique ( if weight gain not adequate) \\n\\uf0b7 Check for exclusive breast feeding \\n\\uf0b7 Do investigations ( if needed) \\n\\uf0b7 Take necessary actions  \\nA separate date or time for the post natal clinic should be given to mothers who had still births/ neonatal \\ndeaths. \\n(For further information please read PCPNC guide and guidelines on postnatal care published by FHB)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 184}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n172 \\n \\n \\nChapter 24 \\nFAMILY PLANNING AFTER DELIVERY \\n \\nHelp pregnant women and new mothers (along with their male partners) decide how they will avoid \\npregnancy after childbirth. Ideally, family planning counseling should start during antenatal care and in \\nparticularly in the third trimester. \\n\\uf0b7 Waiting until her baby is at least 2 years old before a woman tries to become pregnant again is \\nbest for the baby and good for the mother, too. \\n\\uf0b7 A woman who is not fully breastfeeding is able to become pregnant as soon as 4 to 6 weeks after \\nchildbirth. \\n\\uf0b7 For maximum protection, a woman should not wait until the return of monthly bleeding to start a \\ncontraceptive method, but instead she should start as soon as possible.  \\n\\uf0b7 Every woman should be properly counselled to ensure that she uses a family planning method. If \\na method is not provided in the hospital refer to the Medical Officer of Health in the area. \\n\\uf0b7 A woman may decide whether she wants to use a family planning method for spacing (short term \\nmethod) or limiting (long term method) pregnancies. \\n \\nEarliest Time That a Woman Can Start a Family Planning Method after Childbirth \\nFamily Planning Method\\n \\nShort term methods for spacing\\nMale or female condoms \\nImmediately\\nCopper-bearing IUD  \\nWithin 48 hours, otherwise wait 6 \\nweeks \\nProgestin-only injectables (DMPA) \\n6 weeks after childbirth \\nImplants \\n6 weeks after childbirth \\nCombined oral contraceptives\\n6 months after childbirth\\nLong term methods for limiting \\n \\nFemale sterilization  \\nWithin 7 days, otherwise wait 6 \\nweeks \\nVasectomy  \\nduring partner’s pregnancy , \\nImmediately after child birth or later \\nas early as possible'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 185}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n173 \\n \\n \\nChapter  25 \\n \\nSCREENING FOR POSTPARTUM DEPRESSION \\nEdingburgh Postnatal Depression Scale (EPDS) \\nThe EPDS was developed for screening postpartum women for postnatal depression in outpatient, home \\nvisiting settings or at the 6-8 week post partum visit examination. It has been utilized in many countries. \\nThis scale has been validated for Sri Lanka and pilot tested in several settings. \\nThe EPDS consists of ten questions. The test can usually be completed in less than 5 minutes. Responses \\nare scored 0,1,2,or 3 according to increased severity of the symptom. The total score is determined by \\nadding together the scores for each of the 10 items. Validation studies have utilized various threshold \\nscores on determining which women were positive and in need of referral. A woman scoring 9 or more \\npoints or indicating any suicidal ideation – that is she scores 1 or higher on question No. 10, should be \\nreferred immediately for follow up. Even if a woman scores less than 9, if the clinician feels the client is \\nsuffering from depression, an appropriate referral should be made.  \\nThe EPDS is only a screening tool. It does not diagnose depression.  \\nInstruction to use: \\n1. The screening for postnatal depression should be done at the postnatal clinic (4-6 weeks). \\n2. The mother is asked to underline 1 of 4 possible responses that comes the closest to how she has \\nfeeling the previous 7 days. \\n3. All 10 items must be completed. \\n4. Care should be taken to avoid the possibility of the mother discussing her answers with others. \\n5. The mother should complete the scale herself, unless she has limited ability or has difficulties in \\nreading and understanding. \\nEdinburgh Postnatal depression Scale \\nAs you may know, some women become depressed after they have had a baby and it is sometimes \\ndifficult for them to tell anyone how they are feeling. Completeing this questionnaire will help depressed \\nmothers to get the help they need. Please Underline the answer, which comes closest to how you have \\nfelt in the past week. \\nHere is a completed example: \\nI have felt happy \\n \\nYes, all the time \\n \\nYes most of the time \\n \\nNo, not very often \\n \\n \\nNo, not at all'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 186}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n174 \\n \\n \\nThis would mean: “I have felt happy most of the time@ during the past week. Please complete the other questions \\nin the same way. \\n \\nIn the past week \\nCoding Column \\n \\n1 \\nI have been able to laugh and see the funny side of things: \\n \\n \\n               As much as I always could \\n0 \\n \\n               Not quiet so much now \\n1 \\n \\n              Definitely not so much now\\n2\\n \\n                Not at all \\n3 \\n2. \\nI have looked forward with enjoyment to things: \\n \\n \\n              As much as I ever did \\n0 \\n \\n              Rather less than I used to do \\n1 \\n \\n             Definitely less than I used to do\\n2\\n \\n              Hardly at all \\n3 \\n3. \\nI have blamed myself unnecessarily when things went wrong: \\n \\n \\n               Yes, most of the time \\n3 \\n \\n               Yes, some of the time \\n2 \\n \\n              Not very often\\n1\\n \\n             No, never \\n0 \\n4. \\nI have been anxious or worried for no good reason: \\n \\n \\n               No, not at all \\n0 \\n \\n               Hardly ever \\n1 \\n \\n             Yes, some times\\n2\\n \\n              Yes, Very often \\n3 \\n5. \\nI have felt scared or panicky for no good reason: \\n \\n \\n             Yes, quite lot \\n3 \\n \\n             Yes, Some times \\n2 \\n \\n            No, not much\\n1\\n \\n             No, not much at all \\n0 \\n6. \\nThings have been getting on top of me \\n \\n \\n             Yes, most of the time I haven’t been able to cope at all \\n3 \\n \\n            Yes, sometimes I haven’t been copying as well as usual\\n2\\n \\n            No, most of the time I have coped quite well\\n1\\n \\n             No, I have been copying as well as ever \\n0 \\n7. \\nI have been so unhappy that I have had difficulty in sleeping: \\n \\n \\n            Yes, most of the time \\n3 \\n \\n           Yes, sometimes\\n2\\n \\n           Not very often\\n1\\n \\n            No, not at all \\n0 \\n8. \\nI have felt sad or miserable: \\n \\n \\n              Yes, most of the time \\n3 \\n \\n             Yes, sometimes\\n2\\n \\n               Not very often \\n1 \\n \\n               No, not at all \\n0 \\n9. \\nI have been so unhappy that I have been crying: \\n \\n \\n             Yes, most of the time \\n3 \\n \\n           Yes, quite often\\n2\\n \\n            Only occasionally \\n1 \\n \\n            No, never \\n0 \\n10. \\nThe thought of harming myself has occurred to me: \\n \\n \\n             Yes, quite often \\n3 \\n \\n             Sometimes \\n2 \\n \\n             Hardly ever \\n1 \\n \\n             Never \\n0 \\n \\nTotal score'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 187}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n175 \\n \\n \\nChapter 26 \\n \\nMANAGEMENT INFORMATION SYSTEM OF MATERNAL CARE \\n \\n                         \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nFor detailed description please refer the guideline on MCH/FP management information system \\npublished by FHB in 2004. \\n \\nPublic Health Midwife \\nPHM’s Monthly Statement H 524\\nPHM’s Daily Statement H 523\\nMOH office\\nQuarterly MCH return  H 509 \\nMCH Clinics \\nPHM’s Diary H 511\\nClinic attendance registers H 517\\nClinic Summary H 518\\nQuarterly MCH clinic return H527\\nFamily Health Bureau\\nRDHS office'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 188}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n176 \\n \\n \\nChapter 27 \\n \\nSURVEILLANCE ON MATERNAL MORBIDITY AND MORTALITY \\nThe maternal care program in Sri Lanka carried out maternal death surveillance and antenatal and \\npostnatal morbidity surveillance at the field level. Surveillance system for severe maternal morbidities or \\n‘near misses’, will be introduced through the hospital system. \\n \\n27.1  Surveillance on maternal morbidities \\nGuidelines on reporting antenatal and postnatal morbidities \\nReporting of antenatal morbidities \\nMorbidities identified during antenatal period should be entered at the space given in the H512A and B \\nby the field PHM / MOH at the time of the identification. Those identified morbid conditions should be \\nnoted in the diary during the 1st postnatal visit and should be entered in the daily statement on the \\nsame day. This reporting system is necessary to avoid repetition of reporting. The morbid condition \\nshould be entered correctly. \\nReporting of postnatal morbidities \\nThe identified morbidities during postnatal visits should be noted in the H 512 A, H512B and diary \\nunder the date of postnatal visit and should also be entered in the PHM’s daily statement on the same \\nday. \\n(When keeping notes in the PHM’s diary, Mothers Number should be entered in the column for \\npostnatal care and morbidities should be entered in the column for other issues. Mark AN with the \\nantenatal morbid conditions and mark PN with the postnatal morbid conditions.)  \\nProvision of accurate information to the national health information system is a responsibility of all \\nrelevant staff in the health services. Therefore, it is a main responsibility of the supervising staff \\nincluding MOH and AMOH to facilitate PHM to identify morbidities using diagnosis cards and correct \\nreporting.  Supervising officers should encourage PHMM to maximize the reporting of antenatal and \\npostnatal morbidities and to monitor the compliance on medical advice and relevant treatment regimes. \\nThey should also plan necessary interventions for identified issues. \\nFurther, MOH should check the accuracy of the information before entering relevant information into \\nthe quarterly return of MCH (H509).'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 189}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n177 \\n \\n \\nDefinitions for antenatal and postnatal morbidities \\nAntenatal Morbidities \\n1. Hypertension (Chronic or pregnancy induced) \\nAvailability of records with the diagnosis of hypertension or availability of a diagnosis card \\nOr blood pressure of 130/90 or more on at least three occasions (recorded by a medical officer) or \\nIncrease in diastolic pressure by 30mmHg or more comparing to early pregnancy measurement. \\n2. Diabetes Mellitus (Chronic or gestational )  \\nDiagnosis of Diabetes Mellitus / Gestational Diabetes Mellitus by a medical officer or \\nAvailability of a diagnosis card or availability of treatment records \\n3. Heart Diseases \\nAvailability of records kept by a medical officer with the diagnosis of congenital or non-congenital heart \\ndisease or \\nAvailability of a diagnosis card or  \\nPast surgical history for heart disease but currently not on treatment \\nRegistration at a cardiac clinic but currently not on any treatment \\nOn monthly Penicillin prophylaxis for Rheumatic fever or Rheumatic heart disease \\nDiagnosed with Mitral valve Prolapse (MVP) \\nDiagnosed with any other cardiac disease (eg. Heart Failure, cardiomyopathy etc.) \\n4. Anaemia \\nAvailability of a record of Hb <11g/dl during pregnancy. \\n5. Antepartum Haemorrhage \\nAvailability of a diagnosis card for vaginal bleeding during pregnancy. \\n6. Asthma \\nAvailability of a diagnosis card for asthma or \\nWhen mothers says that she is on long term drugs (tablets or inhalers) for asthma \\n7. Malaria \\nAvailability of records on malarial infection during pregnancy, confirmed by a blood smear. \\n8. Tuberculosis \\nAvailability of a diagnosis card for Tuberculosis during pregnancy or taking treatment during pregnancy \\nfor previously diagnosed Tuberculosis. \\n9. Sexually Transmitted Infections (STI) \\nAvailability of a diagnosis card given by a medical officer for sexually Transmitted Infection (Syphilis, \\ngonorrhea, Herpes simplex infections, Trichomonasis, Chamydia Infection, HIV/AIDS) \\n10. Liver Disease \\nAvailability of a diagnosis cards or notes in the pregnancy record confirming Hepatitis or any other liver \\ndisease during pregnancy.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 190}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n178 \\n \\n \\n11. Mental disorders \\nAvailability of a diagnosis card given by a Medical Officer confirming a mental disorder or \\nWhen mothers says that she is on long term drugs for mental disorder. \\n12. Epilepsy \\nAvailability of a diagnosis card given by a Medical Officer confirming Epilepsy or \\nWhen mothers says that she is on long term drugs for epilepsy. \\n13. Urinary Tract Infections \\nAvailability of records for treating UTI after confirmatory urine testing during pregnancy by a medical \\nofficer \\n14. Other disease Conditions \\nNote disease conditions other than the conditions mentioned above, that can affect pregnancy according \\nto the available diagnosis cards. \\n \\nPostnatal Morbidities \\n1. Postpartum Haemorrhage \\nAvailability of a diagnosis card from hospital admission for abnormal or excessive vaginal bleeding \\nduring postnatal period \\n2. Fever \\nBody temperature of 370C (1000F) or more during postnatal period \\n3. Reproductive Tract Infections (Offensive vaginal Discharge)  \\nAvailability of notes regarding the diagnosis and treatment of reproductive tract infections by a medical \\nofficer (sign and symptoms: Fever, lower abdominal pain associated with foul smelling vaginal \\ndischarge) \\n4. Urinary Tract Infection \\nAvailability of notes regarding the diagnosis and treatment for a urinary tract infection during postnatal \\nperiod by a medical officer after confirmatory urine testing \\n5. Infected Episiotomy \\nPurulent discharge from the episiotomy wound. \\n6. Detached Episiotomy sutures \\nGaping of the Episiotomy wound edges \\n7. Presence of Foreign bodies in the vagina \\nWhen Foreign bodies (eg. Gauze swabs or packs) are found in the vaginal during vaginal examination'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 191}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n179 \\n \\n8. Infected Caesarean section wound  \\nPresence of redness, swelling, warmth around the Caesarean section wound or  \\nPus or blood stained discharge form the wound or \\nGaping of the wound \\n9. Deep Vein Thrombosis \\nAvailability of notes regarding diagnosis and treatment for DVT by a medical officer. \\n10. Postpartum Mental Disorders \\nAvailability of a notes regarding diagnosis of mental disorder during postpartum period \\n11. Cracked Nipples \\nPresence or cracks or fissures around the nipple \\n12. Breast Engorgement \\nPresence of following signs and symptoms: \\nBreast and areola gets edematous and painful. \\nMilk flowing from the breast has been stopped. \\nEnlarged blood vessels on the breast can be clearly visualized. \\nFever may be present but usually does not continue beyond 24 hours. \\nCan be relieved by expressing milk \\n \\n13. Breast Infections or Abscesses \\nTreatment taken for following signs and symptoms; \\n \\nPain in the Breast \\n \\nFeeling warmth when touching the breast \\n \\nRedness over the breast skin \\n14. Hypertension \\n \\nAvailability of a diagnosis made by a medical officer for high blood pressure during postnatal period \\n \\n15. Heart failure \\nAvailability of a diagnosis made by a medical officer for heart failure during postnatal period \\n16. Other disease conditions \\nNote disease conditions other than conditions mentioned above that mother has taken treatment \\naccording to the available diagnosis cards \\n17. Postnatal hospital admissions \\nAvailability of a record on hospital admission during postnatal period or statement given by a mother \\nregarding hospital admission during postnatal period due to maternal problem'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 192}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n180 \\n \\n \\n \\n26. 2   MATERNAL M ORTALITY SURVEILLANCE \\n \\nReduction of maternal mortality being identified as a national priority, Family Health Bureau (FHB), Ministry of \\nHealth has set up an island-wide surveillance system of maternal deaths occurring throughout the country since \\n1989.  \\n \\nSurveillance of maternal deaths involves the systematic collection, collation, analysis, interpretation & \\ndissemination of all information related to maternal deaths.  \\n \\n \\n1.0 \\nDefinitions \\n \\n \\nMaternal death -The death of a woman while pregnant or within 42 days of termination of  \\n \\n \\npregnancy, irrespective of the duration and site of pregnancy, from any cause related to or \\n \\n \\naggravated by the pregnancy or its management, but not from accidental or incidental  \\n \\n \\ncauses. (Ninth version of the International Classification of Diseases) \\n \\n \\nMaternal deaths are subdivided into two groups; \\n \\n \\nDirect maternal deaths -Deaths resulting from obstetric complications of the pregnant state  \\n \\n \\n(pregnancy, labour and puerperium), from interventions, omissions, incorrect treatment  \\n \\n \\nor from a chain of events resulting from any of the above. \\n \\n \\nEg. Deaths due to septic abortions, post partum haemorrhage, pregnancy induced   \\n \\n \\nhypertension, amniotic fluid embolism and suicide due to post partum psychosis etc.  \\n \\n \\nIndirect maternal deaths -Deaths resulting from previous existing disease or disease that  \\n \\n \\ndeveloped during pregnancy and not due to direct obstetric causes, but aggravated by the  \\n \\n \\nphysiologic effects of pregnancy are classified as  \\n \\n \\nEg. Deaths due to pregnancy complicated with medical disorders such as heart disease,  \\n \\n \\nanaemia, pneumonia, hepatic diseases etc.  \\n \\n \\nLate maternal death -Death of a woman between 42 days and one year after termination of  \\n \\n \\npregnancy, following direct or indirect maternal causes.   \\n \\n \\nEg: Death of a mother on the 90th day due to renal failure following eclampsia. \\n \\n \\nPregnancy related death -Death of a woman while pregnant or within 42 days of termination of \\n \\n \\npregnancy irrespective of the cause of death. \\n \\n \\nThis category includes all maternal deaths, incidental deaths and accidental deaths. \\n \\n \\nEg: Deaths due to food poisoning during pregnancy, murder during pregnancy.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 193}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n181 \\n \\n2.0  \\nNotification of maternal deaths \\n \\n \\nNotification of maternal deaths has been made a legal requirement by issuing a gazette  notification that \\nall practitioners providing care to women in the country, both at institutional and  field levels, are legally bound to \\nnotify maternal death events to Family Health Bureau –the focal  point in maternal death surveillance. \\n \\nNotification involves informing of all deaths which fulfill the notification criteria to the relevant \\n \\nauthorities, in a uniform manner and without delay for necessary action. \\n \\n2.1 \\nNotification criteria \\n \\n- \\nAll deaths (irrespective of cause) of women in reproductive age group (15 – 49 years) during \\nthe pregnancy period and until one year after termination of pregnancy \\n \\nThis includes; all confirmed maternal deaths, late maternal deaths, pregnancy related deaths and \\nother reproductive age group female deaths. Such a wider notification range will ensure that all \\nprobable maternal deaths are captured by the surveillance system. \\n \\n2.2 \\nNotification procedure \\n \\n \\nThe notification procedure will be described under sections on maternal death surveillance at \\n \\nfield level, maternal death surveillance at institutional level and maternal death surveillance at \\n \\nestate level respectively. \\n \\n \\n3.0  \\nMaternal Death Surveillance at Institutional Level \\n \\n\\uf0b7 Once a maternal death occurs in an institution (government or private hospital), the Head of the \\nInstitution should take the custody of the bed head ticket (BHT) and all the documentation of \\nmanagement details of the deceased mother. All the pages should be numbered and the original \\ndocument should be made available for relevant officers/review meetings for investigation \\nprocedure. The BHT should not be reproduced. BHT should not be taken out of the office of \\nthe Head of the Institution and extraction of information from the BHT should be done within \\nthe office premises only. \\n\\uf0b7 It is compulsory to conduct a post mortem in all cases of maternal deaths as per the circular \\nissued by the Secretary to the Ministry of Justice and Law reforms dated 2008.10.02 to all \\ncoroners and letter issued by director general of health services (DGHS) on 2011.01.12. \\n\\uf0b7 A copy of the post mortem report should be issued by JMO to DGHS, Director – FHB and \\nHead of the hospital where maternal death occurred  \\n3.1    Notification procedure of maternal deaths to be followed at institutional level \\n \\n- \\nImmediately after the occurrence of a death which fulfils above notification criteria (2.1) the \\nrelevant staff should report it to the head of the institution.  \\n- \\nJMO should also notify such deaths to the head of the institution after the post mortem. \\n- \\nCoroners should also be requested to notify such deaths to the RDHS and the head of the \\ninstitution after inquiry into sudden deaths.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 194}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n182 \\n \\n- \\nThe head of the institution will then notify the death within 24 hours by telephone, telegram, \\nfax or email to the following officers; \\n \\nDirector – MCH (Family Health Bureau) \\n \\nPDHS and RDHS (where the institution located) \\n \\nPDHS and RDHS (deceased residence) \\n \\nMOH (deceased residence) \\n \\nHead/s of the previously managed institution/s \\n- \\nThe notification of these deaths should be done according to the format H 677 C (page).  \\n- \\nWhenever the death of such a mother transferred from another institution occurs, the receiving \\ninstitution should notify the head of the previously managed institution of the death.  \\n \\n3.2      Institutional investigation procedure of a maternal death  \\n(Government and private hospitals) \\n \\n- \\nSeparate institutional investigations should be performed by each institution involved in the \\nmanagement of the deceased mother. \\n- \\nThe investigation should be conducted within 14 days of occurrence of a maternal death as this \\nwould enable to identify precisely the circumstances that led to the death with fresh \\ninformation. The circumstances of the death should be discussed in detail with the intention of \\nidentifying preventive measures. \\n- \\nThe institutional investigation is the responsibility of the Head of the Institution.  \\n- \\nInvestigation should be carried out as a team which should comprise of the following officers; \\n \\n\\uf0b7 Head of the Institution (Director/MS/DMO/MO-IC) as the team leader \\n\\uf0b7 Consultant Obstetrician and Gynaecologist or the relevant Specialist of the hospital unit \\nin which the death occurred (acting consultant in his/her absence) and all other relevant \\nconsultants who managed the mother (Physician, Surgeon, Anaesthetist, Psychiatrist etc) \\n\\uf0b7 Medical officer/s who attended the deceased mother (DMO, MO/IC, senior house officer, \\nhouse officer etc.) \\n\\uf0b7 Judicial Medical Officer  \\n\\uf0b7 Medical officer – blood bank – when relevant \\n\\uf0b7 Grade I Nursing Officer /Nursing Officer In Charge of the ward/ labour room - when \\nrelevant \\n\\uf0b7 Head of the Institution of hospitals where the patient was managed before transfer \\n\\uf0b7 Medical Officers Maternal and Child Health (of the districts where the mother is resident \\nand where the hospital is situated) \\n\\uf0b7 Medical Officer of Health from the mother's area of residence \\n\\uf0b7 Public Health Midwife from the mother's area of residence \\n \\n- \\nThe institutional investigation should be coordinated by the medical officer (preventive health) \\non behalf of the head of the institution. \\n- \\nThe Head of the Institution is responsible for the implementation of the corrective actions \\nwithin the hospital without delay as decided at the institutional review.\"),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 195}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n183 \\n \\n3.3      Reporting the institutional investigation  \\n \\n- \\nThe information obtained during the investigation should be entered in form H 677 in \\ntriplicate. A copy of the latest version of H677 should be obtained from the MOMCH or \\ndownloaded from the FHB website: www.familyhealth.gov.lk/downloads.php \\n- \\nConsultant Obstetrician and Gynaecologist or the relevant Specialist of the hospital unit in \\nwhich the death occurred and Head of the Institution should ensure the completeness of the \\nformat. \\n- \\nThe completed format (H 677) should be sent to the following institutions within 14 days of \\noccurrence of the maternal death. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nHead of the institution should also ensure that these deaths are reported through H830 \\n(Monthly Report on Maternal Statistics) and Quarterly Indoor Morbidity and Mortality Returns \\n(MMR) sent to the relevant sectors. Also he/she should ensure that pregnancy and/or childbirth \\nshould be mentioned as an underlying cause of death when the death declaration is given.  \\n \\n4.0 \\nMaternal Death Surveillance at Field Level \\n \\n4.1       Notification procedure of maternal deaths to be followed at field level \\n \\nWhen a notifiable death occurs in her area, the area PHM should immediately notify it to the \\nMOH. Notification by the PHMM can be considered as the single most important step in \\nmaternal death surveillance as this is the means which could have the highest notification rate.  \\n \\nThe MOH may receive a maternal death notification directly from the head of the institution at \\nwhich the death occurred or from the RDHS/MOMCH of the district to whom the death was \\nnotified.  \\n \\n \\n \\n \\n \\n \\n \\n \\nMOH \\nRDHS/MOMCH of \\nthe area\\nPHM \\nDirect notification from the hospital \\nH 677 \\nDirector / MCH \\n231, De Saram Place, Colombo 10\\nRDHS (of the district \\nof mother's residence) \\nOffice copy\"),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 196}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n184 \\n \\nThe MOH should inform the relevant authorities that it is compulsory to conduct a post mortem \\nin all cases of maternal deaths as per the circular issued by the Secretary to the Ministry of \\nJustice and Law reforms dated 2008.10.02 to all coroners and letter issued by director general of \\nhealth services (DGHS) on 2011.01.12. \\nThe MOH should obtain post-mortem details from the JMO. If a copy of the post-mortem \\nnecessary, the MOH should inform the Director – MCH. \\n \\nAll the relevant records (H512A, H512 B) should be taken over & kept safely in the MOH office \\ntill the investigations & review meetings are over. \\n \\nMOH should notify such a death to the following places within 24 hours by telephone, telegram, \\nfax or email using the format H 677 C (See page 190) to the FHB, PDHS and RDHS. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nThe telegram or telephone message should be confirmed  by a letter containing the following \\ninformation \\n(Name of the deceased mother, address, PHM area, MOH area, RDHS area, date of \\ndeath, place of death, tentative cause of death, name and designation of the informant, \\ndate informed) (See page - 190) \\n- \\nIn case of the death of a mother who is temporarily resident in a MOH area, the area MOH \\nshould notify the death to the MOH of the area from where the mother came from (& where \\nshe was registered as an eligible female) \\n- \\nIn cases of deaths within one week of discharge from a hospital, the MOH should notify the \\ndeath to head/s of the previously managed institution/s \\n- \\nMOH should also ensure that all deaths are reported through H 509 (Quarterly Maternal and \\nChild Health Return).  \\n \\n4.2     Field investigation procedure for maternal deaths  \\n \\n- \\nMOH (of the area where the mother is registered in the eligible family register) is the \\nresponsible officer for the field investigation. In case of an absence of the relevant MOH, the \\nacting MOH/AMOOH or MO-MCH should take the responsibility of carrying out the field \\ninvestigation.  \\n- \\nInvestigation should be done as a team comprising of MO-MCH, MOH, all AMOOH, all \\nPHNS, all SPHM and PHM of the area. MO-MCH and MOH should jointly investigate the \\nmaternal death. \\n- \\n \\n      MOH \\nDirector / MCH (FHB), \\n231, De Saram Place, \\nColombo 10 \\nPDHS\\nRDHS'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 197}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n185 \\n \\n \\n- \\nIn case of the death of a mother who is temporarily resident in another MOH area, the MOH of \\nthat area should also investigate the case as a team comprising of MO-MCH, MOH, all \\nAMOOH, all PHNS, all SPHM and PHM of the area and send that report to the MOH of the \\narea of mother's residence (i.e. where the mother was registered in the eligible couple register) \\nwho will then prepare the final investigation report.  \\n- \\nInvestigation should commence as early as possible and should be completed within fourteen \\n(14) days of occurrence of the maternal death.  \\n- \\nThe team should visit the office of the PHM and examine all the relevant documents starting \\nfrom the eligible family register, pregnant mother’s register, pregnancy records (H512B), \\nfamily planning field records, diary, advance programme etc. \\n- \\nThe care received by the mother (antenatal, postnatal) prior to the admission to the hospital \\nshould be assessed. \\n- \\nThe family members should be interviewed by the investigation team in order to obtain \\nrelevant information. \\n- \\nIn the case of a hospital death, MOH should participate as a member in the hospital \\ninvestigation team. If the institutional investigation is delayed, the MOH should visit the \\nhospital and obtain relevant information from the hospital (from health care staff and the BHT) \\nwith permission of the head of the institution, which information should be entered in H 677a. \\n- \\nAfter the maternal death investigation the MOH should implement the necessary corrective \\nactions at field level, and the implementation of these should be discussed at the next monthly \\nconference.  \\n- \\nAll the supervisory staff (MOH, AMOH, PHNS, SPHM) should follow up the work of the area \\nPHM until the deficiencies (if any) at field level are rectified. \\n- \\nIf the maternal death investigation has done by the previous MOH, the present MOH should do \\na fresh field visit to the PHM office and the home of the deceased mother and be thorough with \\nthe information before the DMMR and NMMR.  \\n \\n4.3     Reporting the field investigation \\n \\n- \\nThe information obtained during the investigation should be entered in the form H 677a in \\ntriplicate by the MOH. A copy of the latest version of H677a should be obtained from the \\nMOMCH or downloaded from the FHB website: www.familyhealth.gov.lk/downloads.php  \\n- \\nOn completion, the report should be sent to the following institutions. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nFor deaths in which the delivery has taken place at home or outside hospital (intra partum / \\npost partum home death) MOH should fill the H 677 format (institutional format) which  \\n \\nH 677a \\nRDHS \\nOffice copy  \\nDirector / Maternal & Child Health,\\nFamily Health Bureau \\n231,De Saram Place, Colombo 10.\"),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 198}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n186 \\n \\n \\n- \\nincludes the details regarding the delivery. For the field investigation the same procedure \\nshould be adhered (as given in section 3.2) and H 677a format should be filled by the MOH. \\n \\n4.4     Safety of maternal death documentation \\n \\n- \\nThe MOH is responsible for the safe custody of the all the documentation related to all \\nmaternal deaths \\n- \\nMOH should hand over all the documents related to maternal death investigations and reviews \\nto the next MOH appointed on his/her transfer or retirement. \\n \\n \\n5.0 \\nMaternal death surveillance at estate level (Field) \\n \\n5.1     Notification procedure for estate maternal deaths \\nIf a notifiable death occurs in a mother resident in an estate, the Superintendent of Estate should \\nimmediately notify the maternal death to the PDHS, RDHS, MOH and the Regional Health  \\n \\nManager of the Plantation Trust. MOH will in turn notify about the death to the Director \\n(Maternal & Child Health) as described earlier (refer section 3.1) \\n \\n5.2    Field investigation procedure for estate maternal deaths \\nMOH and MO-MCH should jointly investigate these deaths with the participation of the team \\nincluding the PHNS, SPHM, area PHM and the Regional Health Manager. The team should visit \\nthe residence of the mother and proceed with the field investigation as detailed in section 3.2. \\n \\n5.3     Reporting the field investigation of an estate maternal death \\nSame procedure as in as in section 3.3 should be followed.   \\n \\n6.0  District and National Maternal Mortality Reviews (DMMR / NMMR) \\n \\nAt the end of each half year the MOMCH should prepare a summary of maternal deaths notified during \\nthe half year and also annually (at the end of the year) according to the format H 677E and send these to \\nthe Director (Maternal and Child Health) and PDHS. \\n \\nDirector (maternal and Child Health) will also prepare a feedback summary of the deaths notified from \\neach district and institution to the Family Health Bureau at the end of each quarter and annually \\naccording to the format H 677F  \\n \\nEach reported death should be discussed at these reviews with the aim of identifying circumstances of \\ndeath in order to prevent such deaths in future. \\n \\n\"Format A\" by the MOH and \"Format D\" by the Institution should be used for analysis and a basis for \\npresentation of each death at DMMR and NMMR. MOMCH should send these formats to the relevant \\ninstitutions and the MOOH in advance to complete them and present at the district review. The \\npresentation should include details of the format A / D and any other relevant information. Presenters'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 199}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n187 \\n \\nare encouraged to be creative and innovative in their presentations. It is important to include positive \\nsteps taken out of lessons learnt following the relevant maternal death. \\n \\n \\n6.1  District Maternal Mortality Reviews (DMMR) \\n \\nDistrict Maternal Mortality Reviews are an important aspect of maternal mortality surveillance since it \\nprovides a forum to discuss and learn lessons out of maternal deaths at the district level. It also gives an \\nopportunity to identify service deficiencies and to formulate preventive strategies to further reduce \\nmaternal deaths taking local contexts of the district in to consideration. Data gaps with regard to each \\ndeath could be filled at DMMRs. \\n  \\nTwo half yearly District Reviews should be organized by MO-MCH on behalf of RDHS according to \\nthe following schedule. \\nFirst half yearly review \\n-2nd week of July  \\nSecond half yearly review \\n-2nd week of January  (following year) \\n \\nDistrict Maternal Mortality Review Team should comprise of the following officers  \\n \\nPDHS/ RDHS (chairperson) \\nProvincial or District Consultant Community Physician/s \\nAll Head/s of the Institution/s and (where labour rooms are available) \\nAll Consultant obstetricians Gynecologists \\nMO-MCH \\nAll AMOOH, All AMOOH, all PHNS, SPHM, relevant area PHMM \\nJudicial Medical Officers \\nSenior registrars / SHOO / MOO -–who were involved in the management of the \\ndeceased \\n \\n The participation of all relevant officers is compulsory at DMMR. \\n \\nAt the district review all the deaths reported for that half year should be taken for discussion.  \\n \\nIf a mother had been transferred for ICU care and died subsequently, the intermediate institution from \\nwhere the patient was transferred should present the case using Format D and the end station which \\nprovided ICU care should present a summary.  \\n \\nThe circumstances which led to the death should be identified at the district review using three delay \\nmodel.  \\n \\nThe preventive strategies should be generated to improve the availability, accessibility, utilization & \\nquality of field health care services and essential obstetric services and steps should be taken to initiate \\nthe preventive activities which could be implemented at the district level.  \\n \\nAt the end of the review the MOMCH should fill the cage G of Format A and cage I of Format D \\n(deficiencies identified and action to be taken/ already taken).'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 200}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n188 \\n \\n \\nThen the completed formats A and D should be sent to the following health authorities by the MOMCH. \\nPDHS \\nRDHS \\nDirector (Maternal and Child Health) \\n \\nMinutes of the district review should be prepared by the MOMCH and copies sent to the PDHS, \\nDirector (MCH) and the relevant MOOH / institutions. These minutes should be taken for discussion at \\nthe next district review of maternal deaths. \\n \\n \\n \\n5.2         National Maternal Mortality Review (NMMR)   \\n \\nAnnual reviews are conducted on a district basis to review all the deaths which occurred in a particular \\ndistrict in the previous year with the participation of experts from the national level. \\n \\nDirector/maternal and Child Health, Department of Health in collaboration with the Provincial Director \\nof Health Services will organize the annual review of maternal deaths in a district with the participation \\nof representatives from professional colleges including Sri Lanka College of Obstetricians & \\nGynecologists, College of Anesthetists, College of Physicians, Sri Lanka College of Community \\nPhysicians. \\n \\nDGHS or in his absence the PDHS will chair this meeting. In the absence of the DGHS a ministry \\nofficial nominated by the DGHS should participate at the NMMR to represent the DGHS. \\n \\nThe participation of following categories of health care teams is mandatory at the NMMR; \\n \\nPDHS \\nRDHS and Deputy RDHS \\nProvincial and District Consultant Community Physician/s \\nAll Head/s of the Institution/s  where labour rooms are available) \\nAll consultant Obstetricians and Gynaecologists and other relevant consultants  \\nMO-MCH \\nAll MOOH, all AMOOH, all PHNS, SPHM, relevant area PHMM \\nJudicial Medical Officers \\nSenior registrars / SHOO / MOO –who were involved in the management of the deceased \\n \\nThe RDHS, MOMCH, RSPHNO, all Consultant obstetrician and Gynaecologists, MOOH and AMOOH, \\nall heads of the institutions and the relevant consultants (Consultant obstetrician Anaesthetist, \\nConsultant physician Consultant JMO) of the units where maternal deaths have occurred, all the DMOO \\n/ MOO-IC of the district hospitals and peripheral units (whether or not maternal deaths occurred in their \\ninstitutions) should participate at the annual review.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 201}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n189 \\n \\n \\nAll the reported deaths for the year are taken for discussion by an expert panel consisting of the DGHS \\n(or a representative of the DGHS), PDHS, Director/Maternal & Child Health, other relevant officials \\nfrom the Ministry of Health, representatives of the SLCOG, SLCOA and other professional bodies.  \\n \\nThe relevant presentation of the maternal death should be done by the MOH (field part) and Consultant \\nobstetrician and Gynaecologists or the relevant Specialist (institutional part). It is the responsibility of \\nthe head of the institution and the specialist of the unit where mother was managed to ensure that a \\ndetailed presentation is made at the NMMR. \\n \\nAt the annual review all the deaths will be discussed according to the three delay model. \\n \\nFollowing the review minutes will be prepared by Director (MCH) and sent to the relevant district and \\nprovincial officers. The RDHS will then duplicate these minutes and send the copies to the relevant \\ncurative institutions and MOOH. \\n \\nFinal decisions regarding the type of death, preventability, preventive measures that should be taken at \\nthe national level will be decided during the annual review by the panel of experts. \\n \\n5.3  Follow up action to NMMR \\n \\nFollowing the NMMR the MOMCH should organize a meeting for all MOOH/ heads of institutions and \\nother relevant officers to implement the corrective actions decided at the NMMR. This meeting will be \\nchaired by the RDHS. \\nHead of the institution should call for a separate meeting at the institutional level to discuss these \\nminutes with the relevant consultants/ SHOO/ blood bank and other relevant staff in order to implement \\nthese activities. \\n \\nMOMCH should report the progress of these activities after 3 months to the DGHS/ PDHS/ RDHS/ \\nDMCH. \\nDirector (MCH) should carry out regular discussions with the DGHS, relevant DDGG and other \\nofficials regarding issues which need departmental intervention. \\nWhen all the NMMR meetings are over, the national statistics on maternal mortality will be issued by \\nthe Family Health Bureau before the end of the next year. \\nAt the annual review of the next year the MO/MCH should present the status of implementation of \\npreventive measures suggested at the previous year’s annual review'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 202}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n190 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nH 677 – C \\n \\nNotification Form for Maternal Death Surveillance \\n \\nDate of death \\n \\n \\n \\n \\n:  \\n………………………………….. \\nPlace of Death   \\n \\n \\n \\n:  \\n………………………………….. \\nName of the deceased mother \\n \\n \\n:  \\n………………………………….. \\nAge  \\n \\n \\n \\n \\n \\n:  \\n………………………………….. \\nParity  \\n \\n \\n \\n \\n:  \\n………………………………….. \\nHome address  \\n \\n \\n \\n:  \\n………………………………….. \\n \\n \\n \\n \\n \\n \\n \\n………………………………….. \\nMOH area (of mother's residence)(if known) \\n:  \\n………………………………….. \\nDPDHS area (of mother's residence) \\n \\n:  \\n………………………………….. \\n \\nHospital deaths – Place transferred from (if relevant) \\n………………………………….. \\n \\nCause of death (tentative or confirmed)  \\n:  \\n………………………………….. \\n \\nName & the designation of the informant \\n: \\n………………………………….. \\n \\n \\n \\n \\n \\n \\n \\n………………………………….. \\nDate informed  \\n \\n \\n \\n: \\n………………………………….. \\nThis form should be filled by head of the institution/ medical officer of health or any authorized \\nofficer on behalf of them and should be posted/ faxed/ emailed to - Director (Maternal and Child \\nHealth), Family Health Bureau, No. 231, De Saram Place,Colombo 10.Telephone – 011 2692745 \\nFax  – 011 2681310 \\nemail maternaldeathfhb@yahoo.com\"),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 203}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n191 \\n \\n \\n \\n \\nChapter 28 \\n \\nSUPERVISION OF MATERNAL CARE SERVICES \\n \\n28.1  Supervision on Antenatal care \\n \\nPart I -  PHM Office Supervision \\n \\nName of the supervising officer \\n:- …………………………………………………………………… \\nDesignation of the supervising officer:- ………………………………………………………..…………. \\nDate of supervision \\n \\n \\n:- …………………………………………………………………… \\nTime started supervision \\n \\n:- …………………………  Time ended  :-  ………………….…. \\nMOH area \\n \\n \\n \\n:- …………………………………………………………………… \\nPHM area \\n \\n \\n \\n:- …………………………………………………………………… \\nName of the PHM \\n \\n \\n:- …………………………………………………………………… \\nObjective of the supervision  \\n:- …………………………………………………………………… \\n \\nWas the PHM informed regarding the supervision:  Yes / No \\n \\n1. Basic information: \\n \\na. Extent of the area (sq. km.) \\n \\n:………………………………….………………… \\nb. Population \\n \\n \\n \\n:………………………………….………………… \\nc. Date of first appointment  \\n \\n:………………………………….………………… \\nd. Date of appointment to this area \\n:………………………………….…………………. \\ne. Duration of service as a PHM  \\n:………………………………….…………………. \\nf. Whether PHM was provided with a quarters in her area : \\nYes / No \\ni. If provided, is she living in the quarters? \\n    \\nYes / No \\nii. If not, is she living in the area?  \\n \\n      \\nYes / No \\ng. If she is not living in the area, distance (in km.) to the working area from her residence \\n : ………………………………………………………………………………..… \\nh. How long will it take to reach the area (in hours): …………………….…..……………….. \\ni. Transport facilities: \\ni. Is the PHM provided with transport facilities :  Yes / No                         (Bicycle/ \\nMoped) \\nii. Does she use it \\n \\n  \\n \\n:  Yes / No \\niii. If not, reasons for not using the transport facility: \\n……………………………………………………………………………………… \\n……………………………………………………………………………………… \\nj. Is the PHM in complete uniform? \\n :  Yes / No \\n \\n2.   Information on antenatal care : \\nProvincial Birth Rate  \\n \\n:………………………………………………………… \\nEstimated no. of births for PHM area :………………………………………………………….'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 204}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n192 \\n \\n \\n1. Maintenance of graphs pertaining to antenatal care: \\n \\nGraphs (bar charts) to elicit achievements \\nPerformance on following indicators in previous two years \\nand quarterly in current year. \\n \\nYes \\n \\nNo \\nLast \\nquarter \\n% \\n \\nComments \\n \\ni. \\nAntenatal care  \\n     % of pregnant mothers registered  \\n(of estimated births X 1.1)  \\n \\n \\n \\n \\nii.   % of pregnant mothers registered before 8 weeks \\n    (of total pregnant mothers registered)  \\n \\n \\n \\n \\niii.  % of pregnant mothers registered after 12 weeks \\n     (of total pregnant mothers registered) \\n \\n \\n \\n \\niv.  % of mothers with BMI < 18.5 before 12 weeks \\n(of total pregnant mothers registered before 12 weeks)\\n \\n \\n \\n \\n \\n2. Assessment of antenatal care: \\n \\nNo \\nIndicator \\nNo. \\n% \\n1.  \\nNo. of pregnant mothers under care at any given time  \\n(50% of estimated births) \\n \\n \\n2.  \\nNo. of pregnant mothers under care according to H 524  \\n(of 50% estimated births) \\n \\n \\n3.  \\nNo. of pregnant mothers under care according to the Eligible family register\\n(of 50% estimated births) \\n \\n \\n4.  \\nNo. of mothers under care according to the Pregnant mothers register  \\n(of 50% estimated births) \\n \\n \\n5.  \\nNo.  of mothers according to the EDD register \\n(of 50% of estimated births) \\n \\n \\n6.  \\nNumber of pregnant mothers under care according to H 512B  \\n(of 50% estimated births) \\n \\n \\n7.  \\nNo. of primi mothers \\n \\n(of pregnant mothers under care) \\n \\n \\n8.  \\nOf primi mothers under care, number registered in the eligible family \\nregister, before becoming pregnant  ( of primi mothers under care) \\n \\n \\n9.  \\nNo. of pregnant mothers registered before 8 weeks  \\n(of pregnant mothers under care) \\n \\n \\n10.  \\nNo. of pregnant mothers registered between 8-12 weeks  \\n(of pregnant mothers under care) \\n \\n \\n11.  \\nNo. of pregnant mothers registered after12 weeks  \\n( of pregnant mothers under care)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 205}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n193 \\n \\n \\n 5. Home visits received by antenatal mothers:    \\n *No. of mothers delivered during last 1 or 2 quarters: - ……………………………………………… \\n *Whether to use last quarter or last 2 quarters for the calculation should be decided considering the \\nnumber of mothers delivered       \\n \\nNo \\nIndicator \\nNo. \\n% \\n1. \\nNo. who received antenatal home visits once a month from mothers who \\ndelivered during last 1 or 2 quarters  \\n(of mothers delivered during last 1 or 2 quarters) \\n \\n \\n2. \\nNo. of risk mothers needed extra domiciliary care  \\n(of mothers delivered during last 1 or 2 quarters) \\n \\n \\n3. \\nOf above risk mothers, No. received extra home visits  \\n \\n \\n4. \\nNo. of mothers with antenatal morbidities  \\n(of mothers delivered during last two quarters) \\n \\n \\n5. \\nNo. of mothers protected with tetanus toxoid  \\n(of mothers delivered during last two quarters) \\n \\n \\n              \\n                                 \\n6. Compare relevant records to assess the antenatal home visits and morbidity reporting \\nduring pregnancy by PHM  \\n(During the last month of the last quarter according to post natal cards) \\n \\n \\nQuarter ……………….………. \\n \\nMonth  …………………………. \\n \\nIndicator \\nH  524 \\nH  523 Diary \\n \\nH 512B \\n \\n1. \\nNo. of antenatal home visits done during the last \\nmonth of last quarter  \\n(total of new & subsequent visits) \\n \\n \\n \\n \\n2. \\nNo. of mothers with antenatal morbidities reported  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n12.  \\nNo. of pregnant mothers less than 20 years of age \\n( of pregnant mothers under care) \\n \\n \\n13.  \\nNo. of mothers with high risk conditions \\n(of pregnant  mothers  under care) \\n \\n \\n14.  \\nNo. of mothers referred to specialized clinics \\n( of high risk pregnant mothers under care) \\n \\n \\n15.  \\nNo. of mothers followed up after referring to specialized clinics \\n( of pregnant mothers referred to specialized clinics) \\n \\n \\n16.  \\nNo. of mothers with P5 and above registered \\n(of pregnant  mothers  under care) \\n \\n \\n17.  \\nNo. mothers protected against Rubella before pregnancy \\n(of pregnant mothers under care)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 206}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n194 \\n \\n \\n \\n7. Check whether the mothers from outside the area are included in the registers  \\n*specific time period (Quarters): -…………………………………………………………. \\n \\n \\nIndicator \\nH  524 \\nPregnant \\nmothers \\nregister \\nH \\n512  \\nB \\n1. \\nNo. of mothers who had come to the area \\nfrom outside during the *last quarter \\n \\n \\n \\n \\n2. \\nNo. received once a month home visit  \\n \\n \\n \\n \\n*If there were no mothers who came from outside the PHM area during the last quarter, extend the \\ntime duration up to a level where there were mothers who left the area' This time duration should be \\ndocumented above. \\n \\n8. Maintenance of a register for pregnant mothers left area: Yes/ No \\n \\n            No. of mothers left area during last quarter according to the register:  …………………….. \\nMechanisms available to inform the MOH about it                             \\n :  Yes/ No \\n \\nComments:- ………………………………………………………………………………. \\n            No. indicated in the monthly statements (last quarter) :- …………………………………….. \\n \\n \\nPart II   - \\n Antenatal care field supervision  \\n \\nRandomly select five H 512 B cards (preferably completing 28 weeks) and make home visits.  \\nCompare the information with H 512 A. \\n \\n \\n \\nHouse \\n1 \\nHouse \\n2 \\nHouse \\n3 \\nHouse \\n4 \\nHouse \\n5 \\n \\n \\nRegistration No. in eligible families \\nregister \\n \\n \\n \\n \\n \\nPOA  at the time of registration \\n \\n \\n \\n \\n \\nPOA at the time of supervision  \\n \\n \\n \\n \\n \\nParity \\n \\n \\n \\n \\n \\nNo. \\nIndicator \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\ncomment \\nAnte natal care: \\n1. \\nRegistered before 8 weeks\\n \\n \\n \\n \\n \\n \\nHome visits: \\n2. \\nFirst home visit done before 12\\nWeeks \\n \\n \\n \\n \\n \\n \\nMonthly home visits done \\n \\n \\n \\n \\n \\n \\n Additional home visit done for  \\n mothers with risk a factor / special  \\n problems (if any) \\n \\n \\n \\n \\n \\n \\n3. \\nBreast examination done at home by \\nPHM\"),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 207}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n195 \\n \\n4. \\nFundal \\nheight \\nmeasured \\nand \\nrecorded during last visit \\n \\n \\n \\n \\n \\n \\n5. \\nFetal heart sounds checked & \\nrecorded during last visit \\n \\n \\n \\n \\n \\n \\nAssessing mother’s knowledge \\n6. \\nMother has sufficient knowledge \\non nutrition \\n \\n \\n \\n \\n \\n \\n7. \\nMother is aware about the expected \\ndate of delivery \\n \\n \\n \\n \\n \\n \\n8. \\nMother has knowledge on signs of \\nlabour \\n \\n \\n \\n \\n \\n \\n9. \\nMother uses iron tablets correctly \\n \\n \\n \\n \\n \\n \\n10. \\nMother stores  iron tablets correctly \\n \\n \\n \\n \\n \\n \\n11. \\nMother has a good knowledge on \\nfacilitative and inhibitory factors for \\niron absorption \\n \\n \\n \\n \\n \\n \\n12. \\nMother and family members are \\naware of danger signs of pregnancy \\n(Refer attachment) \\n \\n \\n \\n \\n \\n \\n13. \\nMother is aware of feeling fetal \\nmovements \\n \\n \\n \\n \\n \\n \\n14. \\nMother documents fetal movements \\n \\n \\n \\n \\n \\n \\n15. \\nMother is prepared with necessary \\nitems \\nfor \\nhospitalization \\nfor \\ndelivery \\n \\n \\n \\n \\n \\n \\n16. \\nMother has knowledge on initiation \\nof breast feeding within first half an \\nhour  of delivery \\n \\n \\n \\n \\n \\n \\n17. \\nMothers knows the importance on \\nexclusive breast feeding  \\n \\n \\n \\n \\n \\n \\n18. \\nMother \\nis \\nknowledgeable \\non \\nduration \\nof \\nexclusive \\nbreast \\nfeeding \\n \\n \\n \\n \\n \\n \\n19. \\nMother is knowledgeable on ECCD \\n \\n \\n \\n \\n \\n \\n20. \\nHusband has participated to the \\nclinic with the mother during last \\nvisit \\n \\n \\n \\n \\n \\n \\n21. \\nPlace of delivery and related issues \\nare decided following discussion  \\nwith the mother  \\n \\n \\n \\n \\n \\n \\n22. \\nMother is aware on all 5 modern \\nfamily planning methods \\n \\n \\n \\n \\n \\n \\nRisk mothers \\n23. \\nPHM has identified the risk factors \\nof the mother correctly \\n \\n \\n \\n \\n \\n \\n24 \\nHigh risk mothers are correctly \\nlabeled on pregnancy records'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 208}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n196 \\n \\n25. \\nMother was aware on the above \\nmentioned risk factors  \\n \\n \\n \\n \\n \\n \\n26. \\nHusband and family members are \\naware of the risk factors of the \\nmother \\n \\n \\n \\n \\n \\n \\n27. \\nMother has attended clinic which \\nshe has been referred to \\n \\n \\n \\n \\n \\n \\n \\n9.  PHM’s response for the supervision: \\n…………………………………………….……………………………………………………………\\n…………………………………………………………………………………………………………\\n……………………….………………………………………………… \\n \\n10. Problems identified by the PHM in providing antenatal care in the field: \\n…………………………………………….……………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n11. PHM’s suggestions to provide an even better service: \\n…………………………………………….……………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n12. Details of last supervision on antenatal care provision: \\nDate of supervision \\n \\n \\n: …………………………………..…….…………… \\nDesignation of the supervising officer : …………………………………..……….………… \\nRecommendations are implemented : Yes/No \\nNote on recommendations that were not implemented: …………………………………….. \\n \\n13. Recommendations on today’s supervision: \\n \\nStrong points  \\n \\n \\n       \\nWeak points \\n \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….………'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 209}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n197 \\n \\n \\n \\nNext date for supervision : …………………………………. \\n \\nAction plan to improve antenatal care based on weak points identified: \\n \\nProblems \\nidentified\\nUnderlying \\nreasons\\nProposed \\nsolutions\\nResponsibility\\nTime frame\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate  ........................................ \\nSignature of supervising officer …………………………….…\\n \\n \\n \\nDesignation \\n………………………………………………………….……..'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 210}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n198 \\n \\n \\n28.2 Supervision on Post natal care \\n \\nPart I -  PHM Office Supervision \\nName & designation of the supervising officer/s:- ……………………………………………..……. \\nDate of supervision \\n \\n:- \\n……………………………………………………………………………………………….………… \\nTime started supervision \\n:- …………………………………..… Time ended:- ………………… \\nMOH area \\n \\n \\n:- …………………………………………………..…………………… \\nPHM area    \\n \\n \\n:- ………………………………………………..……………………… \\nName of the PHM \\n \\n:- ………………………………………………..……………………… \\nObjective of the supervision :- ………………………………..……………………………………… \\nWas the PHM informed regarding the supervision:   \\nYes / No \\n \\n1. Basic information : \\n \\nk. Extent of the area (sq. km.) \\n \\n:………………………………………………… \\nl. Population \\n \\n \\n \\n:………………………………………………… \\nm. Date of first appointment  \\n \\n:………………………………………………… \\nn. Date of appointment to this area \\n:………………………………………………… \\no. Duration of service as a PHM  \\n;………………………………………………… \\np. Whether PHM was provided with a quarters in her area  \\n: \\nYes / No \\ni. If provided, is she living in the quarters?  \\n     \\n: \\nYes / No \\nii. If not, is she living in the area?  \\n \\n     \\n:  \\nYes / No \\nq. If she is not living in the area, distance (in km.) to the working area from her residence: \\n…………………… \\n \\n \\n          How long will it take to reach the area (in hours) \\n \\n:……………..…… \\nr. Transport facilities: \\ni. Is the PHM provided with transport facilities: Yes/ No  (Bicycle/ Moped) \\nii. Does she use it  \\n \\n \\n \\n: \\nYes/ No \\niii. If not, reasons for not using the transport facility: \\n………………………………………………………………………………… \\n………………………………………………………………………………… \\ns. Is the PHM in complete uniform? \\n Yes / No \\n \\n2. \\nInformation on postnatal care: \\nProvincial Birth Rate  \\n \\n:-………………………………..  \\nEstimated births for PHM area \\n:-………..…………………….. \\nNo. of postnatal mothers under care :-………………..………………'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 211}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n199 \\n \\n \\n3. Maintenance of graphs on postnatal care: \\n(Annually over last 2 years and quarterly for this year)  \\nNo. \\nIndicator \\nYes \\nNo \\nValue for \\nthe last \\nquarter \\nComments \\n1. \\n% of deliveries reported  \\n(of estimated births) \\n \\n \\n \\n \\n2. \\nLow Birth Weight Rate reported \\n(of total live births reported) \\n \\n \\n \\n \\n3. \\n%  of mothers received postpartum care \\n1st visits within 1-10days \\n (of estimated births)  \\n \\n \\n \\n \\n4. \\n%  of mothers received postpartum care \\nvisit within 11 – 28 days \\n (of estimated births)         \\n \\n \\n \\n \\n5. \\n%  of mothers received postpartum care \\naround 42 days  \\n(of deliveries registered) \\n \\n \\n \\n \\n \\n4. Comparison of records and registers on delivery reporting and postpartum care  \\nincluding morbidity reporting (Within a specified time period): \\nQuarter or Month: - ……………………………… \\nDiary  \\nDaily \\nStatement \\n \\nMonthly \\nStatement \\n \\nEligible \\nCouple \\nRegistry \\nPregnancy \\nRegister \\nEDD \\nRegister \\nH512B \\nNo. of post natal mothers \\nunder care \\n \\n \\n \\n \\n \\n \\n \\nNo. of births registered \\n \\n \\n \\n \\n \\n \\n \\nNo. received new home \\nvisits in first 10 days  \\n \\n \\n \\n \\n \\n \\n \\nNo. of mothers reported \\nwith  postnatal morbidities'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 212}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n200 \\n \\n5. Postnatal care coverage: \\nAssessment of postpartum care of permanently residing mothers during last quarter \\n(According to Pregnancy records) \\nNo.\\nIndicator \\nTotal \\n% \\n1. \\nNo. of mothers had 1 postpartum visit within first 5 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n2. \\nNo. of mothers had 1 postpartum visit within first 10 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n3. \\nNo. of mothers had 2 postpartum visit within first 10 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n4. \\nNo. of mothers had 1 postpartum visit within 11 to 28 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n5. \\nNo. of mothers had a postpartum visit around 42 days \\n(From all mothers delivered in the last quarter & completed 42days) \\n \\n \\n6. \\nNo. of mothers received Vitamin A mega dose \\n(From reported births) \\n- From the hospital  \\n \\n \\n- From the PHM \\n \\n \\n7. \\nNo. of neonates who received breast milk within 30 minutes of birth, \\naccording to CHDR B portion \\n \\n \\n8. \\nNo. of mothers with post natal complications \\nFrom randomly selected cards of mothers completed 45 days \\npostpartum; (No. of cards - ………………) \\n \\n \\n \\n \\n6.    Postpartum care received by mothers who came from outside during last quarter: \\n \\n       \\n \\n \\n \\n \\n \\n \\n \\n \\nIndicator \\nNo. \\n% \\nNo. of outside mothers delivered during last quarter \\n \\n \\n% received 1 home visit within 1st 10 days \\n \\n \\n% received 2 home visits within 1st 10 days \\n \\n \\n% received home visits between 11- 28th day \\n \\n \\n% received home visits around 42 days'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 213}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n201 \\n \\n \\n7. Postpartum care received by mothers delivered at home during last 4 quarters: \\n \\n       \\n \\n8. Interventions carried out at PHM level for following postpartum morbidities:  \\n \\n9. Maintenance of records and registers on delivery reporting and postpartum care  \\n    including morbidity reporting:  \\nNo.\\nRecords / registers \\nMaintenance \\nComments \\nSatisfactory \\nUnsatisfactory \\n \\n1 \\nDiary \\n \\n \\n \\n2 \\nDaily statement \\n \\n \\n \\n3 \\nMonthly statement \\n \\n \\n \\n4 \\nPregnant mothers register \\n \\n \\n \\n5 \\nEDD register \\n \\n \\n \\n6 \\nEligible family register \\n \\n \\n \\n7 \\nPregnancy records \\n \\n \\n \\n8 \\nBI register \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo. of home deliveries \\n \\n% received 3 home \\nvisits within 1st 10 \\ndays \\n% received home \\nvisit between 11- \\n28th  day \\n% received home \\nvisits around 42 \\ndays \\nTrained \\n \\n \\n \\n \\nUntrained \\n \\n \\n \\n \\nMorbidity reported \\nNo. reported \\nduring last year \\nIntervention / action taken \\nBreast problems \\n \\n \\nPostnatal psychosis \\n \\n \\nInfected episiotomy \\n \\n \\nAny other common \\nmorbidity \\n…………… (specify)'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 214}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n202 \\n \\n \\nPart II – Field supervision: \\nSelect randomly five 512 B cards completed 3 months postpartum and visit the household: \\nHouse 1\\nHouse 2\\nHouse 3\\nHouse 4\\nHouse 5\\n \\nEl/F registration No. \\n \\n \\n \\n \\n \\n \\nPregnancy registration No. \\n \\n \\n \\n \\n \\n \\nParity \\n \\n \\n \\n \\n \\n \\nDate of arrival at home \\n \\n \\n \\n \\n \\nNo \\n \\nYes/No \\nYes/No \\nYes/No \\nYes/No \\nYes/No \\n1 \\nPost partum care home visits \\n\\uf0b7 Twice between first 10 days \\n(once in first 5 days and once \\nbetween 5-10days) \\n \\n \\n \\n \\n \\n\\uf0b7 1st visit within first five days \\n \\n \\n \\n \\n \\n\\uf0b7 Once between 11- 28 days \\n \\n \\n \\n \\n \\n\\uf0b7 Once close to 42 days  \\n \\n \\n \\n \\n \\n2 \\nPHM has examined the mother \\n \\n \\n \\n \\n \\n3 \\nHas identified the risk factors  if any \\n \\n \\n \\n \\n \\n4 \\nMother was educated on risk conditions  \\n \\n \\n \\n \\n5 \\nFamily members were aware of the \\nbehavioral changes of the mother \\nduring the early postpartum period \\n \\n \\n \\n \\n \\n6 \\nFamily members are knowledgeable \\nregarding post natal complications \\n \\n \\n \\n \\n \\n7 \\nMother was adequately educated on \\nmaternal nutrition \\n \\n \\n \\n \\n \\n8 \\nFamily members are adequately \\neducated on maternal nutrition \\n \\n \\n \\n \\n \\n9 \\nHas identified danger signs of the \\ninfant (if any) \\n \\n \\n \\n \\n \\n10 \\nDoes  mother have the knowledge to \\nidentify danger signs \\n \\n \\n \\n \\n \\n11 \\nMothers was aware on exclusive breast \\nfeeding  \\n \\n \\n \\n \\n \\n12 \\nFamily members  are aware on \\nexclusive breast feeding  \\n \\n \\n \\n \\n \\n13 \\nMother was aware on correct technique \\nof  breast feeding'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 215}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n203 \\n \\n \\n \\n \\n \\n10. PHM’s response for the supervision: \\n………………..…………………………………………………………………………………………\\n……………………………………………………………..…………………………………………… \\n \\n11. Problems identified by the PHM in providing the postnatal care:  \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n12. PHM’s suggestions to improve her postnatal care service : \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n13.  Details on previous supervision on child care: \\nDate of supervision \\n \\n \\n: ……………………………………………………….. \\nDesignation of the supervising officer : ……………………………………………………….. \\nRecommendations are implemented : Yes/No \\nNote on recommendations that were not implemented: \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n14 \\nObserve the session of breast feeding  \\n- \\nAttachment is correct \\n \\n \\n \\n \\n \\n-\\nPositioning is correct \\n \\n \\n \\n \\n \\n \\n15 \\nMother has correct knowledge on \\nexpression of breast milk  \\n-    Cup feeding \\n \\n \\n \\n \\n \\n-    Storing \\n \\n \\n \\n \\n \\n15 \\nPHM has examined the newborn \\n \\n \\n \\n \\n \\n16. \\nCounseled on use of FP method \\n \\n \\n \\n \\n \\n17 \\nUsing a modern FP method \\n \\n \\n \\n \\n \\n18 \\nMother has received family support \\nduring postnatal period'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 216}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n204 \\n \\n \\nRecommendations on current supervision: \\n \\nStrong points  \\n \\n \\n \\n \\nWeak points \\n1…………………………………………………… \\n  \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n \\n \\n \\nNext date of supervision if necessary:-   …………………… \\n \\n14. Develop an action plan with the PHM to overcome the weak points: \\nProblems identified \\nUnderlying reasons \\nProposed solutions \\nResponsibility \\n \\nTime frame \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate: ………………….. \\n \\nSignature of supervising officer ……………..………….. \\n \\nName and designation …………………………………………………..'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 217}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n205 \\n \\n \\n28.3  Supervision of a Poly clinic \\nName of the supervising officer \\n:- \\n.……………………………………………………………………………………….. \\nDesignation   \\n \\n \\n:- \\n.……………………………………………………………………………………….. \\nDate of supervision \\n \\n \\n:- \\n.……………………………………………………………………………………….. \\nTime started supervision \\n \\n:-…………………………  \\n \\nTime ended:-\\n………………………… \\nObjective of the supervision  \\n:- \\n.……………………………………………………………………………………….. \\nWas the PHM informed regarding the supervision:-  Yes / No \\nMOH area \\n \\n \\n \\n:- \\n……………………………………  \\nName of the clinic \\n \\n \\n:- \\n…………………………………… \\nFrequency of the clinic \\n \\n:- \\n…………………………………… \\nNo. of PHM areas covered by the clinic:- \\n…………………………………… \\nPopulation covered by the clinic         :- \\n…………………………………… \\nNo. of PHMM attended the clinic:  ………………………… …………… \\n \\nNo. of clients for the clinic from each PHM area:  \\nTarget group \\nPHM \\nArea 1 \\nPHM \\nArea 2 \\nPHM \\nArea 3 \\nPHM \\nArea 4 \\nNo. of antenatal mothers \\n \\n \\n \\n \\nNo. of H 512 B cards brought \\nto the clinic \\n \\n \\n \\n \\nNo. of infants \\n \\n \\n \\n \\nNo. of preschoolers \\n \\n \\n \\n \\nNo. CHDR  B portions brought to \\nthe clinic \\n \\n \\n \\n \\nNo. of family planning clients \\n \\n \\n \\n \\n \\n \\nOfficer conduct the clinic: MOH/AMOH/MO/RMO/AMO \\n \\nOther staff category available in the clinic on the supervision day: RSPHNO/PHNS/SPHM  \\n \\n1. Clinic environment: \\na. Cleanliness of the clinic \\n: Satisfactory  \\uf06f \\nNot satisfactory  \\n\\uf06f \\nb. Ventilation  \\n \\n \\n: Adequate      \\uf06f \\nNot adequate      \\n\\uf06f \\nc. Electricity \\n \\n \\n: Available      \\uf06f  \\nNot available      \\n\\uf06f \\nd. Seating facilities \\n \\n: Adequate      \\uf06f \\nNot adequate      \\n\\uf06f \\ne. Toilet facilities \\n \\n: Available     \\uf06f        Not available      \\n\\uf06f \\nf. Accessibility  \\n \\n: Satisfactory  \\uf06f \\nNot satisfactory  \\n\\uf06f \\ng. Adequate Water supply \\n: Available     \\uf06f        Not available      \\n\\uf06f'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 218}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n206 \\n \\n \\n2. Clinic organization: \\n \\nYes \\nNo \\nComments \\n1 \\nClinic duty roster is available \\n \\n \\n \\n2 \\nClinic preparation done on previous day \\n \\n \\n \\n3 \\nHealth education materials displayed on \\nthe wall \\n \\n \\n \\n \\n4 \\nClinic is organized according to  5 ‘S’ \\nconcept \\n \\n \\n \\n5 \\nPlace is organized for different clinic \\nactivities \\n \\n \\n \\n \\n6 \\nNumbers given to all clients at \\nregistration \\n \\n \\n \\n7 \\nClinic sessions are organized for \\ndifferent target groups (eg. ANC- \\n8.30am – 11.00, Immunization 11.00 \\nam- 12.30pm, FPC   1.00pm – 3.30 pm) \\n \\n \\n \\n8 \\nClean linen and a clean examination bed \\nis available \\n \\n \\n \\n9  \\nHealth education is provided according \\nto a plan \\n \\n \\n \\n10\\nReading materials available for the use \\nof clients  \\n \\n \\n \\n11\\nWaste management is satisfactory \\n \\n \\n \\n \\n3. \\nUse of AD syringes: \\na. Use AD syringes for all immunizations \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. Use safety boxes to collect used syringes \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. Safe technique is used for disposal of used syringes   \\nYes \\n\\uf06f  No \\uf06f \\n \\n4.         Sterilization procedure (if any): \\na. Sterilization chart is displayed in the clinic  \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. It is supervised and signed by a senior officer  \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. PHMM is capable of sterilizing the equipment on time \\nYes \\n\\uf06f  No \\uf06f \\nd. Handle sterilized equipment with Cheatle forcep  \\nYes \\n\\uf06f  No \\uf06f \\n \\n5.  \\nAssist MOH in examining the mother: \\na.   Inform the mother that she is going to be examined  \\nYes \\n\\uf06f  No \\uf06f \\nb.   Provide a brief history to the MOH  \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc.   Assist mother in positioning on the bed \\n \\n \\n Yes \\n\\uf06f  No \\uf06f \\nd. Check the mother’s understandability on information  \\n      provided by MOH  \\n \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\ne. Inform mother on the next clinic date  \\n \\n \\nYes \\n\\uf06f  No \\uf06f'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 219}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n207 \\n \\n \\nf. Help mother on getting up from the examination bed \\nYes \\n\\uf06f  No \\uf06f \\ng. Explain mother regarding referral to specialist care  \\nYes \\n\\uf06f  No \\uf06f \\n6.  \\nProviding micronutrients and anti helminthic drugs: \\na. Drugs are packed and ready for distribution among mothers Yes \\n\\uf06f  No \\uf06f \\nb. Explain the mother on how to use drugs \\n \\n            Yes \\n\\uf06f  No \\uf06f \\nc. Explain the mother on how to store them \\n \\n            Yes \\n\\uf06f  No \\uf06f \\nd. Cross check from the mother whether she takes \\n    them correctly   \\n \\n \\n \\n \\n             Yes \\n\\uf06f  No \\uf06f \\n \\n7.  \\nProcedure of Urine testing: \\n \\nYes\\nNo\\nRemarks\\n1\\nSeparate place is allocated for this activity\\n2\\nAvailability of equipment and reagents or strips\\n- Urine test strips\\n- Test tubes\\n- Test tube holder\\n- Test tube rack\\n- Spirit lamp\\n- Container to empty test tubes\\n- Benedict’s solution\\n- Acetic acid\\n- Methyl spirit\\n3\\nTechnique of testing     \\nFor protein: \\n- Fill 2/3 of the test tube with urine\\n- Heat upper 1/3 of test tube\\n- Observe after a while\\nFor sugar :\\n- Add 8 drops of urine to 5 ml of reagent\\n- Heat the test tube, holding the test tube away from  \\nself and client \\n- Heat well until the contents boiled\\n- observe the test tube for 2 mins for a color change\\n4\\nEnter the results in both mother’s cards\\n5\\nGive the feedback to the mother on the test findings\\n6\\nDiscard urine appropriately'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 220}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n208 \\n \\n \\n8. Conduct of health education session: \\n \\nNo.\\nActivity\\nYes\\nNo\\nRemarks\\n1\\nPlanned health education schedule is available for each \\nclinic session \\n2.\\nPHM is pre prepared for the health talk\\n3\\nUse appropriate HE material \\n4\\nContent is relevant to the topic\\n5\\nCorrect messages given\\n6 \\nPresentation skills of PHM is satisfactory\\n7\\nPHM assesses whether the client has increased the \\nknowledge at the end of the session ( by a feedback) \\n8\\nSummarizes the important messages\\n \\n9. Weighing of Infants: \\n \\n \\nActivity \\nYes \\nNo \\n1 \\nAppropriate scale is available (i.e Seca Scale) \\n \\n \\n2 \\nScale placed on a balanced surface \\n \\n \\n3 \\nIt works properly ( Ascertain by measuring a known weight) \\n \\n \\n4 \\nWho measures weight? PHM / Volunteers / Other \\n \\n \\n5 \\nIt is kept in a well lit place, on a stable top \\n \\n \\n6 \\nInfant’s clothes are removed prior keeping on the scale \\n \\n \\n7 \\nWeight is measured following correct balancing \\n \\n \\n8 \\nThe reading is taken standing in front of the scale \\n \\n \\n9 \\nWeight is written on the B portion immediately after weighing \\n \\n \\n10 \\ninform mother regarding the nutrition status of infant \\n \\n \\n \\n10. Measure of length of Infants: \\n \\n \\nActivity \\nYes \\nNo \\n1 \\nInfantometer is kept on the table correctly  \\n \\n \\n2 \\nInfant is kept on the infantometer correctly (The head is \\npositioned to touch the head rest & the head, shoulders, \\nbuttocks and knees should touch the scale) \\n \\n \\n3 \\nThe base is touching the infant’s feet \\n \\n \\n4 \\nThe measurement is read correctly \\n \\n \\n5 \\nIt is written in the B portion correctly'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 221}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n209 \\n \\n \\n11. Height & weight measuring of pregnant mothers: \\n \\nNo.\\nActivity \\nYes \\nNo \\nRemarks \\n1 \\nCheck to clarify all the equipment are in order \\n \\n \\n \\n2 \\nUse correct technique in taking height \\n \\n \\n \\n3 \\nUse correct technique in taking weight \\n \\n \\n \\n4 \\nRecord readings in relevant documents \\n \\n \\n \\n5 \\nMother is provided with the feedback \\n \\n \\n \\n6 \\nInform the MOH if there are any unusual  findings in \\nthe weight \\n \\n \\n \\n7 \\nAccuracy of weighing scale is checked (if so, when) \\n \\n \\n \\n \\n12. Immunization activities: \\nNo.\\nActivity\\nYes\\nNo\\nRemarks\\n1\\nSeparate area is prepared \\n2\\nEmergency tray is available\\n2.1. drug list is available\\n2.2. date of expiry is available on drugs\\n2.3. instruction guide is available\\n3\\nCheck CHDR before immunization for appropriateness of \\nthe vaccination \\n4\\nDiscuss with the mother to identify any contraindications\\n5\\nAsk for AEFI for the previous immunization\\n6\\nCold chain is maintained\\n7\\nCheck vaccine vials before vaccination for quality assurance\\n8\\nFollow correct technique to draw vaccine\\n9\\nMaintain sterility in the process of immunization\\n10\\nEducate mothers before immunization on reporting of AEFI \\n11\\nKeep clients 10-20 minutes to observe adverse reactions\\n12\\nProper record keeping (Date, batch number ect)\\n13\\nInform clients on next visit\\n14\\nMaintain vaccine   movement register  correctly\\n15\\nMaintain open vial policy\\n \\n13. Family planning activities: \\n \\n \\nYes \\nNo \\nRemarks \\n1 \\nMethods available in the clinic \\n \\n \\n \\n     Pills \\n \\n \\n \\n     Condoms \\n \\n \\n \\n     DMPA \\n \\n \\n \\n     IUD \\n \\n \\n \\n2 \\nEntries made when issuing FP items  \\n \\n \\n \\n3 \\nPhysical balance of FP items tallies with book balance \\n \\n \\n \\n4. \\nAdequate stocks are available  \\n \\n \\n \\n5. \\nEquipment needed for insertion of at least 5 IUDs are \\navailable \\n \\n \\n \\n6. \\nEquipment are in working condition'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 222}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n210 \\n \\n \\n7. \\n \\nSpecial bed used for IUD insertion is available in good \\ncondition \\n \\n \\n \\n8. \\nPrivacy is maintained for each & every mother  \\n \\n \\n \\n9. \\nMother allowed to ask questions with regard to the FP \\nmethods \\n \\n \\n \\n10. FP items are shown to mother before enroll into a \\nmethod  \\n \\n \\n \\n11. Mothers counseled before introduced to a method \\n \\n \\n \\n12 \\nUse flash cards during discussions \\n \\n \\n \\n13 \\nIssues a client record \\n \\n \\n \\n14 \\nClinic record is correctly maintained \\n \\n \\n \\n \\nAttitudes of staff towards clients \\n \\n \\n \\nPositive \\nNegative \\n \\nComments………………………………………………………………………………………………\\n…………………………………………………………………………………………………………\\n……………………………………………………………………………….. \\n \\n14.  Disposal of waste and cleaning:  \\na. Adequate number of safety boxes are available \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. Waste disposal is hygienic \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. At the end of the clinic, the equipment and the clinic is cleaned  \\nYes \\n\\uf06f  No \\uf06f \\nd.   FP Clinic records are correctly maintained  \\n \\nYes \\n\\uf06f  No \\uf06f \\n15. Record keeping:  \\na. The clinic attendance  register (H 517) is correctly maintained  Yes \\n\\uf06f  No \\uf06f \\nb. H 518 is correctly filled  \\n \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. Activities are done according to the duty roster \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nd. Clinic returns are correctly filled and sent to relevant institutes Yes \\n\\uf06f  No \\uf06f \\n \\n16. Comments on record keeping :    \\n……………………………………………………………………………………………………………………\\n……………………………………………………………………………………………………………………\\n……………………………………………………………………………………………… \\n……………………………………………………………………………………………………………………\\n…………………………………………….. \\n17. Review clinic performance based on clinic summary and H 527 for the last quarter: \\n \\n \\nNo. of clinic sessions held during the last quarter :- ....................................   \\n \\nNo. of clinic sessions conducted by: \\nMOH/AMOH \\n \\nPHNS \\n \\nPHM \\n \\nOther  \\n \\n \\nAverage attendance of clinic per session: \\nPregnant Mothers \\n \\nInfants \\n \\n1-5 yr Old \\n \\nFP Clients'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 223}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n211 \\n \\n \\nNo. of  FP new acceptors recruited   \\n:- ................................ \\nNo. of DMPA new acceptors  \\n \\n:- ................................ \\nNo. of IUCD inserted  \\n \\n \\n:- ................................ \\nNo. of infants weighed in the clinic  \\n:- ................................ \\n \\nBlood drawn for, \\nVDRL testing  \\n \\n \\n: Performed / Not Performed \\nHb testing \\n \\n \\n \\n: Performed / Not Performed \\nBlood Grouping and DT \\n \\n: Performed / Not Performed \\n \\n18.  Suggestions of the staff to provide better clinic service :- \\n…………………………………………………………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n \\n19. Details on last clinic supervision: \\nDate of previous supervision  \\n \\n \\n: ……………………………………..….. \\nDesignation of the supervising officer  \\n \\n: ………………………….…….……..… \\nRecommendations are carried out \\n \\n \\n: Yes / No \\nDetails on recommendations not materialized : …………………………………………...…… \\n \\n \\n20.  Recommendations on current supervision: \\nStrong points  \\n \\n \\n       \\n \\nWeak points \\n1…………………………………….. \\n        \\n \\n \\n2. …………………………………... . \\n \\n            \\n3. ……………………………….…… \\n \\n            \\n4… .………………………….……… \\n \\n \\n \\n5 .……………………..…………….. \\n \\n \\n \\n1…………………………………….. \\n        \\n \\n \\n2. …………………………………...  \\n \\n            \\n3. ……………………………….…… \\n \\n            \\n4… .………………………….……… \\n \\n \\n \\n5 .……………………..……………..'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 224}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n212 \\n \\n \\n \\nNext date of clinic supervision \\n:   …………………. \\n \\n21. Action plan to improve the clinic services based on weak points identified: \\n \\nProblems identified \\nUnderlying \\nreasons \\nProposed solutions\\nResponsibility \\nTime \\nframe \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate …………………….. \\n \\nSignature of supervising officer ...................................... \\n \\n \\n \\n \\n \\n \\n \\n \\nDesignation …………………………………………..…'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 225}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n213 \\n \\n \\nChapter 29 \\nPLANNING OF DOMICILIARY CARE FOR PREGNANT AND POST \\nPARTUM WOMEN \\n \\nItems needed: \\n\\uf0b7 01 Bristol board \\n\\uf0b7 Pins with red, blue, yellow and green heads \\n \\nMethod: \\nDraw three circles on the Bristol board as follows. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n3rd Trimester \\n2nd Trimester \\n \\n1st Trimester  \\n \\nEach trimester of the pregnancy is reflected by the three areas of these circles. \\nDivide circles according to the same way that you have divided your villages for the eligible couple \\nregister. \\n \\n       \\n \\n \\nA                                                              D \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n  \\n                                                  C                                               B \\n \\nA- Village A \\nB- Village B \\nC- Village C \\nD- Village D \\nMark pregnant women under your care in order to the villages & the trimesters by using pins on the \\ncircles.'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 226}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n214 \\n \\n \\n \\n Blue pin – 1st Trimester pregnancies \\n Red pin -    Mothers with risk conditions \\n Green pin – Mothers without risk conditions (except 1st pregnancy) \\nThis chart should be renewed in every Saturday.  \\nE.g.: Mothers may reach to second trimester from first trimester (By bringing the pin to the relevant \\ncircle) \\n         Identifying risk factors (Put red pin while removing the green pin) \\nEither two red and blue pins or one pin with both red and blue heads should be used for 1st pregnancy \\nwith risk conditions. \\nThis chart can be also used in planning of postpartum care.   \\nThe areas for 3rd trimester, 2nd trimester and 1st trimester can be used as areas for first 10 days, day \\n11-28 & 28 – 42 days respectively. \\nThis chart gives information on pregnant and postpartum mothers under your care at a glance. This \\ncan be used in arranging home visits as well'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 227}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n215 \\n \\n \\nLIST OF REFERENCES \\n \\n1. Antenatal care: Routine care for the healthy pregnant women, National Collaborating Centre \\nfor Women’s and Children’s health Commissioned by the National Institute for Clinical \\nExcellence, October 2003 \\n2. Conceptual framework for the Elimination of Paediatric HIV and Congenital syphilis in Asia \\nPacific 2011-2015, UNICEF East Asia and Pacific Regional Office, August 2011 \\n3. Diabetes in Pregnancy, Management of diabetes and its complications from preconception to \\nthe postnatal period, National Collaborating Centre for Women’s and Children’s health \\nCommissioned by the National Institute for Clinical Excellence, March 2008 \\n4. Guidelines for the Management of HIV infection in Sri Lanka, National STD/AIDS Control \\nprogramme, Ministry of Health, Sri Lanka, 2008 \\n5. IHE Report: Determinants and Prevention of Low Birth weight: A Synopsis of the Evidence, \\nInstitute of health economics, Canada, 2008 \\n6. Integrated Management of Pregnancy and Child Birth:  Pregnancy, Child Birth, Postpartum \\nand Newborn care: guide for provision of essential services by WHO, Adopted for Sri Lanka, \\n2009 \\n7. Integrated Management of Pregnancy and Child Birth: Managing complications in pregnancy \\nand Childbirth: A guide for midwives and doctors, WHO, 2000 \\n8. Low Birth weight- Nutrition policy discussion paper No. 18, UN ACC sub-committee on \\nNutrition, 2000 \\n9. Maternal Mortality Decline: The Sri Lankan Experience, Family Health Bureau,  2003 \\n10. Obstetrics by Ten Teachers, Edited by T L T Lewis and G V P Chamberlain, fifteenth edition \\n1990 \\n11. Packages of Interventions for family planning, Safe abortion care, Maternal , Newborn and \\nChild Health, WHO, 2010 \\n12. Physical Status: the use & Interpretation of Anthropology, WHO, TRS 854 \\n13. Postnatal Care: A guide to field Staff, Family Health Bureau, 2007 \\n14. Regional strategy for the Elimination of Congenital syphilis, WHO, Regional Office for \\nSouth-East Asia, 2009 \\n15. Report: The 7th Asia- Pacific United Nations Prevention of Mother- to – Child Transmission \\nTask Force Meeting, 2009 \\n16. Strategy for the Elimination of Congenital Syphilis in Sri Lanka,  National STD/AIDS \\nControl programme, Ministry of Health, Sri Lanka,2009 \\n17. The Pregnancy Book, NHS,2001 \\n18. WHO Antenatal care Randomized Trail: manual for the Implementation of the New Model, \\nWHO, 2002 \\n19. WHO recommendations for the Prevention of Postpartum Hemorrhage, WHO 2007'),\n",
       " Document(metadata={'producer': 'Python PDF Library - http://pybrary.net/pyPdf/', 'creator': '', 'creationdate': '', 'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'file_path': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf', 'total_pages': 229, 'format': 'PDF 1.3', 'title': '', 'author': '', 'subject': '', 'keywords': '', 'moddate': '', 'trapped': '', 'modDate': '', 'creationDate': '', 'page': 228}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n216 \\n \\n \\nCirculars related to Maternal and newborn care \\n1. Circular letter dated 14th December 2010 by DGHS on provision of Influenza A H1N1 \\nvaccine for pregnant women \\n2. General circular  no. 01-28/2010 on 25th August 2010 by DGHS  on micronutrient \\nsupplementation and anti-helminthic treatment in maternal and school health programmes \\n3. General circular No 01-15/2010 dated 19th April 2010 on by DGHS on promotion of branded \\nmilk powder within health institutions and to the staff of ministry of health care and nutrition \\n4. Letter No. FHB/MCU/ Gen on 10th November 2009  signed by D/MCH on recommendations \\nfor basic investigations package for pregnant mothers \\n5. General circular no 01-14/2008 on guidelines for malaria chemotherapy and the management \\nof patients with malaria \\n6. General circular No 01-10/2007 dated 02nd March 2007 by DGHS on formats on newborn  \\n7. Circular on guidelines on immunization against tetanus by DGHS \\n8. General circular No 02-20/2007 dated 15th February 2007 by DDG/PHS on revised MCH \\nmanagement information system \\n9. General circular No 01-26/2006 by DGHS on duty list of field public health midwives \\n10. Public administration circular no 03/2006 dated 2nd March 2006 issued by Secretary, Ministry \\nof Public administration and Home affairs on paternity Leave – Chapter XII in E Code \\n11. General circular No 01—5/2006 on dated 03rd January 2006  by DGHS on surveillance on \\nperinatal mortality \\n12. Public administration circular no 4/2005 dated 3rd February 2005 issued by Secretary, \\nMinistry of Public administration and home affairs on Maternity Leave – Chapter XII in E \\nCode \\n13. General circular No 01-25/2004 dated 14th October 2004 by DGHS on antenatal clinic care \\n14. General circular No 01-27/2004 on 14th October 2004 by DGHS on streamline the Postnatal \\ncare   \\n15. Internal circular FHB 1/2004 dated 04th August 2004 by D/MCH on pregnancy record \\n16. General circular (revised) 1945 on 16th June 2004 by DGHS on national plan for prevention \\nand control of anaemia among pregnant women')]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "extracted_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "bb8fcf3f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "421"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(extracted_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "700d234c",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List\n",
    "from langchain.schema import Document\n",
    "\n",
    "def filter_to_minimal_docs(docs: List[Document]) -> List[Document]:\n",
    "    \"\"\"\n",
    "    Returns docs with only 'source', 'page', and 'page_content'.\n",
    "    \"\"\"\n",
    "    minimal_docs: List[Document] = []\n",
    "    \n",
    "    for doc in docs:\n",
    "        # Extract the specific metadata you need\n",
    "        src = doc.metadata.get(\"source\")\n",
    "        page_num = doc.metadata.get(\"page\", 0) # Default to 0 if no page found\n",
    "        \n",
    "        minimal_docs.append(\n",
    "            Document(\n",
    "                page_content=doc.page_content,\n",
    "                metadata={\n",
    "                    \"source\": src,\n",
    "                    \"page\": page_num + 1  # PyMuPDF starts at 0, humans start at 1\n",
    "                }\n",
    "            )\n",
    "        )\n",
    "    return minimal_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "6cbdef65",
   "metadata": {},
   "outputs": [],
   "source": [
    "minimal_docs = filter_to_minimal_docs(extracted_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "944fb505",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='1 \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nGuidelines for Management of Pregnant Women \\n with HIV Infection  2024 \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health \\nSri Lanka \\n \\n                 \\n \\nNational Programme on Elimination of Mother to Child Transmission \\n of HIV and Syphilis in Sri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='2 \\n \\n \\nGuidelines for Management of Pregnant Women \\nwith HIV Infection  2024 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health  Sri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='3 \\n \\nGuidelines for Management of Pregnant Mothers with HIV Infection \\n \\nCoordinated by : \\nDr Nimali Jayasuriya \\nConsultant Venereologist ,  \\nNational Coordinator, EMTCT of Syphilis & HIV Programme National STD/AIDS Control Programme. \\n \\nContributors : \\nDr. Nimali Jayasuriya, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Lilani Rajapakse, Consultant Venereologist, former deputy Director NSACP  \\nDr. Geethani Samaraweera, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Jayanthi Elwitigala, Consultant Microbiologist, National STD/AIDS Control Programme \\nDr. Umedha Jayasinghe, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Loshan Moonasinghe, Consultant community physician, Family Health Bureau \\nDr. Nalaka Kulathunga , Senior Registrar in Venereology, National STD/AIDS Control Programme \\nDr. Shirmila Rajapakshe, Acting Consultant Venereologist, National STD/AIDS Control Programme  \\nDr Champika Gunewardhana, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Sithmi Koswaththa, Senior Registrar in Venereology, National STD/AIDS Control Programme  \\n \\n \\n \\n \\nContributors for  the 3rd t edition :  \\nDr. K A M Ariyaratne, Consutant Venereologist, NSACP  \\nDr. Jayanthi Elwitigala, Consultant Microbiologist NSACP \\nDr. Darshani Mallikarachchi, Consultant Venereologist,  \\nDr. Chandrika Jayakody, Consultant Venereologist,  \\nDr. J Nadeeka, Consultant Virologist'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='4 \\n \\n \\nPublished by \\nNational STD/AIDS Control Programme      \\nMinistry of Health \\nColombo, Sri Lanka. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n1st Edition 2008 \\n2nd Edition 2011 \\n3rd Edition 2016 \\n4th Edition  2024'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='5 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nThe guidelines for management of pregnant women with HIV infection - \\n2024 was prepared to assist policymakers to optimize  PMTCT \\ninterventions and healthcare workers to provide optimal services to \\npregnant women with HIV'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='6 \\n \\nContents \\n \\n1. \\nValidation of Elimination of mother to child transmission (EMTCT) of HIV and syphilis programme 13 \\n1.1 Maintenance of eliminated status of MTCT of HIV ........................................................................ 13 \\n2. \\nHIV testing in pregnant women ....................................................................................................... 15 \\n3. Fertility desires among women with HIV ............................................................................................. 18 \\n3.1 Fertility options for PLHIV ............................................................................................................. 18 \\n3.1.1 Sero-discordant Couples ........................................................................................................ 19 \\n4. Pre-Exposure Prophylaxis .................................................................................................................. 20 \\n5. Management of  pregnant women with HIV ........................................................................................ 21 \\n5.1 When to start ART in pregnant and breastfeeding women? .......................................................... 21 \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) ............................ 21 \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy ............................... 21 \\n5.2.2 ARV regimens ........................................................................................................................ 21 \\n5.2.3 Preferred regimens ................................................................................................................ 22 \\n5.2.4 Women with HIV conceiving while on ART ............................................................................. 23 \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got pregnant \\nwhile maintaining successful viral suppression, oral two drug regimen may be continued with more \\nfrequent (every 1-2 months)  viral load monitoring. ......................................................................... 23 \\n5.2.5 Late-presenting woman not on treatment ............................................................................... 23 \\n6. Monitoring of pregnant women receiving ART .................................................................................... 24 \\n7. Obstetric management ....................................................................................................................... 25 \\n7.1 Antenatal management ................................................................................................................. 25 \\n7.2. Mode of delivery .......................................................................................................................... 26 \\n7.3. Multiple pregnancies .................................................................................................................... 27 \\n8. Antenatal care at the primary health care ANC clinic .......................................................................... 28 \\n9. Management of HIV positive pregnant women in the STD clinic......................................................... 29 \\n9.1  Counselling .................................................................................................................................. 29 \\n10. Management of delivery of pregnant mother with HIV ...................................................................... 30 \\n10.1 Plan for delivery .......................................................................................................................... 30 \\n10.2 Planned normal vaginal delivery ................................................................................................. 31 \\n10.3. Planned caesarean section........................................................................................................ 31 \\n10.4 Management of pre-labour spontaneous rupture of membranes ................................................. 32 \\n10.5 Management of women who present in labor without documentation of HIV status or women who \\nhave not received antepartum antiretroviral drugs .............................................................................. 32 \\n11. Post-partum Management ................................................................................................................ 34'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='7 \\n \\n11.1  Immediate management ............................................................................................................ 34 \\n11.2 Additional measures ................................................................................................................... 34 \\n11.3 Antiretroviral therapy................................................................................................................... 35 \\n11.4 Support services ......................................................................................................................... 35 \\n11.5 Mental health assessment and support....................................................................................... 35 \\n12. Neonatal management ..................................................................................................................... 36 \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection ............... 37 \\n13. HIV diagnosis in infants and children................................................................................................ 39 \\n13.1 Timing of assessments ............................................................................................................... 40 \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants ................................................... 40 \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis ..................................................... 43 \\n14.  Antiretroviral drug dosing recommendations for newborns .............................................................. 45 \\n15. Co-trimoxazole prophylaxis .............................................................................................................. 48 \\n16. Infant feeding ................................................................................................................................... 49 \\n17. Contraception for women living with HIV .......................................................................................... 50 \\n19. Immunization .................................................................................................................................... 57 \\n20. References....................................................................................................................................... 59 \\n21. Annexures ........................................................................................................................................ 60'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='8 \\n \\nAbbreviations and acronyms \\nAbacavir  \\nABC \\nAntenatal clinic \\nANC \\nAntiretroviral  \\nARV \\nAntiretroviral therapy \\nART \\nAcquired Immune deficiency syndrome \\nAIDS \\nAtazanavir \\nATV \\nAtazanavir/cobicistat  \\nATV/c \\nAtazanavir/ritonavir  \\nATV/r  * \\nBictegravir  \\nBIC \\nCabotegravir  \\nCAB \\nCaesarean Section   \\nCS \\nCombined hormonal contraception \\nCHC \\nCopper intrauterine device \\nCu- IUD \\nDarunavir/cobicistat (DRV/c \\nDRV/c \\nDarunavir/ritonavir (DRV/r) \\nDRV/r \\nDepot medroxyprogesterone acetate \\nDMPA \\nDolutegravir  \\nDTG \\nDoravirine  \\nDOR \\nDRV darunavir \\nDRV  \\nEarly infant diagnosis \\nEID \\nEfavirenz  \\nEFV \\nElvitegravir  \\nEVG \\nElvitegravir/ cobicistat  \\nEVG/c   \\nEmtricitabine  \\nFTC \\nEnfuvirtide  \\nENF \\nEnhanced postnatal prophylaxis \\nePNP \\nEnzyme Linked Immunosorbent Assay \\nELISA \\nEtonogestrel implant \\nENG-IMP \\nEtravirine  \\nETR \\nExternal cephalic version (ECV)  \\nECV \\nFixed dose combinations  \\nFDCs \\nGlobal validation advisory committee \\nGVAC \\nGlobal AIDS Monitoring  \\nGAM \\nHealth-care worker \\nHCW \\nHIV drug resistance \\nHIVDR \\nHuman immunodeficiency virus \\nHIV \\nIntegrase strand transfer inhibitors  \\nINSTIs \\nLamivudine  \\n3TC \\nLevonorgestrel-releasing intrauterine system \\nLNG-IUD \\nLong-acting injectable cabotegravir \\nCAB-LA \\nLopinavir/ritonavir \\nLPV \\nLopinavir/ritonavir (LPV/r)  \\nLPV/r \\nLower segment caesarean section  \\nLSCS \\nMaraviroc  \\nMVC \\nMaternal and child health \\nMCH \\nMedical officer \\nMO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='9 \\n \\nMinistry of Health \\nMOH \\nMother and child health \\nMCH \\nMother to child transmission \\nMTCT \\nMother-to-child transmission \\nMTCT \\nMultidisciplinary team \\nMDT \\nNational Reference Laboratory  \\nNRL \\nNucleic acid amplification test  \\nNAT \\nNevirapine \\nNVP \\nNon-nucleoside reverse transcriptase inhibitors \\nNNRTIs \\nNucleic acid testing  \\nNAT \\nNucleoside reverse transcriptase inhibitors  \\nNRTI \\nPoint-of-care \\nPOC \\nPolymerase chain reaction \\nPCR \\nPost  Exposure Prophylaxis  \\nPEP \\nPre-Exposure Prophylaxis  \\nPrEP \\nPre-labour Caesarean Section   \\nPLCS \\nPrevention of mother-to-child transmission \\nPMTCT \\nProgestogen-only pill \\nPOP \\nPublic health midwife  \\nPHM \\nRaltegravir  \\nRAL \\nRapid diagnostics test \\nRDT \\nRegional validation committee  \\nRVC \\nRilpivirine  \\nRPV \\nSexually Transmitted Infections \\nSTI \\nSpontaneous Rupture of Membranes \\nSROM \\nTenofovir alafenamide  \\nTAF \\nTenofovir disoproxil fumarate  \\nTDF \\nViral load \\nVL \\nWorld Health Organization \\nWHO \\nZidovudine \\nAZT'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='10 \\n \\nContents of Tables \\n \\n \\n \\nTable 1 : Indicators and targets for validation of EMTCT of the HIV programme \\n13 \\nTable 2 : First line ART regimens \\n22 \\nTable 3 : Recommendations following SROM \\n32 \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\n33 \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high and low risk: \\n36 \\nTable 6 : Infant post-exposure prophylaxis (PEP) \\n38 \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n40 \\nTable 8 : Infant diagnosis among breastfed infants \\n41 \\nTable 9 : ART dosage for infants \\n45 \\nTable 10: Contraceptive methods \\n51 \\nTable 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n52 \\nTable 12: ART and emergency contraception (EC) \\n55 \\nTable 13:  Immunization Schedule \\n57'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='11 \\n \\nTable of figures \\n \\nFigure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n16 \\nFigure 2 : HIV Testing algorithm for pregnant women \\n17 \\nFigure 3: Early Infant diagnosis algorithm \\n42 \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n44'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='12 \\n \\nAnnexures  \\nAnnexure 1 : General circular letter No. 01-51/2016 - English \\n61 \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil \\n64 \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala \\n66 \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\n69 \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n71 \\nAnnexure 6 : Blood Collection request form \\n72 \\nAnnexure 7 : EMTCT HIV Case Investigation form \\n73 \\n Annexure 8 : Pregnancy record \\n74 \\nAnnexure 9 : Poster  for EMTCT of HIV \\n75 \\nAnnexure 10 : Leaflet for pregnant women on service package \\n76'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='13 \\n \\n1. Validation of Elimination of mother to child transmission \\n(EMTCT) of HIV and syphilis programme \\nSri Lanka has been declared as a country that eliminated MTCT of HIV and syphilis by the WHO, \\nGeneva in 2019. The overall goal for EMTCT of HIV and syphilis is to ensure the prevention of MTCT \\nof HIV and syphilis to a level that it is no longer a public health problem. Sri Lanka had to achieve the \\nfollowing impact and process indicators to achieve the elimination status. \\n           Table 1 : Indicators and targets for validation of EMTCT of the HIV programme \\nImpact indicators \\nA case rate of HIV positive infants  ≤50 per 100 000 live births \\nProcess indicators \\n \\nPopulation-level ANC1 coverage (at least one visit) of ≥95% \\nCoverage of HIV testing of pregnant women of ≥95% \\nTreatment coverage of HIV positive pregnant women of ≥95% \\nTreatment coverage of infants exposed to HIV of ≥95% \\n \\nThe EMTCT programme is closely monitored by WHO and will be revalidated once every three years. \\nIt is important to maintain satisfactory process and impact indicators and to sustain the success of the \\nprogramme throughout.  \\nSero-prevalence of HIV among antenatal population has remained at <0.01% for the last two decades \\nin Sri Lanka. \\nThe probability of mother to child transmission of HIV can be eliminated with appropriate \\nmanagement. If there is no intervention, the risk of transmission of HIV from an untreated mother to \\nchild is between 15-45 % depending on the stage of the infection, HIV RNA level and infant feeding \\npractices. \\n \\n1.1 Maintenance of eliminated status of MTCT of HIV  \\nFollowing validation of the EMTCT programme, it is important to maintain the impact and process \\nindicators each year to certify the country as successfully maintaining the services for EMTCT of HIV.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='14 \\n \\nCountries that fail to maintain the required EMTCT impact and  process indicators or maintain human, \\nsexual and  reproductive rights for women, can lose validation status.  \\nMaintenance of validation reports are expected to be submitted by countries every 3 years after initial \\nvalidation. These reports will be submitted through the regional validation committee (RVC) and \\nreviewed by the GVAC and the global secretariat to verify maintenance of validation.  \\nTo sustain elimination, a country requires comprehensive surveillance and monitoring systems \\n(including among vulnerable and key populations at risk of acquiring HIV and STIs). Such strong \\nsystems are needed to provide accurate data on intervention coverage, and quickly detect changes in \\ndisease transmission trends. For MTCT of HIV and syphilis, these systems provide ongoing monitoring \\nof the prevalence of disease in pregnant women and the coverage and effectiveness of treatment.  \\nThe global secretariat will maintain a list of countries that have achieved validation and maintain \\nvalidation criteria and standards over time. A country may lose its validation status if coverage of \\nservices falls or if impact indicators such as case rate or MTCT rate exceed the global validation targets.  \\nTo maintain validation status, data should be reported through global reporting mechanisms such as \\nthe UNAIDS Global AIDS Monitoring (GAM) system. Indicators that are not captured in the GAM should \\nbe reported directly to the WHO country office.  \\nAt the time of assessment of maintenance of validation, countries will be required to prepare a report \\nthat should include data tables on validation targets (process and impact indicators for the previous 3 \\nyears). For countries like Sri Lanka, with small populations and small numbers of HIV-positive and/or \\nsyphilis-positive pregnant women per year, 4 years of pooled data can be used to assess maintenance \\nof validation. Human rights, gender equality and civil society engagement must be reassessed and \\nincluded in the report at this time to ensure that there are no violations or changes in laws pertaining to \\nthis component of validation since the last validation review. Maintenance reports should include \\nupdates on any programmatic data, laboratory and human rights recommendations provided by the \\nGVAC at the time of validation. Maintenance reports should be submitted to the RVS, which will review \\nthe report and, if the validation criteria are still being met, will submit the report to the RVC (if applicable) \\nand the GVAC for final revalidation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='15 \\n \\n2. HIV testing in pregnant women \\n \\nHIV testing services should be offered to all pregnant women during the first visit with the antenatal \\ncare package before 12 weeks of gestation. \\n \\n\\uf0b7 \\nPregnant women should be informed about these tests, with testing being voluntary after \\nproviding adequate information on MTCT of HIV and prevention methods. \\n\\uf0b7 \\nIf a woman declines testing, her decision should be respected, and she should be assured \\nthat it will not affect her access to ANC services. \\n\\uf0b7 \\nFor pregnant women at high risk for HIV or STIs, a second HIV test should be offered at 28 \\nweeks of gestation either through the nearest STD clinic or via RDT. \\n \\n\\uf0b7 \\nAll pregnant women should receive opt-out HIV testing as early as possible during each pregnancy. \\n\\uf0b7 \\nDual HIV and syphilis rapid diagnostic tests can be offered as the first test in antenatal care to \\nincrease testing and treatment coverage.  \\n\\uf0b7 \\nRepeat HIV testing in the third trimester is recommended for pregnant women with negative initial \\nHIV tests who are at increased risk of acquiring HIV. \\n\\uf0b7 \\nRepeat HIV testing is recommended for pregnant women with a sexually transmitted infection, with \\nsigns and symptoms of acute HIV infection, or with ongoing exposure to HIV.  \\n\\uf0b7 \\nExpedited HIV testing should be performed during labor or after delivery for people with \\nundocumented HIV status and for those who tested negative early in pregnancy but are at increased \\nrisk of HIV infection and were not retested in the third trimester.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='16 \\n \\n \\n               Figure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from the  \\nANC clinics. \\nDate of blood sampling \\nshould be recorded in \\n512 pregnancy record \\n \\n \\nBlood samples are sent \\nto the STD clinics \\n \\nHIV /Syphilis Duo rapid \\ntest is performed at the \\nSTD clinic laboratory \\n \\nPositive results are conveyed \\nimmediately to the MOH or VOG of \\nthe relevant ANC clinic \\n(over the phone) \\nNegative results are  sent back to the \\nMOH through the same request form \\n \\n \\nPregnant women who receive a \\npositive HIV screening result are \\nimmediately referred to the STD \\nclinic for further evaluation and \\nmanagement'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='17 \\n \\nFigure 2 : HIV Testing algorithm for pregnant women  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n*Any discrepancy of a test results;  sample should be immediately  sent to the NRL for molecular or viral load \\ntesting\\n+ ELISA or + RDT1 \\nPerform Ag/Ab combo \\nRDT1 \\n(second sample)  \\nPerform ELISA or repeat \\nRDT1 \\nConnect to \\nnational HIV \\ntesting \\nalgorithm* \\n+ RDT1 \\nReport as HIV \\nNegative \\n- ELISA or - RDT1 \\n- RDT1 \\nPerform HIV/Syphilis  \\nDuo RDT \\n+HIV \\n- HIV \\nReport as HIV \\nNegative'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='3. Fertility desires among women with HIV  \\n \\n\\uf0b7 \\nImprovements in life expectancy and quality of life for women living with HIV, along with \\nenhanced access to EMTCT services, have increasingly led HIV positive women to \\ncontemplate the possibility of pregnancy.  \\n\\uf0b7 \\nPre-conception counselling need to be offered to all HIV positive women planning to have \\nchildren. Counselling should include the importance of treatment adherence and virologic \\nsuppression to eliminate the risk of MTCT of HIV. ARV therapy should be discussed with \\nevery woman taking their concerns and preferences into account and management should \\nbe based on the standard treatment guidelines.  \\n\\uf0b7 \\nAll women planning on pregnancy should start folic acid supplementation before pregnancy \\nand continue up to 12 weeks of gestation. \\n \\n3.1 Fertility options for PLHIV \\nIncreasingly, parenting is regarded as a realistic option for couples where one or both partners \\nare infected with HIV and the demand for reproductive care is rising. HIV-positive men and \\nwomen and their partners planning to have children should receive pre-conception counselling \\non all their conception options, including HIV transmission risks associated with each case, so \\nthat they can make an informed choice. All discussions should be documented clearly in clinical \\nnotes. \\nFor sero-concordant or discordant couples who want to conceive, expert consultation is \\nrecommended so that approaches can be tailored to specific needs, which may vary from \\ncouple to couple. \\nThe physician does need to ensure that the uninfected partner has a full understanding of the \\npossibility of becoming infected through unprotected intercourse. More importantly, the need \\nfor ART adherence and regular attendance for STI screening in the couple and viral load \\nchecks in the infected partner should be stressed.  \\nFor couples in which one or both partners are HIV-infected, optimal health should be attained \\nbefore attempting conception.  \\n\\uf0b7 \\nInfected partner/couple should be receiving combination antiretroviral therapy and \\ndemonstrate sustained viral suppression  (two  undetectable viral load over the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='19 \\n \\nperiod of six months) of plasma viral load below the limits of detection (at present \\n<34 copies/ml). \\n\\uf0b7 \\nBoth partners should be screened for genital tract infections. Treatment of such \\ninfections is important because genital tract inflammation is associated with genital \\ntract shedding of HIV. \\n\\uf0b7 \\nShould  undergo fertility screen where necessary. \\n3.1.1 Sero-discordant Couples  \\nBefore conception is attempted, the HIV-infected partner should be receiving ART and \\ndemonstrate sustained suppression of plasma viral load below the limits of detection. The \\npossible fertility options are  as follows.  \\n1. Antiretroviral Therapy (ART) for the HIV-Positive Partner: \\nEnsuring the HIV-positive partner is on effective ART and has an undetectable viral \\nload reduces the risk of sexual transmission to effectively zero. This approach is known \\nas \"U=U\" (Undetectable = Untransmittable). Once the viral load is suppressed, natural \\nconception through timed intercourse becomes safer. \\n2. Pre-Exposure Prophylaxis (PrEP) for the HIV-Negative Partner: \\nThe HIV-negative female partner can take PrEP to further reduce the risk of acquiring \\nHIV during conception attempts. PrEP is most effective when taken consistently as \\nprescribed. \\n3. Timed Intercourse with ART and PrEP: \\nThis involves natural conception through intercourse timed around ovulation, combined \\nwith ART for the HIV-positive partner and PrEP for the HIV-negative partner. \\n4. Sperm Washing: \\nSperm washing is a process where sperm is separated from the seminal fluid, which \\nmay contain HIV. The washed sperm can then be used for intrauterine insemination \\n(IUI) or in vitro fertilization (IVF). This method significantly reduces the risk of HIV \\ntransmission. \\n5. In Vitro Fertilization (IVF): \\nIVF using sperm washing is a common method where the washed sperm is used to \\nfertilize the female partner’s ovum in a laboratory, followed by the transfer of the embryo \\nto the uterus. This option is particularly useful for couples with fertility challenges. \\n6. Donor Sperm: \\nIf the couple prefers to avoid the risk of transmission altogether, donor sperm from an \\nHIV-negative donor can be used for insemination or IVF.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='20 \\n \\n4. Pre-Exposure Prophylaxis  \\n \\nIn sero-discordant couples where the HIV-positive partner is on antiretroviral therapy and has \\nachieved sustained viral suppression, condomless sexual intercourse enables conception \\nwithout the risk of HIV transmission to the HIV-negative partner. As an added precaution, they \\nhave the option to choose PrEP for HIV prevention, even if the HIV-positive partner has achieved \\nviral suppression.  \\nThe preferred PrEP option for HIV prevention in people who have receptive vaginal sex during \\npregnancy and breastfeeding is tenofovir disoproxil fumarate with emtricitabine or lamivudine \\n(TDF+FTC/3TC). People who become pregnant while using TDF/FTC or TDF/3TC as PrEP, can \\ncontinue PrEP throughout pregnancy and breastfeeding. Risk for HIV acquisition should be \\nreassessed, and couple should be counselled regarding the benefits and risks of PrEP use in \\npregnancy and breast feeding. \\nProviders should counsel patients about the importance of adherence to oral PrEP to prevent \\nHIV acquisition. Event driven or non-daily PrEP is not recommended for protection against \\nvaginal exposure to HIV.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='21 \\n \\n5. Management of  pregnant women with HIV  \\n \\n5.1 When to start ART in pregnant and breastfeeding women? \\nAll pregnant and breastfeeding women living with HIV should initiate and continue lifelong ART, \\nregardless of WHO clinical stage or CD4 count. Pregnant women newly diagnosed with HIV \\nshould start ART as early as possible, while those already on ART with sustained viral \\nsuppression should maintain their current regimen. \\nProviding ART to all pregnant and breast-feeding women living with HIV serves three synergistic \\npurposes. \\n1. Improving mothers’ health \\n2. Preventing mother to child transmission of HIV \\n3. Preventing transmission of HIV from mother to sexual partner/partners \\nFollowing a confirmed HIV diagnosis and clinical assessment, rapid ART initiation should be \\noffered to all individuals, ideally within seven days. Those with advanced HIV disease should \\nbe prioritized. Same-day ART initiation should be available for individuals ready to start \\ntreatment immediately. \\n \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy \\nWhen selecting an ARV regimen for pregnancy, factors to consider include adverse effects, \\ndrug interactions, pharmacokinetics, regimen convenience, pregnancy safety data, virologic \\nefficacy, and comorbidities. The selection of  ARV regimen for pregnancy, is a shared and \\nindividualized decision taken with consideration of available data for drug use in pregnant \\npeople as well as durability, tolerability and simplicity of medication regimen to ensure \\ntreatment adherence \\n5.2.2 ARV regimens \\nThere are five categories of drug recommendations in pregnancy as Preferred, Alternative, \\nInsufficient data to recommend, not recommended except in special circumstances and not \\nrecommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='22 \\n \\nOut of them the preferred first line regimen for the treatment of pregnant people with HIV who \\nhave never received ARV drugs consist of the integrase strand transfer inhibitor (INSTI) \\ndolutegravir (DTG) plus a dual-nucleoside reverse transcriptase inhibitor (NRTIs) combination.  \\n5.2.3 Preferred regimens  \\nTable 2 : First line ART regimens \\nFirst line ART \\nPreferred first –line \\nregimens \\nAlternative first –line regimens* \\n  \\nPregnant and breast-\\nfeeding women  \\n \\nTDF + FTC/3TC + DTG \\nTAF + FTC + DTG \\n \\n \\n \\nABC1 + 3TC +DTG/DRV/r2/EFV3//ATV/r \\nAZT + 3TC + DTG/DRV/r /EFV/ATV/r \\nTDF + FTC + DRV/r2 / EFV3 / RPV4 \\nTAF + FTC + DRV/r2 / EFV3 /RPV4 \\n \\n1ABC - Presence of HLA-B 5701 gene indicates higher risk for hypersensitivity. Viral load should be <100,000 \\ncopies/ml and without chronic hepatitis B virus (HBV) coinfection \\n2DRV Twice daily dose is recommended in pregnancy. \\n3If the preferred ART regimen is unavailable or contraindicated, alternatives for pregnant and breastfeeding women \\ninclude substituting TAF/ABC for TDF or using EFV or DRV/r instead of INSTI. The efficacy of low-dose EFV (400 \\nmg) in pregnancy has not been studied \\n4RPV can be used if VL< 100 000 c/ml and CD4 >200 cells/mm3. \\nNote: \\n\\uf0b7 \\nTAF or boosted PIs (DRV/r, ATV/r, LPV/r) can be used in special circumstances. \\n\\uf0b7 \\nINSTI Bictegravir (BIC) classified as an alternative ARV drug for use in pregnancy. \\n\\uf0b7 \\nOther INSTI Elvitegravir (EVG) or Cabotegravir (CAB) are not recommended in pregnancy due \\nto limited data during pregnancy. \\n \\nIf an ARV regimen is stopped during pregnancy, all drugs should be discontinued together, and \\na complete regimen restarted promptly. Pregnant women with HIV who have defaulted on ART \\nshould resume treatment immediately, adjusting the regimen later if resistance test results \\nrequire it \\nIn addition to ART, they should receive comprehensive pregnancy care, including nutritional \\nsupport, infant feeding counseling, and family planning guidance. Monitoring for pregnancy-\\ninduced hypertension and pre-eclampsia, particularly in women on ART before conception, is \\nessential.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='23 \\n \\n5.2.4 Women with HIV conceiving while on ART \\n \\nIt is recommended that women conceiving on an effective ART regimen should be continued. \\nThe ART regimens should not be changed just due to non-inclusion of preferred or alternative \\nregimens or drugs, because the changing could lead to increase in viral load, decline in immune \\nstatus, progression of disease and increased risk of mother to child transmission of HIV \\ninfection. However, ART regimen should be changed if it contains medications which are not \\nrecommended to use in pregnancy. \\nIt is recommended to continue suppressive regimen with frequent viral load monitoring when \\nshe is on an ART regimen with insufficient data about using in pregnancy. \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got \\npregnant while maintaining successful viral suppression, oral two drug regimen may be \\ncontinued with more frequent (every 1-2 months)  viral load monitoring. \\n5.2.5 Late-presenting woman not on treatment \\nINSTIs have an important role to play in late pregnancy as DTG and RAL can suppress viral \\nload rapidly. A decrease of approximately 2 log10 copies/ml occurs by two-week therapy with \\nDTG and RAL. DTG preferred and RAL (Raltegravir) is alternative as RAL requires twice daily \\ndosing and has a lower barrier to development of drug resistance than DTG.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='24 \\n \\n6. Monitoring of pregnant women receiving ART \\n\\uf0b7 \\nClinical and laboratory evaluation is as for non-pregnant women receiving ART.  \\n\\uf0b7 \\nHaematological and biochemistry parameters should be monitored as appropriate to the \\nART regimen used. \\n\\uf0b7 \\nRegular viral load monitoring is needed in pregnancy.  \\n\\uf0b7 \\nAll pregnant women, regardless of when they start ART, may require more intense \\nmonitoring of viral suppression, including conducting viral load testing at 34–36 weeks \\nof gestation (or at the latest at delivery) to identify women who may be at risk of treatment \\nfailure and/or may deliver infants at higher risk of perinatal transmission.  \\n\\uf0b7 \\nIn addition, a viral load test is recommended for all breastfeeding women three months \\nafter delivery and every six months thereafter to detect viraemic episodes during the \\npostnatal period. \\n\\uf0b7 \\nWhen lack of suppression is identified, a thoughtful evaluation of potential contributing \\nfactors is needed, including barriers to adherence, drug resistance, drug–drug and drug–\\nfood interactions, pharmacokinetics  changes in pregnancy that affect drug levels, and \\ncombinations of these factors. \\n\\uf0b7 \\nIn women who commence ART in pregnancy, HIV viral load should be performed four \\nweeks after commencing ART and at 36 weeks. \\n\\uf0b7 \\nIn women commencing ART in pregnancy, liver function tests should be performed at \\ninitiation of ART and then at each antenatal visit. \\n\\uf0b7 \\nIf a woman who has initiated ART during pregnancy has not achieved a plasma viral \\nload of < 50 HIV RNA copies/ml at 36 weeks, following interventions are recommended: \\n\\uf0d8 Review treatment adherence and concurrent use of other medication \\n\\uf0d8 Perform resistance testing if appropriate \\n\\uf0d8 Optimize to the best regimen \\n\\uf0d8 Consider intensification'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='25 \\n \\n7. Obstetric management \\n7.1 Antenatal management \\n\\uf0b7 \\nPregnant women with HIV should receive comprehensive care from a multidisciplinary \\nteam, including an obstetrician, venereologist, paediatrician, anaesthetist, theatre nurse, \\nMOH, microbiologist/virologist, and infection control nurse. Effective coordination, \\nconfidentiality, and shared responsibility are crucial in their management.  \\n\\uf0b7 \\nHealthcare providers must ensure that antenatal, labor, delivery, and postpartum care \\nare delivered in a supportive environment, with institution heads and consultants working \\nto prevent stigma and discrimination. Ensure privacy and confidentiality during \\nconsultations and reassure the woman that her HIV status will be kept confidential. \\n\\uf0b7 \\nExplain to the woman who the information will be shared with. \\n\\uf0b7 \\nExplain to the woman that she will have to follow routine antenatal clinic visits and give \\nher confidence by discussing the management plan with her. \\n\\uf0b7 \\nFoetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal diagnostic testing should not be performed until after the HIV status of \\nthe mother is known and should ideally be deferred until HIV viral load has been \\nadequately suppressed. \\n\\uf0b7 \\nPlan and discuss the mode of delivery with the pregnant woman during antenatal care. \\nGive her clear instructions on when to get admitted for delivery and whom should be \\ncontacted.  \\n\\uf0b7 \\nExternal cephalic version (ECV) can be performed in women with HIV who are virally \\nsuppressed. \\n\\uf0b7 \\nHealth care workers should practice universal infection control measures for all \\ndeliveries irrespective of the infection status of pregnant women. \\n\\uf0b7 \\nAmniocentesis may be performed on virally suppressed pregnant women with HIV after \\nthorough counseling on risks, benefits, and alternatives, if they are on ART with an \\nundetectable viral load. \\n\\uf0b7 \\nCoordinated multidisciplinary team management involving MCH staff, infection control, \\nvenereologists, obstetricians, pediatricians, and other relevant services is crucial for \\ndelivering quality care.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='26 \\n \\n\\uf0b7 \\nDuring pregnancy, pregnant woman needs to be counselled on mode of delivery, family \\nplanning and contraceptive options, infant feeding, infant ARV prophylaxis, and timing \\nof infant diagnostic testing. \\n\\uf0b7 \\nFetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal testing should be delayed until the woman\\'s viral load is suppressed \\nto <50 copies/mL. If invasive testing can\\'t wait for viral suppression, ART with DTG \\nshould be initiated, and a single dose of nevirapine administered 2–4 hours before the \\nprocedure.  \\n \\n   7.2. Mode of delivery \\n\\uf0b7 \\nFor women with a plasma viral load of <50 HIV RNA copies/mL at 36 weeks, and in the \\nabsence of obstetric contraindications, planned vaginal delivery can be  supported. \\n\\uf0b7 \\nFor women with a plasma viral load of ≥ 50 HIV RNA copies/mL at 36 weeks, pre-labour \\nCaesarean Section  (PLCS) is recommended. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been planned and labour has commenced, \\nobstetric management should follow the same guidelines as for the HIV-negative \\npopulation, except for managing the duration of ruptured membranes. \\n\\uf0b7 \\nTraditionally amniotomy, fetal scalp electrodes and blood sampling, instrumental \\ndelivery and episiotomy have been avoided in HIV infection because of theoretical \\ntransmission risks. \\n \\nPoints for consideration \\n• \\nAll known HIV infected pregnant women should have an individualized, regularly \\nupdated, plan of care which summarizes mutually agreed obstetric/HIV management \\nincluding the drug regimen and recommended mode of delivery.  \\n• \\nProperly applied universal infection control measures protect staff from blood borne \\ninfections. Routine use of these precautions is essential to minimize occupational \\nrisk. \\n• \\nWard staff must maintain confidentiality regarding a pregnant woman’s HIV status and \\nprovide nonjudgmental, stigma-free care. Information should be shared only on a \"need \\nto know\" basis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='27 \\n \\n7.3. Multiple pregnancies \\nMultiple pregnancies should be managed according to obstetric need of the woman and as \\nper HIV-negative protocols.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='28 \\n \\n 8. Antenatal care at the primary health care ANC clinic \\n \\n \\n• \\nWhen a pregnant woman is diagnosed as having HIV infection, the venereologist of the \\nSTD clinic will communicate with the MOH regarding the steps need to be taken. \\n• \\nMOH and staff play a key role in caring for pregnant women with HIV. Effective \\ncoordination, confidential communication, and shared responsibility are essential for \\nproper management. \\n• \\nEnsure privacy and confidentiality during consultations and reassure the woman that her \\nHIV status will be kept confidential. \\n• \\nExplain to the pregnant woman who the information will be shared with. \\n• \\nExplain to her that she will have to follow routine antenatal clinic visits.  \\n• \\nThe pregnant woman should be reassured and should be referred immediately to the \\nSTD clinic for further management. \\n• \\nHealth care providers should ensure that pregnant women with HIV are provided \\nantenatal care, labour and delivery care and post-partum services in a user-friendly \\nenvironment.  \\n• \\nThe MOH and the staff should take all measures to maintain confidentiality and prevent \\nstigma and discrimination. \\n• \\nCheck whether she has been seen by a VOG as delivery care needs to be arranged in \\na unit with specialist services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='29 \\n \\n9. Management of HIV positive pregnant women \\nin the STD clinic \\n \\nThere are two possibilities. \\n\\uf0b7 \\nA pregnant woman may be identified as having HIV infection during routine antenatal \\nscreening and referred to the STD clinic by the MOH or VOG for further management. \\n\\uf0b7 \\nA woman already diagnosed as living with HIV and under care services from STD clinic \\ncan become pregnant. \\n\\uf0d8 All pregnant women with HIV should have an individualized, regularly updated plan of \\ncare which summarizes mutually agreed obstetric and HIV management plan.  \\n\\uf0d8 Check whether the woman has already attended for antenatal care and encourage \\nregular attendance at antenatal visits. \\n\\uf0d8 Ask about the health of other children and encourage checking HIV status of partner and  \\nchildren. \\n \\n9.1  Counselling \\n  The following areas need to be covered in counseling. \\n\\uf0b7 \\nART and adherence to treatment \\n\\uf0b7 \\nPartner disclosure/screening \\n\\uf0b7 \\nHIV testing of other children \\n\\uf0b7 \\nMode of delivery \\n\\uf0b7 \\nChoice of infant feeding \\n\\uf0b7 \\nCondom use to prevent acquiring other STIs, entry of other strains of HIV and onward \\ntransmission to a negative partner \\n\\uf0b7 \\nPostpartum family planning \\n \\nPregnant women should be counselled on delivery options, lifelong HIV therapy, family planning, \\ncontraceptives, infant feeding, ARV prophylaxis for the infant, and timing of infant diagnostic \\ntesting.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='30 \\n \\n10. Management of delivery of pregnant mother with \\nHIV \\n \\n10.1 Plan for delivery \\n \\nPlan and discuss the mode of delivery with the pregnant woman (and her partner if possible) \\nduring the  antenatal care. \\nGive her instructions on when to get admitted to the hospital for delivery and whom she should \\ncontact. \\nExplain the possibility of preterm labour and what to do in case of an emergency. \\nWhen admitted for delivery \\n• \\nCheck the expected date of delivery \\n• \\nConfirm normal growth of the foetus \\n• \\nCheck which ART regimen have been prescribed and whether drugs have been taken \\nas prescribed \\n• \\nCheck for recent viral load results \\n• \\nWomen with incomplete viral suppression (>50 copies/mL) at the time of delivery \\npreferably should receive IV zidovudine (if available) while continuing oral ARV \\nregimen. \\n• \\nIn situations where IV administration is not possible/not available, oral \\nadministration of zidovudine using a 600-mg loading dose and 400 mg every 3 \\nhours can be considered. \\n• \\nCheck for availability of antiretroviral treatment for infant prophylaxis. \\n• \\nCheck for infant feeding method and emphasize on adherence and support if she has \\ndecided on breast feeding.  \\n• \\nProvide lactation suppression therapy if mother has decided on formula feeding. \\n• \\nArrange parents to collect formula milk from the NGO. The peripheral STD clinics receive \\nformula milk from the EMTCT unit, which obtains it in bulk from the NGO. \\n• \\nCheck for availability of safe delivery kits and post exposure prophylaxis therapy in the \\nhealth care institution which is identified for delivery.  \\n• \\nConfirm that a post-partum family planning method is arranged before being discharged \\nfrom the hospital.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='31 \\n \\n10.2 Planned normal vaginal delivery \\n \\n\\uf0b7 \\nIf HIV viral load is < 50 copies/mL at 36 weeks, the risk of MTCT of HIV is less in the \\nabsence of other obstetric contraindications. \\n\\uf0b7 \\nMinimize vaginal examinations to reduce the risks of infection to the mother. Maintain \\naseptic techniques throughout labour. \\n\\uf0b7 \\nART should be continued according to the ART plan. \\n\\uf0b7 \\nAmniotomy, fetal scalp electrodes and fetal blood sampling, instrumental delivery and \\nepisiotomy need to be avoided in pregnant women with HIV infection because of \\ntheoretical transmission risks. \\n\\uf0b7 \\nArtificial rupture of membranes increases the risk of infection of the placental \\nmembranes.  \\n\\uf0b7 \\nAvoid prolonged labor by monitoring labour carefully and intervening appropriately (i.e., \\naugmentation of labour through oxytocin or delivery by caesarean section).  \\n\\uf0b7 \\nThe head should be well engaged. \\n\\uf0b7 \\nCheck whether the cervix is effaced and dilated and await spontaneous onset of labour. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been recommended and labour has \\ncommenced, obstetric management should follow the same principles as for the \\nuninfected population.  \\n \\n10.3. Planned caesarean section \\n \\n\\uf0b7 \\nExplain to the pregnant woman about the reason for the caesarean section and obtain \\ninformed consent. \\n\\uf0b7 \\nNotify the Hospital Director, consultant anesthetist, neonatologist, paediatrician, \\ninfection control unit, head of the intensive care unit, sister in charge of the theatre, \\nantenatal ward, postnatal ward and PBU where necessary, while taking every \\nprecaution to maintain confidentiality. \\n\\uf0b7 \\nInform the consultant venereologist of the STD clinic. \\n\\uf0b7 \\nProvide premedication and prepare as usual for surgery. \\n\\uf0b7 \\nRegional analgesia is not contraindicated in delivery care of pregnant women with \\nHIV. \\n\\uf0b7 \\nContinue ARV regimen as recommended. Oral medications can be continued \\npreoperatively with sips of water.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='32 \\n \\n10.4 Management of pre-labour spontaneous rupture of membranes \\n \\n In all cases of term pre-labour spontaneous rupture of membranes (SROM), delivery should be     \\n expedited. \\nTable 3 : Recommendations following SROM \\nScenario \\nRecommendations \\n1. \\nIf maternal HIV viral load is < 50 RNA copies/mL immediate induction of labour is \\nrecommended, preferably under antibiotic cover. \\n2. \\nIf maternal HIV viral load is ≥ 50 RNA copies/mL plasma, immediate caesarean \\nsection is recommended. \\n3. \\nIf maternal HIV viral load is not available, immediate caesarean section is \\nrecommended \\n \\n \\n \\nIt has been observed that the risk of HIV transmission was twice as high among women with \\nruptured membranes for more than 4 hours before delivery compared with those with shorter \\nduration of membrane rupture. \\nThere is no evidence that steroids for foetal lung maturation (with associated 24-hour delay in \\ninduction) are of overall benefit at 34–37 weeks’ gestation in women with ruptured membranes, \\nthus delay for the optimization of fetal lung maturity is not recommended. For this reason, and \\nto minimize the risk of developing chorioamnionitis, delivery is recommended from 34 weeks’ \\ngestation in women with ruptured membranes who are not in labour. \\n \\n10.5 Management of women who present in labor without documentation of \\nHIV status or women who have not received antepartum antiretroviral drugs \\nWomen presenting in labour / ROM / requiring delivery without a documented HIV result must \\nbe recommended to have a Rapid HIV Test. A reactive/positive result must be acted upon \\nimmediately with initiation of the interventions to PMTCT without waiting for further/formal \\nserological confirmation. Pregnant women with positive rapid HIV screening should be \\npresumed to be infected until HIV confirmatory testing clarifies their infection status \\nAn untreated woman presenting in labour at term should be given a stat dose of nevirapine \\n200 \\nmg \\nand \\ncommence \\non \\nfixed-dose \\nzidovudine \\n+ \\nlamivudine \\nand \\nraltegravir/dolutegravir as the preferred additional agent (because it also rapidly crosses the \\nplacenta). Intravenous zidovudine can be administered for the duration of labour and delivery.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='33 \\n \\n \\nA single dose of nevirapine should be given immediately to the pregnant woman as this rapidly \\ncrosses the placenta and within 2 hours achieves and maintains effective concentrations in the \\nneonate for up to 10 days .If delivery is not imminent, a caesarean section should be considered. \\nIf delivery occurs less than 2 hours post maternal nevirapine, the neonate should also be dosed \\nwith nevirapine immediately. After partus, refer mother to the STD Clinic for clinical and \\nimmunological assessment. \\n \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\nIntrapartum intravenous zidovudine infusion is recommended in the following circumstances \\n \\n1.  \\nFor women with a viral load >1000 HIV RNA copies/mL plasma who present in \\nlabour or with SROM or who are admitted for PLCS \\n2.  \\nFor untreated women presenting in labour or SROM \\n3. \\nSROM in whom the current viral load is not known. \\n4. \\nCan be considered for women with viral load >50 HIV RNA copies/mL who present \\nin labour or with SROM or who are admitted for CS'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='34 \\n \\n11. Post-partum Management  \\n \\n11.1  Immediate management \\n• \\nAvoid suctioning the infant’s mouth and pharynx, which may cause trauma to the \\nmucous membranes thus promoting mother to child transmission of HIV. \\n• \\nClean the eyes of the baby with saline at delivery of the head. \\n• \\nClamp the cord as soon as possible to minimize the risk of maternal-fetal micro-\\ntransfusions. \\n• \\nCover the umbilical cord with a swab when cutting to prevent spurting blood. \\n• \\nTowel dry the baby. \\n• \\nClean the baby’s skin thoroughly before any infusions or injections. \\n \\nMinimize the risk of postpartum haemorrhage by: \\no Actively managing the third stage of labor \\no Using controlled cord traction \\no Performing uterine massage \\no Repair any genital tears \\no Carefully removing all products of conception \\n• \\nPhysical assessment in the postpartum period should follow routine guidelines. Examine \\nwomen within 24 hours following delivery. \\n• \\nBe aware of signs of infection following delivery. HIV positive women are also vulnerable \\nto infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early \\ndetection and effective treatment are important measures to prevent complications. \\n• \\nManage infected tears or episiotomy. \\n11.2 Additional measures \\n• \\nAdvice women to come back to the same institution if LSCS wound infection is observed. \\n• \\nWhen they are discharged from the healthcare facility, women should be advised to \\nreturn to the clinic or inform the PHM if they notice symptoms such as fever, lower \\nabdominal pain, burning with urination, foul smelling discharge, abnormal bleeding, \\ncough, shortness of breath, calf pain (increasing on walking), diarrhoea and \\nunusual/abnormal behaviour.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='35 \\n \\n• \\nGive information to the mother on care of the perineum and breasts. Women living with \\nHIV require special care to reduce breast engorgement, mitigate pain and avoid mastitis. \\n• \\nWomen who choose to breast feed should be counselled to avoid breast engorgement \\nwhich could lead to mastitis, since inflammation is associated with increased risk of HIV \\ntransmission. She should be advised to seek immediate medical care if breast \\nengorgement is associated with fever and pain. \\n• \\nInstruct her about the safe disposal of lochia and blood-stained sanitary wear or other \\npotential infectious materials. \\n• \\nIf family planning has not been discussed before delivery it should be done during the \\nearly postpartum period. \\n \\n11.3 Antiretroviral therapy \\n        All women are recommended to continue ART postpartum. \\n \\n11.4 Support services \\nDuring the postpartum period pregnant woman may face serious challenges to ART adherence \\nand retention in HIV care due to new responsibilities. Continued supportive services need to be \\noffered during this critical period. \\n11.5 Mental health assessment and support \\nWomen should have their mental health needs assessed postpartum and those identified as \\nhaving mental health issues should be referred to appropriate services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='36 \\n \\n12. Neonatal management \\n \\nRisk assessment at delivery is essential for identifying high- and low-risk infants, ensuring \\nproper prophylaxis and accurate diagnosis. \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high \\nand low risk: \\nCriteria for infants at high risk \\n \\nCriteria for infants at low risk \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nDid not receive prenatal care. \\n\\uf0b7 \\nReceived no antepartum ARVs or \\nonly intrapartum ARV drugs. \\n\\uf0b7 \\nInitiated ART late in pregnancy \\n(during the late second or third \\ntrimester). \\n\\uf0b7 \\nDiagnosis of acute HIV infection \\nduring pregnancy or in labor. \\n\\uf0b7 \\nHad detectable HIV viral loads        \\n(> 50 copies/mL) close to the time of \\ndelivery, including those who \\nreceived ART but did not achieve \\nsustained viral suppression. \\n \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nReceiving  ART since first trimester \\nor early second trimester . \\n      and  \\n\\uf0b7 \\nHas achieved and maintained viral \\nsuppression. (Defined as \\n<50 copies/mL) \\n     and \\n\\uf0b7 \\nHas reported good adherence and \\nadherence concerns have not been \\nidentified.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='37 \\n \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or \\nHIV Infection \\n \\nAll newborns perinatally exposed to HIV should receive appropriate antiretroviral (ARV) drugs \\nas soon as possible, preferably within 6 hours, after delivery to reduce the risk of perinatal \\ntransmission of HIV. A newborn’s ARV regimen should be determined based on maternal and \\ninfant factors that influence the risk of perinatal transmission of HIV.  \\n\\uf0b7 \\nNewborns at low risk of perinatal HIV acquisition, 4 to 6 weeks zidovudine (ZDV) or \\nNevirapine  (NVP)  is recommended. \\n\\uf0b7 \\nNewborns at high risk of perinatal acquisition of HIV should receive presumptive HIV \\ntherapy with 3-drug regimens administered from birth for 2 to 6 weeks \\n\\uf0b7 \\nAll premature infants <37 weeks gestation who are not at high risk of perinatal \\nacquisition of HIV should receive ZDV or NVP for 4 to 6 weeks . \\n\\uf0b7 \\nInfants of women  who have primary or acute HIV infection during breast feeding period \\nshould be managed like infants at high risk of perinatal transmission with presumptive \\nHIV therapy. \\n\\uf0b7 \\nThe use of ARV drugs other than ZDV, lamivudine (3TC), and NVP cannot be \\nrecommended for any indication in premature newborns (<37 weeks gestational age) \\nbecause of the lack of dosing and safety data. \\n\\uf0b7 \\nIf an individual presents with unknown HIV status and has a positive HIV test during \\nlabor or shortly after delivery, the infant should begin presumptive HIV therapy . If \\nsupplemental maternal testing is negative, the infant’s ARV regimen should be \\ndiscontinued .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='38 \\n \\n Table 6 : Infant post-exposure prophylaxis (PEP) \\nScenario \\nART \\nDuration \\n \\nLow risk Pregnant women and \\nnon-breast-fed  infants \\n \\n \\nNVP (twice daily )  or AZT (twice \\ndaily )   \\n \\n4 - 6 weeks \\n \\nHigh risk Pregnant women and  \\nnon-breast-fed infants \\n \\n \\nAZT (twice daily ) +3TC (twice daily \\n+  NVP (once daily) \\nor  \\nAZT (twice daily ) +3TC (twice daily \\n+  RAL (twice daily) \\n \\n4 -  6 weeks \\n \\nif the duration of the 3-\\ndrug regimen is shorter \\nthan 6 weeks, ZDV / NVP \\nshould be continued \\nalone, to complete a total \\nof 6 weeks of prophylaxis. \\n \\nBreastfed infants* \\n \\n \\n  \\nAZT (twice daily ) and 3TC( twice \\ndaily and  NVP (once daily) \\n \\n12\\u2009weeks or until the \\nmother’s viral load is        \\n<50 cp/mL. \\n* Mothers with acute or primary HIV infection during breastfeeding ,  breastfeeding should be immediately   \\n   discontinued \\n \\nFactors such as prolonged rupture of membranes, preterm delivery and low birth weight are no \\nlonger associated with increased risk of transmission when mothers are with satisfactory viral \\nsuppression. The critical determinant of transmission is maternal viral load. Three-drug infant \\ntherapy is recommended for all circumstances other than where maternal viral load at 36 weeks’ \\ngestation/delivery is < 50 HIV RNA copies/mL. \\nInitiating ART as treatment  in an infant less than 2 weeks of age, a regimen of AZT + 3TC + \\nNVP should be started and NVP be substituted with LPV/r at the earliest opportunity, preferably \\nat 2 weeks of age. In settings where LPV/r syrup is unavailable, NVP should be continued until \\n3 months of age, with close clinical monitoring for children at high risk of NNRTI resistance due \\nto prolonged NVP-based postnatal prophylaxis or documented NNRTI failure in the mother. \\nWhere it is available, raltegravir could also be considered as an option in special circumstances.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='39 \\n \\n13. HIV diagnosis in infants and children \\n \\n\\uf0b7 \\nVirologic assays (HIV RNA or HIV DNA nucleic acid tests [NATs]) that directly detect \\nHIV must be used to diagnose HIV in infants and children aged <18 months with \\nperinatal and postnatal HIV exposure. HIV antibody and HIV antigen/antibody tests \\nshould not be used .  \\n\\uf0b7 \\nPlasma HIV RNA or cell-associated HIV DNA NATs are generally equally \\nrecommended.  \\n\\uf0b7 \\nPlasma HIV RNA or DNA NAT results can be influenced by maternal ART or infant \\nARV prophylaxis or presumptive HIV therapy. \\n\\uf0b7 \\nAll HIV exposed infants should undergo nucleic acid testing (NAT) at birth to identify \\nHIV infection ,  then at 8 weeks of age (at least 2 weeks after cessation of PEP) or \\nat the earliest opportunity thereafter and at 4-6 months. \\n\\uf0b7 \\nAge-appropriate HIV testing also is recommended for infants and children with signs \\nand/or symptoms of HIV. \\n\\uf0b7 \\nFor children older than 24 months, and for those aged 18 to ≤ 24 months with \\nnon-perinatal HIV exposure, HIV antibody (or HIV antigen/antibody) tests are \\nrecommended for diagnostic testing. \\n\\uf0b7 \\nIn infants with an initial positive virological test result, Antiretroviral therapy (Not PEP) \\nshould be started without delay and at the same time a second blood sample is \\ncollected to confirm the initial positive virological test result.  \\n\\uf0b7 \\nConfirmation of HIV infection among infants less than 18 months should be based \\non two positive virologic tests from separate blood samples.  \\n\\uf0b7 \\nDo not delay ART for confirmatory test results. Immediate initiation of ART saves \\nlives and should not be delayed while waiting for the results of the confirmatory test. \\n.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='40 \\n \\n 13.1 Timing of assessments \\n \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n \\nVirological assays (HIV RNA and HIV DNA nucleic acid tests) for HIV infection should \\nbe performed on the following occasions  \\n \\n\\uf0b7 \\nAt Birth (During the first 48 hours)  \\n\\uf0b7 \\nAt  8 weeks (or at least 2 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nAt 4-6 months  (or at least 8 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nInfants who are at high risk of perinatal HIV infection additional virological  test at 2-\\n3  weeks of age.  \\n \\nAntibody testing  \\n \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and 18 months.  \\n\\uf0b7 \\nAlthough an HIV antibody test may be negative before this time, engagement in care \\nwith follow-up of the infant should continue until at least 18 months of age.  \\n \\n \\n\\uf076 HIV antibody testing for sero-reversion should be performed at age 9 and 18 months to \\nexclude HIV infection. (If HIV antibody test is negative, the test should be repeated \\nimmediately with a separate blood sample to confirm HIV negative status).  \\n\\uf076 Children with perinatal HIV exposure aged 18-24 months may have residual \\nmaternal HIV antibodies. In such a case, confirmation should be based on nucleic \\nacid test. \\n \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants \\n\\uf0b7 \\nIs based on 2 or more negative virological tests, with one obtained at age ≥1 month \\nand one at age ≥4 months, or 2 negative HIV antibody tests from separate specimens \\nobtained at age ≥6 months \\n\\uf0b7 \\nSome experts confirm the absence of HIV infection at 12 to 18 months of age in children \\nwith prior negative virological tests by performing an antibody test to document loss of \\nmaternal HIV antibodies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='41 \\n \\n\\uf0b7 \\nHealth care providers should routinely inquire about abstinence of breastfeeding and \\nemphasise HIV-infected mothers/caregivers on safer feeding options. \\n \\nTable 8 : Infant diagnosis among breastfed infants \\n \\nVirological assays for HIV infection should be performed on the following occasions  \\n \\n\\uf0b7 \\nAt birth (During the first 48 hours) \\n\\uf0b7 \\nAt 2 weeks of age.  \\n\\uf0b7 \\nVirologic diagnostic testing should be performed every 3 months during breastfeeding  \\n\\uf0b7 \\nAfter cessation of breastfeeding, irrespective of when breastfeeding ends, virologic \\ndiagnostic testing should be performed at 4 to 6 weeks, 3 months, and 6 months after \\ncessation. \\n \\nAntibody testing  \\n \\n.  \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and  18 months, or \\nat a minimum of 8 weeks after cessation of breastfeeding, if this is later. \\n\\uf0b7 \\nEngagement in care should continue until this time.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='42 \\n \\nFigure 3: Early Infant diagnosis algorithm \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\na Virologic diagnostic testing should be performed every 3 months during breastfeeding \\nb Children with perinatal HIV exposure aged 18-24 months may have residual maternal HIV antibodies.   \\n   In such a case, confirmation should be based on nucleic acid test. \\nHIV-exposed newborn \\n(0-2 days) \\nInfant/child is infected \\nConduct NAT at 8 weeks or at \\nthe earliest opportunity \\nthereafter \\nConsider NAT \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nHIV unlikely unless \\nstill a breastfeeding \\nHIV antibody testing for \\nseroreversion should be checked \\nat age at 9 and  b18 months, or at a \\nminimum of 8 weeks after \\ncessation of breastfeeding \\nNegative \\nPositive  \\nPositive  \\nNegative \\nNegative \\nInfant/child is infected \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nConduct NAT at 4-6 months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='43 \\n \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis \\n \\nDeclining mother-to-child transmission rates globally have led to concerns about false-positive \\nand indeterminate tests. People with indeterminate results need immediate repeat testing and \\nshould be managed according to the standard operating procedures. People with repeated \\nindeterminate results need a multidisciplinary team of health  care providers to support \\nretention, tracking and status resolution. ART programmes need to give priority to confirmatory \\ntesting of all positive test results using a new sample. Clinical monitoring and further testing \\nbased on the national infant testing schedule need to be done until a definitive HIV status is \\nestablished.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='44 \\n \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n \\n \\n \\n \\n \\n                                                                  \\n \\n \\n \\n \\n \\n \\n \\n \\nEID sample no. 1  \\ntest no. 1 \\nEID sample no. 1   \\n test no. 2 \\nRequest a new \\nsample within \\n4 weeks \\n          POSITIVE  \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\n          Positive \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\nFurther review by a \\nclinical and \\nlaboratory team'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content=\"45 \\n \\n14.  Antiretroviral drug dosing recommendations for \\nnewborns \\n \\nAll newborns who were exposed perinatally to HIV should receive postpartum antiretroviral \\n(ARV) drugs to reduce the risk of perinatal transmission of HIV . \\nNewborn ARV regimens should be started as soon as possible after birth, ideally within 6 hours, \\nwith doses appropriate for the infant's gestational age. \\nA newborn’s ARV regimen should be determined based on maternal and infant factors that \\ninfluence the risk of perinatal transmission of HIV  \\n \\nTable 9 : ART dosage for infants \\nDrug \\nDrug Doses by Gestational Age at Birth \\nCommon \\nside effects \\nZDV \\nWeight-Band Dosing for Newborns Aged ≥35 Weeks \\nGestation from Birth to 4 Weeks \\nWeight Band \\nVolume of ZDV 10 mg/mL \\nOral Syrup Twice Daily \\n2 to  < 3kg \\n1 mL \\n3 to <4 kg \\n1.5 mL \\n4 to < 5 kg \\n2 mL \\n \\n \\nAnaemia, \\nneutropenia  \\n \\n \\n \\n≥30 to <35 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 2 Weeks to 6 to 8 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >6 to 8 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; make this \\ndose increase only for infants with confirmed HIV \\ninfection.\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='46 \\n \\n<30 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 4 to 8 to 10 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >8 to 10 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; only make \\nthis dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n3TC \\n≥32 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\n3TC 2 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\n3TC 4 mg/kg per dose orally twice daily \\n \\nAnaemia, \\nneutropenia  \\n(much less \\ncommon than \\nwith AZT) \\nNVP \\n≥37 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\nRash and \\nliver \\ndysfunction – \\nrare in \\nneonates  \\n \\nStop NVP \\nafter 2/52, in \\nview of long \\nhalf-life, \\ncontinue other \\nPEP agents \\nfor full 4/52 \\n≥34 to <37 Weeks’ Gestation at Birth \\nBirth to Age 1 Week \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='47 \\n \\nAge 1 to 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n≥32 to <34 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nNVP 2 mg/kg per dose orally twice daily \\nAge 2 to 4 Weeks \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily \\nAge 4 to 6 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >6 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmake this dose increase for infants with confirmed HIV \\ninfection.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='48 \\n \\n15. Co-trimoxazole prophylaxis \\n \\nPneumocystis pneumonia (PCP) prophylaxis ,  cotrimoxazole, should be initiated from age 4 \\nweeks in: \\n\\uf0b7 \\nAll HIV-infected infants.  \\n\\uf0b7 \\nInfants with an initial positive HIV DNA/RNA test result (and continued until HIV infection \\nhas been excluded). \\nAge Category \\nDose (Sulfamethoxazole/ trimethoprim) \\nInfants below 6 months or < 5 kg \\n100 mg /20 mg  \\nChildren 6 months–5 years or 5-15 kg \\n200 mg/40 mg \\nChildren 6–14 years old or 15–30 kg \\n400 mg/80 mg \\nover 14 years or >30 kg \\n800 mg/160 mg \\n \\nNote : Cotrimoxazole suspension contains 200 mg/40 mg per 5 ml of syrup. Single strength \\ntablets contain 400 mg/80 mg, double strength tablet twice that. It is possible to divide the tablets \\nfor children and infants.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='49 \\n \\n16. Infant feeding \\n \\nInfant feeding intentions need to be discussed  early in pregnancy so that appropriate \\ninformation and support can be provided. \\nFactors that increase the risk of HIV transmission via breast milk when women are not on ART \\ninclude:  \\n\\uf0b7 \\nDetectable HIV viral load.  \\n\\uf0b7 \\nAdvanced maternal HIV disease.  \\n\\uf0b7 \\nLonger duration of breastfeeding.  \\n\\uf0b7 \\nBreast and nipple infection/inflammation.  \\n\\uf0b7 \\nInfant mouth or gut infection/inflammation.  \\n\\uf0b7 \\nMixed feeding, in particular solid food given to infants less than 2 months of age \\n \\nThe safest option for infants born to women with HIV is formula feeding, as it eliminates post-\\nbirth HIV exposure risk Women who choose to breastfeed should be advised of the small on-\\ngoing risk of HIV transmission. They should be supported in their decision, if they maintain the \\nfollowing criteria. \\n\\uf0b7 \\nA fully suppressed HIV viral load (for as long a period as possible, but certainly during \\nthe last trimester of pregnancy).  \\n\\uf0b7 \\nA good adherence history.  \\n\\uf0b7 \\nStrong engagement with the perinatal MDT \\n\\uf0b7 \\nPrepared to attend for monthly clinic review and blood HIV viral load tests for themselves \\nand their infant during and for 2 months after stopping breastfeeding \\nWomen not breastfeeding their infants, should be offered cabergoline to suppress lactation.  \\nFormula milk is provided with the support of the NGO, National AIDS Foundation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='50 \\n \\n17. Contraception for women living with HIV \\n \\nFamily planning is a cornerstone of maternal and child health and a vital component of global \\nhealth initiatives. The integration of family planning and HIV services is essential for achieving \\nthe Sustainable Development Goals, particularly in reducing maternal mortality, unplanned \\npregnancies, and new pediatric HIV infections. By ensuring universal access to comprehensive \\nsexual and reproductive health services, including family planning, for all individuals living with \\nor affected by HIV, we can significantly improve health outcomes and promote social and \\neconomic well-being. \\n\\uf0b7 \\nContraceptive needs should be discussed with all women during antenatal period. \\n\\uf0b7 \\nUsing condoms alongside another method of contraception is recommended for dual \\nprotection against both pregnancy and the transmission of HIV.  \\n\\uf0b7 \\nThe choice of contraception will depend on individual health, potential drug interactions, \\nand personal preferences.  \\n\\uf0b7 \\nOvulation usually resumes at 6 weeks of postpartum but may occur earlier in non-\\nbreastfeeding women. A plan for contraception postnatally should have been discussed \\nin advance of delivery and revisited in the early postpartum period and at the 4- to 6-\\nweek follow-up.  \\n\\uf0b7 \\nWomen should be advised that it is possible to conceive before the first postnatal \\nmenses and therefore to use condoms, if necessary, until the postnatal review. \\n\\uf0b7 \\nThey have options for oral contraceptive pills, injectables (e.g., Medroxy Progesterone \\nAcetate), implants (e.g.,  Jadelle), intrauterine devices (IUDs), and female sterilization. \\n\\uf0b7 \\nSome antiretroviral medications may interact with hormonal contraceptives potentially \\nreducing their effectiveness. Drug interactions between ART and hormonal \\ncontraceptives should be checked with the WHO Medical Eligibility Criteria .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='51 \\n \\nTable 10: Contraceptive methods  \\nNon-hormonal methods \\n \\n\\uf0b7 \\nMale condom \\n\\uf0b7 \\nFemale condom \\n\\uf0b7 \\nIntrauterine device (IUD) \\n\\uf0b7 \\nFemale sterilization \\nHormonal methods \\n \\n\\uf0b7 \\nIntrauterine system (IUS) \\n\\uf0b7 \\nInjection - Depo  Medroxy Progesterone \\nAcetate  is the most common version, and it \\nshould be taken every twelve weeks. \\n\\uf0b7 \\nCombined pill - Contains the hormones \\noestrogen and progestogen. \\n\\uf0b7 \\nImplant - Small flexible rods that are inserted \\nunder the skin, and releases progestogen for up \\nto three years or five years depending on the \\nbrand.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Table 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n(Contraceptive methods: CHC, combined hormonal contraception; Cu-IUD, copper intrauterine device; DMPA, progestogen-only injectable: \\ndepot medroxyprogesterone acetate; ENG-IMP, etonogestrel implant; LNG-IUD, levonorgestrel-releasing intrauterine system; POP, \\nprogestogen-only pill) \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD Cu-IUD \\nNucleoside/nucleotide reverse \\ntranscriptase inhibitors (NRTIs)  \\n \\nAbacavir (ABC) Emtricitabine \\n(FTC) Lamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide (TAF) \\nZidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\n \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\nX \\n✓ \\n✓ \\n✓ \\nContraceptive effectiveness could be reduced. Use not advised. \\nRecommend an No need for extra precautions. alternative effective method \\n \\nEtravirine (ETR) \\nNevirapine (NVP \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential weak interaction but not expected to affect contraceptive effectiveness. To err on the side \\nof caution, recommend an alternative effective method or advise additional condoms use \\nDoravirine (DOR) \\nRilpivirine (RPV \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nRilpivirine (RPV) \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='53 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nBoosted protease inhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat (ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n? \\n \\n \\n \\n \\n? \\n \\n \\n? \\n \\n              \\n              ✓ \\n \\n         ✓ \\n \\n             ✓ \\n\\uf0b7 Interaction that could \\nincrease progestogen \\nexposure but not expected to \\naffect contraceptive \\neffectiveness. \\n\\uf0b7 In case of PIs boosted with \\ncobicistat, recommend an \\nalternative effective method \\nor use with caution due to \\nincreased ethinylestradiol \\nexposure \\n\\uf0b7 Potential weak interaction that could increase progestogen \\nexposure but not expected to affect contraceptive \\neffectiveness. \\nNo need for extra precautions \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) Dolutegravir \\n(DTG) Bictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nBoosted INSTIs \\nElvitegravir/ cobicistat (EVG/c) \\n \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential interaction causing \\ndecreased ethinylestradiol \\nexposure. Should not be given \\nwith a low dose (ie, 20\\uf06dg \\nethinylestradiol) combined oral \\ncontraceptive \\nNo expected effect on contraceptive effectiveness. No need for \\nextra precautions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='54 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Table 12: ART and emergency contraception (EC) \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nNucleoside/nucleotide \\nreverse transcriptase \\ninhibitors (NRTIs)  \\n \\nAbacavir (ABC) \\nEmtricitabine (FTC) \\nLamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide \\n(TAF) Zidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n \\nNo effect on EC effectiveness. \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\n \\n \\n? \\n \\n \\n? \\n \\n \\nThe effectiveness \\nof EC could be \\nreduced. Offer a \\nCu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC. \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nEtravirine (ETR) \\nNevirapine (NVP \\n? \\n \\n? \\n? \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nDoravirine (DOR) \\nRilpivirine (RPV \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='56 \\n \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nBoosted protease \\ninhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat \\n(ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) \\nDolutegravir (DTG) \\nBictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nBoosted INSTIs \\nElvitegravir/ cobicistat \\n(EVG/c) \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\nNo effect on EC effectiveness. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='57 \\n \\n19. Immunization \\n \\nInfants born to HIV-positive mothers should follow the routine national primary immunization. \\nTable 13:  Immunization Schedule \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n0-4 weeks \\nBCG \\nHIV infected infants \\nshould not receive \\nBCG vaccine. BCG \\nshould be avoided till \\nHIV is excluded in \\nHIV exposed infants \\n \\n \\nOn completion of  \\n \\n \\n \\n2 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(1st dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(1st dose) \\nWhen Inactivated \\nPolio vaccine is not \\navailable giving OPV \\ncan be considered \\nwhen the child is not \\nseverely immune \\nsuppressed \\n \\n4 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(2nd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(2nd dose) \\n \\n \\n6 months \\nOPV & Pentavalent \\n(DPT -Hep B-Hib) \\n(3rd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib) \\n(3rd dose) \\n \\n \\n9th month \\nMMR \\nMMR \\n MMR-   should be \\npostponed in severe \\nimmune deficiency \\n \\n12th month \\nLive JE \\nInactivated JE \\nvaccine,  \\nHep A 1st dose (2nd \\ndose in 6-12 months) \\nIf using live attenuated \\nshould not be given to \\nseverely immune \\ncompromised children \\nHep A- patients with \\nsevere \\nimmunosuppression \\nmay have a \\nsuboptimal response \\n \\n13-15 months \\n \\nVaricella -2 doses 3 \\nmonths apart \\nPatients who are \\nseverely'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='58 \\n \\nimmunosuppressed \\nshould not receive the  \\nvaccine. \\n \\n18th month \\nOPV & DTP (4th \\ndose) \\nInactivated Polio \\nvaccine +DTP \\n \\n \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n3rd year \\nMMR 2nd dose \\nMMR 2nd dose \\n \\n \\n5 years \\nOPV+DT \\nInactivated polio+DT \\n \\n \\n12 years \\naTd \\naTd \\n \\n \\n12-13 years \\n(females, males) \\n \\nHPV (Gardasil) \\n2 doses \\n(0, 6 months)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='59 \\n \\n20. References \\n \\n1. British HIV Association guidelines for the management of HIV in pregnancy and \\npostpartum 2018 (2020 third interim update) \\n2. A Guide to Antiretroviral Treatment; 4th Edition, National; STD/AIDS Control \\nProgramme 2020 \\n3. Guidelines for HIV post-exposure prophylaxis (WHO 2024) \\n4. HIV  diagnosis and ARV  use in HIV -exposed infants: a programmatic update             \\n(WHO) July 2018 \\n5. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually \\ntransmitted infections for the period 2022-2030.(WHO 2022) \\n6. Https://www.who.int/tools/elena/interventions/hiv-infant-feeding \\n7. Https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-\\ntransmission-hiv \\n8. Https://npin.cdc.gov/publication/recommendations-use-antiretroviral-drugs-pregnant-\\nhiv-1-infected-women-maternal-health \\n9. Https://www.cdc.gov/pregnancy-hiv-std-tb-hepatitis/about/index.html \\n10. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and \\nmonitoring: recommendations for a public health approach July 2021. \\n11. Pre-Exposure prophylaxis for the prevention of HIV infection in Sri Lanka: A clinical \\npractice guideline; 2023. \\n12. Https://www.who.int/news/item/29-08-2019-who-revises-recommendations-on-\\nhormonal-contraceptive-use-for-women-at-high-hiv-risk. \\n13. Clinical Guidance:  Drug Interactions Between  HIV Antiretroviral Therapy (ART)  and \\nContraception; February 2023 | FSRH. \\n14. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral \\ntherapy July 2017 \\n15. HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update July \\n2018 \\n16. https://clinicalinfo.hiv.gov/en/guidelines/perinatal/pre-exposure-prophylaxis-prep-\\nprevent-hiv \\n17. Antiviral management new borns with perinatal HIV exposure or HIV infection \\nupdated January 31st, 2023.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='60 \\n \\n21. Annexures'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='61 \\n \\n \\nAnnexure 1 : General circular letter No. 01-51/2016 - English'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='62'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='63'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='64 \\n \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='65'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='66 \\n \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='67'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='68'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='69 \\n \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\nAnnexure 2: Standard of care - PMTCT of syphilis and HIV \\n \\nStandard of care in prevention of mother to child transmission of \\nSyphilis and HIV \\n \\n \\nStandard \\nAll pregnant women should be screened for syphilis and HIV at the first antenatal visit \\nwithin the first trimester. At delivery, women who do not have test results should be tested. \\nWomen  with  positive  syphilis  or  HIV  test  results  should  be  managed  according  to  the \\nnational guidelines. Their partners should also be screened and managed and plans should be \\nmade to screen and manage their infants at birth. \\n \\nAim \\nTo reduce maternal morbidity and mortality, fetal loss and neonatal mortality and morbidity \\ndue to syphilis and HIV \\n \\nRequirements \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and care in \\npregnant women are available and are correctly implemented. \\n\\uf0b7 \\nAll women have access to appropriate ANC care during pregnancy, childbirth and the \\npostpartum period. \\n\\uf0b7 \\nHealth  care  providers  are  competent  in  syphilis  and  HIV  prevention,  screening during  \\npregnancy,  ,  counseling  on  STI prevention,    how  to  prevent  re-infection during pregnancy \\nand referral for management of seropositive pregnant women and their partners, \\nprophylaxis and management of the newborn \\n\\uf0b7 \\nSuitable Screening methods for syphilis and HIV are available in antenatal clinics and \\nmaternity wards. \\n\\uf0b7 \\nAdequate Laboratory facilities (at least one per district) for testing of syphilis and \\n\\uf0b7 \\nHIV with system to ensure quality of laboratory testing are available. \\n\\uf0b7 \\nNecessary supplies for collection and transport of samples are available at the ANC clinic \\nand Supplies for testing of syphilis and HIV are available at the laboratory level. \\n\\uf0b7 \\nDrugs (penicillin, ART etc) are available in the STD clinics and maternity wards where relevant. \\n\\uf0b7 \\nA functioning referral system is available to ensure the management of pregnant women \\nwho are identified as having syphilis or HIV \\n\\uf0b7 \\nAn effective information system is available to monitor the programme. \\n\\uf0b7 \\nHealth education activities are carried out to raise the awareness of individuals, families and \\ncommunities of the importance of attending ANC clinics early in pregnancy and syphilis and \\nHIV prevention and management. \\n \\nApplying the standard \\nProviders of maternal and neonatal health care, in particular public health staff must: \\n\\uf0b7 \\nScreen all pregnant women for syphilis and HIV at the first antenatal visit. Screening \\nshould be done preferably before 12 weeks of gestation to prevent congenital infection. \\n\\uf0b7 \\nReview  syphilis  and  HIV  test  results  at  subsequent  visits.  All  the  women  with \\npositive screening test need to be referred to STD clinic for further management. \\n\\uf0b7 \\nIf a woman was not tested during pregnancy, syphilis and HIV screening should be \\noffered after delivery.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='70 \\n \\n\\uf0b7 \\nManage  all  women  who  are  seroreactive  for  syphilis  according  to  the  stage  of \\nsyphilis following national guidelines at the STD clinic. \\n\\uf0b7 \\nManage all women with positive HIV test according to the national guidelines to \\nprevent mother to child transmission of HIV \\n\\uf0b7 \\nDiscuss with the woman the importance of treatment for herself, her partner(s) and the \\nbaby, explain the consequences of not treating the infection, and discuss the necessity \\nof condom use during treatment. \\n\\uf0b7 \\nMake plans to manage the baby at birth. \\n\\uf0b7 \\nAdvise women who test positive that their partner(s) must also be screened and \\nmanaged according to the stage of syphilis. The babies also need to be screened as soon \\nas possible after birth. \\n\\uf0b7 \\nAdvise women and partners who test negative how to remain negative. \\n\\uf0b7 \\nScreen all women with adverse pregnancy outcome (abortion, stillbirth, syphilitic \\ninfant, etc.) for syphilis and HIV, if not screened. \\n\\uf0b7 \\nScreen all women with syphilis or HIV for other STIs, and provide counseling and \\nmanagement accordingly. \\n\\uf0b7 \\nRecord test results and if positive for syphilis or HIV details of management, in the \\nclinic and pregnancy records. \\n\\uf0b7 \\nMaintain the confidentiality of the information regarding the patients. \\n \\nAudit \\n \\nInput indicators \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and \\ncare in pregnant women are available and are correctly implemented. \\n\\uf0b7 \\nThe  proportion  of  health  facilities  providing  ANC  services  that  have  screening \\nfacilities for syphilis and HIV. \\n \\nProcess and output indicators \\n\\uf0b7 \\nCoverage of syphilis screening in pregnant women \\n\\uf0b7 \\nCoverage of HIV screening in pregnant women \\n\\uf0b7 \\nCoverage of correct management of syphilis in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of correct management of HIV in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of partners tested and managed accordingly \\n\\uf0b7 \\nCoverage  of  babies  born  to  syphilis  positive  mothers  who  received  appropriate \\ntreatment. \\n\\uf0b7 \\nCoverage of babies born to HIV positive mothers who received prophylactic ARV \\ntreatment \\nOutcome/ Impact indicators \\n\\uf0b7 \\nIncidence of congenital syphilis \\n\\uf0b7 \\nIncidence of HIV among infants \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to congenital syphilis. \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to paediatric  HIV \\n\\uf0b7 \\nStillbirth rate.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='71 \\n \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n \\nN'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='72 \\n \\nAnnexure 6 : Blood Collection request form \\nNational STD/AIDS Control Programme,  \\nMINISTRY OF HEALTH. \\n \\nREQUEST FORM FOR SYPHILIS/HIV TESTING IN ANTENATAL MOTHERS. \\nInstitution/clinic \\n……………………………………………….. \\nMOH area \\n……………………………………………….. \\n \\nDate of sample collection \\n……………………………………………….. \\n \\n \\n \\n \\nNSACP/ANC/14/V/2 \\n \\nPatient No \\n(ANC) \\nAge \\nParity. \\nPOA \\nHIV \\nResults \\nVDRL \\nResults \\n \\n……………………………………… \\n…………………………………. \\n…………………………….. \\nName of collecting officer \\n…………………………………….. \\nDesignation \\n…………………………………. \\nSignature. \\n…………………….. \\nName of Medical officer \\nDesignation \\nSignature \\nLab use only . \\n \\nDate/Time of receipt of samples:………………………… \\n…………………..am/pm \\nMLT:………………………. \\nMedical officer STD/Lab:……………………….. \\nDate ……………………… \\n Date  ………………………………………………..'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Annexure 7 : EMTCT HIV Case Investigation form \\n \\n \\nEMTCT HIV: Case Investigation Form                                                                   \\nNational STD/AIDS Control Programme, Ministry of Health \\n \\nName of the STD clinic:_______________________       Pregnant Woman’s file number & PHN No: ___________________   \\nBaby’s file number & PHN No: _________________       Pregnant Woman’s HIV clinic registration date:_______________  \\nFilled by(name & designation): _________________      Pregnant Woman referred from:________________________ \\nNote: Fill this form for all HIV confirmed pregnant women registered in the clinic \\n                                                     Details of the pregnant woman with HIV \\n  1.   Age in years \\n \\n  2.   District of residence \\n \\n  3.   Nationality \\n1. \\nSri Lankan  2. Foreign (country:________________) \\n  4.   Ethnicity \\n \\n  5.   Risk & vulnerability factors (e.g. FSW, DU, \\n        Psychosocial etc) \\n \\n  6.   KP Status   \\n \\n  7.   Parity \\n \\n8.  Past obstetric history \\n \\n  9.   Date of HIV confirmation \\n \\nDetails of the current pregnancy \\n10.   LRMP \\n \\n11.   EDD \\n \\n12.   POA at ANC registration \\n \\n13.   POA when registering for EMTCT  \\n         services \\n \\n14.   1st CD4 count during this  \\n         pregnancy(Result & date) \\n \\n15.   1st VL during this pregnancy \\n         (Result & date) \\n \\n \\n16.   Other relevant diagnoses  \\n         (*TB/Syphilis/Other) \\n \\n17.   Date of ART initiation \\n \\n18.   ART regimen during this pregnancy \\n19.   Adherence (>95%, 80-95%,  \\n         <80%) \\n \\n20.   CD4 count at third trimester \\n \\n21.   Viral load closest to 36 \\n         Weeks of POA \\n \\n22.   Number of ANC visits \\n \\n23.   Post-partum family planning method \\n \\n                                                                              Details of the sexual partner/s \\n24.   Partner’s HIV status \\n \\n25.   File no.(STD or HIV) & PHN No. \\n \\n26.  Partner’s ART regimen \\n \\n27.  Partner’s KP status \\n \\n                                                                     Details of the baby \\n28.   Date of birth \\n \\n29.   Facility/Place of birth \\n \\n30.   Mode of delivery \\n         If LSCS – Em/El \\n         Indication \\n \\n31.   Gestational age at \\n         delivery \\n \\n32.   Birth weight \\n           \\n \\n33.   Infant feeding (exclusive  \\n         formula/breastfeeding) \\n \\n34.    ARV prophylaxis  \\n(Type/dose/duration) \\n \\n35.   DNA PCR at birth (date & result) \\n \\n36.   DNA PCR at 8 weeks \\n \\nDate \\n \\n37.   DNA PCR at 16 weeks \\n \\nDate \\n \\n38.   HIV ELISA around 18 months \\n \\nDate \\n \\n39.   Final diagnosis \\n \\n40.   If miscarriage – Date & POA of miscarriage \\nRemarks'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='74 \\n \\n Annexure 8 : Pregnancy record'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='75 \\n \\nAnnexure 9 : Poster  for EMTCT of HIV'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='76 \\n \\nAnnexure 10 : Leaflet for pregnant women on service package'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='NATIONAL GUIDELINES FOR\\nMATERNAL CARE\\nVOLUME I\\nMINISTRY OF HEALTH\\n2013\\n• Management of Labour\\n• Management of Hypertension, Pre Eclampsia \\nand Eclampsia in Pregnancy\\n• Management of Diabetes During Pregnancy\\n• Management of Post-Partum Haemorrhage\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content=''),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='NATIONAL GUIDELINE FOR MATERNAL CARE\\nVOLUME I\\n• \\nManagement of Labour\\n \\n \\nNormal Labour \\n \\n \\nInduction of Labour\\n \\n \\nUse of Oxytocins in Induction and Augmentation\\n \\n \\nFoetal Monitoring in Labour\\n \\n \\nPain Relief\\n \\n \\nAcute Inversion of Uterus\\n• \\nManagement of Hypertension, Pre Eclampsia and \\nEclampsia in Pregnancy\\n• \\nManagement of Diabetes in Pregnancy\\n• \\nManagement of Post-Partum Haemorrhage\\nMINISTRY OF HEALTH\\n2013\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nii\\nThese guidelines are published by the Family Health Bureau, Ministry of \\nHealth, 231, De Saram Place, Colombo 10, Sri Lanka.\\nWeb: www.familyhealth.gov.lk\\nPrepared by Sri Lanka College of Obstetrians and Gynaecologists\\nEdited By Dr. Nilmini Hemachnadra, Consultant Community Physician, \\nFamily Health Bureau & Prof. Hemantha Senanayake, President, Sri Lan-\\nka College of Obstetricians & Gynaecologists.\\nCopyright@2013 Ministry of Health\\nISBN 978 - 955 - 1503 - 15 - 4\\nStatement of Intent\\nThe main purpose of these guidelines are to improve the quality of \\nclinical care provided by the health care providers at all levels. These \\nparameters of practice should be considered recommendations \\nonly. The ultimate judgement regarding a particular clinical \\nprocedure or a treatment plan must be made by the clinician in \\nlight of the clinical data gathered from the patient and the diagnosis \\nand treatment options available.\\nPrinted by Lazergraphic (PVT) Ltd.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\niii\\nForeword from the Secretary to the Ministry of Health\\nAs a country with a mainly government owned health system, maintenance \\nof the uniformity of practices is essential to avoid incurring unnecessary \\nexpenditure. Incorporation and practice of evidence based cost effective \\ninterventions in maternal care will ensure further improvement of the \\nmaternal care indicators.  \\nThe availability and use of guidelines will ensure the quality of the care \\nprovided at each level and facilitate the care provision of practicing \\nclinicians for better care. The Ministry of Health having achieved a \\nsatisfactory level in the coverage of services and geared to improve it \\nfurther, is currently moving towards improving the quality of services \\nprovided. With this view, most of the institutions are now implementing \\nquality improvement programmes.\\nTherefore, this set of guidelines will assist such programmes and auditing \\nsystems in the maternal care such as maternal mortality reviews, \\nconfidential inquiry into maternal deaths, near-miss inquiries and \\nensure a more objective assessment. These guidelines should be link with \\nthe quality standards and the implementation at each level needs to be \\nensured.\\nSri Lanka College of Obstetricians and Gynaecologists has managed to in \\nco-operate the currently available best scientific evidence and the practical \\nexperience of a large number of experts into these guidelines.\\nI wish all the healthcare providers would make maximum use of these \\nguidelines and contribute to the further improvement of the maternal care \\nin our country.\\nDr. Y.D. Nihal Jayathilake\\nSecretary,\\nMinistry of Health,\\nSri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\niv'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nv\\nPreface\\nThis national guideline on maternal care is very well-timed, as a greater \\nemphasis is being given for improving the quality of maternal and \\nnewborn care services for further reduction of maternal and newborn \\nmortality and morbidity in Sri Lanka. This set of guidelines includes \\nthe revised versions of some guidelines published in 2007 under HSDP \\nPhase I and newly developed guidelines. This is an attempt to improve the \\nquality and uniformity of clinical care with efficiency, cost effectiveness \\nand accountability.\\nI highly appreciate the contribution made by the Sri Lanka College of \\nObstetricians and Gynaecologists in developing these guidelines. Their \\nexperience and updated scientific knowledge is reflected in the guidelines. \\nFurther, these guidelines have been developed considering the policies, \\nfacilities and resources available in the country. As such this set of \\nguidelines will be considered as national guidelines for the conditions \\ndescribed.  \\nDr. P. G. Mahipala\\nDirector General of Health Services,\\nMinistry of Health,\\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nvi\\nMessage from the president of Sri Lanka College of \\nObstetricians\\nIt is with a great sense of achievement that I issue this statement for the \\nSri Lanka National Guidelines in obstetrics. There is evidence that the \\nintroduction of guideline-based practice will reduce maternal mortality. \\nWe hope that this effect will be duplicated in Sri Lanka.\\nI must compliment the Guideline Development Group of our College. \\nThis document is testimony to their hard work and their commitment to \\nimproving the quality of care delivered to our women. The group consisted \\nof obstetricians from varying seniority and from hospitals representing \\nall categories of specialist units in the country. We were therefore able to \\ndevelop our guidelines taking into considerations the ground realities in \\nSri Lanka. I was heartened by the maturity shown by the younger members, \\nwho contributed immensely to the many points that were debated while \\nthese were being developed. We have used the latest available evidence \\nand taken into account what would be feasible in a Sri Lankan Unit. For \\nwhat we have recommended as improvements to the existing practice we \\nhave had agreement from the Ministry of Health to procure these. \\nI wish also to acknowledge our general membership who contributed to \\nthese guidelines via email and at a meeting where their views were sought. \\nIt is always a challenge to produce guidelines that will be put into use in \\neveryday practice and it is probable we have achieved this primary goal by \\nhaving a broad based input. \\nThe World Health Organization and the UNFPA supported this activity. \\nDr. Nilmini Hemachandra of the Family Health Bureau helped get the \\nfinal product into a form that was easily understood by the non-specialist. \\nWe are grateful for the advice given by Obstetric Anaesthetists Drs. Saroja'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nvii\\nJayasinghe and Ramani Pallemulla. The guideline on diabetes mellitus \\ncomplicating pregnancy had major inputs from the Nirogi Matha project \\nand many endocrinologists. \\nTo conclude I wish to restate my wish and fervent hope that these \\nguidelines will help save the lives of many Sri Lankan mothers. \\nProf. Hemantha Senanayake\\nPresident,\\nSri Lanka College of Obstetricians & Gynaecologists'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nviii\\nGuideline Development Committee\\nDr. Asoka Weerakkody (Chairman)\\nProf. Hemantha Senanayake\\nProf. Malik Goonawardena\\nDr. Ananda Ranatunga\\nDr.UDP Ratnasiri\\nDr. Sunil Fernando\\nDr. Harsha Atapattu\\nDr. Mangala Dissanayake\\nDr. Chandina Wedamistri\\nDr. Jeevan Marasinghe\\nDr. Tiran Dias\\nDr. Asanka Jayawardena'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nix\\nContent page \\n \\n \\n \\n \\nPage\\n \\nMessage from the Secretary of Ministry of Health \\niii\\n \\nPreface \\n \\nv\\n \\nMessage from the President of the Sri Lanka College of \\n \\nObstetricians and Gynecologists \\nvi \\n \\nGuideline Development Committee \\nviii\\n \\nList of Abbreviations \\nxiii\\n \\nList of Tables \\nxiv\\n \\nDisclaimer \\nxv\\n \\nIntroduction \\nxvi\\n A\\t\\nManagement of Labour\\t\\n3\\n1. \\nIntroduction \\n3\\n2. \\nDiagnosis of labour \\n3\\n3. \\nManagement of Labour \\n4\\n3.1 \\nGeneral considerations \\n4\\n3.1.1 \\nCommunication between women and healthcare  \\n  \\nprofessionals/workers \\n4\\n3.1.2 \\nPreparation of mothers to transfer to labour room \\n4\\n3.1.3 \\nDocumentation \\n5\\n3.1.4  \\nMobilization and Positioning \\n5\\n3.1.6 \\nHygiene during labour \\n5\\n3.1.7 \\nPain relief in labour \\n6\\n3.2. \\nManagement of the three stages of labour \\n6\\n3.2.1.  \\nManagement of the first stage of labour \\n6\\n3.2.1.1 \\nLatent phase  \\n6\\n3.2.1.2 \\nActive phase \\n7\\n3.2.1.2a.  Admitting women to the Labour room \\n7\\n3.2.1.2b.  Management of active phase of first stage \\n8\\n3.2.1.3.  \\nDelayed progress of first stage of labour \\n9\\n3.2.2.  \\nManagement of second stage of labour \\n10\\n3.2.2.1.  \\nPassive second stage of labour (descent phase) \\n10\\n3.2.2.2.  \\nActive second stage of labour (expulsive phase) \\n11\\n3.2.2.3.  \\nObservations for women and babies in the second stage of labour \\n12\\n3.2.2.4.  \\nWomen’s position and pushing in the second stage of labour \\n12\\n3.2.2.5.  \\nIntrapartum interventions to reduce perineal trauma \\n13\\n3.2.2.6.  \\nDelivery \\n13\\n3.2.3 \\nThird stage of Labour \\n14\\n3.2.3.1 \\nActive management of third stage of labour \\n14\\n3.2.3.2 \\nDelayed third stage \\n15\\n4 \\nCare for the newborn baby \\n15\\n5 \\nPerineal care \\n17'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nx\\n B\\t\\nGuideline on Induction of Labour \\n19\\n1 \\nIntroduction \\n19\\n2 \\nDefinition \\n19\\n3 \\nGeneral Principles \\n19\\n4 \\nIndications \\n19\\n4.1 \\nOtherwise uncomplicated pregnancy continuing \\n  \\nbeyond 40 weeks \\n19\\n4.2 \\nPre labour rupture of membranes at term \\n20\\n4.3 \\nPreterm prelabour rupture of membranes (PPROM) \\n20\\n4.4   \\nIntrauterine death \\n20\\n4.5   \\nHistory of precipitate labour \\n20\\n4.6   \\nSuspected macrosomia \\n20\\n4.7   \\nFetal growth restriction \\n21\\n4.8   \\nOlder mothers \\n21\\n5 \\nInduction under specific circumstances \\n21\\n5.1   \\nBreech presentation \\n21\\n5.2 \\nPrevious CS \\n21\\n6.   \\nMethods of induction \\n21\\n6.1 \\nMechanical \\n21\\n6.2   \\nSurgical \\n22\\n6.3   \\nPharmacological \\n22\\n6.3.1   \\nOxytocin \\n22\\n6.3.2 \\nProstaglandins \\n22\\n6.3.3 \\nMifepristone \\n23\\n7.   \\nComplications \\n24\\n7.1 \\nHyperstimulation \\n24\\n7.2 \\nCord prolapse \\n24\\n7.3 \\nUterine rupture \\n25\\n7.4 \\nFailed induction \\n25\\n C\\t\\nGuideline for Use of Oxytocin for Induction and Augmentation \\n\\t\\nof labour\\t \\t\\n27\\n D\\t\\nGuideline on fetal monitoring in labour\\t\\n30\\n\\t\\n E\\t\\nGuideline on Pain Relief in Labour \\n34\\n1 \\nMethods of pain relief in labour \\n34\\n1.1 \\nNon-pharmacological methods of pain relief \\n35\\n1.2 \\nPharmacological methods of pain relief in labour \\n35\\n1.2.1 \\nOral paracetamol/paracetamol& codeine compound \\n35\\n1.2.2 \\nOpioids \\n35\\n1.2.2.A. \\nPethidine \\n35\\n1.2.2.B. \\nMorphine \\n36\\n1.2.2.C. \\nFentanyl \\n36\\n1.2.3 \\nInhalational analgesia – Entonox \\n36\\n1.2.4 \\nRegional Anaesthesia \\n37'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxi\\n F\\t\\nGuidelines to maintain the partograph\\t\\n39\\n\\t\\n G\\t\\nGuideline on acute puerperal inversion of the uterus \\n41\\n1 \\nIntroduction \\n41\\n2 \\nDefinition \\n41\\n3 \\nPrevention \\n41\\n4 \\nPathophysiology (and clinical correlation) \\n41\\n5 \\nClassification \\n42\\n6 \\nClinical Presentation and diagnosis \\n42\\n7 \\nManagement \\n43\\n7.1 \\nGeneral measures \\n43\\n7.2 \\nRepositioning the uterus \\n43\\n7.2.1 \\nManual replacement of uterus \\n43\\n7.2.2 \\nHydrostatc reduction \\n44\\n7.2.3 \\nTocolytics \\n45\\n7.2.4 \\nGeneral Anaesthesia \\n45\\n7.2.5 \\nSurgical methods \\n45\\n8 \\nDebriefing \\n46\\n H\\t\\nManagement of Hypertensive Disease in Pregnancy \\n47\\n1 \\nIntroduction \\n49\\n2 \\nDefinitions \\n49\\n3 \\nScreening for Hypertension during pregnancy \\n50\\n4 \\nPrevention of hypertensive disorders in pregnancy \\n50\\n5 \\nManagement of Chronic Hypertension  \\n51\\n6 \\nManagement of severe pre eclampsia \\n52\\n6.1 \\nGeneral Considerations \\n52\\n6.2 \\nSpecific Management \\n52\\n6.2.1 \\nAnti-hypertensive drugs \\n53\\n6.2.1.1 \\nLabetalol orally or intravenously \\n53\\n6.2.1.2 \\nHydralazine intravenously \\n54\\n6.2.1.3 \\nOral Nifedipine \\n55\\n6.2.2 \\nPrevention of convulsions \\n55\\n6.2.3 \\nFluid Balance \\n56\\n6.2.4 \\nIn utero/neonatal transfer \\n56\\n6.2.5 \\nDelivery \\n57\\n6.2.6 \\nPost-delivery \\n57\\n6.2.7 \\nFollow up \\n58\\n \\n I\\t\\nManagement of Eclampsia \\n59\\n1 \\nDefinition \\n59\\n2 \\nDiagnosis \\n59\\n3 \\nTime of onset of eclampsia \\n59\\n4 \\nComorbidities \\n59\\n5 \\nPrevention \\n60\\n6 \\nManagement \\n60\\n6.1 \\nGeneral considerations \\n60\\n6.2. \\nDuring the seizure \\n61'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxii\\n6.3.  \\nAs soon as possible following a seizure \\n61\\n6.4. \\nManagement of seizures in women receiving \\n  \\nmagnesium sulphate \\n62\\n7. \\nDelivery \\n62\\n8. \\nTransfer of a woman who has had a seizure to another institution \\n63\\n9. \\nPostpartum management \\n63\\n10. \\nCounselling  \\n64\\n J\\t\\nManagement of Diabetes during Pregnancy  \\n67\\n1 \\nPurpose \\n67\\n2 \\nScreening \\n67\\n2.1 \\nTarget groups for screening \\n67\\n2.2 \\nRecommended tests \\n68\\n3 \\nManagement – Women with established Diabetes \\n70\\n3.1 \\nPre Pregnancy care \\n70\\n3.2 \\nAntenatal Care \\n71\\n3.3 \\nMedical nutrition therapy (MNT) \\n72\\n3.4 \\nExercise \\n72\\n4 \\nGlyceamic control and Monitoring  \\n73\\n4.1 \\nGlyceamic Control \\n73\\n4.2 \\nMonitoring of glycaemic control \\n74\\n5 \\nDelivery and intra natal care \\n74\\n5.1 \\nTiming of delivery \\n74\\n5.2 \\nLabour care \\n75\\n6 \\nPost natal care \\n75\\n6.1.a \\nNeonatal care \\n75\\n6.1.b \\nImmediate post partum care \\n76\\n6.2 \\nAt hospital discharge \\n76\\n6.3 \\nLate Postnatal care and follow up \\n77\\n7 \\nFamily Planning \\n77\\n K\\t\\nManagement of Primary Post Partum Haemorrhage \\n81\\n1 \\nIntroduction \\n81\\n2 \\nDefinition \\n81\\n3 \\nPrevention of Post Partum Haemorrhage \\n81\\n4 \\nPrediction of Post Partum Haemorrhage \\n82\\n5 \\nManagement of Primary PPH \\n83\\n5.1 \\nGeneral measures \\n83\\n5.2 \\nSpecific measures \\n84\\n5.2.1 \\nEstablish a cause for the bleeding  \\n84\\n5.2.2. \\nManagement of atonic haemorrhage \\n85\\n5.2.3 \\nManagement of traumatic PPH \\n86\\n5.2.4 \\nRupture of the uterus \\n87\\n5.2.5 \\nCoagulopathy causing PPH \\n87\\n6. \\nResuscitation and Fluid management \\n87\\n7. \\nDebriefing \\n88\\n8. \\nRisk Management \\n89\\n  \\nAppendix 1 \\n90\\n  \\nAppendix 2 \\n92\\n  \\nAppendix 3 \\n94'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxiii\\nList of Abbreviations\\nWHO \\nWorld Health Organization\\nUNFPA \\nUnited Nations Population Fund\\nUNICEF \\nUnited Nations Children’s Fund\\nSLCOG \\nSri Lanka College of Obstetricians and Gynaecologists\\nNICE \\nNational Institutive of Clinical excellency\\nRCOG \\nRoyal College of Obstetricians and Gynaecologists\\nFHR \\nFetal Heart Rate\\nCPD \\nCephalo Pelvic Disproportion\\nNALS \\nNeonatal Advanced Life Support\\nPPROM \\nPreterm prelabour  rapture of the Membranes\\nCS \\nCaesarean Section\\nCTG \\nCardiotocography\\nIV \\nIntravenous\\nIM \\nIntra muscular\\nIU \\nInternational Units\\nEFM \\nElectronic Fetal Monitoring\\nTENS \\nTranscutaneous electrical nerve stimulation\\nHELLP \\nHaemolysis, elevated liver enzymes and low platelet\\nHDU \\nHigh dependency unit\\nICU \\nIntensive care unit\\nPGDM  \\nPre gestational diabetes mellitus\\nGDM \\nGestational Diabetes Mellitus\\nOGCT \\nOral glucose Challenge Test\\nOGTT \\nOral Glucose Tolerance test\\nPPBS \\nPost Prandial Blood Sugar\\nMNT \\nMedical Nutrition therapy\\nDENO \\nDiabetic Educator Nursing officer\\nSMBG \\nSelf-monitoring of blood glucose\\nAC \\nAbdominal Circumference\\nSHO \\nSenior House Officer\\nCBG \\nCapillary Blood Glucose\\nENC \\nEssential  New-born  Care\\nDM \\nDiabetes Mellitus\\nDMPA \\nDepot Medroxy Progesterone Acetate\\nBMI \\nBody Mass Index\\nPPH \\nPost Partum Haemorrhage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxiv\\nList of Tables\\nGuidelines for ruse of oxytocin for induction and augmentation of labour\\nTable 1 \\nmU/minute administered at different rates of administration \\naccording to drop rate\\nTable 2 \\nmU/minute infused per minute when administered via an infusion \\npump\\nGuideline on fetal monitoring in labour\\nTable 1 \\nDefinitions of normal, suspicious and pathological FHR rates\\nTable 2 \\nClassification of fetal heart rate patterns\\nGuideline for screening, diagnosis and management of diabetes in pregnant \\nwomen\\nTable 1 \\nTarget values in glycaemic control'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxv\\nDisclaimer\\nThese guidelines are based on current best available evidence and \\nconsensus opinion of the Guideline Development committee of \\nthe Sri Lanka College of Obstetricians & Gynaecologists. They are \\nneither intended to replace the process of critical evaluation of \\nevery case and nor it is intended to dictate an exclusive course of \\nmanagement or treatment. It must be interpreted with reference to \\nindividual patient needs, available resources and limitations unique \\nto the institution and variations in local populations.\\nMedicine is a continually evolving science and the users must have \\nregard to relevant information, research or material, which may \\nhave been published or become available subsequently.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxvi\\nIntroduction\\nClinical Guidelines are systematically developed statements which assist \\nclinicians and patients in making decisions about appropriate treatment \\nfor specific conditions based on the best scientific evidence at the time of \\ndevelopment. Guidelines are not intended to limit the clinical freedom; \\nhowever, clinicians are expected to follow these recommendations as the \\nbasis for their decision making. Availability of resources, the existing \\nsituations, and the expectations of individual client needs to be considered. \\nThe guidelines are intended to guide all health care workers in all levels \\nof institutions where maternity care is being provided. Although these \\nguidelines are mainly targeted for the government sector institutions, use \\nin the private sector institutions where maternity care is being provided, \\nis also encouraged.\\nThese guidelines are developed by the guideline development committee \\nof the Sri Lanka College of Obstetricians and Gynaecologists in \\nconsultation with other relevant specialists such as anaesthesiologists, \\nphysicians, endocrinologists, and haematologists etc. The existing \\nnational guidelines developed in 2007, NICE guidelines on intranatal \\ncare, WHO guidelines and RCOG guidelines were perused and mixed \\nwith the local scenarios and expert opinion. The latest available scientific \\nevidences were considered and included where ever necessary. Then, the \\ndraft guidelines were presented to the wider forum of obstetricians and \\nconsensuses were arrived. After that the guidelines were handed over to \\nthe Ministry of Health and consensus was built with the participation \\nof multi-disciplinary team including medical administrators, provincial \\nhealth authorities, representatives from SLCOG and  other relevant \\nprofessional colleges, and national programme managers.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n1\\nManagement of Labour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n2'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n3\\nManagement of Normal Labour\\n1.\\t Introduction\\nThe aim of this guideline is to provide recommendations to care providers \\nin the management of a healthy woman with a single fetus in labour at \\nterm (37-42weeks). It does not cover the care of women with complicated \\npregnancies. \\nThe objective of this guideline is to ensure optimal management of \\nwomen in labour, detect any abnormalities, take appropriate action, \\nprevent complications and thus make childbirth safer; and also to make \\nsure that these women are treated with respect and compassion, and kept \\nwell informed and well supported throughout labour. \\n2.\\t Diagnosis of Labour\\nLabour is diagnosed by the presence of regular, painful intermittent \\ncontractions, which are of increasing frequency, duration and intensity, \\nleading to progressive cervical effacement and dilatation. \\nNote:  for the purpose of this guideline, labour is also diagnosed in the \\npresence of painful contractions occurring at a frequency of 2 in 10 \\nminutes or more.\\nDefinitions: \\nLatent phase of the first stage of labour – from the commencement \\nof labour to a cervical dilatation of up to 4 cm. (This is a period \\nof time, not necessarily continuous, when there are painful \\ncontractions and some cervical changes including cervical \\neffacement and dilatation up to 4cm take place)\\nActive phase of the first stage of labour – commences at a cervical \\ndilatation of 4cm and ends with full dilatation. (There are regular \\npainful contractions and progressive cervical dilatation from 4cm \\nup to full dilatation).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n4\\nIf the diagnosis of labour is uncertain, observation should continue and \\nreassessment made in four hours. \\nAny woman who is diagnosed as not being in labour, but continues to \\ncomplain of pain, would require careful reassessment by an experienced \\nmedical officer. Possible diagnoses of placental abruption and non-\\nobstetric causes should be considered. Fetal compromise should be \\nexcluded. \\n3.\\t\\nManagement of labour\\n3.1. \\nGeneral considerations\\n3.1.1. Communication between women and healthcare professionals/\\nworkers\\n• \\nGreet the mother with a smile and a personal welcome\\n• \\nTreat them with respect and dignity \\n• \\nAssure privacy \\n• \\nEstablish a good rapport with the laboring women asking \\nabout their wants and concerns and address them \\n• \\nMaintain a calm and confident approach which will reassure \\nwomen that the situation is under control\\n• \\nAssess the woman’s knowledge of strategies for coping with \\npain and provide balanced information to find out which \\navailable approaches are acceptable to her\\n• \\nAsk her permission before all  procedures and observations, \\nfocusing on the woman rather than technology or the \\ndocumentation\\n3.1.2. Preparation of mothers to transfer to labour room\\n• \\nShaving or trimming of perineal hair may be necessary to \\nfacilitate unhindered performance and repair of the episiotomy.\\n• \\nEfforts must be made to minimize faecal soiling. Where \\nan enema is deemed necessary, a medicated enema is \\nrecommended. \\n      (These two steps should not be considered mandatory)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n5\\n• \\nWomen should be encouraged to have a companion of her \\nchoice during labour, depending on the facilities and clinical \\nsituation.\\n3.1. 3. Documentation \\n• \\nAdmit the mother to the labour room and complete the \\n‘handing over’ form \\n• \\nEnter relevant notes on the BHT and start a partogragh (see \\npage 39)\\n• \\nReview clinical notes and reassess risk factors.\\n• \\nAccurate documentation of all observations and interventions \\nmust be made, with timing.\\n• \\nAll obstetric examinations and procedures carried out must \\nbe documented in the clinical notes. Each entry must be \\naccompanied by a plan for management and be signed by the \\nresponsible person.  \\n3.1.4. Mobilization and Positioning\\n• \\nWomen should be encouraged and helped to move about \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nThey need to be encouraged to void urine at regular intervals.\\n3.1.5. Eating and drinking in labour\\n• \\nMothers must be encouraged to consume clear, non-\\nfizzy liquids during labour. Isotonic solutions such as oral \\nrehydration fluid and king coconut water are more beneficial \\nthan water. \\n• \\nIn addition to clear fluids, women in the latent phase may \\nconsume light solids e.g. biscuits and fruits. \\n3.1.6. Hygiene measures during labour\\n• \\nStrict asepsis must be maintained during labour. \\n• \\nInstruments should be available in packets'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n6\\n• \\nUse proper hand washing technique.\\n• \\nUse of double gloves and disposable gloves is encouraged.  \\n3.1.7. Pain relief in labour\\nRelief of pain should be a major consideration (please refer guidelines on \\npain relief during labour in page 34)\\n3.2. \\nManagement of the three stages of labour\\nThe practice of maintaining a labour room ‘notice board’ - a ‘white \\nboard’ on which the status of all women in labour is summarized \\nand updated regularly is encouraged. This would convey at a glance \\nto all care providers women who require additional attention. The \\nage, parity status, risk factors, salient findings at each assessment \\nand any abnormalities noted must be included in this.\\n3.2.1. Management of first stage of labour\\n3.2.1. 1. Latent phase \\nIt is important to recognize the latent phase of labour, since its prolongation \\ncould lead to maternal exhaustion, dehydration and acidosis, leading to \\nfetal compromise and dysfunctional labour. \\n \\nWomen in the latent phase of labour would be best managed in the \\nantenatal ward.\\nWomen in the latent phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse half hourly\\n• \\nCheck  temperature four hourly\\n• \\nConsider vaginal examination four hourly, depending on the \\ncontraction pattern and initial cervical dilatation\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n7\\n• \\nUse of a sanitary pad may indicate early, the presence of \\nmeconium. \\n• \\nConsider the requirement for analgesia.\\nIt is important to inform the mother and reassure her that it is common to \\nhave slow progress in the latent phase.  \\nThe latent phase is considered prolonged when it lasts more than 12 hours \\nin a primigravida and 8 hours in a multigravida. In these situations an \\nexperienced medical officer (with a minimum one year of experience in \\nthe field) must reassess the mother with a view of augmentation of labour. \\n3.2.1.2. Active phase\\n3.2.1.2a. Admitting women to the Labour Room\\nAll pregnant women diagnosed as being in active phase of the first stage of \\nlabour need to be admitted to the labour room.\\nThe initial assessment of a woman in the labour room should include:\\n• \\nListening to her story, considering her emotional and \\npsychological needs and reviewing her clinical records\\n• \\nPhysical observation: temperature, pulse, blood pressure\\n• \\nLength, strength and frequency of contractions\\n• \\nAbdominal palpation: fundal height, lie, presentation, position \\nand station\\n• \\nVaginal loss: show, liquor, blood\\n• \\nAssessment of woman’s pain including her wishes for coping \\nwith labour along with the range of options for pain relief\\n• \\nThe fetal heart rate (FHR)  should be auscultated preferably with \\na hand held Doppler for a minimum of 1 minute immediately \\nafter a contraction\\n• \\nThe maternal pulse should be recorded to differentiate between \\nmaternal pulse and FHR\\n• \\nA vaginal examination should be offered'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n8\\nHealth care Professionals who conduct vaginal examination should:\\n• \\nBe sure that there is a valid indication for vaginal examination \\nthat it will add important information to the decision making \\nprocess\\n• \\nBe aware that for many women who may already in pain, \\nhighly anxious and in an unfamiliar environment, vaginal \\nexamination can be very distressing\\n• \\nEnsure the woman’s consent, privacy, dignity and comfort\\n• \\nExplain the reason for examination and what will be involved, \\nand\\n• \\nExplain the findings and their impact sensitively to the woman\\n3.2.1.2b.  Management of active phase of first stage\\nMonitoring must be conducted as instructed in the partogram and \\nfindings recorded accordingly. \\nUse of a sanitary pad may indicate presence of meconium early. \\nWomen in the active phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse every 15 minutes ;\\n• \\nCheck temperature and blood pressure four hourly;\\n• \\nVaginal examination four hourly or earlier, depending on the \\nclinical situation; \\n• \\nFrequency of contractions should be monitored as follows:\\n \\nThe interval between two contractions should be assessed by \\npalpation of the abdomen\\n \\nDuring active labor usually there are at least three contractions \\nper ten minutes. In other words the interval between two \\ncontractions should be three minutes\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture;\\n• \\nConsider the requirement for analgesia, (which now becomes \\nmore important).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n9\\nIntermittent auscultation of the fetal heart is best performed using \\nhand-held Doppler devices. The fetal heart rate must be counted \\nfor one minute, beginning immediately after a contraction.\\nThe mother may continue to consume clear fluids in the active phase. \\nShe must be encouraged to assume any position that she is comfortable in \\nand to avoid the dorsal position. \\nWomen who have the following conditions are recommended to be have \\nto continuous electronic fetal monitoring: \\n• \\nSignificant meconium staining of amniotic fluid, \\n• \\nAbnormal Fetal heart rate detected by intermittent \\nauscultation (< 110 beats per minute; > 160 beats per minute; \\nany decelerations after a contraction)\\n• \\nFresh vaginal bleeding and \\n• \\nMaternal pyrexia. \\nIn women with spontaneous labour progressing normally, routine \\nearly amniotomy and use of oxytocin is not recommended.\\n3.2.1.3. Delayed progress of first stage of labour\\nDelayed progress is diagnosed when there is progress of less than \\ntwo cm in four hours. Slowing of progress in a woman who has \\npreviously been progressing satisfactorily must also be considered \\nas a delay.\\nIt is extremely important that delay in progress is assessed by an \\nexperienced medical officer. \\nThis assessment must take into account:\\n• \\nthe uterine contractions, \\n• \\ndescent and position of the fetal head  \\n• \\nfeatures of early obstruction of labor (caput and moulding), and \\n• \\nThe fetal condition'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n10\\nIn women with delay in the active phase of the first stage, every effort must \\nbe made to find a cause for the delay. This may either be due to inadequate \\ncontractions or obstruction due to CPD, mal-presentation or malposition \\n(such as occipito-posterior position), or a combination of these. \\nIn cases of inadequate contractions:\\n• \\nAmniotomy must be performed if membranes are still intact. \\n• \\nFollowing that, the woman must be reassessed in two hours \\n• \\nIn case there is inadequate progress, augmentation with \\noxytocin must be considered. \\n• \\nThe situation must be reassessed after four hours or earlier if \\nrequired.\\nMultiparous women with delayed progress: \\n• \\nMust be viewed with extreme caution. \\n• \\nIt is very important to exclude mechanical causes of delay \\nbefore considering oxytocin. \\n• \\nUse of oxytocin in multipara with obstructed labour could be \\nextremely dangerous. \\nIn all cases where progress is slow in spite of adequate contractions a \\ncareful assessment must be made to exclude obstruction of labour. \\nAttention must be paid to effective pain relief and to correcting dehydration \\nin those situations.\\nAfter paying attention to the above,Cesarean section must be considered \\nwhere the progress continues to be slow after four hours (less than two \\ncm) of commencing oxytocin. \\n3.2.2. Management of second stage of labour\\n3.2.2.1. Passive second stage of labour (descent phase)\\n• \\nIs diagnosed when full cervical dilatation is reached in the \\nabsence of involuntary expulsive efforts by the mother. \\n• \\nBearing down must be discouraged at this stage.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n11\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 10 minutes. The maternal pulse should be palpated if \\nthere is suspected fetal bradycardia or any other FHR anomaly \\nto differentiate the two heart rates. \\n• \\nPresence of meconium must be noted. \\n3.2.2.2. Active second stage of labour (expulsive phase) \\n• \\nIs diagnosed when the mother gets the urge to bear down with \\nfull dilatation.\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 5 minutes. The maternal pulse should be palpated if there \\nis fetal bradycardia or any other FHR anomaly \\n• \\nPresence of meconium must be noted. \\nUse of a hand-held Doppler device is recommended (in preference to a \\nPinnard) for fetal heart rate monitoring in the second stage. \\nWomen must be encouraged to continue consuming clear fluids during \\nthe second stage. \\nSupport by the labour companion must be continued. \\nTotal time durations allowed for the second stage of labour are as follows:\\nPrimigravida: \\n• \\nBirth would be expected to take place within 2 hours of the \\nstart of the active second stage in most women.\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 1 hour and need to seek the advice from a \\nhealth professional trained in the assisted/ Operative vaginal \\nbirth if birth is not imminent.\\nMultigravida:\\n• \\nBirth would be expected to take place within 1 hours of the \\nstart of the active second stage in most women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n12\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 30 minutes and requires advice from a health \\nprofessional trained in assisted/ operative vaginal birth if birth \\nis not imminent.\\n• \\nDelay in the second stage in a multiparous woman must raise \\nsuspicion of disproportion or malposition.\\nOne further hour is permitted for women in each category with an \\nepidural analgesia.\\n3.2.2.3. Observations for women and babies in the second stage of \\nlabour:\\nAll observations should be documented on the partogragh.\\n• \\nChart blood pressure and pulse hourly\\n• \\nContinue four hourly temperature recording \\n• \\nVaginal examination must be offered after an hour in the active \\nsecond stage after abdominal palpation and assessment of \\nvaginal loss\\n• \\nHalf hourly documentation of frequency of contractions\\n• \\nOngoing consideration of the woman’s  emotional and \\npsychological needs\\nIn addition:\\n• \\nAssessment of progress should include maternal behavior, \\neffectiveness of pushing and fetal wellbeing, taking into \\naccount fetal position and station at the onset of the second \\nstage. These factors will assist in deciding the timing of further \\nvaginal examination and the need for obstetric review.\\n• \\nOngoing consideration should be given to the woman’s position, \\nhydration, coping strategies and pain relief throughout the \\nsecond stage.\\n3.2.2.4. Women’s position and pushing in the second stage of labour:\\nAlthough most deliveries in Sri Lanka are conducted in the dorsal/\\nMcRobert’s position, women may be encouraged to adopt squatting, semi \\nupright or lateral positions to aid the expulsion phase.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n13\\nWomen should be informed that in the second stage, they should be \\nguided by their own urge to push.\\nIf pushing is ineffective, strategies to assist birth such as support and \\nencouragement and change of position can be used.\\nIn primigravida in whom contractions have become weak and there \\nis no evidence of fetal compromise or obstruction, oxytocin may \\nbe administered as an infusion. In this case, the expulsive phase \\nmay be continued under close observation for a further 30 minutes. \\nDelivery must be considered at the end of this period.\\n3.2.2.5. Intrapartum interventions to reduce perineal trauma\\nEither the ‘hands on’ (guarding the perineum and flexing the baby’s head) \\nor the ‘hands poised’ (with hands off the perineum and baby’s head but in \\nreadiness) techniques can be used to facilitate spontaneous birth.\\nA routine episiotomy should not be carried out during spontaneous \\nvaginal birth.\\nEpisiotomy should only be performed selectively, in women in whom there \\nis a clinical need such as instrumental birth or suspected fetal compromise \\nor a high chance of perineal tears.  \\nWhere episiotomy is performed, Mediolateral episiotomy, performed at \\n45 – 60 degrees from the midline directed to the right side, beginning at \\nthe vaginal fourchette is preferred to the median episiotomy.  It should be \\nperformed at the time of crowning of the fetal head.\\nEpisiotomy should be performed after infiltration of the perineum up to \\n20 ml of 1% lignocaine. \\n3.2.2.6. Delivery\\nThe fetal head should not be allowed to extend till occiput is felt below \\nthe symphysis pubis. The perineum should be supported during delivery \\nof the head. Once the head is delivered the woman should be discouraged \\nfrom bearing down. Following restitution and external rotation, shoulders'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n14\\nmust be delivered appropriately with directed traction on the fetal head. \\nThe baby must be delivered onto the mother’s abdomen. Breastfeeding \\nshould be initiated within 30 minutes of birth. \\n3.2.3. \\nThird stage of Labour\\nThe third stage of labour is the period from the complete delivery of the \\nbaby to the complete delivery of the placenta and membranes.\\n3.2.3.1. Active Management of the third stage of labour\\nActive management of the third stage of labour is recommended for all \\nmothers. \\nThis includes;\\n• \\nRoutine use of uterotonic drugs: Oxytocin 5 IU intravenously \\nsoon after the delivery of the baby   or 10 IU intramuscularly, \\n• \\nDelayed cord clamping (2 minutes after the birth) and cutting \\nof the cord\\n• \\nFollowed by controlled cord traction. This must be followed by \\nuterine massage.\\nDelayed clamping of the cord allows for placental transfusion, \\nwhich reduces neonatal and infant iron deficiency and anemia. \\nThis policy should be followed unless the baby is born in a poor \\ncondition or if the mother is bleeding or is Rhesus iso-immunized.\\nClamp and cut the cord close to the perineum.  A hand should be placed \\nabove the symphysis pubis to stabilize the uterus by applying counter \\ntraction during controlled cord traction. Application of cord traction \\nwhen the uterus is relaxed could lead to acute inversion of the uterus.\\nAfter delivery, the placenta must be placed on a flat surface and the maternal \\nsurface examined for completeness. On the fetal surface the blood vessels \\nmust be traced to exclude a succenturiate lobe. Completeness of the fetal \\nmembranes must be ensured.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n15\\nObservations in the immediate postpartum period include:\\n• \\nInspection for continued fresh bleeding, \\n• \\nCheck pulse, blood pressure, uterine contraction,  and the level \\nof the fundus every 15 minutes up to 2 hours\\n• \\nHer general  physical condition, as shown by her colour, \\nrespiration and her own report of how she feels \\nExperienced medical personnel should be informed in any one the \\nfollowing instances: \\n• \\nContinuing fresh bleeding;\\n• \\nElevation of the level of the fundus;\\n• \\nIncrease of pulse rate above 100 or by 30 beats per minute;\\n• \\nDrop in systolic blood pressure below 100 or by 30 mmHg. \\nThe level of the fundus must be marked on the skin using a marker to \\nmake observations more objective. \\n3.2.3.2. Delayed third stage\\nDelayed third stage is diagnosed when the placenta is not delivered within \\n30 minutes of active management. \\nThe first step in managing delayed third stage of labour is:\\n• \\nTo proceed to intraumbilical vein oxytocin, in a dose of 50 IU \\nin 30 ml of 0.9% sodium chloride solution. \\n• \\nA period of 30 minutes is allowed and controlled cord traction \\nis attempted again. \\n• \\nIf the placenta is not delivered by this method, manual removal \\nof placenta is proceeded to. \\n4.\\t\\nCare for the newborn baby\\nEffective care at birth is needed in anticipation of problems with the \\ntransition from in utero dependent life to extra utero independent \\nexistence and to provide support to ensure stabilization.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n16\\n• \\nSkilled birth attendant (Medical Officer, Nursing Officer and \\nMidwive) is responsible for the care. \\n• \\nThe care at birth is same irrespective of birthing place or person \\nattending to birth. \\n• \\nAt least one health care provider trained in neonatal \\nresuscitation must be physically available at the time of birth of \\nall infants irrespective of risk status.\\n• \\nThis person must actually be present in the delivery room \\nbefore the birth of the baby.\\n• \\nThe attending personnel should document the details of the \\nbaby such as time of birth, weight, gender and any other \\nrelevant information in all cases.\\nThe aims of neonatal care following birth include the following:\\n• \\nEstablishment of respiration (as per NRP guidelines) \\n• \\nPrevention of hypothermia (Refer to newborn guideline)\\n• \\nEstablishment of breast feeding (Refer to newborn guideline)\\n• \\nPrevention of infection (Refer to newborn guideline)\\n• \\nDetection of danger signs (Refer to newborn guideline)\\nFollowing basic steps should be followed at the time of birth;\\n1. Call out the time of birth\\n2. Deliver the baby onto the mother’s abdomen or into her arms\\n3. Dry baby with a warm towel or a warm piece of cloth\\n4. Wipe baby’s eye\\n5. Assess baby’s breathing while drying \\n6. Make sure that there is no second baby\\n7. Change gloves or remove the first layer of gloves\\n8. Clamp and cut the umbilical cord\\n9. Put the baby between mother’s breast for skin to skin care\\n10. Place an identity label on baby\\n11. Cover mother and baby with warm clothes\\n12. Put a hat on baby’s head\\nThe Apgar score at 1 and 5 minutes should be recorded for all births.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n17\\nInitiation of breast feeding should be aimed for within 1hour after birth. \\nHead circumference, birth weight, length and other measurements should \\nbe carried out once the first feed is complete. A health care professional \\nshould examine the baby to detect any physical abnormality and to \\nidentify any problems that require referral.\\n5.\\t\\nPerineal Care\\nPerineal  or genital trauma caused by either episotomy or tearing need to \\nbe repaired.\\nBefore assessing for genital trauma:\\n• \\nExplain to the woman what they are going to do and why\\n• \\nOffer some analgesia\\n• \\nEnsure good lighting\\n• \\nPosition the woman so that she is comfortable and the genital \\nstructures can be seen clearly.\\nThe initial assessment should be performed gently and with sensitivity \\nand may be done in the immediate period following birth preferably as \\nsoon as the placenta is delivered.\\nClassification of perineal trauma\\nFirst degree: Injury to skin only\\nSecond Degree: Injury to the perineal muscles but not the anal \\nsphincter\\nThird degree: Injury to the perineum involving the anal sphincter  \\ncomplex\\nFourth degree: Injury to the perineum involving the anal sphincter \\ncomplex and anal epithelium\\nPerineal repair should only be undertaken with tested effective analgesia \\nin place using infiltration with up to 20ml of 1% lignocaine or equivalent, \\nor by topping up the epidural, as soon as possible by a medical officer.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n18\\nThe preferred suture material is rapidly absorbable polyglactin acid.\\nThe following basic principles should be observed when performing \\nperineal repairs:\\n• \\nPerineal trauma should be repaired using aseptic techniques.\\n• \\nEquipment should be checked and swabs and needles counted \\nbefore and after the procedure\\n• \\nGood lighting is essential to see and identify the structures \\ninvolved.\\n• \\nDifficult injuries should be repaired by an experienced medical \\nofficer in the theatre under regional or general anaesthesia. An \\nindwelling catheter should be inserted for 24 hours to prevent \\nurinary retention.\\n• \\nGood anatomical alignment of the wound should be achieved, \\nand consideration  given to the cosmetic result.\\n• \\nRectal examination should be carried out after completing the \\nrepair to ensure that suture material has not accidently been \\ninserted through the rectal mucosa.\\n• \\nFollowing completion of repair, an accurate detailed account \\nshould be documented covering the extent of the trauma, the \\nmethod of repair and the materials used.\\n• \\nInformation should be given to the woman regarding the extent \\nof the trauma, pain relief, diet, hygiene and the importance of \\npelvic floor exercises.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n19\\nGuideline on Induction of Labour\\n1.\\t\\nIntroduction \\nThis guideline aims to provide evidence based guidance on induction of \\nlabour to make the process more logical, effective and safer. It also aims to \\nempower women undergoing induction of labour. \\n2.\\t\\nDefinition\\nInduction of labour is defined as initiation of labour by artificial means.\\n3.\\t\\nGeneral Principles\\n• \\nInduction of labour should be performed only in specialist \\nobstetric units when there is a clear indication that its benefits \\noutweigh risks.\\n• \\nA senior clinician must make the decision.\\n• \\nThe reason/s should be clearly explained to the patient, who \\nshould give her consent.\\n• \\nMaternal and fetal wellbeing should be monitored closely.\\n• \\nAdequate pain relief should be an essential part of the \\nmanagement plan, since it is recognized that labor is more \\npainful when it is induced.\\n• \\nPrior to induction of labour, the cervix should be favourable \\n(Modified Bishop score 7 or more). If it is not, an attempt should \\nbe made to ripen the cervix. \\n• \\nDecisions regarding induction of labour should be made taking \\ninto account not only the clinical scenario but also the woman’s \\nviews, the availability of local facilities and cost effectiveness of \\nthe available methods.\\n4.\\t\\nIndications\\n4.1 Otherwise uncomplicated pregnancy continuing beyond 40 weeks\\nInduction of labour is recommended for low-risk women who are known \\nwith certainty to have reached 41 weeks of gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n20\\nHowever, it is good practice to assess fetal wellbeing around 40 weeks to \\nselect women for conservative management until 41 weeks gestation. \\nThe recommended assessments include fetal biometry (at least abdominal \\ncircumference) and amniotic fluid index (lower cut-off = 7 cm). \\n4.2 Prelabour rupture of membranes at term\\nIn the absence of evidence fetal compromise or maternal infection delayed \\ninduction of labour after 24 hours is acceptable. \\nThis may be carried out using either oxytocin infusion or prostaglandins.\\n4.3 Preterm prelabour rupture of membranes (PPROM)\\nPatients with PPROM without evidence of infection or fetal compromise \\nshould be offered induction after the completion 34 weeks.\\n4.4 Intrauterine death\\nThis is a very traumatic time for the woman. Most women would want \\nto be delivered as early as possible and their wishes need to be respected. \\nAmniotomy and repeated vaginal examinations are best avoided. \\nProstaglandins are preferred for induction of labour in these women. \\nAmniotomy is preferred in the presence of abruption placentae. \\n4.5 History of precipitate labour\\nThere are no studies comparing outcomes in induced versus spontaneous \\nlabour.\\n4.6 Suspected macrosomia\\nIn the presence of good clinical and ultrasound evidence of macrosomia \\nor a history of previous shoulder dystocia, there should be a low threshold \\nfor early induction of labour.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n21\\n4.7 Fetal growth restriction\\nThe decision for induction of labour in a growth restricted fetus should be \\nindividualized based on period of gestation at onset, presence or absence \\nof fetal compromise. \\n4.8 Older mothers\\nThere is growing evidence that the risk of stillbirth is higher in older (>40 \\nyrs) women near term. \\nWomen over 40 years should be offered induction between 39-40 weeks.\\n5.\\t\\nInduction under specific circumstances\\n5.1 Breech presentation\\nPresentation per se, is not a contraindication to induction. \\n5.2 Previous CS\\nThere is no contraindication to induction of labour in a woman with a \\npast caesarean section. \\nUse of either oxytocin or prostaglandins increases the risk of scar \\ndehiscence or rupture. \\nThis risk may be lower with artificial separation of membranes or Foley \\ncatheter. \\n6.\\t\\nMethods of induction\\nThis section does not make a distinction between methods of ripening the \\ncervix and induction of labour. \\n6.1 Mechanical\\nThere is good evidence that artificial separation of membranes reduces the \\nneed for formal induction. This method is recommended to be performed \\nwith due regard to asepsis, at 40 weeks gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n22\\nWhere the cervix will not admit a finger, massaging around the cervix in \\nthe vaginal fornices will have a similar effect.\\nExtra-amniotic balloon catheter is an effective method of ripening of the \\ncervix. A Foley catheter is inserted through the cervix and the balloon \\ninflated with 40 – 60 ml of saline. This may be left in situ for a maximum \\nof 48 hours. Following its removal, induction of labour may be proceeded \\nto using another method. \\nIn the presence of evidence of infection, artificial separation of membranes \\nand extra-amniotic Foley catheter must not be used. \\n6.2 Surgical\\n \\nAmniotomy is a definitive mode of induction of labour. It should be \\nundertaken only if one is committed to deliver within 24 hours. Therefore \\nit should be done only when the cervix is ripe and prior cervical assessment \\nby an experienced clinician is essential.\\nThe risk of cord prolapse should be appreciated and steps taken to \\nminimise or to recognize it early.\\nAmniotomy alone may be capable of initiation of labour and it is \\nrecommended that oxytocin be started after a period of observation of at \\nleast two hours. \\n6.3 Pharmacological\\n6.3.1 Oxytocin\\nUse of oxytocin when membranes are intact is not recommended. \\nFor details of how to use oxytocin please refer to the guideline on oxytocin\\n6.3.2 Prostaglandins\\nProstaglandin E2 (PGE2)\\nThese are very effective in inducing labour and are available as vaginal gel, \\ntablet or controlled release pessary.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n23\\nAll preparations carry a risk of hyperstimulation.\\nIntracervical route does not offer any increase in efficacy.\\nCombined use with oxytocin is particularly dangerous. A minimum of six \\nhours from the last vaginal tablet/gel should be allowed before oxytocin \\nis started.\\nPrior to use of prostaglandins the Bishop score should be assessed and \\nthe woman should be monitored electronically to determine the fetal \\ncondition and frequency of contractions.\\nAfter administration the fetal heart should be monitored electronically \\nwhen contractions begin. After confirmation of normal heart rate pattern \\nmonitoring should be done by intermittent auscultation.\\nA second dose may be considered after a minimum interval of 6 hours \\nafter the first, depending on the change of Bishop score, the condition of \\nthe fetus and frequency of contractions.\\nThe dosages are 3 mg for vaginal tablets and 0.5 mg for vaginal gel.\\nMisoprostol\\nThis drug is widely used worldwide for a variety of indications in \\npregnancy. (In Sri Lanka, it is not licensed at present).\\nNevertheless, it is very effective in inducing labour (more than PGE2), \\nespecially in mid trimester fetal death. \\nSensitivity of the uterus increases markedly with advancing pregnancy.\\nThis guideline recommends that it should not be used for induction of \\nlabour with a mature live fetus.\\n6.3.3 Mifepristone\\nIt is a powerful anti-progesterone and is very useful as an adjunct to \\nmisoprostol in cases of intrauterine death. (It is not licenced in Sri Lanka \\nat present)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n24\\n8.\\t\\nComplications\\n8.1 Hyperstimulation\\nThis is a well-recognized complication of induction of labour with \\npharmacological methods. It could have serious consequences including \\nrupture of the uterus, aminiotic fluid embolism, precipitate labor and fetal \\ncompromise. \\nIt is defined either as a contraction free interval of less than sixty seconds \\nand/or contractions lasting more than ninety seconds.\\nIf diagnosed, the prostaglandin tablet must be retrieved from the vagina \\nor oxytocin infusion stopped immediately and a rapid infusion of 0.9% \\nsodium chloride via a fresh giving set administered.    \\nIf still not resolved, tocolytics should be given if available e.g. terbutaline \\n250 µg IV or SC.  Since this is not available in Sri Lanka, salbutamol \\ninhaler may be tried.\\n8.2  Cord prolapse\\nThis is more likely with amniotomy when the head is high and poorly \\napplied to the cervix. \\nPrecautions to avoid and to detect this early include palpation for cord \\npresentation, palpation for the cord immediately after amniotomy and the \\nfetal heart sounds auscultated immediately afterwards.\\n \\nIf cord prolapse is diagnosed help must be called immediately. Assess \\ncervical dilatation and effect delivery if fully dilated. If not fully dilated \\nand cord pulsations are present, insert a Foley catheter into the bladder \\nand fill it with 500 ml saline. Place the mother in the knee-elbow position \\nand displace the presenting part away from the pelvis by keeping pressure \\ninserting a hand in the vagina. Transport for immediate caesarean section \\nin this position.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n25\\n8.3 Uterine rupture\\nPlease also refer to section 5.2 in this guideline\\nExtra care must be exercised in grandmultipara and in women with \\nscarred uteri.\\n8.4 Failed induction\\nFailed induction is defined as labour failing to start after one cycle of \\ntreatment with medical methods or for 12 hours of amniotomy. \\nIt does not necessarily indicate caesarean section in case medical or \\nmechanical methods.\\nThe clinical situation (maternal and fetal condition) must be reassessed \\nand discussed with the woman. \\nIn case of failure to induce labor using one cycle of prostaglandins another \\ncycle may be administered as described  above. Depending on the clinical \\nsituation it is best that the second cycle is delayed for 24 hours. In case of \\namniotomy, failed induction of labour indicates caesarean section.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n26'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n27\\nGuideline for Use of Oxytocin for Induction and \\nAugmentation of labour\\nOxytocin is an invaluable drug when used carefully. However, it has \\nthe potential to cause uterine hyperstimulation, which could result in \\namniotic fluid embolism, uterine rupture and fetal distress, all of which \\nare life threatening. \\nMultigravidae are particularly susceptible to the above consequences \\nand extra care must be taken to exclude obstruction before a decision is \\nmade to use oxytocin in a multigravid woman during labour. Experienced \\npersonnel must be involved in this decision. \\nUse of oxytocin for induction and/or augmentation of labour results in \\na higher risk of rupture of a scarred uterus. Therefore, in such women \\noxytocin should be used only with the concurrence of a Consultant. \\nIts effects will depend on the concentration of the infusion and the volume \\ninfused per minute. \\nTo achieve this predictably, use of infusion pumps is recommended. \\nWhere a gravity-assisted drip system is used, a burette may be used to \\nimprove accuracy. Such systems however, may deliver variable volumes \\ndepending on many factors including the position of the arm into which \\nit is infused.  \\nIrrespective of the method of administration, oxytocin must be \\nadministered in incremental doses at intervals of 30 minutes, to achieve \\na contraction free interval of two minutes. Once this level is reached, the \\ninfusion rate may be continued at the same level, while closely monitoring \\nthe contractions. \\nHyperstimulation is defined either as a contraction free interval of less \\nthan sixty seconds and/or contractions lasting more than ninety seconds. \\nIn this situation the infusion must be stopped immediately. \\nOxytocin is administered with 5 units in 500 ml of 0.9% sodium chloride \\nsolution. In situations where infusion pumps are not available, oxytocin'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n28\\nmay be administered starting at a drop rate of 15 per minute and increased \\nat rates of 15 drops per minute every 30 minutes, up to a maximum of 60 \\ndrops per minute.  An approximate conversion to mU/minute is given in \\ntable 1.\\nTable 1: mU/minute administered at different rates of administration \\naccording to drop rate\\n \\nDrop rate/min \\nEquivalent  mU/min.\\n \\n15 \\n7.5\\n \\n30 \\n15 \\n \\n45 \\n22.5 \\n \\n60 \\n30 \\n \\n            (based on 5U of oxytocin in 500 ml saline)\\nTable 2 gives mU infused per minute when administered via an infusion \\npump. \\nTable 2: mU infused per minute when administered via an infusion \\npump.\\n TIME AFTER STARTING \\nOXYTOCIN DOSE \\nVOLUME INFUSED\\n \\n(MINS) \\n(MU/MIN) DOSE \\n(10U IN 500MLS MLS/HR)\\n \\n \\n \\nRATE\\n \\n0 \\n1 \\n3\\n \\n30 \\n2 \\n6\\n \\n60 \\n4 \\n12\\n \\n90 \\n8 \\n24\\n \\n120 \\n12 \\n36\\n \\n150 \\n16 \\n48\\n \\n180 \\n20 \\n60\\n \\n210 \\n24 \\n72\\n \\n240 \\n28 \\n84\\n \\n270 \\n32 \\n96\\nOxytocin must not be administered to women with intact membranes. It is \\nrecommended that women on oxytocin infusions should have continuous \\nelectronic fetal monitoring.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n29\\nContinuous EFM during administration of oxytocin:\\n• \\nIf the CTG is normal, oxytocin may be continued in incremental \\ndoses until the woman is experiencing 4 or 5 contractions every \\n10 minutes.\\n• \\nIf the FHR trace is suspicious, this should be reviewed by an \\nexperienced medical officer \\n• \\nIf the FHR trace is classified as abnormal/pathological oxytocin \\ninfusion should be stopped and a full assessment of the fetal \\ncondition undertaken by an experienced medical officer.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n30\\nGuideline on fetal monitoring in labour\\nFetal monitoring in labour could be done by :\\n• \\nIntermittent auscultation (preferably by a hand held Doppler \\ndevice) \\n• \\nIntermittent or continuous electronic monitoring  \\nIntermittent auscultation is recommended for low-risk women in \\nspontaneous labour. \\nElectronic monitoring is recommended when:\\n• \\nThe baby’s  growth is restricted  \\n• \\nThere is significant meconium staining of amniotic fluid \\n• \\nAbnormal fetal heart rate detected by intermittent auscultation \\n• \\nFresh vaginal bleeding \\n• \\nMaternal pyrexia \\n• \\nUse of oxytocin for augmentation or induction of labour \\n• \\nWomen with a scarred uterus \\n• \\nWomen on epidural analgesia \\nIntermittent auscultation \\nThis could be done by using either a Pinnard’s stethoscope or preferably a \\nhand-held Doppler device. \\nAuscultation should be carried out immediately after a contraction for \\none full minute. \\nThe maternal pulse should be palpated if there is suspected fetal \\nbradycardia or any other FHR anomaly to differentiate the two heart rates.\\nThe normal rate is between 110 – 160 beats per minute in a term fetus. \\nThe frequency of auscultation should be as specified in the partogram.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n31\\nElectronic fetal monitoring (EFM)\\nEFM is carried out by external cardiotocography (CTG). \\nThe following are recommended at the commencement of a CTG.\\n1. The paper speed must be set at 1 cm per minute.\\n2. The date and time settings on the machine must be validated.\\n3. The CTG must be labeled with the mother’s name, BHT number \\nand date and time. \\n4. Maternal heart rate should be noted on the CTG.\\n5. The presence and the point at which the fetal heart rate is best \\nheard must be delineated by auscultation and the probe placed \\nat that point.\\n6. Ensure that the contraction probe is functioning properly and \\nused for the recording.\\n7. The woman should be positioned in such a way that aortocaval \\ncompression is avoided.\\n8. It should be interpreted without delay and the categorization \\nrecorded as either normal or suspicious or pathological, as per \\ntable 1, and signed by the responsible officer. The entry on the \\nBHT must include a plan for management. \\n9. If the CTG is categorized as suspicious or abnormal, the \\nConsultant must be informed. \\n10. For the management plan the overall clinical picture must be \\ntaken into account. e.g. the rate of progress of labour, presence \\nor absence of fetal growth restriction, meconium staining of \\namniotic fluid and the evolution of the CTG abnormalities. \\nTable 1: Definitions of normal, suspicious and pathological FHR traces\\nCategory  \\nDefinition \\nNormal  \\nAn FHR trace in which all four features are classified as \\nreassuring \\nSuspicious  \\nAn FHR trace with one feature classified as non-reassuring \\nand the remaining features classified as reassuring \\nPathological  \\nAn FHR trace with two or more features classified as non-\\nreassuring or one or more classified as abnormal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n32\\nTable 2: Classification of fetal heart rate patterns\\nFurther useful information on FHR patterns\\n• \\nIf repeated accelerations are present with reduced variability, \\nthe FHR trace should be regarded as reassuring.\\n• \\nTrue early uniform decelerations are rare and benign, and \\ntherefore they are not significant.\\n• \\nMost decelerations that occur during labor are variable.\\n• \\nIf a bradycardia occurs in the baby for more than 3 minutes, \\nurgent medical aid should be sought and preparations \\nshould be made to urgently expedite the birth of the baby, i.e. \\nimmediate commencement of cesarean section.  This could \\ninclude moving the woman to theatre if the fetal heart has \\nnot recovered by 9 minutes. If the fetal heart recovers within \\n9 minutes the decision to deliver should be reconsidered in \\nconjunction with the woman if the post-recovery tracing is \\nreassuring.\\n• \\nA tachycardia in the baby of 160–180 bpm, where accelerations \\nare present and no other adverse features appear, should not be \\nregarded as suspicious. However, an increase in the baseline \\nFeature  \\nBaseline \\n(bpm)  \\nVariability \\n(bpm)  \\nDecelerations  \\nAccelerations  \\nReassuring  \\n110–160  \\n≥ 5  \\nNone  \\nPresent  \\nNon-reassuring  \\n100–109  \\n161–180  \\n< 5 for 40 –90 \\nminutes  \\nTypical variable \\ndecelerations with \\nover 50% of \\ncontractions, \\noccurring for over \\n90 minutes  \\nTe absence of \\naccelerations \\nwith otherwise \\nnormal trace is \\nof uncertain \\nsigniﬁcance  \\nAbnormal \\n< 100  \\n> 180  \\nSinusoidal \\npattern ≥ _10 \\nminutes \\n< 5 for 90 \\nminutes \\nEither atypical \\nvariable \\ndecelerations with \\nover 50% of \\ncontractions or late \\ndecelerations, both \\nfor over 30 \\nminutes'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n33\\nheart rate, even within the normal range, with other non-\\nreassuring or abnormal features should increase concern. In \\nsuch cases inquiry must be made to ascertain if the fetus was \\nactive during the recording.  \\nWhen women are having continuous EFM, systematic assessment of above \\ndefinitions and classification should be undertaken with every review.\\nDuring episodes of abnormal FHR patterns, if woman is lying supine, \\nadvise her to adopt the left lateral position'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n34\\nGuideline on Pain Relief in Labour\\nAdequate relief of pain is a basic right of every mother in labour. It is the \\nduty of every member of the obstetric team to endeavor to achieve this. \\nPoor management of pain during labour will result in maternal exhaustion \\nleading to:\\n• \\nacidosis, \\n• \\ndysfunctional labour and \\n• \\nfetal distress. \\n• \\nLoss of morale and a negative birth experience could have \\nsignificant long-term effects. \\nA well-informed, well supported mother will be more in control of events \\nand in a better position to deal with pain than one who is not. Therefore, \\nit is important to keep the mother informed of the progress of labour and \\nthe condition of the fetus throughout the process. \\nReassurance plays a major adjunctive role in pain relief.\\nPrenatal education should include information regarding the available \\nmethods of pain relief and their accessibility.\\nNon pharmacological methods of pain relief such as breathing and \\nrelaxation techniques should be introduced during the antenatal period.\\nIt is well recognized that women who have a birth companion will tolerate \\npain better and require less analgesia. The policy of allowing a birth \\ncompanion must therefore be encouraged.\\n1.\\t\\nMethods of pain relief in labour\\nThe selection of the method of pain relief should be based on the patient \\npreference, availability of resources and the institutional protocols. \\nFollowing methods can be used.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n35\\n1.1 \\n Non-pharmacological methods of pain relief\\n• \\nBreathing techniques, \\n• \\nTranscutaneous electrical nerve stimulation (TENS), \\n• \\nMassaging, \\n• \\nRelaxation techniques, \\n• \\nPositioning and movement\\nAny of these methods can be used to relieve pain during labour\\n1.2. \\nPharmacological methods of pain relief in labour\\n1.2.1. \\nOral paracetamol/paracetamol & codeine compound: \\nThese oral preparations can be used safely in the latent phase of labour.\\n1.2.2. \\nOpioids\\n1.2.2.A. Pethidine\\nPethidine is safe and effective in the latent and early active phase. The dose \\nis 1-1.5 mg/kg IM, repeated after 4 – 6 hours. Administration of a third \\ndose should be done only with the concurrence of senior personnel. \\nIt is generally avoided where delivery is anticipated within 4 hours. \\nMaternal side effects include nausea, vomiting and a reduction in gastric \\nmotility with a subsequent increase in gastric acidity. Therefore, it should \\nbe administered coupled with metoclopramide 5 mg IV or 10 mg  IM.\\nNeonatal respiratory depression is a recognized consequence of \\nadministration of opioids to the mother. Naloxone, a pure opioid \\nantagonist should be available for treatment in all facilities administering \\nopioids for analgesia. Naloxone is given to the baby in a dose of 100μg /kg \\nIV. It has a short duration of action and additional doses may be required. \\nIf no improvement is seen with the first dose of naloxone, the cause of \\nneonatal respiratory depression is more likely to be a factor other than \\nopioids.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n36\\n1.2.2.B. Morphine \\nThis has a longer duration of action than pethidine and may be particularly \\nuseful in women who require analgesia in early labour. \\nThe dose is 0.15 mg/kg IM should be administered with metoclopramide. \\nThe side effects and neonatal effects are similar to those of pethidine.\\n1.2.2.C. Fentanyl \\nIntravenous fentanyl/ramifentanyl may be administered in either a High \\nDependency or Intensive Care Unit settings under the supervision of an \\nanaesthesiologist. \\nThe dose is 50-100μg per hour as an intravenous infusion.\\nPain relief occurs in 3-5 minutes after commencement.\\n \\n1.2.3. \\nInhalational analgesia – Entonox\\nEntonox is a 50:50 mixture of nitrous oxide and oxygen and it has a very \\nshort half-life. The onset of action is 30sec to one minute. \\n \\nThe mother should receive clear and definite instructions about its correct \\nuse. It should only be self-administered.\\nShe should start using entonox through the controlled valve at the very \\nbeginning of the contraction. The mother should be advised to stop using \\nEntonox inhalation in the contraction free interval.\\nLonger and deeper breaths give better result. There is no limit on the \\nduration of its use.  \\nWomen should be informed that Entonox will make them feel nauseous \\nand light-headed.\\nEntonox is contraindicated in women with intestinal obstruction, \\npneumothorax, middle ear and sinus disease, and following cerebral air-\\ncontrast studies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n37\\n1.2.4. Regional Anaesthesia\\n \\nA.   Epidural analgesia \\nEpidural analgesia is the most effective form of pain relief in labour. \\nTherefore, Its greater use should be encouraged. \\nIt can be given either as a bolus with top-ups or as a continuous infusion. \\nContinuous administration via a syringe pump is preferred to ‘top-ups’, \\nsince it is safer. \\nThe continuous availability of an anesthesiologist is a prerequisite to \\noffering epidural analgesia. It is also essential that staff on site is trained for \\nits setting up, monitoring and to recognize complications early.  Facilities \\nshould be available for emergency resuscitation.\\nBefore offering epidural  analgesia, women should be informed its risks \\nand benefits and its implications on labour:\\n• \\nIt provides more effective pain relief than other methods\\n• \\nIt will not increase the length of the first and the passive second \\nstages of labour. \\n• \\nIt may however increase the length of the expulsive phase \\nand increase the likelihood of an instrumental delivery. An \\nadditional hour is allowed in the expulsive phase therefore.\\n• \\nIt does not increase the chance of cesarean section \\n• \\nIt does not cause long-term backache. \\n• \\nIt needs to be accompanied by a more intensive level of \\nmonitoring.\\nCare and observations for women with regional analgesia in labour\\n• \\nIntravenous access should be secured prior to commencing \\nregional analgesia.\\n• \\nFollowing additional observations should be carried out for \\nwomen with regional analgesia\\n➢ \\nDuring establishment of regional analgesia or after top up \\nbolus blood pressure should be measured every 5 minutes \\nfor 15 minutes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n38\\n➢ \\nIf the woman is not pain free within after each \\nadministration, the anaesthetist should be called.\\n➢ \\nHourly assessment of the level of sensory block should be \\nundertaken.\\n• \\nWomen with regional analgesia should be encouraged to move \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nOnce established, regional analgesia should be continued \\nuntil after completion of the third stage of labour and when \\nnecessary until perineal repair is done.\\n• \\nWomen should be allowed one additional hour in the second \\nstage of labor, depending on maternal and foetal condition. \\nThereafter pushing during contractions should be actively \\nencouraged.\\n• \\nContinuous EFM is recommended for at least 30 minutes during \\nestablishment of regional analgesia and after administration of \\neach bolus.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n39\\nGuidelines to maintain the partograph'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n40'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n41\\nGuideline on Acute Puerperal Inversion of the Uterus\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide recommendations for the \\nmanagement of acute puerperal inversion of the uterus, which is a rare \\nand life threatening condition. The main reason for its high mortality rate \\nis delay in instituting appropriate treatment, which leads to postpartum \\nhemorrhage and rapid development of shock out of proportion to \\nhaemorrhage. \\n2.\\t\\nDefinition\\nIt is defined as ‘the turning inside out of the fundus into the uterine cavity’.\\n3.\\t\\nPrevention\\nMismanagement of the third stage of labor is recognized as the main \\ncause, although 50% have no identifiable cause. The common initiating \\nfactor seems to be a traction force on the fundus of a relaxed uterus. \\nProper retraction of the uterus in the third stage is the primary factor in \\npreventing an inversion. There is no reliable data to suggest that it recurs \\nin a future pregnancy.\\nThe importance of the active management of the third stage could not be \\nover-emphasized. (Please refer Section 3 of the PPH Guideline and the \\nsection on management of delayed third stage (section 3.2.3 in the Normal \\nLabor Guideline for details) \\n4.\\t\\nPathophysiology (and clinical correlation)\\nAs the inversion progresses, the adnexae with their ligaments get drawn \\ninto the inverting uterine fundus and become increasingly stretched. This \\nproduces significant pain and vagal stimulation, leading to neurogenic \\nshock. \\nAn inverted uterus becomes trapped within the cervix creating \\nprogressive oedema and congestion due to interruption of venous and \\nlymphatic drainage. Oedema and congestion will increase the firmness \\nof the inverted segment, making reduction more difficult. Interruption'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n42\\nof the venous drainage will lead to significant haemorrhage. A partially \\nseparated placenta would add to this.\\n5.\\t\\nClassification\\nAlthough acute, subacute and chronic varieties have been described, this \\nguideline would address only the acute variety as it is life threatening. \\nThis occurs soon after birth, just before or after the delivery of the placenta.\\nThree degrees of inversion have been described, depending on the \\nlevel of the inverted fundus. In practice, second-degree inversion is the \\ncommonest. The fundus has come past the cervical os, but is still within \\nthe vagina.\\n6.\\t\\nClinical Presentation and Diagnosis\\nPrompt diagnosis is vital.\\nThe key to diagnosis is awareness and a high degree of suspicion.\\nThe following are early warnings:\\n• \\nA degree of shock that is out of proportion to overt blood loss\\n• \\nA retained placenta\\n• \\nPlacenta delivered but ‘with some difficulty’\\n• \\nSevere, sustained unexplained pain in the third stage.\\nIn this situation:\\n• \\nFeel for the fundus. If absent or ‘cupped’, acute inversion is \\nprobable diagnosis;\\n• \\nConfirm by a vaginal examination:\\n• \\nLook for a hard mass which looks and feels like a huge \\nulcerated fibroid polyp (sometimes described as a foetal \\nhead); \\n• \\nThe cervix is not to be seen or felt in the normal position, \\ninstead it could be felt as a ring around the base of the \\n‘mass’;\\n• \\nIn incomplete cases, the inverted fundus may be felt \\nthrough the cervical canal in the lower uterine cavity.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n43\\n7.\\t\\nManagement\\n7.1 General measures:\\nEarly diagnosis is vital. Treat it as a life-threatening emergency.\\nFirst attempts at reduction should be made at the place where it is \\ndiagnosed, without moving to theatre.\\nIf these attempts fail, move to theatre and give a general anesthetic without \\ndelay (see section 7.2.4). \\nEarly involvement of experienced personnel and teamwork are absolutely \\nessential.\\nTreat shock aggressively, not forgetting the neurogenic element.\\nProvide adequate pain relief\\nReplace the blood loss, which could be considerable, especially if the \\nplacenta has partially or completely separated.\\nDo not attempt to remove the placenta, if still attached.\\n7.2 Repositioning the uterus\\nReposition the uterus as soon as possible; the sooner it is done the easier \\nand better. It reverses the shock and reduces PPH.\\nNon-surgical methods\\n7.2.1  Manual replacement of uterus.\\n(Johnson’s maneuver)\\nThe operator introduces two thirds of his forearm in to the vagina and \\nextends the hand at the wrist to place the palm on the inverted fundus and \\nfingertips at the utero-cervical junction. Lifting the uterus above the level \\nof the umbilicus creates adequate tension for the cervical ring to dilate and \\nfor the fundus to revert to its normal position.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n44\\nThis could be helped by ‘working the fingers up’ gradually from the cervical \\nring towards the fundus, with gentle but persistent pressure applied.\\nWhere the uterus is too hard to respond, consider tocolytics (see below).\\nOnce reduced, hold the fundus in place for a few minutes (making a fist \\ninside the uterus with upward pressure on the fundus helps).\\nAdminister uterotonics (Ergometrine 0.25 mg i.v. or oxytocin 5-10 IU i.v \\nfollowed by oxytocin infusion at the rate of 10 IU per hour), whilst the \\nhand is still inside. When the uterus begins to contract, slowly remove the \\nhand. \\nThis manouvre is possible only soon after the event, and would need \\nadequate analgesia. Unless it is possible to administer either a general \\nanesthetic immediately, administer pethidine 50 mg iv slow and proceed \\nwith the maneuvres. \\nGive antibiotics (e.g. cephradine 1g and metronidazole 500 mg IV).\\n7.2.2   Hydrostatc reduction (O’Sullivan 1945)\\nSeveral novel and useful modifications have been made to this procedure \\nlately, principally to circumvent the problem of inadequate water seal, \\nwhich has been the major cause of failure in the past. \\nInsert 6 cm silastic ventouse cup into vagina, making sure that it is directed \\nat the posterior vaginal fornix and not at, or cupping the fundus. Place \\nhand at introitus to maintain seal between cup and vagina.\\n(Alternatively 500ml balloon catheter can be placed in vagina. If neither is \\navailable, use a wide tube; a standard giving set will not do).\\nConnect via IV giving set to a bag of warmed normal saline placed 1- 1.5 \\nmetres above the patient.\\nInfuse normal saline (typically 2 litres) into vagina to reduce the uterus by \\nhydrostatic pressure.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n45\\nOnce reduced, remove the placenta if still attached and proceed as in the \\nprevious section.\\nWhere a balloon is used, it would be advisable to leave it for 12-24 hours \\nto prevent re-inversion and reduce haemorrhage. \\nSaline embolisation and fluid overload leading to pulmonary oedema are \\nonly theoretical risks as long as one sticks to hydrostatic pressure only.\\n7.2.3  Tocolytics\\nWhere repositioning is difficult due to retraction of the uterine muscle \\nand the constriction of the cervical ring, tocolytics could be helpful. But \\ngiven this could cause PPH, it would have to be a considered and a senior \\ndecision. They are safest given in the theatre setting. \\nVarious preparations have been used; ideally it should be readily available, \\nwith quick onset and short duration of action. E.g.\\nTurbutaline 0 .25mg i.v. slowly (not available in Sri Lanka at present);\\nSalbutamol 0.25mg in 10 ml saline i.v. slowly;\\nNitroglycerine 0.1mg i.v. slowly or sublingually (acts within 90 seconds)\\n7.2.4  General Anaesthesia\\nIf the initial attempt at manual replacement fails, it is safest to move the \\npatient to the theatre and to administer general anaesthesia. This allows \\nfor muscle relaxation, pain relief and elimination of the neurogenic \\ncontribution to the shock. \\n7.2.5  Surgical methods\\nIf managed properly in the early stages, resort to surgery should be a rare \\noccurrence.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n46\\nHuntingdon’s operation\\nAfter a laparotomy, the indrawn uterine cup is identified near the region \\nof the cervix with the tubes and round ligaments pulled into the cup.  By \\nthe use of two Allis forceps the uterus is pulled out of the constriction ring \\nin a progressive fashion and restored to its normal position. The serosa of \\nthe uterus will invariably sustain lacerations and these are repaired with \\nabsorbable sutures. \\nUse of a silastic vacuum cup from above instead of Allis forceps has been \\nshown to circumvent this problem.\\nHaultain’s operation\\nIn this procedure the constriction in the region of cervix is incised \\nposteriorly using a longitudinal incision. As in the Huntingdon’s method \\ntwo Allis forceps are used to pull the uterus to its normal position. The \\nincision is repaired with interrupted sutures. Uterotonics are given to \\nmaintain contraction of the uterus.\\nHysterectomy\\nWhen all the above methods fail, a hysterectomy will become the only \\nviable option. However, it must be remembered that given the distorted \\nanatomy, this must be undertaken by a surgeon of considerable experience. \\n8.\\t\\nDebriefing\\nAlthough there is no evidence of a recurrence risk, it is sensible to advise \\nthe woman to deliver in a specialized Unit next time, and the third stage \\nto be managed actively by experienced personnel.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n47\\nManagement of \\nHypertensive disease \\nduring pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n48'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n49\\nManagement of Hypertensive Disease in  Pregnancy\\n1.\\t\\nIntroduction\\nHypertension in pregnancy is an important cause of direct maternal deaths \\nin Sri Lanka. Early identification, aggressive and intensive treatment of \\nits complications is important in reducing the resulting morbidity and \\nmortality.\\n2.\\t\\nDefinitions\\nChronic Hypertension:\\nWomen with pre-existing hypertension or hypertension detected before \\n20th week of gestation in the absence of trophoblastic disease and \\npersisting more than 42 days post partum. \\nGestational Hypertension\\nA)   Pregnancy Induced Hypertension:\\nHypertension unaccompanied by proteinuria developing after 20 weeks of \\ngestation and resolving within 42 days of delivery.\\nB)   Pre Eclampsia:\\nPregnancy induced hypertension associated with significant proteinuria \\n(300mg/l or 500mg/ 24 hours or dipstick 2+ or more).\\nSevere Preeclampsia:\\nDefined as Pre-eclampsia with severe hypertension and/or with symptoms, \\nand/or biochemical and/or haematological impairment. \\nThe clinical features of severe pre-eclampsia (in addition to hypertension \\nand proteinuria) are:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n50\\n• \\nSevere headache\\n• \\nVisual disturbance such as blurring or flashing before eyes, \\nscotomas\\n•  Epigastric or hypochondrial pain and/or nausea & vomiting\\n•  Clonus (3 beats or more)\\n•  Papilloedema\\n•  Liver tenderness\\n• \\nOliguria (less than 400 ml per day or 0.5 mg/Kg/hour over a 4 \\nhour period)\\n•  Platelet count falling to below 100 x 106/l \\n•  Abnormal liver enzymes (ALT or AST rising to above 70IU/l)\\n•  HELLP syndrome\\nSevere Hypertension:\\nDefined as systolic blood pressure ≥ 160 mmHg and/or diastolic blood \\npressure ≥110 mmHg. \\nEclampsia: \\nDefined as the development of convulsions and/or unexplained coma \\nduring pregnancy or postpartum in patients with features of preeclampsia.\\n3.\\t\\nScreening for Hypertension during pregnancy\\nBlood pressure must be measured in every clinic visit by a Medical Officer \\nand results recorded and plotted in the pregnancy record. \\nProteinuria must be tested for at every clinic visit.\\nIf blood pressure is more than 140/90 mmHg on two occasions at least 2 \\nhours apart, refer for specialist care.\\n4.\\t\\nPrevention of hypertensive disorders in pregnancy\\nAdvise women at high risk of pre-eclampsia to take 75 mg of aspirin daily \\nfrom 12 weeks until delivery of the baby. Women at high risk are:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n51\\n Those with any one of the following risk factors:\\n• \\nHypertensive disease during a previous pregnancy\\n• \\nChronic kidney disease\\n• \\nAutoimmune disease such as systemic lupus erythematosis or \\nantiphospholipid syndrome\\n• \\nType 1 or type 2 diabetes\\n• \\nChronic hypertension\\n• \\nMultiple pregnancy\\nOr, any TWO or more of the following \\n• \\n First pregnancy\\n• \\nAge 40 years or older\\n• \\nPregnancy interval of more than 10 years\\n• \\nBody mass index (BMI) of 35 kg/m² or more at first visit\\n• \\nFamily history of preeclampsia\\nContraindications such as allergy, gastritis, peptic ulcer disease must be \\ntaken into account.\\nAdvice women who have the above risk factors to ensure a higher intake of \\ncalcium to achieve a daily intake of at least 1000 mg taking into account the \\naverage intake by Sri Lankan women the recommended supplementation \\nlevel is 600 mg. \\n5.\\t\\nManagement of Chronic Hypertension \\nWomen with chronic hypertension must be managed in specialist units. \\nAnticipate the development of superimposed pre eclampsia in these \\nwomen. This combination adds risks to both mother and baby. ACE \\ninhibitors should be discontinued in women who are planning pregnancy \\nand its use avoided during pregnancy. \\nTreatment of mild to moderate hypertension\\nSince there is no consensus on the value of treating mild to moderate \\nhypertension, this guideline will not address this issue.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n52\\n6.\\t\\nManagement of Severe Pre-Eclampsia\\nThe basic outline of management\\n• Admit to hospital and inform Consultant\\n• Observe and monitor\\n• Control blood pressure\\n• Prevent seizures\\n• Look for complications – such as HELLP / pulmonary oedema/\\ncerebral haemorrhage\\n• Strict fluid balance\\n• In utero transfer where necessary and safe\\n• Timing of Delivery\\n• Continue vigilance post delivery\\n• Follow up\\n6.1. General Considerations\\n• \\nSevere preeclampsia is a life threatening condition.\\n• \\nThe only known cure is delivery of the baby.\\n• \\nThe immediate task is to determine the urgency to effect \\ndelivery.\\n• \\nStabilization of the mother’s condition within an acceptable \\ntime frame prevents maternal complications and may improve \\nfetal condition.  \\n• \\nThe management has to be individualized depending on the \\nclinical condition and available resources.\\n• \\nThe dangers will continue into the immediate postpartum \\nperiod.\\n6.2. Specific Management\\nAdmit women who have severe preeclampsia and inform the Consultant.\\nTreat hypertension if:\\n• \\nSystolic blood pressure ≥ 160 mmHg, or if\\n• \\nDiastolic blood pressure ≥ 110 mmHg, or if\\n• \\nMean arterial pressure ≥ 125 mmHg,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n53\\nAim to maintain blood pressure at around 130-140/90-100 mmHg.\\nThe main cause of maternal death in severe preeclampsia is poorly \\ncontrolled systolic hypertension causing cerebral haemorrhage. \\nA rapid fall in maternal blood pressure as a result of antihypertensive \\ntreatment may cause fetal heart rate abnormalities & compromise, \\nespecially in growth restricted/compromised fetuses.\\nWhere resources allow, it is recommended to monitor fetal heart with \\ncontinuous CTG during and for 60 minutes after commencing anti-\\nhypertensive therapy.\\nAim to stabilize blood pressure before delivery.\\n6.2.1. \\nAnti-hypertensive drugs\\nOral anti hypertensives may be used when the blood pressure is <180/110 \\nmmHg. Blood pressure must be monitored at 15-minute intervals and \\nintravenous anti hypertensives resorted to in case of an adequate response \\nis not obtained within 30 minutes.\\nThe commonly used antihypertensive drugs for acute control are given \\nbelow. One or the other may be used depending on availability and \\nfamiliarity. \\n6.2.1.1 Labetalol orally or intravenously\\nThis should be avoided in women with a history of bronchial asthma.\\n- 200mg orally stat (only if blood pressure is <180/110 mm Hg)\\n- repeated hourly for up to 4 hours\\n \\nor\\n- 20 mg IV over two minutes\\n• \\nRecord blood pressure after 10 minutes.\\n• \\nIf either value is still above 160 mm Hg systolic and/or 110 \\nmmHg diastolic, give 40 mg iv over 2 minutes.\\n• \\nRecord blood pressure after 10 minutes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n54\\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/or \\n110 mmHg diastolic, give hydralazine 10 mg iv. For instructions \\nregarding giving a fluid bolus with i.v. hydralazine, see the next \\nsection of this guideline. \\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/\\nor 110 mmHg diastolic, start an IV infusion of labetolol, \\nstarting at 40 mg/hour, doubling dose at half hourly intervals \\nas required to a maximum of 160 mg/hour. \\n• \\nWhere these measures fail, the mother must be moved to a \\nhigh-dependency area or an intensive care unit.\\nIf blood pressure is controlled by the above, continue monitoring the \\nblood pressure at 15 minute intervals for 1 hour and at 30 minute intervals \\nthereafter. \\nAdditional bolus doses as described above may be administered if the \\nblood pressure increases above 160 mmHg systolic and/or 110 mmHg \\ndiastolic.\\n6.2.1.2. Hydralazine intravenously:\\n• \\n5 - 10 mg IV bolus over 2 minutes.\\n• \\nThis must be accompanied by a fluid bolus of 5ml/kg of 0.9% \\nsodium chloride or ringer lactate solution over 30 min, started \\nat the same time as iv hydralazine (this helps vasodilatation & \\nprevents drastic hypotension). This should not be used in the \\npresence of pulmonary oedema. \\n• \\nRecord blood pressure at 15 minute intervals.\\n• \\nRepeat boluses of 5 - 10 mg IV after a 15 minute interval may \\nbe given if necessary up to a maximum of 20 mg (the effect of \\na single dose can last up to 6 hours).\\n• \\nIf the response to above doses is inadequate, give labetolol \\nbolus doses as described above.\\n• \\nIf no lasting effect with above boluses, consider an infusion of \\nhydralazine 2.0 mg/hour increasing by 0.5 mg/hour as required \\n(2-20 mg/hour usually required).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n55\\n6.2.1.3. Oral Nifedipine\\n• \\nOral nifedipine may be used where the blood pressure is < \\n180/110 mm Hg, in asymptomatic patients.\\n• \\nGive 10 mg orally.\\n• \\nRepeat at 20 minute intervals up to a maximum of 40 mg.\\n• \\nIf there is no response proceed to intravenous labetalol or \\nhydralazine.\\n6.2.2. \\nPrevention of convulsions\\n \\nMagnesium sulphate\\n• \\nMagnesium sulphate is the anticonvulsant of choice.\\n• \\nIt should be given to any woman with features of impending/\\nimminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, and dizziness). \\n• \\nThe loading dose may be given even when the status of renal \\nfunction is uncertain, since it is unlikely that toxic levels of \\nmagnesium could be reached with this dose alone.\\n• \\nGive loading dose of 4 G IV over 10 minutes. There are two \\nmethods of giving magnesium sulphate intravenously. \\no \\nDiluted to a total volume of 20 ml with 0.9% sodium \\nchloride solution, given via an infusion pump or ‘manually’. \\no \\nDiluted to a total volume of 80 ml with 0.9% sodium \\nchloride solution via a burette\\n• \\nImmediately after the loading dose, start infusion of 1 G IV per \\nhour.  Continue this infusion for at least 24 hours after delivery.\\n• \\nWhere there are difficulties with intravenous access, magnesium \\nsulphate may be administered intramuscularly. Give 5 G deep \\nintramuscularly into each buttock with 1 ml of 2% lignocaine \\nin the same syringe.  \\n• \\nIf intramuscular magnesium sulphate is continued as \\nmaintenance therapy, give 5G to alternate buttocks 4 hourly, \\nwith 1ml of 2% lignocaine in the same syringe.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n56\\n• \\nMonitor the mother to ensure hourly urine output of 30 ml per \\nhour, respiratory rate >16/ minute, oxygen saturation >90% \\nand presence of patellar reflexes. \\n• \\nThese should be recorded every 30 minutes.\\n• \\nShould signs of toxicity appear, the antidote is calcium \\ngluconate, 1 G intravenously (10 ml of 10% solution), given \\nover 10 minutes. \\n• \\nMagnesium sulphate may be used safely in women who have \\npreviously received nifedipine\\n6.2.3. \\nFluid Balance\\n• \\nRestrict total fluid intake to 80 ml per hour.\\n• \\nAccurate recording of fluid balance is essential.\\n• \\nSelective colloid expansion may be necessary prior to \\npharmacological \\nvasodilatation \\nto \\nprevent \\nmaternal \\nhypotension and fetal compromise or in oliguria with a low \\ncentral venous pressure.\\n• \\nThe volumes of all drugs administered must be taken into \\naccount and appropriate reduction of the volume of crystalloids \\nmust be made.\\n• \\nColloid (e.g. Hetastarch) should be administered only after \\ndiscussion with the anaesthetist.\\n• \\nDiuretics must be restricted to specific instances only e.g. for \\nwomen with pulmonary oedema.\\n• \\nAvoid non-steroidal analgesia until fluid recovery.\\n6.2.4. \\nIn utero/neonatal transfer:\\n• \\nIf a Unit does not have access to HDU/ICU or is unable to \\ncope with maternal complications, or with maturity of the \\nbaby, it may be appropriate to consider antenatal transfer of \\nthe mother. \\n• \\nHowever, maternal safety must not be jeopardised and each \\ncase should be considered on its clinical merits.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n57\\n• \\nSteps must be taken to bring down blood pressure from very \\nhigh levels (e.g. using nifedipine). \\n• \\nWomen with imminent/impending eclampsia must be \\nadministered a loading dose of magnesium (IM or IV) before \\ntransfer (see 6.2.2) \\n• \\nIt is recommended that where possible telephone advice is \\nobtained from the relevant specialist unit before transfer.\\n• \\nThe patient must be accompanied by a member of staff who is \\ncapable of dealing with a seizure while the patient in transit. \\nThe required drugs and equipment must be made available.  \\n• \\nFull details of the case, including treatment given should \\naccompany the patient.\\n \\n6.2.5. \\nDelivery\\n• \\nUrgency of delivery depends on the maternal and fetal \\nconditions.\\n• \\nEither caesarean section or induction of labour is appropriate \\ndepending on the urgency and favourability of the cervix.\\n• \\nInstitute adequate pain relief. Severe preeclampsia is not a \\ncontraindication for opioid or epidural anaesthesia (see below). \\nIt is accepted that epidural anaesthesia helps to bring down the \\nblood pressure.\\n• \\nSpinal or epidural anaesthesia is safe in the presence of a \\nplatelet count >80,000/dl.\\n• \\nMaternal condition should be optimised before delivery. \\n• \\nIt is inappropriate to deliver an unstable mother for foetal \\nreasons.\\n• \\nErgometrine should not be used during the third stage.\\n6.2.6. \\nPost-delivery\\n• \\nMaintain vigilance as a high proportion of eclamptic seizures \\noccur after delivery. \\n• \\nHigh dependency care should be provided as clinically \\nindicated.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n58\\n• \\nContinue close monitoring, including fluid balance, platelets, \\nliver enzymes and creatinine until they have returned to \\nnormal values. \\n• \\nMagnesium sulphate if started should be continued for 24 \\nhours after the delivery or after the last fit, whichever is later.\\n• \\nReview anti-hypertensive medication as indicated. Some may \\nneed to continue oral medication for a few weeks. Methyldopa \\nis best avoided following delivery because of its tendency to \\ncause depression. \\n• \\nReview magnesium sulphate medication as indicated.\\n6.2.7. \\nFollow up\\n• \\nInform Public Health Midwife and/or Medical Officer of \\nHealth.\\n• \\nReview in 2 weeks (instead of 4 weeks) if discharged on \\nantihypertensives.\\n• \\nDepending on the clinical picture, some patients may need:\\no \\nLong term follow up for blood pressure\\no \\nHematological investigations for conditions such as anti-\\nphospholipid syndrome, thrombophilia \\n• \\nDebrief the patient. \\n• \\nAdvice preconceptual counseling & check prior to the next \\npregnancy.\\n• \\nWomen may be advised regarding the risk of developing \\nhypertensive disease in a future pregnancy as follows:\\no \\nRisk of gestational hypertension - 53% (1 in 2)\\no \\nRisk of preeclampsia – 16% (1 in 6)\\no \\nRisk of preeclampsia if she had severe hypertension or \\nHELLP syndrome or eclampsia or the birth occurred \\nbefore 34 weeks – 25% (1 in 4); & 55% (1 in 2) if the birth \\noccurred before 28 weeks gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n59\\nManagement of Eclampsia\\n1.\\t\\nDefinition:\\nEclampsia is defined as the development of convulsions and/or \\nunexplained coma during pregnancy or postpartum in patients with \\nfeatures of preeclampsia.\\n2.\\t\\nDiagnosis:\\n• \\nHypertension is considered the hallmark for the diagnosis of \\neclampsia. However, in 16% of the cases hypertension may be \\nabsent.\\n• \\nEclampsia is usually associated with proteinuria, but this may \\nbe absent in 14% of cases.\\n• \\nClinical features of imminent eclampsia include:\\n \\nSevere frontal headache, \\n \\nVisual symptoms (halos, scotomas etc.) \\n \\nEpigastric or right hypochondrial pain,\\n \\nLiver tenderness,\\n \\t\\nClonus (3 beats or more) \\n3.\\t\\nTime of onset of eclampsia\\nThe onset of eclamptic convulsions can be antepartum, intrapartum, or \\npostpartum. \\nAntepartum eclampsia \\nAlmost all cases (91%) develop eclampsia at or beyond 28 weeks \\nPostpartum eclampsia \\nAlthough most cases of postpartum eclampsia occur within the first 48 \\nhours, some cases develop beyond 48 hours, up to 4 weeks postpartum \\n(late postpartum eclampsia). In these cases, an extensive neurological \\nevaluation is needed to rule out the presence of other cerebral pathology.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n60\\n4.\\t\\nComorbidities \\n• \\nEclampsia is often complicated by comorbidities (Box 1). \\n• \\nThese are more common among women who develop eclampsia \\nat earlier periods of gestation.\\nBox 1.\\n• Abruptio placentae \\n• Disseminated intravascular coagulopathy  \\n• Pulmonary oedema \\n• Acute renal failure \\n• Aspiration pneumonia \\n• HELLP syndrome (Haemolysis, elevated liver enzymes, low \\nplatelets)\\n5.\\t\\nPrevention\\nAdministration of magnesium sulphate to women with features of \\nimpending/imminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, dizziness) is the only known preventive measure.\\n6.\\t\\nManagement\\n6.1 General considerations\\n6.1.1 The priorities in management are to support respiratory and \\ncardiovascular function, prevent injury and further seizures \\nand to control hypertension. \\n6.1.2 Magnesium sulphate is the anticonvulsant of choice. It must \\nbe administered as soon as possible. See section 6.2.2 of the \\nsevere preeclampsia guideline for details.\\n6.1.3 The bolus dose of magnesium sulphate must be given even \\nto women with unknown renal function or oliguria/anuria \\nsince this dose is unlikely to elevate magnesium levels to toxic \\nranges.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n61\\n6.1.4 Eclampsia dictates delivery (or induction) once the maternal \\ncondition is stabilized, irrespective of the foetal condition or \\nmaturity. A decision regarding the mode and time of delivery \\nwill require to be made early. \\n6.1.5 There is no place for prolongation of the pregnancy in these \\nwomen, unless under rare, exceptional circumstances.\\n6.1.6 For details on administration of medications and intravenous \\nfluids and care of women receiving magnesium sulphate and \\nintravenous antihypertensives, refer the guideline on severe \\npreeclampsia.\\n6.2.  During the seizure – \\no \\nTurn the patient to a side and support her in that position.\\no \\nSuck out secretions from the mouth.\\no \\nAdminister oxygen via a face mask.\\no \\nMost eclamptic seizures resolve spontaneously.\\no \\nIt is imprudent to diagnose fetal hypoxia based on fetal \\nbradycardia during a seizure. This usually recovers \\nspontaneously following the seizure\\no \\nFetal bradycardia persisting beyond 10 minutes following \\nthe seizure should raise suspicion of abruptio placentae.\\n6.3. As soon as possible following a seizure\\no \\nAttempt to establish intravenous access. \\no \\nObtain blood for full blood count, liver transaminases, \\nblood urea, electrolytes and blood for cross-match.\\no \\nStart magnesium sulphate (intravenous bolus and \\ninfusion or intramuscular – details in guideline on severe \\npreeclampsia section 6.2.2.). \\no \\nTreat blood pressure as appropriate. \\no \\nInsert an indwelling catheter.\\no \\nMonitor respiratory rate, urine output, reflexes, SpO2. \\n(Please refer the guideline on severe preeclampsia for \\nfurther details).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n62\\no \\nCheck for comorbidities (Box 1). \\no \\nInform the Consultant and establish a plan of management\\n6.4. Management of seizures in women receiving magnesium sulphate\\n6.4.1 Women developing a seizure while on magnesium sulphate\\no \\n10% of women receiving magnesium sulphate will develop \\na second seizure.\\no \\nAdminister magnesium sulphate 2 grams diluted to 10 ml \\nwith 0.9% sodium chloride solution over 5 minutes. \\no \\nIncrease the magnesium sulphate infusion to 2 grams per \\nhour with monitoring as above.\\n6.4.2 Women developing more than one seizure while on magnesium \\nsulphate \\no \\nCall a Neurology team for advice. If one is not available, \\nobtain advice from a medical team.\\no \\nConsultant must be informed.\\no \\nInform the anaesthetic team if still not in an intensive care \\nsetting. \\no \\nSecond line anticonvulsants must be considered after \\ndiscussing with anaesthetist.\\no \\nIf the woman develops further seizures, consider moving to \\nintensive care for neuromuscular paralysis and ventilation.\\no \\nThese women will require a full neurological evaluation, \\nincluding imaging.\\n7.\\t\\nDelivery\\no \\nEclampsia is not an indication for caesarean section.\\no \\nConsider caesarean section in women who are not in \\nlabour with a Bishop score below 7.\\no \\nWomen who are in labour may be allowed to continue to \\ndelivery, in the absence of obstetric complications.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n63\\no \\nLabour may be induced where necessary using either \\nprostaglandins or amniotomy and oxytocin infusion. \\no \\nEpidural or spinal anaesthesia may be administered in \\nwomen with platelet counts above 80,000/cu mm. \\no \\nGeneral anaesthesia is best avoided where possible since it \\nincreases the risk of aspiration and failed intubation due to \\nairway oedema. It is also associated with marked increases \\nin systemic and cerebral pressures during intubation and \\nextubation. Women with airway or laryngeal oedema may \\nrequire ‘awake intubation’ under fibre optic observation \\nwith  facilities available  for immediate tracheostomy. The \\nlevel of increase in systemic or cerebral pressures may be \\nreduced by pretreatment with labetalol or nitroglycerine \\ninjections.\\n8.\\t\\nTransfer of a woman who has had a seizure to another institution\\no \\nIn case it is required to transfer a woman who has \\nhad an eclamptic seizure, this must be done only after \\nadministering a bolus of magnesium sulphate. (See section \\n6.2.2 of the severe preeclampsia guideline for details). The \\npatient should ideally be accompanied by a doctor and \\nemergency drugs/equipment (e.g. Ambu bag) must be \\navailable.\\n9.\\t\\nPostpartum management\\no \\nContinue administration of magnesium sulphate and \\nmonitoring as described in the guideline on severe \\npreeclampsia. \\no \\nWomen with abnormal renal function, preexisting \\nhypertension and abruption placentae (due to use of larger \\nthan normal volumes of fluids) are at particularly high \\nrisk of pulmonary oedema. They will require appropriate \\nmonitoring\\no \\nAntihypertensive therapy may be changed to oral and \\ncontinued .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n64\\n10.\\t Counselling \\n10.1.  Women should be advised that in a subsequent pregnancy:\\no \\nThe rate of preeclampsia is approximately 25%.\\no \\nRate of eclampsia is 2%.\\no \\nThese rates are substantially higher in women who develop \\neclampsia in the second trimester.\\no \\nTaking high-dose calcium from early pregnancy (600 mg \\ndaily) and aspirin (75 mg daily) may reduce this risk.\\n10.2. Regarding long term risk of hypertension\\no \\nThere is no increase of risk in women who were \\nnormotensive before the pregnancy.\\no \\nMultigravidae who develop eclampsia may be at high risk.\\nAcknowledgement: \\nThe following article was used as a resource in developing this guideline: \\nBaha M Sibai, Diagnosis, Prevention and Management of Eclampsia. \\nObstetrics & Gynecology, 2005; 105 (2): 402 - 410.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n65\\nManagement of Diabetes \\nduring Pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n66'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n67\\nGuideline for screening, diagnosis and management of \\ndiabetes in pregnant women\\n1.\\t\\nPurpose\\nThe purpose of this guideline is to provide guidance on screening for \\ngestational diabetes mellitus (GDM) and the management of pregnancies \\ncomplicated pre-gestational (PGDM) and GDM in the Sri Lankan setting. \\n2.\\t\\nScreening\\n2.1 Target groups for screening\\nBeing South Asian and pregnant places a woman in Sri Lanka at a higher \\nrisk for diabetes during pregnancy. Therefore, universal screening, using a \\ndiagnostic test is recommended for all Sri Lankan women. \\nA. All pregnant women should be screened for diabetes at the \\nfirst visit unless they are already known to have Diabetes*. This \\nshould be performed as early as possible, preferably before 12 \\nweeks, in order to diagnose previously undetected diabetes.\\nB. Screening using fasting blood glucose, random blood glucose, \\n50g glucose challenge test, HBAIC or urinalysis for reducing \\nsubstances is not recommended.\\nC. Those who are negative for diabetes at the first visit should be \\nscreened for GDM again at 24-28 weeks.\\nD. Women who are known diabetics should not undergo further \\nscreening or diagnostic tests. They should be commenced \\non glycaemic control measures immediately under the \\nsupervision of obstetrician or physician.\\n*Diagnostic criteria for pre pregnancy diabetes are \\nany one of the following\\n \\nFBS \\n \\n≥126mg/dl\\n \\nRBS \\n \\n>200mg/dl\\n \\nHbA1c \\n \\n>6.1%'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n68\\n2.2 Recommended tests\\nA. One stage, non- fasting 75g OGCT as described by the \\nDiabetes in Pregnancy Study Group of India (DIPSI) is \\nrecommended for screening at the first visit and at 28 weeks. \\nA 2- hour blood glucose of more than 140mg/dl confirms \\ngestational diabetes. This is the recommended test for both \\nfield and institutional levels.\\nOne stage Non- fasting 75 g OGCT\\n \\nIn this method 75g oral glucose load is given to the woman \\nirrespective of the fasting status. Therefore a woman could be \\nsubjected to a GTT at any time, without the woman having to \\nfast. \\n \\nA load of 75g of glucose dissolved in 300 ml water is given over \\n3-5 minutes. The water may be flavoured with lime juice. \\n \\n \\nThe plasma glucose level is measured after a period of two \\nhours. \\n(The main advantage of this test is that it would be the best way to \\nensure universal screening. The advantages include reduced cost, the \\nability to make a diagnosis in one test and the woman not requiring \\nto fast for the test. The test has been validated against the WHO and \\nHAPO criteria and been found to correlate well with them (3),(4). \\nData also shows that glucose levels are not significantly affected by \\nthe fasting status and that the non-fasting glucose level effectively \\npredicts adverse effects for the mother and baby (5),(6).)\\nB. Three-point oral GTT - In the event of an equivocal screening \\nresult or when resources permit, the three point OGTT is \\nrecommended. For those who undergo three point OGTT the \\nfollowing cut off should be used for diagnosis.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n69\\nThree-point oral GTT\\nThis is probably the most accepted diagnostic test in the world \\ntoday. \\nThe woman should attend for the test having fasted for eight hours \\nor more, having had a diet unrestricted in carbohydrates. \\nBlood is first drawn for estimation of fasting plasma glucose. \\nThe woman is then given a solution of 75 G glucose dissolved in \\n300 ml of water to be taken within 10 minutes. Squeezing a lime \\ninto this water will make the solution more palatable without \\ninterfering with the result. \\nBlood is then drawn at 60 and 120 minutes for estimation of \\nplasma glucose.\\nC. In situations where neither of the above tests is possible, \\n(Inability to tolerate glucose or non availability of facilities) \\ntwo-stage screening using a 2 hour PPBS is an alternative.  The \\ncut off blood glucose value to refer for a OGTT is ≥120mg/dl.\\n2 hour Post Prandial Blood Glucose Testing (PPBS)\\nAdvice the woman to have normal diet\\nThe time of starting the meal needs to be noted. The meal should \\nbe completed within 15 minutes.\\nThe two-hour cut off is calculated from the time of starting the \\nmeal.\\nAt the end of two hours blood sample should be tested for blood \\nsugar levels using glucometer or other laboratory method.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n70\\n3.\\t\\nManagement – Women with established Diabetes\\n3.1. Pre Pregnancy care\\nThe importance of avoiding unplanned pregnancy is an essential \\ncomponent of diabetes education for women with diabetes.\\nWomen with diabetes who are planning to become pregnant and their \\nfamilies should be offered information on how diabetes affects pregnancy \\nand how pregnancy affects diabetes.\\nDiscuss their plans for pregnancy and reinforce an appropriate \\ncontraceptive method. Any type of contraception can be used except for \\nwomen BMI > 25kg/m2 where DMPA should not be used. Pregnancy is \\ncontraindicated if the woman has proliferative retinopathy, stage 2 or \\nabove Chronic kidney Disease or major cardiac disease. \\nAll women with diabetes wishing to conceive MUST be encouraged to \\nseek specialist advice to ensure satisfactory glycaemic control (HbA1C < \\n6.1%) before conception. \\nIdeally the decision to embark on pregnancy in known diabetics should be \\ndecided on based on her HbA1C .  A value of 6.1 or below would be ideal \\nif safely achievable. Women whose levels are above 10% should be strongly \\nadvised against conception until good glycaemic control is achieved,  in \\nview of higher risk of congenital anomalies. \\nStress that good planning and control will help to achieve pregnancy \\noutcome to be equivalent to that of a non-diabetic women. They should \\nbe informed that establishing good glycaemic control before conception \\nand maintaining this  throughout pregnancy will reduce the risk of \\nmiscarriage, congenital malformation, still births and neonatal deaths.\\nWomen who are using either metformin or insulin for glycaemic control \\nshould be advised that these are safe for use during the peri-conception \\nperiod and into their pregnancy.\\nSelf-testing of blood sugar should be encouraged where ever economically \\nfeasible.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n71\\nWomen must be encouraged to achieve a normal weight before becoming \\npregnant, especially those with a body mass index above 25 kg/m2. They \\nmust receive advice about reducing weight using lifestyle modification. \\nKnown diabetics should be assessed for diabetic nephropathy and \\nretinopathy before and during pregnancy. (see below)\\nStart Folic acid 5 mg daily when trying to conceive.\\n3.2.\\t Antenatal Care\\nAt the first visit \\n• \\nRefer for specialist care immediately once identified. These \\nwomen are best managed with combined inputs from a \\nphysician and an obstetrician. \\n• \\nStart/ continue Folic acid 5 mg daily up-to 12 weeks of \\ngestation. Change to 1mg daily from 12 weeks onwards.\\n• \\nLow dose Aspirin 75mg should be commenced, if there is no \\ncontraindication.\\n• \\nCheck HbA1c (ideally 6.1% or less).\\n• \\nDating ultrasound scan using either crown rump length or \\nhead circumference is recommended.\\n• \\nWomen with pre-existing diabetes mellitus must be screened \\nfor diabetic end-organ damage (retinopathy, nephropathy and \\ncardiovascular disease)\\n• \\nRetinopathy screening is recommended at least twice during \\npregnancy (at first contact and at 28 weeks). \\n• \\nWomen with serum creatinine >120 µmol/litre or 24 hour \\nurinary protein excretion exceeding 300mg must be referred \\nfor renal specialist’s advice.\\n• \\nWomen with complicated diabetes should be managed at a \\ntertiary care institution by a multidisciplinary team\\nAntenatal Appointments\\n• \\nThese women must be identified as high risk and managed \\nalmost entirely by a specialist Obstetrician led team.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n72\\n• \\nPublic Health Midwife should visit such women once in every \\n2 weeks (refer guideline on domiciliary care for high risk \\npregnancies).\\n• \\nReview by the obstetric/diabetic team once every 2 weeks \\nthroughout the pregnancy \\n• \\nAnomaly scans at 18-20 weeks and Obstetric reviews at 22-24, \\n28, 32 and 36-37 weeks with ultrasound growth assessments. \\n• \\nIf required, antenatal steroids for fetal lung maturity may be \\nused. Women should be admitted to hospital for glycaemic \\ncontrol during therapy since glucose levels rise in response to \\nsteroids. \\n• \\nMore attention should be given to the woman with diabetes \\nduring antenatal preparation for breast feeding as they \\nneed to start and establish breast feeding quickly to prevent \\nhypoglycaemia of newborn. \\n• \\nRefer to dental surgeon for screening and maintenance of oral \\nhygiene.\\n3.3.\\t Medical nutrition therapy (MNT) \\nMNT is the cornerstone of the management of diabetes in pregnancy. \\nWomen must be referred to a dietician/ diabetic educator nurse  where \\none is available. \\nEmphasis the importance of small frequent meals, food with low glycaemic \\nindex and the  dietary advice should be culture sensitive. \\n3.4.\\t Exercise \\nExercise has an insulin-like action and women with GDM and pre-existing \\ndiabetes complicating pregnancy. Therefore,  diabetic women must be \\nencouraged to engage in regular exercise. \\nThe intensity of exercise would depend on the woman’s level of fitness, \\npresence of complications and familiarity with exercise. \\nIdeally this should be at least 30 minutes per day of an activity, which \\nleaves her slightly breathless.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n73\\nWomen on insulin must be aware of the  tendency to hypoglycaemia \\nduring exercise. \\n4.\\t\\nGlyceamic control and Monitoring \\n4.1. Glyceamic Control\\n4.1.1. The aim is to achieve optimum glycaemic control throughout the \\nday for the duration of the pregnancy (avoiding hypoglycaemia).\\nThe target values for glycaemic control are given below:\\nTable 1. Target values in glycemic control\\n \\n  Fasting and pre-meal \\n           2 hour post meal\\nVenous plasma \\n70 - 90 (3.9 – 5.0 mMol/L) \\nBelow 120 mg/dl (6.7 mMol/L)\\nCapillary blood \\n80 – 103 (4.4 – 5.7 mMol/L) \\n118 mg/dl (6.5 mMol/L)\\n(The equivalent capillary blood values were derived  using a conversion \\nformula7)\\nRefer to Diabetic Educator Nursing Officer (DENO) where one is available. \\nAt diagnosis, offer diet/ lifestyle advice with a recorded glycaemic \\nassessment within 1-2 weeks.\\nMajority of these women can achieve optimal glycaemia with modest \\nchanges in diet and exercise.\\nConsider insulin and /or metformin treatment if suboptimal glycaemia \\npersists despite diet and exercise modifications. The choice of these \\ntreatments will depend on physician and patient preferences. \\nIdeally the  insulin regimen should be adjusted to achieve targets: in most \\ncases with moderate to severe hyperglycaemia three doses of short acting \\npre prandial insulin combined with a single dose of basal insulin at bed \\ntime is required. However, twice daily dose of pre mixed 30:70 insulin \\nhas high patient compliance with adequate control of blood sugar in most \\ncases. If blood sugar is not controlled by this twice daily regimen, adding \\nmetformin or soluble insulin to cover lunch is an alternative.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n74\\nACE inhibitors, statins and ARBs are contraindicated during pregnancy\\n4.2.\\t Monitoring of glycaemic control\\nSelf-monitoring of blood glucose (SMBG) with close liaison with the \\ndiabetic team is recommended for those who are able to afford a glucometer \\nand test strips. (However, in view of variable quality of glucometers women \\nmust be advised to crosscheck the values occasionally with estimations \\nmade by a reliable laboratory. \\nFor women who cannot afford the cost of SMBG, monitoring with regular \\n6 point blood glucose monitoring should be offered. \\nThe frequency of such monitoring should be decided by the overall \\nglyceamic control, presence or absence of fetal macrosomia and the period \\nof gestation;: with at least four weekly  reviews  in pregnancy two weekly \\nreviews  in late pregnancy\\nSchedule ultrasound measurement of AC at 28, 32 and 36 weeks. If AC > \\n90 centile at any stage, consider insulin therapy to target 2 hour PPBS to \\nbe less than 100mg/dl but avoiding hypoglycaemia.\\nIf crossing centiles or AC <10 centile, do AFI and request obstetrician \\nreview.\\nInsulin requirements change throughout the pregnancy. If requirements \\nare falling (or maternal hypoglycaemia occurs frequently) request early \\nobstetrician review for fetal assessment.\\nHbA1c is not a reliable indicator of glycaemic control in the second \\nand third trimesters. \\n5.\\t\\nDelivery and intra natal care\\n6.1. Timing of delivery\\nFor women with pre-pregnancy diabetes or who receive insulin therapy, \\nschedule obstetrician review at 36-37 weeks for planning their delivery at \\n38-39 weeks.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n75\\nFor women on diet control and/or women having optimal glycaemic \\ncontrol and, carrying a normally grown baby, there is insufficient evidence \\nto suggest the best time for delivery. \\nDiabetes alone is not an indication for a caesarean section.\\nThe obstetrician should make the decision after discussing with the \\nwoman.\\nDelivery should be arranged in the day time, when all supports are more \\neasily available.\\n5.2. Labour care\\nSecond tier obstetric on-call (SHO/Registrar) should be informed of any \\nwoman with diabetes at  the onset of labour. He/she should be present \\nfor the delivery. It is recommended to involve the medical team in the \\nmanagement of difficult cases.\\nInform on-call neonatal team of any planned/ imminent delivery of a \\ndiabetic mother.\\nDuring labour and birth, capillary blood glucose should be monitored \\n1-2 hourly in women with diabetes and maintained at between 4 and 7 \\nmmol/litre. (72 – 126 mg/dl). These CBG records should be entered in the \\npartogram. \\nHartmann’s/ normal saline or Insulin-dextrose – potassium (GIK) \\ninfusion should be started if the values are lower or higher respectively.\\n6.\\t\\nPost natal care\\n6.1a. Neonatal care\\nHandover care of newborn, to neonatal team.\\nEnsure delivery-to-abdomen and initiate breastfeeding as early as possible \\n(within first ½ to 1 hour) unless specific concerns prevent such action.\\nTake all suitable ENC measures to avoid hypothermia.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n76\\nBlood glucose testing should be carried out routinely in babies of women \\nwith diabetes at 2–4 hours after birth. The mother must be informed about \\nthis antenatally to avoid unnecessary distress.\\nNeonatal blood glucose values below 36 mg/dl (2 mMol/L) should trigger \\naction. \\n \\nBlood tests for polycythaemia, hyperbilirubinaemia, hypocalcaemia and \\nhypomagnesaemia should be carried out for babies with clinical signs.\\n6.1b. Immediate post partum care \\nIt is recommended that the mother be tested for RBS within 4 hours of \\ndelivery. The decision to manage maternal diabetes with insulin or oral \\nmedication should be made within the first 48 hours after delivery and \\nprior to discharge from hospital.\\nIf the mother received insulin in the antenatal period, it is recommended \\nthat the dose needs adjustments to pre pregnant doses in those with type \\n2 diabetes mellitus or be maintained on diet alone in those with GDM. \\nThis decision should be based on her post partum blood glucose value. If \\nFBG exceed 126mg/dl or RBS exceeds 200mg/dl, insulin in a lower dose \\n(usually half of the antenatal dose) or metformin would be required. This \\ndecision is best left to the managing physician who should be responsible \\nfor the woman’s long term care. \\n6.2. At hospital discharge\\nInform MOH and area public health midwife (PHM) through woman’s \\npregnancy record.\\nFor women with pre- gestational diabetes, prescribe suitable hypoglycaemic \\nagent, restart statins, schedule follow up clinic date at the medical clinic.\\nFor women who developed GDM, give a date or make arrangements to \\nscreen for DM at 6 weeks postpartum. \\nDiscuss and help to decide on the suitable contraceptive method.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n77\\n6.3. Late Postnatal care and follow up\\nAt 6 -8 weeks postpartum, all women with GDM are screened for diabetes \\nmellitus. The test of screening is ideally the 75g OGTT.  FBS is an alternative \\nif resources are limited. Women whose fasting venous plasma glucose is \\nabove 100 mg/dl (5.5 mMol/L) must be referred for further evaluation. \\nWomen who have been diagnosed with GDM and are screen-negative at \\nthe 6 week review should receive lifestyle advice and screening for diabetes \\nmellitus annually with at least a FBS. The importance of maintaining a \\nnormal BMI and the contribution of breastfeeding to weight loss must be \\nemphasized.\\n7.\\t\\nFamily Planning\\n8.1 All reliable methods of family planning can be used as \\nappropriate for the needs    of the individual woman with \\ndiabetes.\\n8.2  For women with BMI >25kg/m2, DMPA is best avoided.\\n8.3 Women with type 2 diabetes should be advised to complete \\ntheir family within  5-10 years   of diagnosis of diabetes in view \\nof possible development of complications.\\nReferences (need to add the sections taken from NIROGI guide)\\n1. \\nNICE, clinical guideline 63 Diabetes in pregnancy: management \\nof diabetes and its complications from pre-conception to the \\npostnatal period. 2008, National Institute for Health and \\nClinical Excellence.\\n2. \\nSeshiah V., Das AK.,BalajiV et al., Gestational Diabetes Mellitus \\n- Guidelines. Journal of the Association of Physicians of India. \\n2006. 54: 622- 628\\n3. \\nIADPSGCP, International Association of Diabetes and \\nPregnancy Study Groups Recommendations on the Diagnosis \\nand Classification of Hyperglycemia in Pregnancy. Diabetes \\nCare, 2010. 33(3): p. 676-682.\\n4. \\nKuhl C. Insulin Secretion and insulin resistance inpregnancy \\nand GDM. Implications for diagnosis andmanagement. \\nDiabetes 1991;40(December (Suppl. 2)):18–24.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n78\\n5. \\nGough WW, Shack MJ, Bennett PH, Burch TA, Miller \\nM.Evaluation of glucose in the Pima Indians by longitudinal \\nstudies. Diabetes 1970;19(Suppl. 1):388.\\n6. \\nPettitt DJ, Bennett PH, Hanson RL, Narayan KM, KnowlerWC. \\nComparison of World Health Organization and National \\nDiabetes Data Group procedures to detect abnormalities \\nof glucose tolerance during pregnancy. Diabetes Care \\n1994;17(November (11)):1264–8.\\n7. \\nHaeckel R.,  Brinck U, Colic D. et al.,  Comparability of Blood \\nGlucose Concentrations Measured in Different Sample Systems \\nfor Detecting Glucose Intolerance. Clinical Chemistry 2002. 48: \\n(6); 936-939.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n79\\nManagement of \\nPostparum Haemorrhage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n80'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n81\\nGuideline on Managementof Primary post Partum \\nHaemorrhage\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide evidence based recommendations \\nin the management of primary post partum haemorrhage (PPH). This is \\nthe commonest direct cause of maternal death globally and in Sri Lanka. \\nThe objective of this guideline is to ensure anticipation, prevention, early \\ndetection and timely and appropriate management of PPH. \\n2. \\t\\nDefinition\\nFor the purpose of this guideline PPH is defined as blood loss of 500 ml or \\nmore from the genital tract within 24 hours of the birth of a baby. Blood \\nloss of over 1000 ml is defined as major PPH. \\nIrrespective of blood loss, the appearance of cardiovascular instability (i.e. \\ntachycardia and hypotension) signifies major obstetric hemorrhage.\\n• Since blood volume differs between persons, blood loss must \\nbe individualized. \\n \\nIn general, blood volume = body weight in Kg÷12 (e.g. in a 60 \\nkg woman 60/12 = 5 litres)\\n• The loss of 40% or more of the blood volume is life threatening \\nand will be defined as a massive obstetric hemorrhage e.g. \\n2400 ml in a 60 Kg woman.\\n3.\\t\\nPrevention of Post Partum Haemorrhage\\nActive management of the third stage of labour is the cornerstone \\nof prevention of primary PPH. For details please refer guideline on \\nmanagement of third stage of labor.\\nAnemia in pregnancy should be corrected during antenatal period.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n82\\n4.\\t\\nPrediction of Post Partum Haemorrhage\\nPPH occurs most often in women without risk factors. Therefore the \\nblood group of every woman who goes into labor must be known.\\nHowever, there are known risk factors associated with PPH, as listed in \\nBox 1. Such women should be advised to deliver in a specialist obstetric \\nunit under extra vigilance. Out of these, abruptio placentae and placenta \\npraevia have a particularly higher risk.\\nBox 1\\nRisk Factors for PPH\\nRisks existing prior to labour\\nGrand multiparity\\nPrevious PPH \\nFibroids complicating pregnancy\\nAnaemia complicating pregnancy\\nPre-existing haemorrhagic conditions \\nTreatment with anticoagulants \\nObesity \\nPre-eclampsia/gestational hypertension\\nUterine over distension e.g. multiple pregnancy, etc.\\nLarge baby (>4 kg)\\nChorio-amnionitis\\nDengue infection\\nAny woman with risk factors should have intravenous access established \\nwith either a 16 or 14-gauge cannula and a sample of blood taken and \\npreserved.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n83\\n5.\\t\\nManagement of Primary Pph\\nIn Sri Lanka, the usual practice has been to commence treatment when \\nthere is continuing bleeding despite uterine massage irrespective of the \\namount of blood lost. It is recommended that this practice be continued. \\nIt is good practice to estimate and record blood loss in all deliveries.\\n5.1 General measures\\n• \\nCall for help.\\n• \\nMaintain a calm atmosphere.\\n• \\nKeep the mother (and labor companion/family) informed and \\nreassure the mother regularly.\\n• \\nAssess, monitor and record: general condition, estimated \\nblood loss, pulse, blood pressure and respiratory rate (every 15 \\nminutes)\\n• \\nInsert a Foley catheter and monitor urine output hourly. \\n• \\nCommence an ongoing chronological record of patient’s \\ncondition and interventions. It is recommended that one \\nmember of staff is delegated specifically for this task and to \\ncoordinate with other relevant disciplines.\\n• \\nEnsure there is intravenous access with two wide (14 – 16 G) \\nbore cannulae. \\n• \\nSend blood for cross matching and baseline full blood count. \\nIn cases of massive haemorrahge, other investigations such as \\nclotting profile will be needed.\\n• \\nStart Ringer’s lactate (Hartmann’s) solution.\\n• \\nIdentify the cause of bleeding. \\n• \\nKeep the woman warm.\\n• \\nPay attention to the temperature of labor room, operating \\ntheatre, intravenous fluids, blood, blood products and \\nfluids used for lavage. Hypothermia is known to promote \\ncoagulopathy.\\n• \\nWhere available, the early involvement of the anesthetic team, \\neven while the patient is still in the labor room is recommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n84\\n• \\nGive oxygen via a face mask at a minimum rate of 8L/minute \\n(where suitable masks are available, oxygen must be given at a \\nrate of10-15L/min).\\n• \\nIf deterioration of the patient is greater than expected for the \\nvisible blood loss, internal hemorrhage is the probable cause. \\n• \\nCheck for completeness of the placenta. If incomplete or in \\ndoubt consider exploration of the uterus under anesthesia.\\n• \\nThe Consultant must be informed in the situations listed in \\nBox 2.\\nBox 2. Situations in which the Consultant must be informed\\n1. Blood loss of >1000 ml\\n2. Pulse rate of >100/minute\\n3. Systolic blood pressure <100 mm Hg\\n4. Drop of systolic blood pressure by 30 mmHg\\n5. Increase of pulse rate by >30 beats/minute \\n6. Increasing fundal height  \\n7. Deterioration of the patient out of proportion to the overt \\nblood loss.\\n5.2\\t Specific measures\\n5.2.1 Establish a cause for the bleeding \\nPalpate the uterine fundus.\\nA poorly contracted uterus usually indicates atonic PPH, which is the \\ncommonest cause. However, the possibility of concomitant genital tract \\ntrauma needs to be considered. \\nIf the uterus is well contracted, the genital tract must be inspected for \\ntrauma with adequate exposure, in good light.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n85\\n5.2.2. Management of atonic haemorrhage\\n• \\nStart uterine massage by ‘rubbing up the fundus’.\\n• \\nClear the cervical canal and vagina of blood clots by vaginal \\nexamination.\\n• \\nAdminister either ergometrine maleate 0.5 mg slow IV or \\nmethyl ergometrine 0.2 mg slow IV or oxytocin 5 IU IV and \\nstart an infusion of 40 IU in 500 ml of Hartmann’s solution at \\n125 ml per hour via an infusion pump.\\n• \\nStart bimanual compression of uterus.\\n• \\nIf the bleeding fails to abate completely in 5- 10 minutes \\nadminister/repeat ergometrine 0.5mg IV.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nadminister misoprostol 800µg per rectally or sublingually.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nproceed to uterine balloon tamponade and inform the \\nConsultant. At the same time, administer tranexamic acid 1 \\ng by slow IV over 10 minutes. This dose may be repeated after \\n30 minutes if necessary and later if bleeding recommences. \\nFor details of the method of balloon tamponade please refer \\nappendix 1.  \\n• \\nBalloon tamponade is an important step in managing patients \\nwho continue to bleed despite medical measures. It should \\nalways be considered before resorting to surgical measures. \\n• \\nIf the institution does not have personnel trained in the use \\nof balloon tamponade, the woman must be transferred to a \\nhigher institution, at the point where the administration of \\nergometrine and oxytocin infusion has failed to stop bleeding. \\n• \\nTemporizing measures such as manual aortic compression and \\nsand bags to compress the uterus are recommended while the \\npatient is in transit.\\n• \\n Inform the receiving institution.\\n• \\nAfter the balloon is inserted and the vagina packed (to keep \\nthe balloon in the uterus), the woman’s vital parameters and \\nthe level of the fundus must be monitored carefully. Where \\nthese indicate the woman is continuing to bleed, she should'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n86\\nbe moved to the theatre, since the situation would indicate the \\nneed for a laparotomy. \\n• \\nShe should be shifted to the theatre without delay in this \\nsituation. \\n• \\nPrior to laparotomy the woman must be examined under \\nanesthesia for tears in the genital tract. \\n• \\nIn case laparotomy is needed it is best to keep the patient in \\nthe modified Lloyd Davis position so that observations for \\nbleeding could be done with minimum inconvenience and \\ndelay.\\n• \\nThe surgical measures would depend on the woman’s condition. \\n“Too little too late” is the main contributor to mortality in \\nPPH. Surgical measures include brace (compression) sutures \\n(see appendix 2), uterine de-vascularization (See appendix \\n3), haemostatic mattress sutures to bleeding sinusoids, box \\nsutures to include the bleeding lower segment in placenta \\nprevia, internal iliac ligation and hysterectomy. \\n• \\nThe “sandwich technique” involves inserting a balloon \\ntamponade after the application of brace sutures.\\n• \\nIt is important that hysterectomy is resorted to sooner than \\nlater.\\n• \\nHypothermia is a particular risk in the theatre environment. \\nMeasures must be taken to minimize the loss of heat from the \\nwoman. \\n5.2.3 Management of traumatic PPH\\n• \\nExclude high vaginal and cervical tears before suturing \\nepisiotomy.\\n• \\nWhen the apex of the tear or episiotomy is not visible, apply a \\nsuture at the highest visible point, pull downwards and apply \\ncontinuous sutures at progressively higher points until the \\napex is reached. \\n• \\nExamine for paravaginal and broad ligament haematomata \\nwith a combined per vaginal and per rectal examination. \\n• \\nThe management should be individualized according to the \\nsituation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n87\\n• \\nParavaginal hematomas of more than 5 cm diameter will \\nusually require surgical evacuation. A bleeding point is usually \\npresent and must be looked for. In cases where it is difficult to \\ncontrol bleeding, a Foley catheter with its balloon inflated may \\nbe left in the cavity. Packing of the vagina may also be useful. \\n• \\nCervical tears must be identified by systematic inspection of \\nthe cervix using Green-Armytage forceps and sutured. \\n• \\nIn case of multiple tears with venous oozing, it may be better to \\ninsert a balloon catheter into the vagina or to pack the vagina \\nwith moistened vaginal packs than to try to suture all the tears. \\n5.2.4 Rupture of the uterus\\n• \\nRupture of the uterus must be suspected when the general \\ncondition is deteriorating out of proportion to the visible \\nblood loss and there is continuing bleeding in the presence of a \\ncontracted uterus.\\n• \\nThis is particularly so in a woman with a scarred uterus.\\n• \\nImmediate involvement of a Consultant and surgical \\nintervention are important in this situation.\\n5.2.5 Coagulopathy causing PPH\\n• \\nThis could be due to coagulopathy following death in utero, \\nabruptio placentae, severe preeclampsia, HELLP syndrome, \\nsepsis, amniotic fluid embolism, acute fatty liver, pulmonary \\nimmune thrombocytopenia, Von Willebrand’s disease etc. \\n• \\nIt could also be due to suboptimal management of the PPH. \\n• \\nEarly involvement of a haematologist or transfusion medicine \\nspecialist will be important in this situation. Where available, \\nthromboelastometry would be useful in this situation. \\n6.\\t\\nResuscitation and Fluid management\\n \\nPPH up to 1000 ml\\n• \\nCommence a crystalloid infusion of 2-3 times the estimated \\nblood loss.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n88\\nPPH of more than 1000 ml\\n• \\nPPH of over 1000 ml should be managed in consultation with \\nother relevant specialists e.g. anesthesiologists, hematologists, \\ntransfusion specialists etc. \\n• \\nAssess airway, breathing and circulation.\\n• \\nGive oxygen via face mask. \\n• \\nKeep the woman warm and flat.\\n• \\nTransfuse warmed blood as soon as possible.\\n• \\nUntil blood is available, warm crystalloids (up to 2 litres) \\nand colloids (up to 1-2 litres) may be transfused as rapidly as \\nrequired, up to a maximum of 3.5 litres in total.\\n• \\nDepending on urgency, group-specific blood may be given \\nuntil cross-matched blood is available.\\n• \\nIf group-specific blood is not available, O Rhesus D negative \\nblood could be given.\\n• \\nBlood transfusion should be individualized according to the \\nsituation. When available, involve blood transfusion specialist/\\nHaematologist. Where three or more units of blood are being \\ntransfused, an equal number of packs of fresh frozen plasma \\nmust also be transfused. If available, thromboelastometry will \\nenable factor-specific replacement. \\n• \\nDue consideration must be given to keeping transport facilities \\navailable to obtain blood and blood products from another \\ninstitution.\\n7.\\t\\nDebriefing\\n• \\nIt is possible that a major PPH could result in significant \\npsychological morbidity.\\n• \\nThis could be minimized by timely debriefing of the patient \\nand her family, preferably by the Consultant.\\n• \\nThis should be done immediately after the event, before \\ndischarge and at the postnatal visit or at any time as requested \\nby her or the family.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n89\\n8.\\t\\nRisk Management\\n• \\nIt is good practice to conduct a case review with the members \\nof the team involved in the management and other staff as soon \\nas possible after the event.\\n \\n \\nThe spirit of such a meeting should be one of lessons learnt rather \\nthan of apportioning blame.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n90\\nAppendix 1\\nInsertion of a ‘condom catheter’\\nThis may be performed as an independent procedure or following \\ninspection of the cervix and upper vagina for trauma.\\nTherefore, whenever it is planned to inspect the cervix, or where there is \\nan indication that medical therapy may fail to bring the bleeding under \\ncontrol, keep the materials needed for insertion of a condom catheter \\nready.\\n1. Explain to the mother the need to insert a condom catheter \\nand explain the procedure briefly. Be reassuring.\\n2. Wear a pair of sterile gloves.\\n3. The required items are:\\n• \\nSize 20 – 22 (or largest available) Foley catheter, \\n• \\nA condom, \\n• \\nSterile  No. 0 or 1 suture, \\n• \\nA bottle of warmed saline,\\n• \\nIntravenous infusion set released from the pack \\n• \\nArrange these items on a sterile towel laid on a side trolley.\\n4. Take the Foley catheter out of the packing.\\n5. Unfold the condom over the end of the Foley catheter to about \\ntwo thirds of its length. Hand tie it to the catheter firmly, using \\nseveral rounds of sterile suture at a point about 2 cm distal to \\nthe open end of the condom. \\n6. Have an assistant connect the infusion set to the bottle of \\nwarmed normal saline suspended 4-6 feet above the patient.\\n7. Connect the other end to the catheter, run saline into the \\ncondom to make sure the system is water tight by holding the \\ncatheter tip upwards.\\n8. Afterwards, empty the balloon of the saline and leave it on the \\nsterile trolley, ready for insertion.\\n9. Wash the condom with either warm saline or 5% povidone \\niodine lotion.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n91\\n10. Place the woman either in the dorsal or lithotomy position and \\nexpose the cervix by using one or two Sim’s speculae.\\n11. Grasp the anterior lip of the cervix with a sponge holder.\\n12. Now insert the entire condom catheter system into the uterus. \\nYou may keep the condom catheter between the index and \\nmiddle fingers and introduce it like exploring the uterus (or \\ndoing a pelvic examination). \\n13. Reconnect the catheter to a giving set and start filling the \\ncondom with warmed saline.\\n14. Keep watching the cervix for the balloon to bulge out of it and \\nstop filling it any further for now. You may notice cessation of \\nbleeding from the uterine cavity. \\n15. At this point pack the vagina with a moist vaginal pack (Two \\ninch ribbon gauze pack or a gauze towel) around the catheter \\nin a circumferential manner. \\n16. Continue filling till the gravity aided filling stops. Usually 400 \\n– 500 ml is needed.\\n17. Proximal end of the catheter is folded and a tight tie placed on \\nit to prevent backflow.\\n18.  Insert a size 12 Foley catheter to the bladder.\\n19. Mark the level of the fundus on the abdomen with a marker \\npen. Start a pulse and blood pressure chart.\\n20. Give tranexamic acid 1 G slow i.v. and repeat after 8 hours.\\n21. Keep pack and the condom catheter for 12 – 18 hours.\\n22. Consider appropriate antibiotic prophylaxis.\\n23. If there is no vaginal bleeding and vital signs are stable, plan to \\nremove the catheter at a convenient time, after 12 hours.\\n24. Release half the instilled volume of saline. Do not remove the \\npack at this stage.\\n25. Observe for bleeding through the pack.\\n26. 30 minutes later remove the vaginal pack, without removing \\nthe condom catheter.\\n27. If there is no further bleeding for another 30 minutes, release \\nthe total volume of instilled saline and remove the condom \\ncatheter gently.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n92\\nAppendix 2\\nBrace sutures, the best known of which is the modified B-Lynch sutures \\nare very useful in the presence of a bleeding atonic uterus.\\nThe uterus is exteriorized.  An absorbable No. 2 suture (or highest gauge \\navailable) on a curved ‘hand-needle’ is passed anteroposteriorly through \\nthe uterus above the reflection of the bladder about 2 cm medial to the \\nlateral edge. \\nThe process is repeated on the contralateral side. The sutures are tied \\ntightly over the fundus, with an assistant manually squeezing the uterus. \\nAdditional sutures may be applied medially.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n93'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n94\\nAppendix 3\\nSteps of uterine de-vascularization technique\\n \\n(Adapted from: Salah A. AbdRabbo.Stepwise uterine devascularization: \\nA novel technique for management of uncontrollable postpartum \\nhemorrhage with preservation of the uterus AJOG 1994 Volume 171 \\nNumber 3)\\nStep 1: Bilateral uterine vessel ligation\\nIn this step the uterine arteries are ligated at the level where they run along \\nthe uterine border beside the upper part of the lower uterine segment (Fig. \\n1 Note: Steps I and II in the diagram constitute step 1 in our description. \\nWe recommend that both sides are done in one step.).\\nFig. 1.Sites of uterine artery ligation in steps 1, 2 (upper arrow), and 3 \\n(lower arrow).U.U.S., Upper uterine segment; L.U.S., Lower uterine \\nsegment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n95\\nWith the surgeon on the right side of the patient, the uterus is grasped and \\nelevated to the contralateral side. A large needle (48 mm or greater) with \\nnumber 1 absorbable suture is passed through the avascular area of the \\nleft broad ligament from anterior to posterior and then brought forward, \\nguided by the four fingers of the left hand, through the myometrium from \\nposterior to anterior 2 cm medial to the left uterine vessels, and the suture \\nis tied.\\nThis process is repeated on the contralateral side.\\nIn these two steps there is no need for bladder mobilization, because the \\nsutures were not placed low. Also, there is no need for a peritoneal incision \\nin cases having vaginal deliveries; however, in cases having caesarean \\nsection the suture should be placed below the level of the transverse \\nuterine incision, under the reflected peritoneal flap.\\nStep 2: Low bilateral uterine vessel ligation\\nThis step is reserved only for cases having continued lower uterine segment \\nhaemorrhage diagnosed at caesarean section and not controlled by step 1.\\nIn this step the bladder is reflected downwards and lower bilateral uterine \\nvessel ligation is performed at the lower part of the lower uterine segment, \\n3 to 5 cm below the upper ligatures, with the same technique in step 1. At \\nthis level the uterine artery is ligated after its cervicovaginal branch turns \\nabruptly upward to extend along the uterine margin. This ligature would \\nobliterate most of the branches of the uterine artery to the lower uterine \\nsegment and a branch of considerable size that extends to the upper \\nportion of the cervix. It is important to include a significant amount of \\nmyometrium to avoid damage to the uterine vessels and to obliterate some \\nof the intramyometrial ascending arterial branches of the cervicovaginal \\nartery (Fig. 1).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n96\\nStep 3: Ligation of uterine/ovarian arterial anastomosis\\nThis step is indicated in continued uterine bleeding in spite of performing \\nstep 1.The uterus is grasped and pulled to the contralateral side by the \\nleft hand, and a large needle with a number 1 absorbable suture is passed \\nthrough the avascular area in the broad ligament from anterior to posterior, \\nat the level of the ovarian ligament. The needle is then passed anteriorly 2 \\ncm medial to the edge of the uterine wall, to include the uterine muscle. \\nThe suture is tied anteriorly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n97'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n98'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='i'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='ii \\n \\n \\n \\n \\n \\n \\nMaternal Care Package  \\nA Guide to  \\nField Healthcare Workers \\n \\n \\n \\n \\n \\n \\nFamily Health Bureau \\nMinistry of Health \\n \\n \\n \\n \\n \\n2011'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='iii \\n \\n \\n \\n \\n \\n \\n \\n1st Edition \\nOctober 2011 \\n \\n \\n \\n \\nISBN : 978-955-1503-07-9 \\n \\n \\n \\nDraft adaptation and writing by: \\nDr. Nilmini Hemachandra \\nConsultant Community Physician \\nNational Programme Manager Maternal Care \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\nPrinted by:  \\nNew Karunadhara Press, \\n97, Maligakanda Road, \\nColombo 10 \\n \\n \\n \\n \\nPublished by: \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\n \\nSponsored by: \\nWorld Health Organization \\nSri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='iv \\n \\n \\nRESOURCE PERSONS \\nResource  Persons: \\nDr.Deepthi   Perera \\n- \\nDirector /Family Health Bureau \\nDr.C. de Silva \\n- \\nDeputy Director /Family Health Bureau \\nDr.Nilmini Hemachandra \\n- \\nConsultant Community Physician / FHB \\nDr.Dammica Rowel \\n- \\nConsultant Community Physician/ FHB \\nDr.Kapila Jayaratne \\n- \\nConsultant Community physician/ FHB \\nDr.Nethanjalee Mapitigama \\n- \\nConsultant Community physician/ FHB \\nDr.Loshan Moonasinghe \\n- \\nConsultant community Physician/ FHB \\nDr.Nirosha Lansakara \\n- \\nConsultant Community Physician/ FHB \\nDr.Udaya Usgodaarachchi \\n- \\nConsultant Community Dental Surgeon/ FHB \\nDr.Sarath Amarasekara \\n-  Consultant Obstetrician and Gynaecologist / SLCOG \\nDr.Sarath Samarathunga \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Gamini Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Hemantha Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nProf. Hemantha Senanayake \\n-   Prof.of Obstetrics and Gynaecology,Faculty of Medicine, Colombo \\nProf.Harsha Seneviratne \\n-  Prof.of Obstetrics and Gynaecology,Faculty of Medicine,Colombo \\nProf.Chandrika Wijeratne         - \\nProf.of  Reprodutive Health, Faculty  of Medicine, Colombo \\nDr.Lakshman Senanayake     \\n-  Consultant Obstetrician and Gynaecologist \\nDr.Athula Kaluarachchi         \\n-   Consultant Obstetrician and Gynaecologist, Faculty of Medicine-Colombo \\nDr.Sujatha Samarakoon          -   Consulatnt Venereologist, NSACP \\nDr.Renuka Jayatissa               - \\nNutritionist, MRI \\nDr.Anoma Jayathilaka \\n-  National Professional Officer,World Health Organization \\nDr.Deepika Attygalle \\n-  Nutrition Specialist, UNICEF \\nDr.Nishamanie Karawita \\n-  National Health officer, UNICEF \\nDr.Nilani Fernando                  - \\nDeputy RDHS – Kandy \\nDr.Daya Wattearachchi         \\n-  Medical Officer /Maternal and Child Health –Rathnapura \\nDr.Badrika Gunawardena      \\n- \\nMedical Officer of Health- Piliyandala \\nDr.Lalitha Ratnayake           \\n-   Medical Officer of Health   - Piliyandala \\nDr.Sapumal Danapala          \\n- \\nConsultant Community Physician - Central Province \\nDr.Sarath Warusavithana    \\n-  Medical Officer of Maternal and Child health – Matara \\nDr.Priyankara Jayawardena  \\n-  Consultant Physician – Castle Street Hospital for Women \\nDr.Uditha Bulugahapitiya       -  Consultant Endocrinologist \\nDr. Prasad Katulanda                 -   Consultant Physician,NHSL \\nDr.Rabindra Abeysinghe         -  Consultant Community Physician, Anti Malaria Campaign \\nDr.Sudath Pieris                       -  Consultant Epidemiologist, Epidemiology Unit, Ministry of Health \\nDr. S de Alwis                       \\n-  Director, National Respiratory and Chest Disease Control Programme \\nMrs. D. Ubeywarna                  - \\nDirector/Nursing (PHS) \\nDr.Hasitha Aluthge                 - \\nMOH, Deraniyagala \\nDr.Dumithra Kahangamage  \\n- \\nMOH ,Padukka \\nDr. Shanika Senanayake  \\n- \\nMedical Officer – Family Health Bureau \\nMrs.K.A. Sunethra                 \\n- \\nPHNS ,Thihagoda MOH area \\nMrs.Nalika Weeraratne \\n- \\nPHNS, Pelmadulla MOH area           \\nEditing \\nDr. Anoma Jayathilake   \\n- \\nNational Professional Officer, WHO \\nDr. Nilmini Hemachandra  \\n- \\nConsultant Community Physician, FHB \\nDr. Dhammica Rowel \\n- \\nConsultant Community Physician, FHB \\nDr. Shanika Senanayake  \\n- \\nMedical Officer, FHB'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='v'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='vi \\n \\n \\nCONTENT \\nPreface \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nvii \\nAcknowledgement \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n ix \\nList of Abbreviations  \\n \\n \\n \\n \\n \\n \\n \\n \\n xi \\n1. \\nIntroduction \\n01 \\n2. \\nBasic principles of maternal and newborn health interventions \\n07 \\n3. \\nMaternal care models in Sri Lanka \\n13 \\n4. \\nAntenatal care at the clinic \\n19 \\n5. \\nManagement of risk conditions at field level \\n41 \\n6. \\nDomiciliary care for low risk pregnancies \\n46 \\n7. \\nDomiciliary care for high risk pregnancies \\n54 \\n8. \\nDeveloping a birth and emergency plan \\n65 \\n9. \\nAntenatal classes \\n68 \\n10. Clinical procedures for antenatal care \\n \\n10.1 Anthropometric assessment of pregnant women \\n71 \\n \\n10.2 Measuring blood pressure at the clinic setting \\n75 \\n \\n10.3 Obstetric examination \\n76 \\n \\n10.4 Fetal movement chart or kick count chart \\n80 \\n \\n10.5 Urine testing at the clinic setting \\n81 \\n \\n10.6 Antenatal screening for syphilis: Guidelines for sample collection,  \\n                storage and transportation \\n83  \\n \\n10.7 Estimating Haemoglobin levels using a colour scale                                              84 \\n11. Nutrition during pregnancy and lactation \\n85 \\n12. Common discomforts during pregnancy \\n91 \\n13. National guidelines for prevention and control of maternal anaemia \\n100 \\n14. Management of high blood pressure during pregnancy at field level \\n106 \\n15. Guidelines on immunization against tetanus \\n107 \\n16. Guideline on screening and management of diabetes mellitus during  \\n \\npregnancy in the field /non specialized institutions \\n110 \\n17. Prevention of mother to child transmission of HIV infection (PMTCT) \\n114 \\n18. Elimination of congenital syphilis (ECS) \\n127 \\n19. Syndromic management of sexually transmitted infections during pregnancy \\n135 \\n20. National guidelines for prevention and management of Malaria in pregnancy \\n145 \\n21. Management of Tuberculosis during pregnancy \\n147 \\n22. Postnatal Care \\n155 \\n23. Postnatal Clinic \\n170 \\n24. Family planning after delivery \\n172 \\n25. Screening for postpartum depression \\n173 \\n26. Management information system of maternal care \\n175 \\n27. Surveillance on maternal morbidity and mortality \\n176 \\n28. Supervision of maternal care services \\n191 \\n29 Planning of domiciliary care for pregnant and partum women \\n213 \\nList of References  \\n215'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='vii'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='viii \\n \\n \\n \\nPREFACE \\n \\nPregnancy is the most wonderful physiological phenomenon which is responsible for the existence of \\nmankind within the universe, though it creates a high risk environment for a woman’s life. With \\ndevelopment of the discipline of obstetrics and the health systems, the threat to life has been \\nminimized and the world has achieved a lot in maternal and child health. \\nSri Lanka, although a developing country, has been able to achieve remarkable health indices such as \\nlow maternal mortality rate, infant mortality rate, under five mortality rate, higher level of life \\nexpectancy due to the tireless efforts of many stakeholders over the last few decades. The foundation \\nfor these achievements are the policy of free education and free health services for the entire nation, \\ncommitment by all levels of medical and other related professional personnel and the existence of a \\nstrong preventive and curative health infrastructure. \\nProvision of comprehensive maternal, family planning, and child care services through a  well-\\norganized structure at institutional and community level, implementation of evidence based \\ninterventions integrated as packages, use of professionally trained health personnel at the community \\nlevel from the inception of the national MCH/FP programme are the major contributors for the \\nsuccess.   \\nAlthough our targets  in most aspect of the MCH has been  achieved, still some gaps can be \\nidentified in certain areas such as postnatal care, quality of care and geographical  disparity in some \\nindices. Further, some indices such as IMR, MMR, Low birth weight rate have shown slow decline \\nduring the past decade.  \\nTo overcome these gaps and challenges, we need to focus more on targeted interventions, equitable \\nservice provision and quality of care. Therefore, this guide was developed by a group of experts in \\nthe relevant fields considering existing maternal care model and intervention packages, evidence \\nbased interventions, recommendations given by the external review of the Maternal and Newborn \\ncare programme (2007), National Maternal Mortality Reviews, MCH reviews and the felt need of the \\nrelevant experts for the betterment of the maternal care programme in the country.   \\nWe strongly recommend this book as a guide for the health workers who provide maternal and \\nnewborn care in the country and as a hand book for medical, nursing and midwifery students.   \\n \\n \\n \\nDr. Ajith Mendis                                                                        Dr. Deepthi Perera \\nDirector General of Health Services                                            Director/ Maternal and Child Health \\nMinistry of Health \\nFamily Health Bureau \\n                                        \\nSri Lanka. \\nMinistry of Health \\n \\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='ix'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='x \\n \\n \\n \\n \\n \\nACKNOWLEDGEMENT \\n \\nThis guide is an outcome of the efforts of many people. Dr. L. Siyambalagoda, Deputy Director \\nGeneral (Public Health Services), Dr. Deepthi Perera, Director/ Maternal and Child Health, Family \\nHealth Bureau and Dr. Chitramalee de Silva, Deputy Director/ Maternal and Child Health, Family \\nHealth Bureau guided us to develop this guide providing their fullest support and guidance.  \\nDr. Sarath Amarasekara (president /2010), Dr.Ananda Ranathunga, (President/2011), and other \\nmembers of the Sri Lanka College of Obstetricians and Gynaecologists provided us with their \\ntechnical expertise and cooperation during the development of this guide and pilot testing of the \\nrevised maternal care model. Our gratitude is conveyed to SLCOG. \\n We would like to appreciate the contribution of Consultant Community Physicians at the Family \\nHealth Bureau with their technical expertise in their fields and constructive criticism. We would \\nacknowledge all the Medical Officers (Maternal and Child  Health),  Medical Officers of Health, \\nPublic Health Nursing Sisters, Supervising Public Health Midwives and Public Health Midwives \\nwho contributed for the development of this guide in various ways.  \\nWe would like to appreciate the contribution of the Public Health teams of Ratnapura and Kandy \\ndistricts for the pilot testing of the maternal care package and their contribution to fine tune this. We \\nwould like to acknowledge and appreciate the contribution of Dr. Anoma Jayathilake as a public \\nhealth specialist in the field of maternal care for the success of this endures.  \\nFinancial support received from UNICEF for consultative meetings during the process of \\ndevelopment of this package is highly appreciated. Our sincere gratitude is conveyed to the World \\nHealth Organization Country Office for the guidance and financial support received, for pilot testing \\nscaling up and printing of this document in all three languages.  \\n \\n \\nDr. Nilmini Hemachandra \\nNational Programme manager – Maternal care \\nFamily Health Bureau, \\nMinistry of Health, \\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xi'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xii \\n \\n \\n \\n \\nLIST OF ABBREVIATIONS \\n \\nAIDS\\nAcquired Immune Deficiency Syndrome\\nMOMCH\\nMedical Officer-Maternal & Child \\nHealth \\nAMC\\nAnti Malaria Campaign\\nMSD\\nMedical Supplies Division\\nANC\\nAntenatal Care\\nMTCT\\nMother To Child Transmission\\nAPH\\nAntepartum Haemorrhage\\nNCD\\nNon Communicable Disease\\nART\\nAnti retro viral treatment\\nNICU\\nNeonatal Intensive Care Unit\\nBF\\nBreast Feeding\\nNMMR\\nNational Maternal Mortality Review\\nBMI\\nBody Mass Index\\nNSACP\\nNational STD/AIDS Control \\nProgram \\nBP\\nBlood Pressure\\nOCP\\nOral contraceptive Pills\\nCEmOC\\nComprehensive Emergency Obstetric \\nCare \\nOGTT\\nOral Glucose Tolerance Test\\nCHDR\\nChild Health Development Record\\nPDHS\\nProvincial Director of Health \\nServices \\nCS\\nCongenital Syphilis\\nPHI\\nPublic Health Inspector\\nCSB\\nCorn Soya Blend\\nPHM\\nPublic Health Midwife\\nDMMR\\nDistrict Maternal Mortality Review\\nPHNS\\nPublic Health Nursing Sister\\nEBF\\nExclusive Breast Feeding\\nPID\\nPelvic Inflammatory Disease\\nECCD\\nEarly Childhood Care & Development\\nPIH\\nPregnancy Induced Hypertension\\nEDD\\nExpected Date of Delivery\\nPLHIV\\nPeople Living with HIV\\nEmOC\\nEmergency Obstetric Care\\nPMTCT\\nPrevention of Mother To Child \\nTransmission of HIV \\nEPI\\nExpanded Programme of Immunization\\nPOA\\nPeriod of Amenorrhoea\\nFHB\\nFamily Health Bureau\\nPPBS\\nPost Prandial Blood Sugar\\nFHS\\nFetal Heart Sounds\\nPPH\\nPostpartum Haemorrhage\\nFM\\nFetal Movements\\nRDHS\\nRegional Director of Health services\\nGBV\\nGender Based Violence\\nSCBU\\nSpecial Baby Care Unit\\nGDM\\nGestational Diabetes Mellitus\\nSFH\\nSymphysio- Fundal height\\nHb\\nHaemoglobin\\nSMI\\nSchool Medical Inspection\\nHEO\\nHealth Education Officer\\nSPHM\\nSupervising Public Health Midwife\\nHIV\\nHuman Immunodeficiency Syndrome\\nSTD\\nSexually Transmitted Diseases\\nIUD\\nIntra Uterine Device\\nTB\\nTuberculosis\\nIUGR\\nIntra Uterine Growth Retardation\\nTT\\nTetanus Toxoid\\nIVF\\nIn Vitro Fertilization\\nUSS\\nUltra Sound Scan\\nJMO\\nJudicial Medical Officer\\nVDRL\\nVenereal Disease Reference \\nLaboratory \\nJVP\\nJugular Venous Pressure\\nKCC\\nKick Count Chart\\nLRM\\nLast Regular Menstruation\\nLRT\\nLigation and Resection of Tubes\\nLSCS\\nLower Segment Cesarean Section\\nMO\\nMedical Officer\\nMO/STD\\nMedical Officer/STD clinic\\nMOH\\nMedical Officer of Health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xiii'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n1 \\n \\n \\nChapter 01 \\nINTRODUCTION \\n \\nDevelopment of maternal care services in Sri Lanka \\nThe history of health care systems in Sri Lanka is extended to king’s era. The documentary evidence \\nsays that there were several hospitals for indigenous medicine and maternity homes for child birth \\nexisted during the reign of the Sinhalese kings as early as 340-368 AD. The expectant mothers were \\nmade to move into these homes in the ninth month of pregnancy and stay there till child birth. Most \\nmothers delivered in the few maternity homes that were available or in their homes under the care of \\nexperienced birth attendants. \\nAround the 15th century, a systematized network of Ayurvedhic treatment centers and hospitals \\nthroughout the country was established and Ayurvedhic Physicians were trained to work in these \\ntreatment centers. This resulted in gradual diffusion of health care within the country. The \\ndocumentary evidence in the history of ancient Ceylon stated that separate hospitals existed for \\nwomen under the Ayurvedic System of Medicine where deliveries have been conducted. \\nSri Lanka came under the colonial rule in1505 and was successively under the Dutch, Portuguese \\nand the British till achieving independence in 1948. During this period, the Western System of \\nmedicine was introduced and hospitals were built to provide medical care. In 1859, a separate Civil \\nMedical Department was established and public health became a function of this department.  \\nThe first organized effort towards care of the childbearing woman was made in 1879 with the \\nopening of the De Soysa Lying- in- Home now known as the De Soysa Hospital for Women. This \\nwas built by a philanthropist (Sir Charles Henry De Soysa) to provide a home for lying-in-mothers as \\nwell as to provide out-patient care to mothers and children. This was probably the first maternity \\nhospital to be established in Asia and soon afterwards the first training school for midwives was \\nopened at this maternity hospital in 1881. In 1887, Legislation for registration of midwives was \\nintroduced which made it mandatory for all midwives to be registered prior to practicing midwifery. \\nThis was a great step taken towards development of maternal care services since it enhanced the \\nquality of midwifery services provided in Sri Lanka. \\nIn 1902, a maternal and child health department was created with in the Colombo Municipality \\nfollowing an investigation into the high rate of infant mortality within the Municipality. In 1906, a \\nsystem of field maternal services commenced within the Colombo Municipality with the \\nappointment of six midwives. This was followed by the appointment of two health visitors in 1913.  \\nThe MCH services were thereafter gradually expanded.  \\nThe first antenatal clinic was started at the De Soysa Lying-in-home in 1921 following the \\ncommencement of Antenatal Clinics in Boston, USA in 1911, Sydney in 1912 and Edinburgh in \\n1915. \\nThe need for developing the preventive and promotive services was recognized by the government as \\nearly as 1920. In the mid 1920’s steps were taken to introduce a Health Unit System which could \\nprovide a comprehensive health care service (institutional and domiciliary) to mothers and children.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n2 \\n \\n \\nThis scheme was to provide domiciliary as well as clinic based services to mothers during pregnancy \\nand postpartum period and, trained assistance at delivery by encouraging mothers to deliver in \\nmedical institutions or provide trained assistance in the case of home deliveries. The first Health Unit \\nwas established in 1926 at Kalutara and trained Public Health staff (Public Health Midwives and \\nNurses) were appointed to provide the necessary services. This scheme was thereafter extended to \\nother areas and by 1936, eight Health Units were established within the country. \\nUntil 1926, the midwives functioned only in the hospitals and their training was only hospital based. \\nWith the establishment of the Health Unit System, the Midwives were given one month field training \\nin public health midwifery and appointed to the Health Units as Public Health Midwives. After 1938, \\nthe PHM’s training was more systematized with the use of appropriate circular and the field training \\nwas extended to six months.  \\nTraining of Public Health Nurses (PHNs) commenced in 1928 and consisted of six months training \\nin midwifery and six months in public health. Since 1980, training in the public health for nurses \\nconducted at the National Institute of Health Sciences (NIHS) was extended to one year, after which \\na Diploma in Public Health Nursing was awarded. This category is now designated as Public Health \\nNursing Sisters. \\nFormal training for Medical Officers of Health commenced in 1936 and is of one month’s duration. \\nThis facilitated the effective implementation of the Health Unit System. \\nThe control measures adopted following the Malaria epidemic of 1935, led to further expansion of \\nthe Health Unit System. The maternal and child health infrastructure, which originated with the \\nHealth Unit Systems, was linked to the expanding malaria control programme and the medical \\nofficers recruited for malaria control provided MCH services at the health centres in addition to their \\nnormal malaria control activities. \\nThe Government policy in the early 1930’s enunciated the need for diffusion of health services \\nthroughout the country. After the granting of Universal Franchise in 1931, there was political \\ndemand for expansion of health services in rural areas. A large number of maternity homes, rural \\nhospitals and cottage hospitals were constructed and the staff in these medical institutions was \\ntrained in care of the mother and child. The number of Health Units, which was eight in1936, \\nincreased to ninety-one by 1950. Currently there are more than 300 Health Units in the country. \\nThe government provided health care free of charge making health services accessible to the poorest \\nsegments of the population. The introduction of the free education system in 1941 led to an increase \\nin literacy, which helped in increasing the level of health consciousness and greater utilization of \\nhealth facilities. \\nThe number of medical institutions with facilities for delivery increased from 141 in 1941 to 521 in \\n2000. Also the number of health centres increased from 600 in1948 to about 3200 in 2000. \\nSimilarly availability of trained health man power has shown a marked increase since 1940’s. \\nTrained midwives increased from 347 in 1941 to 8741 in 2009 and the Public Health Nurses (now \\ncalled Public Health Nursing Sisters) increased from 41 in 1948 to 254 in 2009.  \\nSince independence in 1948, a more concerted effort was made to provide a comprehensive service \\nto mothers and children throughout the country. The MCH services were extended to the rural areas \\nin an effort to make the service availability more equitable. The second maternity hospital in \\nColombo (Castle Street Maternity Hospital) with accommodation for 144 patients was opened in'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n3 \\n \\n \\n1950. Thereafter, an increasing number of maternity beds and specialist services were provided to \\nthe Provincial and Base Hospitals with blood transfusion facilities extended to these hospitals. \\nThe policies of Sri Lanka in the early years after independence reflected little concern over the high \\ngrowth rate (31 per 1000) that prevailed during that period. The first organized effort for introducing \\nfamily planning was made in 1953 with the founding of the Family Planning Association (FPA) of \\nCeylon. The activities of the Association were focused on family welfare with a view to reducing \\nmaternal mortality, infant mortality and malnutrition and were mainly centered within and around \\nColombo. The work done by the Association was recognized when the government provided a \\nfinancial grant in 1954. \\nRealizing the importance of family planning, in 1958 the government entered into a bilateral \\nagreement with the Royal Government of Sweden to study community’s attitude toward family \\nplanning and its acceptance by the people. Under this agreement, training programmes for doctors, \\nnurses and midwives were started and two pilot projects were conducted in community family \\nplanning. The results of this project were encouraging. In the pilot areas, the crude birth rate showed \\na promising decline and an increase in positive attitudes towards family planning was seen within the \\ncommunity. The activities of the Swedish project during 1958 – 1965 period demonstrated that \\nfamily planning can be successfully integrated into the MCH services without any great increase in \\npersonnel or expenditure. \\nBased on the above experiences, the government accepted family planning as national policy in 1965 \\nand decided to integrate family planning services with the already well-established Maternal and \\nChild Health services provided through the Ministry of Health. This procedure was adventurous \\nsince the personnel and the infrastructure of an already well- organized system could be made use of \\nwithout any additional cost and also family planning could be introduced as an integral part of the \\nmaternal health package offered by the system. Considering its national importance, a separate \\ndivision, ‘the Family Planning Bureau’ which was later re-designated as ‘Maternal and Child Health \\nBureau’ was set up in 1968 within the Ministry with an Assistant Director MCH responsible for \\nimplementation of the programme throughout the country. This Bureau was given the task to plan, \\noperate, supervise and evaluate the family planning programme within the country. \\nThe period 1966 to 1968 could be regarded as an introductory phase where establishment of family \\nplanning clinics, training of relevant health personnel and administrative strengthening of the \\nMinistry of Health laid the foundation for the expected expansion and intensification of the \\nprogramme. \\nIn 1970, the government made a positive statement towards family planning. It stated that ‘though \\nfamily planning would not be a solution to the economic ills of the country, nevertheless family \\nplanning facilities should be made available on a more intensified scale.’ In the national five year \\nplan of 1971, family planning received due importance and a statement was made emphasizing that \\n‘family planning should be made available to all groups and not be confined to the privileged section \\nof society.’ This provided the necessary political endorsement and support from the government for \\nfamily planning, though some groups still resisted the idea. \\nIn 1972, 100 pilot projects were started, one in each MOH area to try out a coordinated approach to \\nmaternal care, family planning, child care including nutrition and immunization, health education \\netc. Based on the experience gained, the MCH/FP programme received a new dimension with a more \\ncomprehensive approach towards the family.  The Bureau was re-designated the ‘Family Health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n4 \\n \\n \\nBureau’ in 1973 and the programme was named ‘Family Health’ so that this would provide a more \\ncomprehensive service to the mother and child. Thereafter maternal and child health services \\nreceived greater emphasis and were given priority in the overall health development plan. This led to \\nmore concerted effort to strengthen the service infrastructure to provide an efficient family health \\nservice through out the country. The government sought the assistance of International Organization \\nto financially support the implementation of services within the country. \\nThe Family Health Bureau was made the central organization of the Ministry of Health responsible \\nfor planning, promoting, coordinating, monitoring and evaluating family health activities. Following \\na revision of the MCH information system in1985, the Family Health Bureau was entrusted the task \\nof collecting, processing and analyzing MCH data from the Health Units  \\nMaternal death investigations were conducted from the early 1950 s, but were actively implemented \\nin the mid 1980’s when instructions were given to investigate and report all maternal deaths \\noccurring in the medical institutions and in the field (community) including those in the plantation \\nsector. These were thereafter reviewed at the district and national levels by the respective health \\nauthorities. Any corrective measures needed to overcome problems and constraints were taken to \\nprevent such deaths in the future. This system was further strengthened in 1989 when maternal \\ndeaths were made a notifiable event and clear guidelines on the procedure for investigation were \\nissued to all hospitals and health units.  \\nSince the International Conference on Population and Development in Cario in 1994, the concept of \\nreproductive health has been introduced which addresses reproductive health issues of the \\nadolescents, young adults, married couples, and women even after menopause thus providing a life \\ncycle approach to family health care. Some of the reproductive health issues that have received \\nemphasis in the programme are RH problems in the adolescents, early identification of reproductive \\nhealth organ malignancies, prevention of reproductive tract infections including sexually transmitted \\ndiseases / HIV-AIDS, concept of women’s empowerment and male involvement in RH activities. \\nServices in respect of sexually transmitted diseases and HIV/AIDS are provided through the National \\nSTD Control Programme (NSACP). The Family Health Bureau in collaboration with the National \\nCancer Control Programme (NCCP) has introduced in 1995 a screening programme for reproductive \\norgan malignancies and certain other conditions. Under this programme ‘Well Women’s Clinics’ \\nhave been established in all Health Unit areas conducted by trained medical officers. Women over 35 \\nyears of age could be screened for such as hypertension, diabetes, breast malignancies and cervical \\ncancers. If any abnormality is detected clients are referred to the health care system for necessary \\nmanagement. The PHM of the area is responsible for follow up of cases in the field and provides \\nnecessary advice and guidance thereafter. \\nTenth anniversary of Safe motherhood concept which was held in Sri Lanka in 1997 was an appraisal \\nof maternal health program in Sri Lanka. \\n \\nInstitutional Framework for Providing Maternal Care \\nMaternal, child health and family planning services are provided through the well-developed health \\ninfrastructure of the Ministry of Health, which has grown steadily over the past few decades. The \\nservices are provided through a net of work of Medical Institutions comprising major hospitals with \\nspecialist services (Teaching, Provincial and Base hospitals), Divisional Hospitals, and central'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n5 \\n \\n \\ndispensaries and Maternity homes. The institutional network is closely linked to a system of Health \\nUnits, which are primarily responsible for providing preventive and promotive health care to the \\ncommunity. \\nSince 1989, the country’s administration was decentralized with devolution of administrative powers \\nto the Provincial Councils. Each province has a Provincial Director of Health Services (PDHS) who \\nis responsible for total health care within the province. He is supported by a Regional Director of \\nHealth Services (RDHS) who is in charge of a Health District. RDHS is supported by a team \\ncomprising a Medical Officer MCH (MO.MCH), Regional Epidemiologist (RE), Regional \\nSupervising Public Health Nursing Officer (RSPHNO), 2-3 Health Education Officers, a Statistical \\nSurvey Officer (SSO) and a Programme Planning Officer (PPO). Each Health District is further sub-\\ndivided into Health Divisions (7-15) consisting of Health Units and a network of medical institutions \\nof different categories. \\nThe Health Units have a clearly defined area, which is congruent with the administrative divisions \\nof the country. It is managed by a Medical Officer of Health (MOH). He is supported by a team of \\npublic health personnel comprising of one or two Public Health Nursing Sisters (PHNS), Supervising \\nPublic Health Inspector (SPHI), few Supervising Public Health Midwives (SPHM), 20 – 25 Public \\nHealth Midwives (PHM s) and 5-6 Public Health Inspectors (PHI). \\nPublic Health Midwife area (PHM areas) is the smallest working unit in the government health \\nsystem. The PHM is the ‘front line’ health worker for providing domiciliary MCH/FP services in the \\ncommunity. Each PHM has a well defined area consisting of a population ranging from 2000-4000. \\nThough systematic home visits, the Public Health Midwife provides care to pregnant women, infants \\nand pre-school children and family planning services to couples in the reproductive age within her \\narea. In case of necessity, she provides trained assistance during home deliveries when called by the \\ncommunity. She also provides necessary education and advice to adolescents on RH where needed \\nand educates women on the importance of screening for reproductive organ malignancies thus \\nmotivating them to attend the ‘well women clinics’ for necessary check up. She also assists at the \\narea MCH/FP clinics, which are conducted fortnightly, linking the community with the institutional \\nhealth system. Her activities are supported by a system of record keeping which enables her tot plan \\nand monitor her routine activities. Her work is regularly supervised by the Supervising Public Health \\nMidwife, Public Health Nursing sister and the MOH of the area. \\nHigher Level Health Institutions; Teaching Hospitals, Provincial General Hospitals, District General \\nHospitals and Base Hospitals provide specialized care for obstetric including Comprehensive \\nEmergency Obstetric and Neonatal Care (CEmONC) and other specialties. Currently there are 72 \\nhospitals within the country belonging to this category giving a ratio of 1 per 275,000 population. \\nAlmost 80 percent of institutional deliveries occur in these hospitals. \\nIntermediate Level Health Institutions; Divisional Hospitals manned by qualified medical graduates \\n(MBBS) and provide a wide range of services including  in-patient and out -patient care. These \\ninstitutions are capable of providing basic EmONC services. Currently there are 455 Divisional \\nHospitals and 525 Primary care units within the country where almost 20 percent of institutional \\ndeliveries take place. \\nPrimary Level Institutions manned by qualified medical graduates (MBBS) or Registered/ Assistant \\nMedical Practitioners. These are the central dispensaries and Maternity Homes (CD & MH) where \\nfacilities for only uncomplicated deliveries are available.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n6 \\n \\n \\nThe private sector, which includes private hospitals/nursing homes and general medical practitioners \\nalso provide maternal care services of a varying degree. Although data is not available, it is known \\nthat a considerable proportion of patients obtain maternal care from the private sector. \\n \\nService delivery and Achievements \\nThe Government of Sri Lanka is committed to providing a comprehensive system of health care to its \\npeople. Maternal and Child health and Family Planning form an important component of the \\nprevailing health care system and are an integral part of the Primary Health Care strategy. \\nMaternal care is provided free of charge to all pregnant women during antenatal, intranatal and \\npostnatal periods through the health care system. The use of skilled attendance during pregnancy and \\nlabour has greatly increased over the past five decades. \\nStudies has shown that more than 99 percent of pregnancy women had received antenatal care during \\npregnancy and almost 99 percent received trained assistance at delivery (DHS-2006/2007). \\nAntenatal care is provided at MCH clinics conducted in health centers both in the field and in \\nmedical institutions. These clinics are usually conducted once a fortnight. In addition, domiciliary \\ncare is provided by Public Health Midwives through routine home visiting. Pregnant women are \\nregistered for antenatal care early and ‘Pregnancy record’ is maintained to facilitate proper follow \\nup. Since the early 1990’s, a home based ‘Pregnancy Record’ was introduced which is kept and \\ncarried by the mother so that vital information regarding the pregnancy is made available to the \\nattending doctors and the health staff at any facility she visits. ‘High risk’ mothers are identified and \\nspecial attention is given throughout pregnancy and delivery. An organized system of referral exists \\nfor cases that need special care and attention. \\nThe number of mothers receiving trained care during delivery has more than doubled since 1948. \\nOnly 48 percent of mothers had received trained assistance at delivery (i.e. delivered either in an \\ninstitution or under supervision of a qualified midwife) during the late 1940’s. Currently almost 99 \\npercent of deliveries receive trained assistance with approximately 99 percent taking place in \\nmedical institutions (95 percent in Government institutions and 4 percent in the private hospitals). \\nOf the total deliveries in the government institutions almost 80% take place in larger hospitals where \\nComprehensive Emergency Obstetric Care is available. This has resulted in overcrowding of \\nmaternity wards in the larger hospitals. One of the main reasons for this overcrowding is the people’s \\npreference to have their confinement in larger hospitals with better facilities rather than going to their \\narea hospital. \\nBirths in government medical institutions have increased steadily during the past four decades. Easy \\naccess to institutional care and regular contact with the PHM appears to have influenced their \\ndecision in favour of institutional deliveries.  \\nAfter delivery the mother and child are followed at home by the area PHM with necessary post \\npartum care (including advice and guidance) being provided during these visits. Routine statistics \\nreveal that approximately 80 percent of women receive post natal care at least once during the first \\nten days after delivery (Annual Family Health Report, 2007-FHB)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n7 \\n \\n \\nChapter 02 \\nBASIC PRINCIPLES OF   MATERNAL AND NEWBORN HEALTH \\nINTERVENTIONS \\nMaternal and Newborn health interventions are treatments, technologies, and key family practices \\nthat prevent or treat Maternal and Newborn illness and reduce deaths in mothers and children (WHO \\n2010).  \\nThese interventions are not only reducing mortality and morbidity in the mother and newborn but \\nalso ensure quality of life. There are simple low-cost interventions for the prevention and treatment \\nof all the most common causes of maternal and newborn, morbidity and mortality. An effective \\nmaternal and newborn health programme must focus on achieving a high level of coverage with such \\ninterventions that have the greatest potential to reduce maternal and newborn mortality and \\nmorbidity in the country. \\n \\nPrinciples of delivering interventions \\n The continuum of care for the mother and child includes the life stages from adolescent, pre \\npregnancy, pregnancy, through birth, the newborn period, infancy and childhood. Interventions \\nshould be targeted at all of these stages in order to maximize impact.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n8 \\n \\n \\nThe continuum of care across the health system includes the levels at which interventions are \\ndelivered: home and community, first-level health facilities (field clinics and medical institutions up \\nto Divisional Hospitals) and referral facilities (hospitals with specialist facilities). Interventions \\nshould be delivered at each of these levels where relevant. Facility-based interventions should be \\nbalanced with those in the home and community, since the prevention and management of maternal \\nand newborn illness and deaths begins in the home. Continuums of care throughout the lifecycle and \\nacross the health system are a useful way of delivering an intervention.  \\n \\n \\nProgrammatic Pathway to improve health status  \\n \\n \\n \\nIMPLEMENTATION \\nOF ACTIVITIES \\nAdvocacy for health \\n \\nHuman, material and \\nfinancial resource \\nmobilization \\nHuman resource \\ncapacity development \\nCommunication with \\nfamilies & communities \\nHealth system \\ndevelopment \\nMonitoring and supervision \\nIMPROVED \\nAvailability and \\naccess to health \\ncare \\nQuality of care \\nDemand for care \\nKnowledge of \\nfamilies \\nand communities \\nINCREASED \\nPOPULATION- \\nBASED \\nCOVERAGE \\nof key effective \\ninterventions \\nIMPROVED \\nSURVIVAL \\nAND HEALTH \\nMortality, \\nMorbidity, \\nfertility, and \\nNutritional \\nstatus \\nOther determinants'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n9 \\nPregnancy care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on self-care at home, nutrition, safer sex, HIV, breast feeding, family \\nplanning, healthy life style including harmful effects of smoking and alcohol use, and use of \\ninsecticide treated bed nets \\n\\uf0b7 \\nBirth planning, advice on labour, danger signs and emergency preparedness \\n\\uf0b7 \\nSupport for compliance with preventive treatments \\n\\uf0b7 \\nSupport for woman living with HIV/AIDS \\n\\uf0b7 \\nAssessment of signs of domestic violence and referral \\n\\uf0b7 \\nEducate and support for compliance with preventive treatment \\n \\nPregnancy care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nConfirmation of pregnancy \\n\\uf0b7 \\nMonitoring of progress of pregnancy and assessment of maternal and fetal well-being including \\nnutritional status \\n\\uf0b7 \\nDetection of problems complicating pregnancy ( eg: anaemia, hypertensive disorders, bleeding, \\nmal-presentations, multiple pregnancy) \\n\\uf0b7 \\nResponds to other reported needs \\n\\uf0b7 \\nTetanus immunization \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation and worm treatment) and \\nnutrition counselling \\n\\uf0b7 \\nSyphilis testing and treatment of syphilis ( woman and her partner) \\n\\uf0b7 \\nTreatment of mild to moderate pregnancy complications (mild to moderate anaemia – urinary \\ntract infection, vaginal infection) \\n\\uf0b7 \\nPost abortion care and family planning \\n\\uf0b7 \\nPre- referral treatment of severe complications (pre-eclampsia, eclampsia, bleeding, infection and \\ncomplicated abortion) \\n\\uf0b7 \\nAntibiotics for premature rupture of the membranes \\n\\uf0b7 \\nSupport for women living with violence and HIV \\nSituational \\nAll of the above plus\\n\\uf0b7 \\n HIV testing and counseling, prevention of mother to child transmission of HIV (PMTCT) by \\nantiretroviral including antiretroviral therapy (ART), infant feeding counseling, mode of delivery \\nadvice \\n\\uf0b7 \\nAntimalarial intermittent preventive treatment (IPT) and promotion of insecticide treated nets \\n(ITN) \\n\\uf0b7 \\nDeworming \\n\\uf0b7 \\nAssessment of female genital mutilation \\n\\uf0b7 \\nTreatment of mild to moderate opportunistic infections \\n\\uf0b7 \\nTreatment of simple malarial cases \\nInterventions at REFERRAL FACILITIES \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe pregnancy complications (anaemia, severe pre – eclampsia, eclampsia, \\nbleeding , infection , other medical complications) \\n\\uf0b7 \\nTreatment of abortion complications \\n\\uf0b7 \\nManagement of mal- presentations, multiple pregnancy \\n\\uf0b7 \\nCorticosteroids for preterm labour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n10 \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe HIV infection \\n\\uf0b7 \\nTreatment of complicated malaria \\nChild birth care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nCompanion of choice to support the woman during delivery \\n\\uf0b7 \\nSupport for care for the rest of the family \\n\\uf0b7 \\nSupport for transport \\n\\uf0b7 \\nPromote and support for skilled care at birth and institutional delivery \\nChild birth care at FIRST LEVEL FACILITY \\nAll of the above plus\\nCare during labour and delivery \\n\\uf0b7 \\nDiagnosis of labour \\n\\uf0b7 \\nMonitoring progress of labour , maternal and fetal well- being with partogragh \\n\\uf0b7 \\nCompanion of choice to support the woman \\n\\uf0b7 \\nInfection prevention \\n\\uf0b7 \\nSupportive care and pain relief \\n\\uf0b7 \\nDetection of problems and treatment of complications (e.g. malpresentation, prolonged and/ or \\nobstructed labour, hypertension, bleeding and infection) \\n\\uf0b7 \\nDelivery and immediate care of the new born baby \\n\\uf0b7 \\nActive management of third stage of labour \\nImmediate postpartum care of mother \\n\\uf0b7 \\nMonitoring and assessment of maternal well being  \\n\\uf0b7 \\nPrevention and detection of complications (e.g. hypertension , infections, bleeding, anaemia) \\n\\uf0b7 \\nTreatment of abnormalities and complications ( e.g. prolonged labour, vacuum extraction, breech \\npresentation, episiotomy, repair of genital tears, manual removal of placenta) \\n\\uf0b7 \\nPre- referral management of serious complications( e.g. obstructed labour, fetal distress, preterm \\nlabour, severe peri- and postpartum haemorrhage ) \\n\\uf0b7 \\nCounseling and Support for the family if maternal and perinatal death \\n\\uf0b7 \\nCounselling for family planning including insertion of IUDs, LRTs \\nImmediate newborn care \\n\\uf0b7 \\nSkin to skin care \\n\\uf0b7 \\nThermal care \\n\\uf0b7 \\nHygienic cord care \\n\\uf0b7 \\nNewborn resuscitation if required \\n\\uf0b7 \\nEarly initiation of breast feeding \\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nRecognition of danger signs and prompt treatment \\n\\uf0b7 \\nIdentification and initial management of newborn complications and appropriate referral \\n\\uf0b7 \\nSpecial care for small babies including Kangaroo Mother Care \\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nBCG immunization \\n\\uf0b7 \\nPrevention of mother to child transmission of HIV (guidance and support for chosen infant \\nfeeding option) \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nVitamin A administration for mother \\n\\uf0b7 \\nHIV testing and counseling \\n\\uf0b7 \\nPrevention of mother – to- child transmission of HIV by mode of delivery, guidance and support \\nfor chosen infant feeding option \\n\\uf0b7 \\nCare for HIV positive women/ ART'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n11 \\nChild birth care at REFFERRAL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe complications in child birth and in the immediate postpartum period, \\nincluding caesarean section, blood transfusion and hysterectomy \\n\\uf0b7 \\nInduction and augmentation of labour \\n\\uf0b7 \\nManagement of other obstetric complications \\n\\uf0b7 \\nManagement of severe newborn complications \\nPostpartum care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on selfcare at home, nutrition, safer sex, breast feeding, family \\nplanning/ birth spacing, healthy lifestyle including harmful effects of smoking and alcohol use \\n\\uf0b7 \\nSupport for rest and less work load \\n\\uf0b7 \\nSupport for exclusive breast feeding \\n\\uf0b7 \\nSafe disposal/ washing of pads \\n\\uf0b7 \\nAssessment of maternal wellbeing including maternal nutrition \\n\\uf0b7 \\nMalaria prevention and management of malaria \\n\\uf0b7 \\nSupport for complications with prevention measures and treatments (infections, bleeding, \\nanaemia, UTI, RTI, wound infections, breast feeding problems) \\n\\uf0b7 \\nFamily planning / birth spacing \\n\\uf0b7 \\nRecognition of danger signs, including blues/ depression \\n\\uf0b7 \\nAwareness of signs of domestic and sexual violence and referral \\n\\uf0b7 \\nSupport  for women living with HIV/ AIDS including ART \\n\\uf0b7 \\nReporting birth and death (vital registration) \\n\\uf0b7 \\nUse of insecticide treated bed nets \\n \\nPostpartum care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nPrevention and detection of complications (e.g. infections, bleeding, anaemia) \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation) \\n\\uf0b7 \\nProvision of contraceptive methods \\n\\uf0b7 \\nTreatment of some problems(e.g. mild to moderate anaemia, mild puerperal depression, mastitis) \\n\\uf0b7 \\nPre – referral treatment of  severe complications  (e.g. severe postpartum bleeding , puerperal \\nsepsis) \\n\\uf0b7 \\nVit. A mega dose suplementation \\n\\uf0b7 \\nRecording and reporting  \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nAntiretroviral treatment (ART) \\n\\uf0b7 \\nTreatment of uncomplicated malaria \\n \\nPostpartum care at REFFERRAL FACILITY \\nAll of the above plus\\nTreatment of all complications \\n\\uf0b7 \\nSevere anaemia \\n\\uf0b7 \\nSevere postpartum bleeding \\n\\uf0b7 \\nSevere postpartum infections \\n\\uf0b7 \\nSevere postpartum depression \\nTubal ligation and vasectomy \\nSituational \\nAll of the above plus\\nTreatment of complicated malaria'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n12 \\n \\n \\nNew born care \\n \\nInterventions at home/ COMMUNITY level \\nPromotion and support for:\\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nThermal protection \\n\\uf0b7 \\nInfection prevention : general hygiene, hand washing , cord care and safe disposal of baby’s \\nfaeces \\n\\uf0b7 \\nCare of a small baby without breathing and feeding problems: frequent  breast feeding , skin – to \\nskin contact \\n\\uf0b7 \\nPrevention of indoor air pollution \\n\\uf0b7 \\nNew born stimulation and play \\n\\uf0b7 \\nRecognition of danger signals, problems, illness and timely care- seeking \\n\\uf0b7 \\nSupport for routine care and follow up visits \\n\\uf0b7 \\nBirth registration \\n\\uf0b7 \\nPromotion, protection and support for exclusive breast feeding \\n\\uf0b7 \\nMonitoring and assessment of wellbeing and response to maternal concerns \\n\\uf0b7 \\nCare of preterm/ low birth weight without breathing problems: support for breast- milk feeding, \\nKangaroo mother care, skin to skin care \\n \\nSituational \\n\\uf0b7 \\nPromotion and provision of insecticide treated bed nets \\n\\uf0b7 \\nAdherence to ARV for PMTCT \\n \\nInterventions at FIRST LEVEL HEALTH FACILITY \\nAll of the above plus\\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nEye infection prophylaxis \\n\\uf0b7 \\nImmunization \\n\\uf0b7 \\nAdditional follow up for at risk babies \\n\\uf0b7 \\nTreatment of local infections (skin , cord, eye, mouth) \\n\\uf0b7 \\nIdentification , initial management and referral of a new born with any sign of severe illness , \\ninjury or malformation \\n\\uf0b7 \\nRecording and reporting \\nSituational \\nAll of the above plus \\n\\uf0b7 \\nARV regimens for PMTCT including ART \\n\\uf0b7 \\nSupport for safer infant feeding options \\n \\nInterventions at REFFERRAL FACILITY \\nAll of the above plus\\nManagement of a new born with severe problems: general care of a sick newborn and specific care for: \\n\\uf0b7 \\nPreterm babies with breathing problem or unable to feed orally (includes provision of KMC) \\n\\uf0b7 \\nSevere infection \\n\\uf0b7 \\nSevere birth asphyxia \\n\\uf0b7 \\nOther: severe jaundice, malformations \\n\\uf0b7 \\nPresumptive treatment of congenital syphilis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n13 \\n \\nChapter 03 \\n \\nMATERNAL CARE MODEL IN SRI LANKA \\n \\nAntenatal care model currently used in Sri Lanka is the traditional multi-visit model; once a \\nmonth up to 28weeks, fortnightly during 28-36weeks and weekly thereafter. The domiciliary \\ncare also follows the same model. Pregnant women are simultaneously receiving maternal \\ncare services at multiple settings eg. Field clinic, hospital clinic, specialized care unit, and \\nsome even visits to obstetricians in the private sector.  Therefore, altogether pregnant woman \\nreceived 12-18 clinic visits and 8-10 home visits during antenatal period as more than 90% of \\nwomen registered for antenatal care before 12 weeks. Postnatal care model consists of two \\nhome visits during 1st 10 days, one visit between 11-28 days, and one visit around 42 days \\n(altogether 4 visits). This model also includes a postnatal clinic visit at 4-6 weeks. However, \\nin contrast to antenatal clinic and domiciliary care coverage which is almost universal, only \\n80% of women receive at least one postnatal home visit. Postnatal clinic care is not well \\nestablished in the country.  \\nThough Sri Lanka has achieved effective service coverage in MCH/FP, the quality of service \\ndelivery needs further improvement in order to attain further reductions of maternal mortality \\nand morbidity. Therefore, an external review of Maternal and New born Health in Sri Lanka \\nwas conducted in 2007 to identify the gaps in existing service delivery system. This review \\nhas identified the need to streamline the provision of maternal care and bring it into line with \\nevidence based interventions with the objective of improving the quality of care and \\npreventing the duplication of the services. Further, recommendations of National Maternal \\nMortality Reviews and District Maternal and Child Health Reviews also pointed out the need \\nfor revision to streamline the services and to address the gaps in service provision. \\nMeanwhile, need of strengthening the integration of elimination of congenital syphilis (ECS) \\nand prevention of mother to child transmission of HIV (PMTCT) programmes into maternal \\ncare programme was highlighted.  \\nTherefore, Family Health Bureau in collaboration with Sri Lanka College of Obstetricians, \\nand Gynecologists, WHO and UNICEF revised the existing service provision model of \\nantenatal and postnatal care. Series of consultative meetings were held with the relevant \\nstakeholders and reviewed available models in the world including WHO Antenatal care \\nrandomized trial and NICE guidelines. After considering the existing health policies and \\nhealth care system in the country, achievements and gaps, ability of packaging evidence \\nbased interventions, client and service providers’ satisfaction, development in transport and \\ncommunication, cost effectiveness and expectation of the public, the following model was \\ndeveloped to deliver evidence based interventions to reduce maternal and child mortality and \\nmortality.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n14 \\n \\n \\nProposed Maternal Care Model \\nDomiciliary and clinic care \\n \\n \\n \\n \\n \\n \\n \\nClinic Visit- 2           12-14weeks \\nClinic Visit -3           18-20 weeks \\nPre pregnancy care\\nEarly Registration of Pregnant Mother \\n(preferably 6-8weeks) either at clinic/home By \\nPHM \\nBooking visit (clinic visit 1) 6-8 weeks \\nLow Risk Pregnancy \\nRisk assessment\\nRisk uncertain \\nHigh Risk Pregnancy  \\nProvide Basic \\nantenatal care \\nRefer to specialized \\ncare to clarify the risk \\nRefer to  Specialized \\ncare\\nClinic Visit -4           22- 24 weeks \\nk\\nClinic Visit – 5       26-28 weeks \\nClinic Visit – 6     32-34 weeks \\nHome visit 1 (6-\\n12 weeks) \\nAt Field Clinic/ \\nMO /MOH/RMO \\nIf registered at home Refer to field ANC\\nAntenatal class I \\n1st Trimester\\nField Clinic/ MO/ \\nMOH/RMO \\nShared care/ Out \\nreach clinic/ field \\nclinic \\nHome visit 2 \\n22-24 weeks\\nAntenatal class II \\n2nd Trimester\\nAntenatal class III \\n3rd Trimester \\nField Clinic/ \\nMO/MOH/RMO\\nField Clinic/ \\nMO/MOH/RMO \\nField Clinic/ \\nMO/MOH/RMO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n15 \\n \\nClinic Visit -7         36 weeks \\nClinic Visit -8       38 weeks \\nDelivery at an Institution \\nPostnatal home visit 1 (0-5 days) \\nKCC chart \\nPostnatal home visit 2 (5-10days) \\nPostnatal home visit 3 (14-21days) \\nPostnatal clinic visit (4-5wks) \\nPostnatal home visit (6-7wks) \\nApply EPDS \\nscreening  tool\\nIf no pains admit for \\ninward review\\nImmediate postnatal care\\nPostnatal screening of mother & baby \\nMother \\nBaby \\nWell women  \\nservices \\nFamily \\nplanning \\nservices \\nInfant care \\nClinic Visit -9       40 weeks \\nHome visit 3 \\n36 -38 weeks\\nField Clinic/ \\nMO/MOH/RM\\nField Clinic/ \\nMO/MOH/RMO\\nPHM \\nPHM \\nPHM \\nMO/MOH \\nPHM \\nField Clinic/ \\nMO/MOH/RM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n16'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n17 \\n \\n \\n \\n \\n \\n \\n \\nAntenatal Care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n18'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n19 \\n \\n \\nChapter 04 \\nANTENATAL CARE \\nAll eligible couples should be registered in the eligible couple register (H 526) by the area \\nPHM. All the women who are getting pregnant are assumed to have pre-pregnancy care \\n(Rubella immunization, preconception folic acid supplementation, screening for medical \\ncondition and nutritional assessment and if required necessary family planning services). \\nDuring pre pregnant care, couples should be educated regarding pregnancy symptoms and \\nimportance of early initiation of antenatal care. They should be educated when to and how to \\ninform PHM once they get pregnant. These services should be provided through women’s \\nhealth program and family planning program. In Sri Lanka, antenatal care provides through \\nclinic care and domiciliary care.  \\nThe main objective of antenatal care is to monitor the health of the pregnant mother as well \\nas the health and development of the fetus. Antenatal care helps to screen for possible adverse \\nconditions during pregnancy and to predict problems with pregnancy, labour or birth. \\nTherefore, they can be either prevented, or manage efficiently. It also helps to initiate a plan \\nfor continuing care during pregnancy and post partum period.  \\n Antenatal care consists of: \\n1. Assessment:  Maternal risk factors, Ongoing assessment of maternal and fetal well-\\nbeing and screening for maternal complications \\n2. Care provision \\n3. Health promotion \\n \\nAntenatal care at the clinic \\nFollowing the registration at the clinic or at home, pregnant mother should receive the clinic \\nantenatal care as early as possible, preferably around 6-8 weeks of gestation. The officers \\nwho provide antenatal care should follow the General Circular No. 01-25/2004 issued by the \\nDirector General of Health Services on 14th September 2004 on antenatal care  Each antenatal \\nclinic visit should be objective. All findings of the clinic antenatal care should be entered on \\nthe Pregnancy Record (H512 A and B) by the officer who performs the examination. \\nDesignation of the officer who performs the obstetric examination should enter in the \\nrelevant cage in both H 512 A & B. The services which should be provided at each clinic \\nvisits are mentioned below. \\n \\nBooking Visit 6-8 weeks \\nObjectives of the visit \\n1. To provisional establishment of pregnancy (either clinically/ with laboratory testing)  \\n2. To assess medical and obstetric risk factors and take necessary actions \\n3. To assess the psychological/nutritional status and take necessary actions \\n4. To provide necessary care and health promotion \\n5. Screening for anaemia, syphilis and testing for blood group and Rh \\n6. Check for dental conditions and appropriate referral \\n7. Examination of heart to identify heart diseases'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n20 \\n \\nWhen mother is registered at the clinic, PHM should visit her home within 12 weeks of \\nPOA as described in the section on domiciliary care. \\nDuring booking Visit/First visit all pregnant mothers must be seen by a medical officer \\n(MOH/AMOH/MO) \\nIf MOH/MO is not available in the first visit, the closest clinic date should be given to the \\nmother for the next visit. A medical officer should examine all the pregnant women. \\na) Obtain information on: \\nPersonal history  \\n\\uf0d8 Name \\n\\uf0d8 Age (date of birth) \\n\\uf0d8 Address and telephone number \\n\\uf0d8 Marital status and duration \\n\\uf0d8 History of consanguinity \\n\\uf0d8 Educational level: primary, secondary, university \\n\\uf0d8 Economic resources: employed? (Salaried work or short-term?) \\n\\uf0d8 Type of occupation of mother and husband \\n\\uf0d8 Substance abuse: alcohol or drugs ( husband & wife)  \\n\\uf0d8 Domestic Violence \\n\\uf0d8 Availability of a responsible person at home in an emergency \\n\\uf0d8 Mode of transport in an emergency \\n\\uf0d8 Closest EMOC facilities –the distance/ transport facility \\n \\nMedical history (Past and present) \\n\\uf0d8  Specific diseases and conditions:\\x00 tuberculosis, heart disease, chronic renal/hepatic \\ndisease, epilepsy, diabetes mellitus, hypertension, psychiatric illnesses and any \\nchronic diseases \\n\\uf0d8 STIs \\n\\uf0d8 HIV status, if known to be positive please follow the guidelines (page 114) without \\nentering into the pregnancy record. \\n\\uf0d8 Other specific conditions depending on prevalence in area (for example, hepatitis, \\nmalaria, Thalaseamia) \\n\\uf0d8 Other diseases; past or chronic; allergy(-ies) \\n\\uf0d8 Operations other than caesarean sections (heart/ lung surgeries) \\n\\uf0d8 Past blood transfusions, Rhesus (D) antibodies \\n\\uf0d8 Current use of medicines – specify \\n\\uf0d8 Period of infertility: when? duration, cause(s), specialized treatment taken for \\ndifficulties in conceiving eg. Ovulation induction, IVF etc. \\n \\nFamily History \\n\\uf0d8 Diabetes mellitus \\n\\uf0d8 Hypertension/ PIH \\n\\uf0d8 Twins \\n\\uf0d8 Congenital abnormalities'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n21 \\n \\nHistory of present pregnancy \\n\\uf0d8 Date of last menstrual period (LMP) \\n\\uf0d8 Certainty of dates (by regularity, cycle length, accuracy of recall and other \\nrelevant information) \\n\\uf0d8 Habits: smoking/chewing tobacco, alcohol, drugs (frequency and quantity) \\n\\uf0d8 Any other concerns with regards to pregnancy (pain, vaginal bleeding, and \\nexcessive vomiting other: specify) \\n\\uf0d8 History of malaria attacks- when was the last attack \\n\\uf0d8 Any other discomforts \\nContraceptive history \\n\\uf0d8 Method use \\n\\uf0d8 When it was  started \\n\\uf0d8 When it was stopped \\n\\uf0d8 Method failure or not \\n \\nObstetric history (review all the available records, diagnostic cards, clinic records etc.) \\n\\uf0d8  Number of previous pregnancies. \\n\\uf0d8 Date (month, year) and outcome of each event (live birth, stillbirth, abortion, ectopic, \\nhydatidiform mole). Specify (validate) preterm births and type of abortion, if \\napplicable and possible. \\n\\uf0d8 Birth weight (if known) \\n\\uf0d8 Sex of the child \\n\\uf0d8 Periods of exclusive breast-feeding: For how long? \\n\\uf0d8 Did she have any feeding difficulties in previous pregnancies? \\n\\uf0d8 Special maternal complications and events in previous pregnancies; specify which \\npregnancy (- ies), validate by records (if possible): \\n \\n\\uf0b7 Recurrent early abortion, induced abortion and any associated complications \\n\\uf0b7 Thrombosis, embolus \\n\\uf0b7 Hypertension, pre-eclampsia or eclampsia \\n\\uf0b7 Gestational diabetes \\n\\uf0b7 Placenta praevia/ APH \\n\\uf0b7 Liver disease/fatty liver \\n\\uf0b7 Breech or transverse presentation \\n\\uf0b7 Obstructed labour, including dystocia \\n\\uf0b7 Third-degree tears \\n\\uf0b7 Retained placenta \\n\\uf0b7 Post partum haemorrhage \\n\\uf0b7 Puerperal sepsis \\n\\uf0b7 Anesthetic complications \\n \\nObstetrical interventions  \\n\\uf0b7 Cervical cerclage (Shirodkar Suturing) \\n\\uf0b7 Caesarean section (indication, if known) \\n\\uf0b7 Forceps or vacuum extraction'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n22 \\n \\n\\uf0b7 Manual/instrumental help in vaginal breech delivery \\n\\uf0b7 Manual removal of the placenta. \\n\\uf0b7 Dilatation and evacuation (D&E) or dilatation and curettage (D&C) \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies \\n specify which pregnancy(- ies), validate by records (if possible): \\n\\uf0b7 Twins or higher order multiples \\n\\uf0b7 Low birth weight: <2500 g/ 2500-2000g / 1999- 1500g/ <1500g \\n\\uf0b7 Intrauterine growth retardation (if validated) \\n\\uf0b7 Rhesus-antibody affection (erythroblastosis, hydrops) \\n\\uf0b7 Malformed or chromosomally abnormal child \\n\\uf0b7 Macrosomic (>3500g) newborn \\n\\uf0b7 resuscitation or other treatment of newborn (SCBU and NICU admissions)/ \\nventilation \\n\\uf0b7 perinatal, intrapartum, neonatal or infant death (also: later death) \\n\\uf0b7 Feeding problems \\n \\nb) Perform clinical examination \\n\\uf0b7 Record weight (Kg) and height (metres) (page 71) \\n\\uf0b7 Calculate BMI using BMI chart/cycle (page 71)and record it in pregnancy \\nrecord \\n\\uf0b7 Check for signs of severe anaemia: pale complexion, fingernails, conjunctiva, \\noral mucosa and shortness of breath  \\n\\uf0b7 Look for edema (ankles, fingers, face and abdoman) \\n\\uf0b7 Do a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities spinal/pelvic, icterus, cyanosis, clubbing  \\n\\uf0b7 Measure blood pressure and record  (Page 75) \\n\\uf0b7 Auscultate heart and  chest: Heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0b7 Perform obstetric examination (page 76) \\n\\uf0b7 Perform breast examination if needs (lumps, nipple problems) \\n \\nc) Perform following tests  \\n\\uf0b7 Urine: Check for glucose (Benedicts test) and protein (coagulation test) or if \\navailable use urine test strips for protein and sugar (page 81) \\n\\uf0b7 VDRL testing as a screening test of Syphilis ( page 83) \\n\\uf0b7 Blood group and Rh (Should be done through government sector) \\n\\uf0b7 Check Haemoglobin at first visit using colour scale/ any other method (page \\n84) \\n \\n(Discuss with the nearest hospital with laboratory facilities to test Hb. This will be more \\naccurate method than colour scale) \\n \\n\\uf0b7 If there are risk factors (BMI above 25kg/m2, previous baby weighing \\n3.5kg or above, previous gestational diabetes, first degree relative with \\ndiabetes) do PPBS, if the value is more than 120mg/dl, refer for OGTT in \\na specialized unit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n23 \\n \\n \\n \\nd) Implement the following interventions \\no If any risk is identified, act according to the guidelines (page 41) \\no If woman is on treatment for diabetes, hypertension, epilepsy, psychiatric disease or \\nany other disease refer them to the relevant clinics for continuous treatment \\no Mothers without high risk conditions should be offered basic antenatal care \\no Folic acid (5mg daily) supplementation  \\no Nutritional supplementation (2 packets of Triposha/CSB for all mothers) \\no Ask to seek medical advise if having vaginal bleeding, severe vomiting or abdominal \\npain or any other concerns  \\n \\ne) Discuss and understand: \\nGive the pregnant woman an opportunity to discuss issues and ask questions: time for free \\ncommunication \\n\\uf0b7 On whom to communicate or where to go in case of bleeding, abdominal pain and any \\nother emergency, or when in need of other advice (page 65) \\n\\uf0b7 On issues related to sexual relationship and activities  \\n\\uf0b7 Nutrition during pregnancy (page 85) \\n\\uf0b7 Minor ailments and their management during early pregnancy (page  91) \\n\\uf0b7 Advise the woman to participate with the husband or any other care giver for \\nantenatal   classes where they can learn how to deal with a pregnancy (page) \\n \\nf) \\nSchedule next appointment:  \\n \\nPlan second clinic visit at 12-14 weeks of  POA. State the date and time  \\n \\nConfirm the date for antenatal classes \\n \\nThis should be written in the pregnancy record (512A) and in the clinic’s appointment book if \\navailable. \\n \\ng)  Maintain complete records \\n            Complete clinic records. \\n            Complete the Pregnancy record.  \\nGive the record to mother and advice her to bring it with her to all appointments with \\nany health services.                  .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n24 \\n \\nSecond Clinic Visit- 12-14 weeks \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. To see the results of the tests and take necessary actions \\n4. Tetanus toxoid immunization  \\n5. To give Antihelminthic  treatment \\n6. To start micronutrient supplementation (Iron, folic acid, Vit C and calcium lactate) \\n7. To provide necessary care and health promotion \\n8. To discuss the birth  and emergency plan \\n \\na) Obtain information on: \\nPersonal/ social history \\n\\uf0d8 Note any changes since first visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc \\n\\uf0d8 Change of home environment \\n\\uf0d8 Change of duty station or occupation of wife or husband  \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at first visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since first visit. \\n\\uf0d8 Review intake of medicines, other than folic acid \\n\\uf0d8 Folic acid intake: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at first visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since first visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral swelling, \\nshortness of breath with mild exertion) observed by the woman herself, by her \\npartner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken  \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart (page 73), Look for deviations \\nof the expected weight gain'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n25 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion \\n\\uf0a7 Perform abdominal examination- compare the fundal height with POA , look for \\nabdominal masses (page 76) \\n \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb% if signs and symptoms of  severe anaemia are detected on examination \\n\\uf0a7 Check urine for protein using coagulation test  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare based on evidence since first visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain of  bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Tetanus toxoid immunization (page 107). \\n\\uf0a7 Start iron folate supplementation with Vit C and calcium supplementation (page \\n100) if mother does not have vomiting or loss of appetite. Advice not to take iron \\nand calcium together (iron at night and calcium in the morning before/after meal.) \\n\\uf0a7 Malaria prophylaxis to be decided by MOH  according guidelines issued by AMC \\n(page 145) \\n\\uf0a7 Nutritional supplementation (Triposha/CSB 2 packets ) \\n\\uf0a7 Ask to seek medical advice if having vaginal bleeding or abdominal pain or any \\nother symptom  \\n\\uf0a7 If risk conditions are identified, refer them to the specialized care  \\n \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Create an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the pregnancy record) as at first visit (page 65) \\n\\uf0a7 Discuss and write down the birth plan \\n\\uf0a7 Schedule the third visit at 18-20 weeks either at field clinic or at specialist clinic \\ndepending on the local policy. \\n\\uf0a7 Advice to write down the date of quickening \\n\\uf0a7 Confirm the date for antenatal class II \\n \\ng) Maintain complete records \\nComplete clinic records and pregnancy record. Give the record to mother and advise her to \\nbring it with her to all appointments with any health services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n26 \\n \\nVisit 3 (18-20 weeks) \\n \\nThis visit may be either at field clinic or at specialist clinic or at out reach clinic. \\nObjectives of this visit in a field clinic \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. For primies, to give second dose of tetanus Toxoid \\n4. To provide necessary care and health promotion \\n5. To Examine the heart to identity abnormalities \\n \\nObjectives of the visit in a specialist clinic \\n1. To confirm dates and placental position \\n2. To serve as a booking visit for delivery \\n3. To assess the progression of pregnancy \\n4. To assess the risk conditions and take necessary actions \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Fetal movements: whether felt or not. Note the date of first recognition in pregnancy \\nrecord. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n27 \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart – look for deviations of the \\nexpected rise\\x00\\x00 (page  73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0a7 Measure SFH and record (page 76). \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n\\uf0a7 Check urine for protein using coagulation test \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 \\x00If complain bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 For primies give second dose of Tetanus toxoid immunization (page 107). \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at second visit  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the forth visit at 22-24 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record to mother and advise her to bring it with \\nher to all appointments with any health services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n28 \\n \\nClinic Visit 4 (22-24 weeks) \\nObjectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To  screen for  risk factors and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge \\n(amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect, refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n29 \\n \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If uterine height (SFH) is above expected: refer for evaluation. \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the fifth visit at 26-28 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n30 \\n \\nClinic Visit 5 (26-28 weeks) \\nObjectives of the visit  \\n1 To assess the progression of pregnancy \\n2 To  screen for  risk factors and take necessary actions \\n3 To screen for gestational diabetes \\n4 To screen for anaemia \\n5 To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n31 \\n \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76). \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria all mothers  \\n\\uf0a7 Screen all pregnant women for anaemia \\n\\uf0a7 All pregnant mothers should screen for GDM using PPBS (cut off 120mg/dl). For \\nfurther details see page 110) \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina : Refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the sixth visit at 32 - 34 weeks \\n\\uf0a7 Confirm the date for antenatal class III \\n \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n32 \\n \\n \\nClinic Visit 6 (32-34 weeks) \\n Objectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n4. To look out for signs of PIH, IUGR, macrosomia, polyhydroamnios  \\n5. To ascertain the lie and presentation  \\n6. To provide necessary care and health promotion \\n7. To reevaluate the birth plan \\n8. To examine the heart to detect any abnormalities \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Any other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n33 \\n \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal \\nbreathing sounds \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH, record, interpret and take necessary action if any deviation from \\nexpected (page 76) \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Look for Lie and Presentation.    \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria   \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit.\\x00 \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina or vaginal discharge: refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n\\uf0a7 If  transverse lie or breech presentation: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal/ written information supported by antenatal classes  \\n\\uf0a7 Give advice on measures to be taken in case of pain, dribbling and bleeding (page 65)  \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency (page 65).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n34 \\n\\uf0a7 Plans to ensure transport is available in case of an emergency (page 65). \\n \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Schedule the  seventh visit at 36 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments any health services. \\n \\n \\nClinic Visit 7 (36 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n3. To assess the risk conditions and take necessary actions \\n4. To ascertain the lie and presentation  \\n5. To introduce kick count chart \\n6. To look out for signs of PIH, IUGR  \\n7. To provide necessary care and health promotion \\n8. To reevaluate the birth plan  \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic  difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review medications other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n35 \\n \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for reduced fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00  \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema (especially facial) and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record \\n\\uf0a7 \\x00Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis,shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 \\x00Any new symptoms of recent onset: refer as required . \\n\\uf0a7 If complained of bleeding per vagina or vaginal discharge, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected : refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n36 \\n \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Introduce the kick count charts (KCC) and give clear guidance to maintain the \\nchart (page 80) \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Re-emphasis the signs and symptoms of labour \\n\\uf0a7 Re-confirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Plans to ensure transport is available in case of an emergency. \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n(page 172). \\n\\uf0a7 Schedule the eight visit at 38 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (38 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Re-evaluate presentation/ lie/ PIH/ SFH/ weight chart/ KCC \\n4. To provide necessary care and health promotion \\n5. To reevaluate the birth and emergency plan  \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron, folate , calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n37 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart,  look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected . \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc) Perform the following tests:  \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH above the expected ; refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n38 \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Explain the signs and symptoms of labour and advice to get admitted to a hospital if \\nshe experience any \\n\\uf0a7 Give advice on measures to be taken in case of labour. \\n\\uf0a7 If no labour pains by 40 weeks ask her to get admitted to a specialized unit for \\nassessment. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Ensure the plans to ensure transport, to whom accompany with her, money and items \\nto be taken  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n\\uf0a7 Schedule the eighth visit at 40 weeks and explain her delivery may occur before the \\nnext clinic visit \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (40 weeks) \\nObjectives of the visit \\n1. To ensure that the mother reaches the place of delivery in time  \\n2. To assess the risk conditions and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n \\nMedical history \\n \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n39 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. abdominal or back pain, bleeding, \\nvaginal discharge (amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n \\nb)  Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart. Check the total weight gain. \\n\\uf0a7 Measure blood pressure and record .Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH and record. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc)  Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n \\nd) Assess for referral  \\n Refer to the hospital where delivery is planned to be taken place for assessment.                                              \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Ask her to get admit to the hospital for an indoor assessment \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on danger signals (reduced fetal movements, bleeding PV, headache, \\nshortness of breathing, severe chest pain, rapture of membranes and high fever) \\n\\uf0a7 Give advice on measures to be taken in case of  labour \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency or ant other need. \\n\\uf0a7 Plans to ensure transport is available in case of an emergency.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n40 \\n \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Ask her to go to the nearest hospital if labour signs and symptoms occurred, or if no \\nlabour pain after 40 weeks, ask her to go to specialized care unit. \\n\\uf0a7 Advice to continue iron, folic acid, Vit C and calcium lactate for 6 months after \\ndelivery. \\n\\uf0a7 Emphasis on following: \\nTo inform the area PHM as soon as the mother came home after delivery \\nTo attend the postpartum clinic after 4 weeks of delivery \\nTo continue micronutrients for 6 months after delivery \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 \\x00Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services.  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during pregnancy\\nAdvise to go to the hospital immediately, day or night, without \\nwaiting if any of the following signs: \\n\\uf0a7 Vaginal bleeding \\n\\uf0a7 Convulsions \\n\\uf0a7 Severe headaches with blurred vision \\n\\uf0a7 Fever and too weak to get out of the bed. \\n\\uf0a7 Severe abdominal pain/ epigastric pain /RHC pain \\n\\uf0a7 Fast or difficult breathing \\n\\uf0a7 Reduced fetal movements \\nShe should go to the hospital as soon as possible if any of the following \\nsigns: \\n\\uf0a7 Fever \\n\\uf0a7 Abdominal pain \\n\\uf0a7 Feels ill \\n\\uf0a7 Swelling of fingers, face, legs \\nDating Scan \\nConfirmation of dates is essential for early identification of IUGR. USS is the \\nmost reliable method of confirmation of dates. However the parameters used \\nare depend on the POA. \\n \\n11- 14 weeks of POA– Crown rump length \\n16- 20 weeks of POA – Head circumference'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n41 \\n \\nChapter 5 \\n \\nMANAGEMENT OF RISK CONDITIONS AT FIELD LEVEL \\nNote: \\n\\uf0b7 When a high risk pregnant woman receives her antenatal care from a specialized unit \\nin a hospital, she should receive domiciliary care from the PHM. If she wish she can \\nattend to the field clinics also. \\n\\uf0b7 When pregnant women are not receiving micronutrients or food supplementations \\nfrom the hospital clinic, they should be supplied from the field clinic. \\n\\uf0b7 If high risk mothers are not receiving the specialized care, they should receive \\nadequate care from the field clinic. \\n\\uf0b7 If pregnant women have any problem they can attend to the field clinic disregarding \\nthe clinic appointment or risk condition \\n\\uf0b7 All the high risk pregnant women should attend to the antenatal classes with their \\nhusbands \\n \\nRisk Condition \\nAction to be taken \\n Past Obstetric History  \\nPrevious stillbirth (antenatal or intrapartum) \\nor neonatal loss or malformed babies \\nRefer at first visit  \\nAct according to the consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM  \\nPay special attention for kick count chart after 36 \\nweeks. \\n \\nHistory of 2 or more consecutive first \\ntrimester miscarriages \\n \\nRefer at first visit.  \\nDepending on the cause, MOH/ consultant \\nObstetricians can decide whether to continue as a \\nrisk mother or not  \\nNeed to do a proper screening including genetic \\nscreening, thrombophilic screening at the specialized \\ncare unit \\n \\nHistory of preterm delivery before 37weeks, \\nor second trimester miscarriage  \\nRefer at first visit.  \\nAct according to the Consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n42 \\n \\nHistory of PIH,  eclampsia/ pre-eclampsia \\n \\nRefer at first visit. \\nIf there is a history of PIH only, no need to refer \\nspecial care. Closely monitor the BP \\nIf there is H/O of pre eclampsia/Eclampsia, refer at \\nthe 1st visit for specialized care. \\nNeed close/ regular monitoring of BP \\nIf abnormally detected in BP, refer immediately \\n \\nHistory of APH             \\nIf it is due to placenta previa, refer to specialized \\ncare at 18-20wks for scan to ascertain the position of \\nthe placenta   as there is a risk of recurrence. \\nPlacental abruption: there is a possibility of \\nrecurrence. Refer at 1st visit. \\nCorrect the anaemia if detected. \\nAscertain blood group and Rh. \\n \\nHistory of retained placenta \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility  \\n \\nHistory of postpartum haemorrhage \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility \\n \\nHistory of cesarean section/ Myomectomy \\nAll the women with history of LSCS or \\nmyomectomy should have a scan at 18-20 weeks to \\ndetect placental localization. \\nRefer to specialized unit for this and to get \\nspecialized advice regarding delivery. \\nNeed to be admit to an institution with CEmOC \\nfacilities by 38weeks \\nIf she gets pain need to admit to the hospital in \\nfasting  state  \\n \\nHistory of surgery on reproductive tract  \\n(removal of septum, cone biopsy, large loop \\nexcision of  transformational zones \\n(LLETZ),  \\nRefer for specialist care at first visit for a scan. Act \\naccording to the consultant obstetrician’s instructions\\nHistory of a birth with birth weight < 2500g \\nRefer for specialist care at first visit. \\n  \\nHistory of a birth with weight > 3500g \\nDo a PBBS and if the result is > 120mg/dl refer to \\nspecialist clinic for OGTT.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n43 \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of  IUGR \\nRefer for specialist care at first visit. They will need \\naccurate dating scan before 14 weeks and regular \\nUSS with growth charts.  \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of Feeding difficulties/ breast \\nsurgery \\nMOH should  identify reasons and plan for  \\nappropriate interventions at last trimester \\nPresent pregnancy \\n Age less than 20yrs \\nIf less than 18 years refer to specialized care. \\n18-20yrs MOH / MO who provide antenatal care \\nshould monitor closely.    \\n \\nAdvanced maternal age (Age  >35yrs) \\nNeed more close monitoring by MOH as more prone \\nto Hypertension, Diabetes Mellitus etc \\nRefer necessary cases such as sub fertile mothers, \\nelderly primies, NCD complicating pregnancies to \\nspecialized care \\n \\nHeight < 145cm \\nRefer to a specialist unit at last trimester for an \\nassessment. To be delivered in a CEmOC  facility \\n \\nBMI  < 18.5kg/m2 \\nMOH should manage according to the given \\nguidelines. \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain \\n \\n BMI  25 -29.9kg/ m2 \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain. \\n \\nBMI ≥30kg/ m2 \\nMOH should thoroughly screen for Hypertension, \\nPIH, Diabetes mellitus. \\nRefer to specialist unit for OGTT. \\nClosely monitor the weight gain and SFH to detect  \\nMacrosomia and polyhydroamnios \\nAscertain the lie after 36weeks \\nManage according to instruction given. \\n \\n Primigravida \\nMOH should manage her at his field clinic if there \\nare no other risk factors.  \\nDuring third trimester look for lie, presentation and \\nhead engagement.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n44 \\n Parity (5 or more) \\n Refer to specialist care at first visit. \\nCorrect anaeamia if her Hb level is  < 11g/dl. \\nNeed   special counseling for Family Planning. \\nTry to identify social problems if any \\nPlan delivery at CEmOC facility \\n \\nMultiple pregnancy \\nIf suspected, refer as early as possible to specialized \\ncare \\n \\nDiastolic blood pressure more than \\n90mmHg   \\nAdmit to a nearest hospital for monitoring for 24 \\nhours, if BP persists above 90mm Hg, transfer to \\nCEMOC facility (refer management guidelines of \\nPIH in the field).  \\n \\nDiastolic > 110mmHg or systolic 160 \\nmmHg or more \\nadmit urgently to the nearest hospital manage \\naccording to guidelines and transfer  immediately to \\na CEmOC facility \\n \\n Vaginal bleeding (any time) \\nAdmit to the nearest hospital  for assessment and \\nmanagement  \\nIf need, refer to a specialist unit \\n \\nMaternal jaundice \\nAdmit to the nearest hospital to transfer specialized \\nunit immediately. \\n \\nSevere maternal anaemia  (Hb% <7g/dl) \\nNeed to admit to a specialized care unit for \\ninvestigation and correction. \\n \\nMaternal malaria \\nAdmit to nearest hospital  medical unit  (manage \\naccording to AMC guideline) \\n \\n Maternal Syphilis \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\n Maternal HIV \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\nUncertain dates/ irregular periods \\nNeed to refer specialized unit to ascertain the dates \\nbefore 20 weeks. (USS is accurate for dating only   \\nbefore 20 weeks.) \\n \\n Intra Uterine Growth Retardation (IUGR) \\nRefer to specialized care. They will need accurate \\ndating and regular USS with growth charts. Need to \\nplan for delivery at a CEmOC facility. POA  of \\ndelivery also need to decide based on the specialist \\nopinion'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n45 \\n Mal-presentations and abnormal lie  after \\n34 weeks \\nRefer to a specialized unit. \\nOther risk conditions \\n \\nDiabetes Mellitus/ Liver disease and renal \\ndiseases \\nRefer to a consultant Obstetrician. He/she will \\nmanage the pregnant woman with other relevant \\nspecialists. \\n \\nRheumatic and congenital heart disease \\nIf there is a suspicion of having a murmur, refer to \\ncardiologist for confirmation and diagnosis. After \\nthat refer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists.  \\nDiagnosed cases need to refer to consultant \\nObstetrician for combined care with a cardiologist. \\n \\nEpilepsy \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(neurologist/ physician) \\n \\n Mental disorders \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(psychiatrist/ MO mental health) \\n \\nAsthma \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(general or chest physician) \\n \\nRh Negative mother \\nRefer to a consultant Obstetrician. \\nSend a blood sample to the blood bank with special \\nreferral form for screening antibodies.  \\n \\nSub fertility ( inability to conceive \\nirrespective of regular unprotected \\nintercourse  for 2 or more years) \\nRefer for specialized care  \\nSocial problems \\n \\nUnmarried mothers/ widows (single \\nmothers), geographically marginalized and \\nother social factors \\nEnsure social support (MOH/PHM) Social service \\nofficer, Grama Niladhari, Samurdhi officer etc. \\nTargeted and more frequent home visits by PHM \\nLink with social security programs'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n46 \\n \\nChapter 06 \\nDOMICILIARY CARE FOR LOW RISK PREGNANCIES \\n \\nDomiciliary care for pregnant women is provided by the area PHM. At the time of \\nregistration as an eligible couple, PHM should give the screening questionnaire for newly \\nmarried couples and help them to fill it. Then she should go through the questionnaire and \\nwith further clarifications try to identify the risk conditions if available. After that she should \\nrefer the couple to MOH clinic for further screening by a medical officer and should give the \\ndates for sensitization classes. PHM should make aware the couple regarding the importance \\nof early commencement of antenatal care and pre pregnancy folic acid supplementation. She \\nalso should inform them how to inform PHM once the wife gets pregnant.  \\nWhen a woman gets pregnant, PHM should register her ideally by 6-8 weeks. PHM should \\nmake aware the community regarding the importance of early registration as a pregnant \\nwoman and the means of communicating with her. PHM can register the pregnant women \\neither at home or in the clinic. It is better to register at home as PHM gets an opportunity to \\nassess the socioeconomic condition, home environment and to meet the other members of the \\nfamily during early pregnancy. This is an opportunity to educate the family members \\nregarding pregnancy and other relevant topics.  \\n \\nHome visit 1 (6 -12 weeks) \\n \\nObjectives: \\n1. To assess the condition of the pregnant woman including socio- economic status  \\n2. To develop a rapport and linkage with the pregnant woman and the family \\n3. To educate the  pregnant woman and the family regarding the maternal care \\n \\nWhen the pregnant woman is registered at the home, that visit can be considered as the first \\nhome visit. When the pregnant woman is registered at the clinic, PHM should visit her before \\n12 weeks of POA. During this visit PHM should: \\na) Assess the condition of the pregnant woman (physical, mental, social and \\nenvironmental) \\n \\nObtain information on: \\n \\nPersonal history : \\n- \\nName \\n- \\nAge /date of birth  \\n- \\nAddress and telephone number  \\n- \\nMarital status- duration and history of subfertility \\n- \\nHistory of consanguinity \\n- \\nPre pregnancy care: Eligible couple registration'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n47 \\n \\n- \\nRubella Immunization  \\n- \\nIntake of folic acid \\n- \\nAttend to a pre pregnancy care programme/not \\n- \\nThalasseamia test if relevant \\n- \\nPlanned/ unplanned pregnancy \\n \\nSocio- economic status:  \\n- \\nHousing: type, size, number of occupants \\n- \\nSanitary conditions: type of toilet, source of water \\n- \\nLighting: Electricity or other sources of  lighting \\n- \\nCooking facilities- gas, electricity, firewood \\n- \\nTobacco use (smoking or chewing habit) or use of other harmful substances \\n- \\nAlcohol use \\n- \\nGender Based Violence \\n- \\nEnvironment: Prone to dengue and accidents, cleanliness etc \\n- \\nDomestic air pollution: smoke inhalation (tobacco smoking, smoke from the \\nhearth, mosquito coils etc.) \\n- \\nEducational level: primary, secondary, university or higher education  \\n- \\nEconomic resources: employed (salaried work or short-term)  \\n- \\nType of work and position: both pregnant woman and husband \\n- \\nOccupation:  distance to travel, harmful occupational exposures, maternity \\nbenefits, work load \\n- \\nNuclear or extended family \\n- \\nRelationship with in-laws \\n- \\nFamily support and social support \\n- \\nAvailability of a responsible person at home  \\n- \\nMode of transport at an emergency \\n- \\nClosest EMOC facilities: distance / transport facilities \\n- \\nHome gardening, iodized salt, eating habits, Myths, House hold food security  \\n- \\nLeisure activities \\n- \\nReligious activities \\n \\nMedical history  \\n \\n- \\nSpecific diseases and conditions:  tuberculosis, heart disease, chronic renal \\ndisease, epilepsy, diabetes mellitus, hypertension, asthma, psychiatric illness \\n- \\nSTIs/ HIV status:  if known \\n- \\nOther specific conditions depending on prevalence in the area: hepatitis, \\nmalaria, thalaseamia \\n- \\nAllergies:  food or drug \\n- \\nOperations other than caesarean sections: heart surgeries, surgeries for \\ngynaecolgical conditions \\n- \\nBlood transfusions: Rhesus (D) antibodies \\n- \\nCurrent use of medicines: specify \\n- \\nPeriod(s) of infertility: Duration, cause(s) treatments etc'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n48 \\n \\nHistory of present pregnancy \\n \\n- \\nDate of commencement of last menstrual period (LMP) \\n- \\nCertainty of dates: by regularity, accuracy of recall and other relevant \\ninformation \\n- \\nAny unexpected event: pain, vaginal bleeding, other- specify \\n- \\nHistory of malaria attacks \\n- \\nContraceptive history: method used, when it was started, when it was stopped, \\nmethod failure or not \\n \\nFamily history (blood relatives) \\n \\n- \\nDiabetes Mellitus, Hypertension, Twins, Congenital abnormalities \\n \\nObstetric history \\nPrevious pregnancies (Review all the available records, diagnosis cards, clinic records)  \\n \\n- \\nNumber of previous pregnancies \\n- \\nDate (month, year), place of delivery  and outcome of each event (live birth, \\nstillbirth, abortion, ectopic, hydatidiform mole) - Specify and validate with \\navailable documents  \\n- \\nPreterm births and types of abortion: If applicable and possible \\n- \\nBirth weight (if known)  \\n- \\nSex and age of the living children \\n \\nSpecial maternal complications and events in previous pregnancies (specify which \\npregnancy/ ies validate by records (if possible):  \\n \\n- \\nRecurrent early abortion \\n- \\nInduced abortion and any associated complications \\n- \\nGestational diabetes \\n- \\nHypertension, pre-eclampsia or eclampsia \\n- \\nPlacental abruption \\n- \\nPlacenta praevia \\n- \\nBreech or transverse presentation \\n- \\nObstructed labour, including dystocia \\n- \\nThird-degree tears \\n- \\nExcessive bleeding (antepartum or postpartum) \\n- \\nPuerperal sepsis \\n \\nObstetrical interventions: \\n \\n- \\nCaesarean section (indication, if known) \\n- \\nForceps or vacuum extraction \\n- \\nManual/instrumental help in vaginal breech delivery \\n- \\nManual removal of the placenta'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n49 \\n \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies  \\nspecify which pregnancy/- ies, validate by records (if possible): \\n \\n- \\nTwins  \\n- \\nHigher order multiples \\n- \\nLow birth weight: <2500 g \\n- \\nMalformed or chromosomally abnormal child \\n- \\nMacrosomic (>3500g) newborn \\n- \\nResuscitation or other treatment of newborn \\n- \\nPerinatal, neonatal or infant death (also: later death) \\n- \\nIUGR \\n- \\nRhesus antibody affection (Erythro blastosis, hydrops fetalis) \\n- \\nSCBU or NICU admissions \\n \\nb) Perform physical examination ) \\n \\n- \\nAssess the personnel hygiene \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, \\nconjunctiva, oral mucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema- ankles, fingers, face, and abdomen \\n- \\nDo a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities (spine, pelvic and limbs),  icterus, clubbing, cyanosis \\n- \\nBreast examination: masses, changes in the skin, nipple  \\n- \\nAbdominal examination – masses, tenderness, palpable uterus (compare with \\nthe POA) \\n \\n \\n \\nc) Investigations \\n \\n- \\nCheck urine for glucose and/or proteins if indicated (PIH, hypertension, renal \\ndisease, diabetes) \\n \\nd) Referral for antenatal care \\n \\n- \\nDetermine the expected date of delivery based on LMP and all other relevant \\ninformation. Use 280-day rule (LRMP + 280 days). Some women will refer to \\nthe date of the first missed period when asked about LMP, which may lead to \\nmiscalculation of term by four weeks. \\nEg. Last LRMP: 23rd March 2010   EDD 30th December 2010 \\n- \\nGive an appointment for antenatal clinic care \\n  \\nf) Advice, questions and answers, and scheduling the next appointment \\n \\n- \\nIf new risk factors identified refer to ANC as early as possible (when 1st home \\nvisit after first clinic visit). \\n- \\nGive advice on safe sex. Emphasize the risk of acquiring or transmitting HIV \\nor STIs.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n50 \\n \\n- \\nAdvise women to stop the use of tobacco (both smoking and chewing), \\nalcohol and other harmful substances. Advice to avoid passive smoking. \\n- \\nAdvice on management of abdominal pain, urinary tract infections and minor \\ndiscomforts during pregnancy, personal hygiene, physical and mental rest and \\nsleep. \\n- \\nAdvice on how to prevent infectious diseases. (use cool boiled  water, hard \\nwashing etc). \\n- \\nAdvice all the family members on family support needed during pregnancy. \\n- \\nAdvice to increase fluid intake, how to prepare a balanced nutritious diet. \\n- \\nExplain the signs and symptoms and actions to be taken in the case of ectopic \\npregnancy or an abortion. \\n- \\nGive advice on whom to call or where to go in case of bleeding, abdominal \\npain and any other emergency, or when in need of other advice. \\n- \\nEmphasis the need of continuation of treatment for medical conditions. \\n- \\nGive advice on how to contact PHM in an emergency (mobile numbers, place \\nof the office and residence). \\n- \\nRequest the woman to record when she notes the first fetal movement. \\n- \\nDiscuss with the woman and the family regarding the importance of \\nmaintaining the good mental status during pregnancy.  \\n- \\nDiscuss with the woman and the husband (or a family member) on the \\nimportance of attending antenatal clinics and antenatal classes. So that they \\ncan be involved in the activities and can learn how to support the woman \\nthrough her pregnancy. \\n- \\nIntroduce the relevant reading material (guide to pregnant mothers, five \\nbooklets on breast feeding, booklets on ECCD) to the pregnant woman and the \\nfamily. \\n \\nSchedule next appointment:  \\n \\n- \\nGive them a date for first antenatal class \\n- \\nMake arrangements for the second home visit, at (or close to) 22 -24 weeks: \\nstate date and hour. This should be written in the pregnancy record (H512) A \\nand B.  \\n- \\nGive a date for the first antenatal clinic visit if she has not gone yet. \\n- \\nAsk her to come to the clinic or inform PHM if there is any problem.  \\n- \\nInform her the dates of the clinic sessions and the dates and place of weighing \\n(children) in the village where she can meet the PHM. \\n \\nh) Maintain complete records \\n \\n- \\nComplete 512 A, B and the diary \\n- \\nIssue properly filled a H512 (pregnancy record) to the mother and explain her \\nand family importance of it and how to self assess the weight gain using \\nweight gain chart and growth of the fetus using SFH chart \\n- \\nAdvise her to bring pregnancy record with her to all appointments she may \\nhave with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n51 \\n \\nHome visit 2 (22 -24 weeks) \\nObjectives: \\n1. To access the progression of the pregnancy \\n2. To help the pregnant woman and the family to deal with the pregnancy \\n3. To advice the family regarding birth plan and emergency plan \\n4. To help the family to prepare for the delivery and newborn \\nAsk: \\n- \\nFor any complains  \\n- \\nWhether she feels fetal movements, if she feels, record first date of quickening and see \\nwhether it is compatible with her POA \\n- \\nAbout her mental wellbeing ( happiness, support from the family members)    \\n- \\nAbout the diet, intake of vitamins, worm treatment and immunization ( Tetanus toxoid)    \\n- \\nAbout the rest, sleep, daily activities done at home \\n- \\nFor any physical discomforts: Headache, dysuria, vaginal discharges, any discharges from \\nthe nipples, breast pain, vomiting and morning sickness \\n- \\nAbout the family support ( from the husband and other family members)  \\n- \\nAbout sexual activities \\n- \\nAbout the plans for delivery and emergency (hospital/ transport/ money/arrangements to \\ncare for the home and other children if any) \\n- \\nWhether  all the investigations are done (Grouping and Rh, Hb, VDRL, PPBS) \\n- \\nWhether she has attended for the referrals \\n \\nExamination: \\n \\n- \\nAssess the personnel hygiene \\n- \\nObserve any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath \\n- \\nLook for thyroid diseases, Dental hygiene, icterus, clubbing, cyanosis \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nAbdominal examination : feel for fundus , fundal height, fetal movements, fetal heart \\nsounds \\n- \\nCheck urine for sugar and protein: If needed (women with renal disease, hypertension, \\ndiabetes) \\n \\nInterventions and actions: \\n \\n- \\nEducate mother and care givers regarding danger signals during pregnancy \\n(antepartum haemorrhage, severe abdominal pain, severe headache), importance of \\nclinic visits, proper nutrition, monitoring of weight gain, working and mental well-\\nbeing during pregnancy, items to be taken to the hospital for the delivery, ECCD, rest \\nand sleeping'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n52 \\n \\n- \\nReferrals should be done if needed- anaemia, severe headache, difficulty in breathing, \\nother difficulties \\n- \\nEmphasis the need of continuation of treatment for medical conditions \\n- \\nCheck for compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nDiscuss with the family: place of delivery, actions to be taken in an emergency, \\narrangement for transport \\n- \\nGive an opportunity to discuss issues and ask questions \\n- \\nGive a date for third home visit \\n- \\nConfirm the attendance for antenatal class II \\n- \\nGive date and place for third antenatal class \\n- \\nMake records in 512 A, B , and in the diary  \\n \\n \\n \\nHome visit 3 (34- 36 weeks) \\nObjectives \\n1. To ensure the birth plan and preparedness for the hospitalization and delivery  \\n2. To help the family to welcome the new member \\n3. To ensure breast feeding, ECCD activities and family planning \\n \\nAsk: \\n- \\nFor any complains, physical discomforts  \\n- \\nWhether she feels fetal movements, and teach her how to maintain a kick count chart \\n- \\nAbout the support from the family \\n- \\nCheck the compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nAdvice and check to prepare the essential items for both mother and baby during \\nhospitalization including transport \\n- \\nAsk about the present illnesses, changes in the vulva, oedema and headache, varicose \\nveins, dysuria, difficulty in breathing \\n- \\nAsk about the advices given in the clinics and see whether she is complying \\n \\n \\nExamination: \\n- \\nAssess personnel hygiene \\n- \\nObserve for any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nExamine abdomen and assess the fundal height compare with POA, check the lie and \\npresentation \\n- \\nListen to fetal heart sounds \\n- \\nCheck urine for sugar and protein- If needed (women with renal disease, \\nhypertension, diabetes)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n53 \\n \\nInterventions and actions: \\n- \\nEducate and reconfirm what mother and care givers knew regarding signs of labour \\n \\n- \\nEnsure that all the items need for delivery and hospitalization are ready \\n \\n- \\nAware the mother regarding vaginal examination, lithotomy position, pain \\nmanagement,  delivery on to abdomen (skin to skin contact with the baby), \\nimportance of cooperation at the labour room, breathing exercises \\n \\n- \\nEducate mother and the family members about the labour, breast feeding, family \\nplanning, early childhood care development, obstetric emergencies: reduced fetal \\nmovements, antepartum haemorrhage, dribbling, severe headache, abdominal pain, \\nand actions to be taken if she experience any of those, new born care, post partum \\nmicronutrient supplementation, EDD and signs of labour  \\n \\n- \\nDiscuss with the family: actions to be taken during an emergency, transport \\narrangements in an emergency, care for other children while mother is in hospital, \\nfamily and social support after delivery \\n \\n- \\nDiscuss the breast feeding: including first feed, exclusive breast feeding, attachment, \\npositioning etc. and ensure that she has read the booklets on breast feeding \\n \\n- \\nInfection control: importance of limiting visitors, handling of baby, hand washing \\n \\n- \\nAdvice to prepare the home environment to welcome the newborn \\n \\n- \\nServices from the hospital: start breast feeding within the first hour of delivery and \\nexclusive breast feeding, BCG immunization, Vit. A mega dose, birth registration, \\npregnancy record to be returned, CHDR, neonatal examination by a MO  \\n \\n- \\nMethod to inform the PHM after delivery: telephone, messenger \\n \\n- \\nRefer to an appropriate health facility if needed  \\n \\n- \\nGive an opportunity to discuss issues and ask questions \\n \\n- \\nRecord the findings in the 512 A,B and complete the diary \\n \\n- \\nIf needed, complete LRT consent form \\n \\n- \\nIf they change the residence after delivery, ask them to inform the area PHM in the \\nnew residence  for postnatal care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n54 \\n \\nChapter 7 \\n \\nDOMICILIARY CARE FOR HIGH RISK PREGNANCIES \\n \\nPlease note all the high risk pregnant women should receive the routine domiciliary care described in the previous chapter.\\nRisk condition \\nFrequency of \\nhome visits \\nAsk\\nExamine\\nRemarks\\nPast Obstetric History \\nPrevious still birth \\n(antenatal or \\nintrapartum) or \\nneonatal loss or \\ncongenitally \\nmalformed babies \\n \\n \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nevery 4 weeks  \\nAsk about fetal \\nmovement \\nInquire about the \\nother risk conditions \\neg. GDM, PIH \\n \\n \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 20 weeks \\n \\nMake aware on conditions which can cause still births \\nE.g. Gestational DM, Placenta abruption , cord round \\nthe neck etc \\nAscertain that blood sugar levels checked. \\nEducate on danger signals \\nAsk pregnant woman:   \\nto be more vigilant about fetal movements  \\nto pay special attention to KCC after 36 weeks \\nto get admit as early as possible if she experience \\nreduced fetal movements  \\nto get admit to hospital as early as possible if she gets a \\nsevere abdominal pain, bleeding per vagina. \\nReassure that it will not happened in consequent \\npregnancies \\nPlan for delivery and emergency  \\nRefer to post-partum clinic for neonatal examination \\nafter delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n55 \\nHistory of 2 or more \\nconsecutive first \\ntrimester abortions \\nDuring first \\ntrimester, provide \\ndomiciliary care \\nin every 4 weeks. \\nAfter that if no \\nrisk conditions \\nidentified, routine \\nantenatal \\ndomiciliary care \\nInquire about vaginal \\nbleeding , abdominal \\npain \\nIf the reasons for the \\nabortions are other \\nmedical condition, \\nact according to the \\nadvice given. \\nRoutine examination\\nAsk her to get admit as early as possible if she \\nexperience abdominal pain or bleeding per vagina \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units  \\n \\nHistory of preterm \\ndelivery before 37 \\nweeks, or second \\ntrimester miscarriage \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nonce in 4 weeks \\nInquire about lower \\nabdominal pain or \\nvaginal bleeding \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 28 weeks \\n \\n \\nAsk her to avoid heavy work and get adequate rest\\nEnsure the family support for domestic work \\nAsk her to get admit as early as possible if she gets \\nlower abdominal pain or blood stained vaginal discharge \\nor per vaginal bleeding \\nAsk to prepare all the things need for the delivery  \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units \\n \\nHistory of PHI \\neclampsia/ \\npreeclampsia \\nIf high blood \\npressure is not \\ndetected in this \\npregnancy, \\nRoutine three \\nhome visits are \\nadequate. \\nAsk about headache, \\nvisual disturbances, \\nchest pain , shortness \\nof breath and \\nepigastric pain \\n \\nMeasure BP if possible\\nCheck urine for albumin \\nduring home visits. \\n \\n \\nEducate family members on signs and symptoms pre \\neclampsia \\nAsk her to get admit if she experience any of those \\nsymptoms \\nAsk  her to check blood pressure at least once a month \\nand maintain the records. \\nRefer to a doctor if BP is high or if albumin is present in \\nurine or any sign of pre eclampsia'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n56 \\nHistory of APH\\nRoutine three \\nhome visits are \\nadequate. \\nAsk about vaginal \\nbleeding and  \\nabdominal pain \\nAsk about shortness \\nof breath while \\nmoderate exercise \\n(features of anaemia) \\nSee whether USS has \\ndone to confirm the \\nplacental site \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are  available \\nExamine for signs of \\naneamia \\nEducate her to take nutritious iron rich diet.\\nAsk her to get admit as early as possible in case of \\nvaginal bleeding or abdominal pain. \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice. \\nHistory of retained \\nplacenta  or  history \\nof postpartum \\nhaemorrhage \\nRoutine three \\nhome visits are \\nadequate. \\nAsk for symptoms of \\nanaemia \\nLook for signs of \\nanaemia \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are available \\nHelp her and the family to decide on place of delivery \\n(place with CEMOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of caesarean \\nsection/ myomectomy\\nAfter 28 weeks, \\ndomiciliary care \\nshould be given \\nevery 4 weeks \\nAsk for abdominal \\npain, vaginal \\nbleeding, pain in the \\nscar \\nExamine for scar \\ntenderness \\nSee whether the USS is \\ndone to confirm the \\nplacental site \\nLook whether the Hb  \\nand blood grouping and \\nRh reports are available \\nAsk her to get admit if she experience abdominal pain, \\nvaginal bleeding and scar tenderness \\nIf so ask her to go to the hospital fasting due to \\npossibility of emergency section \\nHelp her and family to decide on place of delivery \\n(place with CEmOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of surgery on \\nreproductive tract \\n(removal of septum, \\ncone biopsy, large \\nloop excision of \\ntransformational \\nzones) \\nMonthly home \\nvisits from the \\nregistration \\nAsk for abdominal \\npain or  vaginal \\nbleeding  \\nExamine for tenderness \\nin the abdomen \\nSee whether intrauterine \\npregnancy is confirmed \\nAsk mother to get admit as early as possible if she \\nexperience severe abdominal pain during first trimester \\nAdvice to get a scan done to confirm intrauterine \\npregnancy \\nCheck the compliance on medical advice given in the \\nspecialized care unit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n57 \\nBirth with birth \\nweight <2500g \\nMonthly home \\nvisits \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nAsk her to take balanced nutritious diet\\nAdvise on adequate rest. \\nEnsure the family support on domestic work \\nRefer to the clinic if SFH is less than POA \\n \\nBirth weight > 3500g\\nRoutine home \\nvisits are \\nadequate, if there \\nis no additional \\ncomplication \\nInquire about the \\nGestational DM \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nCheck urine for glucose \\nduring home visit \\nRefer to the clinic if SFH is  more than POA  for USS\\nCheck whether screening for GDM has done  \\nHelp mother to decide on place of delivery( with \\nCEMOC facilities) \\nKick count chart after 36 weeks \\nHistory of IUGR\\nMonthly home \\nvisits \\nAsk for fetal \\nmovements \\nAsk for other risk \\nconditions (PIH) \\nAsk for chronic \\ndiseases and \\nfrequently occurring \\nconditions \\nMeasure SFH \\nMeasure BP if possible \\nCheck maternal weight \\ngain \\nCheck for FHS \\nReassure mother \\nIdentify nutritional problems and intervene \\nEnsure family support and adequate rest at home \\nInquire about the type of household work engaged in \\nRefer to the clinic if SFH is less than POA \\n \\nFeeding difficulties/ \\nhistory of breast \\nsurgery \\nMonthly visits \\nduring last \\ntrimester \\n \\n \\n \\nAdvice on breast feeding technique , how to express \\nbreast milk and importance of  breast feeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n58 \\nPresent pregnancy \\nAge less than 20 \\nyears \\nIf she is less than \\n18 years monthly \\nhome visits \\nSee whether she has \\ngone to a specialized \\nunit \\nEnsure the antenatal clinic care\\nEnsure the help from the family or neighbours  \\nDiscuss the care during postnatal period  \\nDiscus about postpartum family planning \\nDiscuss about Breast Feeding  \\nAdvanced maternal \\nage (Age> 35 years) \\nIf mother is more \\nthan 40 years and \\na primi need \\nmonthly home \\nvisits. For others \\nroutine three \\nvisits are \\nadequate \\nAsk for risk \\nconditions \\n(hypertension, \\ndiabetes Mellitus) \\nAsk for fetal \\nmovements \\nMeasure BP if possible\\n \\nCheck for SFH, FHS \\n \\nCheck whether \\nscreening for GDM has \\ndone \\n \\nExplain her about the risk of chromosomal \\nabnormalities, first trimester miscarriages associate with \\nthe age \\nAsk her to be more vigilant on fetal movements after 36 \\nweeks \\nAsk her to admit as early as possible if she experience \\nreduced fetal movements \\nHelp her to decide on place of delivery with CEmOC \\nfacilities \\nHeight< 145cm\\n \\n \\nRoutine three \\nvisits are \\nadequate \\nSee whether she has \\ngone for pelvic \\nassessment to a \\nspecialized unit during \\nthe third trimester \\nExplain her and family members about the process of \\nlabour \\nHelp her to decide the place of delivery with CEmOC \\nfacilities. \\nBMI <18.5kg/m2 \\nMonthly home \\nvisits until the \\nweight gain is \\nadequate \\naccording to BMI \\nCheck whether mother \\nis taking balanced \\nnutritious diet \\nAsk her to take a balanced nutritious diet\\nAssess the level of physical activity and if she is \\ncarrying out heavy work, discuss with her how to reduce \\nthat kind of work. \\nEnsure the help of the family and adequate rest'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n59 \\nBMI > 30kg/m2\\nMonthly home \\nvisits \\nAsk for other risk \\nconditions such as \\nHypertension, PIH, \\nGDM \\nCheck whether \\nscreening for GDM has \\ndone \\nMeasure BP if possible \\nMeasure SFH \\nLook for lie and \\npresentation after 36 \\nweeks \\nRefer to the clinic if SFH>POA\\nAdvice on dietary habits- low fat/ carbohydrates \\nExplain  the risks of obesity/ overweight \\nAsk her to check blood pressure regularly \\n \\nPrimigravida\\nRoutine three \\nvisits are \\nadequate \\nCheck for lie \\npresentation and head \\nengagement after 32 \\nweeks \\nEducate on labour , labour pains, environment of the \\nlabour room \\nEnsure the family support \\nAdvise on the items to be taken to the hospital.  \\nEducate on breast feeding and BF techniques \\nParity (5 or more)\\nMonthly visits\\nAsk about the social \\nproblems (GBV, \\npoverty, low \\neducational level) \\nAsk about the \\nsymptoms of anaemia\\nCheck whether the Hb \\nreport is available \\n \\nAsk her to get admit as soon as possible even with slight \\nlower abdominal pain closer to delivery \\nHelp the her decide the place of delivery with EMOC \\nfacilities \\nDiscuss about the family planning method \\nEnsure the family support and arrangements for other \\nchildren \\nMultiple pregnancy\\nMonthly up to \\nsecond trimester \\nand two weekly \\nduring third \\ntrimester \\nAsk about the \\nvomiting and other \\nsymptoms of \\npregnancy during \\nfirst trimester \\nAsk about the \\nCheck whether the Hb \\nreport is available \\nCheck whether mother \\nhas gone to a specialized \\nunit \\nMeasure BP if possible \\nExplain her about risk of having preterm labour and ask \\nto get admit as early as possible if she experiences any \\nlower abdominal pain close to term. \\nExplain her about risk of PIH associated with multiple \\npregnancies and asked to BP checked regularly \\nAsk her to go to a specialized unit in case of an'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n60 \\nsymptoms of anaemia\\nAsk about other risk \\nconditions (PIH) \\n \\n \\nemergency\\nAdvice on technique of  breast feeding both babies \\n simultaneously \\nAdvice on family planning methods \\nAdvice on how to care twins \\nEmphasis on family support which is very much needed \\nafter delivery  \\nDiastolic BP more \\nthan 90mmhg \\nEvery two weeks \\nafter detecting \\nhigh blood \\npressure \\nAsk about severe \\nheadache , visual \\ndisturbances, chest \\npain and shortness of \\nbreath \\nAsk about fetal \\nmovements \\nMeasure BP if possible \\nCheck  urine for \\nalbumin  \\nCheck the compliance \\non antihypertensives and \\nthe advice given at the \\nclinic \\nCheck FHS \\nRefer to a medical officer  if BP is high or if urine for \\nalbumin is positive \\nAsk her to be fasting while getting admit to hospital in \\ncase of emergency \\nHelp her to decide on place of delivery with C EmOC \\nfacilities \\nEducate the family members regarding danger signals \\nand the actions to be taken in an emergency \\nUncertain dates / \\nirregular periods \\nOnce the dates \\nare corrected, \\nroutine three \\nhome visits are \\nadequate \\nAsk about previously \\nused family planning \\nmethod  method used, \\nwhen did it stop, how \\nlong she has used it,) \\nCheck whether she has \\ngone for dating scan \\nRefer for a dating scan before 20 weeks of POA\\nAsk mother to be more vigilant on date of quickening \\n \\n \\nIntra uterine growth \\nretardation \\n \\n \\nHome visits \\nshould be done \\nevery two weeks \\nonce IUGR is \\ndetected \\nAsk for fetal \\nmovements \\nCheck whether dating \\nscan is done \\nMeasure SFH \\nCheck FHS  \\nCheck the maternal \\nweight gain \\nRefer to specialized clinic for accurate dating and \\nregular USS with growth charts \\nAsk mother to be more vigilant on fetal movements \\nEnsure the adequate rest \\nEnsure that the advice given by the clinics is followed.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n61 \\nMal-presentation and \\nabnormal lie after 34 \\nweeks \\nHome visits every \\n2 weeks \\nReassure mother \\nRefer to specialized unit \\nVaginal bleeding (any \\ntime) \\nAsk mother to get admit to hospital as early as possible\\nMaternal jaundice \\nAsk mother to get admit to hospital as early as possible \\nMaternal anaemia \\n(Hb 7- 11g/dl) \\nMonthly home \\nvisits until the Hb \\nlevel is normal \\nAsk about the \\nsymptoms of anaemia \\n \\nCheck whether warm \\ntreatment are taken \\nCheck the compliance of \\niron therapy \\nAsk mother to get Hb checked until the levels normal\\nEducate on taking iron rich diet \\nEducate on side effects of iron therapy  \\nGive advice on micronutrients and diet \\nSevere maternal \\nanaemia (Hb < 7 g/dl)\\nTwo weekly \\nhome visits until \\nthe Hb levels \\nnormal \\nAsk about the \\nsymptoms of anaemia\\nCheck the compliance \\non advice given \\nRefer to a specialized unit for correction\\nGive advice on micronutrients and diet \\nMaternal malaria\\nTwo weekly \\nhome visits until \\nthe condition \\nresolved \\nCheck the use of bed \\nnets/ insecticide \\nimpregnated bed nets \\nCheck the compliance \\non malaria prophylaxis \\ntreatment \\nRefer to nearest hospital medical unit\\nAdvise to use insecticide impregnated bed nets \\nEnsure the malaria prophylaxis treatment \\n \\n \\nMaternal syphilis \\nMonthly home \\nvisits  \\nAsk about symptoms \\nof other STIs (vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance \\non the drugs given \\nRefer to the STD clinic as early as possible\\nCheck the compliance on advice given \\nEducate on safe sex practices \\nAdvice to get her partner screened for syphilis \\nEnsure the confidentiality of the information.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n62 \\nMaternal HIV\\nMonthly home \\nvisits \\nAsk about symptoms \\nof other STIs(vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance of \\ndrugs given. \\nRefer to the STD clinic \\nAdvice to get her partner screened \\nCheck the compliance on advice and treatment given \\nExplain the mother the risk of transmitting the HIV \\ninfection to the baby is very low when mother is on \\ntreatment for HIV \\nDiscuss on Breast feeding \\nRefer to the MOH for further information   \\nOther risk conditions \\nDiabetes Mellitus\\n \\nHome visits  in \\nevery two weeks \\nAsk for fetal \\nmovements \\nCheck urine for sugar \\nCheck for FHS \\nMonitor maternal \\nweight gain \\nMeasure SFH \\nCheck the compliance \\nwith medical advice \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nAsk mother to mark kick count chart after 36 weeks  \\nAsk mother to get admit as early as possible if she \\nexperience reduced fetal movements \\nEducate mother and family members on co- infections \\neg:UTI, fungal infections \\nHelp to plan the delivery in a CEmOC facility \\nLiver disease and \\nrenal disease \\nHome visits in \\nevery two weeks \\nLook for oedema (facial, \\nfinger, and abdomen) \\nLook for jaundice, \\nitching, clubbing etc. \\nCheck urine for proteins \\nMeasure BP if possible \\nMonitor maternal \\nweight gain \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nDelivery in a CEmOC facility'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n63 \\nRheumatic and \\ncongenital heart \\ndiseases \\nHome visits in \\nevery two weeks \\nAsk for shortness of \\nbreath with exertion \\neg. Climbing stairs \\nAsk for dyspnoea on \\nlying down  \\nAsk whether she need \\ntwo or more pillows \\nfor sleeping \\nLook for features of \\nheart disease( ankle \\nodema, elevated JVP) \\n \\n \\nAdvice to restrict work as advised by cardiologist/ VOG\\nDiscuss about Family Planning \\nDelivery in a CEmOC facility \\n \\nEpilepsy\\nMonthly home \\nvisits \\nAsk for the details of \\nlast attack \\nLook for drug \\ncompliance and places \\nthat can endanger life in \\nthe home environment \\neg: unprotected wells , \\nfloor level fire places \\nAdvice family members on what to do during an \\nepileptic attack, to take necessary precautions \\nExplain  the family members on importance of \\ncompliance on drugs \\n \\nMental disorders \\nMonthly home \\nvisits \\nCheck compliance of \\ndrugs \\nEducate on family members on the disease and advice \\non family support \\nAsk family members to seek medical advice in case of a \\nbehavioural change of the mother \\nExplain that drugs can be used even during breast \\nfeeding and not harmful for the baby \\nExplain family members that mental disorders can be \\naggravated during post-partum period and to be more \\ncautious \\nEducate family members on postpartum psychological \\ndisorders'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n64 \\nAsthma\\nMonthly home \\nvisits \\nAsk for shortness of \\nbreath \\nCheck respiratory rate\\nExamine breathing \\nsounds if possible \\nCheck the compliance of \\ndrugs/ inhalers \\n \\nEducate family members on importance of drug \\ncompliance \\n \\nRh negative mother\\nRoutine three \\nhome visits are \\nadequate \\nAsk for fetal \\nmovements \\nCheck whether the \\nscreening for Rh \\nantibodies is done  \\n \\nEducate mother on RhOGUM after delivery\\n \\nSubfertility\\n(Failure of a couple to \\nconceive with one \\nyear of regular \\nintercourse) \\nMonthly home \\nvisits \\nAsk for any \\nabdominal pain , per \\nvaginal bleeding \\nAsk for fetal \\nmovements \\nCheck for SFH, FHS\\n \\nAsk mother to get admit as early as possible to a \\nhospital with EMOC facilities in case of an emergency. \\nAsk mother to be more vigilant on fetal movements \\nSocial problems\\nUnmarried/ widows/ \\nseparated (single \\nmother) \\n \\nMonthly\\nAsk for social  \\nproblems \\nHelp them to face the social stigma\\nEnsure the proper antenatal care \\nIntroduce a postpartum family planning method \\nExtreme poverty/ \\ngeographical \\ndifficulties, gender \\nbased violence, \\nalcoholic partner etc. \\nMonthly\\nAsk whether she is \\ngetting any \\ngovernment \\nallowances \\n(samurdhi) \\nHelp them to get social support and support from special \\nprograms with GramaNiladari and other relevant \\nofficials \\nIntroduce a postpartum family planning method'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n65 \\n \\nChapter 08 \\nDEVELOPING A BIRTH AND EMERGENCY PLAN \\n \\nExplain why birth in a facility is recommended \\n\\uf0a7 Any complication can develop during delivery and they are not predictable. \\n\\uf0a7 A facility has staff, equipment, supplies and drugs to provide best care if needed, and a \\nreferral system. \\n\\uf0a7 If HIV- positive she will need appropriate ARV treatment, for herself and her baby \\nduring childbirth. Complications are more common in HIV-positive women and her \\nnewborns. HIV-positive women should deliver in s facility. \\n \\nAdvice how to prepare \\nReview the arrangements for delivery: \\n\\uf0a7 Where will she go to get treatment for an emergency or delivery? \\n\\uf0a7 How will she get there?  \\n\\uf0a7 How much will it cost to go to the facility? How will she pay for transport ? \\n\\uf0a7 Can she start saving straight away? \\n\\uf0a7 Who will go with her to the hospital? \\n\\uf0a7 Who will help while she is away to care for her home and other children? \\n\\uf0a7 Who to inform in an emergency? \\n \\nAdvise when to go \\n\\uf0a7 If the mother lives near the facility, she should go at the first signs of labour.or dange \\nsignal \\n\\uf0a7 If living far from the facility, she should go 2-3 weeks before baby due date and stay \\neither at the maternity waiting home or with family or friends near the facility. \\n\\uf0a7 Advise to ask for help from the community, if needed. \\n \\n Advise what to bring \\n\\uf0a7 Pregnancy record. \\n\\uf0a7 Clean clothes for drying and wrapping the baby. \\n\\uf0a7 Adequate amount of sanitary pads after birth. \\n\\uf0a7 Cloths for mother and baby. \\n\\uf0a7 Food and water for mother and support person.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n66 \\n \\nHome delivery in an emergency or due to unavoidable circumstances \\nReinforce the importance of delivery in a health institution. \\nInstruct mother and family on clean and safer delivery at home \\nIf the mother has to deliver at home due to emergency or unavoidable circumstances, review \\nthese simple instructions with the woman and family members. \\nTell her / them to try their best to get down a skilled birth attendant (institutional midwife/ \\nPHM/midwifery qualified nurse or a medical officer) \\n\\uf0a7 To ensure a clean delivery surface for the birth. \\n\\uf0a7 To ensure that the birth attendant should wash her hands with clean water and soap \\nbefore/after touching mother / baby. She should also keep her nails clean. \\n\\uf0a7 To place the baby on the mother’s chest with skin-to skin contact and wipe the baby’s \\neyes using a clean cloth for each eye, after delivery, \\n\\uf0a7 To cover the mother and the baby with a clean cloth. \\n\\uf0a7 To use boiled new blade and a boiled cord to tie and cut the cord. The cord is cut when it \\nstops pulsating. \\n\\uf0a7 To dry the baby after cutting the cord. To wipe clean but not bathe the baby until after 6 \\nhours. \\n\\uf0a7 To wait for the placenta to deliver on its own. \\n\\uf0a7 To start breastfeeding when the baby shows signs of readiness, within the first hour after \\nbirth. \\n\\uf0a7 To NOT leave the mother alone for the first 24 hours. \\n\\uf0a7 To keep the mother and baby warm. To dress or wrap the baby, including baby’s head. \\n\\uf0a7 To dispose of the placenta in a correct, safe and culturally appropriate manner (burn or \\nburry). \\n \\nAdvise to avoid harmful practices \\nFor example: \\nNOT to use local medications to hasten labour. \\nNOT to wait for waters to stop before going to health facility. \\nNOT to insert any substances into the vagina during labour or after delivery. \\nNOT to push on the abdomen during labour or delivery. \\nNOT to pull on the cord to deliver the placenta. \\nNOT to put ashes, cow dung or other substances on umbilical cord /stump.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n67 \\n \\nAdvise on danger signs \\nIf the mother or baby has any of these signs, she/they must go to the hospital immediately, day \\nor night, WITHOUT waiting \\n \\nMother \\n\\uf0a7 Waters break and not in labour after 6 hours. \\n\\uf0a7 Labour pains / contractions continue for more than 12 hours. \\n\\uf0a7 Heavy bleeding after delivery (pad/cloth soaked in less than 5 minutes). \\n\\uf0a7 Bleeding increases. \\n\\uf0a7 Placenta not expelled 1 hour after birth of the baby. \\n \\nBaby \\n\\uf0a7 Very small \\n\\uf0a7 Difficulty in breathing \\n\\uf0a7 Fits \\n\\uf0a7 Fever \\n\\uf0a7 Feels cold \\n\\uf0a7 Bleeding \\n\\uf0a7 Not able to feed'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n68 \\n \\nChapter 09 \\nANTENATAL CLASSES \\nIn this maternal care model, health promotion and education of pregnant women regarding \\npregnancy and related topics is carried out during clinic sessions as group education, \\nopportunistic education during clinic visits and home visits and in the antenatal classes for \\ncouples.  \\nObjectives of the antental classes: \\n1. To educate the pregnant women and their husbands/families on topics related to \\npregnancy, child birth, postnatal care and childcare \\n2. To improve the male participation in maternal care \\n3. To give an opportunity to alleviate the doubts on pregnancy related issues \\n4. To improve the community participation in maternal care \\n5. To change the parenting behavior to fulfill the needs of the child \\n \\nGuideline for conducting antenatal classes \\n1. All pregnant women should be participated in three antenatal classes during pregnancy \\n(one per each trimester) with her husband.  \\n2. All the women participating in a class should be in a same trimester eg. All are in first \\ntrimester or all are in second trimester. \\nAntenatal class 1 – for pregnant women in first trimester \\nAntenatal class 2 – for pregnant women in second trimester \\nAntenatal  class 3 – for pregnant women in third trimester \\n3. The topics/ issues discussed in each class should be related to the trimester of the \\npregnancy of the participants. \\n4. PHM should be kept notes in the relevant cage in the pregnancy record regarding the \\nparticipation. \\n5. Antenatal classes should be conducted once a month at the level of PHI area or 3-4 PHM \\nareas together (depending on the number of pregnant mothers in a PHM area). \\n6. A class for a trimester can be organized once in three months to cover all the mothers. \\nEg.  \\nJanuary – Antenatal class 1 \\n \\nFebruary- Antenatal class 2 \\n \\nMarch - Antenatal class 3 \\nApril - Antenatal class 1 …………so on \\n \\nJanuary\\nFeb\\nMarch\\nApril\\nMay\\nJune\\nJuly\\nAugust\\nClass1 \\nClass 2 \\nClass 3 \\nClass 1 \\nClass 2 \\nClass3 \\nClass1 \\nClass 2'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n69 \\n \\n7. For couples who are unable to attend to classes, arrangement should be made to attend to \\nthe classes at the nearest area. \\n8. The annual plan for antenatal classes should be display in the clinic centres with the \\nvenue, date and time. \\n9. The annual plan for the MOH should be displayed with the annual clinic plan. \\n10. Relevant area PHMM should be organized the classes with the help of the area PHI. \\n11. The lectures and the other activities should be carried out by the PHI and PHMM \\naccording to the guide given. MOMCH, MOH, PHNS, SPHM, HEO or other relevant \\nofficers can be used as special resource persons.   \\n12. MOH, PHNS and SPHM should be supervised the sessions and should be guided them to \\nimprove the quality of the classes. \\n13. All mothers should get breast feeding booklets, guide for pregnant mothers and ECCD \\nbooklets to read. \\n14. Develop a small questionnaire and give it to the couples at the end of the session to assess \\nthe output. \\n15. The places to conduct the classes should be selected from the area eg. Clninic centres, \\ntemples, community centres etc. The recourses to treat the participants should be \\norganized with the community participation. \\n16. Other than the above mentioned facts, there is an enough room for your innovative ideas \\nto improve the quality of the antenatal classes. \\n \\n \\nProposed topics for antenatal classes \\nAntenatal class I: \\n1. Objectives of the antenatal classes \\n2. Activity to identify the participants \\n3. Development of the feotus \\n4. Antenatal care \\n5. Risk conditions and  danger signals during first and second trimesters and emergency \\npreparedness \\n6. Nutrition of the pregnant woman \\n7. Minor discomforts during  first and second trimesters and management of them at home \\n8. Prevention of mother to child transmission of HIV and other sexually transmitted \\ndiseases \\n9. Importance of good oral hygiene during pregnancy \\n10. General wellbeing during pregnancy \\n11. Introduction to the hand book on maternal care (Nirogimath daruparapurak udesa…..)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n70 \\n \\nAntenatal class II: \\n1. Nutrition during pregnancy II \\n2. Risk conditions and  danger signals during second and third trimesters and emergency \\npreparedness \\n3. Minor discomforts during  second and third trimesters and management of them at \\nhome \\n4. Introduction to breast feeding (importance) \\n5. Early Childhood Development and Care (ECCD) \\n6. Maintenance of correct posture during pregnancy \\n7. Preparation for delivery and newborn  \\n8. Any other topic relevant to the area eg. Prevention of alcoholism, gender based \\nviolence, money and time management \\n \\nAntenatal class III: \\n1. Nutrition during lactation \\n2. Labour signs and symptoms \\n3. Risk conditions and  danger signals during third trimester and postpartum period and \\nemergency preparedness \\n4. Minor discomforts during  third trimester and postpartum period and management of \\nthem at home \\n5. Breast feeding (technique and support from the family) \\n6. Early Childhood Development and Care (ECCD) \\n7. Maintenance of correct posture during pregnancy and postpartum period \\n8. Postpartum Family Planning \\n9. Care for the newborn baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n71 \\n \\nChapter 10 \\n \\nCLINICAL PROCEDURES FOR ANTENATAL CARE \\n \\n \\n10.1   Anthropometric assessment of pregnant women \\nMeasuring weight at the clinic setting \\nThe weighing scale should be placed on a smooth, leveled surface. \\nBefore weighing, the person should be asked to remove slippers, heavy clothes, handbags and \\nany other heavy item (keys, coins etc.) with them. \\nThe reading of the scale should be checked and it was adjusted to ‘0’. \\nThen the person should be asked to step onto the scale. It should be made sure that: \\n\\uf0b7 Person stands upright, with her arms hanging loosely at sides. \\n\\uf0b7 Person looked straight ahead and not moving \\n \\nReading of the scale display should be noted down to the nearest 0.1kg when it stopped \\nchanging.  \\n \\nMeasuring height at the clinic setting \\nMicrotoise tape should be used to measure the height. \\nMicrotoise should be set up against a wall in full length. \\nAsk the mother to remove slippers and stand against the wall as straight as she can. \\nLook at the person from the front and made sure that she is under the Microtoise meter and \\nkeeping the feet slightly apart. \\nLook at the person from the side and make sure that her back of the head, shoulders, buttocks \\nand her heels are touching the wall. \\nLower the head piece of Microtoise until it hits firmly on the top of the head and made sure that \\nit touched the head and not the hair. \\nThe reading should be taken to the nearest 0.5cm.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n72 \\n \\n \\nCalculation of the Body Mass Index (BMI) \\nBMI = Weight (Kg) \\n \\n \\nHeight (m2) \\nInstead of calculating BMI, field health care workers can use the BMI chart or BMI wheel, \\nwhich gives BMI comparing weight and height. For pregnant mothers BMI should be calculated \\nbefore 12 weeks, ideally at the booking visit around 6-8 weeks.  \\nInterpretation of BMI \\n<18.5 kg/m2\\nUnder nutrition\\n18.5 – 24.9 kg/m2 \\nNormal \\n25 – 29.9 kg/m2 \\nOver weight \\n≥ 30 kg/m2 \\n \\nObese \\n \\nMonitoring of weight gain during pregnancy \\nMonitoring of the weight gain during pregnancy depend on the BMI during the booking visit/ \\nfirst trimester. Expected weight gains according to the BMI as follows: \\n \\nBMI (kg/m2) \\nExpected Weight Gain in kg \\n<18.5 ( underweight ) \\n12.5-18 \\n18.5-24.9 kg/m2 ( Normal)\\n11.5-16\\n25-29.9 kg/m2 (over weight) \\n7.0-11.5 \\n>/= 30 kg/m2 (Obese) \\n< 6.8 \\n \\nMaternal weight gain should be recorded on the weight gain chart in the pregnancy record.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n73 \\n \\n \\nInstructions to maintain weight gain chart and graph \\n1. Fill in the following information regarding the mother at the first clinic visit  ( before 12 \\nweeks ) in the box located in the left upper corner of the graph: \\n\\uf0b7 Height \\n\\uf0b7 Weight at the first clinic visit ( before 12 weeks ) \\n\\uf0b7 BMI at the first clinic visit ( before 12 weeks ) \\nDuring the first visit no data to plot on the graph. \\n2. During subsequent clinic visits POA and weight should be recorded on the table and \\nweight gain should be calculated (by deducting the mother’s weight at the first clinic visit \\nfrom weight at the current clinic visit).  Then the weight gain should be plotted on the \\ngraph according to the POA. \\n3. Poor weight gain as well as the excessive weight gain should be identified timely and \\nrelevant interventions should be carried out. \\n4. Recommended weight gain \\n\\uf0b7 It is assumed that woman’s pre pregnancy BMI is more or less equal to the BMI \\nat her first clinic (before 12 weeks ) \\n\\uf0b7 For a woman with BMI less than 18.5kg/m2 during first 12 weeks, recommended \\nweight gain range is 12.5 – 18 kg. Her weight gain should be within the areas \\nshown as A & B in the weight gain chart. \\n\\uf0b7 For a woman with normal BMI (18.5 - 24.9kg/m2), recommended weight gain \\nrange is 11.5 – 16 kg. Her weight gain should be within the areas shown as B&C \\nin the weight gain chart. \\n\\uf0b7 For women who are overweight (BMI 25-29.9 kg/m2), recommended weight gain \\nrange is 7 – 11.5 kg (area C & D) while obese women (BMI ≥30kg/m2) should \\ngain weight less than 6.8 g (below area D).  \\n5. Once the infant is born fill the birth weight in the box shown in the right lower corner of \\nthe weight gain graph.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n74'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n75 \\n \\n10.2    Measuring blood pressure at the clinic setting \\nStandard mercury sphygmomanometer should be used with an adult cuff. An extra-large cuff \\nshould be available for obese women. \\nThe following procedure should be followed to measure blood pressure accurately. \\n1. Mothers should be asked to sit at a table quietly with both feet flat on the floor and with \\nthe back supported. The bladder should be empty. The room should be comfortable and \\nwith minimal noise. \\n2.  The bare right arm should be placed on the table (at heart level) slightly flexed, with the \\npalm upward. The examiner should be in a position to see the manometer at eye level. \\n3.  Arm circumference should be assessed. An appropriate cuff should be selected and \\nwrapped around the upper arm. The lower edge of the cuff should be 2.5 cm above the \\nelbow joint. \\n4. Wait 5 minutes. \\n5. Palpate the radial pulse and inflate to 30mm Hg above the level where radial pulse \\ndisappeared (Peak inflation level). Deflate the cuff. \\n6. Wait 30 seconds before re- inflating. \\n7. Inflate to peak inflation level. \\n8. Deflate at 2 mm Hg per second. \\n9. Record the systolic BP (first of at least two regular consecutive sounds). Record to the \\nnearest even number. \\n10. Record diastolic BP (the end of the last sound heard). Record to the nearest even number.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n76 \\n \\n10.3 Obstetric examination \\nThe abdominal examination \\nAlways make sure that the pregnant woman looks comfortable, is laying semi recumbent and has \\na sheet covering her waist and legs, which may be bare. You must examine from the woman’s \\nright side. Remember this order for examining the abdomen: Inspection, palpation and \\nauscultation. \\nInspection: \\n\\uf0b7 Assess shape and size of the uterus, and any obvious asymmetry of the abdomen; fetal \\nmovements. \\n\\uf0b7 Look for surgical scars: loins (kidney transplants); supra pubically (Caesarean sections, \\nectopic pregnancy); grid-iron (appendix); umbilicus (laparoscopy);midline(bowel or \\novarian operations) \\n\\uf0b7 Striae gravidarum (stretch marks) and linea nigra (pigmented vertical line running from \\numbilicus to symphisis pubis) are always commented. \\n \\nPalpation: \\nMeasuring SFH  \\nFirstly measure the fundal height by placing the ulnar border of the left hand gently at the fundus \\nof the uterus, and measuring with the tape in centimeters to the pubic symphysis (keep to 0 cm \\nend at the pubic sympysis). The measurement in cm should give an estimation of gestational age \\nin weeks, i.e. +/- 2 cm from 20 – 38 weeks. Plot the SFH in cm on the SFH chart in the \\npregnancy record according to the POA. \\nThen palpate fetal poles to determine presentation and lie (Fig.1.3b, c and d). When establishing \\nhead engagement in the third trimester, it is better to gently palpate with two hands pacing down \\nover the abdomen as pictured (Fig.1.3b) than to prod around with Paulik’s grip (Fig. 1.5), which \\nin non-experienced hands is painful. \\nTo establish the lie of the fetus, palpate gently using both hands as shown in figures 1.3c and 1.6.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n77'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n78 \\n  \\nIt is important to make eye contact with the woman while you are examining as you may be \\nhurting her by palpating too firmly. \\nAfter you have finished the uterus, gently palpate for kidney tenderness and liver and spleen \\nenlargement. \\nAuscultation: \\nFor a fetus with cephalic presentation, it is relatively easy to palpate the anterior shoulder and \\nlisten for the fetal heart at this point. You will obviously have to modify the position for \\nauscultation if the fetus is in the transverse or breech positions. \\nInternal examination: \\nA pelvic (vaginal examination) is not routinely performed unless specially indicated.  \\nTo perform a digital examination, commonly called vaginal examination (VE), or a speculum \\nexamination, ask your patient to lie comfortably on her back, usually with a slight tilt and the \\nknees drawn up with the ankles together. You should have asked her to remove her underwear, \\nand a sheet may be placed covering her abdomen and genitalia. The procedure should be \\nperformed in the presence of a female third party. Both hands should be gloved. \\nFor a digital examination, the labia are gently parted with the left hand, and index and forefinger \\nof the right hand gently introduced in to the vagina. They may be advanced until the cervix is \\npalpated. In later pregnancy, this will provide information on the length and consistency of the \\ncervix and this allows an assessment of favourability for induction of labour. \\nA digital vaginal examination should not be performed in the following circumstances; \\n\\uf0b7 with suspected placenta previa (risk of precipitated haemorrhage) \\n\\uf0b7 When there is prelabour rapture of membranes (risk of introducing infection) \\n\\uf0b7 When consent is withheld'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n79 \\n \\nA gentle speculum examination is less likely to introduce ascending infection, and may be used \\nto visualize the cervix in prelabour rupture of membranes, or even if a placenta previa is \\nsuspected. The same steps apply as above with the following adjustments: \\n\\uf0b7 Select an appropriate sized speculum; \\n\\uf0b7 The speculum should be pre-warmed to avoid the discomfort of cold metal; \\n\\uf0b7 Lubricating gel or water should be applied to the mouth of the speculum;  \\n\\uf0b7 The labia are parted with the left hand, and speculum held with the right; \\n\\uf0b7 The speculum is inserted through the introitus with the jaws in the vertical plain; it is \\ngently rotated while being advanced into the horizontal plane; \\n\\uf0b7 The speculum’s jaws are slowly opened once the speculum is advanced fully into the \\nvagina; \\n\\uf0b7 At this point, the ratchet nut can be tightened; \\n\\uf0b7 A light source should be at hand to enable easy visualization of the cervix and vaginal \\nwalls; \\n\\uf0b7 On removing the speculum, close the jaws gently and slowly to avoid catching vaginal \\nepithelium in them \\nSymphysio-Fundal Height Chart \\n \\nPOA'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n80 \\n \\n10. 4   Fetal Movement Chart or Kick count Chart \\nWhat is a kick count chart? \\nDuring the 1970’s, it was thought that the number of times a baby kicked each day would \\nindicate the baby’s wellness after birth. Thus, many women began to use a ‘kick chart’ or ‘kick \\ncount chart’. This is a simple chart that on which record the number and/ or intensity of kicks or \\nother movement that the baby makes. Kick chart try to provide guideline for how active a baby \\nshould be. \\nA kick count chart may be reassuring to a mother. Others may find kick charts time consuming, \\nbothersome and stressful, particularly if their baby doesn’t move much during the time they are \\ntrying to do the chart. \\nOne of the most common types of kick charts is called The ‘Cardiff count to ten’ method. With \\nthis method, mother should use an 8 to 12 hour period to record at least 10 of her baby’s \\nmovements. Mother should choose a time when she thinks her baby is most active. If baby has at \\nleast 10 movements within this 12 hour period they are thought to be well. If mother use this \\nmethod she should start timing at same time each day. Record the first time and should write it \\ndown on the graph. Count every movement or kick until the baby has moved 10 times. Write \\ndown the time after feeling the tenth movement. If mother feels more kicks at one moment \\nconsider it as a one  kick   \\nStart marking the kick count chart every day morning around 6.00am-8.00am \\n\\uf0b7 Write the time started clearly in the relevant place \\n\\uf0b7 Mark and pierce each box for each movement that baby makes \\n\\uf0b7 Write the time clearly after finishing of marking 10 boxes. \\n\\uf0b7 Contact a Medical Officer, Public Health Mid Wife or Nursing Officer if the baby is not \\nmoved for 10 times during 12 hours. \\n\\uf0b7 10 movements for a day is enough for the day. \\n\\uf0b7 The time period between 2 kicks should less than 3 hours \\n \\nFetal movement chart \\nName:                                                                         Age: \\nNo. of pregnancy:      \\nWeeks\\n 36\\n 37\\n38\\n39\\nDate\\nTime started\\n1 \\n2\\n3\\n4\\n5\\n6\\n7\\n8\\n9\\n10\\nTime \\nfinished'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n81 \\n         \\n10.5    Urine testing at the clinic setting \\n \\nUrine analysis using two para reagent strip \\nReagent strip is a dip and read test strip and intended for use as an in vitro diagnostic aid using \\nurine specimens. The strip contains solid phase reagent areas affixed to a plastic support and is \\nprovided in a dry reagent format. The strip provides qualitative and semi quantitative test for \\nglucose and protein by the visual comparison with colour charts of each concentration range.  \\nSpecimen collection \\nSpecimens were collected at the clinic. A clean, dry vessel was provided to collect the urine. \\nTests were done as soon as possible after collection.  \\nProcedure \\n1. Confirmed that the product was within the expiration date shown on the label \\n2. The strip was removed from the bottle and the cap was replaced immediately. \\n3. The strip was inspected for dis-colouration or darkening of reagent areas. Changes may \\nindicate deterioration. Such strips did not use. \\n4. The test strip was dipped completely for no more than 1 second in fresh, well mixed and \\nun-centrifuged urine specimen. The excessive urine was removed by touching the plastic \\nfilm on the rim of the vessel. \\n5. The test results were compared carefully with the colour chart on the bottle label in good \\nlight. \\n6. Proper reading time (30-60) seconds is critical for optimal results. \\n7. While comparing, to strip was kept in horizontal position to avoid possible interactions of \\nchemicals by excessive urine. Changes in colour that appeared only along the edges of \\nthe test areas or after more than two minutes were of no diagnostic significance.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n82 \\n \\nCoagulation test for protein \\nNecessary equipment:  Clean bottle, two test tubs, Spirit Lamp, Test tube holder, Acetic acid, \\nPipette \\nProcedure \\nCollect urine into a clean bottle and fill 2/3 of the test tube with collected urine  \\nHeat the upper part of the tube till urine gets boiled \\nIf the heated part gets cloudy, add 4 – 5 drops of acetic acid \\nHeat again. If the cloudiness disappears it is due to urinary phosphates and it is not significant. \\nIf the cloudiness continues it is due to urinary albumin.  \\nResults should be as follows. \\nNegative \\nTrace \\nPositives + 1 to + 4 \\nNormal result should be negative. \\n \\nBenedict’s test for urine sugar \\nNecessary equipment: as for the heat test and   Benedict’s reagent \\nProcedure: \\nPut 2.5 ml of Benedict’s solution to a test tube. \\nAdd 8 drops of urine. Heat this mixture for 2 minutes. \\nPut the tube in the test tube holder till the tube gets cooled. \\nThe colour of urine will change from green to brick red depending on the amount of sugar in \\nurine. \\nThe results should be as follows. \\nNegative – clear blue \\n If present – Green , Yellow, Orange, Brick red'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n83 \\n \\n10.6  Antenatal screening for syphilis: Guidelines for sample collection,                     \\nstorage and transportation \\nScreen all pregnant women for syphilis at the first antenatal visit preferably 6-8 weeks to prevent \\ncongenital infection. For high risk mothers, re- testing should be offered in the third trimester.  \\nRecord POA of screening, place of testing, testing results and treatment in the pregnancy record \\n(H512 A&B) \\nLaboratory testing facilities should be arranged in the nearest STD clinic/ government institution \\nwith the help of RDHS/MOMCH. \\nEducate all mothers and their partners of the importance of screening for syphilis during \\npregnancy to avoid adverse pregnancy outcomes. \\nVDRL test is the screening test use to screen for syphilis in the maternal care programme in Sri \\nLanka. It is carrying out as a joint activity with National STD AIDS control programme.  \\n \\nSample collection, storage and transportation \\n1. Blood drawing should be done by MOH, MO, RMO/AMO, PHNS or Nurse. If it is a \\nfield clinic, either MOH or PHNS should draw blood. When STD clinic team visit ANCs \\nfor blood drawing either MO/STD, nurse or MLT may draw blood. \\n \\n2. Disposable syringes should be used to draw blood and 5cc blood should be taken in to a \\ntube or a plane bottle.  Label the sample with reference number date and time of \\ncollection.  It should be kept in room temperature for at least 2 hours. \\n3. If it is sent within 12 hours to the laboratory no need to keep in the refrigerator or no need \\nto use special carriers for transportation. If not, keep the collected samples in the main \\ncompartment of the refrigerator and sent to the laboratory in a vaccine carrier within three \\ndays.  Given specimen forms should be used. There should be prior arrangement before \\nsending samples to STD lab. There should be a separate carrier for sample transportation. \\n4. In the STD laboratory if the test is not done on the same day serum should be separated \\nand can be kept maximally one month in the main compartment of the refrigerator.  (Not \\nin the freezer compartment) \\n5. Transport method will be either MOH vehicle or STD vehicle depending on the \\navailability and feasibility or else through a messenger.   \\n6. Result of the screening test will be conveyed to PHM through the MOH and positive \\ncases will be referred to STD clinic and confirmatory test will be done there.  Results of \\nthe confirmatory test will be conveyed to MOH and Syphillis confirmed mothers will be \\nfollowed up by MO/STD. \\n7. MOMCH and MO/STD should meet quarterly and discuss the matters related to antenatal \\nsyphillis screening.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n84 \\n \\n8. VDRL test will be the first choice for syphilis screening and in areas where facilities not \\navailable rapid test can be recommended by FHB and NSACP. \\n \\nMothers whose screening test is positive should be contacted and sent to STD clinic with a \\nproperly written referral letter. Confidentiality has to be maintained. When the mother is seen in \\nthe STD clinic a second sample will be collected for re-confirmation after counselling. If the \\nsecond sample is positive, the mother will be counseled and treated appropriately.  \\nIf the woman was not tested during pregnancy, syphilis screening should be offered after \\ndelivery (preferably using a rapid test).  \\n \\n10.7    Estimating Haemoglobin levels using a colour scale \\n1. Use only approved test strips for the colour scale. \\n2. Add a drop of blood to one end of a test strip just enough to cover completely an aperture \\nin the colour scale. \\n3. Wait about 30 seconds; then read immediately by comparing the blood stain with the \\nColour Scale to find the best colour match. \\n\\uf0b7 Keep the test strip close to the back of the Colour Scale \\n\\uf0b7 Avoid direct sunlight \\n\\uf0b7 Avoid marked shade \\n\\uf0b7 Avoid your own shadow or any other shadow \\n4. If the blood stain matches one of the shades of red exactly, record the haemoglobin value. \\nIf the colour lies between two shades, record the mid- value. If in doubt between two \\nshades, record the lower value. \\n5. Discard the test strip after use. Wipe the back surface of the Scale at the end of each \\nsession or if it became soiled during the use.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n85 \\n \\nChapter 11 \\nNUTRITION DURING PREGNANCY AND LACTATION \\n \\nNutrition during the preconception period as well as throughout the pregnancy has a profound \\ninfluence on the course and outcome of the pregnancy as well as mother’s performance during \\nlactation. The association between pre pregnancy weight and BMI, total weight gain and the rate \\nof weight gain in pregnancy and the pregnancy outcome is significant. Weight gain in the second \\nhalf (after 20 weeks) of pregnancy has more pronounced effect on the growth and the birth \\nweight of the baby. Poor weight gain especially in the third trimester is associated with low birth \\nweight of the baby.  \\n      Low birth weight is associated with a higher incidence of infant mortality and morbidity, poor \\ncognitive development and learning disabilities. They are also at a   higher risk of been \\nsubjected to the non-communicable disease such as heart disease, hypertension and diabetes \\nmellitus in later life. Thus , it appears future health of mankind depends to a greater extent on \\nthe nutritional foundation laid during the prenatal life. Therefore, nutrition of the pre pregnant \\nwomen as well as the pregnant mothers should receive utmost attention in order to have a baby \\nwith a good birth weight.  \\nNutrition and care during Pre pregnancy \\nPre pregnancy weight and BMI are strongly linked with the pregnancy outcome. Therefore, \\nnutrition and care of the pre pregnant woman is an essential component in the strategy for low \\nbirth weight reduction. The existing health care system offers following services to improve the \\nnutritional and health status of the pre pregnant woman. \\no Early identification of couples getting married and provision health services and \\nhealth education  \\no Registration of all eligible couples by PHM and provision of necessary services.  \\no Nutritional assessment and take necessary actions: \\n\\uf0b7 Check  Body Mass Index (BMI) do necessary interventions according to \\nthe BMI \\n\\uf0b7 Do Haemoglobin estimations and if anaemic, take necessary actions \\n \\nThe women who intend to become pregnant should be advised that their nutritional status should \\nbe optimal at the time of conception for a successful pregnancy.  \\nProvide Folic acid 5mg daily, for women who expecting a pregnancy. \\nAscertain that they have protected with Rubella immunization.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n86 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of pre-pregnant women with a BMI less than 18.5kg/m2\\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and \\nmicronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. \\n-Help to modify diet by increasing amount of starch based foods such as rice, \\nmanioc, other cereals, flour based foods at each meal \\n-Consuming 1-2 extra meals than other days \\n-Using 1-2 table spoonful of oil \\n \\n-Including fish/dried fish/egg, pulses, vegetables and green leaves to  \\n daily diet \\n\\uf0a7 Asses dietary habbits, food taboos, misconceptions and correct if there are any  \\nnegative one   \\n\\uf0a7 Excessive work load may have an influence on the weight gain. Therefore, assess the \\nworkload and act accordingly  \\n\\uf0a7 Screen for  the presence of any illnesses by referring to the MOH \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight gain is inadequate after 6 months refer to MOH for further advice.  \\nManagement of pre- pregnant women with BMI more than 24.9 kg/m2 \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy / excessive consumption of diet \\n(calorie, protein and micronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. ( to reduce starch, fats, & sugar ) \\n\\uf0a7 Emphasize the importance of  regular exercise \\n\\uf0a7 Assess dietary habits, food taboos, myths and misconceptions and correct if there \\nare any negative ones. \\n\\uf0a7 Should be screened for Diabetes Mellitus, Hypertension, Hypercholesteraemia by \\nreferring to the MOH. \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight reduction is inadequate after 6 months refer to MOH for further advice.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n87 \\n \\nNutritional requirements and advice during pregnancy \\nPregnant women should be advice to consume variety of locally available healthy foods \\ncontaining adequate amounts of cereals, yams, animal foods, pulses, vegetables, green leaves, \\nfruits and milk to meet increasing nutritional demands in pregnancy. Mothers should be \\nencouraged to consume 3 nutritious main meals supplemented by one or two additional small \\nmeals.  They should be advised to consume additional ½ a spoonful (spoon made of coconut \\nshell) of rice at each meal with additional amounts vegetables green leaves, pulses and cereals.  \\nThe amount of food a woman should consume during pregnancy varies according to her level of \\nphysical activity and her BMI at the start of pregnancy. The calorie and other nutritional \\nrequirement during pregnancy is stated in the table. The daily menus should be planned to in-\\ncooperate all the essential nutrients using locally available food items. \\n \\nAge of woman\\nAdditions for\\n16-17yrs\\n18-30yrs\\nPregnancy \\nLactation\\nEnergy, kcals\\n2150\\n1750\\n360\\n700\\nProtein, g\\n44\\n44\\n7+\\n19+\\nVitamin A, µg\\n750\\n750\\n-\\n450\\nVitamin D, µg\\n2.5\\n2.5\\n7.5\\n7.5\\nThiamin, mg\\n0.9\\n0.8\\n0.14\\n0.30\\nRiboflavin, mg\\n1.3\\n1.3\\n0.21\\n0.45\\nNiacin, mg\\n14.2\\n13.2\\n2.31\\n4.95\\nFolic Acid, µg\\n200\\n200\\n200\\n100\\nVitamin B12, µg\\n2.0\\n2.0\\n1.0\\n0.5\\nAscorbic acid, mg\\n30\\n30\\n20\\n20\\nCalcium, mg\\n600\\n500\\n600\\n600\\nIron, mg\\n28\\n28\\n60\\n60\\nZinc, mg\\n22\\n22\\n5\\n22\\n \\n The recommended daily dietary allowances during pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n88 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of a pregnant woman with a BMI less than 18.5kg/m2 at first trimester or \\ninadequate weight gain \\n\\uf0a7 Measurement error has to be eliminated as a cause for inappropriate weight gain \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and micronutrient) \\n\\uf0a7 Assess dietary habits, food taboos, misconceptions and correct if there are any negative ones \\n\\uf0a7 Nutrition counseling on appropriate diet: \\nHelp to modify diet by increasing amount of starch based foods such as rice, manioc, \\nstring hoppers etc at each meal \\nConsuming 1-2 extra meals than other days \\nUsing 1-2 table spoonful of oil \\nIncluding fish/dried fish/egg, pulses, vegetables and green leaves to daily diet \\n \\n\\uf0a7 Thriposha 2 packets monthly (to eat 50grams a day mixed with two teaspoons each of sugar \\nand coconut). Assess the compliance \\n\\uf0a7 Prevent anaemia ( Refer the  Genral circular No. 1945  on prevention of maternal anaemia \\npage 100) \\n\\uf0a7 Micronutrients (Iron folate, vitamin C and Calcium) daily after the 1st trimester.   \\n\\uf0a7 Give worm treatment.  \\n\\uf0a7 Assess the compliance of micronutrients and worm treatment. \\n                Mothers who need close monitoring and evaluation \\no Low pre pregnancy BMI ( < 18.5kg/m2 )  \\no Higher pre pregnancy BMI ( ≥25kg/m2) \\no Multiple pregnancies  \\no Anaemic pregnant women \\no Short interval pregnancies \\no Teenage pregnancies \\no Pregnant while lactation \\no Pregnant women with various social problems such as economically \\ndeprived,   single, unmarried, subject to domestic violence, displaced. \\no Pregnant women with infections such as malaria, TB, intestinal \\ninfections, STD, HIV \\no Pregnant women with medical disorders like Type I & II Diabetes, \\ngestational  diabetes, PIH, Thalassemia. \\no Weight gain  of < 1 kg/ month for women with normal BMI <0.5 Kg \\nfor women who are overweight. \\no Gain of more than 3 Kg per month for any pregnant women'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n89 \\n \\n\\uf0a7 Assess and educate on factors other than dietary which could affect the maternal weight gain  \\n\\uf0d8 Assess the help to reduce the house hold work load and heavy manual work. \\nEducate the husband and the family. \\n\\uf0d8 Assess the mental support she possess and educate regarding the association \\nbetween maternal mental relaxation and fetal well being \\n\\uf0d8 Assess the exposure to house hold smoke and passive tobacco smoke \\n\\uf0d8 Look for any other illnesses from which the mother suffers: eg; Urinary tract \\ninfections, parasitic infections, medical illnesses (Hypertension, DM ). Refer to \\nMOH where necessary. \\n\\uf0d8 Improve the quality of antenatal care received by the mother. \\n\\uf0a7 Follow up monthly \\n\\uf0a7 If weight gain is inadequate, refer to MOH \\n \\nAssessment and management of the nutritional status of overweight or obese pregnant \\nwomen  \\n1. Assess to modify dietary habit; \\n\\uf0b7 Take 24 hour dietary recall and give necessary advice accordingly (to reduce starch, fats, \\n& sugar). \\n\\uf0b7 Assess dietary habits, myths and misconceptions. Correct if there are any. \\n\\uf0b7 Educate regarding the expected weight gain. \\n\\uf0b7 Follow the different dietary menus provided  \\n\\uf0b7 Attain high coverage of micronutrients \\n \\n2. They should be explained the importance of regular exercise in weight management. \\n \\n3. Following advantages of weight management should be explained to them. \\n\\uf0b7 Reduces the risk of hypertension, preeclampsia, gestational diabetes, \\n\\uf0b7 Reduces the risk of obstetric complications such as prolonged labour, and postpartum \\nhaemorrhage. \\n4. Over nourished mothers should be screened for gestational diabetes, pregnancy induced \\nhypertension and fetal wellbeing.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n90 \\n \\nNutrition and care of the lactating mother \\nNutrition during postpartum period is extremely important due to following reasons: \\ni. \\nTo replenish the lost nutrients during pregnancy and labour \\nii. \\nMothers should exclusively breast feed the child till 6/12. \\niii. \\nAs the principle care taker of the infant, mother needs additional calories for her day \\nto \\nday activities geared towards survival, growth and psychosocial development of the \\nchild. \\niv. \\nTo ensure health & nutrition throughout the life time. \\nLactating mothers should be: \\n\\uf0b7 Provided with postpartum Vitamin A megadose 200,000 IU supplementation within 4 \\nweeks of delivery \\n\\uf0b7 Educated on diet \\no Extra serving of starch based foods at each meal \\no Consume extra piece of fish/egg/dried fish, extra serving of pulses, vegetables and \\ngreen leaves daily  \\no Fat (oil, butter, margarine) 1 tea spoonful  \\no Fruits : ½ riped bananna /  any fruit like wood apple, Nellie, mangoes that is \\nlocally available \\n\\uf0b7 Give Ironfolate/ iron+ folic acid, Vitamin C and Calcium for a period of six months \\n\\uf0b7 Provide Thriposha 2 packets \\n\\uf0b7 Educate on importance of attending postpartum clinics \\n\\uf0b7 Asses and support breast feeding \\n\\uf0b7 Special follow up of children born with Low Birth Weight  \\n(Refer the section on nutrition in the postpartum guide)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n91 \\n \\nChapter 12 \\nCOMMON DISCOMFORTS DURING PREGNANCY  \\nNausea and morning sickness \\nNausea is very common in early weeks of pregnancy. Advice women: \\n\\uf0b7 If you feel sick first thing in the morning, give yourself time to get up slowly. If possible, \\neat something like dry toast or a plain biscuit before you get up. Then drink a tea without \\nmilk. \\n\\uf0b7 Get plenty of rest and sleep whenever you can. Feeling tired can make the sickness \\nworse. \\n\\uf0b7 Drink plenty of fluids. Take small amount at a time. Eat sugar less biscuits \\n\\uf0b7 Ask those close to you for extra support. \\n\\uf0b7 Distract yourself as much as you can. Often the nausea gets worse the more you think \\nabout it. \\n\\uf0b7 Avoid the foods and smells that make you feel worse. It helps if someone else can cook. \\n\\uf0b7 Remedies containing ginger may be helpful. \\n\\uf0b7 Wear comfortable clothes. Tight waist bands can make you feel worse \\n \\n \\nBack ache \\n \\nDuring pregnancy ligaments become softer and stretch to prepare for labour. This can put a strain \\non the joints of the lower back and pelvis which can cause backache. As the baby grows, the \\nhollow in the lower back may increase and this may also cause backache. \\nAdvice: \\nTo avoid backache; \\n\\uf0b7 Avoid heavy lifting \\n\\uf0b7 Bend your knees and back straight when lifting or picking up something from the floor. \\n\\uf0b7 If you do have to carry something heavy, hold it close to your body. \\n\\uf0b7 Move your feet when turning round to avoid twisting your spine \\n\\uf0b7 Wear flat shoes as these allow your weight to be evenly distributed \\n\\uf0b7 Work at a surface high enough to prevent you stooping \\n\\uf0b7 Try to balance the weight between two baskets if you are carrying shopping. \\n\\uf0b7 Sit with your back straight and well supported. \\nA firm mattress can help to prevent and relieve back ache. If the mattress is too soft, a piece of \\nhardboard under its length will make it firmer. Massage also can help. If the backache is very \\npainful meet a doctor.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n92 \\n \\nPelvic pain \\n \\nPelvic pain especially if lateral and referring to the upper thighs are usually due to ligamentous \\nstretch. They require reassurance only. Pain is reproduced by gentle sideways traction on an \\notherwise non-tender and soft womb. Low back pain is common due to altered posture; but also \\nto the effects of the hormone relaxing on ligaments, allowing excessive movement of sacro-illiac \\nand apophyseal joints. A regular exercise program, preferably swimming, with physiotherapy as \\nrequired, complements postural back care. Some women develop symphysis-pubis pain, \\nespecially. If coexistent scoliosis, and may a s-p corset, obtainable through physiotherapy \\ndepartments. \\n \\nUrinary Frequency \\nIt is an early sign of pregnancy. Sometimes it continues right throughout the pregnancy. Urinary \\nfrequency is common but should be investigated as 8% of pregnant women will have otherwise \\nasymptomatic UTIs. In later pregnancy it’s the result of the baby’s head pressing on the bladder. \\n\\uf0b7 Try cutting out drinks in the late night but make sure that plenty drinks during daytime \\n\\uf0b7 Later in pregnancy, rock backwards and forwards while they are on the toilet. This lessen \\nthe pressure of the womb on the bladder \\nDysuria \\nIf a pregnant woman has any pain while passing urine or pass any blood, she may have a urine \\ninfection which will need treatment. Ask her to drink plenty of water to dilute the urine and \\nreduce irritation and refer her to a doctor immediately. \\nIncontinence \\nSometimes pregnant women are unable to prevent a sudden spurt of urine or a small leak when \\nmoving suddenly or just getting up from a sitting position. This may be temporary because the \\npelvic floor muscles relax slightly to prepare for the baby’s delivery. Pelvic floor exercises will \\nimprove the condition. \\nSwollen ankles, feet and fingers \\nAnkles, feet and fingers often swell a little in pregnancy because the body holds more water than \\nusual. Ankle oedema may relate to compression of inferior vena cava and to vasodilatation due \\nto increased hormones. Towards the end of the day, especially if the weather is hot or if standing \\nfor a long time, the extra water tends to gather in the lower parts of the body. If no associated \\nproteinuria or hypertension, it is best treated by  \\n\\uf0b7 Try to avoid standing for long periods \\n\\uf0b7 Wear comfortable shoes \\n\\uf0b7 Put your feet up as much as you can – try to rest for an hour a day with your feet higher \\nthan your heart'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n93 \\n \\n\\uf0b7 Try to do foot exercise \\n\\uf0b7 Take celery – natural diuretic or vitamin B6 \\n\\uf0b7 Confirm the number of fetuses \\n \\nVaricose veins \\nVaricosities occur due to compression of inferior vena cava and vasodilatation due to increased \\nhormones. The veins in the legs are most commonly affected. Some may get varicose veins in \\nthe vulva. They usually relieve after confinements.  \\n\\uf0b7 The early use of support stockings is wise; wear stockings before getting down from the \\nbed, the short term use of pelvic elevation and ice packs can ease the symptoms of vulvar \\nvaricosities. \\n\\uf0b7 Try to avoid standing for long periods of time \\n\\uf0b7 Try not to sit with legs crossed \\n\\uf0b7 Try not to put on too much weight as this increases the pressure \\n\\uf0b7 Try to sleep with your legs higher than the rest of your body- use pillow under your \\nankles or put bricks or books under the foot of your bed \\n\\uf0b7 Do foot exercise \\nHeartburn and indigestion \\nHeartburn and indigestion is partly due to hormonal changes and later due to gastro-oesophageal \\nreflux combined with increased abdominal pressure. Postural and dietary advice with the use of \\nantacids settles most, but occasionally H2 antagonists are required.  \\nTo avoid indigestion: \\n\\uf0b7 Try eating smaller meals more often \\n\\uf0b7 Sit up straight when you are eating as this takes the pressure off your stomach \\n\\uf0b7 Avoid particular foods which cause trouble, for example fried or highly spiced ones, but \\nmake sure you are still eating well \\nTo avoid heart burn: \\n\\uf0b7 Sleep well propped up – try raising the head of your bed with bricks or have plenty of \\npillows \\n\\uf0b7 Try drinking a glass of milk – have one by your bed in case you wake with heartburn in \\nthe night \\n\\uf0b7 Avoiding eating or drinking for a few hours before you go to bed'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n94 \\n \\nConstipation \\nConstipation can occur early so at least in part is due to hormones, but is aggravated by enlarging \\npelvic contents. With the vasodilatation and compression of pelvic veins this may result in \\nhaemorrhoids.   \\n\\uf0b7 Make sure you include plenty of fibre in your diet through eating foods like whole meal \\nbreads, whole grain cereals, fruit and vegetables, and pulses such as beans and lentils. \\n\\uf0b7 Exercise regularly to keep your muscles toned up \\n\\uf0b7 Make sure you drink plenty of water \\n\\uf0b7 If laxatives are needed they should be of the fibre based type eg. Fybogel \\n \\n \\nDental decay and periodontal disease \\nDental decay and periodontal disease accelerate in pregnancy and should be reviewed by a \\ndentist as early as possible. To keep your teeth and gums healthy, you should: \\n\\uf0b7 Pay special attention to cleaning your teeth. \\n\\uf0b7 Avoid having sugary drinks and foods too often. Try to keep them only to meal times. \\nSkin changes \\nHormonal changes taking place in pregnancy make the nipples and the areola darker. The skin \\ncolour may also darken a little, either in patches or all over. Birth marks, moles and freckles may \\nalso darken. Some women develop a dark line down the middle of the abdomen (Linea Nigra). \\nThese changes will gradually fade after the delivery. Skin changes such as chloasma and spider \\nnaevi, also disappear after the pregnancy.  \\nStretch Marks \\nThese are pink or purplish lines which usually occur on the abdomen or sometimes on the upper \\nthighs or breasts. Some women get them, some don’t. It depends on the skin type. Women with \\nmore elastic skins don’t get them. Women with more than average weight gain, more prone to \\nget them. It is very doubtful whether oils or creams help to prevent stretch marks. After delivery \\nthe marks should gradually pale and become less noticeable. \\nHair Changes \\nHair growth is also likely to increase in pregnancy. The hair may also ne greasier. After the \\ndelivery it may seem that a woman is losing a lot of hair. In fact she is simply losing the increase \\nthat occurred during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n95 \\n \\nItching  \\nItching occurs in 17% gravid women. Interestingly, 50% women with atopic dermatitis improve \\nduring pregnancy. If no rash, consider iron deficiency, or the potentially more serious \\ncholestatsis of pregnancy. Antihistamines may be helpful. \\nStretch marks may occur when growth has been rapid. The dryness and irritation may be erased \\nby vegetable oil or Vitamin E cream and soap avoidance. \\nCramps \\nCramp is Sudden, sharp pain, usually in your calf muscles or feet. It is most common at night. It \\nusually helps if you pull your toes hard up towards your ankle or rub the muscle hard. Regular, \\ngentle exercise in pregnancy, particularly ankle and leg movements, will improve your \\ncirculation and may help to prevent cramp occurring. \\nTiredness \\nIn the early months of pregnancy, a woman may feel tired or even desperately exhausted. The \\nonly answer is to try to rest as much as possible. Make time to sit with feet up during the day and \\naccept any offers of help from colleagues and family. Towards the end of pregnancy, she may \\nfeel tired because of the extra weight carrying. Make sure that she gets a plenty of rest. \\nFaintness:  \\nPregnant women often feel faint. This happens when not enough blood is getting to the brain. If \\nthe oxygen level gets too low, she may actually faint. It’s more common in pregnancy because of \\nhormonal changes taking place in her body. She is most likely to feel faint if she stand still for \\ntoo long or get up too quickly from a chair. \\n\\uf0b7 Try to get up slowly after sitting or lying down \\n\\uf0b7 If feel faint when standing still, find a seat quickly and the faintness will pass. If it \\ndoesn’t lie down on side. \\n\\uf0b7 If feel faint while lying on her back, turn on side. It’s better not to lie flat on back in later \\npregnancy or during labour. \\nHeadaches \\nSome pregnant women get lots of headaches. A brisk walks may be all they need as well as a \\nlittle more regular rest and relaxation. Although it is wise to avoid drugs in pregnancy, an \\noccasional paracetamol tablets is generally considered safe. If she often has bad headaches meet \\na doctor. It may be a sign of hypertension.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n96 \\n \\nFeeling hot in pregnancy: \\nDuring pregnancy you are likely to feel warmer than normal. This is due to hormonal changes \\nand to increase in blood supply to the skin.  \\n\\uf0b7 Wear loose clothing made out of natural fibres, as these are more absorbent and breathe \\nmore than synthetic fibres. \\n \\n\\uf0b7 Keep your room cool \\n\\uf0b7 Wash frequently to stay fresh \\n \\nVaginal discharge  \\nAlmost all women have more vaginal discharge in pregnancy. It should be clear and white and it \\nshould not smell unpleasant. If the discharge is colored, or smells strange, or if feel itchy or sore, \\nit may be a vaginal infection. Refer her to a doctor. Ask her to wear loose cotton underwear. \\nSleeplessness \\nLate in pregnancy it can be very difficult to get a good night’s sleep. She is uncomfortable lying \\ndown or just when she is beginning to comfortable, she may have to get up to go to the toilet. \\nSome women have strange dreams or nightmares about the baby and about the birth. Talking \\nwith them can help to alleviate their fears. The relaxation and breathing exercises which are \\ntaught in parent crafting classes might be helpful. \\nIf you are not sleeping well: \\n\\uf0b7 Try not to let it bother you. Don’t worry that it will harm your baby- it won’t \\n\\uf0b7 It might be more comfortable to lie on one side with a pillow under your tummy and \\nother between your knees. \\n\\uf0b7 Relaxation technique may help. \\n\\uf0b7 A warm milky drink, a warm bath, some gentle exercise or some restful music before \\nbedtime may help \\n\\uf0b7 A rest during the day can help you to feel less tired. \\n\\uf0b7 Talk to your partner or family or midwife.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n97 \\n \\nRespond to observed signs or volunteered problems \\nIf no fetal movements \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the baby \\nlast move? \\n \\nIf no movement \\nfelt, ask woman to \\nmove around for \\nsome time, \\nreassess fetal \\nmovements \\nFeel for fetal \\nmovements \\n \\nListen for fetal \\nheart after 6 \\nmonths of \\npregnancy \\n \\nIf no heartbeat, \\nrepeat after 1 hour \\nNo fetal movement\\nNo fetal heart beat \\nProbably dead \\nbaby \\nInform the mother \\nand the partner \\nabout the possibility \\nof dead baby. \\nRefer to hospital. \\nNo fetal \\nmovements but \\nfetal heart beat \\npresent \\nWell baby\\nInform the mother \\nthat baby is fine and \\nlikely to be well but \\nto return if problem \\npersists. \\n \\nIf ruptured membranes and no labour \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the \\nmembranes \\nrupture? \\nWhen is your \\nbaby due? \\nLook at pad or \\nunder wear for \\nevidence of: \\namniotic fluid, \\nFoul-smelling \\nvaginal discharge \\nIf no evidence, ask \\nher to wear a pad. \\nCheck again in 1 \\nhour. \\nMeasure \\ntemperature. \\nFever 380 C\\nFoul smelling \\nvaginal discharge \\nUterine and \\nfetal infection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nRupture of \\nmembranes at < 8 \\nmonths of \\npregnancy \\nRisk of uterine \\nand fetal \\ninfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nRupture of \\nmembranes at > 8 \\nmonths of \\npregnancy \\nRupture of \\nmembranes \\nManage as woman in \\nchildbirth.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n98 \\n \\nIf fever or burning on urination \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nHave you had \\nfever? \\nDo you have \\nburning on \\nurination? \\nIf history of fever or \\nfeels hot: \\n- \\nMeasure \\naxillary \\ntemperature \\n- \\nLook or feel \\nfor stiff neck \\n- \\nLook for \\nlethargy \\nPercuss flanks for \\ntenderness \\nFever >380 C and any \\nof: \\n- \\nvery fast \\nbreathing or \\n- \\nStiff neck \\n- \\nLethargy \\n- \\nVery weak/not \\nable to stand \\nVery severe \\nfebrile \\ndisease \\nInsert IV line and \\ngive fluids slowly \\nGive appropriate \\nIM/IV antibiotics \\nGive quinine IM \\nGive glucose \\nRefer urgently to \\nhospital \\nFever >380 C and any \\nof: \\n- \\nFlank pain \\n- \\nBurning on \\nurination  \\nUpper \\nUrinary \\nTract \\nInfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nBurning on urination\\nLower \\nUrinary \\ntract \\nInfection \\nGive appropriate oral \\nantibiotics \\nEncourage her to \\ndrink more fluids \\nIn no improvement in \\n2 days or condition is \\nworse, refer to \\nhospital'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n99 \\n \\nIf cough or breathing difficulty \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nHow long have \\nyou been \\ncoughing? \\nHow long have \\nyou had \\ndifficulty in \\nbreathing? \\nDo you have \\nchest pain? \\nDo you have \\nany blood in \\nsputum? \\nDoes your \\nhusband smoke? \\nLook for \\nbreathlessness. \\nListen for \\nwheezing. \\nMeasure \\ntemperature. \\nAt least 2 of the \\nfollowing signs: \\n-Fever >380 C. \\n-Breathlessness. \\n-Chest pain \\nPossible \\nPneumonia \\nGive first dose of \\nappropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nAt least 1 of the \\nfollowing signs: \\n- \\nCough or \\nbreathing \\ndifficulty for > \\n3 weeks \\n- \\nBlood in \\nsputum. \\n- \\nWheezing \\nPossible Chronic \\nLung Disease \\nRefer to hospital \\nfor assessment. \\nIf severe \\nwheezing, refer \\nurgently to \\nhospital. \\nFever >380 C, and\\nCough < 3 weeks \\nUpper \\nRespiratory \\nTract Infection \\nAdvise safe, \\nsoothing remedy. \\nAdvice to avoid \\npassive smoking.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n100 \\n \\n \\nChapter 13 \\nNATIONAL GUIDELINES FOR PREVENTION AND CONTROL OF \\nMATERNAL ANAEMIA \\n1. Advice pregnant women to add food items abundant with iron for their meals. \\nWomen should be encouraged to consume not only animal foods rich in iron such as meat and \\nfish, but also green leafy vegetables and lentils such as green grams, dhal and chick pea. They \\nshould be encouraged to consume foods which are enhanced the absorption of iron, such as citrus \\nfruits and animal foods with plant foods. They should be discouraged to consume foods such as \\nmilk and tea which inhibit the absorption of iron from plant sources during meals or within one \\nhour of meal. \\n \\n2. Supplementation of iron-folate during pregnancy and lactation  \\nAll pregnant women should receive iron and folic acid with Vitamin C after POA of 12 weeks \\nfor 6 months during pregnancy and 6 months after delivery. A pregnant/lactating woman needs a \\n60mg of elementary iron and 400µg of folic acid per day. This can be given as follows: \\ni. \\nGive one tablet of iron-folate (60mg iron + 400µg of folic acid) per day. (This \\ntablet is distributed by FHB.) \\nii. \\nWhen iron-folate tablets are not available, give 200mg of ferrous sulphate (1 \\ntablet) and 5mg of Folic acid (1 tablet) per day. (These tablets are available in \\nMSD). \\niii. \\nGive 50mg of Vitamin C with iron folate/ ferrous sulphate which enhance the iron \\nabsorption. Calcium tablets, foods containing calcium or tea or milk which \\ninhibits iron absorption should not be taken within 1 hour of taking iron tablets. \\niv. \\nDuring first trimester, all pregnant women should be taken one tablet of folic acid \\n(5mg). Ideally folic acid should be started at the time, the couple decided to have \\na child (pre-conception folic acid supplementation). Mothers, who have a history \\nof having children with neural tube defects, should take folic acid till next \\npregnancy. \\nMother should be informed about possible side effects of iron intake such as vomiting, nausea, \\nloss of appetite before prescribing iron tablets. As these tablets contains very low dose of iron, \\nside effects may be mild. However, mothers should be informed how to reduce side effects, if \\nthey occurred.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n101 \\n \\n \\n \\nAll mothers should receive required number of micronutrient tablets till next clinic visit at once. \\nNext clinic visit\\nNo. of iron folate / iron/ \\nfolic acid tablets \\nNo.of Vit C.(50mg) tablets\\nAfter 1 month \\n30 \\n30 \\nAfter 2 weeks\\n14\\n14\\nAfter 1 week \\n07 \\n07 \\n \\nIron tablets should be stored in dark colored air tight bottles to prevent oxidation. All the women \\nshould be advised to bring a dry container to carry micronutrients. \\nWomen should be   made aware on enhances and inhibitors of iron absorption. \\nCompliance of taking micronutrients should be assessed during each clinic visit and home visits. \\nIf there is any problem with compliance, act accordingly. \\n \\n3. Detection of anaemia during pregnancy \\n \\nAll pregnant mothers should offer Hb testing at the booking visit and at 28weeks. Classification \\nof anaemia based on Hb levels as follows: \\nHb > 11g/dl \\nNo anaemia \\nHb 7-11g/dl \\nModerate anaemia \\nHb < 7g/dl \\nSevere anaemia \\n \\nActions should be taken according to the table given below.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n102 \\nAsk, \\ncheck, \\nrecord \\nLook, \\nlisten, \\nfeel \\nSigns\\nClassify\\nTreat and advice\\nDo \\nyou \\ntire \\neasily? \\nAre \\nyou \\nbreathless (short \\nof \\nbreath) \\nduring \\nroutine \\nhousehold \\nwork? \\nOn first visit:\\nMeasure Hb \\nOn subsequent \\nvisits: \\nLook for \\nconjunctival \\npallor \\nLook for palmar \\npallor. \\nIf pallor: \\n- Is it severe \\npallor? \\n- Some pallor \\n- Count No. of \\nbreaths in a \\nminute \\nHaemoglobin \\n<7mg/dl  \\nAnd/or \\nSevere palmar and \\nconjunctival pallor  \\nor \\nAny pallor with any \\nof \\n- >30 breaths per \\nminute \\n- tires easily \\n- breathless at rest \\nSevere \\nAnaemia \\nRefer urgently to hospital.\\nRevise the birth plan so as to \\ndeliver in a facility with blood \\ntransfusion services. \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nFollow up in 2 weeks to check \\nclinical progress, test results, \\nand compliance with treatment.\\nHaemoglobin 7-\\n11mg/dl  \\nOr \\nPalmar or \\nconjunctival pallor \\nModerate \\nAnaemia \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress. I \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nReassess at next antenatal visit. \\nIf anaemia persists without any \\nimprovement in Hb levels, \\nrefer to hospital.  \\nOnce Hb levels become normal \\ncontinue with single dose of \\niron (60mg of elementary iron) \\nHaemoglobin \\n>11mg/dl. \\nNo pallor. \\nNo \\nclinical \\nanaemia \\nGive iron 1 tablet once daily \\nfor 6 months. \\nCounsel on compliance with \\ntreatment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n103 \\n \\n4. Control of infections related to anaemia \\n \\ni. \\nControl and treatment for intestinal worm infestations \\nAll pregnant mothers should receive worm treatment with Mebendazole just after completion of \\n12 weeks of POA. \\nDosage: \\n  \\nMebendazole 100mg twice a day for 3days or \\n \\n \\nMebendazole 500mg as a single dose \\nMothers should be informed regarding other preventive methods of worm infestations such as \\nuse of sleepers, proper construction and use of toilets, use of safe water, washing hands before \\nmeals and after toileting. \\nii. \\nControl and prevention of malaria \\n \\nAs malaria is low prevalent disease in Sri Lanka, It is not recommended the routine prophylaxis \\ntreatment for pregnant mothers even in the endemic areas. Prophylaxis should be decided by the \\nMOH/ MO after considering the malaria status in the area. If decided on malaria prophylaxis the \\nregime is: \\n \\n\\uf0b7 Chloroquine 300mg (2 tablets) weekly after meal during second and third trimesters and \\n42 days after delivery \\n \\n\\uf0b7 At the booking visit, all pregnant mothers in endemic areas should be tested for malaria \\nusing a blood smear. \\n \\n\\uf0b7 In a malarial endemic area, if a pregnant mother is suffering from fever, she should be \\ntested for malaria. If she is positive for malaria, she should be given the complete course \\nof Chloroquine as follows: \\n \\nDay 1 – Chloroquine 600mg (4 tablets) \\nDay 2 – Chloroquine 600mg (4 tablets) \\nDay 3 - Chloroquine 300mg (2 tablets) \\nAfter that Chloroquine prophylaxis should be continued the rest of the pregnancy and postpartum \\nperiod. Primaquine should not be given during pregnancy and postpartum period.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n104 \\n \\n5. Information, education and communication \\nIt is important to understand the knowledge, attitudes and practices on anaemia in the \\ncommunity, as control and prevention of anaemia is closely link with the practices of the people. \\nTherefore, well organized and targeted health education program is essential. \\nThese health education programs should be targeted to important groups such as adolescent girls, \\nworking women, women in urban slums, estate women and displaced women. \\n6. Ordering, receiving and storage of drugs needed for the maternal care program  \\nThe drugs needed for the program of prevention of anaemia are iron, iron folate, folic acid, \\nvitamin C (ascorbic acid), mebendazole (worm treatment) and chloroquine. It is important to \\nprepare the estimation properly to order drugs and it should be done at the level of MOH/ RDHS \\nor medical institution. \\n \\nDrug Estimation                  Estimated No of Pregnant women = Total Population x CBR \\nIron/ ironfolate tablets \\nNo. of Ironfolate/ Iron tablets required for a MOH area =  \\n(Estimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n   (After first 12 weeks during pregnancy and 6 months after delivery) \\nFolic acid \\nWhen iron and folic acid are in combination, folic acid should be estimated only for the first 3 \\nmonths of pregnancy. \\nWhen Iron folate is available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers X 90days X 1 tablets  \\nWhen Iron tablets are available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers for the year × 450 days × 1 tablet) \\n(During pregnancy 270 days during pregnancy + 180 days after delivery)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n105 \\n \\nCalcium lactate  \\nNo. of calcium lactate tablets required for a MOH area =  \\nEstimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n    \\n(After first 12 weeks during pregnancy and 6 months after delivery) \\nMebendazole \\nRequirement of Mebendazole (100mg)= \\n(Estimated No. of pregnant mothers for the year × 6 tablets) \\nRequirement of Mebendazole  (500mg) =  \\n(Estimated No. of pregnant mothers for the year × 1 tablets) \\nThe estimation for the entire district should be prepared by summarizing the estimates from the \\nMOH areas. It should be included in the yearly drug estimation. Ordering of micronutrients  \\nshould be done in similar way as other drugs in medical institutions. The number of inward \\nmothers taking treatment and number mothers attending the clinic should be taken in to \\nconsideration while preparing the estimation.   \\nThe drugs should be stored in dark dry place to avoid oxidization and destruction.  The regional \\nsuppliers division to MOH office and clinic should follow these instructions. \\nWhen issuing drugs, the calculation of drugs should be done in retail at each level (medical \\nsuppliers division, MOH office, and clinic) and a record should be maintained in each clinic at \\nthe end of the day. \\ne.g. \\nDate   \\nAmount in hand     No of mothers \\nattended       \\n         Amount \\nissued      \\nBalance \\n \\n \\n \\n \\n \\nReceiving of drugs, distribution, storage and issuing should be supervised by MOMCH/ an \\nofficer appointed by RDHS when this post is vacant. \\nThe RDHS, MOH, MOMCH, head of the institution and other supervisory officers such as \\npublic health nursing officer (PHNS) and supervising public health mid wife (SPHM) are \\nresponsible for supervisory work at clinic, field and institutional level. \\nAll the activities in this program should be monitored, supervised and evaluated at regional level \\nas well as district level. It is a responsibility of the supervisory committee of the region and \\nMOMCH at district level.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n106 \\n \\nChapter 14 \\nMANAGEMENT OF HIGH BLOOD PRESSURE DURING PREGNANCY  \\nAT FIELD LEVEL \\nAsk, check \\n&record \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nBlood \\npressure at \\nthe last \\nvisit? \\nMeasure blood pressure in \\nsitting position. \\nIf diastolic blood pressure \\nis ≥90mmHg, repeat after \\n1 hour rest. \\nIf diastolic blood pressure \\nis still ≥90mmHg, ask the \\nwoman if she has: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\n\\uf0a7 \\nCheck protein in \\nurine \\nDiastolic blood pressure \\n≥110 mmHg and 3+ \\nproteinuria,  \\nor \\nDiastolic blood pressure \\n≥90 mmHg on two \\nreadings and 2+ \\nproteinuria, and any of: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\nSevere pre-\\neclampsia \\nRefer Urgently \\nto hospital \\n \\nDiastolic blood pressure \\n90-110 mmHg on two \\nreadings and 2+ \\nproteinuria. \\nPre-\\neclampsia \\nRefer to hospital\\nimmediately. \\nDiastolic blood pressure \\n≥90 mmHg on 2 \\nreadings \\nHypertension\\nAdvise to reduce \\nworkload and to \\nrest. \\nAdvise on danger \\nsigns. \\nReassess at the \\nnext antenatal \\nvisit or in 1 week \\nif >8 months \\npregnant. \\nIf hypertension \\npersists after 1 \\nweek or at next \\nvisit, refer to \\nhospital. \\nNone of the above.\\nNo \\nHypertension\\nNo treatment \\nrequired.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n107 \\n \\nChapter 15 \\nGUIDELINES ON IMMUNIZATION AGAINST TETANUS \\nIntroduction \\nTetanus is a fatal infectious disease caused by toxigenic strains of Clostredium Tetani. Tetanus \\nand neonatal tetanus is still a major public health problem in a considerable number of \\ndeveloping countries. However, both tetanus and neonatal tetanus have reached elimination \\nlevels in Sri Lanka as a result of the successful immunization programme. \\n Protection against tetanus toxoid could be achieved either through active immunization (by \\ngiving tetanus toxoid containing vaccine) or by passive immunization (by giving tetanus specific \\nimmunoglobin). Neonatal   tetanus is prevented by immunizing the pregnant mothers with \\ntetanus toxoid vaccine. \\nTetanus vaccines are based on tetanus toxoid which is a chemically inactivated tetanus toxin \\nwhich could induce production of antibodies against tetanus toxin. Tetanus toxoid is available as \\nmonovalent tetanus toxoid (TT), combined diphtheria, pertussis, tetanus, hepatitis B and Hib \\nvaccine (pentavalent vaccine), combined diphtheria and pertussis, tetanus vaccine (DPT), \\ncombined diphtheria, tetanus vaccine (DT) or as adult tetanus diphtheria vaccine (aTd). \\nThe goal of tetanus immunization in the Expanded Programme of Immunization (EPI) \\nprogramme is to eliminate tetanus and neonatal tetanus from Sri Lanka. With the emergence of \\nnew knowledge on immunological response of patients after receiving tetanus toxoid, the \\nfollowing recommendations have been made regarding immunization with tetanus containing \\nvaccines. \\n1.) Pre exposure immunization against tetanus \\n \\n1.1)  Immunization from infancy up to adolescence \\n \\n \\nDose\\nAge (on \\ncompletion of) \\nVaccine\\nDuration to be kept between different doses of \\ntetanus containing vaccine when tetanus toxoid \\ncontaining vaccines have not been received \\naccording to the scheduled age \\n1st \\n2 months\\n   Pentavalent     \\n   or DPT             \\n6-8 weeks between\\n1. 1st and 2nd dose \\n2. 2nd and 3rd dose \\n2nd\\n4 months\\n3rd\\n6 months\\n4th\\n18 months\\nDPT\\n12 months between 3rd and 4th doses\\n5th\\n5 years\\nDT\\n3 years between 4th and 5th doses\\n6th\\n12 years( in grade \\n7, during SMI) \\naTd\\n7 years between 5th and 6th doses'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n108 \\n \\n1.2) Immunization during pregnancy \\n The number of doses required and timing of boosters during pregnancy will depend on the past \\nimmunization history of the pregnant mother with tetanus containing vaccines. \\n1.2.1) Immunization of pregnant mothers who have not received tetanus containing vaccines \\nin infancy and childhood as per the EPI schedule \\nPregnant mothers who have not received tetanus containing vaccine according to the EPI \\nschedule during infancy and child hood should be immunized according to the following \\nschedule. \\nDose \\nTime of Immunization \\n1st \\nDuring 1st pregnancy after 12 weeks of gestation \\n2nd \\nDuring 1st pregnancy (6 – 8 weeks after the first dose, two weeks before delivery) \\n3rd \\nDuring 2nd pregnancy after 12 weeks of gestation \\n4th \\nDuring 3rd  pregnancy after 12 weeks of gestation \\n5th \\nDuring 4th pregnancy after 12 weeks of gestation \\n \\nPregnant mothers who have received 5 doses of tetanus toxoid during previous pregnancies \\nmentioned above do not need further booster doses of tetanus toxoid during subsequent \\npregnancies. \\n1.2.2) Immunization of pregnant mothers who have documented evidence of receipt of six \\ndoses of tetanus containing vaccines as per the national EPI schedule ( 3 doses of DPT / penta \\nin infancy + DPT at 18 months + DT at 5 years + aTd at 12 years) \\n \\nDose \\nTime of Immunization \\nOne booster dose (TT) \\nIf the gap between the 6th dose or any \\nsubsequent tetanus containing vaccine and the \\ncurrent pregnancy is more than 10 years \\n \\nPregnant mothers who belong to the following categories do not need to be immunized with \\ntetanus toxoid during pregnancy. \\n1. If the gap between the 6th dose of tetanus containing vaccine and the current pregnancy is \\nless than 10 years.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n109 \\n \\n2. If the gap between the subsequent dose of tetanus containing vaccine received after the \\n6th dose and the current pregnancy is less than 10 years. \\n \\n(2) Post exposure vaccination against tetanus \\nDecision on post exposure vaccination should be taken after considering the nature of the injury \\nand the previous history of immunization with tetanus containing vaccine. \\n2.1) Immunization of persons who have been immunized with tetanus containing vaccine \\nduring infancy and childhood \\nIf a person has documented evidence of receipt of six doses of tetanus containing vaccine (with 4 \\ndoses of DPT/ pentavalent, DT, aTd) he/she does not need to be immunized with tetanus toxoid \\nup to 10 years after the 6th dose of tetanus containing vaccine. If a patient presents 10 years after \\nthe 6th dose of tetanus containing vaccine immunity could be boosted up with a dose of tetanus \\ncontaining vaccine. \\nHowever, if a patient presents within 10 years with a severely contaminated wound a booster \\ndose of tetanus toxoid could be given even though the gap between the 6th dose of tetanus and \\nthe injury is less than 10 years. \\n2.2) Immunization of persons who have not been immunized with tetanus containing \\nvaccine according to the EPI schedule \\nAny person who has not been immunized with tetanus containing vaccine during infancy and \\nadolescence according to the national EPI schedule, he/ she should be given a dose of tetanus \\ntoxoid (1st dose) if there is a risk of developing tetanus. Second dose of tetanus toxoid should be \\ngiven 4 weeks after the 1st dose and the third dose 6 months after the second dose. A booster \\ndose (4th dose of tetanus could be given 5 years after the 3rd dose. Fifth dose given 10 years after \\nthe 4th dose will produce long lasting, probably a lifelong immunity. \\n(3) Development of immunity after immunization with tetanus containing vaccines \\nIf there is documentary evidence to show that any infant, child or an adult has been immunized \\nas per EPI schedule, it is not necessary to immunize them in between the routine doses again \\nwhenever they present with trauma as they are protected against tetanus infection in between \\ndoses. However if an infant, child or an adult presents with a severely contaminated wound, a \\ndose of tetanus could be given to boost up the immunity even in between the recommended \\nroutine doses. \\n(4) Storage and administration of tetanus containing vaccines  \\nTetanus containing vaccines should be stored and transported between +2 centigrade and +8 \\ncentigrade and should not be exposed to freezing as it can reduce the potency of these vaccines. \\nOpened tetanus containing vaccine vials should be stored between +2 centigrade and +8 \\ncentigrade and could be re used in subsequent immunization sessions within 4 weeks of opening. \\nTetanus containing vaccines should be given intra muscularly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n110 \\n \\n \\nChapter 16 \\nGUIDELINE ON SCREENING AND MANAGEMENT OF DIABETES MELLITUS DURING \\nPREGNANCY IN THE FIELD/NON SPECIALIZED INSTITUTIONS \\nGestational diabetes Mellitus \\nDefinition \\nGestational Diabetes Mellitus (GDM) is defined as carbohydrate intolerance of variable severity with \\nonset or first recognition during the present pregnancy. \\n\\uf0b7 Detailed, comprehensive history should be obtained from all the pregnant women who attend for \\ntheir first antenatal clinic visit by a medical officer. \\n\\uf0b7 Anthropometric assessment should be done at the first antenatal clinic visit using height and \\nweight and by calculating BMI \\n\\uf0b7 If any of the following risk conditions are identified, offer them a 2hour PBBS testing using \\na glucometer. \\n\\uf0b7 Before testing the 2hr PBBS, check the available test reports, as some of the women may have \\nalready done OGTT, GCT or some other blood sugar values. If those reports are sufficient for \\ndecision making do not repeat the PBBS at the clinic. \\n \\nRisk factors:  \\n\\uf0b7 Body Mass Index above 25kg/m2  \\n\\uf0b7 Maternal weight at booking visit > 65 kg \\n\\uf0b7 Mother’s age >35yrs \\n\\uf0b7 Previous macrosomic babies weighing 3.5 kg or above \\n\\uf0b7 Previous gestational diabetes \\n\\uf0b7 History of IUD, Intrapartum death, Neonatal death \\n\\uf0b7 Recurrent PIH \\n\\uf0b7 Polycystic Ovary Syndrome \\n\\uf0b7 Women on long term steroids, antiepileptic, anti-psychotics \\n\\uf0b7 Previous late miscarriages or three or more consecutive miscarries at first trimester \\n\\uf0b7 Family history of diabetes ( 1st degree relative with diabetes) \\n\\uf0b7 Acanthosis Nigricans  \\n\\uf0b7 Essential Hypertension'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n111 \\n \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl at first antenatal booking refer them to a \\nspecialized unit for urgent OGTT. \\n \\n\\uf0b7 If 2hr PPBS at 1st antenatal visit is >120 mg/dl and OGTT in early pregnancy is normal, they \\nhave repeat OGTT at 24-28 weeks. Therefore, refer such women for OGTT at 24 -28 weeks. \\n \\n\\uf0b7 At the POA of 24-28 weeks, offer all pregnant women 2hr PBBS testing using glucometer. \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl refer them to a specialized unit for urgent OGTT. \\n \\nPreparation for 2hr PBBS: \\n1. Pregnant woman should have an average Sri Lankan meal 2 hours before the test (rice with \\ncurries) \\n2. The meal should be eaten over a maximum period of 15 minutes time. \\n3. The two hours should be calculated from the starting time of the meal. \\nEg. Meal starts at 7.30am. It should be finished by 7.45am and the time for PPBS is 9.30am \\n \\nWomen with gestational diabetes should be offered information covering: \\n• the role of diet, body weight and exercise \\n• the increased risk of having a baby who is large for gestational age, which increases the \\nlikelihood of birth trauma, induction of labour and caesarean section \\n• the importance of maternal glycaemic control during labour and birth and early feeding of the \\nbaby in order to reduce the risk of neonatal hypoglycaemia \\n• the possibility of transient morbidity in the baby during the neonatal period, which may  require \\nadmission to the neonatal unit \\n• The risk of the baby developing obesity and/or diabetes in later life. \\nWomen with gestational diabetes should be advised to choose, where possible, carbohydrates from low \\nglycaemic index sources, lean proteins including oily fish and a balance of polyunsaturated fats and \\nmonounsaturated fats. \\nWomen with gestational diabetes whose pre-pregnancy body mass index was above 25 kg/m2 should be \\nadvised to restrict calorie intake (to 25 kcal/kg/day or less) and to take moderate exercise (of at least 30 \\nminutes daily). \\nHypoglycaemic therapy should be considered by relevant specialists for  \\n\\uf0b7 Women with gestational diabetes if diet and exercise fail to maintain blood glucose targets \\nduring a period of 1–2 weeks.  \\n\\uf0b7 Women with gestational diabetes if ultrasound investigation suggests incipient fetal macrosomia \\n(abdominal circumference above the 70th percentile) at diagnosis.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n112 \\n \\n \\nHypoglycaemic therapy for women with gestational diabetes which may include regular insulin, and \\nrapid-acting insulin analogues and/or hypoglycaemic agents should be tailored to the glycaemic profile \\nof, and acceptability to, the individual woman. \\nIndividualized targets for self-monitoring of blood glucose should be agreed with women with diabetes \\nin pregnancy, taking into account the risk of hypoglycaemia eg. targeted glycaemic control pre meal 70-\\n90 mg/dl and 2 hour post meal <120 mg/dl \\nWomen with insulin-treated diabetes should be advised of the risks of hypoglycaemia particularly in the \\nfirst trimester. \\nDuring pregnancy, women with insulin-treated diabetes should be provided with a concentrated glucose \\nsolution and women with type 1 diabetes should also be given glucagon; women and their partners or \\nother family members should be instructed in their use. \\nDuring pregnancy, women who are suspected of having diabetic ketoacidosis should be admitted \\nimmediately for critical care, where they can receive both medical and obstetric care. \\nMonitoring fetal growth and wellbeing \\nPregnant women with diabetes should be offered ultrasound monitoring of fetal growth and amniotic \\nfluid volume every 4 weeks from 28 to 36 weeks. \\nRoutine monitoring of fetal wellbeing before 28 weeks is not recommended in pregnant women with \\ndiabetes, unless there is a risk of intrauterine growth restriction. \\nWomen with diabetes and a risk of intrauterine growth restriction (macrovascular disease and/or \\nnephropathy) will require an individualized approach to monitoring fetal growth and wellbeing. \\nWomen with diabetes who are pregnant should be offered immediate contact with a joint diabetes and \\nantenatal clinic. \\nPreterm labour in women with diabetes \\nDiabetes should not be considered a contraindication to antenatal steroids for fetal lung maturation or to \\ntocolysis. \\nWomen with insulin-treated diabetes who are receiving steroids for fetal lung maturation should have \\nadditional insulin according to an agreed protocol and should be closely monitored. \\nBetamimetic drugs should not be used for tocolysis in women with diabetes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n113 \\n \\n \\nPostnatal care \\n \\nStart breast feeding immediately and continue. \\n \\nWomen with insulin-treated pre-existing diabetes should reduce their insulin immediately after birth and \\nmonitor their blood glucose levels carefully to establish the appropriate dose. \\nWomen with insulin-treated pre-existing diabetes should be informed that they are at increased risk of \\nhypoglycaemia in the postnatal period, especially when breastfeeding, and they should be advised to \\nhave a meal or snack available before or during feeds \\nWomen who have been diagnosed with gestational diabetes should discontinue hypoglycaemic \\ntreatment immediately after birth. \\nWomen with pre-existing type 2 diabetes who are breastfeeding can resume or continue to take \\nmetformin and glibenclamide immediately following birth but other oral hypoglycaemic agents should \\nbe avoided while breastfeeding. \\nWomen with diabetes who are breastfeeding should continue to avoid any drugs for the treatment of \\ndiabetes complications that were discontinued for safety reasons in the preconception period. \\nInformation and follow-up after birth \\nWomen with pre-existing diabetes should be referred back to their routine diabetes care arrangements. \\nWomen who were diagnosed with gestational diabetes should have their blood glucose tested to exclude \\npersisting hyperglycaemia before they are transferred to community care. \\nWomen who were diagnosed with gestational diabetes should be reminded of the symptoms of \\nhyperglycaemia. \\nWomen who were diagnosed with gestational diabetes should be offered lifestyle advice (including \\nweight control, diet and exercise) and offered a fasting plasma glucose measurement (but not an OGTT) \\nat the 4-6 week postnatal check and annually thereafter. \\nWomen who were diagnosed with gestational diabetes (including those with ongoing impaired glucose \\nregulation) should be informed about the risks of gestational diabetes in future pregnancies and they \\nshould be offered screening (OGTT or fasting plasma glucose) for diabetes when planning future \\npregnancies. \\nWomen with diabetes should be reminded of the importance of contraception and the need for \\npreconception care when planning future pregnancies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n114 \\n \\n \\nChapter 17 \\nPREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV INFECTION \\n \\nThere is convincing evidence from several studies that mother to child transmission of HIV can be \\nreduced successfully by various interventions that are now proven to be highly effective.  \\nAt present Sri Lanka is a country with a low level HIV epidemic. The estimated adult prevalence rate is \\n<0.1%.  As of end 2009, the estimated number of people living with HIV was 3000. The number \\nreported in the country is around 1285. The majority of those living with HIV are unaware of their HIV \\nstatus.  The antenatal care package prepared for the benefit of all antenatal mothers in this country \\nconsists of several interventions and it will now include interventions for prevention of mother to child \\ntransmission of HIV infection.  \\nSri Lanka is adopting a 4 prong strategy to achieve zero incidence of paediatric infection.  \\n1. Primary prevention of HIV among men  and women of childbearing age  \\n2. Prevention of unintended pregnancies among women living with HIV \\n3. Prevention of HIV transmission from a woman living with HIV to her infant   \\n4. Provision of appropriate treatment, care and support to women living with HIV  and their \\nchildren and families  \\n \\nSince the antenatal HIV prevalence rate ranges between 0.02-0.03 % the best method for Sri Lanka is \\nprimary prevention of HIV among men and women of childbearing age. The most effective and humane \\nway to prevent HIV in infants is to help young men and women by promoting safer sexual behaviours to \\nremain free from infection before marriage and before the woman gets pregnant.  Further, voluntary \\ncounselling and testing should be available to any pregnant woman who requests it.  There are several \\nkey entry points within the health service which gives the opportunity for young men and women to \\nknow about HIV/AIDS, PMTCT, counselling and testing opportunities and access the available \\ntreatment, care and support services.  Integration of PMTCT services into the maternal and child health \\nservices will provide women with services to prevent new infections and promote male partner \\ninvolvement to prevent infections among men.  \\nIntegrating screening for HIV infection within the established antenatal investigation package eg \\nscreening for  syphilis, anaemia and blood grouping is being considered strongly as a PMTCT \\nintervention as it has public health benefits to the individual woman, her partner and her baby.  \\nOpportunities should be made available within the existing health services to identify HIV infected \\nantenatal mothers in order for them to utilize ART, safer delivery and feeding practices to reduce \\ntransmission to the offspring.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n115 \\n \\n \\nPrimary prevention strategies  for PMTCT  \\nRaising awareness of antenatal mothers and their partners on PMTCT \\nAll pregnant women, and those planning pregnancy   should have accessibility to appropriate \\ninformation about HIV infection including PMTCT. Information on sexually transmitted infections \\nincluding HIV and syphilis should be included in the general information given to pregnant women \\nalong with information about other infections and antenatal tests. They should be informed about \\nperinatal transmission of HIV and it adverse pregnancy outcomes. They should be aware of the potential \\nbenefits of knowing their HIV infection status by getting tested, both for their own health and to reduce \\nthe risk of perinatal transmission. As part of routine antenatal care all pregnant women should be made \\naware that mother to child transmission of HIV can be greatly reduced through antenatal and perinatal \\ntreatment with anti-retroviral drugs, safer delivery and safer infant feeding practices.  \\nInformation about facilities for screening should be made available to all pregnant women.  Discuss \\nabout the HIV test and the window period and other related issues about the HIV test. Stress those \\nmeasures to prevent unintended pregnancies among women living with HIV and prevention of \\ntransmission of HIV from mother to child can only be offered if HIV infection is diagnosed before or \\nduring pregnancy. In Sri Lanka unfortunately almost 90% of HIV infection in pregnant women remains \\nundiagnosed during pregnancy and often women only discover they are infected when their children \\ndevelop HIV infection or AIDS. Therefore, screening for HIV, as far as possible should be promoted \\nand normalized and should generally be dealt with other conditions discussed within antenatal care. \\nGive details of the procedures for testing and obtaining results. \\nInformation on safe and responsible sexual behaviour and practices should be discussed in a culturally \\nappropriate manner depending on the audience. It should include as appropriate, the importance of \\navoiding commercial and casual sex, reducing the number of sexual partners and consistent condom use.  \\nInformation on services for STI/HIV prevention should also be discussed. Draw their attention to the \\navailability of services to reduce mother to child transmission of HIV for HIV positive women including \\nanti-retrovirals which are offered free of charge.   \\nDiscussions should not be limited only for women. Men should be included when information is \\nprovided at antenatal classes. \\nCommunication \\nInformation should be presented in a way which reflects the positive outcomes of knowing the HIV \\ninfection status for women and men and for their babies. Method of communication should be in forms \\nthat are linguistically, culturally and educationally appropriate to women.  Groups health education \\nshould be utilized for dissemination of information.  \\nDiscussions should include eliciting and giving information about basic facts of STI and HIV and \\nPMTCT, exploring any concerns expressed by women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n116 \\n \\nHealth care workers should be aware of the procedures adopted in the respective institution. In some \\nantenatal settings, HIV testing would be included as a routine test in the standard of care package of \\nservices.  Voluntary counselling & testing should be encouraged if HIV testing is not provided in the \\nantenatal care package.  \\nSignificant efforts should be taken to provide men and women with relevant information and services \\nwhich would help them to assess their own risk to infection. Therefore, the service providers should \\nhave updated, comprehensive knowledge on STI/HIV/AIDS including PMTCT to educate antenatal \\nmothers and their partners. They should have correct communication skills to talk about the following \\nconfidently.  \\nHealthcare workers should have correct technical knowledge and communication skills to talk about the \\nfollowing confidently.  \\n1. Basic facts about STD/HIV/ AIDS  \\n \\no What is HIV and AIDS and the  difference between HIV and AIDS \\no HIV / AIDS /STI overview-Local situation  \\no Natural history and what happens when the virus enters the body \\no Methods of transmission and non transmission  \\no Asymptomatic period an HIV infected person could look healthy \\no An infected person is infectious for life  \\no HIV transmission risk during  pregnancy, delivery and breastfeeding \\no Mother to child transmission of HIV and syphilis. Risk factors and methods of prevention  \\no Adverse pregnancy outcomes of maternal HIV infection and STI \\n \\n\\uf0b7 Make antenatal mothers understand that there will not be paediatric infections  if parents are not \\nHIV infected  \\n\\uf0b7 Discuss Behaviour Change efforts among vulnerable groups with promotion and provision of \\ncondoms. Counsel to change behaviours that place individuals at risk for becoming HIV infected \\nor spreading HIV infection. Promote access to condoms and dual protection  \\n\\uf0b7 How people can continue to stay negative \\n \\n2. Screening for HIV infection  \\n\\uf0b7 How to know the HIV status?  Explain about the screening test.  \\n\\uf0b7 Stress that the only way to know for sure whether a person is infected with HIV or not is by \\ntesting of blood.   \\n\\uf0b7 Discuss the purpose of HIV testing and advantages of knowing the HIV status during \\npregnancy.   \\n\\uf0b7 Discuss what the window period is and its interpretation in relation to the risky sexual \\nexposure  \\n\\uf0b7 If HIV testing is not a routine procedure in the institution, promote voluntary counselling & \\ntesting. Inform the availability of test in STD services.  \\n\\uf0b7 Make her understand that testing is done confidentially. \\n\\uf0b7 Provide information about the test procedures'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n117 \\n \\n \\n\\uf0b7 Discuss the HIV testing process. Explain the types of tests:  client initiated and provider \\ninitiated: screening and confirmatory tests , what the window period means, importance of \\nobtaining test result , implications of both positive and negative results \\n\\uf0b7  Inform that persons who test positive will receive further counselling and referral for \\ntreatment, care and support.  \\n\\uf0b7 Discuss the importance of male partner involvement  \\n\\uf0b7 Approaches for partner disclosure \\n\\uf0b7 If testing is not available in the health institution, it could be done at the closest STD clinic. If \\nit is not possible for the mother to go to the STD clinic inform her that a blood sample could \\nbe collected and sent to the STD clinic for testing  \\n \\nHIV testing is done with informed consent. Informed consent means that the health care worker has \\nexplained the above during the education session and the mother is aware of the implications of a \\nnegative or positive test. No written consent is required for HIV testing. The main objective is to \\neliminate paediatric HIV infection and improve maternal and child survival. \\n \\n \\n3. Interventions available to prevent mother to child transmission of HIV  \\n\\uf0b7 Explain the available interventions to prevent mother to child transmission of HIV to \\neliminate paediatric HIV. Availability of antiretroviral therapy from the government sector \\nfree of charge  \\n\\uf0b7 Promote seeking STD care services and  confidentiality of STD services  \\n\\uf0b7 Discuss  about confidentiality measures and efforts for prevention of stigma and \\ndiscrimination in the institution  \\n\\uf0b7 Discuss about the importance of continuous antenatal and postpartum care  \\n\\uf0b7 Discuss about the importance newborn care  \\n\\uf0b7 Trained healthcare team will provide optimum care for the mother, her partner and the baby  \\n\\uf0b7 Ask her whether she has any questions and concerns. \\n \\nAt the end of the talk, women and men who attend the talk should be able to understand: \\n\\uf0b7 The main modes of transmission of HIV and the need to avoid unsafe sexual behaviours to be \\nHIV free, which is the best method to avoid HIV infection  in the newborn    \\n\\uf0b7 HIV transmission risk to the infant  \\n\\uf0b7 Adverse pregnancy outcomes of maternal HIV infection  \\n\\uf0b7 Importance of HIV testing  as this is the only method of knowing the HIV status of men and \\nwomen. A diagnosis in the mother allows appropriate treatment and follows up of her child. This \\ngives an opportunity for partner testing. In case the partner is negative the couple could take \\nprecautions to help prevent transmission to the sexual partner.  \\n\\uf0b7 Confidentiality of information  \\n\\uf0b7 Available services in the country \\n\\uf0b7 Availability of pre test information/counselling  \\n\\uf0b7 If tests are negative how to stay negative by adopting risk reduction behaviours.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n118 \\n \\n\\uf0b7 If  HIV infection is confirmed  the availability of interventions for HIV  positive mothers, partner  \\nand the infant  \\n\\uf0b7 Advantages of ART to the mother and infant  \\n\\uf0b7 Importance of partner testing   \\n\\uf0b7 To change attitudes towards People living with HIV (PLHIV) so that stigma & discrimination \\ncould also be reduced \\n\\uf0b7 Safer sexual behaviours can protect both parents  and the baby  \\n \\nScreening for HIV during pregnancy \\n \\nHIV screening is not included in the basic investigation package during pregnancy. Voluntary \\ncounseling and testing method is used to screen pregnant mothers and their partners. The information on \\nHIV and PMTCT is given at the first antenatal class during first trimester.  Facilities for screening for \\nHIV are available at the central STD clinic and all the district STD clinics in the government sector.  \\n  \\n\\uf0b7 Explain the woman that the first blood test is called a screening test. A negative result can \\nmean either that she is not infected with HIV or that she is infected with HIV but, has not \\nyet made adequate levels of antibodies against the virus (“window period”). All positive  \\n \\n\\uf0b7 screening tests in Sri Lanka are tested with a confirmatory test. If this confirmatory test is \\npositive, it means that the woman is infected with HIV.   \\n\\uf0b7 The result of the screening test would be available depending on the test that is done. The \\nresult will be available immediately if a rapid test is done. If an ELISA test is done, it will \\ntake about a week for the result. \\n\\uf0b7 Assure the woman that her test result is confidential and will be shared only with her. \\n \\nAsk her to come in 2 weeks time to get the test result. Test result should be given only to the relevant \\nperson.Do not convey any test result over the phone. \\n \\nWhen a woman request for HIV testing,  the field health staff could ;  \\n\\uf0b7 Refer the pregnant mother to the nearest STD clinic if she agrees. (provide the address) or  \\n\\uf0b7 If the mother does not want to go to the STD clinic then draw a sample of blood, label it \\ncorrectly and send to the nearest STD clinic with a pathology request form.  It would be \\nuseful if the STD clinic is informed.  \\n \\nWhen screening test result is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n\\uf0b7 Explain that a negative result can mean either that she is not infected with HIV or that she is \\ninfected with HIV but, has not yet made adequate levels of antibodies against the virus (“window \\nperiod”)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n119 \\n \\n \\nWhen the screening test is positive: \\n\\uf0b7 She should be subjected to a detail one- to- one counseling session prior to the confirmatory test  \\n\\uf0b7 Pre-test counseling will be done by a MOH/MO  if he/she has the capacity to do so   \\n\\uf0b7 Select a suitable place where the counselling session could be carried out  maintaining privacy  \\n\\uf0b7 Discuss the HIV results when the woman is alone or with the person of her choice. \\n\\uf0b7 State test results in a neutral tone. Give the woman adequate time to express her emotions. \\n\\uf0b7 Explain to the woman that this is only a screening test and now  the confirmatory test has to be \\ndone with her consent.  \\n\\uf0b7 For the confirmatory test, a second sample has to be taken and explain this to her. Then with her \\nconsent draw the second sample and label it carefully and send it to NSACP-reference \\nLaboratory with the request form H 1214.  \\n\\uf0b7 Stress and explain to her that only if the confirmatory test is positive, there is evidence that she is \\ninfected with HIV. \\n\\uf0b7 Inform her that if she is positive, there are several interventions including medications, safe \\ndelivery and feeding practices which are able to reduce the risk of transmission of HIV to the \\nbaby.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Depending on the situation, it may be useful to discuss the importance of disclosure and partner \\ntesting (see below). \\n\\uf0b7 Identify what difficulties or problems the woman foresees and how to deal with them  \\n\\uf0b7 Encourage her to ask questions  \\n\\uf0b7 Ask the woman if she has any concerns. \\n \\nWhen the confirmatory test results is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n \\nWhen the confirmatory test result is positive: \\n\\uf0b7 Explain to the woman that a positive test results means that she is carrying the infection. \\n\\uf0b7 Reinforce that there are medications and other interventions to reduce the risk of transmission to \\nthe baby \\n\\uf0b7 Inform that she will be managed by a team of health care workers including obstetricians, \\nvenereologists, paediatricians etc.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Reinforce the importance of disclosure and partner testing (see below). \\n\\uf0b7  Give her an opportunity to discuss her concerns and doubts. \\n\\uf0b7 Be sensitive regarding her special concerns and fears \\n\\uf0b7 She may need more than one post test counseling sessions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n120 \\n \\n\\uf0b7 There are several issues to be addressed when counselling a pregnant woman in addition to the \\ngeneral issues related to HIV. There will be concerns about risk of MTCT and the impact of HIV \\non the outcome of pregnancy, future fertility etc. Therefore, it is best that arrangements are made \\nto refer the mother (if she agrees) to the closest STD clinic for further counselling.  \\n \\nDiscuss the confidentiality of HIV infection \\n\\uf0b7 Assure the woman that the test result is confidential and will be shared only with her. \\n\\uf0b7 Ensure all records are confidential and kept locked away and only health care workers taking \\ncare of her have access to the records. \\n\\uf0b7 Do not label records as HIV positive. HIV positivity may be identified using a code. \\n\\uf0b7 Inform the woman that referral to the STD clinic is important as further counselling, assessment \\nand medication will be initiated there  \\n \\nBenefits of disclosure and testing the male partner \\nEncourage the woman to disclose the HIV testing results to her husband or another person she trusts. By \\ndisclosing her HIV status to her partner and family, the woman may be in a better position to: \\n\\uf0b7 Encourage partner to be tested for HIV \\n\\uf0b7 Prevent the transmission of HIV to her partner if he is not infected. \\n\\uf0b7 If he is infected, to access treatment and care \\n\\uf0b7 Receive support from her partner and family when accessing antenatal care and HIV treatment, \\ncare and supportive services \\n\\uf0b7 Help to decrease the risk of suspicion and violence. \\n \\nSupport to the HIV positive woman \\nPregnant women who are HIV positive benefit greatly from the following support after the first impact \\nof the test result has been overcome. Therefore take steps to provide the following  \\n\\uf0b7 Empathize with her concerns and fears \\n\\uf0b7 Help her to assess the situation and decide whether to link up with existing support services such \\nas support groups, income generating activities, religious support groups, orphan care and home \\ncare. \\n\\uf0b7 Help her to find ways to involve her husband and/or extended family members in sharing \\nresponsibility of care and support to her and the baby. If she is willing, help her to identify a \\nperson from the community who will support and care for her and the baby. \\n\\uf0b7 Discuss how to provide care for the other children and help her to identify a person from the \\nextended family or from the community who will support her children. \\n\\uf0b7 Confirm and support information given during HIV testing and counseling eg. appropriate ARV \\ntreatment, safe sex, infant feeding and family planning advice \\n\\uf0b7 Help her to absorb the information and apply it in her own case.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n121 \\n \\n \\n\\uf0b7 If the woman has signs of AIDS and/or other illnesses, refer her to appropriate services. \\n\\uf0b7 Refer individuals or couples for STD services for further support. \\n\\uf0b7 Advice her to get admitted to the hospital as instructed. \\n\\uf0b7 Tell her to take ART medicine as instructed. \\n\\uf0b7 Discuss the infant feeding options \\n\\uf0b7 Counsel her on post partum family planning. \\n \\n \\nPost partum care  \\n \\n\\uf0b7 Be aware of signs of infection following delivery. Like uninfected women, HIV positive women are \\nalso vulnerable to infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early detection and \\neffective treatment are important measures to prevent complications.  \\n\\uf0b7 Monitor for secondary postpartum haemorrhage \\n\\uf0b7 Manage infected tears or episiotomy \\n\\uf0b7 Advice women to come back to the same institution if LSCS wound infection is observed  \\n\\uf0b7 When they are discharged from the healthcare facility women should be advised to return to the \\nclinic or inform the PHM if they notice symptoms such as fever, lower abdominal pain, burning with \\nurination, foul smelling discharge, abnormal bleeding, cough, shortness of breath, calf pain \\n(increasing on walking), diarrhoea, unusual / abnormal behaviour  \\n\\uf0b7 Give the mother information on care of the perineum and breasts. Women living with HIV require \\nspecial care to reduce breast engorgement, mitigate pain and avoid mastitis \\n\\uf0b7 Women who choose to breast feed should be counselled to avoid breast engorgement which could \\nlead to mastitis, since inflammation is associated with increased risk of HIV transmission. She \\nshould be advised to seek  immediate medical care if breast engorgement is associated with fever \\nand pain   \\n\\uf0b7 Instruct her about the safe disposal of lochia and blood-stained sanitary wear or other potential \\ninfectious materials.  \\n\\uf0b7 If contraception has not been discussed before delivery it should be done during the early postpartum \\nperiod (see below).  \\n \\nCounsel HIV positive woman on family planning \\nAdvice and counsel on family planning during antenatal period and post partum visits. \\nHIV positive women and men should be empowered to take informed choices relating to their \\nreproductive lives, free of coercion. When selecting a family planning method, when only one partner is \\nHIV positive the potential risk of transmitting HIV to the uninfected partner as well as the possibility of \\ninfection with other STI should be taken into account. When both partners are living with HIV, possible \\nre-infection with other HIV strains has to be considered.  \\nThe same contraceptive options which are available to uninfected couples are available to HIV infected \\ncouples. Most methods are considered to be safe and effective for HIV infected women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n122 \\n \\n \\nRecent WHO publications indicate that there are no restrictions on the use of hormonal contraception \\nby HIV positive women who are not on ART.  However, use of OCP containing high dose oestrogen is \\nrecommended when women are on ART. Rifampicin used in tuberculosis treatment may decrease the \\neffectiveness of oral contraceptives.  Long-acting injectables (DMPA) can be safely used in all   HIV \\npositive women including those on ART.     \\nIntra uterine contraceptive devices (IUD) can be used in case of HIV infection, except for women \\nwith AIDS and not on antiretroviral therapy.  \\nFemale sterilization or male sterilization is often the most commonly used family planning method in \\ndeveloping countries.  \\nEmergency contraception can help to prevent unintended pregnancies. It should not be used as a \\nsubstitute to regular contraception. Women on ART should be given double the normal dose, ie 2 tablets \\nwithin 72 hours and 2 tablets 24 hours later.  \\nProtection against both unintended pregnancy and STI is referred to as “dual protection”. Condoms are \\nthe mainstay of dual protection, alone or in combination with another method.  \\nDuring counselling for a contraceptive plan; \\n\\uf0b7 Encourage the woman to bring her husband for contraception counselling as it is best that they both \\ndecide on a suitable method. \\n\\uf0b7 Discuss their thoughts about having more children. \\n\\uf0b7 Ensure that they have the information they need about their own future prognosis, availability of \\nHIV treatment, and risk of transmission of HIV to the baby in future pregnancies.   \\n\\uf0b7 Listen carefully to the couples’ views.  Correct any factual misunderstandings. \\n\\uf0b7 If the husband is HIV negative emphasize the importance of using condoms to protect him from HIV \\ninfection. \\n\\uf0b7 If the husband is HIV positive, explain that although they both have HIV they could become infected \\nwith another strain of HIV and so it is sensible to use condoms to prevent pregnancy and infection. \\n\\uf0b7 Discuss where they could obtain condoms.  Demonstrate how to use condoms correctly.  Let both \\nmembers of the couple handle a condom.  Provide them with condoms and an information leaflet. \\n\\uf0b7 If they have decided that they want no more children, discuss vasectomy and female sterilization. \\n\\uf0b7 If they are uncertain about having more children in future, explain that waiting at least 2 years after \\nthe last birth to become pregnant again is healthiest for mother and child. Discuss the need of a \\nplanned pregnancy.  \\n\\uf0b7 Discuss other temporary methods of contraception. \\n\\uf0b7 Ask the woman if she has had infant feeding counselling and how she is planning to feed her baby.  \\nIf she has not yet been counselled, counsel or refer for counselling. \\n\\uf0b7 Explain that if not breastfeeding, she could get pregnant again as soon as even 4 weeks after \\nchildbirth. It is necessary to consider a family planning method early \\n\\uf0b7 If breastfeeding, explain that exclusive breastfeeding is very important during first six months for the \\nhealth of her child and to prevent pregnancy. During exclusive breastfeeding no mixed feeding is \\nallowed as mixed feeding will increase the risk of transmission of HIV to the baby. Breastfeeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n123 \\n \\n \\nwill provide protection against pregnancy for up to 6 months but only if the mother is breastfeeding \\noften, day and night, and giving no other food or liquids. \\n \\n\\uf0b7 Discuss about ARV and contraception use. Generally, anti-retrovirals and contraceptives do not \\nconflict, however: \\n\\uf0a7 Rifampicin (used for TB treatment) lowers effectiveness of contraceptive pills and \\nimplants. Other antibiotics do not have this problem. \\n\\uf0a7 Some antiretrovirals (protease inhibitors and NNRTIs) may lower effectiveness of \\nhormonal methods. Correct use of the method and use of condoms can make up \\nfor any decrease in contraceptive effectiveness. \\n\\uf0a7 Some women may have other medical conditions that affect choice of a method  \\n\\uf0b7 While breastfeeding non-hormonal methods such as condoms or IUD are suitable. The IUD can be \\ninserted after 6 weeks. \\n\\uf0b7 Progestogen-only methods can also be used while breastfeeding, starting 6 weeks after childbirth \\n(long-acting DMPA injectables, subdermal implants).  \\n\\uf0b7 If not breastfeeding, she can use any method. She can start any  progestogen-only methods \\nimmediately (the mini-pill, long-acting injectables, implants), or the oral combined contraception pill \\nafter 3 weeks.  \\n \\nInfant feeding with HIV \\nCounselling and support for safer infant feeding  \\nInfant feeding practices by mothers known to be HIV infected should support the greatest likelihood of \\nHIV free survival of their children and not harm the health of mothers. In order to achieve this, \\nprioritization of prevention of HIV transmission need to be balanced with meeting the nutritional \\nrequirements and protection of infants against non-HIV morbidity and mortality.  \\nInfant feeding in the context of HIV is complex because of the major influence that feeding practices \\nexerts on child survival. The counselor has to balance the risk of infants acquiring HIV through breast \\nmilk with the higher risk of death from causes other than HIV in particular malnutrition and serious \\nillness such as diarrhea among non-breastfed infants.  \\nInfants born to HIV infected mothers may escape HIV during pregnancy and delivery but remain \\nvulnerable to transmission through breastfeeding. The cumulative risk of postnatal transmission is 12%–\\n16% with 18–24 months of breastfeeding. In the absence of interventions, the overall risk of MTCT of \\nHIV in utero, peripartum and via breast milk is 30-45% with transmission through breast milk \\naccounting for a substantial proportion (30-50%) of these infant HIV infections. The only method \\nknown to completely eliminate breastfeeding associated HIV transmission is to avoid breastfeeding. \\nThis is recommended in settings in which infant replacement feeding is affordable and sustainable, clean \\nwater is widely available, hygiene and sanitation conditions are good and death due to diarrheal and \\nother infectious conditions are relatively uncommon.  However, this approach may not be feasible or \\nsafe for a variety of reasons including low acceptability due to cultural norms associated with \\nbreastfeeding.  \\nBreast-feeding by any woman confers known benefits to the infant. Children who do not breast feed are \\nup to six times more likely to die from diarrhea, malnutrition or pneumonia. Breast feeding substantially'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n124 \\n \\n \\nreduces the risk of infant mortality from other infectious diseases and malnutrition on average by 4–6 \\nfolds in the first six months and close to twofold in the second six months of life. The risks of not breast  \\nfeeding range from higher mortality in settings with unpredictable water supply or unsafe sanitation to \\ncompromising confidentiality regarding HIV status.  The combination of potent ART for the mother \\nduring pregnancy and replacement feeding for the infant prevents almost all transmission to infants in \\ndeveloped countries.  \\nFor the first time there is evidence that giving ART prophylaxis to the mother or child throughout the \\nbreastfeeding period would substantially reduce MTCT. Therefore, mothers known to be HIV infected \\nshould be supported to either: \\n\\uf0b7 Breastfeed and receive ARV interventions or \\n\\uf0b7 Avoid all breastfeeding  \\nAs a strategy that will most likely give infants the greatest chance of HIV free survival and to improve \\nthe health of the HIV infected mother.  \\nThe most appropriate infant feeding option for an HIV positive mother depends on her individual \\ncircumstances, including her health status and the local situation, the health services availability and the \\ncounselling and support she is likely to receive. The expectant mother should be counseled by a \\ncounselor who has adequate knowledge on the safer feeding options that are currently recommended. \\nThis is preferably done by a Venereologist or a Pediatrician who is trained in Lactation Management.  \\nCounsel the mother taking the following into consideration: \\n\\uf0b7 Some babies may escape infection although born to HIV infected mothers. These babies are at \\nrisk of being infected through breastfeeding. At present there are no facilities in Sri Lanka to \\ndiagnose infant HIV infection at birth and 4-6 weeks of age (diagnosis could be confirmed or \\nrefuted only after 18 months of age by the HIV antibody test). \\n\\uf0b7 There is now enough evidence that triple ART given during prenatal period for either as \\nprophylaxis or for mothers own health with safer delivery practices and avoidance of \\nbreastfeeding has substantially lowered MTCT of HIV. ART is available for antenatal mothers \\nthrough government health services \\n\\uf0b7 It should be noted that morbidity due to diarrhoea is 7 times higher, and pneumonia 3 times \\nhigher  in formula fed infants, \\n\\uf0b7 Exclusive breast feeding for 6 months have unlimited benefits to any baby and is the \\nrecommendation in Sri Lanka. The health messages given to achieve EFB should not be \\ncompromised by interventions for HIV infected mothers \\n \\n The counsellor should support the mother to decide on how these very specific conditions are met and \\nsupport the mother to decide on the best feeding option for her own baby which is sustainable and safe \\nin her individual socio economic and cultural circumstances.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n125 \\n \\n \\nRecommendations for use of replacement feeding  \\nMothers known to be HIV infected should only give commercial infant formula milk as a replacement \\nfeed to their HIV uninfected infants or infants who are of unknown HIV status, when specific conditions \\nare met:  \\n\\uf0b7 Safe water and sanitation are assured at the house hold level and in the community  \\n\\uf0b7 The mother or other caregiver can reliably provide sufficient infant formula milk to support \\nnormal growth and development of the infant  \\n\\uf0b7 The mother or caregiver can prepare it cleanly and frequently enough so that it is safe and carries \\nno risk of diarrhoea and malnutrition  \\n\\uf0b7 The mother or caregiver can in the first six months exclusively give infant formula milk and not \\ngive any kind of mixed feeds   \\n\\uf0b7 The family  is supportive of this practice   \\n\\uf0b7 The mother or caregiver can access health care that offers comprehensive child health services \\nFormula fed infants should receive 4-6 weeks of NVP prophylaxis daily or single dose NVP plus 4-6 \\nweeks of zidovudine \\nIf the above conditions cannot be sufficed; and the mother wishes to breast feed then the following is \\nrecommended:  \\nIf breastfeeding is recommended it should be exclusive breastfeeding for 6 months. Breastfeeding \\nshould be stopped only once a nutritionally adequate and safe diet without breast milk can be provided. \\nNo mixed feeding should be allowed during the first 6 months as mixed feeding increases the risk of \\nHIV transmission. EBF should be followed by continued breastfeeding with addition of complementary \\nfoods through age 12 months with gradual weaning over 1 month.The mother should be covered by \\nART as treatment for her or as prophylaxis. Infant prophylaxis for 4-6 weeks is recommended \\nirrespective of the mode of feeding.   \\nThere are two choices for HIV positive women who breastfeed and are not taking ART for their own \\nhealth.  \\n1) If she receives AZT as prophylaxis,  daily NVP is recommended for the infant from birth until \\none week after  the end of the breastfeeding period ( AZT is not recommended for breast fed \\nbabies)  or  \\n2) If a woman received a three drug regimen during pregnancy, she should continue the same \\nregimen until the end of the breastfeeding period. In this situation the infant needs ART only for \\n4-6 weeks.  \\nIf the mother decides to breastfeed it is very important to support the mother to breastfeed. She should \\nbe well trained on proper positioning and attachment of the baby to the breast in order to avoid \\ndifficulties during breastfeeding. A health care worker who is trained on lactation councelling should \\nsupport such a mother.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n126 \\n \\n \\nWhatever the feeding decision, health services should follow-up all HIV-exposed infants, and continue \\nto offer infant feeding counselling and support, particularly at key points when feeding decisions may be \\nreconsidered, such as the time of early infant diagnosis and at six months of age. \\nWhere mother and infant are both HIV positive, breastfeeding should be encouraged for at least the first \\ntwo years of life in line with recommendations for the general population. The message to health care \\nworkers is that breastfeeding is the best for every baby, even those born to HIV positive mothers \\nwhen they have access to ART.  \\nA pregnant woman living with HIV needs help to decide how to feed her baby. In a counselling session \\non HIV and infant feeding the counsellor has three main tasks: \\no to convey  information \\no to help a mother to assess the risks for her baby in her own situation \\no to give the mother confidence in her choices \\nDuring counselling the idea of weighing up risks can be difficult for a woman to understand.  Her choice \\nis not a simple one of deciding whether   to breast feed or not. Her decision will be influenced by many \\nfactors. It is therefore important that the woman makes the decision and not the counsellor. It is \\nimportant that the counsellor have adequate up to date evidence based knowledge to convey correct   \\ninformation.  \\nA woman does not need to make all decisions about how she will feed her baby at the first counselling \\nsession. While she is pregnant she needs to decide whether she will breastfeed at all or not. But she does \\nnot need to decide when she will stop breastfeeding until later. She does not need information about safe \\nweaning foods until the baby is older. However these points should be mentioned so that she \\nunderstands that they are important points to ask about later'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n127 \\n \\n. \\nChapter 18 \\nELIMINATION OF CONGENITAL SYPHILIS \\nSexually transmitted infections (STI) are one of the commonest communicable diseases found in the \\nworld today. Primarily they are transmitted through unprotected sexual intercourse. Transmission can \\nalso occur through contaminated blood and blood products and from an infected untreated mother to \\nchild during pregnancy, child birth or via breast milk. \\nSyphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It is estimated \\nthat globally about 12 million cases of syphilis occur annually and of them about 2 million are among \\npregnant women. If a woman with untreated syphilis becomes pregnant, or a woman acquires syphilis \\nduring pregnancy, depending on the stage of syphilis, the infection can be transmitted to the foetus \\ncausing adverse pregnancy outcomes including congenital syphilis. Although estimated vary, adverse \\npregnancy outcomes occur in up to 80% of women with acute syphilis including still birth (40%), peri \\nnatal death (20%) and serious neonatal infection (20%). Such outcomes are 12 times more likely in \\nwomen with syphilis than in sero-negative women. Early congenital is defined as syphilis from birth and \\nwithin two years of life. Late congenital syphilis is when vertically acquired infection manifests from \\nthird year of life onwards. \\nUnlike many neonatal infections, congenital syphilis (CS) can be effectively prevented, either through \\nprevention of maternal infection or by detection of infection early in pregnancy and provision of \\nadequate treatment. Control of sexually transmitted infections in the community by promoting safer sex, \\nincreasing awareness about syphilis and its adverse effects on mother and infant could also help prevent \\nmaternal infection. Universal screening for syphilis during pregnancy, treatment of infected pregnant \\nwomen, their partners and treatment of infants born to sero-positive woman are shown to be cost \\neffective, inexpensive and feasible in the prevention of congenital syphilis. Preventing even an \\noccasional case is economically worthwhile. Economic analyses have shown that serological screening \\nof pregnant woman is cost effective even at very low prevalence of maternal infection. The cost of \\naverting a case of CS is much lower than for other diseases. Yet in this era of concern about the number \\nof babies who are born with HIV infection, congenital syphilis receives scant attention. \\nMaternal Syphilis \\nThe causative bacterium Treponema pallidumcan be transmitted via blood of an infected mother to her \\ndeveloping foetus through the placenta. Haematogenous spread is dependent upon the occurrence of \\nmaternal spirochaetaemia. The spirochetes can cross the placenta at any time during pregnancy although \\noccurs more commonly in the last two trimesters.  \\nThe risk of congenital infection is directly related to the stage of maternal syphilis during pregnancy and \\nthe stage of pregnancy when infection is acquired. The risk of infection to the foetus is much higher \\nduring early stages of syphilis than during late stages. The more recent the maternal infection, the more'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n128 \\n \\nlikely the foetus will be affected since the early stage of syphilis is characterized by high levels of \\nspirochaetaemia. The probability of transmission to the foetus is nearly 100% when the mother has early \\nsyphilis. The spirochaetaemia diminishes over time and two years after acquisition of syphilis the \\nprobability of transmission to a fetus can take place up to four years after the acquisition of infection by \\nthe mother. \\nClinical manifestation of syphilis in the mother will depend on the stage of syphilis at the time of \\npregnancy. If the mother becomes infected late in pregnancy she may show no signs of before delivery \\nand the infected newborn may also appear normal at birth. \\nThere are two general scenarios that need to be considered when assessing the risk of congenital \\nsyphilis. \\n1. An untreated woman becoming pregnant \\n2. A woman becoming infected during pregnancy. \\nThe latter tends to be associated with overall severe outcomes for the infant as it always involves the \\nearly spirochetemic stages of the disease in which the likelihood of transmission to the fetus is high. \\n \\nDiagnosis of maternal syphilis \\nTraditionally laboratory diagnosis in adults is based on initial use of a non-treponemal screening test. \\nThese tests detect antibody to regain antigen, which is found in both Treponema pallidum and some \\nhuman tissues. They are thus not specific for Treponema pallidum and could give false positive results. \\nExamples include the venereal disease Research laboratory (VDRL) test. If a non-treponemal test is \\npositive it should be confirmed by a treponemal test using an antigen of Treponema pallidum, examples \\ninclude the Treponema pallidum haemagglutination assay (TPHA) and the Treponema pallidum particle \\nagglutination assay (TPPA). Syphilis is diagnosed when the confirmatory treponemal test is positive. \\nWhen a non treponemal test is positive in the absence of a reactive treponemal test is called a biological \\nfalse positive test. The non treponemal test becomes positive sometimes due to technical errors or due to \\ncertain physiological or pathological conditions. Acute false positive tests are found in persons suffering \\nfrom many viral and bacterial infections or who have had certain vaccinations or immunizations. \\nChronic false positives are found in the presence of autoimmune conditions, tuberculosis, leprosy or \\nmalaria. False positives are also found during pregnancy or even without a specific cause or a pre \\nexisting disease. Therefore a positive non-treponemal test should be confirmed by a specific treponemal \\nserological test to arrive at a diagnosis of syphilis \\nThe non treponemal tests have the advantages of being inexpensive and sensitive (especially in early \\ninfection.).  \\nHowever, these tests cannot be done on whole blood, they require a microscope or rotator for \\nprocessing, and misinterpretation is common by inexperienced laboratory technicians because reading of \\nthe result is subjective.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n129 \\n \\n \\nTreponemal tests, while theoretically more specific than non-treponemal tests may also give false \\npositive results. Moreover, they cannot differentiate between individuals with active (untreated syphilis) \\nand those who have previously been successfully treated for infection. In both cases, the treponemal test \\nresult will be positive. Non treponemal tests, on other hand, can distinguish current or recent infections \\nfrom old, treated infections to a certain extent based on titre levels. \\nFor the diagnosis of syphilis, a combination of the two tests is recommended. Traditional confirmatory \\nassays require expensive laboratory equipment and technical expertise, and are therefore seldom \\navailable outside reference laboratories. However, these can now be replaced by simple, rapid, point- of- \\ncare treponemal tests which use whole blood, require minimal training, no equipment or special storage \\nconditions. \\nRapid simple treponemal tests using immunochromatographic strips (ICS) which use whole blood, do \\nnot need equipment or special storage conditions and require minimal training are now available and can \\nbe used on the site including peripheral areas. Sensitivity (85- 98%0) and specificity (92-98%) of these \\ntests are high. The new rapid test has been estimated to cost U$ 7 per each case of congenital syphilis \\naverted. The affordability, convenience and practicality of rapid tests make them attractive tools, as on-\\nsite screening tests in primary care settings or in areas where laboratory services are not available. \\nHow ever since treponemal antibodies persist for years irrespective of treatment, a positive test will not \\nhelp in distinguishing active infection from past treated infection. Treponemal tests cannot be used to \\nmonitor effectiveness of treatment. \\nIn the event the ICS becomes positive, a second sample should be drawn from the mother and sent to \\nSTD clinic for re-confirmation or refer the mother to the STD clinic as early as possible \\nCase Definition of a mother with syphilis- \\nA pregnant mother with serologic evidence of syphilis (positive TPPA test) in the current pregnancy \\nwith or without symptoms of syphilis. A woman who has documentary evidence of having been \\nadequately treated in the past and in whom re-infected during the current pregnancy is ruled out is \\nexcluded from this case definition. \\nTreatment of maternal syphilis \\nSyphilis in adults is easily cured. If not treated in its early stages, the disease can become chronic, often \\nwith a long latent period with some clinically recognizable stages. In pregnancy, however, early \\ntreatment with penicillin is required for successful pregnancy outcomes. Treatment should be provided \\nearly in gestation before significant fetal involvement take place. Treating the mother with penicillin \\nduring the first and second trimester will prevent major outcomes, but later treatment or lack of \\ntreatment may result in fetal death, fetal damage or birth of an infected child. Mothers with syphilis \\nshould be preferably treated at STD clinics.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n130 \\n \\n \\nTreatment of primary, secondary and early latent syphilis \\nA single dose of benzathine benzyl penicillin 2.4 million units IM given after excluding allergy. \\nLate latent syphilis: \\nBenzathine benzyl penicillin 2.4 million units IM once a week for consecutive 3 weeks. \\nAdequate penicillin treatment will end infectively within 24-48 hrs. \\nFollow up \\nPregnant mothers treated for early syphilis should have monthly quantitative serologies throughout \\npregnancy  and  will be followed up in the STD clinic . Those who do not show a fourfold drop in titre at \\nthe end of 3 months or who show a 4 fold rise in titre should be re-treated. \\nIt is not necessary to retreat mothers who have documented evidence of adequate therapy for previous \\nsyphilis so long as there is no evidence of serologic or clinical evidence of re-infection or relapse. \\nBabies born to such mothers do not require prophylactic penicillin therapy. \\nIf doubts exist about the adequacy of previous therapy, re-treatment should be commenced promptly. \\nAllergy to penicillin \\nWhen patient sensitivity to penicillin precludes its use, erythromycin is recommended as an alternative. \\nIn early syphilis (primary, secondary and early latent) give erythromycin 500mg oral 6 hrly for 15 days. \\nIn late latent syphilis give erythromycin 500mg oral 6 hrly for 30 days. \\nHIV infection \\nEvidence suggests that treatment for syphilis in pregnant women who are HIV positive should be similar \\nto that given to other pregnant women and follow up should be the same as for adults with HIV \\ninfection. \\nTreatment of partners \\nSexual partners of mothers with primary, secondary, early latent syphilis \\nEpidemiological treatment of sexual contact is mandatory as these stages of syphilis are infectious. \\nTherefore, take necessary steps to counsel and refer to STD clinic. Those with reactive serology will  be \\ntreated according to the stage of syphilis of the partner.  \\nSexual partners of mothers with late latent syphilis \\nSexual partners should be referred to the STD clinic for assessment. They will be treated according to \\nthe stage of syphilis, if clinical evidence of syphilis is present or if serology is positive.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n131 \\n \\n \\nDiagnosis of congenital syphilis \\nThe diagnosis of congenital syphilis depends on a combination of physical, radiographic, serologic and \\ndirect microscopic evidence. \\nAt birth babies born to mothers with congenital syphilis should be examined thoroughly for physical \\nsigns of congenital syphilis. Serological tests on both the mother and the baby should be done. A sample \\nof fetal blood (5cc) should be sent to the STD clinic together with 5 cc of blood from the mother. Cord \\nblood is not suitable for testing \\nSigns and symptoms \\nAt birth about 50% of babies with congenital syphilis may be asymptomatic. Usually symptoms appear \\nin the first months but the clinical manifestations may be delayed until the second year of life. The most \\nfrequent clinical signs at birth are hapatomegaly with or without splenomegaly (33-100%), blistering \\nskin rash (40%), and bone changes seen on x-ray (75-100%). Other early signs are pseudoparesis (12-\\n36%), bleeding (100%), fever (16%), low birth weight (10-40%), swelling of joints, oedema, abdominal \\ndistension, pallor and respiratory distress. None of these signs are pathognomonic of syphilis and are \\nseen in other congenital infections. \\nInvestigations \\nDark field microscopy \\nA definitive diagnosis of syphilis is made by demonstrating the presence of Treponema pallidum by \\ndark ground microscopy on any suspicious lesions or body fluid eg: nasal discharge, skin rash. However, \\nthis procedure is cumbersome and not always possible. \\nSerology \\nThe diagnosis of congenital syphilis is complicated by passive transfer of maternal non treponemal and \\ntreponemal IgG antibodies to the foetus. The presence of these maternal antibodies makes the \\ninterpretation of reactive serological tests for syphilis in infants difficult. When a positive test for an \\ninfant is due to passively transmitted maternal antibodies they would be catabolized and undetectable in \\nnon-infected infants by 6 months of age. \\nInfants born to mothers with positive serologic tests for syphilis should be evaluated by a quantitative \\nnon-treponemal serologic test at birth. It is necessary to compare the infant’s titre with maternal \\nserologic titre using the same test. A fourfold higher titre in the infants is accepted as significant. Serum \\nfrom the neonate is the preferred specimen, since cord blood may produce false-positive results. \\nThe detection of Immunoglobulin M (IgM) in infant’s serum also indicates active infection because \\nmaternal IgM antibodies do not cross the placenta. IgM antibodies can be detected in more than 80% of \\nsymptomatic infants but data on its sensitivity for asymptomatic infants are limited. Because IgM \\nresponses take time to develop in infants and may be diminished with early treatment or inadequate \\ntreatment. A negative IgM result should not be used to exclude congenital syphilis. False positives also \\ncould occur.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n132 \\n \\n \\nSerologic evidence of congenital syphilis \\n\\uf0b7 Serum quantitative non treponemal serologic titre (VDRL titre) that is fourfold higher \\nthan the mother’s titre at the time of delivery   or \\n\\uf0b7 Presence of IgM antibodies in the infant (EIA test) or \\n\\uf0b7 Rising non treponemal antibodies in infant’s serum \\n \\nPresence of non treponemal antibodies due to other causes other than syphilis in the pregnant mother \\nwill also cross the placenta to produce a reactive serologic test which is of a false positive nature in the \\nnewborn. The titre usually reverts to non reactive by 3 months of life. \\nTreatment of infants \\nTreatment decisions must be made on the basis of: \\n1. Identification of syphilis in the mother, \\n2. Adequacy of maternal treatment \\n3. Presence of clinical, laboratory or radiological evidence of syphilis in infants \\n4. Comparison of maternal (at delivery) and infant non-treponemal serologic titres \\nAll asymptomatic babies who have no serological evidence of syphilis and are born to mothers who \\nwere adequately treated for maternal syphilis with penicillin during the current pregnancy before 4 \\nweeks of delivery according to guidelines should be treated with a single dose of prophylactic penicillin. \\nIM prophylactic treatment regimen \\nBenzathine benzyl penicillin G 50,000 units/kg as a single intra muscular injection. \\n \\nIV treatment regimen \\nAqueous crystalline benzyl penicillin G 100,000 – 150,000 million units/kg/day intravenously. It could \\nbe given as 50,000 units/kg/dose IV every 12 hrs during the first 7 days of life and thereafter every 8 hrs \\nfor 3 days to complete a total of 10 days treatment. \\nThis should be given to: \\n1. All symptomatic babies \\n2. All asymptomatic babies \\ni. \\nWhose VDRL titre is a 4 fold higher than that of the mother at delivery \\nii. \\nHaving a rising non-treponemal titre \\niii. \\nWith a reactive syphilis specific IgM antibody test \\niv. \\nBorn to mothers with clinical evidence of syphilis \\nv. \\nBorn to mothers who were treated with penicillin <4 weeks before delivery, \\nvi. \\nBorn to mothers who did not complete the recommended course of penicillin during \\npregnancy \\nvii. \\nBorn to mothers whose non treponemal high titre had not dropped four fold at the \\ntime of delivery \\nviii. \\nBorn to mothers who were treated with non penicillin regimens (erythromycin0 \\nduring pregnancy \\nix. \\nBorn to mothers whose treatment status is unknown or undocumented'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n133 \\n \\n \\nSteps in syphilis screening and management of pregnant women \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPregnant women present to the \\nantenatal clinic \\nScreen for syphilis with  \\nNon-treponemal test (VDRL) \\nScreen for syphilis with on-site rapid \\nICS test \\n\\uf0b7 \\nNo treatment required \\n\\uf0b7 \\nPromote safer sex practices \\nPositive result\\nNegative result\\nRefer to STD clinic for\\n\\uf0b7 \\nConfirmation of syphilis by treponemal test – TPPA \\n\\uf0b7 \\nTreat mother \\n\\uf0b7 \\nCounsel for partner notification, treat partner \\n\\uf0b7 \\nCounsel for HIV test \\n\\uf0b7 \\nScreen for other STI \\n\\uf0b7 \\nPrepare a plan for management of baby and followup \\nTreatment of baby \\n\\uf0b7 \\nIV penicillin regimen \\n\\uf0b7 \\nIM prophylactic penicillin regimen'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n134 \\n \\n \\nProtocol for antenatal testing for syphilis in the government health system \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from mother (filed clinic, hospitalclinic)\\nSend blood to NSACP/nearest STD clinic/testing institution\\nVDRL test positive. All positives should be confirmed \\nby the specific test (TPPA) and  the laboratory/Mo-IC \\nof STD clinic should inform the positive test results to \\nthe relevant MOH immediately. When a BFP is \\ndetected the MOH should be informed that it is not \\nsyphilis. Hard copy of the positive test results/ BFP \\nshould be sent there after \\nVDRL/TPPA test reports should be \\ncollected by the relevant MOH from \\nthe testing center \\nAll VDRL negative test results \\nshould be entered in pregnancy \\nrecord (H 512 A& B) with the POA \\nby PHM. Sero negative mothers \\nshould be informed that they are \\nfree of syphilis. BFP results and \\nTPPA positive result should be \\nentered by MOH.  Confidentiality \\nof all information should be \\nmaintained   \\nMOH will inform the PHM to trace the respective \\nmother. The mother should be given a referral letter to \\nvisit the STD clinic. Confidentiality should be \\nmaintained. \\nWhen the mother attends the STD clinic a second \\nsample should be collected for re-confirmation after \\ncounseling. When a 2nd sample is positive the mother \\nwill be informed of the diagnosis and a file should be \\nopened\\n1. Detail history + clinical assessment and \\ndetermine the stage of syphilis, whether the \\nmother was treated in the past or this is a new \\ninfection during the current pregnancy \\n2. Screen for other STI \\n3. Treat according to the stage of syphilis  \\n4. Screen spouse/partner and give epidemiological  \\ntreatment/Rx \\n5. Counsel on safer sex \\n6. Promote HIV testing of mother and partner \\n7. Follow up \\n8. Make arrangements for management of baby \\n(Prophylaxis \\npenicillin \\nor \\nIV \\npenicillin \\nregimen) \\n9. Baby should be followed up in the STD clinic \\nat 3,6 and 12 months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n135 \\n \\n \\nChapter 19 \\nSYNDROMIC MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS \\nDURING PREGNANCY \\nIdentifying the syndromes \\nSyndrome \\nSymptoms \\nSigns \\nMost common causes \\nVaginal discharge\\nUnusual vaginal \\ndischarge \\nVaginal itching \\nDysuria (pain on \\nurination) \\nDyspareunia (pain \\nduring sexual \\nintercourse) \\nAbnormal vaginal \\ndischarge (Foul \\nsmelling /grey \\n/yellowish discharge) \\nEvidence of cervicitis  \\n- \\nErythema \\n- \\nOedema \\n- \\nInduced \\nbleeding \\n- \\nHypertrophic \\nectopy \\nVAGINITIS:\\n\\uf0b7 Trichomoniasis \\n\\uf0b7 Candidiasis \\n\\uf0b7 Bacterial vaginosis \\nCERVICITIS: \\n\\uf0b7 Gonorrhoea \\n\\uf0b7 Chlamydia \\nGenital ulcers \\nGenital sore \\nGenital ulcer \\nEnlarged inguinal \\nlymph nodes \\nSyphilis \\nChancroid \\nGenital herpes \\nLower abdominal \\npain \\nLower abdominal \\npain \\nDyspareunia \\nVaginal discharge \\nRebound tenderness  \\nAdenexial tenderness \\nPain on moving cervix  \\nTemperature 38c or \\nhigher \\nGonorrhoea \\nChlamydia \\nMixed anaerobe infections \\nOphthalmia \\nneonatorum \\nSwollen eye lids \\nEye discharge \\nBaby cannot open \\neyes \\nOedema of the eye lids \\nPurulent eye discharge \\nGonorrhoea \\nChlamydia'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n136 \\n \\n \\nVaginal discharge syndrome \\nVaginal discharge in pregnancy may mask signs of abortion complications, rupture of membranes or \\npostpartum infection. If there is no evidence of blood or amniotic fluid, treatment should be given to \\ncover candidiasis, trichomoniasis and bacterial vaginosis. \\nVaginal discharge is due to pathological cause they have either vaginitis or cervicitis or both. Vaginitis \\nis caused by trichomoniasis, candidiasis and bacterial vaginosis whereas cervicitis is causd by \\nGonorrhoea and Chlamydia.  \\nIt is normal for women to have a vaginal discharge during pregnancy. However if the vaginal discharge \\nwith foul smelling, thick and purulent with yellow discolouration, associated with genital ulcer, it could \\nbe due to a pathological cause and therefore it is useful to exclude the presence of a STI. \\n \\n                        \\nVaginitis \\nCervicitis \\n \\n\\uf0b7 Caused by trichomoniasis, candidiasis or \\nbacterial vaginosis      \\n \\n\\uf0b7 Complications are less   \\n \\n \\n\\uf0b7  Need to treat the sexual partner \\n                                                                       \\n\\uf0b7 Caused by gonorrhoea or chlamidia or \\nboth \\n \\n\\uf0b7 If untreated will result in complications to \\nthe mother and neonatal conjunctivitis of \\nthe baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n137 \\n \\n \\nManagement of vaginal discharge- speculum examination is not available \\n \\n \\n \\n \\n \\n \\n \\n \\nYes \\n \\n                                                                  No \\n \\n \\n \\n \\nHistory and examination\\nLower abdominal pain and \\ntenderness \\n       Patient c/o vaginal discharge\\nProfuse \\ndischarge at \\nintroitus/ \\noffensive\\nNo discharge \\nbut risk \\nassessment+ \\nGyn or STD \\nclinic \\nCurdy \\ndischarge at \\nintroitus \\n- \\nTreat for candidiasis\\n- \\nCounsel \\n- \\nScreen for Diabetes \\n- \\nFollow up \\n- \\nTreat for cervicitis & vaginitis\\n- \\nCounsel \\n- \\nPromote provide condoms \\n- \\nPartner treatment \\nAvoid sex until cured and partner treated \\nImproved by 14 days \\nReassure \\nRefer to STD \\nclinic \\nRisk Assessment\\n1. Symptomatic partner \\n2. Recent new sexual partner \\n3. Multiple sexual partner \\n4. Spouse returning after a long stay away'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n138 \\n \\n \\nManagement of vaginal discharge- speculum available \\n \\n \\n \\n \\n \\n \\n \\n \\nTreatment for Vaginitis \\nIncludes treatment for trichomoniasis, candidiasis and bacterial vaginosis \\nRecommended therapy for trichomoniasis and bacterial vaginosis: \\n\\uf0b7 Metronidazole 400 mg given orally twice daily for 7 days is effective \\nNote: Do not prescribe Metronidazole in the first trimester of pregnancy. \\n \\nPatient c/o vaginal discharge \\nHistory and speculum \\nexamination \\nLower abdominal pain+\\nGyn or STD clinic\\nCheese like discharge in \\nthe vagina\\nEvidence of cervicitis\\n\\uf0d8 cervical \\nerythematous/ \\ncervical oedema \\n\\uf0d8 mucopurulent \\ndischarge \\n\\uf0d8 hypertrophic ectopy \\nThick adherent \\noffensive vaginal \\ndischarge \\nRisk \\nassessment \\nTreat for candida \\nTreat for bacterial \\nvaginosis & \\ntricomonas vaginalis \\nTreat for cervicitis and vaginitis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n139 \\n \\n \\nTreat the patient’s partner for trichomoniasis with Metronidazole 2g as a single oral dose or \\nMetronidazole 400mg twice a day for 7 days \\nTreatment for vaginal candidiasis \\nNystatin 100000 units (one pressary), inserted intravaginally, once a day at night for 14 days, or \\nMiconazole or Clotrimazole 200mg, inserted into the vagina once a day at night for three days or  \\nClotrimazole 500mg, inserted into the vagina once only at night \\n(Advise the patient to take the complete course of tablets) \\nTreatment for cervicitis \\nRecommended therapy for Gonacoccal cervicitis: \\nCefuroxime Axetil 1g + Probenecid 1g orally as a single dose, or Ceftriaxone 250mg by intramuscular \\ninjection in a single dose \\nRecommended therapy for chlamydial cervicitis: \\nErythromycin 500mg orally 4 times a day for 7 days ( Preferred treatment is doxycycline 100mg bd for \\n7 days but doxycycline is contraindicated in pregnancy) \\nSexual partners should be treated for gonorrhoea and chlamydia infection. It is preferable to refer to a \\nSTD clinic.  \\n \\nLower abdominal pain syndrome \\nAll sexually active women presenting with lower abdominal pain should be carefully evaluated for signs \\nof pelvic inflammatory disease. Symptoms suggestive of PID include lower abdominal pain, pain on \\nintercourse (dysparunea), bleeding after sex or between periods, and pain associated with periods (if this \\nis a new symptom). Vaginal discharge, pain on urination (dysuria), fever, nausea and vomiting may also \\nbe present. \\nWhen a woman complaints of lower abdominal pain and has missed a menstrual period or a period is \\noverdue, an ectopic pregnancy has to be excluded since it is an obstetric emergency. \\nManagement of lower abdominal pain during pregnancy \\nTreatment for PID \\nCeftriaxone 250mg intra muscular injection in a single dose \\nTreatment of chlamydia infection \\nErythromycin 500mg orally 4 times a day for 14 days, \\nTreatment for anaerobic bacterial infection \\nMetronidazole 400mg orally twice daily for 14 days \\nNote:  Metronidazole should not be used in the first trimester of pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n140 \\n \\n \\nPartner management \\nThe partner has to be treated for gonorrhoea, Chlamydia and mixed anaerobic infections. It is preferable \\nto refer the patient to STD clinic. \\n \\nYes \\nRefer patient for urgent \\nsurgical or \\ngynaecological opinion \\nManage for PID & \\nReview in 3 days \\nImproved\\nYes \\nNO\\nPatient complaints of lower abdominal pain\\nHistory and examination\\nNO\\nAbdomial  \\ntenderness/ vaginal \\ndischarge/ adenexial \\nswelling/ adenexial \\ntenderness/ cervical \\nexcitation \\nYes \\nAny of the following present?\\n\\uf0d8 Missed /overdue period \\n\\uf0d8 Recent delivery/ abortion/ miscarriage \\n\\uf0d8 Abdominal  guarding and /or rebound \\ntenderness \\n\\uf0d8 Abnormal vaginal bleeding \\n\\uf0d8 Abdominal mass \\n\\uf0d8 Fever > 38c \\nReassure\\nRefer\\nContinue treatment until completed\\n\\uf0d8 Educate and counsel \\n\\uf0d8 Promote condom use and provide \\ncondoms \\n\\uf0d8 Treat partner \\n\\uf0d8 Ask patient to return if necessary \\nNO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n141 \\n \\n \\nGenital Ulcer Syndrome \\nGenital Herpes, Chanchroid and syphilis are the most common.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n142 \\n \\n \\nRecommended therapy for syphilis (Primary Chancre) \\nBenzathine penicillin 2.4 million units by single intramuscular injection (Because of the large volume of \\nthe dose, give it as two injections at separate sites.) \\nFor patients who are allergic to penicillin: \\n Doxycycline 100mg orally twice a day for 15 days, or Tetracycline 500mg Orally 4 times daily for 15 \\ndays \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used during pregnancy or lactation \\nIn pregnancy and lactation use: \\nErythromycin 500mg orally four times a day for 15 days \\n\\uf0b7 All babies born to mothers treated for genital ulcers suggestive of syphilis must be treated with \\nBenzathine penicillin 50,000 IU/KG IM or should be referred to a STD clinic for evaluation \\n\\uf0b7 If a baby has signs and symptoms suggestive of congenital syphilis refer to a STD clinic \\n/Peadiatric unit. \\n\\uf0b7 All babies born to mothers treated for GUD syndrome should also be reviewed for symptoms \\nand signs of Neonatal Herpes or referred to a STD clinc. \\n\\uf0b7 Mothers treated for GUD syndrome should be referred to a STD clinic for further evaluation. \\nRecommended therapy for Chancroid: \\n\\uf0b7 Erythromycin 500mg orally four times  a day for seven days \\nAlternatively the following may be used: \\n\\uf0b7 Ciprofloxacin 500mg single oral dose or \\n\\uf0b7  Cotrimoxazole 960mg (2 tablets) orally twice daily for 7 days \\nNote: Ciprofloxacin should not be used during pregnancy \\nRecommended therapy for genital herpes; \\nAcyclovir 200mg orally 5 times a day for 5 days. Advice the patient to keep the ulcers clean by washing \\nwith a weak solution of salt water \\nAdvice the patient to take all the tablets and inform him or her about mode of transmission of STD and \\npossible complications of infection and recurrences.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n143 \\n \\n \\nOphthalmia neonatorum syndrome \\nOphthalmia Neonatorum is the term used to describe a condition where a neonate develops purulent \\nconjunctivitis in one or both eyes within four weeks of birth. It is a medical emergency and unless \\ntreatment is initiated within 24 hours, there could be permanent damage to eyes leading to blindness. It \\nrequires systemic therapy as well as local irrigation with saline or other appropriate solutions. Irrigation \\nis particularly important when recommended therapeutic regimens are not available.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n144 \\n \\n  \\nFor the baby, the treatment for gonococcal ophthalmiais: \\nCeftriaxone 50mg/kg (maximum 125mg) in a single IM dose  \\nWhere Ceftriaxone is not available, use: \\nSpectinomycin 25mg/kg ( maximum 75mg) in a single IM dose \\nTreatment of the baby for Chlamydia Ophthalmia: \\nErythromycin syrup 50mg/kg/day orally four times a day for 14 days \\nClean the baby’s eyes with saline, using a clean swab for each eye. Remember to clean from inside to \\nthe outside edge of each eye. Wash your hands carefully afterwards. \\nTreatment of mother and the father: \\nShould be given treatment for both gonorrhoea and Chlamydia infection. \\nRecommended therapy for Gonorrhoea: \\nCefuroxime axetil 1g orally + Probenecid 1g in a single oral dose or Ceftriaxone 250mg IM in a single \\ndose \\nAlternative therapy \\nCiprofloxacin 500mg orally as a single dose, or  Spectinomycin 2g by intramuscular injection in a single \\ndose PLUS \\nRecommended therapy for Chlamydial infection: \\nDoxycycline 100mg orally twice a day for 7 days or Tetracycline 500mg orally 4 times a day for 7 days \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used by lactating women. \\nWhere tetracyclines are not recommended give:  \\nErythromycin500mg orally, four times daily for seven days \\nAdvice mother to complete the course of tablets and educate her about the mode of transmission of STD, \\nthe nature of the baby’s infection, how to clean the baby’s eyes and possible \\ncomplications of infection. Counsel her and promote the use of condoms. \\n \\nPrevention of Gonococcal ophthalmia \\nOphthalmia neonatorum can be prevented by using timely eye prophylaxis. \\nThe infant’s eye should be carefully cleaned immediately after birth with normal saline. \\nIf available apply 1% tetracycline ointment to the eyes of every infant at the time of delivery. This is \\nstrongly recommended prophylactic measure.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n145 \\n \\n \\nChapter 20 \\nNATIONAL GUIDELINES FOR PREVENTION AND MANAGEMENT OF  \\nMALARIA IN PREGNANCY \\n \\n1. Screening \\nAll pregnant women residing in malaria endemic areas should be screened for malaria parasitaemia at \\nthe time of registration in the antenatal clinic and at the end of the second trimester. The screening \\nshould be done by examining thick and thin blood smears using a finger prick sample of blood. \\n2. Chemoprophylaxis \\nDue to the low incidence of malaria in the country, chemoprophylaxis is not advocated as a policy. \\nHowever, in circumstances where the pregnant women could be considered at risk of acquiring malaria ( \\nas decided by the relevant Obstetrician or the MOH/MO) chemoprophylaxis  may be initiated after the \\nfirst trimester. \\nChoroquine is the drug recommended for prophylaxis. The dose is Chloroquine 300mg base once a \\nweek. \\nChloroquine can be given after the first trimester of the pregnancy and should be continued throughout \\nthe pregnancy and for upto six weeks after delivery. \\nImportant: Before initiating Chloroquine prophylaxis, please ensure that the pregnant woman is free \\nfrom malaria parasitaemia. \\n3. Treatment of malaria during pregnancy \\n(Please refer General Circular No.01-14/2008 dated 7th May 2008 issued by the DGHS “Guidelines \\nfor malaria chemotherapy and management of patients with malaria in Sri Lanka” for further \\ndetails) \\nIf a blood smear is reported positive, ensure that the parasite species is identified (Plasmodium vivax or \\nPlasmodium falciparum). \\nTreatment of a vivax infection in pregnancy: \\nPlasmodium vivax malaria is treated with Chloroquine. \\nDay 1 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 2 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 3 – Chloroquine base 5mg/kg body weight (approx. 300mg = 2 tablets) \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n146 \\n \\n \\nRadical cure of vivvax infection in pregnancy is recommended by the administration of primaquine six \\nweeks after delivery. The dose of primaquine is 0.25mg/kg/day for 14 days. \\nTreatment of falciparum infection in pregnancy: \\nArtemedsinin + Lumifantrin (Coartem®) is the recommended drug for patient with uncomplicated \\nfalciparum infections. All falciparum patients should be admitted and managed as inward patients. \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment. \\nImportant: \\nPregnant women should not be treated with Coartem® during the first trimester of pregnancy and during \\nthe period of exclusive breast feeding. \\nQuinine (oral or IV) can be used safely during first trimester of pregnancy and in situations that the \\npatient cannot take drugs orally. Quinine can be used safely during the period of lactation. \\nDosage: \\nQuinine sulphate orally 10mg/kg body weight 8 hourly for 7 days or \\nQuinine injection in a dose of 10mg/kg body weight diluted in 5% dextrose solution \\ninfused slowly at 8 hourly intervals till the patient can take oral drugs or for at least \\n7days. \\nAll falciparum infected pregnant women should be administered a single day dose of primaquine \\n(0.75mg/kg/day) six weeks after delivery. \\nPersonal protection: \\nAll pregnant women irrespective of their being on chemoprophylaxis or not, are advised to adopt \\nmeasures for personal protection from mosquito bites including the use of insecticide treated bed nets, \\nrepellants and other measures. \\nImportant: \\nAny pregnant woman arriving from malaria endemic country and suspected of having malaria infection \\nshould be admitted to a medical institution and managed appropriately (please contact Anti Malaria \\nCampaign directorate for advice). \\nPregnant women who are travelling to malaria endemic countries should contact the Anti Malaria \\nCampaign directorate for appropriate advice. \\nAnti Malaria Campaign directorate Contact details: \\n+94 112 588408, +94 112 368173, +94 112 368174'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n147 \\n \\n \\nChapter 21  \\n \\n \\n \\nMANAGEMENT OF TUBERCULOSIS DURING PREGNANCY \\n \\nTuberculosis is an infectious disease caused by the bacillus- Mycobacterium tuberculosis and \\noccasionally by Mycobacterium bovis and Mycobacterium africanum. Tuberculosis commonly affects \\nthe lungs, but it can affect any other organ in the body. \\n \\nHow does tuberculosis spread?  \\nThe bacteria that cause tuberculosis usually spread through air. When a patient with infectious \\npulmonary tuberculosis coughs, sneezes or laughs, bacilli are expelled into the air in the form of tiny \\ndroplets. These droplets dry up rapidly to form droplet nuclei and may remain suspended in the air for \\nseveral hours. Adequate through and through ventilation removes and dilutes these droplet nuclei, and \\ndirect sunlight quickly kills the bacilli, but they can survive in the dark for several days. When a healthy \\nperson inhales these droplet nuclei containing the tubercle bacilli, he/she may become infected. \\n \\nRisk of infection  \\nAn individual’s risk of infection depends on the extent of exposure to an infectious source and \\nsusceptibility of the individual to infection. The risk of infection is therefore high in a person who has \\nclose, prolonged exposure to a person with sputum smear positive pulmonary TB. The risk of \\ntransmission of infection from sputum smear-negative pulmonary TB is low and with extrapulmonary \\nTB, still lower. \\n \\nWho is a TB suspect?  \\nA TB suspect is a person who presents with symptoms or signs suggestive of TB, particularly cough of \\nthree weeks or more.  \\nWho is considered a ‘Case’ of tuberculosis?  \\nA case of tuberculosis is a patient in whom TB has been bacteriologically confirmed or diagnosed by a \\nclinician.  \\n \\nDefinite case of TB  \\n \\nA definite case of TB is a patient with positive culture for the Mycobacterium tuberculosis complex. (In \\ncountries where culture is not routinely available, a patient with two sputum smears positive for acid-fast \\nbacilli (AFB) is considered a “definite” case)  \\n \\nCommon symptoms of pulmonary tuberculosis  \\nThe clinical presentation of tuberculosis in pregnant women is similar to that in non-pregnant patients. \\n \\nRespiratory symptoms:  \\nCough – usually more than three weeks  \\nHaemoptysis (blood stained sputum)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n148 \\n \\n \\nShortness of breath  \\nChest pain \\n \\nConstitutional Symaptoms: \\nFever and night sweats \\nLoss of appetite \\nLoss of weight \\nTiredness (Fatigue) \\n \\nSymptoms of Extrapulmonary TB  \\nThe symptoms depend on the organ involved. Patients may present with constitutional features of the \\ndisease – fever, night sweats, loss of weight, and loss of appetite or local symptoms related to the site of \\nthe disease. \\n \\nInvestigations  \\nSputum Smear microscopy  \\nSputum smear microscopy is the most reliable and cost effective method of diagnosing infectious cases \\nof pulmonary tuberculosis cases. Whenever tuberculosis is suspected in a patient who has had a cough \\nof three weeks or more, three sputum samples should be collected and examined by microscopy for \\nAcid-Fast Bacilli (AFB).  \\n \\nCollection of sputum samples  \\nA PTB suspect should submit three sputum samples for microscopy. Three early morning samples are \\npreferable. Patient should be advised to collect sputum after coughing following a deep inspiration and it \\nshould not be saliva.  \\nOutpatients may provide sputum specimens as follows:  \\n \\nFirst spot specimen - Supervised spot specimen at the first visit  \\nEarly morning specimen - Patient is given a sputum container to collect early morning  \\nspecimen on the following day.  \\nSecond spot specimen - Second supervised spot specimen is collected when the patient  \\nreturns with the early morning specimen, on the following day.  \\n \\nChest X-ray  \\nThe chest X-ray has a limited role in confirming the diagnosis of pulmonary tuberculosis. Diagnosis of \\ntuberculosis by means of X-ray alone is unreliable. Abnormalities seen on a chest X-ray may be \\nmimicked by a variety of other conditions. However chest X-ray is helpful particularly to diagnose PTB \\nin a suspect whose sputum smears are negative for AFB. \\n  \\nThe decision to start on anti-TB treatment on patients should not be based solely on abnormal chest X-\\nray findings and all efforts should be made to perform sputum microscopy. \\n  \\nIn pregnancy, chest X-rays should be avoided as far as possible, especially during the first trimester, \\nbecause of the adverse effects of x-rays on the foetus.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n149 \\n \\n \\nTherefore, diagnosis will depend more on sputum examination when a pregnant mother presents with \\nsymptoms suggestive of tuberculosis. However, if an X-ray is absolutely necessary, this may be done \\nwith the abdomen covered with a lead apron.  \\n \\nSputum Culture for AFB  \\nCulture examination of sputum for AFB is more sensitive and specific than direct smear microscopy and \\nmay be useful in detecting cases where the number of organisms are fewer than can be detected by direct \\nsmear microscopy. But this is more expensive and takes at least 6-8 weeks to get the results.  \\nUnder ideal circumstances pre-treatment sputum cultures for AFB should be performed on all PTB \\npatients. \\n \\nTB treatment regimens  \\nTreatment regimens consist of two phases:  \\n1. Initial intensive phase  \\n2. Continuation phase  \\n \\nIntensive phase  \\nDuring the initial intensive phase, there is rapid killing of TB bacilli. Infectious patients quickly become \\nnon-infectious (within about two weeks) and symptoms improve. Most patients with sputum smear-\\npositive pulmonary TB becomes smear negative within two months. Directly Observed Therapy (DOT) \\nis essential in the initial phase to ensure that the patient takes every single dose. This prevents \\ndevelopment of drug resistance. The risk of development of drug resistance is higher during the early \\nstages of anti-TB treatment, when there are more bacilli.  \\n \\nContinuation Phase  \\nDuring the continuation phase, fewer drugs are necessary, but for a longer period. The sterilizing effect \\nof the drugs eliminates the remaining bacilli, thus preventing subsequent relapses.  \\nPatients who have taken anti-tuberculosis drugs previously are much more likely to develop drug \\nresistance, which may have been acquired through inadequate prior chemotherapy. Such patients require \\na stronger regimen consisting of more drugs and for a longer period.  \\n \\nTherefore, before starting treatment, it is essential to question all patients closely and carefully to \\ndetermine whether or not they have previously taken treatment for tuberculosis, so that they can \\nbe given the proper treatment regimen.  \\n \\nStandard code for TB treatment regimens  \\nThere is a standard code for TB treatment regimens and each anti-tuberculosis drug has an abbreviation.  \\nH – Isoniazid  \\nR - Rifampicin  \\nZ - Pyrazinamide  \\nE - Ethambutol  \\nS – Streptomycin  \\n \\nA TB treatment regimen consists of two phases, the intensive phase and the continuation phase. The \\nnumber before a phase is the duration of that phase in months. A subscript number (e.g. 3) after a letter'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n150 \\n \\n \\nindicates the number of doses of that drug per week. No subscript number after a letter indicates that the \\ntreatment is daily.  \\nE.g.: 4 HR means 4 months of Isoniazid and Rifampicin daily.  \\n5 H3 R3 E3 means 5 months of Isoniazid, Rifampicin and Ethambutol three times a week. \\n \\nTable 1 Case definitions, Treatment Categories and Recommended Regimens \\n  \\nCase Definition  \\nTreatment \\nCategory  \\nTreatment Regimen  \\nIntensive \\nPhase  \\nContinuation Phase  \\nNew cases  \\n- PTB smear-positive  \\n- PTB smear-negative  \\n- Extrapulmonary TB  \\nCAT 1 \\n2 HRZE \\n4 HR \\nRe-treatment cases  \\n- Relapses  \\n-Treatment after failure  \\n-Treatment after default  \\n(smear-positive)  \\nCAT 2  \\n2HRZES / 1 HRZE 5 HRE  \\n \\nMonitoring of sputum smear-positive pulmonary TB patients \\nResponse to treatment should be monitored by sputum smear examination \\nFor sputum smear positive PTB patients, sputum smear examinations should be performed at the end of \\nthe intensive phase of treatment (i.e.,second month), during the fifth month and ai the end of treatment. \\nNegative sputum smears indicate good treatment progress. \\nFor sputum smear negative patients sputum smear examination should be performed at the end of two \\nmoths of treatment. \\n \\nTreatment during Pregnancy  \\nAnti-TB treatment should be started as soon as the diagnosis is made, and the full course of treatment \\ngiven.  \\nThe basic principles of treatment are the same in pregnancy. Most anti-TB drugs are safe for use during \\npregnancy except streptomycin.  \\nStreptomycin should not be given because it can cause oto-toxicity in the foetus.  \\nPregnant mothers should be given pyridoxine 10mg daily along with INAH.  \\nVitamin K should be administered at birth to the infant of a mother taking rifampicin because of the risk \\nof post-natal haemorrhage.  \\n \\nTreatment during breast-feeding  \\nA patient who has TB and is breast-feeding should receive the full course of anti-TB treatment. Properly \\ntaken treatment is the best way of preventing transmission of TB to her baby. All anti-TB drugs are \\ncompatible with breast-feeding. A patient taking anti-TB treatment can continue to breastfeed her baby \\nin the normal way.  \\n \\nBreastfeeding should be avoided only in cases where the mother has dual TB/HIV infection.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n151 \\n \\n \\nManagement of a newborn child of a mother with active TB  \\n• Do not separate the child from the mother unless she is acutely ill.  \\n• If the mother is sputum smear negative, and if the infant has no evidence of congenital TB, BCG is \\ngiven to the infant.  \\nIf the mother is sputum smear-positive at the time of delivery, infant should be carefully examined \\nfor evidence of active disease.  \\n- If the infant is ill at birth and congenital TB is suspected, a full course of anti-TB treatment \\nshould be given.  \\n- If the child is well, give prophylactic treatment with INAH 5mg/ kg body weight, daily for \\nthree months. BCG is withheld.  \\n• The Mantoux skin test is done after three months.  \\n- If the Mantoux test is negative and the child is well, prophylactic treatment with INAH is \\nstopped and child is given BCG.  \\n- If the Mantoux test is positive, careful examination of the child for active TB is done \\nincluding a chest X-ray.  \\n- If active disease is diagnosed, a full course of anti-TB treatment should be commenced.  \\n- If the physical examination and the chest X-ray are normal, INAH chemoprophylaxis is \\ncontinued up to six months and BCG is given.  \\n \\nDirectly Observed Treatment  \\nDirectly Observed Treatment (DOT) is one of the important elements of the internationally \\nrecommended strategy for TB control. Directly Observed Treatment means that an observer watches the \\npatient swallow their tablets. This ensures that a TB patient takes the right anti-tuberculosis drugs, in the \\nright doses at the right intervals without interruption and ensures that the patient completes the full \\ncourse of treatment. \\n \\nDOT Providers –  \\nThe following categories will provide Direct Observation of Treatment.  \\n• Health workers at state health care facilities  \\n• Field health care workers  \\n• General practitioners  \\n• Trained volunteers  \\n• Community leaders  \\nPublic health staff especially Public Health Nursing sisters and Public Health Midwives  can play a \\nsignificant role as DOT providers for antenatal and postnatal mothers in their areas who are on \\ntreatment. \\n \\nProvision of drugs for the DOT Centres -  \\nDrugs for each patient will be delivered to the DOT centres from the District Chest Clinic by the PHI or \\nany other staff assigned by the DTCO. \\n \\nInterruption of treatment (default)  \\nDirectly Observed Treatment adapted to the needs of the patient is the best method of avoiding treatment \\ninterruption. However, even with directly observed treatment and during the continuation phase of \\ntreatment, which may be self-administered, there may be treatment interruption.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n152 \\n \\nMeasures to minimize treatment interruption  \\nAt the time of registration of a TB patient, the staff must educate the patient and the family regarding the \\nduration of treatment and the importance of adherence to treatment.  \\n \\nIt is vital to record the patient’s address and other relevant addresses e.g. parents or work place etc. in \\norder to help locate the patients who interrupt treatment. As far as possible, the address should be \\nverified at the beginning of treatment.  \\n  \\nPublic Health Midwives in their field visits and at antenatal clinics should inquire about uninterrupted \\ncontinuation of treatment from patients and should encourage them to continue treatment. \\n \\nManagement of patients who interrupt treatment  \\nIt is important to take action on defaulters immediately. Patients should be contacted the day after \\nmissing a dose during the intensive phase and as soon as possible during the continuation phase. It is \\nimportant to find out the reason for the patient’s absence in order to take appropriate action and continue \\ntreatment. \\n \\nNotification \\nAt the point of diagnosis, all tuberculosis patients should be notified using TB notification Form (H \\n816). \\n \\nContact screening  \\nHousehold contacts of infectious TB patients (adults and children >5 years) should be screened for \\nsymptoms of TB. Those who have symptoms suggestive of TB should be investigated with sputum \\nsmears irrespective of the duration of the symptoms.  \\nChildren under the age of 5 years should be screened with chest X-ray and Mantoux test.  \\n \\nPreventive treatment  \\nThe aim of preventive treatment is to prevent progression of M. tuberculosis infection to disease.  \\n \\nPrimary chemoprophylaxis  \\nWhen a person is exposed to TB bacilli, but not yet infected eg. newborn breastfed baby of a sputum \\nsmear-positive mother  \\n \\nSecondary chemoprophylaxis  \\nA person who is infected, but not yet developed clinical disease e.g. tuberculin positive close contacts of \\nsputum smear-positive patients.  \\nIn Sri Lanka, chemoprophylaxis is given for the following groups:  \\n• Breast fed infants of sputum smear-positive mothers.  \\n \\n• Household contacts below 5 years of age of sputum smear-positive patients, who do not have \\nevidence of active disease.  \\nProphylactic treatment in Sri Lanka is – INAH 5mg/ kg body weight for 6 months.  \\n \\nFor further details refer ‘General Manual for Tuberculosis Control’ published by National \\nProgram for Tuberculosis Control and Chest Diseases.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n153 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPOSTNATAL CARE'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n154'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n155 \\n \\n \\nChapter 22 \\nPOST NATAL CARE \\nPostnatal period begins immediately after birth of the baby and extend up to 6 weeks (42 days) after \\nbirth:  \\nImmediate postnatal period - the phase immediately following child birth up to 24 hours \\nEarly postnatal period - Day 2-7 \\nLate postnatal period - Day 8-42 \\n The major objectives of the postnatal care are: \\n\\uf0b7 To provide a supportive environment in which a woman, her newborn baby and the wider family \\ncan begin the transition of their lives \\n\\uf0b7 To recognize danger signs in the mother and the newborn and to help them to take timely actions \\n\\uf0b7 To maintain good physical and mental health in both mother and the newborn  \\n\\uf0b7 To support, promote and protect breast feeding \\n\\uf0b7 Counseling on family planning to help the mother to select a method and provision of services \\nwhere needed. \\n\\uf0b7 Recognize the child as a service utilizer \\n \\n22.1  Immediate postnatal period \\nThis is the period during which infant’s physiology undergoes adaptation and the risk of postpartum \\nhaemorrhage is highest. Close professional supervision is required in this period to identify problems \\nearly and intervene appropriately. According to the discharging policy in Sri Lanka, postnatal care \\nduring immediate postnatal period is given at a hospital. \\nImmediate Maternal Care \\n\\uf0b7 All women should be examined one hour after delivery of placenta, including assessment of \\nanaemia. \\n\\uf0b7 All postnatal mothers should have regular assessment of vaginal bleeding, uterine contraction, \\nfundal height and temperature. \\n\\uf0b7 All women should be encouraged to mobilize appropriately as soon as following the birth \\n\\uf0b7 Measure and document BP once within 6 hours after the last measurement taken soon after birth  \\n\\uf0b7 Document urine output during first 6 hours \\n\\uf0b7 Toilet facilities that are hygienic and ensure privacy should be provided at a distance with easy \\naccessibility \\n\\uf0b7 Ensure adequate rest for the woman and access to food and drink on demand'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n156 \\n \\n \\nConcerns \\n\\uf0b7 If infection is suspected, a woman’s temperature should be measured and documented. If the \\ntemperature is above 38oC, it should be measured again in 4-6 hours and need to find out the \\ncause. \\n\\uf0b7 If a woman has excessive and offensive vaginal discharge, abdominal tenderness, fever and any \\nabnormalities in the size, tone and position of the uterus, she should be evaluated. These women \\nmay need urgent action. \\n\\uf0b7 If diastolic blood pressure is greater than 90mmHg, and there are no other signs and symptoms \\nof pre-eclampsia, the measurement of blood pressure should be repeated within 4 hours. \\n\\uf0b7 If a woman has not voided by 6 hours postpartum irrespective of measures to encourage \\nmicturition (such as taking a warm bath or shower), bladder volume should be assessed and \\ncatheterization need to be considered (urgent action). If a woman is obese, she will require \\nindividualized care. \\n\\uf0b7 Immediate referral or emergency action is required if there is: \\nSudden or profuse blood loss or loss accompanied by any of the signs and symptoms of \\nshock, including trachycardia, hypotension, hypoperfusion and change in consciousness  \\nDiastolic BP is greater than 90mmHg and accompanied by another sign or symptom of \\npre-eclampsia, or if diastolic BP is greater than 90mmHg and is not reduced below \\n90mmHg within 4 hours. \\nThe temperature remains above 380C on the second reading or there are other observable \\nsymptoms and measurable signs of sepsis \\nA woman complained of unilateral calf pain, redness, swelling, and shortness of breath or \\nchest pain \\nAll women should be given information about the physiological process of recovery after birth, and that \\nsome health problems are common, with advice to report any health concerns to health care workers, in \\nparticular: \\nSigns and symptoms of PPH: sudden and profuse blood loss or persistent increased blood loss: \\nfaintishness; dizziness; palpitations/tachycardia \\nSigns and symptoms of infection: fever, shaking, abdominal pain and/ or offensive vaginal loss \\nSigns and symptoms of thrombo-embolism: unilateral calf pain; redness or swelling of calves; \\nshortness of breath or chest pain \\nSigns and symptoms of pre-eclampsia: Headaches, visual disturbances, nausea, vomiting, feeling \\nfaint. \\nWomen who have had an epidural or spinal anaesthesia should be advised to report any severe \\nheadache, particularly when sitting or standing \\n \\n \\nAdvice on postpartum care and hygiene, especially hand washing and use of clean napkins or pads'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n157 \\n \\n \\nGive advice on proper nutrition during lactation (page 85). \\nCounsel on birth spacing and family planning with special attention to lactational amenorrhoea and \\nemphasis the need of using a family planning method by 6 weeks. \\nAdvise on routine postpartum care at the field and ask them to inform area PHM as soon as they go \\nhome to get routine care. \\nAdvice on postpartum danger signals and discuss the postpartum emergency plan (page 65 ). \\nGive Vit A mega dose (200,000IU) before discharge. \\nIf she is not immunized with Rubella, make arrangement for rubella immunization before discharge. \\nDo a vaginal examination before discharge and ensure that there are no foreign bodies in the vagina eg. \\nGauze packs etc \\nComplete all the documents eg Diagnosis cards, pregnancy record and hand over the relevant documents \\nto mother. \\nHelp the mother to register the birth. \\nAdvice about maternal benefits, if relevant. \\n \\nImmediate Newborn Care \\n\\uf0b7 Baby should be delivered on to the mother’s abdomen \\n\\uf0b7 Immediately dry the baby with a warm clean towel or piece of cloth. Thoroughly dry the baby to \\nprevent it getting cold. Wipe away any blood or meconium. Do not wipe off the vernix ax it \\nhelps to protect the bay’s skin and gets reabsorbed very quickly. \\n\\uf0b7 Assess the baby’s breathing while drying  \\n\\uf0b7 Make sure that there is no second baby \\n\\uf0b7 Change gloves. If this is not possible wash the gloved hands \\n\\uf0b7 Clamp and cut the umbilical cord \\n\\uf0b7 Leave the baby between the mother’s breasts to start skin to skin care \\n\\uf0b7 Place an identity label on the baby \\n\\uf0b7 Cover the baby’s head with a hat and cover the mother and baby with a warm cloth \\n\\uf0b7 Encourage initiation of breastfeeding. Keeping the newborn skin to skin between the mother’s \\nbreasts encourage this process. \\n \\nDuring the first hour of life: \\n\\uf0b7 Ensure the mother and baby are in a warm room which is not  less than 250c with no draught \\n\\uf0b7 Mother and baby should not be separated. Keep the baby in the same room with the mother in \\nher bed or within easy access.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n158 \\n \\n\\uf0b7 Skin to skin contact should be encouraged for all the newborns in the first hour of life. For low \\nbirth weight newborns skin to skin contact (Kangaroo Mother Care) can be practiced as long as \\nthe baby requires. \\n\\uf0b7 Brest feeding should be initiated within the first hour of life and continue on demand. Identity \\nhunger cues and start breastfeeding when the baby is ready. Support exclusive breastfeeding on \\ndemand day and night Newborn should be dressed adequately in order to to maintain the body \\ntemperature. Baby’s head should be covered with a cap. Additional layer of clothing should be \\nworn if it is in a cooler climate. \\n\\uf0b7 Resuscitate a baby that is not breathing spontaneously (weight, length, head circumference etc.), \\n\\uf0b7 Assess the gestational age and take measrements. \\n\\uf0b7 Vitamin K should be offered for all infants and administered with a single dose of 1mg IM. \\n \\nMaintaining infant health \\nRound the clock keep the mother and baby together in the same bed or in the same room within easy \\naccess to the mother. Continuing skin to skin contact, whenever possible. \\nIn areas where it is necessary, cover the mother and baby with a bed net \\nEnsure exclusive breastfeeding on demand during day and night for the newborn. In case if the mother \\ndevelop difficulties in breastfeeding make her aware how to seek support from her area PHM or at the \\nclosest hospital Lactation Management Centre \\n \\nMake the mother aware about routine care of the newborn \\n- \\nKeeping the baby warm – Newborn should be dressed adequately and the head should be \\ncovered with a cap during the first few days. Additional layer of clothing should be worn if it is \\nin a cooler climate.  \\n- \\nDress the baby well and keep covered with a soft cloth. If the baby is not kept with the mother, \\ncheck for warmth every 4 hours by touching bay’s feet. Delay bathing until at least the baby is 6 \\nhours old. \\n- \\nCare of the umbilical cord (should be kept dry, should not apply anything on the cord stump, if it \\nis soiled, wash with soap and water and dry well. \\n- \\nDaily clean the baby’s face, neck and the arm pits. Clean the buttocks when soiled. Bath the baby \\nwhen required using warm water. After bathing make sure to keep the baby warm \\nAssessment for emotional attachment should be carried out at each postnatal contact \\nFirst clinical examination should be done around an hour after the birth to assess if baby can stay with \\nthe mother or needs additional care or referral to special care. \\nAssess the malformations and birth injuries \\nInfants who develop jaundice within the first 24 hours should be urgently investigated. \\nTeach the mother how to care for a small baby (pre-term or low birth weight) eg. Kangaroo-mother care  \\nGive special support to breast feeding the small bays or twins.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n159 \\n \\n \\nTeach the mother to observe for the danger signs in the baby and to call health worker if she has \\nconcerns. \\nExamine before discharge. Discuss with mother postnatal care and emergency plan. \\nOnly discharge small babies if discharge criteria met: Exclusive breast feeding, stable temperature, \\nweight gain, mother feeling competent caring for the baby. \\n \\nSupport for breast feeding: \\nBreast feeding support to a woman should be made available regardless of the location of care. \\nWomen should be offered skilled support including mother to mother or peer support from the \\ncommencement of the breast feeding. \\nAdditional support with positioning and attachment to commence breast feeding should be offered to all \\nwomen who had: \\n\\uf0b7 A caesarean section, particularly to assist with handling and  positioning the baby to protect the \\nceasarean section wound \\n\\uf0b7 Initial contact with their baby delayed \\n\\uf0b7 Twins \\nUnrestricted frequency and duration of breast feeding should be encouraged. \\nA PHM should discuss the woman’s experience with breast feeding daily to assess with her if she is on \\ncourse to breast feed effectively and identify need for additional support. \\nA written breastfeeding education material should be available and health care staff should use them in \\nroutine BF lecture/demonstrations. \\nIf breastfeeding problem is identified, refer mother to lactation management center \\nTeach all mothers how to relieve engorgement and expressing breast milk and feeding the baby with a \\ncup. \\nWomen with flat or inverted nipples should be advised that these are not contraindications to \\nbreastfeeding and support should be offered as needs \\nIf a woman is experiencing breast or nipple pain, healthcare worker should review positioning and \\nattachment. \\nA baby who is not attaching effectively may be encouraged to open his/her mouth using different \\nstimuli. \\nSkin to skin contact or massaging the baby’s feet should be used to wake the baby. \\nOnly discharge the baby if mother feels competent in breast feeding. \\nWomen should be offered information and reassurance on: \\n\\uf0b7 Colostrum which will meet the needs of the baby in the first few days after birth \\n\\uf0b7 Timing of the initial breast feed, including the protective effects of colostrum \\n\\uf0b7 The nurturing benefits of putting the bay to the breast in addition to the nutritional benefits of \\nbreasfeeding. \\n \\nWomen should be reassured that brief discomfort at the start of breast feeds in the first few days is not \\nuncommon, but should not persisits.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n160 \\n \\n \\n22. 2  Post natal care at the field  \\nOnce the mother is discharged from the hospital, professional postnatal care is provided through home \\nvisits by the PHM and postnatal clinics (a component of a poly clinic).  Other than that woman caring \\nfor herself and newborn with the support of the family. Therefore, health workers need to be ensured \\nthat home practices are in line with evidence based best practices and give some skills to the family and \\ncommunity to support women and babies during this critical period.  \\nPostnatal care model in Sri Lanka consists of domiciliary care and clinic care. The area public health \\nmid wife (PHM) is responsible for the post natal home visits while hospital or field clinic manned by a \\nqualified medical officer responsible for clinic care.  \\n \\n \\n \\n \\n \\n \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\nWomen with postnatal complications need more clinic visits as well as home visits. Women who had \\nstill births and infant deaths should be also visited by the PHM.  \\n \\n \\n \\n \\nFor Normal vaginal delivery:    \\n 02 home visits during first 10 days after delivery (first visit first 5 days) \\n \\n01 home visit during 14-21 days (around 15th day) after delivery \\n \\nPostnatal clinic visit at 4-5 weeks  \\n \\n01 visit around 42 days (6-7 weeks) after delivery \\nFor Home delivery:                    \\n  \\n03 visits during first 10 days after delivery \\n01 visit 14-21 days (around 15th day) after delivery \\nPostnatal clinic visit at 4-5 weeks  \\n01 visit around 42 days of delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n161 \\n \\n \\nFirst and second home visits (within the first 10 days post partum) \\n \\nA locally adopted system should be implemented to inform the PHM regarding the child birth as soon as \\nthey are discharged from the hospital eg. messenger, telephone call or a specially designed card etc. \\n \\nPHM  \\n\\uf0b7 Should be able to identify all the post partum mothers in her area including those come from \\nother areas. \\n\\uf0b7 should be able to identify and take necessary action to the problems in mother and baby  \\n \\nObserve: \\nGeneral condition of the mother and the home: \\nCleanliness and order in the house and the place where new born and mother live (ventilation, \\nlight, safety, warmth, humidity, smoke exposure) \\nMother and baby are within easy reach. \\nPersonnel hygiene of the mother \\nBehaviour and the mood of the mother (sad, happy) \\nSupport and general attitude of other family members towards mother and baby \\n \\nBaby: \\nPHM should mainly consider the following important points in the care of the newborn (essential \\nnewborn care): \\n\\uf0b7 Ensure that the baby is kept warm \\n\\uf0b7 Keep the mother and the baby together, in the same room, same bed or within easy reach \\n\\uf0b7 Support exclusive breastfeeding on demand day and night \\n\\uf0b7 Teach the mother how to care for the baby \\nLook at the CHDR and neonatal diagnosis cards, if any \\nEnsure that BCG immunization has received \\nIdentify the presence of any high risk condition which needs special attention   \\n \\nWash hands with soap and water before examining the baby. \\n Select a place with good light for examination. \\n \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0a7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0a7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0a7 Sleep \\n\\uf0a7 Crying \\n\\uf0a7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0a7 Vomiting'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n162 \\n \\n \\nObserve and examine : \\n\\uf0a7 General appearance: weight, colour, any other external abnormalities \\n\\uf0a7 Look at the presenting part : swelling or bruises \\n\\uf0a7 Movements : Normal/abnormal \\n\\uf0a7 Observe the cry \\n\\uf0a7 Hygiene of the baby \\n\\uf0a7 Breathing : Normal/ grunting/ and count breaths (30-60 per minute) \\n\\uf0a7 Feel for warmth. If cold or very warm measure the temperature \\n\\uf0a7 Tone : Normal/ abnormal \\n\\uf0a7 Colour:  tip of the nose, eyes, skin (cyanosis, jaundice) \\n\\uf0a7 Condition of the umbilicus \\n\\uf0a7 Presence of any danger signs – box below \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nIf any danger sign is detected refer the baby immediately for care.  If any other problem is detected refer \\naccordingly \\n \\n \\nDanger signs in the newborn \\n\\uf0b7 \\nFast breathing (more than 60 breaths per minute) \\n\\uf0b7 \\nSlow breathing (less than 30 breaths per minute) \\n\\uf0b7 \\nSevere chest in-drawing \\n\\uf0b7 \\nGrunting \\n\\uf0b7 \\nConvulsions \\n\\uf0b7 \\nFloppy or stiff \\n\\uf0b7 \\nBluish discolouration of the body \\n\\uf0b7 \\nFever (temperature > 380C) \\n\\uf0b7 \\nCold body ((temperature < 350C) or not rising after rewarming \\n\\uf0b7 \\nBleeding from umbilical stum or cut \\n\\uf0b7 \\nYellow discoloration of the body \\n\\uf0b7 \\nPallor \\n\\uf0b7 \\nDiarrhoea \\n\\uf0b7 \\nVomiting after every feed \\n\\uf0b7 \\nIf a baby who was breastfeeding well refuses two consecutive \\nfeeds \\n\\uf0b7 \\nUmbilicus draining pus or umbilical redness extending to skin \\n(periumbilical redness)  \\n\\uf0b7 \\nSwelling in one or more limbs \\n\\uf0b7 \\nWeakness in any one of the limb \\n\\uf0b7 \\nWeak cry \\n\\uf0b7 \\nMore than 10 skin pustules or bullae or swelling, redness, \\nhardness of skin'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n163 \\n \\n \\nBreast feeding: \\nAsk from the mother: \\n\\uf0b7 Any concerns or difficulties in breastfeeding  \\n\\uf0b7 How many times the baby has fed in 24 hours \\n\\uf0b7 Whether the baby is satisfied after a breastfeed \\n\\uf0b7 Whether the baby is exclusively breastfed \\n\\uf0b7 How her breasts are feeling \\n \\nObserve a breast feed: \\nIf the baby has not breastfed in the previous hour ask the mother to put the baby on her breast and \\nobserve breastfeeding for about 5 minutes and observe the following; \\n\\uf0a7 The position of the mother   \\n\\uf0a7 The position of the baby during breastfeeding \\n\\uf0a7 Attachment of the baby to the breast during breast feeding \\n\\uf0a7 Whether the baby is suckling effectively \\n \\nIf the baby has fed in the last hour ask her to tell you when her baby is willing to feed again.  \\n \\n \\nAsses the mother’s breasts if complaining of nipple or breast pain \\n\\uf0b7 Look at the nipples for fissures \\n\\uf0b7 Look at the breasts for swelling, shininess or redness \\n\\uf0b7 Feel gently for the painful part of the breast \\n\\uf0b7 Measure temperature \\n\\uf0b7 Identify and solve problems during breast feeding  \\n\\uf0b7 Advice  to check adequacy of breast milk ( How many times that baby has passed urine, duration \\nof a feed)  \\nEducate mother on activities that should be done for psycho social development of the baby - kissing the \\nbaby, touching, Nalavili gee \\nEducate the mother on how to keep the baby warm. \\nEducate mother on how to keep the home environment safe and clean (with out dust, cold, smoke) \\nAdvice on methods of infection control- the importance of limiting visitors, limiting the number of \\nhandlers, hand washing \\n \\nInquire about the myths and correct them- ratha kalkaya, gammiris pibima \\nInquire and solve the problems with BCG immunization \\nRegister the baby and maintain records \\nDecide on date of next visit according to the problems identified'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n164 \\n \\n \\nMother: \\nAsk: \\nEnquiries should be made about general wellbeing and all common health problems:  \\n\\uf0b7 Micturition, dysuria and urinary incontinence  \\n\\uf0b7 Bowel functions : diarrhea /constipation \\n\\uf0b7 Vaginal  bleeding: amount/ colour \\n\\uf0b7 Vaginal discharge :  amount/ smell/ colour  \\n\\uf0b7 Lower abdominal pain \\n \\n\\uf0b7 Vomiting \\n\\uf0b7 Breathing difficulties \\n\\uf0b7 Severe headache \\n\\uf0b7 Calf pain \\n\\uf0b7 Visual disturbances \\n\\uf0b7 Healing of any perineal wounds \\n\\uf0b7 Back pain \\n \\nExamine: \\n\\uf0b7 General appearance of the mother: shortness of breath, cyanosis, icterus \\n\\uf0b7 Temperature \\n\\uf0b7 Respiratory rate \\n\\uf0b7 Pulse rate \\n\\uf0b7 Features of anaemia: pallor in tongue, conjunctiva , nails \\n\\uf0b7 Oedema: ankle, facial, fingers \\n\\uf0b7 Breast (if not done earlier): breast engorgement, cracked nipples, breast abscesses \\n\\uf0b7 Abdomen: size and consistency of the uterus, LSCS scar \\n\\uf0b7 Perinium:  \\no Lochia: amount, colour and smell \\no Vaginal discharge: colour and amount \\no Vaginal bleeding \\no Episiotomy scar: infected or not, gaping, healing \\no Personnel hygiene of the mother in relation to perineal area \\no Mental status: sad/happy, features of psychosis \\no Check urine if indicated (Pre eclampsia, diabetes, renal disease \\no If need carry out a vaginal examination'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n165 \\n \\n \\nIntervene:  \\nEncourage mother to use self care techniques such as taking gentle exercises, taking time to rest, having \\nhelp to care for her baby, talking to someone about her feelings \\n \\nAsk the mother about her emotional well-being, what family and social support they have and their \\nusual coping strategies for dealing with day to day matters. Post natal mother and her partner and family \\nshould be encouraged to tell their health care workers about any changes in mood, emotional state and \\nbehavior that are outside of the mother’s normal pattern. \\n \\nObserve for any risks, signs and symptoms of domestic abuse and aware who to contact for advice and \\nmanagement. \\n \\nThe PHM should identify, evaluate and manage common health problems as appropriate: \\n1. Carry out assessment of perineum. If perineal pain is present advise on tropical cold therapy or \\nParacetamol for pain relief. \\n2. Signs and symptoms of infection, inadequate repair, wound breakdown or non-healing should be \\nreferred to the nearest hospital or MOH clinic for further evaluation and management. \\n \\n3. Management of mild postnatal headache should be based on differential diagnosis of headache \\ntype. Check the blood pressure if BP apparatus is available. Otherwise refer to nearest hospital or \\nhealthcare centre to check blood pressure and act accordingly. \\n4. If a woman has tension or migraine headaches, the PHM should offer advice on relaxation and \\navoidance of factors associated with the onset of headache eg. coffee, chocolate etc. \\n5. Back pain should be managed with paracetamol and correct postures. \\n6. A woman with some involuntary leakage of a small volume of urine should be taught how to do \\npelvic floor exercises. \\n7. If constipation present, advice increased intake of fibre and fluids. If problem persists advise use \\nof gentle stimulant laxative. \\n8. Women with haemorrhoids should take measures to avoid constipation. If a woman has a \\nhaemorrhoid which is severe and swollen or prolapsed, or any rectal bleeding, refer to the \\nhospital for further evaluation and management. \\n9. If the woman complains of persistent fatigue, refer her for haemoglobin level evaluation. \\n10. Inquire about the antenatal complications and see whether she is complying the advices given  \\nfor the postpartum period. \\n11. Once assesses, women with the following conditions should be referred for treatment: \\nSevere or persistent headache and/ or other symptoms of pre-eclampsia \\nSustained postpartum vaginal bleeding \\nPersistent urinary incontinence \\nFaecal incontinence \\n \\nPostpartum women should be offered information and assurance about: \\n\\uf0b7 Perineal pain and perineal hygiene \\n\\uf0b7 Urinary incontinence and micturition \\n\\uf0b7 Bowel functions \\n\\uf0b7 Rest and sleep'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n166 \\n \\n\\uf0b7 Support from the husband and other family members \\n\\uf0b7 Bathing  \\n\\uf0b7 Nutrition – advise to eat a greater amount and variety. Reassure that she can eat all normal food. \\nAdvise the women against food taboos, continuing iron folate, whether she has got vitamin A \\nmegadose, (if not give her Vit A mega dose) adequate  fluid intake \\n\\uf0b7 Advice the mother and the family on danger signals during postpartum period (heavy vaginal \\nbleeding, severe abdominal pain, fever, foul smelling vaginal discharge, severe headache, calf \\npain etc.)  and actions to be taken if such signal is identified \\n\\uf0b7 Educate the family on importance of breast feeding, rest and possible psychological changes of \\nthe mother. \\n \\nComplete all the relevant records. \\nMothers with problems may need more visits. Decide on date of next visit according to the problems \\nidentified. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during postnatal period \\nIf a postpartum woman has any of the following signs or symptoms, advise to go to a \\nhospital immediately. \\n\\uf0b7  Features of high blood pressure: \\n \\nSevere headache \\n \\nFaintishness \\n \\nBurning pain or tightness in the chest or upper abdomen \\nBlurring of vision or visual disturbances \\nShortness of breathing \\n\\uf0b7 Increased vaginal bleeding or bleeding with clots \\n\\uf0b7 Pain in the calf muscles which increased with walking \\n\\uf0b7 Difficulty in breathing in a mother with heart disease \\nIf a postpartum woman has any of the following signs or symptoms meet a doctor \\nimmediately. \\n\\uf0b7 Foul smelling/ excessive or purulent  vaginal discharge \\n\\uf0b7 Episiotomy wound – gaping, infected, abscess formation or severe pain \\n\\uf0b7 Fever during first six weeks after delivery \\n\\uf0b7 Difficulty in breathing – gradually increasing or increased rate of respiration \\n\\uf0b7 Pain in the chest \\n\\uf0b7 Mental distress- lack of sleep, less attention to the baby, mental liability, feels \\nfrustrated, suicidal thoughts'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n167 \\n \\n \\nHome visit  3 (within 11-21 days) \\n \\nObserve the general condition of the mother and the home as described earlier. \\nBaby: \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0b7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0b7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0b7 Sleep \\n\\uf0b7 Crying \\n\\uf0b7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0b7 Vomiting \\nExamine: \\n\\uf0b7 Color: cyanosis, icterus \\n\\uf0b7 Umbilicus: fallen or not, discharge, peri-umbilical redness \\n\\uf0b7 BCG scar \\n\\uf0b7 Excretion (stool/ urine: frequency, colour) \\n\\uf0b7 Infections: pustules discharges \\n\\uf0b7 Feeding – correct positioning of the baby to breast, adequacy of breast milk, solve  problems \\nduring breast feeding \\n \\nIntervene: \\nEducate on family on the duties of mother/ father for psycho social development of baby \\nECCD practices \\nSafety of the baby – animals, physical environment, older children, \\nRefer to post natal clinic for weighing, examination by 4 weeks  \\nMaintain records. \\nRevisit if needed \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described in first \\nvisit. \\nAll post natal women should be asked about resumption of sexual intercourse and possible dyspareunia \\nas part of an assessment of overall well-being. \\nAsses the mental condition of the mother – rest, sleep, unhappiness, loneliness \\nAll women should be asked about resolution of symptoms of maternal blues. If symptoms have not \\nresolved, the woman’s psychological well-being should continue to be assessed for postnatal depression. \\nRefer to MOH clinic. \\nContinue to observe for any indication of domestic abuse.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n168 \\n \\nExamine: \\n\\uf0b7 Involution of the uterus \\n\\uf0b7 Episiotomy scar and LSCS scar \\n\\uf0b7 Vaginal discharge/ lochia \\n\\uf0b7 Breast examination- engorgement, abscess, nipple cracks \\nIntervene: \\nNutrition of the mother – diet, use of micronutrients, see the compliance of drugs taken for any disease \\nconditions. \\nAny positive response to queries about common health problems should be evaluated, treated or referred \\nappropriately: \\nDyspareunia \\nIf a woman expresses anxiety about resuming intercourse, reasons for this should be explored \\nwith her and help her to resolve those anxieties \\nIf a woman is experiencing dyspareunia and has sustained perineal trauma, examine her \\nperineum and assess the condition and act accordingly \\nA water based lubricant gel to help to ease discomfort during intercourse may be advised. \\nIf a woman continues to express anxiety about sexual health problems refer her to MOH clinic \\nfor further evaluation \\nIf persistent postnatal fatigue is impacting on the woman’s care of herself or baby, underlying physical, \\npsychological and social causes should be evaluated. \\nGive information: \\n\\uf0b7 Family planning methods \\n\\uf0b7 Importance of exclusive BF for 6 months \\n\\uf0b7 Personal hygiene of the mother \\n\\uf0b7 Maternal benefits \\n\\uf0b7 Breast feeding  for working mothers \\n\\uf0b7 Older children’s psychological aspects \\n\\uf0b7 Initiation of sexual activity and possible dyspareunia \\n\\uf0b7 Importance of continuing micronutrient intake \\n \\nAll mothers should be referred to a postnatal clinic during 4-6 weeks of postpartum. Give date for the \\npost natal clinic. \\nComplete all relevant records.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n169 \\n \\n \\nHome visit around 42 days \\n \\nBaby: \\n\\uf0b7 Support mother to maintain the nutrition, cleanliness, and psychosocial development of the baby \\n\\uf0b7 Check whether mother is maintaining the records of psycho social developmental  activities of \\nthe baby according to the age  \\n\\uf0b7 Refer baby for immunization \\n\\uf0b7 Explain the importance of weighing the baby monthly to assess the growth  \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described. \\nEducate mother on family planning method and refer her to family planning clinic (give a date) \\n \\nConfirm the adequacy of breast milk and encourage mother to breast feed exclusively for 6 months \\nEnquire about family support \\nSolve problems in sexual intercourse \\nInquire about mother’s mental status and support mother to develop her self esteem'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n170 \\n \\n \\nChapter 23 \\nPost Natal Clinic \\n \\nArea public health mid wife should refer all post natal mothers to the post natal clinics in 4-6 weeks post \\npartum. Post natal clinic should be a component of a poly clinic. There should be two post natal clinics \\nper month. A date for the post natal clinic should be given to all mothers during the home visits and it \\nshould be mentioned in H 512 & CHDR. The attendance of mothers for post natal clinics should be \\nentered in the clinic attendance register as well as the clinic summary. The number of mothers attended, \\nmothers found with post partum complications and mothers referred for specialized care should be \\nentered in the quarterly clinic record (H -527). \\nThe goals of post natal clinic: \\nMother \\n\\uf0b7 Monitoring and evaluation of field post natal care \\n\\uf0b7 Identifying  the problems not identified by PHM \\n\\uf0b7 Give treatment / advices/ referrals if needed. \\n\\uf0b7 Counseling on family planning  and provision of FP services \\n\\uf0b7 Analysis of postpartum mental status using EPDS \\n\\uf0b7 Strengthening  the support from family and the husband \\n\\uf0b7 Assess and support the ECCD practices of the mother  \\n \\nBaby \\n\\uf0b7 Complete examination of the baby \\n\\uf0b7 Assess breast feeding, identify and solve problems \\n\\uf0b7 Assess the growth and development of the child \\nActivities: \\n\\uf0b7 Registration of mother and baby \\n\\uf0b7 Measuring of head circumference and the weight of the baby \\nCare for the mother \\nAsk:  \\n\\uf0b7 Inspection of previous records (512 A, 512 B, diagnosis cards) \\n\\uf0b7 History of the pregnancy \\n\\uf0b7 Post partum complications – breast problems, episiotomy scar, constipation, behavioral changes, \\npost partum hemorrhage, vaginal discharges etc. \\n\\uf0b7 Nutritional status and personal hygiene \\n\\uf0b7 Sexual intercourse \\n\\uf0b7 Intake of vitamins/ drugs'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n171 \\n \\n \\nExamine:  \\n\\uf0b7 Pallor \\n\\uf0b7 Oedema – facial, finger, ankle \\n\\uf0b7 Icterus \\n\\uf0b7 Sudden onset of breathlessness \\n\\uf0b7 Psychological assessment using EPDS \\n\\uf0b7 Blood pressure  \\n\\uf0b7 Abdomen and perineum(if needed) \\nInvestigations (if needed) : \\n\\uf0b7 Urine albumin/ sugar \\n\\uf0b7 Hb \\nActions: \\n\\uf0b7 Advice , treat and refer  for the identified complications \\n\\uf0b7 Refer for family planning services \\n\\uf0b7 Supply nutritional supplements and vitamins \\n\\uf0b7 Give a date for next visit  for FP /immunization \\n\\uf0b7 Give Rubella vaccine if not given before \\nCare for the baby \\nAks: \\n\\uf0b7 Check the diagnosis card if any \\n\\uf0b7 Breast feeding \\n\\uf0b7 Urine output/ bowel opening \\n\\uf0b7 Sleeping habits \\n\\uf0b7 Eye to eye contact (milestones) \\n\\uf0b7 Any worries for the mother \\nExamine: \\n\\uf0b7 General appearance  \\n\\uf0b7 Fill the neonatal examination form / check list / CHDR \\n\\uf0b7 BCG scar \\n\\uf0b7 Check the neonatal diagnosis card if available \\n\\uf0b7 Check the CHDR \\n\\uf0b7 Supervise breast feeding technique ( if weight gain not adequate) \\n\\uf0b7 Check for exclusive breast feeding \\n\\uf0b7 Do investigations ( if needed) \\n\\uf0b7 Take necessary actions  \\nA separate date or time for the post natal clinic should be given to mothers who had still births/ neonatal \\ndeaths. \\n(For further information please read PCPNC guide and guidelines on postnatal care published by FHB)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n172 \\n \\n \\nChapter 24 \\nFAMILY PLANNING AFTER DELIVERY \\n \\nHelp pregnant women and new mothers (along with their male partners) decide how they will avoid \\npregnancy after childbirth. Ideally, family planning counseling should start during antenatal care and in \\nparticularly in the third trimester. \\n\\uf0b7 Waiting until her baby is at least 2 years old before a woman tries to become pregnant again is \\nbest for the baby and good for the mother, too. \\n\\uf0b7 A woman who is not fully breastfeeding is able to become pregnant as soon as 4 to 6 weeks after \\nchildbirth. \\n\\uf0b7 For maximum protection, a woman should not wait until the return of monthly bleeding to start a \\ncontraceptive method, but instead she should start as soon as possible.  \\n\\uf0b7 Every woman should be properly counselled to ensure that she uses a family planning method. If \\na method is not provided in the hospital refer to the Medical Officer of Health in the area. \\n\\uf0b7 A woman may decide whether she wants to use a family planning method for spacing (short term \\nmethod) or limiting (long term method) pregnancies. \\n \\nEarliest Time That a Woman Can Start a Family Planning Method after Childbirth \\nFamily Planning Method\\n \\nShort term methods for spacing\\nMale or female condoms \\nImmediately\\nCopper-bearing IUD  \\nWithin 48 hours, otherwise wait 6 \\nweeks \\nProgestin-only injectables (DMPA) \\n6 weeks after childbirth \\nImplants \\n6 weeks after childbirth \\nCombined oral contraceptives\\n6 months after childbirth\\nLong term methods for limiting \\n \\nFemale sterilization  \\nWithin 7 days, otherwise wait 6 \\nweeks \\nVasectomy  \\nduring partner’s pregnancy , \\nImmediately after child birth or later \\nas early as possible'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n173 \\n \\n \\nChapter  25 \\n \\nSCREENING FOR POSTPARTUM DEPRESSION \\nEdingburgh Postnatal Depression Scale (EPDS) \\nThe EPDS was developed for screening postpartum women for postnatal depression in outpatient, home \\nvisiting settings or at the 6-8 week post partum visit examination. It has been utilized in many countries. \\nThis scale has been validated for Sri Lanka and pilot tested in several settings. \\nThe EPDS consists of ten questions. The test can usually be completed in less than 5 minutes. Responses \\nare scored 0,1,2,or 3 according to increased severity of the symptom. The total score is determined by \\nadding together the scores for each of the 10 items. Validation studies have utilized various threshold \\nscores on determining which women were positive and in need of referral. A woman scoring 9 or more \\npoints or indicating any suicidal ideation – that is she scores 1 or higher on question No. 10, should be \\nreferred immediately for follow up. Even if a woman scores less than 9, if the clinician feels the client is \\nsuffering from depression, an appropriate referral should be made.  \\nThe EPDS is only a screening tool. It does not diagnose depression.  \\nInstruction to use: \\n1. The screening for postnatal depression should be done at the postnatal clinic (4-6 weeks). \\n2. The mother is asked to underline 1 of 4 possible responses that comes the closest to how she has \\nfeeling the previous 7 days. \\n3. All 10 items must be completed. \\n4. Care should be taken to avoid the possibility of the mother discussing her answers with others. \\n5. The mother should complete the scale herself, unless she has limited ability or has difficulties in \\nreading and understanding. \\nEdinburgh Postnatal depression Scale \\nAs you may know, some women become depressed after they have had a baby and it is sometimes \\ndifficult for them to tell anyone how they are feeling. Completeing this questionnaire will help depressed \\nmothers to get the help they need. Please Underline the answer, which comes closest to how you have \\nfelt in the past week. \\nHere is a completed example: \\nI have felt happy \\n \\nYes, all the time \\n \\nYes most of the time \\n \\nNo, not very often \\n \\n \\nNo, not at all'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n174 \\n \\n \\nThis would mean: “I have felt happy most of the time@ during the past week. Please complete the other questions \\nin the same way. \\n \\nIn the past week \\nCoding Column \\n \\n1 \\nI have been able to laugh and see the funny side of things: \\n \\n \\n               As much as I always could \\n0 \\n \\n               Not quiet so much now \\n1 \\n \\n              Definitely not so much now\\n2\\n \\n                Not at all \\n3 \\n2. \\nI have looked forward with enjoyment to things: \\n \\n \\n              As much as I ever did \\n0 \\n \\n              Rather less than I used to do \\n1 \\n \\n             Definitely less than I used to do\\n2\\n \\n              Hardly at all \\n3 \\n3. \\nI have blamed myself unnecessarily when things went wrong: \\n \\n \\n               Yes, most of the time \\n3 \\n \\n               Yes, some of the time \\n2 \\n \\n              Not very often\\n1\\n \\n             No, never \\n0 \\n4. \\nI have been anxious or worried for no good reason: \\n \\n \\n               No, not at all \\n0 \\n \\n               Hardly ever \\n1 \\n \\n             Yes, some times\\n2\\n \\n              Yes, Very often \\n3 \\n5. \\nI have felt scared or panicky for no good reason: \\n \\n \\n             Yes, quite lot \\n3 \\n \\n             Yes, Some times \\n2 \\n \\n            No, not much\\n1\\n \\n             No, not much at all \\n0 \\n6. \\nThings have been getting on top of me \\n \\n \\n             Yes, most of the time I haven’t been able to cope at all \\n3 \\n \\n            Yes, sometimes I haven’t been copying as well as usual\\n2\\n \\n            No, most of the time I have coped quite well\\n1\\n \\n             No, I have been copying as well as ever \\n0 \\n7. \\nI have been so unhappy that I have had difficulty in sleeping: \\n \\n \\n            Yes, most of the time \\n3 \\n \\n           Yes, sometimes\\n2\\n \\n           Not very often\\n1\\n \\n            No, not at all \\n0 \\n8. \\nI have felt sad or miserable: \\n \\n \\n              Yes, most of the time \\n3 \\n \\n             Yes, sometimes\\n2\\n \\n               Not very often \\n1 \\n \\n               No, not at all \\n0 \\n9. \\nI have been so unhappy that I have been crying: \\n \\n \\n             Yes, most of the time \\n3 \\n \\n           Yes, quite often\\n2\\n \\n            Only occasionally \\n1 \\n \\n            No, never \\n0 \\n10. \\nThe thought of harming myself has occurred to me: \\n \\n \\n             Yes, quite often \\n3 \\n \\n             Sometimes \\n2 \\n \\n             Hardly ever \\n1 \\n \\n             Never \\n0 \\n \\nTotal score'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n175 \\n \\n \\nChapter 26 \\n \\nMANAGEMENT INFORMATION SYSTEM OF MATERNAL CARE \\n \\n                         \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nFor detailed description please refer the guideline on MCH/FP management information system \\npublished by FHB in 2004. \\n \\nPublic Health Midwife \\nPHM’s Monthly Statement H 524\\nPHM’s Daily Statement H 523\\nMOH office\\nQuarterly MCH return  H 509 \\nMCH Clinics \\nPHM’s Diary H 511\\nClinic attendance registers H 517\\nClinic Summary H 518\\nQuarterly MCH clinic return H527\\nFamily Health Bureau\\nRDHS office'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n176 \\n \\n \\nChapter 27 \\n \\nSURVEILLANCE ON MATERNAL MORBIDITY AND MORTALITY \\nThe maternal care program in Sri Lanka carried out maternal death surveillance and antenatal and \\npostnatal morbidity surveillance at the field level. Surveillance system for severe maternal morbidities or \\n‘near misses’, will be introduced through the hospital system. \\n \\n27.1  Surveillance on maternal morbidities \\nGuidelines on reporting antenatal and postnatal morbidities \\nReporting of antenatal morbidities \\nMorbidities identified during antenatal period should be entered at the space given in the H512A and B \\nby the field PHM / MOH at the time of the identification. Those identified morbid conditions should be \\nnoted in the diary during the 1st postnatal visit and should be entered in the daily statement on the \\nsame day. This reporting system is necessary to avoid repetition of reporting. The morbid condition \\nshould be entered correctly. \\nReporting of postnatal morbidities \\nThe identified morbidities during postnatal visits should be noted in the H 512 A, H512B and diary \\nunder the date of postnatal visit and should also be entered in the PHM’s daily statement on the same \\nday. \\n(When keeping notes in the PHM’s diary, Mothers Number should be entered in the column for \\npostnatal care and morbidities should be entered in the column for other issues. Mark AN with the \\nantenatal morbid conditions and mark PN with the postnatal morbid conditions.)  \\nProvision of accurate information to the national health information system is a responsibility of all \\nrelevant staff in the health services. Therefore, it is a main responsibility of the supervising staff \\nincluding MOH and AMOH to facilitate PHM to identify morbidities using diagnosis cards and correct \\nreporting.  Supervising officers should encourage PHMM to maximize the reporting of antenatal and \\npostnatal morbidities and to monitor the compliance on medical advice and relevant treatment regimes. \\nThey should also plan necessary interventions for identified issues. \\nFurther, MOH should check the accuracy of the information before entering relevant information into \\nthe quarterly return of MCH (H509).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n177 \\n \\n \\nDefinitions for antenatal and postnatal morbidities \\nAntenatal Morbidities \\n1. Hypertension (Chronic or pregnancy induced) \\nAvailability of records with the diagnosis of hypertension or availability of a diagnosis card \\nOr blood pressure of 130/90 or more on at least three occasions (recorded by a medical officer) or \\nIncrease in diastolic pressure by 30mmHg or more comparing to early pregnancy measurement. \\n2. Diabetes Mellitus (Chronic or gestational )  \\nDiagnosis of Diabetes Mellitus / Gestational Diabetes Mellitus by a medical officer or \\nAvailability of a diagnosis card or availability of treatment records \\n3. Heart Diseases \\nAvailability of records kept by a medical officer with the diagnosis of congenital or non-congenital heart \\ndisease or \\nAvailability of a diagnosis card or  \\nPast surgical history for heart disease but currently not on treatment \\nRegistration at a cardiac clinic but currently not on any treatment \\nOn monthly Penicillin prophylaxis for Rheumatic fever or Rheumatic heart disease \\nDiagnosed with Mitral valve Prolapse (MVP) \\nDiagnosed with any other cardiac disease (eg. Heart Failure, cardiomyopathy etc.) \\n4. Anaemia \\nAvailability of a record of Hb <11g/dl during pregnancy. \\n5. Antepartum Haemorrhage \\nAvailability of a diagnosis card for vaginal bleeding during pregnancy. \\n6. Asthma \\nAvailability of a diagnosis card for asthma or \\nWhen mothers says that she is on long term drugs (tablets or inhalers) for asthma \\n7. Malaria \\nAvailability of records on malarial infection during pregnancy, confirmed by a blood smear. \\n8. Tuberculosis \\nAvailability of a diagnosis card for Tuberculosis during pregnancy or taking treatment during pregnancy \\nfor previously diagnosed Tuberculosis. \\n9. Sexually Transmitted Infections (STI) \\nAvailability of a diagnosis card given by a medical officer for sexually Transmitted Infection (Syphilis, \\ngonorrhea, Herpes simplex infections, Trichomonasis, Chamydia Infection, HIV/AIDS) \\n10. Liver Disease \\nAvailability of a diagnosis cards or notes in the pregnancy record confirming Hepatitis or any other liver \\ndisease during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n178 \\n \\n \\n11. Mental disorders \\nAvailability of a diagnosis card given by a Medical Officer confirming a mental disorder or \\nWhen mothers says that she is on long term drugs for mental disorder. \\n12. Epilepsy \\nAvailability of a diagnosis card given by a Medical Officer confirming Epilepsy or \\nWhen mothers says that she is on long term drugs for epilepsy. \\n13. Urinary Tract Infections \\nAvailability of records for treating UTI after confirmatory urine testing during pregnancy by a medical \\nofficer \\n14. Other disease Conditions \\nNote disease conditions other than the conditions mentioned above, that can affect pregnancy according \\nto the available diagnosis cards. \\n \\nPostnatal Morbidities \\n1. Postpartum Haemorrhage \\nAvailability of a diagnosis card from hospital admission for abnormal or excessive vaginal bleeding \\nduring postnatal period \\n2. Fever \\nBody temperature of 370C (1000F) or more during postnatal period \\n3. Reproductive Tract Infections (Offensive vaginal Discharge)  \\nAvailability of notes regarding the diagnosis and treatment of reproductive tract infections by a medical \\nofficer (sign and symptoms: Fever, lower abdominal pain associated with foul smelling vaginal \\ndischarge) \\n4. Urinary Tract Infection \\nAvailability of notes regarding the diagnosis and treatment for a urinary tract infection during postnatal \\nperiod by a medical officer after confirmatory urine testing \\n5. Infected Episiotomy \\nPurulent discharge from the episiotomy wound. \\n6. Detached Episiotomy sutures \\nGaping of the Episiotomy wound edges \\n7. Presence of Foreign bodies in the vagina \\nWhen Foreign bodies (eg. Gauze swabs or packs) are found in the vaginal during vaginal examination'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n179 \\n \\n8. Infected Caesarean section wound  \\nPresence of redness, swelling, warmth around the Caesarean section wound or  \\nPus or blood stained discharge form the wound or \\nGaping of the wound \\n9. Deep Vein Thrombosis \\nAvailability of notes regarding diagnosis and treatment for DVT by a medical officer. \\n10. Postpartum Mental Disorders \\nAvailability of a notes regarding diagnosis of mental disorder during postpartum period \\n11. Cracked Nipples \\nPresence or cracks or fissures around the nipple \\n12. Breast Engorgement \\nPresence of following signs and symptoms: \\nBreast and areola gets edematous and painful. \\nMilk flowing from the breast has been stopped. \\nEnlarged blood vessels on the breast can be clearly visualized. \\nFever may be present but usually does not continue beyond 24 hours. \\nCan be relieved by expressing milk \\n \\n13. Breast Infections or Abscesses \\nTreatment taken for following signs and symptoms; \\n \\nPain in the Breast \\n \\nFeeling warmth when touching the breast \\n \\nRedness over the breast skin \\n14. Hypertension \\n \\nAvailability of a diagnosis made by a medical officer for high blood pressure during postnatal period \\n \\n15. Heart failure \\nAvailability of a diagnosis made by a medical officer for heart failure during postnatal period \\n16. Other disease conditions \\nNote disease conditions other than conditions mentioned above that mother has taken treatment \\naccording to the available diagnosis cards \\n17. Postnatal hospital admissions \\nAvailability of a record on hospital admission during postnatal period or statement given by a mother \\nregarding hospital admission during postnatal period due to maternal problem'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n180 \\n \\n \\n \\n26. 2   MATERNAL M ORTALITY SURVEILLANCE \\n \\nReduction of maternal mortality being identified as a national priority, Family Health Bureau (FHB), Ministry of \\nHealth has set up an island-wide surveillance system of maternal deaths occurring throughout the country since \\n1989.  \\n \\nSurveillance of maternal deaths involves the systematic collection, collation, analysis, interpretation & \\ndissemination of all information related to maternal deaths.  \\n \\n \\n1.0 \\nDefinitions \\n \\n \\nMaternal death -The death of a woman while pregnant or within 42 days of termination of  \\n \\n \\npregnancy, irrespective of the duration and site of pregnancy, from any cause related to or \\n \\n \\naggravated by the pregnancy or its management, but not from accidental or incidental  \\n \\n \\ncauses. (Ninth version of the International Classification of Diseases) \\n \\n \\nMaternal deaths are subdivided into two groups; \\n \\n \\nDirect maternal deaths -Deaths resulting from obstetric complications of the pregnant state  \\n \\n \\n(pregnancy, labour and puerperium), from interventions, omissions, incorrect treatment  \\n \\n \\nor from a chain of events resulting from any of the above. \\n \\n \\nEg. Deaths due to septic abortions, post partum haemorrhage, pregnancy induced   \\n \\n \\nhypertension, amniotic fluid embolism and suicide due to post partum psychosis etc.  \\n \\n \\nIndirect maternal deaths -Deaths resulting from previous existing disease or disease that  \\n \\n \\ndeveloped during pregnancy and not due to direct obstetric causes, but aggravated by the  \\n \\n \\nphysiologic effects of pregnancy are classified as  \\n \\n \\nEg. Deaths due to pregnancy complicated with medical disorders such as heart disease,  \\n \\n \\nanaemia, pneumonia, hepatic diseases etc.  \\n \\n \\nLate maternal death -Death of a woman between 42 days and one year after termination of  \\n \\n \\npregnancy, following direct or indirect maternal causes.   \\n \\n \\nEg: Death of a mother on the 90th day due to renal failure following eclampsia. \\n \\n \\nPregnancy related death -Death of a woman while pregnant or within 42 days of termination of \\n \\n \\npregnancy irrespective of the cause of death. \\n \\n \\nThis category includes all maternal deaths, incidental deaths and accidental deaths. \\n \\n \\nEg: Deaths due to food poisoning during pregnancy, murder during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n181 \\n \\n2.0  \\nNotification of maternal deaths \\n \\n \\nNotification of maternal deaths has been made a legal requirement by issuing a gazette  notification that \\nall practitioners providing care to women in the country, both at institutional and  field levels, are legally bound to \\nnotify maternal death events to Family Health Bureau –the focal  point in maternal death surveillance. \\n \\nNotification involves informing of all deaths which fulfill the notification criteria to the relevant \\n \\nauthorities, in a uniform manner and without delay for necessary action. \\n \\n2.1 \\nNotification criteria \\n \\n- \\nAll deaths (irrespective of cause) of women in reproductive age group (15 – 49 years) during \\nthe pregnancy period and until one year after termination of pregnancy \\n \\nThis includes; all confirmed maternal deaths, late maternal deaths, pregnancy related deaths and \\nother reproductive age group female deaths. Such a wider notification range will ensure that all \\nprobable maternal deaths are captured by the surveillance system. \\n \\n2.2 \\nNotification procedure \\n \\n \\nThe notification procedure will be described under sections on maternal death surveillance at \\n \\nfield level, maternal death surveillance at institutional level and maternal death surveillance at \\n \\nestate level respectively. \\n \\n \\n3.0  \\nMaternal Death Surveillance at Institutional Level \\n \\n\\uf0b7 Once a maternal death occurs in an institution (government or private hospital), the Head of the \\nInstitution should take the custody of the bed head ticket (BHT) and all the documentation of \\nmanagement details of the deceased mother. All the pages should be numbered and the original \\ndocument should be made available for relevant officers/review meetings for investigation \\nprocedure. The BHT should not be reproduced. BHT should not be taken out of the office of \\nthe Head of the Institution and extraction of information from the BHT should be done within \\nthe office premises only. \\n\\uf0b7 It is compulsory to conduct a post mortem in all cases of maternal deaths as per the circular \\nissued by the Secretary to the Ministry of Justice and Law reforms dated 2008.10.02 to all \\ncoroners and letter issued by director general of health services (DGHS) on 2011.01.12. \\n\\uf0b7 A copy of the post mortem report should be issued by JMO to DGHS, Director – FHB and \\nHead of the hospital where maternal death occurred  \\n3.1    Notification procedure of maternal deaths to be followed at institutional level \\n \\n- \\nImmediately after the occurrence of a death which fulfils above notification criteria (2.1) the \\nrelevant staff should report it to the head of the institution.  \\n- \\nJMO should also notify such deaths to the head of the institution after the post mortem. \\n- \\nCoroners should also be requested to notify such deaths to the RDHS and the head of the \\ninstitution after inquiry into sudden deaths.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n182 \\n \\n- \\nThe head of the institution will then notify the death within 24 hours by telephone, telegram, \\nfax or email to the following officers; \\n \\nDirector – MCH (Family Health Bureau) \\n \\nPDHS and RDHS (where the institution located) \\n \\nPDHS and RDHS (deceased residence) \\n \\nMOH (deceased residence) \\n \\nHead/s of the previously managed institution/s \\n- \\nThe notification of these deaths should be done according to the format H 677 C (page).  \\n- \\nWhenever the death of such a mother transferred from another institution occurs, the receiving \\ninstitution should notify the head of the previously managed institution of the death.  \\n \\n3.2      Institutional investigation procedure of a maternal death  \\n(Government and private hospitals) \\n \\n- \\nSeparate institutional investigations should be performed by each institution involved in the \\nmanagement of the deceased mother. \\n- \\nThe investigation should be conducted within 14 days of occurrence of a maternal death as this \\nwould enable to identify precisely the circumstances that led to the death with fresh \\ninformation. The circumstances of the death should be discussed in detail with the intention of \\nidentifying preventive measures. \\n- \\nThe institutional investigation is the responsibility of the Head of the Institution.  \\n- \\nInvestigation should be carried out as a team which should comprise of the following officers; \\n \\n\\uf0b7 Head of the Institution (Director/MS/DMO/MO-IC) as the team leader \\n\\uf0b7 Consultant Obstetrician and Gynaecologist or the relevant Specialist of the hospital unit \\nin which the death occurred (acting consultant in his/her absence) and all other relevant \\nconsultants who managed the mother (Physician, Surgeon, Anaesthetist, Psychiatrist etc) \\n\\uf0b7 Medical officer/s who attended the deceased mother (DMO, MO/IC, senior house officer, \\nhouse officer etc.) \\n\\uf0b7 Judicial Medical Officer  \\n\\uf0b7 Medical officer – blood bank – when relevant \\n\\uf0b7 Grade I Nursing Officer /Nursing Officer In Charge of the ward/ labour room - when \\nrelevant \\n\\uf0b7 Head of the Institution of hospitals where the patient was managed before transfer \\n\\uf0b7 Medical Officers Maternal and Child Health (of the districts where the mother is resident \\nand where the hospital is situated) \\n\\uf0b7 Medical Officer of Health from the mother's area of residence \\n\\uf0b7 Public Health Midwife from the mother's area of residence \\n \\n- \\nThe institutional investigation should be coordinated by the medical officer (preventive health) \\non behalf of the head of the institution. \\n- \\nThe Head of the Institution is responsible for the implementation of the corrective actions \\nwithin the hospital without delay as decided at the institutional review.\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n183 \\n \\n3.3      Reporting the institutional investigation  \\n \\n- \\nThe information obtained during the investigation should be entered in form H 677 in \\ntriplicate. A copy of the latest version of H677 should be obtained from the MOMCH or \\ndownloaded from the FHB website: www.familyhealth.gov.lk/downloads.php \\n- \\nConsultant Obstetrician and Gynaecologist or the relevant Specialist of the hospital unit in \\nwhich the death occurred and Head of the Institution should ensure the completeness of the \\nformat. \\n- \\nThe completed format (H 677) should be sent to the following institutions within 14 days of \\noccurrence of the maternal death. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nHead of the institution should also ensure that these deaths are reported through H830 \\n(Monthly Report on Maternal Statistics) and Quarterly Indoor Morbidity and Mortality Returns \\n(MMR) sent to the relevant sectors. Also he/she should ensure that pregnancy and/or childbirth \\nshould be mentioned as an underlying cause of death when the death declaration is given.  \\n \\n4.0 \\nMaternal Death Surveillance at Field Level \\n \\n4.1       Notification procedure of maternal deaths to be followed at field level \\n \\nWhen a notifiable death occurs in her area, the area PHM should immediately notify it to the \\nMOH. Notification by the PHMM can be considered as the single most important step in \\nmaternal death surveillance as this is the means which could have the highest notification rate.  \\n \\nThe MOH may receive a maternal death notification directly from the head of the institution at \\nwhich the death occurred or from the RDHS/MOMCH of the district to whom the death was \\nnotified.  \\n \\n \\n \\n \\n \\n \\n \\n \\nMOH \\nRDHS/MOMCH of \\nthe area\\nPHM \\nDirect notification from the hospital \\nH 677 \\nDirector / MCH \\n231, De Saram Place, Colombo 10\\nRDHS (of the district \\nof mother's residence) \\nOffice copy\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n184 \\n \\nThe MOH should inform the relevant authorities that it is compulsory to conduct a post mortem \\nin all cases of maternal deaths as per the circular issued by the Secretary to the Ministry of \\nJustice and Law reforms dated 2008.10.02 to all coroners and letter issued by director general of \\nhealth services (DGHS) on 2011.01.12. \\nThe MOH should obtain post-mortem details from the JMO. If a copy of the post-mortem \\nnecessary, the MOH should inform the Director – MCH. \\n \\nAll the relevant records (H512A, H512 B) should be taken over & kept safely in the MOH office \\ntill the investigations & review meetings are over. \\n \\nMOH should notify such a death to the following places within 24 hours by telephone, telegram, \\nfax or email using the format H 677 C (See page 190) to the FHB, PDHS and RDHS. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nThe telegram or telephone message should be confirmed  by a letter containing the following \\ninformation \\n(Name of the deceased mother, address, PHM area, MOH area, RDHS area, date of \\ndeath, place of death, tentative cause of death, name and designation of the informant, \\ndate informed) (See page - 190) \\n- \\nIn case of the death of a mother who is temporarily resident in a MOH area, the area MOH \\nshould notify the death to the MOH of the area from where the mother came from (& where \\nshe was registered as an eligible female) \\n- \\nIn cases of deaths within one week of discharge from a hospital, the MOH should notify the \\ndeath to head/s of the previously managed institution/s \\n- \\nMOH should also ensure that all deaths are reported through H 509 (Quarterly Maternal and \\nChild Health Return).  \\n \\n4.2     Field investigation procedure for maternal deaths  \\n \\n- \\nMOH (of the area where the mother is registered in the eligible family register) is the \\nresponsible officer for the field investigation. In case of an absence of the relevant MOH, the \\nacting MOH/AMOOH or MO-MCH should take the responsibility of carrying out the field \\ninvestigation.  \\n- \\nInvestigation should be done as a team comprising of MO-MCH, MOH, all AMOOH, all \\nPHNS, all SPHM and PHM of the area. MO-MCH and MOH should jointly investigate the \\nmaternal death. \\n- \\n \\n      MOH \\nDirector / MCH (FHB), \\n231, De Saram Place, \\nColombo 10 \\nPDHS\\nRDHS'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n185 \\n \\n \\n- \\nIn case of the death of a mother who is temporarily resident in another MOH area, the MOH of \\nthat area should also investigate the case as a team comprising of MO-MCH, MOH, all \\nAMOOH, all PHNS, all SPHM and PHM of the area and send that report to the MOH of the \\narea of mother's residence (i.e. where the mother was registered in the eligible couple register) \\nwho will then prepare the final investigation report.  \\n- \\nInvestigation should commence as early as possible and should be completed within fourteen \\n(14) days of occurrence of the maternal death.  \\n- \\nThe team should visit the office of the PHM and examine all the relevant documents starting \\nfrom the eligible family register, pregnant mother’s register, pregnancy records (H512B), \\nfamily planning field records, diary, advance programme etc. \\n- \\nThe care received by the mother (antenatal, postnatal) prior to the admission to the hospital \\nshould be assessed. \\n- \\nThe family members should be interviewed by the investigation team in order to obtain \\nrelevant information. \\n- \\nIn the case of a hospital death, MOH should participate as a member in the hospital \\ninvestigation team. If the institutional investigation is delayed, the MOH should visit the \\nhospital and obtain relevant information from the hospital (from health care staff and the BHT) \\nwith permission of the head of the institution, which information should be entered in H 677a. \\n- \\nAfter the maternal death investigation the MOH should implement the necessary corrective \\nactions at field level, and the implementation of these should be discussed at the next monthly \\nconference.  \\n- \\nAll the supervisory staff (MOH, AMOH, PHNS, SPHM) should follow up the work of the area \\nPHM until the deficiencies (if any) at field level are rectified. \\n- \\nIf the maternal death investigation has done by the previous MOH, the present MOH should do \\na fresh field visit to the PHM office and the home of the deceased mother and be thorough with \\nthe information before the DMMR and NMMR.  \\n \\n4.3     Reporting the field investigation \\n \\n- \\nThe information obtained during the investigation should be entered in the form H 677a in \\ntriplicate by the MOH. A copy of the latest version of H677a should be obtained from the \\nMOMCH or downloaded from the FHB website: www.familyhealth.gov.lk/downloads.php  \\n- \\nOn completion, the report should be sent to the following institutions. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n- \\nFor deaths in which the delivery has taken place at home or outside hospital (intra partum / \\npost partum home death) MOH should fill the H 677 format (institutional format) which  \\n \\nH 677a \\nRDHS \\nOffice copy  \\nDirector / Maternal & Child Health,\\nFamily Health Bureau \\n231,De Saram Place, Colombo 10.\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n186 \\n \\n \\n- \\nincludes the details regarding the delivery. For the field investigation the same procedure \\nshould be adhered (as given in section 3.2) and H 677a format should be filled by the MOH. \\n \\n4.4     Safety of maternal death documentation \\n \\n- \\nThe MOH is responsible for the safe custody of the all the documentation related to all \\nmaternal deaths \\n- \\nMOH should hand over all the documents related to maternal death investigations and reviews \\nto the next MOH appointed on his/her transfer or retirement. \\n \\n \\n5.0 \\nMaternal death surveillance at estate level (Field) \\n \\n5.1     Notification procedure for estate maternal deaths \\nIf a notifiable death occurs in a mother resident in an estate, the Superintendent of Estate should \\nimmediately notify the maternal death to the PDHS, RDHS, MOH and the Regional Health  \\n \\nManager of the Plantation Trust. MOH will in turn notify about the death to the Director \\n(Maternal & Child Health) as described earlier (refer section 3.1) \\n \\n5.2    Field investigation procedure for estate maternal deaths \\nMOH and MO-MCH should jointly investigate these deaths with the participation of the team \\nincluding the PHNS, SPHM, area PHM and the Regional Health Manager. The team should visit \\nthe residence of the mother and proceed with the field investigation as detailed in section 3.2. \\n \\n5.3     Reporting the field investigation of an estate maternal death \\nSame procedure as in as in section 3.3 should be followed.   \\n \\n6.0  District and National Maternal Mortality Reviews (DMMR / NMMR) \\n \\nAt the end of each half year the MOMCH should prepare a summary of maternal deaths notified during \\nthe half year and also annually (at the end of the year) according to the format H 677E and send these to \\nthe Director (Maternal and Child Health) and PDHS. \\n \\nDirector (maternal and Child Health) will also prepare a feedback summary of the deaths notified from \\neach district and institution to the Family Health Bureau at the end of each quarter and annually \\naccording to the format H 677F  \\n \\nEach reported death should be discussed at these reviews with the aim of identifying circumstances of \\ndeath in order to prevent such deaths in future. \\n \\n\"Format A\" by the MOH and \"Format D\" by the Institution should be used for analysis and a basis for \\npresentation of each death at DMMR and NMMR. MOMCH should send these formats to the relevant \\ninstitutions and the MOOH in advance to complete them and present at the district review. The \\npresentation should include details of the format A / D and any other relevant information. Presenters'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n187 \\n \\nare encouraged to be creative and innovative in their presentations. It is important to include positive \\nsteps taken out of lessons learnt following the relevant maternal death. \\n \\n \\n6.1  District Maternal Mortality Reviews (DMMR) \\n \\nDistrict Maternal Mortality Reviews are an important aspect of maternal mortality surveillance since it \\nprovides a forum to discuss and learn lessons out of maternal deaths at the district level. It also gives an \\nopportunity to identify service deficiencies and to formulate preventive strategies to further reduce \\nmaternal deaths taking local contexts of the district in to consideration. Data gaps with regard to each \\ndeath could be filled at DMMRs. \\n  \\nTwo half yearly District Reviews should be organized by MO-MCH on behalf of RDHS according to \\nthe following schedule. \\nFirst half yearly review \\n-2nd week of July  \\nSecond half yearly review \\n-2nd week of January  (following year) \\n \\nDistrict Maternal Mortality Review Team should comprise of the following officers  \\n \\nPDHS/ RDHS (chairperson) \\nProvincial or District Consultant Community Physician/s \\nAll Head/s of the Institution/s and (where labour rooms are available) \\nAll Consultant obstetricians Gynecologists \\nMO-MCH \\nAll AMOOH, All AMOOH, all PHNS, SPHM, relevant area PHMM \\nJudicial Medical Officers \\nSenior registrars / SHOO / MOO -–who were involved in the management of the \\ndeceased \\n \\n The participation of all relevant officers is compulsory at DMMR. \\n \\nAt the district review all the deaths reported for that half year should be taken for discussion.  \\n \\nIf a mother had been transferred for ICU care and died subsequently, the intermediate institution from \\nwhere the patient was transferred should present the case using Format D and the end station which \\nprovided ICU care should present a summary.  \\n \\nThe circumstances which led to the death should be identified at the district review using three delay \\nmodel.  \\n \\nThe preventive strategies should be generated to improve the availability, accessibility, utilization & \\nquality of field health care services and essential obstetric services and steps should be taken to initiate \\nthe preventive activities which could be implemented at the district level.  \\n \\nAt the end of the review the MOMCH should fill the cage G of Format A and cage I of Format D \\n(deficiencies identified and action to be taken/ already taken).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n188 \\n \\n \\nThen the completed formats A and D should be sent to the following health authorities by the MOMCH. \\nPDHS \\nRDHS \\nDirector (Maternal and Child Health) \\n \\nMinutes of the district review should be prepared by the MOMCH and copies sent to the PDHS, \\nDirector (MCH) and the relevant MOOH / institutions. These minutes should be taken for discussion at \\nthe next district review of maternal deaths. \\n \\n \\n \\n5.2         National Maternal Mortality Review (NMMR)   \\n \\nAnnual reviews are conducted on a district basis to review all the deaths which occurred in a particular \\ndistrict in the previous year with the participation of experts from the national level. \\n \\nDirector/maternal and Child Health, Department of Health in collaboration with the Provincial Director \\nof Health Services will organize the annual review of maternal deaths in a district with the participation \\nof representatives from professional colleges including Sri Lanka College of Obstetricians & \\nGynecologists, College of Anesthetists, College of Physicians, Sri Lanka College of Community \\nPhysicians. \\n \\nDGHS or in his absence the PDHS will chair this meeting. In the absence of the DGHS a ministry \\nofficial nominated by the DGHS should participate at the NMMR to represent the DGHS. \\n \\nThe participation of following categories of health care teams is mandatory at the NMMR; \\n \\nPDHS \\nRDHS and Deputy RDHS \\nProvincial and District Consultant Community Physician/s \\nAll Head/s of the Institution/s  where labour rooms are available) \\nAll consultant Obstetricians and Gynaecologists and other relevant consultants  \\nMO-MCH \\nAll MOOH, all AMOOH, all PHNS, SPHM, relevant area PHMM \\nJudicial Medical Officers \\nSenior registrars / SHOO / MOO –who were involved in the management of the deceased \\n \\nThe RDHS, MOMCH, RSPHNO, all Consultant obstetrician and Gynaecologists, MOOH and AMOOH, \\nall heads of the institutions and the relevant consultants (Consultant obstetrician Anaesthetist, \\nConsultant physician Consultant JMO) of the units where maternal deaths have occurred, all the DMOO \\n/ MOO-IC of the district hospitals and peripheral units (whether or not maternal deaths occurred in their \\ninstitutions) should participate at the annual review.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n189 \\n \\n \\nAll the reported deaths for the year are taken for discussion by an expert panel consisting of the DGHS \\n(or a representative of the DGHS), PDHS, Director/Maternal & Child Health, other relevant officials \\nfrom the Ministry of Health, representatives of the SLCOG, SLCOA and other professional bodies.  \\n \\nThe relevant presentation of the maternal death should be done by the MOH (field part) and Consultant \\nobstetrician and Gynaecologists or the relevant Specialist (institutional part). It is the responsibility of \\nthe head of the institution and the specialist of the unit where mother was managed to ensure that a \\ndetailed presentation is made at the NMMR. \\n \\nAt the annual review all the deaths will be discussed according to the three delay model. \\n \\nFollowing the review minutes will be prepared by Director (MCH) and sent to the relevant district and \\nprovincial officers. The RDHS will then duplicate these minutes and send the copies to the relevant \\ncurative institutions and MOOH. \\n \\nFinal decisions regarding the type of death, preventability, preventive measures that should be taken at \\nthe national level will be decided during the annual review by the panel of experts. \\n \\n5.3  Follow up action to NMMR \\n \\nFollowing the NMMR the MOMCH should organize a meeting for all MOOH/ heads of institutions and \\nother relevant officers to implement the corrective actions decided at the NMMR. This meeting will be \\nchaired by the RDHS. \\nHead of the institution should call for a separate meeting at the institutional level to discuss these \\nminutes with the relevant consultants/ SHOO/ blood bank and other relevant staff in order to implement \\nthese activities. \\n \\nMOMCH should report the progress of these activities after 3 months to the DGHS/ PDHS/ RDHS/ \\nDMCH. \\nDirector (MCH) should carry out regular discussions with the DGHS, relevant DDGG and other \\nofficials regarding issues which need departmental intervention. \\nWhen all the NMMR meetings are over, the national statistics on maternal mortality will be issued by \\nthe Family Health Bureau before the end of the next year. \\nAt the annual review of the next year the MO/MCH should present the status of implementation of \\npreventive measures suggested at the previous year’s annual review'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n190 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nH 677 – C \\n \\nNotification Form for Maternal Death Surveillance \\n \\nDate of death \\n \\n \\n \\n \\n:  \\n………………………………….. \\nPlace of Death   \\n \\n \\n \\n:  \\n………………………………….. \\nName of the deceased mother \\n \\n \\n:  \\n………………………………….. \\nAge  \\n \\n \\n \\n \\n \\n:  \\n………………………………….. \\nParity  \\n \\n \\n \\n \\n:  \\n………………………………….. \\nHome address  \\n \\n \\n \\n:  \\n………………………………….. \\n \\n \\n \\n \\n \\n \\n \\n………………………………….. \\nMOH area (of mother's residence)(if known) \\n:  \\n………………………………….. \\nDPDHS area (of mother's residence) \\n \\n:  \\n………………………………….. \\n \\nHospital deaths – Place transferred from (if relevant) \\n………………………………….. \\n \\nCause of death (tentative or confirmed)  \\n:  \\n………………………………….. \\n \\nName & the designation of the informant \\n: \\n………………………………….. \\n \\n \\n \\n \\n \\n \\n \\n………………………………….. \\nDate informed  \\n \\n \\n \\n: \\n………………………………….. \\nThis form should be filled by head of the institution/ medical officer of health or any authorized \\nofficer on behalf of them and should be posted/ faxed/ emailed to - Director (Maternal and Child \\nHealth), Family Health Bureau, No. 231, De Saram Place,Colombo 10.Telephone – 011 2692745 \\nFax  – 011 2681310 \\nemail maternaldeathfhb@yahoo.com\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n191 \\n \\n \\n \\n \\nChapter 28 \\n \\nSUPERVISION OF MATERNAL CARE SERVICES \\n \\n28.1  Supervision on Antenatal care \\n \\nPart I -  PHM Office Supervision \\n \\nName of the supervising officer \\n:- …………………………………………………………………… \\nDesignation of the supervising officer:- ………………………………………………………..…………. \\nDate of supervision \\n \\n \\n:- …………………………………………………………………… \\nTime started supervision \\n \\n:- …………………………  Time ended  :-  ………………….…. \\nMOH area \\n \\n \\n \\n:- …………………………………………………………………… \\nPHM area \\n \\n \\n \\n:- …………………………………………………………………… \\nName of the PHM \\n \\n \\n:- …………………………………………………………………… \\nObjective of the supervision  \\n:- …………………………………………………………………… \\n \\nWas the PHM informed regarding the supervision:  Yes / No \\n \\n1. Basic information: \\n \\na. Extent of the area (sq. km.) \\n \\n:………………………………….………………… \\nb. Population \\n \\n \\n \\n:………………………………….………………… \\nc. Date of first appointment  \\n \\n:………………………………….………………… \\nd. Date of appointment to this area \\n:………………………………….…………………. \\ne. Duration of service as a PHM  \\n:………………………………….…………………. \\nf. Whether PHM was provided with a quarters in her area : \\nYes / No \\ni. If provided, is she living in the quarters? \\n    \\nYes / No \\nii. If not, is she living in the area?  \\n \\n      \\nYes / No \\ng. If she is not living in the area, distance (in km.) to the working area from her residence \\n : ………………………………………………………………………………..… \\nh. How long will it take to reach the area (in hours): …………………….…..……………….. \\ni. Transport facilities: \\ni. Is the PHM provided with transport facilities :  Yes / No                         (Bicycle/ \\nMoped) \\nii. Does she use it \\n \\n  \\n \\n:  Yes / No \\niii. If not, reasons for not using the transport facility: \\n……………………………………………………………………………………… \\n……………………………………………………………………………………… \\nj. Is the PHM in complete uniform? \\n :  Yes / No \\n \\n2.   Information on antenatal care : \\nProvincial Birth Rate  \\n \\n:………………………………………………………… \\nEstimated no. of births for PHM area :………………………………………………………….'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n192 \\n \\n \\n1. Maintenance of graphs pertaining to antenatal care: \\n \\nGraphs (bar charts) to elicit achievements \\nPerformance on following indicators in previous two years \\nand quarterly in current year. \\n \\nYes \\n \\nNo \\nLast \\nquarter \\n% \\n \\nComments \\n \\ni. \\nAntenatal care  \\n     % of pregnant mothers registered  \\n(of estimated births X 1.1)  \\n \\n \\n \\n \\nii.   % of pregnant mothers registered before 8 weeks \\n    (of total pregnant mothers registered)  \\n \\n \\n \\n \\niii.  % of pregnant mothers registered after 12 weeks \\n     (of total pregnant mothers registered) \\n \\n \\n \\n \\niv.  % of mothers with BMI < 18.5 before 12 weeks \\n(of total pregnant mothers registered before 12 weeks)\\n \\n \\n \\n \\n \\n2. Assessment of antenatal care: \\n \\nNo \\nIndicator \\nNo. \\n% \\n1.  \\nNo. of pregnant mothers under care at any given time  \\n(50% of estimated births) \\n \\n \\n2.  \\nNo. of pregnant mothers under care according to H 524  \\n(of 50% estimated births) \\n \\n \\n3.  \\nNo. of pregnant mothers under care according to the Eligible family register\\n(of 50% estimated births) \\n \\n \\n4.  \\nNo. of mothers under care according to the Pregnant mothers register  \\n(of 50% estimated births) \\n \\n \\n5.  \\nNo.  of mothers according to the EDD register \\n(of 50% of estimated births) \\n \\n \\n6.  \\nNumber of pregnant mothers under care according to H 512B  \\n(of 50% estimated births) \\n \\n \\n7.  \\nNo. of primi mothers \\n \\n(of pregnant mothers under care) \\n \\n \\n8.  \\nOf primi mothers under care, number registered in the eligible family \\nregister, before becoming pregnant  ( of primi mothers under care) \\n \\n \\n9.  \\nNo. of pregnant mothers registered before 8 weeks  \\n(of pregnant mothers under care) \\n \\n \\n10.  \\nNo. of pregnant mothers registered between 8-12 weeks  \\n(of pregnant mothers under care) \\n \\n \\n11.  \\nNo. of pregnant mothers registered after12 weeks  \\n( of pregnant mothers under care)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n193 \\n \\n \\n 5. Home visits received by antenatal mothers:    \\n *No. of mothers delivered during last 1 or 2 quarters: - ……………………………………………… \\n *Whether to use last quarter or last 2 quarters for the calculation should be decided considering the \\nnumber of mothers delivered       \\n \\nNo \\nIndicator \\nNo. \\n% \\n1. \\nNo. who received antenatal home visits once a month from mothers who \\ndelivered during last 1 or 2 quarters  \\n(of mothers delivered during last 1 or 2 quarters) \\n \\n \\n2. \\nNo. of risk mothers needed extra domiciliary care  \\n(of mothers delivered during last 1 or 2 quarters) \\n \\n \\n3. \\nOf above risk mothers, No. received extra home visits  \\n \\n \\n4. \\nNo. of mothers with antenatal morbidities  \\n(of mothers delivered during last two quarters) \\n \\n \\n5. \\nNo. of mothers protected with tetanus toxoid  \\n(of mothers delivered during last two quarters) \\n \\n \\n              \\n                                 \\n6. Compare relevant records to assess the antenatal home visits and morbidity reporting \\nduring pregnancy by PHM  \\n(During the last month of the last quarter according to post natal cards) \\n \\n \\nQuarter ……………….………. \\n \\nMonth  …………………………. \\n \\nIndicator \\nH  524 \\nH  523 Diary \\n \\nH 512B \\n \\n1. \\nNo. of antenatal home visits done during the last \\nmonth of last quarter  \\n(total of new & subsequent visits) \\n \\n \\n \\n \\n2. \\nNo. of mothers with antenatal morbidities reported  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n12.  \\nNo. of pregnant mothers less than 20 years of age \\n( of pregnant mothers under care) \\n \\n \\n13.  \\nNo. of mothers with high risk conditions \\n(of pregnant  mothers  under care) \\n \\n \\n14.  \\nNo. of mothers referred to specialized clinics \\n( of high risk pregnant mothers under care) \\n \\n \\n15.  \\nNo. of mothers followed up after referring to specialized clinics \\n( of pregnant mothers referred to specialized clinics) \\n \\n \\n16.  \\nNo. of mothers with P5 and above registered \\n(of pregnant  mothers  under care) \\n \\n \\n17.  \\nNo. mothers protected against Rubella before pregnancy \\n(of pregnant mothers under care)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content=\"Maternal Care Package A Guide to Field Healthcare Workers \\n194 \\n \\n \\n \\n7. Check whether the mothers from outside the area are included in the registers  \\n*specific time period (Quarters): -…………………………………………………………. \\n \\n \\nIndicator \\nH  524 \\nPregnant \\nmothers \\nregister \\nH \\n512  \\nB \\n1. \\nNo. of mothers who had come to the area \\nfrom outside during the *last quarter \\n \\n \\n \\n \\n2. \\nNo. received once a month home visit  \\n \\n \\n \\n \\n*If there were no mothers who came from outside the PHM area during the last quarter, extend the \\ntime duration up to a level where there were mothers who left the area' This time duration should be \\ndocumented above. \\n \\n8. Maintenance of a register for pregnant mothers left area: Yes/ No \\n \\n            No. of mothers left area during last quarter according to the register:  …………………….. \\nMechanisms available to inform the MOH about it                             \\n :  Yes/ No \\n \\nComments:- ………………………………………………………………………………. \\n            No. indicated in the monthly statements (last quarter) :- …………………………………….. \\n \\n \\nPart II   - \\n Antenatal care field supervision  \\n \\nRandomly select five H 512 B cards (preferably completing 28 weeks) and make home visits.  \\nCompare the information with H 512 A. \\n \\n \\n \\nHouse \\n1 \\nHouse \\n2 \\nHouse \\n3 \\nHouse \\n4 \\nHouse \\n5 \\n \\n \\nRegistration No. in eligible families \\nregister \\n \\n \\n \\n \\n \\nPOA  at the time of registration \\n \\n \\n \\n \\n \\nPOA at the time of supervision  \\n \\n \\n \\n \\n \\nParity \\n \\n \\n \\n \\n \\nNo. \\nIndicator \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\nYes/ \\nNo \\ncomment \\nAnte natal care: \\n1. \\nRegistered before 8 weeks\\n \\n \\n \\n \\n \\n \\nHome visits: \\n2. \\nFirst home visit done before 12\\nWeeks \\n \\n \\n \\n \\n \\n \\nMonthly home visits done \\n \\n \\n \\n \\n \\n \\n Additional home visit done for  \\n mothers with risk a factor / special  \\n problems (if any) \\n \\n \\n \\n \\n \\n \\n3. \\nBreast examination done at home by \\nPHM\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n195 \\n \\n4. \\nFundal \\nheight \\nmeasured \\nand \\nrecorded during last visit \\n \\n \\n \\n \\n \\n \\n5. \\nFetal heart sounds checked & \\nrecorded during last visit \\n \\n \\n \\n \\n \\n \\nAssessing mother’s knowledge \\n6. \\nMother has sufficient knowledge \\non nutrition \\n \\n \\n \\n \\n \\n \\n7. \\nMother is aware about the expected \\ndate of delivery \\n \\n \\n \\n \\n \\n \\n8. \\nMother has knowledge on signs of \\nlabour \\n \\n \\n \\n \\n \\n \\n9. \\nMother uses iron tablets correctly \\n \\n \\n \\n \\n \\n \\n10. \\nMother stores  iron tablets correctly \\n \\n \\n \\n \\n \\n \\n11. \\nMother has a good knowledge on \\nfacilitative and inhibitory factors for \\niron absorption \\n \\n \\n \\n \\n \\n \\n12. \\nMother and family members are \\naware of danger signs of pregnancy \\n(Refer attachment) \\n \\n \\n \\n \\n \\n \\n13. \\nMother is aware of feeling fetal \\nmovements \\n \\n \\n \\n \\n \\n \\n14. \\nMother documents fetal movements \\n \\n \\n \\n \\n \\n \\n15. \\nMother is prepared with necessary \\nitems \\nfor \\nhospitalization \\nfor \\ndelivery \\n \\n \\n \\n \\n \\n \\n16. \\nMother has knowledge on initiation \\nof breast feeding within first half an \\nhour  of delivery \\n \\n \\n \\n \\n \\n \\n17. \\nMothers knows the importance on \\nexclusive breast feeding  \\n \\n \\n \\n \\n \\n \\n18. \\nMother \\nis \\nknowledgeable \\non \\nduration \\nof \\nexclusive \\nbreast \\nfeeding \\n \\n \\n \\n \\n \\n \\n19. \\nMother is knowledgeable on ECCD \\n \\n \\n \\n \\n \\n \\n20. \\nHusband has participated to the \\nclinic with the mother during last \\nvisit \\n \\n \\n \\n \\n \\n \\n21. \\nPlace of delivery and related issues \\nare decided following discussion  \\nwith the mother  \\n \\n \\n \\n \\n \\n \\n22. \\nMother is aware on all 5 modern \\nfamily planning methods \\n \\n \\n \\n \\n \\n \\nRisk mothers \\n23. \\nPHM has identified the risk factors \\nof the mother correctly \\n \\n \\n \\n \\n \\n \\n24 \\nHigh risk mothers are correctly \\nlabeled on pregnancy records'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n196 \\n \\n25. \\nMother was aware on the above \\nmentioned risk factors  \\n \\n \\n \\n \\n \\n \\n26. \\nHusband and family members are \\naware of the risk factors of the \\nmother \\n \\n \\n \\n \\n \\n \\n27. \\nMother has attended clinic which \\nshe has been referred to \\n \\n \\n \\n \\n \\n \\n \\n9.  PHM’s response for the supervision: \\n…………………………………………….……………………………………………………………\\n…………………………………………………………………………………………………………\\n……………………….………………………………………………… \\n \\n10. Problems identified by the PHM in providing antenatal care in the field: \\n…………………………………………….……………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n11. PHM’s suggestions to provide an even better service: \\n…………………………………………….……………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n12. Details of last supervision on antenatal care provision: \\nDate of supervision \\n \\n \\n: …………………………………..…….…………… \\nDesignation of the supervising officer : …………………………………..……….………… \\nRecommendations are implemented : Yes/No \\nNote on recommendations that were not implemented: …………………………………….. \\n \\n13. Recommendations on today’s supervision: \\n \\nStrong points  \\n \\n \\n       \\nWeak points \\n \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….………'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n197 \\n \\n \\n \\nNext date for supervision : …………………………………. \\n \\nAction plan to improve antenatal care based on weak points identified: \\n \\nProblems \\nidentified\\nUnderlying \\nreasons\\nProposed \\nsolutions\\nResponsibility\\nTime frame\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate  ........................................ \\nSignature of supervising officer …………………………….…\\n \\n \\n \\nDesignation \\n………………………………………………………….……..'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n198 \\n \\n \\n28.2 Supervision on Post natal care \\n \\nPart I -  PHM Office Supervision \\nName & designation of the supervising officer/s:- ……………………………………………..……. \\nDate of supervision \\n \\n:- \\n……………………………………………………………………………………………….………… \\nTime started supervision \\n:- …………………………………..… Time ended:- ………………… \\nMOH area \\n \\n \\n:- …………………………………………………..…………………… \\nPHM area    \\n \\n \\n:- ………………………………………………..……………………… \\nName of the PHM \\n \\n:- ………………………………………………..……………………… \\nObjective of the supervision :- ………………………………..……………………………………… \\nWas the PHM informed regarding the supervision:   \\nYes / No \\n \\n1. Basic information : \\n \\nk. Extent of the area (sq. km.) \\n \\n:………………………………………………… \\nl. Population \\n \\n \\n \\n:………………………………………………… \\nm. Date of first appointment  \\n \\n:………………………………………………… \\nn. Date of appointment to this area \\n:………………………………………………… \\no. Duration of service as a PHM  \\n;………………………………………………… \\np. Whether PHM was provided with a quarters in her area  \\n: \\nYes / No \\ni. If provided, is she living in the quarters?  \\n     \\n: \\nYes / No \\nii. If not, is she living in the area?  \\n \\n     \\n:  \\nYes / No \\nq. If she is not living in the area, distance (in km.) to the working area from her residence: \\n…………………… \\n \\n \\n          How long will it take to reach the area (in hours) \\n \\n:……………..…… \\nr. Transport facilities: \\ni. Is the PHM provided with transport facilities: Yes/ No  (Bicycle/ Moped) \\nii. Does she use it  \\n \\n \\n \\n: \\nYes/ No \\niii. If not, reasons for not using the transport facility: \\n………………………………………………………………………………… \\n………………………………………………………………………………… \\ns. Is the PHM in complete uniform? \\n Yes / No \\n \\n2. \\nInformation on postnatal care: \\nProvincial Birth Rate  \\n \\n:-………………………………..  \\nEstimated births for PHM area \\n:-………..…………………….. \\nNo. of postnatal mothers under care :-………………..………………'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n199 \\n \\n \\n3. Maintenance of graphs on postnatal care: \\n(Annually over last 2 years and quarterly for this year)  \\nNo. \\nIndicator \\nYes \\nNo \\nValue for \\nthe last \\nquarter \\nComments \\n1. \\n% of deliveries reported  \\n(of estimated births) \\n \\n \\n \\n \\n2. \\nLow Birth Weight Rate reported \\n(of total live births reported) \\n \\n \\n \\n \\n3. \\n%  of mothers received postpartum care \\n1st visits within 1-10days \\n (of estimated births)  \\n \\n \\n \\n \\n4. \\n%  of mothers received postpartum care \\nvisit within 11 – 28 days \\n (of estimated births)         \\n \\n \\n \\n \\n5. \\n%  of mothers received postpartum care \\naround 42 days  \\n(of deliveries registered) \\n \\n \\n \\n \\n \\n4. Comparison of records and registers on delivery reporting and postpartum care  \\nincluding morbidity reporting (Within a specified time period): \\nQuarter or Month: - ……………………………… \\nDiary  \\nDaily \\nStatement \\n \\nMonthly \\nStatement \\n \\nEligible \\nCouple \\nRegistry \\nPregnancy \\nRegister \\nEDD \\nRegister \\nH512B \\nNo. of post natal mothers \\nunder care \\n \\n \\n \\n \\n \\n \\n \\nNo. of births registered \\n \\n \\n \\n \\n \\n \\n \\nNo. received new home \\nvisits in first 10 days  \\n \\n \\n \\n \\n \\n \\n \\nNo. of mothers reported \\nwith  postnatal morbidities'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n200 \\n \\n5. Postnatal care coverage: \\nAssessment of postpartum care of permanently residing mothers during last quarter \\n(According to Pregnancy records) \\nNo.\\nIndicator \\nTotal \\n% \\n1. \\nNo. of mothers had 1 postpartum visit within first 5 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n2. \\nNo. of mothers had 1 postpartum visit within first 10 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n3. \\nNo. of mothers had 2 postpartum visit within first 10 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n4. \\nNo. of mothers had 1 postpartum visit within 11 to 28 days \\n(From all mothers delivered in the last quarter) \\n \\n \\n5. \\nNo. of mothers had a postpartum visit around 42 days \\n(From all mothers delivered in the last quarter & completed 42days) \\n \\n \\n6. \\nNo. of mothers received Vitamin A mega dose \\n(From reported births) \\n- From the hospital  \\n \\n \\n- From the PHM \\n \\n \\n7. \\nNo. of neonates who received breast milk within 30 minutes of birth, \\naccording to CHDR B portion \\n \\n \\n8. \\nNo. of mothers with post natal complications \\nFrom randomly selected cards of mothers completed 45 days \\npostpartum; (No. of cards - ………………) \\n \\n \\n \\n \\n6.    Postpartum care received by mothers who came from outside during last quarter: \\n \\n       \\n \\n \\n \\n \\n \\n \\n \\n \\nIndicator \\nNo. \\n% \\nNo. of outside mothers delivered during last quarter \\n \\n \\n% received 1 home visit within 1st 10 days \\n \\n \\n% received 2 home visits within 1st 10 days \\n \\n \\n% received home visits between 11- 28th day \\n \\n \\n% received home visits around 42 days'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n201 \\n \\n \\n7. Postpartum care received by mothers delivered at home during last 4 quarters: \\n \\n       \\n \\n8. Interventions carried out at PHM level for following postpartum morbidities:  \\n \\n9. Maintenance of records and registers on delivery reporting and postpartum care  \\n    including morbidity reporting:  \\nNo.\\nRecords / registers \\nMaintenance \\nComments \\nSatisfactory \\nUnsatisfactory \\n \\n1 \\nDiary \\n \\n \\n \\n2 \\nDaily statement \\n \\n \\n \\n3 \\nMonthly statement \\n \\n \\n \\n4 \\nPregnant mothers register \\n \\n \\n \\n5 \\nEDD register \\n \\n \\n \\n6 \\nEligible family register \\n \\n \\n \\n7 \\nPregnancy records \\n \\n \\n \\n8 \\nBI register \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo. of home deliveries \\n \\n% received 3 home \\nvisits within 1st 10 \\ndays \\n% received home \\nvisit between 11- \\n28th  day \\n% received home \\nvisits around 42 \\ndays \\nTrained \\n \\n \\n \\n \\nUntrained \\n \\n \\n \\n \\nMorbidity reported \\nNo. reported \\nduring last year \\nIntervention / action taken \\nBreast problems \\n \\n \\nPostnatal psychosis \\n \\n \\nInfected episiotomy \\n \\n \\nAny other common \\nmorbidity \\n…………… (specify)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n202 \\n \\n \\nPart II – Field supervision: \\nSelect randomly five 512 B cards completed 3 months postpartum and visit the household: \\nHouse 1\\nHouse 2\\nHouse 3\\nHouse 4\\nHouse 5\\n \\nEl/F registration No. \\n \\n \\n \\n \\n \\n \\nPregnancy registration No. \\n \\n \\n \\n \\n \\n \\nParity \\n \\n \\n \\n \\n \\n \\nDate of arrival at home \\n \\n \\n \\n \\n \\nNo \\n \\nYes/No \\nYes/No \\nYes/No \\nYes/No \\nYes/No \\n1 \\nPost partum care home visits \\n\\uf0b7 Twice between first 10 days \\n(once in first 5 days and once \\nbetween 5-10days) \\n \\n \\n \\n \\n \\n\\uf0b7 1st visit within first five days \\n \\n \\n \\n \\n \\n\\uf0b7 Once between 11- 28 days \\n \\n \\n \\n \\n \\n\\uf0b7 Once close to 42 days  \\n \\n \\n \\n \\n \\n2 \\nPHM has examined the mother \\n \\n \\n \\n \\n \\n3 \\nHas identified the risk factors  if any \\n \\n \\n \\n \\n \\n4 \\nMother was educated on risk conditions  \\n \\n \\n \\n \\n5 \\nFamily members were aware of the \\nbehavioral changes of the mother \\nduring the early postpartum period \\n \\n \\n \\n \\n \\n6 \\nFamily members are knowledgeable \\nregarding post natal complications \\n \\n \\n \\n \\n \\n7 \\nMother was adequately educated on \\nmaternal nutrition \\n \\n \\n \\n \\n \\n8 \\nFamily members are adequately \\neducated on maternal nutrition \\n \\n \\n \\n \\n \\n9 \\nHas identified danger signs of the \\ninfant (if any) \\n \\n \\n \\n \\n \\n10 \\nDoes  mother have the knowledge to \\nidentify danger signs \\n \\n \\n \\n \\n \\n11 \\nMothers was aware on exclusive breast \\nfeeding  \\n \\n \\n \\n \\n \\n12 \\nFamily members  are aware on \\nexclusive breast feeding  \\n \\n \\n \\n \\n \\n13 \\nMother was aware on correct technique \\nof  breast feeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n203 \\n \\n \\n \\n \\n \\n10. PHM’s response for the supervision: \\n………………..…………………………………………………………………………………………\\n……………………………………………………………..…………………………………………… \\n \\n11. Problems identified by the PHM in providing the postnatal care:  \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n12. PHM’s suggestions to improve her postnatal care service : \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n13.  Details on previous supervision on child care: \\nDate of supervision \\n \\n \\n: ……………………………………………………….. \\nDesignation of the supervising officer : ……………………………………………………….. \\nRecommendations are implemented : Yes/No \\nNote on recommendations that were not implemented: \\n………………………………………………………………………………………………………… \\n………………………………………………………………………………………………………… \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n14 \\nObserve the session of breast feeding  \\n- \\nAttachment is correct \\n \\n \\n \\n \\n \\n-\\nPositioning is correct \\n \\n \\n \\n \\n \\n \\n15 \\nMother has correct knowledge on \\nexpression of breast milk  \\n-    Cup feeding \\n \\n \\n \\n \\n \\n-    Storing \\n \\n \\n \\n \\n \\n15 \\nPHM has examined the newborn \\n \\n \\n \\n \\n \\n16. \\nCounseled on use of FP method \\n \\n \\n \\n \\n \\n17 \\nUsing a modern FP method \\n \\n \\n \\n \\n \\n18 \\nMother has received family support \\nduring postnatal period'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n204 \\n \\n \\nRecommendations on current supervision: \\n \\nStrong points  \\n \\n \\n \\n \\nWeak points \\n1…………………………………………………… \\n  \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n1……………………………………………………\\n \\n                \\n2.………………………………..………………… \\n \\n3. ……………………………………………….…\\n \\n \\n            \\n4. .……………………………………….……..…\\n \\n \\n \\n5 .………………………………………….……… \\n \\n \\n \\nNext date of supervision if necessary:-   …………………… \\n \\n14. Develop an action plan with the PHM to overcome the weak points: \\nProblems identified \\nUnderlying reasons \\nProposed solutions \\nResponsibility \\n \\nTime frame \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate: ………………….. \\n \\nSignature of supervising officer ……………..………….. \\n \\nName and designation …………………………………………………..'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n205 \\n \\n \\n28.3  Supervision of a Poly clinic \\nName of the supervising officer \\n:- \\n.……………………………………………………………………………………….. \\nDesignation   \\n \\n \\n:- \\n.……………………………………………………………………………………….. \\nDate of supervision \\n \\n \\n:- \\n.……………………………………………………………………………………….. \\nTime started supervision \\n \\n:-…………………………  \\n \\nTime ended:-\\n………………………… \\nObjective of the supervision  \\n:- \\n.……………………………………………………………………………………….. \\nWas the PHM informed regarding the supervision:-  Yes / No \\nMOH area \\n \\n \\n \\n:- \\n……………………………………  \\nName of the clinic \\n \\n \\n:- \\n…………………………………… \\nFrequency of the clinic \\n \\n:- \\n…………………………………… \\nNo. of PHM areas covered by the clinic:- \\n…………………………………… \\nPopulation covered by the clinic         :- \\n…………………………………… \\nNo. of PHMM attended the clinic:  ………………………… …………… \\n \\nNo. of clients for the clinic from each PHM area:  \\nTarget group \\nPHM \\nArea 1 \\nPHM \\nArea 2 \\nPHM \\nArea 3 \\nPHM \\nArea 4 \\nNo. of antenatal mothers \\n \\n \\n \\n \\nNo. of H 512 B cards brought \\nto the clinic \\n \\n \\n \\n \\nNo. of infants \\n \\n \\n \\n \\nNo. of preschoolers \\n \\n \\n \\n \\nNo. CHDR  B portions brought to \\nthe clinic \\n \\n \\n \\n \\nNo. of family planning clients \\n \\n \\n \\n \\n \\n \\nOfficer conduct the clinic: MOH/AMOH/MO/RMO/AMO \\n \\nOther staff category available in the clinic on the supervision day: RSPHNO/PHNS/SPHM  \\n \\n1. Clinic environment: \\na. Cleanliness of the clinic \\n: Satisfactory  \\uf06f \\nNot satisfactory  \\n\\uf06f \\nb. Ventilation  \\n \\n \\n: Adequate      \\uf06f \\nNot adequate      \\n\\uf06f \\nc. Electricity \\n \\n \\n: Available      \\uf06f  \\nNot available      \\n\\uf06f \\nd. Seating facilities \\n \\n: Adequate      \\uf06f \\nNot adequate      \\n\\uf06f \\ne. Toilet facilities \\n \\n: Available     \\uf06f        Not available      \\n\\uf06f \\nf. Accessibility  \\n \\n: Satisfactory  \\uf06f \\nNot satisfactory  \\n\\uf06f \\ng. Adequate Water supply \\n: Available     \\uf06f        Not available      \\n\\uf06f'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n206 \\n \\n \\n2. Clinic organization: \\n \\nYes \\nNo \\nComments \\n1 \\nClinic duty roster is available \\n \\n \\n \\n2 \\nClinic preparation done on previous day \\n \\n \\n \\n3 \\nHealth education materials displayed on \\nthe wall \\n \\n \\n \\n \\n4 \\nClinic is organized according to  5 ‘S’ \\nconcept \\n \\n \\n \\n5 \\nPlace is organized for different clinic \\nactivities \\n \\n \\n \\n \\n6 \\nNumbers given to all clients at \\nregistration \\n \\n \\n \\n7 \\nClinic sessions are organized for \\ndifferent target groups (eg. ANC- \\n8.30am – 11.00, Immunization 11.00 \\nam- 12.30pm, FPC   1.00pm – 3.30 pm) \\n \\n \\n \\n8 \\nClean linen and a clean examination bed \\nis available \\n \\n \\n \\n9  \\nHealth education is provided according \\nto a plan \\n \\n \\n \\n10\\nReading materials available for the use \\nof clients  \\n \\n \\n \\n11\\nWaste management is satisfactory \\n \\n \\n \\n \\n3. \\nUse of AD syringes: \\na. Use AD syringes for all immunizations \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. Use safety boxes to collect used syringes \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. Safe technique is used for disposal of used syringes   \\nYes \\n\\uf06f  No \\uf06f \\n \\n4.         Sterilization procedure (if any): \\na. Sterilization chart is displayed in the clinic  \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. It is supervised and signed by a senior officer  \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. PHMM is capable of sterilizing the equipment on time \\nYes \\n\\uf06f  No \\uf06f \\nd. Handle sterilized equipment with Cheatle forcep  \\nYes \\n\\uf06f  No \\uf06f \\n \\n5.  \\nAssist MOH in examining the mother: \\na.   Inform the mother that she is going to be examined  \\nYes \\n\\uf06f  No \\uf06f \\nb.   Provide a brief history to the MOH  \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc.   Assist mother in positioning on the bed \\n \\n \\n Yes \\n\\uf06f  No \\uf06f \\nd. Check the mother’s understandability on information  \\n      provided by MOH  \\n \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\ne. Inform mother on the next clinic date  \\n \\n \\nYes \\n\\uf06f  No \\uf06f'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n207 \\n \\n \\nf. Help mother on getting up from the examination bed \\nYes \\n\\uf06f  No \\uf06f \\ng. Explain mother regarding referral to specialist care  \\nYes \\n\\uf06f  No \\uf06f \\n6.  \\nProviding micronutrients and anti helminthic drugs: \\na. Drugs are packed and ready for distribution among mothers Yes \\n\\uf06f  No \\uf06f \\nb. Explain the mother on how to use drugs \\n \\n            Yes \\n\\uf06f  No \\uf06f \\nc. Explain the mother on how to store them \\n \\n            Yes \\n\\uf06f  No \\uf06f \\nd. Cross check from the mother whether she takes \\n    them correctly   \\n \\n \\n \\n \\n             Yes \\n\\uf06f  No \\uf06f \\n \\n7.  \\nProcedure of Urine testing: \\n \\nYes\\nNo\\nRemarks\\n1\\nSeparate place is allocated for this activity\\n2\\nAvailability of equipment and reagents or strips\\n- Urine test strips\\n- Test tubes\\n- Test tube holder\\n- Test tube rack\\n- Spirit lamp\\n- Container to empty test tubes\\n- Benedict’s solution\\n- Acetic acid\\n- Methyl spirit\\n3\\nTechnique of testing     \\nFor protein: \\n- Fill 2/3 of the test tube with urine\\n- Heat upper 1/3 of test tube\\n- Observe after a while\\nFor sugar :\\n- Add 8 drops of urine to 5 ml of reagent\\n- Heat the test tube, holding the test tube away from  \\nself and client \\n- Heat well until the contents boiled\\n- observe the test tube for 2 mins for a color change\\n4\\nEnter the results in both mother’s cards\\n5\\nGive the feedback to the mother on the test findings\\n6\\nDiscard urine appropriately'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n208 \\n \\n \\n8. Conduct of health education session: \\n \\nNo.\\nActivity\\nYes\\nNo\\nRemarks\\n1\\nPlanned health education schedule is available for each \\nclinic session \\n2.\\nPHM is pre prepared for the health talk\\n3\\nUse appropriate HE material \\n4\\nContent is relevant to the topic\\n5\\nCorrect messages given\\n6 \\nPresentation skills of PHM is satisfactory\\n7\\nPHM assesses whether the client has increased the \\nknowledge at the end of the session ( by a feedback) \\n8\\nSummarizes the important messages\\n \\n9. Weighing of Infants: \\n \\n \\nActivity \\nYes \\nNo \\n1 \\nAppropriate scale is available (i.e Seca Scale) \\n \\n \\n2 \\nScale placed on a balanced surface \\n \\n \\n3 \\nIt works properly ( Ascertain by measuring a known weight) \\n \\n \\n4 \\nWho measures weight? PHM / Volunteers / Other \\n \\n \\n5 \\nIt is kept in a well lit place, on a stable top \\n \\n \\n6 \\nInfant’s clothes are removed prior keeping on the scale \\n \\n \\n7 \\nWeight is measured following correct balancing \\n \\n \\n8 \\nThe reading is taken standing in front of the scale \\n \\n \\n9 \\nWeight is written on the B portion immediately after weighing \\n \\n \\n10 \\ninform mother regarding the nutrition status of infant \\n \\n \\n \\n10. Measure of length of Infants: \\n \\n \\nActivity \\nYes \\nNo \\n1 \\nInfantometer is kept on the table correctly  \\n \\n \\n2 \\nInfant is kept on the infantometer correctly (The head is \\npositioned to touch the head rest & the head, shoulders, \\nbuttocks and knees should touch the scale) \\n \\n \\n3 \\nThe base is touching the infant’s feet \\n \\n \\n4 \\nThe measurement is read correctly \\n \\n \\n5 \\nIt is written in the B portion correctly'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n209 \\n \\n \\n11. Height & weight measuring of pregnant mothers: \\n \\nNo.\\nActivity \\nYes \\nNo \\nRemarks \\n1 \\nCheck to clarify all the equipment are in order \\n \\n \\n \\n2 \\nUse correct technique in taking height \\n \\n \\n \\n3 \\nUse correct technique in taking weight \\n \\n \\n \\n4 \\nRecord readings in relevant documents \\n \\n \\n \\n5 \\nMother is provided with the feedback \\n \\n \\n \\n6 \\nInform the MOH if there are any unusual  findings in \\nthe weight \\n \\n \\n \\n7 \\nAccuracy of weighing scale is checked (if so, when) \\n \\n \\n \\n \\n12. Immunization activities: \\nNo.\\nActivity\\nYes\\nNo\\nRemarks\\n1\\nSeparate area is prepared \\n2\\nEmergency tray is available\\n2.1. drug list is available\\n2.2. date of expiry is available on drugs\\n2.3. instruction guide is available\\n3\\nCheck CHDR before immunization for appropriateness of \\nthe vaccination \\n4\\nDiscuss with the mother to identify any contraindications\\n5\\nAsk for AEFI for the previous immunization\\n6\\nCold chain is maintained\\n7\\nCheck vaccine vials before vaccination for quality assurance\\n8\\nFollow correct technique to draw vaccine\\n9\\nMaintain sterility in the process of immunization\\n10\\nEducate mothers before immunization on reporting of AEFI \\n11\\nKeep clients 10-20 minutes to observe adverse reactions\\n12\\nProper record keeping (Date, batch number ect)\\n13\\nInform clients on next visit\\n14\\nMaintain vaccine   movement register  correctly\\n15\\nMaintain open vial policy\\n \\n13. Family planning activities: \\n \\n \\nYes \\nNo \\nRemarks \\n1 \\nMethods available in the clinic \\n \\n \\n \\n     Pills \\n \\n \\n \\n     Condoms \\n \\n \\n \\n     DMPA \\n \\n \\n \\n     IUD \\n \\n \\n \\n2 \\nEntries made when issuing FP items  \\n \\n \\n \\n3 \\nPhysical balance of FP items tallies with book balance \\n \\n \\n \\n4. \\nAdequate stocks are available  \\n \\n \\n \\n5. \\nEquipment needed for insertion of at least 5 IUDs are \\navailable \\n \\n \\n \\n6. \\nEquipment are in working condition'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n210 \\n \\n \\n7. \\n \\nSpecial bed used for IUD insertion is available in good \\ncondition \\n \\n \\n \\n8. \\nPrivacy is maintained for each & every mother  \\n \\n \\n \\n9. \\nMother allowed to ask questions with regard to the FP \\nmethods \\n \\n \\n \\n10. FP items are shown to mother before enroll into a \\nmethod  \\n \\n \\n \\n11. Mothers counseled before introduced to a method \\n \\n \\n \\n12 \\nUse flash cards during discussions \\n \\n \\n \\n13 \\nIssues a client record \\n \\n \\n \\n14 \\nClinic record is correctly maintained \\n \\n \\n \\n \\nAttitudes of staff towards clients \\n \\n \\n \\nPositive \\nNegative \\n \\nComments………………………………………………………………………………………………\\n…………………………………………………………………………………………………………\\n……………………………………………………………………………….. \\n \\n14.  Disposal of waste and cleaning:  \\na. Adequate number of safety boxes are available \\n \\nYes \\n\\uf06f  No \\uf06f \\nb. Waste disposal is hygienic \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. At the end of the clinic, the equipment and the clinic is cleaned  \\nYes \\n\\uf06f  No \\uf06f \\nd.   FP Clinic records are correctly maintained  \\n \\nYes \\n\\uf06f  No \\uf06f \\n15. Record keeping:  \\na. The clinic attendance  register (H 517) is correctly maintained  Yes \\n\\uf06f  No \\uf06f \\nb. H 518 is correctly filled  \\n \\n \\n \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nc. Activities are done according to the duty roster \\n \\n \\nYes \\n\\uf06f  No \\uf06f \\nd. Clinic returns are correctly filled and sent to relevant institutes Yes \\n\\uf06f  No \\uf06f \\n \\n16. Comments on record keeping :    \\n……………………………………………………………………………………………………………………\\n……………………………………………………………………………………………………………………\\n……………………………………………………………………………………………… \\n……………………………………………………………………………………………………………………\\n…………………………………………….. \\n17. Review clinic performance based on clinic summary and H 527 for the last quarter: \\n \\n \\nNo. of clinic sessions held during the last quarter :- ....................................   \\n \\nNo. of clinic sessions conducted by: \\nMOH/AMOH \\n \\nPHNS \\n \\nPHM \\n \\nOther  \\n \\n \\nAverage attendance of clinic per session: \\nPregnant Mothers \\n \\nInfants \\n \\n1-5 yr Old \\n \\nFP Clients'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n211 \\n \\n \\nNo. of  FP new acceptors recruited   \\n:- ................................ \\nNo. of DMPA new acceptors  \\n \\n:- ................................ \\nNo. of IUCD inserted  \\n \\n \\n:- ................................ \\nNo. of infants weighed in the clinic  \\n:- ................................ \\n \\nBlood drawn for, \\nVDRL testing  \\n \\n \\n: Performed / Not Performed \\nHb testing \\n \\n \\n \\n: Performed / Not Performed \\nBlood Grouping and DT \\n \\n: Performed / Not Performed \\n \\n18.  Suggestions of the staff to provide better clinic service :- \\n…………………………………………………………………………………………………………\\n………………………………………………………………………………………………………… \\n \\n \\n19. Details on last clinic supervision: \\nDate of previous supervision  \\n \\n \\n: ……………………………………..….. \\nDesignation of the supervising officer  \\n \\n: ………………………….…….……..… \\nRecommendations are carried out \\n \\n \\n: Yes / No \\nDetails on recommendations not materialized : …………………………………………...…… \\n \\n \\n20.  Recommendations on current supervision: \\nStrong points  \\n \\n \\n       \\n \\nWeak points \\n1…………………………………….. \\n        \\n \\n \\n2. …………………………………... . \\n \\n            \\n3. ……………………………….…… \\n \\n            \\n4… .………………………….……… \\n \\n \\n \\n5 .……………………..…………….. \\n \\n \\n \\n1…………………………………….. \\n        \\n \\n \\n2. …………………………………...  \\n \\n            \\n3. ……………………………….…… \\n \\n            \\n4… .………………………….……… \\n \\n \\n \\n5 .……………………..……………..'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n212 \\n \\n \\n \\nNext date of clinic supervision \\n:   …………………. \\n \\n21. Action plan to improve the clinic services based on weak points identified: \\n \\nProblems identified \\nUnderlying \\nreasons \\nProposed solutions\\nResponsibility \\nTime \\nframe \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDate …………………….. \\n \\nSignature of supervising officer ...................................... \\n \\n \\n \\n \\n \\n \\n \\n \\nDesignation …………………………………………..…'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n213 \\n \\n \\nChapter 29 \\nPLANNING OF DOMICILIARY CARE FOR PREGNANT AND POST \\nPARTUM WOMEN \\n \\nItems needed: \\n\\uf0b7 01 Bristol board \\n\\uf0b7 Pins with red, blue, yellow and green heads \\n \\nMethod: \\nDraw three circles on the Bristol board as follows. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n3rd Trimester \\n2nd Trimester \\n \\n1st Trimester  \\n \\nEach trimester of the pregnancy is reflected by the three areas of these circles. \\nDivide circles according to the same way that you have divided your villages for the eligible couple \\nregister. \\n \\n       \\n \\n \\nA                                                              D \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n  \\n                                                  C                                               B \\n \\nA- Village A \\nB- Village B \\nC- Village C \\nD- Village D \\nMark pregnant women under your care in order to the villages & the trimesters by using pins on the \\ncircles.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n214 \\n \\n \\n \\n Blue pin – 1st Trimester pregnancies \\n Red pin -    Mothers with risk conditions \\n Green pin – Mothers without risk conditions (except 1st pregnancy) \\nThis chart should be renewed in every Saturday.  \\nE.g.: Mothers may reach to second trimester from first trimester (By bringing the pin to the relevant \\ncircle) \\n         Identifying risk factors (Put red pin while removing the green pin) \\nEither two red and blue pins or one pin with both red and blue heads should be used for 1st pregnancy \\nwith risk conditions. \\nThis chart can be also used in planning of postpartum care.   \\nThe areas for 3rd trimester, 2nd trimester and 1st trimester can be used as areas for first 10 days, day \\n11-28 & 28 – 42 days respectively. \\nThis chart gives information on pregnant and postpartum mothers under your care at a glance. This \\ncan be used in arranging home visits as well'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n215 \\n \\n \\nLIST OF REFERENCES \\n \\n1. Antenatal care: Routine care for the healthy pregnant women, National Collaborating Centre \\nfor Women’s and Children’s health Commissioned by the National Institute for Clinical \\nExcellence, October 2003 \\n2. Conceptual framework for the Elimination of Paediatric HIV and Congenital syphilis in Asia \\nPacific 2011-2015, UNICEF East Asia and Pacific Regional Office, August 2011 \\n3. Diabetes in Pregnancy, Management of diabetes and its complications from preconception to \\nthe postnatal period, National Collaborating Centre for Women’s and Children’s health \\nCommissioned by the National Institute for Clinical Excellence, March 2008 \\n4. Guidelines for the Management of HIV infection in Sri Lanka, National STD/AIDS Control \\nprogramme, Ministry of Health, Sri Lanka, 2008 \\n5. IHE Report: Determinants and Prevention of Low Birth weight: A Synopsis of the Evidence, \\nInstitute of health economics, Canada, 2008 \\n6. Integrated Management of Pregnancy and Child Birth:  Pregnancy, Child Birth, Postpartum \\nand Newborn care: guide for provision of essential services by WHO, Adopted for Sri Lanka, \\n2009 \\n7. Integrated Management of Pregnancy and Child Birth: Managing complications in pregnancy \\nand Childbirth: A guide for midwives and doctors, WHO, 2000 \\n8. Low Birth weight- Nutrition policy discussion paper No. 18, UN ACC sub-committee on \\nNutrition, 2000 \\n9. Maternal Mortality Decline: The Sri Lankan Experience, Family Health Bureau,  2003 \\n10. Obstetrics by Ten Teachers, Edited by T L T Lewis and G V P Chamberlain, fifteenth edition \\n1990 \\n11. Packages of Interventions for family planning, Safe abortion care, Maternal , Newborn and \\nChild Health, WHO, 2010 \\n12. Physical Status: the use & Interpretation of Anthropology, WHO, TRS 854 \\n13. Postnatal Care: A guide to field Staff, Family Health Bureau, 2007 \\n14. Regional strategy for the Elimination of Congenital syphilis, WHO, Regional Office for \\nSouth-East Asia, 2009 \\n15. Report: The 7th Asia- Pacific United Nations Prevention of Mother- to – Child Transmission \\nTask Force Meeting, 2009 \\n16. Strategy for the Elimination of Congenital Syphilis in Sri Lanka,  National STD/AIDS \\nControl programme, Ministry of Health, Sri Lanka,2009 \\n17. The Pregnancy Book, NHS,2001 \\n18. WHO Antenatal care Randomized Trail: manual for the Implementation of the New Model, \\nWHO, 2002 \\n19. WHO recommendations for the Prevention of Postpartum Hemorrhage, WHO 2007'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n216 \\n \\n \\nCirculars related to Maternal and newborn care \\n1. Circular letter dated 14th December 2010 by DGHS on provision of Influenza A H1N1 \\nvaccine for pregnant women \\n2. General circular  no. 01-28/2010 on 25th August 2010 by DGHS  on micronutrient \\nsupplementation and anti-helminthic treatment in maternal and school health programmes \\n3. General circular No 01-15/2010 dated 19th April 2010 on by DGHS on promotion of branded \\nmilk powder within health institutions and to the staff of ministry of health care and nutrition \\n4. Letter No. FHB/MCU/ Gen on 10th November 2009  signed by D/MCH on recommendations \\nfor basic investigations package for pregnant mothers \\n5. General circular no 01-14/2008 on guidelines for malaria chemotherapy and the management \\nof patients with malaria \\n6. General circular No 01-10/2007 dated 02nd March 2007 by DGHS on formats on newborn  \\n7. Circular on guidelines on immunization against tetanus by DGHS \\n8. General circular No 02-20/2007 dated 15th February 2007 by DDG/PHS on revised MCH \\nmanagement information system \\n9. General circular No 01-26/2006 by DGHS on duty list of field public health midwives \\n10. Public administration circular no 03/2006 dated 2nd March 2006 issued by Secretary, Ministry \\nof Public administration and Home affairs on paternity Leave – Chapter XII in E Code \\n11. General circular No 01—5/2006 on dated 03rd January 2006  by DGHS on surveillance on \\nperinatal mortality \\n12. Public administration circular no 4/2005 dated 3rd February 2005 issued by Secretary, \\nMinistry of Public administration and home affairs on Maternity Leave – Chapter XII in E \\nCode \\n13. General circular No 01-25/2004 dated 14th October 2004 by DGHS on antenatal clinic care \\n14. General circular No 01-27/2004 on 14th October 2004 by DGHS on streamline the Postnatal \\ncare   \\n15. Internal circular FHB 1/2004 dated 04th August 2004 by D/MCH on pregnancy record \\n16. General circular (revised) 1945 on 16th June 2004 by DGHS on national plan for prevention \\nand control of anaemia among pregnant women')]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "minimal_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "0f22baa2",
   "metadata": {},
   "outputs": [],
   "source": [
    "def text_split(minimal_docs):\n",
    "    text_splitter = RecursiveCharacterTextSplitter(\n",
    "        chunk_size=800,      # Big enough for tables, fits in MiniLM limit\n",
    "        chunk_overlap=100,   # Ensures sentences/logic aren't cut off\n",
    "        length_function=len,\n",
    "        separators=[\"\\n\\n\", \"\\n\", \" \", \"\"] # Tries to split by paragraph first\n",
    "    )\n",
    "    texts_chunk = text_splitter.split_documents(minimal_docs)\n",
    "    return texts_chunk"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "e39c9f89",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of chunks: 1110\n"
     ]
    }
   ],
   "source": [
    "texts_chunk = text_split(minimal_docs)\n",
    "print(f\"Number of chunks: {len(texts_chunk)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "5c36e9b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='1 \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nGuidelines for Management of Pregnant Women \\n with HIV Infection  2024 \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health \\nSri Lanka \\n \\n                 \\n \\nNational Programme on Elimination of Mother to Child Transmission \\n of HIV and Syphilis in Sri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='2 \\n \\n \\nGuidelines for Management of Pregnant Women \\nwith HIV Infection  2024 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNational STD/AIDS Control Programme \\nMinistry of Health  Sri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='3 \\n \\nGuidelines for Management of Pregnant Mothers with HIV Infection \\n \\nCoordinated by : \\nDr Nimali Jayasuriya \\nConsultant Venereologist ,  \\nNational Coordinator, EMTCT of Syphilis & HIV Programme National STD/AIDS Control Programme. \\n \\nContributors : \\nDr. Nimali Jayasuriya, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Lilani Rajapakse, Consultant Venereologist, former deputy Director NSACP  \\nDr. Geethani Samaraweera, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Jayanthi Elwitigala, Consultant Microbiologist, National STD/AIDS Control Programme \\nDr. Umedha Jayasinghe, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Loshan Moonasinghe, Consultant community physician, Family Health Bureau'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Dr. Loshan Moonasinghe, Consultant community physician, Family Health Bureau \\nDr. Nalaka Kulathunga , Senior Registrar in Venereology, National STD/AIDS Control Programme \\nDr. Shirmila Rajapakshe, Acting Consultant Venereologist, National STD/AIDS Control Programme  \\nDr Champika Gunewardhana, Consultant Venereologist,  National STD/AIDS Control Programme \\nDr. Sithmi Koswaththa, Senior Registrar in Venereology, National STD/AIDS Control Programme  \\n \\n \\n \\n \\nContributors for  the 3rd t edition :  \\nDr. K A M Ariyaratne, Consutant Venereologist, NSACP  \\nDr. Jayanthi Elwitigala, Consultant Microbiologist NSACP \\nDr. Darshani Mallikarachchi, Consultant Venereologist,  \\nDr. Chandrika Jayakody, Consultant Venereologist,  \\nDr. J Nadeeka, Consultant Virologist'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='4 \\n \\n \\nPublished by \\nNational STD/AIDS Control Programme      \\nMinistry of Health \\nColombo, Sri Lanka. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n1st Edition 2008 \\n2nd Edition 2011 \\n3rd Edition 2016 \\n4th Edition  2024'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='5 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nThe guidelines for management of pregnant women with HIV infection - \\n2024 was prepared to assist policymakers to optimize  PMTCT \\ninterventions and healthcare workers to provide optimal services to \\npregnant women with HIV'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='6 \\n \\nContents \\n \\n1. \\nValidation of Elimination of mother to child transmission (EMTCT) of HIV and syphilis programme 13 \\n1.1 Maintenance of eliminated status of MTCT of HIV ........................................................................ 13 \\n2. \\nHIV testing in pregnant women ....................................................................................................... 15 \\n3. Fertility desires among women with HIV ............................................................................................. 18 \\n3.1 Fertility options for PLHIV ............................................................................................................. 18'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='3.1.1 Sero-discordant Couples ........................................................................................................ 19 \\n4. Pre-Exposure Prophylaxis .................................................................................................................. 20 \\n5. Management of  pregnant women with HIV ........................................................................................ 21 \\n5.1 When to start ART in pregnant and breastfeeding women? .......................................................... 21 \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) ............................ 21 \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy ............................... 21'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='5.2.2 ARV regimens ........................................................................................................................ 21 \\n5.2.3 Preferred regimens ................................................................................................................ 22 \\n5.2.4 Women with HIV conceiving while on ART ............................................................................. 23 \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got pregnant \\nwhile maintaining successful viral suppression, oral two drug regimen may be continued with more \\nfrequent (every 1-2 months)  viral load monitoring. ......................................................................... 23'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='5.2.5 Late-presenting woman not on treatment ............................................................................... 23 \\n6. Monitoring of pregnant women receiving ART .................................................................................... 24 \\n7. Obstetric management ....................................................................................................................... 25 \\n7.1 Antenatal management ................................................................................................................. 25 \\n7.2. Mode of delivery .......................................................................................................................... 26'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='7.3. Multiple pregnancies .................................................................................................................... 27 \\n8. Antenatal care at the primary health care ANC clinic .......................................................................... 28 \\n9. Management of HIV positive pregnant women in the STD clinic......................................................... 29 \\n9.1  Counselling .................................................................................................................................. 29 \\n10. Management of delivery of pregnant mother with HIV ...................................................................... 30'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='10.1 Plan for delivery .......................................................................................................................... 30 \\n10.2 Planned normal vaginal delivery ................................................................................................. 31 \\n10.3. Planned caesarean section........................................................................................................ 31 \\n10.4 Management of pre-labour spontaneous rupture of membranes ................................................. 32 \\n10.5 Management of women who present in labor without documentation of HIV status or women who \\nhave not received antepartum antiretroviral drugs .............................................................................. 32'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='11. Post-partum Management ................................................................................................................ 34'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='7 \\n \\n11.1  Immediate management ............................................................................................................ 34 \\n11.2 Additional measures ................................................................................................................... 34 \\n11.3 Antiretroviral therapy................................................................................................................... 35 \\n11.4 Support services ......................................................................................................................... 35 \\n11.5 Mental health assessment and support....................................................................................... 35'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='12. Neonatal management ..................................................................................................................... 36 \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection ............... 37 \\n13. HIV diagnosis in infants and children................................................................................................ 39 \\n13.1 Timing of assessments ............................................................................................................... 40 \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants ................................................... 40 \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis ..................................................... 43'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='14.  Antiretroviral drug dosing recommendations for newborns .............................................................. 45 \\n15. Co-trimoxazole prophylaxis .............................................................................................................. 48 \\n16. Infant feeding ................................................................................................................................... 49 \\n17. Contraception for women living with HIV .......................................................................................... 50 \\n19. Immunization .................................................................................................................................... 57'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='20. References....................................................................................................................................... 59 \\n21. Annexures ........................................................................................................................................ 60'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='8 \\n \\nAbbreviations and acronyms \\nAbacavir  \\nABC \\nAntenatal clinic \\nANC \\nAntiretroviral  \\nARV \\nAntiretroviral therapy \\nART \\nAcquired Immune deficiency syndrome \\nAIDS \\nAtazanavir \\nATV \\nAtazanavir/cobicistat  \\nATV/c \\nAtazanavir/ritonavir  \\nATV/r  * \\nBictegravir  \\nBIC \\nCabotegravir  \\nCAB \\nCaesarean Section   \\nCS \\nCombined hormonal contraception \\nCHC \\nCopper intrauterine device \\nCu- IUD \\nDarunavir/cobicistat (DRV/c \\nDRV/c \\nDarunavir/ritonavir (DRV/r) \\nDRV/r \\nDepot medroxyprogesterone acetate \\nDMPA \\nDolutegravir  \\nDTG \\nDoravirine  \\nDOR \\nDRV darunavir \\nDRV  \\nEarly infant diagnosis \\nEID \\nEfavirenz  \\nEFV \\nElvitegravir  \\nEVG \\nElvitegravir/ cobicistat  \\nEVG/c   \\nEmtricitabine  \\nFTC \\nEnfuvirtide  \\nENF \\nEnhanced postnatal prophylaxis \\nePNP \\nEnzyme Linked Immunosorbent Assay \\nELISA'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Enfuvirtide  \\nENF \\nEnhanced postnatal prophylaxis \\nePNP \\nEnzyme Linked Immunosorbent Assay \\nELISA \\nEtonogestrel implant \\nENG-IMP \\nEtravirine  \\nETR \\nExternal cephalic version (ECV)  \\nECV \\nFixed dose combinations  \\nFDCs \\nGlobal validation advisory committee \\nGVAC \\nGlobal AIDS Monitoring  \\nGAM \\nHealth-care worker \\nHCW \\nHIV drug resistance \\nHIVDR \\nHuman immunodeficiency virus \\nHIV \\nIntegrase strand transfer inhibitors  \\nINSTIs \\nLamivudine  \\n3TC \\nLevonorgestrel-releasing intrauterine system \\nLNG-IUD \\nLong-acting injectable cabotegravir \\nCAB-LA \\nLopinavir/ritonavir \\nLPV \\nLopinavir/ritonavir (LPV/r)  \\nLPV/r \\nLower segment caesarean section  \\nLSCS \\nMaraviroc  \\nMVC \\nMaternal and child health \\nMCH \\nMedical officer \\nMO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='9 \\n \\nMinistry of Health \\nMOH \\nMother and child health \\nMCH \\nMother to child transmission \\nMTCT \\nMother-to-child transmission \\nMTCT \\nMultidisciplinary team \\nMDT \\nNational Reference Laboratory  \\nNRL \\nNucleic acid amplification test  \\nNAT \\nNevirapine \\nNVP \\nNon-nucleoside reverse transcriptase inhibitors \\nNNRTIs \\nNucleic acid testing  \\nNAT \\nNucleoside reverse transcriptase inhibitors  \\nNRTI \\nPoint-of-care \\nPOC \\nPolymerase chain reaction \\nPCR \\nPost  Exposure Prophylaxis  \\nPEP \\nPre-Exposure Prophylaxis  \\nPrEP \\nPre-labour Caesarean Section   \\nPLCS \\nPrevention of mother-to-child transmission \\nPMTCT \\nProgestogen-only pill \\nPOP \\nPublic health midwife  \\nPHM \\nRaltegravir  \\nRAL \\nRapid diagnostics test \\nRDT \\nRegional validation committee  \\nRVC \\nRilpivirine  \\nRPV \\nSexually Transmitted Infections \\nSTI'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='RDT \\nRegional validation committee  \\nRVC \\nRilpivirine  \\nRPV \\nSexually Transmitted Infections \\nSTI \\nSpontaneous Rupture of Membranes \\nSROM \\nTenofovir alafenamide  \\nTAF \\nTenofovir disoproxil fumarate  \\nTDF \\nViral load \\nVL \\nWorld Health Organization \\nWHO \\nZidovudine \\nAZT'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='10 \\n \\nContents of Tables \\n \\n \\n \\nTable 1 : Indicators and targets for validation of EMTCT of the HIV programme \\n13 \\nTable 2 : First line ART regimens \\n22 \\nTable 3 : Recommendations following SROM \\n32 \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\n33 \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high and low risk: \\n36 \\nTable 6 : Infant post-exposure prophylaxis (PEP) \\n38 \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n40 \\nTable 8 : Infant diagnosis among breastfed infants \\n41 \\nTable 9 : ART dosage for infants \\n45 \\nTable 10: Contraceptive methods \\n51 \\nTable 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n52 \\nTable 12: ART and emergency contraception (EC) \\n55'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='52 \\nTable 12: ART and emergency contraception (EC) \\n55 \\nTable 13:  Immunization Schedule \\n57'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='11 \\n \\nTable of figures \\n \\nFigure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n16 \\nFigure 2 : HIV Testing algorithm for pregnant women \\n17 \\nFigure 3: Early Infant diagnosis algorithm \\n42 \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n44'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='12 \\n \\nAnnexures  \\nAnnexure 1 : General circular letter No. 01-51/2016 - English \\n61 \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil \\n64 \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala \\n66 \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\n69 \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n71 \\nAnnexure 6 : Blood Collection request form \\n72 \\nAnnexure 7 : EMTCT HIV Case Investigation form \\n73 \\n Annexure 8 : Pregnancy record \\n74 \\nAnnexure 9 : Poster  for EMTCT of HIV \\n75 \\nAnnexure 10 : Leaflet for pregnant women on service package \\n76'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='13 \\n \\n1. Validation of Elimination of mother to child transmission \\n(EMTCT) of HIV and syphilis programme \\nSri Lanka has been declared as a country that eliminated MTCT of HIV and syphilis by the WHO, \\nGeneva in 2019. The overall goal for EMTCT of HIV and syphilis is to ensure the prevention of MTCT \\nof HIV and syphilis to a level that it is no longer a public health problem. Sri Lanka had to achieve the \\nfollowing impact and process indicators to achieve the elimination status. \\n           Table 1 : Indicators and targets for validation of EMTCT of the HIV programme \\nImpact indicators \\nA case rate of HIV positive infants  ≤50 per 100 000 live births \\nProcess indicators \\n \\nPopulation-level ANC1 coverage (at least one visit) of ≥95% \\nCoverage of HIV testing of pregnant women of ≥95%'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Coverage of HIV testing of pregnant women of ≥95% \\nTreatment coverage of HIV positive pregnant women of ≥95% \\nTreatment coverage of infants exposed to HIV of ≥95% \\n \\nThe EMTCT programme is closely monitored by WHO and will be revalidated once every three years. \\nIt is important to maintain satisfactory process and impact indicators and to sustain the success of the \\nprogramme throughout.  \\nSero-prevalence of HIV among antenatal population has remained at <0.01% for the last two decades \\nin Sri Lanka. \\nThe probability of mother to child transmission of HIV can be eliminated with appropriate \\nmanagement. If there is no intervention, the risk of transmission of HIV from an untreated mother to \\nchild is between 15-45 % depending on the stage of the infection, HIV RNA level and infant feeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='child is between 15-45 % depending on the stage of the infection, HIV RNA level and infant feeding \\npractices. \\n \\n1.1 Maintenance of eliminated status of MTCT of HIV  \\nFollowing validation of the EMTCT programme, it is important to maintain the impact and process \\nindicators each year to certify the country as successfully maintaining the services for EMTCT of HIV.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='14 \\n \\nCountries that fail to maintain the required EMTCT impact and  process indicators or maintain human, \\nsexual and  reproductive rights for women, can lose validation status.  \\nMaintenance of validation reports are expected to be submitted by countries every 3 years after initial \\nvalidation. These reports will be submitted through the regional validation committee (RVC) and \\nreviewed by the GVAC and the global secretariat to verify maintenance of validation.  \\nTo sustain elimination, a country requires comprehensive surveillance and monitoring systems \\n(including among vulnerable and key populations at risk of acquiring HIV and STIs). Such strong \\nsystems are needed to provide accurate data on intervention coverage, and quickly detect changes in'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='disease transmission trends. For MTCT of HIV and syphilis, these systems provide ongoing monitoring \\nof the prevalence of disease in pregnant women and the coverage and effectiveness of treatment.  \\nThe global secretariat will maintain a list of countries that have achieved validation and maintain \\nvalidation criteria and standards over time. A country may lose its validation status if coverage of \\nservices falls or if impact indicators such as case rate or MTCT rate exceed the global validation targets.  \\nTo maintain validation status, data should be reported through global reporting mechanisms such as \\nthe UNAIDS Global AIDS Monitoring (GAM) system. Indicators that are not captured in the GAM should \\nbe reported directly to the WHO country office.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='be reported directly to the WHO country office.  \\nAt the time of assessment of maintenance of validation, countries will be required to prepare a report \\nthat should include data tables on validation targets (process and impact indicators for the previous 3 \\nyears). For countries like Sri Lanka, with small populations and small numbers of HIV-positive and/or \\nsyphilis-positive pregnant women per year, 4 years of pooled data can be used to assess maintenance \\nof validation. Human rights, gender equality and civil society engagement must be reassessed and \\nincluded in the report at this time to ensure that there are no violations or changes in laws pertaining to \\nthis component of validation since the last validation review. Maintenance reports should include'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='this component of validation since the last validation review. Maintenance reports should include \\nupdates on any programmatic data, laboratory and human rights recommendations provided by the \\nGVAC at the time of validation. Maintenance reports should be submitted to the RVS, which will review \\nthe report and, if the validation criteria are still being met, will submit the report to the RVC (if applicable) \\nand the GVAC for final revalidation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='15 \\n \\n2. HIV testing in pregnant women \\n \\nHIV testing services should be offered to all pregnant women during the first visit with the antenatal \\ncare package before 12 weeks of gestation. \\n \\n\\uf0b7 \\nPregnant women should be informed about these tests, with testing being voluntary after \\nproviding adequate information on MTCT of HIV and prevention methods. \\n\\uf0b7 \\nIf a woman declines testing, her decision should be respected, and she should be assured \\nthat it will not affect her access to ANC services. \\n\\uf0b7 \\nFor pregnant women at high risk for HIV or STIs, a second HIV test should be offered at 28 \\nweeks of gestation either through the nearest STD clinic or via RDT. \\n \\n\\uf0b7 \\nAll pregnant women should receive opt-out HIV testing as early as possible during each pregnancy. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nDual HIV and syphilis rapid diagnostic tests can be offered as the first test in antenatal care to \\nincrease testing and treatment coverage.  \\n\\uf0b7 \\nRepeat HIV testing in the third trimester is recommended for pregnant women with negative initial \\nHIV tests who are at increased risk of acquiring HIV. \\n\\uf0b7 \\nRepeat HIV testing is recommended for pregnant women with a sexually transmitted infection, with \\nsigns and symptoms of acute HIV infection, or with ongoing exposure to HIV.  \\n\\uf0b7 \\nExpedited HIV testing should be performed during labor or after delivery for people with \\nundocumented HIV status and for those who tested negative early in pregnancy but are at increased \\nrisk of HIV infection and were not retested in the third trimester.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='16 \\n \\n \\n               Figure 1: Referral flow system of a HIV positive pregnant woman from the ANC clinic to the STD clinic \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from the  \\nANC clinics. \\nDate of blood sampling \\nshould be recorded in \\n512 pregnancy record \\n \\n \\nBlood samples are sent \\nto the STD clinics \\n \\nHIV /Syphilis Duo rapid \\ntest is performed at the \\nSTD clinic laboratory \\n \\nPositive results are conveyed \\nimmediately to the MOH or VOG of \\nthe relevant ANC clinic \\n(over the phone) \\nNegative results are  sent back to the \\nMOH through the same request form \\n \\n \\nPregnant women who receive a \\npositive HIV screening result are \\nimmediately referred to the STD \\nclinic for further evaluation and \\nmanagement'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='17 \\n \\nFigure 2 : HIV Testing algorithm for pregnant women  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n*Any discrepancy of a test results;  sample should be immediately  sent to the NRL for molecular or viral load \\ntesting\\n+ ELISA or + RDT1 \\nPerform Ag/Ab combo \\nRDT1 \\n(second sample)  \\nPerform ELISA or repeat \\nRDT1 \\nConnect to \\nnational HIV \\ntesting \\nalgorithm* \\n+ RDT1 \\nReport as HIV \\nNegative \\n- ELISA or - RDT1 \\n- RDT1 \\nPerform HIV/Syphilis  \\nDuo RDT \\n+HIV \\n- HIV \\nReport as HIV \\nNegative'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='3. Fertility desires among women with HIV  \\n \\n\\uf0b7 \\nImprovements in life expectancy and quality of life for women living with HIV, along with \\nenhanced access to EMTCT services, have increasingly led HIV positive women to \\ncontemplate the possibility of pregnancy.  \\n\\uf0b7 \\nPre-conception counselling need to be offered to all HIV positive women planning to have \\nchildren. Counselling should include the importance of treatment adherence and virologic \\nsuppression to eliminate the risk of MTCT of HIV. ARV therapy should be discussed with \\nevery woman taking their concerns and preferences into account and management should \\nbe based on the standard treatment guidelines.  \\n\\uf0b7 \\nAll women planning on pregnancy should start folic acid supplementation before pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nAll women planning on pregnancy should start folic acid supplementation before pregnancy \\nand continue up to 12 weeks of gestation. \\n \\n3.1 Fertility options for PLHIV \\nIncreasingly, parenting is regarded as a realistic option for couples where one or both partners \\nare infected with HIV and the demand for reproductive care is rising. HIV-positive men and \\nwomen and their partners planning to have children should receive pre-conception counselling \\non all their conception options, including HIV transmission risks associated with each case, so \\nthat they can make an informed choice. All discussions should be documented clearly in clinical \\nnotes. \\nFor sero-concordant or discordant couples who want to conceive, expert consultation is'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='notes. \\nFor sero-concordant or discordant couples who want to conceive, expert consultation is \\nrecommended so that approaches can be tailored to specific needs, which may vary from \\ncouple to couple. \\nThe physician does need to ensure that the uninfected partner has a full understanding of the \\npossibility of becoming infected through unprotected intercourse. More importantly, the need \\nfor ART adherence and regular attendance for STI screening in the couple and viral load \\nchecks in the infected partner should be stressed.  \\nFor couples in which one or both partners are HIV-infected, optimal health should be attained \\nbefore attempting conception.  \\n\\uf0b7 \\nInfected partner/couple should be receiving combination antiretroviral therapy and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nInfected partner/couple should be receiving combination antiretroviral therapy and \\ndemonstrate sustained viral suppression  (two  undetectable viral load over the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='19 \\n \\nperiod of six months) of plasma viral load below the limits of detection (at present \\n<34 copies/ml). \\n\\uf0b7 \\nBoth partners should be screened for genital tract infections. Treatment of such \\ninfections is important because genital tract inflammation is associated with genital \\ntract shedding of HIV. \\n\\uf0b7 \\nShould  undergo fertility screen where necessary. \\n3.1.1 Sero-discordant Couples  \\nBefore conception is attempted, the HIV-infected partner should be receiving ART and \\ndemonstrate sustained suppression of plasma viral load below the limits of detection. The \\npossible fertility options are  as follows.  \\n1. Antiretroviral Therapy (ART) for the HIV-Positive Partner: \\nEnsuring the HIV-positive partner is on effective ART and has an undetectable viral'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Ensuring the HIV-positive partner is on effective ART and has an undetectable viral \\nload reduces the risk of sexual transmission to effectively zero. This approach is known \\nas \"U=U\" (Undetectable = Untransmittable). Once the viral load is suppressed, natural \\nconception through timed intercourse becomes safer. \\n2. Pre-Exposure Prophylaxis (PrEP) for the HIV-Negative Partner: \\nThe HIV-negative female partner can take PrEP to further reduce the risk of acquiring \\nHIV during conception attempts. PrEP is most effective when taken consistently as \\nprescribed. \\n3. Timed Intercourse with ART and PrEP: \\nThis involves natural conception through intercourse timed around ovulation, combined \\nwith ART for the HIV-positive partner and PrEP for the HIV-negative partner. \\n4. Sperm Washing:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='with ART for the HIV-positive partner and PrEP for the HIV-negative partner. \\n4. Sperm Washing: \\nSperm washing is a process where sperm is separated from the seminal fluid, which \\nmay contain HIV. The washed sperm can then be used for intrauterine insemination \\n(IUI) or in vitro fertilization (IVF). This method significantly reduces the risk of HIV \\ntransmission. \\n5. In Vitro Fertilization (IVF): \\nIVF using sperm washing is a common method where the washed sperm is used to \\nfertilize the female partner’s ovum in a laboratory, followed by the transfer of the embryo \\nto the uterus. This option is particularly useful for couples with fertility challenges. \\n6. Donor Sperm: \\nIf the couple prefers to avoid the risk of transmission altogether, donor sperm from an'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='If the couple prefers to avoid the risk of transmission altogether, donor sperm from an \\nHIV-negative donor can be used for insemination or IVF.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='20 \\n \\n4. Pre-Exposure Prophylaxis  \\n \\nIn sero-discordant couples where the HIV-positive partner is on antiretroviral therapy and has \\nachieved sustained viral suppression, condomless sexual intercourse enables conception \\nwithout the risk of HIV transmission to the HIV-negative partner. As an added precaution, they \\nhave the option to choose PrEP for HIV prevention, even if the HIV-positive partner has achieved \\nviral suppression.  \\nThe preferred PrEP option for HIV prevention in people who have receptive vaginal sex during \\npregnancy and breastfeeding is tenofovir disoproxil fumarate with emtricitabine or lamivudine \\n(TDF+FTC/3TC). People who become pregnant while using TDF/FTC or TDF/3TC as PrEP, can'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='(TDF+FTC/3TC). People who become pregnant while using TDF/FTC or TDF/3TC as PrEP, can \\ncontinue PrEP throughout pregnancy and breastfeeding. Risk for HIV acquisition should be \\nreassessed, and couple should be counselled regarding the benefits and risks of PrEP use in \\npregnancy and breast feeding. \\nProviders should counsel patients about the importance of adherence to oral PrEP to prevent \\nHIV acquisition. Event driven or non-daily PrEP is not recommended for protection against \\nvaginal exposure to HIV.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='21 \\n \\n5. Management of  pregnant women with HIV  \\n \\n5.1 When to start ART in pregnant and breastfeeding women? \\nAll pregnant and breastfeeding women living with HIV should initiate and continue lifelong ART, \\nregardless of WHO clinical stage or CD4 count. Pregnant women newly diagnosed with HIV \\nshould start ART as early as possible, while those already on ART with sustained viral \\nsuppression should maintain their current regimen. \\nProviding ART to all pregnant and breast-feeding women living with HIV serves three synergistic \\npurposes. \\n1. Improving mothers’ health \\n2. Preventing mother to child transmission of HIV \\n3. Preventing transmission of HIV from mother to sexual partner/partners \\nFollowing a confirmed HIV diagnosis and clinical assessment, rapid ART initiation should be'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Following a confirmed HIV diagnosis and clinical assessment, rapid ART initiation should be \\noffered to all individuals, ideally within seven days. Those with advanced HIV disease should \\nbe prioritized. Same-day ART initiation should be available for individuals ready to start \\ntreatment immediately. \\n \\n5.2 What ART regimens to initiate (Refer Guide to Anti-retroviral treatment 2024 ) \\n5.2.1 Recommendations for the Use of Antiretroviral Drugs During Pregnancy \\nWhen selecting an ARV regimen for pregnancy, factors to consider include adverse effects, \\ndrug interactions, pharmacokinetics, regimen convenience, pregnancy safety data, virologic \\nefficacy, and comorbidities. The selection of  ARV regimen for pregnancy, is a shared and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='efficacy, and comorbidities. The selection of  ARV regimen for pregnancy, is a shared and \\nindividualized decision taken with consideration of available data for drug use in pregnant \\npeople as well as durability, tolerability and simplicity of medication regimen to ensure \\ntreatment adherence \\n5.2.2 ARV regimens \\nThere are five categories of drug recommendations in pregnancy as Preferred, Alternative, \\nInsufficient data to recommend, not recommended except in special circumstances and not \\nrecommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='22 \\n \\nOut of them the preferred first line regimen for the treatment of pregnant people with HIV who \\nhave never received ARV drugs consist of the integrase strand transfer inhibitor (INSTI) \\ndolutegravir (DTG) plus a dual-nucleoside reverse transcriptase inhibitor (NRTIs) combination.  \\n5.2.3 Preferred regimens  \\nTable 2 : First line ART regimens \\nFirst line ART \\nPreferred first –line \\nregimens \\nAlternative first –line regimens* \\n  \\nPregnant and breast-\\nfeeding women  \\n \\nTDF + FTC/3TC + DTG \\nTAF + FTC + DTG \\n \\n \\n \\nABC1 + 3TC +DTG/DRV/r2/EFV3//ATV/r \\nAZT + 3TC + DTG/DRV/r /EFV/ATV/r \\nTDF + FTC + DRV/r2 / EFV3 / RPV4 \\nTAF + FTC + DRV/r2 / EFV3 /RPV4 \\n \\n1ABC - Presence of HLA-B 5701 gene indicates higher risk for hypersensitivity. Viral load should be <100,000'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='copies/ml and without chronic hepatitis B virus (HBV) coinfection \\n2DRV Twice daily dose is recommended in pregnancy. \\n3If the preferred ART regimen is unavailable or contraindicated, alternatives for pregnant and breastfeeding women \\ninclude substituting TAF/ABC for TDF or using EFV or DRV/r instead of INSTI. The efficacy of low-dose EFV (400 \\nmg) in pregnancy has not been studied \\n4RPV can be used if VL< 100 000 c/ml and CD4 >200 cells/mm3. \\nNote: \\n\\uf0b7 \\nTAF or boosted PIs (DRV/r, ATV/r, LPV/r) can be used in special circumstances. \\n\\uf0b7 \\nINSTI Bictegravir (BIC) classified as an alternative ARV drug for use in pregnancy. \\n\\uf0b7 \\nOther INSTI Elvitegravir (EVG) or Cabotegravir (CAB) are not recommended in pregnancy due \\nto limited data during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='to limited data during pregnancy. \\n \\nIf an ARV regimen is stopped during pregnancy, all drugs should be discontinued together, and \\na complete regimen restarted promptly. Pregnant women with HIV who have defaulted on ART \\nshould resume treatment immediately, adjusting the regimen later if resistance test results \\nrequire it \\nIn addition to ART, they should receive comprehensive pregnancy care, including nutritional \\nsupport, infant feeding counseling, and family planning guidance. Monitoring for pregnancy-\\ninduced hypertension and pre-eclampsia, particularly in women on ART before conception, is \\nessential.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='23 \\n \\n5.2.4 Women with HIV conceiving while on ART \\n \\nIt is recommended that women conceiving on an effective ART regimen should be continued. \\nThe ART regimens should not be changed just due to non-inclusion of preferred or alternative \\nregimens or drugs, because the changing could lead to increase in viral load, decline in immune \\nstatus, progression of disease and increased risk of mother to child transmission of HIV \\ninfection. However, ART regimen should be changed if it contains medications which are not \\nrecommended to use in pregnancy. \\nIt is recommended to continue suppressive regimen with frequent viral load monitoring when \\nshe is on an ART regimen with insufficient data about using in pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='she is on an ART regimen with insufficient data about using in pregnancy. \\nOral two drug regimens are not recommended for use in pregnancy. How ever if patient got \\npregnant while maintaining successful viral suppression, oral two drug regimen may be \\ncontinued with more frequent (every 1-2 months)  viral load monitoring. \\n5.2.5 Late-presenting woman not on treatment \\nINSTIs have an important role to play in late pregnancy as DTG and RAL can suppress viral \\nload rapidly. A decrease of approximately 2 log10 copies/ml occurs by two-week therapy with \\nDTG and RAL. DTG preferred and RAL (Raltegravir) is alternative as RAL requires twice daily \\ndosing and has a lower barrier to development of drug resistance than DTG.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='24 \\n \\n6. Monitoring of pregnant women receiving ART \\n\\uf0b7 \\nClinical and laboratory evaluation is as for non-pregnant women receiving ART.  \\n\\uf0b7 \\nHaematological and biochemistry parameters should be monitored as appropriate to the \\nART regimen used. \\n\\uf0b7 \\nRegular viral load monitoring is needed in pregnancy.  \\n\\uf0b7 \\nAll pregnant women, regardless of when they start ART, may require more intense \\nmonitoring of viral suppression, including conducting viral load testing at 34–36 weeks \\nof gestation (or at the latest at delivery) to identify women who may be at risk of treatment \\nfailure and/or may deliver infants at higher risk of perinatal transmission.  \\n\\uf0b7 \\nIn addition, a viral load test is recommended for all breastfeeding women three months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nIn addition, a viral load test is recommended for all breastfeeding women three months \\nafter delivery and every six months thereafter to detect viraemic episodes during the \\npostnatal period. \\n\\uf0b7 \\nWhen lack of suppression is identified, a thoughtful evaluation of potential contributing \\nfactors is needed, including barriers to adherence, drug resistance, drug–drug and drug–\\nfood interactions, pharmacokinetics  changes in pregnancy that affect drug levels, and \\ncombinations of these factors. \\n\\uf0b7 \\nIn women who commence ART in pregnancy, HIV viral load should be performed four \\nweeks after commencing ART and at 36 weeks. \\n\\uf0b7 \\nIn women commencing ART in pregnancy, liver function tests should be performed at \\ninitiation of ART and then at each antenatal visit. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='initiation of ART and then at each antenatal visit. \\n\\uf0b7 \\nIf a woman who has initiated ART during pregnancy has not achieved a plasma viral \\nload of < 50 HIV RNA copies/ml at 36 weeks, following interventions are recommended: \\n\\uf0d8 Review treatment adherence and concurrent use of other medication \\n\\uf0d8 Perform resistance testing if appropriate \\n\\uf0d8 Optimize to the best regimen \\n\\uf0d8 Consider intensification'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='25 \\n \\n7. Obstetric management \\n7.1 Antenatal management \\n\\uf0b7 \\nPregnant women with HIV should receive comprehensive care from a multidisciplinary \\nteam, including an obstetrician, venereologist, paediatrician, anaesthetist, theatre nurse, \\nMOH, microbiologist/virologist, and infection control nurse. Effective coordination, \\nconfidentiality, and shared responsibility are crucial in their management.  \\n\\uf0b7 \\nHealthcare providers must ensure that antenatal, labor, delivery, and postpartum care \\nare delivered in a supportive environment, with institution heads and consultants working \\nto prevent stigma and discrimination. Ensure privacy and confidentiality during \\nconsultations and reassure the woman that her HIV status will be kept confidential. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='consultations and reassure the woman that her HIV status will be kept confidential. \\n\\uf0b7 \\nExplain to the woman who the information will be shared with. \\n\\uf0b7 \\nExplain to the woman that she will have to follow routine antenatal clinic visits and give \\nher confidence by discussing the management plan with her. \\n\\uf0b7 \\nFoetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal diagnostic testing should not be performed until after the HIV status of \\nthe mother is known and should ideally be deferred until HIV viral load has been \\nadequately suppressed. \\n\\uf0b7 \\nPlan and discuss the mode of delivery with the pregnant woman during antenatal care. \\nGive her clear instructions on when to get admitted for delivery and whom should be'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Give her clear instructions on when to get admitted for delivery and whom should be \\ncontacted.  \\n\\uf0b7 \\nExternal cephalic version (ECV) can be performed in women with HIV who are virally \\nsuppressed. \\n\\uf0b7 \\nHealth care workers should practice universal infection control measures for all \\ndeliveries irrespective of the infection status of pregnant women. \\n\\uf0b7 \\nAmniocentesis may be performed on virally suppressed pregnant women with HIV after \\nthorough counseling on risks, benefits, and alternatives, if they are on ART with an \\nundetectable viral load. \\n\\uf0b7 \\nCoordinated multidisciplinary team management involving MCH staff, infection control, \\nvenereologists, obstetricians, pediatricians, and other relevant services is crucial for \\ndelivering quality care.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content=\"26 \\n \\n\\uf0b7 \\nDuring pregnancy, pregnant woman needs to be counselled on mode of delivery, family \\nplanning and contraceptive options, infant feeding, infant ARV prophylaxis, and timing \\nof infant diagnostic testing. \\n\\uf0b7 \\nFetal ultrasound imaging should be performed as per national guidelines regardless of \\nmaternal HIV status. \\n\\uf0b7 \\nInvasive prenatal testing should be delayed until the woman's viral load is suppressed \\nto <50 copies/mL. If invasive testing can't wait for viral suppression, ART with DTG \\nshould be initiated, and a single dose of nevirapine administered 2–4 hours before the \\nprocedure.  \\n \\n   7.2. Mode of delivery \\n\\uf0b7 \\nFor women with a plasma viral load of <50 HIV RNA copies/mL at 36 weeks, and in the\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nFor women with a plasma viral load of <50 HIV RNA copies/mL at 36 weeks, and in the \\nabsence of obstetric contraindications, planned vaginal delivery can be  supported. \\n\\uf0b7 \\nFor women with a plasma viral load of ≥ 50 HIV RNA copies/mL at 36 weeks, pre-labour \\nCaesarean Section  (PLCS) is recommended. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been planned and labour has commenced, \\nobstetric management should follow the same guidelines as for the HIV-negative \\npopulation, except for managing the duration of ruptured membranes. \\n\\uf0b7 \\nTraditionally amniotomy, fetal scalp electrodes and blood sampling, instrumental \\ndelivery and episiotomy have been avoided in HIV infection because of theoretical \\ntransmission risks. \\n \\nPoints for consideration \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='transmission risks. \\n \\nPoints for consideration \\n• \\nAll known HIV infected pregnant women should have an individualized, regularly \\nupdated, plan of care which summarizes mutually agreed obstetric/HIV management \\nincluding the drug regimen and recommended mode of delivery.  \\n• \\nProperly applied universal infection control measures protect staff from blood borne \\ninfections. Routine use of these precautions is essential to minimize occupational \\nrisk. \\n• \\nWard staff must maintain confidentiality regarding a pregnant woman’s HIV status and \\nprovide nonjudgmental, stigma-free care. Information should be shared only on a \"need \\nto know\" basis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='27 \\n \\n7.3. Multiple pregnancies \\nMultiple pregnancies should be managed according to obstetric need of the woman and as \\nper HIV-negative protocols.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='28 \\n \\n 8. Antenatal care at the primary health care ANC clinic \\n \\n \\n• \\nWhen a pregnant woman is diagnosed as having HIV infection, the venereologist of the \\nSTD clinic will communicate with the MOH regarding the steps need to be taken. \\n• \\nMOH and staff play a key role in caring for pregnant women with HIV. Effective \\ncoordination, confidential communication, and shared responsibility are essential for \\nproper management. \\n• \\nEnsure privacy and confidentiality during consultations and reassure the woman that her \\nHIV status will be kept confidential. \\n• \\nExplain to the pregnant woman who the information will be shared with. \\n• \\nExplain to her that she will have to follow routine antenatal clinic visits.  \\n• \\nThe pregnant woman should be reassured and should be referred immediately to the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='• \\nThe pregnant woman should be reassured and should be referred immediately to the \\nSTD clinic for further management. \\n• \\nHealth care providers should ensure that pregnant women with HIV are provided \\nantenatal care, labour and delivery care and post-partum services in a user-friendly \\nenvironment.  \\n• \\nThe MOH and the staff should take all measures to maintain confidentiality and prevent \\nstigma and discrimination. \\n• \\nCheck whether she has been seen by a VOG as delivery care needs to be arranged in \\na unit with specialist services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='29 \\n \\n9. Management of HIV positive pregnant women \\nin the STD clinic \\n \\nThere are two possibilities. \\n\\uf0b7 \\nA pregnant woman may be identified as having HIV infection during routine antenatal \\nscreening and referred to the STD clinic by the MOH or VOG for further management. \\n\\uf0b7 \\nA woman already diagnosed as living with HIV and under care services from STD clinic \\ncan become pregnant. \\n\\uf0d8 All pregnant women with HIV should have an individualized, regularly updated plan of \\ncare which summarizes mutually agreed obstetric and HIV management plan.  \\n\\uf0d8 Check whether the woman has already attended for antenatal care and encourage \\nregular attendance at antenatal visits. \\n\\uf0d8 Ask about the health of other children and encourage checking HIV status of partner and  \\nchildren. \\n \\n9.1  Counselling'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='children. \\n \\n9.1  Counselling \\n  The following areas need to be covered in counseling. \\n\\uf0b7 \\nART and adherence to treatment \\n\\uf0b7 \\nPartner disclosure/screening \\n\\uf0b7 \\nHIV testing of other children \\n\\uf0b7 \\nMode of delivery \\n\\uf0b7 \\nChoice of infant feeding \\n\\uf0b7 \\nCondom use to prevent acquiring other STIs, entry of other strains of HIV and onward \\ntransmission to a negative partner \\n\\uf0b7 \\nPostpartum family planning \\n \\nPregnant women should be counselled on delivery options, lifelong HIV therapy, family planning, \\ncontraceptives, infant feeding, ARV prophylaxis for the infant, and timing of infant diagnostic \\ntesting.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='30 \\n \\n10. Management of delivery of pregnant mother with \\nHIV \\n \\n10.1 Plan for delivery \\n \\nPlan and discuss the mode of delivery with the pregnant woman (and her partner if possible) \\nduring the  antenatal care. \\nGive her instructions on when to get admitted to the hospital for delivery and whom she should \\ncontact. \\nExplain the possibility of preterm labour and what to do in case of an emergency. \\nWhen admitted for delivery \\n• \\nCheck the expected date of delivery \\n• \\nConfirm normal growth of the foetus \\n• \\nCheck which ART regimen have been prescribed and whether drugs have been taken \\nas prescribed \\n• \\nCheck for recent viral load results \\n• \\nWomen with incomplete viral suppression (>50 copies/mL) at the time of delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='• \\nWomen with incomplete viral suppression (>50 copies/mL) at the time of delivery \\npreferably should receive IV zidovudine (if available) while continuing oral ARV \\nregimen. \\n• \\nIn situations where IV administration is not possible/not available, oral \\nadministration of zidovudine using a 600-mg loading dose and 400 mg every 3 \\nhours can be considered. \\n• \\nCheck for availability of antiretroviral treatment for infant prophylaxis. \\n• \\nCheck for infant feeding method and emphasize on adherence and support if she has \\ndecided on breast feeding.  \\n• \\nProvide lactation suppression therapy if mother has decided on formula feeding. \\n• \\nArrange parents to collect formula milk from the NGO. The peripheral STD clinics receive'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='• \\nArrange parents to collect formula milk from the NGO. The peripheral STD clinics receive \\nformula milk from the EMTCT unit, which obtains it in bulk from the NGO. \\n• \\nCheck for availability of safe delivery kits and post exposure prophylaxis therapy in the \\nhealth care institution which is identified for delivery.  \\n• \\nConfirm that a post-partum family planning method is arranged before being discharged \\nfrom the hospital.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='31 \\n \\n10.2 Planned normal vaginal delivery \\n \\n\\uf0b7 \\nIf HIV viral load is < 50 copies/mL at 36 weeks, the risk of MTCT of HIV is less in the \\nabsence of other obstetric contraindications. \\n\\uf0b7 \\nMinimize vaginal examinations to reduce the risks of infection to the mother. Maintain \\naseptic techniques throughout labour. \\n\\uf0b7 \\nART should be continued according to the ART plan. \\n\\uf0b7 \\nAmniotomy, fetal scalp electrodes and fetal blood sampling, instrumental delivery and \\nepisiotomy need to be avoided in pregnant women with HIV infection because of \\ntheoretical transmission risks. \\n\\uf0b7 \\nArtificial rupture of membranes increases the risk of infection of the placental \\nmembranes.  \\n\\uf0b7 \\nAvoid prolonged labor by monitoring labour carefully and intervening appropriately (i.e.,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nAvoid prolonged labor by monitoring labour carefully and intervening appropriately (i.e., \\naugmentation of labour through oxytocin or delivery by caesarean section).  \\n\\uf0b7 \\nThe head should be well engaged. \\n\\uf0b7 \\nCheck whether the cervix is effaced and dilated and await spontaneous onset of labour. \\n\\uf0b7 \\nIn women for whom a vaginal delivery has been recommended and labour has \\ncommenced, obstetric management should follow the same principles as for the \\nuninfected population.  \\n \\n10.3. Planned caesarean section \\n \\n\\uf0b7 \\nExplain to the pregnant woman about the reason for the caesarean section and obtain \\ninformed consent. \\n\\uf0b7 \\nNotify the Hospital Director, consultant anesthetist, neonatologist, paediatrician,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nNotify the Hospital Director, consultant anesthetist, neonatologist, paediatrician, \\ninfection control unit, head of the intensive care unit, sister in charge of the theatre, \\nantenatal ward, postnatal ward and PBU where necessary, while taking every \\nprecaution to maintain confidentiality. \\n\\uf0b7 \\nInform the consultant venereologist of the STD clinic. \\n\\uf0b7 \\nProvide premedication and prepare as usual for surgery. \\n\\uf0b7 \\nRegional analgesia is not contraindicated in delivery care of pregnant women with \\nHIV. \\n\\uf0b7 \\nContinue ARV regimen as recommended. Oral medications can be continued \\npreoperatively with sips of water.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='32 \\n \\n10.4 Management of pre-labour spontaneous rupture of membranes \\n \\n In all cases of term pre-labour spontaneous rupture of membranes (SROM), delivery should be     \\n expedited. \\nTable 3 : Recommendations following SROM \\nScenario \\nRecommendations \\n1. \\nIf maternal HIV viral load is < 50 RNA copies/mL immediate induction of labour is \\nrecommended, preferably under antibiotic cover. \\n2. \\nIf maternal HIV viral load is ≥ 50 RNA copies/mL plasma, immediate caesarean \\nsection is recommended. \\n3. \\nIf maternal HIV viral load is not available, immediate caesarean section is \\nrecommended \\n \\n \\n \\nIt has been observed that the risk of HIV transmission was twice as high among women with \\nruptured membranes for more than 4 hours before delivery compared with those with shorter'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='ruptured membranes for more than 4 hours before delivery compared with those with shorter \\nduration of membrane rupture. \\nThere is no evidence that steroids for foetal lung maturation (with associated 24-hour delay in \\ninduction) are of overall benefit at 34–37 weeks’ gestation in women with ruptured membranes, \\nthus delay for the optimization of fetal lung maturity is not recommended. For this reason, and \\nto minimize the risk of developing chorioamnionitis, delivery is recommended from 34 weeks’ \\ngestation in women with ruptured membranes who are not in labour. \\n \\n10.5 Management of women who present in labor without documentation of \\nHIV status or women who have not received antepartum antiretroviral drugs'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='HIV status or women who have not received antepartum antiretroviral drugs \\nWomen presenting in labour / ROM / requiring delivery without a documented HIV result must \\nbe recommended to have a Rapid HIV Test. A reactive/positive result must be acted upon \\nimmediately with initiation of the interventions to PMTCT without waiting for further/formal \\nserological confirmation. Pregnant women with positive rapid HIV screening should be \\npresumed to be infected until HIV confirmatory testing clarifies their infection status \\nAn untreated woman presenting in labour at term should be given a stat dose of nevirapine \\n200 \\nmg \\nand \\ncommence \\non \\nfixed-dose \\nzidovudine \\n+ \\nlamivudine \\nand \\nraltegravir/dolutegravir as the preferred additional agent (because it also rapidly crosses the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='raltegravir/dolutegravir as the preferred additional agent (because it also rapidly crosses the \\nplacenta). Intravenous zidovudine can be administered for the duration of labour and delivery.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='33 \\n \\n \\nA single dose of nevirapine should be given immediately to the pregnant woman as this rapidly \\ncrosses the placenta and within 2 hours achieves and maintains effective concentrations in the \\nneonate for up to 10 days .If delivery is not imminent, a caesarean section should be considered. \\nIf delivery occurs less than 2 hours post maternal nevirapine, the neonate should also be dosed \\nwith nevirapine immediately. After partus, refer mother to the STD Clinic for clinical and \\nimmunological assessment. \\n \\nTable 4 : Recommendations for Intrapartum intravenous zidovudine infusion \\nIntrapartum intravenous zidovudine infusion is recommended in the following circumstances \\n \\n1.  \\nFor women with a viral load >1000 HIV RNA copies/mL plasma who present in'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='1.  \\nFor women with a viral load >1000 HIV RNA copies/mL plasma who present in \\nlabour or with SROM or who are admitted for PLCS \\n2.  \\nFor untreated women presenting in labour or SROM \\n3. \\nSROM in whom the current viral load is not known. \\n4. \\nCan be considered for women with viral load >50 HIV RNA copies/mL who present \\nin labour or with SROM or who are admitted for CS'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='34 \\n \\n11. Post-partum Management  \\n \\n11.1  Immediate management \\n• \\nAvoid suctioning the infant’s mouth and pharynx, which may cause trauma to the \\nmucous membranes thus promoting mother to child transmission of HIV. \\n• \\nClean the eyes of the baby with saline at delivery of the head. \\n• \\nClamp the cord as soon as possible to minimize the risk of maternal-fetal micro-\\ntransfusions. \\n• \\nCover the umbilical cord with a swab when cutting to prevent spurting blood. \\n• \\nTowel dry the baby. \\n• \\nClean the baby’s skin thoroughly before any infusions or injections. \\n \\nMinimize the risk of postpartum haemorrhage by: \\no Actively managing the third stage of labor \\no Using controlled cord traction \\no Performing uterine massage \\no Repair any genital tears \\no Carefully removing all products of conception'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='o Repair any genital tears \\no Carefully removing all products of conception \\n• \\nPhysical assessment in the postpartum period should follow routine guidelines. Examine \\nwomen within 24 hours following delivery. \\n• \\nBe aware of signs of infection following delivery. HIV positive women are also vulnerable \\nto infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early \\ndetection and effective treatment are important measures to prevent complications. \\n• \\nManage infected tears or episiotomy. \\n11.2 Additional measures \\n• \\nAdvice women to come back to the same institution if LSCS wound infection is observed. \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='• \\nAdvice women to come back to the same institution if LSCS wound infection is observed. \\n• \\nWhen they are discharged from the healthcare facility, women should be advised to \\nreturn to the clinic or inform the PHM if they notice symptoms such as fever, lower \\nabdominal pain, burning with urination, foul smelling discharge, abnormal bleeding, \\ncough, shortness of breath, calf pain (increasing on walking), diarrhoea and \\nunusual/abnormal behaviour.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='35 \\n \\n• \\nGive information to the mother on care of the perineum and breasts. Women living with \\nHIV require special care to reduce breast engorgement, mitigate pain and avoid mastitis. \\n• \\nWomen who choose to breast feed should be counselled to avoid breast engorgement \\nwhich could lead to mastitis, since inflammation is associated with increased risk of HIV \\ntransmission. She should be advised to seek immediate medical care if breast \\nengorgement is associated with fever and pain. \\n• \\nInstruct her about the safe disposal of lochia and blood-stained sanitary wear or other \\npotential infectious materials. \\n• \\nIf family planning has not been discussed before delivery it should be done during the \\nearly postpartum period. \\n \\n11.3 Antiretroviral therapy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='early postpartum period. \\n \\n11.3 Antiretroviral therapy \\n        All women are recommended to continue ART postpartum. \\n \\n11.4 Support services \\nDuring the postpartum period pregnant woman may face serious challenges to ART adherence \\nand retention in HIV care due to new responsibilities. Continued supportive services need to be \\noffered during this critical period. \\n11.5 Mental health assessment and support \\nWomen should have their mental health needs assessed postpartum and those identified as \\nhaving mental health issues should be referred to appropriate services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='36 \\n \\n12. Neonatal management \\n \\nRisk assessment at delivery is essential for identifying high- and low-risk infants, ensuring \\nproper prophylaxis and accurate diagnosis. \\nTable 5 :  Criteria for risk assessment at the time of delivery and to identify infants at high \\nand low risk: \\nCriteria for infants at high risk \\n \\nCriteria for infants at low risk \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nDid not receive prenatal care. \\n\\uf0b7 \\nReceived no antepartum ARVs or \\nonly intrapartum ARV drugs. \\n\\uf0b7 \\nInitiated ART late in pregnancy \\n(during the late second or third \\ntrimester). \\n\\uf0b7 \\nDiagnosis of acute HIV infection \\nduring pregnancy or in labor. \\n\\uf0b7 \\nHad detectable HIV viral loads        \\n(> 50 copies/mL) close to the time of \\ndelivery, including those who \\nreceived ART but did not achieve'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='delivery, including those who \\nreceived ART but did not achieve \\nsustained viral suppression. \\n \\n \\nInfants born to mothers with HIV who \\n\\uf0b7 \\nReceiving  ART since first trimester \\nor early second trimester . \\n      and  \\n\\uf0b7 \\nHas achieved and maintained viral \\nsuppression. (Defined as \\n<50 copies/mL) \\n     and \\n\\uf0b7 \\nHas reported good adherence and \\nadherence concerns have not been \\nidentified.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='37 \\n \\n12.1 Antiretroviral Management of Newborns with Perinatal HIV Exposure or \\nHIV Infection \\n \\nAll newborns perinatally exposed to HIV should receive appropriate antiretroviral (ARV) drugs \\nas soon as possible, preferably within 6 hours, after delivery to reduce the risk of perinatal \\ntransmission of HIV. A newborn’s ARV regimen should be determined based on maternal and \\ninfant factors that influence the risk of perinatal transmission of HIV.  \\n\\uf0b7 \\nNewborns at low risk of perinatal HIV acquisition, 4 to 6 weeks zidovudine (ZDV) or \\nNevirapine  (NVP)  is recommended. \\n\\uf0b7 \\nNewborns at high risk of perinatal acquisition of HIV should receive presumptive HIV \\ntherapy with 3-drug regimens administered from birth for 2 to 6 weeks \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='therapy with 3-drug regimens administered from birth for 2 to 6 weeks \\n\\uf0b7 \\nAll premature infants <37 weeks gestation who are not at high risk of perinatal \\nacquisition of HIV should receive ZDV or NVP for 4 to 6 weeks . \\n\\uf0b7 \\nInfants of women  who have primary or acute HIV infection during breast feeding period \\nshould be managed like infants at high risk of perinatal transmission with presumptive \\nHIV therapy. \\n\\uf0b7 \\nThe use of ARV drugs other than ZDV, lamivudine (3TC), and NVP cannot be \\nrecommended for any indication in premature newborns (<37 weeks gestational age) \\nbecause of the lack of dosing and safety data. \\n\\uf0b7 \\nIf an individual presents with unknown HIV status and has a positive HIV test during \\nlabor or shortly after delivery, the infant should begin presumptive HIV therapy . If'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='labor or shortly after delivery, the infant should begin presumptive HIV therapy . If \\nsupplemental maternal testing is negative, the infant’s ARV regimen should be \\ndiscontinued .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='38 \\n \\n Table 6 : Infant post-exposure prophylaxis (PEP) \\nScenario \\nART \\nDuration \\n \\nLow risk Pregnant women and \\nnon-breast-fed  infants \\n \\n \\nNVP (twice daily )  or AZT (twice \\ndaily )   \\n \\n4 - 6 weeks \\n \\nHigh risk Pregnant women and  \\nnon-breast-fed infants \\n \\n \\nAZT (twice daily ) +3TC (twice daily \\n+  NVP (once daily) \\nor  \\nAZT (twice daily ) +3TC (twice daily \\n+  RAL (twice daily) \\n \\n4 -  6 weeks \\n \\nif the duration of the 3-\\ndrug regimen is shorter \\nthan 6 weeks, ZDV / NVP \\nshould be continued \\nalone, to complete a total \\nof 6 weeks of prophylaxis. \\n \\nBreastfed infants* \\n \\n \\n  \\nAZT (twice daily ) and 3TC( twice \\ndaily and  NVP (once daily) \\n \\n12\\u2009weeks or until the \\nmother’s viral load is        \\n<50 cp/mL.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='daily and  NVP (once daily) \\n \\n12\\u2009weeks or until the \\nmother’s viral load is        \\n<50 cp/mL. \\n* Mothers with acute or primary HIV infection during breastfeeding ,  breastfeeding should be immediately   \\n   discontinued \\n \\nFactors such as prolonged rupture of membranes, preterm delivery and low birth weight are no \\nlonger associated with increased risk of transmission when mothers are with satisfactory viral \\nsuppression. The critical determinant of transmission is maternal viral load. Three-drug infant \\ntherapy is recommended for all circumstances other than where maternal viral load at 36 weeks’ \\ngestation/delivery is < 50 HIV RNA copies/mL. \\nInitiating ART as treatment  in an infant less than 2 weeks of age, a regimen of AZT + 3TC +'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Initiating ART as treatment  in an infant less than 2 weeks of age, a regimen of AZT + 3TC + \\nNVP should be started and NVP be substituted with LPV/r at the earliest opportunity, preferably \\nat 2 weeks of age. In settings where LPV/r syrup is unavailable, NVP should be continued until \\n3 months of age, with close clinical monitoring for children at high risk of NNRTI resistance due \\nto prolonged NVP-based postnatal prophylaxis or documented NNRTI failure in the mother. \\nWhere it is available, raltegravir could also be considered as an option in special circumstances.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='39 \\n \\n13. HIV diagnosis in infants and children \\n \\n\\uf0b7 \\nVirologic assays (HIV RNA or HIV DNA nucleic acid tests [NATs]) that directly detect \\nHIV must be used to diagnose HIV in infants and children aged <18 months with \\nperinatal and postnatal HIV exposure. HIV antibody and HIV antigen/antibody tests \\nshould not be used .  \\n\\uf0b7 \\nPlasma HIV RNA or cell-associated HIV DNA NATs are generally equally \\nrecommended.  \\n\\uf0b7 \\nPlasma HIV RNA or DNA NAT results can be influenced by maternal ART or infant \\nARV prophylaxis or presumptive HIV therapy. \\n\\uf0b7 \\nAll HIV exposed infants should undergo nucleic acid testing (NAT) at birth to identify \\nHIV infection ,  then at 8 weeks of age (at least 2 weeks after cessation of PEP) or \\nat the earliest opportunity thereafter and at 4-6 months. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='at the earliest opportunity thereafter and at 4-6 months. \\n\\uf0b7 \\nAge-appropriate HIV testing also is recommended for infants and children with signs \\nand/or symptoms of HIV. \\n\\uf0b7 \\nFor children older than 24 months, and for those aged 18 to ≤ 24 months with \\nnon-perinatal HIV exposure, HIV antibody (or HIV antigen/antibody) tests are \\nrecommended for diagnostic testing. \\n\\uf0b7 \\nIn infants with an initial positive virological test result, Antiretroviral therapy (Not PEP) \\nshould be started without delay and at the same time a second blood sample is \\ncollected to confirm the initial positive virological test result.  \\n\\uf0b7 \\nConfirmation of HIV infection among infants less than 18 months should be based \\non two positive virologic tests from separate blood samples.  \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='on two positive virologic tests from separate blood samples.  \\n\\uf0b7 \\nDo not delay ART for confirmatory test results. Immediate initiation of ART saves \\nlives and should not be delayed while waiting for the results of the confirmatory test. \\n.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='40 \\n \\n 13.1 Timing of assessments \\n \\nTable 7 : Infant diagnosis among exclusively non-breastfed infants \\n \\nVirological assays (HIV RNA and HIV DNA nucleic acid tests) for HIV infection should \\nbe performed on the following occasions  \\n \\n\\uf0b7 \\nAt Birth (During the first 48 hours)  \\n\\uf0b7 \\nAt  8 weeks (or at least 2 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nAt 4-6 months  (or at least 8 weeks after cessation of infant prophylaxis  \\n\\uf0b7 \\nInfants who are at high risk of perinatal HIV infection additional virological  test at 2-\\n3  weeks of age.  \\n \\nAntibody testing  \\n \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and 18 months.  \\n\\uf0b7 \\nAlthough an HIV antibody test may be negative before this time, engagement in care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nAlthough an HIV antibody test may be negative before this time, engagement in care \\nwith follow-up of the infant should continue until at least 18 months of age.  \\n \\n \\n\\uf076 HIV antibody testing for sero-reversion should be performed at age 9 and 18 months to \\nexclude HIV infection. (If HIV antibody test is negative, the test should be repeated \\nimmediately with a separate blood sample to confirm HIV negative status).  \\n\\uf076 Children with perinatal HIV exposure aged 18-24 months may have residual \\nmaternal HIV antibodies. In such a case, confirmation should be based on nucleic \\nacid test. \\n \\n13.1.2 Definitive exclusion of HIV infection in non-breastfed infants \\n\\uf0b7 \\nIs based on 2 or more negative virological tests, with one obtained at age ≥1 month'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nIs based on 2 or more negative virological tests, with one obtained at age ≥1 month \\nand one at age ≥4 months, or 2 negative HIV antibody tests from separate specimens \\nobtained at age ≥6 months \\n\\uf0b7 \\nSome experts confirm the absence of HIV infection at 12 to 18 months of age in children \\nwith prior negative virological tests by performing an antibody test to document loss of \\nmaternal HIV antibodies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='41 \\n \\n\\uf0b7 \\nHealth care providers should routinely inquire about abstinence of breastfeeding and \\nemphasise HIV-infected mothers/caregivers on safer feeding options. \\n \\nTable 8 : Infant diagnosis among breastfed infants \\n \\nVirological assays for HIV infection should be performed on the following occasions  \\n \\n\\uf0b7 \\nAt birth (During the first 48 hours) \\n\\uf0b7 \\nAt 2 weeks of age.  \\n\\uf0b7 \\nVirologic diagnostic testing should be performed every 3 months during breastfeeding  \\n\\uf0b7 \\nAfter cessation of breastfeeding, irrespective of when breastfeeding ends, virologic \\ndiagnostic testing should be performed at 4 to 6 weeks, 3 months, and 6 months after \\ncessation. \\n \\nAntibody testing  \\n \\n.  \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and  18 months, or'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='.  \\n\\uf0b7 \\nHIV antibody testing for seroreversion should be checked at age 9 and  18 months, or \\nat a minimum of 8 weeks after cessation of breastfeeding, if this is later. \\n\\uf0b7 \\nEngagement in care should continue until this time.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='42 \\n \\nFigure 3: Early Infant diagnosis algorithm \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\na Virologic diagnostic testing should be performed every 3 months during breastfeeding \\nb Children with perinatal HIV exposure aged 18-24 months may have residual maternal HIV antibodies.   \\n   In such a case, confirmation should be based on nucleic acid test. \\nHIV-exposed newborn \\n(0-2 days) \\nInfant/child is infected \\nConduct NAT at 8 weeks or at \\nthe earliest opportunity \\nthereafter \\nConsider NAT \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nHIV unlikely unless \\nstill a breastfeeding \\nHIV antibody testing for \\nseroreversion should be checked \\nat age at 9 and  b18 months, or at a \\nminimum of 8 weeks after \\ncessation of breastfeeding \\nNegative \\nPositive  \\nPositive  \\nNegative'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='minimum of 8 weeks after \\ncessation of breastfeeding \\nNegative \\nPositive  \\nPositive  \\nNegative \\nNegative \\nInfant/child is infected \\nImmediately start \\nART Repeat NAT to \\nconfirm infection \\nConduct NAT at 4-6 months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='43 \\n \\n13.2 Managing indeterminate HIV test results in infants’ diagnosis \\n \\nDeclining mother-to-child transmission rates globally have led to concerns about false-positive \\nand indeterminate tests. People with indeterminate results need immediate repeat testing and \\nshould be managed according to the standard operating procedures. People with repeated \\nindeterminate results need a multidisciplinary team of health  care providers to support \\nretention, tracking and status resolution. ART programmes need to give priority to confirmatory \\ntesting of all positive test results using a new sample. Clinical monitoring and further testing \\nbased on the national infant testing schedule need to be done until a definitive HIV status is \\nestablished.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='44 \\n \\nFigure 4: Managing indeterminate test results: standard operating procedure \\n \\n \\n \\n \\n \\n                                                                  \\n \\n \\n \\n \\n \\n \\n \\n \\nEID sample no. 1  \\ntest no. 1 \\nEID sample no. 1   \\n test no. 2 \\nRequest a new \\nsample within \\n4 weeks \\n          POSITIVE  \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\n          Positive \\nManage in accordance with \\ncurrent guidance \\n          Negative \\nManage in accordance with \\ncurrent guidance \\nINDETERMINATE \\nFurther review by a \\nclinical and \\nlaboratory team'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content=\"45 \\n \\n14.  Antiretroviral drug dosing recommendations for \\nnewborns \\n \\nAll newborns who were exposed perinatally to HIV should receive postpartum antiretroviral \\n(ARV) drugs to reduce the risk of perinatal transmission of HIV . \\nNewborn ARV regimens should be started as soon as possible after birth, ideally within 6 hours, \\nwith doses appropriate for the infant's gestational age. \\nA newborn’s ARV regimen should be determined based on maternal and infant factors that \\ninfluence the risk of perinatal transmission of HIV  \\n \\nTable 9 : ART dosage for infants \\nDrug \\nDrug Doses by Gestational Age at Birth \\nCommon \\nside effects \\nZDV \\nWeight-Band Dosing for Newborns Aged ≥35 Weeks \\nGestation from Birth to 4 Weeks \\nWeight Band \\nVolume of ZDV 10 mg/mL \\nOral Syrup Twice Daily \\n2 to  < 3kg \\n1 mL\"),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Weight Band \\nVolume of ZDV 10 mg/mL \\nOral Syrup Twice Daily \\n2 to  < 3kg \\n1 mL \\n3 to <4 kg \\n1.5 mL \\n4 to < 5 kg \\n2 mL \\n \\n \\nAnaemia, \\nneutropenia  \\n \\n \\n \\n≥30 to <35 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 2 Weeks to 6 to 8 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >6 to 8 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; make this \\ndose increase only for infants with confirmed HIV \\ninfection.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='46 \\n \\n<30 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nZDV 2 mg/kg per dose orally twice daily \\nAge 4 to 8 to 10 Weeks \\n\\uf0b7 \\nZDV 3 mg/kg per dose orally twice daily \\nAge >8 to 10 Weeks \\n\\uf0b7 \\nZDV 12 mg/kg per dose orally twice daily; only make \\nthis dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n3TC \\n≥32 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\n3TC 2 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\n3TC 4 mg/kg per dose orally twice daily \\n \\nAnaemia, \\nneutropenia  \\n(much less \\ncommon than \\nwith AZT) \\nNVP \\n≥37 Weeks’ Gestation at Birth \\nBirth to Age 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\nRash and \\nliver'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='makes this dose increase for infants with confirmed HIV \\ninfection. \\n \\nRash and \\nliver \\ndysfunction – \\nrare in \\nneonates  \\n \\nStop NVP \\nafter 2/52, in \\nview of long \\nhalf-life, \\ncontinue other \\nPEP agents \\nfor full 4/52 \\n≥34 to <37 Weeks’ Gestation at Birth \\nBirth to Age 1 Week \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='47 \\n \\nAge 1 to 4 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >4 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmakes this dose increase for infants with confirmed HIV \\ninfection. \\n \\n \\n≥32 to <34 Weeks’ Gestation at Birth \\nBirth to Age 2 Weeks \\n\\uf0b7 \\nNVP 2 mg/kg per dose orally twice daily \\nAge 2 to 4 Weeks \\n\\uf0b7 \\nNVP 4 mg/kg per dose orally twice daily \\nAge 4 to 6 Weeks \\n\\uf0b7 \\nNVP 6 mg/kg per dose orally twice daily \\nAge >6 Weeks \\n\\uf0b7 \\nNVP 200 mg/m2 BSA per dose orally twice daily; only \\nmake this dose increase for infants with confirmed HIV \\ninfection.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='48 \\n \\n15. Co-trimoxazole prophylaxis \\n \\nPneumocystis pneumonia (PCP) prophylaxis ,  cotrimoxazole, should be initiated from age 4 \\nweeks in: \\n\\uf0b7 \\nAll HIV-infected infants.  \\n\\uf0b7 \\nInfants with an initial positive HIV DNA/RNA test result (and continued until HIV infection \\nhas been excluded). \\nAge Category \\nDose (Sulfamethoxazole/ trimethoprim) \\nInfants below 6 months or < 5 kg \\n100 mg /20 mg  \\nChildren 6 months–5 years or 5-15 kg \\n200 mg/40 mg \\nChildren 6–14 years old or 15–30 kg \\n400 mg/80 mg \\nover 14 years or >30 kg \\n800 mg/160 mg \\n \\nNote : Cotrimoxazole suspension contains 200 mg/40 mg per 5 ml of syrup. Single strength \\ntablets contain 400 mg/80 mg, double strength tablet twice that. It is possible to divide the tablets \\nfor children and infants.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='49 \\n \\n16. Infant feeding \\n \\nInfant feeding intentions need to be discussed  early in pregnancy so that appropriate \\ninformation and support can be provided. \\nFactors that increase the risk of HIV transmission via breast milk when women are not on ART \\ninclude:  \\n\\uf0b7 \\nDetectable HIV viral load.  \\n\\uf0b7 \\nAdvanced maternal HIV disease.  \\n\\uf0b7 \\nLonger duration of breastfeeding.  \\n\\uf0b7 \\nBreast and nipple infection/inflammation.  \\n\\uf0b7 \\nInfant mouth or gut infection/inflammation.  \\n\\uf0b7 \\nMixed feeding, in particular solid food given to infants less than 2 months of age \\n \\nThe safest option for infants born to women with HIV is formula feeding, as it eliminates post-\\nbirth HIV exposure risk Women who choose to breastfeed should be advised of the small on-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='birth HIV exposure risk Women who choose to breastfeed should be advised of the small on-\\ngoing risk of HIV transmission. They should be supported in their decision, if they maintain the \\nfollowing criteria. \\n\\uf0b7 \\nA fully suppressed HIV viral load (for as long a period as possible, but certainly during \\nthe last trimester of pregnancy).  \\n\\uf0b7 \\nA good adherence history.  \\n\\uf0b7 \\nStrong engagement with the perinatal MDT \\n\\uf0b7 \\nPrepared to attend for monthly clinic review and blood HIV viral load tests for themselves \\nand their infant during and for 2 months after stopping breastfeeding \\nWomen not breastfeeding their infants, should be offered cabergoline to suppress lactation.  \\nFormula milk is provided with the support of the NGO, National AIDS Foundation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='50 \\n \\n17. Contraception for women living with HIV \\n \\nFamily planning is a cornerstone of maternal and child health and a vital component of global \\nhealth initiatives. The integration of family planning and HIV services is essential for achieving \\nthe Sustainable Development Goals, particularly in reducing maternal mortality, unplanned \\npregnancies, and new pediatric HIV infections. By ensuring universal access to comprehensive \\nsexual and reproductive health services, including family planning, for all individuals living with \\nor affected by HIV, we can significantly improve health outcomes and promote social and \\neconomic well-being. \\n\\uf0b7 \\nContraceptive needs should be discussed with all women during antenatal period. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nContraceptive needs should be discussed with all women during antenatal period. \\n\\uf0b7 \\nUsing condoms alongside another method of contraception is recommended for dual \\nprotection against both pregnancy and the transmission of HIV.  \\n\\uf0b7 \\nThe choice of contraception will depend on individual health, potential drug interactions, \\nand personal preferences.  \\n\\uf0b7 \\nOvulation usually resumes at 6 weeks of postpartum but may occur earlier in non-\\nbreastfeeding women. A plan for contraception postnatally should have been discussed \\nin advance of delivery and revisited in the early postpartum period and at the 4- to 6-\\nweek follow-up.  \\n\\uf0b7 \\nWomen should be advised that it is possible to conceive before the first postnatal \\nmenses and therefore to use condoms, if necessary, until the postnatal review.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='menses and therefore to use condoms, if necessary, until the postnatal review. \\n\\uf0b7 \\nThey have options for oral contraceptive pills, injectables (e.g., Medroxy Progesterone \\nAcetate), implants (e.g.,  Jadelle), intrauterine devices (IUDs), and female sterilization. \\n\\uf0b7 \\nSome antiretroviral medications may interact with hormonal contraceptives potentially \\nreducing their effectiveness. Drug interactions between ART and hormonal \\ncontraceptives should be checked with the WHO Medical Eligibility Criteria .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='51 \\n \\nTable 10: Contraceptive methods  \\nNon-hormonal methods \\n \\n\\uf0b7 \\nMale condom \\n\\uf0b7 \\nFemale condom \\n\\uf0b7 \\nIntrauterine device (IUD) \\n\\uf0b7 \\nFemale sterilization \\nHormonal methods \\n \\n\\uf0b7 \\nIntrauterine system (IUS) \\n\\uf0b7 \\nInjection - Depo  Medroxy Progesterone \\nAcetate  is the most common version, and it \\nshould be taken every twelve weeks. \\n\\uf0b7 \\nCombined pill - Contains the hormones \\noestrogen and progestogen. \\n\\uf0b7 \\nImplant - Small flexible rods that are inserted \\nunder the skin, and releases progestogen for up \\nto three years or five years depending on the \\nbrand.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Table 11: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception \\n(Contraceptive methods: CHC, combined hormonal contraception; Cu-IUD, copper intrauterine device; DMPA, progestogen-only injectable: \\ndepot medroxyprogesterone acetate; ENG-IMP, etonogestrel implant; LNG-IUD, levonorgestrel-releasing intrauterine system; POP, \\nprogestogen-only pill) \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD Cu-IUD \\nNucleoside/nucleotide reverse \\ntranscriptase inhibitors (NRTIs)  \\n \\nAbacavir (ABC) Emtricitabine \\n(FTC) Lamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide (TAF) \\nZidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\n \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Non-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\nX \\n✓ \\n✓ \\n✓ \\nContraceptive effectiveness could be reduced. Use not advised. \\nRecommend an No need for extra precautions. alternative effective method \\n \\nEtravirine (ETR) \\nNevirapine (NVP \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential weak interaction but not expected to affect contraceptive effectiveness. To err on the side \\nof caution, recommend an alternative effective method or advise additional condoms use \\nDoravirine (DOR) \\nRilpivirine (RPV \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\nRilpivirine (RPV) \\n✓ \\n✓ \\n✓ \\n✓ \\n✓ \\n✓'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='53 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nBoosted protease inhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat (ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n? \\n \\n \\n \\n \\n? \\n \\n \\n? \\n \\n              \\n              ✓ \\n \\n         ✓ \\n \\n             ✓ \\n\\uf0b7 Interaction that could \\nincrease progestogen \\nexposure but not expected to \\naffect contraceptive \\neffectiveness. \\n\\uf0b7 In case of PIs boosted with \\ncobicistat, recommend an \\nalternative effective method \\nor use with caution due to \\nincreased ethinylestradiol \\nexposure \\n\\uf0b7 Potential weak interaction that could increase progestogen \\nexposure but not expected to affect contraceptive \\neffectiveness. \\nNo need for extra precautions \\nIntegrase strand transfer'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='effectiveness. \\nNo need for extra precautions \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) Dolutegravir \\n(DTG) Bictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nBoosted INSTIs \\nElvitegravir/ cobicistat (EVG/c) \\n \\n \\n? \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nPotential interaction causing \\ndecreased ethinylestradiol \\nexposure. Should not be given \\nwith a low dose (ie, 20\\uf06dg \\nethinylestradiol) combined oral \\ncontraceptive \\nNo expected effect on contraceptive effectiveness. No need for \\nextra precautions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='54 \\n \\nART Class \\n \\nCHC \\nPOP \\nENG-IMP \\nDMPA \\nLNG-IUD \\nCu-IUD \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\n✓ \\nNo expected effect on contraceptive effectiveness. No need for extra precautions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Table 12: ART and emergency contraception (EC) \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nNucleoside/nucleotide \\nreverse transcriptase \\ninhibitors (NRTIs)  \\n \\nAbacavir (ABC) \\nEmtricitabine (FTC) \\nLamivudine (3TC) Tenofovir \\ndisoproxil fumarate (TDF) \\nTenofovir alafenamide \\n(TAF) Zidovudine (AZT) \\n \\n✓ \\n✓ \\n✓ \\n \\nNo effect on EC effectiveness. \\nNon-nucleoside reverse \\ntranscriptase inhibitors \\n(NNRTIs) \\n \\nEfavirenz (EFV) \\n \\n \\n? \\n \\n \\n? \\n \\n \\nThe effectiveness \\nof EC could be \\nreduced. Offer a \\nCu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC. \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nThe effectiveness of \\nEC could be \\nreduced. Offer a Cu-\\nIUD if appropriate. \\nDouble dose UPA-\\nEC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\nEtravirine (ETR) \\nNevirapine (NVP \\n? \\n \\n? \\n? \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. If Cu-\\nIUD not appropriate \\nor not acceptable, \\noffer double dose \\nLNG-EC \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nEffectiveness of EC \\ncould be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='could be reduced. \\nOffer a Cu-IUD if \\nappropriate. Double \\ndose UPA-EC is not \\nrecommended. The \\neffectiveness of \\nUPAEC compared to \\ndouble dose LNG-\\nEC is not known \\n \\nDoravirine (DOR) \\nRilpivirine (RPV \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='56 \\n \\nART  Class \\n \\nLNG-EC \\nUPA-EC \\nCu-IUD \\nBoosted protease \\ninhibitors \\n \\nAtazanavir/ritonavir (ATV/r) \\nDarunavir/ritonavir (DRV/r) \\nLopinavir/ritonavir (LPV/r) \\nAtazanavir/cobicistat \\n(ATV/c)* \\nDarunavir/cobicistat (DRV/c \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nIntegrase strand transfer \\ninhibitors (INSTIs) \\n \\nRaltegravir (RAL) \\nDolutegravir (DTG) \\nBictegravir (BIC) \\nCabotegravir CAB) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nBoosted INSTIs \\nElvitegravir/ cobicistat \\n(EVG/c) \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\nNo effect on EC effectiveness. \\nFusion inhibitors \\nEnfuvirtide (ENF) \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\n \\n✓ \\n \\n✓ \\n \\n✓'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='✓ \\n \\nNo effect on EC effectiveness. \\nCCR5 antagonists \\nMaraviroc (MVC) \\n \\n \\n \\n \\n \\n✓ \\n \\n✓ \\n \\n✓ \\n \\nNo effect on EC effectiveness.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='57 \\n \\n19. Immunization \\n \\nInfants born to HIV-positive mothers should follow the routine national primary immunization. \\nTable 13:  Immunization Schedule \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n0-4 weeks \\nBCG \\nHIV infected infants \\nshould not receive \\nBCG vaccine. BCG \\nshould be avoided till \\nHIV is excluded in \\nHIV exposed infants \\n \\n \\nOn completion of  \\n \\n \\n \\n2 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(1st dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(1st dose) \\nWhen Inactivated \\nPolio vaccine is not \\navailable giving OPV \\ncan be considered \\nwhen the child is not \\nseverely immune \\nsuppressed \\n \\n4 months \\nOPV & Pentavalent \\n(DPT-Hep B-Hib) \\n(2nd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(2nd dose) \\n \\n \\n6 months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='(2nd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib)  \\n(2nd dose) \\n \\n \\n6 months \\nOPV & Pentavalent \\n(DPT -Hep B-Hib) \\n(3rd dose) \\nInactivated Polio \\nvaccine + \\nPentavalent (DPT-\\nHep B-Hib) \\n(3rd dose) \\n \\n \\n9th month \\nMMR \\nMMR \\n MMR-   should be \\npostponed in severe \\nimmune deficiency \\n \\n12th month \\nLive JE \\nInactivated JE \\nvaccine,  \\nHep A 1st dose (2nd \\ndose in 6-12 months) \\nIf using live attenuated \\nshould not be given to \\nseverely immune \\ncompromised children \\nHep A- patients with \\nsevere \\nimmunosuppression \\nmay have a \\nsuboptimal response \\n \\n13-15 months \\n \\nVaricella -2 doses 3 \\nmonths apart \\nPatients who are \\nseverely'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='58 \\n \\nimmunosuppressed \\nshould not receive the  \\nvaccine. \\n \\n18th month \\nOPV & DTP (4th \\ndose) \\nInactivated Polio \\nvaccine +DTP \\n \\n \\nAge \\nStandard schedule \\nInfant with HIV \\nRemarks \\n \\n3rd year \\nMMR 2nd dose \\nMMR 2nd dose \\n \\n \\n5 years \\nOPV+DT \\nInactivated polio+DT \\n \\n \\n12 years \\naTd \\naTd \\n \\n \\n12-13 years \\n(females, males) \\n \\nHPV (Gardasil) \\n2 doses \\n(0, 6 months)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='59 \\n \\n20. References \\n \\n1. British HIV Association guidelines for the management of HIV in pregnancy and \\npostpartum 2018 (2020 third interim update) \\n2. A Guide to Antiretroviral Treatment; 4th Edition, National; STD/AIDS Control \\nProgramme 2020 \\n3. Guidelines for HIV post-exposure prophylaxis (WHO 2024) \\n4. HIV  diagnosis and ARV  use in HIV -exposed infants: a programmatic update             \\n(WHO) July 2018 \\n5. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually \\ntransmitted infections for the period 2022-2030.(WHO 2022) \\n6. Https://www.who.int/tools/elena/interventions/hiv-infant-feeding \\n7. Https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-\\ntransmission-hiv'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='7. Https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-\\ntransmission-hiv \\n8. Https://npin.cdc.gov/publication/recommendations-use-antiretroviral-drugs-pregnant-\\nhiv-1-infected-women-maternal-health \\n9. Https://www.cdc.gov/pregnancy-hiv-std-tb-hepatitis/about/index.html \\n10. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and \\nmonitoring: recommendations for a public health approach July 2021. \\n11. Pre-Exposure prophylaxis for the prevention of HIV infection in Sri Lanka: A clinical \\npractice guideline; 2023. \\n12. Https://www.who.int/news/item/29-08-2019-who-revises-recommendations-on-\\nhormonal-contraceptive-use-for-women-at-high-hiv-risk. \\n13. Clinical Guidance:  Drug Interactions Between  HIV Antiretroviral Therapy (ART)  and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='13. Clinical Guidance:  Drug Interactions Between  HIV Antiretroviral Therapy (ART)  and \\nContraception; February 2023 | FSRH. \\n14. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral \\ntherapy July 2017 \\n15. HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update July \\n2018 \\n16. https://clinicalinfo.hiv.gov/en/guidelines/perinatal/pre-exposure-prophylaxis-prep-\\nprevent-hiv \\n17. Antiviral management new borns with perinatal HIV exposure or HIV infection \\nupdated January 31st, 2023.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='60 \\n \\n21. Annexures'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='61 \\n \\n \\nAnnexure 1 : General circular letter No. 01-51/2016 - English'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='62'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='63'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='64 \\n \\nAnnexure 2 : General circular letter No. 01-51/2016 - Tamil'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='65'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='66 \\n \\nAnnexure 3 : General circular letter No. 01-51/2016- Sinhala'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='67'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='68'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='69 \\n \\nAnnexure 4 : Standard of care - PMTCT of syphilis and HIV \\nAnnexure 2: Standard of care - PMTCT of syphilis and HIV \\n \\nStandard of care in prevention of mother to child transmission of \\nSyphilis and HIV \\n \\n \\nStandard \\nAll pregnant women should be screened for syphilis and HIV at the first antenatal visit \\nwithin the first trimester. At delivery, women who do not have test results should be tested. \\nWomen  with  positive  syphilis  or  HIV  test  results  should  be  managed  according  to  the \\nnational guidelines. Their partners should also be screened and managed and plans should be \\nmade to screen and manage their infants at birth. \\n \\nAim \\nTo reduce maternal morbidity and mortality, fetal loss and neonatal mortality and morbidity \\ndue to syphilis and HIV \\n \\nRequirements \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='due to syphilis and HIV \\n \\nRequirements \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and care in \\npregnant women are available and are correctly implemented. \\n\\uf0b7 \\nAll women have access to appropriate ANC care during pregnancy, childbirth and the \\npostpartum period. \\n\\uf0b7 \\nHealth  care  providers  are  competent  in  syphilis  and  HIV  prevention,  screening during  \\npregnancy,  ,  counseling  on  STI prevention,    how  to  prevent  re-infection during pregnancy \\nand referral for management of seropositive pregnant women and their partners, \\nprophylaxis and management of the newborn \\n\\uf0b7 \\nSuitable Screening methods for syphilis and HIV are available in antenatal clinics and \\nmaternity wards. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='maternity wards. \\n\\uf0b7 \\nAdequate Laboratory facilities (at least one per district) for testing of syphilis and \\n\\uf0b7 \\nHIV with system to ensure quality of laboratory testing are available. \\n\\uf0b7 \\nNecessary supplies for collection and transport of samples are available at the ANC clinic \\nand Supplies for testing of syphilis and HIV are available at the laboratory level. \\n\\uf0b7 \\nDrugs (penicillin, ART etc) are available in the STD clinics and maternity wards where relevant. \\n\\uf0b7 \\nA functioning referral system is available to ensure the management of pregnant women \\nwho are identified as having syphilis or HIV \\n\\uf0b7 \\nAn effective information system is available to monitor the programme. \\n\\uf0b7 \\nHealth education activities are carried out to raise the awareness of individuals, families and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nHealth education activities are carried out to raise the awareness of individuals, families and \\ncommunities of the importance of attending ANC clinics early in pregnancy and syphilis and \\nHIV prevention and management. \\n \\nApplying the standard \\nProviders of maternal and neonatal health care, in particular public health staff must: \\n\\uf0b7 \\nScreen all pregnant women for syphilis and HIV at the first antenatal visit. Screening \\nshould be done preferably before 12 weeks of gestation to prevent congenital infection. \\n\\uf0b7 \\nReview  syphilis  and  HIV  test  results  at  subsequent  visits.  All  the  women  with \\npositive screening test need to be referred to STD clinic for further management. \\n\\uf0b7 \\nIf a woman was not tested during pregnancy, syphilis and HIV screening should be'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='\\uf0b7 \\nIf a woman was not tested during pregnancy, syphilis and HIV screening should be \\noffered after delivery.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='70 \\n \\n\\uf0b7 \\nManage  all  women  who  are  seroreactive  for  syphilis  according  to  the  stage  of \\nsyphilis following national guidelines at the STD clinic. \\n\\uf0b7 \\nManage all women with positive HIV test according to the national guidelines to \\nprevent mother to child transmission of HIV \\n\\uf0b7 \\nDiscuss with the woman the importance of treatment for herself, her partner(s) and the \\nbaby, explain the consequences of not treating the infection, and discuss the necessity \\nof condom use during treatment. \\n\\uf0b7 \\nMake plans to manage the baby at birth. \\n\\uf0b7 \\nAdvise women who test positive that their partner(s) must also be screened and \\nmanaged according to the stage of syphilis. The babies also need to be screened as soon \\nas possible after birth. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='as possible after birth. \\n\\uf0b7 \\nAdvise women and partners who test negative how to remain negative. \\n\\uf0b7 \\nScreen all women with adverse pregnancy outcome (abortion, stillbirth, syphilitic \\ninfant, etc.) for syphilis and HIV, if not screened. \\n\\uf0b7 \\nScreen all women with syphilis or HIV for other STIs, and provide counseling and \\nmanagement accordingly. \\n\\uf0b7 \\nRecord test results and if positive for syphilis or HIV details of management, in the \\nclinic and pregnancy records. \\n\\uf0b7 \\nMaintain the confidentiality of the information regarding the patients. \\n \\nAudit \\n \\nInput indicators \\n\\uf0b7 \\nNational policies and guidelines on syphilis and HIV prevention, management and \\ncare in pregnant women are available and are correctly implemented. \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='care in pregnant women are available and are correctly implemented. \\n\\uf0b7 \\nThe  proportion  of  health  facilities  providing  ANC  services  that  have  screening \\nfacilities for syphilis and HIV. \\n \\nProcess and output indicators \\n\\uf0b7 \\nCoverage of syphilis screening in pregnant women \\n\\uf0b7 \\nCoverage of HIV screening in pregnant women \\n\\uf0b7 \\nCoverage of correct management of syphilis in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of correct management of HIV in pregnant women at the STD clinic \\n\\uf0b7 \\nCoverage of partners tested and managed accordingly \\n\\uf0b7 \\nCoverage  of  babies  born  to  syphilis  positive  mothers  who  received  appropriate \\ntreatment. \\n\\uf0b7 \\nCoverage of babies born to HIV positive mothers who received prophylactic ARV \\ntreatment \\nOutcome/ Impact indicators \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='treatment \\nOutcome/ Impact indicators \\n\\uf0b7 \\nIncidence of congenital syphilis \\n\\uf0b7 \\nIncidence of HIV among infants \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to congenital syphilis. \\n\\uf0b7 \\nPerinatal and neonatal mortality and morbidity due to paediatric  HIV \\n\\uf0b7 \\nStillbirth rate.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='71 \\n \\nAnnexure 5 : Guideline to collect blood samples for VDRL and HIV \\n \\nN'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='72 \\n \\nAnnexure 6 : Blood Collection request form \\nNational STD/AIDS Control Programme,  \\nMINISTRY OF HEALTH. \\n \\nREQUEST FORM FOR SYPHILIS/HIV TESTING IN ANTENATAL MOTHERS. \\nInstitution/clinic \\n……………………………………………….. \\nMOH area \\n……………………………………………….. \\n \\nDate of sample collection \\n……………………………………………….. \\n \\n \\n \\n \\nNSACP/ANC/14/V/2 \\n \\nPatient No \\n(ANC) \\nAge \\nParity. \\nPOA \\nHIV \\nResults \\nVDRL \\nResults \\n \\n……………………………………… \\n…………………………………. \\n…………………………….. \\nName of collecting officer \\n…………………………………….. \\nDesignation \\n…………………………………. \\nSignature. \\n…………………….. \\nName of Medical officer \\nDesignation \\nSignature \\nLab use only . \\n \\nDate/Time of receipt of samples:………………………… \\n…………………..am/pm \\nMLT:………………………. \\nMedical officer STD/Lab:……………………….. \\nDate ……………………… \\n Date  ………………………………………………..'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='Annexure 7 : EMTCT HIV Case Investigation form \\n \\n \\nEMTCT HIV: Case Investigation Form                                                                   \\nNational STD/AIDS Control Programme, Ministry of Health \\n \\nName of the STD clinic:_______________________       Pregnant Woman’s file number & PHN No: ___________________   \\nBaby’s file number & PHN No: _________________       Pregnant Woman’s HIV clinic registration date:_______________  \\nFilled by(name & designation): _________________      Pregnant Woman referred from:________________________ \\nNote: Fill this form for all HIV confirmed pregnant women registered in the clinic \\n                                                     Details of the pregnant woman with HIV \\n  1.   Age in years \\n \\n  2.   District of residence'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='1.   Age in years \\n \\n  2.   District of residence \\n \\n  3.   Nationality \\n1. \\nSri Lankan  2. Foreign (country:________________) \\n  4.   Ethnicity \\n \\n  5.   Risk & vulnerability factors (e.g. FSW, DU, \\n        Psychosocial etc) \\n \\n  6.   KP Status   \\n \\n  7.   Parity \\n \\n8.  Past obstetric history \\n \\n  9.   Date of HIV confirmation \\n \\nDetails of the current pregnancy \\n10.   LRMP \\n \\n11.   EDD \\n \\n12.   POA at ANC registration \\n \\n13.   POA when registering for EMTCT  \\n         services \\n \\n14.   1st CD4 count during this  \\n         pregnancy(Result & date) \\n \\n15.   1st VL during this pregnancy \\n         (Result & date) \\n \\n \\n16.   Other relevant diagnoses  \\n         (*TB/Syphilis/Other) \\n \\n17.   Date of ART initiation \\n \\n18.   ART regimen during this pregnancy \\n19.   Adherence (>95%, 80-95%,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='18.   ART regimen during this pregnancy \\n19.   Adherence (>95%, 80-95%,  \\n         <80%) \\n \\n20.   CD4 count at third trimester \\n \\n21.   Viral load closest to 36 \\n         Weeks of POA \\n \\n22.   Number of ANC visits \\n \\n23.   Post-partum family planning method \\n \\n                                                                              Details of the sexual partner/s \\n24.   Partner’s HIV status \\n \\n25.   File no.(STD or HIV) & PHN No. \\n \\n26.  Partner’s ART regimen \\n \\n27.  Partner’s KP status \\n \\n                                                                     Details of the baby \\n28.   Date of birth \\n \\n29.   Facility/Place of birth \\n \\n30.   Mode of delivery \\n         If LSCS – Em/El \\n         Indication \\n \\n31.   Gestational age at \\n         delivery \\n \\n32.   Birth weight'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='31.   Gestational age at \\n         delivery \\n \\n32.   Birth weight \\n           \\n \\n33.   Infant feeding (exclusive  \\n         formula/breastfeeding) \\n \\n34.    ARV prophylaxis  \\n(Type/dose/duration) \\n \\n35.   DNA PCR at birth (date & result) \\n \\n36.   DNA PCR at 8 weeks \\n \\nDate \\n \\n37.   DNA PCR at 16 weeks \\n \\nDate \\n \\n38.   HIV ELISA around 18 months \\n \\nDate \\n \\n39.   Final diagnosis \\n \\n40.   If miscarriage – Date & POA of miscarriage \\nRemarks'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='74 \\n \\n Annexure 8 : Pregnancy record'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='75 \\n \\nAnnexure 9 : Poster  for EMTCT of HIV'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\Guidelines_for_management_of_pregnant_women_with_HIV_infection_2024.pdf'}, page_content='76 \\n \\nAnnexure 10 : Leaflet for pregnant women on service package'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='NATIONAL GUIDELINES FOR\\nMATERNAL CARE\\nVOLUME I\\nMINISTRY OF HEALTH\\n2013\\n• Management of Labour\\n• Management of Hypertension, Pre Eclampsia \\nand Eclampsia in Pregnancy\\n• Management of Diabetes During Pregnancy\\n• Management of Post-Partum Haemorrhage\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='NATIONAL GUIDELINE FOR MATERNAL CARE\\nVOLUME I\\n• \\nManagement of Labour\\n \\n \\nNormal Labour \\n \\n \\nInduction of Labour\\n \\n \\nUse of Oxytocins in Induction and Augmentation\\n \\n \\nFoetal Monitoring in Labour\\n \\n \\nPain Relief\\n \\n \\nAcute Inversion of Uterus\\n• \\nManagement of Hypertension, Pre Eclampsia and \\nEclampsia in Pregnancy\\n• \\nManagement of Diabetes in Pregnancy\\n• \\nManagement of Post-Partum Haemorrhage\\nMINISTRY OF HEALTH\\n2013\\nWorld Health\\nOrganization\\nFamily Health Bureau'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nii\\nThese guidelines are published by the Family Health Bureau, Ministry of \\nHealth, 231, De Saram Place, Colombo 10, Sri Lanka.\\nWeb: www.familyhealth.gov.lk\\nPrepared by Sri Lanka College of Obstetrians and Gynaecologists\\nEdited By Dr. Nilmini Hemachnadra, Consultant Community Physician, \\nFamily Health Bureau & Prof. Hemantha Senanayake, President, Sri Lan-\\nka College of Obstetricians & Gynaecologists.\\nCopyright@2013 Ministry of Health\\nISBN 978 - 955 - 1503 - 15 - 4\\nStatement of Intent\\nThe main purpose of these guidelines are to improve the quality of \\nclinical care provided by the health care providers at all levels. These \\nparameters of practice should be considered recommendations'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='parameters of practice should be considered recommendations \\nonly. The ultimate judgement regarding a particular clinical \\nprocedure or a treatment plan must be made by the clinician in \\nlight of the clinical data gathered from the patient and the diagnosis \\nand treatment options available.\\nPrinted by Lazergraphic (PVT) Ltd.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\niii\\nForeword from the Secretary to the Ministry of Health\\nAs a country with a mainly government owned health system, maintenance \\nof the uniformity of practices is essential to avoid incurring unnecessary \\nexpenditure. Incorporation and practice of evidence based cost effective \\ninterventions in maternal care will ensure further improvement of the \\nmaternal care indicators.  \\nThe availability and use of guidelines will ensure the quality of the care \\nprovided at each level and facilitate the care provision of practicing \\nclinicians for better care. The Ministry of Health having achieved a \\nsatisfactory level in the coverage of services and geared to improve it \\nfurther, is currently moving towards improving the quality of services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='further, is currently moving towards improving the quality of services \\nprovided. With this view, most of the institutions are now implementing \\nquality improvement programmes.\\nTherefore, this set of guidelines will assist such programmes and auditing \\nsystems in the maternal care such as maternal mortality reviews, \\nconfidential inquiry into maternal deaths, near-miss inquiries and \\nensure a more objective assessment. These guidelines should be link with \\nthe quality standards and the implementation at each level needs to be \\nensured.\\nSri Lanka College of Obstetricians and Gynaecologists has managed to in \\nco-operate the currently available best scientific evidence and the practical \\nexperience of a large number of experts into these guidelines.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='experience of a large number of experts into these guidelines.\\nI wish all the healthcare providers would make maximum use of these \\nguidelines and contribute to the further improvement of the maternal care \\nin our country.\\nDr. Y.D. Nihal Jayathilake\\nSecretary,\\nMinistry of Health,\\nSri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\niv'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nv\\nPreface\\nThis national guideline on maternal care is very well-timed, as a greater \\nemphasis is being given for improving the quality of maternal and \\nnewborn care services for further reduction of maternal and newborn \\nmortality and morbidity in Sri Lanka. This set of guidelines includes \\nthe revised versions of some guidelines published in 2007 under HSDP \\nPhase I and newly developed guidelines. This is an attempt to improve the \\nquality and uniformity of clinical care with efficiency, cost effectiveness \\nand accountability.\\nI highly appreciate the contribution made by the Sri Lanka College of \\nObstetricians and Gynaecologists in developing these guidelines. Their'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Obstetricians and Gynaecologists in developing these guidelines. Their \\nexperience and updated scientific knowledge is reflected in the guidelines. \\nFurther, these guidelines have been developed considering the policies, \\nfacilities and resources available in the country. As such this set of \\nguidelines will be considered as national guidelines for the conditions \\ndescribed.  \\nDr. P. G. Mahipala\\nDirector General of Health Services,\\nMinistry of Health,\\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nvi\\nMessage from the president of Sri Lanka College of \\nObstetricians\\nIt is with a great sense of achievement that I issue this statement for the \\nSri Lanka National Guidelines in obstetrics. There is evidence that the \\nintroduction of guideline-based practice will reduce maternal mortality. \\nWe hope that this effect will be duplicated in Sri Lanka.\\nI must compliment the Guideline Development Group of our College. \\nThis document is testimony to their hard work and their commitment to \\nimproving the quality of care delivered to our women. The group consisted \\nof obstetricians from varying seniority and from hospitals representing \\nall categories of specialist units in the country. We were therefore able to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='all categories of specialist units in the country. We were therefore able to \\ndevelop our guidelines taking into considerations the ground realities in \\nSri Lanka. I was heartened by the maturity shown by the younger members, \\nwho contributed immensely to the many points that were debated while \\nthese were being developed. We have used the latest available evidence \\nand taken into account what would be feasible in a Sri Lankan Unit. For \\nwhat we have recommended as improvements to the existing practice we \\nhave had agreement from the Ministry of Health to procure these. \\nI wish also to acknowledge our general membership who contributed to \\nthese guidelines via email and at a meeting where their views were sought.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='these guidelines via email and at a meeting where their views were sought. \\nIt is always a challenge to produce guidelines that will be put into use in \\neveryday practice and it is probable we have achieved this primary goal by \\nhaving a broad based input. \\nThe World Health Organization and the UNFPA supported this activity. \\nDr. Nilmini Hemachandra of the Family Health Bureau helped get the \\nfinal product into a form that was easily understood by the non-specialist. \\nWe are grateful for the advice given by Obstetric Anaesthetists Drs. Saroja'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nvii\\nJayasinghe and Ramani Pallemulla. The guideline on diabetes mellitus \\ncomplicating pregnancy had major inputs from the Nirogi Matha project \\nand many endocrinologists. \\nTo conclude I wish to restate my wish and fervent hope that these \\nguidelines will help save the lives of many Sri Lankan mothers. \\nProf. Hemantha Senanayake\\nPresident,\\nSri Lanka College of Obstetricians & Gynaecologists'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nviii\\nGuideline Development Committee\\nDr. Asoka Weerakkody (Chairman)\\nProf. Hemantha Senanayake\\nProf. Malik Goonawardena\\nDr. Ananda Ranatunga\\nDr.UDP Ratnasiri\\nDr. Sunil Fernando\\nDr. Harsha Atapattu\\nDr. Mangala Dissanayake\\nDr. Chandina Wedamistri\\nDr. Jeevan Marasinghe\\nDr. Tiran Dias\\nDr. Asanka Jayawardena'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nix\\nContent page \\n \\n \\n \\n \\nPage\\n \\nMessage from the Secretary of Ministry of Health \\niii\\n \\nPreface \\n \\nv\\n \\nMessage from the President of the Sri Lanka College of \\n \\nObstetricians and Gynecologists \\nvi \\n \\nGuideline Development Committee \\nviii\\n \\nList of Abbreviations \\nxiii\\n \\nList of Tables \\nxiv\\n \\nDisclaimer \\nxv\\n \\nIntroduction \\nxvi\\n A\\t\\nManagement of Labour\\t\\n3\\n1. \\nIntroduction \\n3\\n2. \\nDiagnosis of labour \\n3\\n3. \\nManagement of Labour \\n4\\n3.1 \\nGeneral considerations \\n4\\n3.1.1 \\nCommunication between women and healthcare  \\n  \\nprofessionals/workers \\n4\\n3.1.2 \\nPreparation of mothers to transfer to labour room \\n4\\n3.1.3 \\nDocumentation \\n5\\n3.1.4  \\nMobilization and Positioning \\n5\\n3.1.6 \\nHygiene during labour \\n5\\n3.1.7 \\nPain relief in labour \\n6\\n3.2.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='5\\n3.1.6 \\nHygiene during labour \\n5\\n3.1.7 \\nPain relief in labour \\n6\\n3.2. \\nManagement of the three stages of labour \\n6\\n3.2.1.  \\nManagement of the first stage of labour \\n6\\n3.2.1.1 \\nLatent phase  \\n6\\n3.2.1.2 \\nActive phase \\n7\\n3.2.1.2a.  Admitting women to the Labour room \\n7\\n3.2.1.2b.  Management of active phase of first stage \\n8\\n3.2.1.3.  \\nDelayed progress of first stage of labour \\n9\\n3.2.2.  \\nManagement of second stage of labour \\n10\\n3.2.2.1.  \\nPassive second stage of labour (descent phase) \\n10\\n3.2.2.2.  \\nActive second stage of labour (expulsive phase) \\n11\\n3.2.2.3.  \\nObservations for women and babies in the second stage of labour \\n12\\n3.2.2.4.  \\nWomen’s position and pushing in the second stage of labour \\n12\\n3.2.2.5.  \\nIntrapartum interventions to reduce perineal trauma \\n13\\n3.2.2.6.  \\nDelivery \\n13'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='12\\n3.2.2.5.  \\nIntrapartum interventions to reduce perineal trauma \\n13\\n3.2.2.6.  \\nDelivery \\n13\\n3.2.3 \\nThird stage of Labour \\n14\\n3.2.3.1 \\nActive management of third stage of labour \\n14\\n3.2.3.2 \\nDelayed third stage \\n15\\n4 \\nCare for the newborn baby \\n15\\n5 \\nPerineal care \\n17'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nx\\n B\\t\\nGuideline on Induction of Labour \\n19\\n1 \\nIntroduction \\n19\\n2 \\nDefinition \\n19\\n3 \\nGeneral Principles \\n19\\n4 \\nIndications \\n19\\n4.1 \\nOtherwise uncomplicated pregnancy continuing \\n  \\nbeyond 40 weeks \\n19\\n4.2 \\nPre labour rupture of membranes at term \\n20\\n4.3 \\nPreterm prelabour rupture of membranes (PPROM) \\n20\\n4.4   \\nIntrauterine death \\n20\\n4.5   \\nHistory of precipitate labour \\n20\\n4.6   \\nSuspected macrosomia \\n20\\n4.7   \\nFetal growth restriction \\n21\\n4.8   \\nOlder mothers \\n21\\n5 \\nInduction under specific circumstances \\n21\\n5.1   \\nBreech presentation \\n21\\n5.2 \\nPrevious CS \\n21\\n6.   \\nMethods of induction \\n21\\n6.1 \\nMechanical \\n21\\n6.2   \\nSurgical \\n22\\n6.3   \\nPharmacological \\n22\\n6.3.1   \\nOxytocin \\n22\\n6.3.2 \\nProstaglandins \\n22\\n6.3.3 \\nMifepristone \\n23\\n7.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Pharmacological \\n22\\n6.3.1   \\nOxytocin \\n22\\n6.3.2 \\nProstaglandins \\n22\\n6.3.3 \\nMifepristone \\n23\\n7.   \\nComplications \\n24\\n7.1 \\nHyperstimulation \\n24\\n7.2 \\nCord prolapse \\n24\\n7.3 \\nUterine rupture \\n25\\n7.4 \\nFailed induction \\n25\\n C\\t\\nGuideline for Use of Oxytocin for Induction and Augmentation \\n\\t\\nof labour\\t \\t\\n27\\n D\\t\\nGuideline on fetal monitoring in labour\\t\\n30\\n\\t\\n E\\t\\nGuideline on Pain Relief in Labour \\n34\\n1 \\nMethods of pain relief in labour \\n34\\n1.1 \\nNon-pharmacological methods of pain relief \\n35\\n1.2 \\nPharmacological methods of pain relief in labour \\n35\\n1.2.1 \\nOral paracetamol/paracetamol& codeine compound \\n35\\n1.2.2 \\nOpioids \\n35\\n1.2.2.A. \\nPethidine \\n35\\n1.2.2.B. \\nMorphine \\n36\\n1.2.2.C. \\nFentanyl \\n36\\n1.2.3 \\nInhalational analgesia – Entonox \\n36\\n1.2.4 \\nRegional Anaesthesia \\n37'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxi\\n F\\t\\nGuidelines to maintain the partograph\\t\\n39\\n\\t\\n G\\t\\nGuideline on acute puerperal inversion of the uterus \\n41\\n1 \\nIntroduction \\n41\\n2 \\nDefinition \\n41\\n3 \\nPrevention \\n41\\n4 \\nPathophysiology (and clinical correlation) \\n41\\n5 \\nClassification \\n42\\n6 \\nClinical Presentation and diagnosis \\n42\\n7 \\nManagement \\n43\\n7.1 \\nGeneral measures \\n43\\n7.2 \\nRepositioning the uterus \\n43\\n7.2.1 \\nManual replacement of uterus \\n43\\n7.2.2 \\nHydrostatc reduction \\n44\\n7.2.3 \\nTocolytics \\n45\\n7.2.4 \\nGeneral Anaesthesia \\n45\\n7.2.5 \\nSurgical methods \\n45\\n8 \\nDebriefing \\n46\\n H\\t\\nManagement of Hypertensive Disease in Pregnancy \\n47\\n1 \\nIntroduction \\n49\\n2 \\nDefinitions \\n49\\n3 \\nScreening for Hypertension during pregnancy \\n50\\n4 \\nPrevention of hypertensive disorders in pregnancy \\n50\\n5'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='50\\n4 \\nPrevention of hypertensive disorders in pregnancy \\n50\\n5 \\nManagement of Chronic Hypertension  \\n51\\n6 \\nManagement of severe pre eclampsia \\n52\\n6.1 \\nGeneral Considerations \\n52\\n6.2 \\nSpecific Management \\n52\\n6.2.1 \\nAnti-hypertensive drugs \\n53\\n6.2.1.1 \\nLabetalol orally or intravenously \\n53\\n6.2.1.2 \\nHydralazine intravenously \\n54\\n6.2.1.3 \\nOral Nifedipine \\n55\\n6.2.2 \\nPrevention of convulsions \\n55\\n6.2.3 \\nFluid Balance \\n56\\n6.2.4 \\nIn utero/neonatal transfer \\n56\\n6.2.5 \\nDelivery \\n57\\n6.2.6 \\nPost-delivery \\n57\\n6.2.7 \\nFollow up \\n58\\n \\n I\\t\\nManagement of Eclampsia \\n59\\n1 \\nDefinition \\n59\\n2 \\nDiagnosis \\n59\\n3 \\nTime of onset of eclampsia \\n59\\n4 \\nComorbidities \\n59\\n5 \\nPrevention \\n60\\n6 \\nManagement \\n60\\n6.1 \\nGeneral considerations \\n60\\n6.2. \\nDuring the seizure \\n61'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxii\\n6.3.  \\nAs soon as possible following a seizure \\n61\\n6.4. \\nManagement of seizures in women receiving \\n  \\nmagnesium sulphate \\n62\\n7. \\nDelivery \\n62\\n8. \\nTransfer of a woman who has had a seizure to another institution \\n63\\n9. \\nPostpartum management \\n63\\n10. \\nCounselling  \\n64\\n J\\t\\nManagement of Diabetes during Pregnancy  \\n67\\n1 \\nPurpose \\n67\\n2 \\nScreening \\n67\\n2.1 \\nTarget groups for screening \\n67\\n2.2 \\nRecommended tests \\n68\\n3 \\nManagement – Women with established Diabetes \\n70\\n3.1 \\nPre Pregnancy care \\n70\\n3.2 \\nAntenatal Care \\n71\\n3.3 \\nMedical nutrition therapy (MNT) \\n72\\n3.4 \\nExercise \\n72\\n4 \\nGlyceamic control and Monitoring  \\n73\\n4.1 \\nGlyceamic Control \\n73\\n4.2 \\nMonitoring of glycaemic control \\n74\\n5 \\nDelivery and intra natal care \\n74\\n5.1 \\nTiming of delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Monitoring of glycaemic control \\n74\\n5 \\nDelivery and intra natal care \\n74\\n5.1 \\nTiming of delivery \\n74\\n5.2 \\nLabour care \\n75\\n6 \\nPost natal care \\n75\\n6.1.a \\nNeonatal care \\n75\\n6.1.b \\nImmediate post partum care \\n76\\n6.2 \\nAt hospital discharge \\n76\\n6.3 \\nLate Postnatal care and follow up \\n77\\n7 \\nFamily Planning \\n77\\n K\\t\\nManagement of Primary Post Partum Haemorrhage \\n81\\n1 \\nIntroduction \\n81\\n2 \\nDefinition \\n81\\n3 \\nPrevention of Post Partum Haemorrhage \\n81\\n4 \\nPrediction of Post Partum Haemorrhage \\n82\\n5 \\nManagement of Primary PPH \\n83\\n5.1 \\nGeneral measures \\n83\\n5.2 \\nSpecific measures \\n84\\n5.2.1 \\nEstablish a cause for the bleeding  \\n84\\n5.2.2. \\nManagement of atonic haemorrhage \\n85\\n5.2.3 \\nManagement of traumatic PPH \\n86\\n5.2.4 \\nRupture of the uterus \\n87\\n5.2.5 \\nCoagulopathy causing PPH \\n87\\n6.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='86\\n5.2.4 \\nRupture of the uterus \\n87\\n5.2.5 \\nCoagulopathy causing PPH \\n87\\n6. \\nResuscitation and Fluid management \\n87\\n7. \\nDebriefing \\n88\\n8. \\nRisk Management \\n89\\n  \\nAppendix 1 \\n90\\n  \\nAppendix 2 \\n92\\n  \\nAppendix 3 \\n94'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxiii\\nList of Abbreviations\\nWHO \\nWorld Health Organization\\nUNFPA \\nUnited Nations Population Fund\\nUNICEF \\nUnited Nations Children’s Fund\\nSLCOG \\nSri Lanka College of Obstetricians and Gynaecologists\\nNICE \\nNational Institutive of Clinical excellency\\nRCOG \\nRoyal College of Obstetricians and Gynaecologists\\nFHR \\nFetal Heart Rate\\nCPD \\nCephalo Pelvic Disproportion\\nNALS \\nNeonatal Advanced Life Support\\nPPROM \\nPreterm prelabour  rapture of the Membranes\\nCS \\nCaesarean Section\\nCTG \\nCardiotocography\\nIV \\nIntravenous\\nIM \\nIntra muscular\\nIU \\nInternational Units\\nEFM \\nElectronic Fetal Monitoring\\nTENS \\nTranscutaneous electrical nerve stimulation\\nHELLP \\nHaemolysis, elevated liver enzymes and low platelet\\nHDU \\nHigh dependency unit\\nICU \\nIntensive care unit\\nPGDM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='HDU \\nHigh dependency unit\\nICU \\nIntensive care unit\\nPGDM  \\nPre gestational diabetes mellitus\\nGDM \\nGestational Diabetes Mellitus\\nOGCT \\nOral glucose Challenge Test\\nOGTT \\nOral Glucose Tolerance test\\nPPBS \\nPost Prandial Blood Sugar\\nMNT \\nMedical Nutrition therapy\\nDENO \\nDiabetic Educator Nursing officer\\nSMBG \\nSelf-monitoring of blood glucose\\nAC \\nAbdominal Circumference\\nSHO \\nSenior House Officer\\nCBG \\nCapillary Blood Glucose\\nENC \\nEssential  New-born  Care\\nDM \\nDiabetes Mellitus\\nDMPA \\nDepot Medroxy Progesterone Acetate\\nBMI \\nBody Mass Index\\nPPH \\nPost Partum Haemorrhage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxiv\\nList of Tables\\nGuidelines for ruse of oxytocin for induction and augmentation of labour\\nTable 1 \\nmU/minute administered at different rates of administration \\naccording to drop rate\\nTable 2 \\nmU/minute infused per minute when administered via an infusion \\npump\\nGuideline on fetal monitoring in labour\\nTable 1 \\nDefinitions of normal, suspicious and pathological FHR rates\\nTable 2 \\nClassification of fetal heart rate patterns\\nGuideline for screening, diagnosis and management of diabetes in pregnant \\nwomen\\nTable 1 \\nTarget values in glycaemic control'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxv\\nDisclaimer\\nThese guidelines are based on current best available evidence and \\nconsensus opinion of the Guideline Development committee of \\nthe Sri Lanka College of Obstetricians & Gynaecologists. They are \\nneither intended to replace the process of critical evaluation of \\nevery case and nor it is intended to dictate an exclusive course of \\nmanagement or treatment. It must be interpreted with reference to \\nindividual patient needs, available resources and limitations unique \\nto the institution and variations in local populations.\\nMedicine is a continually evolving science and the users must have \\nregard to relevant information, research or material, which may \\nhave been published or become available subsequently.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\nxvi\\nIntroduction\\nClinical Guidelines are systematically developed statements which assist \\nclinicians and patients in making decisions about appropriate treatment \\nfor specific conditions based on the best scientific evidence at the time of \\ndevelopment. Guidelines are not intended to limit the clinical freedom; \\nhowever, clinicians are expected to follow these recommendations as the \\nbasis for their decision making. Availability of resources, the existing \\nsituations, and the expectations of individual client needs to be considered. \\nThe guidelines are intended to guide all health care workers in all levels \\nof institutions where maternity care is being provided. Although these'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='of institutions where maternity care is being provided. Although these \\nguidelines are mainly targeted for the government sector institutions, use \\nin the private sector institutions where maternity care is being provided, \\nis also encouraged.\\nThese guidelines are developed by the guideline development committee \\nof the Sri Lanka College of Obstetricians and Gynaecologists in \\nconsultation with other relevant specialists such as anaesthesiologists, \\nphysicians, endocrinologists, and haematologists etc. The existing \\nnational guidelines developed in 2007, NICE guidelines on intranatal \\ncare, WHO guidelines and RCOG guidelines were perused and mixed \\nwith the local scenarios and expert opinion. The latest available scientific'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='with the local scenarios and expert opinion. The latest available scientific \\nevidences were considered and included where ever necessary. Then, the \\ndraft guidelines were presented to the wider forum of obstetricians and \\nconsensuses were arrived. After that the guidelines were handed over to \\nthe Ministry of Health and consensus was built with the participation \\nof multi-disciplinary team including medical administrators, provincial \\nhealth authorities, representatives from SLCOG and  other relevant \\nprofessional colleges, and national programme managers.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n1\\nManagement of Labour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n2'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n3\\nManagement of Normal Labour\\n1.\\t Introduction\\nThe aim of this guideline is to provide recommendations to care providers \\nin the management of a healthy woman with a single fetus in labour at \\nterm (37-42weeks). It does not cover the care of women with complicated \\npregnancies. \\nThe objective of this guideline is to ensure optimal management of \\nwomen in labour, detect any abnormalities, take appropriate action, \\nprevent complications and thus make childbirth safer; and also to make \\nsure that these women are treated with respect and compassion, and kept \\nwell informed and well supported throughout labour. \\n2.\\t Diagnosis of Labour\\nLabour is diagnosed by the presence of regular, painful intermittent'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='2.\\t Diagnosis of Labour\\nLabour is diagnosed by the presence of regular, painful intermittent \\ncontractions, which are of increasing frequency, duration and intensity, \\nleading to progressive cervical effacement and dilatation. \\nNote:  for the purpose of this guideline, labour is also diagnosed in the \\npresence of painful contractions occurring at a frequency of 2 in 10 \\nminutes or more.\\nDefinitions: \\nLatent phase of the first stage of labour – from the commencement \\nof labour to a cervical dilatation of up to 4 cm. (This is a period \\nof time, not necessarily continuous, when there are painful \\ncontractions and some cervical changes including cervical \\neffacement and dilatation up to 4cm take place)\\nActive phase of the first stage of labour – commences at a cervical'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Active phase of the first stage of labour – commences at a cervical \\ndilatation of 4cm and ends with full dilatation. (There are regular \\npainful contractions and progressive cervical dilatation from 4cm \\nup to full dilatation).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n4\\nIf the diagnosis of labour is uncertain, observation should continue and \\nreassessment made in four hours. \\nAny woman who is diagnosed as not being in labour, but continues to \\ncomplain of pain, would require careful reassessment by an experienced \\nmedical officer. Possible diagnoses of placental abruption and non-\\nobstetric causes should be considered. Fetal compromise should be \\nexcluded. \\n3.\\t\\nManagement of labour\\n3.1. \\nGeneral considerations\\n3.1.1. Communication between women and healthcare professionals/\\nworkers\\n• \\nGreet the mother with a smile and a personal welcome\\n• \\nTreat them with respect and dignity \\n• \\nAssure privacy \\n• \\nEstablish a good rapport with the laboring women asking \\nabout their wants and concerns and address them \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='about their wants and concerns and address them \\n• \\nMaintain a calm and confident approach which will reassure \\nwomen that the situation is under control\\n• \\nAssess the woman’s knowledge of strategies for coping with \\npain and provide balanced information to find out which \\navailable approaches are acceptable to her\\n• \\nAsk her permission before all  procedures and observations, \\nfocusing on the woman rather than technology or the \\ndocumentation\\n3.1.2. Preparation of mothers to transfer to labour room\\n• \\nShaving or trimming of perineal hair may be necessary to \\nfacilitate unhindered performance and repair of the episiotomy.\\n• \\nEfforts must be made to minimize faecal soiling. Where \\nan enema is deemed necessary, a medicated enema is \\nrecommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='an enema is deemed necessary, a medicated enema is \\nrecommended. \\n      (These two steps should not be considered mandatory)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n5\\n• \\nWomen should be encouraged to have a companion of her \\nchoice during labour, depending on the facilities and clinical \\nsituation.\\n3.1. 3. Documentation \\n• \\nAdmit the mother to the labour room and complete the \\n‘handing over’ form \\n• \\nEnter relevant notes on the BHT and start a partogragh (see \\npage 39)\\n• \\nReview clinical notes and reassess risk factors.\\n• \\nAccurate documentation of all observations and interventions \\nmust be made, with timing.\\n• \\nAll obstetric examinations and procedures carried out must \\nbe documented in the clinical notes. Each entry must be \\naccompanied by a plan for management and be signed by the \\nresponsible person.  \\n3.1.4. Mobilization and Positioning\\n• \\nWomen should be encouraged and helped to move about'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='3.1.4. Mobilization and Positioning\\n• \\nWomen should be encouraged and helped to move about \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nThey need to be encouraged to void urine at regular intervals.\\n3.1.5. Eating and drinking in labour\\n• \\nMothers must be encouraged to consume clear, non-\\nfizzy liquids during labour. Isotonic solutions such as oral \\nrehydration fluid and king coconut water are more beneficial \\nthan water. \\n• \\nIn addition to clear fluids, women in the latent phase may \\nconsume light solids e.g. biscuits and fruits. \\n3.1.6. Hygiene measures during labour\\n• \\nStrict asepsis must be maintained during labour. \\n• \\nInstruments should be available in packets'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n6\\n• \\nUse proper hand washing technique.\\n• \\nUse of double gloves and disposable gloves is encouraged.  \\n3.1.7. Pain relief in labour\\nRelief of pain should be a major consideration (please refer guidelines on \\npain relief during labour in page 34)\\n3.2. \\nManagement of the three stages of labour\\nThe practice of maintaining a labour room ‘notice board’ - a ‘white \\nboard’ on which the status of all women in labour is summarized \\nand updated regularly is encouraged. This would convey at a glance \\nto all care providers women who require additional attention. The \\nage, parity status, risk factors, salient findings at each assessment \\nand any abnormalities noted must be included in this.\\n3.2.1. Management of first stage of labour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='and any abnormalities noted must be included in this.\\n3.2.1. Management of first stage of labour\\n3.2.1. 1. Latent phase \\nIt is important to recognize the latent phase of labour, since its prolongation \\ncould lead to maternal exhaustion, dehydration and acidosis, leading to \\nfetal compromise and dysfunctional labour. \\n \\nWomen in the latent phase of labour would be best managed in the \\nantenatal ward.\\nWomen in the latent phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse half hourly\\n• \\nCheck  temperature four hourly\\n• \\nConsider vaginal examination four hourly, depending on the \\ncontraction pattern and initial cervical dilatation\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n7\\n• \\nUse of a sanitary pad may indicate early, the presence of \\nmeconium. \\n• \\nConsider the requirement for analgesia.\\nIt is important to inform the mother and reassure her that it is common to \\nhave slow progress in the latent phase.  \\nThe latent phase is considered prolonged when it lasts more than 12 hours \\nin a primigravida and 8 hours in a multigravida. In these situations an \\nexperienced medical officer (with a minimum one year of experience in \\nthe field) must reassess the mother with a view of augmentation of labour. \\n3.2.1.2. Active phase\\n3.2.1.2a. Admitting women to the Labour Room\\nAll pregnant women diagnosed as being in active phase of the first stage of \\nlabour need to be admitted to the labour room.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='labour need to be admitted to the labour room.\\nThe initial assessment of a woman in the labour room should include:\\n• \\nListening to her story, considering her emotional and \\npsychological needs and reviewing her clinical records\\n• \\nPhysical observation: temperature, pulse, blood pressure\\n• \\nLength, strength and frequency of contractions\\n• \\nAbdominal palpation: fundal height, lie, presentation, position \\nand station\\n• \\nVaginal loss: show, liquor, blood\\n• \\nAssessment of woman’s pain including her wishes for coping \\nwith labour along with the range of options for pain relief\\n• \\nThe fetal heart rate (FHR)  should be auscultated preferably with \\na hand held Doppler for a minimum of 1 minute immediately \\nafter a contraction\\n• \\nThe maternal pulse should be recorded to differentiate between'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='after a contraction\\n• \\nThe maternal pulse should be recorded to differentiate between \\nmaternal pulse and FHR\\n• \\nA vaginal examination should be offered'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n8\\nHealth care Professionals who conduct vaginal examination should:\\n• \\nBe sure that there is a valid indication for vaginal examination \\nthat it will add important information to the decision making \\nprocess\\n• \\nBe aware that for many women who may already in pain, \\nhighly anxious and in an unfamiliar environment, vaginal \\nexamination can be very distressing\\n• \\nEnsure the woman’s consent, privacy, dignity and comfort\\n• \\nExplain the reason for examination and what will be involved, \\nand\\n• \\nExplain the findings and their impact sensitively to the woman\\n3.2.1.2b.  Management of active phase of first stage\\nMonitoring must be conducted as instructed in the partogram and \\nfindings recorded accordingly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Monitoring must be conducted as instructed in the partogram and \\nfindings recorded accordingly. \\nUse of a sanitary pad may indicate presence of meconium early. \\nWomen in the active phase of labour must be assessed on a regular basis, \\nas follows: \\n• \\nCheck the fetal heart and maternal pulse every 15 minutes ;\\n• \\nCheck temperature and blood pressure four hourly;\\n• \\nVaginal examination four hourly or earlier, depending on the \\nclinical situation; \\n• \\nFrequency of contractions should be monitored as follows:\\n \\nThe interval between two contractions should be assessed by \\npalpation of the abdomen\\n \\nDuring active labor usually there are at least three contractions \\nper ten minutes. In other words the interval between two \\ncontractions should be three minutes\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='per ten minutes. In other words the interval between two \\ncontractions should be three minutes\\n• \\nDocument the colour of amniotic fluid if the membranes \\nrupture;\\n• \\nConsider the requirement for analgesia, (which now becomes \\nmore important).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n9\\nIntermittent auscultation of the fetal heart is best performed using \\nhand-held Doppler devices. The fetal heart rate must be counted \\nfor one minute, beginning immediately after a contraction.\\nThe mother may continue to consume clear fluids in the active phase. \\nShe must be encouraged to assume any position that she is comfortable in \\nand to avoid the dorsal position. \\nWomen who have the following conditions are recommended to be have \\nto continuous electronic fetal monitoring: \\n• \\nSignificant meconium staining of amniotic fluid, \\n• \\nAbnormal Fetal heart rate detected by intermittent \\nauscultation (< 110 beats per minute; > 160 beats per minute; \\nany decelerations after a contraction)\\n• \\nFresh vaginal bleeding and \\n• \\nMaternal pyrexia.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='any decelerations after a contraction)\\n• \\nFresh vaginal bleeding and \\n• \\nMaternal pyrexia. \\nIn women with spontaneous labour progressing normally, routine \\nearly amniotomy and use of oxytocin is not recommended.\\n3.2.1.3. Delayed progress of first stage of labour\\nDelayed progress is diagnosed when there is progress of less than \\ntwo cm in four hours. Slowing of progress in a woman who has \\npreviously been progressing satisfactorily must also be considered \\nas a delay.\\nIt is extremely important that delay in progress is assessed by an \\nexperienced medical officer. \\nThis assessment must take into account:\\n• \\nthe uterine contractions, \\n• \\ndescent and position of the fetal head  \\n• \\nfeatures of early obstruction of labor (caput and moulding), and \\n• \\nThe fetal condition'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n10\\nIn women with delay in the active phase of the first stage, every effort must \\nbe made to find a cause for the delay. This may either be due to inadequate \\ncontractions or obstruction due to CPD, mal-presentation or malposition \\n(such as occipito-posterior position), or a combination of these. \\nIn cases of inadequate contractions:\\n• \\nAmniotomy must be performed if membranes are still intact. \\n• \\nFollowing that, the woman must be reassessed in two hours \\n• \\nIn case there is inadequate progress, augmentation with \\noxytocin must be considered. \\n• \\nThe situation must be reassessed after four hours or earlier if \\nrequired.\\nMultiparous women with delayed progress: \\n• \\nMust be viewed with extreme caution. \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='required.\\nMultiparous women with delayed progress: \\n• \\nMust be viewed with extreme caution. \\n• \\nIt is very important to exclude mechanical causes of delay \\nbefore considering oxytocin. \\n• \\nUse of oxytocin in multipara with obstructed labour could be \\nextremely dangerous. \\nIn all cases where progress is slow in spite of adequate contractions a \\ncareful assessment must be made to exclude obstruction of labour. \\nAttention must be paid to effective pain relief and to correcting dehydration \\nin those situations.\\nAfter paying attention to the above,Cesarean section must be considered \\nwhere the progress continues to be slow after four hours (less than two \\ncm) of commencing oxytocin. \\n3.2.2. Management of second stage of labour\\n3.2.2.1. Passive second stage of labour (descent phase)\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='3.2.2.1. Passive second stage of labour (descent phase)\\n• \\nIs diagnosed when full cervical dilatation is reached in the \\nabsence of involuntary expulsive efforts by the mother. \\n• \\nBearing down must be discouraged at this stage.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n11\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 10 minutes. The maternal pulse should be palpated if \\nthere is suspected fetal bradycardia or any other FHR anomaly \\nto differentiate the two heart rates. \\n• \\nPresence of meconium must be noted. \\n3.2.2.2. Active second stage of labour (expulsive phase) \\n• \\nIs diagnosed when the mother gets the urge to bear down with \\nfull dilatation.\\n• \\nIntermittent auscultation of the fetal heart should be done \\nimmediately after a contraction for at least one minute, at least \\nevery 5 minutes. The maternal pulse should be palpated if there \\nis fetal bradycardia or any other FHR anomaly \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='is fetal bradycardia or any other FHR anomaly \\n• \\nPresence of meconium must be noted. \\nUse of a hand-held Doppler device is recommended (in preference to a \\nPinnard) for fetal heart rate monitoring in the second stage. \\nWomen must be encouraged to continue consuming clear fluids during \\nthe second stage. \\nSupport by the labour companion must be continued. \\nTotal time durations allowed for the second stage of labour are as follows:\\nPrimigravida: \\n• \\nBirth would be expected to take place within 2 hours of the \\nstart of the active second stage in most women.\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 1 hour and need to seek the advice from a \\nhealth professional trained in the assisted/ Operative vaginal \\nbirth if birth is not imminent.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='health professional trained in the assisted/ Operative vaginal \\nbirth if birth is not imminent.\\nMultigravida:\\n• \\nBirth would be expected to take place within 1 hours of the \\nstart of the active second stage in most women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n12\\n• \\nA diagnosis of delay in the active second stage should be made \\nwhen it has lasted 30 minutes and requires advice from a health \\nprofessional trained in assisted/ operative vaginal birth if birth \\nis not imminent.\\n• \\nDelay in the second stage in a multiparous woman must raise \\nsuspicion of disproportion or malposition.\\nOne further hour is permitted for women in each category with an \\nepidural analgesia.\\n3.2.2.3. Observations for women and babies in the second stage of \\nlabour:\\nAll observations should be documented on the partogragh.\\n• \\nChart blood pressure and pulse hourly\\n• \\nContinue four hourly temperature recording \\n• \\nVaginal examination must be offered after an hour in the active'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nVaginal examination must be offered after an hour in the active \\nsecond stage after abdominal palpation and assessment of \\nvaginal loss\\n• \\nHalf hourly documentation of frequency of contractions\\n• \\nOngoing consideration of the woman’s  emotional and \\npsychological needs\\nIn addition:\\n• \\nAssessment of progress should include maternal behavior, \\neffectiveness of pushing and fetal wellbeing, taking into \\naccount fetal position and station at the onset of the second \\nstage. These factors will assist in deciding the timing of further \\nvaginal examination and the need for obstetric review.\\n• \\nOngoing consideration should be given to the woman’s position, \\nhydration, coping strategies and pain relief throughout the \\nsecond stage.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='hydration, coping strategies and pain relief throughout the \\nsecond stage.\\n3.2.2.4. Women’s position and pushing in the second stage of labour:\\nAlthough most deliveries in Sri Lanka are conducted in the dorsal/\\nMcRobert’s position, women may be encouraged to adopt squatting, semi \\nupright or lateral positions to aid the expulsion phase.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n13\\nWomen should be informed that in the second stage, they should be \\nguided by their own urge to push.\\nIf pushing is ineffective, strategies to assist birth such as support and \\nencouragement and change of position can be used.\\nIn primigravida in whom contractions have become weak and there \\nis no evidence of fetal compromise or obstruction, oxytocin may \\nbe administered as an infusion. In this case, the expulsive phase \\nmay be continued under close observation for a further 30 minutes. \\nDelivery must be considered at the end of this period.\\n3.2.2.5. Intrapartum interventions to reduce perineal trauma\\nEither the ‘hands on’ (guarding the perineum and flexing the baby’s head)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Either the ‘hands on’ (guarding the perineum and flexing the baby’s head) \\nor the ‘hands poised’ (with hands off the perineum and baby’s head but in \\nreadiness) techniques can be used to facilitate spontaneous birth.\\nA routine episiotomy should not be carried out during spontaneous \\nvaginal birth.\\nEpisiotomy should only be performed selectively, in women in whom there \\nis a clinical need such as instrumental birth or suspected fetal compromise \\nor a high chance of perineal tears.  \\nWhere episiotomy is performed, Mediolateral episiotomy, performed at \\n45 – 60 degrees from the midline directed to the right side, beginning at \\nthe vaginal fourchette is preferred to the median episiotomy.  It should be \\nperformed at the time of crowning of the fetal head.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='performed at the time of crowning of the fetal head.\\nEpisiotomy should be performed after infiltration of the perineum up to \\n20 ml of 1% lignocaine. \\n3.2.2.6. Delivery\\nThe fetal head should not be allowed to extend till occiput is felt below \\nthe symphysis pubis. The perineum should be supported during delivery \\nof the head. Once the head is delivered the woman should be discouraged \\nfrom bearing down. Following restitution and external rotation, shoulders'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n14\\nmust be delivered appropriately with directed traction on the fetal head. \\nThe baby must be delivered onto the mother’s abdomen. Breastfeeding \\nshould be initiated within 30 minutes of birth. \\n3.2.3. \\nThird stage of Labour\\nThe third stage of labour is the period from the complete delivery of the \\nbaby to the complete delivery of the placenta and membranes.\\n3.2.3.1. Active Management of the third stage of labour\\nActive management of the third stage of labour is recommended for all \\nmothers. \\nThis includes;\\n• \\nRoutine use of uterotonic drugs: Oxytocin 5 IU intravenously \\nsoon after the delivery of the baby   or 10 IU intramuscularly, \\n• \\nDelayed cord clamping (2 minutes after the birth) and cutting \\nof the cord\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nDelayed cord clamping (2 minutes after the birth) and cutting \\nof the cord\\n• \\nFollowed by controlled cord traction. This must be followed by \\nuterine massage.\\nDelayed clamping of the cord allows for placental transfusion, \\nwhich reduces neonatal and infant iron deficiency and anemia. \\nThis policy should be followed unless the baby is born in a poor \\ncondition or if the mother is bleeding or is Rhesus iso-immunized.\\nClamp and cut the cord close to the perineum.  A hand should be placed \\nabove the symphysis pubis to stabilize the uterus by applying counter \\ntraction during controlled cord traction. Application of cord traction \\nwhen the uterus is relaxed could lead to acute inversion of the uterus.\\nAfter delivery, the placenta must be placed on a flat surface and the maternal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='After delivery, the placenta must be placed on a flat surface and the maternal \\nsurface examined for completeness. On the fetal surface the blood vessels \\nmust be traced to exclude a succenturiate lobe. Completeness of the fetal \\nmembranes must be ensured.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n15\\nObservations in the immediate postpartum period include:\\n• \\nInspection for continued fresh bleeding, \\n• \\nCheck pulse, blood pressure, uterine contraction,  and the level \\nof the fundus every 15 minutes up to 2 hours\\n• \\nHer general  physical condition, as shown by her colour, \\nrespiration and her own report of how she feels \\nExperienced medical personnel should be informed in any one the \\nfollowing instances: \\n• \\nContinuing fresh bleeding;\\n• \\nElevation of the level of the fundus;\\n• \\nIncrease of pulse rate above 100 or by 30 beats per minute;\\n• \\nDrop in systolic blood pressure below 100 or by 30 mmHg. \\nThe level of the fundus must be marked on the skin using a marker to \\nmake observations more objective. \\n3.2.3.2. Delayed third stage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='make observations more objective. \\n3.2.3.2. Delayed third stage\\nDelayed third stage is diagnosed when the placenta is not delivered within \\n30 minutes of active management. \\nThe first step in managing delayed third stage of labour is:\\n• \\nTo proceed to intraumbilical vein oxytocin, in a dose of 50 IU \\nin 30 ml of 0.9% sodium chloride solution. \\n• \\nA period of 30 minutes is allowed and controlled cord traction \\nis attempted again. \\n• \\nIf the placenta is not delivered by this method, manual removal \\nof placenta is proceeded to. \\n4.\\t\\nCare for the newborn baby\\nEffective care at birth is needed in anticipation of problems with the \\ntransition from in utero dependent life to extra utero independent \\nexistence and to provide support to ensure stabilization.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n16\\n• \\nSkilled birth attendant (Medical Officer, Nursing Officer and \\nMidwive) is responsible for the care. \\n• \\nThe care at birth is same irrespective of birthing place or person \\nattending to birth. \\n• \\nAt least one health care provider trained in neonatal \\nresuscitation must be physically available at the time of birth of \\nall infants irrespective of risk status.\\n• \\nThis person must actually be present in the delivery room \\nbefore the birth of the baby.\\n• \\nThe attending personnel should document the details of the \\nbaby such as time of birth, weight, gender and any other \\nrelevant information in all cases.\\nThe aims of neonatal care following birth include the following:\\n• \\nEstablishment of respiration (as per NRP guidelines) \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nEstablishment of respiration (as per NRP guidelines) \\n• \\nPrevention of hypothermia (Refer to newborn guideline)\\n• \\nEstablishment of breast feeding (Refer to newborn guideline)\\n• \\nPrevention of infection (Refer to newborn guideline)\\n• \\nDetection of danger signs (Refer to newborn guideline)\\nFollowing basic steps should be followed at the time of birth;\\n1. Call out the time of birth\\n2. Deliver the baby onto the mother’s abdomen or into her arms\\n3. Dry baby with a warm towel or a warm piece of cloth\\n4. Wipe baby’s eye\\n5. Assess baby’s breathing while drying \\n6. Make sure that there is no second baby\\n7. Change gloves or remove the first layer of gloves\\n8. Clamp and cut the umbilical cord\\n9. Put the baby between mother’s breast for skin to skin care\\n10. Place an identity label on baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='9. Put the baby between mother’s breast for skin to skin care\\n10. Place an identity label on baby\\n11. Cover mother and baby with warm clothes\\n12. Put a hat on baby’s head\\nThe Apgar score at 1 and 5 minutes should be recorded for all births.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n17\\nInitiation of breast feeding should be aimed for within 1hour after birth. \\nHead circumference, birth weight, length and other measurements should \\nbe carried out once the first feed is complete. A health care professional \\nshould examine the baby to detect any physical abnormality and to \\nidentify any problems that require referral.\\n5.\\t\\nPerineal Care\\nPerineal  or genital trauma caused by either episotomy or tearing need to \\nbe repaired.\\nBefore assessing for genital trauma:\\n• \\nExplain to the woman what they are going to do and why\\n• \\nOffer some analgesia\\n• \\nEnsure good lighting\\n• \\nPosition the woman so that she is comfortable and the genital \\nstructures can be seen clearly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nPosition the woman so that she is comfortable and the genital \\nstructures can be seen clearly.\\nThe initial assessment should be performed gently and with sensitivity \\nand may be done in the immediate period following birth preferably as \\nsoon as the placenta is delivered.\\nClassification of perineal trauma\\nFirst degree: Injury to skin only\\nSecond Degree: Injury to the perineal muscles but not the anal \\nsphincter\\nThird degree: Injury to the perineum involving the anal sphincter  \\ncomplex\\nFourth degree: Injury to the perineum involving the anal sphincter \\ncomplex and anal epithelium\\nPerineal repair should only be undertaken with tested effective analgesia \\nin place using infiltration with up to 20ml of 1% lignocaine or equivalent,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='in place using infiltration with up to 20ml of 1% lignocaine or equivalent, \\nor by topping up the epidural, as soon as possible by a medical officer.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n18\\nThe preferred suture material is rapidly absorbable polyglactin acid.\\nThe following basic principles should be observed when performing \\nperineal repairs:\\n• \\nPerineal trauma should be repaired using aseptic techniques.\\n• \\nEquipment should be checked and swabs and needles counted \\nbefore and after the procedure\\n• \\nGood lighting is essential to see and identify the structures \\ninvolved.\\n• \\nDifficult injuries should be repaired by an experienced medical \\nofficer in the theatre under regional or general anaesthesia. An \\nindwelling catheter should be inserted for 24 hours to prevent \\nurinary retention.\\n• \\nGood anatomical alignment of the wound should be achieved, \\nand consideration  given to the cosmetic result.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='and consideration  given to the cosmetic result.\\n• \\nRectal examination should be carried out after completing the \\nrepair to ensure that suture material has not accidently been \\ninserted through the rectal mucosa.\\n• \\nFollowing completion of repair, an accurate detailed account \\nshould be documented covering the extent of the trauma, the \\nmethod of repair and the materials used.\\n• \\nInformation should be given to the woman regarding the extent \\nof the trauma, pain relief, diet, hygiene and the importance of \\npelvic floor exercises.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n19\\nGuideline on Induction of Labour\\n1.\\t\\nIntroduction \\nThis guideline aims to provide evidence based guidance on induction of \\nlabour to make the process more logical, effective and safer. It also aims to \\nempower women undergoing induction of labour. \\n2.\\t\\nDefinition\\nInduction of labour is defined as initiation of labour by artificial means.\\n3.\\t\\nGeneral Principles\\n• \\nInduction of labour should be performed only in specialist \\nobstetric units when there is a clear indication that its benefits \\noutweigh risks.\\n• \\nA senior clinician must make the decision.\\n• \\nThe reason/s should be clearly explained to the patient, who \\nshould give her consent.\\n• \\nMaternal and fetal wellbeing should be monitored closely.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='should give her consent.\\n• \\nMaternal and fetal wellbeing should be monitored closely.\\n• \\nAdequate pain relief should be an essential part of the \\nmanagement plan, since it is recognized that labor is more \\npainful when it is induced.\\n• \\nPrior to induction of labour, the cervix should be favourable \\n(Modified Bishop score 7 or more). If it is not, an attempt should \\nbe made to ripen the cervix. \\n• \\nDecisions regarding induction of labour should be made taking \\ninto account not only the clinical scenario but also the woman’s \\nviews, the availability of local facilities and cost effectiveness of \\nthe available methods.\\n4.\\t\\nIndications\\n4.1 Otherwise uncomplicated pregnancy continuing beyond 40 weeks\\nInduction of labour is recommended for low-risk women who are known'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Induction of labour is recommended for low-risk women who are known \\nwith certainty to have reached 41 weeks of gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n20\\nHowever, it is good practice to assess fetal wellbeing around 40 weeks to \\nselect women for conservative management until 41 weeks gestation. \\nThe recommended assessments include fetal biometry (at least abdominal \\ncircumference) and amniotic fluid index (lower cut-off = 7 cm). \\n4.2 Prelabour rupture of membranes at term\\nIn the absence of evidence fetal compromise or maternal infection delayed \\ninduction of labour after 24 hours is acceptable. \\nThis may be carried out using either oxytocin infusion or prostaglandins.\\n4.3 Preterm prelabour rupture of membranes (PPROM)\\nPatients with PPROM without evidence of infection or fetal compromise \\nshould be offered induction after the completion 34 weeks.\\n4.4 Intrauterine death'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='should be offered induction after the completion 34 weeks.\\n4.4 Intrauterine death\\nThis is a very traumatic time for the woman. Most women would want \\nto be delivered as early as possible and their wishes need to be respected. \\nAmniotomy and repeated vaginal examinations are best avoided. \\nProstaglandins are preferred for induction of labour in these women. \\nAmniotomy is preferred in the presence of abruption placentae. \\n4.5 History of precipitate labour\\nThere are no studies comparing outcomes in induced versus spontaneous \\nlabour.\\n4.6 Suspected macrosomia\\nIn the presence of good clinical and ultrasound evidence of macrosomia \\nor a history of previous shoulder dystocia, there should be a low threshold \\nfor early induction of labour.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n21\\n4.7 Fetal growth restriction\\nThe decision for induction of labour in a growth restricted fetus should be \\nindividualized based on period of gestation at onset, presence or absence \\nof fetal compromise. \\n4.8 Older mothers\\nThere is growing evidence that the risk of stillbirth is higher in older (>40 \\nyrs) women near term. \\nWomen over 40 years should be offered induction between 39-40 weeks.\\n5.\\t\\nInduction under specific circumstances\\n5.1 Breech presentation\\nPresentation per se, is not a contraindication to induction. \\n5.2 Previous CS\\nThere is no contraindication to induction of labour in a woman with a \\npast caesarean section. \\nUse of either oxytocin or prostaglandins increases the risk of scar \\ndehiscence or rupture.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Use of either oxytocin or prostaglandins increases the risk of scar \\ndehiscence or rupture. \\nThis risk may be lower with artificial separation of membranes or Foley \\ncatheter. \\n6.\\t\\nMethods of induction\\nThis section does not make a distinction between methods of ripening the \\ncervix and induction of labour. \\n6.1 Mechanical\\nThere is good evidence that artificial separation of membranes reduces the \\nneed for formal induction. This method is recommended to be performed \\nwith due regard to asepsis, at 40 weeks gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n22\\nWhere the cervix will not admit a finger, massaging around the cervix in \\nthe vaginal fornices will have a similar effect.\\nExtra-amniotic balloon catheter is an effective method of ripening of the \\ncervix. A Foley catheter is inserted through the cervix and the balloon \\ninflated with 40 – 60 ml of saline. This may be left in situ for a maximum \\nof 48 hours. Following its removal, induction of labour may be proceeded \\nto using another method. \\nIn the presence of evidence of infection, artificial separation of membranes \\nand extra-amniotic Foley catheter must not be used. \\n6.2 Surgical\\n \\nAmniotomy is a definitive mode of induction of labour. It should be \\nundertaken only if one is committed to deliver within 24 hours. Therefore'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='undertaken only if one is committed to deliver within 24 hours. Therefore \\nit should be done only when the cervix is ripe and prior cervical assessment \\nby an experienced clinician is essential.\\nThe risk of cord prolapse should be appreciated and steps taken to \\nminimise or to recognize it early.\\nAmniotomy alone may be capable of initiation of labour and it is \\nrecommended that oxytocin be started after a period of observation of at \\nleast two hours. \\n6.3 Pharmacological\\n6.3.1 Oxytocin\\nUse of oxytocin when membranes are intact is not recommended. \\nFor details of how to use oxytocin please refer to the guideline on oxytocin\\n6.3.2 Prostaglandins\\nProstaglandin E2 (PGE2)\\nThese are very effective in inducing labour and are available as vaginal gel, \\ntablet or controlled release pessary.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n23\\nAll preparations carry a risk of hyperstimulation.\\nIntracervical route does not offer any increase in efficacy.\\nCombined use with oxytocin is particularly dangerous. A minimum of six \\nhours from the last vaginal tablet/gel should be allowed before oxytocin \\nis started.\\nPrior to use of prostaglandins the Bishop score should be assessed and \\nthe woman should be monitored electronically to determine the fetal \\ncondition and frequency of contractions.\\nAfter administration the fetal heart should be monitored electronically \\nwhen contractions begin. After confirmation of normal heart rate pattern \\nmonitoring should be done by intermittent auscultation.\\nA second dose may be considered after a minimum interval of 6 hours'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='A second dose may be considered after a minimum interval of 6 hours \\nafter the first, depending on the change of Bishop score, the condition of \\nthe fetus and frequency of contractions.\\nThe dosages are 3 mg for vaginal tablets and 0.5 mg for vaginal gel.\\nMisoprostol\\nThis drug is widely used worldwide for a variety of indications in \\npregnancy. (In Sri Lanka, it is not licensed at present).\\nNevertheless, it is very effective in inducing labour (more than PGE2), \\nespecially in mid trimester fetal death. \\nSensitivity of the uterus increases markedly with advancing pregnancy.\\nThis guideline recommends that it should not be used for induction of \\nlabour with a mature live fetus.\\n6.3.3 Mifepristone\\nIt is a powerful anti-progesterone and is very useful as an adjunct to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='6.3.3 Mifepristone\\nIt is a powerful anti-progesterone and is very useful as an adjunct to \\nmisoprostol in cases of intrauterine death. (It is not licenced in Sri Lanka \\nat present)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n24\\n8.\\t\\nComplications\\n8.1 Hyperstimulation\\nThis is a well-recognized complication of induction of labour with \\npharmacological methods. It could have serious consequences including \\nrupture of the uterus, aminiotic fluid embolism, precipitate labor and fetal \\ncompromise. \\nIt is defined either as a contraction free interval of less than sixty seconds \\nand/or contractions lasting more than ninety seconds.\\nIf diagnosed, the prostaglandin tablet must be retrieved from the vagina \\nor oxytocin infusion stopped immediately and a rapid infusion of 0.9% \\nsodium chloride via a fresh giving set administered.    \\nIf still not resolved, tocolytics should be given if available e.g. terbutaline'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='If still not resolved, tocolytics should be given if available e.g. terbutaline \\n250 µg IV or SC.  Since this is not available in Sri Lanka, salbutamol \\ninhaler may be tried.\\n8.2  Cord prolapse\\nThis is more likely with amniotomy when the head is high and poorly \\napplied to the cervix. \\nPrecautions to avoid and to detect this early include palpation for cord \\npresentation, palpation for the cord immediately after amniotomy and the \\nfetal heart sounds auscultated immediately afterwards.\\n \\nIf cord prolapse is diagnosed help must be called immediately. Assess \\ncervical dilatation and effect delivery if fully dilated. If not fully dilated \\nand cord pulsations are present, insert a Foley catheter into the bladder \\nand fill it with 500 ml saline. Place the mother in the knee-elbow position'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='and fill it with 500 ml saline. Place the mother in the knee-elbow position \\nand displace the presenting part away from the pelvis by keeping pressure \\ninserting a hand in the vagina. Transport for immediate caesarean section \\nin this position.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n25\\n8.3 Uterine rupture\\nPlease also refer to section 5.2 in this guideline\\nExtra care must be exercised in grandmultipara and in women with \\nscarred uteri.\\n8.4 Failed induction\\nFailed induction is defined as labour failing to start after one cycle of \\ntreatment with medical methods or for 12 hours of amniotomy. \\nIt does not necessarily indicate caesarean section in case medical or \\nmechanical methods.\\nThe clinical situation (maternal and fetal condition) must be reassessed \\nand discussed with the woman. \\nIn case of failure to induce labor using one cycle of prostaglandins another \\ncycle may be administered as described  above. Depending on the clinical \\nsituation it is best that the second cycle is delayed for 24 hours. In case of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='situation it is best that the second cycle is delayed for 24 hours. In case of \\namniotomy, failed induction of labour indicates caesarean section.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n26'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n27\\nGuideline for Use of Oxytocin for Induction and \\nAugmentation of labour\\nOxytocin is an invaluable drug when used carefully. However, it has \\nthe potential to cause uterine hyperstimulation, which could result in \\namniotic fluid embolism, uterine rupture and fetal distress, all of which \\nare life threatening. \\nMultigravidae are particularly susceptible to the above consequences \\nand extra care must be taken to exclude obstruction before a decision is \\nmade to use oxytocin in a multigravid woman during labour. Experienced \\npersonnel must be involved in this decision. \\nUse of oxytocin for induction and/or augmentation of labour results in \\na higher risk of rupture of a scarred uterus. Therefore, in such women'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='a higher risk of rupture of a scarred uterus. Therefore, in such women \\noxytocin should be used only with the concurrence of a Consultant. \\nIts effects will depend on the concentration of the infusion and the volume \\ninfused per minute. \\nTo achieve this predictably, use of infusion pumps is recommended. \\nWhere a gravity-assisted drip system is used, a burette may be used to \\nimprove accuracy. Such systems however, may deliver variable volumes \\ndepending on many factors including the position of the arm into which \\nit is infused.  \\nIrrespective of the method of administration, oxytocin must be \\nadministered in incremental doses at intervals of 30 minutes, to achieve \\na contraction free interval of two minutes. Once this level is reached, the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='a contraction free interval of two minutes. Once this level is reached, the \\ninfusion rate may be continued at the same level, while closely monitoring \\nthe contractions. \\nHyperstimulation is defined either as a contraction free interval of less \\nthan sixty seconds and/or contractions lasting more than ninety seconds. \\nIn this situation the infusion must be stopped immediately. \\nOxytocin is administered with 5 units in 500 ml of 0.9% sodium chloride \\nsolution. In situations where infusion pumps are not available, oxytocin'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n28\\nmay be administered starting at a drop rate of 15 per minute and increased \\nat rates of 15 drops per minute every 30 minutes, up to a maximum of 60 \\ndrops per minute.  An approximate conversion to mU/minute is given in \\ntable 1.\\nTable 1: mU/minute administered at different rates of administration \\naccording to drop rate\\n \\nDrop rate/min \\nEquivalent  mU/min.\\n \\n15 \\n7.5\\n \\n30 \\n15 \\n \\n45 \\n22.5 \\n \\n60 \\n30 \\n \\n            (based on 5U of oxytocin in 500 ml saline)\\nTable 2 gives mU infused per minute when administered via an infusion \\npump. \\nTable 2: mU infused per minute when administered via an infusion \\npump.\\n TIME AFTER STARTING \\nOXYTOCIN DOSE \\nVOLUME INFUSED\\n \\n(MINS) \\n(MU/MIN) DOSE \\n(10U IN 500MLS MLS/HR)\\n \\n \\n \\nRATE\\n \\n0 \\n1 \\n3\\n \\n30 \\n2 \\n6\\n \\n60 \\n4'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='(MINS) \\n(MU/MIN) DOSE \\n(10U IN 500MLS MLS/HR)\\n \\n \\n \\nRATE\\n \\n0 \\n1 \\n3\\n \\n30 \\n2 \\n6\\n \\n60 \\n4 \\n12\\n \\n90 \\n8 \\n24\\n \\n120 \\n12 \\n36\\n \\n150 \\n16 \\n48\\n \\n180 \\n20 \\n60\\n \\n210 \\n24 \\n72\\n \\n240 \\n28 \\n84\\n \\n270 \\n32 \\n96\\nOxytocin must not be administered to women with intact membranes. It is \\nrecommended that women on oxytocin infusions should have continuous \\nelectronic fetal monitoring.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n29\\nContinuous EFM during administration of oxytocin:\\n• \\nIf the CTG is normal, oxytocin may be continued in incremental \\ndoses until the woman is experiencing 4 or 5 contractions every \\n10 minutes.\\n• \\nIf the FHR trace is suspicious, this should be reviewed by an \\nexperienced medical officer \\n• \\nIf the FHR trace is classified as abnormal/pathological oxytocin \\ninfusion should be stopped and a full assessment of the fetal \\ncondition undertaken by an experienced medical officer.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n30\\nGuideline on fetal monitoring in labour\\nFetal monitoring in labour could be done by :\\n• \\nIntermittent auscultation (preferably by a hand held Doppler \\ndevice) \\n• \\nIntermittent or continuous electronic monitoring  \\nIntermittent auscultation is recommended for low-risk women in \\nspontaneous labour. \\nElectronic monitoring is recommended when:\\n• \\nThe baby’s  growth is restricted  \\n• \\nThere is significant meconium staining of amniotic fluid \\n• \\nAbnormal fetal heart rate detected by intermittent auscultation \\n• \\nFresh vaginal bleeding \\n• \\nMaternal pyrexia \\n• \\nUse of oxytocin for augmentation or induction of labour \\n• \\nWomen with a scarred uterus \\n• \\nWomen on epidural analgesia \\nIntermittent auscultation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nWomen with a scarred uterus \\n• \\nWomen on epidural analgesia \\nIntermittent auscultation \\nThis could be done by using either a Pinnard’s stethoscope or preferably a \\nhand-held Doppler device. \\nAuscultation should be carried out immediately after a contraction for \\none full minute. \\nThe maternal pulse should be palpated if there is suspected fetal \\nbradycardia or any other FHR anomaly to differentiate the two heart rates.\\nThe normal rate is between 110 – 160 beats per minute in a term fetus. \\nThe frequency of auscultation should be as specified in the partogram.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n31\\nElectronic fetal monitoring (EFM)\\nEFM is carried out by external cardiotocography (CTG). \\nThe following are recommended at the commencement of a CTG.\\n1. The paper speed must be set at 1 cm per minute.\\n2. The date and time settings on the machine must be validated.\\n3. The CTG must be labeled with the mother’s name, BHT number \\nand date and time. \\n4. Maternal heart rate should be noted on the CTG.\\n5. The presence and the point at which the fetal heart rate is best \\nheard must be delineated by auscultation and the probe placed \\nat that point.\\n6. Ensure that the contraction probe is functioning properly and \\nused for the recording.\\n7. The woman should be positioned in such a way that aortocaval \\ncompression is avoided.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='7. The woman should be positioned in such a way that aortocaval \\ncompression is avoided.\\n8. It should be interpreted without delay and the categorization \\nrecorded as either normal or suspicious or pathological, as per \\ntable 1, and signed by the responsible officer. The entry on the \\nBHT must include a plan for management. \\n9. If the CTG is categorized as suspicious or abnormal, the \\nConsultant must be informed. \\n10. For the management plan the overall clinical picture must be \\ntaken into account. e.g. the rate of progress of labour, presence \\nor absence of fetal growth restriction, meconium staining of \\namniotic fluid and the evolution of the CTG abnormalities. \\nTable 1: Definitions of normal, suspicious and pathological FHR traces\\nCategory  \\nDefinition \\nNormal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Category  \\nDefinition \\nNormal  \\nAn FHR trace in which all four features are classified as \\nreassuring \\nSuspicious  \\nAn FHR trace with one feature classified as non-reassuring \\nand the remaining features classified as reassuring \\nPathological  \\nAn FHR trace with two or more features classified as non-\\nreassuring or one or more classified as abnormal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n32\\nTable 2: Classification of fetal heart rate patterns\\nFurther useful information on FHR patterns\\n• \\nIf repeated accelerations are present with reduced variability, \\nthe FHR trace should be regarded as reassuring.\\n• \\nTrue early uniform decelerations are rare and benign, and \\ntherefore they are not significant.\\n• \\nMost decelerations that occur during labor are variable.\\n• \\nIf a bradycardia occurs in the baby for more than 3 minutes, \\nurgent medical aid should be sought and preparations \\nshould be made to urgently expedite the birth of the baby, i.e. \\nimmediate commencement of cesarean section.  This could \\ninclude moving the woman to theatre if the fetal heart has \\nnot recovered by 9 minutes. If the fetal heart recovers within'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='not recovered by 9 minutes. If the fetal heart recovers within \\n9 minutes the decision to deliver should be reconsidered in \\nconjunction with the woman if the post-recovery tracing is \\nreassuring.\\n• \\nA tachycardia in the baby of 160–180 bpm, where accelerations \\nare present and no other adverse features appear, should not be \\nregarded as suspicious. However, an increase in the baseline \\nFeature  \\nBaseline \\n(bpm)  \\nVariability \\n(bpm)  \\nDecelerations  \\nAccelerations  \\nReassuring  \\n110–160  \\n≥ 5  \\nNone  \\nPresent  \\nNon-reassuring  \\n100–109  \\n161–180  \\n< 5 for 40 –90 \\nminutes  \\nTypical variable \\ndecelerations with \\nover 50% of \\ncontractions, \\noccurring for over \\n90 minutes  \\nTe absence of \\naccelerations \\nwith otherwise \\nnormal trace is \\nof uncertain \\nsigniﬁcance  \\nAbnormal \\n< 100  \\n> 180'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='with otherwise \\nnormal trace is \\nof uncertain \\nsigniﬁcance  \\nAbnormal \\n< 100  \\n> 180  \\nSinusoidal \\npattern ≥ _10 \\nminutes \\n< 5 for 90 \\nminutes \\nEither atypical \\nvariable \\ndecelerations with \\nover 50% of \\ncontractions or late \\ndecelerations, both \\nfor over 30 \\nminutes'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n33\\nheart rate, even within the normal range, with other non-\\nreassuring or abnormal features should increase concern. In \\nsuch cases inquiry must be made to ascertain if the fetus was \\nactive during the recording.  \\nWhen women are having continuous EFM, systematic assessment of above \\ndefinitions and classification should be undertaken with every review.\\nDuring episodes of abnormal FHR patterns, if woman is lying supine, \\nadvise her to adopt the left lateral position'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n34\\nGuideline on Pain Relief in Labour\\nAdequate relief of pain is a basic right of every mother in labour. It is the \\nduty of every member of the obstetric team to endeavor to achieve this. \\nPoor management of pain during labour will result in maternal exhaustion \\nleading to:\\n• \\nacidosis, \\n• \\ndysfunctional labour and \\n• \\nfetal distress. \\n• \\nLoss of morale and a negative birth experience could have \\nsignificant long-term effects. \\nA well-informed, well supported mother will be more in control of events \\nand in a better position to deal with pain than one who is not. Therefore, \\nit is important to keep the mother informed of the progress of labour and \\nthe condition of the fetus throughout the process.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='the condition of the fetus throughout the process. \\nReassurance plays a major adjunctive role in pain relief.\\nPrenatal education should include information regarding the available \\nmethods of pain relief and their accessibility.\\nNon pharmacological methods of pain relief such as breathing and \\nrelaxation techniques should be introduced during the antenatal period.\\nIt is well recognized that women who have a birth companion will tolerate \\npain better and require less analgesia. The policy of allowing a birth \\ncompanion must therefore be encouraged.\\n1.\\t\\nMethods of pain relief in labour\\nThe selection of the method of pain relief should be based on the patient \\npreference, availability of resources and the institutional protocols. \\nFollowing methods can be used.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n35\\n1.1 \\n Non-pharmacological methods of pain relief\\n• \\nBreathing techniques, \\n• \\nTranscutaneous electrical nerve stimulation (TENS), \\n• \\nMassaging, \\n• \\nRelaxation techniques, \\n• \\nPositioning and movement\\nAny of these methods can be used to relieve pain during labour\\n1.2. \\nPharmacological methods of pain relief in labour\\n1.2.1. \\nOral paracetamol/paracetamol & codeine compound: \\nThese oral preparations can be used safely in the latent phase of labour.\\n1.2.2. \\nOpioids\\n1.2.2.A. Pethidine\\nPethidine is safe and effective in the latent and early active phase. The dose \\nis 1-1.5 mg/kg IM, repeated after 4 – 6 hours. Administration of a third \\ndose should be done only with the concurrence of senior personnel.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='dose should be done only with the concurrence of senior personnel. \\nIt is generally avoided where delivery is anticipated within 4 hours. \\nMaternal side effects include nausea, vomiting and a reduction in gastric \\nmotility with a subsequent increase in gastric acidity. Therefore, it should \\nbe administered coupled with metoclopramide 5 mg IV or 10 mg  IM.\\nNeonatal respiratory depression is a recognized consequence of \\nadministration of opioids to the mother. Naloxone, a pure opioid \\nantagonist should be available for treatment in all facilities administering \\nopioids for analgesia. Naloxone is given to the baby in a dose of 100μg /kg \\nIV. It has a short duration of action and additional doses may be required. \\nIf no improvement is seen with the first dose of naloxone, the cause of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='If no improvement is seen with the first dose of naloxone, the cause of \\nneonatal respiratory depression is more likely to be a factor other than \\nopioids.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n36\\n1.2.2.B. Morphine \\nThis has a longer duration of action than pethidine and may be particularly \\nuseful in women who require analgesia in early labour. \\nThe dose is 0.15 mg/kg IM should be administered with metoclopramide. \\nThe side effects and neonatal effects are similar to those of pethidine.\\n1.2.2.C. Fentanyl \\nIntravenous fentanyl/ramifentanyl may be administered in either a High \\nDependency or Intensive Care Unit settings under the supervision of an \\nanaesthesiologist. \\nThe dose is 50-100μg per hour as an intravenous infusion.\\nPain relief occurs in 3-5 minutes after commencement.\\n \\n1.2.3. \\nInhalational analgesia – Entonox\\nEntonox is a 50:50 mixture of nitrous oxide and oxygen and it has a very'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Entonox is a 50:50 mixture of nitrous oxide and oxygen and it has a very \\nshort half-life. The onset of action is 30sec to one minute. \\n \\nThe mother should receive clear and definite instructions about its correct \\nuse. It should only be self-administered.\\nShe should start using entonox through the controlled valve at the very \\nbeginning of the contraction. The mother should be advised to stop using \\nEntonox inhalation in the contraction free interval.\\nLonger and deeper breaths give better result. There is no limit on the \\nduration of its use.  \\nWomen should be informed that Entonox will make them feel nauseous \\nand light-headed.\\nEntonox is contraindicated in women with intestinal obstruction, \\npneumothorax, middle ear and sinus disease, and following cerebral air-\\ncontrast studies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n37\\n1.2.4. Regional Anaesthesia\\n \\nA.   Epidural analgesia \\nEpidural analgesia is the most effective form of pain relief in labour. \\nTherefore, Its greater use should be encouraged. \\nIt can be given either as a bolus with top-ups or as a continuous infusion. \\nContinuous administration via a syringe pump is preferred to ‘top-ups’, \\nsince it is safer. \\nThe continuous availability of an anesthesiologist is a prerequisite to \\noffering epidural analgesia. It is also essential that staff on site is trained for \\nits setting up, monitoring and to recognize complications early.  Facilities \\nshould be available for emergency resuscitation.\\nBefore offering epidural  analgesia, women should be informed its risks'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Before offering epidural  analgesia, women should be informed its risks \\nand benefits and its implications on labour:\\n• \\nIt provides more effective pain relief than other methods\\n• \\nIt will not increase the length of the first and the passive second \\nstages of labour. \\n• \\nIt may however increase the length of the expulsive phase \\nand increase the likelihood of an instrumental delivery. An \\nadditional hour is allowed in the expulsive phase therefore.\\n• \\nIt does not increase the chance of cesarean section \\n• \\nIt does not cause long-term backache. \\n• \\nIt needs to be accompanied by a more intensive level of \\nmonitoring.\\nCare and observations for women with regional analgesia in labour\\n• \\nIntravenous access should be secured prior to commencing \\nregional analgesia.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nIntravenous access should be secured prior to commencing \\nregional analgesia.\\n• \\nFollowing additional observations should be carried out for \\nwomen with regional analgesia\\n➢ \\nDuring establishment of regional analgesia or after top up \\nbolus blood pressure should be measured every 5 minutes \\nfor 15 minutes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n38\\n➢ \\nIf the woman is not pain free within after each \\nadministration, the anaesthetist should be called.\\n➢ \\nHourly assessment of the level of sensory block should be \\nundertaken.\\n• \\nWomen with regional analgesia should be encouraged to move \\nand adopt whatever positions they find most comfortable \\nthroughout labour.\\n• \\nOnce established, regional analgesia should be continued \\nuntil after completion of the third stage of labour and when \\nnecessary until perineal repair is done.\\n• \\nWomen should be allowed one additional hour in the second \\nstage of labor, depending on maternal and foetal condition. \\nThereafter pushing during contractions should be actively \\nencouraged.\\n• \\nContinuous EFM is recommended for at least 30 minutes during'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='encouraged.\\n• \\nContinuous EFM is recommended for at least 30 minutes during \\nestablishment of regional analgesia and after administration of \\neach bolus.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n39\\nGuidelines to maintain the partograph'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n40'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n41\\nGuideline on Acute Puerperal Inversion of the Uterus\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide recommendations for the \\nmanagement of acute puerperal inversion of the uterus, which is a rare \\nand life threatening condition. The main reason for its high mortality rate \\nis delay in instituting appropriate treatment, which leads to postpartum \\nhemorrhage and rapid development of shock out of proportion to \\nhaemorrhage. \\n2.\\t\\nDefinition\\nIt is defined as ‘the turning inside out of the fundus into the uterine cavity’.\\n3.\\t\\nPrevention\\nMismanagement of the third stage of labor is recognized as the main \\ncause, although 50% have no identifiable cause. The common initiating'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='cause, although 50% have no identifiable cause. The common initiating \\nfactor seems to be a traction force on the fundus of a relaxed uterus. \\nProper retraction of the uterus in the third stage is the primary factor in \\npreventing an inversion. There is no reliable data to suggest that it recurs \\nin a future pregnancy.\\nThe importance of the active management of the third stage could not be \\nover-emphasized. (Please refer Section 3 of the PPH Guideline and the \\nsection on management of delayed third stage (section 3.2.3 in the Normal \\nLabor Guideline for details) \\n4.\\t\\nPathophysiology (and clinical correlation)\\nAs the inversion progresses, the adnexae with their ligaments get drawn \\ninto the inverting uterine fundus and become increasingly stretched. This'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='into the inverting uterine fundus and become increasingly stretched. This \\nproduces significant pain and vagal stimulation, leading to neurogenic \\nshock. \\nAn inverted uterus becomes trapped within the cervix creating \\nprogressive oedema and congestion due to interruption of venous and \\nlymphatic drainage. Oedema and congestion will increase the firmness \\nof the inverted segment, making reduction more difficult. Interruption'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n42\\nof the venous drainage will lead to significant haemorrhage. A partially \\nseparated placenta would add to this.\\n5.\\t\\nClassification\\nAlthough acute, subacute and chronic varieties have been described, this \\nguideline would address only the acute variety as it is life threatening. \\nThis occurs soon after birth, just before or after the delivery of the placenta.\\nThree degrees of inversion have been described, depending on the \\nlevel of the inverted fundus. In practice, second-degree inversion is the \\ncommonest. The fundus has come past the cervical os, but is still within \\nthe vagina.\\n6.\\t\\nClinical Presentation and Diagnosis\\nPrompt diagnosis is vital.\\nThe key to diagnosis is awareness and a high degree of suspicion.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Prompt diagnosis is vital.\\nThe key to diagnosis is awareness and a high degree of suspicion.\\nThe following are early warnings:\\n• \\nA degree of shock that is out of proportion to overt blood loss\\n• \\nA retained placenta\\n• \\nPlacenta delivered but ‘with some difficulty’\\n• \\nSevere, sustained unexplained pain in the third stage.\\nIn this situation:\\n• \\nFeel for the fundus. If absent or ‘cupped’, acute inversion is \\nprobable diagnosis;\\n• \\nConfirm by a vaginal examination:\\n• \\nLook for a hard mass which looks and feels like a huge \\nulcerated fibroid polyp (sometimes described as a foetal \\nhead); \\n• \\nThe cervix is not to be seen or felt in the normal position, \\ninstead it could be felt as a ring around the base of the \\n‘mass’;\\n• \\nIn incomplete cases, the inverted fundus may be felt'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='‘mass’;\\n• \\nIn incomplete cases, the inverted fundus may be felt \\nthrough the cervical canal in the lower uterine cavity.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n43\\n7.\\t\\nManagement\\n7.1 General measures:\\nEarly diagnosis is vital. Treat it as a life-threatening emergency.\\nFirst attempts at reduction should be made at the place where it is \\ndiagnosed, without moving to theatre.\\nIf these attempts fail, move to theatre and give a general anesthetic without \\ndelay (see section 7.2.4). \\nEarly involvement of experienced personnel and teamwork are absolutely \\nessential.\\nTreat shock aggressively, not forgetting the neurogenic element.\\nProvide adequate pain relief\\nReplace the blood loss, which could be considerable, especially if the \\nplacenta has partially or completely separated.\\nDo not attempt to remove the placenta, if still attached.\\n7.2 Repositioning the uterus'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Do not attempt to remove the placenta, if still attached.\\n7.2 Repositioning the uterus\\nReposition the uterus as soon as possible; the sooner it is done the easier \\nand better. It reverses the shock and reduces PPH.\\nNon-surgical methods\\n7.2.1  Manual replacement of uterus.\\n(Johnson’s maneuver)\\nThe operator introduces two thirds of his forearm in to the vagina and \\nextends the hand at the wrist to place the palm on the inverted fundus and \\nfingertips at the utero-cervical junction. Lifting the uterus above the level \\nof the umbilicus creates adequate tension for the cervical ring to dilate and \\nfor the fundus to revert to its normal position.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n44\\nThis could be helped by ‘working the fingers up’ gradually from the cervical \\nring towards the fundus, with gentle but persistent pressure applied.\\nWhere the uterus is too hard to respond, consider tocolytics (see below).\\nOnce reduced, hold the fundus in place for a few minutes (making a fist \\ninside the uterus with upward pressure on the fundus helps).\\nAdminister uterotonics (Ergometrine 0.25 mg i.v. or oxytocin 5-10 IU i.v \\nfollowed by oxytocin infusion at the rate of 10 IU per hour), whilst the \\nhand is still inside. When the uterus begins to contract, slowly remove the \\nhand. \\nThis manouvre is possible only soon after the event, and would need \\nadequate analgesia. Unless it is possible to administer either a general'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='adequate analgesia. Unless it is possible to administer either a general \\nanesthetic immediately, administer pethidine 50 mg iv slow and proceed \\nwith the maneuvres. \\nGive antibiotics (e.g. cephradine 1g and metronidazole 500 mg IV).\\n7.2.2   Hydrostatc reduction (O’Sullivan 1945)\\nSeveral novel and useful modifications have been made to this procedure \\nlately, principally to circumvent the problem of inadequate water seal, \\nwhich has been the major cause of failure in the past. \\nInsert 6 cm silastic ventouse cup into vagina, making sure that it is directed \\nat the posterior vaginal fornix and not at, or cupping the fundus. Place \\nhand at introitus to maintain seal between cup and vagina.\\n(Alternatively 500ml balloon catheter can be placed in vagina. If neither is'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='(Alternatively 500ml balloon catheter can be placed in vagina. If neither is \\navailable, use a wide tube; a standard giving set will not do).\\nConnect via IV giving set to a bag of warmed normal saline placed 1- 1.5 \\nmetres above the patient.\\nInfuse normal saline (typically 2 litres) into vagina to reduce the uterus by \\nhydrostatic pressure.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n45\\nOnce reduced, remove the placenta if still attached and proceed as in the \\nprevious section.\\nWhere a balloon is used, it would be advisable to leave it for 12-24 hours \\nto prevent re-inversion and reduce haemorrhage. \\nSaline embolisation and fluid overload leading to pulmonary oedema are \\nonly theoretical risks as long as one sticks to hydrostatic pressure only.\\n7.2.3  Tocolytics\\nWhere repositioning is difficult due to retraction of the uterine muscle \\nand the constriction of the cervical ring, tocolytics could be helpful. But \\ngiven this could cause PPH, it would have to be a considered and a senior \\ndecision. They are safest given in the theatre setting. \\nVarious preparations have been used; ideally it should be readily available,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Various preparations have been used; ideally it should be readily available, \\nwith quick onset and short duration of action. E.g.\\nTurbutaline 0 .25mg i.v. slowly (not available in Sri Lanka at present);\\nSalbutamol 0.25mg in 10 ml saline i.v. slowly;\\nNitroglycerine 0.1mg i.v. slowly or sublingually (acts within 90 seconds)\\n7.2.4  General Anaesthesia\\nIf the initial attempt at manual replacement fails, it is safest to move the \\npatient to the theatre and to administer general anaesthesia. This allows \\nfor muscle relaxation, pain relief and elimination of the neurogenic \\ncontribution to the shock. \\n7.2.5  Surgical methods\\nIf managed properly in the early stages, resort to surgery should be a rare \\noccurrence.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n46\\nHuntingdon’s operation\\nAfter a laparotomy, the indrawn uterine cup is identified near the region \\nof the cervix with the tubes and round ligaments pulled into the cup.  By \\nthe use of two Allis forceps the uterus is pulled out of the constriction ring \\nin a progressive fashion and restored to its normal position. The serosa of \\nthe uterus will invariably sustain lacerations and these are repaired with \\nabsorbable sutures. \\nUse of a silastic vacuum cup from above instead of Allis forceps has been \\nshown to circumvent this problem.\\nHaultain’s operation\\nIn this procedure the constriction in the region of cervix is incised \\nposteriorly using a longitudinal incision. As in the Huntingdon’s method'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='posteriorly using a longitudinal incision. As in the Huntingdon’s method \\ntwo Allis forceps are used to pull the uterus to its normal position. The \\nincision is repaired with interrupted sutures. Uterotonics are given to \\nmaintain contraction of the uterus.\\nHysterectomy\\nWhen all the above methods fail, a hysterectomy will become the only \\nviable option. However, it must be remembered that given the distorted \\nanatomy, this must be undertaken by a surgeon of considerable experience. \\n8.\\t\\nDebriefing\\nAlthough there is no evidence of a recurrence risk, it is sensible to advise \\nthe woman to deliver in a specialized Unit next time, and the third stage \\nto be managed actively by experienced personnel.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n47\\nManagement of \\nHypertensive disease \\nduring pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n48'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n49\\nManagement of Hypertensive Disease in  Pregnancy\\n1.\\t\\nIntroduction\\nHypertension in pregnancy is an important cause of direct maternal deaths \\nin Sri Lanka. Early identification, aggressive and intensive treatment of \\nits complications is important in reducing the resulting morbidity and \\nmortality.\\n2.\\t\\nDefinitions\\nChronic Hypertension:\\nWomen with pre-existing hypertension or hypertension detected before \\n20th week of gestation in the absence of trophoblastic disease and \\npersisting more than 42 days post partum. \\nGestational Hypertension\\nA)   Pregnancy Induced Hypertension:\\nHypertension unaccompanied by proteinuria developing after 20 weeks of \\ngestation and resolving within 42 days of delivery.\\nB)   Pre Eclampsia:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='gestation and resolving within 42 days of delivery.\\nB)   Pre Eclampsia:\\nPregnancy induced hypertension associated with significant proteinuria \\n(300mg/l or 500mg/ 24 hours or dipstick 2+ or more).\\nSevere Preeclampsia:\\nDefined as Pre-eclampsia with severe hypertension and/or with symptoms, \\nand/or biochemical and/or haematological impairment. \\nThe clinical features of severe pre-eclampsia (in addition to hypertension \\nand proteinuria) are:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n50\\n• \\nSevere headache\\n• \\nVisual disturbance such as blurring or flashing before eyes, \\nscotomas\\n•  Epigastric or hypochondrial pain and/or nausea & vomiting\\n•  Clonus (3 beats or more)\\n•  Papilloedema\\n•  Liver tenderness\\n• \\nOliguria (less than 400 ml per day or 0.5 mg/Kg/hour over a 4 \\nhour period)\\n•  Platelet count falling to below 100 x 106/l \\n•  Abnormal liver enzymes (ALT or AST rising to above 70IU/l)\\n•  HELLP syndrome\\nSevere Hypertension:\\nDefined as systolic blood pressure ≥ 160 mmHg and/or diastolic blood \\npressure ≥110 mmHg. \\nEclampsia: \\nDefined as the development of convulsions and/or unexplained coma \\nduring pregnancy or postpartum in patients with features of preeclampsia.\\n3.\\t\\nScreening for Hypertension during pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='3.\\t\\nScreening for Hypertension during pregnancy\\nBlood pressure must be measured in every clinic visit by a Medical Officer \\nand results recorded and plotted in the pregnancy record. \\nProteinuria must be tested for at every clinic visit.\\nIf blood pressure is more than 140/90 mmHg on two occasions at least 2 \\nhours apart, refer for specialist care.\\n4.\\t\\nPrevention of hypertensive disorders in pregnancy\\nAdvise women at high risk of pre-eclampsia to take 75 mg of aspirin daily \\nfrom 12 weeks until delivery of the baby. Women at high risk are:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n51\\n Those with any one of the following risk factors:\\n• \\nHypertensive disease during a previous pregnancy\\n• \\nChronic kidney disease\\n• \\nAutoimmune disease such as systemic lupus erythematosis or \\nantiphospholipid syndrome\\n• \\nType 1 or type 2 diabetes\\n• \\nChronic hypertension\\n• \\nMultiple pregnancy\\nOr, any TWO or more of the following \\n• \\n First pregnancy\\n• \\nAge 40 years or older\\n• \\nPregnancy interval of more than 10 years\\n• \\nBody mass index (BMI) of 35 kg/m² or more at first visit\\n• \\nFamily history of preeclampsia\\nContraindications such as allergy, gastritis, peptic ulcer disease must be \\ntaken into account.\\nAdvice women who have the above risk factors to ensure a higher intake of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='taken into account.\\nAdvice women who have the above risk factors to ensure a higher intake of \\ncalcium to achieve a daily intake of at least 1000 mg taking into account the \\naverage intake by Sri Lankan women the recommended supplementation \\nlevel is 600 mg. \\n5.\\t\\nManagement of Chronic Hypertension \\nWomen with chronic hypertension must be managed in specialist units. \\nAnticipate the development of superimposed pre eclampsia in these \\nwomen. This combination adds risks to both mother and baby. ACE \\ninhibitors should be discontinued in women who are planning pregnancy \\nand its use avoided during pregnancy. \\nTreatment of mild to moderate hypertension\\nSince there is no consensus on the value of treating mild to moderate \\nhypertension, this guideline will not address this issue.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n52\\n6.\\t\\nManagement of Severe Pre-Eclampsia\\nThe basic outline of management\\n• Admit to hospital and inform Consultant\\n• Observe and monitor\\n• Control blood pressure\\n• Prevent seizures\\n• Look for complications – such as HELLP / pulmonary oedema/\\ncerebral haemorrhage\\n• Strict fluid balance\\n• In utero transfer where necessary and safe\\n• Timing of Delivery\\n• Continue vigilance post delivery\\n• Follow up\\n6.1. General Considerations\\n• \\nSevere preeclampsia is a life threatening condition.\\n• \\nThe only known cure is delivery of the baby.\\n• \\nThe immediate task is to determine the urgency to effect \\ndelivery.\\n• \\nStabilization of the mother’s condition within an acceptable \\ntime frame prevents maternal complications and may improve \\nfetal condition.  \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='time frame prevents maternal complications and may improve \\nfetal condition.  \\n• \\nThe management has to be individualized depending on the \\nclinical condition and available resources.\\n• \\nThe dangers will continue into the immediate postpartum \\nperiod.\\n6.2. Specific Management\\nAdmit women who have severe preeclampsia and inform the Consultant.\\nTreat hypertension if:\\n• \\nSystolic blood pressure ≥ 160 mmHg, or if\\n• \\nDiastolic blood pressure ≥ 110 mmHg, or if\\n• \\nMean arterial pressure ≥ 125 mmHg,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n53\\nAim to maintain blood pressure at around 130-140/90-100 mmHg.\\nThe main cause of maternal death in severe preeclampsia is poorly \\ncontrolled systolic hypertension causing cerebral haemorrhage. \\nA rapid fall in maternal blood pressure as a result of antihypertensive \\ntreatment may cause fetal heart rate abnormalities & compromise, \\nespecially in growth restricted/compromised fetuses.\\nWhere resources allow, it is recommended to monitor fetal heart with \\ncontinuous CTG during and for 60 minutes after commencing anti-\\nhypertensive therapy.\\nAim to stabilize blood pressure before delivery.\\n6.2.1. \\nAnti-hypertensive drugs\\nOral anti hypertensives may be used when the blood pressure is <180/110'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Anti-hypertensive drugs\\nOral anti hypertensives may be used when the blood pressure is <180/110 \\nmmHg. Blood pressure must be monitored at 15-minute intervals and \\nintravenous anti hypertensives resorted to in case of an adequate response \\nis not obtained within 30 minutes.\\nThe commonly used antihypertensive drugs for acute control are given \\nbelow. One or the other may be used depending on availability and \\nfamiliarity. \\n6.2.1.1 Labetalol orally or intravenously\\nThis should be avoided in women with a history of bronchial asthma.\\n- 200mg orally stat (only if blood pressure is <180/110 mm Hg)\\n- repeated hourly for up to 4 hours\\n \\nor\\n- 20 mg IV over two minutes\\n• \\nRecord blood pressure after 10 minutes.\\n• \\nIf either value is still above 160 mm Hg systolic and/or 110'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nIf either value is still above 160 mm Hg systolic and/or 110 \\nmmHg diastolic, give 40 mg iv over 2 minutes.\\n• \\nRecord blood pressure after 10 minutes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n54\\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/or \\n110 mmHg diastolic, give hydralazine 10 mg iv. For instructions \\nregarding giving a fluid bolus with i.v. hydralazine, see the next \\nsection of this guideline. \\n• \\nIf the blood pressure is still above 160 mm Hg systolic and/\\nor 110 mmHg diastolic, start an IV infusion of labetolol, \\nstarting at 40 mg/hour, doubling dose at half hourly intervals \\nas required to a maximum of 160 mg/hour. \\n• \\nWhere these measures fail, the mother must be moved to a \\nhigh-dependency area or an intensive care unit.\\nIf blood pressure is controlled by the above, continue monitoring the \\nblood pressure at 15 minute intervals for 1 hour and at 30 minute intervals \\nthereafter.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='blood pressure at 15 minute intervals for 1 hour and at 30 minute intervals \\nthereafter. \\nAdditional bolus doses as described above may be administered if the \\nblood pressure increases above 160 mmHg systolic and/or 110 mmHg \\ndiastolic.\\n6.2.1.2. Hydralazine intravenously:\\n• \\n5 - 10 mg IV bolus over 2 minutes.\\n• \\nThis must be accompanied by a fluid bolus of 5ml/kg of 0.9% \\nsodium chloride or ringer lactate solution over 30 min, started \\nat the same time as iv hydralazine (this helps vasodilatation & \\nprevents drastic hypotension). This should not be used in the \\npresence of pulmonary oedema. \\n• \\nRecord blood pressure at 15 minute intervals.\\n• \\nRepeat boluses of 5 - 10 mg IV after a 15 minute interval may \\nbe given if necessary up to a maximum of 20 mg (the effect of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='be given if necessary up to a maximum of 20 mg (the effect of \\na single dose can last up to 6 hours).\\n• \\nIf the response to above doses is inadequate, give labetolol \\nbolus doses as described above.\\n• \\nIf no lasting effect with above boluses, consider an infusion of \\nhydralazine 2.0 mg/hour increasing by 0.5 mg/hour as required \\n(2-20 mg/hour usually required).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n55\\n6.2.1.3. Oral Nifedipine\\n• \\nOral nifedipine may be used where the blood pressure is < \\n180/110 mm Hg, in asymptomatic patients.\\n• \\nGive 10 mg orally.\\n• \\nRepeat at 20 minute intervals up to a maximum of 40 mg.\\n• \\nIf there is no response proceed to intravenous labetalol or \\nhydralazine.\\n6.2.2. \\nPrevention of convulsions\\n \\nMagnesium sulphate\\n• \\nMagnesium sulphate is the anticonvulsant of choice.\\n• \\nIt should be given to any woman with features of impending/\\nimminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, and dizziness). \\n• \\nThe loading dose may be given even when the status of renal \\nfunction is uncertain, since it is unlikely that toxic levels of \\nmagnesium could be reached with this dose alone.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='magnesium could be reached with this dose alone.\\n• \\nGive loading dose of 4 G IV over 10 minutes. There are two \\nmethods of giving magnesium sulphate intravenously. \\no \\nDiluted to a total volume of 20 ml with 0.9% sodium \\nchloride solution, given via an infusion pump or ‘manually’. \\no \\nDiluted to a total volume of 80 ml with 0.9% sodium \\nchloride solution via a burette\\n• \\nImmediately after the loading dose, start infusion of 1 G IV per \\nhour.  Continue this infusion for at least 24 hours after delivery.\\n• \\nWhere there are difficulties with intravenous access, magnesium \\nsulphate may be administered intramuscularly. Give 5 G deep \\nintramuscularly into each buttock with 1 ml of 2% lignocaine \\nin the same syringe.  \\n• \\nIf intramuscular magnesium sulphate is continued as'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='in the same syringe.  \\n• \\nIf intramuscular magnesium sulphate is continued as \\nmaintenance therapy, give 5G to alternate buttocks 4 hourly, \\nwith 1ml of 2% lignocaine in the same syringe.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n56\\n• \\nMonitor the mother to ensure hourly urine output of 30 ml per \\nhour, respiratory rate >16/ minute, oxygen saturation >90% \\nand presence of patellar reflexes. \\n• \\nThese should be recorded every 30 minutes.\\n• \\nShould signs of toxicity appear, the antidote is calcium \\ngluconate, 1 G intravenously (10 ml of 10% solution), given \\nover 10 minutes. \\n• \\nMagnesium sulphate may be used safely in women who have \\npreviously received nifedipine\\n6.2.3. \\nFluid Balance\\n• \\nRestrict total fluid intake to 80 ml per hour.\\n• \\nAccurate recording of fluid balance is essential.\\n• \\nSelective colloid expansion may be necessary prior to \\npharmacological \\nvasodilatation \\nto \\nprevent \\nmaternal \\nhypotension and fetal compromise or in oliguria with a low'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='vasodilatation \\nto \\nprevent \\nmaternal \\nhypotension and fetal compromise or in oliguria with a low \\ncentral venous pressure.\\n• \\nThe volumes of all drugs administered must be taken into \\naccount and appropriate reduction of the volume of crystalloids \\nmust be made.\\n• \\nColloid (e.g. Hetastarch) should be administered only after \\ndiscussion with the anaesthetist.\\n• \\nDiuretics must be restricted to specific instances only e.g. for \\nwomen with pulmonary oedema.\\n• \\nAvoid non-steroidal analgesia until fluid recovery.\\n6.2.4. \\nIn utero/neonatal transfer:\\n• \\nIf a Unit does not have access to HDU/ICU or is unable to \\ncope with maternal complications, or with maturity of the \\nbaby, it may be appropriate to consider antenatal transfer of \\nthe mother. \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='baby, it may be appropriate to consider antenatal transfer of \\nthe mother. \\n• \\nHowever, maternal safety must not be jeopardised and each \\ncase should be considered on its clinical merits.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n57\\n• \\nSteps must be taken to bring down blood pressure from very \\nhigh levels (e.g. using nifedipine). \\n• \\nWomen with imminent/impending eclampsia must be \\nadministered a loading dose of magnesium (IM or IV) before \\ntransfer (see 6.2.2) \\n• \\nIt is recommended that where possible telephone advice is \\nobtained from the relevant specialist unit before transfer.\\n• \\nThe patient must be accompanied by a member of staff who is \\ncapable of dealing with a seizure while the patient in transit. \\nThe required drugs and equipment must be made available.  \\n• \\nFull details of the case, including treatment given should \\naccompany the patient.\\n \\n6.2.5. \\nDelivery\\n• \\nUrgency of delivery depends on the maternal and fetal \\nconditions.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='6.2.5. \\nDelivery\\n• \\nUrgency of delivery depends on the maternal and fetal \\nconditions.\\n• \\nEither caesarean section or induction of labour is appropriate \\ndepending on the urgency and favourability of the cervix.\\n• \\nInstitute adequate pain relief. Severe preeclampsia is not a \\ncontraindication for opioid or epidural anaesthesia (see below). \\nIt is accepted that epidural anaesthesia helps to bring down the \\nblood pressure.\\n• \\nSpinal or epidural anaesthesia is safe in the presence of a \\nplatelet count >80,000/dl.\\n• \\nMaternal condition should be optimised before delivery. \\n• \\nIt is inappropriate to deliver an unstable mother for foetal \\nreasons.\\n• \\nErgometrine should not be used during the third stage.\\n6.2.6. \\nPost-delivery\\n• \\nMaintain vigilance as a high proportion of eclamptic seizures'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='6.2.6. \\nPost-delivery\\n• \\nMaintain vigilance as a high proportion of eclamptic seizures \\noccur after delivery. \\n• \\nHigh dependency care should be provided as clinically \\nindicated.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n58\\n• \\nContinue close monitoring, including fluid balance, platelets, \\nliver enzymes and creatinine until they have returned to \\nnormal values. \\n• \\nMagnesium sulphate if started should be continued for 24 \\nhours after the delivery or after the last fit, whichever is later.\\n• \\nReview anti-hypertensive medication as indicated. Some may \\nneed to continue oral medication for a few weeks. Methyldopa \\nis best avoided following delivery because of its tendency to \\ncause depression. \\n• \\nReview magnesium sulphate medication as indicated.\\n6.2.7. \\nFollow up\\n• \\nInform Public Health Midwife and/or Medical Officer of \\nHealth.\\n• \\nReview in 2 weeks (instead of 4 weeks) if discharged on \\nantihypertensives.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Health.\\n• \\nReview in 2 weeks (instead of 4 weeks) if discharged on \\nantihypertensives.\\n• \\nDepending on the clinical picture, some patients may need:\\no \\nLong term follow up for blood pressure\\no \\nHematological investigations for conditions such as anti-\\nphospholipid syndrome, thrombophilia \\n• \\nDebrief the patient. \\n• \\nAdvice preconceptual counseling & check prior to the next \\npregnancy.\\n• \\nWomen may be advised regarding the risk of developing \\nhypertensive disease in a future pregnancy as follows:\\no \\nRisk of gestational hypertension - 53% (1 in 2)\\no \\nRisk of preeclampsia – 16% (1 in 6)\\no \\nRisk of preeclampsia if she had severe hypertension or \\nHELLP syndrome or eclampsia or the birth occurred \\nbefore 34 weeks – 25% (1 in 4); & 55% (1 in 2) if the birth \\noccurred before 28 weeks gestation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n59\\nManagement of Eclampsia\\n1.\\t\\nDefinition:\\nEclampsia is defined as the development of convulsions and/or \\nunexplained coma during pregnancy or postpartum in patients with \\nfeatures of preeclampsia.\\n2.\\t\\nDiagnosis:\\n• \\nHypertension is considered the hallmark for the diagnosis of \\neclampsia. However, in 16% of the cases hypertension may be \\nabsent.\\n• \\nEclampsia is usually associated with proteinuria, but this may \\nbe absent in 14% of cases.\\n• \\nClinical features of imminent eclampsia include:\\n \\nSevere frontal headache, \\n \\nVisual symptoms (halos, scotomas etc.) \\n \\nEpigastric or right hypochondrial pain,\\n \\nLiver tenderness,\\n \\t\\nClonus (3 beats or more) \\n3.\\t\\nTime of onset of eclampsia'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Liver tenderness,\\n \\t\\nClonus (3 beats or more) \\n3.\\t\\nTime of onset of eclampsia\\nThe onset of eclamptic convulsions can be antepartum, intrapartum, or \\npostpartum. \\nAntepartum eclampsia \\nAlmost all cases (91%) develop eclampsia at or beyond 28 weeks \\nPostpartum eclampsia \\nAlthough most cases of postpartum eclampsia occur within the first 48 \\nhours, some cases develop beyond 48 hours, up to 4 weeks postpartum \\n(late postpartum eclampsia). In these cases, an extensive neurological \\nevaluation is needed to rule out the presence of other cerebral pathology.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n60\\n4.\\t\\nComorbidities \\n• \\nEclampsia is often complicated by comorbidities (Box 1). \\n• \\nThese are more common among women who develop eclampsia \\nat earlier periods of gestation.\\nBox 1.\\n• Abruptio placentae \\n• Disseminated intravascular coagulopathy  \\n• Pulmonary oedema \\n• Acute renal failure \\n• Aspiration pneumonia \\n• HELLP syndrome (Haemolysis, elevated liver enzymes, low \\nplatelets)\\n5.\\t\\nPrevention\\nAdministration of magnesium sulphate to women with features of \\nimpending/imminent eclampsia (presence of clonus, severe headache, \\nvisual disturbances, dizziness) is the only known preventive measure.\\n6.\\t\\nManagement\\n6.1 General considerations\\n6.1.1 The priorities in management are to support respiratory and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='6.1 General considerations\\n6.1.1 The priorities in management are to support respiratory and \\ncardiovascular function, prevent injury and further seizures \\nand to control hypertension. \\n6.1.2 Magnesium sulphate is the anticonvulsant of choice. It must \\nbe administered as soon as possible. See section 6.2.2 of the \\nsevere preeclampsia guideline for details.\\n6.1.3 The bolus dose of magnesium sulphate must be given even \\nto women with unknown renal function or oliguria/anuria \\nsince this dose is unlikely to elevate magnesium levels to toxic \\nranges.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n61\\n6.1.4 Eclampsia dictates delivery (or induction) once the maternal \\ncondition is stabilized, irrespective of the foetal condition or \\nmaturity. A decision regarding the mode and time of delivery \\nwill require to be made early. \\n6.1.5 There is no place for prolongation of the pregnancy in these \\nwomen, unless under rare, exceptional circumstances.\\n6.1.6 For details on administration of medications and intravenous \\nfluids and care of women receiving magnesium sulphate and \\nintravenous antihypertensives, refer the guideline on severe \\npreeclampsia.\\n6.2.  During the seizure – \\no \\nTurn the patient to a side and support her in that position.\\no \\nSuck out secretions from the mouth.\\no \\nAdminister oxygen via a face mask.\\no'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='o \\nSuck out secretions from the mouth.\\no \\nAdminister oxygen via a face mask.\\no \\nMost eclamptic seizures resolve spontaneously.\\no \\nIt is imprudent to diagnose fetal hypoxia based on fetal \\nbradycardia during a seizure. This usually recovers \\nspontaneously following the seizure\\no \\nFetal bradycardia persisting beyond 10 minutes following \\nthe seizure should raise suspicion of abruptio placentae.\\n6.3. As soon as possible following a seizure\\no \\nAttempt to establish intravenous access. \\no \\nObtain blood for full blood count, liver transaminases, \\nblood urea, electrolytes and blood for cross-match.\\no \\nStart magnesium sulphate (intravenous bolus and \\ninfusion or intramuscular – details in guideline on severe \\npreeclampsia section 6.2.2.). \\no \\nTreat blood pressure as appropriate. \\no'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='preeclampsia section 6.2.2.). \\no \\nTreat blood pressure as appropriate. \\no \\nInsert an indwelling catheter.\\no \\nMonitor respiratory rate, urine output, reflexes, SpO2. \\n(Please refer the guideline on severe preeclampsia for \\nfurther details).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n62\\no \\nCheck for comorbidities (Box 1). \\no \\nInform the Consultant and establish a plan of management\\n6.4. Management of seizures in women receiving magnesium sulphate\\n6.4.1 Women developing a seizure while on magnesium sulphate\\no \\n10% of women receiving magnesium sulphate will develop \\na second seizure.\\no \\nAdminister magnesium sulphate 2 grams diluted to 10 ml \\nwith 0.9% sodium chloride solution over 5 minutes. \\no \\nIncrease the magnesium sulphate infusion to 2 grams per \\nhour with monitoring as above.\\n6.4.2 Women developing more than one seizure while on magnesium \\nsulphate \\no \\nCall a Neurology team for advice. If one is not available, \\nobtain advice from a medical team.\\no \\nConsultant must be informed.\\no'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='obtain advice from a medical team.\\no \\nConsultant must be informed.\\no \\nInform the anaesthetic team if still not in an intensive care \\nsetting. \\no \\nSecond line anticonvulsants must be considered after \\ndiscussing with anaesthetist.\\no \\nIf the woman develops further seizures, consider moving to \\nintensive care for neuromuscular paralysis and ventilation.\\no \\nThese women will require a full neurological evaluation, \\nincluding imaging.\\n7.\\t\\nDelivery\\no \\nEclampsia is not an indication for caesarean section.\\no \\nConsider caesarean section in women who are not in \\nlabour with a Bishop score below 7.\\no \\nWomen who are in labour may be allowed to continue to \\ndelivery, in the absence of obstetric complications.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n63\\no \\nLabour may be induced where necessary using either \\nprostaglandins or amniotomy and oxytocin infusion. \\no \\nEpidural or spinal anaesthesia may be administered in \\nwomen with platelet counts above 80,000/cu mm. \\no \\nGeneral anaesthesia is best avoided where possible since it \\nincreases the risk of aspiration and failed intubation due to \\nairway oedema. It is also associated with marked increases \\nin systemic and cerebral pressures during intubation and \\nextubation. Women with airway or laryngeal oedema may \\nrequire ‘awake intubation’ under fibre optic observation \\nwith  facilities available  for immediate tracheostomy. The \\nlevel of increase in systemic or cerebral pressures may be \\nreduced by pretreatment with labetalol or nitroglycerine'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='reduced by pretreatment with labetalol or nitroglycerine \\ninjections.\\n8.\\t\\nTransfer of a woman who has had a seizure to another institution\\no \\nIn case it is required to transfer a woman who has \\nhad an eclamptic seizure, this must be done only after \\nadministering a bolus of magnesium sulphate. (See section \\n6.2.2 of the severe preeclampsia guideline for details). The \\npatient should ideally be accompanied by a doctor and \\nemergency drugs/equipment (e.g. Ambu bag) must be \\navailable.\\n9.\\t\\nPostpartum management\\no \\nContinue administration of magnesium sulphate and \\nmonitoring as described in the guideline on severe \\npreeclampsia. \\no \\nWomen with abnormal renal function, preexisting \\nhypertension and abruption placentae (due to use of larger'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='hypertension and abruption placentae (due to use of larger \\nthan normal volumes of fluids) are at particularly high \\nrisk of pulmonary oedema. They will require appropriate \\nmonitoring\\no \\nAntihypertensive therapy may be changed to oral and \\ncontinued .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n64\\n10.\\t Counselling \\n10.1.  Women should be advised that in a subsequent pregnancy:\\no \\nThe rate of preeclampsia is approximately 25%.\\no \\nRate of eclampsia is 2%.\\no \\nThese rates are substantially higher in women who develop \\neclampsia in the second trimester.\\no \\nTaking high-dose calcium from early pregnancy (600 mg \\ndaily) and aspirin (75 mg daily) may reduce this risk.\\n10.2. Regarding long term risk of hypertension\\no \\nThere is no increase of risk in women who were \\nnormotensive before the pregnancy.\\no \\nMultigravidae who develop eclampsia may be at high risk.\\nAcknowledgement: \\nThe following article was used as a resource in developing this guideline: \\nBaha M Sibai, Diagnosis, Prevention and Management of Eclampsia.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Baha M Sibai, Diagnosis, Prevention and Management of Eclampsia. \\nObstetrics & Gynecology, 2005; 105 (2): 402 - 410.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n65\\nManagement of Diabetes \\nduring Pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n66'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n67\\nGuideline for screening, diagnosis and management of \\ndiabetes in pregnant women\\n1.\\t\\nPurpose\\nThe purpose of this guideline is to provide guidance on screening for \\ngestational diabetes mellitus (GDM) and the management of pregnancies \\ncomplicated pre-gestational (PGDM) and GDM in the Sri Lankan setting. \\n2.\\t\\nScreening\\n2.1 Target groups for screening\\nBeing South Asian and pregnant places a woman in Sri Lanka at a higher \\nrisk for diabetes during pregnancy. Therefore, universal screening, using a \\ndiagnostic test is recommended for all Sri Lankan women. \\nA. All pregnant women should be screened for diabetes at the \\nfirst visit unless they are already known to have Diabetes*. This'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='first visit unless they are already known to have Diabetes*. This \\nshould be performed as early as possible, preferably before 12 \\nweeks, in order to diagnose previously undetected diabetes.\\nB. Screening using fasting blood glucose, random blood glucose, \\n50g glucose challenge test, HBAIC or urinalysis for reducing \\nsubstances is not recommended.\\nC. Those who are negative for diabetes at the first visit should be \\nscreened for GDM again at 24-28 weeks.\\nD. Women who are known diabetics should not undergo further \\nscreening or diagnostic tests. They should be commenced \\non glycaemic control measures immediately under the \\nsupervision of obstetrician or physician.\\n*Diagnostic criteria for pre pregnancy diabetes are \\nany one of the following\\n \\nFBS \\n \\n≥126mg/dl\\n \\nRBS \\n \\n>200mg/dl\\n \\nHbA1c'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='any one of the following\\n \\nFBS \\n \\n≥126mg/dl\\n \\nRBS \\n \\n>200mg/dl\\n \\nHbA1c \\n \\n>6.1%'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n68\\n2.2 Recommended tests\\nA. One stage, non- fasting 75g OGCT as described by the \\nDiabetes in Pregnancy Study Group of India (DIPSI) is \\nrecommended for screening at the first visit and at 28 weeks. \\nA 2- hour blood glucose of more than 140mg/dl confirms \\ngestational diabetes. This is the recommended test for both \\nfield and institutional levels.\\nOne stage Non- fasting 75 g OGCT\\n \\nIn this method 75g oral glucose load is given to the woman \\nirrespective of the fasting status. Therefore a woman could be \\nsubjected to a GTT at any time, without the woman having to \\nfast. \\n \\nA load of 75g of glucose dissolved in 300 ml water is given over \\n3-5 minutes. The water may be flavoured with lime juice.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='3-5 minutes. The water may be flavoured with lime juice. \\n \\n \\nThe plasma glucose level is measured after a period of two \\nhours. \\n(The main advantage of this test is that it would be the best way to \\nensure universal screening. The advantages include reduced cost, the \\nability to make a diagnosis in one test and the woman not requiring \\nto fast for the test. The test has been validated against the WHO and \\nHAPO criteria and been found to correlate well with them (3),(4). \\nData also shows that glucose levels are not significantly affected by \\nthe fasting status and that the non-fasting glucose level effectively \\npredicts adverse effects for the mother and baby (5),(6).)\\nB. Three-point oral GTT - In the event of an equivocal screening'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='B. Three-point oral GTT - In the event of an equivocal screening \\nresult or when resources permit, the three point OGTT is \\nrecommended. For those who undergo three point OGTT the \\nfollowing cut off should be used for diagnosis.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n69\\nThree-point oral GTT\\nThis is probably the most accepted diagnostic test in the world \\ntoday. \\nThe woman should attend for the test having fasted for eight hours \\nor more, having had a diet unrestricted in carbohydrates. \\nBlood is first drawn for estimation of fasting plasma glucose. \\nThe woman is then given a solution of 75 G glucose dissolved in \\n300 ml of water to be taken within 10 minutes. Squeezing a lime \\ninto this water will make the solution more palatable without \\ninterfering with the result. \\nBlood is then drawn at 60 and 120 minutes for estimation of \\nplasma glucose.\\nC. In situations where neither of the above tests is possible, \\n(Inability to tolerate glucose or non availability of facilities)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='(Inability to tolerate glucose or non availability of facilities) \\ntwo-stage screening using a 2 hour PPBS is an alternative.  The \\ncut off blood glucose value to refer for a OGTT is ≥120mg/dl.\\n2 hour Post Prandial Blood Glucose Testing (PPBS)\\nAdvice the woman to have normal diet\\nThe time of starting the meal needs to be noted. The meal should \\nbe completed within 15 minutes.\\nThe two-hour cut off is calculated from the time of starting the \\nmeal.\\nAt the end of two hours blood sample should be tested for blood \\nsugar levels using glucometer or other laboratory method.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n70\\n3.\\t\\nManagement – Women with established Diabetes\\n3.1. Pre Pregnancy care\\nThe importance of avoiding unplanned pregnancy is an essential \\ncomponent of diabetes education for women with diabetes.\\nWomen with diabetes who are planning to become pregnant and their \\nfamilies should be offered information on how diabetes affects pregnancy \\nand how pregnancy affects diabetes.\\nDiscuss their plans for pregnancy and reinforce an appropriate \\ncontraceptive method. Any type of contraception can be used except for \\nwomen BMI > 25kg/m2 where DMPA should not be used. Pregnancy is \\ncontraindicated if the woman has proliferative retinopathy, stage 2 or \\nabove Chronic kidney Disease or major cardiac disease.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='above Chronic kidney Disease or major cardiac disease. \\nAll women with diabetes wishing to conceive MUST be encouraged to \\nseek specialist advice to ensure satisfactory glycaemic control (HbA1C < \\n6.1%) before conception. \\nIdeally the decision to embark on pregnancy in known diabetics should be \\ndecided on based on her HbA1C .  A value of 6.1 or below would be ideal \\nif safely achievable. Women whose levels are above 10% should be strongly \\nadvised against conception until good glycaemic control is achieved,  in \\nview of higher risk of congenital anomalies. \\nStress that good planning and control will help to achieve pregnancy \\noutcome to be equivalent to that of a non-diabetic women. They should \\nbe informed that establishing good glycaemic control before conception'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='be informed that establishing good glycaemic control before conception \\nand maintaining this  throughout pregnancy will reduce the risk of \\nmiscarriage, congenital malformation, still births and neonatal deaths.\\nWomen who are using either metformin or insulin for glycaemic control \\nshould be advised that these are safe for use during the peri-conception \\nperiod and into their pregnancy.\\nSelf-testing of blood sugar should be encouraged where ever economically \\nfeasible.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n71\\nWomen must be encouraged to achieve a normal weight before becoming \\npregnant, especially those with a body mass index above 25 kg/m2. They \\nmust receive advice about reducing weight using lifestyle modification. \\nKnown diabetics should be assessed for diabetic nephropathy and \\nretinopathy before and during pregnancy. (see below)\\nStart Folic acid 5 mg daily when trying to conceive.\\n3.2.\\t Antenatal Care\\nAt the first visit \\n• \\nRefer for specialist care immediately once identified. These \\nwomen are best managed with combined inputs from a \\nphysician and an obstetrician. \\n• \\nStart/ continue Folic acid 5 mg daily up-to 12 weeks of \\ngestation. Change to 1mg daily from 12 weeks onwards.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='gestation. Change to 1mg daily from 12 weeks onwards.\\n• \\nLow dose Aspirin 75mg should be commenced, if there is no \\ncontraindication.\\n• \\nCheck HbA1c (ideally 6.1% or less).\\n• \\nDating ultrasound scan using either crown rump length or \\nhead circumference is recommended.\\n• \\nWomen with pre-existing diabetes mellitus must be screened \\nfor diabetic end-organ damage (retinopathy, nephropathy and \\ncardiovascular disease)\\n• \\nRetinopathy screening is recommended at least twice during \\npregnancy (at first contact and at 28 weeks). \\n• \\nWomen with serum creatinine >120 µmol/litre or 24 hour \\nurinary protein excretion exceeding 300mg must be referred \\nfor renal specialist’s advice.\\n• \\nWomen with complicated diabetes should be managed at a \\ntertiary care institution by a multidisciplinary team'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='tertiary care institution by a multidisciplinary team\\nAntenatal Appointments\\n• \\nThese women must be identified as high risk and managed \\nalmost entirely by a specialist Obstetrician led team.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n72\\n• \\nPublic Health Midwife should visit such women once in every \\n2 weeks (refer guideline on domiciliary care for high risk \\npregnancies).\\n• \\nReview by the obstetric/diabetic team once every 2 weeks \\nthroughout the pregnancy \\n• \\nAnomaly scans at 18-20 weeks and Obstetric reviews at 22-24, \\n28, 32 and 36-37 weeks with ultrasound growth assessments. \\n• \\nIf required, antenatal steroids for fetal lung maturity may be \\nused. Women should be admitted to hospital for glycaemic \\ncontrol during therapy since glucose levels rise in response to \\nsteroids. \\n• \\nMore attention should be given to the woman with diabetes \\nduring antenatal preparation for breast feeding as they \\nneed to start and establish breast feeding quickly to prevent'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='need to start and establish breast feeding quickly to prevent \\nhypoglycaemia of newborn. \\n• \\nRefer to dental surgeon for screening and maintenance of oral \\nhygiene.\\n3.3.\\t Medical nutrition therapy (MNT) \\nMNT is the cornerstone of the management of diabetes in pregnancy. \\nWomen must be referred to a dietician/ diabetic educator nurse  where \\none is available. \\nEmphasis the importance of small frequent meals, food with low glycaemic \\nindex and the  dietary advice should be culture sensitive. \\n3.4.\\t Exercise \\nExercise has an insulin-like action and women with GDM and pre-existing \\ndiabetes complicating pregnancy. Therefore,  diabetic women must be \\nencouraged to engage in regular exercise. \\nThe intensity of exercise would depend on the woman’s level of fitness,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='The intensity of exercise would depend on the woman’s level of fitness, \\npresence of complications and familiarity with exercise. \\nIdeally this should be at least 30 minutes per day of an activity, which \\nleaves her slightly breathless.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n73\\nWomen on insulin must be aware of the  tendency to hypoglycaemia \\nduring exercise. \\n4.\\t\\nGlyceamic control and Monitoring \\n4.1. Glyceamic Control\\n4.1.1. The aim is to achieve optimum glycaemic control throughout the \\nday for the duration of the pregnancy (avoiding hypoglycaemia).\\nThe target values for glycaemic control are given below:\\nTable 1. Target values in glycemic control\\n \\n  Fasting and pre-meal \\n           2 hour post meal\\nVenous plasma \\n70 - 90 (3.9 – 5.0 mMol/L) \\nBelow 120 mg/dl (6.7 mMol/L)\\nCapillary blood \\n80 – 103 (4.4 – 5.7 mMol/L) \\n118 mg/dl (6.5 mMol/L)\\n(The equivalent capillary blood values were derived  using a conversion \\nformula7)\\nRefer to Diabetic Educator Nursing Officer (DENO) where one is available.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='formula7)\\nRefer to Diabetic Educator Nursing Officer (DENO) where one is available. \\nAt diagnosis, offer diet/ lifestyle advice with a recorded glycaemic \\nassessment within 1-2 weeks.\\nMajority of these women can achieve optimal glycaemia with modest \\nchanges in diet and exercise.\\nConsider insulin and /or metformin treatment if suboptimal glycaemia \\npersists despite diet and exercise modifications. The choice of these \\ntreatments will depend on physician and patient preferences. \\nIdeally the  insulin regimen should be adjusted to achieve targets: in most \\ncases with moderate to severe hyperglycaemia three doses of short acting \\npre prandial insulin combined with a single dose of basal insulin at bed \\ntime is required. However, twice daily dose of pre mixed 30:70 insulin'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='time is required. However, twice daily dose of pre mixed 30:70 insulin \\nhas high patient compliance with adequate control of blood sugar in most \\ncases. If blood sugar is not controlled by this twice daily regimen, adding \\nmetformin or soluble insulin to cover lunch is an alternative.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n74\\nACE inhibitors, statins and ARBs are contraindicated during pregnancy\\n4.2.\\t Monitoring of glycaemic control\\nSelf-monitoring of blood glucose (SMBG) with close liaison with the \\ndiabetic team is recommended for those who are able to afford a glucometer \\nand test strips. (However, in view of variable quality of glucometers women \\nmust be advised to crosscheck the values occasionally with estimations \\nmade by a reliable laboratory. \\nFor women who cannot afford the cost of SMBG, monitoring with regular \\n6 point blood glucose monitoring should be offered. \\nThe frequency of such monitoring should be decided by the overall \\nglyceamic control, presence or absence of fetal macrosomia and the period'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='glyceamic control, presence or absence of fetal macrosomia and the period \\nof gestation;: with at least four weekly  reviews  in pregnancy two weekly \\nreviews  in late pregnancy\\nSchedule ultrasound measurement of AC at 28, 32 and 36 weeks. If AC > \\n90 centile at any stage, consider insulin therapy to target 2 hour PPBS to \\nbe less than 100mg/dl but avoiding hypoglycaemia.\\nIf crossing centiles or AC <10 centile, do AFI and request obstetrician \\nreview.\\nInsulin requirements change throughout the pregnancy. If requirements \\nare falling (or maternal hypoglycaemia occurs frequently) request early \\nobstetrician review for fetal assessment.\\nHbA1c is not a reliable indicator of glycaemic control in the second \\nand third trimesters. \\n5.\\t\\nDelivery and intra natal care\\n6.1. Timing of delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='and third trimesters. \\n5.\\t\\nDelivery and intra natal care\\n6.1. Timing of delivery\\nFor women with pre-pregnancy diabetes or who receive insulin therapy, \\nschedule obstetrician review at 36-37 weeks for planning their delivery at \\n38-39 weeks.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n75\\nFor women on diet control and/or women having optimal glycaemic \\ncontrol and, carrying a normally grown baby, there is insufficient evidence \\nto suggest the best time for delivery. \\nDiabetes alone is not an indication for a caesarean section.\\nThe obstetrician should make the decision after discussing with the \\nwoman.\\nDelivery should be arranged in the day time, when all supports are more \\neasily available.\\n5.2. Labour care\\nSecond tier obstetric on-call (SHO/Registrar) should be informed of any \\nwoman with diabetes at  the onset of labour. He/she should be present \\nfor the delivery. It is recommended to involve the medical team in the \\nmanagement of difficult cases.\\nInform on-call neonatal team of any planned/ imminent delivery of a'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='management of difficult cases.\\nInform on-call neonatal team of any planned/ imminent delivery of a \\ndiabetic mother.\\nDuring labour and birth, capillary blood glucose should be monitored \\n1-2 hourly in women with diabetes and maintained at between 4 and 7 \\nmmol/litre. (72 – 126 mg/dl). These CBG records should be entered in the \\npartogram. \\nHartmann’s/ normal saline or Insulin-dextrose – potassium (GIK) \\ninfusion should be started if the values are lower or higher respectively.\\n6.\\t\\nPost natal care\\n6.1a. Neonatal care\\nHandover care of newborn, to neonatal team.\\nEnsure delivery-to-abdomen and initiate breastfeeding as early as possible \\n(within first ½ to 1 hour) unless specific concerns prevent such action.\\nTake all suitable ENC measures to avoid hypothermia.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n76\\nBlood glucose testing should be carried out routinely in babies of women \\nwith diabetes at 2–4 hours after birth. The mother must be informed about \\nthis antenatally to avoid unnecessary distress.\\nNeonatal blood glucose values below 36 mg/dl (2 mMol/L) should trigger \\naction. \\n \\nBlood tests for polycythaemia, hyperbilirubinaemia, hypocalcaemia and \\nhypomagnesaemia should be carried out for babies with clinical signs.\\n6.1b. Immediate post partum care \\nIt is recommended that the mother be tested for RBS within 4 hours of \\ndelivery. The decision to manage maternal diabetes with insulin or oral \\nmedication should be made within the first 48 hours after delivery and \\nprior to discharge from hospital.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='prior to discharge from hospital.\\nIf the mother received insulin in the antenatal period, it is recommended \\nthat the dose needs adjustments to pre pregnant doses in those with type \\n2 diabetes mellitus or be maintained on diet alone in those with GDM. \\nThis decision should be based on her post partum blood glucose value. If \\nFBG exceed 126mg/dl or RBS exceeds 200mg/dl, insulin in a lower dose \\n(usually half of the antenatal dose) or metformin would be required. This \\ndecision is best left to the managing physician who should be responsible \\nfor the woman’s long term care. \\n6.2. At hospital discharge\\nInform MOH and area public health midwife (PHM) through woman’s \\npregnancy record.\\nFor women with pre- gestational diabetes, prescribe suitable hypoglycaemic'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='pregnancy record.\\nFor women with pre- gestational diabetes, prescribe suitable hypoglycaemic \\nagent, restart statins, schedule follow up clinic date at the medical clinic.\\nFor women who developed GDM, give a date or make arrangements to \\nscreen for DM at 6 weeks postpartum. \\nDiscuss and help to decide on the suitable contraceptive method.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n77\\n6.3. Late Postnatal care and follow up\\nAt 6 -8 weeks postpartum, all women with GDM are screened for diabetes \\nmellitus. The test of screening is ideally the 75g OGTT.  FBS is an alternative \\nif resources are limited. Women whose fasting venous plasma glucose is \\nabove 100 mg/dl (5.5 mMol/L) must be referred for further evaluation. \\nWomen who have been diagnosed with GDM and are screen-negative at \\nthe 6 week review should receive lifestyle advice and screening for diabetes \\nmellitus annually with at least a FBS. The importance of maintaining a \\nnormal BMI and the contribution of breastfeeding to weight loss must be \\nemphasized.\\n7.\\t\\nFamily Planning\\n8.1 All reliable methods of family planning can be used as'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='emphasized.\\n7.\\t\\nFamily Planning\\n8.1 All reliable methods of family planning can be used as \\nappropriate for the needs    of the individual woman with \\ndiabetes.\\n8.2  For women with BMI >25kg/m2, DMPA is best avoided.\\n8.3 Women with type 2 diabetes should be advised to complete \\ntheir family within  5-10 years   of diagnosis of diabetes in view \\nof possible development of complications.\\nReferences (need to add the sections taken from NIROGI guide)\\n1. \\nNICE, clinical guideline 63 Diabetes in pregnancy: management \\nof diabetes and its complications from pre-conception to the \\npostnatal period. 2008, National Institute for Health and \\nClinical Excellence.\\n2. \\nSeshiah V., Das AK.,BalajiV et al., Gestational Diabetes Mellitus \\n- Guidelines. Journal of the Association of Physicians of India.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='- Guidelines. Journal of the Association of Physicians of India. \\n2006. 54: 622- 628\\n3. \\nIADPSGCP, International Association of Diabetes and \\nPregnancy Study Groups Recommendations on the Diagnosis \\nand Classification of Hyperglycemia in Pregnancy. Diabetes \\nCare, 2010. 33(3): p. 676-682.\\n4. \\nKuhl C. Insulin Secretion and insulin resistance inpregnancy \\nand GDM. Implications for diagnosis andmanagement. \\nDiabetes 1991;40(December (Suppl. 2)):18–24.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n78\\n5. \\nGough WW, Shack MJ, Bennett PH, Burch TA, Miller \\nM.Evaluation of glucose in the Pima Indians by longitudinal \\nstudies. Diabetes 1970;19(Suppl. 1):388.\\n6. \\nPettitt DJ, Bennett PH, Hanson RL, Narayan KM, KnowlerWC. \\nComparison of World Health Organization and National \\nDiabetes Data Group procedures to detect abnormalities \\nof glucose tolerance during pregnancy. Diabetes Care \\n1994;17(November (11)):1264–8.\\n7. \\nHaeckel R.,  Brinck U, Colic D. et al.,  Comparability of Blood \\nGlucose Concentrations Measured in Different Sample Systems \\nfor Detecting Glucose Intolerance. Clinical Chemistry 2002. 48: \\n(6); 936-939.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n79\\nManagement of \\nPostparum Haemorrhage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n80'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n81\\nGuideline on Managementof Primary post Partum \\nHaemorrhage\\n1.\\t\\nIntroduction\\nThe aim of this guideline is to provide evidence based recommendations \\nin the management of primary post partum haemorrhage (PPH). This is \\nthe commonest direct cause of maternal death globally and in Sri Lanka. \\nThe objective of this guideline is to ensure anticipation, prevention, early \\ndetection and timely and appropriate management of PPH. \\n2. \\t\\nDefinition\\nFor the purpose of this guideline PPH is defined as blood loss of 500 ml or \\nmore from the genital tract within 24 hours of the birth of a baby. Blood \\nloss of over 1000 ml is defined as major PPH. \\nIrrespective of blood loss, the appearance of cardiovascular instability (i.e.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Irrespective of blood loss, the appearance of cardiovascular instability (i.e. \\ntachycardia and hypotension) signifies major obstetric hemorrhage.\\n• Since blood volume differs between persons, blood loss must \\nbe individualized. \\n \\nIn general, blood volume = body weight in Kg÷12 (e.g. in a 60 \\nkg woman 60/12 = 5 litres)\\n• The loss of 40% or more of the blood volume is life threatening \\nand will be defined as a massive obstetric hemorrhage e.g. \\n2400 ml in a 60 Kg woman.\\n3.\\t\\nPrevention of Post Partum Haemorrhage\\nActive management of the third stage of labour is the cornerstone \\nof prevention of primary PPH. For details please refer guideline on \\nmanagement of third stage of labor.\\nAnemia in pregnancy should be corrected during antenatal period.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n82\\n4.\\t\\nPrediction of Post Partum Haemorrhage\\nPPH occurs most often in women without risk factors. Therefore the \\nblood group of every woman who goes into labor must be known.\\nHowever, there are known risk factors associated with PPH, as listed in \\nBox 1. Such women should be advised to deliver in a specialist obstetric \\nunit under extra vigilance. Out of these, abruptio placentae and placenta \\npraevia have a particularly higher risk.\\nBox 1\\nRisk Factors for PPH\\nRisks existing prior to labour\\nGrand multiparity\\nPrevious PPH \\nFibroids complicating pregnancy\\nAnaemia complicating pregnancy\\nPre-existing haemorrhagic conditions \\nTreatment with anticoagulants \\nObesity \\nPre-eclampsia/gestational hypertension'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='Treatment with anticoagulants \\nObesity \\nPre-eclampsia/gestational hypertension\\nUterine over distension e.g. multiple pregnancy, etc.\\nLarge baby (>4 kg)\\nChorio-amnionitis\\nDengue infection\\nAny woman with risk factors should have intravenous access established \\nwith either a 16 or 14-gauge cannula and a sample of blood taken and \\npreserved.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n83\\n5.\\t\\nManagement of Primary Pph\\nIn Sri Lanka, the usual practice has been to commence treatment when \\nthere is continuing bleeding despite uterine massage irrespective of the \\namount of blood lost. It is recommended that this practice be continued. \\nIt is good practice to estimate and record blood loss in all deliveries.\\n5.1 General measures\\n• \\nCall for help.\\n• \\nMaintain a calm atmosphere.\\n• \\nKeep the mother (and labor companion/family) informed and \\nreassure the mother regularly.\\n• \\nAssess, monitor and record: general condition, estimated \\nblood loss, pulse, blood pressure and respiratory rate (every 15 \\nminutes)\\n• \\nInsert a Foley catheter and monitor urine output hourly. \\n• \\nCommence an ongoing chronological record of patient’s'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nCommence an ongoing chronological record of patient’s \\ncondition and interventions. It is recommended that one \\nmember of staff is delegated specifically for this task and to \\ncoordinate with other relevant disciplines.\\n• \\nEnsure there is intravenous access with two wide (14 – 16 G) \\nbore cannulae. \\n• \\nSend blood for cross matching and baseline full blood count. \\nIn cases of massive haemorrahge, other investigations such as \\nclotting profile will be needed.\\n• \\nStart Ringer’s lactate (Hartmann’s) solution.\\n• \\nIdentify the cause of bleeding. \\n• \\nKeep the woman warm.\\n• \\nPay attention to the temperature of labor room, operating \\ntheatre, intravenous fluids, blood, blood products and \\nfluids used for lavage. Hypothermia is known to promote \\ncoagulopathy.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='fluids used for lavage. Hypothermia is known to promote \\ncoagulopathy.\\n• \\nWhere available, the early involvement of the anesthetic team, \\neven while the patient is still in the labor room is recommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n84\\n• \\nGive oxygen via a face mask at a minimum rate of 8L/minute \\n(where suitable masks are available, oxygen must be given at a \\nrate of10-15L/min).\\n• \\nIf deterioration of the patient is greater than expected for the \\nvisible blood loss, internal hemorrhage is the probable cause. \\n• \\nCheck for completeness of the placenta. If incomplete or in \\ndoubt consider exploration of the uterus under anesthesia.\\n• \\nThe Consultant must be informed in the situations listed in \\nBox 2.\\nBox 2. Situations in which the Consultant must be informed\\n1. Blood loss of >1000 ml\\n2. Pulse rate of >100/minute\\n3. Systolic blood pressure <100 mm Hg\\n4. Drop of systolic blood pressure by 30 mmHg\\n5. Increase of pulse rate by >30 beats/minute \\n6. Increasing fundal height'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='5. Increase of pulse rate by >30 beats/minute \\n6. Increasing fundal height  \\n7. Deterioration of the patient out of proportion to the overt \\nblood loss.\\n5.2\\t Specific measures\\n5.2.1 Establish a cause for the bleeding \\nPalpate the uterine fundus.\\nA poorly contracted uterus usually indicates atonic PPH, which is the \\ncommonest cause. However, the possibility of concomitant genital tract \\ntrauma needs to be considered. \\nIf the uterus is well contracted, the genital tract must be inspected for \\ntrauma with adequate exposure, in good light.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n85\\n5.2.2. Management of atonic haemorrhage\\n• \\nStart uterine massage by ‘rubbing up the fundus’.\\n• \\nClear the cervical canal and vagina of blood clots by vaginal \\nexamination.\\n• \\nAdminister either ergometrine maleate 0.5 mg slow IV or \\nmethyl ergometrine 0.2 mg slow IV or oxytocin 5 IU IV and \\nstart an infusion of 40 IU in 500 ml of Hartmann’s solution at \\n125 ml per hour via an infusion pump.\\n• \\nStart bimanual compression of uterus.\\n• \\nIf the bleeding fails to abate completely in 5- 10 minutes \\nadminister/repeat ergometrine 0.5mg IV.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nadminister misoprostol 800µg per rectally or sublingually.\\n• \\nIf the bleeding fails to abate completely in a further 10 minutes'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nIf the bleeding fails to abate completely in a further 10 minutes \\nproceed to uterine balloon tamponade and inform the \\nConsultant. At the same time, administer tranexamic acid 1 \\ng by slow IV over 10 minutes. This dose may be repeated after \\n30 minutes if necessary and later if bleeding recommences. \\nFor details of the method of balloon tamponade please refer \\nappendix 1.  \\n• \\nBalloon tamponade is an important step in managing patients \\nwho continue to bleed despite medical measures. It should \\nalways be considered before resorting to surgical measures. \\n• \\nIf the institution does not have personnel trained in the use \\nof balloon tamponade, the woman must be transferred to a \\nhigher institution, at the point where the administration of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='higher institution, at the point where the administration of \\nergometrine and oxytocin infusion has failed to stop bleeding. \\n• \\nTemporizing measures such as manual aortic compression and \\nsand bags to compress the uterus are recommended while the \\npatient is in transit.\\n• \\n Inform the receiving institution.\\n• \\nAfter the balloon is inserted and the vagina packed (to keep \\nthe balloon in the uterus), the woman’s vital parameters and \\nthe level of the fundus must be monitored carefully. Where \\nthese indicate the woman is continuing to bleed, she should'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n86\\nbe moved to the theatre, since the situation would indicate the \\nneed for a laparotomy. \\n• \\nShe should be shifted to the theatre without delay in this \\nsituation. \\n• \\nPrior to laparotomy the woman must be examined under \\nanesthesia for tears in the genital tract. \\n• \\nIn case laparotomy is needed it is best to keep the patient in \\nthe modified Lloyd Davis position so that observations for \\nbleeding could be done with minimum inconvenience and \\ndelay.\\n• \\nThe surgical measures would depend on the woman’s condition. \\n“Too little too late” is the main contributor to mortality in \\nPPH. Surgical measures include brace (compression) sutures \\n(see appendix 2), uterine de-vascularization (See appendix'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='(see appendix 2), uterine de-vascularization (See appendix \\n3), haemostatic mattress sutures to bleeding sinusoids, box \\nsutures to include the bleeding lower segment in placenta \\nprevia, internal iliac ligation and hysterectomy. \\n• \\nThe “sandwich technique” involves inserting a balloon \\ntamponade after the application of brace sutures.\\n• \\nIt is important that hysterectomy is resorted to sooner than \\nlater.\\n• \\nHypothermia is a particular risk in the theatre environment. \\nMeasures must be taken to minimize the loss of heat from the \\nwoman. \\n5.2.3 Management of traumatic PPH\\n• \\nExclude high vaginal and cervical tears before suturing \\nepisiotomy.\\n• \\nWhen the apex of the tear or episiotomy is not visible, apply a \\nsuture at the highest visible point, pull downwards and apply'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='suture at the highest visible point, pull downwards and apply \\ncontinuous sutures at progressively higher points until the \\napex is reached. \\n• \\nExamine for paravaginal and broad ligament haematomata \\nwith a combined per vaginal and per rectal examination. \\n• \\nThe management should be individualized according to the \\nsituation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n87\\n• \\nParavaginal hematomas of more than 5 cm diameter will \\nusually require surgical evacuation. A bleeding point is usually \\npresent and must be looked for. In cases where it is difficult to \\ncontrol bleeding, a Foley catheter with its balloon inflated may \\nbe left in the cavity. Packing of the vagina may also be useful. \\n• \\nCervical tears must be identified by systematic inspection of \\nthe cervix using Green-Armytage forceps and sutured. \\n• \\nIn case of multiple tears with venous oozing, it may be better to \\ninsert a balloon catheter into the vagina or to pack the vagina \\nwith moistened vaginal packs than to try to suture all the tears. \\n5.2.4 Rupture of the uterus\\n• \\nRupture of the uterus must be suspected when the general'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='5.2.4 Rupture of the uterus\\n• \\nRupture of the uterus must be suspected when the general \\ncondition is deteriorating out of proportion to the visible \\nblood loss and there is continuing bleeding in the presence of a \\ncontracted uterus.\\n• \\nThis is particularly so in a woman with a scarred uterus.\\n• \\nImmediate involvement of a Consultant and surgical \\nintervention are important in this situation.\\n5.2.5 Coagulopathy causing PPH\\n• \\nThis could be due to coagulopathy following death in utero, \\nabruptio placentae, severe preeclampsia, HELLP syndrome, \\nsepsis, amniotic fluid embolism, acute fatty liver, pulmonary \\nimmune thrombocytopenia, Von Willebrand’s disease etc. \\n• \\nIt could also be due to suboptimal management of the PPH. \\n• \\nEarly involvement of a haematologist or transfusion medicine'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nEarly involvement of a haematologist or transfusion medicine \\nspecialist will be important in this situation. Where available, \\nthromboelastometry would be useful in this situation. \\n6.\\t\\nResuscitation and Fluid management\\n \\nPPH up to 1000 ml\\n• \\nCommence a crystalloid infusion of 2-3 times the estimated \\nblood loss.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n88\\nPPH of more than 1000 ml\\n• \\nPPH of over 1000 ml should be managed in consultation with \\nother relevant specialists e.g. anesthesiologists, hematologists, \\ntransfusion specialists etc. \\n• \\nAssess airway, breathing and circulation.\\n• \\nGive oxygen via face mask. \\n• \\nKeep the woman warm and flat.\\n• \\nTransfuse warmed blood as soon as possible.\\n• \\nUntil blood is available, warm crystalloids (up to 2 litres) \\nand colloids (up to 1-2 litres) may be transfused as rapidly as \\nrequired, up to a maximum of 3.5 litres in total.\\n• \\nDepending on urgency, group-specific blood may be given \\nuntil cross-matched blood is available.\\n• \\nIf group-specific blood is not available, O Rhesus D negative \\nblood could be given.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nIf group-specific blood is not available, O Rhesus D negative \\nblood could be given.\\n• \\nBlood transfusion should be individualized according to the \\nsituation. When available, involve blood transfusion specialist/\\nHaematologist. Where three or more units of blood are being \\ntransfused, an equal number of packs of fresh frozen plasma \\nmust also be transfused. If available, thromboelastometry will \\nenable factor-specific replacement. \\n• \\nDue consideration must be given to keeping transport facilities \\navailable to obtain blood and blood products from another \\ninstitution.\\n7.\\t\\nDebriefing\\n• \\nIt is possible that a major PPH could result in significant \\npsychological morbidity.\\n• \\nThis could be minimized by timely debriefing of the patient \\nand her family, preferably by the Consultant.\\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='and her family, preferably by the Consultant.\\n• \\nThis should be done immediately after the event, before \\ndischarge and at the postnatal visit or at any time as requested \\nby her or the family.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n89\\n8.\\t\\nRisk Management\\n• \\nIt is good practice to conduct a case review with the members \\nof the team involved in the management and other staff as soon \\nas possible after the event.\\n \\n \\nThe spirit of such a meeting should be one of lessons learnt rather \\nthan of apportioning blame.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n90\\nAppendix 1\\nInsertion of a ‘condom catheter’\\nThis may be performed as an independent procedure or following \\ninspection of the cervix and upper vagina for trauma.\\nTherefore, whenever it is planned to inspect the cervix, or where there is \\nan indication that medical therapy may fail to bring the bleeding under \\ncontrol, keep the materials needed for insertion of a condom catheter \\nready.\\n1. Explain to the mother the need to insert a condom catheter \\nand explain the procedure briefly. Be reassuring.\\n2. Wear a pair of sterile gloves.\\n3. The required items are:\\n• \\nSize 20 – 22 (or largest available) Foley catheter, \\n• \\nA condom, \\n• \\nSterile  No. 0 or 1 suture, \\n• \\nA bottle of warmed saline,\\n• \\nIntravenous infusion set released from the pack \\n•'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='• \\nA bottle of warmed saline,\\n• \\nIntravenous infusion set released from the pack \\n• \\nArrange these items on a sterile towel laid on a side trolley.\\n4. Take the Foley catheter out of the packing.\\n5. Unfold the condom over the end of the Foley catheter to about \\ntwo thirds of its length. Hand tie it to the catheter firmly, using \\nseveral rounds of sterile suture at a point about 2 cm distal to \\nthe open end of the condom. \\n6. Have an assistant connect the infusion set to the bottle of \\nwarmed normal saline suspended 4-6 feet above the patient.\\n7. Connect the other end to the catheter, run saline into the \\ncondom to make sure the system is water tight by holding the \\ncatheter tip upwards.\\n8. Afterwards, empty the balloon of the saline and leave it on the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='catheter tip upwards.\\n8. Afterwards, empty the balloon of the saline and leave it on the \\nsterile trolley, ready for insertion.\\n9. Wash the condom with either warm saline or 5% povidone \\niodine lotion.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n91\\n10. Place the woman either in the dorsal or lithotomy position and \\nexpose the cervix by using one or two Sim’s speculae.\\n11. Grasp the anterior lip of the cervix with a sponge holder.\\n12. Now insert the entire condom catheter system into the uterus. \\nYou may keep the condom catheter between the index and \\nmiddle fingers and introduce it like exploring the uterus (or \\ndoing a pelvic examination). \\n13. Reconnect the catheter to a giving set and start filling the \\ncondom with warmed saline.\\n14. Keep watching the cervix for the balloon to bulge out of it and \\nstop filling it any further for now. You may notice cessation of \\nbleeding from the uterine cavity. \\n15. At this point pack the vagina with a moist vaginal pack (Two'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='15. At this point pack the vagina with a moist vaginal pack (Two \\ninch ribbon gauze pack or a gauze towel) around the catheter \\nin a circumferential manner. \\n16. Continue filling till the gravity aided filling stops. Usually 400 \\n– 500 ml is needed.\\n17. Proximal end of the catheter is folded and a tight tie placed on \\nit to prevent backflow.\\n18.  Insert a size 12 Foley catheter to the bladder.\\n19. Mark the level of the fundus on the abdomen with a marker \\npen. Start a pulse and blood pressure chart.\\n20. Give tranexamic acid 1 G slow i.v. and repeat after 8 hours.\\n21. Keep pack and the condom catheter for 12 – 18 hours.\\n22. Consider appropriate antibiotic prophylaxis.\\n23. If there is no vaginal bleeding and vital signs are stable, plan to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='23. If there is no vaginal bleeding and vital signs are stable, plan to \\nremove the catheter at a convenient time, after 12 hours.\\n24. Release half the instilled volume of saline. Do not remove the \\npack at this stage.\\n25. Observe for bleeding through the pack.\\n26. 30 minutes later remove the vaginal pack, without removing \\nthe condom catheter.\\n27. If there is no further bleeding for another 30 minutes, release \\nthe total volume of instilled saline and remove the condom \\ncatheter gently.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n92\\nAppendix 2\\nBrace sutures, the best known of which is the modified B-Lynch sutures \\nare very useful in the presence of a bleeding atonic uterus.\\nThe uterus is exteriorized.  An absorbable No. 2 suture (or highest gauge \\navailable) on a curved ‘hand-needle’ is passed anteroposteriorly through \\nthe uterus above the reflection of the bladder about 2 cm medial to the \\nlateral edge. \\nThe process is repeated on the contralateral side. The sutures are tied \\ntightly over the fundus, with an assistant manually squeezing the uterus. \\nAdditional sutures may be applied medially.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n93'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n94\\nAppendix 3\\nSteps of uterine de-vascularization technique\\n \\n(Adapted from: Salah A. AbdRabbo.Stepwise uterine devascularization: \\nA novel technique for management of uncontrollable postpartum \\nhemorrhage with preservation of the uterus AJOG 1994 Volume 171 \\nNumber 3)\\nStep 1: Bilateral uterine vessel ligation\\nIn this step the uterine arteries are ligated at the level where they run along \\nthe uterine border beside the upper part of the lower uterine segment (Fig. \\n1 Note: Steps I and II in the diagram constitute step 1 in our description. \\nWe recommend that both sides are done in one step.).\\nFig. 1.Sites of uterine artery ligation in steps 1, 2 (upper arrow), and 3 \\n(lower arrow).U.U.S., Upper uterine segment; L.U.S., Lower uterine \\nsegment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n95\\nWith the surgeon on the right side of the patient, the uterus is grasped and \\nelevated to the contralateral side. A large needle (48 mm or greater) with \\nnumber 1 absorbable suture is passed through the avascular area of the \\nleft broad ligament from anterior to posterior and then brought forward, \\nguided by the four fingers of the left hand, through the myometrium from \\nposterior to anterior 2 cm medial to the left uterine vessels, and the suture \\nis tied.\\nThis process is repeated on the contralateral side.\\nIn these two steps there is no need for bladder mobilization, because the \\nsutures were not placed low. Also, there is no need for a peritoneal incision \\nin cases having vaginal deliveries; however, in cases having caesarean'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='in cases having vaginal deliveries; however, in cases having caesarean \\nsection the suture should be placed below the level of the transverse \\nuterine incision, under the reflected peritoneal flap.\\nStep 2: Low bilateral uterine vessel ligation\\nThis step is reserved only for cases having continued lower uterine segment \\nhaemorrhage diagnosed at caesarean section and not controlled by step 1.\\nIn this step the bladder is reflected downwards and lower bilateral uterine \\nvessel ligation is performed at the lower part of the lower uterine segment, \\n3 to 5 cm below the upper ligatures, with the same technique in step 1. At \\nthis level the uterine artery is ligated after its cervicovaginal branch turns \\nabruptly upward to extend along the uterine margin. This ligature would'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='abruptly upward to extend along the uterine margin. This ligature would \\nobliterate most of the branches of the uterine artery to the lower uterine \\nsegment and a branch of considerable size that extends to the upper \\nportion of the cervix. It is important to include a significant amount of \\nmyometrium to avoid damage to the uterine vessels and to obliterate some \\nof the intramyometrial ascending arterial branches of the cervicovaginal \\nartery (Fig. 1).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n96\\nStep 3: Ligation of uterine/ovarian arterial anastomosis\\nThis step is indicated in continued uterine bleeding in spite of performing \\nstep 1.The uterus is grasped and pulled to the contralateral side by the \\nleft hand, and a large needle with a number 1 absorbable suture is passed \\nthrough the avascular area in the broad ligament from anterior to posterior, \\nat the level of the ovarian ligament. The needle is then passed anteriorly 2 \\ncm medial to the edge of the uterine wall, to include the uterine muscle. \\nThe suture is tied anteriorly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n97'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\lka-mn-32-01-guideline-2013-eng-national-guideline-for-maternalcare-(1).pdf'}, page_content='National Guideline for Maternal Care - Volume I\\n98'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='i'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='ii \\n \\n \\n \\n \\n \\n \\nMaternal Care Package  \\nA Guide to  \\nField Healthcare Workers \\n \\n \\n \\n \\n \\n \\nFamily Health Bureau \\nMinistry of Health \\n \\n \\n \\n \\n \\n2011'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='iii \\n \\n \\n \\n \\n \\n \\n \\n1st Edition \\nOctober 2011 \\n \\n \\n \\n \\nISBN : 978-955-1503-07-9 \\n \\n \\n \\nDraft adaptation and writing by: \\nDr. Nilmini Hemachandra \\nConsultant Community Physician \\nNational Programme Manager Maternal Care \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\nPrinted by:  \\nNew Karunadhara Press, \\n97, Maligakanda Road, \\nColombo 10 \\n \\n \\n \\n \\nPublished by: \\nFamily Health Bureau, \\nMinistry of Health \\nSri Lanka \\n \\n \\n \\n \\nSponsored by: \\nWorld Health Organization \\nSri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='iv \\n \\n \\nRESOURCE PERSONS \\nResource  Persons: \\nDr.Deepthi   Perera \\n- \\nDirector /Family Health Bureau \\nDr.C. de Silva \\n- \\nDeputy Director /Family Health Bureau \\nDr.Nilmini Hemachandra \\n- \\nConsultant Community Physician / FHB \\nDr.Dammica Rowel \\n- \\nConsultant Community Physician/ FHB \\nDr.Kapila Jayaratne \\n- \\nConsultant Community physician/ FHB \\nDr.Nethanjalee Mapitigama \\n- \\nConsultant Community physician/ FHB \\nDr.Loshan Moonasinghe \\n- \\nConsultant community Physician/ FHB \\nDr.Nirosha Lansakara \\n- \\nConsultant Community Physician/ FHB \\nDr.Udaya Usgodaarachchi \\n- \\nConsultant Community Dental Surgeon/ FHB \\nDr.Sarath Amarasekara \\n-  Consultant Obstetrician and Gynaecologist / SLCOG \\nDr.Sarath Samarathunga \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Gamini Perera \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Dr.Sarath Samarathunga \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Gamini Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nDr.Hemantha Perera \\n- \\nConsultant Obstetrician and Gynaecologist/ SLCOG \\nProf. Hemantha Senanayake \\n-   Prof.of Obstetrics and Gynaecology,Faculty of Medicine, Colombo \\nProf.Harsha Seneviratne \\n-  Prof.of Obstetrics and Gynaecology,Faculty of Medicine,Colombo \\nProf.Chandrika Wijeratne         - \\nProf.of  Reprodutive Health, Faculty  of Medicine, Colombo \\nDr.Lakshman Senanayake     \\n-  Consultant Obstetrician and Gynaecologist \\nDr.Athula Kaluarachchi         \\n-   Consultant Obstetrician and Gynaecologist, Faculty of Medicine-Colombo \\nDr.Sujatha Samarakoon          -   Consulatnt Venereologist, NSACP \\nDr.Renuka Jayatissa               -'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Dr.Renuka Jayatissa               - \\nNutritionist, MRI \\nDr.Anoma Jayathilaka \\n-  National Professional Officer,World Health Organization \\nDr.Deepika Attygalle \\n-  Nutrition Specialist, UNICEF \\nDr.Nishamanie Karawita \\n-  National Health officer, UNICEF \\nDr.Nilani Fernando                  - \\nDeputy RDHS – Kandy \\nDr.Daya Wattearachchi         \\n-  Medical Officer /Maternal and Child Health –Rathnapura \\nDr.Badrika Gunawardena      \\n- \\nMedical Officer of Health- Piliyandala \\nDr.Lalitha Ratnayake           \\n-   Medical Officer of Health   - Piliyandala \\nDr.Sapumal Danapala          \\n- \\nConsultant Community Physician - Central Province \\nDr.Sarath Warusavithana    \\n-  Medical Officer of Maternal and Child health – Matara \\nDr.Priyankara Jayawardena'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='-  Medical Officer of Maternal and Child health – Matara \\nDr.Priyankara Jayawardena  \\n-  Consultant Physician – Castle Street Hospital for Women \\nDr.Uditha Bulugahapitiya       -  Consultant Endocrinologist \\nDr. Prasad Katulanda                 -   Consultant Physician,NHSL \\nDr.Rabindra Abeysinghe         -  Consultant Community Physician, Anti Malaria Campaign \\nDr.Sudath Pieris                       -  Consultant Epidemiologist, Epidemiology Unit, Ministry of Health \\nDr. S de Alwis                       \\n-  Director, National Respiratory and Chest Disease Control Programme \\nMrs. D. Ubeywarna                  - \\nDirector/Nursing (PHS) \\nDr.Hasitha Aluthge                 - \\nMOH, Deraniyagala \\nDr.Dumithra Kahangamage  \\n- \\nMOH ,Padukka \\nDr. Shanika Senanayake  \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='MOH, Deraniyagala \\nDr.Dumithra Kahangamage  \\n- \\nMOH ,Padukka \\nDr. Shanika Senanayake  \\n- \\nMedical Officer – Family Health Bureau \\nMrs.K.A. Sunethra                 \\n- \\nPHNS ,Thihagoda MOH area \\nMrs.Nalika Weeraratne \\n- \\nPHNS, Pelmadulla MOH area           \\nEditing \\nDr. Anoma Jayathilake   \\n- \\nNational Professional Officer, WHO \\nDr. Nilmini Hemachandra  \\n- \\nConsultant Community Physician, FHB \\nDr. Dhammica Rowel \\n- \\nConsultant Community Physician, FHB \\nDr. Shanika Senanayake  \\n- \\nMedical Officer, FHB'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='v'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='vi \\n \\n \\nCONTENT \\nPreface \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nvii \\nAcknowledgement \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n ix \\nList of Abbreviations  \\n \\n \\n \\n \\n \\n \\n \\n \\n xi \\n1. \\nIntroduction \\n01 \\n2. \\nBasic principles of maternal and newborn health interventions \\n07 \\n3. \\nMaternal care models in Sri Lanka \\n13 \\n4. \\nAntenatal care at the clinic \\n19 \\n5. \\nManagement of risk conditions at field level \\n41 \\n6. \\nDomiciliary care for low risk pregnancies \\n46 \\n7. \\nDomiciliary care for high risk pregnancies \\n54 \\n8. \\nDeveloping a birth and emergency plan \\n65 \\n9. \\nAntenatal classes \\n68 \\n10. Clinical procedures for antenatal care \\n \\n10.1 Anthropometric assessment of pregnant women \\n71 \\n \\n10.2 Measuring blood pressure at the clinic setting \\n75 \\n \\n10.3 Obstetric examination \\n76 \\n \\n10.4 Fetal movement chart or kick count chart \\n80'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='75 \\n \\n10.3 Obstetric examination \\n76 \\n \\n10.4 Fetal movement chart or kick count chart \\n80 \\n \\n10.5 Urine testing at the clinic setting \\n81 \\n \\n10.6 Antenatal screening for syphilis: Guidelines for sample collection,  \\n                storage and transportation \\n83  \\n \\n10.7 Estimating Haemoglobin levels using a colour scale                                              84 \\n11. Nutrition during pregnancy and lactation \\n85 \\n12. Common discomforts during pregnancy \\n91 \\n13. National guidelines for prevention and control of maternal anaemia \\n100 \\n14. Management of high blood pressure during pregnancy at field level \\n106 \\n15. Guidelines on immunization against tetanus \\n107 \\n16. Guideline on screening and management of diabetes mellitus during'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='107 \\n16. Guideline on screening and management of diabetes mellitus during  \\n \\npregnancy in the field /non specialized institutions \\n110 \\n17. Prevention of mother to child transmission of HIV infection (PMTCT) \\n114 \\n18. Elimination of congenital syphilis (ECS) \\n127 \\n19. Syndromic management of sexually transmitted infections during pregnancy \\n135 \\n20. National guidelines for prevention and management of Malaria in pregnancy \\n145 \\n21. Management of Tuberculosis during pregnancy \\n147 \\n22. Postnatal Care \\n155 \\n23. Postnatal Clinic \\n170 \\n24. Family planning after delivery \\n172 \\n25. Screening for postpartum depression \\n173 \\n26. Management information system of maternal care \\n175 \\n27. Surveillance on maternal morbidity and mortality \\n176 \\n28. Supervision of maternal care services \\n191'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='176 \\n28. Supervision of maternal care services \\n191 \\n29 Planning of domiciliary care for pregnant and partum women \\n213 \\nList of References  \\n215'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='vii'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='viii \\n \\n \\n \\nPREFACE \\n \\nPregnancy is the most wonderful physiological phenomenon which is responsible for the existence of \\nmankind within the universe, though it creates a high risk environment for a woman’s life. With \\ndevelopment of the discipline of obstetrics and the health systems, the threat to life has been \\nminimized and the world has achieved a lot in maternal and child health. \\nSri Lanka, although a developing country, has been able to achieve remarkable health indices such as \\nlow maternal mortality rate, infant mortality rate, under five mortality rate, higher level of life \\nexpectancy due to the tireless efforts of many stakeholders over the last few decades. The foundation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='for these achievements are the policy of free education and free health services for the entire nation, \\ncommitment by all levels of medical and other related professional personnel and the existence of a \\nstrong preventive and curative health infrastructure. \\nProvision of comprehensive maternal, family planning, and child care services through a  well-\\norganized structure at institutional and community level, implementation of evidence based \\ninterventions integrated as packages, use of professionally trained health personnel at the community \\nlevel from the inception of the national MCH/FP programme are the major contributors for the \\nsuccess.   \\nAlthough our targets  in most aspect of the MCH has been  achieved, still some gaps can be'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Although our targets  in most aspect of the MCH has been  achieved, still some gaps can be \\nidentified in certain areas such as postnatal care, quality of care and geographical  disparity in some \\nindices. Further, some indices such as IMR, MMR, Low birth weight rate have shown slow decline \\nduring the past decade.  \\nTo overcome these gaps and challenges, we need to focus more on targeted interventions, equitable \\nservice provision and quality of care. Therefore, this guide was developed by a group of experts in \\nthe relevant fields considering existing maternal care model and intervention packages, evidence \\nbased interventions, recommendations given by the external review of the Maternal and Newborn'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='based interventions, recommendations given by the external review of the Maternal and Newborn \\ncare programme (2007), National Maternal Mortality Reviews, MCH reviews and the felt need of the \\nrelevant experts for the betterment of the maternal care programme in the country.   \\nWe strongly recommend this book as a guide for the health workers who provide maternal and \\nnewborn care in the country and as a hand book for medical, nursing and midwifery students.   \\n \\n \\n \\nDr. Ajith Mendis                                                                        Dr. Deepthi Perera \\nDirector General of Health Services                                            Director/ Maternal and Child Health \\nMinistry of Health \\nFamily Health Bureau \\n                                        \\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Ministry of Health \\nFamily Health Bureau \\n                                        \\nSri Lanka. \\nMinistry of Health \\n \\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='ix'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='x \\n \\n \\n \\n \\n \\nACKNOWLEDGEMENT \\n \\nThis guide is an outcome of the efforts of many people. Dr. L. Siyambalagoda, Deputy Director \\nGeneral (Public Health Services), Dr. Deepthi Perera, Director/ Maternal and Child Health, Family \\nHealth Bureau and Dr. Chitramalee de Silva, Deputy Director/ Maternal and Child Health, Family \\nHealth Bureau guided us to develop this guide providing their fullest support and guidance.  \\nDr. Sarath Amarasekara (president /2010), Dr.Ananda Ranathunga, (President/2011), and other \\nmembers of the Sri Lanka College of Obstetricians and Gynaecologists provided us with their \\ntechnical expertise and cooperation during the development of this guide and pilot testing of the \\nrevised maternal care model. Our gratitude is conveyed to SLCOG.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='revised maternal care model. Our gratitude is conveyed to SLCOG. \\n We would like to appreciate the contribution of Consultant Community Physicians at the Family \\nHealth Bureau with their technical expertise in their fields and constructive criticism. We would \\nacknowledge all the Medical Officers (Maternal and Child  Health),  Medical Officers of Health, \\nPublic Health Nursing Sisters, Supervising Public Health Midwives and Public Health Midwives \\nwho contributed for the development of this guide in various ways.  \\nWe would like to appreciate the contribution of the Public Health teams of Ratnapura and Kandy \\ndistricts for the pilot testing of the maternal care package and their contribution to fine tune this. We'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='would like to acknowledge and appreciate the contribution of Dr. Anoma Jayathilake as a public \\nhealth specialist in the field of maternal care for the success of this endures.  \\nFinancial support received from UNICEF for consultative meetings during the process of \\ndevelopment of this package is highly appreciated. Our sincere gratitude is conveyed to the World \\nHealth Organization Country Office for the guidance and financial support received, for pilot testing \\nscaling up and printing of this document in all three languages.  \\n \\n \\nDr. Nilmini Hemachandra \\nNational Programme manager – Maternal care \\nFamily Health Bureau, \\nMinistry of Health, \\nSri Lanka.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xi'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xii \\n \\n \\n \\n \\nLIST OF ABBREVIATIONS \\n \\nAIDS\\nAcquired Immune Deficiency Syndrome\\nMOMCH\\nMedical Officer-Maternal & Child \\nHealth \\nAMC\\nAnti Malaria Campaign\\nMSD\\nMedical Supplies Division\\nANC\\nAntenatal Care\\nMTCT\\nMother To Child Transmission\\nAPH\\nAntepartum Haemorrhage\\nNCD\\nNon Communicable Disease\\nART\\nAnti retro viral treatment\\nNICU\\nNeonatal Intensive Care Unit\\nBF\\nBreast Feeding\\nNMMR\\nNational Maternal Mortality Review\\nBMI\\nBody Mass Index\\nNSACP\\nNational STD/AIDS Control \\nProgram \\nBP\\nBlood Pressure\\nOCP\\nOral contraceptive Pills\\nCEmOC\\nComprehensive Emergency Obstetric \\nCare \\nOGTT\\nOral Glucose Tolerance Test\\nCHDR\\nChild Health Development Record\\nPDHS\\nProvincial Director of Health \\nServices \\nCS\\nCongenital Syphilis\\nPHI\\nPublic Health Inspector\\nCSB\\nCorn Soya Blend\\nPHM\\nPublic Health Midwife\\nDMMR'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Congenital Syphilis\\nPHI\\nPublic Health Inspector\\nCSB\\nCorn Soya Blend\\nPHM\\nPublic Health Midwife\\nDMMR\\nDistrict Maternal Mortality Review\\nPHNS\\nPublic Health Nursing Sister\\nEBF\\nExclusive Breast Feeding\\nPID\\nPelvic Inflammatory Disease\\nECCD\\nEarly Childhood Care & Development\\nPIH\\nPregnancy Induced Hypertension\\nEDD\\nExpected Date of Delivery\\nPLHIV\\nPeople Living with HIV\\nEmOC\\nEmergency Obstetric Care\\nPMTCT\\nPrevention of Mother To Child \\nTransmission of HIV \\nEPI\\nExpanded Programme of Immunization\\nPOA\\nPeriod of Amenorrhoea\\nFHB\\nFamily Health Bureau\\nPPBS\\nPost Prandial Blood Sugar\\nFHS\\nFetal Heart Sounds\\nPPH\\nPostpartum Haemorrhage\\nFM\\nFetal Movements\\nRDHS\\nRegional Director of Health services\\nGBV\\nGender Based Violence\\nSCBU\\nSpecial Baby Care Unit\\nGDM\\nGestational Diabetes Mellitus\\nSFH\\nSymphysio- Fundal height'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='SCBU\\nSpecial Baby Care Unit\\nGDM\\nGestational Diabetes Mellitus\\nSFH\\nSymphysio- Fundal height\\nHb\\nHaemoglobin\\nSMI\\nSchool Medical Inspection\\nHEO\\nHealth Education Officer\\nSPHM\\nSupervising Public Health Midwife\\nHIV\\nHuman Immunodeficiency Syndrome\\nSTD\\nSexually Transmitted Diseases\\nIUD\\nIntra Uterine Device\\nTB\\nTuberculosis\\nIUGR\\nIntra Uterine Growth Retardation\\nTT\\nTetanus Toxoid\\nIVF\\nIn Vitro Fertilization\\nUSS\\nUltra Sound Scan\\nJMO\\nJudicial Medical Officer\\nVDRL\\nVenereal Disease Reference \\nLaboratory \\nJVP\\nJugular Venous Pressure\\nKCC\\nKick Count Chart\\nLRM\\nLast Regular Menstruation\\nLRT\\nLigation and Resection of Tubes\\nLSCS\\nLower Segment Cesarean Section\\nMO\\nMedical Officer\\nMO/STD\\nMedical Officer/STD clinic\\nMOH\\nMedical Officer of Health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='xiii'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n1 \\n \\n \\nChapter 01 \\nINTRODUCTION \\n \\nDevelopment of maternal care services in Sri Lanka \\nThe history of health care systems in Sri Lanka is extended to king’s era. The documentary evidence \\nsays that there were several hospitals for indigenous medicine and maternity homes for child birth \\nexisted during the reign of the Sinhalese kings as early as 340-368 AD. The expectant mothers were \\nmade to move into these homes in the ninth month of pregnancy and stay there till child birth. Most \\nmothers delivered in the few maternity homes that were available or in their homes under the care of \\nexperienced birth attendants. \\nAround the 15th century, a systematized network of Ayurvedhic treatment centers and hospitals'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Around the 15th century, a systematized network of Ayurvedhic treatment centers and hospitals \\nthroughout the country was established and Ayurvedhic Physicians were trained to work in these \\ntreatment centers. This resulted in gradual diffusion of health care within the country. The \\ndocumentary evidence in the history of ancient Ceylon stated that separate hospitals existed for \\nwomen under the Ayurvedic System of Medicine where deliveries have been conducted. \\nSri Lanka came under the colonial rule in1505 and was successively under the Dutch, Portuguese \\nand the British till achieving independence in 1948. During this period, the Western System of \\nmedicine was introduced and hospitals were built to provide medical care. In 1859, a separate Civil'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Medical Department was established and public health became a function of this department.  \\nThe first organized effort towards care of the childbearing woman was made in 1879 with the \\nopening of the De Soysa Lying- in- Home now known as the De Soysa Hospital for Women. This \\nwas built by a philanthropist (Sir Charles Henry De Soysa) to provide a home for lying-in-mothers as \\nwell as to provide out-patient care to mothers and children. This was probably the first maternity \\nhospital to be established in Asia and soon afterwards the first training school for midwives was \\nopened at this maternity hospital in 1881. In 1887, Legislation for registration of midwives was \\nintroduced which made it mandatory for all midwives to be registered prior to practicing midwifery.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='This was a great step taken towards development of maternal care services since it enhanced the \\nquality of midwifery services provided in Sri Lanka. \\nIn 1902, a maternal and child health department was created with in the Colombo Municipality \\nfollowing an investigation into the high rate of infant mortality within the Municipality. In 1906, a \\nsystem of field maternal services commenced within the Colombo Municipality with the \\nappointment of six midwives. This was followed by the appointment of two health visitors in 1913.  \\nThe MCH services were thereafter gradually expanded.  \\nThe first antenatal clinic was started at the De Soysa Lying-in-home in 1921 following the \\ncommencement of Antenatal Clinics in Boston, USA in 1911, Sydney in 1912 and Edinburgh in \\n1915.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='commencement of Antenatal Clinics in Boston, USA in 1911, Sydney in 1912 and Edinburgh in \\n1915. \\nThe need for developing the preventive and promotive services was recognized by the government as \\nearly as 1920. In the mid 1920’s steps were taken to introduce a Health Unit System which could \\nprovide a comprehensive health care service (institutional and domiciliary) to mothers and children.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n2 \\n \\n \\nThis scheme was to provide domiciliary as well as clinic based services to mothers during pregnancy \\nand postpartum period and, trained assistance at delivery by encouraging mothers to deliver in \\nmedical institutions or provide trained assistance in the case of home deliveries. The first Health Unit \\nwas established in 1926 at Kalutara and trained Public Health staff (Public Health Midwives and \\nNurses) were appointed to provide the necessary services. This scheme was thereafter extended to \\nother areas and by 1936, eight Health Units were established within the country. \\nUntil 1926, the midwives functioned only in the hospitals and their training was only hospital based.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='With the establishment of the Health Unit System, the Midwives were given one month field training \\nin public health midwifery and appointed to the Health Units as Public Health Midwives. After 1938, \\nthe PHM’s training was more systematized with the use of appropriate circular and the field training \\nwas extended to six months.  \\nTraining of Public Health Nurses (PHNs) commenced in 1928 and consisted of six months training \\nin midwifery and six months in public health. Since 1980, training in the public health for nurses \\nconducted at the National Institute of Health Sciences (NIHS) was extended to one year, after which \\na Diploma in Public Health Nursing was awarded. This category is now designated as Public Health \\nNursing Sisters.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Nursing Sisters. \\nFormal training for Medical Officers of Health commenced in 1936 and is of one month’s duration. \\nThis facilitated the effective implementation of the Health Unit System. \\nThe control measures adopted following the Malaria epidemic of 1935, led to further expansion of \\nthe Health Unit System. The maternal and child health infrastructure, which originated with the \\nHealth Unit Systems, was linked to the expanding malaria control programme and the medical \\nofficers recruited for malaria control provided MCH services at the health centres in addition to their \\nnormal malaria control activities. \\nThe Government policy in the early 1930’s enunciated the need for diffusion of health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='The Government policy in the early 1930’s enunciated the need for diffusion of health services \\nthroughout the country. After the granting of Universal Franchise in 1931, there was political \\ndemand for expansion of health services in rural areas. A large number of maternity homes, rural \\nhospitals and cottage hospitals were constructed and the staff in these medical institutions was \\ntrained in care of the mother and child. The number of Health Units, which was eight in1936, \\nincreased to ninety-one by 1950. Currently there are more than 300 Health Units in the country. \\nThe government provided health care free of charge making health services accessible to the poorest \\nsegments of the population. The introduction of the free education system in 1941 led to an increase'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='in literacy, which helped in increasing the level of health consciousness and greater utilization of \\nhealth facilities. \\nThe number of medical institutions with facilities for delivery increased from 141 in 1941 to 521 in \\n2000. Also the number of health centres increased from 600 in1948 to about 3200 in 2000. \\nSimilarly availability of trained health man power has shown a marked increase since 1940’s. \\nTrained midwives increased from 347 in 1941 to 8741 in 2009 and the Public Health Nurses (now \\ncalled Public Health Nursing Sisters) increased from 41 in 1948 to 254 in 2009.  \\nSince independence in 1948, a more concerted effort was made to provide a comprehensive service \\nto mothers and children throughout the country. The MCH services were extended to the rural areas'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='to mothers and children throughout the country. The MCH services were extended to the rural areas \\nin an effort to make the service availability more equitable. The second maternity hospital in \\nColombo (Castle Street Maternity Hospital) with accommodation for 144 patients was opened in'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n3 \\n \\n \\n1950. Thereafter, an increasing number of maternity beds and specialist services were provided to \\nthe Provincial and Base Hospitals with blood transfusion facilities extended to these hospitals. \\nThe policies of Sri Lanka in the early years after independence reflected little concern over the high \\ngrowth rate (31 per 1000) that prevailed during that period. The first organized effort for introducing \\nfamily planning was made in 1953 with the founding of the Family Planning Association (FPA) of \\nCeylon. The activities of the Association were focused on family welfare with a view to reducing \\nmaternal mortality, infant mortality and malnutrition and were mainly centered within and around'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='maternal mortality, infant mortality and malnutrition and were mainly centered within and around \\nColombo. The work done by the Association was recognized when the government provided a \\nfinancial grant in 1954. \\nRealizing the importance of family planning, in 1958 the government entered into a bilateral \\nagreement with the Royal Government of Sweden to study community’s attitude toward family \\nplanning and its acceptance by the people. Under this agreement, training programmes for doctors, \\nnurses and midwives were started and two pilot projects were conducted in community family \\nplanning. The results of this project were encouraging. In the pilot areas, the crude birth rate showed \\na promising decline and an increase in positive attitudes towards family planning was seen within the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='community. The activities of the Swedish project during 1958 – 1965 period demonstrated that \\nfamily planning can be successfully integrated into the MCH services without any great increase in \\npersonnel or expenditure. \\nBased on the above experiences, the government accepted family planning as national policy in 1965 \\nand decided to integrate family planning services with the already well-established Maternal and \\nChild Health services provided through the Ministry of Health. This procedure was adventurous \\nsince the personnel and the infrastructure of an already well- organized system could be made use of \\nwithout any additional cost and also family planning could be introduced as an integral part of the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='maternal health package offered by the system. Considering its national importance, a separate \\ndivision, ‘the Family Planning Bureau’ which was later re-designated as ‘Maternal and Child Health \\nBureau’ was set up in 1968 within the Ministry with an Assistant Director MCH responsible for \\nimplementation of the programme throughout the country. This Bureau was given the task to plan, \\noperate, supervise and evaluate the family planning programme within the country. \\nThe period 1966 to 1968 could be regarded as an introductory phase where establishment of family \\nplanning clinics, training of relevant health personnel and administrative strengthening of the \\nMinistry of Health laid the foundation for the expected expansion and intensification of the \\nprogramme.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='programme. \\nIn 1970, the government made a positive statement towards family planning. It stated that ‘though \\nfamily planning would not be a solution to the economic ills of the country, nevertheless family \\nplanning facilities should be made available on a more intensified scale.’ In the national five year \\nplan of 1971, family planning received due importance and a statement was made emphasizing that \\n‘family planning should be made available to all groups and not be confined to the privileged section \\nof society.’ This provided the necessary political endorsement and support from the government for \\nfamily planning, though some groups still resisted the idea. \\nIn 1972, 100 pilot projects were started, one in each MOH area to try out a coordinated approach to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='maternal care, family planning, child care including nutrition and immunization, health education \\netc. Based on the experience gained, the MCH/FP programme received a new dimension with a more \\ncomprehensive approach towards the family.  The Bureau was re-designated the ‘Family Health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n4 \\n \\n \\nBureau’ in 1973 and the programme was named ‘Family Health’ so that this would provide a more \\ncomprehensive service to the mother and child. Thereafter maternal and child health services \\nreceived greater emphasis and were given priority in the overall health development plan. This led to \\nmore concerted effort to strengthen the service infrastructure to provide an efficient family health \\nservice through out the country. The government sought the assistance of International Organization \\nto financially support the implementation of services within the country. \\nThe Family Health Bureau was made the central organization of the Ministry of Health responsible'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='The Family Health Bureau was made the central organization of the Ministry of Health responsible \\nfor planning, promoting, coordinating, monitoring and evaluating family health activities. Following \\na revision of the MCH information system in1985, the Family Health Bureau was entrusted the task \\nof collecting, processing and analyzing MCH data from the Health Units  \\nMaternal death investigations were conducted from the early 1950 s, but were actively implemented \\nin the mid 1980’s when instructions were given to investigate and report all maternal deaths \\noccurring in the medical institutions and in the field (community) including those in the plantation \\nsector. These were thereafter reviewed at the district and national levels by the respective health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='authorities. Any corrective measures needed to overcome problems and constraints were taken to \\nprevent such deaths in the future. This system was further strengthened in 1989 when maternal \\ndeaths were made a notifiable event and clear guidelines on the procedure for investigation were \\nissued to all hospitals and health units.  \\nSince the International Conference on Population and Development in Cario in 1994, the concept of \\nreproductive health has been introduced which addresses reproductive health issues of the \\nadolescents, young adults, married couples, and women even after menopause thus providing a life \\ncycle approach to family health care. Some of the reproductive health issues that have received'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='cycle approach to family health care. Some of the reproductive health issues that have received \\nemphasis in the programme are RH problems in the adolescents, early identification of reproductive \\nhealth organ malignancies, prevention of reproductive tract infections including sexually transmitted \\ndiseases / HIV-AIDS, concept of women’s empowerment and male involvement in RH activities. \\nServices in respect of sexually transmitted diseases and HIV/AIDS are provided through the National \\nSTD Control Programme (NSACP). The Family Health Bureau in collaboration with the National \\nCancer Control Programme (NCCP) has introduced in 1995 a screening programme for reproductive \\norgan malignancies and certain other conditions. Under this programme ‘Well Women’s Clinics’'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='organ malignancies and certain other conditions. Under this programme ‘Well Women’s Clinics’ \\nhave been established in all Health Unit areas conducted by trained medical officers. Women over 35 \\nyears of age could be screened for such as hypertension, diabetes, breast malignancies and cervical \\ncancers. If any abnormality is detected clients are referred to the health care system for necessary \\nmanagement. The PHM of the area is responsible for follow up of cases in the field and provides \\nnecessary advice and guidance thereafter. \\nTenth anniversary of Safe motherhood concept which was held in Sri Lanka in 1997 was an appraisal \\nof maternal health program in Sri Lanka. \\n \\nInstitutional Framework for Providing Maternal Care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of maternal health program in Sri Lanka. \\n \\nInstitutional Framework for Providing Maternal Care \\nMaternal, child health and family planning services are provided through the well-developed health \\ninfrastructure of the Ministry of Health, which has grown steadily over the past few decades. The \\nservices are provided through a net of work of Medical Institutions comprising major hospitals with \\nspecialist services (Teaching, Provincial and Base hospitals), Divisional Hospitals, and central'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n5 \\n \\n \\ndispensaries and Maternity homes. The institutional network is closely linked to a system of Health \\nUnits, which are primarily responsible for providing preventive and promotive health care to the \\ncommunity. \\nSince 1989, the country’s administration was decentralized with devolution of administrative powers \\nto the Provincial Councils. Each province has a Provincial Director of Health Services (PDHS) who \\nis responsible for total health care within the province. He is supported by a Regional Director of \\nHealth Services (RDHS) who is in charge of a Health District. RDHS is supported by a team \\ncomprising a Medical Officer MCH (MO.MCH), Regional Epidemiologist (RE), Regional'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='comprising a Medical Officer MCH (MO.MCH), Regional Epidemiologist (RE), Regional \\nSupervising Public Health Nursing Officer (RSPHNO), 2-3 Health Education Officers, a Statistical \\nSurvey Officer (SSO) and a Programme Planning Officer (PPO). Each Health District is further sub-\\ndivided into Health Divisions (7-15) consisting of Health Units and a network of medical institutions \\nof different categories. \\nThe Health Units have a clearly defined area, which is congruent with the administrative divisions \\nof the country. It is managed by a Medical Officer of Health (MOH). He is supported by a team of \\npublic health personnel comprising of one or two Public Health Nursing Sisters (PHNS), Supervising'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='public health personnel comprising of one or two Public Health Nursing Sisters (PHNS), Supervising \\nPublic Health Inspector (SPHI), few Supervising Public Health Midwives (SPHM), 20 – 25 Public \\nHealth Midwives (PHM s) and 5-6 Public Health Inspectors (PHI). \\nPublic Health Midwife area (PHM areas) is the smallest working unit in the government health \\nsystem. The PHM is the ‘front line’ health worker for providing domiciliary MCH/FP services in the \\ncommunity. Each PHM has a well defined area consisting of a population ranging from 2000-4000. \\nThough systematic home visits, the Public Health Midwife provides care to pregnant women, infants \\nand pre-school children and family planning services to couples in the reproductive age within her'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='and pre-school children and family planning services to couples in the reproductive age within her \\narea. In case of necessity, she provides trained assistance during home deliveries when called by the \\ncommunity. She also provides necessary education and advice to adolescents on RH where needed \\nand educates women on the importance of screening for reproductive organ malignancies thus \\nmotivating them to attend the ‘well women clinics’ for necessary check up. She also assists at the \\narea MCH/FP clinics, which are conducted fortnightly, linking the community with the institutional \\nhealth system. Her activities are supported by a system of record keeping which enables her tot plan \\nand monitor her routine activities. Her work is regularly supervised by the Supervising Public Health'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Midwife, Public Health Nursing sister and the MOH of the area. \\nHigher Level Health Institutions; Teaching Hospitals, Provincial General Hospitals, District General \\nHospitals and Base Hospitals provide specialized care for obstetric including Comprehensive \\nEmergency Obstetric and Neonatal Care (CEmONC) and other specialties. Currently there are 72 \\nhospitals within the country belonging to this category giving a ratio of 1 per 275,000 population. \\nAlmost 80 percent of institutional deliveries occur in these hospitals. \\nIntermediate Level Health Institutions; Divisional Hospitals manned by qualified medical graduates \\n(MBBS) and provide a wide range of services including  in-patient and out -patient care. These'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='(MBBS) and provide a wide range of services including  in-patient and out -patient care. These \\ninstitutions are capable of providing basic EmONC services. Currently there are 455 Divisional \\nHospitals and 525 Primary care units within the country where almost 20 percent of institutional \\ndeliveries take place. \\nPrimary Level Institutions manned by qualified medical graduates (MBBS) or Registered/ Assistant \\nMedical Practitioners. These are the central dispensaries and Maternity Homes (CD & MH) where \\nfacilities for only uncomplicated deliveries are available.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n6 \\n \\n \\nThe private sector, which includes private hospitals/nursing homes and general medical practitioners \\nalso provide maternal care services of a varying degree. Although data is not available, it is known \\nthat a considerable proportion of patients obtain maternal care from the private sector. \\n \\nService delivery and Achievements \\nThe Government of Sri Lanka is committed to providing a comprehensive system of health care to its \\npeople. Maternal and Child health and Family Planning form an important component of the \\nprevailing health care system and are an integral part of the Primary Health Care strategy. \\nMaternal care is provided free of charge to all pregnant women during antenatal, intranatal and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal care is provided free of charge to all pregnant women during antenatal, intranatal and \\npostnatal periods through the health care system. The use of skilled attendance during pregnancy and \\nlabour has greatly increased over the past five decades. \\nStudies has shown that more than 99 percent of pregnancy women had received antenatal care during \\npregnancy and almost 99 percent received trained assistance at delivery (DHS-2006/2007). \\nAntenatal care is provided at MCH clinics conducted in health centers both in the field and in \\nmedical institutions. These clinics are usually conducted once a fortnight. In addition, domiciliary \\ncare is provided by Public Health Midwives through routine home visiting. Pregnant women are'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='care is provided by Public Health Midwives through routine home visiting. Pregnant women are \\nregistered for antenatal care early and ‘Pregnancy record’ is maintained to facilitate proper follow \\nup. Since the early 1990’s, a home based ‘Pregnancy Record’ was introduced which is kept and \\ncarried by the mother so that vital information regarding the pregnancy is made available to the \\nattending doctors and the health staff at any facility she visits. ‘High risk’ mothers are identified and \\nspecial attention is given throughout pregnancy and delivery. An organized system of referral exists \\nfor cases that need special care and attention. \\nThe number of mothers receiving trained care during delivery has more than doubled since 1948.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='The number of mothers receiving trained care during delivery has more than doubled since 1948. \\nOnly 48 percent of mothers had received trained assistance at delivery (i.e. delivered either in an \\ninstitution or under supervision of a qualified midwife) during the late 1940’s. Currently almost 99 \\npercent of deliveries receive trained assistance with approximately 99 percent taking place in \\nmedical institutions (95 percent in Government institutions and 4 percent in the private hospitals). \\nOf the total deliveries in the government institutions almost 80% take place in larger hospitals where \\nComprehensive Emergency Obstetric Care is available. This has resulted in overcrowding of \\nmaternity wards in the larger hospitals. One of the main reasons for this overcrowding is the people’s'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='preference to have their confinement in larger hospitals with better facilities rather than going to their \\narea hospital. \\nBirths in government medical institutions have increased steadily during the past four decades. Easy \\naccess to institutional care and regular contact with the PHM appears to have influenced their \\ndecision in favour of institutional deliveries.  \\nAfter delivery the mother and child are followed at home by the area PHM with necessary post \\npartum care (including advice and guidance) being provided during these visits. Routine statistics \\nreveal that approximately 80 percent of women receive post natal care at least once during the first \\nten days after delivery (Annual Family Health Report, 2007-FHB)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n7 \\n \\n \\nChapter 02 \\nBASIC PRINCIPLES OF   MATERNAL AND NEWBORN HEALTH \\nINTERVENTIONS \\nMaternal and Newborn health interventions are treatments, technologies, and key family practices \\nthat prevent or treat Maternal and Newborn illness and reduce deaths in mothers and children (WHO \\n2010).  \\nThese interventions are not only reducing mortality and morbidity in the mother and newborn but \\nalso ensure quality of life. There are simple low-cost interventions for the prevention and treatment \\nof all the most common causes of maternal and newborn, morbidity and mortality. An effective \\nmaternal and newborn health programme must focus on achieving a high level of coverage with such'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='maternal and newborn health programme must focus on achieving a high level of coverage with such \\ninterventions that have the greatest potential to reduce maternal and newborn mortality and \\nmorbidity in the country. \\n \\nPrinciples of delivering interventions \\n The continuum of care for the mother and child includes the life stages from adolescent, pre \\npregnancy, pregnancy, through birth, the newborn period, infancy and childhood. Interventions \\nshould be targeted at all of these stages in order to maximize impact.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n8 \\n \\n \\nThe continuum of care across the health system includes the levels at which interventions are \\ndelivered: home and community, first-level health facilities (field clinics and medical institutions up \\nto Divisional Hospitals) and referral facilities (hospitals with specialist facilities). Interventions \\nshould be delivered at each of these levels where relevant. Facility-based interventions should be \\nbalanced with those in the home and community, since the prevention and management of maternal \\nand newborn illness and deaths begins in the home. Continuums of care throughout the lifecycle and \\nacross the health system are a useful way of delivering an intervention.  \\n \\n \\nProgrammatic Pathway to improve health status'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Programmatic Pathway to improve health status  \\n \\n \\n \\nIMPLEMENTATION \\nOF ACTIVITIES \\nAdvocacy for health \\n \\nHuman, material and \\nfinancial resource \\nmobilization \\nHuman resource \\ncapacity development \\nCommunication with \\nfamilies & communities \\nHealth system \\ndevelopment \\nMonitoring and supervision \\nIMPROVED \\nAvailability and \\naccess to health \\ncare \\nQuality of care \\nDemand for care \\nKnowledge of \\nfamilies \\nand communities \\nINCREASED \\nPOPULATION- \\nBASED \\nCOVERAGE \\nof key effective \\ninterventions \\nIMPROVED \\nSURVIVAL \\nAND HEALTH \\nMortality, \\nMorbidity, \\nfertility, and \\nNutritional \\nstatus \\nOther determinants'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n9 \\nPregnancy care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on self-care at home, nutrition, safer sex, HIV, breast feeding, family \\nplanning, healthy life style including harmful effects of smoking and alcohol use, and use of \\ninsecticide treated bed nets \\n\\uf0b7 \\nBirth planning, advice on labour, danger signs and emergency preparedness \\n\\uf0b7 \\nSupport for compliance with preventive treatments \\n\\uf0b7 \\nSupport for woman living with HIV/AIDS \\n\\uf0b7 \\nAssessment of signs of domestic violence and referral \\n\\uf0b7 \\nEducate and support for compliance with preventive treatment \\n \\nPregnancy care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nConfirmation of pregnancy \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Pregnancy care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nConfirmation of pregnancy \\n\\uf0b7 \\nMonitoring of progress of pregnancy and assessment of maternal and fetal well-being including \\nnutritional status \\n\\uf0b7 \\nDetection of problems complicating pregnancy ( eg: anaemia, hypertensive disorders, bleeding, \\nmal-presentations, multiple pregnancy) \\n\\uf0b7 \\nResponds to other reported needs \\n\\uf0b7 \\nTetanus immunization \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation and worm treatment) and \\nnutrition counselling \\n\\uf0b7 \\nSyphilis testing and treatment of syphilis ( woman and her partner) \\n\\uf0b7 \\nTreatment of mild to moderate pregnancy complications (mild to moderate anaemia – urinary \\ntract infection, vaginal infection) \\n\\uf0b7 \\nPost abortion care and family planning \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='tract infection, vaginal infection) \\n\\uf0b7 \\nPost abortion care and family planning \\n\\uf0b7 \\nPre- referral treatment of severe complications (pre-eclampsia, eclampsia, bleeding, infection and \\ncomplicated abortion) \\n\\uf0b7 \\nAntibiotics for premature rupture of the membranes \\n\\uf0b7 \\nSupport for women living with violence and HIV \\nSituational \\nAll of the above plus\\n\\uf0b7 \\n HIV testing and counseling, prevention of mother to child transmission of HIV (PMTCT) by \\nantiretroviral including antiretroviral therapy (ART), infant feeding counseling, mode of delivery \\nadvice \\n\\uf0b7 \\nAntimalarial intermittent preventive treatment (IPT) and promotion of insecticide treated nets \\n(ITN) \\n\\uf0b7 \\nDeworming \\n\\uf0b7 \\nAssessment of female genital mutilation \\n\\uf0b7 \\nTreatment of mild to moderate opportunistic infections \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nTreatment of mild to moderate opportunistic infections \\n\\uf0b7 \\nTreatment of simple malarial cases \\nInterventions at REFERRAL FACILITIES \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe pregnancy complications (anaemia, severe pre – eclampsia, eclampsia, \\nbleeding , infection , other medical complications) \\n\\uf0b7 \\nTreatment of abortion complications \\n\\uf0b7 \\nManagement of mal- presentations, multiple pregnancy \\n\\uf0b7 \\nCorticosteroids for preterm labour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n10 \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe HIV infection \\n\\uf0b7 \\nTreatment of complicated malaria \\nChild birth care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nCompanion of choice to support the woman during delivery \\n\\uf0b7 \\nSupport for care for the rest of the family \\n\\uf0b7 \\nSupport for transport \\n\\uf0b7 \\nPromote and support for skilled care at birth and institutional delivery \\nChild birth care at FIRST LEVEL FACILITY \\nAll of the above plus\\nCare during labour and delivery \\n\\uf0b7 \\nDiagnosis of labour \\n\\uf0b7 \\nMonitoring progress of labour , maternal and fetal well- being with partogragh \\n\\uf0b7 \\nCompanion of choice to support the woman \\n\\uf0b7 \\nInfection prevention \\n\\uf0b7 \\nSupportive care and pain relief \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nInfection prevention \\n\\uf0b7 \\nSupportive care and pain relief \\n\\uf0b7 \\nDetection of problems and treatment of complications (e.g. malpresentation, prolonged and/ or \\nobstructed labour, hypertension, bleeding and infection) \\n\\uf0b7 \\nDelivery and immediate care of the new born baby \\n\\uf0b7 \\nActive management of third stage of labour \\nImmediate postpartum care of mother \\n\\uf0b7 \\nMonitoring and assessment of maternal well being  \\n\\uf0b7 \\nPrevention and detection of complications (e.g. hypertension , infections, bleeding, anaemia) \\n\\uf0b7 \\nTreatment of abnormalities and complications ( e.g. prolonged labour, vacuum extraction, breech \\npresentation, episiotomy, repair of genital tears, manual removal of placenta) \\n\\uf0b7 \\nPre- referral management of serious complications( e.g. obstructed labour, fetal distress, preterm'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Pre- referral management of serious complications( e.g. obstructed labour, fetal distress, preterm \\nlabour, severe peri- and postpartum haemorrhage ) \\n\\uf0b7 \\nCounseling and Support for the family if maternal and perinatal death \\n\\uf0b7 \\nCounselling for family planning including insertion of IUDs, LRTs \\nImmediate newborn care \\n\\uf0b7 \\nSkin to skin care \\n\\uf0b7 \\nThermal care \\n\\uf0b7 \\nHygienic cord care \\n\\uf0b7 \\nNewborn resuscitation if required \\n\\uf0b7 \\nEarly initiation of breast feeding \\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nRecognition of danger signs and prompt treatment \\n\\uf0b7 \\nIdentification and initial management of newborn complications and appropriate referral \\n\\uf0b7 \\nSpecial care for small babies including Kangaroo Mother Care \\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nBCG immunization \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nBCG immunization \\n\\uf0b7 \\nPrevention of mother to child transmission of HIV (guidance and support for chosen infant \\nfeeding option) \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nVitamin A administration for mother \\n\\uf0b7 \\nHIV testing and counseling \\n\\uf0b7 \\nPrevention of mother – to- child transmission of HIV by mode of delivery, guidance and support \\nfor chosen infant feeding option \\n\\uf0b7 \\nCare for HIV positive women/ ART'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n11 \\nChild birth care at REFFERRAL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nTreatment of severe complications in child birth and in the immediate postpartum period, \\nincluding caesarean section, blood transfusion and hysterectomy \\n\\uf0b7 \\nInduction and augmentation of labour \\n\\uf0b7 \\nManagement of other obstetric complications \\n\\uf0b7 \\nManagement of severe newborn complications \\nPostpartum care \\n \\nInterventions at home/ COMMUNITY level \\n\\uf0b7 \\nInformation and counseling on selfcare at home, nutrition, safer sex, breast feeding, family \\nplanning/ birth spacing, healthy lifestyle including harmful effects of smoking and alcohol use \\n\\uf0b7 \\nSupport for rest and less work load \\n\\uf0b7 \\nSupport for exclusive breast feeding \\n\\uf0b7 \\nSafe disposal/ washing of pads \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nSupport for exclusive breast feeding \\n\\uf0b7 \\nSafe disposal/ washing of pads \\n\\uf0b7 \\nAssessment of maternal wellbeing including maternal nutrition \\n\\uf0b7 \\nMalaria prevention and management of malaria \\n\\uf0b7 \\nSupport for complications with prevention measures and treatments (infections, bleeding, \\nanaemia, UTI, RTI, wound infections, breast feeding problems) \\n\\uf0b7 \\nFamily planning / birth spacing \\n\\uf0b7 \\nRecognition of danger signs, including blues/ depression \\n\\uf0b7 \\nAwareness of signs of domestic and sexual violence and referral \\n\\uf0b7 \\nSupport  for women living with HIV/ AIDS including ART \\n\\uf0b7 \\nReporting birth and death (vital registration) \\n\\uf0b7 \\nUse of insecticide treated bed nets \\n \\nPostpartum care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Postpartum care at FIRST LEVEL FACILITY \\nAll of the above plus\\n\\uf0b7 \\nPrevention and detection of complications (e.g. infections, bleeding, anaemia) \\n\\uf0b7 \\nAnaemia prevention and control ( iron and folic acid supplementation) \\n\\uf0b7 \\nProvision of contraceptive methods \\n\\uf0b7 \\nTreatment of some problems(e.g. mild to moderate anaemia, mild puerperal depression, mastitis) \\n\\uf0b7 \\nPre – referral treatment of  severe complications  (e.g. severe postpartum bleeding , puerperal \\nsepsis) \\n\\uf0b7 \\nVit. A mega dose suplementation \\n\\uf0b7 \\nRecording and reporting  \\nSituational \\nAll of the above plus\\n\\uf0b7 \\nAntiretroviral treatment (ART) \\n\\uf0b7 \\nTreatment of uncomplicated malaria \\n \\nPostpartum care at REFFERRAL FACILITY \\nAll of the above plus\\nTreatment of all complications \\n\\uf0b7 \\nSevere anaemia \\n\\uf0b7 \\nSevere postpartum bleeding \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Treatment of all complications \\n\\uf0b7 \\nSevere anaemia \\n\\uf0b7 \\nSevere postpartum bleeding \\n\\uf0b7 \\nSevere postpartum infections \\n\\uf0b7 \\nSevere postpartum depression \\nTubal ligation and vasectomy \\nSituational \\nAll of the above plus\\nTreatment of complicated malaria'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n12 \\n \\n \\nNew born care \\n \\nInterventions at home/ COMMUNITY level \\nPromotion and support for:\\n\\uf0b7 \\nExclusive breast feeding \\n\\uf0b7 \\nThermal protection \\n\\uf0b7 \\nInfection prevention : general hygiene, hand washing , cord care and safe disposal of baby’s \\nfaeces \\n\\uf0b7 \\nCare of a small baby without breathing and feeding problems: frequent  breast feeding , skin – to \\nskin contact \\n\\uf0b7 \\nPrevention of indoor air pollution \\n\\uf0b7 \\nNew born stimulation and play \\n\\uf0b7 \\nRecognition of danger signals, problems, illness and timely care- seeking \\n\\uf0b7 \\nSupport for routine care and follow up visits \\n\\uf0b7 \\nBirth registration \\n\\uf0b7 \\nPromotion, protection and support for exclusive breast feeding \\n\\uf0b7 \\nMonitoring and assessment of wellbeing and response to maternal concerns \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nMonitoring and assessment of wellbeing and response to maternal concerns \\n\\uf0b7 \\nCare of preterm/ low birth weight without breathing problems: support for breast- milk feeding, \\nKangaroo mother care, skin to skin care \\n \\nSituational \\n\\uf0b7 \\nPromotion and provision of insecticide treated bed nets \\n\\uf0b7 \\nAdherence to ARV for PMTCT \\n \\nInterventions at FIRST LEVEL HEALTH FACILITY \\nAll of the above plus\\n\\uf0b7 \\nRooming in \\n\\uf0b7 \\nEye infection prophylaxis \\n\\uf0b7 \\nImmunization \\n\\uf0b7 \\nAdditional follow up for at risk babies \\n\\uf0b7 \\nTreatment of local infections (skin , cord, eye, mouth) \\n\\uf0b7 \\nIdentification , initial management and referral of a new born with any sign of severe illness , \\ninjury or malformation \\n\\uf0b7 \\nRecording and reporting \\nSituational \\nAll of the above plus \\n\\uf0b7 \\nARV regimens for PMTCT including ART \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Situational \\nAll of the above plus \\n\\uf0b7 \\nARV regimens for PMTCT including ART \\n\\uf0b7 \\nSupport for safer infant feeding options \\n \\nInterventions at REFFERRAL FACILITY \\nAll of the above plus\\nManagement of a new born with severe problems: general care of a sick newborn and specific care for: \\n\\uf0b7 \\nPreterm babies with breathing problem or unable to feed orally (includes provision of KMC) \\n\\uf0b7 \\nSevere infection \\n\\uf0b7 \\nSevere birth asphyxia \\n\\uf0b7 \\nOther: severe jaundice, malformations \\n\\uf0b7 \\nPresumptive treatment of congenital syphilis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n13 \\n \\nChapter 03 \\n \\nMATERNAL CARE MODEL IN SRI LANKA \\n \\nAntenatal care model currently used in Sri Lanka is the traditional multi-visit model; once a \\nmonth up to 28weeks, fortnightly during 28-36weeks and weekly thereafter. The domiciliary \\ncare also follows the same model. Pregnant women are simultaneously receiving maternal \\ncare services at multiple settings eg. Field clinic, hospital clinic, specialized care unit, and \\nsome even visits to obstetricians in the private sector.  Therefore, altogether pregnant woman \\nreceived 12-18 clinic visits and 8-10 home visits during antenatal period as more than 90% of \\nwomen registered for antenatal care before 12 weeks. Postnatal care model consists of two'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='women registered for antenatal care before 12 weeks. Postnatal care model consists of two \\nhome visits during 1st 10 days, one visit between 11-28 days, and one visit around 42 days \\n(altogether 4 visits). This model also includes a postnatal clinic visit at 4-6 weeks. However, \\nin contrast to antenatal clinic and domiciliary care coverage which is almost universal, only \\n80% of women receive at least one postnatal home visit. Postnatal clinic care is not well \\nestablished in the country.  \\nThough Sri Lanka has achieved effective service coverage in MCH/FP, the quality of service \\ndelivery needs further improvement in order to attain further reductions of maternal mortality \\nand morbidity. Therefore, an external review of Maternal and New born Health in Sri Lanka'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='and morbidity. Therefore, an external review of Maternal and New born Health in Sri Lanka \\nwas conducted in 2007 to identify the gaps in existing service delivery system. This review \\nhas identified the need to streamline the provision of maternal care and bring it into line with \\nevidence based interventions with the objective of improving the quality of care and \\npreventing the duplication of the services. Further, recommendations of National Maternal \\nMortality Reviews and District Maternal and Child Health Reviews also pointed out the need \\nfor revision to streamline the services and to address the gaps in service provision. \\nMeanwhile, need of strengthening the integration of elimination of congenital syphilis (ECS)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Meanwhile, need of strengthening the integration of elimination of congenital syphilis (ECS) \\nand prevention of mother to child transmission of HIV (PMTCT) programmes into maternal \\ncare programme was highlighted.  \\nTherefore, Family Health Bureau in collaboration with Sri Lanka College of Obstetricians, \\nand Gynecologists, WHO and UNICEF revised the existing service provision model of \\nantenatal and postnatal care. Series of consultative meetings were held with the relevant \\nstakeholders and reviewed available models in the world including WHO Antenatal care \\nrandomized trial and NICE guidelines. After considering the existing health policies and \\nhealth care system in the country, achievements and gaps, ability of packaging evidence'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='health care system in the country, achievements and gaps, ability of packaging evidence \\nbased interventions, client and service providers’ satisfaction, development in transport and \\ncommunication, cost effectiveness and expectation of the public, the following model was \\ndeveloped to deliver evidence based interventions to reduce maternal and child mortality and \\nmortality.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n14 \\n \\n \\nProposed Maternal Care Model \\nDomiciliary and clinic care \\n \\n \\n \\n \\n \\n \\n \\nClinic Visit- 2           12-14weeks \\nClinic Visit -3           18-20 weeks \\nPre pregnancy care\\nEarly Registration of Pregnant Mother \\n(preferably 6-8weeks) either at clinic/home By \\nPHM \\nBooking visit (clinic visit 1) 6-8 weeks \\nLow Risk Pregnancy \\nRisk assessment\\nRisk uncertain \\nHigh Risk Pregnancy  \\nProvide Basic \\nantenatal care \\nRefer to specialized \\ncare to clarify the risk \\nRefer to  Specialized \\ncare\\nClinic Visit -4           22- 24 weeks \\nk\\nClinic Visit – 5       26-28 weeks \\nClinic Visit – 6     32-34 weeks \\nHome visit 1 (6-\\n12 weeks) \\nAt Field Clinic/ \\nMO /MOH/RMO \\nIf registered at home Refer to field ANC\\nAntenatal class I \\n1st Trimester'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='MO /MOH/RMO \\nIf registered at home Refer to field ANC\\nAntenatal class I \\n1st Trimester\\nField Clinic/ MO/ \\nMOH/RMO \\nShared care/ Out \\nreach clinic/ field \\nclinic \\nHome visit 2 \\n22-24 weeks\\nAntenatal class II \\n2nd Trimester\\nAntenatal class III \\n3rd Trimester \\nField Clinic/ \\nMO/MOH/RMO\\nField Clinic/ \\nMO/MOH/RMO \\nField Clinic/ \\nMO/MOH/RMO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n15 \\n \\nClinic Visit -7         36 weeks \\nClinic Visit -8       38 weeks \\nDelivery at an Institution \\nPostnatal home visit 1 (0-5 days) \\nKCC chart \\nPostnatal home visit 2 (5-10days) \\nPostnatal home visit 3 (14-21days) \\nPostnatal clinic visit (4-5wks) \\nPostnatal home visit (6-7wks) \\nApply EPDS \\nscreening  tool\\nIf no pains admit for \\ninward review\\nImmediate postnatal care\\nPostnatal screening of mother & baby \\nMother \\nBaby \\nWell women  \\nservices \\nFamily \\nplanning \\nservices \\nInfant care \\nClinic Visit -9       40 weeks \\nHome visit 3 \\n36 -38 weeks\\nField Clinic/ \\nMO/MOH/RM\\nField Clinic/ \\nMO/MOH/RMO\\nPHM \\nPHM \\nPHM \\nMO/MOH \\nPHM \\nField Clinic/ \\nMO/MOH/RM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n16'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n17 \\n \\n \\n \\n \\n \\n \\n \\nAntenatal Care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n18'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n19 \\n \\n \\nChapter 04 \\nANTENATAL CARE \\nAll eligible couples should be registered in the eligible couple register (H 526) by the area \\nPHM. All the women who are getting pregnant are assumed to have pre-pregnancy care \\n(Rubella immunization, preconception folic acid supplementation, screening for medical \\ncondition and nutritional assessment and if required necessary family planning services). \\nDuring pre pregnant care, couples should be educated regarding pregnancy symptoms and \\nimportance of early initiation of antenatal care. They should be educated when to and how to \\ninform PHM once they get pregnant. These services should be provided through women’s'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='inform PHM once they get pregnant. These services should be provided through women’s \\nhealth program and family planning program. In Sri Lanka, antenatal care provides through \\nclinic care and domiciliary care.  \\nThe main objective of antenatal care is to monitor the health of the pregnant mother as well \\nas the health and development of the fetus. Antenatal care helps to screen for possible adverse \\nconditions during pregnancy and to predict problems with pregnancy, labour or birth. \\nTherefore, they can be either prevented, or manage efficiently. It also helps to initiate a plan \\nfor continuing care during pregnancy and post partum period.  \\n Antenatal care consists of: \\n1. Assessment:  Maternal risk factors, Ongoing assessment of maternal and fetal well-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='1. Assessment:  Maternal risk factors, Ongoing assessment of maternal and fetal well-\\nbeing and screening for maternal complications \\n2. Care provision \\n3. Health promotion \\n \\nAntenatal care at the clinic \\nFollowing the registration at the clinic or at home, pregnant mother should receive the clinic \\nantenatal care as early as possible, preferably around 6-8 weeks of gestation. The officers \\nwho provide antenatal care should follow the General Circular No. 01-25/2004 issued by the \\nDirector General of Health Services on 14th September 2004 on antenatal care  Each antenatal \\nclinic visit should be objective. All findings of the clinic antenatal care should be entered on \\nthe Pregnancy Record (H512 A and B) by the officer who performs the examination.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the Pregnancy Record (H512 A and B) by the officer who performs the examination. \\nDesignation of the officer who performs the obstetric examination should enter in the \\nrelevant cage in both H 512 A & B. The services which should be provided at each clinic \\nvisits are mentioned below. \\n \\nBooking Visit 6-8 weeks \\nObjectives of the visit \\n1. To provisional establishment of pregnancy (either clinically/ with laboratory testing)  \\n2. To assess medical and obstetric risk factors and take necessary actions \\n3. To assess the psychological/nutritional status and take necessary actions \\n4. To provide necessary care and health promotion \\n5. Screening for anaemia, syphilis and testing for blood group and Rh \\n6. Check for dental conditions and appropriate referral'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='6. Check for dental conditions and appropriate referral \\n7. Examination of heart to identify heart diseases'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n20 \\n \\nWhen mother is registered at the clinic, PHM should visit her home within 12 weeks of \\nPOA as described in the section on domiciliary care. \\nDuring booking Visit/First visit all pregnant mothers must be seen by a medical officer \\n(MOH/AMOH/MO) \\nIf MOH/MO is not available in the first visit, the closest clinic date should be given to the \\nmother for the next visit. A medical officer should examine all the pregnant women. \\na) Obtain information on: \\nPersonal history  \\n\\uf0d8 Name \\n\\uf0d8 Age (date of birth) \\n\\uf0d8 Address and telephone number \\n\\uf0d8 Marital status and duration \\n\\uf0d8 History of consanguinity \\n\\uf0d8 Educational level: primary, secondary, university \\n\\uf0d8 Economic resources: employed? (Salaried work or short-term?)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Economic resources: employed? (Salaried work or short-term?) \\n\\uf0d8 Type of occupation of mother and husband \\n\\uf0d8 Substance abuse: alcohol or drugs ( husband & wife)  \\n\\uf0d8 Domestic Violence \\n\\uf0d8 Availability of a responsible person at home in an emergency \\n\\uf0d8 Mode of transport in an emergency \\n\\uf0d8 Closest EMOC facilities –the distance/ transport facility \\n \\nMedical history (Past and present) \\n\\uf0d8  Specific diseases and conditions:\\x00 tuberculosis, heart disease, chronic renal/hepatic \\ndisease, epilepsy, diabetes mellitus, hypertension, psychiatric illnesses and any \\nchronic diseases \\n\\uf0d8 STIs \\n\\uf0d8 HIV status, if known to be positive please follow the guidelines (page 114) without \\nentering into the pregnancy record. \\n\\uf0d8 Other specific conditions depending on prevalence in area (for example, hepatitis,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Other specific conditions depending on prevalence in area (for example, hepatitis, \\nmalaria, Thalaseamia) \\n\\uf0d8 Other diseases; past or chronic; allergy(-ies) \\n\\uf0d8 Operations other than caesarean sections (heart/ lung surgeries) \\n\\uf0d8 Past blood transfusions, Rhesus (D) antibodies \\n\\uf0d8 Current use of medicines – specify \\n\\uf0d8 Period of infertility: when? duration, cause(s), specialized treatment taken for \\ndifficulties in conceiving eg. Ovulation induction, IVF etc. \\n \\nFamily History \\n\\uf0d8 Diabetes mellitus \\n\\uf0d8 Hypertension/ PIH \\n\\uf0d8 Twins \\n\\uf0d8 Congenital abnormalities'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n21 \\n \\nHistory of present pregnancy \\n\\uf0d8 Date of last menstrual period (LMP) \\n\\uf0d8 Certainty of dates (by regularity, cycle length, accuracy of recall and other \\nrelevant information) \\n\\uf0d8 Habits: smoking/chewing tobacco, alcohol, drugs (frequency and quantity) \\n\\uf0d8 Any other concerns with regards to pregnancy (pain, vaginal bleeding, and \\nexcessive vomiting other: specify) \\n\\uf0d8 History of malaria attacks- when was the last attack \\n\\uf0d8 Any other discomforts \\nContraceptive history \\n\\uf0d8 Method use \\n\\uf0d8 When it was  started \\n\\uf0d8 When it was stopped \\n\\uf0d8 Method failure or not \\n \\nObstetric history (review all the available records, diagnostic cards, clinic records etc.) \\n\\uf0d8  Number of previous pregnancies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8  Number of previous pregnancies. \\n\\uf0d8 Date (month, year) and outcome of each event (live birth, stillbirth, abortion, ectopic, \\nhydatidiform mole). Specify (validate) preterm births and type of abortion, if \\napplicable and possible. \\n\\uf0d8 Birth weight (if known) \\n\\uf0d8 Sex of the child \\n\\uf0d8 Periods of exclusive breast-feeding: For how long? \\n\\uf0d8 Did she have any feeding difficulties in previous pregnancies? \\n\\uf0d8 Special maternal complications and events in previous pregnancies; specify which \\npregnancy (- ies), validate by records (if possible): \\n \\n\\uf0b7 Recurrent early abortion, induced abortion and any associated complications \\n\\uf0b7 Thrombosis, embolus \\n\\uf0b7 Hypertension, pre-eclampsia or eclampsia \\n\\uf0b7 Gestational diabetes \\n\\uf0b7 Placenta praevia/ APH \\n\\uf0b7 Liver disease/fatty liver'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Gestational diabetes \\n\\uf0b7 Placenta praevia/ APH \\n\\uf0b7 Liver disease/fatty liver \\n\\uf0b7 Breech or transverse presentation \\n\\uf0b7 Obstructed labour, including dystocia \\n\\uf0b7 Third-degree tears \\n\\uf0b7 Retained placenta \\n\\uf0b7 Post partum haemorrhage \\n\\uf0b7 Puerperal sepsis \\n\\uf0b7 Anesthetic complications \\n \\nObstetrical interventions  \\n\\uf0b7 Cervical cerclage (Shirodkar Suturing) \\n\\uf0b7 Caesarean section (indication, if known) \\n\\uf0b7 Forceps or vacuum extraction'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n22 \\n \\n\\uf0b7 Manual/instrumental help in vaginal breech delivery \\n\\uf0b7 Manual removal of the placenta. \\n\\uf0b7 Dilatation and evacuation (D&E) or dilatation and curettage (D&C) \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies \\n specify which pregnancy(- ies), validate by records (if possible): \\n\\uf0b7 Twins or higher order multiples \\n\\uf0b7 Low birth weight: <2500 g/ 2500-2000g / 1999- 1500g/ <1500g \\n\\uf0b7 Intrauterine growth retardation (if validated) \\n\\uf0b7 Rhesus-antibody affection (erythroblastosis, hydrops) \\n\\uf0b7 Malformed or chromosomally abnormal child \\n\\uf0b7 Macrosomic (>3500g) newborn \\n\\uf0b7 resuscitation or other treatment of newborn (SCBU and NICU admissions)/ \\nventilation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 resuscitation or other treatment of newborn (SCBU and NICU admissions)/ \\nventilation \\n\\uf0b7 perinatal, intrapartum, neonatal or infant death (also: later death) \\n\\uf0b7 Feeding problems \\n \\nb) Perform clinical examination \\n\\uf0b7 Record weight (Kg) and height (metres) (page 71) \\n\\uf0b7 Calculate BMI using BMI chart/cycle (page 71)and record it in pregnancy \\nrecord \\n\\uf0b7 Check for signs of severe anaemia: pale complexion, fingernails, conjunctiva, \\noral mucosa and shortness of breath  \\n\\uf0b7 Look for edema (ankles, fingers, face and abdoman) \\n\\uf0b7 Do a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities spinal/pelvic, icterus, cyanosis, clubbing  \\n\\uf0b7 Measure blood pressure and record  (Page 75) \\n\\uf0b7 Auscultate heart and  chest: Heart sounds, murmurs and abnormal breathing \\nsounds'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Auscultate heart and  chest: Heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0b7 Perform obstetric examination (page 76) \\n\\uf0b7 Perform breast examination if needs (lumps, nipple problems) \\n \\nc) Perform following tests  \\n\\uf0b7 Urine: Check for glucose (Benedicts test) and protein (coagulation test) or if \\navailable use urine test strips for protein and sugar (page 81) \\n\\uf0b7 VDRL testing as a screening test of Syphilis ( page 83) \\n\\uf0b7 Blood group and Rh (Should be done through government sector) \\n\\uf0b7 Check Haemoglobin at first visit using colour scale/ any other method (page \\n84) \\n \\n(Discuss with the nearest hospital with laboratory facilities to test Hb. This will be more \\naccurate method than colour scale) \\n \\n\\uf0b7 If there are risk factors (BMI above 25kg/m2, previous baby weighing'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 If there are risk factors (BMI above 25kg/m2, previous baby weighing \\n3.5kg or above, previous gestational diabetes, first degree relative with \\ndiabetes) do PPBS, if the value is more than 120mg/dl, refer for OGTT in \\na specialized unit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n23 \\n \\n \\n \\nd) Implement the following interventions \\no If any risk is identified, act according to the guidelines (page 41) \\no If woman is on treatment for diabetes, hypertension, epilepsy, psychiatric disease or \\nany other disease refer them to the relevant clinics for continuous treatment \\no Mothers without high risk conditions should be offered basic antenatal care \\no Folic acid (5mg daily) supplementation  \\no Nutritional supplementation (2 packets of Triposha/CSB for all mothers) \\no Ask to seek medical advise if having vaginal bleeding, severe vomiting or abdominal \\npain or any other concerns  \\n \\ne) Discuss and understand: \\nGive the pregnant woman an opportunity to discuss issues and ask questions: time for free \\ncommunication'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='communication \\n\\uf0b7 On whom to communicate or where to go in case of bleeding, abdominal pain and any \\nother emergency, or when in need of other advice (page 65) \\n\\uf0b7 On issues related to sexual relationship and activities  \\n\\uf0b7 Nutrition during pregnancy (page 85) \\n\\uf0b7 Minor ailments and their management during early pregnancy (page  91) \\n\\uf0b7 Advise the woman to participate with the husband or any other care giver for \\nantenatal   classes where they can learn how to deal with a pregnancy (page) \\n \\nf) \\nSchedule next appointment:  \\n \\nPlan second clinic visit at 12-14 weeks of  POA. State the date and time  \\n \\nConfirm the date for antenatal classes \\n \\nThis should be written in the pregnancy record (512A) and in the clinic’s appointment book if \\navailable. \\n \\ng)  Maintain complete records'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='available. \\n \\ng)  Maintain complete records \\n            Complete clinic records. \\n            Complete the Pregnancy record.  \\nGive the record to mother and advice her to bring it with her to all appointments with \\nany health services.                  .'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n24 \\n \\nSecond Clinic Visit- 12-14 weeks \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. To see the results of the tests and take necessary actions \\n4. Tetanus toxoid immunization  \\n5. To give Antihelminthic  treatment \\n6. To start micronutrient supplementation (Iron, folic acid, Vit C and calcium lactate) \\n7. To provide necessary care and health promotion \\n8. To discuss the birth  and emergency plan \\n \\na) Obtain information on: \\nPersonal/ social history \\n\\uf0d8 Note any changes since first visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc \\n\\uf0d8 Change of home environment \\n\\uf0d8 Change of duty station or occupation of wife or husband  \\n \\nMedical history'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Change of duty station or occupation of wife or husband  \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at first visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since first visit. \\n\\uf0d8 Review intake of medicines, other than folic acid \\n\\uf0d8 Folic acid intake: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at first visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since first visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral swelling,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral swelling, \\nshortness of breath with mild exertion) observed by the woman herself, by her \\npartner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken  \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart (page 73), Look for deviations \\nof the expected weight gain'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n25 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion \\n\\uf0a7 Perform abdominal examination- compare the fundal height with POA , look for \\nabdominal masses (page 76) \\n \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb% if signs and symptoms of  severe anaemia are detected on examination \\n\\uf0a7 Check urine for protein using coagulation test  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare based on evidence since first visit and observations at present visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='care based on evidence since first visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain of  bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Tetanus toxoid immunization (page 107). \\n\\uf0a7 Start iron folate supplementation with Vit C and calcium supplementation (page \\n100) if mother does not have vomiting or loss of appetite. Advice not to take iron \\nand calcium together (iron at night and calcium in the morning before/after meal.) \\n\\uf0a7 Malaria prophylaxis to be decided by MOH  according guidelines issued by AMC \\n(page 145) \\n\\uf0a7 Nutritional supplementation (Triposha/CSB 2 packets ) \\n\\uf0a7 Ask to seek medical advice if having vaginal bleeding or abdominal pain or any \\nother symptom'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Ask to seek medical advice if having vaginal bleeding or abdominal pain or any \\nother symptom  \\n\\uf0a7 If risk conditions are identified, refer them to the specialized care  \\n \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Create an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the pregnancy record) as at first visit (page 65) \\n\\uf0a7 Discuss and write down the birth plan \\n\\uf0a7 Schedule the third visit at 18-20 weeks either at field clinic or at specialist clinic'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Schedule the third visit at 18-20 weeks either at field clinic or at specialist clinic \\ndepending on the local policy. \\n\\uf0a7 Advice to write down the date of quickening \\n\\uf0a7 Confirm the date for antenatal class II \\n \\ng) Maintain complete records \\nComplete clinic records and pregnancy record. Give the record to mother and advise her to \\nbring it with her to all appointments with any health services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n26 \\n \\nVisit 3 (18-20 weeks) \\n \\nThis visit may be either at field clinic or at specialist clinic or at out reach clinic. \\nObjectives of this visit in a field clinic \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. For primies, to give second dose of tetanus Toxoid \\n4. To provide necessary care and health promotion \\n5. To Examine the heart to identity abnormalities \\n \\nObjectives of the visit in a specialist clinic \\n1. To confirm dates and placental position \\n2. To serve as a booking visit for delivery \\n3. To assess the progression of pregnancy \\n4. To assess the risk conditions and take necessary actions \\n \\na) Obtain information on: \\nPersonal history'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='a) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Record symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia  \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Fetal movements: whether felt or not. Note the date of first recognition in pregnancy \\nrecord. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n27 \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart – look for deviations of the \\nexpected rise\\x00\\x00 (page  73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal breathing \\nsounds \\n\\uf0a7 Measure SFH and record (page 76). \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\nc) Perform the following tests: \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n\\uf0a7 Check urine for protein using coagulation test'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='treatment for anaemia  \\n\\uf0a7 Check urine for protein using coagulation test \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 \\x00If complain bleeding per vagina: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 For primies give second dose of Tetanus toxoid immunization (page 107). \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n(booklets, leaflets etc.) \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at second visit  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the forth visit at 22-24 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record to mother and advise her to bring it with \\nher to all appointments with any health services.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n28 \\n \\nClinic Visit 4 (22-24 weeks) \\nObjectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To  screen for  risk factors and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge \\n(amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\nb) Perform physical examination'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='b) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect, refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n29 \\n \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina, refer for evaluation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 If complain bleeding per vagina, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If uterine height (SFH) is above expected: refer for evaluation. \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page 145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the fifth visit at 26-28 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n30 \\n \\nClinic Visit 5 (26-28 weeks) \\nObjectives of the visit  \\n1 To assess the progression of pregnancy \\n2 To  screen for  risk factors and take necessary actions \\n3 To screen for gestational diabetes \\n4 To screen for anaemia \\n5 To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron folate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. pain, bleeding, vaginal discharge, \\nsigns and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all screening tests undertaken.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Review, discuss and record the results of all screening tests undertaken. \\n \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart, look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n31 \\n \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected (page 76). \\n\\uf0a7 Ask about FM and listen for FHS and record. \\n\\uf0a7 Other alarming signs of disease :  gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis, shortness of breathing with mild exertion  \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria all mothers  \\n\\uf0a7 Screen all pregnant women for anaemia \\n\\uf0a7 All pregnant mothers should screen for GDM using PPBS (cut off 120mg/dl). For \\nfurther details see page 110) \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='care, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina : Refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation ( uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on whom to call or where to go in case of bleeding, abdominal pain or \\nany other emergency, or when in need of other advice. This should be confirmed in \\nwriting (e.g. on the antenatal card), as at last visit (page 65). \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Schedule the sixth visit at 32 - 34 weeks \\n\\uf0a7 Confirm the date for antenatal class III \\n \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n32 \\n \\n \\nClinic Visit 6 (32-34 weeks) \\n Objectives of the visit  \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n4. To look out for signs of PIH, IUGR, macrosomia, polyhydroamnios  \\n5. To ascertain the lie and presentation  \\n6. To provide necessary care and health promotion \\n7. To reevaluate the birth plan \\n8. To examine the heart to detect any abnormalities \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Medical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Any other specific symptoms or events.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='severe anaemia. \\n\\uf0d8 Any other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n33 \\n \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 (page 73) \\n\\uf0a7 Recheck heart and lungs and listen for heart sounds, murmurs and abnormal \\nbreathing sounds \\n\\uf0a7 Measure blood pressure and record. Respond accordingly (page 75) \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH, record, interpret and take necessary action if any deviation from \\nexpected (page 76) \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Look for Lie and Presentation.    \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis, shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria   \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit.\\x00 \\n\\uf0a7 Any new symptoms of recent onset: refer as required (page 41). \\n\\uf0a7 If complain bleeding per vagina or vaginal discharge: refer for evaluation \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above expected: refer for evaluation \\n\\uf0a7 Suspicion of twins: Refer for confirmation and plan for delivery. \\n\\uf0a7 If  transverse lie or breech presentation: refer for evaluation \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed (page145) \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal/ written information supported by antenatal classes  \\n\\uf0a7 Give advice on measures to be taken in case of pain, dribbling and bleeding (page 65)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Give advice on measures to be taken in case of pain, dribbling and bleeding (page 65)  \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency (page 65).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n34 \\n\\uf0a7 Plans to ensure transport is available in case of an emergency (page 65). \\n \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Schedule the  seventh visit at 36 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments any health services. \\n \\n \\nClinic Visit 7 (36 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. Review the SFH chart and weight gain chart to ascertain the fetal growth \\n3. To assess the risk conditions and take necessary actions \\n4. To ascertain the lie and presentation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='4. To ascertain the lie and presentation  \\n5. To introduce kick count chart \\n6. To look out for signs of PIH, IUGR  \\n7. To provide necessary care and health promotion \\n8. To reevaluate the birth plan  \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic  difficulties : disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review medications other than ironfolate, Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Check compliance with other advice given during last visit \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n35 \\n \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Ask for reduced fetal movements \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination  \\n \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Weigh the mother and plot the weight gain in the chart look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00  \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema (especially facial) and pallor. \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record \\n\\uf0a7 \\x00Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, \\njaundice (icterus), cyanosis,shortness of breathing with mild exertion \\n \\nc) Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 \\x00Any new symptoms of recent onset: refer as required . \\n\\uf0a7 If complained of bleeding per vagina or vaginal discharge, refer for evaluation. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH is above the expected : refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='e) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n36 \\n \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Introduce the kick count charts (KCC) and give clear guidance to maintain the \\nchart (page 80) \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Re-emphasis the signs and symptoms of labour \\n\\uf0a7 Re-confirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Plans to ensure transport is available in case of an emergency. \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='immediately. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n(page 172). \\n\\uf0a7 Schedule the eight visit at 38 weeks \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (38 weeks) \\nObjectives of the visit \\n1. To assess the progression of pregnancy \\n2. To assess the risk conditions and take necessary actions \\n3. Re-evaluate presentation/ lie/ PIH/ SFH/ weight chart/ KCC \\n4. To provide necessary care and health promotion \\n5. To reevaluate the birth and emergency plan  \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='a) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n\\uf0d8 Domestic difficulties: disharmony, violence etc. \\n \\nMedical history \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than iron, folate , calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n37 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Look for symptoms and events since last visit: e.g. abdominal or back pain (preterm \\nlabour?), bleeding, vaginal discharge (amniotic fluid?), signs and symptoms of \\nsevere anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n\\uf0d8 Review, discuss and record the results of all tests undertaken. \\n \\nb) Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart,  look for deviations of the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Weigh the mother and plot the weight gain in the chart,  look for deviations of the \\nexpected rise- consider macrosomia and IUGR, if suspect refer\\x00 \\n\\uf0a7 Measure blood pressure and record. Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor \\n\\uf0a7 Measure SFH , record, interpret and take necessary action if any deviation from \\nexpected . \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease:  gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc) Perform the following tests:  \\n\\uf0a7 Check urine for proteinuria  \\n\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Repeat Hb % if signs and symptoms of  anaemia are detected on examination or on \\ntreatment for anaemia  \\n \\nd) Assess for referral \\n\\uf0a7 Reassess whether the woman can still follow the basic component of the antenatal \\ncare, based on evidence since last visit and observations at present visit. \\n\\uf0a7 Any new symptoms of recent onset: refer as required. \\n\\uf0a7 Suspicion of fetal growth retardation (uterine height values below expected or \\nindicative of poor growth as evidenced by the chart curve): refer \\n\\uf0a7 If SFH above the expected ; refer for evaluation. \\n\\uf0a7 Suspicion of breech presentation or abnormal lie: Refer for specialized care \\n \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed  \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n38 \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Explain the signs and symptoms of labour and advice to get admitted to a hospital if \\nshe experience any \\n\\uf0a7 Give advice on measures to be taken in case of labour. \\n\\uf0a7 If no labour pains by 40 weeks ask her to get admitted to a specialized unit for \\nassessment. \\n\\uf0a7 If experience of reduced fetal movement, advice mother to get admit to the hospital \\nimmediately \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency  \\n\\uf0a7 Ensure the plans to ensure transport, to whom accompany with her, money and items \\nto be taken  \\n\\uf0a7 Discuss the birth plan and make changes if any. \\n\\uf0a7 Provide recommendations on breast feeding, family planning and postpartum care \\n\\uf0a7 Schedule the eighth visit at 40 weeks and explain her delivery may occur before the \\nnext clinic visit \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services. \\n \\nClinic Visit 8 (40 weeks) \\nObjectives of the visit \\n1. To ensure that the mother reaches the place of delivery in time'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Objectives of the visit \\n1. To ensure that the mother reaches the place of delivery in time  \\n2. To assess the risk conditions and take necessary actions \\n3. To provide necessary care and health promotion \\n \\na) Obtain information on: \\nPersonal history \\n\\uf0d8 Note any changes since last visit. \\n \\nMedical history \\n \\n\\uf0d8 Review relevant issues of medical history as recorded at last visit. \\n\\uf0d8 Note intercurrent diseases, injuries, or other conditions since last visit. \\n\\uf0d8 Review intake of medicines, other than ironfolate Vit C and calcium \\n\\uf0d8 Ironfolate, Vit C and calcium: check compliance. \\n\\uf0d8 Note other medical consultations, hospitalization or sick-leave since last visit. \\n\\uf0d8 Check compliance with other advice given during last visit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n39 \\n \\nObstetric history \\n\\uf0d8 Review relevant issues of obstetric history as recorded at last visit. \\n \\nPresent pregnancy \\n\\uf0d8 Record symptoms and events since last visit: e.g. abdominal or back pain, bleeding, \\nvaginal discharge (amniotic fluid?), signs and symptoms of severe anaemia. \\n\\uf0d8 Other specific symptoms or events. \\n\\uf0d8 Note abnormal changes in body features or physical capacity (e.g. peripheral \\nswelling, shortness of breath with mild exertion), observed by the woman herself, by \\nher partner, or other family members. \\n \\nb)  Perform physical examination \\n\\uf0a7 Weigh the mother and plot the weight gain in the chart. Check the total weight gain. \\n\\uf0a7 Measure blood pressure and record .Respond accordingly'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Measure blood pressure and record .Respond accordingly  \\n\\uf0a7 Look for generalized oedema and pallor. \\n\\uf0a7 Measure SFH and record. \\n\\uf0a7 Ask about FM and listen for FHS and record \\n\\uf0a7 Check for presentation and fetal lie (head, breech, transverse) and record\\x00 \\n\\uf0a7 Other alarming signs of disease: gross oedema of feet, facial oedema, pallor, jaundice \\n(icterus), cyanosis,shortness of breathing with mild exertion:  \\n \\nc)  Perform the following tests: \\n\\uf0a7 Check urine for proteinuria  \\n \\nd) Assess for referral  \\n Refer to the hospital where delivery is planned to be taken place for assessment.                                              \\ne) Implement the following interventions: \\n\\uf0a7 Give malaria prophylaxis if needed \\n\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Continue micronutrient supplementation \\n\\uf0a7 Give nutrition supplementation \\n\\uf0a7 Ask her to get admit to the hospital for an indoor assessment \\n \\nf) Advice, questions and answers, and scheduling the next appointment \\n\\uf0a7 Give an opportunity to discuss issues and ask questions  \\n\\uf0a7 Offer verbal information supported by antenatal classes and written information \\n\\uf0a7 Give advice on danger signals (reduced fetal movements, bleeding PV, headache, \\nshortness of breathing, severe chest pain, rapture of membranes and high fever) \\n\\uf0a7 Give advice on measures to be taken in case of  labour \\n\\uf0a7 Reconfirm the written information on whom to call and where to go in case of \\nemergency or ant other need. \\n\\uf0a7 Plans to ensure transport is available in case of an emergency.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n40 \\n \\n\\uf0a7 Provide recommendations on breast feeding, family planning and post partum care. \\n\\uf0a7 Ask her to go to the nearest hospital if labour signs and symptoms occurred, or if no \\nlabour pain after 40 weeks, ask her to go to specialized care unit. \\n\\uf0a7 Advice to continue iron, folic acid, Vit C and calcium lactate for 6 months after \\ndelivery. \\n\\uf0a7 Emphasis on following: \\nTo inform the area PHM as soon as the mother came home after delivery \\nTo attend the postpartum clinic after 4 weeks of delivery \\nTo continue micronutrients for 6 months after delivery \\n \\ng) Maintain complete records \\n\\uf0a7 Complete clinic records. \\n\\uf0a7 \\x00Complete Pregnancy record. Give the record the mother and advise her to bring it'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 \\x00Complete Pregnancy record. Give the record the mother and advise her to bring it \\nwith her to all appointments with any health services.  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during pregnancy\\nAdvise to go to the hospital immediately, day or night, without \\nwaiting if any of the following signs: \\n\\uf0a7 Vaginal bleeding \\n\\uf0a7 Convulsions \\n\\uf0a7 Severe headaches with blurred vision \\n\\uf0a7 Fever and too weak to get out of the bed. \\n\\uf0a7 Severe abdominal pain/ epigastric pain /RHC pain \\n\\uf0a7 Fast or difficult breathing \\n\\uf0a7 Reduced fetal movements \\nShe should go to the hospital as soon as possible if any of the following \\nsigns: \\n\\uf0a7 Fever \\n\\uf0a7 Abdominal pain \\n\\uf0a7 Feels ill \\n\\uf0a7 Swelling of fingers, face, legs \\nDating Scan'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='signs: \\n\\uf0a7 Fever \\n\\uf0a7 Abdominal pain \\n\\uf0a7 Feels ill \\n\\uf0a7 Swelling of fingers, face, legs \\nDating Scan \\nConfirmation of dates is essential for early identification of IUGR. USS is the \\nmost reliable method of confirmation of dates. However the parameters used \\nare depend on the POA. \\n \\n11- 14 weeks of POA– Crown rump length \\n16- 20 weeks of POA – Head circumference'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n41 \\n \\nChapter 5 \\n \\nMANAGEMENT OF RISK CONDITIONS AT FIELD LEVEL \\nNote: \\n\\uf0b7 When a high risk pregnant woman receives her antenatal care from a specialized unit \\nin a hospital, she should receive domiciliary care from the PHM. If she wish she can \\nattend to the field clinics also. \\n\\uf0b7 When pregnant women are not receiving micronutrients or food supplementations \\nfrom the hospital clinic, they should be supplied from the field clinic. \\n\\uf0b7 If high risk mothers are not receiving the specialized care, they should receive \\nadequate care from the field clinic. \\n\\uf0b7 If pregnant women have any problem they can attend to the field clinic disregarding \\nthe clinic appointment or risk condition'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the clinic appointment or risk condition \\n\\uf0b7 All the high risk pregnant women should attend to the antenatal classes with their \\nhusbands \\n \\nRisk Condition \\nAction to be taken \\n Past Obstetric History  \\nPrevious stillbirth (antenatal or intrapartum) \\nor neonatal loss or malformed babies \\nRefer at first visit  \\nAct according to the consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM  \\nPay special attention for kick count chart after 36 \\nweeks. \\n \\nHistory of 2 or more consecutive first \\ntrimester miscarriages \\n \\nRefer at first visit.  \\nDepending on the cause, MOH/ consultant \\nObstetricians can decide whether to continue as a \\nrisk mother or not  \\nNeed to do a proper screening including genetic \\nscreening, thrombophilic screening at the specialized \\ncare unit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='screening, thrombophilic screening at the specialized \\ncare unit \\n \\nHistory of preterm delivery before 37weeks, \\nor second trimester miscarriage  \\nRefer at first visit.  \\nAct according to the Consultant Obstetricians \\ninstructions.  \\nArrange targeted home visits by PHM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n42 \\n \\nHistory of PIH,  eclampsia/ pre-eclampsia \\n \\nRefer at first visit. \\nIf there is a history of PIH only, no need to refer \\nspecial care. Closely monitor the BP \\nIf there is H/O of pre eclampsia/Eclampsia, refer at \\nthe 1st visit for specialized care. \\nNeed close/ regular monitoring of BP \\nIf abnormally detected in BP, refer immediately \\n \\nHistory of APH             \\nIf it is due to placenta previa, refer to specialized \\ncare at 18-20wks for scan to ascertain the position of \\nthe placenta   as there is a risk of recurrence. \\nPlacental abruption: there is a possibility of \\nrecurrence. Refer at 1st visit. \\nCorrect the anaemia if detected. \\nAscertain blood group and Rh. \\n \\nHistory of retained placenta \\nCorrect aneamia if detected'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Ascertain blood group and Rh. \\n \\nHistory of retained placenta \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility  \\n \\nHistory of postpartum haemorrhage \\nCorrect aneamia if detected \\nCheck Blood group and Rh. \\nRefer to consultant Obstetricians at 36 weeks for \\nassessment. \\nPlan for delivery in a CEmOC facility \\n \\nHistory of cesarean section/ Myomectomy \\nAll the women with history of LSCS or \\nmyomectomy should have a scan at 18-20 weeks to \\ndetect placental localization. \\nRefer to specialized unit for this and to get \\nspecialized advice regarding delivery. \\nNeed to be admit to an institution with CEmOC \\nfacilities by 38weeks \\nIf she gets pain need to admit to the hospital in'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='facilities by 38weeks \\nIf she gets pain need to admit to the hospital in \\nfasting  state  \\n \\nHistory of surgery on reproductive tract  \\n(removal of septum, cone biopsy, large loop \\nexcision of  transformational zones \\n(LLETZ),  \\nRefer for specialist care at first visit for a scan. Act \\naccording to the consultant obstetrician’s instructions\\nHistory of a birth with birth weight < 2500g \\nRefer for specialist care at first visit. \\n  \\nHistory of a birth with weight > 3500g \\nDo a PBBS and if the result is > 120mg/dl refer to \\nspecialist clinic for OGTT.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n43 \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of  IUGR \\nRefer for specialist care at first visit. They will need \\naccurate dating scan before 14 weeks and regular \\nUSS with growth charts.  \\nAct according to the consultant Obstetricians \\ninstructions. \\n \\nHistory of Feeding difficulties/ breast \\nsurgery \\nMOH should  identify reasons and plan for  \\nappropriate interventions at last trimester \\nPresent pregnancy \\n Age less than 20yrs \\nIf less than 18 years refer to specialized care. \\n18-20yrs MOH / MO who provide antenatal care \\nshould monitor closely.    \\n \\nAdvanced maternal age (Age  >35yrs) \\nNeed more close monitoring by MOH as more prone \\nto Hypertension, Diabetes Mellitus etc'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Need more close monitoring by MOH as more prone \\nto Hypertension, Diabetes Mellitus etc \\nRefer necessary cases such as sub fertile mothers, \\nelderly primies, NCD complicating pregnancies to \\nspecialized care \\n \\nHeight < 145cm \\nRefer to a specialist unit at last trimester for an \\nassessment. To be delivered in a CEmOC  facility \\n \\nBMI  < 18.5kg/m2 \\nMOH should manage according to the given \\nguidelines. \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain \\n \\n BMI  25 -29.9kg/ m2 \\nMOH should monitor the   intra uterine growth of \\nthe fetus using SFH and maternal weight gain. \\n \\nBMI ≥30kg/ m2 \\nMOH should thoroughly screen for Hypertension, \\nPIH, Diabetes mellitus. \\nRefer to specialist unit for OGTT. \\nClosely monitor the weight gain and SFH to detect'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Refer to specialist unit for OGTT. \\nClosely monitor the weight gain and SFH to detect  \\nMacrosomia and polyhydroamnios \\nAscertain the lie after 36weeks \\nManage according to instruction given. \\n \\n Primigravida \\nMOH should manage her at his field clinic if there \\nare no other risk factors.  \\nDuring third trimester look for lie, presentation and \\nhead engagement.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n44 \\n Parity (5 or more) \\n Refer to specialist care at first visit. \\nCorrect anaeamia if her Hb level is  < 11g/dl. \\nNeed   special counseling for Family Planning. \\nTry to identify social problems if any \\nPlan delivery at CEmOC facility \\n \\nMultiple pregnancy \\nIf suspected, refer as early as possible to specialized \\ncare \\n \\nDiastolic blood pressure more than \\n90mmHg   \\nAdmit to a nearest hospital for monitoring for 24 \\nhours, if BP persists above 90mm Hg, transfer to \\nCEMOC facility (refer management guidelines of \\nPIH in the field).  \\n \\nDiastolic > 110mmHg or systolic 160 \\nmmHg or more \\nadmit urgently to the nearest hospital manage \\naccording to guidelines and transfer  immediately to \\na CEmOC facility'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='according to guidelines and transfer  immediately to \\na CEmOC facility \\n \\n Vaginal bleeding (any time) \\nAdmit to the nearest hospital  for assessment and \\nmanagement  \\nIf need, refer to a specialist unit \\n \\nMaternal jaundice \\nAdmit to the nearest hospital to transfer specialized \\nunit immediately. \\n \\nSevere maternal anaemia  (Hb% <7g/dl) \\nNeed to admit to a specialized care unit for \\ninvestigation and correction. \\n \\nMaternal malaria \\nAdmit to nearest hospital  medical unit  (manage \\naccording to AMC guideline) \\n \\n Maternal Syphilis \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\n Maternal HIV \\nRefer to STD clinic, as early as possible, \\nConfidentiality should be strictly assured. \\n \\nUncertain dates/ irregular periods'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Confidentiality should be strictly assured. \\n \\nUncertain dates/ irregular periods \\nNeed to refer specialized unit to ascertain the dates \\nbefore 20 weeks. (USS is accurate for dating only   \\nbefore 20 weeks.) \\n \\n Intra Uterine Growth Retardation (IUGR) \\nRefer to specialized care. They will need accurate \\ndating and regular USS with growth charts. Need to \\nplan for delivery at a CEmOC facility. POA  of \\ndelivery also need to decide based on the specialist \\nopinion'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n45 \\n Mal-presentations and abnormal lie  after \\n34 weeks \\nRefer to a specialized unit. \\nOther risk conditions \\n \\nDiabetes Mellitus/ Liver disease and renal \\ndiseases \\nRefer to a consultant Obstetrician. He/she will \\nmanage the pregnant woman with other relevant \\nspecialists. \\n \\nRheumatic and congenital heart disease \\nIf there is a suspicion of having a murmur, refer to \\ncardiologist for confirmation and diagnosis. After \\nthat refer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists.  \\nDiagnosed cases need to refer to consultant \\nObstetrician for combined care with a cardiologist. \\n \\nEpilepsy \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Refer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(neurologist/ physician) \\n \\n Mental disorders \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(psychiatrist/ MO mental health) \\n \\nAsthma \\nRefer to a consultant Obstetrician. He/she will \\nmanage the case with other relevant specialists \\n(general or chest physician) \\n \\nRh Negative mother \\nRefer to a consultant Obstetrician. \\nSend a blood sample to the blood bank with special \\nreferral form for screening antibodies.  \\n \\nSub fertility ( inability to conceive \\nirrespective of regular unprotected \\nintercourse  for 2 or more years) \\nRefer for specialized care  \\nSocial problems \\n \\nUnmarried mothers/ widows (single'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Refer for specialized care  \\nSocial problems \\n \\nUnmarried mothers/ widows (single \\nmothers), geographically marginalized and \\nother social factors \\nEnsure social support (MOH/PHM) Social service \\nofficer, Grama Niladhari, Samurdhi officer etc. \\nTargeted and more frequent home visits by PHM \\nLink with social security programs'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n46 \\n \\nChapter 06 \\nDOMICILIARY CARE FOR LOW RISK PREGNANCIES \\n \\nDomiciliary care for pregnant women is provided by the area PHM. At the time of \\nregistration as an eligible couple, PHM should give the screening questionnaire for newly \\nmarried couples and help them to fill it. Then she should go through the questionnaire and \\nwith further clarifications try to identify the risk conditions if available. After that she should \\nrefer the couple to MOH clinic for further screening by a medical officer and should give the \\ndates for sensitization classes. PHM should make aware the couple regarding the importance \\nof early commencement of antenatal care and pre pregnancy folic acid supplementation. She'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of early commencement of antenatal care and pre pregnancy folic acid supplementation. She \\nalso should inform them how to inform PHM once the wife gets pregnant.  \\nWhen a woman gets pregnant, PHM should register her ideally by 6-8 weeks. PHM should \\nmake aware the community regarding the importance of early registration as a pregnant \\nwoman and the means of communicating with her. PHM can register the pregnant women \\neither at home or in the clinic. It is better to register at home as PHM gets an opportunity to \\nassess the socioeconomic condition, home environment and to meet the other members of the \\nfamily during early pregnancy. This is an opportunity to educate the family members \\nregarding pregnancy and other relevant topics.  \\n \\nHome visit 1 (6 -12 weeks) \\n \\nObjectives:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='regarding pregnancy and other relevant topics.  \\n \\nHome visit 1 (6 -12 weeks) \\n \\nObjectives: \\n1. To assess the condition of the pregnant woman including socio- economic status  \\n2. To develop a rapport and linkage with the pregnant woman and the family \\n3. To educate the  pregnant woman and the family regarding the maternal care \\n \\nWhen the pregnant woman is registered at the home, that visit can be considered as the first \\nhome visit. When the pregnant woman is registered at the clinic, PHM should visit her before \\n12 weeks of POA. During this visit PHM should: \\na) Assess the condition of the pregnant woman (physical, mental, social and \\nenvironmental) \\n \\nObtain information on: \\n \\nPersonal history : \\n- \\nName \\n- \\nAge /date of birth  \\n- \\nAddress and telephone number  \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Personal history : \\n- \\nName \\n- \\nAge /date of birth  \\n- \\nAddress and telephone number  \\n- \\nMarital status- duration and history of subfertility \\n- \\nHistory of consanguinity \\n- \\nPre pregnancy care: Eligible couple registration'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n47 \\n \\n- \\nRubella Immunization  \\n- \\nIntake of folic acid \\n- \\nAttend to a pre pregnancy care programme/not \\n- \\nThalasseamia test if relevant \\n- \\nPlanned/ unplanned pregnancy \\n \\nSocio- economic status:  \\n- \\nHousing: type, size, number of occupants \\n- \\nSanitary conditions: type of toilet, source of water \\n- \\nLighting: Electricity or other sources of  lighting \\n- \\nCooking facilities- gas, electricity, firewood \\n- \\nTobacco use (smoking or chewing habit) or use of other harmful substances \\n- \\nAlcohol use \\n- \\nGender Based Violence \\n- \\nEnvironment: Prone to dengue and accidents, cleanliness etc \\n- \\nDomestic air pollution: smoke inhalation (tobacco smoking, smoke from the \\nhearth, mosquito coils etc.) \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='hearth, mosquito coils etc.) \\n- \\nEducational level: primary, secondary, university or higher education  \\n- \\nEconomic resources: employed (salaried work or short-term)  \\n- \\nType of work and position: both pregnant woman and husband \\n- \\nOccupation:  distance to travel, harmful occupational exposures, maternity \\nbenefits, work load \\n- \\nNuclear or extended family \\n- \\nRelationship with in-laws \\n- \\nFamily support and social support \\n- \\nAvailability of a responsible person at home  \\n- \\nMode of transport at an emergency \\n- \\nClosest EMOC facilities: distance / transport facilities \\n- \\nHome gardening, iodized salt, eating habits, Myths, House hold food security  \\n- \\nLeisure activities \\n- \\nReligious activities \\n \\nMedical history  \\n \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nLeisure activities \\n- \\nReligious activities \\n \\nMedical history  \\n \\n- \\nSpecific diseases and conditions:  tuberculosis, heart disease, chronic renal \\ndisease, epilepsy, diabetes mellitus, hypertension, asthma, psychiatric illness \\n- \\nSTIs/ HIV status:  if known \\n- \\nOther specific conditions depending on prevalence in the area: hepatitis, \\nmalaria, thalaseamia \\n- \\nAllergies:  food or drug \\n- \\nOperations other than caesarean sections: heart surgeries, surgeries for \\ngynaecolgical conditions \\n- \\nBlood transfusions: Rhesus (D) antibodies \\n- \\nCurrent use of medicines: specify \\n- \\nPeriod(s) of infertility: Duration, cause(s) treatments etc'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n48 \\n \\nHistory of present pregnancy \\n \\n- \\nDate of commencement of last menstrual period (LMP) \\n- \\nCertainty of dates: by regularity, accuracy of recall and other relevant \\ninformation \\n- \\nAny unexpected event: pain, vaginal bleeding, other- specify \\n- \\nHistory of malaria attacks \\n- \\nContraceptive history: method used, when it was started, when it was stopped, \\nmethod failure or not \\n \\nFamily history (blood relatives) \\n \\n- \\nDiabetes Mellitus, Hypertension, Twins, Congenital abnormalities \\n \\nObstetric history \\nPrevious pregnancies (Review all the available records, diagnosis cards, clinic records)  \\n \\n- \\nNumber of previous pregnancies \\n- \\nDate (month, year), place of delivery  and outcome of each event (live birth,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nDate (month, year), place of delivery  and outcome of each event (live birth, \\nstillbirth, abortion, ectopic, hydatidiform mole) - Specify and validate with \\navailable documents  \\n- \\nPreterm births and types of abortion: If applicable and possible \\n- \\nBirth weight (if known)  \\n- \\nSex and age of the living children \\n \\nSpecial maternal complications and events in previous pregnancies (specify which \\npregnancy/ ies validate by records (if possible):  \\n \\n- \\nRecurrent early abortion \\n- \\nInduced abortion and any associated complications \\n- \\nGestational diabetes \\n- \\nHypertension, pre-eclampsia or eclampsia \\n- \\nPlacental abruption \\n- \\nPlacenta praevia \\n- \\nBreech or transverse presentation \\n- \\nObstructed labour, including dystocia \\n- \\nThird-degree tears \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nObstructed labour, including dystocia \\n- \\nThird-degree tears \\n- \\nExcessive bleeding (antepartum or postpartum) \\n- \\nPuerperal sepsis \\n \\nObstetrical interventions: \\n \\n- \\nCaesarean section (indication, if known) \\n- \\nForceps or vacuum extraction \\n- \\nManual/instrumental help in vaginal breech delivery \\n- \\nManual removal of the placenta'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n49 \\n \\nSpecial perinatal (fetal, newborn) complications and events in previous pregnancies  \\nspecify which pregnancy/- ies, validate by records (if possible): \\n \\n- \\nTwins  \\n- \\nHigher order multiples \\n- \\nLow birth weight: <2500 g \\n- \\nMalformed or chromosomally abnormal child \\n- \\nMacrosomic (>3500g) newborn \\n- \\nResuscitation or other treatment of newborn \\n- \\nPerinatal, neonatal or infant death (also: later death) \\n- \\nIUGR \\n- \\nRhesus antibody affection (Erythro blastosis, hydrops fetalis) \\n- \\nSCBU or NICU admissions \\n \\nb) Perform physical examination ) \\n \\n- \\nAssess the personnel hygiene \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, \\nconjunctiva, oral mucosa, tip of tongue and shortness of breath. \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='conjunctiva, oral mucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema- ankles, fingers, face, and abdomen \\n- \\nDo a general examination: Look for thyroid diseases, dental hygiene, \\ndeformities (spine, pelvic and limbs),  icterus, clubbing, cyanosis \\n- \\nBreast examination: masses, changes in the skin, nipple  \\n- \\nAbdominal examination – masses, tenderness, palpable uterus (compare with \\nthe POA) \\n \\n \\n \\nc) Investigations \\n \\n- \\nCheck urine for glucose and/or proteins if indicated (PIH, hypertension, renal \\ndisease, diabetes) \\n \\nd) Referral for antenatal care \\n \\n- \\nDetermine the expected date of delivery based on LMP and all other relevant \\ninformation. Use 280-day rule (LRMP + 280 days). Some women will refer to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='information. Use 280-day rule (LRMP + 280 days). Some women will refer to \\nthe date of the first missed period when asked about LMP, which may lead to \\nmiscalculation of term by four weeks. \\nEg. Last LRMP: 23rd March 2010   EDD 30th December 2010 \\n- \\nGive an appointment for antenatal clinic care \\n  \\nf) Advice, questions and answers, and scheduling the next appointment \\n \\n- \\nIf new risk factors identified refer to ANC as early as possible (when 1st home \\nvisit after first clinic visit). \\n- \\nGive advice on safe sex. Emphasize the risk of acquiring or transmitting HIV \\nor STIs.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n50 \\n \\n- \\nAdvise women to stop the use of tobacco (both smoking and chewing), \\nalcohol and other harmful substances. Advice to avoid passive smoking. \\n- \\nAdvice on management of abdominal pain, urinary tract infections and minor \\ndiscomforts during pregnancy, personal hygiene, physical and mental rest and \\nsleep. \\n- \\nAdvice on how to prevent infectious diseases. (use cool boiled  water, hard \\nwashing etc). \\n- \\nAdvice all the family members on family support needed during pregnancy. \\n- \\nAdvice to increase fluid intake, how to prepare a balanced nutritious diet. \\n- \\nExplain the signs and symptoms and actions to be taken in the case of ectopic \\npregnancy or an abortion. \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnancy or an abortion. \\n- \\nGive advice on whom to call or where to go in case of bleeding, abdominal \\npain and any other emergency, or when in need of other advice. \\n- \\nEmphasis the need of continuation of treatment for medical conditions. \\n- \\nGive advice on how to contact PHM in an emergency (mobile numbers, place \\nof the office and residence). \\n- \\nRequest the woman to record when she notes the first fetal movement. \\n- \\nDiscuss with the woman and the family regarding the importance of \\nmaintaining the good mental status during pregnancy.  \\n- \\nDiscuss with the woman and the husband (or a family member) on the \\nimportance of attending antenatal clinics and antenatal classes. So that they \\ncan be involved in the activities and can learn how to support the woman \\nthrough her pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='can be involved in the activities and can learn how to support the woman \\nthrough her pregnancy. \\n- \\nIntroduce the relevant reading material (guide to pregnant mothers, five \\nbooklets on breast feeding, booklets on ECCD) to the pregnant woman and the \\nfamily. \\n \\nSchedule next appointment:  \\n \\n- \\nGive them a date for first antenatal class \\n- \\nMake arrangements for the second home visit, at (or close to) 22 -24 weeks: \\nstate date and hour. This should be written in the pregnancy record (H512) A \\nand B.  \\n- \\nGive a date for the first antenatal clinic visit if she has not gone yet. \\n- \\nAsk her to come to the clinic or inform PHM if there is any problem.  \\n- \\nInform her the dates of the clinic sessions and the dates and place of weighing \\n(children) in the village where she can meet the PHM.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='(children) in the village where she can meet the PHM. \\n \\nh) Maintain complete records \\n \\n- \\nComplete 512 A, B and the diary \\n- \\nIssue properly filled a H512 (pregnancy record) to the mother and explain her \\nand family importance of it and how to self assess the weight gain using \\nweight gain chart and growth of the fetus using SFH chart \\n- \\nAdvise her to bring pregnancy record with her to all appointments she may \\nhave with any health services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n51 \\n \\nHome visit 2 (22 -24 weeks) \\nObjectives: \\n1. To access the progression of the pregnancy \\n2. To help the pregnant woman and the family to deal with the pregnancy \\n3. To advice the family regarding birth plan and emergency plan \\n4. To help the family to prepare for the delivery and newborn \\nAsk: \\n- \\nFor any complains  \\n- \\nWhether she feels fetal movements, if she feels, record first date of quickening and see \\nwhether it is compatible with her POA \\n- \\nAbout her mental wellbeing ( happiness, support from the family members)    \\n- \\nAbout the diet, intake of vitamins, worm treatment and immunization ( Tetanus toxoid)    \\n- \\nAbout the rest, sleep, daily activities done at home \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nAbout the rest, sleep, daily activities done at home \\n- \\nFor any physical discomforts: Headache, dysuria, vaginal discharges, any discharges from \\nthe nipples, breast pain, vomiting and morning sickness \\n- \\nAbout the family support ( from the husband and other family members)  \\n- \\nAbout sexual activities \\n- \\nAbout the plans for delivery and emergency (hospital/ transport/ money/arrangements to \\ncare for the home and other children if any) \\n- \\nWhether  all the investigations are done (Grouping and Rh, Hb, VDRL, PPBS) \\n- \\nWhether she has attended for the referrals \\n \\nExamination: \\n \\n- \\nAssess the personnel hygiene \\n- \\nObserve any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='mucosa, tip of tongue and shortness of breath \\n- \\nLook for thyroid diseases, Dental hygiene, icterus, clubbing, cyanosis \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nAbdominal examination : feel for fundus , fundal height, fetal movements, fetal heart \\nsounds \\n- \\nCheck urine for sugar and protein: If needed (women with renal disease, hypertension, \\ndiabetes) \\n \\nInterventions and actions: \\n \\n- \\nEducate mother and care givers regarding danger signals during pregnancy \\n(antepartum haemorrhage, severe abdominal pain, severe headache), importance of \\nclinic visits, proper nutrition, monitoring of weight gain, working and mental well-\\nbeing during pregnancy, items to be taken to the hospital for the delivery, ECCD, rest \\nand sleeping'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n52 \\n \\n- \\nReferrals should be done if needed- anaemia, severe headache, difficulty in breathing, \\nother difficulties \\n- \\nEmphasis the need of continuation of treatment for medical conditions \\n- \\nCheck for compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nDiscuss with the family: place of delivery, actions to be taken in an emergency, \\narrangement for transport \\n- \\nGive an opportunity to discuss issues and ask questions \\n- \\nGive a date for third home visit \\n- \\nConfirm the attendance for antenatal class II \\n- \\nGive date and place for third antenatal class \\n- \\nMake records in 512 A, B , and in the diary  \\n \\n \\n \\nHome visit 3 (34- 36 weeks) \\nObjectives'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nMake records in 512 A, B , and in the diary  \\n \\n \\n \\nHome visit 3 (34- 36 weeks) \\nObjectives \\n1. To ensure the birth plan and preparedness for the hospitalization and delivery  \\n2. To help the family to welcome the new member \\n3. To ensure breast feeding, ECCD activities and family planning \\n \\nAsk: \\n- \\nFor any complains, physical discomforts  \\n- \\nWhether she feels fetal movements, and teach her how to maintain a kick count chart \\n- \\nAbout the support from the family \\n- \\nCheck the compliance on taking micronutrients, food supplementation and medical \\nadvice given in the clinic \\n- \\nAdvice and check to prepare the essential items for both mother and baby during \\nhospitalization including transport \\n- \\nAsk about the present illnesses, changes in the vulva, oedema and headache, varicose'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nAsk about the present illnesses, changes in the vulva, oedema and headache, varicose \\nveins, dysuria, difficulty in breathing \\n- \\nAsk about the advices given in the clinics and see whether she is complying \\n \\n \\nExamination: \\n- \\nAssess personnel hygiene \\n- \\nObserve for any behavioural changes \\n- \\nCheck for signs of severe anaemia: pale complexion in fingernails, conjunctiva, oral \\nmucosa, tip of tongue and shortness of breath. \\n- \\nLook for oedema: ankles, fingers, face, abdomen \\n- \\nExamine abdomen and assess the fundal height compare with POA, check the lie and \\npresentation \\n- \\nListen to fetal heart sounds \\n- \\nCheck urine for sugar and protein- If needed (women with renal disease, \\nhypertension, diabetes)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n53 \\n \\nInterventions and actions: \\n- \\nEducate and reconfirm what mother and care givers knew regarding signs of labour \\n \\n- \\nEnsure that all the items need for delivery and hospitalization are ready \\n \\n- \\nAware the mother regarding vaginal examination, lithotomy position, pain \\nmanagement,  delivery on to abdomen (skin to skin contact with the baby), \\nimportance of cooperation at the labour room, breathing exercises \\n \\n- \\nEducate mother and the family members about the labour, breast feeding, family \\nplanning, early childhood care development, obstetric emergencies: reduced fetal \\nmovements, antepartum haemorrhage, dribbling, severe headache, abdominal pain,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='movements, antepartum haemorrhage, dribbling, severe headache, abdominal pain, \\nand actions to be taken if she experience any of those, new born care, post partum \\nmicronutrient supplementation, EDD and signs of labour  \\n \\n- \\nDiscuss with the family: actions to be taken during an emergency, transport \\narrangements in an emergency, care for other children while mother is in hospital, \\nfamily and social support after delivery \\n \\n- \\nDiscuss the breast feeding: including first feed, exclusive breast feeding, attachment, \\npositioning etc. and ensure that she has read the booklets on breast feeding \\n \\n- \\nInfection control: importance of limiting visitors, handling of baby, hand washing \\n \\n- \\nAdvice to prepare the home environment to welcome the newborn \\n \\n-'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='- \\nAdvice to prepare the home environment to welcome the newborn \\n \\n- \\nServices from the hospital: start breast feeding within the first hour of delivery and \\nexclusive breast feeding, BCG immunization, Vit. A mega dose, birth registration, \\npregnancy record to be returned, CHDR, neonatal examination by a MO  \\n \\n- \\nMethod to inform the PHM after delivery: telephone, messenger \\n \\n- \\nRefer to an appropriate health facility if needed  \\n \\n- \\nGive an opportunity to discuss issues and ask questions \\n \\n- \\nRecord the findings in the 512 A,B and complete the diary \\n \\n- \\nIf needed, complete LRT consent form \\n \\n- \\nIf they change the residence after delivery, ask them to inform the area PHM in the \\nnew residence  for postnatal care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n54 \\n \\nChapter 7 \\n \\nDOMICILIARY CARE FOR HIGH RISK PREGNANCIES \\n \\nPlease note all the high risk pregnant women should receive the routine domiciliary care described in the previous chapter.\\nRisk condition \\nFrequency of \\nhome visits \\nAsk\\nExamine\\nRemarks\\nPast Obstetric History \\nPrevious still birth \\n(antenatal or \\nintrapartum) or \\nneonatal loss or \\ncongenitally \\nmalformed babies \\n \\n \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nevery 4 weeks  \\nAsk about fetal \\nmovement \\nInquire about the \\nother risk conditions \\neg. GDM, PIH \\n \\n \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 20 weeks \\n \\nMake aware on conditions which can cause still births \\nE.g. Gestational DM, Placenta abruption , cord round \\nthe neck etc'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='E.g. Gestational DM, Placenta abruption , cord round \\nthe neck etc \\nAscertain that blood sugar levels checked. \\nEducate on danger signals \\nAsk pregnant woman:   \\nto be more vigilant about fetal movements  \\nto pay special attention to KCC after 36 weeks \\nto get admit as early as possible if she experience \\nreduced fetal movements  \\nto get admit to hospital as early as possible if she gets a \\nsevere abdominal pain, bleeding per vagina. \\nReassure that it will not happened in consequent \\npregnancies \\nPlan for delivery and emergency  \\nRefer to post-partum clinic for neonatal examination \\nafter delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n55 \\nHistory of 2 or more \\nconsecutive first \\ntrimester abortions \\nDuring first \\ntrimester, provide \\ndomiciliary care \\nin every 4 weeks. \\nAfter that if no \\nrisk conditions \\nidentified, routine \\nantenatal \\ndomiciliary care \\nInquire about vaginal \\nbleeding , abdominal \\npain \\nIf the reasons for the \\nabortions are other \\nmedical condition, \\nact according to the \\nadvice given. \\nRoutine examination\\nAsk her to get admit as early as possible if she \\nexperience abdominal pain or bleeding per vagina \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units  \\n \\nHistory of preterm \\ndelivery before 37 \\nweeks, or second \\ntrimester miscarriage \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='weeks, or second \\ntrimester miscarriage \\nAfter 28 weeks \\nPHM should \\nprovide \\ndomiciliary care \\nonce in 4 weeks \\nInquire about lower \\nabdominal pain or \\nvaginal bleeding \\n \\nRoutine examination \\nand focus more on FHS \\nfrom 28 weeks \\n \\n \\nAsk her to avoid heavy work and get adequate rest\\nEnsure the family support for domestic work \\nAsk her to get admit as early as possible if she gets \\nlower abdominal pain or blood stained vaginal discharge \\nor per vaginal bleeding \\nAsk to prepare all the things need for the delivery  \\nSee the compliance of medication and instructions given \\nby antenatal clinic/ specialized care units \\n \\nHistory of PHI \\neclampsia/ \\npreeclampsia \\nIf high blood \\npressure is not \\ndetected in this \\npregnancy, \\nRoutine three \\nhome visits are \\nadequate. \\nAsk about headache,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='detected in this \\npregnancy, \\nRoutine three \\nhome visits are \\nadequate. \\nAsk about headache, \\nvisual disturbances, \\nchest pain , shortness \\nof breath and \\nepigastric pain \\n \\nMeasure BP if possible\\nCheck urine for albumin \\nduring home visits. \\n \\n \\nEducate family members on signs and symptoms pre \\neclampsia \\nAsk her to get admit if she experience any of those \\nsymptoms \\nAsk  her to check blood pressure at least once a month \\nand maintain the records. \\nRefer to a doctor if BP is high or if albumin is present in \\nurine or any sign of pre eclampsia'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n56 \\nHistory of APH\\nRoutine three \\nhome visits are \\nadequate. \\nAsk about vaginal \\nbleeding and  \\nabdominal pain \\nAsk about shortness \\nof breath while \\nmoderate exercise \\n(features of anaemia) \\nSee whether USS has \\ndone to confirm the \\nplacental site \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are  available \\nExamine for signs of \\naneamia \\nEducate her to take nutritious iron rich diet.\\nAsk her to get admit as early as possible in case of \\nvaginal bleeding or abdominal pain. \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice. \\nHistory of retained \\nplacenta  or  history \\nof postpartum \\nhaemorrhage \\nRoutine three \\nhome visits are \\nadequate. \\nAsk for symptoms of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of postpartum \\nhaemorrhage \\nRoutine three \\nhome visits are \\nadequate. \\nAsk for symptoms of \\nanaemia \\nLook for signs of \\nanaemia \\nSee whether the reports \\nof blood grouping and \\nRh and Hb are available \\nHelp her and the family to decide on place of delivery \\n(place with CEMOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of caesarean \\nsection/ myomectomy\\nAfter 28 weeks, \\ndomiciliary care \\nshould be given \\nevery 4 weeks \\nAsk for abdominal \\npain, vaginal \\nbleeding, pain in the \\nscar \\nExamine for scar \\ntenderness \\nSee whether the USS is \\ndone to confirm the \\nplacental site \\nLook whether the Hb  \\nand blood grouping and \\nRh reports are available \\nAsk her to get admit if she experience abdominal pain,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Rh reports are available \\nAsk her to get admit if she experience abdominal pain, \\nvaginal bleeding and scar tenderness \\nIf so ask her to go to the hospital fasting due to \\npossibility of emergency section \\nHelp her and family to decide on place of delivery \\n(place with CEmOC facilities) \\nIf anaemic, act according to the guidelines given. \\nSee the compliance on ironfolate and nutrition advice \\nHistory of surgery on \\nreproductive tract \\n(removal of septum, \\ncone biopsy, large \\nloop excision of \\ntransformational \\nzones) \\nMonthly home \\nvisits from the \\nregistration \\nAsk for abdominal \\npain or  vaginal \\nbleeding  \\nExamine for tenderness \\nin the abdomen \\nSee whether intrauterine \\npregnancy is confirmed \\nAsk mother to get admit as early as possible if she'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnancy is confirmed \\nAsk mother to get admit as early as possible if she \\nexperience severe abdominal pain during first trimester \\nAdvice to get a scan done to confirm intrauterine \\npregnancy \\nCheck the compliance on medical advice given in the \\nspecialized care unit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n57 \\nBirth with birth \\nweight <2500g \\nMonthly home \\nvisits \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nAsk her to take balanced nutritious diet\\nAdvise on adequate rest. \\nEnsure the family support on domestic work \\nRefer to the clinic if SFH is less than POA \\n \\nBirth weight > 3500g\\nRoutine home \\nvisits are \\nadequate, if there \\nis no additional \\ncomplication \\nInquire about the \\nGestational DM \\nMeasure SFH\\nCheck maternal weight \\ngain \\nCheck for  FHS \\nCheck urine for glucose \\nduring home visit \\nRefer to the clinic if SFH is  more than POA  for USS\\nCheck whether screening for GDM has done  \\nHelp mother to decide on place of delivery( with \\nCEMOC facilities) \\nKick count chart after 36 weeks \\nHistory of IUGR\\nMonthly home'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='CEMOC facilities) \\nKick count chart after 36 weeks \\nHistory of IUGR\\nMonthly home \\nvisits \\nAsk for fetal \\nmovements \\nAsk for other risk \\nconditions (PIH) \\nAsk for chronic \\ndiseases and \\nfrequently occurring \\nconditions \\nMeasure SFH \\nMeasure BP if possible \\nCheck maternal weight \\ngain \\nCheck for FHS \\nReassure mother \\nIdentify nutritional problems and intervene \\nEnsure family support and adequate rest at home \\nInquire about the type of household work engaged in \\nRefer to the clinic if SFH is less than POA \\n \\nFeeding difficulties/ \\nhistory of breast \\nsurgery \\nMonthly visits \\nduring last \\ntrimester \\n \\n \\n \\nAdvice on breast feeding technique , how to express \\nbreast milk and importance of  breast feeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n58 \\nPresent pregnancy \\nAge less than 20 \\nyears \\nIf she is less than \\n18 years monthly \\nhome visits \\nSee whether she has \\ngone to a specialized \\nunit \\nEnsure the antenatal clinic care\\nEnsure the help from the family or neighbours  \\nDiscuss the care during postnatal period  \\nDiscus about postpartum family planning \\nDiscuss about Breast Feeding  \\nAdvanced maternal \\nage (Age> 35 years) \\nIf mother is more \\nthan 40 years and \\na primi need \\nmonthly home \\nvisits. For others \\nroutine three \\nvisits are \\nadequate \\nAsk for risk \\nconditions \\n(hypertension, \\ndiabetes Mellitus) \\nAsk for fetal \\nmovements \\nMeasure BP if possible\\n \\nCheck for SFH, FHS \\n \\nCheck whether \\nscreening for GDM has \\ndone \\n \\nExplain her about the risk of chromosomal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Check whether \\nscreening for GDM has \\ndone \\n \\nExplain her about the risk of chromosomal \\nabnormalities, first trimester miscarriages associate with \\nthe age \\nAsk her to be more vigilant on fetal movements after 36 \\nweeks \\nAsk her to admit as early as possible if she experience \\nreduced fetal movements \\nHelp her to decide on place of delivery with CEmOC \\nfacilities \\nHeight< 145cm\\n \\n \\nRoutine three \\nvisits are \\nadequate \\nSee whether she has \\ngone for pelvic \\nassessment to a \\nspecialized unit during \\nthe third trimester \\nExplain her and family members about the process of \\nlabour \\nHelp her to decide the place of delivery with CEmOC \\nfacilities. \\nBMI <18.5kg/m2 \\nMonthly home \\nvisits until the \\nweight gain is \\nadequate \\naccording to BMI \\nCheck whether mother \\nis taking balanced'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='weight gain is \\nadequate \\naccording to BMI \\nCheck whether mother \\nis taking balanced \\nnutritious diet \\nAsk her to take a balanced nutritious diet\\nAssess the level of physical activity and if she is \\ncarrying out heavy work, discuss with her how to reduce \\nthat kind of work. \\nEnsure the help of the family and adequate rest'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n59 \\nBMI > 30kg/m2\\nMonthly home \\nvisits \\nAsk for other risk \\nconditions such as \\nHypertension, PIH, \\nGDM \\nCheck whether \\nscreening for GDM has \\ndone \\nMeasure BP if possible \\nMeasure SFH \\nLook for lie and \\npresentation after 36 \\nweeks \\nRefer to the clinic if SFH>POA\\nAdvice on dietary habits- low fat/ carbohydrates \\nExplain  the risks of obesity/ overweight \\nAsk her to check blood pressure regularly \\n \\nPrimigravida\\nRoutine three \\nvisits are \\nadequate \\nCheck for lie \\npresentation and head \\nengagement after 32 \\nweeks \\nEducate on labour , labour pains, environment of the \\nlabour room \\nEnsure the family support \\nAdvise on the items to be taken to the hospital.  \\nEducate on breast feeding and BF techniques \\nParity (5 or more)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Educate on breast feeding and BF techniques \\nParity (5 or more)\\nMonthly visits\\nAsk about the social \\nproblems (GBV, \\npoverty, low \\neducational level) \\nAsk about the \\nsymptoms of anaemia\\nCheck whether the Hb \\nreport is available \\n \\nAsk her to get admit as soon as possible even with slight \\nlower abdominal pain closer to delivery \\nHelp the her decide the place of delivery with EMOC \\nfacilities \\nDiscuss about the family planning method \\nEnsure the family support and arrangements for other \\nchildren \\nMultiple pregnancy\\nMonthly up to \\nsecond trimester \\nand two weekly \\nduring third \\ntrimester \\nAsk about the \\nvomiting and other \\nsymptoms of \\npregnancy during \\nfirst trimester \\nAsk about the \\nCheck whether the Hb \\nreport is available \\nCheck whether mother \\nhas gone to a specialized \\nunit'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Check whether the Hb \\nreport is available \\nCheck whether mother \\nhas gone to a specialized \\nunit \\nMeasure BP if possible \\nExplain her about risk of having preterm labour and ask \\nto get admit as early as possible if she experiences any \\nlower abdominal pain close to term. \\nExplain her about risk of PIH associated with multiple \\npregnancies and asked to BP checked regularly \\nAsk her to go to a specialized unit in case of an'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n60 \\nsymptoms of anaemia\\nAsk about other risk \\nconditions (PIH) \\n \\n \\nemergency\\nAdvice on technique of  breast feeding both babies \\n simultaneously \\nAdvice on family planning methods \\nAdvice on how to care twins \\nEmphasis on family support which is very much needed \\nafter delivery  \\nDiastolic BP more \\nthan 90mmhg \\nEvery two weeks \\nafter detecting \\nhigh blood \\npressure \\nAsk about severe \\nheadache , visual \\ndisturbances, chest \\npain and shortness of \\nbreath \\nAsk about fetal \\nmovements \\nMeasure BP if possible \\nCheck  urine for \\nalbumin  \\nCheck the compliance \\non antihypertensives and \\nthe advice given at the \\nclinic \\nCheck FHS \\nRefer to a medical officer  if BP is high or if urine for \\nalbumin is positive'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='clinic \\nCheck FHS \\nRefer to a medical officer  if BP is high or if urine for \\nalbumin is positive \\nAsk her to be fasting while getting admit to hospital in \\ncase of emergency \\nHelp her to decide on place of delivery with C EmOC \\nfacilities \\nEducate the family members regarding danger signals \\nand the actions to be taken in an emergency \\nUncertain dates / \\nirregular periods \\nOnce the dates \\nare corrected, \\nroutine three \\nhome visits are \\nadequate \\nAsk about previously \\nused family planning \\nmethod  method used, \\nwhen did it stop, how \\nlong she has used it,) \\nCheck whether she has \\ngone for dating scan \\nRefer for a dating scan before 20 weeks of POA\\nAsk mother to be more vigilant on date of quickening \\n \\n \\nIntra uterine growth \\nretardation \\n \\n \\nHome visits \\nshould be done \\nevery two weeks'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Intra uterine growth \\nretardation \\n \\n \\nHome visits \\nshould be done \\nevery two weeks \\nonce IUGR is \\ndetected \\nAsk for fetal \\nmovements \\nCheck whether dating \\nscan is done \\nMeasure SFH \\nCheck FHS  \\nCheck the maternal \\nweight gain \\nRefer to specialized clinic for accurate dating and \\nregular USS with growth charts \\nAsk mother to be more vigilant on fetal movements \\nEnsure the adequate rest \\nEnsure that the advice given by the clinics is followed.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n61 \\nMal-presentation and \\nabnormal lie after 34 \\nweeks \\nHome visits every \\n2 weeks \\nReassure mother \\nRefer to specialized unit \\nVaginal bleeding (any \\ntime) \\nAsk mother to get admit to hospital as early as possible\\nMaternal jaundice \\nAsk mother to get admit to hospital as early as possible \\nMaternal anaemia \\n(Hb 7- 11g/dl) \\nMonthly home \\nvisits until the Hb \\nlevel is normal \\nAsk about the \\nsymptoms of anaemia \\n \\nCheck whether warm \\ntreatment are taken \\nCheck the compliance of \\niron therapy \\nAsk mother to get Hb checked until the levels normal\\nEducate on taking iron rich diet \\nEducate on side effects of iron therapy  \\nGive advice on micronutrients and diet \\nSevere maternal \\nanaemia (Hb < 7 g/dl)\\nTwo weekly \\nhome visits until'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Severe maternal \\nanaemia (Hb < 7 g/dl)\\nTwo weekly \\nhome visits until \\nthe Hb levels \\nnormal \\nAsk about the \\nsymptoms of anaemia\\nCheck the compliance \\non advice given \\nRefer to a specialized unit for correction\\nGive advice on micronutrients and diet \\nMaternal malaria\\nTwo weekly \\nhome visits until \\nthe condition \\nresolved \\nCheck the use of bed \\nnets/ insecticide \\nimpregnated bed nets \\nCheck the compliance \\non malaria prophylaxis \\ntreatment \\nRefer to nearest hospital medical unit\\nAdvise to use insecticide impregnated bed nets \\nEnsure the malaria prophylaxis treatment \\n \\n \\nMaternal syphilis \\nMonthly home \\nvisits  \\nAsk about symptoms \\nof other STIs (vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance \\non the drugs given \\nRefer to the STD clinic as early as possible'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='vulva) \\nCheck the compliance \\non the drugs given \\nRefer to the STD clinic as early as possible\\nCheck the compliance on advice given \\nEducate on safe sex practices \\nAdvice to get her partner screened for syphilis \\nEnsure the confidentiality of the information.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n62 \\nMaternal HIV\\nMonthly home \\nvisits \\nAsk about symptoms \\nof other STIs(vaginal \\ndischarge, itching of \\nvulva) \\nCheck the compliance of \\ndrugs given. \\nRefer to the STD clinic \\nAdvice to get her partner screened \\nCheck the compliance on advice and treatment given \\nExplain the mother the risk of transmitting the HIV \\ninfection to the baby is very low when mother is on \\ntreatment for HIV \\nDiscuss on Breast feeding \\nRefer to the MOH for further information   \\nOther risk conditions \\nDiabetes Mellitus\\n \\nHome visits  in \\nevery two weeks \\nAsk for fetal \\nmovements \\nCheck urine for sugar \\nCheck for FHS \\nMonitor maternal \\nweight gain \\nMeasure SFH \\nCheck the compliance \\nwith medical advice \\nManage as decided by VOG and relevant specialists'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Check the compliance \\nwith medical advice \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nAsk mother to mark kick count chart after 36 weeks  \\nAsk mother to get admit as early as possible if she \\nexperience reduced fetal movements \\nEducate mother and family members on co- infections \\neg:UTI, fungal infections \\nHelp to plan the delivery in a CEmOC facility \\nLiver disease and \\nrenal disease \\nHome visits in \\nevery two weeks \\nLook for oedema (facial, \\nfinger, and abdomen) \\nLook for jaundice, \\nitching, clubbing etc. \\nCheck urine for proteins \\nMeasure BP if possible \\nMonitor maternal \\nweight gain \\nManage as decided by VOG and relevant specialists\\nEducate mother and family members on diet \\nDelivery in a CEmOC facility'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n63 \\nRheumatic and \\ncongenital heart \\ndiseases \\nHome visits in \\nevery two weeks \\nAsk for shortness of \\nbreath with exertion \\neg. Climbing stairs \\nAsk for dyspnoea on \\nlying down  \\nAsk whether she need \\ntwo or more pillows \\nfor sleeping \\nLook for features of \\nheart disease( ankle \\nodema, elevated JVP) \\n \\n \\nAdvice to restrict work as advised by cardiologist/ VOG\\nDiscuss about Family Planning \\nDelivery in a CEmOC facility \\n \\nEpilepsy\\nMonthly home \\nvisits \\nAsk for the details of \\nlast attack \\nLook for drug \\ncompliance and places \\nthat can endanger life in \\nthe home environment \\neg: unprotected wells , \\nfloor level fire places \\nAdvice family members on what to do during an \\nepileptic attack, to take necessary precautions'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Advice family members on what to do during an \\nepileptic attack, to take necessary precautions \\nExplain  the family members on importance of \\ncompliance on drugs \\n \\nMental disorders \\nMonthly home \\nvisits \\nCheck compliance of \\ndrugs \\nEducate on family members on the disease and advice \\non family support \\nAsk family members to seek medical advice in case of a \\nbehavioural change of the mother \\nExplain that drugs can be used even during breast \\nfeeding and not harmful for the baby \\nExplain family members that mental disorders can be \\naggravated during post-partum period and to be more \\ncautious \\nEducate family members on postpartum psychological \\ndisorders'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n64 \\nAsthma\\nMonthly home \\nvisits \\nAsk for shortness of \\nbreath \\nCheck respiratory rate\\nExamine breathing \\nsounds if possible \\nCheck the compliance of \\ndrugs/ inhalers \\n \\nEducate family members on importance of drug \\ncompliance \\n \\nRh negative mother\\nRoutine three \\nhome visits are \\nadequate \\nAsk for fetal \\nmovements \\nCheck whether the \\nscreening for Rh \\nantibodies is done  \\n \\nEducate mother on RhOGUM after delivery\\n \\nSubfertility\\n(Failure of a couple to \\nconceive with one \\nyear of regular \\nintercourse) \\nMonthly home \\nvisits \\nAsk for any \\nabdominal pain , per \\nvaginal bleeding \\nAsk for fetal \\nmovements \\nCheck for SFH, FHS\\n \\nAsk mother to get admit as early as possible to a \\nhospital with EMOC facilities in case of an emergency.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='hospital with EMOC facilities in case of an emergency. \\nAsk mother to be more vigilant on fetal movements \\nSocial problems\\nUnmarried/ widows/ \\nseparated (single \\nmother) \\n \\nMonthly\\nAsk for social  \\nproblems \\nHelp them to face the social stigma\\nEnsure the proper antenatal care \\nIntroduce a postpartum family planning method \\nExtreme poverty/ \\ngeographical \\ndifficulties, gender \\nbased violence, \\nalcoholic partner etc. \\nMonthly\\nAsk whether she is \\ngetting any \\ngovernment \\nallowances \\n(samurdhi) \\nHelp them to get social support and support from special \\nprograms with GramaNiladari and other relevant \\nofficials \\nIntroduce a postpartum family planning method'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n65 \\n \\nChapter 08 \\nDEVELOPING A BIRTH AND EMERGENCY PLAN \\n \\nExplain why birth in a facility is recommended \\n\\uf0a7 Any complication can develop during delivery and they are not predictable. \\n\\uf0a7 A facility has staff, equipment, supplies and drugs to provide best care if needed, and a \\nreferral system. \\n\\uf0a7 If HIV- positive she will need appropriate ARV treatment, for herself and her baby \\nduring childbirth. Complications are more common in HIV-positive women and her \\nnewborns. HIV-positive women should deliver in s facility. \\n \\nAdvice how to prepare \\nReview the arrangements for delivery: \\n\\uf0a7 Where will she go to get treatment for an emergency or delivery? \\n\\uf0a7 How will she get there?'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Where will she go to get treatment for an emergency or delivery? \\n\\uf0a7 How will she get there?  \\n\\uf0a7 How much will it cost to go to the facility? How will she pay for transport ? \\n\\uf0a7 Can she start saving straight away? \\n\\uf0a7 Who will go with her to the hospital? \\n\\uf0a7 Who will help while she is away to care for her home and other children? \\n\\uf0a7 Who to inform in an emergency? \\n \\nAdvise when to go \\n\\uf0a7 If the mother lives near the facility, she should go at the first signs of labour.or dange \\nsignal \\n\\uf0a7 If living far from the facility, she should go 2-3 weeks before baby due date and stay \\neither at the maternity waiting home or with family or friends near the facility. \\n\\uf0a7 Advise to ask for help from the community, if needed. \\n \\n Advise what to bring \\n\\uf0a7 Pregnancy record.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Advise what to bring \\n\\uf0a7 Pregnancy record. \\n\\uf0a7 Clean clothes for drying and wrapping the baby. \\n\\uf0a7 Adequate amount of sanitary pads after birth. \\n\\uf0a7 Cloths for mother and baby. \\n\\uf0a7 Food and water for mother and support person.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n66 \\n \\nHome delivery in an emergency or due to unavoidable circumstances \\nReinforce the importance of delivery in a health institution. \\nInstruct mother and family on clean and safer delivery at home \\nIf the mother has to deliver at home due to emergency or unavoidable circumstances, review \\nthese simple instructions with the woman and family members. \\nTell her / them to try their best to get down a skilled birth attendant (institutional midwife/ \\nPHM/midwifery qualified nurse or a medical officer) \\n\\uf0a7 To ensure a clean delivery surface for the birth. \\n\\uf0a7 To ensure that the birth attendant should wash her hands with clean water and soap \\nbefore/after touching mother / baby. She should also keep her nails clean.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='before/after touching mother / baby. She should also keep her nails clean. \\n\\uf0a7 To place the baby on the mother’s chest with skin-to skin contact and wipe the baby’s \\neyes using a clean cloth for each eye, after delivery, \\n\\uf0a7 To cover the mother and the baby with a clean cloth. \\n\\uf0a7 To use boiled new blade and a boiled cord to tie and cut the cord. The cord is cut when it \\nstops pulsating. \\n\\uf0a7 To dry the baby after cutting the cord. To wipe clean but not bathe the baby until after 6 \\nhours. \\n\\uf0a7 To wait for the placenta to deliver on its own. \\n\\uf0a7 To start breastfeeding when the baby shows signs of readiness, within the first hour after \\nbirth. \\n\\uf0a7 To NOT leave the mother alone for the first 24 hours. \\n\\uf0a7 To keep the mother and baby warm. To dress or wrap the baby, including baby’s head.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 To keep the mother and baby warm. To dress or wrap the baby, including baby’s head. \\n\\uf0a7 To dispose of the placenta in a correct, safe and culturally appropriate manner (burn or \\nburry). \\n \\nAdvise to avoid harmful practices \\nFor example: \\nNOT to use local medications to hasten labour. \\nNOT to wait for waters to stop before going to health facility. \\nNOT to insert any substances into the vagina during labour or after delivery. \\nNOT to push on the abdomen during labour or delivery. \\nNOT to pull on the cord to deliver the placenta. \\nNOT to put ashes, cow dung or other substances on umbilical cord /stump.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n67 \\n \\nAdvise on danger signs \\nIf the mother or baby has any of these signs, she/they must go to the hospital immediately, day \\nor night, WITHOUT waiting \\n \\nMother \\n\\uf0a7 Waters break and not in labour after 6 hours. \\n\\uf0a7 Labour pains / contractions continue for more than 12 hours. \\n\\uf0a7 Heavy bleeding after delivery (pad/cloth soaked in less than 5 minutes). \\n\\uf0a7 Bleeding increases. \\n\\uf0a7 Placenta not expelled 1 hour after birth of the baby. \\n \\nBaby \\n\\uf0a7 Very small \\n\\uf0a7 Difficulty in breathing \\n\\uf0a7 Fits \\n\\uf0a7 Fever \\n\\uf0a7 Feels cold \\n\\uf0a7 Bleeding \\n\\uf0a7 Not able to feed'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n68 \\n \\nChapter 09 \\nANTENATAL CLASSES \\nIn this maternal care model, health promotion and education of pregnant women regarding \\npregnancy and related topics is carried out during clinic sessions as group education, \\nopportunistic education during clinic visits and home visits and in the antenatal classes for \\ncouples.  \\nObjectives of the antental classes: \\n1. To educate the pregnant women and their husbands/families on topics related to \\npregnancy, child birth, postnatal care and childcare \\n2. To improve the male participation in maternal care \\n3. To give an opportunity to alleviate the doubts on pregnancy related issues \\n4. To improve the community participation in maternal care'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='4. To improve the community participation in maternal care \\n5. To change the parenting behavior to fulfill the needs of the child \\n \\nGuideline for conducting antenatal classes \\n1. All pregnant women should be participated in three antenatal classes during pregnancy \\n(one per each trimester) with her husband.  \\n2. All the women participating in a class should be in a same trimester eg. All are in first \\ntrimester or all are in second trimester. \\nAntenatal class 1 – for pregnant women in first trimester \\nAntenatal class 2 – for pregnant women in second trimester \\nAntenatal  class 3 – for pregnant women in third trimester \\n3. The topics/ issues discussed in each class should be related to the trimester of the \\npregnancy of the participants.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnancy of the participants. \\n4. PHM should be kept notes in the relevant cage in the pregnancy record regarding the \\nparticipation. \\n5. Antenatal classes should be conducted once a month at the level of PHI area or 3-4 PHM \\nareas together (depending on the number of pregnant mothers in a PHM area). \\n6. A class for a trimester can be organized once in three months to cover all the mothers. \\nEg.  \\nJanuary – Antenatal class 1 \\n \\nFebruary- Antenatal class 2 \\n \\nMarch - Antenatal class 3 \\nApril - Antenatal class 1 …………so on \\n \\nJanuary\\nFeb\\nMarch\\nApril\\nMay\\nJune\\nJuly\\nAugust\\nClass1 \\nClass 2 \\nClass 3 \\nClass 1 \\nClass 2 \\nClass3 \\nClass1 \\nClass 2'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n69 \\n \\n7. For couples who are unable to attend to classes, arrangement should be made to attend to \\nthe classes at the nearest area. \\n8. The annual plan for antenatal classes should be display in the clinic centres with the \\nvenue, date and time. \\n9. The annual plan for the MOH should be displayed with the annual clinic plan. \\n10. Relevant area PHMM should be organized the classes with the help of the area PHI. \\n11. The lectures and the other activities should be carried out by the PHI and PHMM \\naccording to the guide given. MOMCH, MOH, PHNS, SPHM, HEO or other relevant \\nofficers can be used as special resource persons.   \\n12. MOH, PHNS and SPHM should be supervised the sessions and should be guided them to'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='12. MOH, PHNS and SPHM should be supervised the sessions and should be guided them to \\nimprove the quality of the classes. \\n13. All mothers should get breast feeding booklets, guide for pregnant mothers and ECCD \\nbooklets to read. \\n14. Develop a small questionnaire and give it to the couples at the end of the session to assess \\nthe output. \\n15. The places to conduct the classes should be selected from the area eg. Clninic centres, \\ntemples, community centres etc. The recourses to treat the participants should be \\norganized with the community participation. \\n16. Other than the above mentioned facts, there is an enough room for your innovative ideas \\nto improve the quality of the antenatal classes. \\n \\n \\nProposed topics for antenatal classes \\nAntenatal class I:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Proposed topics for antenatal classes \\nAntenatal class I: \\n1. Objectives of the antenatal classes \\n2. Activity to identify the participants \\n3. Development of the feotus \\n4. Antenatal care \\n5. Risk conditions and  danger signals during first and second trimesters and emergency \\npreparedness \\n6. Nutrition of the pregnant woman \\n7. Minor discomforts during  first and second trimesters and management of them at home \\n8. Prevention of mother to child transmission of HIV and other sexually transmitted \\ndiseases \\n9. Importance of good oral hygiene during pregnancy \\n10. General wellbeing during pregnancy \\n11. Introduction to the hand book on maternal care (Nirogimath daruparapurak udesa…..)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n70 \\n \\nAntenatal class II: \\n1. Nutrition during pregnancy II \\n2. Risk conditions and  danger signals during second and third trimesters and emergency \\npreparedness \\n3. Minor discomforts during  second and third trimesters and management of them at \\nhome \\n4. Introduction to breast feeding (importance) \\n5. Early Childhood Development and Care (ECCD) \\n6. Maintenance of correct posture during pregnancy \\n7. Preparation for delivery and newborn  \\n8. Any other topic relevant to the area eg. Prevention of alcoholism, gender based \\nviolence, money and time management \\n \\nAntenatal class III: \\n1. Nutrition during lactation \\n2. Labour signs and symptoms \\n3. Risk conditions and  danger signals during third trimester and postpartum period and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='3. Risk conditions and  danger signals during third trimester and postpartum period and \\nemergency preparedness \\n4. Minor discomforts during  third trimester and postpartum period and management of \\nthem at home \\n5. Breast feeding (technique and support from the family) \\n6. Early Childhood Development and Care (ECCD) \\n7. Maintenance of correct posture during pregnancy and postpartum period \\n8. Postpartum Family Planning \\n9. Care for the newborn baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n71 \\n \\nChapter 10 \\n \\nCLINICAL PROCEDURES FOR ANTENATAL CARE \\n \\n \\n10.1   Anthropometric assessment of pregnant women \\nMeasuring weight at the clinic setting \\nThe weighing scale should be placed on a smooth, leveled surface. \\nBefore weighing, the person should be asked to remove slippers, heavy clothes, handbags and \\nany other heavy item (keys, coins etc.) with them. \\nThe reading of the scale should be checked and it was adjusted to ‘0’. \\nThen the person should be asked to step onto the scale. It should be made sure that: \\n\\uf0b7 Person stands upright, with her arms hanging loosely at sides. \\n\\uf0b7 Person looked straight ahead and not moving \\n \\nReading of the scale display should be noted down to the nearest 0.1kg when it stopped \\nchanging.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Reading of the scale display should be noted down to the nearest 0.1kg when it stopped \\nchanging.  \\n \\nMeasuring height at the clinic setting \\nMicrotoise tape should be used to measure the height. \\nMicrotoise should be set up against a wall in full length. \\nAsk the mother to remove slippers and stand against the wall as straight as she can. \\nLook at the person from the front and made sure that she is under the Microtoise meter and \\nkeeping the feet slightly apart. \\nLook at the person from the side and make sure that her back of the head, shoulders, buttocks \\nand her heels are touching the wall. \\nLower the head piece of Microtoise until it hits firmly on the top of the head and made sure that \\nit touched the head and not the hair. \\nThe reading should be taken to the nearest 0.5cm.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n72 \\n \\n \\nCalculation of the Body Mass Index (BMI) \\nBMI = Weight (Kg) \\n \\n \\nHeight (m2) \\nInstead of calculating BMI, field health care workers can use the BMI chart or BMI wheel, \\nwhich gives BMI comparing weight and height. For pregnant mothers BMI should be calculated \\nbefore 12 weeks, ideally at the booking visit around 6-8 weeks.  \\nInterpretation of BMI \\n<18.5 kg/m2\\nUnder nutrition\\n18.5 – 24.9 kg/m2 \\nNormal \\n25 – 29.9 kg/m2 \\nOver weight \\n≥ 30 kg/m2 \\n \\nObese \\n \\nMonitoring of weight gain during pregnancy \\nMonitoring of the weight gain during pregnancy depend on the BMI during the booking visit/ \\nfirst trimester. Expected weight gains according to the BMI as follows: \\n \\nBMI (kg/m2) \\nExpected Weight Gain in kg \\n<18.5 ( underweight )'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='BMI (kg/m2) \\nExpected Weight Gain in kg \\n<18.5 ( underweight ) \\n12.5-18 \\n18.5-24.9 kg/m2 ( Normal)\\n11.5-16\\n25-29.9 kg/m2 (over weight) \\n7.0-11.5 \\n>/= 30 kg/m2 (Obese) \\n< 6.8 \\n \\nMaternal weight gain should be recorded on the weight gain chart in the pregnancy record.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n73 \\n \\n \\nInstructions to maintain weight gain chart and graph \\n1. Fill in the following information regarding the mother at the first clinic visit  ( before 12 \\nweeks ) in the box located in the left upper corner of the graph: \\n\\uf0b7 Height \\n\\uf0b7 Weight at the first clinic visit ( before 12 weeks ) \\n\\uf0b7 BMI at the first clinic visit ( before 12 weeks ) \\nDuring the first visit no data to plot on the graph. \\n2. During subsequent clinic visits POA and weight should be recorded on the table and \\nweight gain should be calculated (by deducting the mother’s weight at the first clinic visit \\nfrom weight at the current clinic visit).  Then the weight gain should be plotted on the \\ngraph according to the POA.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='graph according to the POA. \\n3. Poor weight gain as well as the excessive weight gain should be identified timely and \\nrelevant interventions should be carried out. \\n4. Recommended weight gain \\n\\uf0b7 It is assumed that woman’s pre pregnancy BMI is more or less equal to the BMI \\nat her first clinic (before 12 weeks ) \\n\\uf0b7 For a woman with BMI less than 18.5kg/m2 during first 12 weeks, recommended \\nweight gain range is 12.5 – 18 kg. Her weight gain should be within the areas \\nshown as A & B in the weight gain chart. \\n\\uf0b7 For a woman with normal BMI (18.5 - 24.9kg/m2), recommended weight gain \\nrange is 11.5 – 16 kg. Her weight gain should be within the areas shown as B&C \\nin the weight gain chart. \\n\\uf0b7 For women who are overweight (BMI 25-29.9 kg/m2), recommended weight gain'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 For women who are overweight (BMI 25-29.9 kg/m2), recommended weight gain \\nrange is 7 – 11.5 kg (area C & D) while obese women (BMI ≥30kg/m2) should \\ngain weight less than 6.8 g (below area D).  \\n5. Once the infant is born fill the birth weight in the box shown in the right lower corner of \\nthe weight gain graph.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n74'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n75 \\n \\n10.2    Measuring blood pressure at the clinic setting \\nStandard mercury sphygmomanometer should be used with an adult cuff. An extra-large cuff \\nshould be available for obese women. \\nThe following procedure should be followed to measure blood pressure accurately. \\n1. Mothers should be asked to sit at a table quietly with both feet flat on the floor and with \\nthe back supported. The bladder should be empty. The room should be comfortable and \\nwith minimal noise. \\n2.  The bare right arm should be placed on the table (at heart level) slightly flexed, with the \\npalm upward. The examiner should be in a position to see the manometer at eye level.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='palm upward. The examiner should be in a position to see the manometer at eye level. \\n3.  Arm circumference should be assessed. An appropriate cuff should be selected and \\nwrapped around the upper arm. The lower edge of the cuff should be 2.5 cm above the \\nelbow joint. \\n4. Wait 5 minutes. \\n5. Palpate the radial pulse and inflate to 30mm Hg above the level where radial pulse \\ndisappeared (Peak inflation level). Deflate the cuff. \\n6. Wait 30 seconds before re- inflating. \\n7. Inflate to peak inflation level. \\n8. Deflate at 2 mm Hg per second. \\n9. Record the systolic BP (first of at least two regular consecutive sounds). Record to the \\nnearest even number. \\n10. Record diastolic BP (the end of the last sound heard). Record to the nearest even number.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n76 \\n \\n10.3 Obstetric examination \\nThe abdominal examination \\nAlways make sure that the pregnant woman looks comfortable, is laying semi recumbent and has \\na sheet covering her waist and legs, which may be bare. You must examine from the woman’s \\nright side. Remember this order for examining the abdomen: Inspection, palpation and \\nauscultation. \\nInspection: \\n\\uf0b7 Assess shape and size of the uterus, and any obvious asymmetry of the abdomen; fetal \\nmovements. \\n\\uf0b7 Look for surgical scars: loins (kidney transplants); supra pubically (Caesarean sections, \\nectopic pregnancy); grid-iron (appendix); umbilicus (laparoscopy);midline(bowel or \\novarian operations)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='ovarian operations) \\n\\uf0b7 Striae gravidarum (stretch marks) and linea nigra (pigmented vertical line running from \\numbilicus to symphisis pubis) are always commented. \\n \\nPalpation: \\nMeasuring SFH  \\nFirstly measure the fundal height by placing the ulnar border of the left hand gently at the fundus \\nof the uterus, and measuring with the tape in centimeters to the pubic symphysis (keep to 0 cm \\nend at the pubic sympysis). The measurement in cm should give an estimation of gestational age \\nin weeks, i.e. +/- 2 cm from 20 – 38 weeks. Plot the SFH in cm on the SFH chart in the \\npregnancy record according to the POA. \\nThen palpate fetal poles to determine presentation and lie (Fig.1.3b, c and d). When establishing'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Then palpate fetal poles to determine presentation and lie (Fig.1.3b, c and d). When establishing \\nhead engagement in the third trimester, it is better to gently palpate with two hands pacing down \\nover the abdomen as pictured (Fig.1.3b) than to prod around with Paulik’s grip (Fig. 1.5), which \\nin non-experienced hands is painful. \\nTo establish the lie of the fetus, palpate gently using both hands as shown in figures 1.3c and 1.6.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n77'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n78 \\n  \\nIt is important to make eye contact with the woman while you are examining as you may be \\nhurting her by palpating too firmly. \\nAfter you have finished the uterus, gently palpate for kidney tenderness and liver and spleen \\nenlargement. \\nAuscultation: \\nFor a fetus with cephalic presentation, it is relatively easy to palpate the anterior shoulder and \\nlisten for the fetal heart at this point. You will obviously have to modify the position for \\nauscultation if the fetus is in the transverse or breech positions. \\nInternal examination: \\nA pelvic (vaginal examination) is not routinely performed unless specially indicated.  \\nTo perform a digital examination, commonly called vaginal examination (VE), or a speculum'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='To perform a digital examination, commonly called vaginal examination (VE), or a speculum \\nexamination, ask your patient to lie comfortably on her back, usually with a slight tilt and the \\nknees drawn up with the ankles together. You should have asked her to remove her underwear, \\nand a sheet may be placed covering her abdomen and genitalia. The procedure should be \\nperformed in the presence of a female third party. Both hands should be gloved. \\nFor a digital examination, the labia are gently parted with the left hand, and index and forefinger \\nof the right hand gently introduced in to the vagina. They may be advanced until the cervix is \\npalpated. In later pregnancy, this will provide information on the length and consistency of the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='palpated. In later pregnancy, this will provide information on the length and consistency of the \\ncervix and this allows an assessment of favourability for induction of labour. \\nA digital vaginal examination should not be performed in the following circumstances; \\n\\uf0b7 with suspected placenta previa (risk of precipitated haemorrhage) \\n\\uf0b7 When there is prelabour rapture of membranes (risk of introducing infection) \\n\\uf0b7 When consent is withheld'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n79 \\n \\nA gentle speculum examination is less likely to introduce ascending infection, and may be used \\nto visualize the cervix in prelabour rupture of membranes, or even if a placenta previa is \\nsuspected. The same steps apply as above with the following adjustments: \\n\\uf0b7 Select an appropriate sized speculum; \\n\\uf0b7 The speculum should be pre-warmed to avoid the discomfort of cold metal; \\n\\uf0b7 Lubricating gel or water should be applied to the mouth of the speculum;  \\n\\uf0b7 The labia are parted with the left hand, and speculum held with the right; \\n\\uf0b7 The speculum is inserted through the introitus with the jaws in the vertical plain; it is \\ngently rotated while being advanced into the horizontal plane;'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='gently rotated while being advanced into the horizontal plane; \\n\\uf0b7 The speculum’s jaws are slowly opened once the speculum is advanced fully into the \\nvagina; \\n\\uf0b7 At this point, the ratchet nut can be tightened; \\n\\uf0b7 A light source should be at hand to enable easy visualization of the cervix and vaginal \\nwalls; \\n\\uf0b7 On removing the speculum, close the jaws gently and slowly to avoid catching vaginal \\nepithelium in them \\nSymphysio-Fundal Height Chart \\n \\nPOA'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n80 \\n \\n10. 4   Fetal Movement Chart or Kick count Chart \\nWhat is a kick count chart? \\nDuring the 1970’s, it was thought that the number of times a baby kicked each day would \\nindicate the baby’s wellness after birth. Thus, many women began to use a ‘kick chart’ or ‘kick \\ncount chart’. This is a simple chart that on which record the number and/ or intensity of kicks or \\nother movement that the baby makes. Kick chart try to provide guideline for how active a baby \\nshould be. \\nA kick count chart may be reassuring to a mother. Others may find kick charts time consuming, \\nbothersome and stressful, particularly if their baby doesn’t move much during the time they are \\ntrying to do the chart.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='trying to do the chart. \\nOne of the most common types of kick charts is called The ‘Cardiff count to ten’ method. With \\nthis method, mother should use an 8 to 12 hour period to record at least 10 of her baby’s \\nmovements. Mother should choose a time when she thinks her baby is most active. If baby has at \\nleast 10 movements within this 12 hour period they are thought to be well. If mother use this \\nmethod she should start timing at same time each day. Record the first time and should write it \\ndown on the graph. Count every movement or kick until the baby has moved 10 times. Write \\ndown the time after feeling the tenth movement. If mother feels more kicks at one moment \\nconsider it as a one  kick   \\nStart marking the kick count chart every day morning around 6.00am-8.00am'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Start marking the kick count chart every day morning around 6.00am-8.00am \\n\\uf0b7 Write the time started clearly in the relevant place \\n\\uf0b7 Mark and pierce each box for each movement that baby makes \\n\\uf0b7 Write the time clearly after finishing of marking 10 boxes. \\n\\uf0b7 Contact a Medical Officer, Public Health Mid Wife or Nursing Officer if the baby is not \\nmoved for 10 times during 12 hours. \\n\\uf0b7 10 movements for a day is enough for the day. \\n\\uf0b7 The time period between 2 kicks should less than 3 hours \\n \\nFetal movement chart \\nName:                                                                         Age: \\nNo. of pregnancy:      \\nWeeks\\n 36\\n 37\\n38\\n39\\nDate\\nTime started\\n1 \\n2\\n3\\n4\\n5\\n6\\n7\\n8\\n9\\n10\\nTime \\nfinished'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n81 \\n         \\n10.5    Urine testing at the clinic setting \\n \\nUrine analysis using two para reagent strip \\nReagent strip is a dip and read test strip and intended for use as an in vitro diagnostic aid using \\nurine specimens. The strip contains solid phase reagent areas affixed to a plastic support and is \\nprovided in a dry reagent format. The strip provides qualitative and semi quantitative test for \\nglucose and protein by the visual comparison with colour charts of each concentration range.  \\nSpecimen collection \\nSpecimens were collected at the clinic. A clean, dry vessel was provided to collect the urine. \\nTests were done as soon as possible after collection.  \\nProcedure'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Tests were done as soon as possible after collection.  \\nProcedure \\n1. Confirmed that the product was within the expiration date shown on the label \\n2. The strip was removed from the bottle and the cap was replaced immediately. \\n3. The strip was inspected for dis-colouration or darkening of reagent areas. Changes may \\nindicate deterioration. Such strips did not use. \\n4. The test strip was dipped completely for no more than 1 second in fresh, well mixed and \\nun-centrifuged urine specimen. The excessive urine was removed by touching the plastic \\nfilm on the rim of the vessel. \\n5. The test results were compared carefully with the colour chart on the bottle label in good \\nlight. \\n6. Proper reading time (30-60) seconds is critical for optimal results.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='light. \\n6. Proper reading time (30-60) seconds is critical for optimal results. \\n7. While comparing, to strip was kept in horizontal position to avoid possible interactions of \\nchemicals by excessive urine. Changes in colour that appeared only along the edges of \\nthe test areas or after more than two minutes were of no diagnostic significance.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n82 \\n \\nCoagulation test for protein \\nNecessary equipment:  Clean bottle, two test tubs, Spirit Lamp, Test tube holder, Acetic acid, \\nPipette \\nProcedure \\nCollect urine into a clean bottle and fill 2/3 of the test tube with collected urine  \\nHeat the upper part of the tube till urine gets boiled \\nIf the heated part gets cloudy, add 4 – 5 drops of acetic acid \\nHeat again. If the cloudiness disappears it is due to urinary phosphates and it is not significant. \\nIf the cloudiness continues it is due to urinary albumin.  \\nResults should be as follows. \\nNegative \\nTrace \\nPositives + 1 to + 4 \\nNormal result should be negative. \\n \\nBenedict’s test for urine sugar \\nNecessary equipment: as for the heat test and   Benedict’s reagent \\nProcedure:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Necessary equipment: as for the heat test and   Benedict’s reagent \\nProcedure: \\nPut 2.5 ml of Benedict’s solution to a test tube. \\nAdd 8 drops of urine. Heat this mixture for 2 minutes. \\nPut the tube in the test tube holder till the tube gets cooled. \\nThe colour of urine will change from green to brick red depending on the amount of sugar in \\nurine. \\nThe results should be as follows. \\nNegative – clear blue \\n If present – Green , Yellow, Orange, Brick red'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n83 \\n \\n10.6  Antenatal screening for syphilis: Guidelines for sample collection,                     \\nstorage and transportation \\nScreen all pregnant women for syphilis at the first antenatal visit preferably 6-8 weeks to prevent \\ncongenital infection. For high risk mothers, re- testing should be offered in the third trimester.  \\nRecord POA of screening, place of testing, testing results and treatment in the pregnancy record \\n(H512 A&B) \\nLaboratory testing facilities should be arranged in the nearest STD clinic/ government institution \\nwith the help of RDHS/MOMCH. \\nEducate all mothers and their partners of the importance of screening for syphilis during \\npregnancy to avoid adverse pregnancy outcomes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnancy to avoid adverse pregnancy outcomes. \\nVDRL test is the screening test use to screen for syphilis in the maternal care programme in Sri \\nLanka. It is carrying out as a joint activity with National STD AIDS control programme.  \\n \\nSample collection, storage and transportation \\n1. Blood drawing should be done by MOH, MO, RMO/AMO, PHNS or Nurse. If it is a \\nfield clinic, either MOH or PHNS should draw blood. When STD clinic team visit ANCs \\nfor blood drawing either MO/STD, nurse or MLT may draw blood. \\n \\n2. Disposable syringes should be used to draw blood and 5cc blood should be taken in to a \\ntube or a plane bottle.  Label the sample with reference number date and time of \\ncollection.  It should be kept in room temperature for at least 2 hours.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='collection.  It should be kept in room temperature for at least 2 hours. \\n3. If it is sent within 12 hours to the laboratory no need to keep in the refrigerator or no need \\nto use special carriers for transportation. If not, keep the collected samples in the main \\ncompartment of the refrigerator and sent to the laboratory in a vaccine carrier within three \\ndays.  Given specimen forms should be used. There should be prior arrangement before \\nsending samples to STD lab. There should be a separate carrier for sample transportation. \\n4. In the STD laboratory if the test is not done on the same day serum should be separated \\nand can be kept maximally one month in the main compartment of the refrigerator.  (Not \\nin the freezer compartment)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='in the freezer compartment) \\n5. Transport method will be either MOH vehicle or STD vehicle depending on the \\navailability and feasibility or else through a messenger.   \\n6. Result of the screening test will be conveyed to PHM through the MOH and positive \\ncases will be referred to STD clinic and confirmatory test will be done there.  Results of \\nthe confirmatory test will be conveyed to MOH and Syphillis confirmed mothers will be \\nfollowed up by MO/STD. \\n7. MOMCH and MO/STD should meet quarterly and discuss the matters related to antenatal \\nsyphillis screening.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n84 \\n \\n8. VDRL test will be the first choice for syphilis screening and in areas where facilities not \\navailable rapid test can be recommended by FHB and NSACP. \\n \\nMothers whose screening test is positive should be contacted and sent to STD clinic with a \\nproperly written referral letter. Confidentiality has to be maintained. When the mother is seen in \\nthe STD clinic a second sample will be collected for re-confirmation after counselling. If the \\nsecond sample is positive, the mother will be counseled and treated appropriately.  \\nIf the woman was not tested during pregnancy, syphilis screening should be offered after \\ndelivery (preferably using a rapid test).  \\n \\n10.7    Estimating Haemoglobin levels using a colour scale'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='10.7    Estimating Haemoglobin levels using a colour scale \\n1. Use only approved test strips for the colour scale. \\n2. Add a drop of blood to one end of a test strip just enough to cover completely an aperture \\nin the colour scale. \\n3. Wait about 30 seconds; then read immediately by comparing the blood stain with the \\nColour Scale to find the best colour match. \\n\\uf0b7 Keep the test strip close to the back of the Colour Scale \\n\\uf0b7 Avoid direct sunlight \\n\\uf0b7 Avoid marked shade \\n\\uf0b7 Avoid your own shadow or any other shadow \\n4. If the blood stain matches one of the shades of red exactly, record the haemoglobin value. \\nIf the colour lies between two shades, record the mid- value. If in doubt between two \\nshades, record the lower value.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='shades, record the lower value. \\n5. Discard the test strip after use. Wipe the back surface of the Scale at the end of each \\nsession or if it became soiled during the use.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n85 \\n \\nChapter 11 \\nNUTRITION DURING PREGNANCY AND LACTATION \\n \\nNutrition during the preconception period as well as throughout the pregnancy has a profound \\ninfluence on the course and outcome of the pregnancy as well as mother’s performance during \\nlactation. The association between pre pregnancy weight and BMI, total weight gain and the rate \\nof weight gain in pregnancy and the pregnancy outcome is significant. Weight gain in the second \\nhalf (after 20 weeks) of pregnancy has more pronounced effect on the growth and the birth \\nweight of the baby. Poor weight gain especially in the third trimester is associated with low birth \\nweight of the baby.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='weight of the baby.  \\n      Low birth weight is associated with a higher incidence of infant mortality and morbidity, poor \\ncognitive development and learning disabilities. They are also at a   higher risk of been \\nsubjected to the non-communicable disease such as heart disease, hypertension and diabetes \\nmellitus in later life. Thus , it appears future health of mankind depends to a greater extent on \\nthe nutritional foundation laid during the prenatal life. Therefore, nutrition of the pre pregnant \\nwomen as well as the pregnant mothers should receive utmost attention in order to have a baby \\nwith a good birth weight.  \\nNutrition and care during Pre pregnancy \\nPre pregnancy weight and BMI are strongly linked with the pregnancy outcome. Therefore,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Pre pregnancy weight and BMI are strongly linked with the pregnancy outcome. Therefore, \\nnutrition and care of the pre pregnant woman is an essential component in the strategy for low \\nbirth weight reduction. The existing health care system offers following services to improve the \\nnutritional and health status of the pre pregnant woman. \\no Early identification of couples getting married and provision health services and \\nhealth education  \\no Registration of all eligible couples by PHM and provision of necessary services.  \\no Nutritional assessment and take necessary actions: \\n\\uf0b7 Check  Body Mass Index (BMI) do necessary interventions according to \\nthe BMI \\n\\uf0b7 Do Haemoglobin estimations and if anaemic, take necessary actions'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the BMI \\n\\uf0b7 Do Haemoglobin estimations and if anaemic, take necessary actions \\n \\nThe women who intend to become pregnant should be advised that their nutritional status should \\nbe optimal at the time of conception for a successful pregnancy.  \\nProvide Folic acid 5mg daily, for women who expecting a pregnancy. \\nAscertain that they have protected with Rubella immunization.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n86 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of pre-pregnant women with a BMI less than 18.5kg/m2\\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and \\nmicronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. \\n-Help to modify diet by increasing amount of starch based foods such as rice, \\nmanioc, other cereals, flour based foods at each meal \\n-Consuming 1-2 extra meals than other days \\n-Using 1-2 table spoonful of oil \\n \\n-Including fish/dried fish/egg, pulses, vegetables and green leaves to  \\n daily diet \\n\\uf0a7 Asses dietary habbits, food taboos, misconceptions and correct if there are any  \\nnegative one'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Asses dietary habbits, food taboos, misconceptions and correct if there are any  \\nnegative one   \\n\\uf0a7 Excessive work load may have an influence on the weight gain. Therefore, assess the \\nworkload and act accordingly  \\n\\uf0a7 Screen for  the presence of any illnesses by referring to the MOH \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight gain is inadequate after 6 months refer to MOH for further advice.  \\nManagement of pre- pregnant women with BMI more than 24.9 kg/m2 \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy / excessive consumption of diet \\n(calorie, protein and micronutrient) \\n\\uf0a7 Nutrition counseling on appropriate diet. ( to reduce starch, fats, & sugar ) \\n\\uf0a7 Emphasize the importance of  regular exercise'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Emphasize the importance of  regular exercise \\n\\uf0a7 Assess dietary habits, food taboos, myths and misconceptions and correct if there \\nare any negative ones. \\n\\uf0a7 Should be screened for Diabetes Mellitus, Hypertension, Hypercholesteraemia by \\nreferring to the MOH. \\n\\uf0a7 Follow up and monitor weight gain monthly \\n\\uf0a7 If weight reduction is inadequate after 6 months refer to MOH for further advice.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n87 \\n \\nNutritional requirements and advice during pregnancy \\nPregnant women should be advice to consume variety of locally available healthy foods \\ncontaining adequate amounts of cereals, yams, animal foods, pulses, vegetables, green leaves, \\nfruits and milk to meet increasing nutritional demands in pregnancy. Mothers should be \\nencouraged to consume 3 nutritious main meals supplemented by one or two additional small \\nmeals.  They should be advised to consume additional ½ a spoonful (spoon made of coconut \\nshell) of rice at each meal with additional amounts vegetables green leaves, pulses and cereals.  \\nThe amount of food a woman should consume during pregnancy varies according to her level of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='The amount of food a woman should consume during pregnancy varies according to her level of \\nphysical activity and her BMI at the start of pregnancy. The calorie and other nutritional \\nrequirement during pregnancy is stated in the table. The daily menus should be planned to in-\\ncooperate all the essential nutrients using locally available food items. \\n \\nAge of woman\\nAdditions for\\n16-17yrs\\n18-30yrs\\nPregnancy \\nLactation\\nEnergy, kcals\\n2150\\n1750\\n360\\n700\\nProtein, g\\n44\\n44\\n7+\\n19+\\nVitamin A, µg\\n750\\n750\\n-\\n450\\nVitamin D, µg\\n2.5\\n2.5\\n7.5\\n7.5\\nThiamin, mg\\n0.9\\n0.8\\n0.14\\n0.30\\nRiboflavin, mg\\n1.3\\n1.3\\n0.21\\n0.45\\nNiacin, mg\\n14.2\\n13.2\\n2.31\\n4.95\\nFolic Acid, µg\\n200\\n200\\n200\\n100\\nVitamin B12, µg\\n2.0\\n2.0\\n1.0\\n0.5\\nAscorbic acid, mg\\n30\\n30\\n20\\n20\\nCalcium, mg\\n600\\n500\\n600\\n600\\nIron, mg\\n28\\n28\\n60\\n60\\nZinc, mg\\n22\\n22\\n5\\n22'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='30\\n30\\n20\\n20\\nCalcium, mg\\n600\\n500\\n600\\n600\\nIron, mg\\n28\\n28\\n60\\n60\\nZinc, mg\\n22\\n22\\n5\\n22\\n \\n The recommended daily dietary allowances during pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n88 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nManagement of a pregnant woman with a BMI less than 18.5kg/m2 at first trimester or \\ninadequate weight gain \\n\\uf0a7 Measurement error has to be eliminated as a cause for inappropriate weight gain \\n\\uf0a7 Take 24 hour dietary recall and assess adequacy of diet (calorie, protein and micronutrient) \\n\\uf0a7 Assess dietary habits, food taboos, misconceptions and correct if there are any negative ones \\n\\uf0a7 Nutrition counseling on appropriate diet: \\nHelp to modify diet by increasing amount of starch based foods such as rice, manioc, \\nstring hoppers etc at each meal \\nConsuming 1-2 extra meals than other days \\nUsing 1-2 table spoonful of oil'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Consuming 1-2 extra meals than other days \\nUsing 1-2 table spoonful of oil \\nIncluding fish/dried fish/egg, pulses, vegetables and green leaves to daily diet \\n \\n\\uf0a7 Thriposha 2 packets monthly (to eat 50grams a day mixed with two teaspoons each of sugar \\nand coconut). Assess the compliance \\n\\uf0a7 Prevent anaemia ( Refer the  Genral circular No. 1945  on prevention of maternal anaemia \\npage 100) \\n\\uf0a7 Micronutrients (Iron folate, vitamin C and Calcium) daily after the 1st trimester.   \\n\\uf0a7 Give worm treatment.  \\n\\uf0a7 Assess the compliance of micronutrients and worm treatment. \\n                Mothers who need close monitoring and evaluation \\no Low pre pregnancy BMI ( < 18.5kg/m2 )  \\no Higher pre pregnancy BMI ( ≥25kg/m2) \\no Multiple pregnancies  \\no Anaemic pregnant women \\no Short interval pregnancies'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='o Multiple pregnancies  \\no Anaemic pregnant women \\no Short interval pregnancies \\no Teenage pregnancies \\no Pregnant while lactation \\no Pregnant women with various social problems such as economically \\ndeprived,   single, unmarried, subject to domestic violence, displaced. \\no Pregnant women with infections such as malaria, TB, intestinal \\ninfections, STD, HIV \\no Pregnant women with medical disorders like Type I & II Diabetes, \\ngestational  diabetes, PIH, Thalassemia. \\no Weight gain  of < 1 kg/ month for women with normal BMI <0.5 Kg \\nfor women who are overweight. \\no Gain of more than 3 Kg per month for any pregnant women'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n89 \\n \\n\\uf0a7 Assess and educate on factors other than dietary which could affect the maternal weight gain  \\n\\uf0d8 Assess the help to reduce the house hold work load and heavy manual work. \\nEducate the husband and the family. \\n\\uf0d8 Assess the mental support she possess and educate regarding the association \\nbetween maternal mental relaxation and fetal well being \\n\\uf0d8 Assess the exposure to house hold smoke and passive tobacco smoke \\n\\uf0d8 Look for any other illnesses from which the mother suffers: eg; Urinary tract \\ninfections, parasitic infections, medical illnesses (Hypertension, DM ). Refer to \\nMOH where necessary. \\n\\uf0d8 Improve the quality of antenatal care received by the mother. \\n\\uf0a7 Follow up monthly \\n\\uf0a7 If weight gain is inadequate, refer to MOH'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Follow up monthly \\n\\uf0a7 If weight gain is inadequate, refer to MOH \\n \\nAssessment and management of the nutritional status of overweight or obese pregnant \\nwomen  \\n1. Assess to modify dietary habit; \\n\\uf0b7 Take 24 hour dietary recall and give necessary advice accordingly (to reduce starch, fats, \\n& sugar). \\n\\uf0b7 Assess dietary habits, myths and misconceptions. Correct if there are any. \\n\\uf0b7 Educate regarding the expected weight gain. \\n\\uf0b7 Follow the different dietary menus provided  \\n\\uf0b7 Attain high coverage of micronutrients \\n \\n2. They should be explained the importance of regular exercise in weight management. \\n \\n3. Following advantages of weight management should be explained to them. \\n\\uf0b7 Reduces the risk of hypertension, preeclampsia, gestational diabetes,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Reduces the risk of hypertension, preeclampsia, gestational diabetes, \\n\\uf0b7 Reduces the risk of obstetric complications such as prolonged labour, and postpartum \\nhaemorrhage. \\n4. Over nourished mothers should be screened for gestational diabetes, pregnancy induced \\nhypertension and fetal wellbeing.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n90 \\n \\nNutrition and care of the lactating mother \\nNutrition during postpartum period is extremely important due to following reasons: \\ni. \\nTo replenish the lost nutrients during pregnancy and labour \\nii. \\nMothers should exclusively breast feed the child till 6/12. \\niii. \\nAs the principle care taker of the infant, mother needs additional calories for her day \\nto \\nday activities geared towards survival, growth and psychosocial development of the \\nchild. \\niv. \\nTo ensure health & nutrition throughout the life time. \\nLactating mothers should be: \\n\\uf0b7 Provided with postpartum Vitamin A megadose 200,000 IU supplementation within 4 \\nweeks of delivery \\n\\uf0b7 Educated on diet \\no Extra serving of starch based foods at each meal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='weeks of delivery \\n\\uf0b7 Educated on diet \\no Extra serving of starch based foods at each meal \\no Consume extra piece of fish/egg/dried fish, extra serving of pulses, vegetables and \\ngreen leaves daily  \\no Fat (oil, butter, margarine) 1 tea spoonful  \\no Fruits : ½ riped bananna /  any fruit like wood apple, Nellie, mangoes that is \\nlocally available \\n\\uf0b7 Give Ironfolate/ iron+ folic acid, Vitamin C and Calcium for a period of six months \\n\\uf0b7 Provide Thriposha 2 packets \\n\\uf0b7 Educate on importance of attending postpartum clinics \\n\\uf0b7 Asses and support breast feeding \\n\\uf0b7 Special follow up of children born with Low Birth Weight  \\n(Refer the section on nutrition in the postpartum guide)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n91 \\n \\nChapter 12 \\nCOMMON DISCOMFORTS DURING PREGNANCY  \\nNausea and morning sickness \\nNausea is very common in early weeks of pregnancy. Advice women: \\n\\uf0b7 If you feel sick first thing in the morning, give yourself time to get up slowly. If possible, \\neat something like dry toast or a plain biscuit before you get up. Then drink a tea without \\nmilk. \\n\\uf0b7 Get plenty of rest and sleep whenever you can. Feeling tired can make the sickness \\nworse. \\n\\uf0b7 Drink plenty of fluids. Take small amount at a time. Eat sugar less biscuits \\n\\uf0b7 Ask those close to you for extra support. \\n\\uf0b7 Distract yourself as much as you can. Often the nausea gets worse the more you think \\nabout it.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Distract yourself as much as you can. Often the nausea gets worse the more you think \\nabout it. \\n\\uf0b7 Avoid the foods and smells that make you feel worse. It helps if someone else can cook. \\n\\uf0b7 Remedies containing ginger may be helpful. \\n\\uf0b7 Wear comfortable clothes. Tight waist bands can make you feel worse \\n \\n \\nBack ache \\n \\nDuring pregnancy ligaments become softer and stretch to prepare for labour. This can put a strain \\non the joints of the lower back and pelvis which can cause backache. As the baby grows, the \\nhollow in the lower back may increase and this may also cause backache. \\nAdvice: \\nTo avoid backache; \\n\\uf0b7 Avoid heavy lifting \\n\\uf0b7 Bend your knees and back straight when lifting or picking up something from the floor.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Bend your knees and back straight when lifting or picking up something from the floor. \\n\\uf0b7 If you do have to carry something heavy, hold it close to your body. \\n\\uf0b7 Move your feet when turning round to avoid twisting your spine \\n\\uf0b7 Wear flat shoes as these allow your weight to be evenly distributed \\n\\uf0b7 Work at a surface high enough to prevent you stooping \\n\\uf0b7 Try to balance the weight between two baskets if you are carrying shopping. \\n\\uf0b7 Sit with your back straight and well supported. \\nA firm mattress can help to prevent and relieve back ache. If the mattress is too soft, a piece of \\nhardboard under its length will make it firmer. Massage also can help. If the backache is very \\npainful meet a doctor.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n92 \\n \\nPelvic pain \\n \\nPelvic pain especially if lateral and referring to the upper thighs are usually due to ligamentous \\nstretch. They require reassurance only. Pain is reproduced by gentle sideways traction on an \\notherwise non-tender and soft womb. Low back pain is common due to altered posture; but also \\nto the effects of the hormone relaxing on ligaments, allowing excessive movement of sacro-illiac \\nand apophyseal joints. A regular exercise program, preferably swimming, with physiotherapy as \\nrequired, complements postural back care. Some women develop symphysis-pubis pain, \\nespecially. If coexistent scoliosis, and may a s-p corset, obtainable through physiotherapy \\ndepartments. \\n \\nUrinary Frequency'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='departments. \\n \\nUrinary Frequency \\nIt is an early sign of pregnancy. Sometimes it continues right throughout the pregnancy. Urinary \\nfrequency is common but should be investigated as 8% of pregnant women will have otherwise \\nasymptomatic UTIs. In later pregnancy it’s the result of the baby’s head pressing on the bladder. \\n\\uf0b7 Try cutting out drinks in the late night but make sure that plenty drinks during daytime \\n\\uf0b7 Later in pregnancy, rock backwards and forwards while they are on the toilet. This lessen \\nthe pressure of the womb on the bladder \\nDysuria \\nIf a pregnant woman has any pain while passing urine or pass any blood, she may have a urine \\ninfection which will need treatment. Ask her to drink plenty of water to dilute the urine and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='infection which will need treatment. Ask her to drink plenty of water to dilute the urine and \\nreduce irritation and refer her to a doctor immediately. \\nIncontinence \\nSometimes pregnant women are unable to prevent a sudden spurt of urine or a small leak when \\nmoving suddenly or just getting up from a sitting position. This may be temporary because the \\npelvic floor muscles relax slightly to prepare for the baby’s delivery. Pelvic floor exercises will \\nimprove the condition. \\nSwollen ankles, feet and fingers \\nAnkles, feet and fingers often swell a little in pregnancy because the body holds more water than \\nusual. Ankle oedema may relate to compression of inferior vena cava and to vasodilatation due'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='usual. Ankle oedema may relate to compression of inferior vena cava and to vasodilatation due \\nto increased hormones. Towards the end of the day, especially if the weather is hot or if standing \\nfor a long time, the extra water tends to gather in the lower parts of the body. If no associated \\nproteinuria or hypertension, it is best treated by  \\n\\uf0b7 Try to avoid standing for long periods \\n\\uf0b7 Wear comfortable shoes \\n\\uf0b7 Put your feet up as much as you can – try to rest for an hour a day with your feet higher \\nthan your heart'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n93 \\n \\n\\uf0b7 Try to do foot exercise \\n\\uf0b7 Take celery – natural diuretic or vitamin B6 \\n\\uf0b7 Confirm the number of fetuses \\n \\nVaricose veins \\nVaricosities occur due to compression of inferior vena cava and vasodilatation due to increased \\nhormones. The veins in the legs are most commonly affected. Some may get varicose veins in \\nthe vulva. They usually relieve after confinements.  \\n\\uf0b7 The early use of support stockings is wise; wear stockings before getting down from the \\nbed, the short term use of pelvic elevation and ice packs can ease the symptoms of vulvar \\nvaricosities. \\n\\uf0b7 Try to avoid standing for long periods of time \\n\\uf0b7 Try not to sit with legs crossed \\n\\uf0b7 Try not to put on too much weight as this increases the pressure'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Try not to put on too much weight as this increases the pressure \\n\\uf0b7 Try to sleep with your legs higher than the rest of your body- use pillow under your \\nankles or put bricks or books under the foot of your bed \\n\\uf0b7 Do foot exercise \\nHeartburn and indigestion \\nHeartburn and indigestion is partly due to hormonal changes and later due to gastro-oesophageal \\nreflux combined with increased abdominal pressure. Postural and dietary advice with the use of \\nantacids settles most, but occasionally H2 antagonists are required.  \\nTo avoid indigestion: \\n\\uf0b7 Try eating smaller meals more often \\n\\uf0b7 Sit up straight when you are eating as this takes the pressure off your stomach \\n\\uf0b7 Avoid particular foods which cause trouble, for example fried or highly spiced ones, but \\nmake sure you are still eating well'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='make sure you are still eating well \\nTo avoid heart burn: \\n\\uf0b7 Sleep well propped up – try raising the head of your bed with bricks or have plenty of \\npillows \\n\\uf0b7 Try drinking a glass of milk – have one by your bed in case you wake with heartburn in \\nthe night \\n\\uf0b7 Avoiding eating or drinking for a few hours before you go to bed'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n94 \\n \\nConstipation \\nConstipation can occur early so at least in part is due to hormones, but is aggravated by enlarging \\npelvic contents. With the vasodilatation and compression of pelvic veins this may result in \\nhaemorrhoids.   \\n\\uf0b7 Make sure you include plenty of fibre in your diet through eating foods like whole meal \\nbreads, whole grain cereals, fruit and vegetables, and pulses such as beans and lentils. \\n\\uf0b7 Exercise regularly to keep your muscles toned up \\n\\uf0b7 Make sure you drink plenty of water \\n\\uf0b7 If laxatives are needed they should be of the fibre based type eg. Fybogel \\n \\n \\nDental decay and periodontal disease \\nDental decay and periodontal disease accelerate in pregnancy and should be reviewed by a'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Dental decay and periodontal disease accelerate in pregnancy and should be reviewed by a \\ndentist as early as possible. To keep your teeth and gums healthy, you should: \\n\\uf0b7 Pay special attention to cleaning your teeth. \\n\\uf0b7 Avoid having sugary drinks and foods too often. Try to keep them only to meal times. \\nSkin changes \\nHormonal changes taking place in pregnancy make the nipples and the areola darker. The skin \\ncolour may also darken a little, either in patches or all over. Birth marks, moles and freckles may \\nalso darken. Some women develop a dark line down the middle of the abdomen (Linea Nigra). \\nThese changes will gradually fade after the delivery. Skin changes such as chloasma and spider \\nnaevi, also disappear after the pregnancy.  \\nStretch Marks'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='naevi, also disappear after the pregnancy.  \\nStretch Marks \\nThese are pink or purplish lines which usually occur on the abdomen or sometimes on the upper \\nthighs or breasts. Some women get them, some don’t. It depends on the skin type. Women with \\nmore elastic skins don’t get them. Women with more than average weight gain, more prone to \\nget them. It is very doubtful whether oils or creams help to prevent stretch marks. After delivery \\nthe marks should gradually pale and become less noticeable. \\nHair Changes \\nHair growth is also likely to increase in pregnancy. The hair may also ne greasier. After the \\ndelivery it may seem that a woman is losing a lot of hair. In fact she is simply losing the increase \\nthat occurred during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n95 \\n \\nItching  \\nItching occurs in 17% gravid women. Interestingly, 50% women with atopic dermatitis improve \\nduring pregnancy. If no rash, consider iron deficiency, or the potentially more serious \\ncholestatsis of pregnancy. Antihistamines may be helpful. \\nStretch marks may occur when growth has been rapid. The dryness and irritation may be erased \\nby vegetable oil or Vitamin E cream and soap avoidance. \\nCramps \\nCramp is Sudden, sharp pain, usually in your calf muscles or feet. It is most common at night. It \\nusually helps if you pull your toes hard up towards your ankle or rub the muscle hard. Regular, \\ngentle exercise in pregnancy, particularly ankle and leg movements, will improve your'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='gentle exercise in pregnancy, particularly ankle and leg movements, will improve your \\ncirculation and may help to prevent cramp occurring. \\nTiredness \\nIn the early months of pregnancy, a woman may feel tired or even desperately exhausted. The \\nonly answer is to try to rest as much as possible. Make time to sit with feet up during the day and \\naccept any offers of help from colleagues and family. Towards the end of pregnancy, she may \\nfeel tired because of the extra weight carrying. Make sure that she gets a plenty of rest. \\nFaintness:  \\nPregnant women often feel faint. This happens when not enough blood is getting to the brain. If \\nthe oxygen level gets too low, she may actually faint. It’s more common in pregnancy because of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the oxygen level gets too low, she may actually faint. It’s more common in pregnancy because of \\nhormonal changes taking place in her body. She is most likely to feel faint if she stand still for \\ntoo long or get up too quickly from a chair. \\n\\uf0b7 Try to get up slowly after sitting or lying down \\n\\uf0b7 If feel faint when standing still, find a seat quickly and the faintness will pass. If it \\ndoesn’t lie down on side. \\n\\uf0b7 If feel faint while lying on her back, turn on side. It’s better not to lie flat on back in later \\npregnancy or during labour. \\nHeadaches \\nSome pregnant women get lots of headaches. A brisk walks may be all they need as well as a \\nlittle more regular rest and relaxation. Although it is wise to avoid drugs in pregnancy, an'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='little more regular rest and relaxation. Although it is wise to avoid drugs in pregnancy, an \\noccasional paracetamol tablets is generally considered safe. If she often has bad headaches meet \\na doctor. It may be a sign of hypertension.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n96 \\n \\nFeeling hot in pregnancy: \\nDuring pregnancy you are likely to feel warmer than normal. This is due to hormonal changes \\nand to increase in blood supply to the skin.  \\n\\uf0b7 Wear loose clothing made out of natural fibres, as these are more absorbent and breathe \\nmore than synthetic fibres. \\n \\n\\uf0b7 Keep your room cool \\n\\uf0b7 Wash frequently to stay fresh \\n \\nVaginal discharge  \\nAlmost all women have more vaginal discharge in pregnancy. It should be clear and white and it \\nshould not smell unpleasant. If the discharge is colored, or smells strange, or if feel itchy or sore, \\nit may be a vaginal infection. Refer her to a doctor. Ask her to wear loose cotton underwear. \\nSleeplessness'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Sleeplessness \\nLate in pregnancy it can be very difficult to get a good night’s sleep. She is uncomfortable lying \\ndown or just when she is beginning to comfortable, she may have to get up to go to the toilet. \\nSome women have strange dreams or nightmares about the baby and about the birth. Talking \\nwith them can help to alleviate their fears. The relaxation and breathing exercises which are \\ntaught in parent crafting classes might be helpful. \\nIf you are not sleeping well: \\n\\uf0b7 Try not to let it bother you. Don’t worry that it will harm your baby- it won’t \\n\\uf0b7 It might be more comfortable to lie on one side with a pillow under your tummy and \\nother between your knees. \\n\\uf0b7 Relaxation technique may help. \\n\\uf0b7 A warm milky drink, a warm bath, some gentle exercise or some restful music before'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 A warm milky drink, a warm bath, some gentle exercise or some restful music before \\nbedtime may help \\n\\uf0b7 A rest during the day can help you to feel less tired. \\n\\uf0b7 Talk to your partner or family or midwife.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n97 \\n \\nRespond to observed signs or volunteered problems \\nIf no fetal movements \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the baby \\nlast move? \\n \\nIf no movement \\nfelt, ask woman to \\nmove around for \\nsome time, \\nreassess fetal \\nmovements \\nFeel for fetal \\nmovements \\n \\nListen for fetal \\nheart after 6 \\nmonths of \\npregnancy \\n \\nIf no heartbeat, \\nrepeat after 1 hour \\nNo fetal movement\\nNo fetal heart beat \\nProbably dead \\nbaby \\nInform the mother \\nand the partner \\nabout the possibility \\nof dead baby. \\nRefer to hospital. \\nNo fetal \\nmovements but \\nfetal heart beat \\npresent \\nWell baby\\nInform the mother \\nthat baby is fine and \\nlikely to be well but \\nto return if problem \\npersists.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Inform the mother \\nthat baby is fine and \\nlikely to be well but \\nto return if problem \\npersists. \\n \\nIf ruptured membranes and no labour \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nWhen did the \\nmembranes \\nrupture? \\nWhen is your \\nbaby due? \\nLook at pad or \\nunder wear for \\nevidence of: \\namniotic fluid, \\nFoul-smelling \\nvaginal discharge \\nIf no evidence, ask \\nher to wear a pad. \\nCheck again in 1 \\nhour. \\nMeasure \\ntemperature. \\nFever 380 C\\nFoul smelling \\nvaginal discharge \\nUterine and \\nfetal infection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nRupture of \\nmembranes at < 8 \\nmonths of \\npregnancy \\nRisk of uterine \\nand fetal \\ninfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nRupture of \\nmembranes at > 8 \\nmonths of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='IM/IV antibiotics \\nRefer urgently to \\nhospital. \\nRupture of \\nmembranes at > 8 \\nmonths of \\npregnancy \\nRupture of \\nmembranes \\nManage as woman in \\nchildbirth.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n98 \\n \\nIf fever or burning on urination \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and advice\\nHave you had \\nfever? \\nDo you have \\nburning on \\nurination? \\nIf history of fever or \\nfeels hot: \\n- \\nMeasure \\naxillary \\ntemperature \\n- \\nLook or feel \\nfor stiff neck \\n- \\nLook for \\nlethargy \\nPercuss flanks for \\ntenderness \\nFever >380 C and any \\nof: \\n- \\nvery fast \\nbreathing or \\n- \\nStiff neck \\n- \\nLethargy \\n- \\nVery weak/not \\nable to stand \\nVery severe \\nfebrile \\ndisease \\nInsert IV line and \\ngive fluids slowly \\nGive appropriate \\nIM/IV antibiotics \\nGive quinine IM \\nGive glucose \\nRefer urgently to \\nhospital \\nFever >380 C and any \\nof: \\n- \\nFlank pain \\n- \\nBurning on \\nurination  \\nUpper \\nUrinary \\nTract \\nInfection \\nGive appropriate'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of: \\n- \\nFlank pain \\n- \\nBurning on \\nurination  \\nUpper \\nUrinary \\nTract \\nInfection \\nGive appropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital \\nBurning on urination\\nLower \\nUrinary \\ntract \\nInfection \\nGive appropriate oral \\nantibiotics \\nEncourage her to \\ndrink more fluids \\nIn no improvement in \\n2 days or condition is \\nworse, refer to \\nhospital'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n99 \\n \\nIf cough or breathing difficulty \\nAsk, check & \\nrecord \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nHow long have \\nyou been \\ncoughing? \\nHow long have \\nyou had \\ndifficulty in \\nbreathing? \\nDo you have \\nchest pain? \\nDo you have \\nany blood in \\nsputum? \\nDoes your \\nhusband smoke? \\nLook for \\nbreathlessness. \\nListen for \\nwheezing. \\nMeasure \\ntemperature. \\nAt least 2 of the \\nfollowing signs: \\n-Fever >380 C. \\n-Breathlessness. \\n-Chest pain \\nPossible \\nPneumonia \\nGive first dose of \\nappropriate \\nIM/IV antibiotics \\nRefer urgently to \\nhospital. \\nAt least 1 of the \\nfollowing signs: \\n- \\nCough or \\nbreathing \\ndifficulty for > \\n3 weeks \\n- \\nBlood in \\nsputum. \\n- \\nWheezing \\nPossible Chronic \\nLung Disease \\nRefer to hospital \\nfor assessment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Blood in \\nsputum. \\n- \\nWheezing \\nPossible Chronic \\nLung Disease \\nRefer to hospital \\nfor assessment. \\nIf severe \\nwheezing, refer \\nurgently to \\nhospital. \\nFever >380 C, and\\nCough < 3 weeks \\nUpper \\nRespiratory \\nTract Infection \\nAdvise safe, \\nsoothing remedy. \\nAdvice to avoid \\npassive smoking.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n100 \\n \\n \\nChapter 13 \\nNATIONAL GUIDELINES FOR PREVENTION AND CONTROL OF \\nMATERNAL ANAEMIA \\n1. Advice pregnant women to add food items abundant with iron for their meals. \\nWomen should be encouraged to consume not only animal foods rich in iron such as meat and \\nfish, but also green leafy vegetables and lentils such as green grams, dhal and chick pea. They \\nshould be encouraged to consume foods which are enhanced the absorption of iron, such as citrus \\nfruits and animal foods with plant foods. They should be discouraged to consume foods such as \\nmilk and tea which inhibit the absorption of iron from plant sources during meals or within one \\nhour of meal. \\n \\n2. Supplementation of iron-folate during pregnancy and lactation'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='hour of meal. \\n \\n2. Supplementation of iron-folate during pregnancy and lactation  \\nAll pregnant women should receive iron and folic acid with Vitamin C after POA of 12 weeks \\nfor 6 months during pregnancy and 6 months after delivery. A pregnant/lactating woman needs a \\n60mg of elementary iron and 400µg of folic acid per day. This can be given as follows: \\ni. \\nGive one tablet of iron-folate (60mg iron + 400µg of folic acid) per day. (This \\ntablet is distributed by FHB.) \\nii. \\nWhen iron-folate tablets are not available, give 200mg of ferrous sulphate (1 \\ntablet) and 5mg of Folic acid (1 tablet) per day. (These tablets are available in \\nMSD). \\niii. \\nGive 50mg of Vitamin C with iron folate/ ferrous sulphate which enhance the iron'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='MSD). \\niii. \\nGive 50mg of Vitamin C with iron folate/ ferrous sulphate which enhance the iron \\nabsorption. Calcium tablets, foods containing calcium or tea or milk which \\ninhibits iron absorption should not be taken within 1 hour of taking iron tablets. \\niv. \\nDuring first trimester, all pregnant women should be taken one tablet of folic acid \\n(5mg). Ideally folic acid should be started at the time, the couple decided to have \\na child (pre-conception folic acid supplementation). Mothers, who have a history \\nof having children with neural tube defects, should take folic acid till next \\npregnancy. \\nMother should be informed about possible side effects of iron intake such as vomiting, nausea, \\nloss of appetite before prescribing iron tablets. As these tablets contains very low dose of iron,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='loss of appetite before prescribing iron tablets. As these tablets contains very low dose of iron, \\nside effects may be mild. However, mothers should be informed how to reduce side effects, if \\nthey occurred.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n101 \\n \\n \\n \\nAll mothers should receive required number of micronutrient tablets till next clinic visit at once. \\nNext clinic visit\\nNo. of iron folate / iron/ \\nfolic acid tablets \\nNo.of Vit C.(50mg) tablets\\nAfter 1 month \\n30 \\n30 \\nAfter 2 weeks\\n14\\n14\\nAfter 1 week \\n07 \\n07 \\n \\nIron tablets should be stored in dark colored air tight bottles to prevent oxidation. All the women \\nshould be advised to bring a dry container to carry micronutrients. \\nWomen should be   made aware on enhances and inhibitors of iron absorption. \\nCompliance of taking micronutrients should be assessed during each clinic visit and home visits. \\nIf there is any problem with compliance, act accordingly. \\n \\n3. Detection of anaemia during pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='3. Detection of anaemia during pregnancy \\n \\nAll pregnant mothers should offer Hb testing at the booking visit and at 28weeks. Classification \\nof anaemia based on Hb levels as follows: \\nHb > 11g/dl \\nNo anaemia \\nHb 7-11g/dl \\nModerate anaemia \\nHb < 7g/dl \\nSevere anaemia \\n \\nActions should be taken according to the table given below.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n102 \\nAsk, \\ncheck, \\nrecord \\nLook, \\nlisten, \\nfeel \\nSigns\\nClassify\\nTreat and advice\\nDo \\nyou \\ntire \\neasily? \\nAre \\nyou \\nbreathless (short \\nof \\nbreath) \\nduring \\nroutine \\nhousehold \\nwork? \\nOn first visit:\\nMeasure Hb \\nOn subsequent \\nvisits: \\nLook for \\nconjunctival \\npallor \\nLook for palmar \\npallor. \\nIf pallor: \\n- Is it severe \\npallor? \\n- Some pallor \\n- Count No. of \\nbreaths in a \\nminute \\nHaemoglobin \\n<7mg/dl  \\nAnd/or \\nSevere palmar and \\nconjunctival pallor  \\nor \\nAny pallor with any \\nof \\n- >30 breaths per \\nminute \\n- tires easily \\n- breathless at rest \\nSevere \\nAnaemia \\nRefer urgently to hospital.\\nRevise the birth plan so as to \\ndeliver in a facility with blood \\ntransfusion services. \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='transfusion services. \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nFollow up in 2 weeks to check \\nclinical progress, test results, \\nand compliance with treatment.\\nHaemoglobin 7-\\n11mg/dl  \\nOr \\nPalmar or \\nconjunctival pallor \\nModerate \\nAnaemia \\nGive double dose of iron for 3 \\nmonths \\nand \\nmonitor \\nthe \\nprogress. I \\nCounsel on compliance with \\ntreatment. \\nGive worm treatment and oral \\nantimalarial \\ntreatment \\nappropriately. \\nReassess at next antenatal visit. \\nIf anaemia persists without any \\nimprovement in Hb levels, \\nrefer to hospital.  \\nOnce Hb levels become normal \\ncontinue with single dose of \\niron (60mg of elementary iron) \\nHaemoglobin \\n>11mg/dl.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='continue with single dose of \\niron (60mg of elementary iron) \\nHaemoglobin \\n>11mg/dl. \\nNo pallor. \\nNo \\nclinical \\nanaemia \\nGive iron 1 tablet once daily \\nfor 6 months. \\nCounsel on compliance with \\ntreatment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n103 \\n \\n4. Control of infections related to anaemia \\n \\ni. \\nControl and treatment for intestinal worm infestations \\nAll pregnant mothers should receive worm treatment with Mebendazole just after completion of \\n12 weeks of POA. \\nDosage: \\n  \\nMebendazole 100mg twice a day for 3days or \\n \\n \\nMebendazole 500mg as a single dose \\nMothers should be informed regarding other preventive methods of worm infestations such as \\nuse of sleepers, proper construction and use of toilets, use of safe water, washing hands before \\nmeals and after toileting. \\nii. \\nControl and prevention of malaria \\n \\nAs malaria is low prevalent disease in Sri Lanka, It is not recommended the routine prophylaxis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='As malaria is low prevalent disease in Sri Lanka, It is not recommended the routine prophylaxis \\ntreatment for pregnant mothers even in the endemic areas. Prophylaxis should be decided by the \\nMOH/ MO after considering the malaria status in the area. If decided on malaria prophylaxis the \\nregime is: \\n \\n\\uf0b7 Chloroquine 300mg (2 tablets) weekly after meal during second and third trimesters and \\n42 days after delivery \\n \\n\\uf0b7 At the booking visit, all pregnant mothers in endemic areas should be tested for malaria \\nusing a blood smear. \\n \\n\\uf0b7 In a malarial endemic area, if a pregnant mother is suffering from fever, she should be \\ntested for malaria. If she is positive for malaria, she should be given the complete course \\nof Chloroquine as follows: \\n \\nDay 1 – Chloroquine 600mg (4 tablets)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of Chloroquine as follows: \\n \\nDay 1 – Chloroquine 600mg (4 tablets) \\nDay 2 – Chloroquine 600mg (4 tablets) \\nDay 3 - Chloroquine 300mg (2 tablets) \\nAfter that Chloroquine prophylaxis should be continued the rest of the pregnancy and postpartum \\nperiod. Primaquine should not be given during pregnancy and postpartum period.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n104 \\n \\n5. Information, education and communication \\nIt is important to understand the knowledge, attitudes and practices on anaemia in the \\ncommunity, as control and prevention of anaemia is closely link with the practices of the people. \\nTherefore, well organized and targeted health education program is essential. \\nThese health education programs should be targeted to important groups such as adolescent girls, \\nworking women, women in urban slums, estate women and displaced women. \\n6. Ordering, receiving and storage of drugs needed for the maternal care program  \\nThe drugs needed for the program of prevention of anaemia are iron, iron folate, folic acid,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='The drugs needed for the program of prevention of anaemia are iron, iron folate, folic acid, \\nvitamin C (ascorbic acid), mebendazole (worm treatment) and chloroquine. It is important to \\nprepare the estimation properly to order drugs and it should be done at the level of MOH/ RDHS \\nor medical institution. \\n \\nDrug Estimation                  Estimated No of Pregnant women = Total Population x CBR \\nIron/ ironfolate tablets \\nNo. of Ironfolate/ Iron tablets required for a MOH area =  \\n(Estimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n   (After first 12 weeks during pregnancy and 6 months after delivery) \\nFolic acid \\nWhen iron and folic acid are in combination, folic acid should be estimated only for the first 3 \\nmonths of pregnancy. \\nWhen Iron folate is available'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='months of pregnancy. \\nWhen Iron folate is available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers X 90days X 1 tablets  \\nWhen Iron tablets are available  \\nRequirement of folic acid =  \\nEstimated No. of pregnant mothers for the year × 450 days × 1 tablet) \\n(During pregnancy 270 days during pregnancy + 180 days after delivery)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n105 \\n \\nCalcium lactate  \\nNo. of calcium lactate tablets required for a MOH area =  \\nEstimated No. of pregnant mothers for the year × 360 days × 1 tablet) \\n    \\n(After first 12 weeks during pregnancy and 6 months after delivery) \\nMebendazole \\nRequirement of Mebendazole (100mg)= \\n(Estimated No. of pregnant mothers for the year × 6 tablets) \\nRequirement of Mebendazole  (500mg) =  \\n(Estimated No. of pregnant mothers for the year × 1 tablets) \\nThe estimation for the entire district should be prepared by summarizing the estimates from the \\nMOH areas. It should be included in the yearly drug estimation. Ordering of micronutrients  \\nshould be done in similar way as other drugs in medical institutions. The number of inward'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='should be done in similar way as other drugs in medical institutions. The number of inward \\nmothers taking treatment and number mothers attending the clinic should be taken in to \\nconsideration while preparing the estimation.   \\nThe drugs should be stored in dark dry place to avoid oxidization and destruction.  The regional \\nsuppliers division to MOH office and clinic should follow these instructions. \\nWhen issuing drugs, the calculation of drugs should be done in retail at each level (medical \\nsuppliers division, MOH office, and clinic) and a record should be maintained in each clinic at \\nthe end of the day. \\ne.g. \\nDate   \\nAmount in hand     No of mothers \\nattended       \\n         Amount \\nissued      \\nBalance'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Amount in hand     No of mothers \\nattended       \\n         Amount \\nissued      \\nBalance \\n \\n \\n \\n \\n \\nReceiving of drugs, distribution, storage and issuing should be supervised by MOMCH/ an \\nofficer appointed by RDHS when this post is vacant. \\nThe RDHS, MOH, MOMCH, head of the institution and other supervisory officers such as \\npublic health nursing officer (PHNS) and supervising public health mid wife (SPHM) are \\nresponsible for supervisory work at clinic, field and institutional level. \\nAll the activities in this program should be monitored, supervised and evaluated at regional level \\nas well as district level. It is a responsibility of the supervisory committee of the region and \\nMOMCH at district level.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n106 \\n \\nChapter 14 \\nMANAGEMENT OF HIGH BLOOD PRESSURE DURING PREGNANCY  \\nAT FIELD LEVEL \\nAsk, check \\n&record \\nLook, listen, feel\\nSigns\\nClassify\\nTreat and \\nadvice \\nBlood \\npressure at \\nthe last \\nvisit? \\nMeasure blood pressure in \\nsitting position. \\nIf diastolic blood pressure \\nis ≥90mmHg, repeat after \\n1 hour rest. \\nIf diastolic blood pressure \\nis still ≥90mmHg, ask the \\nwoman if she has: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\n\\uf0a7 \\nCheck protein in \\nurine \\nDiastolic blood pressure \\n≥110 mmHg and 3+ \\nproteinuria,  \\nor \\nDiastolic blood pressure \\n≥90 mmHg on two \\nreadings and 2+ \\nproteinuria, and any of: \\n\\uf0a7 \\nSevere headache \\n\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\nSevere pre-\\neclampsia \\nRefer Urgently \\nto hospital'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 \\nBlurred vision \\n\\uf0a7 \\nEpigastric pain \\nSevere pre-\\neclampsia \\nRefer Urgently \\nto hospital \\n \\nDiastolic blood pressure \\n90-110 mmHg on two \\nreadings and 2+ \\nproteinuria. \\nPre-\\neclampsia \\nRefer to hospital\\nimmediately. \\nDiastolic blood pressure \\n≥90 mmHg on 2 \\nreadings \\nHypertension\\nAdvise to reduce \\nworkload and to \\nrest. \\nAdvise on danger \\nsigns. \\nReassess at the \\nnext antenatal \\nvisit or in 1 week \\nif >8 months \\npregnant. \\nIf hypertension \\npersists after 1 \\nweek or at next \\nvisit, refer to \\nhospital. \\nNone of the above.\\nNo \\nHypertension\\nNo treatment \\nrequired.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n107 \\n \\nChapter 15 \\nGUIDELINES ON IMMUNIZATION AGAINST TETANUS \\nIntroduction \\nTetanus is a fatal infectious disease caused by toxigenic strains of Clostredium Tetani. Tetanus \\nand neonatal tetanus is still a major public health problem in a considerable number of \\ndeveloping countries. However, both tetanus and neonatal tetanus have reached elimination \\nlevels in Sri Lanka as a result of the successful immunization programme. \\n Protection against tetanus toxoid could be achieved either through active immunization (by \\ngiving tetanus toxoid containing vaccine) or by passive immunization (by giving tetanus specific \\nimmunoglobin). Neonatal   tetanus is prevented by immunizing the pregnant mothers with \\ntetanus toxoid vaccine.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='tetanus toxoid vaccine. \\nTetanus vaccines are based on tetanus toxoid which is a chemically inactivated tetanus toxin \\nwhich could induce production of antibodies against tetanus toxin. Tetanus toxoid is available as \\nmonovalent tetanus toxoid (TT), combined diphtheria, pertussis, tetanus, hepatitis B and Hib \\nvaccine (pentavalent vaccine), combined diphtheria and pertussis, tetanus vaccine (DPT), \\ncombined diphtheria, tetanus vaccine (DT) or as adult tetanus diphtheria vaccine (aTd). \\nThe goal of tetanus immunization in the Expanded Programme of Immunization (EPI) \\nprogramme is to eliminate tetanus and neonatal tetanus from Sri Lanka. With the emergence of \\nnew knowledge on immunological response of patients after receiving tetanus toxoid, the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='new knowledge on immunological response of patients after receiving tetanus toxoid, the \\nfollowing recommendations have been made regarding immunization with tetanus containing \\nvaccines. \\n1.) Pre exposure immunization against tetanus \\n \\n1.1)  Immunization from infancy up to adolescence \\n \\n \\nDose\\nAge (on \\ncompletion of) \\nVaccine\\nDuration to be kept between different doses of \\ntetanus containing vaccine when tetanus toxoid \\ncontaining vaccines have not been received \\naccording to the scheduled age \\n1st \\n2 months\\n   Pentavalent     \\n   or DPT             \\n6-8 weeks between\\n1. 1st and 2nd dose \\n2. 2nd and 3rd dose \\n2nd\\n4 months\\n3rd\\n6 months\\n4th\\n18 months\\nDPT\\n12 months between 3rd and 4th doses\\n5th\\n5 years\\nDT\\n3 years between 4th and 5th doses\\n6th\\n12 years( in grade \\n7, during SMI) \\naTd'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='5th\\n5 years\\nDT\\n3 years between 4th and 5th doses\\n6th\\n12 years( in grade \\n7, during SMI) \\naTd\\n7 years between 5th and 6th doses'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n108 \\n \\n1.2) Immunization during pregnancy \\n The number of doses required and timing of boosters during pregnancy will depend on the past \\nimmunization history of the pregnant mother with tetanus containing vaccines. \\n1.2.1) Immunization of pregnant mothers who have not received tetanus containing vaccines \\nin infancy and childhood as per the EPI schedule \\nPregnant mothers who have not received tetanus containing vaccine according to the EPI \\nschedule during infancy and child hood should be immunized according to the following \\nschedule. \\nDose \\nTime of Immunization \\n1st \\nDuring 1st pregnancy after 12 weeks of gestation \\n2nd \\nDuring 1st pregnancy (6 – 8 weeks after the first dose, two weeks before delivery) \\n3rd'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='2nd \\nDuring 1st pregnancy (6 – 8 weeks after the first dose, two weeks before delivery) \\n3rd \\nDuring 2nd pregnancy after 12 weeks of gestation \\n4th \\nDuring 3rd  pregnancy after 12 weeks of gestation \\n5th \\nDuring 4th pregnancy after 12 weeks of gestation \\n \\nPregnant mothers who have received 5 doses of tetanus toxoid during previous pregnancies \\nmentioned above do not need further booster doses of tetanus toxoid during subsequent \\npregnancies. \\n1.2.2) Immunization of pregnant mothers who have documented evidence of receipt of six \\ndoses of tetanus containing vaccines as per the national EPI schedule ( 3 doses of DPT / penta \\nin infancy + DPT at 18 months + DT at 5 years + aTd at 12 years) \\n \\nDose \\nTime of Immunization \\nOne booster dose (TT) \\nIf the gap between the 6th dose or any'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Dose \\nTime of Immunization \\nOne booster dose (TT) \\nIf the gap between the 6th dose or any \\nsubsequent tetanus containing vaccine and the \\ncurrent pregnancy is more than 10 years \\n \\nPregnant mothers who belong to the following categories do not need to be immunized with \\ntetanus toxoid during pregnancy. \\n1. If the gap between the 6th dose of tetanus containing vaccine and the current pregnancy is \\nless than 10 years.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n109 \\n \\n2. If the gap between the subsequent dose of tetanus containing vaccine received after the \\n6th dose and the current pregnancy is less than 10 years. \\n \\n(2) Post exposure vaccination against tetanus \\nDecision on post exposure vaccination should be taken after considering the nature of the injury \\nand the previous history of immunization with tetanus containing vaccine. \\n2.1) Immunization of persons who have been immunized with tetanus containing vaccine \\nduring infancy and childhood \\nIf a person has documented evidence of receipt of six doses of tetanus containing vaccine (with 4 \\ndoses of DPT/ pentavalent, DT, aTd) he/she does not need to be immunized with tetanus toxoid'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='doses of DPT/ pentavalent, DT, aTd) he/she does not need to be immunized with tetanus toxoid \\nup to 10 years after the 6th dose of tetanus containing vaccine. If a patient presents 10 years after \\nthe 6th dose of tetanus containing vaccine immunity could be boosted up with a dose of tetanus \\ncontaining vaccine. \\nHowever, if a patient presents within 10 years with a severely contaminated wound a booster \\ndose of tetanus toxoid could be given even though the gap between the 6th dose of tetanus and \\nthe injury is less than 10 years. \\n2.2) Immunization of persons who have not been immunized with tetanus containing \\nvaccine according to the EPI schedule \\nAny person who has not been immunized with tetanus containing vaccine during infancy and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Any person who has not been immunized with tetanus containing vaccine during infancy and \\nadolescence according to the national EPI schedule, he/ she should be given a dose of tetanus \\ntoxoid (1st dose) if there is a risk of developing tetanus. Second dose of tetanus toxoid should be \\ngiven 4 weeks after the 1st dose and the third dose 6 months after the second dose. A booster \\ndose (4th dose of tetanus could be given 5 years after the 3rd dose. Fifth dose given 10 years after \\nthe 4th dose will produce long lasting, probably a lifelong immunity. \\n(3) Development of immunity after immunization with tetanus containing vaccines \\nIf there is documentary evidence to show that any infant, child or an adult has been immunized'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='If there is documentary evidence to show that any infant, child or an adult has been immunized \\nas per EPI schedule, it is not necessary to immunize them in between the routine doses again \\nwhenever they present with trauma as they are protected against tetanus infection in between \\ndoses. However if an infant, child or an adult presents with a severely contaminated wound, a \\ndose of tetanus could be given to boost up the immunity even in between the recommended \\nroutine doses. \\n(4) Storage and administration of tetanus containing vaccines  \\nTetanus containing vaccines should be stored and transported between +2 centigrade and +8 \\ncentigrade and should not be exposed to freezing as it can reduce the potency of these vaccines.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='centigrade and should not be exposed to freezing as it can reduce the potency of these vaccines. \\nOpened tetanus containing vaccine vials should be stored between +2 centigrade and +8 \\ncentigrade and could be re used in subsequent immunization sessions within 4 weeks of opening. \\nTetanus containing vaccines should be given intra muscularly.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n110 \\n \\n \\nChapter 16 \\nGUIDELINE ON SCREENING AND MANAGEMENT OF DIABETES MELLITUS DURING \\nPREGNANCY IN THE FIELD/NON SPECIALIZED INSTITUTIONS \\nGestational diabetes Mellitus \\nDefinition \\nGestational Diabetes Mellitus (GDM) is defined as carbohydrate intolerance of variable severity with \\nonset or first recognition during the present pregnancy. \\n\\uf0b7 Detailed, comprehensive history should be obtained from all the pregnant women who attend for \\ntheir first antenatal clinic visit by a medical officer. \\n\\uf0b7 Anthropometric assessment should be done at the first antenatal clinic visit using height and \\nweight and by calculating BMI \\n\\uf0b7 If any of the following risk conditions are identified, offer them a 2hour PBBS testing using \\na glucometer.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='a glucometer. \\n\\uf0b7 Before testing the 2hr PBBS, check the available test reports, as some of the women may have \\nalready done OGTT, GCT or some other blood sugar values. If those reports are sufficient for \\ndecision making do not repeat the PBBS at the clinic. \\n \\nRisk factors:  \\n\\uf0b7 Body Mass Index above 25kg/m2  \\n\\uf0b7 Maternal weight at booking visit > 65 kg \\n\\uf0b7 Mother’s age >35yrs \\n\\uf0b7 Previous macrosomic babies weighing 3.5 kg or above \\n\\uf0b7 Previous gestational diabetes \\n\\uf0b7 History of IUD, Intrapartum death, Neonatal death \\n\\uf0b7 Recurrent PIH \\n\\uf0b7 Polycystic Ovary Syndrome \\n\\uf0b7 Women on long term steroids, antiepileptic, anti-psychotics \\n\\uf0b7 Previous late miscarriages or three or more consecutive miscarries at first trimester \\n\\uf0b7 Family history of diabetes ( 1st degree relative with diabetes)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Family history of diabetes ( 1st degree relative with diabetes) \\n\\uf0b7 Acanthosis Nigricans  \\n\\uf0b7 Essential Hypertension'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n111 \\n \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl at first antenatal booking refer them to a \\nspecialized unit for urgent OGTT. \\n \\n\\uf0b7 If 2hr PPBS at 1st antenatal visit is >120 mg/dl and OGTT in early pregnancy is normal, they \\nhave repeat OGTT at 24-28 weeks. Therefore, refer such women for OGTT at 24 -28 weeks. \\n \\n\\uf0b7 At the POA of 24-28 weeks, offer all pregnant women 2hr PBBS testing using glucometer. \\n \\n\\uf0b7 If the 2hr PBBS value is more than 120mg/dl refer them to a specialized unit for urgent OGTT. \\n \\nPreparation for 2hr PBBS: \\n1. Pregnant woman should have an average Sri Lankan meal 2 hours before the test (rice with \\ncurries) \\n2. The meal should be eaten over a maximum period of 15 minutes time.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='curries) \\n2. The meal should be eaten over a maximum period of 15 minutes time. \\n3. The two hours should be calculated from the starting time of the meal. \\nEg. Meal starts at 7.30am. It should be finished by 7.45am and the time for PPBS is 9.30am \\n \\nWomen with gestational diabetes should be offered information covering: \\n• the role of diet, body weight and exercise \\n• the increased risk of having a baby who is large for gestational age, which increases the \\nlikelihood of birth trauma, induction of labour and caesarean section \\n• the importance of maternal glycaemic control during labour and birth and early feeding of the \\nbaby in order to reduce the risk of neonatal hypoglycaemia \\n• the possibility of transient morbidity in the baby during the neonatal period, which may  require'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='admission to the neonatal unit \\n• The risk of the baby developing obesity and/or diabetes in later life. \\nWomen with gestational diabetes should be advised to choose, where possible, carbohydrates from low \\nglycaemic index sources, lean proteins including oily fish and a balance of polyunsaturated fats and \\nmonounsaturated fats. \\nWomen with gestational diabetes whose pre-pregnancy body mass index was above 25 kg/m2 should be \\nadvised to restrict calorie intake (to 25 kcal/kg/day or less) and to take moderate exercise (of at least 30 \\nminutes daily). \\nHypoglycaemic therapy should be considered by relevant specialists for  \\n\\uf0b7 Women with gestational diabetes if diet and exercise fail to maintain blood glucose targets \\nduring a period of 1–2 weeks.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='during a period of 1–2 weeks.  \\n\\uf0b7 Women with gestational diabetes if ultrasound investigation suggests incipient fetal macrosomia \\n(abdominal circumference above the 70th percentile) at diagnosis.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n112 \\n \\n \\nHypoglycaemic therapy for women with gestational diabetes which may include regular insulin, and \\nrapid-acting insulin analogues and/or hypoglycaemic agents should be tailored to the glycaemic profile \\nof, and acceptability to, the individual woman. \\nIndividualized targets for self-monitoring of blood glucose should be agreed with women with diabetes \\nin pregnancy, taking into account the risk of hypoglycaemia eg. targeted glycaemic control pre meal 70-\\n90 mg/dl and 2 hour post meal <120 mg/dl \\nWomen with insulin-treated diabetes should be advised of the risks of hypoglycaemia particularly in the \\nfirst trimester. \\nDuring pregnancy, women with insulin-treated diabetes should be provided with a concentrated glucose'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='solution and women with type 1 diabetes should also be given glucagon; women and their partners or \\nother family members should be instructed in their use. \\nDuring pregnancy, women who are suspected of having diabetic ketoacidosis should be admitted \\nimmediately for critical care, where they can receive both medical and obstetric care. \\nMonitoring fetal growth and wellbeing \\nPregnant women with diabetes should be offered ultrasound monitoring of fetal growth and amniotic \\nfluid volume every 4 weeks from 28 to 36 weeks. \\nRoutine monitoring of fetal wellbeing before 28 weeks is not recommended in pregnant women with \\ndiabetes, unless there is a risk of intrauterine growth restriction. \\nWomen with diabetes and a risk of intrauterine growth restriction (macrovascular disease and/or'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Women with diabetes and a risk of intrauterine growth restriction (macrovascular disease and/or \\nnephropathy) will require an individualized approach to monitoring fetal growth and wellbeing. \\nWomen with diabetes who are pregnant should be offered immediate contact with a joint diabetes and \\nantenatal clinic. \\nPreterm labour in women with diabetes \\nDiabetes should not be considered a contraindication to antenatal steroids for fetal lung maturation or to \\ntocolysis. \\nWomen with insulin-treated diabetes who are receiving steroids for fetal lung maturation should have \\nadditional insulin according to an agreed protocol and should be closely monitored. \\nBetamimetic drugs should not be used for tocolysis in women with diabetes.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n113 \\n \\n \\nPostnatal care \\n \\nStart breast feeding immediately and continue. \\n \\nWomen with insulin-treated pre-existing diabetes should reduce their insulin immediately after birth and \\nmonitor their blood glucose levels carefully to establish the appropriate dose. \\nWomen with insulin-treated pre-existing diabetes should be informed that they are at increased risk of \\nhypoglycaemia in the postnatal period, especially when breastfeeding, and they should be advised to \\nhave a meal or snack available before or during feeds \\nWomen who have been diagnosed with gestational diabetes should discontinue hypoglycaemic \\ntreatment immediately after birth.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='treatment immediately after birth. \\nWomen with pre-existing type 2 diabetes who are breastfeeding can resume or continue to take \\nmetformin and glibenclamide immediately following birth but other oral hypoglycaemic agents should \\nbe avoided while breastfeeding. \\nWomen with diabetes who are breastfeeding should continue to avoid any drugs for the treatment of \\ndiabetes complications that were discontinued for safety reasons in the preconception period. \\nInformation and follow-up after birth \\nWomen with pre-existing diabetes should be referred back to their routine diabetes care arrangements. \\nWomen who were diagnosed with gestational diabetes should have their blood glucose tested to exclude \\npersisting hyperglycaemia before they are transferred to community care.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='persisting hyperglycaemia before they are transferred to community care. \\nWomen who were diagnosed with gestational diabetes should be reminded of the symptoms of \\nhyperglycaemia. \\nWomen who were diagnosed with gestational diabetes should be offered lifestyle advice (including \\nweight control, diet and exercise) and offered a fasting plasma glucose measurement (but not an OGTT) \\nat the 4-6 week postnatal check and annually thereafter. \\nWomen who were diagnosed with gestational diabetes (including those with ongoing impaired glucose \\nregulation) should be informed about the risks of gestational diabetes in future pregnancies and they \\nshould be offered screening (OGTT or fasting plasma glucose) for diabetes when planning future \\npregnancies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnancies. \\nWomen with diabetes should be reminded of the importance of contraception and the need for \\npreconception care when planning future pregnancies.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n114 \\n \\n \\nChapter 17 \\nPREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV INFECTION \\n \\nThere is convincing evidence from several studies that mother to child transmission of HIV can be \\nreduced successfully by various interventions that are now proven to be highly effective.  \\nAt present Sri Lanka is a country with a low level HIV epidemic. The estimated adult prevalence rate is \\n<0.1%.  As of end 2009, the estimated number of people living with HIV was 3000. The number \\nreported in the country is around 1285. The majority of those living with HIV are unaware of their HIV \\nstatus.  The antenatal care package prepared for the benefit of all antenatal mothers in this country'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='consists of several interventions and it will now include interventions for prevention of mother to child \\ntransmission of HIV infection.  \\nSri Lanka is adopting a 4 prong strategy to achieve zero incidence of paediatric infection.  \\n1. Primary prevention of HIV among men  and women of childbearing age  \\n2. Prevention of unintended pregnancies among women living with HIV \\n3. Prevention of HIV transmission from a woman living with HIV to her infant   \\n4. Provision of appropriate treatment, care and support to women living with HIV  and their \\nchildren and families  \\n \\nSince the antenatal HIV prevalence rate ranges between 0.02-0.03 % the best method for Sri Lanka is \\nprimary prevention of HIV among men and women of childbearing age. The most effective and humane'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='primary prevention of HIV among men and women of childbearing age. The most effective and humane \\nway to prevent HIV in infants is to help young men and women by promoting safer sexual behaviours to \\nremain free from infection before marriage and before the woman gets pregnant.  Further, voluntary \\ncounselling and testing should be available to any pregnant woman who requests it.  There are several \\nkey entry points within the health service which gives the opportunity for young men and women to \\nknow about HIV/AIDS, PMTCT, counselling and testing opportunities and access the available \\ntreatment, care and support services.  Integration of PMTCT services into the maternal and child health \\nservices will provide women with services to prevent new infections and promote male partner'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='services will provide women with services to prevent new infections and promote male partner \\ninvolvement to prevent infections among men.  \\nIntegrating screening for HIV infection within the established antenatal investigation package eg \\nscreening for  syphilis, anaemia and blood grouping is being considered strongly as a PMTCT \\nintervention as it has public health benefits to the individual woman, her partner and her baby.  \\nOpportunities should be made available within the existing health services to identify HIV infected \\nantenatal mothers in order for them to utilize ART, safer delivery and feeding practices to reduce \\ntransmission to the offspring.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n115 \\n \\n \\nPrimary prevention strategies  for PMTCT  \\nRaising awareness of antenatal mothers and their partners on PMTCT \\nAll pregnant women, and those planning pregnancy   should have accessibility to appropriate \\ninformation about HIV infection including PMTCT. Information on sexually transmitted infections \\nincluding HIV and syphilis should be included in the general information given to pregnant women \\nalong with information about other infections and antenatal tests. They should be informed about \\nperinatal transmission of HIV and it adverse pregnancy outcomes. They should be aware of the potential \\nbenefits of knowing their HIV infection status by getting tested, both for their own health and to reduce'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the risk of perinatal transmission. As part of routine antenatal care all pregnant women should be made \\naware that mother to child transmission of HIV can be greatly reduced through antenatal and perinatal \\ntreatment with anti-retroviral drugs, safer delivery and safer infant feeding practices.  \\nInformation about facilities for screening should be made available to all pregnant women.  Discuss \\nabout the HIV test and the window period and other related issues about the HIV test. Stress those \\nmeasures to prevent unintended pregnancies among women living with HIV and prevention of \\ntransmission of HIV from mother to child can only be offered if HIV infection is diagnosed before or \\nduring pregnancy. In Sri Lanka unfortunately almost 90% of HIV infection in pregnant women remains'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='during pregnancy. In Sri Lanka unfortunately almost 90% of HIV infection in pregnant women remains \\nundiagnosed during pregnancy and often women only discover they are infected when their children \\ndevelop HIV infection or AIDS. Therefore, screening for HIV, as far as possible should be promoted \\nand normalized and should generally be dealt with other conditions discussed within antenatal care. \\nGive details of the procedures for testing and obtaining results. \\nInformation on safe and responsible sexual behaviour and practices should be discussed in a culturally \\nappropriate manner depending on the audience. It should include as appropriate, the importance of \\navoiding commercial and casual sex, reducing the number of sexual partners and consistent condom use.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Information on services for STI/HIV prevention should also be discussed. Draw their attention to the \\navailability of services to reduce mother to child transmission of HIV for HIV positive women including \\nanti-retrovirals which are offered free of charge.   \\nDiscussions should not be limited only for women. Men should be included when information is \\nprovided at antenatal classes. \\nCommunication \\nInformation should be presented in a way which reflects the positive outcomes of knowing the HIV \\ninfection status for women and men and for their babies. Method of communication should be in forms \\nthat are linguistically, culturally and educationally appropriate to women.  Groups health education \\nshould be utilized for dissemination of information.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='should be utilized for dissemination of information.  \\nDiscussions should include eliciting and giving information about basic facts of STI and HIV and \\nPMTCT, exploring any concerns expressed by women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n116 \\n \\nHealth care workers should be aware of the procedures adopted in the respective institution. In some \\nantenatal settings, HIV testing would be included as a routine test in the standard of care package of \\nservices.  Voluntary counselling & testing should be encouraged if HIV testing is not provided in the \\nantenatal care package.  \\nSignificant efforts should be taken to provide men and women with relevant information and services \\nwhich would help them to assess their own risk to infection. Therefore, the service providers should \\nhave updated, comprehensive knowledge on STI/HIV/AIDS including PMTCT to educate antenatal \\nmothers and their partners. They should have correct communication skills to talk about the following'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='confidently.  \\nHealthcare workers should have correct technical knowledge and communication skills to talk about the \\nfollowing confidently.  \\n1. Basic facts about STD/HIV/ AIDS  \\n \\no What is HIV and AIDS and the  difference between HIV and AIDS \\no HIV / AIDS /STI overview-Local situation  \\no Natural history and what happens when the virus enters the body \\no Methods of transmission and non transmission  \\no Asymptomatic period an HIV infected person could look healthy \\no An infected person is infectious for life  \\no HIV transmission risk during  pregnancy, delivery and breastfeeding \\no Mother to child transmission of HIV and syphilis. Risk factors and methods of prevention  \\no Adverse pregnancy outcomes of maternal HIV infection and STI'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='o Adverse pregnancy outcomes of maternal HIV infection and STI \\n \\n\\uf0b7 Make antenatal mothers understand that there will not be paediatric infections  if parents are not \\nHIV infected  \\n\\uf0b7 Discuss Behaviour Change efforts among vulnerable groups with promotion and provision of \\ncondoms. Counsel to change behaviours that place individuals at risk for becoming HIV infected \\nor spreading HIV infection. Promote access to condoms and dual protection  \\n\\uf0b7 How people can continue to stay negative \\n \\n2. Screening for HIV infection  \\n\\uf0b7 How to know the HIV status?  Explain about the screening test.  \\n\\uf0b7 Stress that the only way to know for sure whether a person is infected with HIV or not is by \\ntesting of blood.   \\n\\uf0b7 Discuss the purpose of HIV testing and advantages of knowing the HIV status during'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Discuss the purpose of HIV testing and advantages of knowing the HIV status during \\npregnancy.   \\n\\uf0b7 Discuss what the window period is and its interpretation in relation to the risky sexual \\nexposure  \\n\\uf0b7 If HIV testing is not a routine procedure in the institution, promote voluntary counselling & \\ntesting. Inform the availability of test in STD services.  \\n\\uf0b7 Make her understand that testing is done confidentially. \\n\\uf0b7 Provide information about the test procedures'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n117 \\n \\n \\n\\uf0b7 Discuss the HIV testing process. Explain the types of tests:  client initiated and provider \\ninitiated: screening and confirmatory tests , what the window period means, importance of \\nobtaining test result , implications of both positive and negative results \\n\\uf0b7  Inform that persons who test positive will receive further counselling and referral for \\ntreatment, care and support.  \\n\\uf0b7 Discuss the importance of male partner involvement  \\n\\uf0b7 Approaches for partner disclosure \\n\\uf0b7 If testing is not available in the health institution, it could be done at the closest STD clinic. If \\nit is not possible for the mother to go to the STD clinic inform her that a blood sample could \\nbe collected and sent to the STD clinic for testing'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='be collected and sent to the STD clinic for testing  \\n \\nHIV testing is done with informed consent. Informed consent means that the health care worker has \\nexplained the above during the education session and the mother is aware of the implications of a \\nnegative or positive test. No written consent is required for HIV testing. The main objective is to \\neliminate paediatric HIV infection and improve maternal and child survival. \\n \\n \\n3. Interventions available to prevent mother to child transmission of HIV  \\n\\uf0b7 Explain the available interventions to prevent mother to child transmission of HIV to \\neliminate paediatric HIV. Availability of antiretroviral therapy from the government sector \\nfree of charge  \\n\\uf0b7 Promote seeking STD care services and  confidentiality of STD services'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='free of charge  \\n\\uf0b7 Promote seeking STD care services and  confidentiality of STD services  \\n\\uf0b7 Discuss  about confidentiality measures and efforts for prevention of stigma and \\ndiscrimination in the institution  \\n\\uf0b7 Discuss about the importance of continuous antenatal and postpartum care  \\n\\uf0b7 Discuss about the importance newborn care  \\n\\uf0b7 Trained healthcare team will provide optimum care for the mother, her partner and the baby  \\n\\uf0b7 Ask her whether she has any questions and concerns. \\n \\nAt the end of the talk, women and men who attend the talk should be able to understand: \\n\\uf0b7 The main modes of transmission of HIV and the need to avoid unsafe sexual behaviours to be \\nHIV free, which is the best method to avoid HIV infection  in the newborn    \\n\\uf0b7 HIV transmission risk to the infant'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 HIV transmission risk to the infant  \\n\\uf0b7 Adverse pregnancy outcomes of maternal HIV infection  \\n\\uf0b7 Importance of HIV testing  as this is the only method of knowing the HIV status of men and \\nwomen. A diagnosis in the mother allows appropriate treatment and follows up of her child. This \\ngives an opportunity for partner testing. In case the partner is negative the couple could take \\nprecautions to help prevent transmission to the sexual partner.  \\n\\uf0b7 Confidentiality of information  \\n\\uf0b7 Available services in the country \\n\\uf0b7 Availability of pre test information/counselling  \\n\\uf0b7 If tests are negative how to stay negative by adopting risk reduction behaviours.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n118 \\n \\n\\uf0b7 If  HIV infection is confirmed  the availability of interventions for HIV  positive mothers, partner  \\nand the infant  \\n\\uf0b7 Advantages of ART to the mother and infant  \\n\\uf0b7 Importance of partner testing   \\n\\uf0b7 To change attitudes towards People living with HIV (PLHIV) so that stigma & discrimination \\ncould also be reduced \\n\\uf0b7 Safer sexual behaviours can protect both parents  and the baby  \\n \\nScreening for HIV during pregnancy \\n \\nHIV screening is not included in the basic investigation package during pregnancy. Voluntary \\ncounseling and testing method is used to screen pregnant mothers and their partners. The information on \\nHIV and PMTCT is given at the first antenatal class during first trimester.  Facilities for screening for'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='HIV are available at the central STD clinic and all the district STD clinics in the government sector.  \\n  \\n\\uf0b7 Explain the woman that the first blood test is called a screening test. A negative result can \\nmean either that she is not infected with HIV or that she is infected with HIV but, has not \\nyet made adequate levels of antibodies against the virus (“window period”). All positive  \\n \\n\\uf0b7 screening tests in Sri Lanka are tested with a confirmatory test. If this confirmatory test is \\npositive, it means that the woman is infected with HIV.   \\n\\uf0b7 The result of the screening test would be available depending on the test that is done. The \\nresult will be available immediately if a rapid test is done. If an ELISA test is done, it will \\ntake about a week for the result.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='take about a week for the result. \\n\\uf0b7 Assure the woman that her test result is confidential and will be shared only with her. \\n \\nAsk her to come in 2 weeks time to get the test result. Test result should be given only to the relevant \\nperson.Do not convey any test result over the phone. \\n \\nWhen a woman request for HIV testing,  the field health staff could ;  \\n\\uf0b7 Refer the pregnant mother to the nearest STD clinic if she agrees. (provide the address) or  \\n\\uf0b7 If the mother does not want to go to the STD clinic then draw a sample of blood, label it \\ncorrectly and send to the nearest STD clinic with a pathology request form.  It would be \\nuseful if the STD clinic is informed.  \\n \\nWhen screening test result is negative:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='useful if the STD clinic is informed.  \\n \\nWhen screening test result is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n\\uf0b7 Explain that a negative result can mean either that she is not infected with HIV or that she is \\ninfected with HIV but, has not yet made adequate levels of antibodies against the virus (“window \\nperiod”)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n119 \\n \\n \\nWhen the screening test is positive: \\n\\uf0b7 She should be subjected to a detail one- to- one counseling session prior to the confirmatory test  \\n\\uf0b7 Pre-test counseling will be done by a MOH/MO  if he/she has the capacity to do so   \\n\\uf0b7 Select a suitable place where the counselling session could be carried out  maintaining privacy  \\n\\uf0b7 Discuss the HIV results when the woman is alone or with the person of her choice. \\n\\uf0b7 State test results in a neutral tone. Give the woman adequate time to express her emotions. \\n\\uf0b7 Explain to the woman that this is only a screening test and now  the confirmatory test has to be \\ndone with her consent.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='done with her consent.  \\n\\uf0b7 For the confirmatory test, a second sample has to be taken and explain this to her. Then with her \\nconsent draw the second sample and label it carefully and send it to NSACP-reference \\nLaboratory with the request form H 1214.  \\n\\uf0b7 Stress and explain to her that only if the confirmatory test is positive, there is evidence that she is \\ninfected with HIV. \\n\\uf0b7 Inform her that if she is positive, there are several interventions including medications, safe \\ndelivery and feeding practices which are able to reduce the risk of transmission of HIV to the \\nbaby.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Depending on the situation, it may be useful to discuss the importance of disclosure and partner \\ntesting (see below).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='testing (see below). \\n\\uf0b7 Identify what difficulties or problems the woman foresees and how to deal with them  \\n\\uf0b7 Encourage her to ask questions  \\n\\uf0b7 Ask the woman if she has any concerns. \\n \\nWhen the confirmatory test results is negative: \\n\\uf0b7 Counsel on the importance of staying negative by safer sex including use of condoms. \\n \\nWhen the confirmatory test result is positive: \\n\\uf0b7 Explain to the woman that a positive test results means that she is carrying the infection. \\n\\uf0b7 Reinforce that there are medications and other interventions to reduce the risk of transmission to \\nthe baby \\n\\uf0b7 Inform that she will be managed by a team of health care workers including obstetricians, \\nvenereologists, paediatricians etc.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='venereologists, paediatricians etc.  \\n\\uf0b7 Inform her that support and counseling is available if needed to cope on living with HIV. \\n\\uf0b7 Reinforce the importance of disclosure and partner testing (see below). \\n\\uf0b7  Give her an opportunity to discuss her concerns and doubts. \\n\\uf0b7 Be sensitive regarding her special concerns and fears \\n\\uf0b7 She may need more than one post test counseling sessions.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n120 \\n \\n\\uf0b7 There are several issues to be addressed when counselling a pregnant woman in addition to the \\ngeneral issues related to HIV. There will be concerns about risk of MTCT and the impact of HIV \\non the outcome of pregnancy, future fertility etc. Therefore, it is best that arrangements are made \\nto refer the mother (if she agrees) to the closest STD clinic for further counselling.  \\n \\nDiscuss the confidentiality of HIV infection \\n\\uf0b7 Assure the woman that the test result is confidential and will be shared only with her. \\n\\uf0b7 Ensure all records are confidential and kept locked away and only health care workers taking \\ncare of her have access to the records.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='care of her have access to the records. \\n\\uf0b7 Do not label records as HIV positive. HIV positivity may be identified using a code. \\n\\uf0b7 Inform the woman that referral to the STD clinic is important as further counselling, assessment \\nand medication will be initiated there  \\n \\nBenefits of disclosure and testing the male partner \\nEncourage the woman to disclose the HIV testing results to her husband or another person she trusts. By \\ndisclosing her HIV status to her partner and family, the woman may be in a better position to: \\n\\uf0b7 Encourage partner to be tested for HIV \\n\\uf0b7 Prevent the transmission of HIV to her partner if he is not infected. \\n\\uf0b7 If he is infected, to access treatment and care \\n\\uf0b7 Receive support from her partner and family when accessing antenatal care and HIV treatment,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Receive support from her partner and family when accessing antenatal care and HIV treatment, \\ncare and supportive services \\n\\uf0b7 Help to decrease the risk of suspicion and violence. \\n \\nSupport to the HIV positive woman \\nPregnant women who are HIV positive benefit greatly from the following support after the first impact \\nof the test result has been overcome. Therefore take steps to provide the following  \\n\\uf0b7 Empathize with her concerns and fears \\n\\uf0b7 Help her to assess the situation and decide whether to link up with existing support services such \\nas support groups, income generating activities, religious support groups, orphan care and home \\ncare. \\n\\uf0b7 Help her to find ways to involve her husband and/or extended family members in sharing'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='care. \\n\\uf0b7 Help her to find ways to involve her husband and/or extended family members in sharing \\nresponsibility of care and support to her and the baby. If she is willing, help her to identify a \\nperson from the community who will support and care for her and the baby. \\n\\uf0b7 Discuss how to provide care for the other children and help her to identify a person from the \\nextended family or from the community who will support her children. \\n\\uf0b7 Confirm and support information given during HIV testing and counseling eg. appropriate ARV \\ntreatment, safe sex, infant feeding and family planning advice \\n\\uf0b7 Help her to absorb the information and apply it in her own case.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n121 \\n \\n \\n\\uf0b7 If the woman has signs of AIDS and/or other illnesses, refer her to appropriate services. \\n\\uf0b7 Refer individuals or couples for STD services for further support. \\n\\uf0b7 Advice her to get admitted to the hospital as instructed. \\n\\uf0b7 Tell her to take ART medicine as instructed. \\n\\uf0b7 Discuss the infant feeding options \\n\\uf0b7 Counsel her on post partum family planning. \\n \\n \\nPost partum care  \\n \\n\\uf0b7 Be aware of signs of infection following delivery. Like uninfected women, HIV positive women are \\nalso vulnerable to infection following delivery and retained blood and placental tissues. Postpartum \\nuterine infection is a common and potentially life-threatening condition, and early detection and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='uterine infection is a common and potentially life-threatening condition, and early detection and \\neffective treatment are important measures to prevent complications.  \\n\\uf0b7 Monitor for secondary postpartum haemorrhage \\n\\uf0b7 Manage infected tears or episiotomy \\n\\uf0b7 Advice women to come back to the same institution if LSCS wound infection is observed  \\n\\uf0b7 When they are discharged from the healthcare facility women should be advised to return to the \\nclinic or inform the PHM if they notice symptoms such as fever, lower abdominal pain, burning with \\nurination, foul smelling discharge, abnormal bleeding, cough, shortness of breath, calf pain \\n(increasing on walking), diarrhoea, unusual / abnormal behaviour'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='(increasing on walking), diarrhoea, unusual / abnormal behaviour  \\n\\uf0b7 Give the mother information on care of the perineum and breasts. Women living with HIV require \\nspecial care to reduce breast engorgement, mitigate pain and avoid mastitis \\n\\uf0b7 Women who choose to breast feed should be counselled to avoid breast engorgement which could \\nlead to mastitis, since inflammation is associated with increased risk of HIV transmission. She \\nshould be advised to seek  immediate medical care if breast engorgement is associated with fever \\nand pain   \\n\\uf0b7 Instruct her about the safe disposal of lochia and blood-stained sanitary wear or other potential \\ninfectious materials.  \\n\\uf0b7 If contraception has not been discussed before delivery it should be done during the early postpartum \\nperiod (see below).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='period (see below).  \\n \\nCounsel HIV positive woman on family planning \\nAdvice and counsel on family planning during antenatal period and post partum visits. \\nHIV positive women and men should be empowered to take informed choices relating to their \\nreproductive lives, free of coercion. When selecting a family planning method, when only one partner is \\nHIV positive the potential risk of transmitting HIV to the uninfected partner as well as the possibility of \\ninfection with other STI should be taken into account. When both partners are living with HIV, possible \\nre-infection with other HIV strains has to be considered.  \\nThe same contraceptive options which are available to uninfected couples are available to HIV infected'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='couples. Most methods are considered to be safe and effective for HIV infected women.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n122 \\n \\n \\nRecent WHO publications indicate that there are no restrictions on the use of hormonal contraception \\nby HIV positive women who are not on ART.  However, use of OCP containing high dose oestrogen is \\nrecommended when women are on ART. Rifampicin used in tuberculosis treatment may decrease the \\neffectiveness of oral contraceptives.  Long-acting injectables (DMPA) can be safely used in all   HIV \\npositive women including those on ART.     \\nIntra uterine contraceptive devices (IUD) can be used in case of HIV infection, except for women \\nwith AIDS and not on antiretroviral therapy.  \\nFemale sterilization or male sterilization is often the most commonly used family planning method in \\ndeveloping countries.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='developing countries.  \\nEmergency contraception can help to prevent unintended pregnancies. It should not be used as a \\nsubstitute to regular contraception. Women on ART should be given double the normal dose, ie 2 tablets \\nwithin 72 hours and 2 tablets 24 hours later.  \\nProtection against both unintended pregnancy and STI is referred to as “dual protection”. Condoms are \\nthe mainstay of dual protection, alone or in combination with another method.  \\nDuring counselling for a contraceptive plan; \\n\\uf0b7 Encourage the woman to bring her husband for contraception counselling as it is best that they both \\ndecide on a suitable method. \\n\\uf0b7 Discuss their thoughts about having more children. \\n\\uf0b7 Ensure that they have the information they need about their own future prognosis, availability of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='HIV treatment, and risk of transmission of HIV to the baby in future pregnancies.   \\n\\uf0b7 Listen carefully to the couples’ views.  Correct any factual misunderstandings. \\n\\uf0b7 If the husband is HIV negative emphasize the importance of using condoms to protect him from HIV \\ninfection. \\n\\uf0b7 If the husband is HIV positive, explain that although they both have HIV they could become infected \\nwith another strain of HIV and so it is sensible to use condoms to prevent pregnancy and infection. \\n\\uf0b7 Discuss where they could obtain condoms.  Demonstrate how to use condoms correctly.  Let both \\nmembers of the couple handle a condom.  Provide them with condoms and an information leaflet. \\n\\uf0b7 If they have decided that they want no more children, discuss vasectomy and female sterilization.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 If they are uncertain about having more children in future, explain that waiting at least 2 years after \\nthe last birth to become pregnant again is healthiest for mother and child. Discuss the need of a \\nplanned pregnancy.  \\n\\uf0b7 Discuss other temporary methods of contraception. \\n\\uf0b7 Ask the woman if she has had infant feeding counselling and how she is planning to feed her baby.  \\nIf she has not yet been counselled, counsel or refer for counselling. \\n\\uf0b7 Explain that if not breastfeeding, she could get pregnant again as soon as even 4 weeks after \\nchildbirth. It is necessary to consider a family planning method early \\n\\uf0b7 If breastfeeding, explain that exclusive breastfeeding is very important during first six months for the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='health of her child and to prevent pregnancy. During exclusive breastfeeding no mixed feeding is \\nallowed as mixed feeding will increase the risk of transmission of HIV to the baby. Breastfeeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n123 \\n \\n \\nwill provide protection against pregnancy for up to 6 months but only if the mother is breastfeeding \\noften, day and night, and giving no other food or liquids. \\n \\n\\uf0b7 Discuss about ARV and contraception use. Generally, anti-retrovirals and contraceptives do not \\nconflict, however: \\n\\uf0a7 Rifampicin (used for TB treatment) lowers effectiveness of contraceptive pills and \\nimplants. Other antibiotics do not have this problem. \\n\\uf0a7 Some antiretrovirals (protease inhibitors and NNRTIs) may lower effectiveness of \\nhormonal methods. Correct use of the method and use of condoms can make up \\nfor any decrease in contraceptive effectiveness. \\n\\uf0a7 Some women may have other medical conditions that affect choice of a method'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Some women may have other medical conditions that affect choice of a method  \\n\\uf0b7 While breastfeeding non-hormonal methods such as condoms or IUD are suitable. The IUD can be \\ninserted after 6 weeks. \\n\\uf0b7 Progestogen-only methods can also be used while breastfeeding, starting 6 weeks after childbirth \\n(long-acting DMPA injectables, subdermal implants).  \\n\\uf0b7 If not breastfeeding, she can use any method. She can start any  progestogen-only methods \\nimmediately (the mini-pill, long-acting injectables, implants), or the oral combined contraception pill \\nafter 3 weeks.  \\n \\nInfant feeding with HIV \\nCounselling and support for safer infant feeding  \\nInfant feeding practices by mothers known to be HIV infected should support the greatest likelihood of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='HIV free survival of their children and not harm the health of mothers. In order to achieve this, \\nprioritization of prevention of HIV transmission need to be balanced with meeting the nutritional \\nrequirements and protection of infants against non-HIV morbidity and mortality.  \\nInfant feeding in the context of HIV is complex because of the major influence that feeding practices \\nexerts on child survival. The counselor has to balance the risk of infants acquiring HIV through breast \\nmilk with the higher risk of death from causes other than HIV in particular malnutrition and serious \\nillness such as diarrhea among non-breastfed infants.  \\nInfants born to HIV infected mothers may escape HIV during pregnancy and delivery but remain'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Infants born to HIV infected mothers may escape HIV during pregnancy and delivery but remain \\nvulnerable to transmission through breastfeeding. The cumulative risk of postnatal transmission is 12%–\\n16% with 18–24 months of breastfeeding. In the absence of interventions, the overall risk of MTCT of \\nHIV in utero, peripartum and via breast milk is 30-45% with transmission through breast milk \\naccounting for a substantial proportion (30-50%) of these infant HIV infections. The only method \\nknown to completely eliminate breastfeeding associated HIV transmission is to avoid breastfeeding. \\nThis is recommended in settings in which infant replacement feeding is affordable and sustainable, clean \\nwater is widely available, hygiene and sanitation conditions are good and death due to diarrheal and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='other infectious conditions are relatively uncommon.  However, this approach may not be feasible or \\nsafe for a variety of reasons including low acceptability due to cultural norms associated with \\nbreastfeeding.  \\nBreast-feeding by any woman confers known benefits to the infant. Children who do not breast feed are \\nup to six times more likely to die from diarrhea, malnutrition or pneumonia. Breast feeding substantially'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n124 \\n \\n \\nreduces the risk of infant mortality from other infectious diseases and malnutrition on average by 4–6 \\nfolds in the first six months and close to twofold in the second six months of life. The risks of not breast  \\nfeeding range from higher mortality in settings with unpredictable water supply or unsafe sanitation to \\ncompromising confidentiality regarding HIV status.  The combination of potent ART for the mother \\nduring pregnancy and replacement feeding for the infant prevents almost all transmission to infants in \\ndeveloped countries.  \\nFor the first time there is evidence that giving ART prophylaxis to the mother or child throughout the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='breastfeeding period would substantially reduce MTCT. Therefore, mothers known to be HIV infected \\nshould be supported to either: \\n\\uf0b7 Breastfeed and receive ARV interventions or \\n\\uf0b7 Avoid all breastfeeding  \\nAs a strategy that will most likely give infants the greatest chance of HIV free survival and to improve \\nthe health of the HIV infected mother.  \\nThe most appropriate infant feeding option for an HIV positive mother depends on her individual \\ncircumstances, including her health status and the local situation, the health services availability and the \\ncounselling and support she is likely to receive. The expectant mother should be counseled by a \\ncounselor who has adequate knowledge on the safer feeding options that are currently recommended.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='counselor who has adequate knowledge on the safer feeding options that are currently recommended. \\nThis is preferably done by a Venereologist or a Pediatrician who is trained in Lactation Management.  \\nCounsel the mother taking the following into consideration: \\n\\uf0b7 Some babies may escape infection although born to HIV infected mothers. These babies are at \\nrisk of being infected through breastfeeding. At present there are no facilities in Sri Lanka to \\ndiagnose infant HIV infection at birth and 4-6 weeks of age (diagnosis could be confirmed or \\nrefuted only after 18 months of age by the HIV antibody test). \\n\\uf0b7 There is now enough evidence that triple ART given during prenatal period for either as \\nprophylaxis or for mothers own health with safer delivery practices and avoidance of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='prophylaxis or for mothers own health with safer delivery practices and avoidance of \\nbreastfeeding has substantially lowered MTCT of HIV. ART is available for antenatal mothers \\nthrough government health services \\n\\uf0b7 It should be noted that morbidity due to diarrhoea is 7 times higher, and pneumonia 3 times \\nhigher  in formula fed infants, \\n\\uf0b7 Exclusive breast feeding for 6 months have unlimited benefits to any baby and is the \\nrecommendation in Sri Lanka. The health messages given to achieve EFB should not be \\ncompromised by interventions for HIV infected mothers \\n \\n The counsellor should support the mother to decide on how these very specific conditions are met and \\nsupport the mother to decide on the best feeding option for her own baby which is sustainable and safe'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='in her individual socio economic and cultural circumstances.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n125 \\n \\n \\nRecommendations for use of replacement feeding  \\nMothers known to be HIV infected should only give commercial infant formula milk as a replacement \\nfeed to their HIV uninfected infants or infants who are of unknown HIV status, when specific conditions \\nare met:  \\n\\uf0b7 Safe water and sanitation are assured at the house hold level and in the community  \\n\\uf0b7 The mother or other caregiver can reliably provide sufficient infant formula milk to support \\nnormal growth and development of the infant  \\n\\uf0b7 The mother or caregiver can prepare it cleanly and frequently enough so that it is safe and carries \\nno risk of diarrhoea and malnutrition'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='no risk of diarrhoea and malnutrition  \\n\\uf0b7 The mother or caregiver can in the first six months exclusively give infant formula milk and not \\ngive any kind of mixed feeds   \\n\\uf0b7 The family  is supportive of this practice   \\n\\uf0b7 The mother or caregiver can access health care that offers comprehensive child health services \\nFormula fed infants should receive 4-6 weeks of NVP prophylaxis daily or single dose NVP plus 4-6 \\nweeks of zidovudine \\nIf the above conditions cannot be sufficed; and the mother wishes to breast feed then the following is \\nrecommended:  \\nIf breastfeeding is recommended it should be exclusive breastfeeding for 6 months. Breastfeeding \\nshould be stopped only once a nutritionally adequate and safe diet without breast milk can be provided.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='No mixed feeding should be allowed during the first 6 months as mixed feeding increases the risk of \\nHIV transmission. EBF should be followed by continued breastfeeding with addition of complementary \\nfoods through age 12 months with gradual weaning over 1 month.The mother should be covered by \\nART as treatment for her or as prophylaxis. Infant prophylaxis for 4-6 weeks is recommended \\nirrespective of the mode of feeding.   \\nThere are two choices for HIV positive women who breastfeed and are not taking ART for their own \\nhealth.  \\n1) If she receives AZT as prophylaxis,  daily NVP is recommended for the infant from birth until \\none week after  the end of the breastfeeding period ( AZT is not recommended for breast fed \\nbabies)  or'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='babies)  or  \\n2) If a woman received a three drug regimen during pregnancy, she should continue the same \\nregimen until the end of the breastfeeding period. In this situation the infant needs ART only for \\n4-6 weeks.  \\nIf the mother decides to breastfeed it is very important to support the mother to breastfeed. She should \\nbe well trained on proper positioning and attachment of the baby to the breast in order to avoid \\ndifficulties during breastfeeding. A health care worker who is trained on lactation councelling should \\nsupport such a mother.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n126 \\n \\n \\nWhatever the feeding decision, health services should follow-up all HIV-exposed infants, and continue \\nto offer infant feeding counselling and support, particularly at key points when feeding decisions may be \\nreconsidered, such as the time of early infant diagnosis and at six months of age. \\nWhere mother and infant are both HIV positive, breastfeeding should be encouraged for at least the first \\ntwo years of life in line with recommendations for the general population. The message to health care \\nworkers is that breastfeeding is the best for every baby, even those born to HIV positive mothers \\nwhen they have access to ART.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='when they have access to ART.  \\nA pregnant woman living with HIV needs help to decide how to feed her baby. In a counselling session \\non HIV and infant feeding the counsellor has three main tasks: \\no to convey  information \\no to help a mother to assess the risks for her baby in her own situation \\no to give the mother confidence in her choices \\nDuring counselling the idea of weighing up risks can be difficult for a woman to understand.  Her choice \\nis not a simple one of deciding whether   to breast feed or not. Her decision will be influenced by many \\nfactors. It is therefore important that the woman makes the decision and not the counsellor. It is \\nimportant that the counsellor have adequate up to date evidence based knowledge to convey correct   \\ninformation.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='information.  \\nA woman does not need to make all decisions about how she will feed her baby at the first counselling \\nsession. While she is pregnant she needs to decide whether she will breastfeed at all or not. But she does \\nnot need to decide when she will stop breastfeeding until later. She does not need information about safe \\nweaning foods until the baby is older. However these points should be mentioned so that she \\nunderstands that they are important points to ask about later'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n127 \\n \\n. \\nChapter 18 \\nELIMINATION OF CONGENITAL SYPHILIS \\nSexually transmitted infections (STI) are one of the commonest communicable diseases found in the \\nworld today. Primarily they are transmitted through unprotected sexual intercourse. Transmission can \\nalso occur through contaminated blood and blood products and from an infected untreated mother to \\nchild during pregnancy, child birth or via breast milk. \\nSyphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It is estimated \\nthat globally about 12 million cases of syphilis occur annually and of them about 2 million are among \\npregnant women. If a woman with untreated syphilis becomes pregnant, or a woman acquires syphilis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='pregnant women. If a woman with untreated syphilis becomes pregnant, or a woman acquires syphilis \\nduring pregnancy, depending on the stage of syphilis, the infection can be transmitted to the foetus \\ncausing adverse pregnancy outcomes including congenital syphilis. Although estimated vary, adverse \\npregnancy outcomes occur in up to 80% of women with acute syphilis including still birth (40%), peri \\nnatal death (20%) and serious neonatal infection (20%). Such outcomes are 12 times more likely in \\nwomen with syphilis than in sero-negative women. Early congenital is defined as syphilis from birth and \\nwithin two years of life. Late congenital syphilis is when vertically acquired infection manifests from \\nthird year of life onwards.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='third year of life onwards. \\nUnlike many neonatal infections, congenital syphilis (CS) can be effectively prevented, either through \\nprevention of maternal infection or by detection of infection early in pregnancy and provision of \\nadequate treatment. Control of sexually transmitted infections in the community by promoting safer sex, \\nincreasing awareness about syphilis and its adverse effects on mother and infant could also help prevent \\nmaternal infection. Universal screening for syphilis during pregnancy, treatment of infected pregnant \\nwomen, their partners and treatment of infants born to sero-positive woman are shown to be cost \\neffective, inexpensive and feasible in the prevention of congenital syphilis. Preventing even an'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='effective, inexpensive and feasible in the prevention of congenital syphilis. Preventing even an \\noccasional case is economically worthwhile. Economic analyses have shown that serological screening \\nof pregnant woman is cost effective even at very low prevalence of maternal infection. The cost of \\naverting a case of CS is much lower than for other diseases. Yet in this era of concern about the number \\nof babies who are born with HIV infection, congenital syphilis receives scant attention. \\nMaternal Syphilis \\nThe causative bacterium Treponema pallidumcan be transmitted via blood of an infected mother to her \\ndeveloping foetus through the placenta. Haematogenous spread is dependent upon the occurrence of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='developing foetus through the placenta. Haematogenous spread is dependent upon the occurrence of \\nmaternal spirochaetaemia. The spirochetes can cross the placenta at any time during pregnancy although \\noccurs more commonly in the last two trimesters.  \\nThe risk of congenital infection is directly related to the stage of maternal syphilis during pregnancy and \\nthe stage of pregnancy when infection is acquired. The risk of infection to the foetus is much higher \\nduring early stages of syphilis than during late stages. The more recent the maternal infection, the more'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n128 \\n \\nlikely the foetus will be affected since the early stage of syphilis is characterized by high levels of \\nspirochaetaemia. The probability of transmission to the foetus is nearly 100% when the mother has early \\nsyphilis. The spirochaetaemia diminishes over time and two years after acquisition of syphilis the \\nprobability of transmission to a fetus can take place up to four years after the acquisition of infection by \\nthe mother. \\nClinical manifestation of syphilis in the mother will depend on the stage of syphilis at the time of \\npregnancy. If the mother becomes infected late in pregnancy she may show no signs of before delivery \\nand the infected newborn may also appear normal at birth.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='and the infected newborn may also appear normal at birth. \\nThere are two general scenarios that need to be considered when assessing the risk of congenital \\nsyphilis. \\n1. An untreated woman becoming pregnant \\n2. A woman becoming infected during pregnancy. \\nThe latter tends to be associated with overall severe outcomes for the infant as it always involves the \\nearly spirochetemic stages of the disease in which the likelihood of transmission to the fetus is high. \\n \\nDiagnosis of maternal syphilis \\nTraditionally laboratory diagnosis in adults is based on initial use of a non-treponemal screening test. \\nThese tests detect antibody to regain antigen, which is found in both Treponema pallidum and some'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='These tests detect antibody to regain antigen, which is found in both Treponema pallidum and some \\nhuman tissues. They are thus not specific for Treponema pallidum and could give false positive results. \\nExamples include the venereal disease Research laboratory (VDRL) test. If a non-treponemal test is \\npositive it should be confirmed by a treponemal test using an antigen of Treponema pallidum, examples \\ninclude the Treponema pallidum haemagglutination assay (TPHA) and the Treponema pallidum particle \\nagglutination assay (TPPA). Syphilis is diagnosed when the confirmatory treponemal test is positive. \\nWhen a non treponemal test is positive in the absence of a reactive treponemal test is called a biological'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='false positive test. The non treponemal test becomes positive sometimes due to technical errors or due to \\ncertain physiological or pathological conditions. Acute false positive tests are found in persons suffering \\nfrom many viral and bacterial infections or who have had certain vaccinations or immunizations. \\nChronic false positives are found in the presence of autoimmune conditions, tuberculosis, leprosy or \\nmalaria. False positives are also found during pregnancy or even without a specific cause or a pre \\nexisting disease. Therefore a positive non-treponemal test should be confirmed by a specific treponemal \\nserological test to arrive at a diagnosis of syphilis \\nThe non treponemal tests have the advantages of being inexpensive and sensitive (especially in early \\ninfection.).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='infection.).  \\nHowever, these tests cannot be done on whole blood, they require a microscope or rotator for \\nprocessing, and misinterpretation is common by inexperienced laboratory technicians because reading of \\nthe result is subjective.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n129 \\n \\n \\nTreponemal tests, while theoretically more specific than non-treponemal tests may also give false \\npositive results. Moreover, they cannot differentiate between individuals with active (untreated syphilis) \\nand those who have previously been successfully treated for infection. In both cases, the treponemal test \\nresult will be positive. Non treponemal tests, on other hand, can distinguish current or recent infections \\nfrom old, treated infections to a certain extent based on titre levels. \\nFor the diagnosis of syphilis, a combination of the two tests is recommended. Traditional confirmatory \\nassays require expensive laboratory equipment and technical expertise, and are therefore seldom'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='assays require expensive laboratory equipment and technical expertise, and are therefore seldom \\navailable outside reference laboratories. However, these can now be replaced by simple, rapid, point- of- \\ncare treponemal tests which use whole blood, require minimal training, no equipment or special storage \\nconditions. \\nRapid simple treponemal tests using immunochromatographic strips (ICS) which use whole blood, do \\nnot need equipment or special storage conditions and require minimal training are now available and can \\nbe used on the site including peripheral areas. Sensitivity (85- 98%0) and specificity (92-98%) of these \\ntests are high. The new rapid test has been estimated to cost U$ 7 per each case of congenital syphilis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='averted. The affordability, convenience and practicality of rapid tests make them attractive tools, as on-\\nsite screening tests in primary care settings or in areas where laboratory services are not available. \\nHow ever since treponemal antibodies persist for years irrespective of treatment, a positive test will not \\nhelp in distinguishing active infection from past treated infection. Treponemal tests cannot be used to \\nmonitor effectiveness of treatment. \\nIn the event the ICS becomes positive, a second sample should be drawn from the mother and sent to \\nSTD clinic for re-confirmation or refer the mother to the STD clinic as early as possible \\nCase Definition of a mother with syphilis- \\nA pregnant mother with serologic evidence of syphilis (positive TPPA test) in the current pregnancy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='with or without symptoms of syphilis. A woman who has documentary evidence of having been \\nadequately treated in the past and in whom re-infected during the current pregnancy is ruled out is \\nexcluded from this case definition. \\nTreatment of maternal syphilis \\nSyphilis in adults is easily cured. If not treated in its early stages, the disease can become chronic, often \\nwith a long latent period with some clinically recognizable stages. In pregnancy, however, early \\ntreatment with penicillin is required for successful pregnancy outcomes. Treatment should be provided \\nearly in gestation before significant fetal involvement take place. Treating the mother with penicillin \\nduring the first and second trimester will prevent major outcomes, but later treatment or lack of'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='during the first and second trimester will prevent major outcomes, but later treatment or lack of \\ntreatment may result in fetal death, fetal damage or birth of an infected child. Mothers with syphilis \\nshould be preferably treated at STD clinics.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n130 \\n \\n \\nTreatment of primary, secondary and early latent syphilis \\nA single dose of benzathine benzyl penicillin 2.4 million units IM given after excluding allergy. \\nLate latent syphilis: \\nBenzathine benzyl penicillin 2.4 million units IM once a week for consecutive 3 weeks. \\nAdequate penicillin treatment will end infectively within 24-48 hrs. \\nFollow up \\nPregnant mothers treated for early syphilis should have monthly quantitative serologies throughout \\npregnancy  and  will be followed up in the STD clinic . Those who do not show a fourfold drop in titre at \\nthe end of 3 months or who show a 4 fold rise in titre should be re-treated.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the end of 3 months or who show a 4 fold rise in titre should be re-treated. \\nIt is not necessary to retreat mothers who have documented evidence of adequate therapy for previous \\nsyphilis so long as there is no evidence of serologic or clinical evidence of re-infection or relapse. \\nBabies born to such mothers do not require prophylactic penicillin therapy. \\nIf doubts exist about the adequacy of previous therapy, re-treatment should be commenced promptly. \\nAllergy to penicillin \\nWhen patient sensitivity to penicillin precludes its use, erythromycin is recommended as an alternative. \\nIn early syphilis (primary, secondary and early latent) give erythromycin 500mg oral 6 hrly for 15 days. \\nIn late latent syphilis give erythromycin 500mg oral 6 hrly for 30 days. \\nHIV infection'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='In late latent syphilis give erythromycin 500mg oral 6 hrly for 30 days. \\nHIV infection \\nEvidence suggests that treatment for syphilis in pregnant women who are HIV positive should be similar \\nto that given to other pregnant women and follow up should be the same as for adults with HIV \\ninfection. \\nTreatment of partners \\nSexual partners of mothers with primary, secondary, early latent syphilis \\nEpidemiological treatment of sexual contact is mandatory as these stages of syphilis are infectious. \\nTherefore, take necessary steps to counsel and refer to STD clinic. Those with reactive serology will  be \\ntreated according to the stage of syphilis of the partner.  \\nSexual partners of mothers with late latent syphilis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Sexual partners of mothers with late latent syphilis \\nSexual partners should be referred to the STD clinic for assessment. They will be treated according to \\nthe stage of syphilis, if clinical evidence of syphilis is present or if serology is positive.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n131 \\n \\n \\nDiagnosis of congenital syphilis \\nThe diagnosis of congenital syphilis depends on a combination of physical, radiographic, serologic and \\ndirect microscopic evidence. \\nAt birth babies born to mothers with congenital syphilis should be examined thoroughly for physical \\nsigns of congenital syphilis. Serological tests on both the mother and the baby should be done. A sample \\nof fetal blood (5cc) should be sent to the STD clinic together with 5 cc of blood from the mother. Cord \\nblood is not suitable for testing \\nSigns and symptoms \\nAt birth about 50% of babies with congenital syphilis may be asymptomatic. Usually symptoms appear'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='At birth about 50% of babies with congenital syphilis may be asymptomatic. Usually symptoms appear \\nin the first months but the clinical manifestations may be delayed until the second year of life. The most \\nfrequent clinical signs at birth are hapatomegaly with or without splenomegaly (33-100%), blistering \\nskin rash (40%), and bone changes seen on x-ray (75-100%). Other early signs are pseudoparesis (12-\\n36%), bleeding (100%), fever (16%), low birth weight (10-40%), swelling of joints, oedema, abdominal \\ndistension, pallor and respiratory distress. None of these signs are pathognomonic of syphilis and are \\nseen in other congenital infections. \\nInvestigations \\nDark field microscopy \\nA definitive diagnosis of syphilis is made by demonstrating the presence of Treponema pallidum by'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='A definitive diagnosis of syphilis is made by demonstrating the presence of Treponema pallidum by \\ndark ground microscopy on any suspicious lesions or body fluid eg: nasal discharge, skin rash. However, \\nthis procedure is cumbersome and not always possible. \\nSerology \\nThe diagnosis of congenital syphilis is complicated by passive transfer of maternal non treponemal and \\ntreponemal IgG antibodies to the foetus. The presence of these maternal antibodies makes the \\ninterpretation of reactive serological tests for syphilis in infants difficult. When a positive test for an \\ninfant is due to passively transmitted maternal antibodies they would be catabolized and undetectable in \\nnon-infected infants by 6 months of age.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='non-infected infants by 6 months of age. \\nInfants born to mothers with positive serologic tests for syphilis should be evaluated by a quantitative \\nnon-treponemal serologic test at birth. It is necessary to compare the infant’s titre with maternal \\nserologic titre using the same test. A fourfold higher titre in the infants is accepted as significant. Serum \\nfrom the neonate is the preferred specimen, since cord blood may produce false-positive results. \\nThe detection of Immunoglobulin M (IgM) in infant’s serum also indicates active infection because \\nmaternal IgM antibodies do not cross the placenta. IgM antibodies can be detected in more than 80% of \\nsymptomatic infants but data on its sensitivity for asymptomatic infants are limited. Because IgM'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='symptomatic infants but data on its sensitivity for asymptomatic infants are limited. Because IgM \\nresponses take time to develop in infants and may be diminished with early treatment or inadequate \\ntreatment. A negative IgM result should not be used to exclude congenital syphilis. False positives also \\ncould occur.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n132 \\n \\n \\nSerologic evidence of congenital syphilis \\n\\uf0b7 Serum quantitative non treponemal serologic titre (VDRL titre) that is fourfold higher \\nthan the mother’s titre at the time of delivery   or \\n\\uf0b7 Presence of IgM antibodies in the infant (EIA test) or \\n\\uf0b7 Rising non treponemal antibodies in infant’s serum \\n \\nPresence of non treponemal antibodies due to other causes other than syphilis in the pregnant mother \\nwill also cross the placenta to produce a reactive serologic test which is of a false positive nature in the \\nnewborn. The titre usually reverts to non reactive by 3 months of life. \\nTreatment of infants \\nTreatment decisions must be made on the basis of: \\n1. Identification of syphilis in the mother,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Treatment decisions must be made on the basis of: \\n1. Identification of syphilis in the mother, \\n2. Adequacy of maternal treatment \\n3. Presence of clinical, laboratory or radiological evidence of syphilis in infants \\n4. Comparison of maternal (at delivery) and infant non-treponemal serologic titres \\nAll asymptomatic babies who have no serological evidence of syphilis and are born to mothers who \\nwere adequately treated for maternal syphilis with penicillin during the current pregnancy before 4 \\nweeks of delivery according to guidelines should be treated with a single dose of prophylactic penicillin. \\nIM prophylactic treatment regimen \\nBenzathine benzyl penicillin G 50,000 units/kg as a single intra muscular injection. \\n \\nIV treatment regimen'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='IV treatment regimen \\nAqueous crystalline benzyl penicillin G 100,000 – 150,000 million units/kg/day intravenously. It could \\nbe given as 50,000 units/kg/dose IV every 12 hrs during the first 7 days of life and thereafter every 8 hrs \\nfor 3 days to complete a total of 10 days treatment. \\nThis should be given to: \\n1. All symptomatic babies \\n2. All asymptomatic babies \\ni. \\nWhose VDRL titre is a 4 fold higher than that of the mother at delivery \\nii. \\nHaving a rising non-treponemal titre \\niii. \\nWith a reactive syphilis specific IgM antibody test \\niv. \\nBorn to mothers with clinical evidence of syphilis \\nv. \\nBorn to mothers who were treated with penicillin <4 weeks before delivery, \\nvi. \\nBorn to mothers who did not complete the recommended course of penicillin during \\npregnancy \\nvii.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Born to mothers who did not complete the recommended course of penicillin during \\npregnancy \\nvii. \\nBorn to mothers whose non treponemal high titre had not dropped four fold at the \\ntime of delivery \\nviii. \\nBorn to mothers who were treated with non penicillin regimens (erythromycin0 \\nduring pregnancy \\nix. \\nBorn to mothers whose treatment status is unknown or undocumented'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n133 \\n \\n \\nSteps in syphilis screening and management of pregnant women \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPregnant women present to the \\nantenatal clinic \\nScreen for syphilis with  \\nNon-treponemal test (VDRL) \\nScreen for syphilis with on-site rapid \\nICS test \\n\\uf0b7 \\nNo treatment required \\n\\uf0b7 \\nPromote safer sex practices \\nPositive result\\nNegative result\\nRefer to STD clinic for\\n\\uf0b7 \\nConfirmation of syphilis by treponemal test – TPPA \\n\\uf0b7 \\nTreat mother \\n\\uf0b7 \\nCounsel for partner notification, treat partner \\n\\uf0b7 \\nCounsel for HIV test \\n\\uf0b7 \\nScreen for other STI \\n\\uf0b7 \\nPrepare a plan for management of baby and followup \\nTreatment of baby \\n\\uf0b7 \\nIV penicillin regimen \\n\\uf0b7 \\nIM prophylactic penicillin regimen'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n134 \\n \\n \\nProtocol for antenatal testing for syphilis in the government health system \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nCollect blood from mother (filed clinic, hospitalclinic)\\nSend blood to NSACP/nearest STD clinic/testing institution\\nVDRL test positive. All positives should be confirmed \\nby the specific test (TPPA) and  the laboratory/Mo-IC \\nof STD clinic should inform the positive test results to \\nthe relevant MOH immediately. When a BFP is \\ndetected the MOH should be informed that it is not \\nsyphilis. Hard copy of the positive test results/ BFP \\nshould be sent there after \\nVDRL/TPPA test reports should be \\ncollected by the relevant MOH from \\nthe testing center \\nAll VDRL negative test results'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='collected by the relevant MOH from \\nthe testing center \\nAll VDRL negative test results \\nshould be entered in pregnancy \\nrecord (H 512 A& B) with the POA \\nby PHM. Sero negative mothers \\nshould be informed that they are \\nfree of syphilis. BFP results and \\nTPPA positive result should be \\nentered by MOH.  Confidentiality \\nof all information should be \\nmaintained   \\nMOH will inform the PHM to trace the respective \\nmother. The mother should be given a referral letter to \\nvisit the STD clinic. Confidentiality should be \\nmaintained. \\nWhen the mother attends the STD clinic a second \\nsample should be collected for re-confirmation after \\ncounseling. When a 2nd sample is positive the mother \\nwill be informed of the diagnosis and a file should be \\nopened\\n1. Detail history + clinical assessment and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='opened\\n1. Detail history + clinical assessment and \\ndetermine the stage of syphilis, whether the \\nmother was treated in the past or this is a new \\ninfection during the current pregnancy \\n2. Screen for other STI \\n3. Treat according to the stage of syphilis  \\n4. Screen spouse/partner and give epidemiological  \\ntreatment/Rx \\n5. Counsel on safer sex \\n6. Promote HIV testing of mother and partner \\n7. Follow up \\n8. Make arrangements for management of baby \\n(Prophylaxis \\npenicillin \\nor \\nIV \\npenicillin \\nregimen) \\n9. Baby should be followed up in the STD clinic \\nat 3,6 and 12 months'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n135 \\n \\n \\nChapter 19 \\nSYNDROMIC MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS \\nDURING PREGNANCY \\nIdentifying the syndromes \\nSyndrome \\nSymptoms \\nSigns \\nMost common causes \\nVaginal discharge\\nUnusual vaginal \\ndischarge \\nVaginal itching \\nDysuria (pain on \\nurination) \\nDyspareunia (pain \\nduring sexual \\nintercourse) \\nAbnormal vaginal \\ndischarge (Foul \\nsmelling /grey \\n/yellowish discharge) \\nEvidence of cervicitis  \\n- \\nErythema \\n- \\nOedema \\n- \\nInduced \\nbleeding \\n- \\nHypertrophic \\nectopy \\nVAGINITIS:\\n\\uf0b7 Trichomoniasis \\n\\uf0b7 Candidiasis \\n\\uf0b7 Bacterial vaginosis \\nCERVICITIS: \\n\\uf0b7 Gonorrhoea \\n\\uf0b7 Chlamydia \\nGenital ulcers \\nGenital sore \\nGenital ulcer \\nEnlarged inguinal \\nlymph nodes \\nSyphilis \\nChancroid \\nGenital herpes \\nLower abdominal \\npain \\nLower abdominal'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='lymph nodes \\nSyphilis \\nChancroid \\nGenital herpes \\nLower abdominal \\npain \\nLower abdominal \\npain \\nDyspareunia \\nVaginal discharge \\nRebound tenderness  \\nAdenexial tenderness \\nPain on moving cervix  \\nTemperature 38c or \\nhigher \\nGonorrhoea \\nChlamydia \\nMixed anaerobe infections \\nOphthalmia \\nneonatorum \\nSwollen eye lids \\nEye discharge \\nBaby cannot open \\neyes \\nOedema of the eye lids \\nPurulent eye discharge \\nGonorrhoea \\nChlamydia'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n136 \\n \\n \\nVaginal discharge syndrome \\nVaginal discharge in pregnancy may mask signs of abortion complications, rupture of membranes or \\npostpartum infection. If there is no evidence of blood or amniotic fluid, treatment should be given to \\ncover candidiasis, trichomoniasis and bacterial vaginosis. \\nVaginal discharge is due to pathological cause they have either vaginitis or cervicitis or both. Vaginitis \\nis caused by trichomoniasis, candidiasis and bacterial vaginosis whereas cervicitis is causd by \\nGonorrhoea and Chlamydia.  \\nIt is normal for women to have a vaginal discharge during pregnancy. However if the vaginal discharge'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='with foul smelling, thick and purulent with yellow discolouration, associated with genital ulcer, it could \\nbe due to a pathological cause and therefore it is useful to exclude the presence of a STI. \\n \\n                        \\nVaginitis \\nCervicitis \\n \\n\\uf0b7 Caused by trichomoniasis, candidiasis or \\nbacterial vaginosis      \\n \\n\\uf0b7 Complications are less   \\n \\n \\n\\uf0b7  Need to treat the sexual partner \\n                                                                       \\n\\uf0b7 Caused by gonorrhoea or chlamidia or \\nboth \\n \\n\\uf0b7 If untreated will result in complications to \\nthe mother and neonatal conjunctivitis of \\nthe baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n137 \\n \\n \\nManagement of vaginal discharge- speculum examination is not available \\n \\n \\n \\n \\n \\n \\n \\n \\nYes \\n \\n                                                                  No \\n \\n \\n \\n \\nHistory and examination\\nLower abdominal pain and \\ntenderness \\n       Patient c/o vaginal discharge\\nProfuse \\ndischarge at \\nintroitus/ \\noffensive\\nNo discharge \\nbut risk \\nassessment+ \\nGyn or STD \\nclinic \\nCurdy \\ndischarge at \\nintroitus \\n- \\nTreat for candidiasis\\n- \\nCounsel \\n- \\nScreen for Diabetes \\n- \\nFollow up \\n- \\nTreat for cervicitis & vaginitis\\n- \\nCounsel \\n- \\nPromote provide condoms \\n- \\nPartner treatment \\nAvoid sex until cured and partner treated \\nImproved by 14 days \\nReassure \\nRefer to STD \\nclinic \\nRisk Assessment\\n1. Symptomatic partner'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Improved by 14 days \\nReassure \\nRefer to STD \\nclinic \\nRisk Assessment\\n1. Symptomatic partner \\n2. Recent new sexual partner \\n3. Multiple sexual partner \\n4. Spouse returning after a long stay away'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n138 \\n \\n \\nManagement of vaginal discharge- speculum available \\n \\n \\n \\n \\n \\n \\n \\n \\nTreatment for Vaginitis \\nIncludes treatment for trichomoniasis, candidiasis and bacterial vaginosis \\nRecommended therapy for trichomoniasis and bacterial vaginosis: \\n\\uf0b7 Metronidazole 400 mg given orally twice daily for 7 days is effective \\nNote: Do not prescribe Metronidazole in the first trimester of pregnancy. \\n \\nPatient c/o vaginal discharge \\nHistory and speculum \\nexamination \\nLower abdominal pain+\\nGyn or STD clinic\\nCheese like discharge in \\nthe vagina\\nEvidence of cervicitis\\n\\uf0d8 cervical \\nerythematous/ \\ncervical oedema \\n\\uf0d8 mucopurulent \\ndischarge \\n\\uf0d8 hypertrophic ectopy \\nThick adherent \\noffensive vaginal \\ndischarge \\nRisk \\nassessment \\nTreat for candida'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Thick adherent \\noffensive vaginal \\ndischarge \\nRisk \\nassessment \\nTreat for candida \\nTreat for bacterial \\nvaginosis & \\ntricomonas vaginalis \\nTreat for cervicitis and vaginitis'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n139 \\n \\n \\nTreat the patient’s partner for trichomoniasis with Metronidazole 2g as a single oral dose or \\nMetronidazole 400mg twice a day for 7 days \\nTreatment for vaginal candidiasis \\nNystatin 100000 units (one pressary), inserted intravaginally, once a day at night for 14 days, or \\nMiconazole or Clotrimazole 200mg, inserted into the vagina once a day at night for three days or  \\nClotrimazole 500mg, inserted into the vagina once only at night \\n(Advise the patient to take the complete course of tablets) \\nTreatment for cervicitis \\nRecommended therapy for Gonacoccal cervicitis: \\nCefuroxime Axetil 1g + Probenecid 1g orally as a single dose, or Ceftriaxone 250mg by intramuscular \\ninjection in a single dose'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='injection in a single dose \\nRecommended therapy for chlamydial cervicitis: \\nErythromycin 500mg orally 4 times a day for 7 days ( Preferred treatment is doxycycline 100mg bd for \\n7 days but doxycycline is contraindicated in pregnancy) \\nSexual partners should be treated for gonorrhoea and chlamydia infection. It is preferable to refer to a \\nSTD clinic.  \\n \\nLower abdominal pain syndrome \\nAll sexually active women presenting with lower abdominal pain should be carefully evaluated for signs \\nof pelvic inflammatory disease. Symptoms suggestive of PID include lower abdominal pain, pain on \\nintercourse (dysparunea), bleeding after sex or between periods, and pain associated with periods (if this'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='is a new symptom). Vaginal discharge, pain on urination (dysuria), fever, nausea and vomiting may also \\nbe present. \\nWhen a woman complaints of lower abdominal pain and has missed a menstrual period or a period is \\noverdue, an ectopic pregnancy has to be excluded since it is an obstetric emergency. \\nManagement of lower abdominal pain during pregnancy \\nTreatment for PID \\nCeftriaxone 250mg intra muscular injection in a single dose \\nTreatment of chlamydia infection \\nErythromycin 500mg orally 4 times a day for 14 days, \\nTreatment for anaerobic bacterial infection \\nMetronidazole 400mg orally twice daily for 14 days \\nNote:  Metronidazole should not be used in the first trimester of pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n140 \\n \\n \\nPartner management \\nThe partner has to be treated for gonorrhoea, Chlamydia and mixed anaerobic infections. It is preferable \\nto refer the patient to STD clinic. \\n \\nYes \\nRefer patient for urgent \\nsurgical or \\ngynaecological opinion \\nManage for PID & \\nReview in 3 days \\nImproved\\nYes \\nNO\\nPatient complaints of lower abdominal pain\\nHistory and examination\\nNO\\nAbdomial  \\ntenderness/ vaginal \\ndischarge/ adenexial \\nswelling/ adenexial \\ntenderness/ cervical \\nexcitation \\nYes \\nAny of the following present?\\n\\uf0d8 Missed /overdue period \\n\\uf0d8 Recent delivery/ abortion/ miscarriage \\n\\uf0d8 Abdominal  guarding and /or rebound \\ntenderness \\n\\uf0d8 Abnormal vaginal bleeding \\n\\uf0d8 Abdominal mass \\n\\uf0d8 Fever > 38c \\nReassure\\nRefer\\nContinue treatment until completed'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0d8 Abdominal mass \\n\\uf0d8 Fever > 38c \\nReassure\\nRefer\\nContinue treatment until completed\\n\\uf0d8 Educate and counsel \\n\\uf0d8 Promote condom use and provide \\ncondoms \\n\\uf0d8 Treat partner \\n\\uf0d8 Ask patient to return if necessary \\nNO'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n141 \\n \\n \\nGenital Ulcer Syndrome \\nGenital Herpes, Chanchroid and syphilis are the most common.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n142 \\n \\n \\nRecommended therapy for syphilis (Primary Chancre) \\nBenzathine penicillin 2.4 million units by single intramuscular injection (Because of the large volume of \\nthe dose, give it as two injections at separate sites.) \\nFor patients who are allergic to penicillin: \\n Doxycycline 100mg orally twice a day for 15 days, or Tetracycline 500mg Orally 4 times daily for 15 \\ndays \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used during pregnancy or lactation \\nIn pregnancy and lactation use: \\nErythromycin 500mg orally four times a day for 15 days \\n\\uf0b7 All babies born to mothers treated for genital ulcers suggestive of syphilis must be treated with'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Benzathine penicillin 50,000 IU/KG IM or should be referred to a STD clinic for evaluation \\n\\uf0b7 If a baby has signs and symptoms suggestive of congenital syphilis refer to a STD clinic \\n/Peadiatric unit. \\n\\uf0b7 All babies born to mothers treated for GUD syndrome should also be reviewed for symptoms \\nand signs of Neonatal Herpes or referred to a STD clinc. \\n\\uf0b7 Mothers treated for GUD syndrome should be referred to a STD clinic for further evaluation. \\nRecommended therapy for Chancroid: \\n\\uf0b7 Erythromycin 500mg orally four times  a day for seven days \\nAlternatively the following may be used: \\n\\uf0b7 Ciprofloxacin 500mg single oral dose or \\n\\uf0b7  Cotrimoxazole 960mg (2 tablets) orally twice daily for 7 days \\nNote: Ciprofloxacin should not be used during pregnancy \\nRecommended therapy for genital herpes;'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Note: Ciprofloxacin should not be used during pregnancy \\nRecommended therapy for genital herpes; \\nAcyclovir 200mg orally 5 times a day for 5 days. Advice the patient to keep the ulcers clean by washing \\nwith a weak solution of salt water \\nAdvice the patient to take all the tablets and inform him or her about mode of transmission of STD and \\npossible complications of infection and recurrences.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n143 \\n \\n \\nOphthalmia neonatorum syndrome \\nOphthalmia Neonatorum is the term used to describe a condition where a neonate develops purulent \\nconjunctivitis in one or both eyes within four weeks of birth. It is a medical emergency and unless \\ntreatment is initiated within 24 hours, there could be permanent damage to eyes leading to blindness. It \\nrequires systemic therapy as well as local irrigation with saline or other appropriate solutions. Irrigation \\nis particularly important when recommended therapeutic regimens are not available.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n144 \\n \\n  \\nFor the baby, the treatment for gonococcal ophthalmiais: \\nCeftriaxone 50mg/kg (maximum 125mg) in a single IM dose  \\nWhere Ceftriaxone is not available, use: \\nSpectinomycin 25mg/kg ( maximum 75mg) in a single IM dose \\nTreatment of the baby for Chlamydia Ophthalmia: \\nErythromycin syrup 50mg/kg/day orally four times a day for 14 days \\nClean the baby’s eyes with saline, using a clean swab for each eye. Remember to clean from inside to \\nthe outside edge of each eye. Wash your hands carefully afterwards. \\nTreatment of mother and the father: \\nShould be given treatment for both gonorrhoea and Chlamydia infection. \\nRecommended therapy for Gonorrhoea:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Recommended therapy for Gonorrhoea: \\nCefuroxime axetil 1g orally + Probenecid 1g in a single oral dose or Ceftriaxone 250mg IM in a single \\ndose \\nAlternative therapy \\nCiprofloxacin 500mg orally as a single dose, or  Spectinomycin 2g by intramuscular injection in a single \\ndose PLUS \\nRecommended therapy for Chlamydial infection: \\nDoxycycline 100mg orally twice a day for 7 days or Tetracycline 500mg orally 4 times a day for 7 days \\nNote: Ciprofloxacin, doxycycline and tetracycline should not be used by lactating women. \\nWhere tetracyclines are not recommended give:  \\nErythromycin500mg orally, four times daily for seven days \\nAdvice mother to complete the course of tablets and educate her about the mode of transmission of STD,'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the nature of the baby’s infection, how to clean the baby’s eyes and possible \\ncomplications of infection. Counsel her and promote the use of condoms. \\n \\nPrevention of Gonococcal ophthalmia \\nOphthalmia neonatorum can be prevented by using timely eye prophylaxis. \\nThe infant’s eye should be carefully cleaned immediately after birth with normal saline. \\nIf available apply 1% tetracycline ointment to the eyes of every infant at the time of delivery. This is \\nstrongly recommended prophylactic measure.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n145 \\n \\n \\nChapter 20 \\nNATIONAL GUIDELINES FOR PREVENTION AND MANAGEMENT OF  \\nMALARIA IN PREGNANCY \\n \\n1. Screening \\nAll pregnant women residing in malaria endemic areas should be screened for malaria parasitaemia at \\nthe time of registration in the antenatal clinic and at the end of the second trimester. The screening \\nshould be done by examining thick and thin blood smears using a finger prick sample of blood. \\n2. Chemoprophylaxis \\nDue to the low incidence of malaria in the country, chemoprophylaxis is not advocated as a policy. \\nHowever, in circumstances where the pregnant women could be considered at risk of acquiring malaria ( \\nas decided by the relevant Obstetrician or the MOH/MO) chemoprophylaxis  may be initiated after the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='first trimester. \\nChoroquine is the drug recommended for prophylaxis. The dose is Chloroquine 300mg base once a \\nweek. \\nChloroquine can be given after the first trimester of the pregnancy and should be continued throughout \\nthe pregnancy and for upto six weeks after delivery. \\nImportant: Before initiating Chloroquine prophylaxis, please ensure that the pregnant woman is free \\nfrom malaria parasitaemia. \\n3. Treatment of malaria during pregnancy \\n(Please refer General Circular No.01-14/2008 dated 7th May 2008 issued by the DGHS “Guidelines \\nfor malaria chemotherapy and management of patients with malaria in Sri Lanka” for further \\ndetails) \\nIf a blood smear is reported positive, ensure that the parasite species is identified (Plasmodium vivax or \\nPlasmodium falciparum).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Plasmodium falciparum). \\nTreatment of a vivax infection in pregnancy: \\nPlasmodium vivax malaria is treated with Chloroquine. \\nDay 1 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 2 – Chloroquine base 10mg/kg body weight (approx. 600mg = 4 tablets) \\nDay 3 – Chloroquine base 5mg/kg body weight (approx. 300mg = 2 tablets) \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n146 \\n \\n \\nRadical cure of vivvax infection in pregnancy is recommended by the administration of primaquine six \\nweeks after delivery. The dose of primaquine is 0.25mg/kg/day for 14 days. \\nTreatment of falciparum infection in pregnancy: \\nArtemedsinin + Lumifantrin (Coartem®) is the recommended drug for patient with uncomplicated \\nfalciparum infections. All falciparum patients should be admitted and managed as inward patients. \\nPrimaquine is contraindicated during pregnancy. \\nAfter initiation of treatment, repeat blood smears should be examined on day 3, day 14 and day 28 to \\nassess the efficacy of the treatment. \\nImportant: \\nPregnant women should not be treated with Coartem® during the first trimester of pregnancy and during'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the period of exclusive breast feeding. \\nQuinine (oral or IV) can be used safely during first trimester of pregnancy and in situations that the \\npatient cannot take drugs orally. Quinine can be used safely during the period of lactation. \\nDosage: \\nQuinine sulphate orally 10mg/kg body weight 8 hourly for 7 days or \\nQuinine injection in a dose of 10mg/kg body weight diluted in 5% dextrose solution \\ninfused slowly at 8 hourly intervals till the patient can take oral drugs or for at least \\n7days. \\nAll falciparum infected pregnant women should be administered a single day dose of primaquine \\n(0.75mg/kg/day) six weeks after delivery. \\nPersonal protection: \\nAll pregnant women irrespective of their being on chemoprophylaxis or not, are advised to adopt'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='All pregnant women irrespective of their being on chemoprophylaxis or not, are advised to adopt \\nmeasures for personal protection from mosquito bites including the use of insecticide treated bed nets, \\nrepellants and other measures. \\nImportant: \\nAny pregnant woman arriving from malaria endemic country and suspected of having malaria infection \\nshould be admitted to a medical institution and managed appropriately (please contact Anti Malaria \\nCampaign directorate for advice). \\nPregnant women who are travelling to malaria endemic countries should contact the Anti Malaria \\nCampaign directorate for appropriate advice. \\nAnti Malaria Campaign directorate Contact details: \\n+94 112 588408, +94 112 368173, +94 112 368174'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n147 \\n \\n \\nChapter 21  \\n \\n \\n \\nMANAGEMENT OF TUBERCULOSIS DURING PREGNANCY \\n \\nTuberculosis is an infectious disease caused by the bacillus- Mycobacterium tuberculosis and \\noccasionally by Mycobacterium bovis and Mycobacterium africanum. Tuberculosis commonly affects \\nthe lungs, but it can affect any other organ in the body. \\n \\nHow does tuberculosis spread?  \\nThe bacteria that cause tuberculosis usually spread through air. When a patient with infectious \\npulmonary tuberculosis coughs, sneezes or laughs, bacilli are expelled into the air in the form of tiny \\ndroplets. These droplets dry up rapidly to form droplet nuclei and may remain suspended in the air for'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='several hours. Adequate through and through ventilation removes and dilutes these droplet nuclei, and \\ndirect sunlight quickly kills the bacilli, but they can survive in the dark for several days. When a healthy \\nperson inhales these droplet nuclei containing the tubercle bacilli, he/she may become infected. \\n \\nRisk of infection  \\nAn individual’s risk of infection depends on the extent of exposure to an infectious source and \\nsusceptibility of the individual to infection. The risk of infection is therefore high in a person who has \\nclose, prolonged exposure to a person with sputum smear positive pulmonary TB. The risk of \\ntransmission of infection from sputum smear-negative pulmonary TB is low and with extrapulmonary \\nTB, still lower. \\n \\nWho is a TB suspect?'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='TB, still lower. \\n \\nWho is a TB suspect?  \\nA TB suspect is a person who presents with symptoms or signs suggestive of TB, particularly cough of \\nthree weeks or more.  \\nWho is considered a ‘Case’ of tuberculosis?  \\nA case of tuberculosis is a patient in whom TB has been bacteriologically confirmed or diagnosed by a \\nclinician.  \\n \\nDefinite case of TB  \\n \\nA definite case of TB is a patient with positive culture for the Mycobacterium tuberculosis complex. (In \\ncountries where culture is not routinely available, a patient with two sputum smears positive for acid-fast \\nbacilli (AFB) is considered a “definite” case)  \\n \\nCommon symptoms of pulmonary tuberculosis  \\nThe clinical presentation of tuberculosis in pregnant women is similar to that in non-pregnant patients. \\n \\nRespiratory symptoms:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Respiratory symptoms:  \\nCough – usually more than three weeks  \\nHaemoptysis (blood stained sputum)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n148 \\n \\n \\nShortness of breath  \\nChest pain \\n \\nConstitutional Symaptoms: \\nFever and night sweats \\nLoss of appetite \\nLoss of weight \\nTiredness (Fatigue) \\n \\nSymptoms of Extrapulmonary TB  \\nThe symptoms depend on the organ involved. Patients may present with constitutional features of the \\ndisease – fever, night sweats, loss of weight, and loss of appetite or local symptoms related to the site of \\nthe disease. \\n \\nInvestigations  \\nSputum Smear microscopy  \\nSputum smear microscopy is the most reliable and cost effective method of diagnosing infectious cases \\nof pulmonary tuberculosis cases. Whenever tuberculosis is suspected in a patient who has had a cough'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='of three weeks or more, three sputum samples should be collected and examined by microscopy for \\nAcid-Fast Bacilli (AFB).  \\n \\nCollection of sputum samples  \\nA PTB suspect should submit three sputum samples for microscopy. Three early morning samples are \\npreferable. Patient should be advised to collect sputum after coughing following a deep inspiration and it \\nshould not be saliva.  \\nOutpatients may provide sputum specimens as follows:  \\n \\nFirst spot specimen - Supervised spot specimen at the first visit  \\nEarly morning specimen - Patient is given a sputum container to collect early morning  \\nspecimen on the following day.  \\nSecond spot specimen - Second supervised spot specimen is collected when the patient  \\nreturns with the early morning specimen, on the following day.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='returns with the early morning specimen, on the following day.  \\n \\nChest X-ray  \\nThe chest X-ray has a limited role in confirming the diagnosis of pulmonary tuberculosis. Diagnosis of \\ntuberculosis by means of X-ray alone is unreliable. Abnormalities seen on a chest X-ray may be \\nmimicked by a variety of other conditions. However chest X-ray is helpful particularly to diagnose PTB \\nin a suspect whose sputum smears are negative for AFB. \\n  \\nThe decision to start on anti-TB treatment on patients should not be based solely on abnormal chest X-\\nray findings and all efforts should be made to perform sputum microscopy. \\n  \\nIn pregnancy, chest X-rays should be avoided as far as possible, especially during the first trimester, \\nbecause of the adverse effects of x-rays on the foetus.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n149 \\n \\n \\nTherefore, diagnosis will depend more on sputum examination when a pregnant mother presents with \\nsymptoms suggestive of tuberculosis. However, if an X-ray is absolutely necessary, this may be done \\nwith the abdomen covered with a lead apron.  \\n \\nSputum Culture for AFB  \\nCulture examination of sputum for AFB is more sensitive and specific than direct smear microscopy and \\nmay be useful in detecting cases where the number of organisms are fewer than can be detected by direct \\nsmear microscopy. But this is more expensive and takes at least 6-8 weeks to get the results.  \\nUnder ideal circumstances pre-treatment sputum cultures for AFB should be performed on all PTB \\npatients. \\n \\nTB treatment regimens'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='patients. \\n \\nTB treatment regimens  \\nTreatment regimens consist of two phases:  \\n1. Initial intensive phase  \\n2. Continuation phase  \\n \\nIntensive phase  \\nDuring the initial intensive phase, there is rapid killing of TB bacilli. Infectious patients quickly become \\nnon-infectious (within about two weeks) and symptoms improve. Most patients with sputum smear-\\npositive pulmonary TB becomes smear negative within two months. Directly Observed Therapy (DOT) \\nis essential in the initial phase to ensure that the patient takes every single dose. This prevents \\ndevelopment of drug resistance. The risk of development of drug resistance is higher during the early \\nstages of anti-TB treatment, when there are more bacilli.  \\n \\nContinuation Phase'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='stages of anti-TB treatment, when there are more bacilli.  \\n \\nContinuation Phase  \\nDuring the continuation phase, fewer drugs are necessary, but for a longer period. The sterilizing effect \\nof the drugs eliminates the remaining bacilli, thus preventing subsequent relapses.  \\nPatients who have taken anti-tuberculosis drugs previously are much more likely to develop drug \\nresistance, which may have been acquired through inadequate prior chemotherapy. Such patients require \\na stronger regimen consisting of more drugs and for a longer period.  \\n \\nTherefore, before starting treatment, it is essential to question all patients closely and carefully to \\ndetermine whether or not they have previously taken treatment for tuberculosis, so that they can \\nbe given the proper treatment regimen.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='be given the proper treatment regimen.  \\n \\nStandard code for TB treatment regimens  \\nThere is a standard code for TB treatment regimens and each anti-tuberculosis drug has an abbreviation.  \\nH – Isoniazid  \\nR - Rifampicin  \\nZ - Pyrazinamide  \\nE - Ethambutol  \\nS – Streptomycin  \\n \\nA TB treatment regimen consists of two phases, the intensive phase and the continuation phase. The \\nnumber before a phase is the duration of that phase in months. A subscript number (e.g. 3) after a letter'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n150 \\n \\n \\nindicates the number of doses of that drug per week. No subscript number after a letter indicates that the \\ntreatment is daily.  \\nE.g.: 4 HR means 4 months of Isoniazid and Rifampicin daily.  \\n5 H3 R3 E3 means 5 months of Isoniazid, Rifampicin and Ethambutol three times a week. \\n \\nTable 1 Case definitions, Treatment Categories and Recommended Regimens \\n  \\nCase Definition  \\nTreatment \\nCategory  \\nTreatment Regimen  \\nIntensive \\nPhase  \\nContinuation Phase  \\nNew cases  \\n- PTB smear-positive  \\n- PTB smear-negative  \\n- Extrapulmonary TB  \\nCAT 1 \\n2 HRZE \\n4 HR \\nRe-treatment cases  \\n- Relapses  \\n-Treatment after failure  \\n-Treatment after default  \\n(smear-positive)  \\nCAT 2  \\n2HRZES / 1 HRZE 5 HRE'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='-Treatment after default  \\n(smear-positive)  \\nCAT 2  \\n2HRZES / 1 HRZE 5 HRE  \\n \\nMonitoring of sputum smear-positive pulmonary TB patients \\nResponse to treatment should be monitored by sputum smear examination \\nFor sputum smear positive PTB patients, sputum smear examinations should be performed at the end of \\nthe intensive phase of treatment (i.e.,second month), during the fifth month and ai the end of treatment. \\nNegative sputum smears indicate good treatment progress. \\nFor sputum smear negative patients sputum smear examination should be performed at the end of two \\nmoths of treatment. \\n \\nTreatment during Pregnancy  \\nAnti-TB treatment should be started as soon as the diagnosis is made, and the full course of treatment \\ngiven.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='given.  \\nThe basic principles of treatment are the same in pregnancy. Most anti-TB drugs are safe for use during \\npregnancy except streptomycin.  \\nStreptomycin should not be given because it can cause oto-toxicity in the foetus.  \\nPregnant mothers should be given pyridoxine 10mg daily along with INAH.  \\nVitamin K should be administered at birth to the infant of a mother taking rifampicin because of the risk \\nof post-natal haemorrhage.  \\n \\nTreatment during breast-feeding  \\nA patient who has TB and is breast-feeding should receive the full course of anti-TB treatment. Properly \\ntaken treatment is the best way of preventing transmission of TB to her baby. All anti-TB drugs are \\ncompatible with breast-feeding. A patient taking anti-TB treatment can continue to breastfeed her baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='in the normal way.  \\n \\nBreastfeeding should be avoided only in cases where the mother has dual TB/HIV infection.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n151 \\n \\n \\nManagement of a newborn child of a mother with active TB  \\n• Do not separate the child from the mother unless she is acutely ill.  \\n• If the mother is sputum smear negative, and if the infant has no evidence of congenital TB, BCG is \\ngiven to the infant.  \\nIf the mother is sputum smear-positive at the time of delivery, infant should be carefully examined \\nfor evidence of active disease.  \\n- If the infant is ill at birth and congenital TB is suspected, a full course of anti-TB treatment \\nshould be given.  \\n- If the child is well, give prophylactic treatment with INAH 5mg/ kg body weight, daily for \\nthree months. BCG is withheld.  \\n• The Mantoux skin test is done after three months.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='three months. BCG is withheld.  \\n• The Mantoux skin test is done after three months.  \\n- If the Mantoux test is negative and the child is well, prophylactic treatment with INAH is \\nstopped and child is given BCG.  \\n- If the Mantoux test is positive, careful examination of the child for active TB is done \\nincluding a chest X-ray.  \\n- If active disease is diagnosed, a full course of anti-TB treatment should be commenced.  \\n- If the physical examination and the chest X-ray are normal, INAH chemoprophylaxis is \\ncontinued up to six months and BCG is given.  \\n \\nDirectly Observed Treatment  \\nDirectly Observed Treatment (DOT) is one of the important elements of the internationally \\nrecommended strategy for TB control. Directly Observed Treatment means that an observer watches the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='patient swallow their tablets. This ensures that a TB patient takes the right anti-tuberculosis drugs, in the \\nright doses at the right intervals without interruption and ensures that the patient completes the full \\ncourse of treatment. \\n \\nDOT Providers –  \\nThe following categories will provide Direct Observation of Treatment.  \\n• Health workers at state health care facilities  \\n• Field health care workers  \\n• General practitioners  \\n• Trained volunteers  \\n• Community leaders  \\nPublic health staff especially Public Health Nursing sisters and Public Health Midwives  can play a \\nsignificant role as DOT providers for antenatal and postnatal mothers in their areas who are on \\ntreatment. \\n \\nProvision of drugs for the DOT Centres -'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='treatment. \\n \\nProvision of drugs for the DOT Centres -  \\nDrugs for each patient will be delivered to the DOT centres from the District Chest Clinic by the PHI or \\nany other staff assigned by the DTCO. \\n \\nInterruption of treatment (default)  \\nDirectly Observed Treatment adapted to the needs of the patient is the best method of avoiding treatment \\ninterruption. However, even with directly observed treatment and during the continuation phase of \\ntreatment, which may be self-administered, there may be treatment interruption.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n152 \\n \\nMeasures to minimize treatment interruption  \\nAt the time of registration of a TB patient, the staff must educate the patient and the family regarding the \\nduration of treatment and the importance of adherence to treatment.  \\n \\nIt is vital to record the patient’s address and other relevant addresses e.g. parents or work place etc. in \\norder to help locate the patients who interrupt treatment. As far as possible, the address should be \\nverified at the beginning of treatment.  \\n  \\nPublic Health Midwives in their field visits and at antenatal clinics should inquire about uninterrupted \\ncontinuation of treatment from patients and should encourage them to continue treatment. \\n \\nManagement of patients who interrupt treatment'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Management of patients who interrupt treatment  \\nIt is important to take action on defaulters immediately. Patients should be contacted the day after \\nmissing a dose during the intensive phase and as soon as possible during the continuation phase. It is \\nimportant to find out the reason for the patient’s absence in order to take appropriate action and continue \\ntreatment. \\n \\nNotification \\nAt the point of diagnosis, all tuberculosis patients should be notified using TB notification Form (H \\n816). \\n \\nContact screening  \\nHousehold contacts of infectious TB patients (adults and children >5 years) should be screened for \\nsymptoms of TB. Those who have symptoms suggestive of TB should be investigated with sputum \\nsmears irrespective of the duration of the symptoms.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='smears irrespective of the duration of the symptoms.  \\nChildren under the age of 5 years should be screened with chest X-ray and Mantoux test.  \\n \\nPreventive treatment  \\nThe aim of preventive treatment is to prevent progression of M. tuberculosis infection to disease.  \\n \\nPrimary chemoprophylaxis  \\nWhen a person is exposed to TB bacilli, but not yet infected eg. newborn breastfed baby of a sputum \\nsmear-positive mother  \\n \\nSecondary chemoprophylaxis  \\nA person who is infected, but not yet developed clinical disease e.g. tuberculin positive close contacts of \\nsputum smear-positive patients.  \\nIn Sri Lanka, chemoprophylaxis is given for the following groups:  \\n• Breast fed infants of sputum smear-positive mothers.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='• Breast fed infants of sputum smear-positive mothers.  \\n \\n• Household contacts below 5 years of age of sputum smear-positive patients, who do not have \\nevidence of active disease.  \\nProphylactic treatment in Sri Lanka is – INAH 5mg/ kg body weight for 6 months.  \\n \\nFor further details refer ‘General Manual for Tuberculosis Control’ published by National \\nProgram for Tuberculosis Control and Chest Diseases.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n153 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nPOSTNATAL CARE'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n154'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n155 \\n \\n \\nChapter 22 \\nPOST NATAL CARE \\nPostnatal period begins immediately after birth of the baby and extend up to 6 weeks (42 days) after \\nbirth:  \\nImmediate postnatal period - the phase immediately following child birth up to 24 hours \\nEarly postnatal period - Day 2-7 \\nLate postnatal period - Day 8-42 \\n The major objectives of the postnatal care are: \\n\\uf0b7 To provide a supportive environment in which a woman, her newborn baby and the wider family \\ncan begin the transition of their lives \\n\\uf0b7 To recognize danger signs in the mother and the newborn and to help them to take timely actions \\n\\uf0b7 To maintain good physical and mental health in both mother and the newborn  \\n\\uf0b7 To support, promote and protect breast feeding'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 To support, promote and protect breast feeding \\n\\uf0b7 Counseling on family planning to help the mother to select a method and provision of services \\nwhere needed. \\n\\uf0b7 Recognize the child as a service utilizer \\n \\n22.1  Immediate postnatal period \\nThis is the period during which infant’s physiology undergoes adaptation and the risk of postpartum \\nhaemorrhage is highest. Close professional supervision is required in this period to identify problems \\nearly and intervene appropriately. According to the discharging policy in Sri Lanka, postnatal care \\nduring immediate postnatal period is given at a hospital. \\nImmediate Maternal Care \\n\\uf0b7 All women should be examined one hour after delivery of placenta, including assessment of \\nanaemia.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='anaemia. \\n\\uf0b7 All postnatal mothers should have regular assessment of vaginal bleeding, uterine contraction, \\nfundal height and temperature. \\n\\uf0b7 All women should be encouraged to mobilize appropriately as soon as following the birth \\n\\uf0b7 Measure and document BP once within 6 hours after the last measurement taken soon after birth  \\n\\uf0b7 Document urine output during first 6 hours \\n\\uf0b7 Toilet facilities that are hygienic and ensure privacy should be provided at a distance with easy \\naccessibility \\n\\uf0b7 Ensure adequate rest for the woman and access to food and drink on demand'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n156 \\n \\n \\nConcerns \\n\\uf0b7 If infection is suspected, a woman’s temperature should be measured and documented. If the \\ntemperature is above 38oC, it should be measured again in 4-6 hours and need to find out the \\ncause. \\n\\uf0b7 If a woman has excessive and offensive vaginal discharge, abdominal tenderness, fever and any \\nabnormalities in the size, tone and position of the uterus, she should be evaluated. These women \\nmay need urgent action. \\n\\uf0b7 If diastolic blood pressure is greater than 90mmHg, and there are no other signs and symptoms \\nof pre-eclampsia, the measurement of blood pressure should be repeated within 4 hours. \\n\\uf0b7 If a woman has not voided by 6 hours postpartum irrespective of measures to encourage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 If a woman has not voided by 6 hours postpartum irrespective of measures to encourage \\nmicturition (such as taking a warm bath or shower), bladder volume should be assessed and \\ncatheterization need to be considered (urgent action). If a woman is obese, she will require \\nindividualized care. \\n\\uf0b7 Immediate referral or emergency action is required if there is: \\nSudden or profuse blood loss or loss accompanied by any of the signs and symptoms of \\nshock, including trachycardia, hypotension, hypoperfusion and change in consciousness  \\nDiastolic BP is greater than 90mmHg and accompanied by another sign or symptom of \\npre-eclampsia, or if diastolic BP is greater than 90mmHg and is not reduced below \\n90mmHg within 4 hours.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='90mmHg within 4 hours. \\nThe temperature remains above 380C on the second reading or there are other observable \\nsymptoms and measurable signs of sepsis \\nA woman complained of unilateral calf pain, redness, swelling, and shortness of breath or \\nchest pain \\nAll women should be given information about the physiological process of recovery after birth, and that \\nsome health problems are common, with advice to report any health concerns to health care workers, in \\nparticular: \\nSigns and symptoms of PPH: sudden and profuse blood loss or persistent increased blood loss: \\nfaintishness; dizziness; palpitations/tachycardia \\nSigns and symptoms of infection: fever, shaking, abdominal pain and/ or offensive vaginal loss'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Signs and symptoms of infection: fever, shaking, abdominal pain and/ or offensive vaginal loss \\nSigns and symptoms of thrombo-embolism: unilateral calf pain; redness or swelling of calves; \\nshortness of breath or chest pain \\nSigns and symptoms of pre-eclampsia: Headaches, visual disturbances, nausea, vomiting, feeling \\nfaint. \\nWomen who have had an epidural or spinal anaesthesia should be advised to report any severe \\nheadache, particularly when sitting or standing \\n \\n \\nAdvice on postpartum care and hygiene, especially hand washing and use of clean napkins or pads'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n157 \\n \\n \\nGive advice on proper nutrition during lactation (page 85). \\nCounsel on birth spacing and family planning with special attention to lactational amenorrhoea and \\nemphasis the need of using a family planning method by 6 weeks. \\nAdvise on routine postpartum care at the field and ask them to inform area PHM as soon as they go \\nhome to get routine care. \\nAdvice on postpartum danger signals and discuss the postpartum emergency plan (page 65 ). \\nGive Vit A mega dose (200,000IU) before discharge. \\nIf she is not immunized with Rubella, make arrangement for rubella immunization before discharge. \\nDo a vaginal examination before discharge and ensure that there are no foreign bodies in the vagina eg. \\nGauze packs etc'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Gauze packs etc \\nComplete all the documents eg Diagnosis cards, pregnancy record and hand over the relevant documents \\nto mother. \\nHelp the mother to register the birth. \\nAdvice about maternal benefits, if relevant. \\n \\nImmediate Newborn Care \\n\\uf0b7 Baby should be delivered on to the mother’s abdomen \\n\\uf0b7 Immediately dry the baby with a warm clean towel or piece of cloth. Thoroughly dry the baby to \\nprevent it getting cold. Wipe away any blood or meconium. Do not wipe off the vernix ax it \\nhelps to protect the bay’s skin and gets reabsorbed very quickly. \\n\\uf0b7 Assess the baby’s breathing while drying  \\n\\uf0b7 Make sure that there is no second baby \\n\\uf0b7 Change gloves. If this is not possible wash the gloved hands \\n\\uf0b7 Clamp and cut the umbilical cord'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Change gloves. If this is not possible wash the gloved hands \\n\\uf0b7 Clamp and cut the umbilical cord \\n\\uf0b7 Leave the baby between the mother’s breasts to start skin to skin care \\n\\uf0b7 Place an identity label on the baby \\n\\uf0b7 Cover the baby’s head with a hat and cover the mother and baby with a warm cloth \\n\\uf0b7 Encourage initiation of breastfeeding. Keeping the newborn skin to skin between the mother’s \\nbreasts encourage this process. \\n \\nDuring the first hour of life: \\n\\uf0b7 Ensure the mother and baby are in a warm room which is not  less than 250c with no draught \\n\\uf0b7 Mother and baby should not be separated. Keep the baby in the same room with the mother in \\nher bed or within easy access.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n158 \\n \\n\\uf0b7 Skin to skin contact should be encouraged for all the newborns in the first hour of life. For low \\nbirth weight newborns skin to skin contact (Kangaroo Mother Care) can be practiced as long as \\nthe baby requires. \\n\\uf0b7 Brest feeding should be initiated within the first hour of life and continue on demand. Identity \\nhunger cues and start breastfeeding when the baby is ready. Support exclusive breastfeeding on \\ndemand day and night Newborn should be dressed adequately in order to to maintain the body \\ntemperature. Baby’s head should be covered with a cap. Additional layer of clothing should be \\nworn if it is in a cooler climate.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='worn if it is in a cooler climate. \\n\\uf0b7 Resuscitate a baby that is not breathing spontaneously (weight, length, head circumference etc.), \\n\\uf0b7 Assess the gestational age and take measrements. \\n\\uf0b7 Vitamin K should be offered for all infants and administered with a single dose of 1mg IM. \\n \\nMaintaining infant health \\nRound the clock keep the mother and baby together in the same bed or in the same room within easy \\naccess to the mother. Continuing skin to skin contact, whenever possible. \\nIn areas where it is necessary, cover the mother and baby with a bed net \\nEnsure exclusive breastfeeding on demand during day and night for the newborn. In case if the mother \\ndevelop difficulties in breastfeeding make her aware how to seek support from her area PHM or at the'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='closest hospital Lactation Management Centre \\n \\nMake the mother aware about routine care of the newborn \\n- \\nKeeping the baby warm – Newborn should be dressed adequately and the head should be \\ncovered with a cap during the first few days. Additional layer of clothing should be worn if it is \\nin a cooler climate.  \\n- \\nDress the baby well and keep covered with a soft cloth. If the baby is not kept with the mother, \\ncheck for warmth every 4 hours by touching bay’s feet. Delay bathing until at least the baby is 6 \\nhours old. \\n- \\nCare of the umbilical cord (should be kept dry, should not apply anything on the cord stump, if it \\nis soiled, wash with soap and water and dry well. \\n- \\nDaily clean the baby’s face, neck and the arm pits. Clean the buttocks when soiled. Bath the baby'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Daily clean the baby’s face, neck and the arm pits. Clean the buttocks when soiled. Bath the baby \\nwhen required using warm water. After bathing make sure to keep the baby warm \\nAssessment for emotional attachment should be carried out at each postnatal contact \\nFirst clinical examination should be done around an hour after the birth to assess if baby can stay with \\nthe mother or needs additional care or referral to special care. \\nAssess the malformations and birth injuries \\nInfants who develop jaundice within the first 24 hours should be urgently investigated. \\nTeach the mother how to care for a small baby (pre-term or low birth weight) eg. Kangaroo-mother care  \\nGive special support to breast feeding the small bays or twins.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n159 \\n \\n \\nTeach the mother to observe for the danger signs in the baby and to call health worker if she has \\nconcerns. \\nExamine before discharge. Discuss with mother postnatal care and emergency plan. \\nOnly discharge small babies if discharge criteria met: Exclusive breast feeding, stable temperature, \\nweight gain, mother feeling competent caring for the baby. \\n \\nSupport for breast feeding: \\nBreast feeding support to a woman should be made available regardless of the location of care. \\nWomen should be offered skilled support including mother to mother or peer support from the \\ncommencement of the breast feeding. \\nAdditional support with positioning and attachment to commence breast feeding should be offered to all \\nwomen who had:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='women who had: \\n\\uf0b7 A caesarean section, particularly to assist with handling and  positioning the baby to protect the \\nceasarean section wound \\n\\uf0b7 Initial contact with their baby delayed \\n\\uf0b7 Twins \\nUnrestricted frequency and duration of breast feeding should be encouraged. \\nA PHM should discuss the woman’s experience with breast feeding daily to assess with her if she is on \\ncourse to breast feed effectively and identify need for additional support. \\nA written breastfeeding education material should be available and health care staff should use them in \\nroutine BF lecture/demonstrations. \\nIf breastfeeding problem is identified, refer mother to lactation management center \\nTeach all mothers how to relieve engorgement and expressing breast milk and feeding the baby with a \\ncup.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='cup. \\nWomen with flat or inverted nipples should be advised that these are not contraindications to \\nbreastfeeding and support should be offered as needs \\nIf a woman is experiencing breast or nipple pain, healthcare worker should review positioning and \\nattachment. \\nA baby who is not attaching effectively may be encouraged to open his/her mouth using different \\nstimuli. \\nSkin to skin contact or massaging the baby’s feet should be used to wake the baby. \\nOnly discharge the baby if mother feels competent in breast feeding. \\nWomen should be offered information and reassurance on: \\n\\uf0b7 Colostrum which will meet the needs of the baby in the first few days after birth \\n\\uf0b7 Timing of the initial breast feed, including the protective effects of colostrum'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Timing of the initial breast feed, including the protective effects of colostrum \\n\\uf0b7 The nurturing benefits of putting the bay to the breast in addition to the nutritional benefits of \\nbreasfeeding. \\n \\nWomen should be reassured that brief discomfort at the start of breast feeds in the first few days is not \\nuncommon, but should not persisits.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n160 \\n \\n \\n22. 2  Post natal care at the field  \\nOnce the mother is discharged from the hospital, professional postnatal care is provided through home \\nvisits by the PHM and postnatal clinics (a component of a poly clinic).  Other than that woman caring \\nfor herself and newborn with the support of the family. Therefore, health workers need to be ensured \\nthat home practices are in line with evidence based best practices and give some skills to the family and \\ncommunity to support women and babies during this critical period.  \\nPostnatal care model in Sri Lanka consists of domiciliary care and clinic care. The area public health \\nmid wife (PHM) is responsible for the post natal home visits while hospital or field clinic manned by a'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='qualified medical officer responsible for clinic care.  \\n \\n \\n \\n \\n \\n \\n \\n  \\n \\n \\n \\n \\n \\n \\n \\nWomen with postnatal complications need more clinic visits as well as home visits. Women who had \\nstill births and infant deaths should be also visited by the PHM.  \\n \\n \\n \\n \\nFor Normal vaginal delivery:    \\n 02 home visits during first 10 days after delivery (first visit first 5 days) \\n \\n01 home visit during 14-21 days (around 15th day) after delivery \\n \\nPostnatal clinic visit at 4-5 weeks  \\n \\n01 visit around 42 days (6-7 weeks) after delivery \\nFor Home delivery:                    \\n  \\n03 visits during first 10 days after delivery \\n01 visit 14-21 days (around 15th day) after delivery \\nPostnatal clinic visit at 4-5 weeks  \\n01 visit around 42 days of delivery'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n161 \\n \\n \\nFirst and second home visits (within the first 10 days post partum) \\n \\nA locally adopted system should be implemented to inform the PHM regarding the child birth as soon as \\nthey are discharged from the hospital eg. messenger, telephone call or a specially designed card etc. \\n \\nPHM  \\n\\uf0b7 Should be able to identify all the post partum mothers in her area including those come from \\nother areas. \\n\\uf0b7 should be able to identify and take necessary action to the problems in mother and baby  \\n \\nObserve: \\nGeneral condition of the mother and the home: \\nCleanliness and order in the house and the place where new born and mother live (ventilation, \\nlight, safety, warmth, humidity, smoke exposure) \\nMother and baby are within easy reach.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='light, safety, warmth, humidity, smoke exposure) \\nMother and baby are within easy reach. \\nPersonnel hygiene of the mother \\nBehaviour and the mood of the mother (sad, happy) \\nSupport and general attitude of other family members towards mother and baby \\n \\nBaby: \\nPHM should mainly consider the following important points in the care of the newborn (essential \\nnewborn care): \\n\\uf0b7 Ensure that the baby is kept warm \\n\\uf0b7 Keep the mother and the baby together, in the same room, same bed or within easy reach \\n\\uf0b7 Support exclusive breastfeeding on demand day and night \\n\\uf0b7 Teach the mother how to care for the baby \\nLook at the CHDR and neonatal diagnosis cards, if any \\nEnsure that BCG immunization has received \\nIdentify the presence of any high risk condition which needs special attention'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Identify the presence of any high risk condition which needs special attention   \\n \\nWash hands with soap and water before examining the baby. \\n Select a place with good light for examination. \\n \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0a7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0a7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0a7 Sleep \\n\\uf0a7 Crying \\n\\uf0a7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0a7 Vomiting'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n162 \\n \\n \\nObserve and examine : \\n\\uf0a7 General appearance: weight, colour, any other external abnormalities \\n\\uf0a7 Look at the presenting part : swelling or bruises \\n\\uf0a7 Movements : Normal/abnormal \\n\\uf0a7 Observe the cry \\n\\uf0a7 Hygiene of the baby \\n\\uf0a7 Breathing : Normal/ grunting/ and count breaths (30-60 per minute) \\n\\uf0a7 Feel for warmth. If cold or very warm measure the temperature \\n\\uf0a7 Tone : Normal/ abnormal \\n\\uf0a7 Colour:  tip of the nose, eyes, skin (cyanosis, jaundice) \\n\\uf0a7 Condition of the umbilicus \\n\\uf0a7 Presence of any danger signs – box below \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nIf any danger sign is detected refer the baby immediately for care.  If any other problem is detected refer \\naccordingly'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='accordingly \\n \\n \\nDanger signs in the newborn \\n\\uf0b7 \\nFast breathing (more than 60 breaths per minute) \\n\\uf0b7 \\nSlow breathing (less than 30 breaths per minute) \\n\\uf0b7 \\nSevere chest in-drawing \\n\\uf0b7 \\nGrunting \\n\\uf0b7 \\nConvulsions \\n\\uf0b7 \\nFloppy or stiff \\n\\uf0b7 \\nBluish discolouration of the body \\n\\uf0b7 \\nFever (temperature > 380C) \\n\\uf0b7 \\nCold body ((temperature < 350C) or not rising after rewarming \\n\\uf0b7 \\nBleeding from umbilical stum or cut \\n\\uf0b7 \\nYellow discoloration of the body \\n\\uf0b7 \\nPallor \\n\\uf0b7 \\nDiarrhoea \\n\\uf0b7 \\nVomiting after every feed \\n\\uf0b7 \\nIf a baby who was breastfeeding well refuses two consecutive \\nfeeds \\n\\uf0b7 \\nUmbilicus draining pus or umbilical redness extending to skin \\n(periumbilical redness)  \\n\\uf0b7 \\nSwelling in one or more limbs \\n\\uf0b7 \\nWeakness in any one of the limb \\n\\uf0b7 \\nWeak cry \\n\\uf0b7'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 \\nSwelling in one or more limbs \\n\\uf0b7 \\nWeakness in any one of the limb \\n\\uf0b7 \\nWeak cry \\n\\uf0b7 \\nMore than 10 skin pustules or bullae or swelling, redness, \\nhardness of skin'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n163 \\n \\n \\nBreast feeding: \\nAsk from the mother: \\n\\uf0b7 Any concerns or difficulties in breastfeeding  \\n\\uf0b7 How many times the baby has fed in 24 hours \\n\\uf0b7 Whether the baby is satisfied after a breastfeed \\n\\uf0b7 Whether the baby is exclusively breastfed \\n\\uf0b7 How her breasts are feeling \\n \\nObserve a breast feed: \\nIf the baby has not breastfed in the previous hour ask the mother to put the baby on her breast and \\nobserve breastfeeding for about 5 minutes and observe the following; \\n\\uf0a7 The position of the mother   \\n\\uf0a7 The position of the baby during breastfeeding \\n\\uf0a7 Attachment of the baby to the breast during breast feeding \\n\\uf0a7 Whether the baby is suckling effectively'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0a7 Whether the baby is suckling effectively \\n \\nIf the baby has fed in the last hour ask her to tell you when her baby is willing to feed again.  \\n \\n \\nAsses the mother’s breasts if complaining of nipple or breast pain \\n\\uf0b7 Look at the nipples for fissures \\n\\uf0b7 Look at the breasts for swelling, shininess or redness \\n\\uf0b7 Feel gently for the painful part of the breast \\n\\uf0b7 Measure temperature \\n\\uf0b7 Identify and solve problems during breast feeding  \\n\\uf0b7 Advice  to check adequacy of breast milk ( How many times that baby has passed urine, duration \\nof a feed)  \\nEducate mother on activities that should be done for psycho social development of the baby - kissing the \\nbaby, touching, Nalavili gee \\nEducate the mother on how to keep the baby warm.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='baby, touching, Nalavili gee \\nEducate the mother on how to keep the baby warm. \\nEducate mother on how to keep the home environment safe and clean (with out dust, cold, smoke) \\nAdvice on methods of infection control- the importance of limiting visitors, limiting the number of \\nhandlers, hand washing \\n \\nInquire about the myths and correct them- ratha kalkaya, gammiris pibima \\nInquire and solve the problems with BCG immunization \\nRegister the baby and maintain records \\nDecide on date of next visit according to the problems identified'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n164 \\n \\n \\nMother: \\nAsk: \\nEnquiries should be made about general wellbeing and all common health problems:  \\n\\uf0b7 Micturition, dysuria and urinary incontinence  \\n\\uf0b7 Bowel functions : diarrhea /constipation \\n\\uf0b7 Vaginal  bleeding: amount/ colour \\n\\uf0b7 Vaginal discharge :  amount/ smell/ colour  \\n\\uf0b7 Lower abdominal pain \\n \\n\\uf0b7 Vomiting \\n\\uf0b7 Breathing difficulties \\n\\uf0b7 Severe headache \\n\\uf0b7 Calf pain \\n\\uf0b7 Visual disturbances \\n\\uf0b7 Healing of any perineal wounds \\n\\uf0b7 Back pain \\n \\nExamine: \\n\\uf0b7 General appearance of the mother: shortness of breath, cyanosis, icterus \\n\\uf0b7 Temperature \\n\\uf0b7 Respiratory rate \\n\\uf0b7 Pulse rate \\n\\uf0b7 Features of anaemia: pallor in tongue, conjunctiva , nails \\n\\uf0b7 Oedema: ankle, facial, fingers'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Features of anaemia: pallor in tongue, conjunctiva , nails \\n\\uf0b7 Oedema: ankle, facial, fingers \\n\\uf0b7 Breast (if not done earlier): breast engorgement, cracked nipples, breast abscesses \\n\\uf0b7 Abdomen: size and consistency of the uterus, LSCS scar \\n\\uf0b7 Perinium:  \\no Lochia: amount, colour and smell \\no Vaginal discharge: colour and amount \\no Vaginal bleeding \\no Episiotomy scar: infected or not, gaping, healing \\no Personnel hygiene of the mother in relation to perineal area \\no Mental status: sad/happy, features of psychosis \\no Check urine if indicated (Pre eclampsia, diabetes, renal disease \\no If need carry out a vaginal examination'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n165 \\n \\n \\nIntervene:  \\nEncourage mother to use self care techniques such as taking gentle exercises, taking time to rest, having \\nhelp to care for her baby, talking to someone about her feelings \\n \\nAsk the mother about her emotional well-being, what family and social support they have and their \\nusual coping strategies for dealing with day to day matters. Post natal mother and her partner and family \\nshould be encouraged to tell their health care workers about any changes in mood, emotional state and \\nbehavior that are outside of the mother’s normal pattern. \\n \\nObserve for any risks, signs and symptoms of domestic abuse and aware who to contact for advice and \\nmanagement.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='management. \\n \\nThe PHM should identify, evaluate and manage common health problems as appropriate: \\n1. Carry out assessment of perineum. If perineal pain is present advise on tropical cold therapy or \\nParacetamol for pain relief. \\n2. Signs and symptoms of infection, inadequate repair, wound breakdown or non-healing should be \\nreferred to the nearest hospital or MOH clinic for further evaluation and management. \\n \\n3. Management of mild postnatal headache should be based on differential diagnosis of headache \\ntype. Check the blood pressure if BP apparatus is available. Otherwise refer to nearest hospital or \\nhealthcare centre to check blood pressure and act accordingly. \\n4. If a woman has tension or migraine headaches, the PHM should offer advice on relaxation and'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='4. If a woman has tension or migraine headaches, the PHM should offer advice on relaxation and \\navoidance of factors associated with the onset of headache eg. coffee, chocolate etc. \\n5. Back pain should be managed with paracetamol and correct postures. \\n6. A woman with some involuntary leakage of a small volume of urine should be taught how to do \\npelvic floor exercises. \\n7. If constipation present, advice increased intake of fibre and fluids. If problem persists advise use \\nof gentle stimulant laxative. \\n8. Women with haemorrhoids should take measures to avoid constipation. If a woman has a \\nhaemorrhoid which is severe and swollen or prolapsed, or any rectal bleeding, refer to the \\nhospital for further evaluation and management.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='hospital for further evaluation and management. \\n9. If the woman complains of persistent fatigue, refer her for haemoglobin level evaluation. \\n10. Inquire about the antenatal complications and see whether she is complying the advices given  \\nfor the postpartum period. \\n11. Once assesses, women with the following conditions should be referred for treatment: \\nSevere or persistent headache and/ or other symptoms of pre-eclampsia \\nSustained postpartum vaginal bleeding \\nPersistent urinary incontinence \\nFaecal incontinence \\n \\nPostpartum women should be offered information and assurance about: \\n\\uf0b7 Perineal pain and perineal hygiene \\n\\uf0b7 Urinary incontinence and micturition \\n\\uf0b7 Bowel functions \\n\\uf0b7 Rest and sleep'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n166 \\n \\n\\uf0b7 Support from the husband and other family members \\n\\uf0b7 Bathing  \\n\\uf0b7 Nutrition – advise to eat a greater amount and variety. Reassure that she can eat all normal food. \\nAdvise the women against food taboos, continuing iron folate, whether she has got vitamin A \\nmegadose, (if not give her Vit A mega dose) adequate  fluid intake \\n\\uf0b7 Advice the mother and the family on danger signals during postpartum period (heavy vaginal \\nbleeding, severe abdominal pain, fever, foul smelling vaginal discharge, severe headache, calf \\npain etc.)  and actions to be taken if such signal is identified \\n\\uf0b7 Educate the family on importance of breast feeding, rest and possible psychological changes of \\nthe mother. \\n \\nComplete all the relevant records.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='the mother. \\n \\nComplete all the relevant records. \\nMothers with problems may need more visits. Decide on date of next visit according to the problems \\nidentified. \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nDanger signals during postnatal period \\nIf a postpartum woman has any of the following signs or symptoms, advise to go to a \\nhospital immediately. \\n\\uf0b7  Features of high blood pressure: \\n \\nSevere headache \\n \\nFaintishness \\n \\nBurning pain or tightness in the chest or upper abdomen \\nBlurring of vision or visual disturbances \\nShortness of breathing \\n\\uf0b7 Increased vaginal bleeding or bleeding with clots \\n\\uf0b7 Pain in the calf muscles which increased with walking \\n\\uf0b7 Difficulty in breathing in a mother with heart disease'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Difficulty in breathing in a mother with heart disease \\nIf a postpartum woman has any of the following signs or symptoms meet a doctor \\nimmediately. \\n\\uf0b7 Foul smelling/ excessive or purulent  vaginal discharge \\n\\uf0b7 Episiotomy wound – gaping, infected, abscess formation or severe pain \\n\\uf0b7 Fever during first six weeks after delivery \\n\\uf0b7 Difficulty in breathing – gradually increasing or increased rate of respiration \\n\\uf0b7 Pain in the chest \\n\\uf0b7 Mental distress- lack of sleep, less attention to the baby, mental liability, feels \\nfrustrated, suicidal thoughts'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n167 \\n \\n \\nHome visit  3 (within 11-21 days) \\n \\nObserve the general condition of the mother and the home as described earlier. \\nBaby: \\nAsk: \\n\\uf0b7 Mothers feelings or observations about the baby \\n\\uf0b7 Feeding: On demand feeding, frequency of feeds, any concerns of the mother \\n\\uf0b7 Excretion: Urine - frequency / stool - colour and consistency \\n\\uf0b7 Sleep \\n\\uf0b7 Crying \\n\\uf0b7 Any abnormalities observed – eye discharge, vaginal discharge, umbilicus, yellow discoloration, \\netc \\n\\uf0b7 Vomiting \\nExamine: \\n\\uf0b7 Color: cyanosis, icterus \\n\\uf0b7 Umbilicus: fallen or not, discharge, peri-umbilical redness \\n\\uf0b7 BCG scar \\n\\uf0b7 Excretion (stool/ urine: frequency, colour) \\n\\uf0b7 Infections: pustules discharges'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 BCG scar \\n\\uf0b7 Excretion (stool/ urine: frequency, colour) \\n\\uf0b7 Infections: pustules discharges \\n\\uf0b7 Feeding – correct positioning of the baby to breast, adequacy of breast milk, solve  problems \\nduring breast feeding \\n \\nIntervene: \\nEducate on family on the duties of mother/ father for psycho social development of baby \\nECCD practices \\nSafety of the baby – animals, physical environment, older children, \\nRefer to post natal clinic for weighing, examination by 4 weeks  \\nMaintain records. \\nRevisit if needed \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described in first \\nvisit. \\nAll post natal women should be asked about resumption of sexual intercourse and possible dyspareunia \\nas part of an assessment of overall well-being.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='as part of an assessment of overall well-being. \\nAsses the mental condition of the mother – rest, sleep, unhappiness, loneliness \\nAll women should be asked about resolution of symptoms of maternal blues. If symptoms have not \\nresolved, the woman’s psychological well-being should continue to be assessed for postnatal depression. \\nRefer to MOH clinic. \\nContinue to observe for any indication of domestic abuse.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n168 \\n \\nExamine: \\n\\uf0b7 Involution of the uterus \\n\\uf0b7 Episiotomy scar and LSCS scar \\n\\uf0b7 Vaginal discharge/ lochia \\n\\uf0b7 Breast examination- engorgement, abscess, nipple cracks \\nIntervene: \\nNutrition of the mother – diet, use of micronutrients, see the compliance of drugs taken for any disease \\nconditions. \\nAny positive response to queries about common health problems should be evaluated, treated or referred \\nappropriately: \\nDyspareunia \\nIf a woman expresses anxiety about resuming intercourse, reasons for this should be explored \\nwith her and help her to resolve those anxieties \\nIf a woman is experiencing dyspareunia and has sustained perineal trauma, examine her \\nperineum and assess the condition and act accordingly'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='perineum and assess the condition and act accordingly \\nA water based lubricant gel to help to ease discomfort during intercourse may be advised. \\nIf a woman continues to express anxiety about sexual health problems refer her to MOH clinic \\nfor further evaluation \\nIf persistent postnatal fatigue is impacting on the woman’s care of herself or baby, underlying physical, \\npsychological and social causes should be evaluated. \\nGive information: \\n\\uf0b7 Family planning methods \\n\\uf0b7 Importance of exclusive BF for 6 months \\n\\uf0b7 Personal hygiene of the mother \\n\\uf0b7 Maternal benefits \\n\\uf0b7 Breast feeding  for working mothers \\n\\uf0b7 Older children’s psychological aspects \\n\\uf0b7 Initiation of sexual activity and possible dyspareunia \\n\\uf0b7 Importance of continuing micronutrient intake'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Importance of continuing micronutrient intake \\n \\nAll mothers should be referred to a postnatal clinic during 4-6 weeks of postpartum. Give date for the \\npost natal clinic. \\nComplete all relevant records.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n169 \\n \\n \\nHome visit around 42 days \\n \\nBaby: \\n\\uf0b7 Support mother to maintain the nutrition, cleanliness, and psychosocial development of the baby \\n\\uf0b7 Check whether mother is maintaining the records of psycho social developmental  activities of \\nthe baby according to the age  \\n\\uf0b7 Refer baby for immunization \\n\\uf0b7 Explain the importance of weighing the baby monthly to assess the growth  \\n \\nMother: \\nEnquiries should be made about general wellbeing and all common health problems as described. \\nEducate mother on family planning method and refer her to family planning clinic (give a date) \\n \\nConfirm the adequacy of breast milk and encourage mother to breast feed exclusively for 6 months \\nEnquire about family support'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Enquire about family support \\nSolve problems in sexual intercourse \\nInquire about mother’s mental status and support mother to develop her self esteem'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n170 \\n \\n \\nChapter 23 \\nPost Natal Clinic \\n \\nArea public health mid wife should refer all post natal mothers to the post natal clinics in 4-6 weeks post \\npartum. Post natal clinic should be a component of a poly clinic. There should be two post natal clinics \\nper month. A date for the post natal clinic should be given to all mothers during the home visits and it \\nshould be mentioned in H 512 & CHDR. The attendance of mothers for post natal clinics should be \\nentered in the clinic attendance register as well as the clinic summary. The number of mothers attended, \\nmothers found with post partum complications and mothers referred for specialized care should be \\nentered in the quarterly clinic record (H -527).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='entered in the quarterly clinic record (H -527). \\nThe goals of post natal clinic: \\nMother \\n\\uf0b7 Monitoring and evaluation of field post natal care \\n\\uf0b7 Identifying  the problems not identified by PHM \\n\\uf0b7 Give treatment / advices/ referrals if needed. \\n\\uf0b7 Counseling on family planning  and provision of FP services \\n\\uf0b7 Analysis of postpartum mental status using EPDS \\n\\uf0b7 Strengthening  the support from family and the husband \\n\\uf0b7 Assess and support the ECCD practices of the mother  \\n \\nBaby \\n\\uf0b7 Complete examination of the baby \\n\\uf0b7 Assess breast feeding, identify and solve problems \\n\\uf0b7 Assess the growth and development of the child \\nActivities: \\n\\uf0b7 Registration of mother and baby \\n\\uf0b7 Measuring of head circumference and the weight of the baby \\nCare for the mother \\nAsk:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Measuring of head circumference and the weight of the baby \\nCare for the mother \\nAsk:  \\n\\uf0b7 Inspection of previous records (512 A, 512 B, diagnosis cards) \\n\\uf0b7 History of the pregnancy \\n\\uf0b7 Post partum complications – breast problems, episiotomy scar, constipation, behavioral changes, \\npost partum hemorrhage, vaginal discharges etc. \\n\\uf0b7 Nutritional status and personal hygiene \\n\\uf0b7 Sexual intercourse \\n\\uf0b7 Intake of vitamins/ drugs'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n171 \\n \\n \\nExamine:  \\n\\uf0b7 Pallor \\n\\uf0b7 Oedema – facial, finger, ankle \\n\\uf0b7 Icterus \\n\\uf0b7 Sudden onset of breathlessness \\n\\uf0b7 Psychological assessment using EPDS \\n\\uf0b7 Blood pressure  \\n\\uf0b7 Abdomen and perineum(if needed) \\nInvestigations (if needed) : \\n\\uf0b7 Urine albumin/ sugar \\n\\uf0b7 Hb \\nActions: \\n\\uf0b7 Advice , treat and refer  for the identified complications \\n\\uf0b7 Refer for family planning services \\n\\uf0b7 Supply nutritional supplements and vitamins \\n\\uf0b7 Give a date for next visit  for FP /immunization \\n\\uf0b7 Give Rubella vaccine if not given before \\nCare for the baby \\nAks: \\n\\uf0b7 Check the diagnosis card if any \\n\\uf0b7 Breast feeding \\n\\uf0b7 Urine output/ bowel opening \\n\\uf0b7 Sleeping habits \\n\\uf0b7 Eye to eye contact (milestones) \\n\\uf0b7 Any worries for the mother \\nExamine: \\n\\uf0b7 General appearance'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='\\uf0b7 Eye to eye contact (milestones) \\n\\uf0b7 Any worries for the mother \\nExamine: \\n\\uf0b7 General appearance  \\n\\uf0b7 Fill the neonatal examination form / check list / CHDR \\n\\uf0b7 BCG scar \\n\\uf0b7 Check the neonatal diagnosis card if available \\n\\uf0b7 Check the CHDR \\n\\uf0b7 Supervise breast feeding technique ( if weight gain not adequate) \\n\\uf0b7 Check for exclusive breast feeding \\n\\uf0b7 Do investigations ( if needed) \\n\\uf0b7 Take necessary actions  \\nA separate date or time for the post natal clinic should be given to mothers who had still births/ neonatal \\ndeaths. \\n(For further information please read PCPNC guide and guidelines on postnatal care published by FHB)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n172 \\n \\n \\nChapter 24 \\nFAMILY PLANNING AFTER DELIVERY \\n \\nHelp pregnant women and new mothers (along with their male partners) decide how they will avoid \\npregnancy after childbirth. Ideally, family planning counseling should start during antenatal care and in \\nparticularly in the third trimester. \\n\\uf0b7 Waiting until her baby is at least 2 years old before a woman tries to become pregnant again is \\nbest for the baby and good for the mother, too. \\n\\uf0b7 A woman who is not fully breastfeeding is able to become pregnant as soon as 4 to 6 weeks after \\nchildbirth. \\n\\uf0b7 For maximum protection, a woman should not wait until the return of monthly bleeding to start a \\ncontraceptive method, but instead she should start as soon as possible.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='contraceptive method, but instead she should start as soon as possible.  \\n\\uf0b7 Every woman should be properly counselled to ensure that she uses a family planning method. If \\na method is not provided in the hospital refer to the Medical Officer of Health in the area. \\n\\uf0b7 A woman may decide whether she wants to use a family planning method for spacing (short term \\nmethod) or limiting (long term method) pregnancies. \\n \\nEarliest Time That a Woman Can Start a Family Planning Method after Childbirth \\nFamily Planning Method\\n \\nShort term methods for spacing\\nMale or female condoms \\nImmediately\\nCopper-bearing IUD  \\nWithin 48 hours, otherwise wait 6 \\nweeks \\nProgestin-only injectables (DMPA) \\n6 weeks after childbirth \\nImplants \\n6 weeks after childbirth \\nCombined oral contraceptives'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='6 weeks after childbirth \\nImplants \\n6 weeks after childbirth \\nCombined oral contraceptives\\n6 months after childbirth\\nLong term methods for limiting \\n \\nFemale sterilization  \\nWithin 7 days, otherwise wait 6 \\nweeks \\nVasectomy  \\nduring partner’s pregnancy , \\nImmediately after child birth or later \\nas early as possible'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n173 \\n \\n \\nChapter  25 \\n \\nSCREENING FOR POSTPARTUM DEPRESSION \\nEdingburgh Postnatal Depression Scale (EPDS) \\nThe EPDS was developed for screening postpartum women for postnatal depression in outpatient, home \\nvisiting settings or at the 6-8 week post partum visit examination. It has been utilized in many countries. \\nThis scale has been validated for Sri Lanka and pilot tested in several settings. \\nThe EPDS consists of ten questions. The test can usually be completed in less than 5 minutes. Responses \\nare scored 0,1,2,or 3 according to increased severity of the symptom. The total score is determined by \\nadding together the scores for each of the 10 items. Validation studies have utilized various threshold'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='scores on determining which women were positive and in need of referral. A woman scoring 9 or more \\npoints or indicating any suicidal ideation – that is she scores 1 or higher on question No. 10, should be \\nreferred immediately for follow up. Even if a woman scores less than 9, if the clinician feels the client is \\nsuffering from depression, an appropriate referral should be made.  \\nThe EPDS is only a screening tool. It does not diagnose depression.  \\nInstruction to use: \\n1. The screening for postnatal depression should be done at the postnatal clinic (4-6 weeks). \\n2. The mother is asked to underline 1 of 4 possible responses that comes the closest to how she has \\nfeeling the previous 7 days. \\n3. All 10 items must be completed.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='feeling the previous 7 days. \\n3. All 10 items must be completed. \\n4. Care should be taken to avoid the possibility of the mother discussing her answers with others. \\n5. The mother should complete the scale herself, unless she has limited ability or has difficulties in \\nreading and understanding. \\nEdinburgh Postnatal depression Scale \\nAs you may know, some women become depressed after they have had a baby and it is sometimes \\ndifficult for them to tell anyone how they are feeling. Completeing this questionnaire will help depressed \\nmothers to get the help they need. Please Underline the answer, which comes closest to how you have \\nfelt in the past week. \\nHere is a completed example: \\nI have felt happy \\n \\nYes, all the time \\n \\nYes most of the time \\n \\nNo, not very often \\n \\n \\nNo, not at all'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n174 \\n \\n \\nThis would mean: “I have felt happy most of the time@ during the past week. Please complete the other questions \\nin the same way. \\n \\nIn the past week \\nCoding Column \\n \\n1 \\nI have been able to laugh and see the funny side of things: \\n \\n \\n               As much as I always could \\n0 \\n \\n               Not quiet so much now \\n1 \\n \\n              Definitely not so much now\\n2\\n \\n                Not at all \\n3 \\n2. \\nI have looked forward with enjoyment to things: \\n \\n \\n              As much as I ever did \\n0 \\n \\n              Rather less than I used to do \\n1 \\n \\n             Definitely less than I used to do\\n2\\n \\n              Hardly at all \\n3 \\n3. \\nI have blamed myself unnecessarily when things went wrong:'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Hardly at all \\n3 \\n3. \\nI have blamed myself unnecessarily when things went wrong: \\n \\n \\n               Yes, most of the time \\n3 \\n \\n               Yes, some of the time \\n2 \\n \\n              Not very often\\n1\\n \\n             No, never \\n0 \\n4. \\nI have been anxious or worried for no good reason: \\n \\n \\n               No, not at all \\n0 \\n \\n               Hardly ever \\n1 \\n \\n             Yes, some times\\n2\\n \\n              Yes, Very often \\n3 \\n5. \\nI have felt scared or panicky for no good reason: \\n \\n \\n             Yes, quite lot \\n3 \\n \\n             Yes, Some times \\n2 \\n \\n            No, not much\\n1\\n \\n             No, not much at all \\n0 \\n6. \\nThings have been getting on top of me \\n \\n \\n             Yes, most of the time I haven’t been able to cope at all \\n3'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Yes, most of the time I haven’t been able to cope at all \\n3 \\n \\n            Yes, sometimes I haven’t been copying as well as usual\\n2\\n \\n            No, most of the time I have coped quite well\\n1\\n \\n             No, I have been copying as well as ever \\n0 \\n7. \\nI have been so unhappy that I have had difficulty in sleeping: \\n \\n \\n            Yes, most of the time \\n3 \\n \\n           Yes, sometimes\\n2\\n \\n           Not very often\\n1\\n \\n            No, not at all \\n0 \\n8. \\nI have felt sad or miserable: \\n \\n \\n              Yes, most of the time \\n3 \\n \\n             Yes, sometimes\\n2\\n \\n               Not very often \\n1 \\n \\n               No, not at all \\n0 \\n9. \\nI have been so unhappy that I have been crying: \\n \\n \\n             Yes, most of the time \\n3 \\n \\n           Yes, quite often\\n2'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Yes, most of the time \\n3 \\n \\n           Yes, quite often\\n2\\n \\n            Only occasionally \\n1 \\n \\n            No, never \\n0 \\n10. \\nThe thought of harming myself has occurred to me: \\n \\n \\n             Yes, quite often \\n3 \\n \\n             Sometimes \\n2 \\n \\n             Hardly ever \\n1 \\n \\n             Never \\n0 \\n \\nTotal score'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n175 \\n \\n \\nChapter 26 \\n \\nMANAGEMENT INFORMATION SYSTEM OF MATERNAL CARE \\n \\n                         \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nFor detailed description please refer the guideline on MCH/FP management information system \\npublished by FHB in 2004. \\n \\nPublic Health Midwife \\nPHM’s Monthly Statement H 524\\nPHM’s Daily Statement H 523\\nMOH office\\nQuarterly MCH return  H 509 \\nMCH Clinics \\nPHM’s Diary H 511\\nClinic attendance registers H 517\\nClinic Summary H 518\\nQuarterly MCH clinic return H527\\nFamily Health Bureau\\nRDHS office'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n176 \\n \\n \\nChapter 27 \\n \\nSURVEILLANCE ON MATERNAL MORBIDITY AND MORTALITY \\nThe maternal care program in Sri Lanka carried out maternal death surveillance and antenatal and \\npostnatal morbidity surveillance at the field level. Surveillance system for severe maternal morbidities or \\n‘near misses’, will be introduced through the hospital system. \\n \\n27.1  Surveillance on maternal morbidities \\nGuidelines on reporting antenatal and postnatal morbidities \\nReporting of antenatal morbidities \\nMorbidities identified during antenatal period should be entered at the space given in the H512A and B \\nby the field PHM / MOH at the time of the identification. Those identified morbid conditions should be'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='noted in the diary during the 1st postnatal visit and should be entered in the daily statement on the \\nsame day. This reporting system is necessary to avoid repetition of reporting. The morbid condition \\nshould be entered correctly. \\nReporting of postnatal morbidities \\nThe identified morbidities during postnatal visits should be noted in the H 512 A, H512B and diary \\nunder the date of postnatal visit and should also be entered in the PHM’s daily statement on the same \\nday. \\n(When keeping notes in the PHM’s diary, Mothers Number should be entered in the column for \\npostnatal care and morbidities should be entered in the column for other issues. Mark AN with the \\nantenatal morbid conditions and mark PN with the postnatal morbid conditions.)'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='antenatal morbid conditions and mark PN with the postnatal morbid conditions.)  \\nProvision of accurate information to the national health information system is a responsibility of all \\nrelevant staff in the health services. Therefore, it is a main responsibility of the supervising staff \\nincluding MOH and AMOH to facilitate PHM to identify morbidities using diagnosis cards and correct \\nreporting.  Supervising officers should encourage PHMM to maximize the reporting of antenatal and \\npostnatal morbidities and to monitor the compliance on medical advice and relevant treatment regimes. \\nThey should also plan necessary interventions for identified issues. \\nFurther, MOH should check the accuracy of the information before entering relevant information into \\nthe quarterly return of MCH (H509).'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n177 \\n \\n \\nDefinitions for antenatal and postnatal morbidities \\nAntenatal Morbidities \\n1. Hypertension (Chronic or pregnancy induced) \\nAvailability of records with the diagnosis of hypertension or availability of a diagnosis card \\nOr blood pressure of 130/90 or more on at least three occasions (recorded by a medical officer) or \\nIncrease in diastolic pressure by 30mmHg or more comparing to early pregnancy measurement. \\n2. Diabetes Mellitus (Chronic or gestational )  \\nDiagnosis of Diabetes Mellitus / Gestational Diabetes Mellitus by a medical officer or \\nAvailability of a diagnosis card or availability of treatment records \\n3. Heart Diseases'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Availability of a diagnosis card or availability of treatment records \\n3. Heart Diseases \\nAvailability of records kept by a medical officer with the diagnosis of congenital or non-congenital heart \\ndisease or \\nAvailability of a diagnosis card or  \\nPast surgical history for heart disease but currently not on treatment \\nRegistration at a cardiac clinic but currently not on any treatment \\nOn monthly Penicillin prophylaxis for Rheumatic fever or Rheumatic heart disease \\nDiagnosed with Mitral valve Prolapse (MVP) \\nDiagnosed with any other cardiac disease (eg. Heart Failure, cardiomyopathy etc.) \\n4. Anaemia \\nAvailability of a record of Hb <11g/dl during pregnancy. \\n5. Antepartum Haemorrhage \\nAvailability of a diagnosis card for vaginal bleeding during pregnancy. \\n6. Asthma'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Availability of a diagnosis card for vaginal bleeding during pregnancy. \\n6. Asthma \\nAvailability of a diagnosis card for asthma or \\nWhen mothers says that she is on long term drugs (tablets or inhalers) for asthma \\n7. Malaria \\nAvailability of records on malarial infection during pregnancy, confirmed by a blood smear. \\n8. Tuberculosis \\nAvailability of a diagnosis card for Tuberculosis during pregnancy or taking treatment during pregnancy \\nfor previously diagnosed Tuberculosis. \\n9. Sexually Transmitted Infections (STI) \\nAvailability of a diagnosis card given by a medical officer for sexually Transmitted Infection (Syphilis, \\ngonorrhea, Herpes simplex infections, Trichomonasis, Chamydia Infection, HIV/AIDS) \\n10. Liver Disease'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='10. Liver Disease \\nAvailability of a diagnosis cards or notes in the pregnancy record confirming Hepatitis or any other liver \\ndisease during pregnancy.'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n178 \\n \\n \\n11. Mental disorders \\nAvailability of a diagnosis card given by a Medical Officer confirming a mental disorder or \\nWhen mothers says that she is on long term drugs for mental disorder. \\n12. Epilepsy \\nAvailability of a diagnosis card given by a Medical Officer confirming Epilepsy or \\nWhen mothers says that she is on long term drugs for epilepsy. \\n13. Urinary Tract Infections \\nAvailability of records for treating UTI after confirmatory urine testing during pregnancy by a medical \\nofficer \\n14. Other disease Conditions \\nNote disease conditions other than the conditions mentioned above, that can affect pregnancy according \\nto the available diagnosis cards. \\n \\nPostnatal Morbidities \\n1. Postpartum Haemorrhage'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='to the available diagnosis cards. \\n \\nPostnatal Morbidities \\n1. Postpartum Haemorrhage \\nAvailability of a diagnosis card from hospital admission for abnormal or excessive vaginal bleeding \\nduring postnatal period \\n2. Fever \\nBody temperature of 370C (1000F) or more during postnatal period \\n3. Reproductive Tract Infections (Offensive vaginal Discharge)  \\nAvailability of notes regarding the diagnosis and treatment of reproductive tract infections by a medical \\nofficer (sign and symptoms: Fever, lower abdominal pain associated with foul smelling vaginal \\ndischarge) \\n4. Urinary Tract Infection \\nAvailability of notes regarding the diagnosis and treatment for a urinary tract infection during postnatal \\nperiod by a medical officer after confirmatory urine testing \\n5. Infected Episiotomy'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='period by a medical officer after confirmatory urine testing \\n5. Infected Episiotomy \\nPurulent discharge from the episiotomy wound. \\n6. Detached Episiotomy sutures \\nGaping of the Episiotomy wound edges \\n7. Presence of Foreign bodies in the vagina \\nWhen Foreign bodies (eg. Gauze swabs or packs) are found in the vaginal during vaginal examination'),\n",
       " Document(metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n179 \\n \\n8. Infected Caesarean section wound  \\nPresence of redness, swelling, warmth around the Caesarean section wound or  \\nPus or blood stained discharge form the wound or \\nGaping of the wound \\n9. Deep Vein Thrombosis \\nAvailability of notes regarding diagnosis and treatment for DVT by a medical officer. \\n10. Postpartum Mental Disorders \\nAvailability of a notes regarding diagnosis of mental disorder during postpartum period \\n11. Cracked Nipples \\nPresence or cracks or fissures around the nipple \\n12. Breast Engorgement \\nPresence of following signs and symptoms: \\nBreast and areola gets edematous and painful. \\nMilk flowing from the breast has been stopped. \\nEnlarged blood vessels on the breast can be clearly visualized.'),\n",
       " ...]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "texts_chunk"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "7ac2fccf",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\ASUS\\AppData\\Local\\Temp\\ipykernel_25788\\3442255882.py:8: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings = HuggingFaceEmbeddings(\n",
      "c:\\Users\\ASUS\\anaconda3\\envs\\chatbot_env\\lib\\site-packages\\huggingface_hub\\file_download.py:143: UserWarning: `huggingface_hub` cache-system uses symlinks by default to efficiently store duplicated files but your machine does not support them in C:\\Users\\ASUS\\.cache\\huggingface\\hub\\models--sentence-transformers--all-mpnet-base-v2. Caching files will still work but in a degraded version that might require more space on your disk. This warning can be disabled by setting the `HF_HUB_DISABLE_SYMLINKS_WARNING` environment variable. For more details, see https://huggingface.co/docs/huggingface_hub/how-to-cache#limitations.\n",
      "To support symlinks on Windows, you either need to activate Developer Mode or to run Python as an administrator. In order to activate developer mode, see this article: https://docs.microsoft.com/en-us/windows/apps/get-started/enable-your-device-for-development\n",
      "  warnings.warn(message)\n",
      "Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n"
     ]
    }
   ],
   "source": [
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "\n",
    "def download_embeddings():\n",
    "    # Using MPNET because it allows 2000+ characters per chunk\n",
    "    # This is perfect for your 1100 chunk size!\n",
    "    model_name = \"sentence-transformers/all-mpnet-base-v2\"\n",
    "    \n",
    "    embeddings = HuggingFaceEmbeddings(\n",
    "        model_name=model_name\n",
    "    )\n",
    "    return embeddings\n",
    "\n",
    "embedding = download_embeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "1bfee390",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "HuggingFaceEmbeddings(client=SentenceTransformer(\n",
       "  (0): Transformer({'max_seq_length': 384, 'do_lower_case': False}) with Transformer model: MPNetModel \n",
       "  (1): Pooling({'word_embedding_dimension': 768, 'pooling_mode_cls_token': False, 'pooling_mode_mean_tokens': True, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})\n",
       "  (2): Normalize()\n",
       "), model_name='sentence-transformers/all-mpnet-base-v2', cache_folder=None, model_kwargs={}, encode_kwargs={}, multi_process=False, show_progress=False)"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "3720c62c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[0.02624971978366375,\n",
       " 0.013395597226917744,\n",
       " -0.004533165134489536,\n",
       " -0.021791458129882812,\n",
       " 0.05455183982849121,\n",
       " -0.004966510459780693,\n",
       " 0.006655589677393436,\n",
       " 0.030626295134425163,\n",
       " -0.005762827582657337,\n",
       " -0.004562050104141235,\n",
       " -0.003313298337161541,\n",
       " -0.04849625006318092,\n",
       " -0.011364003643393517,\n",
       " 0.03507741168141365,\n",
       " 0.09309464693069458,\n",
       " -0.08668739348649979,\n",
       " 0.051086556166410446,\n",
       " 0.009886142797768116,\n",
       " -0.06356924772262573,\n",
       " -0.0085501903668046,\n",
       " 0.007054393645375967,\n",
       " -0.003862416837364435,\n",
       " 0.0247443076223135,\n",
       " 0.04288493096828461,\n",
       " 0.035094134509563446,\n",
       " -0.029848245903849602,\n",
       " 0.010252577252686024,\n",
       " 0.022344952449202538,\n",
       " 0.02088995650410652,\n",
       " 0.009492229670286179,\n",
       " -0.03304444998502731,\n",
       " -0.01228412240743637,\n",
       " 0.053528930991888046,\n",
       " 0.025429194793105125,\n",
       " 2.022176886384841e-06,\n",
       " -0.034191031008958817,\n",
       " 0.009609980508685112,\n",
       " -0.01648453250527382,\n",
       " 0.005609510000795126,\n",
       " -0.004250049591064453,\n",
       " -0.02280120551586151,\n",
       " 0.040354691445827484,\n",
       " 0.0030520367436110973,\n",
       " 0.031372565776109695,\n",
       " -0.010812345892190933,\n",
       " -0.03557078167796135,\n",
       " 0.02229292131960392,\n",
       " 0.0016871339175850153,\n",
       " 0.002077186945825815,\n",
       " 0.023116247728466988,\n",
       " 0.006885874085128307,\n",
       " -0.006830928381532431,\n",
       " -0.048761334270238876,\n",
       " -0.027010783553123474,\n",
       " 0.015491163358092308,\n",
       " 0.037316903471946716,\n",
       " 0.027279339730739594,\n",
       " 0.026498930528759956,\n",
       " -0.0016922997310757637,\n",
       " -0.028822358697652817,\n",
       " 0.02566291205585003,\n",
       " -0.004661579616367817,\n",
       " -0.027064090594649315,\n",
       " -0.006095438729971647,\n",
       " 0.01816672272980213,\n",
       " 0.04138831049203873,\n",
       " -0.03703116253018379,\n",
       " 0.005540383048355579,\n",
       " 0.014725928194820881,\n",
       " 0.06878934055566788,\n",
       " 0.023648448288440704,\n",
       " -0.024684511125087738,\n",
       " 0.01029456127434969,\n",
       " 0.08591809868812561,\n",
       " 0.008080972358584404,\n",
       " -0.08048774302005768,\n",
       " -0.035835862159729004,\n",
       " 0.07399853318929672,\n",
       " 0.014271555468440056,\n",
       " 0.020142467692494392,\n",
       " -0.014921145513653755,\n",
       " 0.028452491387724876,\n",
       " 0.002442454220727086,\n",
       " 0.005628978833556175,\n",
       " -0.03743971884250641,\n",
       " 0.08276889473199844,\n",
       " 0.013042869977653027,\n",
       " -0.021596699953079224,\n",
       " 0.00958255585283041,\n",
       " -0.0057533676736056805,\n",
       " -0.03633501008152962,\n",
       " -0.0015577677404507995,\n",
       " 0.0012776143848896027,\n",
       " 0.022488249465823174,\n",
       " 0.0001466912217438221,\n",
       " -0.03706813231110573,\n",
       " 0.0059373206458985806,\n",
       " 0.014829509891569614,\n",
       " 0.02463035099208355,\n",
       " -0.09740082174539566,\n",
       " 0.020025664940476418,\n",
       " 0.04415544867515564,\n",
       " 0.01797429658472538,\n",
       " 0.043487925082445145,\n",
       " -0.003153253812342882,\n",
       " 0.04379494488239288,\n",
       " 0.01069928240031004,\n",
       " -0.09923218935728073,\n",
       " 0.005017586052417755,\n",
       " 0.002878880826756358,\n",
       " -0.028301894664764404,\n",
       " 0.0041015660390257835,\n",
       " 0.046619962900877,\n",
       " 0.00195325561799109,\n",
       " -0.05541551113128662,\n",
       " -0.027967721223831177,\n",
       " 0.012364968657493591,\n",
       " 0.033371537923812866,\n",
       " 0.028845524415373802,\n",
       " 0.013699373230338097,\n",
       " 0.00741834519430995,\n",
       " -0.010876833461225033,\n",
       " 0.010057048872113228,\n",
       " 0.014483303762972355,\n",
       " 0.043869972229003906,\n",
       " -0.01985759101808071,\n",
       " -0.0508849062025547,\n",
       " 0.03388291597366333,\n",
       " -0.02175869606435299,\n",
       " -0.07018046826124191,\n",
       " -0.019555624574422836,\n",
       " 0.010530528612434864,\n",
       " 0.022220609709620476,\n",
       " 0.03386983647942543,\n",
       " 0.02788681350648403,\n",
       " 0.04430244863033295,\n",
       " -0.03166963532567024,\n",
       " 0.02387617714703083,\n",
       " 0.03172842785716057,\n",
       " -0.001200653612613678,\n",
       " -0.04047573357820511,\n",
       " 0.018793243914842606,\n",
       " 0.007720003370195627,\n",
       " -0.01319460105150938,\n",
       " 0.0057064564898610115,\n",
       " -0.01352466270327568,\n",
       " 0.05613812804222107,\n",
       " 0.06577472388744354,\n",
       " 0.022538963705301285,\n",
       " -0.022849110886454582,\n",
       " -0.013980035670101643,\n",
       " -0.014985364861786366,\n",
       " -0.11692575365304947,\n",
       " 0.007804612163454294,\n",
       " 0.03731032833456993,\n",
       " 0.025834694504737854,\n",
       " 0.03988255560398102,\n",
       " -0.024655267596244812,\n",
       " -0.07076143473386765,\n",
       " -0.05755319073796272,\n",
       " -0.017976388335227966,\n",
       " 0.027785472571849823,\n",
       " 0.037470072507858276,\n",
       " 0.01857832819223404,\n",
       " 0.03556608036160469,\n",
       " 0.03145295009016991,\n",
       " 0.021026989445090294,\n",
       " -0.013369902037084103,\n",
       " -0.008704517036676407,\n",
       " -0.06778058409690857,\n",
       " 0.0011322187492623925,\n",
       " 0.010492764413356781,\n",
       " -0.014862417243421078,\n",
       " 0.028050430119037628,\n",
       " 0.0004501463263295591,\n",
       " -0.02934163808822632,\n",
       " -0.07885505259037018,\n",
       " 0.035560574382543564,\n",
       " -0.006516608409583569,\n",
       " -0.0022945876698940992,\n",
       " -0.03992081806063652,\n",
       " -0.09326402842998505,\n",
       " -0.026265988126397133,\n",
       " -0.023833198472857475,\n",
       " -0.04457193985581398,\n",
       " 0.04152984917163849,\n",
       " 0.00046563666546717286,\n",
       " 0.010605302639305592,\n",
       " -0.04306980222463608,\n",
       " 0.03625214099884033,\n",
       " 0.01195446401834488,\n",
       " 0.038606178015470505,\n",
       " -0.05759897828102112,\n",
       " 0.002572205848991871,\n",
       " 0.002368422457948327,\n",
       " 0.025992972776293755,\n",
       " 0.0342809222638607,\n",
       " -0.010379957966506481,\n",
       " 0.049165915697813034,\n",
       " -0.07218475639820099,\n",
       " -0.03627687692642212,\n",
       " 0.04886231943964958,\n",
       " 0.027275748550891876,\n",
       " -0.033376678824424744,\n",
       " -0.023163091391324997,\n",
       " 0.015082033351063728,\n",
       " 0.060041554272174835,\n",
       " -0.02044272981584072,\n",
       " 0.0319599024951458,\n",
       " 0.030664175748825073,\n",
       " -0.00869865994900465,\n",
       " 0.0026443733368068933,\n",
       " 0.018267782405018806,\n",
       " 0.04330715909600258,\n",
       " -0.034688569605350494,\n",
       " -0.011762723326683044,\n",
       " 0.005638086702674627,\n",
       " 0.0668613463640213,\n",
       " -0.010310042649507523,\n",
       " 0.0821336954832077,\n",
       " -0.016256120055913925,\n",
       " 0.000694414833560586,\n",
       " 0.04943377152085304,\n",
       " -0.017310047522187233,\n",
       " 0.05905086547136307,\n",
       " -0.08812668919563293,\n",
       " 0.023782487958669662,\n",
       " 0.0163236353546381,\n",
       " -0.003353658365085721,\n",
       " 0.023440785706043243,\n",
       " -0.032797958701848984,\n",
       " -0.017844561487436295,\n",
       " -0.007084893062710762,\n",
       " -0.008532887324690819,\n",
       " 0.004012757446616888,\n",
       " -0.006454106420278549,\n",
       " 0.04807111993432045,\n",
       " -0.052829254418611526,\n",
       " 0.052517618983983994,\n",
       " -0.12337727844715118,\n",
       " 0.041920680552721024,\n",
       " 0.053660620003938675,\n",
       " 0.02755776047706604,\n",
       " -0.041635092347860336,\n",
       " 0.06671746075153351,\n",
       " 0.043844208121299744,\n",
       " 6.959721213206649e-05,\n",
       " 0.024712588638067245,\n",
       " -0.0008701171609573066,\n",
       " -0.021306291222572327,\n",
       " 0.008814588189125061,\n",
       " 0.007482232991605997,\n",
       " -0.07889620959758759,\n",
       " 0.006322700530290604,\n",
       " -0.0021795027423650026,\n",
       " -0.05313749983906746,\n",
       " -0.0353153795003891,\n",
       " -0.000272872595814988,\n",
       " -0.05505911633372307,\n",
       " -0.07047577947378159,\n",
       " 0.021063515916466713,\n",
       " -0.02373826503753662,\n",
       " 0.013495157472789288,\n",
       " 0.03281174227595329,\n",
       " 0.03495213761925697,\n",
       " 0.011835957877337933,\n",
       " -0.007469139527529478,\n",
       " -0.08200205862522125,\n",
       " -0.027418477460741997,\n",
       " -0.00451464531943202,\n",
       " 0.021692395210266113,\n",
       " 0.024737760424613953,\n",
       " 0.03472532704472542,\n",
       " -0.01906714215874672,\n",
       " -0.02304507978260517,\n",
       " -0.011651545763015747,\n",
       " 0.05891457945108414,\n",
       " 0.010421502403914928,\n",
       " -0.000995444948785007,\n",
       " 0.02967454493045807,\n",
       " 0.025783797726035118,\n",
       " 0.014973439276218414,\n",
       " -0.031178617849946022,\n",
       " 0.010349779389798641,\n",
       " 0.01989840716123581,\n",
       " 0.04435642063617706,\n",
       " 0.05435006320476532,\n",
       " -0.051432088017463684,\n",
       " 0.03653308376669884,\n",
       " 0.005297234747558832,\n",
       " -0.06547217816114426,\n",
       " 0.021221593022346497,\n",
       " -0.04364621639251709,\n",
       " -0.02599354088306427,\n",
       " 0.0124233178794384,\n",
       " -0.01416772697120905,\n",
       " -0.010088594630360603,\n",
       " -0.06318499892950058,\n",
       " 0.015795649960637093,\n",
       " 0.011789200827479362,\n",
       " -0.015052560716867447,\n",
       " 0.04036775231361389,\n",
       " 0.023427531123161316,\n",
       " -0.011655058711767197,\n",
       " 0.009298019111156464,\n",
       " -0.013838129118084908,\n",
       " -0.0009013735689222813,\n",
       " -0.07619258016347885,\n",
       " 0.006516137160360813,\n",
       " 0.044136207550764084,\n",
       " 0.04531910642981529,\n",
       " -0.02281040884554386,\n",
       " 0.015957731753587723,\n",
       " 0.04980497062206268,\n",
       " 0.004302907269448042,\n",
       " -0.022586995735764503,\n",
       " -0.03301424905657768,\n",
       " -0.09512034803628922,\n",
       " 0.034978680312633514,\n",
       " -0.0335722342133522,\n",
       " 0.0352199412882328,\n",
       " 0.0333828441798687,\n",
       " -0.007370417006313801,\n",
       " 0.008542279712855816,\n",
       " -0.05324341356754303,\n",
       " 0.08698795735836029,\n",
       " -0.024827776476740837,\n",
       " 0.04805665835738182,\n",
       " 0.02689754031598568,\n",
       " 0.03825503587722778,\n",
       " 0.017772579565644264,\n",
       " 0.01926322840154171,\n",
       " -0.014446287415921688,\n",
       " -0.012907039374113083,\n",
       " -0.06714537739753723,\n",
       " -0.03934824839234352,\n",
       " 0.049394283443689346,\n",
       " -0.04650326818227768,\n",
       " -0.009490988217294216,\n",
       " -0.01837814413011074,\n",
       " -0.045614730566740036,\n",
       " -0.04452440142631531,\n",
       " -0.04483700916171074,\n",
       " -0.007839596830308437,\n",
       " -0.04271157830953598,\n",
       " -0.016047649085521698,\n",
       " -0.0018448294140398502,\n",
       " -0.027529815211892128,\n",
       " -0.0940900519490242,\n",
       " -0.021395882591605186,\n",
       " -0.002245967509225011,\n",
       " -0.04154864698648453,\n",
       " 0.021337201818823814,\n",
       " -0.024989847093820572,\n",
       " 0.009490366093814373,\n",
       " -0.059074047952890396,\n",
       " 0.016943585127592087,\n",
       " -0.011004642583429813,\n",
       " -0.0018336344510316849,\n",
       " -0.03558018431067467,\n",
       " 0.009159625507891178,\n",
       " -0.03713515028357506,\n",
       " 0.05477570742368698,\n",
       " 0.07624709606170654,\n",
       " -0.004246416501700878,\n",
       " -0.021526888012886047,\n",
       " 0.010821808129549026,\n",
       " 0.0376884788274765,\n",
       " -0.028805645182728767,\n",
       " -0.008368599228560925,\n",
       " -0.0016722421860322356,\n",
       " 0.04817064478993416,\n",
       " -0.015492061153054237,\n",
       " 0.06909316033124924,\n",
       " -0.014471299014985561,\n",
       " 0.022921932861208916,\n",
       " -0.04311652109026909,\n",
       " -0.01753319427371025,\n",
       " 0.009505311027169228,\n",
       " -0.010702990926802158,\n",
       " 0.028666634112596512,\n",
       " -0.019981037825345993,\n",
       " 0.01078093983232975,\n",
       " -0.004066414665430784,\n",
       " -0.018467778339982033,\n",
       " -0.053176235407590866,\n",
       " -0.013222959823906422,\n",
       " 0.009252256713807583,\n",
       " 0.0028710337355732918,\n",
       " 0.040333688259124756,\n",
       " 0.028591327369213104,\n",
       " -0.08191238343715668,\n",
       " 0.013726077042520046,\n",
       " 0.004590712953358889,\n",
       " -0.0036419404204934835,\n",
       " 0.030904609709978104,\n",
       " 0.00165565125644207,\n",
       " 0.009054967202246189,\n",
       " -0.054919544607400894,\n",
       " 0.030259249731898308,\n",
       " -0.035543859004974365,\n",
       " 0.03586919233202934,\n",
       " 0.08151547610759735,\n",
       " 0.006921778898686171,\n",
       " 0.025103682652115822,\n",
       " 0.01026327908039093,\n",
       " 0.058474041521549225,\n",
       " 0.01809360645711422,\n",
       " -0.0038196034729480743,\n",
       " 0.012429882772266865,\n",
       " -0.03220871090888977,\n",
       " 0.01620246097445488,\n",
       " 0.009931610897183418,\n",
       " -0.028961315751075745,\n",
       " -0.028586292639374733,\n",
       " -0.025957532227039337,\n",
       " -0.039231933653354645,\n",
       " -0.05241487920284271,\n",
       " -0.016450418159365654,\n",
       " -0.008665405213832855,\n",
       " 0.02038666605949402,\n",
       " 0.02066798508167267,\n",
       " -0.008197647519409657,\n",
       " 0.06043471023440361,\n",
       " -0.03507959097623825,\n",
       " 0.006689412519335747,\n",
       " 0.04373123124241829,\n",
       " 0.09935157001018524,\n",
       " 0.015627797693014145,\n",
       " 0.012048900127410889,\n",
       " -0.008992478251457214,\n",
       " 0.009422514587640762,\n",
       " 0.036812037229537964,\n",
       " 0.04701801389455795,\n",
       " 0.018507637083530426,\n",
       " -0.011137612164020538,\n",
       " -0.00524671608582139,\n",
       " 0.009609140455722809,\n",
       " -0.0500846765935421,\n",
       " -0.03262558951973915,\n",
       " -0.002257611369714141,\n",
       " -0.008219106122851372,\n",
       " -0.01959931291639805,\n",
       " -0.003957387059926987,\n",
       " -0.02259868197143078,\n",
       " 0.06969037652015686,\n",
       " 0.004613857716321945,\n",
       " -0.020690681412816048,\n",
       " 0.0016830717213451862,\n",
       " -0.059661176055669785,\n",
       " 0.009722442366182804,\n",
       " -0.023853229358792305,\n",
       " -0.009983669966459274,\n",
       " -0.05318216234445572,\n",
       " 0.005985208787024021,\n",
       " -0.08082769811153412,\n",
       " 0.014591371640563011,\n",
       " 0.0243462435901165,\n",
       " 0.022630970925092697,\n",
       " -0.03526220843195915,\n",
       " 0.09614990651607513,\n",
       " 0.028253717347979546,\n",
       " -0.02891351468861103,\n",
       " 0.025948114693164825,\n",
       " 0.047523368149995804,\n",
       " -0.03472335264086723,\n",
       " -0.01925952173769474,\n",
       " 0.046011582016944885,\n",
       " 0.048462435603141785,\n",
       " -0.004264556337147951,\n",
       " -0.07452888041734695,\n",
       " 0.009601949714124203,\n",
       " -0.02457844652235508,\n",
       " -0.03744065761566162,\n",
       " -0.005404505413025618,\n",
       " 0.07390863448381424,\n",
       " -0.03899027407169342,\n",
       " -0.03723234683275223,\n",
       " -0.06633483618497849,\n",
       " -0.021570803597569466,\n",
       " -0.013432669453322887,\n",
       " -0.02516058087348938,\n",
       " 0.005526035092771053,\n",
       " 0.014381150715053082,\n",
       " -0.009465218521654606,\n",
       " -0.07712256908416748,\n",
       " 0.07954982668161392,\n",
       " -0.037196915596723557,\n",
       " -0.027506183832883835,\n",
       " 0.004170738160610199,\n",
       " -0.004183008801192045,\n",
       " 0.030468329787254333,\n",
       " 0.06775727868080139,\n",
       " 0.029337462037801743,\n",
       " -0.047126997262239456,\n",
       " 0.0388246513903141,\n",
       " 0.031586214900016785,\n",
       " -0.026740100234746933,\n",
       " -0.013012080453336239,\n",
       " 0.04248744621872902,\n",
       " 0.017997629940509796,\n",
       " 0.04021979868412018,\n",
       " -0.015515157952904701,\n",
       " -0.025586970150470734,\n",
       " 0.00252628605812788,\n",
       " -0.03847767412662506,\n",
       " 0.0051151481457054615,\n",
       " -0.018289560452103615,\n",
       " 0.0269921962171793,\n",
       " -0.039904557168483734,\n",
       " 0.034577880054712296,\n",
       " 0.021926332265138626,\n",
       " -0.030530445277690887,\n",
       " -0.09270782768726349,\n",
       " 0.030424708500504494,\n",
       " 0.09682188928127289,\n",
       " -0.00038872333243489265,\n",
       " -0.004475629888474941,\n",
       " 0.01328462827950716,\n",
       " -0.03486108034849167,\n",
       " 0.02517385222017765,\n",
       " -0.004634349141269922,\n",
       " 3.1381055123347323e-06,\n",
       " 0.009199327789247036,\n",
       " 0.02066006138920784,\n",
       " 0.021171841770410538,\n",
       " 0.0025059415493160486,\n",
       " -0.017133427783846855,\n",
       " 0.015062023885548115,\n",
       " -0.004563244991004467,\n",
       " -0.056242432445287704,\n",
       " -0.021872416138648987,\n",
       " 0.05297837033867836,\n",
       " 0.0015514736296609044,\n",
       " -0.048072826117277145,\n",
       " 0.07103203982114792,\n",
       " 0.0496218167245388,\n",
       " 0.03273390978574753,\n",
       " -0.004322769120335579,\n",
       " 0.07824971526861191,\n",
       " -0.018487239256501198,\n",
       " 0.04808169975876808,\n",
       " -0.014792202971875668,\n",
       " 0.03339920938014984,\n",
       " 0.016657013446092606,\n",
       " 0.09762322157621384,\n",
       " 0.005983996205031872,\n",
       " 0.004437379539012909,\n",
       " -0.01973024755716324,\n",
       " -0.031107308343052864,\n",
       " 0.002273498335853219,\n",
       " 0.0439244881272316,\n",
       " -0.004601860418915749,\n",
       " -0.011302385479211807,\n",
       " -0.01559040043503046,\n",
       " -7.42216463595602e-33,\n",
       " -0.024979373440146446,\n",
       " 0.029912779107689857,\n",
       " -0.053028885275125504,\n",
       " -0.014636456035077572,\n",
       " -0.0789250060915947,\n",
       " -0.024865873157978058,\n",
       " 0.012854201719164848,\n",
       " 0.011149204336106777,\n",
       " -0.037321675568819046,\n",
       " 0.03247968479990959,\n",
       " -0.039110567420721054,\n",
       " 0.006528375670313835,\n",
       " 0.026438483968377113,\n",
       " 0.006142102647572756,\n",
       " -0.018655866384506226,\n",
       " 0.0034097281750291586,\n",
       " 0.03812937065958977,\n",
       " 0.02422412671148777,\n",
       " -0.029595589265227318,\n",
       " 0.020448846742510796,\n",
       " 0.0034931045956909657,\n",
       " 0.009550764225423336,\n",
       " 0.06408235430717468,\n",
       " 0.014981009066104889,\n",
       " 0.08848587423563004,\n",
       " -0.021082447841763496,\n",
       " -0.040169619023799896,\n",
       " -0.04406866058707237,\n",
       " 0.04379603639245033,\n",
       " -0.022586848586797714,\n",
       " -0.05578789487481117,\n",
       " -0.0017554197693243623,\n",
       " -0.008298961445689201,\n",
       " 0.04675415903329849,\n",
       " -0.004986489191651344,\n",
       " 0.052176740020513535,\n",
       " -0.01511170994490385,\n",
       " -0.0126756951212883,\n",
       " 0.03616882860660553,\n",
       " -0.011518843472003937,\n",
       " -0.006843147799372673,\n",
       " 0.04897443950176239,\n",
       " -0.028541158884763718,\n",
       " -0.047857191413640976,\n",
       " 0.013607773929834366,\n",
       " 0.022674253210425377,\n",
       " -0.013731034472584724,\n",
       " 0.010278402827680111,\n",
       " 0.020900197327136993,\n",
       " -0.00963363703340292,\n",
       " -0.05329940840601921,\n",
       " -0.036158882081508636,\n",
       " -0.008142960257828236,\n",
       " -0.04950123280286789,\n",
       " -0.0954938754439354,\n",
       " -0.012199107557535172,\n",
       " -0.00874385517090559,\n",
       " -0.005238653626292944,\n",
       " 0.006486224476248026,\n",
       " 0.014537641778588295,\n",
       " 0.07761509716510773,\n",
       " -0.04120563715696335,\n",
       " -0.04281499236822128,\n",
       " 0.023514436557888985,\n",
       " 0.032923582941293716,\n",
       " 0.06109737977385521,\n",
       " 0.1185494065284729,\n",
       " 0.006075646728277206,\n",
       " -0.031101293861865997,\n",
       " -0.07655253261327744,\n",
       " -0.030432475730776787,\n",
       " -0.014461181126534939,\n",
       " -0.05452165752649307,\n",
       " 0.03348902240395546,\n",
       " -0.03242194652557373,\n",
       " -0.024998372420668602,\n",
       " -0.06520546227693558,\n",
       " -0.021536972373723984,\n",
       " -0.017865244299173355,\n",
       " -0.022192804142832756,\n",
       " -0.015162259340286255,\n",
       " 0.002348492853343487,\n",
       " -0.01197768747806549,\n",
       " 0.00584642868489027,\n",
       " 0.016001179814338684,\n",
       " 0.03545473888516426,\n",
       " -0.015774192288517952,\n",
       " 0.02860073931515217,\n",
       " -0.04166243597865105,\n",
       " 0.01173589751124382,\n",
       " -0.01680649258196354,\n",
       " -0.043073397129774094,\n",
       " 0.01783921755850315,\n",
       " -0.03770900517702103,\n",
       " -0.036752138286828995,\n",
       " -0.03389237821102142,\n",
       " 0.039372313767671585,\n",
       " -0.024240544065833092,\n",
       " 0.012149179354310036,\n",
       " -0.016354043036699295,\n",
       " 0.012111900374293327,\n",
       " -0.005702112801373005,\n",
       " -0.04870014637708664,\n",
       " 0.024931369349360466,\n",
       " -0.005004575476050377,\n",
       " 0.06189972907304764,\n",
       " -0.03407372534275055,\n",
       " 0.0040198625065386295,\n",
       " -0.052421800792217255,\n",
       " -0.023559344932436943,\n",
       " 0.0082221869379282,\n",
       " -0.00014838892093393952,\n",
       " 0.021252354606986046,\n",
       " 0.019656794145703316,\n",
       " -0.030415846034884453,\n",
       " 0.021859075874090195,\n",
       " 0.022153442725539207,\n",
       " 0.004489762708544731,\n",
       " -0.04513739421963692,\n",
       " -0.018923353403806686,\n",
       " 0.029233941808342934,\n",
       " -0.026109900325536728,\n",
       " -0.04777495563030243,\n",
       " 0.02395990490913391,\n",
       " -0.031827524304389954,\n",
       " -0.012403623200953007,\n",
       " -0.024706970900297165,\n",
       " 0.04309449344873428,\n",
       " 0.03403283283114433,\n",
       " 0.00646175118163228,\n",
       " 0.017298689112067223,\n",
       " -0.03291630744934082,\n",
       " 2.589665371033334e-07,\n",
       " -0.008848787285387516,\n",
       " -0.03630736842751503,\n",
       " -0.017381129786372185,\n",
       " 0.08198835700750351,\n",
       " 0.0021983340848237276,\n",
       " 0.029041776433587074,\n",
       " -0.018067006021738052,\n",
       " 0.08862540125846863,\n",
       " 0.02423611842095852,\n",
       " 0.023613322526216507,\n",
       " -0.013104482553899288,\n",
       " -0.02190682291984558,\n",
       " 0.011557293124496937,\n",
       " -0.08912064880132675,\n",
       " -0.06380237638950348,\n",
       " -0.009555661119520664,\n",
       " -0.05437050759792328,\n",
       " -0.11822576820850372,\n",
       " -0.009211841970682144,\n",
       " -0.0036960826255381107,\n",
       " -0.028769759461283684,\n",
       " 0.018765736371278763,\n",
       " 0.0005117752589285374,\n",
       " 0.0024560086894780397,\n",
       " 0.015607128851115704,\n",
       " -0.007230798713862896,\n",
       " 0.028010647743940353,\n",
       " -0.036571767181158066,\n",
       " 0.0170415211468935,\n",
       " 0.009626287966966629,\n",
       " -0.04827096313238144,\n",
       " -0.061702195554971695,\n",
       " 0.016839632764458656,\n",
       " -0.03689945116639137,\n",
       " 0.017405925318598747,\n",
       " -0.0212020855396986,\n",
       " 0.0365191251039505,\n",
       " 0.032484766095876694,\n",
       " 0.015166029334068298,\n",
       " 0.08810391277074814,\n",
       " -0.01647018827497959,\n",
       " 0.014158635400235653,\n",
       " -0.026597201824188232,\n",
       " -0.03824491426348686,\n",
       " 0.022149991244077682,\n",
       " 0.01816026121377945,\n",
       " 0.016499875113368034,\n",
       " 0.0010087268892675638,\n",
       " -0.06776735931634903,\n",
       " -0.029793182387948036,\n",
       " 0.0036888159811496735,\n",
       " -0.02121773548424244,\n",
       " 0.014949630945920944,\n",
       " 0.009262300096452236,\n",
       " -0.024820128455758095,\n",
       " 0.011967633850872517,\n",
       " 0.061906930059194565,\n",
       " 0.019780822098255157,\n",
       " 0.013480202294886112,\n",
       " -0.02259555086493492,\n",
       " -0.012310962192714214,\n",
       " -0.06700605899095535,\n",
       " 0.012755519710481167,\n",
       " 0.033227384090423584,\n",
       " -0.024980081245303154,\n",
       " -7.899610500317067e-05,\n",
       " -0.0031257104128599167,\n",
       " 1.159153946196526e-34,\n",
       " -0.004750354681164026,\n",
       " 0.03324595466256142,\n",
       " 0.03277945518493652,\n",
       " 0.04581353813409805,\n",
       " -0.02862674370408058,\n",
       " -0.003784162923693657,\n",
       " -0.058271728456020355,\n",
       " -0.006224826443940401,\n",
       " 0.035534027963876724,\n",
       " -0.030796919018030167,\n",
       " -0.010551447980105877]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vector = embedding.embed_query(\"Hello world\")\n",
    "vector"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "c20e7900",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vector length: 768\n"
     ]
    }
   ],
   "source": [
    "print( \"Vector length:\", len(vector))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "61743ff4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "8b111b87",
   "metadata": {},
   "outputs": [],
   "source": [
    "PINECONE_API_KEY = os.getenv(\"PINECONE_API_KEY\")\n",
    "GOOGLE_API_KEY = os.getenv(\"GOOGLE_API_KEY\")\n",
    "\n",
    "\n",
    "os.environ[\"PINECONE_API_KEY\"] = PINECONE_API_KEY\n",
    "os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "071d43b4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import Pinecone \n",
    "pinecone_api_key = PINECONE_API_KEY\n",
    "\n",
    "pc = Pinecone(api_key=pinecone_api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "d770bf75",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pinecone.pinecone.Pinecone at 0x2278678dd80>"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "96a425e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import ServerlessSpec \n",
    "\n",
    "index_name = \"medical-chatbot\"\n",
    "\n",
    "if not pc.has_index(index_name):\n",
    "    pc.create_index(\n",
    "        name = index_name,\n",
    "        dimension=768,  # Dimension of the embeddings\n",
    "        metric= \"cosine\",  # Cosine similarity\n",
    "        spec=ServerlessSpec(cloud=\"aws\", region=\"us-east-1\")\n",
    "    )\n",
    "\n",
    "\n",
    "index = pc.Index(index_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "ad42da48",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting manual upload...\n",
      "Uploaded: 5 / 1110\n",
      "Uploaded: 10 / 1110\n",
      "Uploaded: 15 / 1110\n",
      "Uploaded: 20 / 1110\n",
      "Uploaded: 25 / 1110\n",
      "Uploaded: 30 / 1110\n",
      "Uploaded: 35 / 1110\n",
      "Uploaded: 40 / 1110\n",
      "Uploaded: 45 / 1110\n",
      "Uploaded: 50 / 1110\n",
      "Uploaded: 55 / 1110\n",
      "Uploaded: 60 / 1110\n",
      "Uploaded: 65 / 1110\n",
      "Uploaded: 70 / 1110\n",
      "Uploaded: 75 / 1110\n",
      "Uploaded: 80 / 1110\n",
      "Uploaded: 85 / 1110\n",
      "Uploaded: 90 / 1110\n",
      "Uploaded: 95 / 1110\n",
      "Uploaded: 100 / 1110\n",
      "Uploaded: 105 / 1110\n",
      "Uploaded: 110 / 1110\n",
      "Uploaded: 115 / 1110\n",
      "Uploaded: 120 / 1110\n",
      "Uploaded: 125 / 1110\n",
      "Uploaded: 130 / 1110\n",
      "Uploaded: 135 / 1110\n",
      "Uploaded: 140 / 1110\n",
      "Uploaded: 145 / 1110\n",
      "Uploaded: 150 / 1110\n",
      "Uploaded: 155 / 1110\n",
      "Uploaded: 160 / 1110\n",
      "Uploaded: 165 / 1110\n",
      "Uploaded: 170 / 1110\n",
      "Uploaded: 175 / 1110\n",
      "Uploaded: 180 / 1110\n",
      "Uploaded: 185 / 1110\n",
      "Uploaded: 190 / 1110\n",
      "Uploaded: 195 / 1110\n",
      "Uploaded: 200 / 1110\n",
      "Uploaded: 205 / 1110\n",
      "Uploaded: 210 / 1110\n",
      "Uploaded: 215 / 1110\n",
      "Uploaded: 220 / 1110\n",
      "Uploaded: 225 / 1110\n",
      "Uploaded: 230 / 1110\n",
      "Uploaded: 235 / 1110\n",
      "Uploaded: 240 / 1110\n",
      "Uploaded: 245 / 1110\n",
      "Uploaded: 250 / 1110\n",
      "Uploaded: 255 / 1110\n",
      "Uploaded: 260 / 1110\n",
      "Uploaded: 265 / 1110\n",
      "Uploaded: 270 / 1110\n",
      "Uploaded: 275 / 1110\n",
      "Uploaded: 280 / 1110\n",
      "Uploaded: 285 / 1110\n",
      "Uploaded: 290 / 1110\n",
      "Uploaded: 295 / 1110\n",
      "Uploaded: 300 / 1110\n",
      "Uploaded: 305 / 1110\n",
      "Uploaded: 310 / 1110\n",
      "Uploaded: 315 / 1110\n",
      "Uploaded: 320 / 1110\n",
      "Uploaded: 325 / 1110\n",
      "Uploaded: 330 / 1110\n",
      "Uploaded: 335 / 1110\n",
      "Uploaded: 340 / 1110\n",
      "Uploaded: 345 / 1110\n",
      "Uploaded: 350 / 1110\n",
      "Uploaded: 355 / 1110\n",
      "Uploaded: 360 / 1110\n",
      "Uploaded: 365 / 1110\n",
      "Uploaded: 370 / 1110\n",
      "Uploaded: 375 / 1110\n",
      "Uploaded: 380 / 1110\n",
      "Uploaded: 385 / 1110\n",
      "Uploaded: 390 / 1110\n",
      "Uploaded: 395 / 1110\n",
      "Uploaded: 400 / 1110\n",
      "Uploaded: 405 / 1110\n",
      "Uploaded: 410 / 1110\n",
      "Uploaded: 415 / 1110\n",
      "Uploaded: 420 / 1110\n",
      "Uploaded: 425 / 1110\n",
      "Uploaded: 430 / 1110\n",
      "Uploaded: 435 / 1110\n",
      "Uploaded: 440 / 1110\n",
      "Uploaded: 445 / 1110\n",
      "Uploaded: 450 / 1110\n",
      "Uploaded: 455 / 1110\n",
      "Uploaded: 460 / 1110\n",
      "Uploaded: 465 / 1110\n",
      "Uploaded: 470 / 1110\n",
      "Uploaded: 475 / 1110\n",
      "Uploaded: 480 / 1110\n",
      "Uploaded: 485 / 1110\n",
      "Uploaded: 490 / 1110\n",
      "Uploaded: 495 / 1110\n",
      "Uploaded: 500 / 1110\n",
      "Uploaded: 505 / 1110\n",
      "Uploaded: 510 / 1110\n",
      "Uploaded: 515 / 1110\n",
      "Uploaded: 520 / 1110\n",
      "Uploaded: 525 / 1110\n",
      "Uploaded: 530 / 1110\n",
      "Uploaded: 535 / 1110\n",
      "Uploaded: 540 / 1110\n",
      "Uploaded: 545 / 1110\n",
      "Uploaded: 550 / 1110\n",
      "Uploaded: 555 / 1110\n",
      "Uploaded: 560 / 1110\n",
      "Uploaded: 565 / 1110\n",
      "Uploaded: 570 / 1110\n",
      "Uploaded: 575 / 1110\n",
      "Uploaded: 580 / 1110\n",
      "Uploaded: 585 / 1110\n",
      "Uploaded: 590 / 1110\n",
      "Uploaded: 595 / 1110\n",
      "Uploaded: 600 / 1110\n",
      "Uploaded: 605 / 1110\n",
      "Uploaded: 610 / 1110\n",
      "Uploaded: 615 / 1110\n",
      "Uploaded: 620 / 1110\n",
      "Uploaded: 625 / 1110\n",
      "Uploaded: 630 / 1110\n",
      "Uploaded: 635 / 1110\n",
      "Uploaded: 640 / 1110\n",
      "Uploaded: 645 / 1110\n",
      "Uploaded: 650 / 1110\n",
      "Uploaded: 655 / 1110\n",
      "Uploaded: 660 / 1110\n",
      "Uploaded: 665 / 1110\n",
      "Uploaded: 670 / 1110\n",
      "Uploaded: 675 / 1110\n",
      "Uploaded: 680 / 1110\n",
      "Uploaded: 685 / 1110\n",
      "Uploaded: 690 / 1110\n",
      "Uploaded: 695 / 1110\n",
      "Uploaded: 700 / 1110\n",
      "Uploaded: 705 / 1110\n",
      "Uploaded: 710 / 1110\n",
      "Uploaded: 715 / 1110\n",
      "Uploaded: 720 / 1110\n",
      "Uploaded: 725 / 1110\n",
      "Uploaded: 730 / 1110\n",
      "Uploaded: 735 / 1110\n",
      "Uploaded: 740 / 1110\n",
      "Uploaded: 745 / 1110\n",
      "Uploaded: 750 / 1110\n",
      "Uploaded: 755 / 1110\n",
      "Uploaded: 760 / 1110\n",
      "Uploaded: 765 / 1110\n",
      "Uploaded: 770 / 1110\n",
      "Uploaded: 775 / 1110\n",
      "Uploaded: 780 / 1110\n",
      "Uploaded: 785 / 1110\n",
      "Uploaded: 790 / 1110\n",
      "Uploaded: 795 / 1110\n",
      "Uploaded: 800 / 1110\n",
      "Uploaded: 805 / 1110\n",
      "Uploaded: 810 / 1110\n",
      "Uploaded: 815 / 1110\n",
      "Uploaded: 820 / 1110\n",
      "Uploaded: 825 / 1110\n",
      "Uploaded: 830 / 1110\n",
      "Uploaded: 835 / 1110\n",
      "Uploaded: 840 / 1110\n",
      "Uploaded: 845 / 1110\n",
      "Uploaded: 850 / 1110\n",
      "Uploaded: 855 / 1110\n",
      "Uploaded: 860 / 1110\n",
      "Uploaded: 865 / 1110\n",
      "Uploaded: 870 / 1110\n",
      "Uploaded: 875 / 1110\n",
      "Uploaded: 880 / 1110\n",
      "Uploaded: 885 / 1110\n",
      "Uploaded: 890 / 1110\n",
      "Uploaded: 895 / 1110\n",
      "Uploaded: 900 / 1110\n",
      "Uploaded: 905 / 1110\n",
      "Uploaded: 910 / 1110\n",
      "Uploaded: 915 / 1110\n",
      "Uploaded: 920 / 1110\n",
      "Uploaded: 925 / 1110\n",
      "Uploaded: 930 / 1110\n",
      "Uploaded: 935 / 1110\n",
      "Uploaded: 940 / 1110\n",
      "Uploaded: 945 / 1110\n",
      "Uploaded: 950 / 1110\n",
      "Uploaded: 955 / 1110\n",
      "Uploaded: 960 / 1110\n",
      "Uploaded: 965 / 1110\n",
      "Uploaded: 970 / 1110\n",
      "Uploaded: 975 / 1110\n",
      "Uploaded: 980 / 1110\n",
      "Uploaded: 985 / 1110\n",
      "Uploaded: 990 / 1110\n",
      "Uploaded: 995 / 1110\n",
      "Uploaded: 1000 / 1110\n",
      "Uploaded: 1005 / 1110\n",
      "Uploaded: 1010 / 1110\n",
      "Uploaded: 1015 / 1110\n",
      "Uploaded: 1020 / 1110\n",
      "Uploaded: 1025 / 1110\n",
      "Uploaded: 1030 / 1110\n",
      "Uploaded: 1035 / 1110\n",
      "Uploaded: 1040 / 1110\n",
      "Uploaded: 1045 / 1110\n",
      "Uploaded: 1050 / 1110\n",
      "Uploaded: 1055 / 1110\n",
      "Uploaded: 1060 / 1110\n",
      "Uploaded: 1065 / 1110\n",
      "Uploaded: 1070 / 1110\n",
      "Uploaded: 1075 / 1110\n",
      "Uploaded: 1080 / 1110\n",
      "Uploaded: 1085 / 1110\n",
      "Uploaded: 1090 / 1110\n",
      "Uploaded: 1095 / 1110\n",
      "Uploaded: 1100 / 1110\n",
      "Uploaded: 1105 / 1110\n",
      "Uploaded: 1110 / 1110\n",
      "Upload Complete!\n"
     ]
    }
   ],
   "source": [
    "from langchain_pinecone import PineconeVectorStore\n",
    "import time\n",
    "\n",
    "print(\"Starting manual upload...\")\n",
    "\n",
    "# 1. Initialize the Vector Store (But don't add documents yet)\n",
    "docsearch = PineconeVectorStore(\n",
    "    index_name=index_name,\n",
    "    embedding=embedding\n",
    ")\n",
    "\n",
    "# 2. Define a small batch size (Safe for your internet)\n",
    "batch_limit = 5 \n",
    "\n",
    "# 3. Loop through your chunks and add them piece by piece\n",
    "total_chunks = len(texts_chunk)\n",
    "\n",
    "for i in range(0, total_chunks, batch_limit):\n",
    "    # Slice the list to get just 5 documents\n",
    "    batch = texts_chunk[i : i + batch_limit]\n",
    "    \n",
    "    # Upload them\n",
    "    docsearch.add_documents(batch)\n",
    "    \n",
    "    # Print progress\n",
    "    print(f\"Uploaded: {min(i + batch_limit, total_chunks)} / {total_chunks}\")\n",
    "    \n",
    "    # Small sleep to prevent hitting API rate limits\n",
    "    time.sleep(1)\n",
    "\n",
    "print(\"Upload Complete!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "3050a817",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load Existing index \n",
    "\n",
    "from langchain_pinecone import PineconeVectorStore\n",
    "# Embed each chunk and upsert the embeddings into your Pinecone index.\n",
    "docsearch = PineconeVectorStore.from_existing_index(\n",
    "    index_name=index_name,\n",
    "    embedding=embedding\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "5101bdd4",
   "metadata": {},
   "outputs": [],
   "source": [
    "retriever = docsearch.as_retriever(search_type=\"similarity\", search_kwargs={\"k\":3})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "28fa35ae",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='7974a5a9-ca8b-48a7-976b-883253798ed4', metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Maternal Care Package A Guide to Field Healthcare Workers \\n147 \\n \\n \\nChapter 21  \\n \\n \\n \\nMANAGEMENT OF TUBERCULOSIS DURING PREGNANCY \\n \\nTuberculosis is an infectious disease caused by the bacillus- Mycobacterium tuberculosis and \\noccasionally by Mycobacterium bovis and Mycobacterium africanum. Tuberculosis commonly affects \\nthe lungs, but it can affect any other organ in the body. \\n \\nHow does tuberculosis spread?  \\nThe bacteria that cause tuberculosis usually spread through air. When a patient with infectious \\npulmonary tuberculosis coughs, sneezes or laughs, bacilli are expelled into the air in the form of tiny \\ndroplets. These droplets dry up rapidly to form droplet nuclei and may remain suspended in the air for'),\n",
       " Document(id='334dc4e5-170d-4a0c-b88e-fc863680a804', metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='several hours. Adequate through and through ventilation removes and dilutes these droplet nuclei, and \\ndirect sunlight quickly kills the bacilli, but they can survive in the dark for several days. When a healthy \\nperson inhales these droplet nuclei containing the tubercle bacilli, he/she may become infected. \\n \\nRisk of infection  \\nAn individual’s risk of infection depends on the extent of exposure to an infectious source and \\nsusceptibility of the individual to infection. The risk of infection is therefore high in a person who has \\nclose, prolonged exposure to a person with sputum smear positive pulmonary TB. The risk of \\ntransmission of infection from sputum smear-negative pulmonary TB is low and with extrapulmonary \\nTB, still lower. \\n \\nWho is a TB suspect?'),\n",
       " Document(id='2b336ded-9171-4c23-a2da-2cbd646d5b2b', metadata={'source': 'C:\\\\Users\\\\ASUS\\\\Desktop\\\\chat-bot\\\\data\\\\maternal_care_package_a_guide_to_field_healthcare_workers_english.pdf'}, page_content='Management of patients who interrupt treatment  \\nIt is important to take action on defaulters immediately. Patients should be contacted the day after \\nmissing a dose during the intensive phase and as soon as possible during the continuation phase. It is \\nimportant to find out the reason for the patient’s absence in order to take appropriate action and continue \\ntreatment. \\n \\nNotification \\nAt the point of diagnosis, all tuberculosis patients should be notified using TB notification Form (H \\n816). \\n \\nContact screening  \\nHousehold contacts of infectious TB patients (adults and children >5 years) should be screened for \\nsymptoms of TB. Those who have symptoms suggestive of TB should be investigated with sputum \\nsmears irrespective of the duration of the symptoms.')]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retrieved_docs = retriever.invoke(\"How does tuberculosis spread?\")\n",
    "retrieved_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "135ba19f",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\ASUS\\anaconda3\\envs\\chatbot_env\\lib\\site-packages\\google\\api_core\\_python_version_support.py:266: FutureWarning: You are using a Python version (3.10.19) which Google will stop supporting in new releases of google.api_core once it reaches its end of life (2026-10-04). Please upgrade to the latest Python version, or at least Python 3.11, to continue receiving updates for google.api_core past that date.\n",
      "  warnings.warn(message, FutureWarning)\n"
     ]
    }
   ],
   "source": [
    "# 1. Import the Google GenAI library\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langchain_google_genai import ChatGoogleGenerativeAI\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "d8225a04",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "13a41d14",
   "metadata": {},
   "outputs": [],
   "source": [
    "chatModel = ChatGoogleGenerativeAI(\n",
    "    model=\"gemini-2.0-flash\",\n",
    "    temperature=0.3  # Low temperature = More factual answers (Good for Medical)\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "76107e1b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# These are universal imports. Keep them exactly like this.\n",
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain_core.prompts import ChatPromptTemplate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "835e84d0",
   "metadata": {},
   "outputs": [],
   "source": [
    "system_prompt = (\n",
    "    \"You are a Medical Assistant specialized in Clinical Guidelines. \"\n",
    "    \"Use the following pieces of retrieved context to answer the question. \"\n",
    "    \n",
    "    \"RULES:\"\n",
    "    \"1. If the user asks for treatments, you MUST list the specific drug names, dosages, and regimens found in the context.\"\n",
    "    \"2. Do NOT summarize medical protocols. Be exact.\"\n",
    "    \"3. If the answer is in a table in the context, try to present it clearly.\"\n",
    "    \"4. If the user asks in Sinhala, answer in Sinhala.\"\n",
    "    \"5. If you don't know, say you don't know.\"\n",
    "    \n",
    "    \"\\n\\n\"\n",
    "    \"{context}\"\n",
    ")\n",
    "\n",
    "prompt = ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\"system\", system_prompt),\n",
    "        (\"human\", \"{input}\"),\n",
    "    ]\n",
    ")\n",
    "\n",
    "# Re-create the chain with the new prompt\n",
    "question_answer_chain = create_stuff_documents_chain(chatModel, prompt)\n",
    "rag_chain = create_retrieval_chain(retriever, question_answer_chain)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "4e3cd2a9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All pregnant and breastfeeding women living with HIV should initiate and continue lifelong ART, regardless of WHO clinical stage or CD4 count. Pregnant women newly diagnosed with HIV should start ART as early as possible, while those already on ART with sustained viral suppression should maintain their current regimen.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"What are the treatments for HIV in pregnancy?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "acf12f93",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Available Chat Models ---\n",
      "models/gemini-2.5-pro-preview-03-25\n",
      "models/gemini-2.5-flash\n",
      "models/gemini-2.5-pro-preview-05-06\n",
      "models/gemini-2.5-pro-preview-06-05\n",
      "models/gemini-2.5-pro\n",
      "models/gemini-2.0-flash-exp\n",
      "models/gemini-2.0-flash\n",
      "models/gemini-2.0-flash-001\n",
      "models/gemini-2.0-flash-exp-image-generation\n",
      "models/gemini-2.0-flash-lite-001\n",
      "models/gemini-2.0-flash-lite\n",
      "models/gemini-2.0-flash-lite-preview-02-05\n",
      "models/gemini-2.0-flash-lite-preview\n",
      "models/gemini-2.0-pro-exp\n",
      "models/gemini-2.0-pro-exp-02-05\n",
      "models/gemini-exp-1206\n",
      "models/gemini-2.0-flash-thinking-exp-01-21\n",
      "models/gemini-2.0-flash-thinking-exp\n",
      "models/gemini-2.0-flash-thinking-exp-1219\n",
      "models/gemini-2.5-flash-preview-tts\n",
      "models/gemini-2.5-pro-preview-tts\n",
      "models/learnlm-2.0-flash-experimental\n",
      "models/gemma-3-1b-it\n",
      "models/gemma-3-4b-it\n",
      "models/gemma-3-12b-it\n",
      "models/gemma-3-27b-it\n",
      "models/gemma-3n-e4b-it\n",
      "models/gemma-3n-e2b-it\n",
      "models/gemini-flash-latest\n",
      "models/gemini-flash-lite-latest\n",
      "models/gemini-pro-latest\n",
      "models/gemini-2.5-flash-lite\n",
      "models/gemini-2.5-flash-image-preview\n",
      "models/gemini-2.5-flash-image\n",
      "models/gemini-2.5-flash-preview-09-2025\n",
      "models/gemini-2.5-flash-lite-preview-09-2025\n",
      "models/gemini-3-pro-preview\n",
      "models/gemini-3-pro-image-preview\n",
      "models/nano-banana-pro-preview\n",
      "models/gemini-robotics-er-1.5-preview\n",
      "models/gemini-2.5-computer-use-preview-10-2025\n"
     ]
    }
   ],
   "source": [
    "import google.generativeai as genai\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "# 1. Load your API Key\n",
    "load_dotenv()\n",
    "api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "\n",
    "# 2. Configure the Google Library\n",
    "genai.configure(api_key=api_key)\n",
    "\n",
    "print(\"--- Available Chat Models ---\")\n",
    "\n",
    "# 3. Ask Google for the list\n",
    "try:\n",
    "    for m in genai.list_models():\n",
    "        # We only want models that can generate text (Chat)\n",
    "        if 'generateContent' in m.supported_generation_methods:\n",
    "            print(m.name)\n",
    "except Exception as e:\n",
    "    print(\"Error:\", e)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "06d622b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I can answer questions based on the provided medical context. I can provide information related to maternal and child health, family planning, reproductive health, and general health advice. I can also give advice on newborn care, nutrition, and danger signs during pregnancy.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"hi what can you do?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "934485a7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tuberculosis spreads through the air when a person with infectious pulmonary tuberculosis coughs, sneezes, or laughs, releasing bacilli into the air in tiny droplets. A healthy person can become infected by inhaling these droplets. Ventilation and direct sunlight can help to remove and kill the bacilli.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"How does tuberculosis spread?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "75e2c957",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hi there! How can I help you today?\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"Hi\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "fbc28bda",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Retrying langchain_google_genai.chat_models._chat_with_retry.<locals>._chat_with_retry in 2.0 seconds as it raised ResourceExhausted: 429 Resource exhausted. Please try again later. Please refer to https://cloud.google.com/vertex-ai/generative-ai/docs/error-code-429 for more details..\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I can help you by:\n",
      "\n",
      "*   Enquiring about family support.\n",
      "*   Solving problems in sexual intercourse.\n",
      "*   Inquiring about the mother’s mental status and supporting the mother to develop her self-esteem.\n",
      "*   Giving advice on whom to call or where to go in case of bleeding, abdominal pain, and any other emergency, or when in need of other advice.\n",
      "*   Emphasizing the need for continuation of treatment for medical conditions.\n",
      "*   Giving advice on how to contact PHM in an emergency (mobile numbers, place of the office and residence).\n",
      "*   Requesting the woman to record when she notes the first fetal movement.\n",
      "*   Discussing with the woman and the family regarding the importance of maintaining good mental status during pregnancy.\n",
      "*   Discussing with the woman and the husband (or a family member) on the importance of attending antenatal clinics and antenatal classes so that they can be involved in the activities and can learn how to support the woman through her pregnancy.\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"how can you help me?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "0c7acfe5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Contact the PHM in an emergency using the following methods:\n",
      "\n",
      "*   Mobile numbers\n",
      "*   Place of the office\n",
      "*   Residence\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"can you give me how to contact PHM in an emergency?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "042e5186",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Screening for Postpartum Depression:\n",
      "*   Edinburgh Postnatal Depression Scale (EPDS): This consists of ten questions and can usually be completed in less than 5 minutes. Responses are scored 0, 1, 2, or 3 according to increased severity of the symptom. The total score is determined by adding together the scores for each of the 10 items.\n",
      "\n",
      "General advice for postpartum care:\n",
      "\n",
      "*   Assess the mental condition of the mother – rest, sleep, unhappiness, loneliness\n",
      "*   All women should be asked about resolution of symptoms of maternal blues. If symptoms have not resolved, the woman’s psychological well-being should continue to be assessed for postnatal depression. Refer to MOH clinic.\n",
      "*   Continue to observe for any indication of domestic abuse.\n",
      "*   Complete all the relevant records.\n",
      "*   Mothers with problems may need more visits. Decide on date of next visit according to the problems identified.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \" what are the screening for postpartum depression and general advice for postpartum care.?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "04151012",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "chatbot_env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
